<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ü¶é ÁöÑÁü•Ë≠òËä±Âúí üå± on</title><link>https://www.physician.tw/</link><description>Recent content in ü¶é ÁöÑÁü•Ë≠òËä±Âúí üå± on</description><generator>Hugo -- gohugo.io</generator><language>zh-tw</language><atom:link href="https://www.physician.tw/index.xml" rel="self" type="application/rss+xml"/><item><title>recent</title><link>https://www.physician.tw/recent/</link><pubDate>Tue, 28 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/recent/</guid><description> [!info]
üå±‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
ÊúÄËøëÁ∑®ËºØÁöÑÊ™îÊ°à Êò®Â§© [[mermaid]] date: 2023-02-27 23:45 [[Type of Idiopathic interstitial pneumonias (IIPs)]] date: 2023-02-27 20:44 [[COP cryptogenic organizing PNA]] date: 2023-02-27 19:50 [[NSIP nonspecific IP]] date: 2023-02-27 19:50 [[Á®ãÂºèË™ûË®Ä]] date: 2023-02-27 19:47 [[markdown-lab]] date: 2023-02-27 19:46 [[Early Rhythm-Control Therapy in Patients with Atrial Fibrillation]] date: 2023-02-27 00:24 [[stable]] date: 2023-02-27 00:24 [[coronary]] date: 2023-02-27 00:24 [[chest]] date: 2023-02-27 00:24 [[Clostridioides difficile - sanford guide]] date: 2023-02-27 00:24 [[HBV Treatment]] date: 2023-02-27 00:24 [[Diagnosis of adrenal insufficiency in adults]] date: 2023-02-27 00:24 [[NSCLC Treatment]] date: 2023-02-27 00:24 [[esophageal cancer]] date: 2023-02-27 00:24 [[prostate cancer]] date: 2023-02-27 00:24 [[Localization of MI]] date: 2023-02-27 00:24 [[Sanford Guide HBV Natural History]] date: 2023-02-27 00:24 [[Aldosterone and Treatment-Resistant Hypertension]] date: 2023-02-27 00:24 [[Treatment of idiopathic pulmonary fibrosis]] date: 2023-02-27 00:23 [[back pain]] date: 2023-02-27 00:23 [[fecal microbiota transplantation]] date: 2023-02-27 00:23 [[PD-1 PD-L1 pathway]] date: 2023-02-27 00:23 [[Phases of Infection]] date: 2023-02-27 00:23 [[Intestinal Pseudo-obstruction]] date: 2023-02-27 00:23 [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]] date: 2023-02-27 00:23 [[solitary pulmonary nodule]] date: 2023-02-27 00:23 [[HBV Clinical Presentation]] date: 2023-02-27 00:22 [[alcohol withdrawal]] date: 2023-02-27 00:22 [[tick-borne diseases]] date: 2023-02-27 00:22 [[inpatient oncology]] date: 2023-02-27 00:22 [[weakness and neuromuscular dysfunction]] date: 2023-02-27 00:21 [[Acute hemolytic]] date: 2023-02-27 00:21 [[Êú™ÂëΩÂêç]] date: 2023-02-27 00:19 [[Calcium Homeostasis]] date: 2023-02-27 00:19 [[Pneumocystis pneumonia, PJP, Adult]] date: 2023-02-27 00:19 [[Diagnostic Use of Base Excess in Acid‚ÄìBase Disorders]] date: 2023-02-27 00:19 [[osmolal gap]] date: 2023-02-27 00:19 [[myeloproliferative neoplasms]] date: 2023-02-27 00:19 [[Serum osmolal gap]] date: 2023-02-27 00:19 [[surgical issues]] date: 2023-02-27 00:19 [[Dako 28-8]] date: 2023-02-27 00:19 [[Pathology pathogenesis esophageal cancer]] date: 2023-02-27 00:19 ÂâçÂ§© [[pH of Urine Dipstick]] date: 2023-02-26 20:53</description></item><item><title>mermaid</title><link>https://www.physician.tw/mermaid/</link><pubDate>Mon, 27 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mermaid/</guid><description>[!info]
üå± ‰æÜËá™: [[markdown-lab]]
mermaid ÊÄéÈ∫ºÁî® Use mermaid with code fences - tips &amp;amp; tricks - HUGO When using code fences syntax for mermaid code blocks, you‚Äôll notice that Hugo turns this into &amp;hellip;.</description></item><item><title>all list of resident360</title><link>https://www.physician.tw/all-list-of-resident/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/all-list-of-resident/</guid><description> [!info]
üå± ‰æÜËá™: [[resident360]]
all list of resident360 [[Women‚Äôs Health - Miscarriage and Abortion - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Infertility - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Preconception Care and Pregnancy - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Menopause - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Menstrual and Bleeding Disorders - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Polycystic Ovary Syndrome - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Vaginitis, Sexually Transmitted Infections, Pelvic Inflammatory Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Women‚Äôs Health - Contraception - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:43 [[Rheumatology - Inflammatory Myopathies - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Systemic Sclerosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Systemic Lupus Erythematosus - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Selected Vasculitides - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Acute Septic Arthritis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Crystal-Induced Arthritis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Spondyloarthritis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Rheumatoid Arthritis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Undifferentiated Inflammatory Arthritis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Rheumatology - Osteoarthritis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:42 [[Pulmonology - Cystic Fibrosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Bronchiectasis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Pleural Effusion - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Pneumothorax - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Pulmonary Hypertension - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Obstructive Sleep Apnea - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Interstitial Lung Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Asthma - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Pulmonology - Chronic Obstructive Pulmonary Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Hospice Care - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Ethical Issues - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Discussing Goals of Care and Prognosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Care of the Imminently Dying Patient - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Dyspnea - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Nausea and Vomiting - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:41 [[Palliative Care - Pain Management - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Palliative Care - Core Principles of Palliative Care Practice - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Treatment Toxicities - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Malignant Bowel Obstruction - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Venous Thromboembolism in Malignancy - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Metastatic Spinal Cord Compression &amp;amp; Brain Metastases - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Symptom Management - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Superior Vena Cava Syndrome - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Neutropenic Fever - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Tumor Lysis Syndrome - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Oncology - Inpatient Oncology - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:40 [[Neurology - Headache - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Altered Mental Status - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Targeted Temperature Management - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Seizures &amp;amp; Epilepsy - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Epidural Abscess &amp;amp; Vertebral Osteomyelitis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Meningitis &amp;amp; Encephalitis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Carotid Stenosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Neurology - Acute Stroke - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Nephrology - Kidney Stones - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Nephrology - Kidney Transplant Immunosuppression - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Nephrology - Disorders of Sodium Homeostasis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Nephrology - Glomerular Diseases - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:39 [[Nephrology - Chronic Kidney Disease (CKD) and End-Stage Kidney Disease (ESKD) - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Nephrology - Acute Kidney Injury - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Tick-Borne Diseases - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Clostridium difficile Infection - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Tuberculosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Opportunistic Infections - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Human Immunodeficiency Virus Acquired Immunodeficiency Syndrome - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Urinary Tract Infections - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Diabetic Foot Infection - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Skin and Soft-Tissue Infections - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Infectious Diseases - Pneumonia - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:38 [[Hematology - Hemoglobinopathies - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Bleeding Disorders - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Hematopoietic Stem-Cell Transplantation (HSCT) and Related Complications - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Hematologic Malignancies - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Venous Thromboembolism (VTE) and Anticoagulation - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Transfusion Reactions - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Thrombocytopenia - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Hematology - Anemia - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Geriatrics - Geriatric Assessment - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Geriatrics - Medication Management - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Geriatrics - Delirium - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Geriatrics - Dementia - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Geriatrics - Frailty - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Geriatrics - Falls - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:37 [[Gastroenterology - Malabsorption - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Intestinal Ischemia - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Diverticulitis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Pancreatitis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Biliary Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Inflammatory Bowel Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Liver Cirrhosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Acute Liver Failure and Hepatitis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Esophageal Disorders and Gastroesophageal Reflux Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Gastroenterology - Gastrointestinal Bleeding - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:36 [[Endocrinology - Transgender Health - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Male Hypogonadism - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Pituitary Disorders - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Obesity - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Calcium-Based Disorders - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Osteoporosis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Adrenal Disorders - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:34 [[Endocrinology - Thyroid Disorders - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Endocrinology - Inpatient Diabetes Management - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Endocrinology - Diabetes - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Emergency Medicine - Common Procedures - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Emergency Medicine - Clinical Rules and Guidance - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Emergency Medicine - Abdominopelvic Emergencies - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Emergency Medicine - Cardiopulmonary Emergencies - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:33 [[Critical Care - Nutrition in the ICU - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Critical Care - Sedation and ICU Delirium - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Critical Care - Acid‚ÄìBase Disturbances - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Critical Care - Resuscitation Fluids and Blood Transfusion - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Critical Care - Acute Respiratory Distress Syndrome - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Critical Care - Shock and Sepsis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Cardiology - Coronary Artery Disease and Acute Coronary Syndrome - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Cardiology - Pericardial Disease and Myocarditis - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:32 [[Cardiology - Valvular Disease - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:31 [[Cardiology - Arrhythmias - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:31 [[Cardiology - Congestive Heart Failure - Fast Facts NEJM Resident 360]] date: 2023-02-23 18:31 [[Ambulatory Care - Chronic Pain and Opioids - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Smoking Cessation - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Vaccination - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Cancer Screening - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Hypercholesterolemia - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Hypertension - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Low Back Pain - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Dizziness - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[Ambulatory Care - Acute Respiratory Tract Infection - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:56 [[AllergyImmunology - Immunodeficiency - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55 [[AllergyImmunology - Eosinophilia - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55 [[AllergyImmunology - Urticaria &amp;amp; Angioedema - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55 [[AllergyImmunology - Food Allergy - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55 [[AllergyImmunology - Drug Allergy - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55 [[AllergyImmunology - Anaphylaxis - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55 [[AllergyImmunology - Rhinitis, Conjunctivitis, and Sinusitis - Fast Facts NEJM Resident 360]] date: 2023-02-23 17:55</description></item><item><title>Allergy/Immunology - Anaphylaxis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Anaphylaxis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Anaphylaxis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Anaphylaxis - Fast Facts | NEJM Resident 360 Anaphylaxis is defined as a serious allergic or hypersensitivity reaction that is rapid in onset and may be life-threatening.</description></item><item><title>Allergy/Immunology - Drug Allergy¬† - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Drug-Allergy-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Drug-Allergy-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Drug Allergy¬†- Fast Facts | NEJM Resident 360 The World Health Organization defines an adverse drug reaction (ADR) as ‚Äúa response to a drug which is noxious and unintended, and which occurs at doses usually used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function.</description></item><item><title>Allergy/Immunology - Eosinophilia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Eosinophilia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Eosinophilia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Eosinophilia - Fast Facts | NEJM Resident 360 Eosinophilia is defined as an absolute eosinophil count in the peripheral blood of ‚â•500 eosinophils/¬µL.</description></item><item><title>Allergy/Immunology - Food Allergy¬† - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Food-Allergy-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Food-Allergy-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Food Allergy¬†- Fast Facts | NEJM Resident 360 Adverse food reactions are untoward responses¬†following the ingestion of a food and can be divided into food allergies (immunologically mediated) and all other reactions (nonimmunologic).</description></item><item><title>Allergy/Immunology - Immunodeficiency - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Immunodeficiency-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Immunodeficiency-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Immunodeficiency - Fast Facts | NEJM Resident 360 Primary immunodeficiencies (PIDs) are inherited defects of the innate or adaptive arms of the immune system that lead to an increased incidence, frequency, or severity of infections.</description></item><item><title>Allergy/Immunology - Rhinitis, Conjunctivitis, and Sinusitis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Rhinitis-Conjunctivitis-and-Sinusitis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Rhinitis-Conjunctivitis-and-Sinusitis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Rhinitis, Conjunctivitis, and Sinusitis - Fast Facts | NEJM Resident 360 Rhinitis Rhinitis is defined as inflammation of the nasal mucous membranes and encompasses a broad group of disorders with etiologies including the following:</description></item><item><title>Allergy/Immunology - Urticaria &amp; Angioedema - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/AllergyImmunology-Urticaria-Angioedema-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AllergyImmunology-Urticaria-Angioedema-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Allergy/Immunology - Urticaria &amp;amp; Angioedema - Fast Facts | NEJM Resident 360 Urticaria (also known as hives) is characterized by severely pruritic raised, erythematous, circumscribed lesions resulting from mast cell activation and subsequent release of histamine and other vasoactive mediators that lead to increased vascular permeability of postcapillary venules and subsequent edema, erythema, and pruritus.</description></item><item><title>Ambulatory Care - Acute Respiratory Tract Infection - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Acute-Respiratory-Tract-Infection-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Acute-Respiratory-Tract-Infection-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Acute Respiratory Tract Infection - Fast Facts | NEJM Resident 360 Most acute respiratory infections encountered in adult patients in ambulatory practice (e.</description></item><item><title>Ambulatory Care - Cancer Screening - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Cancer-Screening-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Cancer-Screening-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Cancer Screening - Fast Facts | NEJM Resident 360 Screening for cancer has been controversial, and recommendations have evolved over time.</description></item><item><title>Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Chronic-Pain-and-Opioids-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Chronic-Pain-and-Opioids-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360 Caring for patients with chronic non‚Äìcancer-related pain remains challenging.</description></item><item><title>Ambulatory Care - Dizziness - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Dizziness-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Dizziness-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Dizziness - Fast Facts | NEJM Resident 360 Undifferentiated dizziness is a high-risk symptom that can be caused by multiple organ systems.</description></item><item><title>Ambulatory Care - Hypercholesterolemia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Hypercholesterolemia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Hypercholesterolemia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Hypercholesterolemia - Fast Facts | NEJM Resident 360 Although elevated blood cholesterol level is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD) and very likely to be causal in the development of ASCVD, recommendations for how and when to treat hypercholesterolemia for primary prevention of ASCVD continue to evolve.</description></item><item><title>Ambulatory Care - Hypertension - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Hypertension-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Hypertension-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Hypertension - Fast Facts | NEJM Resident 360 Hypertension is a very common condition encountered in the outpatient setting and responsible for a significant portion of the mortality and morbidity from cardiovascular disease (CVD).</description></item><item><title>Ambulatory Care - Low Back Pain - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Low-Back-Pain-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Low-Back-Pain-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Low Back Pain - Fast Facts | NEJM Resident 360 Many people experience low back pain at some point in their lives, and most cases will resolve within days or weeks with minimal intervention.</description></item><item><title>Ambulatory Care - Smoking Cessation - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Smoking-Cessation-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Smoking-Cessation-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Smoking Cessation - Fast Facts | NEJM Resident 360 Tobacco use is responsible for about one in five deaths in the United States and is the leading cause of preventable death.</description></item><item><title>Ambulatory Care - Vaccination - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Ambulatory-Care-Vaccination-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ambulatory-Care-Vaccination-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Ambulatory Care - Vaccination - Fast Facts | NEJM Resident 360 Many relatively new vaccinations are now recommended for adults, with specific recommendations for particular conditions.</description></item><item><title>approach to the patient with neutrophilia</title><link>https://www.physician.tw/approach-to-the-patient-with-neutrophilia/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-the-patient-with-neutrophilia/</guid><description>[!info]
üå± ‰æÜËá™: [[neutrophilia]]
approach to the patient with neutrophilia Active or prior infection or inflammation (see &amp;lsquo;Infection&amp;rsquo; above and &amp;lsquo;Inflammation&amp;rsquo; above)</description></item><item><title>Cardiology - Arrhythmias - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Cardiology-Arrhythmias-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-Arrhythmias-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Cardiology - Arrhythmias - Fast Facts | NEJM Resident 360 Arrhythmias can manifest as disorders of abnormally fast or slow heart rates, the former typically caused by foci of enhanced electrical activity or a rapidly conducting reentrant circuit and the latter caused by blockage in the normal cardiac conduction system.</description></item><item><title>Cardiology - Congestive Heart Failure - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Cardiology-Congestive-Heart-Failure-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-Congestive-Heart-Failure-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Cardiology - Congestive Heart Failure - Fast Facts | NEJM Resident 360 Congestive heart failure (CHF) is a clinical syndrome of abnormal ventricular filling and elevated cardiac filling pressures caused by a reduction in cardiac systolic and/or diastolic function.</description></item><item><title>Cardiology - Coronary Artery Disease and Acute Coronary Syndrome - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Cardiology-Coronary-Artery-Disease-and-Acute-Coronary-Syndrome-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-Coronary-Artery-Disease-and-Acute-Coronary-Syndrome-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Cardiology - Coronary Artery Disease and Acute Coronary Syndrome - Fast Facts | NEJM Resident 360 Atherosclerotic coronary artery disease (CAD) is a leading cause of mortality and morbidity worldwide.</description></item><item><title>Cardiology - Pericardial Disease and Myocarditis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Cardiology-Pericardial-Disease-and-Myocarditis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-Pericardial-Disease-and-Myocarditis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Cardiology - Pericardial Disease and Myocarditis - Fast Facts | NEJM Resident 360 Common pericardial diseases include pericarditis, cardiac tamponade, and constrictive pericarditis.</description></item><item><title>Cardiology - Valvular Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Cardiology-Valvular-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-Valvular-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Cardiology - Valvular Disease - Fast Facts | NEJM Resident 360 The most common forms of valvular heart disease encountered on the general inpatient service are aortic stenosis (AS), mitral regurgitation (MR), and infective endocarditis (IE).</description></item><item><title>classification of neutrophilia</title><link>https://www.physician.tw/classification-of-neutrophilia/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classification-of-neutrophilia/</guid><description> [!info]
üå± ‰æÜËá™: [[neutrophilia]]
classification of neutrophilia Spurious Platelet clumping Mixed cryoglobulinemia Primary (no other evident associated disease) Myeloproliferative neoplasms (eg, CML, PV, ET) Genetic/inherited conditions Leukocyte adhesion deficiency Chronic neutrophilic leukemia Down syndrome Cryoporin-associated periodic syndromes Secondary Infection Inflammation (eg, autoimmune conditions, non-hematologic malignancies) Medications Glucocorticoids Recombinant G-CSF or GM-CSF* Catecholamines (epinephrine) Lithium All-trans retinoic acid Isolated case reports for occasional other drugs Asplenia/hyposplenism Cigarette smoking Stress (physical or emotional stress, vigorous exercise, heatstroke)</description></item><item><title>Complications of Peritoneal Dialysis</title><link>https://www.physician.tw/complications-of-peritoneal-dialysis/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-peritoneal-dialysis/</guid><description>[!info]
üå± ‰æÜËá™: [[Peritoneal dialysis (PD)]]
Complications of Peritoneal Dialysis Infectious complications [[PD peritonitis]] Exit-site or tunnel infections Noninfectious complications Catheter-related Impaired flow (unidirectional or bidirectional) Leak Pain (during infusion or drainage) Related to increased intraabdominal pressure Back pain Hernia Hydrothorax Metabolic Hypokalemia Metabolic syndrome Encapsulating peritoneal sclerosis Sclerosing peritonitis, a rare long-term complication (NEJM 2002; 347:737) ÂèÉËÄÉ‚û°Ô∏è Sclerosing peritonitis during continuous ambulatory peritoneal dialysis</description></item><item><title>Critical Care - Acid‚ÄìBase Disturbances - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Critical-Care-AcidBase-Disturbances-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-AcidBase-Disturbances-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Critical Care - Acid‚ÄìBase Disturbances - Fast Facts | NEJM Resident 360 Acid‚Äìbase disturbances are common in the critically ill.</description></item><item><title>Critical Care - Acute Respiratory Distress Syndrome - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Critical-Care-Acute-Respiratory-Distress-Syndrome-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Acute-Respiratory-Distress-Syndrome-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Critical Care - Acute Respiratory Distress Syndrome - Fast Facts | NEJM Resident 360 First described in 1967, acute respiratory distress syndrome (ARDS) has had many names ‚Äî double pneumonia, shock lung, post-traumatic lung, respirator lung, and Da Nang lung ‚Äî reflecting the heterogeneity of the syndrome.</description></item><item><title>Critical Care - Nutrition in the ICU - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Critical-Care-Nutrition-in-the-ICU-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Nutrition-in-the-ICU-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Critical Care - Nutrition in the ICU - Fast Facts | NEJM Resident 360 Patients in the intensive care unit (ICU) are at increased risk of malnutrition, and few can feed themselves.</description></item><item><title>Critical Care - Resuscitation Fluids and Blood Transfusion - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Critical-Care-Resuscitation-Fluids-and-Blood-Transfusion-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Resuscitation-Fluids-and-Blood-Transfusion-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Critical Care - Resuscitation Fluids and Blood Transfusion - Fast Facts | NEJM Resident 360 Intravascular volume repletion is crucial to resuscitating critically ill adults.</description></item><item><title>Critical Care - Sedation and ICU Delirium - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Critical-Care-Sedation-and-ICU-Delirium-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Sedation-and-ICU-Delirium-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Critical Care - Sedation and ICU Delirium - Fast Facts | NEJM Resident 360 Sedation and analgesia are important treatments for critically ill patients who often receive painful interventions in the intensive care unit (ICU) and for whom an ICU stay can be a traumatic experience.</description></item><item><title>Critical Care - Shock and Sepsis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Critical-Care-Shock-and-Sepsis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Shock-and-Sepsis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Critical Care - Shock and Sepsis - Fast Facts | NEJM Resident 360 Shock ‚Äî most frequently caused by sepsis ‚Äî is a common reason for ICU admission because of the need for close hemodynamic monitoring and nursing care.</description></item><item><title>D√∂hle bodies</title><link>https://www.physician.tw/dhle-bodies/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dhle-bodies/</guid><description>[!info]
üå± ‰æÜËá™: [[neutrophilia]]
D√∂hle bodies D√∂hle bodies are single or multiple blue cytoplasmic inclusions that are remnants of rough endoplasmic reticulum.</description></item><item><title>Emergency Medicine - Abdominopelvic Emergencies - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Emergency-Medicine-Abdominopelvic-Emergencies-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Emergency-Medicine-Abdominopelvic-Emergencies-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Emergency Medicine - Abdominopelvic Emergencies - Fast Facts | NEJM Resident 360 In this section, we cover the following abdominopelvic emergencies:</description></item><item><title>Emergency Medicine - Cardiopulmonary Emergencies - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Emergency-Medicine-Cardiopulmonary-Emergencies-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Emergency-Medicine-Cardiopulmonary-Emergencies-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Emergency Medicine - Cardiopulmonary Emergencies - Fast Facts | NEJM Resident 360 In this section, we cover the following cardiopulmonary emergencies:</description></item><item><title>Emergency Medicine - Clinical Rules and Guidance - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Emergency-Medicine-Clinical-Rules-and-Guidance-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Emergency-Medicine-Clinical-Rules-and-Guidance-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Emergency Medicine - Clinical Rules and Guidance - Fast Facts | NEJM Resident 360 In this section, we review the following clinical rules and provide links to relevant online calculators and videos.</description></item><item><title>Emergency Medicine - Common Procedures - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Emergency-Medicine-Common-Procedures-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Emergency-Medicine-Common-Procedures-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Emergency Medicine - Common Procedures - Fast Facts | NEJM Resident 360 In this section, we review the following procedures.</description></item><item><title>Endocrinology - Adrenal Disorders - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Adrenal-Disorders-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Adrenal-Disorders-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Adrenal Disorders - Fast Facts | NEJM Resident 360 The cortex of the adrenal glands secrete three primary hormones: glucocorticoids, mineralocorticoids, and adrenal androgens.</description></item><item><title>Endocrinology - Calcium-Based Disorders - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Calcium-Based-Disorders-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Calcium-Based-Disorders-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Calcium-Based Disorders - Fast Facts | NEJM Resident 360 More than 99% of calcium in the human body is found in the skeleton.</description></item><item><title>Endocrinology - Diabetes - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Diabetes-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Diabetes-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Diabetes - Fast Facts | NEJM Resident 360 Diabetes is a common condition that is managed in both the inpatient and outpatient settings.</description></item><item><title>Endocrinology - Inpatient Diabetes Management - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Inpatient-Diabetes-Management-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Inpatient-Diabetes-Management-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Inpatient Diabetes Management - Fast Facts | NEJM Resident 360 Differentiating between type 1 and type 2 diabetes (see Diabetes in this rotation guide) when a patient presents to the hospital is crucial to ensure safe management.</description></item><item><title>Endocrinology - Male Hypogonadism - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Male-Hypogonadism-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Male-Hypogonadism-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Male Hypogonadism - Fast Facts | NEJM Resident 360 Male hypogonadism refers to a decrease in one or both major functions of the testes ‚Äî sperm production and testosterone production.</description></item><item><title>Endocrinology - Obesity - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Obesity-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Obesity-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Obesity - Fast Facts | NEJM Resident 360 Obesity has emerged as a leading public health concern in the last century.</description></item><item><title>Endocrinology - Osteoporosis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Osteoporosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Osteoporosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Osteoporosis - Fast Facts | NEJM Resident 360 Osteoporosis is the most common endocrine bone disease and is characterized by low bone mass, disruption of bone microarchitecture, and increased risk of fracture.</description></item><item><title>Endocrinology - Pituitary Disorders - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Pituitary-Disorders-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Pituitary-Disorders-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Pituitary Disorders - Fast Facts | NEJM Resident 360 The pituitary gland weighs approximately 600 mg and consists of anatomically and functionally distinct anterior and posterior lobes.</description></item><item><title>Endocrinology - Thyroid Disorders - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Thyroid-Disorders-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Thyroid-Disorders-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Thyroid Disorders - Fast Facts | NEJM Resident 360 Thyroid disorders are often encountered in both inpatient and outpatient settings.</description></item><item><title>Endocrinology - Transgender Health - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Endocrinology-Transgender-Health-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-Transgender-Health-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Endocrinology - Transgender Health - Fast Facts | NEJM Resident 360 The World Health Organization (WHO) defines gender incongruence as ‚Äúa marked and persistent incongruence between an individual‚Äôs experienced gender and the assigned sex, which often leads to a desire to ‚Äòtransition‚Äô, in order to live and be accepted as a person of the experienced gender, through hormonal treatment, surgery or other health care services to make the individual‚Äôs body align, as much as desired and to the extent possible, with the experienced gender.</description></item><item><title>Gastroenterology - Acute Liver Failure and Hepatitis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Acute-Liver-Failure-and-Hepatitis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Acute-Liver-Failure-and-Hepatitis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Acute Liver Failure and Hepatitis - Fast Facts | NEJM Resident 360 Acute liver failure (ALF) and hepatitis can develop from a wide range of underlying causes, including alcoholic hepatitis and viral hepatitis.</description></item><item><title>Gastroenterology - Biliary Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Biliary-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Biliary-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Biliary Disease - Fast Facts | NEJM Resident 360 The most commonly encountered biliary diseases are cholelithiasis (gallstones in the gallbladder), cholecystitis (inflammation of the gallbladder), choledocholithiasis (gallstones in the common bile duct), and gallstone pancreatitis (inflammation of the pancreas from gallstone blockage of the pancreas duct).</description></item><item><title>Gastroenterology - Diverticulitis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Diverticulitis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Diverticulitis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Diverticulitis - Fast Facts | NEJM Resident 360 Diverticulosis refers to the presence of colonic diverticula or saclike pouches of colonic mucosa and submucosa that herniate through the muscle layer, covered only by serosa.</description></item><item><title>Gastroenterology - Esophageal Disorders and Gastroesophageal Reflux Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Esophageal-Disorders-and-Gastroesophageal-Reflux-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Esophageal-Disorders-and-Gastroesophageal-Reflux-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Esophageal Disorders and Gastroesophageal Reflux Disease - Fast Facts | NEJM Resident 360 Patients with esophageal disorders often present with difficulty swallowing or dysphagia, typically related to a structural or motility abnormality.</description></item><item><title>Gastroenterology - Gastrointestinal Bleeding - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Gastrointestinal-Bleeding-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Gastrointestinal-Bleeding-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Gastrointestinal Bleeding - Fast Facts | NEJM Resident 360 Gastrointestinal (GI) bleeding can occur from many sources and can present acutely as a medical emergency or insidiously with evidence of anemia and iron deficiency.</description></item><item><title>Gastroenterology - Inflammatory Bowel Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Inflammatory-Bowel-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Inflammatory-Bowel-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Inflammatory Bowel Disease - Fast Facts | NEJM Resident 360 Inflammatory bowel disease (IBD) describes a range of idiopathic, chronic inflammatory diseases of the gastrointestinal (GI) tract.</description></item><item><title>Gastroenterology - Intestinal Ischemia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Intestinal-Ischemia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Intestinal-Ischemia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Intestinal Ischemia - Fast Facts | NEJM Resident 360 Intestinal ischemia can be broadly categorized as either mesenteric (small bowel) ischemia or colonic ischemia and can present as acute or chronic disease.</description></item><item><title>Gastroenterology - Liver Cirrhosis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Liver-Cirrhosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Liver-Cirrhosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Liver Cirrhosis - Fast Facts | NEJM Resident 360 Cirrhosis is defined as irreversible fibrosis of the liver and is the final stage of chronic liver disease following years of progression.</description></item><item><title>Gastroenterology - Malabsorption - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Malabsorption-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Malabsorption-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Malabsorption - Fast Facts | NEJM Resident 360 Malabsorption is the impaired absorption of nutrients in the gastrointestinal (GI) tract, caused by congenital or acquired defects in the epithelial absorptive surface or failure of secretion of digestive enzymes by the pancreas.</description></item><item><title>Gastroenterology - Pancreatitis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Gastroenterology-Pancreatitis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-Pancreatitis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Gastroenterology - Pancreatitis - Fast Facts | NEJM Resident 360 The pancreas has both endocrine (secretion of hormones such as insulin and glucagon) and exocrine (secretion of digestive enzymes such as lipase) functions.</description></item><item><title>Geriatrics - Delirium - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Geriatrics-Delirium-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Geriatrics-Delirium-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Geriatrics - Delirium - Fast Facts | NEJM Resident 360 Delirium is an acute fluctuating change in mental state, usually due to reversible causes.</description></item><item><title>Geriatrics - Dementia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Geriatrics-Dementia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Geriatrics-Dementia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Geriatrics - Dementia - Fast Facts | NEJM Resident 360 Dementia is a progressive neurodegenerative disorder that results in difficulties in at least two of the cognitive domains (memory, executive function, language, and behavior) that result in impaired function.</description></item><item><title>Geriatrics - Falls - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Geriatrics-Falls-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Geriatrics-Falls-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Geriatrics - Falls - Fast Facts | NEJM Resident 360 Falls are common in older adults and the risk increases with age.</description></item><item><title>Geriatrics - Frailty - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Geriatrics-Frailty-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Geriatrics-Frailty-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Geriatrics - Frailty - Fast Facts | NEJM Resident 360 Frailty refers to a state of reduced physiological reserve that occurs with age and leads to increasing vulnerability to adverse health outcomes from even minor stressor events.</description></item><item><title>Geriatrics - Geriatric Assessment - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Geriatrics-Geriatric-Assessment-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Geriatrics-Geriatric-Assessment-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Geriatrics - Geriatric Assessment - Fast Facts | NEJM Resident 360 Older adults often do not present with typical signs and symptoms associated with their medical conditions.</description></item><item><title>Geriatrics - Medication Management - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Geriatrics-Medication-Management-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Geriatrics-Medication-Management-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Geriatrics - Medication Management - Fast Facts | NEJM Resident 360 In the United States, nearly 50% of people older than age 65 take at least five prescription drugs per day.</description></item><item><title>Hematology - Anemia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Anemia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Anemia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Anemia - Fast Facts | NEJM Resident 360 Anemia is a common presentation in all medical practice settings.</description></item><item><title>Hematology - Bleeding Disorders - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Bleeding-Disorders-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Bleeding-Disorders-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Bleeding Disorders - Fast Facts | NEJM Resident 360 Bleeding disorders may be due to a variety of causes, ranging from platelet dysfunction to coagulation factor disorders, and can be categorized as follows:</description></item><item><title>Hematology - Hematologic Malignancies - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Hematologic-Malignancies-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Hematologic-Malignancies-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Hematologic Malignancies - Fast Facts | NEJM Resident 360 Hematologic malignancies are cancers that affect blood, bone marrow, and lymph nodes.</description></item><item><title>Hematology - Hematopoietic Stem-Cell Transplantation (HSCT) and Related Complications - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Hematopoietic-Stem-Cell-Transplantation-HSCT-and-Related-Complications-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Hematopoietic-Stem-Cell-Transplantation-HSCT-and-Related-Complications-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Hematopoietic Stem-Cell Transplantation (HSCT) and Related Complications - Fast Facts | NEJM Resident 360 HSCT is often the only treatment providing a chance of cure in refractory hematological malignancies and some bone-marrow disorders.</description></item><item><title>Hematology - Hemoglobinopathies - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Hemoglobinopathies-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Hemoglobinopathies-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Hemoglobinopathies - Fast Facts | NEJM Resident 360 Hemoglobinopathies are a group of genetic disorders that affect the structure of hemoglobin within red blood cells, thereby leading to reduced quality or quantity of effective hemoglobin.</description></item><item><title>Hematology - Thrombocytopenia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Thrombocytopenia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Thrombocytopenia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Thrombocytopenia - Fast Facts | NEJM Resident 360 Isolated thrombocytopenia is a deficiency of platelets in the blood and one of the most common disorders encountered in the inpatient setting.</description></item><item><title>Hematology - Transfusion Reactions - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Transfusion-Reactions-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Transfusion-Reactions-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Transfusion Reactions - Fast Facts | NEJM Resident 360 Blood product transfusion is ubiquitous in the hospital setting.</description></item><item><title>Hematology - Venous Thromboembolism (VTE) and Anticoagulation - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Hematology-Venous-Thromboembolism-VTE-and-Anticoagulation-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematology-Venous-Thromboembolism-VTE-and-Anticoagulation-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Hematology - Venous Thromboembolism (VTE) and Anticoagulation - Fast Facts | NEJM Resident 360 Venous thromboembolism (VTE) is a common condition encountered in general internal medicine practice and includes pulmonary embolism (PE) and lower-extremity deep-vein thrombosis (DVT).</description></item><item><title>Infectious Diseases - Clostridium difficile Infection - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Clostridium-difficile-Infection-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Clostridium-difficile-Infection-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Clostridium difficile Infection - Fast Facts | NEJM Resident 360 Clostridium difficile is an anaerobic, spore-forming, gram-positive bacillus that is responsible for significant health-care‚Äìassociated diarrhea.</description></item><item><title>Infectious Diseases - Diabetic Foot Infection - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Diabetic-Foot-Infection-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Diabetic-Foot-Infection-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Diabetic Foot Infection - Fast Facts | NEJM Resident 360 Diabetic foot ulcer (DFU) is the most frequently recognized complication of diabetes.</description></item><item><title>Infectious Diseases - Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Human-Immunodeficiency-Virus-Acquired-Immunodeficiency-Syndrome-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Human-Immunodeficiency-Virus-Acquired-Immunodeficiency-Syndrome-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome - Fast Facts | NEJM Resident 360 Care for patients with human immunodeficiency virus (HIV) has transformed dramatically since acquired immunodeficiency syndrome (AIDS) was first observed in 1981.</description></item><item><title>Infectious Diseases - Opportunistic Infections - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Opportunistic-Infections-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Opportunistic-Infections-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Opportunistic Infections - Fast Facts | NEJM Resident 360 Opportunistic infection refers to illness caused by a microorganism that does not usually cause disease in immunocompetent individuals but is pathogenic in those with comprised immune systems.</description></item><item><title>Infectious Diseases - Pneumonia - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Pneumonia-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Pneumonia-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Pneumonia - Fast Facts | NEJM Resident 360 Pneumonia is a common infection and a major cause of death, particularly in the elderly.</description></item><item><title>Infectious Diseases - Skin and Soft-Tissue Infections - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Skin-and-Soft-Tissue-Infections-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Skin-and-Soft-Tissue-Infections-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Skin and Soft-Tissue Infections - Fast Facts | NEJM Resident 360 Skin and soft-tissue infections (SSTIs) are common, and they range from mild cellulitis to life-threatening necrotizing soft-tissue infections (NSTIs).</description></item><item><title>Infectious Diseases - Tick-Borne Diseases - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Tick-Borne-Diseases-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Tick-Borne-Diseases-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Tick-Borne Diseases - Fast Facts | NEJM Resident 360 According to the Centers for Disease Control (CDC), the number of cases of tick-borne diseases more than doubled in the last decade.</description></item><item><title>Infectious Diseases - Tuberculosis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Tuberculosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Tuberculosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Tuberculosis - Fast Facts | NEJM Resident 360 Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis bacteria.</description></item><item><title>Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Infectious-Diseases-Urinary-Tract-Infections-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-Urinary-Tract-Infections-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Infectious Diseases - Urinary Tract Infections - Fast Facts | NEJM Resident 360 Urinary tract infections (UTIs) are frequently encountered in the outpatient and inpatient settings.</description></item><item><title>Nephrology - Acute Kidney Injury - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Nephrology-Acute-Kidney-Injury-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-Acute-Kidney-Injury-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Nephrology - Acute Kidney Injury - Fast Facts | NEJM Resident 360 The term acute kidney injury (AKI) has largely replaced the term acute renal failure (ARF).</description></item><item><title>Nephrology - Chronic Kidney Disease (CKD) and End-Stage Kidney Disease (ESKD) - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Nephrology-Chronic-Kidney-Disease-CKD-and-End-Stage-Kidney-Disease-ESKD-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-Chronic-Kidney-Disease-CKD-and-End-Stage-Kidney-Disease-ESKD-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Nephrology - Chronic Kidney Disease (CKD) and End-Stage Kidney Disease (ESKD) - Fast Facts | NEJM Resident 360 Chronic kidney disease (CKD) is defined by the presence of kidney damage or decreased kidney function or a progressive decline in the glomerular filtration rate (GFR) for at least 3 months.</description></item><item><title>Nephrology - Disorders of Sodium Homeostasis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Nephrology-Disorders-of-Sodium-Homeostasis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-Disorders-of-Sodium-Homeostasis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Nephrology - Disorders of Sodium Homeostasis - Fast Facts | NEJM Resident 360 Disorders of sodium concentration (hyponatremia and hypernatremia) are generally due to water balance (too much in the case of hyponatremia; too little in the case of hypernatremia) rather than due to too little or too much sodium in the body.</description></item><item><title>Nephrology - Glomerular Diseases - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Nephrology-Glomerular-Diseases-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-Glomerular-Diseases-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Nephrology - Glomerular Diseases - Fast Facts | NEJM Resident 360 A full review of glomerular diseases is beyond the scope of this rotation guide.</description></item><item><title>Nephrology - Kidney Stones - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Nephrology-Kidney-Stones-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-Kidney-Stones-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Nephrology - Kidney Stones - Fast Facts | NEJM Resident 360 Acute renal colic typically presents with intermittent colicky flank pain that may radiate to the groin, s often associated with nausea and vomiting and may be associated with lower urinary tract symptoms such as dysuria.</description></item><item><title>Nephrology - Kidney Transplant Immunosuppression - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Nephrology-Kidney-Transplant-Immunosuppression-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-Kidney-Transplant-Immunosuppression-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Nephrology - Kidney Transplant Immunosuppression - Fast Facts | NEJM Resident 360 Drug Description Mechanism Toxicity and Comments Cyclosporine 11-amino-acid cyclic peptide from Tolypocladium inflatum Binds to cyclophilin; complex inhibits calcineurin phosphatase and T-cell activation Nephrotoxicity, hemolytic‚Äìuremic syndrome, hypertension, neurotoxicity, gum hyperplasia, skin changes, hirsutism, post-transplantation diabetes mellitus, hyperlipidemia Requires trough monitoring or checking levels 2 hours after administration | | Tacrolimus</description></item><item><title>Neurology - Acute Stroke - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Acute-Stroke-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Acute-Stroke-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Acute Stroke - Fast Facts | NEJM Resident 360 Acute stroke is divided into two types:</description></item><item><title>Neurology - Altered Mental Status - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Altered-Mental-Status-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Altered-Mental-Status-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Altered Mental Status - Fast Facts | NEJM Resident 360 Patients admitted to the hospital are often confused.</description></item><item><title>Neurology - Carotid Stenosis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Carotid-Stenosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Carotid-Stenosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Carotid Stenosis - Fast Facts | NEJM Resident 360 Carotid stenosis can be symptomatic (i.e., cause of syncope or transient ischemic attack [TIA]/stroke) or asymptomatic (i.</description></item><item><title>Neurology - Epidural Abscess &amp; Vertebral Osteomyelitis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Epidural-Abscess-Vertebral-Osteomyelitis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Epidural-Abscess-Vertebral-Osteomyelitis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Epidural Abscess &amp;amp; Vertebral Osteomyelitis - Fast Facts | NEJM Resident 360 Spinal epidural abscess can be difficult to diagnose.</description></item><item><title>Neurology - Headache - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Headache-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Headache-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Headache - Fast Facts | NEJM Resident 360 Headaches are categorized as either primary or secondary, based on etiology, and are considered chronic if they occur for more than 15 days per month, for 3 months or more.</description></item><item><title>Neurology - Meningitis &amp; Encephalitis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Meningitis-Encephalitis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Meningitis-Encephalitis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Meningitis &amp;amp; Encephalitis - Fast Facts | NEJM Resident 360 Acute Bacterial Meningitis Streptococcus pneumoniae and Neisseria meningitidis are responsible for 80% of all cases of acute bacterial meningitis in adults.</description></item><item><title>Neurology - Seizures &amp; Epilepsy - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Seizures-Epilepsy-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Seizures-Epilepsy-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Seizures &amp;amp; Epilepsy - Fast Facts | NEJM Resident 360 Seizures Seizure is a common occurrence in hospitalized medical patients.</description></item><item><title>Neurology - Targeted Temperature Management - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Neurology-Targeted-Temperature-Management-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-Targeted-Temperature-Management-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Neurology - Targeted Temperature Management - Fast Facts | NEJM Resident 360 Many organs are sensitive to the ischemia that occurs during cardiac arrest, especially the brain.</description></item><item><title>nonstatin drugs</title><link>https://www.physician.tw/nonstatin-drugs/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nonstatin-drugs/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment of other lipid fractions]]
nonstatin drugs Ezetimibe: Ezetimibe is a generic medication that lowers blood cholesterol level by inhibiting intestinal absorption and is FDA-approved for the treatment of primary hyperlipidemia and familial hypercholesterolemia.</description></item><item><title>Oncology - Inpatient Oncology - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Inpatient-Oncology-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Inpatient-Oncology-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Inpatient Oncology - Fast Facts | NEJM Resident 360 A structured approach to understanding a cancer diagnosis informs the formulation and implementation of an individual patient&amp;rsquo;s care plan.</description></item><item><title>Oncology - Malignant Bowel Obstruction - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Malignant-Bowel-Obstruction-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Malignant-Bowel-Obstruction-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Malignant Bowel Obstruction - Fast Facts | NEJM Resident 360 Malignant bowel obstruction (MBO), especially of abdominal or gynecological origin, is common in patients with advanced cancer.</description></item><item><title>Oncology - Metastatic Spinal Cord Compression &amp; Brain Metastases - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Metastatic-Spinal-Cord-Compression-Brain-Metastases-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Metastatic-Spinal-Cord-Compression-Brain-Metastases-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Metastatic Spinal Cord Compression &amp;amp; Brain Metastases - Fast Facts | NEJM Resident 360 Metastatic Spinal Cord Compression (MSCC) Epidural spinal cord compression secondary to metastases is an oncologic emergency and one of the most feared complications of malignancy.</description></item><item><title>Oncology - Neutropenic Fever - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Neutropenic-Fever-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Neutropenic-Fever-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Neutropenic Fever - Fast Facts | NEJM Resident 360 Fever during chemotherapy-induced neutropenia may be the earliest sign of infection and should be taken seriously¬†since immunosuppressed patients may not exhibit the typical inflammatory signs of infection.</description></item><item><title>Oncology - Superior Vena Cava Syndrome - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Superior-Vena-Cava-Syndrome-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Superior-Vena-Cava-Syndrome-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Superior Vena Cava Syndrome - Fast Facts | NEJM Resident 360 Superior vena cava (SVC) syndrome results from obstruction of the SVC.</description></item><item><title>Oncology - Symptom Management - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Symptom-Management-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Symptom-Management-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Symptom Management - Fast Facts | NEJM Resident 360 Pain Management Symptom management, particularly pain management, is an integral part of treatment for patients with cancer and has been linked to improved quality of life and survival.</description></item><item><title>Oncology - Treatment Toxicities - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Treatment-Toxicities-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Treatment-Toxicities-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Treatment Toxicities - Fast Facts | NEJM Resident 360 As a resident, you will encounter patients with immediate and long-term toxicities from chemotherapy or other cancer treatment and you may be unfamiliar with the names of some cancer therapies as the number of cancer diagnoses increases.</description></item><item><title>Oncology - Tumor Lysis Syndrome - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Tumor-Lysis-Syndrome-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Tumor-Lysis-Syndrome-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Tumor Lysis Syndrome - Fast Facts | NEJM Resident 360 Tumor lysis syndrome (TLS) is a medical emergency that occurs when the contents of tumor cells are released into the bloodstream, either spontaneously or in response to therapy.</description></item><item><title>Oncology - Venous Thromboembolism in Malignancy - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Oncology-Venous-Thromboembolism-in-Malignancy-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-Venous-Thromboembolism-in-Malignancy-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Oncology - Venous Thromboembolism in Malignancy - Fast Facts | NEJM Resident 360 Malignancy is associated with a significantly increased risk of venous thromboembolism (VTE).</description></item><item><title>Palliative Care - Care of the Imminently Dying Patient - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Care-of-the-Imminently-Dying-Patient-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Care-of-the-Imminently-Dying-Patient-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Care of the Imminently Dying Patient - Fast Facts | NEJM Resident 360 Providing high-level, evidence-based, empathetic care at the end of life is an important skill for all clinicians.</description></item><item><title>Palliative Care - Core Principles of Palliative Care Practice - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Core-Principles-of-Palliative-Care-Practice-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Core-Principles-of-Palliative-Care-Practice-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Core Principles of Palliative Care Practice - Fast Facts | NEJM Resident 360 Interdisciplinary care: Palliative care is provided by an interdisciplinary team that includes physicians, nurses, social workers, chaplains, pharmacists, and others.</description></item><item><title>Palliative Care - Discussing Goals of Care and Prognosis¬† - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Discussing-Goals-of-Care-and-Prognosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Discussing-Goals-of-Care-and-Prognosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Discussing Goals of Care and Prognosis¬†- Fast Facts | NEJM Resident 360 Understanding a patient‚Äôs goals as they face a serious illness is a crucial step in providing quality care.</description></item><item><title>Palliative Care - Dyspnea - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Dyspnea-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Dyspnea-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Dyspnea - Fast Facts | NEJM Resident 360 Dyspnea is an uncomfortable sensation of breathlessness related to difficulty with air movement, increased breathing effort, general distress associated with respiration, or any combination of these.</description></item><item><title>Palliative Care - Ethical Issues - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Ethical-Issues-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Ethical-Issues-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Ethical Issues - Fast Facts | NEJM Resident 360 Medical Ethics Framework A standard approach to biomedical ethics, developed by Thomas Beauchamp and James Childress in Principles of Biomedical Ethics (first published in 1985), evaluates ethical dilemmas based on the balance of four ethical principles:</description></item><item><title>Palliative Care - Hospice Care¬† - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Hospice-Care-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Hospice-Care-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Hospice Care¬†- Fast Facts | NEJM Resident 360 Definition and Key Aspects of Hospice Care Hospice care is both a system and a philosophy of care, focused on enhancing quality of life for patients in the final months of life.</description></item><item><title>Palliative Care - Nausea and Vomiting - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Nausea-and-Vomiting-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Nausea-and-Vomiting-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Nausea and Vomiting - Fast Facts | NEJM Resident 360 Nausea, vomiting, or both in the setting of serious illness are common, distressing, and debilitating symptoms.</description></item><item><title>Palliative Care - Pain Management - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Palliative-Care-Pain-Management-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Palliative-Care-Pain-Management-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Palliative Care - Pain Management - Fast Facts | NEJM Resident 360 Pain assessment and management is a broad topic.</description></item><item><title>physiology of acid-base disturbances</title><link>https://www.physician.tw/physiology-of-acid-base-disturbances/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/physiology-of-acid-base-disturbances/</guid><description>[!info]
üå± ‰æÜËá™: [[acid-base disturbances]]
physiology of acid-base disturbances Proximal tubule Reabsorbs majority of filtered bicarbonate (normally about 80%) Produces and secretes ammonium</description></item><item><title>primary prevention of clinical ASCVD in patients at increased risk but who have not had a vascular event</title><link>https://www.physician.tw/primary-prevention-of-clinical-ascvd-in-patients-at-increased-risk-but-who-have-not-had-a-vascular-event/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/primary-prevention-of-clinical-ascvd-in-patients-at-increased-risk-but-who-have-not-had-a-vascular-event/</guid><description>[!info]
üå± ‰æÜËá™: [[2018 ACC AHA Cholesterol Guidelines]]
primary prevention of clinical ASCVD in patients at increased risk but who have not had a vascular event LDL-C &amp;gt;190 mg/dL No risk assessment, commence high- or maximally tolerated intensity statin Rule out secondary causes of hyperlipidemia Diabetes mellitus age 40‚Äì75 LDL-C &amp;lt;190 mg/dL Commence moderate-intensity statin with consideration for high-intensity statin based on ASCVD risk assessment No diabetes mellitus age 40‚Äì75 LDL-C &amp;lt;190 mg/dL Calculate 10-year ASCVD risk percent to begin discussion:</description></item><item><title>Pulmonology - Asthma - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Asthma-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Asthma-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Asthma - Fast Facts | NEJM Resident 360 Asthma is a chronic lung disease characterized by airway inflammation that manifests as intermittent episodic coughing, wheezing, dyspnea, and chest tightness.</description></item><item><title>Pulmonology - Bronchiectasis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Bronchiectasis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Bronchiectasis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Bronchiectasis - Fast Facts | NEJM Resident 360 Bronchiectasis is a descriptor for a number of conditions that lead to structural and anatomic abnormalities in the airways.</description></item><item><title>Pulmonology - Chronic Obstructive Pulmonary Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Chronic-Obstructive-Pulmonary-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Chronic-Obstructive-Pulmonary-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Chronic Obstructive Pulmonary Disease - Fast Facts | NEJM Resident 360 Chronic obstructive pulmonary disease (COPD) is characterized by persistent expiratory airflow limitation due to destruction of lung parenchyma and decrease in elastic recoil.</description></item><item><title>Pulmonology - Cystic Fibrosis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Cystic-Fibrosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Cystic-Fibrosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Cystic Fibrosis - Fast Facts | NEJM Resident 360 Cystic fibrosis (CF) is a multisystem, autosomal recessive genetic disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR).</description></item><item><title>Pulmonology - Interstitial Lung Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Interstitial-Lung-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Interstitial-Lung-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Interstitial Lung Disease - Fast Facts | NEJM Resident 360 The interstitial lung diseases (ILDs) are a collection of chronic lung conditions characterized by impaired gas exchange caused by abnormalities in the lung interstitium.</description></item><item><title>Pulmonology - Obstructive Sleep Apnea - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Obstructive-Sleep-Apnea-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Obstructive-Sleep-Apnea-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Obstructive Sleep Apnea - Fast Facts | NEJM Resident 360 Obstructive sleep apnea (OSA) is a disorder caused by episodic airway obstruction (apnea) or partial upper-airway collapse with reduced airflow (hypopnea) during sleep.</description></item><item><title>Pulmonology - Pleural Effusion - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Pleural-Effusion-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Pleural-Effusion-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Pleural Effusion - Fast Facts | NEJM Resident 360 The pleural cavity is a potential space bordered by the parietal pleura (covering the chest wall, diaphragm, and mediastinum) and the visceral pleura (covering the lung).</description></item><item><title>Pulmonology - Pneumothorax - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Pneumothorax-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Pneumothorax-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Pneumothorax - Fast Facts | NEJM Resident 360 Pneumothorax is defined as the presence of gas within the pleural cavity, which is the potential space bordered by the chest wall and lung.</description></item><item><title>Pulmonology - Pulmonary Hypertension - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Pulmonology-Pulmonary-Hypertension-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-Pulmonary-Hypertension-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Pulmonology - Pulmonary Hypertension - Fast Facts | NEJM Resident 360 The pulmonary vasculature accommodates cardiac output at pressures less than one-quarter of the systemic circulation because it is a low-resistance, high-capacitance system.</description></item><item><title>Rheumatology - Acute Septic Arthritis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Acute-Septic-Arthritis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Acute-Septic-Arthritis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Acute Septic Arthritis - Fast Facts | NEJM Resident 360 Acute septic arthritis is an infection of the joint that requires prompt diagnosis and treatment to prevent joint destruction.</description></item><item><title>Rheumatology - Crystal-Induced Arthritis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Crystal-Induced-Arthritis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Crystal-Induced-Arthritis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Crystal-Induced Arthritis - Fast Facts | NEJM Resident 360 Crystal-induced arthritis is characterized by an acute arthritis of one or several joints; typical features include pain, swelling, erythema, heat, and restricted function.</description></item><item><title>Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Inflammatory-Myopathies-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Inflammatory-Myopathies-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360 Inflammatory, or immune-mediated, myopathies (IMM) are a group of systemic diseases characterized by autoimmunity, inflammation, muscle involvement, and often systemic features.</description></item><item><title>Rheumatology - Osteoarthritis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Osteoarthritis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Osteoarthritis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Osteoarthritis - Fast Facts | NEJM Resident 360 Osteoarthritis (OA) is the most common joint disorder in the United States and most often affects the knees, hips, hands, and the metatarsophalangeal joints of the great toes.</description></item><item><title>Rheumatology - Rheumatoid Arthritis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Rheumatoid-Arthritis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Rheumatoid-Arthritis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Rheumatoid Arthritis - Fast Facts | NEJM Resident 360 Rheumatoid arthritis (RA) is an autoimmune disorder characterized by a chronic, symmetric, inflammatory arthritis that classically affects multiple joints, particularly the the hands, wrists, and feet.</description></item><item><title>Rheumatology - Selected Vasculitides - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Selected-Vasculitides-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Selected-Vasculitides-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Selected Vasculitides - Fast Facts | NEJM Resident 360 Vasculitis is inflammation within blood vessels that can affect vessels of all sizes (small, medium, or large) and can have a broad array of presentations.</description></item><item><title>Rheumatology - Spondyloarthritis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Spondyloarthritis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Spondyloarthritis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Spondyloarthritis - Fast Facts | NEJM Resident 360 Spondyloarthritis is an inflammatory arthritis characterized by the following features:</description></item><item><title>Rheumatology - Systemic Lupus Erythematosus - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Systemic-Lupus-Erythematosus-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Systemic-Lupus-Erythematosus-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Systemic Lupus Erythematosus - Fast Facts | NEJM Resident 360 Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder with varied manifestations and severity.</description></item><item><title>Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Systemic-Sclerosis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Systemic-Sclerosis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Systemic Sclerosis - Fast Facts | NEJM Resident 360 Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disease characterized by vasculopathy and fibrosis of the skin and internal organs.</description></item><item><title>Rheumatology - Undifferentiated Inflammatory Arthritis - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Rheumatology-Undifferentiated-Inflammatory-Arthritis-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-Undifferentiated-Inflammatory-Arthritis-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Rheumatology - Undifferentiated Inflammatory Arthritis - Fast Facts | NEJM Resident 360 Inflammatory arthritis is a group of diseases that affect the joints, is characterized by an inflammatory response, and can sometimes involve an autoimmune process.</description></item><item><title>secondary prevention of clinical ascvd in patients with preexisting occlusive vascular disease</title><link>https://www.physician.tw/secondary-prevention-of-clinical-ascvd-in-patients-with-preexisting-occlusive-vascular-disease/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/secondary-prevention-of-clinical-ascvd-in-patients-with-preexisting-occlusive-vascular-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[2018 ACC AHA Cholesterol Guidelines]]
secondary prevention of clinical ascvd in patients with preexisting occlusive vascular disease Age ‚â§75 without safety concerns High- or maximally tolerated intensity statin to achieve LDL-C lowering of 50% or greater</description></item><item><title>sos Checklist</title><link>https://www.physician.tw/sos-checklist/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sos-checklist/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
SOS ÊäΩË°ÄÂñÆ CBC CBC/DC Ë°ÄÂûã: ABO + RH typing Â¶ÇÊûú‰πãÂâçÊ≤íÈ©óÁöÑË©± ÁîüÂåñÁÆ° BUN/Cr/Glucose/Na/K/Ca++/Mg/P/Cl AST/ALT/ALP/gamma-GT/Amylase/Lipase TnI/CRP Lactate ABG Amonia ÂáùË°ÄÁÆ° PT/aPTT D-dimer Fibrinogen ÂÖçÁñ´ÁÆ° Procalcitonin NT-pro-BNP Free T4 / TSH ACTH/ Cortiol ÂæÆÁîüÁâ© Blood Culture X2 sets Sputum (esp.</description></item><item><title>toxic granulations</title><link>https://www.physician.tw/toxic-granulations/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/toxic-granulations/</guid><description>[!info]
üå± ‰æÜËá™: [[neutrophilia]]
toxic granulations large purple or dark blue cytoplasmic granules (primary granules) in neutrophils, bands, and metamyelocytes.</description></item><item><title>types of peritoneal dialysis</title><link>https://www.physician.tw/types-of-peritoneal-dialysis/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/types-of-peritoneal-dialysis/</guid><description>[!info]
üå± ‰æÜËá™: [[Peritoneal dialysis (PD)]]
types of peritoneal dialysis Continuous ambulatory peritoneal dialysis (CAPD) Manual instillation and drainage of dialytic fluid several times per day</description></item><item><title>Women‚Äôs Health - Contraception - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Contraception-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Contraception-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Contraception - Fast Facts | NEJM Resident 360 An estimated 45% of pregnancies in the United States are unplanned.</description></item><item><title>Women‚Äôs Health - Infertility - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Infertility-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Infertility-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Infertility - Fast Facts | NEJM Resident 360 Couples who are unable to conceive after 1 year of unprotected intercourse should undergo an evaluation for infertility.</description></item><item><title>Women‚Äôs Health - Menopause - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Menopause-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Menopause-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Menopause - Fast Facts | NEJM Resident 360 Diagnosis Menopause is a clinical diagnosis that can only be made in retrospect one year after the last menstrual period.</description></item><item><title>Women‚Äôs Health - Menstrual and Bleeding Disorders - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Menstrual-and-Bleeding-Disorders-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Menstrual-and-Bleeding-Disorders-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Menstrual and Bleeding Disorders - Fast Facts | NEJM Resident 360 Fibroids Fibroids (uterine leiomyomas) are common benign tumors of the uterus, made of smooth muscle cells and fibroblasts.</description></item><item><title>Women‚Äôs Health - Miscarriage and Abortion - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Miscarriage-and-Abortion-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Miscarriage-and-Abortion-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Miscarriage and Abortion - Fast Facts | NEJM Resident 360 Early Pregnancy Loss (Miscarriage) Miscarriage is the spontaneous loss of the conceptus before 20 weeks‚Äô gestation.</description></item><item><title>Women‚Äôs Health - Polycystic Ovary Syndrome - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Polycystic-Ovary-Syndrome-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Polycystic-Ovary-Syndrome-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Polycystic Ovary Syndrome - Fast Facts | NEJM Resident 360 Polycystic ovary syndrome (PCOS) is a relatively common disorder affecting 6% to 20% of reproductive-age women.</description></item><item><title>Women‚Äôs Health - Preconception Care and Pregnancy - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Preconception-Care-and-Pregnancy-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Preconception-Care-and-Pregnancy-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Preconception Care and Pregnancy - Fast Facts | NEJM Resident 360 Preconception counseling: Many women seek advice from their primary care physician before trying to conceive.</description></item><item><title>Women‚Äôs Health - Vaginitis, Sexually Transmitted Infections, Pelvic Inflammatory Disease - Fast Facts | NEJM Resident 360</title><link>https://www.physician.tw/Womens-Health-Vaginitis-Sexually-Transmitted-Infections-Pelvic-Inflammatory-Disease-Fast-Facts-NEJM-Resident-360/</link><pubDate>Thu, 23 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Womens-Health-Vaginitis-Sexually-Transmitted-Infections-Pelvic-Inflammatory-Disease-Fast-Facts-NEJM-Resident-360/</guid><description>at: [[inbox]]
Women‚Äôs Health - Vaginitis, Sexually Transmitted Infections, Pelvic Inflammatory Disease - Fast Facts | NEJM Resident 360 The CDC Sexually Transmitted Diseases Treatment Guidelines, 2021¬†is the most comprehensive resource for screening, diagnosis, and treatment of STIs and includes recommendations for STIs not covered in this rotation guide (including hepatitis C, hepatitis B, genital herpes simplex virus, lymphogranuloma venereum, Mycoplasma genitalium, and viral hepatitis).</description></item><item><title>analysis of joint fluid</title><link>https://www.physician.tw/analysis-of-joint-fluid/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/analysis-of-joint-fluid/</guid><description>[!info]
üå± ‰æÜËá™: [[approach to rheumatic disease]]
analysis of joint fluid Normal Clear Ôºú200 ‚â§25% negative negative
Noninflamm Clear.</description></item><item><title>approach to arthritis</title><link>https://www.physician.tw/approach-to-arthritis/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-arthritis/</guid><description> [!info]
üå± ‰æÜËá™: [[Approach to patient with joint pain]]
approach to arthritis Figure:</description></item><item><title>Approach to patient with joint pain</title><link>https://www.physician.tw/Approach-to-patient-with-joint-pain/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-patient-with-joint-pain/</guid><description>[!info]
üå±‰æÜËá™: [[approach to rheumatic disease]]
Approach to patient with joint pain ‚Ä¢ Articular vs. periarticular (bursitis, tendinitis) source of pain: typically active ROM more painful than passive ROM in periarticular process ‚Ä¢ Inflammatory vs.</description></item><item><title>Calcium Homeostasis</title><link>https://www.physician.tw/Calcium-Homeostasis/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium-Homeostasis/</guid><description>at: [[inbox]]
Calcium Homeostasis Calcium Homeostasis / PTH / Vitamin D
Physiology of Calcium, Phosphate and Bone:
99% of the body&amp;rsquo;s Ca2+ is present in bones</description></item><item><title>ddx &amp; approach to common inpatient rheum presentations</title><link>https://www.physician.tw/ddx-approach-to-common-inpatient-rheum-presentations/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ddx-approach-to-common-inpatient-rheum-presentations/</guid><description> [!info]
üå±‰æÜËá™: [[approach to rheumatic disease]]
ddx &amp;amp; approach to common inpatient rheum presentations</description></item><item><title>Imaging features of major arthritides</title><link>https://www.physician.tw/Imaging-features-of-major-arthritides/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-features-of-major-arthritides/</guid><description>[!info]
üå±‰æÜËá™: [[approach to rheumatic disease]]
Imaging features of major arthritides ‚Ä¢ OA: plain films: asym joint space narrowing (JSN), osteophytes, subchondral sclerosis &amp;amp; cysts; subchondral ‚Äúgull-wing‚Äù erosions may be seen in less-common erosive OA; MRI may show early disease not seen on plain films; U/S ‚âà MRI for structural damage ‚äñ ‚Ä¢ RA: plain films: symmetric JSN, early = periarticular osteopenia; late = marginal erosions; subluxations; MRI &amp;amp; U/S can detect early and subclinical disease; MRI ‚âà U/S for erosions ‚Ä¢ Gout: plain films: early = nonspec swelling; late = tophus, joint erosions w/ overhanging edges; U/S for detection of microtophi (double-contour sign); dual-energy CT (DECT): identify articular/periarticular UrA deposits vs.</description></item><item><title>inflammatory marker &amp; autoantibody testing</title><link>https://www.physician.tw/inflammatory-marker-autoantibody-testing/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inflammatory-marker-autoantibody-testing/</guid><description>[!info]
üå±‰æÜËá™: [[approach to rheumatic disease]]
inflammatory marker &amp;amp; autoantibody testing Inflammatory markers (Mod Rheumatol 2009;19:469; NEJM 1999;340:448) ‚Ä¢ ESR: indirect measure of inflammation [‚Üë RBC aggregation due to acute-phase proteins (fibrinogen, Ig)]; slow to rise; may ‚Üë w/ age, preg.</description></item><item><title>key physical exam findings in joint pain</title><link>https://www.physician.tw/key-physical-exam-findings-in-joint-pain/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/key-physical-exam-findings-in-joint-pain/</guid><description>[!info]
üå± ‰æÜËá™: [[Approach to patient with joint pain]]
key physical exam findings in joint pain Figure: May initially present as arthralgia w/o overt arthritis.</description></item><item><title>Major categories of inflammatory rheumatic disease</title><link>https://www.physician.tw/Major-categories-of-inflammatory-rheumatic-disease/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-categories-of-inflammatory-rheumatic-disease/</guid><description> [!info]
üå±‰æÜËá™: [[approach to rheumatic disease]]
Major categories of inflammatory rheumatic disease Inflammatory arthritis: crystalline (gout, CPPD), RA, spondyloarthritis, adult-onset Still‚Äôs Connective tissue disease: SLE, Sj√∂gren‚Äôs, scleroderma, myositides (DM, PM), MCTD Vasculitis: large (GCA, Takayasu‚Äôs); medium (PAN); small (ANCA, IgA, cryo); Beh√ßet‚Äôs Other: IgG4-related disease, autoinflammatory disease (familial Mediterranean fever, TNF receptor-associated periodic syndrome, VEXAS = vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic), sarcoid (see ‚ÄúILD‚Äù), HLH/MAS, relapsing polychondritis</description></item><item><title>management of secondary hyperparathyroidism in adult nondialysis patients with chronic kidney disease</title><link>https://www.physician.tw/management-of-secondary-hyperparathyroidism-in-adult-nondialysis-patients-with-chronic-kidney-disease/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-of-secondary-hyperparathyroidism-in-adult-nondialysis-patients-with-chronic-kidney-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Secondary hyperPTH]]
management of secondary hyperparathyroidism in adult nondialysis patients with chronic kidney disease Chronic kidney disease mineral and bone disorder (CKD-MBD) (ie, calcium, phosphate, PTH, vitamin D).</description></item><item><title>mechanisms and sites of action of some of the drugs used in the treatment of cancer</title><link>https://www.physician.tw/mechanisms-and-sites-of-action-of-some-of-the-drugs-used-in-the-treatment-of-cancer/</link><pubDate>Wed, 22 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mechanisms-and-sites-of-action-of-some-of-the-drugs-used-in-the-treatment-of-cancer/</guid><description> [!info]
üå± ‰æÜËá™: [[cancer biology]]
mechanisms and sites of action of some of the drugs used in the treatment of cancer Figure:</description></item><item><title>Aspiration pneumonitis</title><link>https://www.physician.tw/aspiration-pneumonitis/</link><pubDate>Tue, 21 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aspiration-pneumonitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Definitions-and-clinical-manifestations]]
Aspiration pneumonitis Treatment recommendations for community-acquired aspiration pneumonia ‚Äì For patients with a clinical picture that is strongly suggestive of aspiration pneumonia acquired in a community setting (eg, witnessed aspiration event, risk factors for aspiration, compatible imaging, subacute course, putrid breath), we select an antibiotic regimen that includes coverage for most pathogenic oral flora, including anaerobic bacteria.</description></item><item><title>management of statin myopathy</title><link>https://www.physician.tw/management-of-statin-myopathy/</link><pubDate>Tue, 21 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-of-statin-myopathy/</guid><description> [!info]
üå± ‰æÜËá™: [[muscle adverse event terminology]]
management of statin myopathy Statins: Actions, side effects, and administration - UpToDate</description></item><item><title>statins actions, side effects, and administration</title><link>https://www.physician.tw/statins-actions-side-effects-and-administration/</link><pubDate>Tue, 21 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/statins-actions-side-effects-and-administration/</guid><description> [!info]
üå± ‰æÜËá™: [[lipid disorders]]
statins actions, side effects, and administration [[muscle adverse event terminology]] statin doses and low-density lipoprotein Reduction High &amp;gt; 50% Rosuva 20-40 Atorva 40-80 Mod 30~50% Rosuva 5-10 Atorva 10-20 Figure:</description></item><item><title>diagnostic error</title><link>https://www.physician.tw/diagnostic-error/</link><pubDate>Sun, 19 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-error/</guid><description> [!info]
üå± ‰æÜËá™: [[selected cognitive biases contributing to diagnostic errors]]
diagnostic error Figure:</description></item><item><title>open graph</title><link>https://www.physician.tw/open-graph/</link><pubDate>Sun, 19 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/open-graph/</guid><description>[!info]
üå± ‰æÜËá™: [[Quartz]]
open graph ‰ªÄÈ∫ºÊòØOpen GraphÔºü Open GraphÊòØ‰∏ÄÂÄãÁî±FacebookÂâµÂª∫ÁöÑÂçîË≠∞ÔºåÊó®Âú®ËÆìÁ∂≤Á´ôÁÆ°ÁêÜÂì°Êõ¥Â•ΩÂú∞ÊéßÂà∂‰ªñÂÄëÁöÑÂÖßÂÆπÂú®Á§æ‰∫§Â™íÈ´îÂπ≥Âè∞‰∏äÁöÑÈ°ØÁ§∫ÊñπÂºè„ÄÇÂÆÉÂÖÅË®±Á∂≤Á´ôÁÆ°ÁêÜÂì°ÊåáÂÆöÁ∂≤È†ÅÁöÑÂÖÉÊï∏ÊìöÔºåÂåÖÊã¨Ê®ôÈ°å„ÄÅÊèèËø∞„ÄÅÂúñÁâáÁ≠âÔºå‰ª•‰æøÂú®Facebook„ÄÅTwitterÂíåÂÖ∂‰ªñÁ§æ‰∫§Â™íÈ´îÂπ≥Âè∞‰∏äÂàÜ‰∫´ÊôÇÊõ¥Â•ΩÂú∞Â±ïÁ§∫„ÄÇ
Open GraphÁöÑÊ†∏ÂøÉÊòØÂÖÉÊ®ôÁ±§Ôºàmeta tagsÔºâÔºåÂÆÉÂÄëÂú®Á∂≤È†ÅÁöÑÈ†≠ÈÉ®ÊåáÂÆöÁ∂≤È†ÅÁöÑÂÖÉÊï∏Êìö„ÄÇÂú®Open Graph‰∏≠ÔºåÈÄô‰∫õÊ®ôÁ±§ÁöÑÂ±¨ÊÄßÂÆöÁæ©‰∫ÜË©≤Á∂≤È†ÅÁöÑÂÖßÂÆπÔºå‰æãÂ¶ÇÊ®ôÈ°å„ÄÅÊèèËø∞„ÄÅÁ∏ÆÁï•ÂúñÁ≠â„ÄÇÁï∂Áî®Êà∂ÂàÜ‰∫´Ë©≤Á∂≤È†ÅÊôÇÔºåÁ§æ‰∫§Â™íÈ´îÂπ≥Âè∞Â∞á‰ΩøÁî®ÈÄô‰∫õÊ®ôÁ±§‰æÜÊ±∫ÂÆöÂ¶Ç‰ΩïÂëàÁèæË©≤Á∂≤È†ÅÁöÑÂÖßÂÆπ„ÄÇ
ÂèØ‰ª•È´îÈ©ó‰∏Ä‰∏ãÔºåÂú®Á∂≤ÂùÄÂàóË≤º‰∏ä 1 https://og-ph6wrfvo1-htlin222.vercel.app/api/blog?templateTitle=‰ªÄÈ∫ºÊòØOpenGraph ÊáâË©≤Â∞±ÊúÉÂæóÂà∞‰∏ÄÂºµÔºö ÊïôÂ≠∏ Fork htlin222/og: üçá Open Graph Generator made using @vercel/og for personal use ÁÑ∂Âæå New Project ‚Äì Vercel ÈÅ∏Êìá‰Ω†ÁöÑÂ∞àÊ°àÂæåDeploy ÊáâË©≤Â∞±ÂèØ‰ª•ÂæóÂà∞ og-username.</description></item><item><title>pandoc in vim</title><link>https://www.physician.tw/pandoc-in-vim/</link><pubDate>Sun, 19 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pandoc-in-vim/</guid><description>pandoc in vim pandoc in vim #üöß ÊñΩÂ∑•‰∏≠ pandoc --citeproc --bibliography=&amp;quot;$HOME/Zotero/zotero_main.bib&amp;quot; -s -t gfm --csl=&amp;quot;$HOME/Zotero/styles/american-medical-association.csl&amp;quot; &amp;quot;%&amp;quot; -o &amp;quot;%&amp;quot;
Shell script for converting a batch of *.</description></item><item><title>python print(): how to select color as green</title><link>https://www.physician.tw/print-green/</link><pubDate>Sun, 19 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/print-green/</guid><description>python print(): how to select color as green To print text in green color using Python&amp;rsquo;s print() function, you can use ANSI escape codes.</description></item><item><title>Á∑®Á¢ºÁ≥ªÁµ±</title><link>https://www.physician.tw/coding-system/</link><pubDate>Sun, 19 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coding-system/</guid><description> [!info]
üå± ‰æÜËá™: [[medical textexapnd]]
Á∑®Á¢ºÁ≥ªÁµ± Âπ≥Â∏∏Â∞±ÂæàÊÉ≥ÂØ´Á∏ÆÂØ´ÁöÑÂ≠ó ÂÆπÊòìÊãºÈåØÁöÑÂ≠ó Ëó•Áâ©ÁöÑÂ≠∏Âêç„ÄÅÂïÜÂìÅÂêç„ÄÅÂèäÂ∏∏Áî®ÁöÑÂäëÈáè„ÄÅ‰ΩøÁî®ÊôÇÈï∑ ÂÖ¨Âºè e.g. creatinine clearance, IBW Criteria, Scoring system ‰ª•‰∏ªË®¥ÁÇ∫Âá∫ÁôºÈªûÁöÑDutyNote Procedure Notes Âü∫Êú¨Ë©ï‰º∞ÁöÑcheck list: physical exam, NE, chest radiograph, POCUS</description></item><item><title>happy</title><link>https://www.physician.tw/blog/happy/</link><pubDate>Sat, 18 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/happy/</guid><description> [!info]
üå± ‰æÜËá™: [[index]]
happy</description></item><item><title>Conceptualizing Diagnosis and Diagnosis Improvement</title><link>https://www.physician.tw/conceptualizing-diagnosis-and-diagnosis-improvement/</link><pubDate>Fri, 17 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/conceptualizing-diagnosis-and-diagnosis-improvement/</guid><description>[!info]
üå± ‰æÜËá™: [[clinical reasoning]]
Conceptualizing Diagnosis and Diagnosis Improvement ÂÇ≥Áµ±ÁöÑË®∫Êñ∑ÊÄùÁ∂≠ÊñπÂºèÂíåË®∫Êñ∑ÈåØË™§ vs ÊÄùËÄÉË®∫Êñ∑ÂíåÊîπÂñÑË®∫Êñ∑ÁöÑÊñ∞ÁØÑÂºè/Êõ¥Â•ΩÊñπÊ≥ï TABLE 9-3
‚ùå ‰∏ÄÂÄãÂ•ΩÁöÑË®∫Êñ∑Â∏´Âπæ‰πéÁ∏ΩÊòØÂú®Á¨¨‰∏ÄÊ¨°Â∞±ÂÅöÂ∞ç</description></item><item><title>National Academy of Medicine Recommendations for Improving Diagnosis in Health Care</title><link>https://www.physician.tw/national-academy-of-medicine-recommendations-for-improving-diagnosis-in-health-care/</link><pubDate>Fri, 17 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/national-academy-of-medicine-recommendations-for-improving-diagnosis-in-health-care/</guid><description>[!info]
üå± ‰æÜËá™: [[clinical reasoning]]
National Academy of Medicine Recommendations for Improving Diagnosis in Health Care Facilitate more effective teamwork in the diagnostic process among health care professionals, patients, and their families.</description></item><item><title>selected cognitive biases contributing to diagnostic errors</title><link>https://www.physician.tw/selected-cognitive-biases-contributing-to-diagnostic-errors/</link><pubDate>Fri, 17 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/selected-cognitive-biases-contributing-to-diagnostic-errors/</guid><description>[!info]
üå± ‰æÜËá™: [[clinical reasoning]]
selected cognitive biases contributing to diagnostic errors [[diagnostic error]]
Premature closure: accepting a diagnosis before it has been fully verified</description></item><item><title>Abstract of Metabolic Alkalosis A Brief Pathophysiologic Review</title><link>https://www.physician.tw/Abstract-of-Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Abstract-of-Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</guid><description>[!info]
üå±‰æÜËá™: [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
Abstract of Metabolic Alkalosis A Brief Pathophysiologic Review Metabolic alkalosis is a very commonly encountered acid-base disorder that may be generated by a variety of exogenous and/or endogenous, pathophysiologic mechanisms.</description></item><item><title>clinical prediction rules for the diagnosis of pulmonary embolism</title><link>https://www.physician.tw/clinical-prediction-rules-for-the-diagnosis-of-pulmonary-embolism/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-prediction-rules-for-the-diagnosis-of-pulmonary-embolism/</guid><description>[!info]
üå± ‰æÜËá™: [[Modified Wells Pretest Probability Scoring for PE ]]
clinical prediction rules for the diagnosis of pulmonary embolism PERC</description></item><item><title>desmopressin</title><link>https://www.physician.tw/desmopressin/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/desmopressin/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment-polyuria]]
desmopressin Desmopressin can cause hyponatremia, which can be life-threatening. Desmopressin is contraindicated in patients at increased risk of severe hyponatremia.</description></item><item><title>Graham Steell</title><link>https://www.physician.tw/graham-steell/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/graham-steell/</guid><description>[!info]
üå± ‰æÜËá™: [[Clinical manifestations‚ÄîPE]]
Graham Steell murmur ÂèÉËÄÉ‚û°Ô∏è The Graham-Steell murmur re-evaluated
IN 1888 Graham Steell described his now famous left-sternal-border diastolic murmur and attributed its origin to pulmonary regurgitation caused by high pressure in the pulmonary artery in patients with mitral stenosis,1:In cases of mitral obstruction there is occasionally heard over the pulmonary area and below this region, for the distance of an inch or two along the left border of the sternum, and rarely over the lowest part of the bone itself, a soft blowing diastolic murmur immediately following or, more exactly, running off from the accentuated second sound, while the usual indications of aortic regurgitation afforded by .</description></item><item><title>Introduction of Metabolic Alkalosis A Brief Pathophysiologic Review</title><link>https://www.physician.tw/Introduction-of-Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Introduction-of-Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</guid><description>[!info]
üå±‰æÜËá™: [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
Introduction of Metabolic Alkalosis A Brief Pathophysiologic Review Metabolic alkalosis is a primary acid-base disorder that increases the serum bicarbonate concentration [HCO3‚àí] (this is usually approximated by its surrogate the venous total [CO2]) above 30 meq/L (1), causing the arterial blood [H+] to fall, i.</description></item><item><title>Maintenance of Metabolic Alkalosis</title><link>https://www.physician.tw/Maintenance-of-Metabolic-Alkalosis/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Maintenance-of-Metabolic-Alkalosis/</guid><description>[!info]
üå±‰æÜËá™: [[Pathogenesis: Generation and Maintenance of Metabolic Alkalosis A Brief Pathophysiologic Review]]
Maintenance of Metabolic Alkalosis The various mechanisms responsible for the maintanence of metabolic alkalosis are shown in Table 3.</description></item><item><title>medical textexapnd</title><link>https://www.physician.tw/medical-textexapnd/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medical-textexapnd/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
ÈóúÊñºÁ∏ÆÂØ´ÈÄô‰ª∂‰∫ãÔºå‰ª•‰∏ãÊèê‰æõÂπæÈªûÂéüÂâáÔºö Âì™‰∫õÊù±Ë•øÂÄºÂæóÂª∫Êàê‰∏ÄÂÄãÁ∏ÆÂØ´Ôºö Âπ≥Â∏∏Â∞±ÂæàÊÉ≥ÂØ´Á∏ÆÂØ´ÁöÑÂ≠ó ÂÆπÊòìÊãºÈåØÁöÑÂ≠ó Ëó•Áâ©ÁöÑÂ≠∏Âêç„ÄÅÂïÜÂìÅÂêç„ÄÅÂèäÂ∏∏Áî®ÁöÑÂäëÈáè„ÄÅ‰ΩøÁî®ÊôÇÈï∑ ÂÖ¨Âºè e.g. creatinine clearance, IBW Criteria, Scoring system ‰ª•‰∏ªË®¥ÁÇ∫Âá∫ÁôºÈªûÁöÑDutyNote Procedure Notes Âü∫Êú¨Ë©ï‰º∞ÁöÑcheck list: physical exam, NE, chest radiograph, POCUS Á∏ÆÂØ´ÂëΩÂêçÂéüÂâáÔºö Áµ±‰∏ÄÂ§ßÂ∞èÂØ´ÔºåÂÖ®ÈÉ®Â§ßÂØ´ÊàñÂÖ®ÈÉ®Â∞èÂØ´Ôºå‰∏çÁÑ∂Âæå‰æÜÊòìÊêûÊ∑∑ ÂÑòÈáè‰∏âÂà∞ÂõõÁ¢ºÔºåÂÖ©Á¢ºÂÆπÊòìÊúâÊ≠ßÁæ© ÊÉ≥Êñ∑Âè•ÁöÑË©±Áî®‰∏ÄÂÄã.</description></item><item><title>Metabolic Alkalosis: A Brief Pathophysiologic Review</title><link>https://www.physician.tw/Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</guid><description>at: [[inbox]]
Metabolic Alkalosis: A Brief Pathophysiologic Review Clin J Am Soc Nephrol. 2020 Dec 7; 15(12): 1848‚Äì1856.
Published online 2020 Jun 25.</description></item><item><title>Metabolic Alkalosis‚ÄîSource of Excess HCO3‚àí</title><link>https://www.physician.tw/Metabolic-AlkalosisSource-of-Excess-HCO3/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-AlkalosisSource-of-Excess-HCO3/</guid><description>[!info]
üå±‰æÜËá™: [[Pathogenesis: Generation and Maintenance of Metabolic Alkalosis A Brief Pathophysiologic Review]]
Metabolic Alkalosis‚ÄîSource of Excess HCO3‚àí Usually metabolic alkalosis indicates an accumulation of ‚Äúexcess‚Äù HCO3‚àí.</description></item><item><title>Modified Wells Pretest Probability Scoring for PE</title><link>https://www.physician.tw/modified-wells-pretest-probability-scoring-for-pe/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/modified-wells-pretest-probability-scoring-for-pe/</guid><description>[!info]
üå± ‰æÜËá™: [[pulmonary embolism]]
Modified Wells Pretest Probability Scoring for PE compare: [[clinical prediction rules for the diagnosis of pulmonary embolism]]</description></item><item><title>Normal HCO3‚àí Reclamation, Regeneration, and Generation</title><link>https://www.physician.tw/Normal-HCO3-Reclamation-Regeneration-and-Generation/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Normal-HCO3-Reclamation-Regeneration-and-Generation/</guid><description>[!info]
üå±‰æÜËá™: [[Pathogenesis: Generation and Maintenance of Metabolic Alkalosis A Brief Pathophysiologic Review]]
Normal HCO3‚àí Reclamation, Regeneration, and Generation Nonvolatile acids are generated by metabolism of ingested foods and oxidation of endogenous substrates.</description></item><item><title>Pathogenesis: Generation and Maintenance of Metabolic Alkalosis A Brief Pathophysiologic Review</title><link>https://www.physician.tw/Pathogenesis-Generation-and-Maintenance-of-Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-Generation-and-Maintenance-of-Metabolic-Alkalosis-A-Brief-Pathophysiologic-Review/</guid><description>[!info]
üå±‰æÜËá™: [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
Pathogenesis: Generation and Maintenance of Metabolic Alkalosis A Brief Pathophysiologic Review Seldin and Rector published a classic review, ‚ÄúThe Generation and Maintenance of Metabolic Alkalosis,‚Äù in 1972 (12).</description></item><item><title>Respiratory Compensation</title><link>https://www.physician.tw/Respiratory-Compensation/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Compensation/</guid><description>[!info]
üå±‰æÜËá™: [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
Respiratory Compensation Uncomplicated metabolic alkalosis rapidly (minutes to hours) generates hypoventilatory compensation that elevates the pCO2.</description></item><item><title>Serum Chloride Concentration and Metabolic Alkalosis</title><link>https://www.physician.tw/Serum-Chloride-Concentration-and-Metabolic-Alkalosis/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serum-Chloride-Concentration-and-Metabolic-Alkalosis/</guid><description>[!info]
üå±‰æÜËá™: [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
Serum Chloride Concentration and Metabolic Alkalosis Hyper- or hypochloremia can reflect water/hydration disorders, acid/base disorders, or both.</description></item><item><title>simplified pulmonary embolism severity index</title><link>https://www.physician.tw/simplified-pulmonary-embolism-severity-index/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/simplified-pulmonary-embolism-severity-index/</guid><description>[!info]
üå± ‰æÜËá™: [[Approach to suspected PE]]
simplified pulmonary embolism severity index Patient Characteristicsa Age &amp;gt;80 years Medical history: Cancer Chronic cardiopulmonary disease Heart rate &amp;gt;109/min Systolic blood pressure &amp;lt;100 mm Hg Oxygen saturation by pulse oximetry on room air &amp;lt;90% Each item on the index, if present, is indicated by a score of 1.</description></item><item><title>summary of metabolic alkalosis</title><link>https://www.physician.tw/summary-of-metabolic-alkalosis/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/summary-of-metabolic-alkalosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Etiologies-of-Metabolic-Alkalosis]]
summary of metabolic alkalosis Metabolic alkalosis: Metabolic alkalosis, which produces an elevation of the serum bicarbonate, is a relatively frequent clinical problem that is most commonly generated by excess loss of hydrogen ions from the gastrointestinal tract or in the urine, and/or by hydrogen ion movement into cells (table 1).</description></item><item><title>The Metabolic Alkaloses: Etiology on the Basis of ECF Volume Status</title><link>https://www.physician.tw/The-Metabolic-Alkaloses-Etiology-on-the-Basis-of-ECF-Volume-Status/</link><pubDate>Thu, 16 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Metabolic-Alkaloses-Etiology-on-the-Basis-of-ECF-Volume-Status/</guid><description>[!info]
üå±‰æÜËá™: [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
The Metabolic Alkaloses: Etiology on the Basis of ECF Volume Status The generation, maintenance, and resolution of ‚Äúclassic‚Äù examples of metabolic alkalosis in each ECF volume status category are described below.</description></item><item><title>Amivantamab</title><link>https://www.physician.tw/amivantamab/</link><pubDate>Wed, 15 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/amivantamab/</guid><description>[!info]
üå± ‰æÜËá™: [[NSCLC Treatment]]
Amivantamab [!tldr] TLDR
Amivantamab is a novel anti-EGFR/c-MET bispecific antibody that has been approved for the treatment of advanced non-small cell lung cancer (NSCLC).</description></item><item><title>Screening of THORACIC MALIGNANCIES</title><link>https://www.physician.tw/screening-of-thoracic-malignancies/</link><pubDate>Wed, 15 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/screening-of-thoracic-malignancies/</guid><description>[!info]
üå± ‰æÜËá™: [[THORACIC MALIGNANCIES]]
Screening of THORACIC MALIGNANCIES Annual low-dose chest CT in ‚â•20 pack-year current or former (quit w/in 15 y) smokers, age 50‚Äì80 y ‚Üí 20% ‚Üì lung cancer-related mortality (NEJM 2020;382:503) High rates of screen-detected nodules.</description></item><item><title>thiazide</title><link>https://www.physician.tw/thiazide/</link><pubDate>Wed, 15 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thiazide/</guid><description> [!info]
üå± ‰æÜËá™: [[treatment of Central DI]]
thiazide</description></item><item><title>treatment of Central DI</title><link>https://www.physician.tw/treatment-of-central-di/</link><pubDate>Wed, 15 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-central-di/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment-polyuria]]
treatment of Central DI There are three major therapeutic options: a low-solute (sodium and protein) diet; desmopressin (dDAVP), an antidiuretic hormone (ADH, also known as arginine vasopressin [AVP]) analog; and other drugs, including [[thiazide]] diuretics.</description></item><item><title>Coronary artery calcium (CAC) score</title><link>https://www.physician.tw/coronary-artery-calcium-cac-score/</link><pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronary-artery-calcium-cac-score/</guid><description> [!info]
üå± ‰æÜËá™: [[noninvasive evaluation of CAD]]
Coronary artery calcium (CAC) score Quantifies extent of calcium; thus, estimates plaque burden (but not % coronary stenosis) CAC sensitive (91%) but not specific (49%) for presence of CAD; high NPV to r/o CAD In intermediate-risk or selected borderline-risk adults (ie, 10-year ASCVD risk of 5‚Äì20%), if decision about statin remains uncertain, reasonable to use CAC score to help guide</description></item><item><title>Coronary CT angiography</title><link>https://www.physician.tw/coronary-ct-angiography/</link><pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronary-ct-angiography/</guid><description>[!info]
üå± ‰æÜËá™: [[noninvasive evaluation of CAD]]
Coronary CT angiography Gated CT of heart timed during peak contrast enhancement in coronary arteries NTG given to dilate coronary arteries.</description></item><item><title>Epidemiology of hypertension</title><link>https://www.physician.tw/epidemiology-of-hypertension/</link><pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-of-hypertension/</guid><description> [!info]
üå± ‰æÜËá™: [[hypertension]]
Epidemiology of hypertension (Circ 2021;143:e254; Lancet 2021;398:957)
Prevalence 47% in U.S. adults, higher in African-Americans; M = F Of those with HTN, ~40% unaware of dx; of those dx w/ HTN, only ¬Ω achieve target BP</description></item><item><title>Myocardial viability</title><link>https://www.physician.tw/myocardial-viability/</link><pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myocardial-viability/</guid><description>[!info]
üå± ‰æÜËá™: [[noninvasive evaluation of CAD]]
Myocardial viability Goal: identify hibernating myocardium that could regain fxn after revascularization Options: MRI (Se ~95%, Sp ~50%), PET (Se ~90%, Sp ~65%), dobutamine stress echo (Se ~80%, Sp ~80%); SPECT/rest-redistribution (Se ~85%, Sp ~65%) Pts w/ ischemic CMP (EF &amp;lt;35%), viability predicts ‚Üë EF w/ CABG but not survival or benefit of CABG vs.</description></item><item><title>Acquired dyslipidemias</title><link>https://www.physician.tw/acquired-dyslipidemias/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acquired-dyslipidemias/</guid><description> [!info]
üå± ‰æÜËá™: [[Dyslipidemias]]
Acquired dyslipidemias diabetes, hypothyroidism, nephrotic syndrome, liver failure, alcohol thiazides [[protease inhibitors]].</description></item><item><title>cholestyramine</title><link>https://www.physician.tw/cholestyramine/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholestyramine/</guid><description>[!info]
üå± ‰æÜËá™: [[Initial treatment-clostridioides difficile infection ]]
cholestyramine ËÜΩÂõ∫ÈÜáÂê∏Êî∂ÊäëÂà∂ÂäëEzetimibe ÂíåËÜΩÈÖ∏ÁµêÂêàÊ®πÈÖØCholestyramine ÂâáÊòØ‰ΩúÁî®Âú®ËÖ∏ÈÅìÔºåÂâçËÄÖÊòØÊäëÂà∂ËÜΩÂõ∫ÈÜáÁöÑÂê∏Êî∂ÔºõÂæåËÄÖÊòØÂ¢ûÂä†ËÜΩÂõ∫ÈÜáÁöÑÊéíÈô§„ÄÇ Êï¥È´î‰æÜË™™ÔºåÂÖ©ËÄÖÈÉΩÂèØ‰ª•ÊúâÊïàÂú∞Èôç‰ΩéË°ÄÊ∂≤‰∏≠ËÜΩÂõ∫ÈÜáÁöÑÊøÉÂ∫¶Ôºå‰ΩÜCholestyramine ÂèØËÉΩÊúÉ‰Ωø‰∏âÈÖ∏ÁîòÊ≤πÈÖØÂ¢ûÂä†„ÄÇ</description></item><item><title>clinical features of preseptal and orbital cellulitis</title><link>https://www.physician.tw/clinical-features-of-preseptal-and-orbital-cellulitis/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-features-of-preseptal-and-orbital-cellulitis/</guid><description> [!info]
üå± ‰æÜËá™: [[preseptal celluitis]]
clinical features of preseptal and orbital cellulitis Clinical Feature Preseptal Cellulitis Orbital Cellulitis Eyelid swelling with or without erythema Yes Yes Eye pain/tenderness May be present Yes; may cause deep eye pain Pain with eye movements No Yes Proptosis No Usually, but may be subtle Ophthalmoplegia +/- diplopia No May be present Vision impairment No May be present* Chemosis Rarely present May be present Fever May be present Usually present Leukocytosis May be present May be present</description></item><item><title>Complications of familial hypercholesterolemia</title><link>https://www.physician.tw/Complications-of-familial-hypercholesterolemia/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-of-familial-hypercholesterolemia/</guid><description>[!info]
üå±‰æÜËá™: [[familial hypercholesterolemia]]
Complications of familial hypercholesterolemia People who have familial hypercholesterolemia have a higher risk of heart disease and death at a younger age.</description></item><item><title>familial hypercholesterolemia</title><link>https://www.physician.tw/familial-hypercholesterolemia/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/familial-hypercholesterolemia/</guid><description> [!info]
üå± ‰æÜËá™: [[Dyslipidemias]]
familial hypercholesterolemia [[Overview of familial hypercholesterolemia]] [[Symptoms of familial hypercholesterolemia]] [[Risk factors of familial hypercholesterolemia]] [[Complications of familial hypercholesterolemia]]</description></item><item><title>Metabolic syndrome</title><link>https://www.physician.tw/metabolic-syndrome/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metabolic-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[Measurements-lipid disorders]]
Metabolic syndrome (‚â•3 of following):
waist ‚â•40‚Ä≥ (‚ôÇ) or ‚â•35‚Ä≥ (‚ôÄ); TG ‚â•150 mg/dL; HDL&amp;lt;40 (‚ôÇ) or &amp;lt;50 mg/dL (‚ôÄ); BP ‚â•130/85 mmHg; fasting glc ‚â•100 mg/dL (Circ 2009;120:1640)</description></item><item><title>muscle adverse event terminology</title><link>https://www.physician.tw/muscle-adverse-event-terminology/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/muscle-adverse-event-terminology/</guid><description>[!info]
üå± ‰æÜËá™: [[lipid disorders]]
muscle adverse event terminology [[management of statin myopathy]]
Statin-associated muscle symptoms (SAMS): Muscle symptoms reported during statin therapy but not necessarily caused by the statin Myalgia: Muscle pain or aches Myopathy: Unexplained muscle pain or weakness accompanied by CK concentration -Rhabdomyolysis: Severe form of myopathy, with CK typically 10 times the upper limit of normal Á™©ÁöÑËã±Êñá‰∏çÂ§™Â•Ω Ê≠£Â∏∏‰∏äÈôêÁöÑ10ÂÄç</description></item><item><title>Overview of familial hypercholesterolemia</title><link>https://www.physician.tw/Overview-of-familial-hypercholesterolemia/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-of-familial-hypercholesterolemia/</guid><description>[!info]
üå±‰æÜËá™: [[familial hypercholesterolemia]]
Overview of familial hypercholesterolemia Familial hypercholesterolemia affects the way the body processes cholesterol. As a result, people with familial hypercholesterolemia have a higher risk of heart disease and a greater risk of early heart attack.</description></item><item><title>preseptal celluitis</title><link>https://www.physician.tw/preseptal-celluitis/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preseptal-celluitis/</guid><description> [!info]
üå± ‰æÜËá™: [[skin and soft tissue infections]]
preseptal celluitis [[clinical features of preseptal and orbital cellulitis]]</description></item><item><title>protease inhibitors</title><link>https://www.physician.tw/protease-inhibitors/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protease-inhibitors/</guid><description>[!info]
üå± ‰æÜËá™: [[Dyslipidemias]]
protease inhibitors ÊäóÈÄÜËΩâÈåÑÁóÖÊØíËó•Áâ©
ËõãÁôΩÈÖ∂ÊäëÂà∂ÂäëÔºàËã±Ë™ûÔºöProtease inhibitor, antiproteaseÔºâÊòØÂ∏∂ÊúâÁí∞ÁãÄÁµêÊßãÁöÑËÇΩÂåñÂêàÁâ©ÔºåÂèØÁ´∂Áà≠ÊÄßÊàñÈùûÁ´∂Áà≠ÊÄßÊäëÂà∂ËõãÁôΩÈÖ∂Ê¥ªÊÄßÔºåÊ≠§Â§ñÔºåËõãÁôΩÈÖ∂ÊäëÂà∂ÂäëÈÇÑÂèØ‰ª•Èôç‰ΩéÁôΩ‰ªãÁ¥†Ôºç1Œ≤ËΩâÊèõÈÖ∂ÁöÑË°®ÈÅîÔºåÂæûËÄå‰ΩøÁóÖÊØíÈ°ÜÁ≤íÁÑ°Ê≥ïÊàêÁÜü„ÄÅÊäëÂà∂ÁóÖÊØíÁöÑË§áË£Ω„ÄÇFDAÂ∑≤ÊâπÂáÜ‰∏äÂ∏Ç7Á®ÆËó•Áâ©ÔºàSQV„ÄÅRTV„ÄÅIDV„ÄÅNFV„ÄÅAPVÁ≠âÔºâ„ÄÇ
Ëá™ÁÑ∂ÁïåÊú¨Â∞±Â≠òÂú®Ë®±Â§öËõãÁôΩÈÖ∂ÊäëÂà∂ÂäëÔºåÂÆÉÂÄëËàáËõãÁôΩÈÖ∂‰∫íÁõ∏Âà∂Á¥ÑËÄåËôïÊñºÂãïÊÖãÂπ≥Ë°°ÔºõË®±Â§öÂ§©ÁÑ∂ËõãÁôΩÈÖ∂ÊäëÂà∂ÂäëÊú¨Ë∫´ÁµêÊßã‰πüÊòØËõãÁôΩË≥™„ÄÇËõãÁôΩÈÖ∂ÊäëÂà∂ÂäëÈÄöÈÅéËàáËõãÁôΩÈÖ∂Ê¥ªÊÄß‰ΩçÈªûÁµêÂêàË™øÊéßÈù∂ËõãÁôΩÈÖ∂Ê¥ªÊÄßÔºåÂæûËÄåÂΩ±ÈüøËõãÁôΩË≥™‰ª£Ë¨ù[1]„ÄÇ</description></item><item><title>Risk factors of familial hypercholesterolemia</title><link>https://www.physician.tw/Risk-factors-of-familial-hypercholesterolemia/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-of-familial-hypercholesterolemia/</guid><description>[!info]
üå±‰æÜËá™: [[familial hypercholesterolemia]]
Risk factors of familial hypercholesterolemia The risk of familial hypercholesterolemia is higher if one or both of your parents have the gene alteration that causes it.</description></item><item><title>statins</title><link>https://www.physician.tw/statins/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/statins/</guid><description>[!info]
üå± ‰æÜËá™: [[Drug Treatment-lipid disorders]]
statins ‚Üë ALT in 0.5‚Äì3%; ‚úì before starting and then prn</description></item><item><title>Symptoms of familial hypercholesterolemia</title><link>https://www.physician.tw/Symptoms-of-familial-hypercholesterolemia/</link><pubDate>Mon, 13 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Symptoms-of-familial-hypercholesterolemia/</guid><description>[!info]
üå±‰æÜËá™: [[familial hypercholesterolemia]]
Symptoms of familial hypercholesterolemia Adults and children who have familial hypercholesterolemia have very high levels of low-density lipoprotein (LDL) cholesterol in their blood.</description></item><item><title>diagram of acute coronary syndromes</title><link>https://www.physician.tw/diagram-of-acute-coronary-syndromes/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagram-of-acute-coronary-syndromes/</guid><description>[!info]
üå± ‰æÜËá™: [[acute coronary syndromes]]
diagram of acute coronary syndromes Figure: How are stenoses in nonculprit coronary arteries managed in patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI)?</description></item><item><title>Inotropes</title><link>https://www.physician.tw/inotropes/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inotropes/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment of acute advanced heart failure]]
Inotropes dobutamine: vasodilation at doses ‚â§5 ¬µg/kg/min; mild ‚Üì PVR; desensitization over time</description></item><item><title>mechanical circulatory support</title><link>https://www.physician.tw/mechanical-circulatory-support/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mechanical-circulatory-support/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment of acute advanced heart failure]]
mechanical circulatory support Temporary: bridge to recovery, transplant, or durable MCS; periprocedural support</description></item><item><title>Sanford Guide: Clostridioides difficile, C. diff</title><link>https://www.physician.tw/Clostridioides-difficile-sanford-guide/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clostridioides-difficile-sanford-guide/</guid><description>at: [[inbox]]
Sanford Guide: Clostridioides difficile, C. diff Clostridioides difficile, C. diff formerly Clostridium difficile, C diff
Clinical Setting Clostridioides difficile associated diarrhea (CDAD), C.</description></item><item><title>secondary causes of diabetes</title><link>https://www.physician.tw/secondary-causes-of-diabetes/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/secondary-causes-of-diabetes/</guid><description>[!info]
üå± ‰æÜËá™: [[Categories-diabetes mellitus]]
secondary causes of diabetes exogenous glucocorticoids, glucagonoma (3 Ds = DM, DVT, diarrhea), pancreatic (pancreatitis, hemochromatosis, CF, resection), endocrino-pathies (Cushing‚Äôs, acromegaly), gestational, drugs (protease inhibitors, atypical antiœà)</description></item><item><title>testforwft</title><link>https://www.physician.tw/testforwft/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/testforwft/</guid><description> [!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
testforwft [[title 1 is here]]
[[title 2 is herer]]</description></item><item><title>title 1 is here</title><link>https://www.physician.tw/title-1-is-here/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/title-1-is-here/</guid><description>[!info]
üå±‰æÜËá™: [[testforwft]]
title 1 is here ad;k;ajfk;j;lkj</description></item><item><title>title 2 is herer</title><link>https://www.physician.tw/title-2-is-herer/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/title-2-is-herer/</guid><description>[!info]
üå±‰æÜËá™: [[testforwft]]
title 2 is herer ka;fakj;lk</description></item><item><title>type 1 diabetes mellitus</title><link>https://www.physician.tw/type-diabetes-mellitus/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-diabetes-mellitus/</guid><description>[!info]
üå± ‰æÜËá™: [[Categories-diabetes mellitus]]
type 1 diabetes mellitus (Lancet 2018;391:2449):
ÂèÉËÄÉ‚û°Ô∏è Type 1 diabetes islet cell destruction; absolute insulin deficiency; ketosis in absence of insulin; prevalence 0.</description></item><item><title>What is the general approach to the treatment of acute coronary syndromes without ST-segment elevation?</title><link>https://www.physician.tw/what-is-the-general-approach-to-the-treatment-of-acute-coronary-syndromes-without-st-segment-elevation/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/what-is-the-general-approach-to-the-treatment-of-acute-coronary-syndromes-without-st-segment-elevation/</guid><description>[!info]
üå± ‰æÜËá™: [[diagram of acute coronary syndromes]]
What is the general approach to the treatment of acute coronary syndromes without ST-segment elevation?</description></item><item><title>Zar score</title><link>https://www.physician.tw/zar-score/</link><pubDate>Sun, 12 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zar-score/</guid><description>[!info]
üå± ‰æÜËá™: [[Clinical manifestations-clostridioides difficile infection]]
Zar score Clostridium Difficile Diarrhea- Severity Assessment Score - Equation | Medicalalgorithms.</description></item><item><title>markdown-lab</title><link>https://www.physician.tw/markdown-lab/</link><pubDate>Sat, 11 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/markdown-lab/</guid><description> [!info]
üå± ‰æÜËá™: [[Á®ãÂºèË™ûË®Ä]]
markdown-lab [[remark]] [[mermaid]]</description></item><item><title>BENIGN HEMATOLOGY</title><link>https://www.physician.tw/BENIGN-HEMATOLOGY/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BENIGN-HEMATOLOGY/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
BENIGN HEMATOLOGY Biology of Hematopoiesis Anemias of Underproduction Hemolytic Anemias Hemoglobinopathies Hypercoagulable States Porphyrias Bleeding Diatheses Platelet Disorders Transfusion Medicine Screening Tests in Hemostasis</description></item><item><title>breast cancer</title><link>https://www.physician.tw/breast-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/breast-cancer/</guid><description>breast cancer Ëä±ÂúíÂ§ßÈñÄÂè£
[[Epidemiology of breast cancer]] [[Clinical manifestations of breast cancer]] [[Screening of breast cancer]] [[Diagnostic evaluation of breast cancer]] [[Staging of breast cancer]] [[general approach to treatment of breast cancer]] (JAMA 2019;321:288 &amp;amp; 1716) [[surgery and radiation for local control of breast cancer]] [[systemic therapy of breast cancer]] [!</description></item><item><title>CANCER BIOLOGY</title><link>https://www.physician.tw/cancer-biology/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-biology/</guid><description> [!info]
üå±‰æÜËá™: [[Pocket Oncology]]
CANCER BIOLOGY cancer hallmarks and stem cells mechanisms of oncogenesis growth factor signaling cell cycle control transcription, apoptosis, and tp53 dna repair and angiogenesis [[mechanisms and sites of action of some of the drugs used in the treatment of cancer]]</description></item><item><title>cancer complications</title><link>https://www.physician.tw/cancer-complications/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-complications/</guid><description>cancer complications Tumor Lysis Syndrome (TLS) Neutropenic Fever Superior Vena Cava (SVC) Syndrome Symptom Management Metastatic Spinal Cord Compression &amp;amp; Brain Metastases [[leptomeningeal disease]] Venous Thromboembolism (VTE) in Malignancy Malignant Bowel Obstruction (MBO) Treatment Toxicities [!</description></item><item><title>CANCER GENETICS</title><link>https://www.physician.tw/CANCER-GENETICS/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CANCER-GENETICS/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
CANCER GENETICS Principles of Hereditary Cancer Syndromes and Hereditary Breast and Ovarian Cancers Lynch Syndrome Familial Adenomatous Polyposis (FAP) Li‚ÄìFraumeni Syndrome Other Genetic Syndromes</description></item><item><title>Cancer genetics of colorectal cancer</title><link>https://www.physician.tw/Cancer-genetics-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cancer-genetics-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Cancer genetics of colorectal cancer (Nature 2014;513:382) ‚Ä¢ Microsatellite stable (MSS) vs. high instability (MSI-H): latter sign of mismatch repair gene failure, accounts for 15% CRC, presents more often as early stage, ~5% of met dis.</description></item><item><title>CANCER IMMUNOLOGY</title><link>https://www.physician.tw/CANCER-IMMUNOLOGY/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CANCER-IMMUNOLOGY/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
CANCER IMMUNOLOGY Cancer Immunobiology Immunoregulatory Antibody Therapy Toxicities of Immune Checkpoint Inhibitors Miscellaneous Immunotherapies CAR T-Cell Therapy Tumor Infiltrating Lymphocytes (TILs)</description></item><item><title>CANCER PHARMACOLOGY</title><link>https://www.physician.tw/cancer-pharmacology/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-pharmacology/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
CANCER PHARMACOLOGY Pharmacogenetics and Pharmacogenomics Antibody Drug Conjugates Monoclonal Antibodies Antimetabolites Alkylating Agents Antimicrotubular Agents Antitumor Antibiotics Topoisomerase Inhibitors Immunomodulators/Epigenetic Modifiers Small Molecule Pathway Inhibitors Hormonal Agents Bone-Modifying Agents Novel Oral Anticoagulants (NOAC) Growth Factor Therapy Miscellaneous Agents [[antimetabolites]]</description></item><item><title>Cancer stage</title><link>https://www.physician.tw/cancer-stage/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-stage/</guid><description>[!info]
üå± ‰æÜËá™: [[inpatient oncology]]
Cancer stage Refers to tumor location, size, and extent in the body</description></item><item><title>CANCER SURVIVORSHIP AND FERTILITY PRESERVATION</title><link>https://www.physician.tw/CANCER-SURVIVORSHIP-AND-FERTILITY-PRESERVATION/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CANCER-SURVIVORSHIP-AND-FERTILITY-PRESERVATION/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
CANCER SURVIVORSHIP AND FERTILITY PRESERVATION Cancer Survivorship Fertility Preservation</description></item><item><title>chemo side effects</title><link>https://www.physician.tw/chemo-side-effects/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chemo-side-effects/</guid><description> [!info]
üå± ‰æÜËá™: [[oncology]]
chemo side effects</description></item><item><title>Clinical (Radiologic) Staging Pancreatic Adenocarcinoma</title><link>https://www.physician.tw/Clinical-Radiologic-Staging-Pancreatic-Adenocarcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Radiologic-Staging-Pancreatic-Adenocarcinoma/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Clinical (Radiologic) Staging Pancreatic Adenocarcinoma Resectable No extrapanc. dis. or bulky LAN; no arterial tumor contact [celiac axis (CA), SMA, common hepatic (CHA)]; and no venous contact [SMV, portal vein (PV)] or ‚â§180¬∞ + patent veins (ie, no tumor thrombus) Borderline resectable No extrapanc dis.</description></item><item><title>Clinical manifestations of colorectal cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Clinical manifestations of colorectal cancer ‚Ä¢ Distal colon: Œî bowel habits/ caliber, obstruction, colicky abd.</description></item><item><title>Clinical manifestations of esophageal cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-esophageal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-esophageal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[esophageal cancer]]
Clinical manifestations of esophageal cancer ‚Ä¢ Dysphagia, wt loss, early satiety, nausea, typically occult GI bleed, vague abd discomfort ‚Ä¢ Exam: diffuse seborrheic keratoses (Leser-Tr√©lat sign, though non-specific)</description></item><item><title>Clinical manifestations of hepatocellular carcinoma</title><link>https://www.physician.tw/Clinical-manifestations-of-hepatocellular-carcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-hepatocellular-carcinoma/</guid><description> [!info]
üå±‰æÜËá™: [[hepatocellular carcinoma]]
Clinical manifestations of hepatocellular carcinoma Exam: nonspec. c/w liver dysfxn (eg, hepatomegaly, ascites, jaundice, encephalopathy) Labs: coagulopathy, low albumin, elevated LFTs; r/o other etiologies of liver dysfxn</description></item><item><title>Clinical manifestations of ovarian cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-ovarian-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-ovarian-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[ovarian cancer]]
Clinical manifestations of ovarian cancer ‚Ä¢ Nonspecific history of bloating, pelvic/abdominal pain, bowel sx, urinary sx ‚Ä¢ Exam may reveal palpable pelvic mass, abdominal distention, or ascites</description></item><item><title>Clinical manifestations of pancreatic cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-pancreatic-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-pancreatic-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Clinical manifestations of pancreatic cancer ‚Ä¢ Painless jaundice (w/ pancreatic head mass), pain radiates to back, ‚Üì weight &amp;amp; appetite ‚Ä¢ New-onset atypical DM (25%); migratory thrombophlebitis (Trousseau‚Äôs syndrome) ‚Ä¢ Exam: jaundice, RUQ/epigastric nontender mass, palpable gallbladder (Courvoisier‚Äôs sign); hepatomegaly; ascites; L supraclavicular node (Virchow‚Äôs) ‚Ä¢ Laboratory tests may show ‚Üë bilirubin, ‚Üë alk phos, anemia</description></item><item><title>Clinical manifestations of tumor lysis syndrome</title><link>https://www.physician.tw/Clinical-manifestations-of-tumor-lysis-syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-tumor-lysis-syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[tumor lysis syndrome]]
Clinical manifestations of tumor lysis syndrome (NEJM 2011;364:1844) ‚Ä¢ Large tumor burden or a rapidly proliferating tumor ‚Üí spontaneous or chemotherapy-induced release of intracellular electrolytes and nucleic acids ‚Ä¢ Most common w/ treatment of high-grade lymphomas (Burkitt‚Äôs) and leukemias (ALL, AML, CML in blast crisis).</description></item><item><title>CLINICAL RESEARCH METHODS</title><link>https://www.physician.tw/clinical-research-methods/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-research-methods/</guid><description>clinical research methods Phase I Clinical Trials Phase IÔºå‰∫∫È´îËó•ÁêÜÁ†îÁ©∂ Phase II and III Clinical Trials Phase IIÔºåÊ≤ªÁôÇÊé¢Á¥¢ Phase IIIÔºåÊ≤ªÁôÇÁ¢∫Ë™ç Èï∑Â∫öÁ¥ÄÂøµÈÜ´Èô¢Ëá®Â∫äË©¶È©ó‰∏≠ÂøÉ Biomarker Development Biostatistics Regulatory Aspects of Clinical Trials</description></item><item><title>CNS metastatic disease</title><link>https://www.physician.tw/cns-metastatic-disease/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cns-metastatic-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[NEUROLOGICAL ONCOLOGY]]
CNS metastatic disease ‚Ä¢ ‚Üë incidence than 1¬∞ CNS. Most common: lung, breast, melanoma, RCC, gastro-esoph.</description></item><item><title>colonoscopy of Screening of colorectal cancer</title><link>https://www.physician.tw/colonoscopy-of-screening-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/colonoscopy-of-screening-of-colorectal-cancer/</guid><description>[!info]
üå± ‰æÜËá™: [[Screening of colorectal cancer]]
colonoscopy of Screening of colorectal cancer : preferred; 90% Se for lesions &amp;gt;1 cm.</description></item><item><title>Cystic lesions of the pancreas</title><link>https://www.physician.tw/Cystic-lesions-of-the-pancreas/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cystic-lesions-of-the-pancreas/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Cystic lesions of the pancreas (Am J Gastroenterol 2018;113:464) ‚Ä¢ Serous cystadenoma: usually benign; central scar or honeycomb appearance on imaging ‚Ä¢ Mucinous cystic neoplasm (MCN): predominantly young females; multiloculated tumors in body or tail w/ ovarian-type stroma and mucin-rich fluid w/ ‚Üë CEA levels; precancerous ‚Ä¢ Intraductal papillary mucinous neoplasm (IPMN): arises in main panc duct or branch</description></item><item><title>Definitions of Laboratory and Clinical TLS</title><link>https://www.physician.tw/Definitions-of-Laboratory-and-Clinical-TLS/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-of-Laboratory-and-Clinical-TLS/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Definitions of Laboratory and Clinical TLS (Source: The Tumor Lysis Syndrome.</description></item><item><title>Diagnosis and staging of esophageal cancer</title><link>https://www.physician.tw/Diagnosis-and-staging-of-esophageal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-and-staging-of-esophageal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[esophageal cancer]]
Diagnosis and staging of esophageal cancer ‚Ä¢ Both diagnosed w/ endoscopic biopsy. CT chest/abd/pelvis for staging.</description></item><item><title>Diagnosis of hepatocellular carcinoma</title><link>https://www.physician.tw/Diagnosis-of-hepatocellular-carcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-hepatocellular-carcinoma/</guid><description> [!info]
üå±‰æÜËá™: [[hepatocellular carcinoma]]
Diagnosis of hepatocellular carcinoma Can diagnose w/o biopsy in high-risk Pts with 3-phase contrast CT or MRI Only 15% of liver masses are HCC; liver metastases from other 1¬∞ more common</description></item><item><title>Diagnosis of ovarian cancer</title><link>https://www.physician.tw/Diagnosis-of-ovarian-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-ovarian-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[ovarian cancer]]
Diagnosis of ovarian cancer ‚Ä¢ No screening modalities have shown survival benefit; no data to support at this time ‚Ä¢ If concerning signs/sx (above), obtain pelvic U/S and/or CT A/P or pelvic MRI, CA-125 ‚Ä¢ Pathologic dx based on biopsy of lesion or sampling of ascitic fluid</description></item><item><title>Diagnosis of Tumor Lysis Syndrom</title><link>https://www.physician.tw/Diagnosis-of-Tumor-Lysis-Syndrom/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-Tumor-Lysis-Syndrom/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Diagnosis of Tumor Lysis Syndrom The diagnosis of TLS requires two or more of the following clinical abnormalities:</description></item><item><title>Diagnosis of Tumor Lysis Syndrome</title><link>https://www.physician.tw/Diagnosis-of-Tumor-Lysis-Syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-Tumor-Lysis-Syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Diagnosis of Tumor Lysis Syndrom The diagnosis of TLS requires two or more of the following clinical abnormalities:</description></item><item><title>Diagnostic and staging evaluation of pancreatic cancer</title><link>https://www.physician.tw/Diagnostic-and-staging-evaluation-of-pancreatic-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-and-staging-evaluation-of-pancreatic-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Diagnostic and staging evaluation of pancreatic cancer (NCCN Guidelines v.2.2021) ‚Ä¢ Pancreatic protocol CT scan (I+ w/ arterial &amp;amp; venous phase imaging) or MRI w/ contrast ‚Ä¢ If no lesion seen but concerning signs &amp;amp; sx as above ‚Üí EUS, ERCP, or MRCP ‚Ä¢ Biopsy pancreatic lesion via EUS-guided FNA (pref.</description></item><item><title>Diagnostic Test Panels</title><link>https://www.physician.tw/HBV-Natural-History/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HBV-Natural-History/</guid><description>at: [[inbox]]
Diagnostic Test Panels Interpretation of Diagnostic Test Panels ¬† Acute HBV Inactive Chronic HBV Active Chronic HBV Vaccinated/Immune Cleared/Latent Infection HBsAg +++ + ++ ‚Äì ‚Äì Anti-HBs _ ‚Äì ‚Äì ++ ++ Anti-HBc (IgM) ++ ‚Äì ‚Äì ‚Äì ‚Äì Anti-HBc (IgG) +++ + + ‚Äì + HBeAg +++ ‚Äì ¬± ‚Äì ‚Äì Anti-HBe ‚Äì ‚Äì ¬± ‚Äì ¬± HBV DNA +++ + ++/+++ ‚Äì ‚Äì ALT/AST Elevated Normal Elevated Normal Normal [[inbox]]</description></item><item><title>ENDOCRINE MALIGNANCIES</title><link>https://www.physician.tw/ENDOCRINE-MALIGNANCIES/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ENDOCRINE-MALIGNANCIES/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
ENDOCRINE MALIGNANCIES Thyroid Cancer Sellar Tumors Pheochromocytomas and MEN Syndrome Tumors of the Adrenal Cortex</description></item><item><title>Epidemiology and risk factors of pancreatic cancer</title><link>https://www.physician.tw/Epidemiology-and-risk-factors-of-pancreatic-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-risk-factors-of-pancreatic-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Epidemiology and risk factors of pancreatic cancer (Lancet 2016;388:73) ‚Ä¢ 4th leading cause of cancer death in U.</description></item><item><title>Epidemiology and risk factors of colorectal cancer</title><link>https://www.physician.tw/Epidemiology-and-risk-factors-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-risk-factors-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Epidemiology and risk factors of colorectal cancer (CA Cancer J Clin 2018;68:7) ‚Ä¢ 4th most common cancer in U.</description></item><item><title>Epidemiology of esophageal cancer</title><link>https://www.physician.tw/Epidemiology-of-esophageal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-of-esophageal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[esophageal cancer]]
Epidemiology of esophageal cancer (Lancet 2017;390:2383 &amp;amp; 2020;29:635) ‚Ä¢ Esophageal: Predominantly adenocarcinoma in U.S. (&amp;gt;60%), squamous cell (SCC) more common globally.</description></item><item><title>Extrahepatic Manifestations of HBV Clinical Presentation</title><link>https://www.physician.tw/Extrahepatic-Manifestations-of-HBV-Clinical-Presentation/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extrahepatic-Manifestations-of-HBV-Clinical-Presentation/</guid><description>[!info]
üå±‰æÜËá™: [[HBV Clinical Presentation]]
Extrahepatic Manifestations of HBV Clinical Presentation Lymphoma, mixed cryoglobulinemia, glomerulonephritis (membranoproliferative), auto-antibody disorders (e.</description></item><item><title>GASTROINTESTINAL MALIGNANCIES</title><link>https://www.physician.tw/GASTROINTESTINAL-MALIGNANCIES/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GASTROINTESTINAL-MALIGNANCIES/</guid><description> [!info]
üå±‰æÜËá™: [[Pocket Oncology]]
GASTROINTESTINAL MALIGNANCIES [[hepatocellular carcinoma]] (HCC) [[cancer of the biliary tree]] [[pancreatic cancer]] pancreatic and gi neuroendocrine neoplasms [[esophageal cancer]] gastric cancer appendix and small bowel carcinoma [[colorectal cancer]] (CRC) anal cancer</description></item><item><title>GENERAL ONCOLOGY</title><link>https://www.physician.tw/general-oncology/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/general-oncology/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
GENERAL ONCOLOGY Cancer Epidemiology Cancer Prevention &amp;amp; Screening Tele-Oncology
[[cancer epidemiology]] [[cancer prevention and screening]]</description></item><item><title>Genetics and path of pancreatic cancer</title><link>https://www.physician.tw/Genetics-and-path-of-pancreatic-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genetics-and-path-of-pancreatic-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Genetics and path of pancreatic cancer (Nat Rev Dis Primers 2016;2:16022) ‚Ä¢ Histologic types: adenocarcinoma (~85%), acinar cell carcinoma, endocrine tumors, cystic neoplasms (&amp;lt;10%); rarely, mets to pancreas (eg, lung, breast, renal cell) ‚Ä¢ Location: ~60% in head, 15% in body, 5% in tail; in 20% diffuse infiltration of pancreas ‚Ä¢ Adeno.</description></item><item><title>GENITOURINARY MALIGNANCIES</title><link>https://www.physician.tw/genitourinary-malignancies/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/genitourinary-malignancies/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
GENITOURINARY MALIGNANCIES Localized Prostate Cancer Recurrent/Metastatic Prostate Cancer Bladder Cancer Renal Cell Carcinoma (RCC) Germ Cell Tumors Penile Cancer</description></item><item><title>GYNECOLOGIC MALIGNANCIES</title><link>https://www.physician.tw/GYNECOLOGIC-MALIGNANCIES/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GYNECOLOGIC-MALIGNANCIES/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
GYNECOLOGIC MALIGNANCIES [[ovarian cancer]] Ovarian Germ Cell Tumors Endometrial Carcinoma Gestational Trophoblastic Disease Cervical Cancer Vulvar and Vaginal Cancer</description></item><item><title>HEAD AND NECK MALIGNANCIES</title><link>https://www.physician.tw/HEAD-AND-NECK-MALIGNANCIES/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HEAD-AND-NECK-MALIGNANCIES/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
HEAD AND NECK MALIGNANCIES Head &amp;amp; Neck Squamous Cell Cancer Nasopharyngeal Carcinoma Salivary Gland Tumors</description></item><item><title>Heritable Genetic Syndromes of colorectal cancer</title><link>https://www.physician.tw/Heritable-Genetic-Syndromes-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heritable-Genetic-Syndromes-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Heritable Genetic Syndromes of colorectal cancer Disorder CRC risk</description></item><item><title>Histopathology of ovarian cancer</title><link>https://www.physician.tw/Histopathology-of-ovarian-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Histopathology-of-ovarian-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[ovarian cancer]]
Histopathology of ovarian cancer ‚Ä¢ Epithelial ovarian carcinoma (EOC, 95%): high-grade serous (most common, often dx at late stage, poor prognosis), low-grade serous, endometroid, clear cell, mucinous ‚Ä¢ Non-epithelial (~5%): germ cell, sex cord-stromal.</description></item><item><title>Laboratory Abnormalities of HBV Clinical Presentation</title><link>https://www.physician.tw/Laboratory-Abnormalities-of-HBV-Clinical-Presentation/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-Abnormalities-of-HBV-Clinical-Presentation/</guid><description>[!info]
üå±‰æÜËá™: [[HBV Clinical Presentation]]
Laboratory Abnormalities of HBV Clinical Presentation Transaminase elevation: 1/3 normal transaminase levels, only 25% have &amp;gt; 2x ULN, poor correlation between transaminase elevation and liver history.</description></item><item><title>LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES</title><link>https://www.physician.tw/LEUKEMIAS-AND-MYELODYSPLASTIC-SYNDROMES/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/LEUKEMIAS-AND-MYELODYSPLASTIC-SYNDROMES/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES Myelodysplastic Syndromes Acute Myeloid Leukemia (AML) Acute Lymphoblastic Leukemia/Lymphoma Chronic Myelogenous Leukemia (CML) Chronic Lymphocytic Leukemia (CLL) Hairy Cell and Prolymphocytic Leukemia Clonal Hematopoiesis (CH)</description></item><item><title>MOLECULAR DIAGNOSTICS</title><link>https://www.physician.tw/molecular-diagnostics/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/molecular-diagnostics/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
MOLECULAR DIAGNOSTICS Sequencing Cytogenetics RNA Sequencing</description></item><item><title>NEUROLOGICAL ONCOLOGY</title><link>https://www.physician.tw/NEUROLOGICAL-ONCOLOGY/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NEUROLOGICAL-ONCOLOGY/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
NEUROLOGICAL ONCOLOGY Presentation and diagnosis ‚Ä¢ Suspect if new focal neurologic deficits, seizure, memory or balance issues, or evidence of ‚Üë intracranial pressure (HA, n/v, vision change) ‚Ä¢ MRI brain for suspected CNS tumors; CT less Se.</description></item><item><title>ovarian cancer</title><link>https://www.physician.tw/ovarian-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ovarian-cancer/</guid><description> [!info]
üå± ‰æÜËá™: [[GYNECOLOGIC MALIGNANCIES]]
ovarian cancer [[Histopathology of ovarian cancer]] [[Risk factors for EOC]] [[Clinical manifestations of ovarian cancer]] [[Diagnosis of ovarian cancer]] [[Treatment of ovarian cancer]]</description></item><item><title>palliative and supportive care</title><link>https://www.physician.tw/PALLIATIVE-AND-SUPPORTIVE-CARE/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PALLIATIVE-AND-SUPPORTIVE-CARE/</guid><description> [!info]
üå±‰æÜËá™: [[Pocket Oncology]]
PALLIATIVE AND SUPPORTIVE CARE principles of palliative care pain medications nonpain symptom management malignant bowel obstruction and tpn adolescent and young adult oncology older adult oncology psycho-oncology</description></item><item><title>pancreatic cancer</title><link>https://www.physician.tw/pancreatic-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatic-cancer/</guid><description> [!info]
üå± ‰æÜËá™: [[GASTROINTESTINAL MALIGNANCIES]]
pancreatic cancer [[Genetics and path of pancreatic cancer]] [[Epidemiology and risk factors of pancreatic cancer]] [[Clinical manifestations of pancreatic cancer]] [[Diagnostic and staging evaluation of pancreatic cancer]] [[Clinical (Radiologic) Staging Pancreatic Adenocarcinoma]] [[Treatment of pancreatic adenocarcinoma]] [[Prognosis of pancreatic cancer]] [[Cystic lesions of the pancreas]]</description></item><item><title>Pathophysiology of colorectal cancer</title><link>https://www.physician.tw/Pathophysiology-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Pathophysiology of colorectal cancer Assoc Cancers Hereditary nonpolyposis colorectal cancer (HNPCC or Lynch) ~80% lifetime Most common hered.</description></item><item><title>PEDIATRIC CANCERS</title><link>https://www.physician.tw/PEDIATRIC-CANCERS/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PEDIATRIC-CANCERS/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
PEDIATRIC CANCERS General Pediatric Considerations Pediatric Oncologic Emergencies Pediatric Hematologic Malignancies Bone Marrow Failure Syndromes Transplant and Cellular Therapy Central Nervous System Malignancies Malignant Bone Tumors Soft Tissue Sarcomas Neuroblastoma (NB) Hepatic and Renal Tumors Retinoblastoma (RB) Germ Cell Tumors</description></item><item><title>Pretreatment of Tumor Lysis Syndrom</title><link>https://www.physician.tw/Pretreatment-of-Tumor-Lysis-Syndrom/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pretreatment-of-Tumor-Lysis-Syndrom/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Pretreatment of Tumor Lysis Syndrom Pretreatment for patients identified at high risk for TLS:</description></item><item><title>Pretreatment of Tumor Lysis Syndrome</title><link>https://www.physician.tw/Pretreatment-of-Tumor-Lysis-Syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pretreatment-of-Tumor-Lysis-Syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Pretreatment of Tumor Lysis Syndrom Pretreatment for patients identified at high risk for TLS:</description></item><item><title>Prevention of HBV Clinical Presentation</title><link>https://www.physician.tw/Prevention-of-HBV-Clinical-Presentation/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-of-HBV-Clinical-Presentation/</guid><description>[!info]
üå±‰æÜËá™: [[HBV Clinical Presentation]]
Prevention of HBV Clinical Presentation See Hepatitis B, Vaccine¬†for indications, available products, dosing, and vaccine characteristics for pre-exposure prevention.</description></item><item><title>PRINCIPLES OF SURGERY AND INTERVENTIONAL ONCOLOGY</title><link>https://www.physician.tw/PRINCIPLES-OF-SURGERY-AND-INTERVENTIONAL-ONCOLOGY/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PRINCIPLES-OF-SURGERY-AND-INTERVENTIONAL-ONCOLOGY/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
PRINCIPLES OF SURGERY AND INTERVENTIONAL ONCOLOGY Principles of Surgical Oncology Surgical Emergencies Interventional Pulmonology Interventional Radiology Introduction Transarterial Therapies Image-Guided Percutaneous Ablation Musculoskeletal Interventions Interventional Radiology Emergencies</description></item><item><title>Prognosis of pancreatic cancer</title><link>https://www.physician.tw/Prognosis-of-pancreatic-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-of-pancreatic-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Prognosis of pancreatic cancer ‚Ä¢ Resectable: if Rx‚Äôd w/ adjuvant FOLFIRINOX, 50+ mos, o/w ~30 mos ‚Ä¢ Unresectable: if locally advanced ~1‚Äì2 y; if metastatic, ~1 y</description></item><item><title>Prophylaxis of tumor lysis syndrome</title><link>https://www.physician.tw/Prophylaxis-of-tumor-lysis-syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prophylaxis-of-tumor-lysis-syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[tumor lysis syndrome]]
Prophylaxis of tumor lysis syndrome ‚Ä¢ Allopurinol 300 mg qd to bid PO or 200‚Äì400 mg/m2 IV (adjusted for renal fxn) &amp;amp; aggressive hydration prior to beginning chemotherapy or RT</description></item><item><title>RADIATION ONCOLOGY</title><link>https://www.physician.tw/radiation-oncology/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/radiation-oncology/</guid><description>radiation oncology Basic Radiation Biology and Physics [[external beam radiation therapy]] Stereotactic Radiotherapy Brachytherapy Total Body Irradiation and TSEB Radiation Oncology Emergencies</description></item><item><title>Risk factors for EOC</title><link>https://www.physician.tw/Risk-factors-for-EOC/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-for-EOC/</guid><description>[!info]
üå±‰æÜËá™: [[ovarian cancer]]
Risk factors for EOC (Nat Rev Dis Primers 2016;2:16061) ‚Ä¢ Nulliparity, early menarche, late menopause; EOC risk ‚Üë 2‚Äì7% each additional ovulatory yr ‚Ä¢ Genetics: germline testing / genetics referral for all Pts (25% w/ heritable mutation), can inform Rx (eg, PARPi maintenance, JCO 2020;38:1222).</description></item><item><title>Risk factors of hepatocellular carcinoma</title><link>https://www.physician.tw/Risk-factors-of-hepatocellular-carcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-of-hepatocellular-carcinoma/</guid><description>[!info]
üå±‰æÜËá™: [[hepatocellular carcinoma]]
Risk factors of hepatocellular carcinoma (globally, 3rd leading cause of cancer death, espec. in Africa &amp;amp; Asia)</description></item><item><title>Risk Factors of Tumor Lysis Syndrome</title><link>https://www.physician.tw/Risk-Factors-of-Tumor-Lysis-Syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Factors-of-Tumor-Lysis-Syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Risk Factors of Tumor Lysis Syndrome renal dysfunction</description></item><item><title>Sanford Guide: HBV Clinical Presentation</title><link>https://www.physician.tw/HBV-Clinical-Presentation/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HBV-Clinical-Presentation/</guid><description>at: [[inbox]]
Sanford Guide: HBV Clinical Presentation</description></item><item><title>Sanford Guide: HBV Natural History</title><link>https://www.physician.tw/Phases-of-Infection/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phases-of-Infection/</guid><description>at: [[inbox]]
Sanford Guide: HBV Natural History Phases of Infection Three phases of HBV infection.
Not all patients successfully make it through all 3 phases:</description></item><item><title>Sanford Guide: HBV Natural History</title><link>https://www.physician.tw/Sanford-Guide-HBV-Natural-History/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sanford-Guide-HBV-Natural-History/</guid><description>at: [[inbox]]
Sanford Guide: HBV Natural History Diagnostic Test Panels Interpretation of Diagnostic Test Panels ¬† Acute HBV Inactive Chronic HBV Active Chronic HBV Vaccinated/Immune Cleared/Latent Infection HBsAg +++ + ++ ‚Äì ‚Äì Anti-HBs _ ‚Äì ‚Äì ++ ++ Anti-HBc (IgM) ++ ‚Äì ‚Äì ‚Äì ‚Äì Anti-HBc (IgG) +++ + + ‚Äì + HBeAg +++ ‚Äì ¬± ‚Äì ‚Äì Anti-HBe ‚Äì ‚Äì ¬± ‚Äì ¬± HBV DNA +++ + ++/+++ ‚Äì ‚Äì ALT/AST Elevated Normal Elevated Normal Normal [[inbox]]</description></item><item><title>Sanford Guide: HBV Treatment</title><link>https://www.physician.tw/HBV-Treatment/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HBV-Treatment/</guid><description>at: [[inbox]]
Sanford Guide: HBV Treatment Indications for TreatmentWhen to TreatTreatment RegimensPreventionComments
Indications for Treatment Treatment of Hepatitis B (HBV) infection.</description></item><item><title>Screening of colorectal cancer</title><link>https://www.physician.tw/Screening-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Screening of colorectal cancer (JAMA 2021;325:1965) ‚Ä¢ Average-risk Pts: start at age 45, repeat q1‚Äì10y based on screening modality ‚Ä¢ ‚Üë risk Pts: ‚äï FHx: screen age 40 or 10 y before index dx, then q5y.</description></item><item><title>Screening of esophageal cancer</title><link>https://www.physician.tw/Screening-of-esophageal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-of-esophageal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[esophageal cancer]]
Screening of esophageal cancer ‚Ä¢ Esophageal: screen for Barrett‚Äôs w/ endoscopy if multiple risk factors (eg, hiatal hernia, age ‚â•50, male, chronic GERD, obese, smoking, FHx).</description></item><item><title>Screening of hepatocellular carcinoma</title><link>https://www.physician.tw/Screening-of-hepatocellular-carcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-of-hepatocellular-carcinoma/</guid><description> [!info]
üå±‰æÜËá™: [[hepatocellular carcinoma]]
Screening of hepatocellular carcinoma (screen high-risk Pts: cirrhosis, chronic HBV)
Ultrasonography (U/S) + AFP q 6 mos; if high-risk may alternate U/S w/ MRI If lesion found or increasing AFP, perform 3-phase contrast CT or MRI</description></item><item><title>SKIN CANCERS AND SARCOMAS</title><link>https://www.physician.tw/SKIN-CANCERS-AND-SARCOMAS/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SKIN-CANCERS-AND-SARCOMAS/</guid><description>[!info]
üå±‰æÜËá™: [[Pocket Oncology]]
SKIN CANCERS AND SARCOMAS Basal and Squamous Cell Carcinomas [[Melanoma]] Soft Tissue Sarcomas (STS) Gastrointestinal Stromal Tumor Bone Sarcomas Ewing Sarcoma Family (ESFT)</description></item><item><title>Staging and treatment of colorectal cancer</title><link>https://www.physician.tw/Staging-and-treatment-of-colorectal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-and-treatment-of-colorectal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[colorectal cancer]]
Staging and treatment of colorectal cancer (NCCN Clin Pract Guidelines; version 3.2021) ‚Ä¢ TNM staging, including CT chest and abdomen/pelvis with contrast ¬± MRI pelvis for rectal ‚Ä¢ Baseline CEA: monitor post resection or follow response; not for screening ‚Ä¢ Chemo options (Lancet 2014;383:1490): 5-FU/leucovorin (LV) foundation.</description></item><item><title>Staging of HBV Clinical Presentation</title><link>https://www.physician.tw/Staging-of-HBV-Clinical-Presentation/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-of-HBV-Clinical-Presentation/</guid><description>[!info]
üå±‰æÜËá™: [[HBV Clinical Presentation]]
Staging of HBV Clinical Presentation Current treatment recommendations depend, in part, on the amount of liver fibrosis and hepatic inflammation.</description></item><item><title>Symptoms of HBV Clinical Presentation</title><link>https://www.physician.tw/Symptoms-of-HBV-Clinical-Presentation/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Symptoms-of-HBV-Clinical-Presentation/</guid><description>[!info]
üå±‰æÜËá™: [[HBV Clinical Presentation]]
Symptoms of HBV Clinical Presentation Patients with Hepatitis B (HBV) are usually asymptomatic.</description></item><item><title>THORACIC MALIGNANCIES</title><link>https://www.physician.tw/THORACIC-MALIGNANCIES/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/THORACIC-MALIGNANCIES/</guid><description> [!info]
üå±‰æÜËá™: [[Pocket Oncology]]
THORACIC MALIGNANCIES [[Epidemiology and risk factors-lung cancer]] [[Screening of THORACIC MALIGNANCIES]] ([[JAMA 2021;325:962]]) [[Clinical manifestations of lung cancer]] [[Diagnostic and staging evaluation of lung cancer]] [[NSCLC Treatment]] [[SCLC staging and treatment]] Non-Small Cell Lung Cancers Small Cell Lung Cancer Thymoma and Thymic Carcinoma Malignant Pleural Mesothelioma</description></item><item><title>Treatment of esophageal cancer</title><link>https://www.physician.tw/Treatment-of-esophageal-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-esophageal-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[esophageal cancer]]
Treatment of esophageal cancer (NCCN Guidelines v5.2021 Gastric &amp;amp; v4.2021 Esophageal) ‚Ä¢ If localized disease and good performance status/fit, goal is cure with surgery ‚Ä¢ Localized: resection.</description></item><item><title>Treatment of hepatocellular carcinoma</title><link>https://www.physician.tw/Treatment-of-hepatocellular-carcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-hepatocellular-carcinoma/</guid><description>[!info]
üå±‰æÜËá™: [[hepatocellular carcinoma]]
Treatment of hepatocellular carcinoma (NEJM 2019;380:1450) Hepatocellular Carcinoma | NEJM
Localized disease (goal = cure) ‚Üí resection if feasible (preferred), ablation, transarterial chemoembolization, or radiotherapy (SBRT) also options.</description></item><item><title>Treatment of ovarian cancer</title><link>https://www.physician.tw/Treatment-of-ovarian-cancer/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-ovarian-cancer/</guid><description>[!info]
üå±‰æÜËá™: [[ovarian cancer]]
Treatment of ovarian cancer ‚Ä¢ Cytoreductive surgery: survival benefit even for stage IV and relapsed disease (Gynecol Oncol 2013;130:493; NEJM 2021;385:2123).</description></item><item><title>Treatment of pancreatic adenocarcinoma</title><link>https://www.physician.tw/Treatment-of-pancreatic-adenocarcinoma/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-pancreatic-adenocarcinoma/</guid><description>[!info]
üå±‰æÜËá™: [[pancreatic cancer]]
Treatment of pancreatic adenocarcinoma (Lancet 2016;388:73) ‚Ä¢ Resectable: pancreaticoduodenectomy (Whipple procedure) + adjuvant chemo: modified FOLFIRINOX (5-FU + leucovorin, irinotecan, oxaliplatin) if ECOG 0-1 (NEJM 2018;379:2395), o/w gemcitabine + capecitabine (Lancet 2017;389:1011).</description></item><item><title>Treatment of Tumor Lysis Syndrome</title><link>https://www.physician.tw/Treatment-of-Tumor-Lysis-Syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Tumor-Lysis-Syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[Tumor Lysis Syndrome - Fast Facts]]
Treatment of Tumor Lysis Syndrome ‚Ä¢ Avoid IV contrast and NSAIDs; treat hyperK, hyperPO4, and only symptomatic hypoCa ‚Ä¢ Allopurinol + aggressive IV hydration ¬± diuretics to ‚Üë UOP for goal 80‚Äì100 cc/h ‚Ä¢ Rasburicase (0.</description></item><item><title>tumor lysis syndrome</title><link>https://www.physician.tw/tumor-lysis-syndrome/</link><pubDate>Wed, 08 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tumor-lysis-syndrome/</guid><description>[!info]
üå±‰æÜËá™: [[oncologic emergencies]]
tumor lysis syndrome Tumor lysis syndrome (TLS) is a medical emergency that occurs when the contents of tumor cells are released into the bloodstream, either spontaneously or in response to therapy.</description></item><item><title/><link>https://www.physician.tw/Neutropenia-Febrile-High-Risk/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neutropenia-Febrile-High-Risk/</guid><description>at: [[inbox]]
Neutropenia, Febrile, High-Risk [[Clinical Setting of Neutropenia-Febrile-High-Risk]]
[[Etiologies of Neutropenia-Febrile-High-Risk]]
[[Primary Regimens of Neutropenia-Febrile-High-Risk]]</description></item><item><title>Agents without benefit of Treatment of idiopathic pulmonary fibrosis</title><link>https://www.physician.tw/Agents-without-benefit-of-Treatment-of-idiopathic-pulmonary-fibrosis/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Agents-without-benefit-of-Treatment-of-idiopathic-pulmonary-fibrosis/</guid><description>[!info]
üå±‰æÜËá™: [[Treatment of idiopathic pulmonary fibrosis]]
Agents without benefit of Treatment of idiopathic pulmonary fibrosis ‚Ä¢Adjunctive therapies Use of empiric antireflux medications, anticoagulants, or antibiotics for the improvement of pulmonary outcomes in patients with IPF is unlikely to be beneficial based on negative results from clinical trials.</description></item><item><title>Alternative Regimens of Neutropenia-Febrile-High-Risk</title><link>https://www.physician.tw/Alternative-Regimens-of-Neutropenia-Febrile-High-Risk/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alternative-Regimens-of-Neutropenia-Febrile-High-Risk/</guid><description> [!info]
üå±‰æÜËá™: [[Neutropenia-Febrile-High-Risk]]
Alternative Regimens of Neutropenia-Febrile-High-Risk Initial therapy for fever: [Ceftazidime][18] 2 gm IV q8-12h; see comment for duration Enhanced Gram+ coverage: [Linezolid][19] 600 mg IV/po q12h or [Daptomycin][20] 6 mg/kg IV q24h (if not concerned for pneumonia) Empiric antifungal therapy active against candida and mold: [Liposomal Amphotericin B][21] 3-5 mg/kg IV q24h</description></item><item><title>Alternative Regimens of Pneumocystis pneumonia, PJP, Adult</title><link>https://www.physician.tw/Alternative-Regimens-of-Pneumocystis-pneumonia-PJP-Adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alternative-Regimens-of-Pneumocystis-pneumonia-PJP-Adult/</guid><description>[!info]
üå±‰æÜËá™: [[Pneumocystis pneumonia, PJP, Adult]]
Alternative Regimens of Pneumocystis pneumonia, PJP, Adult Adult Treatment
Patient not critically ill, able to take po meds:</description></item><item><title>Antifibrotic therapy of Treatment of idiopathic pulmonary fibrosis</title><link>https://www.physician.tw/Antifibrotic-therapy-of-Treatment-of-idiopathic-pulmonary-fibrosis/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antifibrotic-therapy-of-Treatment-of-idiopathic-pulmonary-fibrosis/</guid><description>[!info]
üå±‰æÜËá™: [[Treatment of idiopathic pulmonary fibrosis]]
Antifibrotic therapy of Treatment of idiopathic pulmonary fibrosis For patients with mild-to-moderate IPF based on pulmonary function tests who live in an area where either pirfenidone or nintedanib is available, we recommend initiating therapy with the available agent (Grade 1B).</description></item><item><title>calcium channel blocker</title><link>https://www.physician.tw/calcium-channel-blocker/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/calcium-channel-blocker/</guid><description>[!info]
üå± ‰æÜËá™: [[Rate Control-atrial fibrillation]]
calcium channel blocker lower BP (Rx w/ Ca gluc) Can worsen HF Nondihydropyridine calcium channel antagonists should not be used in decompensated HF</description></item><item><title>Clinical Setting of Neutropenia-Febrile-High-Risk</title><link>https://www.physician.tw/Clinical-Setting-of-Neutropenia-Febrile-High-Risk/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Setting-of-Neutropenia-Febrile-High-Risk/</guid><description>[!info]
üå±‰æÜËá™: [[Neutropenia-Febrile-High-Risk]]
Clinical Setting of Neutropenia-Febrile-High-Risk Febrile neutropenia: Post-cancer chemotherapy or post-allogeneic bone marrow transplant patient with fever (‚â•38.</description></item><item><title>Clinical Setting of Pneumocystis pneumonia, PJP, Adult</title><link>https://www.physician.tw/Clinical-Setting-of-Pneumocystis-pneumonia-PJP-Adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Setting-of-Pneumocystis-pneumonia-PJP-Adult/</guid><description>[!info]
üå±‰æÜËá™: [[Pneumocystis pneumonia, PJP, Adult]]
Clinical Setting of Pneumocystis pneumonia, PJP, Adult Pneumocystis pneumonia (PJP) is a potentially life-threatening fungal pneumonia in immunocompromised patients, especially HIV/AIDS.</description></item><item><title>Comments of Neutropenia-Febrile-High-Risk</title><link>https://www.physician.tw/Comments-of-Neutropenia-Febrile-High-Risk/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Comments-of-Neutropenia-Febrile-High-Risk/</guid><description>[!info]
üå±‰æÜËá™: [[Neutropenia-Febrile-High-Risk]]
Comments of Neutropenia-Febrile-High-Risk Duration of empiric therapy:¬†when clinically recovered and afebrile for 72 hrs In a multicenter randomized study, control patients continued empiric antibiotic therapy until the absolute neutrophil count was ‚â• 0.</description></item><item><title>Comments of Pneumocystis pneumonia, PJP, Adult</title><link>https://www.physician.tw/Comments-of-Pneumocystis-pneumonia-PJP-Adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Comments-of-Pneumocystis-pneumonia-PJP-Adult/</guid><description>[!info]
üå±‰æÜËá™: [[Pneumocystis pneumonia, PJP, Adult]]
Comments of Pneumocystis pneumonia, PJP, Adult Report of TMP-SMX associated psychosis during treatment of PJP: J Antimic Chemother 66:1117, 2011.</description></item><item><title>consider cardioversion if</title><link>https://www.physician.tw/consider-cardioversion-if/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consider-cardioversion-if/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardioversion]]
consider cardioversion if 1st AF, sx, tachycardia- mediated CMP, or difficult to rate control</description></item><item><title>Consider cardioversion of Approach to acute AF</title><link>https://www.physician.tw/consider-cardioversion-of-approach-to-acute-af/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consider-cardioversion-of-approach-to-acute-af/</guid><description>[!info]
üå± ‰æÜËá™: [[Approach to acute AF]]
Consider cardioversion of Approach to acute AF &amp;lt;48 hour if low risk of stroke</description></item><item><title>cosyntropin stimulation test</title><link>https://www.physician.tw/cosyntropin-stimulation-test/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cosyntropin-stimulation-test/</guid><description>[!info]
üå± ‰æÜËá™: [[Diagnostic studies-adrenal insufficiency]]
cosyntropin stimulation test Œî The ACTH stimulation test may be performed any time of day.</description></item><item><title>Diagnosis of adrenal insufficiency in adults</title><link>https://www.physician.tw/Diagnosis-of-adrenal-insufficiency-in-adults/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-adrenal-insufficiency-in-adults/</guid><description>at: [[inbox]]
Diagnosis of adrenal insufficiency in adults INTRODUCTION¬†‚Äî¬†The clinical presentation of adrenal insufficiency is variable, depending on whether the onset is acute, leading to adrenal crisis, or chronic, with symptoms that are more insidious and vague.</description></item><item><title>diagnostic approach to suspected adrenal insufficiency</title><link>https://www.physician.tw/diagnostic-approach-to-suspected-adrenal-insufficiency/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-approach-to-suspected-adrenal-insufficiency/</guid><description>[!info]
üå± ‰æÜËá™: [[Diagnostic studies-adrenal insufficiency]]
diagnostic approach to suspected adrenal insufficiency Figure: Signs and symptoms that are relatively specific for chronic primary adrenal insufficiency include hyperkalemia, skin hyperpigmentation, postural hypotension, and salt craving.</description></item><item><title>Early Rhythm-Control Therapy in Patients with Atrial Fibrillation</title><link>https://www.physician.tw/Early-Rhythm-Control-Therapy-in-Patients-with-Atrial-Fibrillation/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Early-Rhythm-Control-Therapy-in-Patients-with-Atrial-Fibrillation/</guid><description>at: [[inbox]]
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Original Article
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Abstract Background Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications.</description></item><item><title>Etiologies of Neutropenia-Febrile-High-Risk</title><link>https://www.physician.tw/Etiologies-of-Neutropenia-Febrile-High-Risk/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Neutropenia-Febrile-High-Risk/</guid><description>[!info]
üå±‰æÜËá™: [[Neutropenia-Febrile-High-Risk]]
Etiologies of Neutropenia-Febrile-High-Risk Bacteria: aerobic gram-negative bacilli (Enterobacteriaceae, Pseudomonas), aerobic gram-positive cocci (includes staphylococci and streptococci) Fungi: Candida sp &amp;gt; molds (Aspergillus, Fusarium, etc.</description></item><item><title>Etiologies of Pneumocystis pneumonia, PJP, Adult</title><link>https://www.physician.tw/Etiologies-of-Pneumocystis-pneumonia-PJP-Adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Pneumocystis-pneumonia-PJP-Adult/</guid><description> [!info]
üå±‰æÜËá™: [[Pneumocystis pneumonia, PJP, Adult]]
Etiologies of Pneumocystis pneumonia, PJP, Adult Pneumocystis jirovecii</description></item><item><title>idea on medical practice</title><link>https://www.physician.tw/idea-on-medical-practice/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/idea-on-medical-practice/</guid><description> [!info]
üå± ‰æÜËá™: [[clinical reasoning]]
idea on medical practice Where&amp;rsquo;s the money? ÊÖ¢‰∏ÄÈªûÔºåÂÖàÁ¢∫ÂÆöË®∫Êñ∑Ôºå‰∏çË¶ÅËÆì‰Ω†ÁöÑÊ≤ªÁôÇÂπ≤Êìæ‰∫ÜË®∫Êñ∑ Êú™ÁïôÂüπÈ§äÂ∞±ÂÖà‰∏äÊäóÁîüÁ¥†„ÄÅÊú™ÁïôË°ÄÁâáÂ∞±Ëº∏Ë°Ä„ÄÅÊú™Êü•Â∞±ÂÖàÁµ¶È°ûÂõ∫ÈÜá</description></item><item><title>imaging studies to consider of diagnostic studies-adrenal insufficiency</title><link>https://www.physician.tw/imaging-studies-to-consider-of-diagnostic-studies-adrenal-insufficiency/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/imaging-studies-to-consider-of-diagnostic-studies-adrenal-insufficiency/</guid><description>[!info]
üå± ‰æÜËá™: [[Diagnostic studies-adrenal insufficiency]]
imaging studies to consider of diagnostic studies-adrenal insufficiency pituitary MRI to detect anatomical abnormalities adrenal CT: small, noncalcified adrenals in autoimmune, enlarged in metastatic disease, hemorrhage, infection or deposition (although they may be normal-appearing)</description></item><item><title>Lung transplantation of Treatment of idiopathic pulmonary fibrosis</title><link>https://www.physician.tw/Lung-transplantation-of-Treatment-of-idiopathic-pulmonary-fibrosis/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lung-transplantation-of-Treatment-of-idiopathic-pulmonary-fibrosis/</guid><description>[!info]
üå±‰æÜËá™: [[Treatment of idiopathic pulmonary fibrosis]]
Lung transplantation of Treatment of idiopathic pulmonary fibrosis Lung transplantation may be an option for patients with progressive disease and minimal comorbidities.</description></item><item><title>metoprolol</title><link>https://www.physician.tw/metoprolol/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metoprolol/</guid><description>[!info]
üå± ‰æÜËá™: [[Rate Control-atrial fibrillation]]
metoprolol 2.5-5 mg over 2' may repeat q5‚Äô √ó 3 25-100 mg bid or tid lower BP (Rx w/ glucagon) Preferred if CAD Risks: HF &amp;amp; bronchospasm.</description></item><item><title>metyrapone</title><link>https://www.physician.tw/metyrapone/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metyrapone/</guid><description>[!info]
üå± ‰æÜËá™: [[Diagnostic studies-adrenal insufficiency]]
metyrapone (blocks cortisol synthesis and therefore stimulates ACTH, measure plasma 11-deoxycortisol and urinary 17-hydroxycorticosteroid levels)</description></item><item><title>Participation in clinical trials of Treatment of idiopathic pulmonary fibrosis</title><link>https://www.physician.tw/Participation-in-clinical-trials-of-Treatment-of-idiopathic-pulmonary-fibrosis/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Participation-in-clinical-trials-of-Treatment-of-idiopathic-pulmonary-fibrosis/</guid><description>[!info]
üå±‰æÜËá™: [[Treatment of idiopathic pulmonary fibrosis]]
Participation in clinical trials of Treatment of idiopathic pulmonary fibrosis While antifibrotic agents slow disease progression, a therapeutic response is obtained in only a portion of patients, and survival is poor even for those who respond.</description></item><item><title>Patients at risk PJP, Adult</title><link>https://www.physician.tw/patients-at-risk-pjp-adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/patients-at-risk-pjp-adult/</guid><description>[!info]
üå± ‰æÜËá™: [[Clinical Setting of Pneumocystis pneumonia, PJP, Adult]]
Patients at risk PJP, Adult HIV/AIDS patients with CD4 counts &amp;lt;200 cells/ŒºL.</description></item><item><title>Primary Regimens of Neutropenia-Febrile-High-Risk</title><link>https://www.physician.tw/Primary-Regimens-of-Neutropenia-Febrile-High-Risk/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Regimens-of-Neutropenia-Febrile-High-Risk/</guid><description>[!info]
üå±‰æÜËá™: [[Neutropenia-Febrile-High-Risk]]
Primary Regimens of Neutropenia-Febrile-High-Risk Initial therapy for fever:
[Cefepime][6] 2 gm IV q8h OR an anti-pseudomonal carbapenem [(Meropenem][7] 1-2 gm IV q8h or [Imipenem][8] 500 IV q6h or [Doripenem][9] 500 mg IV q8h)</description></item><item><title>Primary Regimens of Pneumocystis pneumonia, PJP, Adult</title><link>https://www.physician.tw/Primary-Regimens-of-Pneumocystis-pneumonia-PJP-Adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Regimens-of-Pneumocystis-pneumonia-PJP-Adult/</guid><description>[!info]
üå±‰æÜËá™: [[Pneumocystis pneumonia, PJP, Adult]]
Primary Regimens of Pneumocystis pneumonia, PJP, Adult Adult Treatment; Patient able to take po meds:</description></item><item><title>Sanford Guide: Pneumocystis pneumonia, PJP, Adult</title><link>https://www.physician.tw/Pneumocystis-pneumonia-PJP-Adult/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pneumocystis-pneumonia-PJP-Adult/</guid><description>at: [[inbox]]
Sanford Guide: Pneumocystis pneumonia, PJP, Adult [[Clinical Setting of Pneumocystis pneumonia, PJP, Adult]] [[Etiologies of Pneumocystis pneumonia, PJP, Adult]] [[Primary Regimens of Pneumocystis pneumonia, PJP, Adult]] [[Alternative Regimens of Pneumocystis pneumonia, PJP, Adult]] [[Comments of Pneumocystis pneumonia, PJP, Adult]]</description></item><item><title>Sonlol</title><link>https://www.physician.tw/sonlol/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sonlol/</guid><description>[!info]
üå± ‰æÜËá™: [[Antiarrhythmic Drugs (AAD) for AF]]
Sonlol na 80-160 mg bidy for + HR.t QT: renal adj</description></item><item><title>Supportive care of Treatment of idiopathic pulmonary fibrosis</title><link>https://www.physician.tw/Supportive-care-of-Treatment-of-idiopathic-pulmonary-fibrosis/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Supportive-care-of-Treatment-of-idiopathic-pulmonary-fibrosis/</guid><description>[!info]
üå±‰æÜËá™: [[Treatment of idiopathic pulmonary fibrosis]]
Supportive care of Treatment of idiopathic pulmonary fibrosis We offer supportive care (eg, supplemental oxygen, pulmonary rehabilitation, and COVID-19, pneumococcal, and seasonal influenza vaccination) and provide information about end-of-life issues and advanced directives to all patients.</description></item><item><title>Treatment of idiopathic pulmonary fibrosis</title><link>https://www.physician.tw/Treatment-of-idiopathic-pulmonary-fibrosis/</link><pubDate>Tue, 07 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-idiopathic-pulmonary-fibrosis/</guid><description>at: [[inbox]]
Treatment of idiopathic pulmonary fibrosis SUMMARY AND RECOMMENDATIONS
Overview Management of IPF generally includes a combination of supportive care, use of selected medications (eg, pirfenidone, nintedanib), consideration for participation in clinical trials, referral for lung transplant evaluation (when appropriate), and identification and treatment of comorbidities.</description></item><item><title>Dextrose (Glucose) Injection</title><link>https://www.physician.tw/dextrose-glucose-injection/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dextrose-glucose-injection/</guid><description> [!info]
üå± ‰æÜËá™: [[replenishers and regulators of water and electrolytes]]
Dextrose (Glucose) Injection</description></item><item><title>Dextrose 2_5% and Sodium Chloride 0_45 Injection</title><link>https://www.physician.tw/dextrose-and-sodium-chloride-injection/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dextrose-and-sodium-chloride-injection/</guid><description> [!info]
üå± ‰æÜËá™: [[replenishers and regulators of water and electrolytes]]
Dextrose 2_5% and Sodium Chloride 0_45 Injection</description></item><item><title>Lactated Ringer's</title><link>https://www.physician.tw/Lactated-Ringers/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lactated-Ringers/</guid><description>[!info]
üå± ‰æÜËá™: [[replenishers and regulators of water and electrolytes]]
Lactated Ringer&amp;rsquo;s a.k.a. Hartmann&amp;rsquo;s
Na: 131 K:5 Ca:4 Cl:111 Bicarbonate: 29</description></item><item><title>markdown garden</title><link>https://www.physician.tw/markdown-garden/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/markdown-garden/</guid><description> [!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
markdown garden</description></item><item><title>replenishers and regulators of water and electrolytes</title><link>https://www.physician.tw/replenishers-and-regulators-of-water-and-electrolytes/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/replenishers-and-regulators-of-water-and-electrolytes/</guid><description> [!info]
üå± ‰æÜËá™: [[nephrology]]
replenishers and regulators of water and electrolytes [[Calcium Carbonate]] (CaCO3) [[Calcium Chloride]] Dextrose (Glucose) and Electrolyte Solutions ([[Taita no5]]) [[Dextrose (Glucose) Injection]] [[Dextrose 2_5% and Sodium Chloride 0_45 Injection]] Dialysis Solutions Hemodialysis concentrate Solutions [[Lactated Ringer&amp;rsquo;s]] Injection [[Magnesium Sulfate]] Injection [[Potassium Chloride]] Injection [[Potassium Gluconate]] [[Potassium Phosphate]] Ringer&amp;rsquo;s Injection [[Sodium Bicarbonate]] [[Sodium Chloride]] (NaCl) Injection [[Sodium glycerophosphate pentahydrate]] [[Sodium Polystyrene Sulfonate]] [[Trace Elements]]</description></item><item><title>serum calcium</title><link>https://www.physician.tw/calcium-serum/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/calcium-serum/</guid><description>[!info]
üå± ‰æÜËá™: [[hypocalcemia]]
serum calcium Calcium Correction for Hypoalbuminemia Corrected Calcium = (0.8 * (Normal Albumin - Pt&amp;rsquo;s Albumin)) + Serum Ca Note: formula assumes albumin units in g/dL.</description></item><item><title>Taita no5</title><link>https://www.physician.tw/Taita-no-five/</link><pubDate>Mon, 06 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Taita-no-five/</guid><description>[!info]
üå± ‰æÜËá™: [[replenishers and regulators of water and electrolytes]]
Taita no5 Na: 36 K:18 Mg:3 Cl:17 Acetate: 28 Phosphate: 12</description></item><item><title>Absent a Misdiagnosis, What Causes Treatment-Resistant Hypertension?</title><link>https://www.physician.tw/Absent-a-Misdiagnosis-What-Causes-Treatment-Resistant-Hypertension/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Absent-a-Misdiagnosis-What-Causes-Treatment-Resistant-Hypertension/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
Absent a Misdiagnosis, What Causes Treatment-Resistant Hypertension? Treatment-resistant hypertension is defined as a blood pressure that is higher than the goal of less than 130/80 mm Hg in patients who are receiving at least three medications, including a diuretic.</description></item><item><title>Aldosterone and Treatment-Resistant Hypertension</title><link>https://www.physician.tw/Aldosterone-and-Treatment-Resistant-Hypertension/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aldosterone-and-Treatment-Resistant-Hypertension/</guid><description>at: [[inbox]]
Aldosterone and Treatment-Resistant Hypertension [[Introduction of Aldosterone and Treatment-Resistant Hypertension]]
[[What Is Hypertension, and Why Should We Care?</description></item><item><title>Can Medication Target or Treat It? of Aldosterone and Treatment-Resistant Hypertension</title><link>https://www.physician.tw/Can-Medication-Target-or-Treat-It-of-Aldosterone-and-Treatment-Resistant-Hypertension/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Can-Medication-Target-or-Treat-It-of-Aldosterone-and-Treatment-Resistant-Hypertension/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
Can Medication Target or Treat It? of Aldosterone and Treatment-Resistant Hypertension Fortunately, yes.</description></item><item><title>Diagnostic Use of Base Excess in Acid‚ÄìBase Disorders</title><link>https://www.physician.tw/Diagnostic-Use-of-Base-Excess-in-AcidBase-Disorders/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Use-of-Base-Excess-in-AcidBase-Disorders/</guid><description>at: [[inbox]]
Diagnostic Use of Base Excess in Acid‚ÄìBase Disorders Introduction For almost 100 years, clinicians have been trying to assess acid‚Äìbase disturbances accurately and to unravel the mechanisms involved.</description></item><item><title>How Does Baxdrostat Affect Aldosterone Levels?</title><link>https://www.physician.tw/How-Does-Baxdrostat-Affect-Aldosterone-Levels/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-Does-Baxdrostat-Affect-Aldosterone-Levels/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
How Does Baxdrostat Affect Aldosterone Levels? Figure 2. Figure 2. Aldosterone Synthesis in the [[Zona Glomerulosa]].</description></item><item><title>How Does Spironolactone Work?</title><link>https://www.physician.tw/How-Does-Spironolactone-Work/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-Does-Spironolactone-Work/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
How Does Spironolactone Work? Spironolactone competes with aldosterone to bind to the mineralocorticoid receptor (also known as the aldosterone receptor), which is expressed in the distal convoluted tubule cells of the kidney.</description></item><item><title>How Is Treatment-Resistant Hypertension Defined?</title><link>https://www.physician.tw/How-Is-Treatment-Resistant-Hypertension-Defined/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-Is-Treatment-Resistant-Hypertension-Defined/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
How Is Treatment-Resistant Hypertension Defined? For several reasons, blood pressure in a patient with hypertension may not be lowered to ideal target levels, despite the use of antihypertensive medications.</description></item><item><title>Introduction of Aldosterone and Treatment-Resistant Hypertension</title><link>https://www.physician.tw/Introduction-of-Aldosterone-and-Treatment-Resistant-Hypertension/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Introduction-of-Aldosterone-and-Treatment-Resistant-Hypertension/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
Introduction of Aldosterone and Treatment-Resistant Hypertension Aldosterone has long been a pharmacologic target for the treatment of hypertension.</description></item><item><title>Is Sodium Retention a Major Feature of Treatment-Resistant Hypertension?</title><link>https://www.physician.tw/Is-Sodium-Retention-a-Major-Feature-of-Treatment-Resistant-Hypertension/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Is-Sodium-Retention-a-Major-Feature-of-Treatment-Resistant-Hypertension/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
Is Sodium Retention a Major Feature of Treatment-Resistant Hypertension? Yes. Many patients with treatment-resistant hypertension have salt-sensitive hypertension, a condition in which increased sodium intake results in increased blood pressure through sodium and water retention.</description></item><item><title>What Is Hypertension, and Why Should We Care?</title><link>https://www.physician.tw/What-Is-Hypertension-and-Why-Should-We-Care/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/What-Is-Hypertension-and-Why-Should-We-Care/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
What Is Hypertension, and Why Should We Care? The definition of ideal or ‚Äúnormal‚Äù blood pressure, which is presently based on population-level data, is a blood pressure of 120/80 mm Hg or lower in adults.</description></item><item><title>What‚Äôs Next? of Aldosterone and Treatment-Resistant Hypertension</title><link>https://www.physician.tw/Whats-Next-of-Aldosterone-and-Treatment-Resistant-Hypertension/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Whats-Next-of-Aldosterone-and-Treatment-Resistant-Hypertension/</guid><description>[!info]
üå±‰æÜËá™: [[Aldosterone and Treatment-Resistant Hypertension]]
What‚Äôs Next? of Aldosterone and Treatment-Resistant Hypertension Among the new therapeutic agents that target the renin‚Äìangiotensin‚Äìaldosterone system in patients with treatment-resistant hypertension are nonsteroidal mineralocorticoid receptor antagonists and [antisense oligonucleotide.</description></item><item><title>Zona Glomerulosa</title><link>https://www.physician.tw/glomerular-zone/</link><pubDate>Sun, 05 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glomerular-zone/</guid><description> [!info]
üå± ‰æÜËá™: [[How Does Baxdrostat Affect Aldosterone Levels?]]
Zona Glomerulosa</description></item><item><title>Brugada</title><link>https://www.physician.tw/brugada/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/brugada/</guid><description> [!info]
üå± ‰æÜËá™: [[ECG-in-young-athletes]]
Brugada</description></item><item><title>Cheyne-Stokes respirations</title><link>https://www.physician.tw/cheyne-stokes-respirations/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cheyne-stokes-respirations/</guid><description>[!info]
üå± ‰æÜËá™: [[Kussmaul‚Äôs respirations]]
Cheyne-Stokes respirations Cheyne-Stokes breathing involves a period of fast, shallow breathing followed by slow, heavier breathing and moments without any breath at all (apneas).</description></item><item><title>clinical problem solvers</title><link>https://www.physician.tw/clinical-problem-solvers/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-problem-solvers/</guid><description>[!info]
üå± ‰æÜËá™: [[clinical reasoning]]
clinical problem solvers [[Renal of clinical problem solvers]]
[[Infectious of clinical problem solvers]]</description></item><item><title>dysmorphic red blood cell</title><link>https://www.physician.tw/dysmorphic-red-blood-cell/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysmorphic-red-blood-cell/</guid><description> [!info]
üå± ‰æÜËá™: [[Urinalysis interpretation]]
dysmorphic red blood cell Dysmorphic RBC(urine); Â∞ø‰∏≠ËÆäÂΩ¢Á¥ÖË°ÄÁêÉ
Â§ßÂ∞è‰∏ç‰∏Ä Á™ÅÂá∫ÊàñÂÉèÁ¢éÁâáÁ®±ÁÇ∫ËÆäÂΩ¢Á¥ÖË°ÄÁêÉ(dysmorphic RBC)Ôºå ËàáËÖéÁµ≤ÁêÉÂá∫Ë°ÄÊúâÈóú ddx &amp;ndash;&amp;gt; Áï∂80%‰ª•‰∏äÁ¥ÖË°ÄÁêÉÂΩ¢ÁãÄ‰∏ÄËá¥‰∏î Êú™Êâ≠Êõ≤ËÆäÂΩ¢ÊôÇ * Âá∫Ë°ÄÈÉ®‰Ωç‰∏çÂú®ËÖéÁµ≤ÁêÉ * ËÄåÂú®ËÖéÂ∞èÁÆ°ÊàñËàáÁµêÁü≥Êàñ‰∏ãÊ≥åÂ∞øÈÅìÁñæÁóÖÊúâÈóú BacklinkÔºö [[Definition-glomerulonephritis]] [[Intrinsic acute kidney injury etiology]] [[Urinalysis interpretation]]</description></item><item><title>IUPAC</title><link>https://www.physician.tw/iupac/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/iupac/</guid><description> [!info]
üå± ‰æÜËá™: [[ketone bodies]]
IUPAC Organic Nomenclature
me eat pro but
Methyl Ethyl Propyl Butyl</description></item><item><title>ketone bodies</title><link>https://www.physician.tw/ketone-bodies/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ketone-bodies/</guid><description>[!info]
üå± ‰æÜËá™: [[Pathophysiology-diabetic ketoacidosis]]
ketone bodies acetoacetate ÈòøË•øÈòøË•ø ÊîæÁ¨¨‰∏ÄÂÄãÊòØÂõ†ÁÇ∫Â∞øË£°Âè™ÁúãÂæóÂà∞ÂÆÉ Œ≤-hydroxybutyrate ÊèπÂó®Ê°åÂ∏É acetone ÈòøË•øÈÖÆ Explain by ChatGPT Acetoacetate, Œ≤-hydroxybutyrate, and acetone are ketone bodies.</description></item><item><title>Kussmaul‚Äôs respirations</title><link>https://www.physician.tw/kussmauls-respirations/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/kussmauls-respirations/</guid><description>[!info]
üå± ‰æÜËá™: [[Clinical manifestations-diabetic ketoacidosis]]
Kussmaul‚Äôs respirations Kussmaul breathing (also called Kussmaul respirations) is an abnormal breathing pattern characterized by rapid, deep breathing at a consistent pace.</description></item><item><title>Metabolic Acidosis: Overview</title><link>https://www.physician.tw/metabolic-acidosis-overview/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metabolic-acidosis-overview/</guid><description>[!info]
üå± ‰æÜËá™: [[Renal of clinical problem solvers]]
Metabolic Acidosis: Overview cation anion na, k anion gap, HCO3-, Cl- High A/G acidosis ÂæóÂà∞ÈÖ∏ A/G ++ , HCO3 &amp;ndash;</description></item><item><title>nitrate reductase</title><link>https://www.physician.tw/nitrate-reductase/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nitrate-reductase/</guid><description>[!info]
üå± ‰æÜËá™: [[Urine Dipstick]]
nitrate reductase NADH or NADPH to nitrate.</description></item><item><title>Renal of clinical problem solvers</title><link>https://www.physician.tw/renal-of-clinical-problem-solvers/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-of-clinical-problem-solvers/</guid><description>[!info]
üå± ‰æÜËá™: [[clinical problem solvers]]
Renal of clinical problem solvers [[AKI ‚Äì overview]]
[[AKI and Cancer]]
[[Aldosterone ‚Äì Inappropriate]]</description></item><item><title>sensitivity and specificity</title><link>https://www.physician.tw/sensitivity-and-specificity/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sensitivity-and-specificity/</guid><description> [!info]
üå± ‰æÜËá™: [[diagnostic process]]
sensitivity and specificity sen high -&amp;gt; if negative -&amp;gt; exclude ÊïèËã•Èô∞ÊéíÈô§ spe high -&amp;gt; if positive -&amp;gt; include ÁâπËã•ÈôΩÊúâÁóÖ</description></item><item><title>Serum osmolal gap - UpToDate</title><link>https://www.physician.tw/osmolal-gap/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/osmolal-gap/</guid><description>at: [[inbox]]
Serum osmolal gap - UpToDate All topics are updated as new evidence becomes available and our peer review process is complete.</description></item><item><title>Serum osmolal gap - UpToDate</title><link>https://www.physician.tw/Serum-osmolal-gap/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serum-osmolal-gap/</guid><description>at: [[inbox]]
Serum osmolal gap - UpToDate All topics are updated as new evidence becomes available and our peer review process is complete.</description></item><item><title>urinalysis interpretation</title><link>https://www.physician.tw/urinalysis-interpretation/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urinalysis-interpretation/</guid><description>[!info]
üå± ‰æÜËá™: [[Renal of clinical problem solvers]]
Urinalysis interpretation [!tldr] TLDR
Squamous Epithelial CellÔºö ÂèØÂÅöÁÇ∫Êé°Ê™¢‰∏çËâØÁöÑ‰∏ÄÂÄãÊåáÊ®ôÊàñÈô∞ÈÅìÁôºÁÇé„ÄÇ
Âà§ËÆÄÈ†ÜÂ∫èÔºö [!</description></item><item><title>you can do something</title><link>https://www.physician.tw/you-can-do-something/</link><pubDate>Sat, 04 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/you-can-do-something/</guid><description>[!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
you can do something title here</description></item><item><title>autonomic neuropathy</title><link>https://www.physician.tw/autonomic-neuropathy/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autonomic-neuropathy/</guid><description> [!info]
üå± ‰æÜËá™: [[neuropathy of diabetes mellitus]]
autonomic neuropathy include [[gastroparesis]] [[constipation]] neurogenic bladder erectile dysfunction orthostasis</description></item><item><title>ChatGPT</title><link>https://www.physician.tw/chatgpt/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chatgpt/</guid><description>[!info]
üå± ‰æÜËá™: [[AiÁõ∏Èóú]]
ChatGPT Library ChatGPT Prompt Library</description></item><item><title>echocardiogram as diagnosis of bacterial endocarditis</title><link>https://www.physician.tw/echocardiogram-as-diagnosis-of-bacterial-endocarditis/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/echocardiogram-as-diagnosis-of-bacterial-endocarditis/</guid><description>[!info]
üå± ‰æÜËá™: [[Diagnosis-bacterial endocarditis]]
echocardiogram as diagnosis of bacterial endocarditis TTE in all Pts. TEE if
(i) TTE abnl but nondx, (ii) TTE ‚äñ but high suspicion, (iii) complications suspected or present (eg, AVB), (iv) high-risk (prosthetic valve, CIED, prior IE, congenital heart dis.</description></item><item><title>ESR</title><link>https://www.physician.tw/esr/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/esr/</guid><description> [!info]
üå± ‰æÜËá™: [[Diagnosis-osteomyelitis]]
ESR</description></item><item><title>Finerenone</title><link>https://www.physician.tw/finerenone/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/finerenone/</guid><description>[!info]
üå± ‰æÜËá™: [[nephropathy of diabetes mellitus]]
Finerenone ÂèÉËÄÉ‚û°Ô∏è Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes</description></item><item><title>ileus vs small bowel obstruction</title><link>https://www.physician.tw/ileus-vs-small-bowel-obstruction/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ileus-vs-small-bowel-obstruction/</guid><description>[!info]
üå± ‰æÜËá™: [[dysmotility and nutrition]]
ileus vs small bowel obstruction ileus defined as nonmechanical obstruction of bowel usually secondary to inhibition of peristalsis.</description></item><item><title>necrobiosis lipoidica diabeticorum</title><link>https://www.physician.tw/necrobiosis-lipoidica-of-diabetics/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/necrobiosis-lipoidica-of-diabetics/</guid><description> [!info]
üå± ‰æÜËá™: [[neuropathy of diabetes mellitus]]
necrobiosis lipoidica diabeticorum</description></item><item><title>nephropathy of diabetes mellitus</title><link>https://www.physician.tw/nephropathy-of-diabetes-mellitus/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephropathy-of-diabetes-mellitus/</guid><description>[!info]
üå±‰æÜËá™: [[Complications-diabetes mellitus]]
nephropathy of diabetes mellitus microalbuminuria ‚Üí proteinuria ¬± nephrotic syndrome ‚Üí renal failure. Strict BP control using ACEI or ARB; SGLT-2 inhib (NEJM 2016;375:323 &amp;amp; 2019;380:2295); finerenone (NEJM 2020;383:2219); low-protein diet; dialysis or transplant.</description></item><item><title>neuropathy of diabetes mellitus</title><link>https://www.physician.tw/neuropathy-of-diabetes-mellitus/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neuropathy-of-diabetes-mellitus/</guid><description>[!info]
üå±‰æÜËá™: [[Complications- diabetes mellitus]]
neuropathy of diabetes mellitus peripheral: symmetric distal sensory loss, paresthesias, ¬± motor loss autonomic: gastroparesis, constipation, neurogenic bladder, erectile dysfxn, orthostasis mononeuropathy: sudden-onset peripheral or CN deficit (footdrop, CN III &amp;gt;VI &amp;gt;IV)</description></item><item><title>retinopathy of diabetes mellitus</title><link>https://www.physician.tw/retinopathy-of-diabetes-mellitus/</link><pubDate>Fri, 03 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/retinopathy-of-diabetes-mellitus/</guid><description>[!info]
üå±‰æÜËá™: [[Complications-diabetes mellitus]]
retinopathy of diabetes mellitus nonproliferative: ‚Äúdot &amp;amp; blot‚Äù and retinal hemorrhages, cotton-wool/protein exudates proliferative: neovascularization, vitreous hemorrhage, retinal detachment, blindness treatment: photocoagulation, surgery, intravitreal bevacizumab injections Explain by ChatGPT Retinopathy of diabetes mellitus is a condition that affects the retina.</description></item><item><title>acute necrotic collection</title><link>https://www.physician.tw/acute-necrotic-collection/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-necrotic-collection/</guid><description> [!info]
üå± ‰æÜËá™: [[WOPN]]
acute necrotic collection</description></item><item><title>acute peripancreatic fluid collections</title><link>https://www.physician.tw/acute-peripancreatic-fluid-collections/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-peripancreatic-fluid-collections/</guid><description>[!info]
üå± ‰æÜËá™: [[WOPN]]
acute peripancreatic fluid collections (APFC): in the first 4 weeks: non-encapsulated peripancreatic fluid collections</description></item><item><title>Available Products of Fecal Microbiota Transplantation</title><link>https://www.physician.tw/Available-Products-of-Fecal-Microbiota-Transplantation/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Available-Products-of-Fecal-Microbiota-Transplantation/</guid><description>[!info]
üå±‰æÜËá™: [[fecal microbiota transplantation]]
Available Products of Fecal Microbiota Transplantation Potentially Practice-Changing
Drug/Device Alert Updated 9 Dec 2022</description></item><item><title>Background of Intestinal Pseudo-obstruction</title><link>https://www.physician.tw/Background-of-Intestinal-Pseudo-obstruction/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Background-of-Intestinal-Pseudo-obstruction/</guid><description>[!info]
üå±‰æÜËá™: [[Intestinal Pseudo-obstruction]]
Background of Intestinal Pseudo-obstruction [Intestinal pseudo-obstruction][1] refers to a heterogeneous group of conditions with impaired gastrointestinal motility, leading to signs and symptoms of intestinal obstruction in absence of any obstructive or occluding mechanical blockage.</description></item><item><title>BISAP</title><link>https://www.physician.tw/canap/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/canap/</guid><description>[!info]
üå± ‰æÜËá™: [[Prognosis-acute pancreatitis]]
BISAP The BISAP is a more-recent score than the older Ranson&amp;rsquo;s Criteria, and does not require data points from 48 hours into a patient&amp;rsquo;s hospital admission.</description></item><item><title>Clinical manifestations of autoimmune pancreatitis</title><link>https://www.physician.tw/Clinical-manifestations-of-autoimmune-pancreatitis/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-autoimmune-pancreatitis/</guid><description> [!info]
üå±‰æÜËá™: [[autoimmune pancreatitis]]
Clinical manifestations of autoimmune pancreatitis Abdominal pain, can p/w obstructive jaundice and panc mass mimicking panc Ca Can be primary, or in a/w IgG4 cholangiopathy, salivary gland disease (eg, Sj√∂gren‚Äôs), mediastinal or RP fibrosis, interstitial nephritis, autoimmune thyroiditis, UC/PSC, RA</description></item><item><title>Cooley‚Äôs anemia</title><link>https://www.physician.tw/cooleys-anemia/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cooleys-anemia/</guid><description> [!info]
üå± ‰æÜËá™: [[Œ≤-thalassemia]]
Cooley‚Äôs anemia</description></item><item><title>Diagnosis of autoimmune pancreatitis</title><link>https://www.physician.tw/Diagnosis-of-autoimmune-pancreatitis/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-autoimmune-pancreatitis/</guid><description> [!info]
üå±‰æÜËá™: [[autoimmune pancreatitis]]
Diagnosis of autoimmune pancreatitis Labs: cholestatic LFTs (‚Üë Aœï &amp;gt;AST/ALT), ‚Üë Œ≥-globulins and IgG4, ‚äï ANA, RF HISORt criteria: Histology, Imaging (‚Äúsausage pancreas,‚Äù bile duct stricture), Serology, other Organ involvement, Response to therapy</description></item><item><title>drugs as etiologies of acute pancreatitis</title><link>https://www.physician.tw/drugs-as-etiologies-of-acute-pancreatitis/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/drugs-as-etiologies-of-acute-pancreatitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Etiologies-acute pancreatitis]]
drugs as etiologies of acute pancreatitis 5-ASA, 6-MP/AZA, ACEI, cytosine, didanosine, dapsone, estrogen, furosemide, isoniazid, MNZ, pentamidine, statins, sulfa, thiazides, tetracycline, valproate Here&amp;rsquo;s an overview of the medications listed:</description></item><item><title>Efficacy of Fecal Microbiota Transplantation</title><link>https://www.physician.tw/Efficacy-of-Fecal-Microbiota-Transplantation/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Efficacy-of-Fecal-Microbiota-Transplantation/</guid><description>[!info]
üå±‰æÜËá™: [[fecal microbiota transplantation]]
Efficacy of Fecal Microbiota Transplantation Evidence Synopsis
In adults and children with recurrent or refractory C.</description></item><item><title>estrogen-receptor‚Äìsignaling pathways</title><link>https://www.physician.tw/estrogen-receptorsignaling-pathways/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/estrogen-receptorsignaling-pathways/</guid><description> [!info]
üå± ‰æÜËá™: [[Epidemiology of breast cancer]]
estrogen-receptor‚Äìsignaling pathways</description></item><item><title>Evaluation of Intestinal Pseudo-obstruction</title><link>https://www.physician.tw/Evaluation-of-Intestinal-Pseudo-obstruction/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-Intestinal-Pseudo-obstruction/</guid><description>[!info]
üå±‰æÜËá™: [[Intestinal Pseudo-obstruction]]
Evaluation of Intestinal Pseudo-obstruction A plain [abdominal x-ray][6] will usually show colonic and small bowel dilation and air-fluid levels.</description></item><item><title>familial hyperlipemia</title><link>https://www.physician.tw/familial-hyperlipemia/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/familial-hyperlipemia/</guid><description> [!info]
üå± ‰æÜËá™: [[Etiologies-acute pancreatitis]]
familial hyperlipemia</description></item><item><title>Fecal Microbiota Transplantation</title><link>https://www.physician.tw/fecal-microbiota-transplantation/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fecal-microbiota-transplantation/</guid><description>at: [[inbox]]
Fecal Microbiota Transplantation Use in Clostridioides (Clostridium) difficile Infection Use in Clostridium Difficile Infection
[[Indications of Fecal Microbiota Transplantation]]</description></item><item><title>Flatbush diabetes</title><link>https://www.physician.tw/flatbush-diabetes/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/flatbush-diabetes/</guid><description>[!info]
üå± ‰æÜËá™: [[Categories-diabetes mellitus]]
Flatbush diabetes Flatbush diabetes, also known as ketosis-prone diabetes, is a form of type 2 diabetes.</description></item><item><title>Indications of Fecal Microbiota Transplantation</title><link>https://www.physician.tw/Indications-of-Fecal-Microbiota-Transplantation/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-of-Fecal-Microbiota-Transplantation/</guid><description>[!info]
üå±‰æÜËá™: [[fecal microbiota transplantation]]
Indications of Fecal Microbiota Transplantation limited evidence to define who may benefit most from fecal microbiota transplantation (FMT) FMT typically offered to patients with1,2 ‚â• 3 episodes of Clostridioides (Clostridium) difficile infection (CDI) proven by positive stool assay and failure of first-line therapies for CDI (including vancomycin, metronidazole, or fidaxomicin) 2 previous episodes of CDI requiring hospitalization severe disease without response to appropriate therapy after 48 hours moderate CDI without response to appropriate therapy (oral vancomycin or fidaxomicin) after 5 days (these patients typically have severe CDI or other cause of diarrhea) before FMT, confirm that disease is caused by C.</description></item><item><title>Intestinal Pseudo-obstruction</title><link>https://www.physician.tw/Intestinal-Pseudo-obstruction/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intestinal-Pseudo-obstruction/</guid><description>at: [[inbox]]
Intestinal Pseudo-obstruction [[Background of Intestinal Pseudo-obstruction]]
[[Evaluation of Intestinal Pseudo-obstruction]]
[[Management of Intestinal Pseudo-obstruction]]</description></item><item><title>Management of Intestinal Pseudo-obstruction</title><link>https://www.physician.tw/Management-of-Intestinal-Pseudo-obstruction/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-Intestinal-Pseudo-obstruction/</guid><description>[!info]
üå±‰æÜËá™: [[Intestinal Pseudo-obstruction]]
Management of Intestinal Pseudo-obstruction Conservative management for 48-72 hours is the preferred initial management if cecal diameter is &amp;lt; 12 cm and there are no signs of ischemia, perforation, or peritonitis ( Strong recommendation) which includes: nothing by mouth intravenous hydration and/or correction of fluid and electrolyte imbalances discontinuation of narcotic, sedative, calcium-channel blocker, or anticholinergic medications placement of nasogastric tube for proximal intestinal decompression aggressive use of body positioning and ambulation placement of rectal tube (with or without use of limited tap water enemas) With conservative management, monitor the patient every 12-24 hours for electrolytes, leukocyte count, and cecal diameter (with supine and dependent abdominal x-ray) and treat any emergent complications.</description></item><item><title>pancreatic pseudocyst</title><link>https://www.physician.tw/pancreatic-pseudocyst/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatic-pseudocyst/</guid><description> [!info]
üå± ‰æÜËá™: [[WOPN]]
pancreatic pseudocyst Pancreatic pseudocyst - Wikiwand</description></item><item><title>prevention of breast cancer</title><link>https://www.physician.tw/prevention-of-breast-cancer/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prevention-of-breast-cancer/</guid><description>[!info]
üå± ‰æÜËá™: [[Epidemiology of breast cancer]]
prevention of breast cancer (if high-risk: eg, FHx, LCIS, atypical hyperplasia)</description></item><item><title>Recommendations from Professional Organizations of Fecal Microbiota Transplantation</title><link>https://www.physician.tw/Recommendations-from-Professional-Organizations-of-Fecal-Microbiota-Transplantation/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recommendations-from-Professional-Organizations-of-Fecal-Microbiota-Transplantation/</guid><description>[!info]
üå±‰æÜËá™: [[fecal microbiota transplantation]]
Recommendations from Professional Organizations of Fecal Microbiota Transplantation Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) fecal microbiota transplantation (FMT) recommended in adult patients with ‚â• 2 recurrences of Clostridioides (Clostridium) difficile infection (CDI) who have failed appropriate antibiotic treatments consider FMT in pediatric patients with recurrent CDI after standard antibiotic treatments Reference - [Clin Infect Dis 2018 Mar 19;66(7):e1][10][full-text][11], [Clin Infect Dis 2021 Sep 7;73(5):e1029][12] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations on use of fecal microbiota transplantation (FMT) in management of Clostridioides difficile infection (CDI) in adults * consider fecal microbiota transplantation (FMT) in patients with severe complicated CDI that have deteriorated despite CDI antibiotic treatment and surgery is not feasible, with decisions made case-by-case by multidisciplinary team ([ESCMID Weak recommendation, Very low-quality evidence][13]) * consider FMT after standard-of-care antibiotic pre-treatment in patients with multiple recurrence( [ESCMID Weak recommendation, Moderate-quality evidence][14]) * adequate multidisciplinary risk assessment needed * FMT products should go through standardized preparation and screening * Reference - [Clin Microbiol Infect 2021 Dec;27 Suppl 2:S1][15]</description></item><item><title>SBO</title><link>https://www.physician.tw/sbo/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sbo/</guid><description>[!info]
üå± ‰æÜËá™: [[Clinical manifestations-acute pancreatitis]]
SBO [[short bowel obstruction]]</description></item><item><title>short bowel obstruction</title><link>https://www.physician.tw/short-bowel-obstruction/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/short-bowel-obstruction/</guid><description> [!info]
üå± ‰æÜËá™: [[SBO]]
short bowel obstruction</description></item><item><title>Treatment of autoimmune pancreatitis</title><link>https://www.physician.tw/Treatment-of-autoimmune-pancreatitis/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-autoimmune-pancreatitis/</guid><description> [!info]
üå±‰æÜËá™: [[autoimmune pancreatitis]]
Treatment of autoimmune pancreatitis Glucocorticoids 1st-line; immunomod. (AZA, MMF, cyclophosphamide, rituximab) if relapse</description></item><item><title>uploads a file as public gist to Github</title><link>https://www.physician.tw/uploads-a-file-as-public-gist-to-github/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/uploads-a-file-as-public-gist-to-github/</guid><description>[!info]
üå± ‰æÜËá™: [[shell scripts]]
uploads a file as public gist to Github 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 #!</description></item><item><title>WOPN</title><link>https://www.physician.tw/wopn/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wopn/</guid><description>[!info]
üå± ‰æÜËá™: [[Complications-acute pancreatitis]]
WOPN Walled-off pancreatic necrosis | Radiology Reference Article | Radiopaedia.org
Walled-off pancreatic necrosis (WOPN) is a late complication of acute pancreatitis, although it can occur in chronic pancreatitis or as a result of pancreatic trauma.</description></item><item><title>Œ±-thalassemia</title><link>https://www.physician.tw/thalassemia/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thalassemia/</guid><description>[!info]
üå± ‰æÜËá™: [[Thalassemias]]
Œ±-thalassemia (NEJM 2014;371:1908): deletions in Œ±-globin gene complex (nl 4 Œ± genes), seen w/ Southeast Asian, Mediterranean, African, Middle East ancestry</description></item><item><title>Œ≤-thalassemia</title><link>https://www.physician.tw/thalassemia/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thalassemia/</guid><description>[!info]
üå± ‰æÜËá™: [[Thalassemias]]
Œ≤-thalassemia mutations in Œ≤-globin gene ‚Üí absent or ‚Üì gene product seen w/ Mediterranean (espec.</description></item><item><title>ÁôåÁóáÁØ©Ê™¢‰ªãÁ¥π</title><link>https://www.physician.tw/introduction-to-cancer-screening/</link><pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/introduction-to-cancer-screening/</guid><description> [!info]
üå± ‰æÜËá™: [[Screening of breast cancer]]
ÁôåÁóáÁØ©Ê™¢‰ªãÁ¥π ÊØèÂπ¥ÊúâË∂ÖÈÅé10,000‰∫∫Ê≠ªÊñº‰π≥Áôå„ÄÅÂ≠êÂÆÆÈ†∏Áôå„ÄÅÂ§ßËÖ∏ÁôåËàáÂè£ËÖîÁôå„ÄÇÁØ©Ê™¢ÂèØ‰ª•Êó©ÊúüÁôºÁèæÁôåÁóáÊàñÂÖ∂ÁôåÂâçÁóÖËÆäÔºåÁ∂ìÊ≤ªÁôÇÂæåÂèØ‰ª•Èôç‰ΩéÊ≠ª‰∫°ÁéáÂ§ñÔºåÈÇÑÂèØ‰ª•ÈòªÊñ∑ÁôåÂâçÁóÖËÆäÈÄ≤Â±ïÁÇ∫ÁôåÁóá„ÄÇÁõÆÂâçÊîøÂ∫úË£úÂä©ÂõõÂ§ßÁôåÁóáÁØ©Ê™¢‰πãÊîøÁ≠ñËàáÁØÑÂúçÂ¶Ç‰∏ã:
‰π≥Ôºö‰π≥ÊàøXÂÖâÊîùÂΩ±Ê™¢Êü•Ôºö45-69Ê≠≤Â©¶Â•≥„ÄÅ40-44Ê≠≤‰∫åÁ≠âË°ÄË¶™ÂÖßÊõæÁΩπÊÇ£‰π≥Áôå‰πãÂ©¶Â•≥ÔºåÊØè2Âπ¥1Ê¨°„ÄÇ Â§ßÔºöÂ§ß‰æøÊΩõË°ÄÊ™¢Êü•Ôºö50Ëá≥Êú™Êªø75Ê≠≤Ê∞ëÁúæÔºåÊØè2Âπ¥1Ê¨°„ÄÇ Â≠êÔºöÂ≠êÂÆÆÈ†∏ÊäπÁâáÊ™¢Êü•Ôºö30Ê≠≤‰ª•‰∏äÂ©¶Â•≥ÔºåÂª∫Ë≠∞ÊØè3Âπ¥1Ê¨°„ÄÇ Âè£ÔºöÂè£ËÖîÈªèËÜúÊ™¢Êü•Ôºö30Ê≠≤‰ª•‰∏äÊúâÂöºÊ™≥Ê¶îÔºàÂê´Â∑≤ÊàíÊ™≥Ê¶îÔºâÊàñÂê∏Ëè∏ËÄÖ„ÄÅ18Ê≠≤‰ª•‰∏äÊúâÂöºÊ™≥Ê¶îÔºàÂê´Â∑≤ÊàíÊ™≥Ê¶îÔºâÂéü‰ΩèÊ∞ëÔºåÊØè2Âπ¥1Ê¨°„ÄÇ</description></item><item><title>ASCVD risk estimation</title><link>https://www.physician.tw/ascvd-risk-estimation/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ascvd-risk-estimation/</guid><description> [!info]
üå± ‰æÜËá™: [[top 10 take-home messages for the primary prevention of cardiovascular disease]]
ASCVD risk estimation Atherosclerotic cardiovascular disease risk assessment for primary prevention in adults: Our approach - UpToDate [[cardiovascular disease risk assessment in adults without a history of atherosclerotic cardiovascular disease]]</description></item><item><title>cardiovascular disease risk assessment in adults without a history of atherosclerotic cardiovascular disease</title><link>https://www.physician.tw/cardiovascular-disease-risk-assessment-in-adults-without-a-history-of-atherosclerotic-cardiovascular-disease/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiovascular-disease-risk-assessment-in-adults-without-a-history-of-atherosclerotic-cardiovascular-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[ASCVD risk estimation]]
cardiovascular disease risk assessment in adults without a history of atherosclerotic cardiovascular disease Identify risk factors of cardiovascular risk Check lipid profile Is [[low-density lipoprotein above 190mg per dL]] If not, then consider age: 20-39 years 40-75 years 75 years</description></item><item><title>digest markdown by python</title><link>https://www.physician.tw/digest-markdown-by-python/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/digest-markdown-by-python/</guid><description>[!info]
üå± ‰æÜËá™: [[project and idea of python]]
digest markdown by python enzyme Create a folder with the same name as the file.</description></item><item><title>enzyme</title><link>https://www.physician.tw/enzyme/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/enzyme/</guid><description>enzyme create a folder with same name as the file copy the file.md into the folder rename the origin file as origin_file.</description></item><item><title>how to write a history and physical</title><link>https://www.physician.tw/how-to-write-a-history-and-physical/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-write-a-history-and-physical/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
how to write a history and physical [[Chief Complaint and History of Present Illness (HPI)]]</description></item><item><title>intensive care unit onboarding</title><link>https://www.physician.tw/intensive-care-unit-onboarding/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/intensive-care-unit-onboarding/</guid><description>[!info]
üå± ‰æÜËá™: [[critical care]]
intensive care unit onboarding [[progress note in icu]]</description></item><item><title>lipid biomarkers that associated with increased ASCVD risk</title><link>https://www.physician.tw/lipid-biomarkers-that-associated-with-increased-ascvd-risk/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lipid-biomarkers-that-associated-with-increased-ascvd-risk/</guid><description>[!info]
üå± ‰æÜËá™: [[risk-enhancing factors for clinician‚Äìpatient risk discussion]]
lipid biomarkers that associated with increased ASCVD risk Persistently* elevated, primary hypertriglyceridemia (2175 mg/dL); if measured:</description></item><item><title>low-density lipoprotein above 190mg per dL</title><link>https://www.physician.tw/low-density-lipoprotein-above-mg-per-dl/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/low-density-lipoprotein-above-mg-per-dl/</guid><description> [!info]
üå± ‰æÜËá™: [[cardiovascular disease risk assessment in adults without a history of atherosclerotic cardiovascular disease]]
low-density lipoprotein above 190mg per dL posible [[familial hypercholestrolemia]] treat aggresively with lifestyle changes and statin consider aspirin and referreal for genetic counselling</description></item><item><title>other subspecialties</title><link>https://www.physician.tw/other-subspecialties/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-subspecialties/</guid><description> [!info]
üå± ‰æÜËá™: [[medical]]
other subspecialties [[dermatology]] [[ophthalmic]] [[woman health]] [[obs gyn issues]] [[radiology]] [[mental health]] [[surgical issues]] [[psychiatric]] [[geriatrics]]</description></item><item><title>PocketBrain</title><link>https://www.physician.tw/pocketbrain/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pocketbrain/</guid><description>PocketBrain Section 00.1 - Table of CONTENTS -
00.1 ‚Äì Table of CONTENTS
00.2 ‚Äì** **Front Matter: TITLE Page
00.3 ‚Äì Acknowledgements/Copyright</description></item><item><title>Primary prevention</title><link>https://www.physician.tw/primary-prevention/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/primary-prevention/</guid><description> [!info]
üå± ‰æÜËá™: [[2018 ACC AHA Cholesterol Guidelines]]
Primary prevention Figure:</description></item><item><title>progress note in icu</title><link>https://www.physician.tw/progress-note-in-icu/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/progress-note-in-icu/</guid><description>[!info]
üå± ‰æÜËá™: [[intensive care unit onboarding]]
progress note in icu 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ==Problems== [hemodynamic] [infection] [ventilation] [nutrition/digestion/electrolytes] [PADIS] ÁñºÁóõ(Pain) Ë∫ÅÂãï(Agitation)Ë≠´Â¶Ñ(Delirium)‰∏çÂãï(Immobility) [ÂèØËá™Â∑±Âä†ÂàÜÈ°ûe.</description></item><item><title>project and idea of python</title><link>https://www.physician.tw/project-and-idea-of-python/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/project-and-idea-of-python/</guid><description>[!info]
üå± ‰æÜËá™: [[python]]
project and idea of python [[digest markdown by python]]</description></item><item><title>python</title><link>https://www.physician.tw/python/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/python/</guid><description> [!info]
üå± ‰æÜËá™: [[Á®ãÂºèË™ûË®Ä]]
python [[project and idea of python]] [[Python_print_green]]
Explain by ChatGPT Python print green : (project and idea of python); Python print green : (Python_print_green); Á™©ÁöÑËã±Êñá‰∏çÂ§™Â•ΩÔºåÂè™Â•ΩË´ã‰º∞üê∂ Python ÊâìÂç∞Á∂†Ëâ≤ÔºöÔºàpython ÁöÑÈ†ÖÁõÆÂíåÊÉ≥Ê≥ïÔºâÔºõ Python ÊâìÂç∞Á∂†Ëâ≤ÔºöÔºàPython_print_greenÔºâÔºõ</description></item><item><title>risk-enhancing factors for clinician‚Äìpatient risk discussion</title><link>https://www.physician.tw/risk-enhancing-factors-for-clinicianpatient-risk-discussion/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/risk-enhancing-factors-for-clinicianpatient-risk-discussion/</guid><description>[!info]
üå± ‰æÜËá™: [[2018 ACC AHA Cholesterol Guidelines]]
risk-enhancing factors for clinician‚Äìpatient risk discussion Risk-Enhancing Factors Family history of premature ASCVD (males, age &amp;lt;55 y; females, age &amp;lt;65 y) Primary hypercholesterolemia (LDL-C.</description></item><item><title>shell scripts projects</title><link>https://www.physician.tw/shell-scripts-projects/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/shell-scripts-projects/</guid><description> [!info]
üå± ‰æÜËá™: [[shell scripts]]
shell scripts projects</description></item><item><title>top 10 take-home messages for the primary prevention of cardiovascular disease</title><link>https://www.physician.tw/top-take-home-messages-for-the-primary-prevention-of-cardiovascular-disease/</link><pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/top-take-home-messages-for-the-primary-prevention-of-cardiovascular-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[2018 ACC AHA Cholesterol Guidelines]]
top 10 take-home messages for the primary prevention of cardiovascular disease The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.</description></item><item><title>99mTc-pertechnetate</title><link>https://www.physician.tw/mtc-pertechnetate/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mtc-pertechnetate/</guid><description>[!info]
üå± ‰æÜËá™: [[Obscure GIB]]
99mTc-pertechnetate The primary mechanism of elimination is through the kidney, where the radionuclide is filtered from the blood and excreted in the urine.</description></item><item><title>Acalculous cholecystitis</title><link>https://www.physician.tw/acalculous-cholecystitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acalculous-cholecystitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Pathogenesis-cholecystitis]]
Acalculous cholecystitis [!tldr] TLDR
GB stasis &amp;amp; ischemia (w/o cholelithiasis) ‚Üí necroinflammation. Occurs in critically ill.</description></item><item><title>additional history of general evaluation or chronic diarrhea</title><link>https://www.physician.tw/additional-history-of-general-evaluation-or-chronic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/additional-history-of-general-evaluation-or-chronic-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[General evaluation or chronic diarrhea]]
additional history of general evaluation or chronic diarrhea [!tldr] timing</description></item><item><title>Aging</title><link>https://www.physician.tw/aging/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aging/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Aging Chapter 476:¬†[[Biology of Aging]] Chapter 477:¬†[[Caring for the Geriatric Patient]]</description></item><item><title>Alterations in the Skin</title><link>https://www.physician.tw/alterations-in-the-skin/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/alterations-in-the-skin/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Alterations in the Skin Chapter 56:¬†[[Approach to the Patient with a Skin Disorder]] Chapter 57:¬†[[Eczema, Psoriasis, Cutaneous Infections, Acne, and Other Common Skin Disorders]] Chapter 58:¬†[[Skin Manifestations of Internal Disease]] Chapter 59:¬†[[Immunologically Mediated Skin Diseases]] Chapter 60:¬†[[Cutaneous Drug Reactions]] Chapter 61:¬†[[Photosensitivity and Other Reactions to Sunlight]]</description></item><item><title>analgesia as treatment ofcholecystitis</title><link>https://www.physician.tw/analgesia-as-treatment-ofcholecystitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/analgesia-as-treatment-ofcholecystitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment-cholecystitis]]
analgesia as treatment ofcholecystitis Class Summary Pain is a prominent feature of cholecystitis. The classic teaching is that morphine is not the agent of choice because of the possibility of increasing tone at the sphincter of Oddi.</description></item><item><title>aortitis</title><link>https://www.physician.tw/aortitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortitis/</guid><description> [!info]
üå± ‰æÜËá™: [[salmonella]]
aortitis</description></item><item><title>Approach to the Patient with Pancreatic Disease</title><link>https://www.physician.tw/approach-to-the-patient-with-pancreatic-disease/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-the-patient-with-pancreatic-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[Disorders of the Gastrointestinal System]]
Approach to the Patient with Pancreatic Disease</description></item><item><title>Arterial supply to the upper GI tract</title><link>https://www.physician.tw/arterial-supply-to-the-upper-gi-tract/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/arterial-supply-to-the-upper-gi-tract/</guid><description> [!info]
üå± ‰æÜËá™: [[Vasculature of the GI Tract]]
Arterial supply to the upper GI tract</description></item><item><title>Atlases</title><link>https://www.physician.tw/atlases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atlases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Atlases Chapter A1:¬†[[Atlas of Rashes Associated with Fever]] Chapter A2:¬†[[Atlas of Blood Smears of Malaria and Babesiosis]] Chapter A3:¬†[[Atlas of Oral Manifestations of Disease]] Chapter A4:¬†[[Atlas of Urinary Sediments and Renal Biopsies]] Chapter A5:¬†[[Atlas of Skin Manifestations of Internal Disease]] Chapter A6:¬†[[Atlas of Hematology]] Chapter A7:¬†[[Atlas of Electrocardiography]] Chapter A8:¬†[[Atlas of Cardiac Arrhythmias]] Chapter A9:¬†[[Atlas of Noninvasive Imaging]] Chapter A10:¬†[[Atlas of Atherosclerosis]] Chapter A11:¬†[[Atlas of Percutaneous Revascularization and Adult Structural Heart Interventions]] Chapter A12:¬†[[Atlas of Chest Imaging]] Chapter A13:¬†[[Atlas of Liver Biopsies]] Chapter A14:¬†[[Atlas of the Vasculitic Syndromes]] Chapter A15:¬†[[Atlas of Clinical Manifestations of Endocrine and Metabolic Diseases]] Chapter A16:¬†[[Atlas of Neuroimaging]]</description></item><item><title>Autoimmune hepatitis</title><link>https://www.physician.tw/autoimmune-hepatitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-hepatitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Etiologies-cirrhosis]]
Autoimmune hepatitis [!tldr] TLDR
‚ôÄ, ‚Üë IgG, ‚äï ANA, ASMA, anti-LKM-1, anti-LC1
This disease is more common in women and is characterized by elevated levels of IgG (a type of antibody), and positive tests for antinuclear antibody (ANA), anti-smooth muscle antibody (ASMA), anti-liver-kidney microsomal antibody type 1 (anti-LKM-1), and anti-liver cytosol type 1 antibody (anti-LC1).</description></item><item><title>Bacterial diarrhea</title><link>https://www.physician.tw/bacterial-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacterial-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[NONINFLAMMATORY-Acute Infectious Etiologies]]
Bacterial diarrhea E. coli (toxigenic) 50% of traveler‚Äôs diarrhea; cholera-like toxin; &amp;lt;7 d.</description></item><item><title>bacterial inflammatory acute diarrhea</title><link>https://www.physician.tw/bacterial-inflammatory-acute-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacterial-inflammatory-acute-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[INFLAMMATORY-Acute Infectious Etiologies]]
bacterial inflammatory acute diarrhea [[Campylobacter]] [[salmonella]] (nontyphoidal) [[Shigella]] E. coli (O157:H7 &amp;amp; inv/hemorrhagic non-O157:H7) Undercooked beef, unpasteurized milk, raw produce; PTP.</description></item><item><title>Basic Considerations in Infectious Diseases</title><link>https://www.physician.tw/basic-considerations-in-infectious-diseases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basic-considerations-in-infectious-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Basic Considerations in Infectious Diseases Chapter 119:¬†[[Approach to the Patient with an Infectious Disease]] Chapter 120:¬†[[Molecular Mechanisms of Microbial Pathogenesis]] Chapter 121:¬†[[Microbial Genomics and Infectious Disease]] Chapter 122:¬†[[Approach to the Acutely Ill Infected Febrile Patient]] Chapter 124:¬†[[Health Recommendations for International Travel]] Chapter 123:¬†[[Immunization Principles and Vaccine Use]] Chapter 125:¬†[[Climate Change and Infectious Disease]]</description></item><item><title>Campylobacter</title><link>https://www.physician.tw/campylobacter/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/campylobacter/</guid><description>[!info]
üå± ‰æÜËá™: [[bacterial inflammatory acute diarrhea]]
Campylobacter Undercooked poultry, unpasteurized milk; carried by -puppies &amp;amp; kittens. Prodrome w/ abd pain, ‚Äúpseudoappendicitis‚Äù; c/b GBS, reactive arthritis.</description></item><item><title>Cardinal Manifestations and Presentation of Diseases</title><link>https://www.physician.tw/cardinal-manifestations-and-presentation-of-diseases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardinal-manifestations-and-presentation-of-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Cardinal Manifestations and Presentation of Diseases Section 1:¬†[[Pain]] Section 2:¬†[[Alterations in Body Temperature]] Section 3:¬†[[Nervous System Dysfunction]] Section 4:¬†[[Disorders of Eyes, Ears, Nose, and Throat]] Section 5:¬†[[Alterations in Circulatory and Respiratory Functions]] Section 6:¬†[[Alterations in Gastrointestinal Function]] Section 7:¬†[[Alterations in Renal and Urinary Tract Function]] Section 8:¬†[[Alterations in the Skin]] Section 9:¬†[[Hematologic Alterations]]</description></item><item><title>Charcot‚Äôs triad</title><link>https://www.physician.tw/charcots-triad/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/charcots-triad/</guid><description>[!info]
üå± ‰æÜËá™: [[cholangitis]]
Charcot‚Äôs triad Charcot&amp;rsquo;s triad is a medical term that refers to three symptoms commonly seen in patients with cholecystitis, which is an inflammation of the gallbladder.</description></item><item><title>cholecystitis</title><link>https://www.physician.tw/cholecystitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholecystitis/</guid><description>cholecystitis [[Pathogenesis-cholecystitis]] [[Clinical manifestations-cholecystitis]] [[Diagnostic studies-cholecystitis]] [[Treatment-cholecystitis]] [[Complications-cholecystitis]]</description></item><item><title>chronic diarrhea</title><link>https://www.physician.tw/chronic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-diarrhea/</guid><description> [!info]
üå± ‰æÜËá™: [[diarrhea]]
chronic diarrhea [[General evaluation or chronic diarrhea]] [[Osmotic diarrhea]] [[Secretory diarrhea]] [[Functional IBS]] [[Malabsorption]] [[Maldigestion]] [[Inflammatory diarrhea]] [[Workup of chronic diarrhea]]</description></item><item><title>Classification of GI regulatory substances</title><link>https://www.physician.tw/classification-of-gi-regulatory-substances/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classification-of-gi-regulatory-substances/</guid><description>[!info]
üå± ‰æÜËá™: [[The Neuroendocrine System of the Gut]]
Classification of GI regulatory substances *¬†Hormones: Released from endocrine cells in the GI tract into the portal circulation.</description></item><item><title>Clinical Procedure Tutorials</title><link>https://www.physician.tw/clinical-procedure-tutorials/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-procedure-tutorials/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Clinical Procedure Tutorials Chapter CP1:¬†[[Central Venous Catheter Placement]] Chapter CP2:¬†[[Thoracentesis]] Chapter CP3:¬†[[Abdominal Paracentesis]] Chapter CP4:¬†[[Endotracheal Intubation]] Chapter CP5:¬†[[Percutaneous Arterial Blood Gas Sampling]] Chapter CP6:¬†[[Lumbar Puncture]] Chapter CP7:¬†[[Phlebotomy]] Chapter CP8:¬†[[Insertion of Female Urethral Catheter]] Chapter CP9:¬†[[Insertion of Male Urethral Catheter]] Chapter CP10:¬†[[Fine Needle Aspiration of Breast Cyst]] Chapter CP11:¬†[[IV Insertion]] Chapter CP12:¬†[[Fine Needle Aspiration of Thyroid Nodules]] Chapter CP13:¬†[[Gynecologic Examination with Pap Smear]] Chapter CP14:¬†[[Knee Arthrocentesis]] Chapter CP15:¬†[[Pericardiocentesis]] Chapter CP16:¬†[[Bone Marrow Biopsy]] Chapter CP17:¬†[[Basic Suturing]]</description></item><item><title>Clinical Syndromes Community-Acquired Infections</title><link>https://www.physician.tw/clinical-syndromes-community-acquired-infections/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-syndromes-community-acquired-infections/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Clinical Syndromes: Community-Acquired Infections Chapter 126:¬†[[Pneumonia]] Chapter 127:¬†[[Lung Abscess]] Chapter 128:¬†[[Infective Endocarditis]] Chapter 129:¬†[[Infections of the Skin, Muscles, and Soft Tissues]] Chapter 130:¬†[[Infectious Arthritis]] Chapter 131:¬†[[Osteomyelitis]] Chapter 132:¬†[[Intraabdominal Infections and Abscesses]] Chapter 133:¬†[[Acute Infectious Diarrheal Diseases and Bacterial Food Poisoning]] Infection, Including Pseudomembranous Colitis]] Chapter 135:¬†[[Urinary Tract Infections, Pyelonephritis, and Prostatitis]] Chapter 136:¬†[[Sexually Transmitted Infections: Overview and Clinical Approach]] Chapter 137:¬†[[Encephalitis]] Chapter 138:¬†[[Acute Meningitis]] Chapter 139:¬†[[Chronic and Recurrent Meningitis]] Chapter 140:¬†[[Brain Abscess and Empyema]] Chapter 141:¬†[[Infectious Complications of Bites]]</description></item><item><title>Clinical Syndromes Health Care-Associated Infections</title><link>https://www.physician.tw/clinical-syndromes-health-care-associated-infections/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-syndromes-health-care-associated-infections/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Clinical Syndromes: Health Care-Associated Infections Chapter 142:¬†[[Infections Acquired in Health Care Facilities]] Chapter 143:¬†[[Infections in Transplant Recipients]]</description></item><item><title>CMV colitis</title><link>https://www.physician.tw/cmv-colitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cmv-colitis/</guid><description> [!info]
üå± ‰æÜËá™: [[INFLAMMATORY-Acute Infectious Etiologies]]
CMV colitis Immunosuppressed; dx by shell vial cx of colon biopsy</description></item><item><title>Colitis</title><link>https://www.physician.tw/Colitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Colitis/</guid><description>Colitis Infectious (see ‚ÄúAcute Diarrhea‚Äù), IBD, ischemic colitis, XRT
[[diarrhea]] [[inflammatory bowel disease]]</description></item><item><title>Consultative Medicine</title><link>https://www.physician.tw/consultative-medicine/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consultative-medicine/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Consultative Medicine Chapter 478:¬†[[Approach to Medical Consultation]] Chapter 479:¬†[[Medical Disorders During Pregnancy]] Chapter 480:¬†[[Medical Evaluation of the Surgical Patient]]</description></item><item><title>Crigler-Najjar</title><link>https://www.physician.tw/crigler-najjar/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crigler-najjar/</guid><description>[!info]
üå± ‰æÜËá™: [[Tests of hepatocellular injury or cholestasis]]
Crigler-Najjar ÂÖãÊûúÁ¥çÂÇëÊ∞èÁóáÂÄôÁæ§ÔºèÊöóÂ§úËóçÂÖâ Êò†ÁÖßÁΩïÁóÖÊÇ≤Ê≠å - ÁîüÊ¥ª - Ëá™Áî±ÊôÇÂ†±ÈõªÂ≠êÂ†±
Áº∫‰πèÁâπÂÆöËÇùËáüÈÖµÁ¥†ÔºåË∫´È´îÁÑ°Ê≥ïÂàÜËß£Ê≠ªÂéªÁ¥ÖË°ÄÁêÉÊâÄÁî¢ÁîüÁöÑËÜΩÁ¥ÖÁ¥†„ÄÇÂõ†Ê≠§ÔºåÂæûÂπºÂÖíËµ∑ÔºåÊÇ£ËÄÖÂ∞±ÂøÖÈ†àËµ§Ë∫´Ë£∏È´îÊØèÂ§©ÊõùÊõ¨Âú®Áî±È°û‰ººÊó•Êõ¨Ê©üÂÑÄÂô®ÁôºÂ∞ÑÂá∫ÁöÑËóçÂÖâ‰∏≠ÂçÅËá≥ÂçÅ‰∫åÂ∞èÊôÇÔºå‰æÜÂàÜËß£ÊúâÊØíÁöÑËÜΩÁ¥ÖÁ¥†Ôºå‰∏çÁÑ∂ÊúÉÂá∫ÁèæÂö¥ÈáçÈªÉÁñ∏ÁèæË±°ÔºåÊÇ£ËÄÖËÖ¶Á¥∞ËÉû„ÄÅËÇåËÇâËàáÁ•ûÁ∂ìÁ≥ªÁµ±Â∞áÈÅ≠Âà∞ÊêçÂ£ûÔºåÊúÄÂæåÂ∞éËá¥Ê≠ª‰∫°„ÄÇ</description></item><item><title>dairreha caused by ingestion of poorly absorbed cations or anions</title><link>https://www.physician.tw/dairreha-caused-by-ingestion-of-poorly-absorbed-cations-or-anions/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dairreha-caused-by-ingestion-of-poorly-absorbed-cations-or-anions/</guid><description>[!info]
üå± ‰æÜËá™: [[Osmotic diarrhea]]
dairreha caused by ingestion of poorly absorbed cations or anions Diarrhea caused by ingestion of poorly absorbed cations/anions or poorly absorbed carbohydrates - A type of osmotic diarrhea that occurs when the small intestine is not able to absorb certain substances, causing them to remain in the intestine and draw water into the intestine, leading to watery stools.</description></item><item><title>Diabetes Mellitus Complications</title><link>https://www.physician.tw/diabetes-mellitus-complications/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetes-mellitus-complications/</guid><description> [!info]
üå± ‰æÜËá™: [[Endocrinology and Metabolism]]
Diabetes Mellitus Complications</description></item><item><title>Diabetic autonomic neuropathy</title><link>https://www.physician.tw/diabetic-autonomic-neuropathy/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetic-autonomic-neuropathy/</guid><description> [!info]
üå± ‰æÜËá™: [[Early chronic diarrhea]]
Diabetic autonomic neuropathy</description></item><item><title>diagnostic test of Budd-Chiari syndrome</title><link>https://www.physician.tw/diagnostic-test-of-budd-chiari-syndrome/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-test-of-budd-chiari-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Budd-Chiari syndrome]]
diagnostic test of Budd-Chiari syndrome [!tldr] TLDR
¬± ‚Üë AST, ALT &amp;amp; Aœï; Doppler U/S of hepatic veins (85% Se &amp;amp; Sp); CT (I+) or MRI/MRV ‚Üí vein occlusion or ‚Üë caudate lobe (separate venous drainage); hepatic venography gold standard w/ ‚Äúspider- web‚Äù pattern + assess venous pressure; biopsy only if unclear</description></item><item><title>diarrhea</title><link>https://www.physician.tw/diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diarrhea/</guid><description>diarrhea [[definitions mimics of diarrhea]]
acute diarrhea [[Acute Infectious Etiologies ]] [[Evaluation acute diarrhea]] [[Treatment acute diarrhea]] [[clostridioides difficile infection]] [[chronic diarrhea]] (&amp;gt;4 wk)</description></item><item><title>Diseases Caused by Gram-Negative Bacteria</title><link>https://www.physician.tw/diseases-caused-by-gram-negative-bacteria/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diseases-caused-by-gram-negative-bacteria/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Diseases Caused by Gram-Negative Bacteria Chapter 155:¬†[[Meningococcal Infections]] Chapter 156:¬†[[Gonococcal Infections]] Infections]] Chapter 158:¬†[[Infections Due to the HACEK Group and Miscellaneous Gram-Negative Bacteria]] Infections]] Infections]] Chapter 161:¬†[[Diseases Caused by Gram-Negative Enteric Bacilli]] Infections]] Infections]] Species]] Chapter 165:¬†[[Salmonellosis]] Chapter 166:¬†[[Shigellosis]] and Related Organisms]] Chapter 168:¬†[[Cholera and Other Vibrioses]] Chapter 169:¬†[[Brucellosis]] Chapter 170:¬†[[Tularemia Infections]] Infections, Including Cat-Scratch Disease]] Chapter 173:¬†[[Donovanosis]]</description></item><item><title>Diseases Caused by Gram-Positive Bacteria</title><link>https://www.physician.tw/diseases-caused-by-gram-positive-bacteria/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diseases-caused-by-gram-positive-bacteria/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Diseases Caused by Gram-Positive Bacteria Chapter 146:¬†[[Pneumococcal Infections]] Chapter 147:¬†[[Staphylococcal Infections]] Chapter 148:¬†[[Streptococcal Infections]] Chapter 149:¬†[[Enterococcal Infections]] Chapter 150:¬†[[Diphtheria and Other Corynebacterial Infections]] Infections]] Chapter 152:¬†[[Tetanus]] Chapter 153:¬†[[Botulism]] Chapter 154:¬†[[Gas Gangrene and Other Clostridial Infections]]</description></item><item><title>Diseases Caused by Rickettsiae, Mycoplasmas, and Chlamydiae</title><link>https://www.physician.tw/diseases-caused-by-rickettsiae-mycoplasmas-and-chlamydiae/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diseases-caused-by-rickettsiae-mycoplasmas-and-chlamydiae/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Diseases Caused by Rickettsiae, Mycoplasmas, and Chlamydiae Chapter 187:¬†[[Rickettsial Diseases]] Chapter 188:¬†[[Infections Due to Mycoplasmas]] Chapter 189:¬†[[Chlamydial Infections]]</description></item><item><title>Disorders Associated with Environmental Exposures</title><link>https://www.physician.tw/disorders-associated-with-environmental-exposures/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-associated-with-environmental-exposures/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Disorders Associated with Environmental Exposures Chapter 462:¬†[[Altitude Illness]] Chapter 463:¬†[[Hyperbaric and Diving Medicine]] Chapter 464:¬†[[Hypothermia and Peripheral Cold Injuries]] Chapter 465:¬†[[Heat-Related Illnesses]]</description></item><item><title>Disorders of Immune-Mediated Injury</title><link>https://www.physician.tw/disorders-of-immune-mediated-injury/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-immune-mediated-injury/</guid><description> [!info]
üå± ‰æÜËá™: [[Immune-Mediated, Inflammatory, and Rheumatologic Disorders]]
Disorders of Immune-Mediated Injury Chapter 352:¬†[[Urticaria, Angioedema, and Allergic Rhinitis]] Chapter 353:¬†[[Anaphylaxis]] Chapter 354:¬†[[Mastocytosis]] Chapter 355:¬†[[Autoimmunity and Autoimmune Diseases]] Chapter 356:¬†[[Systemic Lupus Erythematosus]] Chapter 357:¬†[[Antiphospholipid Syndrome]] Chapter 358:¬†[[Rheumatoid Arthritis]] Chapter 359:¬†[[Acute Rheumatic Fever]] Chapter 360:¬†[[Systemic Sclerosis (Scleroderma) and Related Disorders]] Chapter 361:¬†[[Sj√∂gren‚Äôs Syndrome]] Chapter 362:¬†[[Spondyloarthritis]] Chapter 363:¬†[[The Vasculitis Syndromes]] Chapter 364:¬†[[Beh√ßet Syndrome]] Chapter 365:¬†[[Inflammatory Myopathies]] Chapter 366:¬†[[Relapsing Polychondritis]] Chapter 367:¬†[[Sarcoidosis]] Chapter 368:¬†[[IgG4-Related Disease]] Chapter 369:¬†[[Familial Mediterranean Fever and Other Hereditary Autoinflammatory Diseases]]</description></item><item><title>Disorders of the Cardiovascular System</title><link>https://www.physician.tw/disorders-of-the-cardiovascular-system/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-cardiovascular-system/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Disorders of the Cardiovascular System Section 1:¬†[[Introduction to Cardiovascular Disorders]] Chapter 236:¬†[[Approach to the Patient with Possible Cardiovascular Disease]] Chapter 237:¬†[[Basic Biology of the Cardiovascular System]] Chapter 238:¬†[[Epidemiology of Cardiovascular Disease]] Section 2:¬†[[Diagnosis of Cardiovascular Disorders]] Chapter 239:¬†[[Physical Examination of the Cardiovascular System]] Chapter 240:¬†[[Electrocardiography]] Chapter 241:¬†[[Noninvasive Cardiac Imaging: Echocardiography, Nuclear Cardiology, and Magnetic Resonance Computed Tomography Imaging]] Chapter 242:¬†[[Diagnostic Cardiac Catheterization and Coronary Angiography]] Section 3:¬†[[Disorders of Rhythm]] Chapter 243:¬†[[Principles of Clinical Cardiac Electrophysiology]] Chapter 244:¬†[[The Bradyarrhythmias: Disorders of the Sinoatrial Node]] Chapter 245:¬†[[The Bradyarrhythmias: Disorders of the Atrioventricular Node]] Chapter 246:¬†[[Approach to Supraventricular Tachyarrhythmias]] Chapter 247:¬†[[Physiologic and Nonphysiologic Sinus Tachycardia]] Chapter 248:¬†[[Focal Atrial Tachycardia]] Chapter 249:¬†[[Paroxysmal Supraventricular Tachycardias]] Chapter 250:¬†[[Common Atrial Flutter and Macroreentrant and Multifocal Atrial Tachycardias]] Chapter 251:¬†[[Atrial Fibrillation]] Chapter 252:¬†[[Approach to Ventricular Arrhythmias]] Chapter 253:¬†[[Premature Ventricular Contractions, Nonsustained Ventricular Tachycardia, and Accelerated Idioventricular Rhythm]] Chapter 254:¬†[[Sustained Ventricular Tachycardia]] Chapter 255:¬†[[Polymorphic Ventricular Tachycardia and Ventricular Fibrillation]] Chapter 256:¬†[[Electrical Storm and Incessant Ventricular Tachycardia]] Section 4:¬†[[Disorders of the Heart, Muscles, Valves, and Pericardium]] Chapter 257:¬†[[Heart Failure: Pathophysiology and Diagnosis]] Chapter 258:¬†[[Heart Failure: Management]] Chapter 259:¬†[[Cardiomyopathy and Myocarditis]] Chapter 260:¬†[[Cardiac Transplantation and Prolonged Assisted Circulation]] Chapter 261:¬†[[Aortic Stenosis]] Chapter 262:¬†[[Aortic Regurgitation]] Chapter 263:¬†[[Mitral Stenosis]] Chapter 264:¬†[[Mitral Regurgitation]] Chapter 265:¬†[[Mitral Valve Prolapse]] Chapter 266:¬†[[Tricuspid Valve Disease]] Chapter 267:¬†[[Pulmonic Valve Disease]] Chapter 268:¬†[[Multiple and Mixed Valvular Heart Disease]] Chapter 269:¬†[[Congenital Heart Disease in the Adult]] Chapter 270:¬†[[Pericardial Disease]] Chapter 271:¬†[[Atrial Myxoma and Other Cardiac Tumors]] Chapter 272:¬†[[Cardiac Trauma]] Section 5:¬†[[Coronary and Peripheral Vascular Disease]] Chapter 273:¬†[[Ischemic Heart Disease]] Chapter 274:¬†[[Non-ST-Segment Elevation Acute Coronary Syndrome (Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina)]] Chapter 275:¬†[[ST-Segment Elevation Myocardial Infarction]] Chapter 276:¬†[[Percutaneous Coronary Interventions and Other Interventional Procedures]] Chapter 277:¬†[[Hypertension]] Chapter 278:¬†[[Renovascular Disease]] Chapter 279:¬†[[Deep-Venous Thrombosis and Pulmonary Thromboembolism]] Chapter 280:¬†[[Diseases of the Aorta]] Chapter 281:¬†[[Arterial Diseases of the Extremities]] Chapter 282:¬†[[Chronic Venous Disease and Lymphedema]] Chapter 283:¬†[[Pulmonary Hypertension]]</description></item><item><title>Disorders of the Gastrointestinal System</title><link>https://www.physician.tw/disorders-of-the-gastrointestinal-system/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-gastrointestinal-system/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Disorders of the Gastrointestinal System Section 1:¬†[[Disorders of the Alimentary Tract]] Chapter 321:¬†[[Approach to the Patient with Gastrointestinal Disease]] Chapter 322:¬†[[Gastrointestinal Endoscopy]] Chapter 323:¬†[[Diseases of the Esophagus]] Chapter 324:¬†[[Peptic Ulcer Disease and Related Disorders]] Chapter 325:¬†[[Disorders of Absorption]] Chapter 326:¬†[[Inflammatory Bowel Disease]] Chapter 327:¬†[[Irritable Bowel Syndrome]] Chapter 328:¬†[[Diverticular Disease and Common Anorectal Disorders]] Chapter 329:¬†[[Mesenteric Vascular Insufficiency]] Chapter 330:¬†[[Acute Intestinal Obstruction]] Chapter 331:¬†[[Acute Appendicitis and Peritonitis]] Section 2:¬†[[Nutrition]] Chapter 332:¬†[[Nutrient Requirements and Dietary Assessment]] Chapter 333:¬†[[Vitamin and Trace Mineral Deficiency and Excess]] Chapter 334:¬†[[Malnutrition and Nutritional Assessment]] Chapter 335:¬†[[Enteral and Parenteral Nutrition]] Section 3:¬†[[Liver and Biliary Tract Disease]] Chapter 336:¬†[[Approach to the Patient with Liver Disease]] Chapter 337:¬†[[Evaluation of Liver Function]] Chapter 338:¬†[[The Hyperbilirubinemias]] Chapter 339:¬†[[Acute Viral Hepatitis]] Chapter 340:¬†[[Toxic and Drug-Induced Hepatitis]] Chapter 341:¬†[[Chronic Hepatitis]] Chapter 342:¬†[[Alcohol-Associated Liver Disease]] Chapter 343:¬†[[Nonalcoholic Fatty Liver Diseases and Nonalcoholic Steatohepatitis]] Chapter 344:¬†[[Cirrhosis and Its Complications]] Chapter 345:¬†[[Liver Transplantation]] Chapter 346:¬†[[Diseases of the Gallbladder and Bile Ducts]] Section 4:¬†[[Disorders of the Pancreas]] Chapter 347:¬†[[Approach to the Patient with Pancreatic Disease]] Chapter 348:¬†[[Acute and Chronic Pancreatitis]]</description></item><item><title>Disorders of the Joints and Adjacent Tissues</title><link>https://www.physician.tw/disorders-of-the-joints-and-adjacent-tissues/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-joints-and-adjacent-tissues/</guid><description> [!info]
üå± ‰æÜËá™: [[Immune-Mediated, Inflammatory, and Rheumatologic Disorders]]
Disorders of the Joints and Adjacent Tissues Chapter 370:¬†[[Approach to Articular and Musculoskeletal Disorders]] Chapter 371:¬†[[Osteoarthritis]] Chapter 372:¬†[[Gout and Other Crystal-Associated Arthropathies]] Chapter 373:¬†[[Fibromyalgia]] Chapter 374:¬†[[Arthritis Associated with Systemic Disease, and Other Arthritides]] Chapter 375:¬†[[Periarticular Disorders of the Extremities]]</description></item><item><title>Disorders of the Kidney and Urinary Tract</title><link>https://www.physician.tw/disorders-of-the-kidney-and-urinary-tract/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-kidney-and-urinary-tract/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Disorders of the Kidney and Urinary Tract Chapter 308:¬†[[Approach to the Patient with Renal Disease or Urinary Tract Disease]] Chapter 309:¬†[[Cell Biology and Physiology of the Kidney]] Chapter 310:¬†[[Acute Kidney Injury]] Chapter 311:¬†[[Chronic Kidney Disease]] Chapter 312:¬†[[Dialysis in the Treatment of Kidney Failure]] Chapter 313:¬†[[Transplantation in the Treatment of Renal Failure]] Chapter 314:¬†[[Glomerular Diseases]] Chapter 315:¬†[[Polycystic Kidney Disease and Other Inherited Disorders of Tubule Growth and Development]] Chapter 316:¬†[[Tubulointerstitial Diseases of the Kidney]] Chapter 317:¬†[[Vascular Injury to the Kidney]] Chapter 318:¬†[[Nephrolithiasis]] Chapter 319:¬†[[Urinary Tract Obstruction]] Chapter 320:¬†[[Interventional Nephrology]]</description></item><item><title>Disorders of the Respiratory System</title><link>https://www.physician.tw/disorders-of-the-respiratory-system/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-respiratory-system/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Disorders of the Respiratory System Section 1:¬†[[Diagnosis of Respiratory Disorders]] Chapter 284:¬†[[Approach to the Patient with Disease of the Respiratory System]] Chapter 285:¬†[[Disturbances of Respiratory Function]] Chapter 286:¬†[[Diagnostic Procedures in Respiratory Disease]] Section 2:¬†[[Diseases of the Respiratory System]] Chapter 287:¬†[[Asthma]] Chapter 288:¬†[[Hypersensitivity Pneumonitis and Pulmonary Infiltrates with Eosinophilia]] Chapter 289:¬†[[Occupational and Environmental Lung Disease]] Chapter 291:¬†[[Cystic Fibrosis]] Chapter 290:¬†[[Bronchiectasis]] Chapter 292:¬†[[Chronic Obstructive Pulmonary Disease]] Chapter 293:¬†[[Interstitial Lung Disease]] Chapter 294:¬†[[Disorders of the Pleura]] Chapter 295:¬†[[Disorders of the Mediastinum]] Chapter 296:¬†[[Disorders of Ventilation]] Chapter 297:¬†[[Sleep Apnea]] Chapter 298:¬†[[Lung Transplantation]] Chapter 299:¬†[[Interventional Pulmonary Medicine]]</description></item><item><title>Early chronic diarrhea</title><link>https://www.physician.tw/early-chronic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/early-chronic-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[Acute Diarrhea (3 weeks)]]
Early chronic diarrhea ‚Ä¢¬†Malabsorption/inflammatory: Small intestine bacterial overgrowth (SIBO), celiac disease, exocrine pancreatic insufficiency</description></item><item><title>Endocrinology and Metabolism</title><link>https://www.physician.tw/endocrinology-and-metabolism/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrinology-and-metabolism/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Endocrinology and Metabolism Section 1:¬†[[Endocrinology]] Chapter 376:¬†[[Approach to the Patient with Endocrine Disorders]] Chapter 377:¬†[[Mechanisms of Hormone Action]] Chapter 378:¬†[[Physiology of Anterior Pituitary Hormones]] Chapter 379:¬†[[Hypopituitarism]] Chapter 380:¬†[[Pituitary Tumor Syndromes]] Chapter 381:¬†[[Disorders of the Neurohypophysis]] Chapter 382:¬†[[Thyroid Gland Physiology and Testing]] Chapter 383:¬†[[Hypothyroidism]] Chapter 384:¬†[[Hyperthyroidism and Other Causes of Thyrotoxicosis]] Chapter 385:¬†[[Thyroid Nodular Disease and Thyroid Cancer]] Chapter 386:¬†[[Disorders of the Adrenal Cortex]] Chapter 387:¬†[[Pheochromocytoma]] Chapter 388:¬†[[Multiple Endocrine Neoplasia Syndromes]] Chapter 389:¬†[[Autoimmune Polyendocrine Syndromes]] Section 2:¬†[[Sex- and Gender-Based Medicine]] Chapter 390:¬†[[Sex Development]] Chapter 391:¬†[[Disorders of the Testes and Male Reproductive System]] Chapter 392:¬†[[Disorders of the Female Reproductive System]] Chapter 393:¬†[[Menstrual Disorders and Pelvic Pain]] Chapter 394:¬†[[Hirsutism]] Chapter 395:¬†[[Menopause and Postmenopausal Hormone Therapy]] Chapter 396:¬†[[Infertility and Contraception]] Chapter 397:¬†[[Sexual Dysfunction]] Chapter 398:¬†[[Women‚Äôs Health]] Chapter 399:¬†[[Men‚Äôs Health]] Chapter 400:¬†[[Lesbian, Gay, Bisexual, and Transgender (LGBT) Health]] Section 3:¬†[[Obesity, Diabetes Mellitus, and Metabolic Syndrome]] Chapter 401:¬†[[Pathobiology of Obesity]] Chapter 402:¬†[[Evaluation and Management of Obesity]] Chapter 404:¬†[[Diabetes Mellitus Management and Therapies]] Chapter 403:¬†[[Diabetes Mellitus Diagnosis, Classification, and Pathophysiology]] Chapter 405:¬†[[Diabetes Mellitus Complications]] Chapter 406:¬†[[Hypoglycemia]] Chapter 407:¬†[[Disorders of Lipoprotein Metabolism]] Chapter 408:¬†[[The Metabolic Syndrome]] Section 4:¬†[[Disorders of Bone and Mineral Metabolism]] Chapter 409:¬†[[Bone and Mineral Metabolism in Health and Disease]] Chapter 410:¬†[[Disorders of the Parathyroid Gland and Calcium Homeostasis]] Chapter 411:¬†[[Osteoporosis]] Chapter 412:¬†[[Paget‚Äôs Disease and Other Dysplasias of Bone]] Section 5:¬†[[Disorders of Intermediary Metabolism]] Chapter 413:¬†[[Heritable Disorders of Connective Tissue]] Chapter 414:¬†[[Hemochromatosis]] Chapter 415:¬†[[Wilson‚Äôs Disease]] Chapter 416:¬†[[The Porphyrias]] Chapter 417:¬†[[Disorders of Purine and Pyrimidine Metabolism]] Chapter 418:¬†[[Lysosomal Storage Diseases]] Chapter 419:¬†[[Glycogen Storage Diseases and Other Inherited Disorders of Carbohydrate Metabolism]] Chapter 420:¬†[[Inherited Disorders of Amino Acid Metabolism in Adults]] Chapter 421:¬†[[Inherited Defects of Membrane Transport]]</description></item><item><title>Entamoeba histolytica</title><link>https://www.physician.tw/entamoeba-histolytica/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/entamoeba-histolytica/</guid><description>[!info]
üå± ‰æÜËá™: [[Acute Diarrhea (3 weeks)]]
Entamoeba histolytica (amebiasis): Parasite transmitted via fecal-oral route. Clinically, causes bloody diarrhea, typically with subacute symptom onset (over 1‚Äì3 weeks).</description></item><item><title>Frontiers</title><link>https://www.physician.tw/frontiers/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/frontiers/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Frontiers Chapter 481:¬†[[Behavioral Economics and Health]] Chapter 482:¬†[[Complementary and Integrative Therapies and Practices]] Chapter 483:¬†[[The Role of Epigenetics in Disease and Treatment]] Chapter 484:¬†[[Applications of Stem Cell Biology in Clinical Medicine]] Chapter 485:¬†[[The Role of Circadian Biology in Health and Disease]] Chapter 486:¬†[[Network Medicine Systems Biology in Health and Disease]] Chapter 487:¬†[[Emerging Neurotherapeutic Technologies]] Chapter 488:¬†[[Machine Learning and Augmented Intelligence in Clinical Medicine]] Chapter 489:¬†[[Metabolomics]] Chapter 490:¬†[[Circulating Nucleic Acids as Liquid Biopsies and Noninvasive Disease Biomarkers]] Chapter 491:¬†[[Protein Folding Disorders]] Chapter 492:¬†[[Novel Approaches to Diseases of Unknown Etiology]]</description></item><item><title>Functional IBS</title><link>https://www.physician.tw/functional-ibs/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/functional-ibs/</guid><description>Functional IBS Functional IBS (normal osmotic gap, ‚Üì diarrhea with fasting): see [[dysmotility and nutrition]]</description></item><item><title>Gastric secretions</title><link>https://www.physician.tw/gastric-secretions/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastric-secretions/</guid><description>[!info]
üå± ‰æÜËá™: [[The Neuroendocrine System of the Gut]]
Gastric secretions *¬†HCl: Produced by parietal cells in the stomach.</description></item><item><title>Gastrin</title><link>https://www.physician.tw/gastrin/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastrin/</guid><description>[!info]
üå± ‰æÜËá™: [[GI regulatory substances]]
Gastrin Hormone. Produced by G cells in the stomach, stimulated by high pH, stomach distention.</description></item><item><title>Genes, the Environment, and Disease</title><link>https://www.physician.tw/genes-the-environment-and-disease/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/genes-the-environment-and-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Genes, the Environment, and Disease Chapter 466:¬†[[Principles of Human Genetics]] Chapter 467:¬†[[The Practice of Genetics in Clinical Medicine]] Chapter 468:¬†[[Mitochondrial DNA and Heritable Traits and Diseases]] Chapter 469:¬†[[Telomere Disease]] Chapter 470:¬†[[Gene- and Cell-Based Therapy in Clinical Medicine]] Chapter 471:¬†[[The Human Microbiome]]</description></item><item><title>GI regulatory substances</title><link>https://www.physician.tw/gi-regulatory-substances/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gi-regulatory-substances/</guid><description>[!info]
üå± ‰æÜËá™: [[The Neuroendocrine System of the Gut]]
GI regulatory substances ‚Ä¢¬†[[Gastrin]]:
‚Ä¢¬†Gastrin-releasing peptide (GRP): Neurocrine.</description></item><item><title>Global Medicine</title><link>https://www.physician.tw/global-medicine/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/global-medicine/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Global Medicine Chapter 472:¬†[[Global Issues in Medicine]] Chapter 473:¬†[[Emerging and Reemerging Infectious Diseases]] Chapter 474:¬†[[Primary Care and Global Health]] Chapter 475:¬†[[Health Effects of Climate Change]]</description></item><item><title>Grade III acute cholecystitis</title><link>https://www.physician.tw/grade-iii-acute-cholecystitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/grade-iii-acute-cholecystitis/</guid><description>[!info]
üå± ‰æÜËá™: [[guidelines for the diagnosis and determination of severity of acute cholecystitis]]
Grade III acute cholecystitis c.</description></item><item><title>guidelines for the diagnosis and determination of severity of acute cholecystitis</title><link>https://www.physician.tw/guidelines-for-the-diagnosis-and-determination-of-severity-of-acute-cholecystitis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/guidelines-for-the-diagnosis-and-determination-of-severity-of-acute-cholecystitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment-cholecystitis]]
guidelines for the diagnosis and determination of severity of acute cholecystitis Disease severity: TG18/TG13 severity grading for acute cholecystitis</description></item><item><title>Harrisons</title><link>https://www.physician.tw/Harrisons/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Harrisons/</guid><description>at: [[inbox]]
Harrison&amp;rsquo;s Principles of Internal Medicine, 21e | AccessPharmacy Part 1:¬†[[The Profession of Medicine]]
Part 2:¬†[[Cardinal Manifestations and Presentation of Diseases]]</description></item><item><title>Heart Failure Management</title><link>https://www.physician.tw/heart-failure-management/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/heart-failure-management/</guid><description> [!info]
üå± ‰æÜËá™: [[Disorders of the Cardiovascular System]]
Heart Failure: Management</description></item><item><title>Heart Failure Pathophysiology and Diagnosis</title><link>https://www.physician.tw/heart-failure-pathophysiology-and-diagnosis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/heart-failure-pathophysiology-and-diagnosis/</guid><description> [!info]
üå± ‰æÜËá™: [[Disorders of the Cardiovascular System]]
Heart Failure: Pathophysiology and Diagnosis</description></item><item><title>Helminthic Infections</title><link>https://www.physician.tw/helminthic-infections/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/helminthic-infections/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Helminthic Infections Chapter 230:¬†[[Introduction to Helminthic Infections]] Chapter 231:¬†[[Trichinellosis and Other Tissue Nematode Infections]] Chapter 232:¬†[[Intestinal Nematode Infections]] Chapter 233:¬†[[Filarial and Related Infections]] Chapter 234:¬†[[Schistosomiasis and Other Trematode Infections]] Chapter 235:¬†[[Cestode Infections]]</description></item><item><title>Hematopoietic Disorders</title><link>https://www.physician.tw/hematopoietic-disorders/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematopoietic-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Hematopoietic Disorders Chapter 96:¬†[[Hematopoietic Stem Cells]] Chapter 97:¬†[[Iron Deficiency and Other Hypoproliferative Anemias]] Chapter 98:¬†[[Disorders of Hemoglobin]] Chapter 99:¬†[[Megaloblastic Anemias]] Chapter 100:¬†[[Hemolytic Anemias]] Chapter 101:¬†[[Anemia Due to Acute Blood Loss]] Chapter 102:¬†[[Bone Marrow Failure Syndromes Including Aplastic Anemia and Myelodysplasia]] Chapter 103:¬†[[Polycythemia Vera and Other Myeloproliferative Neoplasms]] Chapter 104:¬†[[Acute Myeloid Leukemia]] Chapter 105:¬†[[Chronic Myeloid Leukemia]] Chapter 106:¬†[[Acute Lymphoid Leukemia]] Chapter 107:¬†[[Chronic Lymphocytic Leukemia]] Chapter 108:¬†[[Non-Hodgkin‚Äôs Lymphoma]] Chapter 109:¬†[[Hodgkin‚Äôs Lymphoma]] Chapter 110:¬†[[Less Common Lymphoid and Myeloid Malignancies]] Chapter 111:¬†[[Plasma Cell Disorders]] Chapter 112:¬†[[Amyloidosis]] Chapter 113:¬†[[Transfusion Therapy and Biology]] Chapter 114:¬†[[Hematopoietic Cell Transplantation]]</description></item><item><title>hemochromatosis</title><link>https://www.physician.tw/hemochromatosis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemochromatosis/</guid><description> [!info]
üå± ‰æÜËá™: [[Etiologies-cirrhosis]]
hemochromatosis</description></item><item><title>Hereditary hemorrhagic telangiectasia</title><link>https://www.physician.tw/hereditary-hemorrhagic-telangiectasia/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hereditary-hemorrhagic-telangiectasia/</guid><description>[!info]
üå± ‰æÜËá™: [[lower gastrointestinal bleeding]]
Hereditary hemorrhagic telangiectasia [!note] Note
a.k.a [[Weber-Osler-Rendu]]
diffuse AVMs throughout GI mucosa (also involve lips, oral mucosa, fingertips).</description></item><item><title>iminodiacetic</title><link>https://www.physician.tw/iminodiacetic/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/iminodiacetic/</guid><description> [!info]
üå± ‰æÜËá™: [[Diagnostic studies-cholecystitis]]
iminodiacetic ‰∫ûÊ∞®Âü∫‰∫å‰πôÈÖ∏
HIDA scan</description></item><item><title>Immune-Mediated, Inflammatory, and Rheumatologic Disorders</title><link>https://www.physician.tw/immune-mediated-inflammatory-and-rheumatologic-disorders/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-mediated-inflammatory-and-rheumatologic-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Immune-Mediated, Inflammatory, and Rheumatologic Disorders Section 1:¬†[[The Immune System in Health and Disease]] Section 2:¬†[[Disorders of Immune-Mediated Injury]] Section 3:¬†[[Disorders of the Joints and Adjacent Tissues]]</description></item><item><title>Infections Due to DNA and RNA Respiratory Viruses</title><link>https://www.physician.tw/infections-due-to-dna-and-rna-respiratory-viruses/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infections-due-to-dna-and-rna-respiratory-viruses/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Infections Due to DNA and RNA Respiratory Viruses Chapter 199:¬†[[Common Viral Respiratory Infections, Including COVID-19]] Chapter 200:¬†[[Influenza]]</description></item><item><title>Infections Due to DNA Viruses</title><link>https://www.physician.tw/infections-due-to-dna-viruses/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infections-due-to-dna-viruses/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Infections Due to DNA Viruses Chapter 192:¬†[[Herpes Simplex Virus Infections]] Chapter 193:¬†[[Varicella-Zoster Virus Infections]] Chapter 194:¬†[[Epstein-Barr Virus Infections, Including Infectious Mononucleosis]] Chapter 195:¬†[[Cytomegalovirus and Human Herpesvirus Types 6, 7, and 8]] Chapter 196:¬†[[Molluscum Contagiosum, Mpox, and Other Poxvirus Infections]] Chapter 197:¬†[[Parvovirus Infections]] Chapter 198:¬†[[Human Papillomavirus Infections]]</description></item><item><title>Infections Due to Human Immunodeficiency Virus and Other Human Retroviruses</title><link>https://www.physician.tw/infections-due-to-human-immunodeficiency-virus-and-other-human-retroviruses/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infections-due-to-human-immunodeficiency-virus-and-other-human-retroviruses/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Infections Due to Human Immunodeficiency Virus and Other Human Retroviruses Chapter 201:¬†[[The Human Retroviruses]] Chapter 202:¬†[[Human Immunodeficiency Virus Disease: AIDS and Related Disorders]]</description></item><item><title>Infections Due to RNA Viruses</title><link>https://www.physician.tw/infections-due-to-rna-viruses/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infections-due-to-rna-viruses/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Infections Due to RNA Viruses Chapter 203:¬†[[Viral Gastroenteritis]] Chapter 204:¬†[[Enterovirus, Parechovirus, and Reovirus Infections]] Chapter 205:¬†[[Measles (Rubeola)]] Chapter 206:¬†[[Rubella (German Measles)]] Chapter 207:¬†[[Mumps]] Chapter 208:¬†[[Rabies and Other Rhabdovirus Infections]] Chapter 209:¬†[[Arthropod-Borne and Rodent-Borne Virus Infections]] Chapter 210:¬†[[Ebolavirus and Marburgvirus Infections]]</description></item><item><title>Infectious Diseases</title><link>https://www.physician.tw/infectious-diseases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Infectious Diseases Section 1:¬†[[Basic Considerations in Infectious Diseases]] Section 2:¬†[[Clinical Syndromes: Community-Acquired Infections]] Section 3:¬†[[Clinical Syndromes: Health Care-Associated Infections]] Section 4:¬†[[Therapy for Bacterial Diseases]] Section 5:¬†[[Diseases Caused by Gram-Positive Bacteria]] Section 6:¬†[[Diseases Caused by Gram-Negative Bacteria]] Section 7:¬†[[Miscellaneous Bacterial Infections]] Section 8:¬†[[Mycobacterial Diseases]] Section 9:¬†[[Spirochetal Diseases]] Section 10:¬†[[Diseases Caused by Rickettsiae, Mycoplasmas, and Chlamydiae]] Section 11:¬†[[Viral Diseases: General Considerations]] Section 12:¬†[[Infections Due to DNA Viruses]] Section 13:¬†[[Infections Due to DNA and RNA Respiratory Viruses]] Section 14:¬†[[Infections Due to Human Immunodeficiency Virus and Other Human Retroviruses]] Section 15:¬†[[Infections Due to RNA Viruses]] Section 16:¬†[[Fungal Infections]] Section 17:¬†[[Protozoal and Helminthic Infections: General Considerations]] Section 18:¬†[[Protozoal Infections]] Section 19:¬†[[Helminthic Infections]]</description></item><item><title>Inflammatory diarrhea</title><link>https://www.physician.tw/inflammatory-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inflammatory-diarrhea/</guid><description>Inflammatory diarrhea (‚äï fecal WBC, calprotectin, lactoferrin; ‚äï FOB; fever, abd pain)
Infections: chronic C. diff, Entamoeba histolytica, [[Yersinia]], [[CMV colitis]], TB especially in immunocompromised hosts.</description></item><item><title>Insertion of Female Urethral Catheter</title><link>https://www.physician.tw/insertion-of-female-urethral-catheter/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/insertion-of-female-urethral-catheter/</guid><description> [!info]
üå± ‰æÜËá™: [[Clinical Procedure Tutorials]]
Insertion of Female Urethral Catheter</description></item><item><title>Insertion of Male Urethral Catheter</title><link>https://www.physician.tw/insertion-of-male-urethral-catheter/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/insertion-of-male-urethral-catheter/</guid><description> [!info]
üå± ‰æÜËá™: [[Clinical Procedure Tutorials]]
Insertion of Male Urethral Catheter</description></item><item><title>introduction of Budd-Chiari syndrome</title><link>https://www.physician.tw/introduction-of-budd-chiari-syndrome/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/introduction-of-budd-chiari-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Budd-Chiari syndrome]]
introduction of Budd-Chiari syndrome Budd-Chiari syndrome is a rare vascular disorder caused by obstruction of hepatic blood outflow at the level of the hepatic veins or hepatic portion of the inferior vena cava.</description></item><item><title>lab testing of general evaluation or chronic diarrhea</title><link>https://www.physician.tw/lab-testing-of-general-evaluation-or-chronic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lab-testing-of-general-evaluation-or-chronic-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[General evaluation or chronic diarrhea]]
lab testing of general evaluation or chronic diarrhea CBC (Complete Blood Count) - A blood test that measures the number of red and white blood cells, hemoglobin levels, and platelet count.</description></item><item><title>Lactose intolerance</title><link>https://www.physician.tw/lactose-intolerance/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lactose-intolerance/</guid><description>[!info]
üå± ‰æÜËá™: [[Osmotic diarrhea]]
Lactose intolerance Lactose intolerance - A digestive disorder where the body is unable to properly digest lactose, a type of sugar found in milk and dairy products.</description></item><item><title>Leptospirosis Disease</title><link>https://www.physician.tw/leptospirosis-disease/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leptospirosis-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Leptospirosis Disease</description></item><item><title>likelihood high of diagnostic studies choledocholithiasis</title><link>https://www.physician.tw/likelihood-high-of-diagnostic-studies-choledocholithiasis/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/likelihood-high-of-diagnostic-studies-choledocholithiasis/</guid><description>[!info]
üå± ‰æÜËá™: [[Diagnostic studies-choledocholithiasis]]
likelihood high of diagnostic studies choledocholithiasis (eg, visualized stone, cholangitis, bili &amp;gt;4, or dilated CBD on U/S + bili 1.</description></item><item><title>Maldigestion</title><link>https://www.physician.tw/maldigestion/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/maldigestion/</guid><description>Maldigestion (fatty; ‚Üë fecal fat, ‚Üë osmotic gap, ‚Üì diarrhea w/ fasting) Fatty diarrhea with increased fecal fat, increased osmotic gap, and decreased diarrhea with fasting - A type of diarrhea characterized by fatty, greasy stools with a high concentration of fat, indicated by an increased fecal fat level.</description></item><item><title>Meperidine</title><link>https://www.physician.tw/meperidine/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/meperidine/</guid><description>[!info]
üå± ‰æÜËá™: [[analgesia as treatment ofcholecystitis]]
Meperidine (Demerol)</description></item><item><title>Miscellaneous Bacterial Infections</title><link>https://www.physician.tw/miscellaneous-bacterial-infections/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/miscellaneous-bacterial-infections/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Miscellaneous Bacterial Infections Chapter 174:¬†[[Nocardiosis]] Chapter 175:¬†[[Actinomycosis]] Chapter 176:¬†[[Whipple‚Äôs Disease]] Chapter 177:¬†[[Infections Due to Mixed Anaerobic Organisms]]</description></item><item><title>Mycobacterial Diseases</title><link>https://www.physician.tw/mycobacterial-diseases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mycobacterial-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Mycobacterial Diseases Chapter 178:¬†[[Tuberculosis]] Chapter 179:¬†[[Leprosy]] Chapter 180:¬†[[Nontuberculous Mycobacterial Infections]] Chapter 181:¬†[[Antimycobacterial Agents]]</description></item><item><title>myeloproliferative disorders</title><link>https://www.physician.tw/myeloproliferative-disorders/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myeloproliferative-disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[hematology]] üå±‰æÜËá™: [[Pocket Oncology]]
myeloproliferative disorders Essential Thrombocythemia Polycythemia Vera (PV) Myelofibrosis Mastocytosis/Hypereosinophilic Syndrome</description></item><item><title>Neoplastic Disorders</title><link>https://www.physician.tw/neoplastic-disorders/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neoplastic-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Neoplastic Disorders Chapter 69:¬†[[Approach to the Patient with Cancer]] Chapter 70:¬†[[Prevention and Early Detection of Cancer]] Chapter 71:¬†[[Cancer Genetics]] Chapter 72:¬†[[Cancer Cell Biology]] Chapter 73:¬†[[Principles of Cancer Treatment]] Chapter 74:¬†[[Infections in Patients with Cancer]] Chapter 75:¬†[[Oncologic Emergencies]] Chapter 76:¬†[[Cancer of the Skin]] Chapter 77:¬†[[Head and Neck Cancer]] Chapter 78:¬†[[Neoplasms of the Lung]] Chapter 79:¬†[[Breast Cancer]] Chapter 80:¬†[[Upper Gastrointestinal Tract Cancers]] Chapter 81:¬†[[Lower Gastrointestinal Cancers]] Chapter 82:¬†[[Tumors of the Liver and Biliary Tree]] Chapter 83:¬†[[Pancreatic Cancer]] Chapter 84:¬†[[Gastrointestinal Neuroendocrine Tumors]] Chapter 85:¬†[[Renal Cell Carcinoma]] Chapter 86:¬†[[Cancer of the Bladder and Urinary Tract]] Chapter 87:¬†[[Benign and Malignant Diseases of the Prostate]] Chapter 88:¬†[[Testicular Cancer]] Chapter 89:¬†[[Gynecologic Malignancies]] Chapter 90:¬†[[Primary and Metastatic Tumors of the Nervous System]] Chapter 91:¬†[[Soft Tissue and Bone Sarcomas and Bone Metastases]] Chapter 92:¬†[[Carcinoma of Unknown Primary]] Chapter 93:¬†[[Paraneoplastic Syndromes: Endocrinologic/Hematologic]] Chapter 94:¬†[[Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis]] Chapter 95:¬†[[Cancer Survivorship and the Long-Term Impact of Cancer and Its Treatment]]</description></item><item><title>Neurologic Disorders</title><link>https://www.physician.tw/neurologic-disorders/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Neurologic Disorders Section 1:¬†[[Diagnosis of Neurologic Disorders]] Chapter 422:¬†[[Approach to the Patient with Neurologic Disease]] Chapter 423:¬†[[Neuroimaging in Neurologic Disorders]] Chapter 424:¬†[[Pathobiology of Neurologic Diseases]] Section 2:¬†[[Diseases of the Central Nervous System]] Chapter 425:¬†[[Seizures and Epilepsy]] Chapter 426:¬†[[Introduction to Cerebrovascular Diseases]] Chapter 427:¬†[[Ischemic Stroke]] Chapter 428:¬†[[Intracranial Hemorrhage]] Chapter 429:¬†[[Subarachnoid Hemorrhage]] Chapter 430:¬†[[Migraine and Other Primary Headache Disorders]] Chapter 431:¬†[[Alzheimer‚Äôs Disease]] Chapter 432:¬†[[Frontotemporal Dementia]] Chapter 433:¬†[[Vascular Dementia]] Chapter 434:¬†[[Dementia with Lewy Bodies]] Chapter 435:¬†[[Parkinson‚Äôs Disease]] Chapter 436:¬†[[Tremor, Chorea, and Other Movement Disorders]] Chapter 437:¬†[[Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases]] Chapter 438:¬†[[Prion Diseases]] Chapter 439:¬†[[Ataxic Disorders]] Chapter 440:¬†[[Disorders of the Autonomic Nervous System]] Chapter 441:¬†[[Trigeminal Neuralgia, Bell‚Äôs Palsy, and Other Cranial Nerve Disorders]] Chapter 442:¬†[[Diseases of the Spinal Cord]] Chapter 443:¬†[[Concussion and Other Traumatic Brain Injuries]] Chapter 444:¬†[[Multiple Sclerosis]] Chapter 445:¬†[[Neuromyelitis Optica]] Section 3:¬†[[Nerve and Muscle Disorders]] Chapter 446:¬†[[Peripheral Neuropathy]] Chapter 447:¬†[[Guillain-Barr√© Syndrome and Other Immune-Mediated Neuropathies]] Chapter 448:¬†[[Myasthenia Gravis and Other Diseases of the Neuromuscular Junction]] Chapter 449:¬†[[Muscular Dystrophies and Other Muscle Diseases]] Section 4:¬†[[Chronic Fatigue Syndrome]] Chapter 450:¬†[[Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] Section 5:¬†[[Psychiatric and Addiction Disorders]] Chapter 451:¬†[[Biology of Psychiatric Disorders]] Chapter 452:¬†[[Psychiatric Disorders]] Chapter 453:¬†[[Alcohol and Alcohol Use Disorders]] Chapter 454:¬†[[Nicotine Addiction]] Chapter 455:¬†[[Marijuana and Marijuana Use Disorders]] Chapter 456:¬†[[Opioid-Related Disorders]] Chapter 457:¬†[[Cocaine, Other Psychostimulants, and Hallucinogens]]</description></item><item><title>Noninvasive Cardiac Imaging Echocardiography, Nuclear Cardiology, and Magnetic Resonance Computed Tomography Imaging</title><link>https://www.physician.tw/noninvasive-cardiac-imaging-echocardiography-nuclear-cardiology-and-magnetic-resonance-computed-tomography-imaging/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/noninvasive-cardiac-imaging-echocardiography-nuclear-cardiology-and-magnetic-resonance-computed-tomography-imaging/</guid><description> [!info]
üå± ‰æÜËá™: [[Disorders of the Cardiovascular System]]
Noninvasive Cardiac Imaging: Echocardiography, Nuclear Cardiology, and Magnetic Resonance Computed Tomography Imaging</description></item><item><title>offending meds cause chronic diarrhea</title><link>https://www.physician.tw/offending-meds-cause-chronic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/offending-meds-cause-chronic-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[General evaluation or chronic diarrhea]]
offending meds cause chronic diarrhea PPI (Proton Pump Inhibitor) - A type of medication used to reduce the amount of acid produced in the stomach.</description></item><item><title>Oncology and Hematology</title><link>https://www.physician.tw/oncology-and-hematology/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oncology-and-hematology/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Oncology and Hematology</description></item><item><title>Osmotic diarrhea</title><link>https://www.physician.tw/osmotic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/osmotic-diarrhea/</guid><description>Osmotic diarrhea Osmotic diarrhea Watery diarrhea - A condition characterized by frequent loose or watery stools, indicating an increased fluid content in the intestine.</description></item><item><title>pancreatic insufficiency</title><link>https://www.physician.tw/pancreatic-insufficiency/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatic-insufficiency/</guid><description>[!info]
üå± ‰æÜËá™: [[Maldigestion]]
pancreatic insufficiency Chronic pancreatitis or pancreatic cancer - The most common causes of fatty diarrhea with increased fecal fat, increased osmotic gap, and decreased diarrhea with fasting.</description></item><item><title>Parasitic diarrhea</title><link>https://www.physician.tw/parasitic-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/parasitic-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[NONINFLAMMATORY-Acute Infectious Etiologies]]
Parasitic diarrhea (¬± malab for mos after Rx)
Giardia Streams/outdoor sports, travel, outbreaks.</description></item><item><title>Pharmacology</title><link>https://www.physician.tw/pharmacology/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pharmacology/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Pharmacology Chapter 67:¬†[[Principles of Clinical Pharmacology]] Chapter 68:¬†[[Pharmacogenomics]]</description></item><item><title>Poisoning, Drug Overdose, and Envenomation</title><link>https://www.physician.tw/poisoning-drug-overdose-and-envenomation/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/poisoning-drug-overdose-and-envenomation/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Poisoning, Drug Overdose, and Envenomation Chapter 458:¬†[[Heavy Metal Poisoning]] Chapter 459:¬†[[Poisoning and Drug Overdose]] Chapter 460:¬†[[Disorders Caused by Venomous Snakebites and Marine Animal Exposures]] Chapter 461:¬†[[Ectoparasite Infestations and Arthropod Injuries]]</description></item><item><title>preformed toxin</title><link>https://www.physician.tw/preformed-toxin/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preformed-toxin/</guid><description>[!info]
üå± ‰æÜËá™: [[NONINFLAMMATORY-Acute Infectious Etiologies]]
preformed toxin ‚ÄúFood poisoning,‚Äù &amp;lt;24 h dur.
S. aureus (meats &amp;amp; dairy), B.</description></item><item><title>Protozoal and Helminthic Infections General Considerations</title><link>https://www.physician.tw/protozoal-and-helminthic-infections-general-considerations/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protozoal-and-helminthic-infections-general-considerations/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Protozoal and Helminthic Infections: General Considerations Chapter 221:¬†[[Introduction to Parasitic Infections]] Chapter 222:¬†[[Agents Used to Treat Parasitic Infections]]</description></item><item><title>Protozoal Infections</title><link>https://www.physician.tw/protozoal-infections/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protozoal-infections/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Protozoal Infections Chapter 223:¬†[[Amebiasis and Infection with Free-Living Amebae]] Chapter 224:¬†[[Malaria]] Chapter 225:¬†[[Babesiosis]] Chapter 226:¬†[[Leishmaniasis]] Chapter 227:¬†[[Chagas Disease and African Trypanosomiasis Infections]] Chapter 229:¬†[[Protozoal Intestinal Infections and Trichomoniasis]]</description></item><item><title>Reynolds‚Äô pentad</title><link>https://www.physician.tw/reynolds-pentad/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/reynolds-pentad/</guid><description> [!info]
üå± ‰æÜËá™: [[cholangitis]]
Reynolds‚Äô pentad [[Charcot‚Äôs triad]]
shock and Œî MS; present in ~15% of Pts</description></item><item><title>Rotavirus</title><link>https://www.physician.tw/rotavirus/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rotavirus/</guid><description>[!info]
üå± ‰æÜËá™: [[Acute Diarrhea (3 weeks)]]
Rotavirus Transmitted via fecal-oral route with an incubation period of &amp;lt;48 hours.</description></item><item><title>salmonella</title><link>https://www.physician.tw/salmonella/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/salmonella/</guid><description>[!info]
üå± ‰æÜËá™: [[bacterial inflammatory acute diarrhea]]
salmonella Eggs, poultry, milk, hamsters. Bacteremia in 5‚Äì10%. 10‚Äì33% of bacteremic Pts &amp;gt;50 y may develop [[aortitis]].</description></item><item><title>Salmonella typhi</title><link>https://www.physician.tw/salmonella-typhi/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/salmonella-typhi/</guid><description>[!info]
üå± ‰æÜËá™: [[bacterial inflammatory acute diarrhea]]
Salmonella typhi Travel to Asia, Africa, South America. Systemic toxicity, relative bradycardia, rose spot rash, ileus ‚Üí ‚Äùpea-soup‚Äù diarrhea, bacteremia.</description></item><item><title>Secretory diarrhea</title><link>https://www.physician.tw/secretory-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/secretory-diarrhea/</guid><description>Secretory diarrhea [!tldr] Sx
watery; nl osmotic gap, no Œî diarrhea w/ fasting, nocturnal, cramps
Watery diarrhea with normal osmotic gap and no change with fasting, nocturnal, and cramps - A type of diarrhea characterized by frequent and watery stools, with a normal osmotic gap (indicating normal absorption of substances in the intestine) and no change in frequency with fasting.</description></item><item><title>Shigella</title><link>https://www.physician.tw/shigella/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/shigella/</guid><description>[!info]
üå± ‰æÜËá™: [[bacterial inflammatory acute diarrhea]]
Shigella Abrupt onset; no N/V; gross blood &amp;amp; pus in stool; ‚Üë‚Üë WBC Colonic infection.</description></item><item><title>SOFA</title><link>https://www.physician.tw/sofa/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sofa/</guid><description>[!info]
üå± ‰æÜËá™: [[Definitions-sepsis and shock]]
SOFA Sequential Organ Failure Assessment ([[SOFA]]): ‚Üë points for worsening organ dysfxn:</description></item><item><title>Spirochetal Diseases</title><link>https://www.physician.tw/spirochetal-diseases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spirochetal-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Spirochetal Diseases Chapter 182:¬†[[Syphilis]] Chapter 183:¬†[[Endemic Treponematoses]] Chapter 184:¬†[[Leptospirosis Disease]] Chapter 186:¬†[[Lyme Borreliosis]]</description></item><item><title>stem cell transplantation</title><link>https://www.physician.tw/stem-cell-transplantation/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stem-cell-transplantation/</guid><description>[!info]
üå± ‰æÜËá™: [[hematology]]
stem cell transplantation [!info]
üå±‰æÜËá™: [[Pocket Oncology]]
STEM CELL TRANSPLANTATION Autologous Stem Cell Transplantation Allogeneic Stem Cell Transplantation</description></item><item><title>Supplementary Topics</title><link>https://www.physician.tw/supplementary-topics/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/supplementary-topics/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Supplementary Topics Chapter S1:¬†[[Fluid and Electrolyte Imbalances and Acid-Base Disturbances: Case Examples]] Chapter S2:¬†[[Cerebrospinal Fluid Disturbances: Case Examples]] Chapter S3:¬†[[Microbial Bioterrorism]] Chapter S4:¬†[[Chemical Terrorism]] Chapter S5:¬†[[Radiation Terrorism]] Chapter S6:¬†[[Infections in War Veterans]] Chapter S7:¬†[[Health Care for Military Veterans]] Chapter S8:¬†[[Primary Immunodeficiencies Associated with (or Secondary to) Other Diseases]] Chapter S9:¬†[[Technique of Lumbar Puncture]] Chapter S10:¬†[[The Clinical Laboratory in Modern Health Care]] Chapter S11:¬†[[Laboratory Diagnosis of Infectious Diseases]] Chapter S12:¬†[[Laboratory Diagnosis of Parasitic Infections]]</description></item><item><title>The Bradyarrhythmias Disorders of the Atrioventricular Node</title><link>https://www.physician.tw/the-bradyarrhythmias-disorders-of-the-atrioventricular-node/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/the-bradyarrhythmias-disorders-of-the-atrioventricular-node/</guid><description> [!info]
üå± ‰æÜËá™: [[Disorders of the Cardiovascular System]]
The Bradyarrhythmias: Disorders of the Atrioventricular Node</description></item><item><title>The Bradyarrhythmias Disorders of the Sinoatrial Node</title><link>https://www.physician.tw/the-bradyarrhythmias-disorders-of-the-sinoatrial-node/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/the-bradyarrhythmias-disorders-of-the-sinoatrial-node/</guid><description> [!info]
üå± ‰æÜËá™: [[Disorders of the Cardiovascular System]]
The Bradyarrhythmias: Disorders of the Sinoatrial Node</description></item><item><title>The Immune System in Health and Disease</title><link>https://www.physician.tw/the-immune-system-in-health-and-disease/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/the-immune-system-in-health-and-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[Immune-Mediated, Inflammatory, and Rheumatologic Disorders]]
The Immune System in Health and Disease Chapter 349:¬†[[Introduction to the Immune System]] Chapter 350:¬†[[Mechanisms of Regulation and Dysregulation of the Immune System]] Chapter 351:¬†[[Primary Immune Deficiency Diseases]]</description></item><item><title>The Practice of Medicine</title><link>https://www.physician.tw/the-practice-of-medicine/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/the-practice-of-medicine/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
The Practice of Medicine</description></item><item><title>The Profession of Medicine</title><link>https://www.physician.tw/the-profession-of-medicine/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/the-profession-of-medicine/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
The Profession of Medicine Chapter 1:¬†[[The Practice of Medicine]] Chapter 2:¬†[[Promoting Good Health]] Chapter 3:¬†[[Vaccine Opposition and Hesitancy]] Chapter 4:¬†[[Decision-Making in Clinical Medicine]] Chapter 5:¬†[[Precision Medicine and Clinical Care]] Chapter 6:¬†[[Screening and Prevention of Disease]] Chapter 7:¬†[[Global Diversity of Health System Financing and Delivery]] Chapter 8:¬†[[The Safety and Quality of Health Care]] Chapter 9:¬†[[Diagnosis: Reducing Errors and Improving Quality]] Chapter 10:¬†[[Racial and Ethnic Disparities in Health Care]] Chapter 11:¬†[[Ethical Issues in Clinical Medicine]] Chapter 12:¬†[[Palliative and End-of-Life Care]]</description></item><item><title>Therapy for Bacterial Diseases</title><link>https://www.physician.tw/therapy-for-bacterial-diseases/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/therapy-for-bacterial-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Therapy for Bacterial Diseases Chapter 144:¬†[[Treatment and Prophylaxis of Bacterial Infections]] Chapter 145:¬†[[Bacterial Resistance to Antimicrobial Agents]]</description></item><item><title>Video Collection</title><link>https://www.physician.tw/video-collection/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/video-collection/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Video Collection Chapter V1:¬†[[Video Library of Gait Disorders]] Chapter V2:¬†[[Primary Progressive Aphasia, Memory Loss, and Other Focal Cerebral Disorders]] Chapter V3:¬†[[Video Library of Neuro-Ophthalmology]] Chapter V4:¬†[[Examination of the Comatose Patient]] Chapter V5:¬†[[Video Atlas of Gastrointestinal Endoscopic Lesions]] Chapter V6:¬†[[The Neurologic Screening Exam]] Chapter V7:¬†[[Video Atlas of the Detailed Neurologic Examination]]</description></item><item><title>Viral diarrhea</title><link>https://www.physician.tw/viral-diarrhea/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/viral-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[NONINFLAMMATORY-Acute Infectious Etiologies]]
Viral diarrhea Rotavirus Outbreak person to person (PTP), daycare; lasts 4‚Äì8 d.</description></item><item><title>Viral Diseases General Considerations</title><link>https://www.physician.tw/viral-diseases-general-considerations/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/viral-diseases-general-considerations/</guid><description> [!info]
üå± ‰æÜËá™: [[Harrions]]
Viral Diseases: General Considerations Chapter 190:¬†[[Principles of Medical Virology]] Chapter 191:¬†[[Antiviral Chemotherapy, Excluding Antiretroviral Drugs]]</description></item><item><title>Weber-Osler-Rendu</title><link>https://www.physician.tw/weber-osler-rendering/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/weber-osler-rendering/</guid><description> [!info]
üå± ‰æÜËá™: [[lower gastrointestinal bleeding]]
Weber-Osler-Rendu [!note] Note
a.k.a.[[Hereditary hemorrhagic telangiectasia]]</description></item><item><title>Yersinia</title><link>https://www.physician.tw/yersinia/</link><pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/yersinia/</guid><description>[!info]
üå± ‰æÜËá™: [[bacterial inflammatory acute diarrhea]]
Yersinia undercooked pork; unpasteurized milk, abd pain ‚Üí ‚Äùpseudoappendicitis‚Äù (aka mesenteric adenitis) Can pass through the stomach, adhere to the gut epithelium, and localize in lymphoid tissue to evade the immune response.</description></item><item><title>AiÁõ∏Èóú</title><link>https://www.physician.tw/ai-related/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ai-related/</guid><description> [!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
AiÁõ∏Èóú [[ChatGPT]] Êé®Ëñ¶Â•ΩÂ∑•ÂÖ∑ All your video needs in one place | Clipchamp Image Background Remover | Remove Bg from Image for Free Rytr - Best AI Writer, Content Generator &amp;amp; Writing Assistant</description></item><item><title>Child-Pugh score</title><link>https://www.physician.tw/child-pugh-score/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/child-pugh-score/</guid><description>[!info]
üå± ‰æÜËá™: [[Esophageal or gastric varices]]
Child-Pugh score üöß total bilirubin: yellow compound in bile from hemoglobin breakdown serum albumin: blood protein produced in the liver prothrombin time, prolongation(s) or INR: time for blood to clot ascites: fluid in peritoneal cavity [[hepatic encephalopathy]]: brain disorder from liver disease [[encephalopathy grades]] (from the FDA)</description></item><item><title>CLIF-C ACLF</title><link>https://www.physician.tw/clif-c-aclf/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clif-c-aclf/</guid><description>[!info]
üå± ‰æÜËá™: [[Child-Pugh score]]
CLIF-C ACLF üöß Use in adult patients with decompensated chronic (cirrhotic) liver disease; it does not predict outcome in acute liver failure.</description></item><item><title>encephalopathy grades</title><link>https://www.physician.tw/encephalopathy-grades/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/encephalopathy-grades/</guid><description>[!info]
üå± ‰æÜËá™: [[Child-Pugh score]]
encephalopathy grades üöß Grade 0: normal consciousness, personality, neurological examination, electroencephalogram Grade 1: restless, sleep disturbed, irritable/agitated, tremor, impaired handwriting, 5 cps waves Grade 2: lethargic, time-disoriented, inappropriate, asterixis, ataxia, slow triphasic waves Grade 3: somnolent, stuporous, place-disoriented, hyperactive reflexes, rigidity, slower waves Grade 4: unrousable coma, no personality/behavior, decerebrate, slow 2-3 cps delta activity Hepatic Encephalopathy Grades/Stages - MDCalc</description></item><item><title>Gastric antral vascular ectasia</title><link>https://www.physician.tw/gastric-antral-vascular-ectasia/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastric-antral-vascular-ectasia/</guid><description>[!info]
üå± ‰æÜËá™: [[vascular etiology of lower gastrointestinal bleeding]]
Gastric antral vascular ectasia üçâ
Diagnosis and management of gastric antral vascular ectasia - PMC</description></item><item><title>Go</title><link>https://www.physician.tw/go/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/go/</guid><description>[!info]
üå± ‰æÜËá™: [[Á®ãÂºèË™ûË®Ä]]
Go Golang ‚Äî GOROOT„ÄÅGOPATH„ÄÅGo-Modules-‰∏âËÄÖÁöÑÈóú‰øÇ‰ªãÁ¥π | by Èô≥ÂÜ†ÂÑÑ Kenny | ‰ºÅÈµù‰πüÊáÇÁ®ãÂºèË®≠Ë®à | Medium</description></item><item><title>hepatic encephalopathy</title><link>https://www.physician.tw/hepatic-encephalopathy/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatic-encephalopathy/</guid><description> [!info]
üå± ‰æÜËá™: [[Child-Pugh score]]
hepatic encephalopathy üöß [[encephalopathy grades]] (from the FDA)</description></item><item><title>High-risk (for rebleeding) ulcer</title><link>https://www.physician.tw/high-risk-for-rebleeding-ulcer/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/high-risk-for-rebleeding-ulcer/</guid><description>[!info]
üå± ‰æÜËá™: [[peptic ulcer disease]]
High-risk (for rebleeding) ulcer üöß Arterial spurting: Refers to the sudden and forceful ejection of blood from a vessel, in this case, a blood vessel in the stomach or duodenum.</description></item><item><title>intestinal ischemia</title><link>https://www.physician.tw/intestinal-ischemia/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/intestinal-ischemia/</guid><description> [!info]
üå± ‰æÜËá™: [[gastroenterology]]
intestinal ischemia</description></item><item><title>lower gastrointestinal bleeding</title><link>https://www.physician.tw/lower-gastrointestinal-bleeding/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lower-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[gastrointestinal bleeding]]
lower gastrointestinal bleeding (NEJM 2017;376:1054) Ë©≥Ë¶ã Acute Lower Gastrointestinal Bleeding.
[[diverticular bleed]] (30%) Polyp/Tumor (20%) Typically slow ooze, p/w fatigue, weight loss, iron deficiency, anemia [[Colitis]] (20%) Infectious (see ‚ÄúAcute Diarrhea‚Äù), IBD, ischemic colitis, XRT Anorectal disorders (20%) Internal, external hemorrhoids anal fissures, rectal ulcers, rectal varices (Rx by ‚Üì portal venous pressure in cirrhosis), XRT Vascular (&amp;lt;10%) Angioectasia &amp;amp; AVMs.</description></item><item><title>management of gastrointestinal bleeding</title><link>https://www.physician.tw/management-of-gastrointestinal-bleeding/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-of-gastrointestinal-bleeding/</guid><description> [!info]
üå± ‰æÜËá™: [[gastrointestinal bleeding]]
management of gastrointestinal bleeding [[vasopressin of management of gastrointestinal bleeding]]</description></item><item><title>NAFLD Activity Score</title><link>https://www.physician.tw/nafld-activity-score/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nafld-activity-score/</guid><description> [!info]
üå± ‰æÜËá™: [[Child-Pugh score]]
NAFLD Activity Score üöß</description></item><item><title>octreotide</title><link>https://www.physician.tw/octreotide/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/octreotide/</guid><description>[!info]
üå± ‰æÜËá™: [[Esophageal or gastric varices]]
octreotide üöß Sandostatin Injection‚Äù 100 mcg octreotide/1 mL/amp
Â∏∏Áî®ÂäëÈáè SC (preferred), IV (over 3 mins), IVF (in NS or D5W 50 - 200 mL; infuse over 15 to 30 mins)</description></item><item><title>tagged RBC scan</title><link>https://www.physician.tw/tagged-rbc-scan/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tagged-rbc-scan/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnostic studies of gastrointestinal bleeding]]
tagged RBC scan can identify general luminal location if bleeding rate ‚â•0.</description></item><item><title>UKELD Score</title><link>https://www.physician.tw/ukeld-score/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ukeld-score/</guid><description>[!info]
üå± ‰æÜËá™: [[Child-Pugh score]]
UKELD Score Use in context of national liver transplantation guidelines. In the UK, refer to NHS Blood and Transplant policy.</description></item><item><title>vascular etiology of lower gastrointestinal bleeding</title><link>https://www.physician.tw/vascular-etiology-of-lower-gastrointestinal-bleeding/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vascular-etiology-of-lower-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[lower gastrointestinal bleeding]]
vascular etiology of lower gastrointestinal bleeding Angioectasia AVMs, HHT (see below) AVMs congenital.</description></item><item><title>vasopressin of management of gastrointestinal bleeding</title><link>https://www.physician.tw/vasopressin-of-management-of-gastrointestinal-bleeding/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vasopressin-of-management-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[management of gastrointestinal bleeding]]
vasopressin of management of gastrointestinal bleeding Vasopressin (Pitressin) ËÖ∏ËÉÉÈÅìÂá∫Ë°ÄÔºö0.2~0.4 U/min IVF 5 amps/NS Êàñ D5W 100 ml 12~24 ml/hr (ËÖ∏ËÉÉÈÅìÂá∫Ë°Ä) Important 100U in N/S 500mL max 0.</description></item><item><title>ÈÄôÊòØ‰∏ÄÁØáÊ∏¨ÂºèÊó•Ë®ò</title><link>https://www.physician.tw/2023-01-30/</link><pubDate>Mon, 30 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/2023-01-30/</guid><description> [!info]
üå± ‰æÜËá™: [[NAFLD Activity Score]]
Daily checklist Todo Notes</description></item><item><title>Alterations in Gastrointestinal Function</title><link>https://www.physician.tw/alterations-in-gastrointestinal-function/</link><pubDate>Sun, 29 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/alterations-in-gastrointestinal-function/</guid><description> [!info]
üå± ‰æÜËá™: [[jaundice]]
Alterations in Gastrointestinal Function üöß Chapter 44:¬†[[Dysphagia]] Chapter 45:¬†[[Nausea, Vomiting, and Indigestion]] Chapter 46:¬†[[Diarrhea and Constipation]] Chapter 47:¬†[[Unintentional Weight Loss]] Chapter 48:¬†[[Gastrointestinal Bleeding]] Chapter 49:¬†[[Jaundice]] Chapter 50:¬†[[Abdominal Swelling and Ascites]]</description></item><item><title>brisk UGIB</title><link>https://www.physician.tw/brisk-ugib/</link><pubDate>Sun, 29 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/brisk-ugib/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnostic studies of gastrointestinal bleeding]]
brisk UGIB Upper Gastrointestinal Bleeding - StatPearls - NCBI Bookshelf</description></item><item><title>hematochezia</title><link>https://www.physician.tw/hematochezia/</link><pubDate>Sun, 29 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematochezia/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnostic studies of gastrointestinal bleeding]]
hematochezia ‰æøË°ÄÔºàËã±Ë™ûÔºöHemato-cheziaÔºâ ÊòØÊåáÊñ∞ÈÆÆË°ÄÊ∂≤ÈÄöÈÅéËÇõÈñÄÊéíÂá∫Ôºå ÈÄöÂ∏∏ÊòØÂ§ß‰æø‰∏≠Â∏∂Ë°ÄÔºàÊ≥®ÊÑèÂíåÈªë‰æøÔºàËã±Ë™ûÔºöMelena]]ÔºâÈëëÂà•Ôºâ ‰æøË°Ä‰∏ÄËà¨ÊòØÂíå‰∏ãÊ∂àÂåñÈÅìÔºàÂç≥Â±àÊ∞èÈüåÂ∏∂‰ª•‰∏ãÁöÑÊ∂àÂåñÈÅìÔºâÂá∫Ë°ÄÔºàËã±Ë™ûÔºöLower gastrointestinal bleedingÔºâÊúâÈóúÔºå‰ΩÜ‰πüÂèØËÉΩÂõ†Âø´ÈÄüÁöÑ‰∏äÊ∂àÂåñÈÅìÂá∫Ë°ÄËÄåÈÄ†Êàê„ÄÇ‰æøË°ÄÂíåÁõ¥ËÖ∏Âá∫Ë°ÄÔºàrectorrhagiaÔºâ‰∏çÂêåÔºåÁõ¥ËÖ∏Âá∫Ë°Ä‰∏ÄËà¨ÂíåÊéí‰æøÁÑ°ÈóúÔºåÊòØÂú®Ê≤íÊúâÊéí‰æøÊôÇÈÆÆË°ÄÂæûËÇõÈñÄÊéíÂá∫ÁöÑÁóáÁãÄ„ÄÇ
bright red blood per rectum ÔºàÁ∂ìÁõ¥ËÖ∏ÊéíÂá∫ÁöÑÈÆÆË°ÄÔºåÁ∞°Á®±BRBPRÔºâÊòØÊåá‰æøË°ÄÊàñÊòØÁõ¥ËÖ∏Âá∫Ë°Ä„ÄÇ ‰æøË°Ä‰πüÂíåÂ§ß‰æøÂæåÊì¶Êã≠ÁöÑË°õÁîüÁ¥ô‰∏äÊúâË°ÄÁöÑhematopapyrusÁóáÁãÄ‰∏çÂêå</description></item><item><title>ligament of Treitz</title><link>https://www.physician.tw/ligament-of-treitz/</link><pubDate>Sun, 29 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ligament-of-treitz/</guid><description> [!info]
üå± ‰æÜËá™: [[Definition of gastrointestinal bleeding]]
ligament of Treitz üöß Á∂†Ëâ≤ÁöÑÈÇ£Ê¢ù
Figure:</description></item><item><title>balloon-retrograde transvenous obliteration</title><link>https://www.physician.tw/balloon-retrograde-transvenous-obliteration/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/balloon-retrograde-transvenous-obliteration/</guid><description>balloon-retrograde transvenous obliteration</description></item><item><title>bivalirudin</title><link>https://www.physician.tw/bivalirudin/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bivalirudin/</guid><description>bivalirudin</description></item><item><title>capsule endoscopy</title><link>https://www.physician.tw/capsule-endoscopy/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/capsule-endoscopy/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnostic studies of gastrointestinal bleeding]]
capsule endoscopy üöß A capsule endoscopy is a type of procedure that allows your doctor to see the inside of your gastrointestinal tract.</description></item><item><title>chloroquine</title><link>https://www.physician.tw/chloroquine/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chloroquine/</guid><description>[!info]
üå± ‰æÜËá™: [[Transcellular shifts]]
chloroquine Chloroquine is an antimalarial and anti-inflammatory drug used to treat and prevent malariaÔøΩ</description></item><item><title>hepatopulmonary syndrome</title><link>https://www.physician.tw/hepatopulmonary-syndrome/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatopulmonary-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Definition-cirrhosis]]
hepatopulmonary syndrome üöß Hepatopulmonary syndrome is a chronic lung condition that occurs when there is an insufficient blood supply to the lungs.</description></item><item><title>lua</title><link>https://www.physician.tw/lua/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lua/</guid><description>[!info]
üå± ‰æÜËá™: [[neovim]]
lua Lua is a lightweight, interpreted, scripting language with a design based on the concept of prototypes</description></item><item><title>medical statistics</title><link>https://www.physician.tw/medical-statistics/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medical-statistics/</guid><description> [!info]
üå± ‰æÜËá™: [[researcher]]
medical statistics #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>multiprocessing</title><link>https://www.physician.tw/multiprocessing/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/multiprocessing/</guid><description>[!info]
üå± ‰æÜËá™: [[UNIX systems]]
multiprocessing Multiprocessing is a process where two or more processors are working on two or more separate programs at the same time</description></item><item><title>open-source</title><link>https://www.physician.tw/open-source/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/open-source/</guid><description>[!info]
üå± ‰æÜËá™: [[zotero]]
open-source Open-source software (OSS) is software that is licensed under an open-source license. Open-source licenses are licenses that comply with the Open Source Definition ‚Äî in brief, they allow software to be freely used, modified, and shared</description></item><item><title>PUD</title><link>https://www.physician.tw/PUD/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PUD/</guid><description>[!info]
üå± ‰æÜËá™: [[peptic ulcer disease]]
PUD üöß A peptic ulcer is a sore that forms in the lining of your digestive tract.</description></item><item><title>researcher</title><link>https://www.physician.tw/researcher/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/researcher/</guid><description>[!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
researcher A researcher is someone who conducts research, which is defined as a process of gathering, processing, and analyzing data in order to answer a question or solve a problem</description></item><item><title>UNIX systems</title><link>https://www.physician.tw/UNIX-systems/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/UNIX-systems/</guid><description>[!info]
üå± ‰æÜËá™: [[vimscripts]]
UNIX systems #üöß ÊñΩÂ∑•‰∏≠ UNIX is a [[multiprocessing]], multitasking operating system that was developed in the early 1970s.</description></item><item><title>villous adenoma</title><link>https://www.physician.tw/villous-adenoma/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/villous-adenoma/</guid><description>[!info]
üå± ‰æÜËá™: [[GI potassium losses]]
villous adenoma A villous adenoma is a type of adenoma that occurs in the lining of the intestine.</description></item><item><title>vim buffer</title><link>https://www.physician.tw/vim-buffer/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim-buffer/</guid><description>[!info]
üå± ‰æÜËá™: [[vim]]
vim buffer A buffer is a file that is loaded into memory for editing.</description></item><item><title>vimscripts</title><link>https://www.physician.tw/vimscripts/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vimscripts/</guid><description>[!info]
üå± ‰æÜËá™: [[vim]]
vimscripts #üöß ÊñΩÂ∑•‰∏≠ Vim is a highly configurable text editor built to enable efficient text editing.</description></item><item><title>zotero</title><link>https://www.physician.tw/zotero/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zotero/</guid><description>[!info]
üå± ‰æÜËá™: [[zotero plugin]]
zotero Zotero is a free, [[open-source]] reference management tool for tracking and organizing research sources.</description></item><item><title>zotero plugin</title><link>https://www.physician.tw/zotero-plugin/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zotero-plugin/</guid><description> [!info]
üå± ‰æÜËá™: [[Áî®Zotero‰æÜÁÆ°ÁêÜPaper]]
[[zotero]] plugin I&amp;rsquo;m not sure what you&amp;rsquo;re asking</description></item><item><title>Œ≤2-agonists</title><link>https://www.physician.tw/%CE%B22-agonists/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B22-agonists/</guid><description>[!info]
üå± ‰æÜËá™: [[Transcellular shifts]]
Œ≤2-agonists Œ≤2-agonists is a class of medications that stimulate the Œ≤2-adrenergic receptors, resulting in bronchodilation and relaxation of smooth muscle in the bronchi and uterus</description></item><item><title>ABC Score</title><link>https://www.physician.tw/ABC-Score/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ABC-Score/</guid><description>[!info]
üå± ‰æÜËá™: [[Assess severity as initial management of gastrointestinal bleeding]]
ABC Score #üöß ÊñΩÂ∑•‰∏≠ Penetrating mechanism (Yes = 1, No = 0) Systolic BP ‚â§ 90 mmHg in the Emergency Department (Yes = 1, No = 0) HR ‚â• 120 in the Emergency Department (Yes = 1, No = 0) Positive FAST Ultrasound (Yes = 1, No = 0) [!</description></item><item><title>AIMS65</title><link>https://www.physician.tw/AIMS65/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AIMS65/</guid><description>[!info]
üå± ‰æÜËá™: [[Assess severity as initial management of gastrointestinal bleeding]]
AIMS65 Albumin &amp;lt;3 g/dL (30 g/L) INR &amp;gt;1.</description></item><item><title>Assess severity as initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/Assess-severity-as-initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Assess-severity-as-initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Assess severity as initial management of gastrointestinal bleeding VS including orthostatic Œîs, JVP.</description></item><item><title>blood urea nitrogen creatinine (BUN Cr) ratio</title><link>https://www.physician.tw/blood-urea-nitrogen-creatinine-BUN-Cr-ratio/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blood-urea-nitrogen-creatinine-BUN-Cr-ratio/</guid><description> [!info]
üå± ‰æÜËá™: [[Lab studies for gastrointestinal bleeding]]
blood urea nitrogen creatinine (BUN Cr) ratio #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Clinical manifestations of gastrointestinal bleeding</title><link>https://www.physician.tw/Clinical-manifestations-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[gastrointestinal bleeding]]
Clinical manifestations of gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ Hematemesis = blood in vomitus (UGIB) Coffee-ground emesis = emesis of blood exposed to gastric acid (UGIB) Melena = black, tarry stools from digested blood (usually UGIB, but can be SB or R colon) Hematochezia = bloody or maroon-colored stools (LGIB or rapid UGIB) Hematemesis refers to blood in vomit, which is commonly caused by upper gastrointestinal bleeding (UGIB).</description></item><item><title>Definition of gastrointestinal bleeding</title><link>https://www.physician.tw/Definition-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[gastrointestinal bleeding]]
Definition of gastrointestinal bleeding Intraluminal blood loss anywhere from the oropharynx to the anus Classification: upper = above the [[ligament of Treitz]]; lower = below the ligament of Treitz ‚ÄúSevere‚Äù GIB: defined as having associated shock, orthostatic hypotension, ‚Üì Hct by 6% (or ‚Üì Hb by 2 g/dL), or requiring transfusion ‚â•2U PRBCs.</description></item><item><title>diagnostic studies of gastrointestinal bleeding</title><link>https://www.physician.tw/diagnostic-studies-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[gastrointestinal bleeding]]
diagnostic studies of gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ Ë©≥Ë¶ã‚û°Ô∏èÔºö JACR 2021;18:S139
UGIB: EGD w/in 24 h (NEJM 2020;382:1299).</description></item><item><title>erythromycin 250 mg</title><link>https://www.physician.tw/erythromycin-250-mg/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/erythromycin-250-mg/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnostic studies of gastrointestinal bleeding]]
erythromycin 250 mg #üöß ÊñΩÂ∑•‰∏≠ We suggest that patients only undergo NGT lavage if particulate matter, fresh blood, or clots need to be removed from the stomach to facilitate endoscopy.</description></item><item><title>exit 0</title><link>https://www.physician.tw/exit-0/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/exit-0/</guid><description>[!info]
üå± ‰æÜËá™: [[Shell Scripting Âü∫Á§éÊåáÂçó]]
exit 0 In a shell script, exit 0 typically indicates that the script has completed successfully and the shell should exit with a status code of 0.</description></item><item><title>Fitz-Hugh-Curtis syndrome</title><link>https://www.physician.tw/Fitz-Hugh-Curtis-syndrome/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fitz-Hugh-Curtis-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[Etiologies-ascites]]
Fitz-Hugh-Curtis syndrome #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>gastroesophageal reflux disease</title><link>https://www.physician.tw/gastroesophageal-reflux-disease/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroesophageal-reflux-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[Treatment gastroesophageal reflux disease ]]
gastroesophageal reflux disease [[pathophysiology gastroesophageal reflux disease]] [[clinical manifestations gastroesophageal reflux disease]] [[diagnosis gastroesophageal reflux disease]] [[treatment gastroesophageal reflux disease]] [[complications gastroesophageal reflux disease]]</description></item><item><title>gastrointestinal bleeding</title><link>https://www.physician.tw/gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastrointestinal-bleeding/</guid><description> [!info]
üå± ‰æÜËá™: [[gastroenterology]]
gastrointestinal bleeding [[sxtodx]]: [[GI bleeding]]
[[Definition of gastrointestinal bleeding]] [[Clinical manifestations of gastrointestinal bleeding]] [[initial management of gastrointestinal bleeding]] [[diagnostic studies of gastrointestinal bleeding]] etiology of [[upper gastrointestinal bleeding]] etiology of [[lower gastrointestinal bleeding]] [[Obscure GIB]] [[management of gastrointestinal bleeding]]</description></item><item><title>Henoch-Sch√∂nlein purpura</title><link>https://www.physician.tw/Henoch-Sch%C3%B6nlein-purpura/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Henoch-Sch%C3%B6nlein-purpura/</guid><description> [!info]
üå± ‰æÜËá™: [[IgA nephropathy]]
Henoch-Sch√∂nlein purpura #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[gastrointestinal bleeding]]
initial management of gastrointestinal bleeding Uptodate: [[rapid overview of emergency management of gastrointestinal bleeding]]</description></item><item><title>Lab studies for gastrointestinal bleeding</title><link>https://www.physician.tw/Lab-studies-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lab-studies-for-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Lab studies for gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ Hct (may be normal in first 24 h of acute GIB before equilibration) 2‚Äì3% ‚Üí 500 mL blood loss; low MCV ‚Üí Fe deficient and chronic blood loss; plt, PT/INR, PTT; BUN/Cr (ratio &amp;gt;36 in UGIB b/c GI resorption of blood ¬± prerenal azotemia); LFTs</description></item><item><title>Pathogenesis of ascites and related complications of cirrhosis</title><link>https://www.physician.tw/Pathogenesis-of-ascites-and-related-complications-of-cirrhosis/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-of-ascites-and-related-complications-of-cirrhosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Pathophysiology-ascites]]
Pathogenesis of ascites and related complications of cirrhosis #üöß ÊñΩÂ∑•‰∏≠ Figure: I. Introduction
Pathogenesis of ascites and related complications of cirrhosis II.</description></item><item><title>Physical exam of gastrointestinal bleeding</title><link>https://www.physician.tw/Physical-exam-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Physical exam of gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ When evaluating a patient for abdominal conditions, it is important to assess for localizable tenderness, signs of peritoneal irritation, masses, and localized adenopathy.</description></item><item><title>rapid overview of emergency management of gastrointestinal bleeding</title><link>https://www.physician.tw/rapid-overview-of-emergency-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rapid-overview-of-emergency-management-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
rapid overview of emergency management of gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ Major causes Peptic ulcer, esophagogastric varices, arteriovenous malformation, tumor, esophageal (Mallory-Weiss) tear</description></item><item><title>Resuscitation for gastrointestinal bleeding</title><link>https://www.physician.tw/Resuscitation-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Resuscitation-for-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Resuscitation for gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ To support a patient&amp;rsquo;s fluid and electrolyte balance, two large-bore intravenous lines (18-gauge or larger) are inserted.</description></item><item><title>Reverse coagulopathy for gastrointestinal bleeding</title><link>https://www.physician.tw/Reverse-coagulopathy-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Reverse-coagulopathy-for-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Reverse coagulopathy for gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ consider FFP to normalize INR (however caution in ESLD where INR does not correlate with bleeding risk); plts &amp;gt;50k, ddAVP if uremic, consider reversal agents if on anticoagulants (qv)</description></item><item><title>Risk factor of initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/Risk-factor-of-initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factor-of-initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Risk factor of initial management of gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ When evaluating a patient for gastrointestinal bleeding (GIB), it is important to consider the patient&amp;rsquo;s past history of GIB, the speed at which the current bleed is occurring, specific symptoms related to the bleed (such as hematemesis or melena) other gastrointestinal symptoms (such as abdominal pain, changes in bowel habits, weight loss, or nausea and vomiting) use of medications such as aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) or alcohol, use of anticoagulant or antiplatelet medications, a history or risk factors for cirrhosis, radiation therapy, or prior gastrointestinal or aortic surgery.</description></item><item><title>sclerotherapy</title><link>https://www.physician.tw/sclerotherapy/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sclerotherapy/</guid><description> [!info]
üå± ‰æÜËá™: [[rapid overview of emergency management of gastrointestinal bleeding]]
sclerotherapy #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Shell Scripting Âü∫Á§éÊåáÂçó</title><link>https://www.physician.tw/Shell-Scripting-%E5%9F%BA%E7%A4%8E%E6%8C%87%E5%8D%97/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Shell-Scripting-%E5%9F%BA%E7%A4%8E%E6%8C%87%E5%8D%97/</guid><description>[!info]
üå± ‰æÜËá™: [[command line know how]]
Shell Scripting Âü∫Á§éÊåáÂçó #üöß ÊñΩÂ∑•‰∏≠ ‰ªÄÈ∫ºÊòØ Shell ScriptingÔºü Shell Scripting ÊòØ‰∏ÄÁ®ÆÂú®ÂëΩ‰ª§ÊèêÁ§∫Â≠óÂÖÉ ([[command line interface]]) ‰∏≠‰ΩøÁî®ÁöÑÁ®ãÂºèË™ûË®ÄÔºåÁî®ÊñºËá™ÂãïÂåñÁ≥ªÁµ±ÁÆ°ÁêÜÂíåÂÖ∂‰ªñ‰ªªÂãô„ÄÇ</description></item><item><title>small-vessel vasculitis</title><link>https://www.physician.tw/small-vessel-vasculitis/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/small-vessel-vasculitis/</guid><description> [!info]
üå± ‰æÜËá™: [[IgA nephropathy]]
small-vessel vasculitis #üöß ÊñΩÂ∑•‰∏≠ BacklinkÔºö [[Clinical manifestations of Eosinophilic gran with polyangiitis]] [[Glomerular Pathology Associated with Nephritic Syndrome]] [[IgA nephropathy]] [[IgA vasculitis]] [[immune complex IC ‚Äìassociated small-vessel vasculitis]] [[vasculitis]]</description></item><item><title>Transfuse for gastrointestinal bleeding</title><link>https://www.physician.tw/Transfuse-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfuse-for-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Transfuse for gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ type &amp;amp; cross; use O-neg if emerg; for UGIB (esp.</description></item><item><title>transjugular intrahepatic portosystemic shunt</title><link>https://www.physician.tw/transjugular-intrahepatic-portosystemic-shunt/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transjugular-intrahepatic-portosystemic-shunt/</guid><description> [!info]
üå± ‰æÜËá™: [[Portal HTN gastropathy]]
transjugular intrahepatic portosystemic shunt</description></item><item><title>Triage of initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/Triage-of-initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Triage-of-initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[initial management of gastrointestinal bleeding]]
Triage of initial management of gastrointestinal bleeding alert endoscopist Consider ICU if unstable VS or poor end organ perfusion.</description></item><item><title>upper gastrointestinal bleeding</title><link>https://www.physician.tw/upper-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/upper-gastrointestinal-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnostic studies of gastrointestinal bleeding]]
upper gastrointestinal bleeding #üöß ÊñΩÂ∑•‰∏≠ [[peptic ulcer disease]] (20‚Äì60%; duodenal&amp;gt;gastric) [[erosive gastropathy]] (4‚Äì30%) [[esophagitis]] [[esophageal or gastric varices]] [[portal HTN gastropathy]] [vascular etiology of lower gastrointestinal bleeding] Malignancy (5%) Endoscopic hemostasis of mass temporizing measure till cancer Rx Mallory-Weiss tear (5‚Äì10%) GE jxn lacerations due to vomiting ‚Üí ‚Üë intraabd pressure &amp;amp; shearing Often self-resolve; Rx‚Üí antiemetics, PPI, endoscopic therapy [[Cameron‚Äôs lesions]] Linear erosions in hiatal hernia due to mech trauma of diaphragm * Post-sphincterotomy bleeding Occurs in ~2% of ERCP w/ sphincterotomy; ‚Üë risk w/ more complic.</description></item><item><title>vascular-enteric fistula</title><link>https://www.physician.tw/vascular-enteric-fistula/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vascular-enteric-fistula/</guid><description> [!info]
üå± ‰æÜËá™: [[rapid overview of emergency management of gastrointestinal bleeding]]
vascular-enteric fistula #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>checkifalive</title><link>https://www.physician.tw/checkifalive/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/checkifalive/</guid><description>checkifalive</description></item><item><title>checkifalivedd</title><link>https://www.physician.tw/checkifalivedd/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/checkifalivedd/</guid><description>checkifalivedd</description></item><item><title>Meigs‚Äô syndrome</title><link>https://www.physician.tw/Meigs-syndrome/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Meigs-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
Meigs‚Äô syndrome #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>protein-losing enteropathy</title><link>https://www.physician.tw/protein-losing-enteropathy/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protein-losing-enteropathy/</guid><description> [!info]
üå± ‰æÜËá™: [[Etiologies-ascites]]
protein-losing enteropathy #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>abdominal pain</title><link>https://www.physician.tw/abdominal-pain/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abdominal-pain/</guid><description>abdominal pain [[approach to abdominal pain]]
BacklinkÔºö [[Acetaminophen hepatotoxicity]] [[Acute Diarrhea (3 weeks)]] [[acute diarrhea]] [[Adrenal Insufficiency (AI)]] [[an acid-base abnormality]] [[autoimmune pancreatitis]] [[Calcium]] [[Cholestatic Liver Diseases]] [[Cirrhosis and its Complications]] [[Clinical manifestations of IgA vasculitis]] [[clinical manifestations of peptic ulcer disease]] [[clinical manifestations of primary myelofibrosis (PMF)]] [[Clinical manifestations peptic ulcer disease ]] [[Clinical manifestations-crohn‚Äôs disease]] [[Clinical manifestations-diabetic ketoacidosis]] [[Clinical manifestations-hypercalcemia]] [[Complications-aortic aneurysms]] [[Contents]] [[Contributing Authors]] [[Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS)]] [[Diseases of the Vasculature]] [[Functional Bowel Disorders]] [[Gallbladder Stone Diseases]] [[gastroenterology approaches and chief complaints]] [[Genitourinary (GU) Infections]] [[GI bleeding]] [[hyponatremia.</description></item><item><title>approach to abdominal pain</title><link>https://www.physician.tw/approach-to-abdominal-pain/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-abdominal-pain/</guid><description> [!info]
üå± ‰æÜËá™: [[abdominal pain]]
approach to abdominal pain #üöß ÊñΩÂ∑•‰∏≠ [[differential diagnoses in abdominal pain organized by time course]]</description></item><item><title>differential diagnoses in abdominal pain organized by time course</title><link>https://www.physician.tw/differential-diagnoses-in-abdominal-pain-organized-by-time-course/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/differential-diagnoses-in-abdominal-pain-organized-by-time-course/</guid><description> [!info]
üå± ‰æÜËá™: [[approach to abdominal pain]]
differential diagnoses in abdominal pain organized by time course #üöß ÊñΩÂ∑•‰∏≠ acute first episode AAA Acute mesenteric ischemia Appendicitis Biliary disease Diverticulitis DKA Ectopic pregnancy Gastroenteritis schemic colitis Myocardial infarction Ovarian torsion Nephrolithiasis Pancreatitis Peritonitis (from ruptured PUD, diverticulitis, etc) PID Small or large bowel obstruction Splenic rupture recurrent episode Biliary disease Diverticulitis DKA Nephrolithiasis Pancreatitis PID Small or large bowel obstruction subacute Chronic mesenteric ischemia IBD IBS Hepatitis PUD</description></item><item><title>Etiologies-hemoptysis</title><link>https://www.physician.tw/Etiologies-hemoptysis/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hemoptysis/</guid><description>Etiologies-hemoptysis (Crit Care Med 2000;28:1642)
I-N-C-V
Parenchyma Bronchitis 70% Endobronchial lesions cavitary leion Vascular Artery Pulmonary emolism / aneurysms Capillary DAH AVM Vein CHF PVOD Infection/Inflammation Bronchitis (most common cause of trivial hemoptysis) Bronchiectasis incl CF (common cause of massive hemoptysis) TB or aspergilloma (can be massive); pneumonia or lung abscess Neoplasm Usually primary lung cancer, sometimes metastasis (can be massive) Cardiovasc PE (can be massive), pulmonary artery rupture (2¬∞ to instrumentation), CHF, mitral stenosis, trauma/foreign body, bronchovascular fistula Other Vasculitis (GPA, anti-GBM, Beh√ßet‚Äôs, SLE), AVM, anticoag (withunderlying lung disease), coagulopathy, cocaine, pulm hemosiderosis</description></item><item><title>sxtodx</title><link>https://www.physician.tw/sxtodx/</link><pubDate>Tue, 24 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sxtodx/</guid><description>sxtodx [[I have a patient with a problem. How do I figure out the possible causes]] [[I have a healthy patient.</description></item><item><title>ambulatory</title><link>https://www.physician.tw/ambulatory/</link><pubDate>Mon, 23 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ambulatory/</guid><description>ambulatory Acute Respiratory Tract Infection Dizziness [[low back pain]] [[hypertension]] Hypercholesterolemia Cancer Screening [[vaccination]] [[smoking cessation]] Chronic Pain and Opioids</description></item><item><title>osteoarthritis</title><link>https://www.physician.tw/osteoarthritis/</link><pubDate>Mon, 23 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/osteoarthritis/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory]]
osteoarthritis #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>a bleeding disorder</title><link>https://www.physician.tw/a-bleeding-disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/a-bleeding-disorder/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
a bleeding disorder #üöß ÊñΩÂ∑•‰∏≠ a bleeding disorder Philip Hoffman, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>a rash</title><link>https://www.physician.tw/a-rash/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/a-rash/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
a rash #üöß ÊñΩÂ∑•‰∏≠ a rash Sarah Stein, MD
CHIEF COMPLAINT PATIENT
Ms. N is a 23-year-old woman who comes to see you complaining of a rash.</description></item><item><title>ACE Inhibitor-ARB Combination</title><link>https://www.physician.tw/ACE-Inhibitor-ARB-Combination/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACE-Inhibitor-ARB-Combination/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
ACE Inhibitor-ARB Combination #üöß ÊñΩÂ∑•‰∏≠ ACE Inhibitor-ARB Combination ‚Ä¢¬†VA-NEPHRON D. N Eng J Med 2013;369(20):1892‚Äì1903.</description></item><item><title>Acid‚ÄìBase Disorders</title><link>https://www.physician.tw/AcidBase-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AcidBase-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acid‚ÄìBase Disorders #üöß ÊñΩÂ∑•‰∏≠ Acid‚ÄìBase Disorders First, a reminder of the normal values:</description></item><item><title>Acknowledgments</title><link>https://www.physician.tw/Acknowledgments/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acknowledgments/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
Acknowledgments #üöß ÊñΩÂ∑•‰∏≠ Acknowledgments We would like to thank our coauthors, who now number twenty one, for their hard work in expanding this text.</description></item><item><title>Acneiform Eruptions</title><link>https://www.physician.tw/Acneiform-Eruptions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acneiform-Eruptions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acneiform Eruptions #üöß ÊñΩÂ∑•‰∏≠ Acneiform Eruptions Acne vulgaris ‚Ä¢¬†Pathophysiology: Inflammation of the hair follicle/sebaceous gland due to increased sebum production (androgen driven), abnormal keratinization, and proliferation of Cutibacterium acnes (formerly P.</description></item><item><title>Acute Coronary Syndrome (ACS) and Post-ACS Care</title><link>https://www.physician.tw/Acute-Coronary-Syndrome-ACS-and-Post-ACS-Care/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Coronary-Syndrome-ACS-and-Post-ACS-Care/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acute Coronary Syndrome (ACS) and Post-ACS Care #üöß ÊñΩÂ∑•‰∏≠ Acute Coronary Syndrome (ACS) and Post-ACS Care ‚Ä¢¬†CAPRICORN.</description></item><item><title>acute diarrhea</title><link>https://www.physician.tw/acute-diarrhea/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-diarrhea/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
acute diarrhea #üöß ÊñΩÂ∑•‰∏≠ acute diarrhea Keith W. Hamilton, MD
CHIEF COMPLAINT PATIENT
Mr. C is a 35-year-old man who comes to your outpatient office complaining of 3 days of diarrhea.</description></item><item><title>Acute Diarrhea (3 weeks)</title><link>https://www.physician.tw/Acute-Diarrhea-3-weeks/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Diarrhea-3-weeks/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acute Diarrhea (3 weeks) #üöß ÊñΩÂ∑•‰∏≠ Acute Diarrhea (&amp;lt;3 weeks) Infection
Bloody:
‚Ä¢¬†[[shigella]]</description></item><item><title>Acute GVHD</title><link>https://www.physician.tw/Acute-GVHD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-GVHD/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
Acute GVHD #üöß ÊñΩÂ∑•‰∏≠ Acute GVHD (usually within 6 mo of transplant; NEJM 2017;377:2167) Clinical grades I‚ÄìIV based on scores for skin (severity of maculopapular rash), liver (bilirubin level) and GI (volume of diarrhea); bx supports diagnosis Prevention: immunosuppression (MTX + cyclosporine, or tacrolimus), T-cell depletion of graft, post-Tx cyclophos.</description></item><item><title>Acute Liver Failure (ALF)</title><link>https://www.physician.tw/Acute-Liver-Failure-ALF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Liver-Failure-ALF/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acute Liver Failure (ALF) #üöß ÊñΩÂ∑•‰∏≠ Acute Liver Failure (ALF) ‚Ä¢¬†Definitions:
-¬†Acute liver injury (ALI): AST/ALT &amp;gt;100 IU/L</description></item><item><title>Acute Myeloid Leukemia</title><link>https://www.physician.tw/Acute-Myeloid-Leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Myeloid-Leukemia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acute Myeloid Leukemia #üöß ÊñΩÂ∑•‰∏≠ Acute Myeloid Leukemia ‚Ä¢¬†Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation.</description></item><item><title>acute promyelocytic leukemia (APL)</title><link>https://www.physician.tw/acute-promyelocytic-leukemia-APL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-promyelocytic-leukemia-APL/</guid><description>[!info]
üå± ‰æÜËá™: [[acute myelogenous leukemia (AML)]]
acute promyelocytic leukemia (APL) #üöß ÊñΩÂ∑•‰∏≠ acute promyelocytic leukemia (APL)¬† (Blood¬†2009;113:1875)</description></item><item><title>Acute Red Eye</title><link>https://www.physician.tw/Acute-Red-Eye/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Red-Eye/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acute Red Eye #üöß ÊñΩÂ∑•‰∏≠ Acute Red Eye ‚Ä¢¬†Physical exam: Fundoscopic exam, pupillary examination, visual acuity, EOM, peripheral vision</description></item><item><title>acute respiratory complaints of cough and congestion</title><link>https://www.physician.tw/acute-respiratory-complaints-of-cough-and-congestion/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-respiratory-complaints-of-cough-and-congestion/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
acute respiratory complaints of cough and congestion #üöß ÊñΩÂ∑•‰∏≠ acute respiratory complaints of cough and congestion Scott D.</description></item><item><title>Acute Respiratory Distress Syndrome (ARDS)</title><link>https://www.physician.tw/Acute-Respiratory-Distress-Syndrome-ARDS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Respiratory-Distress-Syndrome-ARDS/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Acute Respiratory Distress Syndrome (ARDS) #üöß ÊñΩÂ∑•‰∏≠ Acute Respiratory Distress Syndrome (ARDS) ‚Ä¢¬†Berlin Definition.</description></item><item><title>acute¬†leukemia</title><link>https://www.physician.tw/acute-leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-leukemia/</guid><description>[!info]
üå± ‰æÜËá™: [[leukemia]]
acute¬†leukemia Definition
‚Ä¢ Clonal proliferation of hematopoietic progenitor with failed differentiation into mature elements ‚Üí ‚Üë blasts in bone marrow and periphery ‚Üí ‚Üì RBCs, platelets, and neutrophils</description></item><item><title>acute¬†lymphoblastic¬†leukemia¬†(ALL)</title><link>https://www.physician.tw/acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[leukemia]]
acute¬†lymphoblastic¬†leukemia¬†(ALL) Lancet2020;395:1146
[[classification of acute lymphoblastic leukemia (ALL)]]
[[treatment of acute lymphoblastic leukemia (ALL)]]</description></item><item><title>acute¬†myelogenous¬†leukemia¬†(AML)</title><link>https://www.physician.tw/acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-myelogenous-leukemia-AML/</guid><description>[!info]
üå± ‰æÜËá™: [[leukemia]]
acute¬†myelogenous¬†leukemia¬†(AML) [[classification of acute myelogenous leukemia (AML)]]
[[ENL 2017 Genetic Risk Classification]]</description></item><item><title>Additional Details about the Platelet Destructive Processes</title><link>https://www.physician.tw/Additional-Details-about-the-Platelet-Destructive-Processes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-Details-about-the-Platelet-Destructive-Processes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Additional Details about the Platelet Destructive Processes #üöß ÊñΩÂ∑•‰∏≠ Additional Details about the Platelet Destructive Processes Immune Thrombocytopenic Purpura (ITP)</description></item><item><title>Additional History</title><link>https://www.physician.tw/Additional-History/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-History/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Additional History #üöß ÊñΩÂ∑•‰∏≠ Additional History TABLE A1.3 ‚Ä¢ PMH, PSH, Meds, Allergies, FHx, SoHx</description></item><item><title>Adrenal Insufficiency (AI)</title><link>https://www.physician.tw/Adrenal-Insufficiency-AI/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-Insufficiency-AI/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Adrenal Insufficiency (AI) #üöß ÊñΩÂ∑•‰∏≠ Adrenal Insufficiency (AI) ‚Ä¢¬†Etiologies:
-¬†Primary:
‚Ä¢¬†Autoimmune: Antibody against adrenal enzymes (most common)</description></item><item><title>Adrenal Masses</title><link>https://www.physician.tw/Adrenal-Masses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-Masses/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Adrenal Masses #üöß ÊñΩÂ∑•‰∏≠ Adrenal Masses Incidentally discovered adrenal mass ‚Ä¢¬†Epidemiology: Common (at least 2% in the general population, more common with increasing age)</description></item><item><title>Advanced Care Planning</title><link>https://www.physician.tw/Advanced-Care-Planning/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Advanced-Care-Planning/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Advanced Care Planning #üöß ÊñΩÂ∑•‰∏≠ Advanced Care Planning ‚Ä¢¬†Advanced Directives and Outcomes of Surrogate Decision Making Before Death.</description></item><item><title>Alcohol-Induced Liver Disease</title><link>https://www.physician.tw/Alcohol-Induced-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alcohol-Induced-Liver-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Alcohol-Induced Liver Disease #üöß ÊñΩÂ∑•‰∏≠ Alcohol-Induced Liver Disease Alcoholic hepatitis ‚Ä¢¬†Clinical features: Jaundice, anorexia, fever, tender hepatomegaly</description></item><item><title>Alcoholic Hepatitis</title><link>https://www.physician.tw/Alcoholic-Hepatitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alcoholic-Hepatitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Alcoholic Hepatitis #üöß ÊñΩÂ∑•‰∏≠ Alcoholic Hepatitis ‚Ä¢¬†STOPAH. N Engl J Med 2015;372(17):1619‚Äì1628.</description></item><item><title>Altered Mental Status</title><link>https://www.physician.tw/Altered-Mental-Status/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Altered-Mental-Status/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Altered Mental Status #üöß ÊñΩÂ∑•‰∏≠ Altered Mental Status There are many approaches to altered mental status (AMS).</description></item><item><title>Alveolar Hemorrhage</title><link>https://www.physician.tw/Alveolar-Hemorrhage/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alveolar-Hemorrhage/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Alveolar Hemorrhage #üöß ÊñΩÂ∑•‰∏≠ Alveolar Hemorrhage ‚Ä¢¬†Definition: Bleeding into the alveolar space due to disruption of the alveolar‚Äìcapillary basement membrane</description></item><item><title>an acid-base abnormality</title><link>https://www.physician.tw/an-acid-base-abnormality/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/an-acid-base-abnormality/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
an acid-base abnormality #üöß ÊñΩÂ∑•‰∏≠ an acid-base abnormality Scott D. C. Stern, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>An Approach to Diagnosing and Treating Infectious Diseases</title><link>https://www.physician.tw/An-Approach-to-Diagnosing-and-Treating-Infectious-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/An-Approach-to-Diagnosing-and-Treating-Infectious-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
APPROACHES &amp;amp; CHIEF COMPLAINTS #üöß ÊñΩÂ∑•‰∏≠ APPROACHES &amp;amp; CHIEF COMPLAINTS TABLE 8.</description></item><item><title>ANA-Associated Connective Tissue Disorders</title><link>https://www.physician.tw/ANA-Associated-Connective-Tissue-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ANA-Associated-Connective-Tissue-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
ANA-Associated Connective Tissue Disorders #üöß ÊñΩÂ∑•‰∏≠ ANA-Associated Connective Tissue Disorders ‚Ä¢¬†Rheumatologic conditions associated with a +ANA:</description></item><item><title>Analgesia, Sedation, Paralytics, and Vasoactive Medications</title><link>https://www.physician.tw/Analgesia-Sedation-Paralytics-and-Vasoactive-Medications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Analgesia-Sedation-Paralytics-and-Vasoactive-Medications/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Analgesia, Sedation, Paralytics, and Vasoactive Medications #üöß ÊñΩÂ∑•‰∏≠ Analgesia, Sedation, Paralytics, and Vasoactive Medications This section includes key medications used in the ICU, including their indications, pharmacokinetics, and adverse effects.</description></item><item><title>Anatomy of the Lungs</title><link>https://www.physician.tw/Anatomy-of-the-Lungs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anatomy-of-the-Lungs/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Anatomy of the Lungs #üöß ÊñΩÂ∑•‰∏≠ Anatomy of the Lungs FIGURE 2.1: Anatomy of the lungs.</description></item><item><title>Ann Arbor Staging System with Cotswolds Modifications</title><link>https://www.physician.tw/Ann-Arbor-Staging-System-with-Cotswolds-Modifications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ann-Arbor-Staging-System-with-Cotswolds-Modifications/</guid><description>[!info]
üå± ‰æÜËá™: [[overview of lymphoma and CLL]]
Ann Arbor Staging System with Cotswolds Modifications #üöß ÊñΩÂ∑•‰∏≠ Ann Arbor Staging System with Cotswolds Modifications Stage Features I Single lymph node (LN) region II ‚â•2 LN regions on the same side of the diaphragm III LN regions on both sides of the diaphragm IV Disseminated involvement of one or more extralymphatic organs Modifiers: A = no symptoms; B = fever, night sweats or weight loss; X = ‚Äùbulky‚Äù mediastinal disease or mass &amp;gt;10 cm; E = single contiguous extranodal site; H = hepatic; S = splenic</description></item><item><title>Anterior Mediastinal Mass</title><link>https://www.physician.tw/Anterior-Mediastinal-Mass/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anterior-Mediastinal-Mass/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Anterior Mediastinal Mass #üöß ÊñΩÂ∑•‰∏≠ Anterior Mediastinal Mass ‚Ä¢¬†Anterior mediastinal mass: 4Ts: Thymus, Teratoma/germ cell, (Terrible) lymphoma, Thyroid</description></item><item><title>Anterior Pituitary</title><link>https://www.physician.tw/Anterior-Pituitary/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anterior-Pituitary/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Anterior Pituitary #üöß ÊñΩÂ∑•‰∏≠ Anterior Pituitary Hypopituitarism ‚Ä¢¬†Etiologies:
-¬†Impaired synthesis or secretion of one or more hormones; can be primary or secondary (process impairs hypothalamic hormones, with resultant pituitary failure)</description></item><item><title>Anti-Inflammatory Agents</title><link>https://www.physician.tw/Anti-Inflammatory-Agents/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-Inflammatory-Agents/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Anti-Inflammatory Agents #üöß ÊñΩÂ∑•‰∏≠ Anti-Inflammatory Agents NSAIDS ‚Ä¢¬†Mechanism: Decreased prostaglandin production and thus reduced prostaglandin-mediated capillary leakage and inflammatory cell recruitment.</description></item><item><title>Anticoagulation</title><link>https://www.physician.tw/Anticoagulation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulation/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Anticoagulation #üöß ÊñΩÂ∑•‰∏≠ Anticoagulation TABLE 7.6 ‚Ä¢ Parenteral and Oral Anticoagulants</description></item><item><title>Antifungal Therapies</title><link>https://www.physician.tw/Antifungal-Therapies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antifungal-Therapies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Antifungal Therapies #üöß ÊñΩÂ∑•‰∏≠ Antifungal Therapies First-line treatments for invasive fungal infections ‚Ä¢¬†Anti-fungal agents: See Table 8.</description></item><item><title>Antipsychotic Medications</title><link>https://www.physician.tw/Antipsychotic-Medications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antipsychotic-Medications/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Antipsychotic Medications #üöß ÊñΩÂ∑•‰∏≠ Antipsychotic Medications ‚Ä¢¬†CATIE Study (Phase 1). N Engl J Med 2005;353:1209‚Äì1223.</description></item><item><title>Antiretroviral Therapy (ART)</title><link>https://www.physician.tw/Antiretroviral-Therapy-ART/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiretroviral-Therapy-ART/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Antiretroviral Therapy (ART) #üöß ÊñΩÂ∑•‰∏≠ Antiretroviral Therapy (ART) Antiretroviral therapies are listed here, with select pros (+) and cons (-) indicated.</description></item><item><title>Anxiety Disorders</title><link>https://www.physician.tw/Anxiety-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anxiety-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Anxiety Disorders #üöß ÊñΩÂ∑•‰∏≠ Anxiety Disorders ‚Ä¢¬†Panic disorder: Recurrent unexpected panic attacks, resulting in a fear of future panic attacks and avoidance of potential panic triggers.</description></item><item><title>Aortic Stenosis</title><link>https://www.physician.tw/Aortic-Stenosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aortic-Stenosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Aortic Stenosis #üöß ÊñΩÂ∑•‰∏≠ Aortic Stenosis ‚Ä¢¬†PARTNER A. N Engl J Med 2011;364(23):2187‚Äì2198; PARTNER B.</description></item><item><title>Approach to Analysis of an Arterial Blood Gas (ABG)</title><link>https://www.physician.tw/Approach-to-Analysis-of-an-Arterial-Blood-Gas-ABG/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Analysis-of-an-Arterial-Blood-Gas-ABG/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Analysis of an Arterial Blood Gas (ABG) #üöß ÊñΩÂ∑•‰∏≠ Approach to Analysis of an Arterial Blood Gas (ABG) FIGURE 3.</description></item><item><title>Approach to Bradycardia (HR 60 bpm)</title><link>https://www.physician.tw/Approach-to-Bradycardia-HR-60-bpm/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Bradycardia-HR-60-bpm/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Bradycardia (HR 60 bpm) #üöß ÊñΩÂ∑•‰∏≠ Approach to Bradycardia (HR &amp;lt; 60 bpm) ‚Ä¢¬†UNSTABLE:</description></item><item><title>Approach to Headaches</title><link>https://www.physician.tw/Approach-to-Headaches/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Headaches/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Headaches #üöß ÊñΩÂ∑•‰∏≠ Approach to Headaches ‚Ä¢¬†History:
-¬†Is this an old or new headache?</description></item><item><title>Approach to Lactic Acidosis</title><link>https://www.physician.tw/Approach-to-Lactic-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Lactic-Acidosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Lactic Acidosis #üöß ÊñΩÂ∑•‰∏≠ Approach to Lactic Acidosis ‚Ä¢¬†Description: Elevated serum lactate.</description></item><item><title>Approach to Managing a Patient with Cardiac Arrest, aka ‚ÄúCode Blue‚Äù</title><link>https://www.physician.tw/Approach-to-Managing-a-Patient-with-Cardiac-Arrest-aka-Code-Blue/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Managing-a-Patient-with-Cardiac-Arrest-aka-Code-Blue/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Managing a Patient with Cardiac Arrest, aka ‚ÄúCode Blue‚Äù #üöß ÊñΩÂ∑•‰∏≠ Approach to Managing a Patient with Cardiac Arrest, aka ‚ÄúCode Blue‚Äù ‚Ä¢¬†Three key principles:</description></item><item><title>Approach to Narrow QRS Complex Tachycardia</title><link>https://www.physician.tw/Approach-to-Narrow-QRS-Complex-Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Narrow-QRS-Complex-Tachycardia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Narrow QRS Complex Tachycardia #üöß ÊñΩÂ∑•‰∏≠ Approach to Narrow QRS Complex Tachycardia ‚Ä¢¬†UNSTABLE: If sinus tachycardia, treat the underlying cause if present (e.</description></item><item><title>Approach to Reading a Hand X-Ray</title><link>https://www.physician.tw/Approach-to-Reading-a-Hand-X-Ray/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Reading-a-Hand-X-Ray/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Reading a Hand X-Ray #üöß ÊñΩÂ∑•‰∏≠ Approach to Reading a Hand X-Ray ‚Ä¢¬†Alignment: Misaligned joints can help suggest specific pathologies.</description></item><item><title>Approach to Shock</title><link>https://www.physician.tw/Approach-to-Shock/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Shock/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Shock #üöß ÊñΩÂ∑•‰∏≠ Approach to Shock ‚Ä¢¬†Important formulas:
-¬†MAP = CO x SVR</description></item><item><title>Approach to Vascular Access</title><link>https://www.physician.tw/Approach-to-Vascular-Access/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Vascular-Access/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Approach to Vascular Access #üöß ÊñΩÂ∑•‰∏≠ Approach to Vascular Access TABLE 3.1 ‚Ä¢ Flow Relationship Defined by the Poiseuille Equation</description></item><item><title>Arthridities</title><link>https://www.physician.tw/Arthridities/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Arthridities/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Arthridities #üöß ÊñΩÂ∑•‰∏≠ Arthridities Osteoarthritis (OA) ‚Ä¢¬†Pathogenesis: Progressive cartilage and meniscal degradation due to complex interplay of pathologic joint loading (due to obesity, joint malalignment, specific types of exercise or occupation, etc.</description></item><item><title>Assessment of Fluid Responsiveness</title><link>https://www.physician.tw/Assessment-of-Fluid-Responsiveness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Assessment-of-Fluid-Responsiveness/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Assessment of Fluid Responsiveness #üöß ÊñΩÂ∑•‰∏≠ Assessment of Fluid Responsiveness ‚Ä¢¬†Hypotension is a common problem in the ICU</description></item><item><title>Autoimmune Bullous Diseases</title><link>https://www.physician.tw/Autoimmune-Bullous-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-Bullous-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Autoimmune Bullous Diseases #üöß ÊñΩÂ∑•‰∏≠ Autoimmune Bullous Diseases Bullous pemphigoid (BP) ‚Ä¢¬†Pathophysiology: Chronic autoimmune blistering disease most commonly seen in the elderly due to autoantibodies targeting hemidesmosomes in the basement membrane, resulting in sub-epidermal blistering (‚Äúbullow‚Äù).</description></item><item><title>Autoimmune Etiologies of Liver Disease</title><link>https://www.physician.tw/Autoimmune-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-Etiologies-of-Liver-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Autoimmune Etiologies of Liver Disease #üöß ÊñΩÂ∑•‰∏≠ Autoimmune Etiologies of Liver Disease Autoimmune hepatitis ‚Ä¢¬†Epidemiology: F:M = 4:1, associated with other autoimmune conditions</description></item><item><title>Axial and Appendicular Skeleton</title><link>https://www.physician.tw/Axial-and-Appendicular-Skeleton/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Axial-and-Appendicular-Skeleton/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Axial and Appendicular Skeleton #üöß ÊñΩÂ∑•‰∏≠ Axial and Appendicular Skeleton The skeletal system is divided into the axial skeleton and the appendicular skeleton (Figure 9.</description></item><item><title>Bacterial Infections</title><link>https://www.physician.tw/Bacterial-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bacterial-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Bacterial Infections #üöß ÊñΩÂ∑•‰∏≠ Bacterial Infections Gram-positive bacteria TABLE 8.2 ‚Ä¢ Key Clinically Relevant Gram-Positive Bacteria</description></item><item><title>Barrett‚Äôs Esophagus</title><link>https://www.physician.tw/Barretts-Esophagus/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Barretts-Esophagus/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Barrett‚Äôs Esophagus #üöß ÊñΩÂ∑•‰∏≠ Barrett‚Äôs Esophagus ‚Ä¢¬†Radiofrequency Ablation in Barrett‚Äôs Esophagus with Dysplasia.</description></item><item><title>Biases</title><link>https://www.physician.tw/Biases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Biases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Biases #üöß ÊñΩÂ∑•‰∏≠ Biases Recruitment ‚Ä¢¬†Selection bias: Bias in selecting the study group.</description></item><item><title>Biologic Disease-Modifying Antirheumatic Drugs (aka ‚ÄúBiologics‚Äù or Biologic DMARDs)</title><link>https://www.physician.tw/Biologic-Disease-Modifying-Antirheumatic-Drugs-aka-Biologics-or-Biologic-DMARDs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Biologic-Disease-Modifying-Antirheumatic-Drugs-aka-Biologics-or-Biologic-DMARDs/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Biologic Disease-Modifying Antirheumatic Drugs (aka ‚ÄúBiologics‚Äù or Biologic DMARDs) #üöß ÊñΩÂ∑•‰∏≠ Biologic Disease-Modifying Antirheumatic Drugs (aka ‚ÄúBiologics‚Äù or Biologic DMARDs) ‚Ä¢¬†Definition: DMARDs that work by targeting immune system pathways</description></item><item><title>Bipolar Disorder</title><link>https://www.physician.tw/Bipolar-Disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bipolar-Disorder/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Bipolar Disorder #üöß ÊñΩÂ∑•‰∏≠ Bipolar Disorder ‚Ä¢¬†The STEP-BD Trial. N Engl J Med 2007;356:1711‚Äì1722.</description></item><item><title>Bleeding as complications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/Bleeding-as-complications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bleeding-as-complications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
Bleeding as complications of hematopoietic stem cell transplantation #üöß ÊñΩÂ∑•‰∏≠ Bleeding as complications of hematopoietic stem cell transplantation incidence ~25%, 2/2 ‚Üì‚Üì plts; sites: CNS, GI, pulm.</description></item><item><title>Bloodstream Infections</title><link>https://www.physician.tw/Bloodstream-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bloodstream-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Bloodstream Infections #üöß ÊñΩÂ∑•‰∏≠ Bloodstream Infections ‚Ä¢¬†Pathophysiology: A bloodstream infection can arise from:</description></item><item><title>BoneJoint Infections</title><link>https://www.physician.tw/BoneJoint-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BoneJoint-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
BoneJoint Infections #üöß ÊñΩÂ∑•‰∏≠ Bone/Joint Infections Osteomyelitis ‚Ä¢¬†Types of osteomyelitis and pathogenesis:</description></item><item><title>Bradycardia</title><link>https://www.physician.tw/Bradycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bradycardia/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Bradycardia #üöß ÊñΩÂ∑•‰∏≠ Bradycardia</description></item><item><title>Bradycardic Rhythms</title><link>https://www.physician.tw/Bradycardic-Rhythms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bradycardic-Rhythms/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Bradycardic Rhythms #üöß ÊñΩÂ∑•‰∏≠ Bradycardic Rhythms Sinus bradycardia ‚Ä¢¬†ECG: See Figure 1.14</description></item><item><title>Brain</title><link>https://www.physician.tw/Brain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Brain/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Brain #üöß ÊñΩÂ∑•‰∏≠ Brain Cerebral cortex ‚Ä¢¬†Functions: Higher processing
‚Ä¢¬†Clinical effects of a lesion: Contralateral motor, sensory, visual symptoms</description></item><item><title>Brain abscess</title><link>https://www.physician.tw/Brain-abscess/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Brain-abscess/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Brain abscess #üöß ÊñΩÂ∑•‰∏≠ Brain abscess ‚Ä¢¬†Pathophysiology: Complication of otitis media, sinusitis, odontogenic infection, post-surgical infection</description></item><item><title>Bridging Anticoagulation</title><link>https://www.physician.tw/Bridging-Anticoagulation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bridging-Anticoagulation/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Bridging Anticoagulation #üöß ÊñΩÂ∑•‰∏≠ Bridging Anticoagulation ‚Ä¢¬†Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures.</description></item><item><title>Calcium</title><link>https://www.physician.tw/Calcium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Calcium Calcium regulation (Ca2+ 8.5‚Äì10.5 mg/dL) ‚Ä¢¬†Physiology: Most calcium is bound to albumin; free ionized calcium is the physiologic active form under control of PTH</description></item><item><title>Cardiac Anatomy</title><link>https://www.physician.tw/Cardiac-Anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Anatomy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cardiac Anatomy #üöß ÊñΩÂ∑•‰∏≠ Cardiac Anatomy FIGURE 1.1: Cardiac chambers, valves, and major vessels.</description></item><item><title>Cardiac Electrophysiology</title><link>https://www.physician.tw/Cardiac-Electrophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Electrophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cardiac Electrophysiology #üöß ÊñΩÂ∑•‰∏≠ Cardiac Electrophysiology ‚Ä¢¬†Cardiac electrical conduction system: Sinoatrial (SA) node (1¬∞ pacemaker) ‚Üí Atrioventricular (AV) node (stalls conduction; can also act as a backup pacemaker with rate of 40‚Äì60 bpm) ‚Üí Bundle of His ‚Üí Right/left bundle ‚Üí Purkinje fibers ‚Üí Ventricle</description></item><item><title>Cardiac Stress Testing</title><link>https://www.physician.tw/Cardiac-Stress-Testing/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Stress-Testing/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cardiac Stress Testing #üöß ÊñΩÂ∑•‰∏≠ Cardiac Stress Testing ‚Ä¢¬†Indications:
-¬†Assessment for a new diagnosis of coronary artery disease (CAD) in patients with chest pain who have been ruled out for acute coronary syndrome (ACS)</description></item><item><title>Cardiac Valve Infection and Inflammation</title><link>https://www.physician.tw/Cardiac-Valve-Infection-and-Inflammation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Valve-Infection-and-Inflammation/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cardiac Valve Infection and Inflammation #üöß ÊñΩÂ∑•‰∏≠ Cardiac Valve Infection and Inflammation Rheumatic fever ‚Ä¢¬†Etiology: Complication of inflammatory reaction to group A strep spp.</description></item><item><title>Cardiology anatomy and physiology of cardiology</title><link>https://www.physician.tw/Cardiology-anatomy-and-physiology-of-cardiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-anatomy-and-physiology-of-cardiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology anatomy and physiology of cardiology #üöß ÊñΩÂ∑•‰∏≠ Cardiology anatomy and physiology of cardiology [[Cardiac Anatomy]]</description></item><item><title>Cardiology approaches and chief complaints</title><link>https://www.physician.tw/Cardiology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-approaches-and-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology approaches and chief complaints #üöß ÊñΩÂ∑•‰∏≠ Cardiology approaches and chief complaints [[books/h_note/Chest Pain]]</description></item><item><title>Cardiology diagnostics</title><link>https://www.physician.tw/Cardiology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-diagnostics/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology diagnostics #üöß ÊñΩÂ∑•‰∏≠ Cardiology diagnostics [[books/h_note/Electrocardiography]]
[[Echocardiography]]
[[Cardiac Stress Testing]]</description></item><item><title>Cardiology diseases and pathophysiology</title><link>https://www.physician.tw/Cardiology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-diseases-and-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology diseases and pathophysiology #üöß ÊñΩÂ∑•‰∏≠ Cardiology diseases and pathophysiology [[Ischemic Heart Disease]]</description></item><item><title>Cardiology key clinical trials and publications</title><link>https://www.physician.tw/Cardiology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-key-clinical-trials-and-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology key clinical trials and publications #üöß ÊñΩÂ∑•‰∏≠ Cardiology key clinical trials and publications [[Cardiovascular Disease Risk Prevention]]</description></item><item><title>Cardiology key medications and interventions</title><link>https://www.physician.tw/Cardiology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-key-medications-and-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology key medications and interventions #üöß ÊñΩÂ∑•‰∏≠ Cardiology key medications and interventions TABLE 1.</description></item><item><title>Cardiology of Huppert's Notes</title><link>https://www.physician.tw/Cardiology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-of-Hupperts-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cardiology of Huppert&amp;rsquo;s Notes [[Cardiology anatomy and physiology of cardiology]]
[[Cardiology diagnostics]]
[[Cardiology approaches and chief complaints]]</description></item><item><title>Cardiovascular Disease Risk Prevention</title><link>https://www.physician.tw/Cardiovascular-Disease-Risk-Prevention/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiovascular-Disease-Risk-Prevention/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cardiovascular Disease Risk Prevention #üöß ÊñΩÂ∑•‰∏≠ Cardiovascular Disease Risk Prevention ‚Ä¢¬†FOURIER. N Engl J Med 2017;376(18):1713-1722.</description></item><item><title>Categories of MPN</title><link>https://www.physician.tw/Categories-of-MPN/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Categories-of-MPN/</guid><description>[!info]
üå± ‰æÜËá™: [[overview of myeloproliferative neoplasms]]
Categories of MPN #üöß ÊñΩÂ∑•‰∏≠ Categories of MPN :¬†polycythemia vera¬†(PV);¬†essential thrombocythemia¬†(ET);¬†primary myelofibrosis¬†(PMF); chronic myelogenous leukemia (CML;¬†BCR-ABL1¬†‚äï); atypical CML (aCML); chronic neutrophilic leukemia (CNL); systemic mastocytosis; chronic eosinophilic leukemia; MPN-NOS/unclassifiable</description></item><item><title>Categories of Stem Cell Transplantation</title><link>https://www.physician.tw/categories-of-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/categories-of-stem-cell-transplantation/</guid><description>[!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
Categories of Stem Cell Transplantation #üöß ÊñΩÂ∑•‰∏≠ Categories of Stem Cell Transplantation Feature Allogeneic (Allo) Autologous (Auto) Donor‚Äìrecipient relationship Immunologically distinct Donor is also recipient Graft-vs.</description></item><item><title>Cellulitis and Cellulitis Mimickers</title><link>https://www.physician.tw/Cellulitis-and-Cellulitis-Mimickers/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cellulitis-and-Cellulitis-Mimickers/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cellulitis and Cellulitis Mimickers #üöß ÊñΩÂ∑•‰∏≠ Cellulitis and Cellulitis Mimickers ‚Ä¢¬†Effect of dermatology consultation on outcomes for patients with presumed cellulitis.</description></item><item><title>Central Nervous System (CNS)</title><link>https://www.physician.tw/Central-Nervous-System-CNS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Nervous-System-CNS/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Central Nervous System (CNS) #üöß ÊñΩÂ∑•‰∏≠ Central Nervous System (CNS)</description></item><item><title>Central Nervous System (CNS) Tumors</title><link>https://www.physician.tw/Central-Nervous-System-CNS-Tumors/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Nervous-System-CNS-Tumors/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Central Nervous System (CNS) Tumors #üöß ÊñΩÂ∑•‰∏≠ Central Nervous System (CNS) Tumors ‚Ä¢¬†Epidemiology:</description></item><item><title>Central Nervous System Infections</title><link>https://www.physician.tw/Central-Nervous-System-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Nervous-System-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Central Nervous System Infections #üöß ÊñΩÂ∑•‰∏≠ Central Nervous System Infections Meningitis ‚Ä¢¬†Note: Meningitis and encephalitis are two distinct clinical entities, each with their own list of causative organisms.</description></item><item><title>Central Venous Pressure (CVP) Waveform Jugular Venous Pulse (JVP)</title><link>https://www.physician.tw/Central-Venous-Pressure-CVP-Waveform-Jugular-Venous-Pulse-JVP/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Venous-Pressure-CVP-Waveform-Jugular-Venous-Pulse-JVP/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Central Venous Pressure (CVP) Waveform Jugular Venous Pulse (JVP) #üöß ÊñΩÂ∑•‰∏≠ Central Venous Pressure (CVP) Waveform / Jugular Venous Pulse (JVP) ‚Ä¢¬†a wave: atrial contraction</description></item><item><title>Chemotherapy</title><link>https://www.physician.tw/Chemotherapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chemotherapy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chemotherapy #üöß ÊñΩÂ∑•‰∏≠ Chemotherapy ‚Ä¢¬†Cell cycle non-specific phase: Activity not dependent upon the agent being available during a certain phase of the cell cycle.</description></item><item><title>Chemotherapy, Targeted Therapy, and Immunotherapy</title><link>https://www.physician.tw/Chemotherapy-Targeted-Therapy-and-Immunotherapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chemotherapy-Targeted-Therapy-and-Immunotherapy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chemotherapy, Targeted Therapy, and Immunotherapy #üöß ÊñΩÂ∑•‰∏≠ Chemotherapy, Targeted Therapy, and Immunotherapy See Oncology treatment section at the end of this chapter.</description></item><item><title>Chest CT</title><link>https://www.physician.tw/Chest-CT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-CT/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chest CT #üöß ÊñΩÂ∑•‰∏≠ Chest CT ‚Ä¢¬†Types of Chest CT:
-¬†Standard: Images may be obtained with or without contrast.</description></item><item><title>Chest Tubes</title><link>https://www.physician.tw/Chest-Tubes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-Tubes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chest Tubes #üöß ÊñΩÂ∑•‰∏≠ Chest Tubes ‚Ä¢¬†Description: Flexible plastic tube placed into the pleural space (or mediastinum) through the chest wall for drainage of air, fluid, or pus</description></item><item><title>Chest x-ray (CXR)</title><link>https://www.physician.tw/Chest-x-ray-CXR/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-x-ray-CXR/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chest x-ray (CXR) #üöß ÊñΩÂ∑•‰∏≠ Chest x-ray (CXR) ‚Ä¢¬†Types of CXR:
-¬†PA and lateral CXR: Method: Radiation posterior ‚Üí anterior; obtained with lateral images.</description></item><item><title>Chief Complaint and History of Present Illness (HPI)</title><link>https://www.physician.tw/Chief-Complaint-and-History-of-Present-Illness-HPI/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chief-Complaint-and-History-of-Present-Illness-HPI/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chief Complaint and History of Present Illness (HPI) #üöß ÊñΩÂ∑•‰∏≠ Chief Complaint and History of Present Illness (HPI) TABLE A1.</description></item><item><title>Chimeric-Antigen Receptor (CAR)-T cell therapy</title><link>https://www.physician.tw/Chimeric-Antigen-Receptor-CAR-T-cell-therapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chimeric-Antigen-Receptor-CAR-T-cell-therapy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chimeric-Antigen Receptor (CAR)-T cell therapy #üöß ÊñΩÂ∑•‰∏≠ Chimeric-Antigen Receptor (CAR)-T cell therapy ‚Ä¢¬†Mechanism: T cells are collected from the patient and genetically modified with a chimeric antigen receptor (CAR) to direct the T-cells against the tumor cells.</description></item><item><title>Cholecystectomy</title><link>https://www.physician.tw/Cholecystectomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cholecystectomy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cholecystectomy #üöß ÊñΩÂ∑•‰∏≠ Cholecystectomy ‚Ä¢¬†ACDC. Ann Surg 2013;258:385‚Äì393.
-¬†Parallel-group, open-label, randomized controlled trial comparing early laparoscopic cholecystectomy (&amp;lt;24 hours) versus initial antibiotics and delayed surgery (7‚Äì45 days).</description></item><item><title>Cholestatic Liver Diseases</title><link>https://www.physician.tw/Cholestatic-Liver-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cholestatic-Liver-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cholestatic Liver Diseases #üöß ÊñΩÂ∑•‰∏≠ Cholestatic Liver Diseases Primary biliary cholangitis (PBC) ‚Ä¢¬†Etiology: Immune-mediated destruction of intrahepatic bile ducts, most common in females 40‚Äì50 yr</description></item><item><title>Chronic Cough (8 wk) in Immunocompetent Adults</title><link>https://www.physician.tw/Chronic-Cough-8-wk-in-Immunocompetent-Adults/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Cough-8-wk-in-Immunocompetent-Adults/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chronic Cough (8 wk) in Immunocompetent Adults #üöß ÊñΩÂ∑•‰∏≠ Chronic Cough (&amp;gt;8 wk) in Immunocompetent Adults ‚Ä¢¬†Evaluate for red flags: Evaluate for red flags and consider CXR.</description></item><item><title>Chronic Diarrhea (3 weeks)</title><link>https://www.physician.tw/Chronic-Diarrhea-3-weeks/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Diarrhea-3-weeks/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chronic Diarrhea (3 weeks) #üöß ÊñΩÂ∑•‰∏≠ Chronic Diarrhea (&amp;gt;3 weeks) ‚Ä¢¬†Work-up:
-¬†Use history/physical to determine the probable subtype of diarrhea (i.</description></item><item><title>Chronic GVHD</title><link>https://www.physician.tw/Chronic-GVHD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-GVHD/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
Chronic GVHD #üöß ÊñΩÂ∑•‰∏≠ Chronic GVHD (developing or persisting &amp;gt;3 mo posttransplant; NEJM 2017;377:2565) Clinical: malar rash, sicca syndrome, arthritis, obliterative bronchiolitis, bile duct degeneration, cholestasis, and many others.</description></item><item><title>Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)</title><link>https://www.physician.tw/Chronic-Kidney-Disease-CKD-and-End-Stage-Renal-Disease-ESRD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Kidney-Disease-CKD-and-End-Stage-Renal-Disease-ESRD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) #üöß ÊñΩÂ∑•‰∏≠ Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) ‚Ä¢¬†Definitions:</description></item><item><title>Chronic Noncancer Pain</title><link>https://www.physician.tw/Chronic-Noncancer-Pain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Noncancer-Pain/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chronic Noncancer Pain #üöß ÊñΩÂ∑•‰∏≠ Chronic Noncancer Pain ‚Ä¢¬†Clinical:
-¬†Assess pain: OPQRST- Onset, Provocation/Palliation, Quality, Region/Radiation, Severity, Timing</description></item><item><title>Chronic Pain Management</title><link>https://www.physician.tw/Chronic-Pain-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Pain-Management/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Chronic Pain Management #üöß ÊñΩÂ∑•‰∏≠ Chronic Pain Management ‚Ä¢¬†Pain Management With Opioids in 2019-2020.</description></item><item><title>chronic¬†myelogenous¬†leukemia¬†(CML)</title><link>https://www.physician.tw/chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[leukemia]]
chronic¬†myelogenous¬†leukemia¬†(CML) Lancet2021;398:1914)
[[definition of chronic myelogenous leukemia (CML)]]
[[epidemiology and risk factors of chronic myelogenous leukemia (CML)]]</description></item><item><title>Cirrhosis and its Complications</title><link>https://www.physician.tw/Cirrhosis-and-its-Complications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cirrhosis-and-its-Complications/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cirrhosis and its Complications #üöß ÊñΩÂ∑•‰∏≠ Cirrhosis and its Complications Decompensated cirrhosis ‚Ä¢¬†Decompensated cirrhosis: Defined by any one of: ascites, hepatic encephalopathy, and/or variceal bleed</description></item><item><title>Cirrhosis Management</title><link>https://www.physician.tw/Cirrhosis-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cirrhosis-Management/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cirrhosis Management #üöß ÊñΩÂ∑•‰∏≠ Cirrhosis Management ‚Ä¢¬†Norfloxacin vs. Ceftriaxone in the Prophylaxis of Infections in Patients with Advanced Cirrhosis and Hemorrhage.</description></item><item><title>classification of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/classification-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classification-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[acute lymphoblastic leukemia (ALL)]]
classification of acute lymphoblastic leukemia (ALL) #üöß ÊñΩÂ∑•‰∏≠ classification of acute lymphoblastic leukemia (ALL) ‚Ä¢ Lymphoblastic neoplasms may present as acute leukemia (ALL) w/ &amp;gt;20% BM blasts¬†or as lymphoblastic lymphoma (LBL, more common in T-cell) w/ mass lesion w/ &amp;lt;20% BM blast</description></item><item><title>classification of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/classification-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classification-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
üå± ‰æÜËá™: [[acute myelogenous leukemia (AML)]]
classification of acute myelogenous leukemia (AML) #üöß ÊñΩÂ∑•‰∏≠ classification of acute myelogenous leukemia (AML)¬† (WHO;¬†Blood¬†2016;127:2391)</description></item><item><title>clinical manifestations of acute leukemia</title><link>https://www.physician.tw/clinical-manifestations-of-acute-leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-acute-leukemia/</guid><description>[!info]
üå± ‰æÜËá™: [[acute leukemia]]
clinical manifestations of acute leukemia #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of acute leukemia ‚Ä¢ Cytopenias ‚Üí¬†fatigue¬†(anemia),¬†infection¬†(neutropenia),¬†bleeding(thrombocytopenia)</description></item><item><title>clinical manifestations of multiple myeloma (MM)</title><link>https://www.physician.tw/clinical-manifestations-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-multiple-myeloma-MM/</guid><description>[!info]
üå± ‰æÜËá™: [[multiple myeloma (MM)]]
clinical manifestations of multiple myeloma (MM) #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of multiple myeloma (MM) (CRAB criteria and other less common features) ‚Ä¢ HyperCalcemia due to ‚Üë osteoclast activity ‚Ä¢ Renal disease: multiple mechanisms include toxic effect of filtered light chains ‚Üí renal failure (cast nephropathy) or type II RTA; amyloidosis or light chain deposition disease ‚Üí nephrotic syndrome; hypercalcemia, urate nephropathy, type I cryoglobulinemia ‚Ä¢ Anemia (normocytic) due to bone marrow involvement; rarely, may see AIHA ‚Ä¢ Lytic Bone lesions due to ‚Üë osteoclast activity ‚Üí pathologic fx ‚Ä¢ Recurrent infxns due to relative hypogammaglob.</description></item><item><title>clinical manifestations of overview of lymphoma and CLL</title><link>https://www.physician.tw/clinical-manifestations-of-overview-of-lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-overview-of-lymphoma-and-CLL/</guid><description>[!info]
üå± ‰æÜËá™: [[overview of lymphoma and CLL]]
clinical manifestations of overview of lymphoma and CLL #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of overview of lymphoma and CLL ‚Ä¢ Lymphadenopathy (usually nontender) HL: superficial (usually cervical/supraclavicular) ¬± mediastinal LAN; nodal disease with orderly, anatomic spread to adjacent nodes NHL: diffuse; nodal and/or extranodal disease with noncontiguous spread; symptoms reflect involved sites (abdominal fullness, bone pain) ‚Ä¢ Constitutional (‚ÄúB‚Äù) symptoms: fever (&amp;gt;38¬∞), drenching sweats, ‚Üì weight (&amp;gt;10% in 6 mo) HL: periodic, recurrent ‚ÄúPel-Ebstein‚Äù fever; 10‚Äì15% have pruritus; ~35% ‚ÄúB‚Äù symptoms NHL: ‚ÄúB‚Äù symptoms vary between subtypes, ~15‚Äì50%</description></item><item><title>clinical manifestations of polycythemia vera</title><link>https://www.physician.tw/clinical-manifestations-of-polycythemia-vera/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-polycythemia-vera/</guid><description>[!info]
üå± ‰æÜËá™: [[polycythemia vera (PV)]]
clinical manifestations of polycythemia vera #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of polycythemia vera (common between PV and ET)</description></item><item><title>clinical manifestations of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/clinical-manifestations-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-primary-myelofibrosis-PMF/</guid><description>[!info]
üå± ‰æÜËá™: [[primary myelofibrosis (PMF)]]
clinical manifestations of primary myelofibrosis (PMF) #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of primary myelofibrosis (PMF) (BJH¬†2012;158:453)</description></item><item><title>clinical manifestations of small¬†lymphocytic¬†lymphoma</title><link>https://www.physician.tw/clinical-manifestations-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-small-lymphocytic-lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[small lymphocytic lymphoma]]
clinical manifestations of small¬†lymphocytic¬†lymphoma #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of small¬†lymphocytic¬†lymphoma ‚Ä¢¬†Often asx¬†&amp;amp; identified by lymphocytosis on CBC; 10‚Äì20% p/w ‚ÄúB symptoms‚Äù</description></item><item><title>clinical manifestations of waldenstrom‚Äôs macroglobulinemia (WM)</title><link>https://www.physician.tw/clinical-manifestations-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
üå± ‰æÜËá™: [[waldenstrom‚Äôs macroglobulinemia (WM)]]
clinical manifestations of waldenstrom‚Äôs macroglobulinemia (WM) #üöß ÊñΩÂ∑•‰∏≠ clinical manifestations of waldenstrom‚Äôs macroglobulinemia (WM) ‚Ä¢ Fatigue from anemia is most common sx ‚Ä¢ Tumor infiltration: BM (cytopenias), hepatomegaly, splenomegaly, lymphadenopathy ‚Ä¢ Circulating monoclonal IgM Hyperviscosity syndrome (~15%): Neurologic: blurred vision (‚Äúsausage‚Äù retinal veins), HA, dizziness, Œî MS.</description></item><item><title>clinical trials</title><link>https://www.physician.tw/clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-trials/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
clinical trials #üöß ÊñΩÂ∑•‰∏≠ clinical trials [[Types of Clinical Studies &amp;amp; Trials]]
[[Biases]]</description></item><item><title>Clostridium difficile</title><link>https://www.physician.tw/Clostridium-difficile/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clostridium-difficile/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Clostridium difficile #üöß ÊñΩÂ∑•‰∏≠ Clostridium difficile ‚Ä¢¬†[Guideline] Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA).</description></item><item><title>CNS Infections</title><link>https://www.physician.tw/CNS-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CNS-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
CNS Infections #üöß ÊñΩÂ∑•‰∏≠ CNS Infections ‚Ä¢¬†Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015;2015(9):CD004405.</description></item><item><title>CNS prophylaxis of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/CNS-prophylaxis-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CNS-prophylaxis-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[treatment of acute lymphoblastic leukemia (ALL)]]
CNS prophylaxis of treatment of acute lymphoblastic leukemia (ALL) #üöß ÊñΩÂ∑•‰∏≠ CNS prophylaxis of treatment of acute lymphoblastic leukemia (ALL) intrathecal MTX/cytarabine ¬± cranial irradiation¬†_or_systemic MTX</description></item><item><title>Coagulation Disorders</title><link>https://www.physician.tw/Coagulation-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coagulation-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Coagulation Disorders #üöß ÊñΩÂ∑•‰∏≠ Coagulation Disorders ‚Ä¢¬†Definition: Elevated prothrombin time (PT) and/or partial thromboplastin time (PTT) with normal platelet count and bleeding time</description></item><item><title>Cognitive Impairment</title><link>https://www.physician.tw/Cognitive-Impairment/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cognitive-Impairment/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cognitive Impairment #üöß ÊñΩÂ∑•‰∏≠ Cognitive Impairment Alzheimer‚Äôs disease ‚Ä¢¬†Epidemiology: Most common form of dementia.</description></item><item><title>Colon</title><link>https://www.physician.tw/Colon/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Colon/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Colon #üöß ÊñΩÂ∑•‰∏≠ Colon</description></item><item><title>Colon Cancer</title><link>https://www.physician.tw/Colon-Cancer/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Colon-Cancer/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Colon Cancer #üöß ÊñΩÂ∑•‰∏≠ Colon Cancer ‚Ä¢¬†Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.</description></item><item><title>command line know how</title><link>https://www.physician.tw/command-line-know-how/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/command-line-know-how/</guid><description> [!info]
üå± ‰æÜËá™: [[command line interface]]
command line know how #üöß ÊñΩÂ∑•‰∏≠ [[Shell Scripting Âü∫Á§éÊåáÂçó]]
[[Âú®macÈóúÈñâmicrfosoft update]]</description></item><item><title>Common ICU Indications</title><link>https://www.physician.tw/Common-ICU-Indications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-ICU-Indications/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Common ICU Indications #üöß ÊñΩÂ∑•‰∏≠ Common ICU Indications ‚Ä¢¬†Need for mechanical ventilation or noninvasive ventilation</description></item><item><title>Common Skin Cancers</title><link>https://www.physician.tw/Common-Skin-Cancers/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Skin-Cancers/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Common Skin Cancers #üöß ÊñΩÂ∑•‰∏≠ Common Skin Cancers Benign skin conditions ‚Ä¢¬†Seborrheic keratosis (SK): Benign pigmented neoplasm; common after age 50 yr; presents as tan-brown ‚Äústuck on‚Äù papules or plaques.</description></item><item><title>Common Skin Infections</title><link>https://www.physician.tw/Common-Skin-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Skin-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Common Skin Infections #üöß ÊñΩÂ∑•‰∏≠ Common Skin Infections Bacterial Folliculitis ‚Ä¢¬†Pathophysiology: Staph aureus &amp;raquo; Klebsiella, Enterobacter, and Pseudomonas (hot tub exposure).</description></item><item><title>common toxicities of Rx of multiple myeloma (MM)</title><link>https://www.physician.tw/common-toxicities-of-Rx-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/common-toxicities-of-Rx-of-multiple-myeloma-MM/</guid><description>[!info]
üå± ‰æÜËá™: [[multiple myeloma (MM)]]
common toxicities of Rx of multiple myeloma (MM) #üöß ÊñΩÂ∑•‰∏≠ common toxicities of Rx of multiple myeloma (MM) melphalan ‚Üí myelosuppression; lenalidomide ‚Üí low plts &amp;amp; thromboembolism; bortezomib ‚Üí periph.</description></item><item><title>Complications Associated with Mechanical Ventilation</title><link>https://www.physician.tw/Complications-Associated-with-Mechanical-Ventilation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-Associated-with-Mechanical-Ventilation/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Complications Associated with Mechanical Ventilation #üöß ÊñΩÂ∑•‰∏≠ Complications Associated with Mechanical Ventilation ‚Ä¢¬†See ‚ÄúIntubation and Mechanical Ventilation‚Äù under Key Medications and Interventions</description></item><item><title>complications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/complications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
complications of hematopoietic stem cell transplantation ‚Ä¢ Either direct chemoradiotoxicities associated with preparative regimen or consequences of interaction between donor and recipient immune systems</description></item><item><title>Congenital Adrenal Hyperplasia</title><link>https://www.physician.tw/Congenital-Adrenal-Hyperplasia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Adrenal-Hyperplasia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Congenital Adrenal Hyperplasia #üöß ÊñΩÂ∑•‰∏≠ Congenital Adrenal Hyperplasia 21-hydroxylase deficiency ‚Ä¢¬†Pathophysiology: Autosomal recessive genetic disorder.</description></item><item><title>Congenital Heart Disease with Early Cyanosis (R ‚Üí L shunt)</title><link>https://www.physician.tw/Congenital-Heart-Disease-with-Early-Cyanosis-R-L-shunt/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Heart-Disease-with-Early-Cyanosis-R-L-shunt/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Congenital Heart Disease with Early Cyanosis (R ‚Üí L shunt) #üöß ÊñΩÂ∑•‰∏≠ Congenital Heart Disease with Early Cyanosis (R ‚Üí L shunt) Tetralogy of Fallot ‚Ä¢¬†Etiology: Associated with Down syndrome; includes four anatomic components: 1) VSD; 2) Right ventricular hypertrophy; 3) Pulmonary stenosis; 4) Overriding aorta</description></item><item><title>Congenital Heart disease with late Cyanosis (L ‚Üí R shunt)</title><link>https://www.physician.tw/Congenital-Heart-disease-with-late-Cyanosis-L-R-shunt/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Heart-disease-with-late-Cyanosis-L-R-shunt/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Congenital Heart disease with late Cyanosis (L ‚Üí R shunt) #üöß ÊñΩÂ∑•‰∏≠ Congenital Heart disease with late Cyanosis (L ‚Üí R shunt) Atrial septal defect (ASD) ‚Ä¢¬†Etiolgy: Defect in the middle (ostum secundum, most common) or lower (ostum primum, which occurs in Down syndrome) part of atrial septum</description></item><item><title>Congenital Heart Diseases</title><link>https://www.physician.tw/Congenital-Heart-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Heart-Diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Congenital Heart Diseases #üöß ÊñΩÂ∑•‰∏≠ Congenital Heart Diseases</description></item><item><title>consolidation therapy of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/consolidation-therapy-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consolidation-therapy-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
üå± ‰æÜËá™: [[acute myelogenous leukemia (AML)]]
consolidation therapy of acute myelogenous leukemia (AML) #üöß ÊñΩÂ∑•‰∏≠ consolidation therapy of acute myelogenous leukemia (AML) ‚Ä¢ If c_omplete remission_¬†(CR) = ANC &amp;gt;103, plt &amp;gt;100, no RBC Rx, &amp;lt;5% BM blasts;¬†CR ‚â† cure</description></item><item><title>Contents</title><link>https://www.physician.tw/Contents/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contents/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
Contents #üöß ÊñΩÂ∑•‰∏≠ Contents Contributing Authors
Preface
Acknowledgments
1. Diagnostic Process
Diane Altkorn, MD</description></item><item><title>Contraception</title><link>https://www.physician.tw/Contraception/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contraception/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Contraception #üöß ÊñΩÂ∑•‰∏≠ Contraception ‚Ä¢¬†Approach to contraception counseling: Recommend discussion of contraception with all patients of reproductive age.</description></item><item><title>Contributing Authors</title><link>https://www.physician.tw/Contributing-Authors/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contributing-Authors/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
Contributing Authors #üöß ÊñΩÂ∑•‰∏≠ Contributing Authors Jason Alexander, MD
Assistant Professor of Medicine
Section of General Internal Medicine</description></item><item><title>COPD</title><link>https://www.physician.tw/COPD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COPD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
COPD #üöß ÊñΩÂ∑•‰∏≠ COPD ‚Ä¢¬†Antibiotic therapy in exacerbations of COPD. Ann Intern Med 1987;106:196‚Äì204.</description></item><item><title>Coronary Artery Disease (CAD)</title><link>https://www.physician.tw/Coronary-Artery-Disease-CAD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-Artery-Disease-CAD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Coronary Artery Disease (CAD) #üöß ÊñΩÂ∑•‰∏≠ Coronary Artery Disease (CAD) ‚Ä¢¬†FAME-2. N Engl J Med 2012;367(11):991‚Äì1001.</description></item><item><title>Coronary CT Angiography (CCTA)</title><link>https://www.physician.tw/Coronary-CT-Angiography-CCTA/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-CT-Angiography-CCTA/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Coronary CT Angiography (CCTA) #üöß ÊñΩÂ∑•‰∏≠ Coronary CT Angiography (CCTA) ‚Ä¢¬†Indications: Direct anatomic assessment of the coronary anatomy (less sensitive than invasive coronary angiography); CT can increasingly provide physiologic assessment with FFR (fractional flow reserve, a measure of pressure/flow across a coronary lesion); CT-FFR allows clinicians to estimate the hemodynamic significance of coronary lesions noninvasively.</description></item><item><title>critical care common complications of icu admission</title><link>https://www.physician.tw/critical-care-common-complications-of-icu-admission/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-common-complications-of-icu-admission/</guid><description>[!info]
üå± ‰æÜËá™: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care common complications of icu admission #üöß ÊñΩÂ∑•‰∏≠ critical care common complications of icu admission [[Post-Intensive Care Syndrome &amp;amp; Other Long-Term Physical and Cognitive Disability]]</description></item><item><title>critical care diseases and pathophysiology</title><link>https://www.physician.tw/critical-care-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-diseases-and-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care diseases and pathophysiology #üöß ÊñΩÂ∑•‰∏≠ critical care diseases and pathophysiology [[SIRS, Sepsis, Severe Sepsis, and Septic Shock]]</description></item><item><title>critical care key clinical trials and publications</title><link>https://www.physician.tw/critical-care-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-key-clinical-trials-and-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care key clinical trials and publications #üöß ÊñΩÂ∑•‰∏≠ critical care key clinical trials and publications [[Shock Management]]</description></item><item><title>critical care key medications and interventions</title><link>https://www.physician.tw/critical-care-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-key-medications-and-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care key medications and interventions #üöß ÊñΩÂ∑•‰∏≠ critical care key medications and interventions [[Respiratory Support]]</description></item><item><title>critical care medicine</title><link>https://www.physician.tw/critical-care-medicine/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-medicine/</guid><description>[!info]
üå± ‰æÜËá™: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care medicine [[Goals of Intensive Care Unit (ICU) Care]]</description></item><item><title>Critical Care Medicine of Huppert's Notes</title><link>https://www.physician.tw/Critical-Care-Medicine-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Medicine-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Critical Care Medicine of Huppert&amp;rsquo;s Notes #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Critical Illness Polyneuropathy, Critical Illness Myopathy, and ICU-Acquired Weakness</title><link>https://www.physician.tw/Critical-Illness-Polyneuropathy-Critical-Illness-Myopathy-and-ICU-Acquired-Weakness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Illness-Polyneuropathy-Critical-Illness-Myopathy-and-ICU-Acquired-Weakness/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Critical Illness Polyneuropathy, Critical Illness Myopathy, and ICU-Acquired Weakness #üöß ÊñΩÂ∑•‰∏≠ Critical Illness Polyneuropathy, Critical Illness Myopathy, and ICU-Acquired Weakness ‚Ä¢¬†Risk factors: Mechanical ventilation, sepsis, prolonged use of paralytics, multiorgan failure, ARDS</description></item><item><title>Cutaneous Drug Reactions</title><link>https://www.physician.tw/Cutaneous-Drug-Reactions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutaneous-Drug-Reactions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Cutaneous Drug Reactions #üöß ÊñΩÂ∑•‰∏≠ Cutaneous Drug Reactions Morbilliform drug eruption ‚Ä¢¬†Pathophysiology: Most common type of cutaneous drug reaction (~75 to 90% of cases); common culprits include antibiotics, antiepileptics, NSAIDs, and calcium channel blockers</description></item><item><title>daily presentations and notes</title><link>https://www.physician.tw/daily-presentations-and-notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/daily-presentations-and-notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
daily presentations and notes #üöß ÊñΩÂ∑•‰∏≠ daily presentations and notes [[How to Do Daily Presentations and Notes]]</description></item><item><title>Decubitus Ulcers</title><link>https://www.physician.tw/Decubitus-Ulcers/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Decubitus-Ulcers/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Decubitus Ulcers #üöß ÊñΩÂ∑•‰∏≠ Decubitus Ulcers ‚Ä¢¬†Definition: Injury to skin and underlying tissue from prolonged pressure on the skin</description></item><item><title>definition and epidemiology of multiple myeloma (MM)</title><link>https://www.physician.tw/definition-and-epidemiology-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-and-epidemiology-of-multiple-myeloma-MM/</guid><description>[!info]
üå± ‰æÜËá™: [[multiple myeloma (MM)]]
definition and epidemiology of multiple myeloma (MM) #üöß ÊñΩÂ∑•‰∏≠ definition and epidemiology of multiple myeloma (MM) (Lancet 2021;397:410) ‚Ä¢ Malignant neoplasm of plasma cells producing a monoclonal Ig = ‚ÄúM protein‚Äù ‚Ä¢ ~27,000 new cases/y; median age at diagnosis 69 y; more common in African Americans</description></item><item><title>definition of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/definition-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[chronic myelogenous leukemia (CML)]]
definition of chronic myelogenous leukemia (CML) #üöß ÊñΩÂ∑•‰∏≠ definition of chronic myelogenous leukemia (CML) ¬†(Blood¬†2009;114:937)</description></item><item><title>definition of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/definition-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-primary-myelofibrosis-PMF/</guid><description>[!info]
üå± ‰æÜËá™: [[primary myelofibrosis (PMF)]]
definition of primary myelofibrosis (PMF) #üöß ÊñΩÂ∑•‰∏≠ definition of primary myelofibrosis (PMF) ‚Ä¢ Clonal myeloproliferation with reactive marrow fibrosis &amp;amp; extramedullary hematopoiesis</description></item><item><title>definition of small¬†lymphocytic¬†lymphoma</title><link>https://www.physician.tw/definition-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-small-lymphocytic-lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[small lymphocytic lymphoma]]
definition of small¬†lymphocytic¬†lymphoma #üöß ÊñΩÂ∑•‰∏≠ definition of small¬†lymphocytic¬†lymphoma¬† (NEJM¬†2005;352:804;¬†Blood¬†2008;111:5446)</description></item><item><title>definition of waldenstrom‚Äôs macroglobulinemia (WM)</title><link>https://www.physician.tw/definition-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
üå± ‰æÜËá™: [[waldenstrom‚Äôs macroglobulinemia (WM)]]
definition of waldenstrom‚Äôs macroglobulinemia (WM) #üöß ÊñΩÂ∑•‰∏≠ definition of waldenstrom‚Äôs macroglobulinemia (WM) (Blood 2009;114:2375; NEJM 2012;367:826) ‚Ä¢ B-cell neoplasm (lymphoplasmacytic lymphoma) that secretes monoclonal IgM ‚Ä¢ 91% w/ MYD88 (NF-Œ∫B pathway) L265P mut.</description></item><item><title>delirium or dementia</title><link>https://www.physician.tw/delirium-or-dementia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/delirium-or-dementia/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
delirium or dementia #üöß ÊñΩÂ∑•‰∏≠ delirium or dementia Payal K. Sanghani, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>Depressed MoodSuicidal Ideation</title><link>https://www.physician.tw/Depressed-MoodSuicidal-Ideation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Depressed-MoodSuicidal-Ideation/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Depressed MoodSuicidal Ideation #üöß ÊñΩÂ∑•‰∏≠ Depressed Mood/Suicidal Ideation ‚Ä¢¬†Definitions:
-¬†Suicidal ideation (SI)</description></item><item><title>dermatology key medications and interventions</title><link>https://www.physician.tw/dermatology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dermatology-key-medications-and-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Dermatology of Huppert&amp;rsquo;s Notes]]
dermatology key medications and interventions #üöß ÊñΩÂ∑•‰∏≠ ‚Ä¢¬†Treatment pearls:
-¬†Steroid strength typically: Ointment &amp;gt; Cream &amp;gt; Lotion</description></item><item><title>Dermatology of Huppert's Notes</title><link>https://www.physician.tw/Dermatology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dermatology-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]</description></item><item><title>Determinants of Cardiac Function</title><link>https://www.physician.tw/Determinants-of-Cardiac-Function/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Determinants-of-Cardiac-Function/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Determinants of Cardiac Function #üöß ÊñΩÂ∑•‰∏≠ Determinants of Cardiac Function ‚Ä¢¬†Preload: Myocardial stretch before contraction (i.</description></item><item><title>Diabetes</title><link>https://www.physician.tw/Diabetes-key-clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetes-key-clinical-trials/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diabetes #üöß ÊñΩÂ∑•‰∏≠ Diabetes ‚Ä¢¬†Diabetes Control and Complication Trial (DCCT). N Engl J Med 1993;329(14):977‚Äì986.</description></item><item><title>Diabetes Prevention</title><link>https://www.physician.tw/Diabetes-Prevention-key-clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetes-Prevention-key-clinical-trials/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diabetes Prevention #üöß ÊñΩÂ∑•‰∏≠ Diabetes Prevention ‚Ä¢¬†Diabetes Prevention Program (DPP). N Engl J Med 2002;346(6):393‚Äì403.</description></item><item><title>Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS)</title><link>https://www.physician.tw/Diabetic-Ketoacidosis-DKA-and-Hyperosmolar-Hyperglycemic-Syndrome-HHS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetic-Ketoacidosis-DKA-and-Hyperosmolar-Hyperglycemic-Syndrome-HHS/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS) #üöß ÊñΩÂ∑•‰∏≠ Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS) DKA and HHS are medical emergencies that require prompt triaging, evaluation, and treatment, often in the ICU, due to the need for close monitoring, frequent lab draws, and IV insulin therapy.</description></item><item><title>diagnostic and staging evaluation of overview of lymphoma and CLL</title><link>https://www.physician.tw/diagnostic-and-staging-evaluation-of-overview-of-lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-and-staging-evaluation-of-overview-of-lymphoma-and-CLL/</guid><description>[!info]
üå± ‰æÜËá™: [[overview of lymphoma and CLL]]
diagnostic and staging evaluation of overview of lymphoma and CLL #üöß ÊñΩÂ∑•‰∏≠ diagnostic and staging evaluation of overview of lymphoma and CLL ‚Ä¢ Physical exam: lymph nodes, liver/spleen size, Waldeyer‚Äôs ring, testes (~1% of NHL), skin ‚Ä¢ Pathology: excisional lymph node bx (not FNA b/c need surrounding architecture) with immunophenotyping and cytogenetics (Reed-Sternberg (RS) cells in HL); BM bx if cytopenias; CLL by peripheral flow in patients w/ peripheral disease; LP if CNS involvement clinically suspected ‚Ä¢ Lab tests: CBC, BUN/Cr, LFTs, ESR, LDH, UA, Ca, alb; ‚úì HBV &amp;amp; HCV (and must ‚úì HBsAg &amp;amp; anti-HBc if planning rituximab Rx due to risk of HBV reactivation); HIV ‚Ä¢ Imaging: PET-CT to assess disease burden and guide biopsy/therapy, especially in HL, DLBCL.</description></item><item><title>Diagnostic Approach to Joint Pain</title><link>https://www.physician.tw/Diagnostic-Approach-to-Joint-Pain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Approach-to-Joint-Pain/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diagnostic Approach to Joint Pain #üöß ÊñΩÂ∑•‰∏≠ Diagnostic Approach to Joint Pain (1) Consider non-articular mimics of joint pain ‚Ä¢¬†Articular structures: Synovium, synovial fluid, articular cartilage, intraarticular ligaments, joint capsule, and juxtaarticular bone</description></item><item><title>diagnostic evaluation</title><link>https://www.physician.tw/diagnostic-evaluation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation/</guid><description>[!info]
üå± ‰æÜËá™: [[acute leukemia]]
diagnostic evaluation #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation¬† (Blood¬†2009;114:937)
‚Ä¢¬†Peripheral smear:¬†thrombocytopenia,¬†blasts¬†(seen in &amp;gt;95%; ‚äï Auer Rods in AML)</description></item><item><title>diagnostic evaluation of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/diagnostic-evaluation-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[chronic myelogenous leukemia (CML)]]
diagnostic evaluation of chronic myelogenous leukemia (CML) #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation of chronic myelogenous leukemia (CML) ‚Ä¢¬†Peripheral smear: leukocytosis, left-shifted with¬†all stages of myeloid maturation;¬†thrombocytosis,¬†basophilia</description></item><item><title>diagnostic evaluation of essential thrombocythemia (ET)</title><link>https://www.physician.tw/diagnostic-evaluation-of-essential-thrombocythemia-ET/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-essential-thrombocythemia-ET/</guid><description>[!info]
üå± ‰æÜËá™: [[essential thrombocythemia (ET)]]
diagnostic evaluation of essential thrombocythemia (ET) #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation of essential thrombocythemia (ET) ‚Ä¢ Peripheral smear: large hypogranular platelets</description></item><item><title>diagnostic evaluation of polycythemia vera</title><link>https://www.physician.tw/diagnostic-evaluation-of-polycythemia-vera/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-polycythemia-vera/</guid><description>[!info]
üå± ‰æÜËá™: [[polycythemia vera (PV)]]
diagnostic evaluation of polycythemia vera #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation of polycythemia vera ‚Ä¢ Men: Hb &amp;gt;16.</description></item><item><title>diagnostic evaluation of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/diagnostic-evaluation-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-primary-myelofibrosis-PMF/</guid><description>[!info]
üå± ‰æÜËá™: [[primary myelofibrosis (PMF)]]
diagnostic evaluation of primary myelofibrosis (PMF) #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation of primary myelofibrosis (PMF)¬† (Blood¬†2010;115:1703 &amp;amp; 2016;127:2391)</description></item><item><title>diagnostic evaluation of small¬†lymphocytic¬†lymphoma</title><link>https://www.physician.tw/diagnostic-evaluation-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-small-lymphocytic-lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[small lymphocytic lymphoma]]
diagnostic evaluation of small¬†lymphocytic¬†lymphoma #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation of small¬†lymphocytic¬†lymphoma ‚Ä¢¬†CBC w/ diff:¬†B-cell count</description></item><item><title>diagnostic evaluation of waldenstrom‚Äôs macroglobulinemia (WM)</title><link>https://www.physician.tw/diagnostic-evaluation-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
üå± ‰æÜËá™: [[waldenstrom‚Äôs macroglobulinemia (WM)]]
diagnostic evaluation of waldenstrom‚Äôs macroglobulinemia (WM) #üöß ÊñΩÂ∑•‰∏≠ diagnostic evaluation of waldenstrom‚Äôs macroglobulinemia (WM) ‚Ä¢ SPEP + immunofixation with IgM &amp;gt;3 g/dL; 24-h urine for UPEP (only 20% have ‚äï UPEP) ‚Ä¢ Bone marrow biopsy: ‚Üë plasmacytoid lymphocytes; Œ≤2-microglobulin for prognostic eval ‚Ä¢ Relative serum viscosity: ratio serum viscosity to H2O (nl 1.</description></item><item><title>Diagnostic Reasoning in Rheumatology</title><link>https://www.physician.tw/Diagnostic-Reasoning-in-Rheumatology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Reasoning-in-Rheumatology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diagnostic Reasoning in Rheumatology #üöß ÊñΩÂ∑•‰∏≠ Diagnostic Reasoning in Rheumatology ‚Ä¢¬†Most rheumatologic diseases are diagnosed ‚Äúclinically‚Äù ‚Äì e.</description></item><item><title>DIAGNOSTICS</title><link>https://www.physician.tw/DIAGNOSTICS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DIAGNOSTICS/</guid><description> [!info]
üå± ‰æÜËá™: [[Nephrology of Huppert&amp;rsquo;s Notes]]
DIAGNOSTICS #üöß ÊñΩÂ∑•‰∏≠ DIAGNOSTICS</description></item><item><title>DialysisAccess</title><link>https://www.physician.tw/DialysisAccess/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DialysisAccess/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
DialysisAccess #üöß ÊñΩÂ∑•‰∏≠ Dialysis/Access Types of dialysis ‚Ä¢¬†Hemodialysis (HD):
-¬†Blood is pumped along a semipermeable membrane across which electrolytes, water, and toxins are removed by diffusion into another fluid being pumped along the other side of the membrane (dialysate).</description></item><item><title>Diarrhea in a Patient with HIV and a Low CD4 Count</title><link>https://www.physician.tw/Diarrhea-in-a-Patient-with-HIV-and-a-Low-CD4-Count/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diarrhea-in-a-Patient-with-HIV-and-a-Low-CD4-Count/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diarrhea in a Patient with HIV and a Low CD4 Count #üöß ÊñΩÂ∑•‰∏≠ Diarrhea in a Patient with HIV and a Low CD4 Count May be due to a common cause, but also consider the following broader differential diagnosis:</description></item><item><title>Diet and Exercise</title><link>https://www.physician.tw/Diet-and-Exercise/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diet-and-Exercise/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diet and Exercise #üöß ÊñΩÂ∑•‰∏≠ Diet and Exercise ‚Ä¢¬†Association of Step Volume and Intensity With All-Cause Mortality in Older Woman.</description></item><item><title>Diffuse alveolar hemorrhage (DAH)</title><link>https://www.physician.tw/Diffuse-alveolar-hemorrhage-DAH/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diffuse-alveolar-hemorrhage-DAH/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
Diffuse alveolar hemorrhage (DAH) #üöß ÊñΩÂ∑•‰∏≠ Diffuse alveolar hemorrhage (DAH) Dx: bronchoscopy to exclude infection; ‚Üë bloody lavage fluid.</description></item><item><title>Discharge Checklist</title><link>https://www.physician.tw/Discharge-Checklist/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Discharge-Checklist/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Discharge Checklist #üöß ÊñΩÂ∑•‰∏≠ Discharge Checklist ‚Ä¢¬†Approach to discharging a patient: Discharges from the hospital are a transition that creates a risk for breakdown in a patient‚Äôs care.</description></item><item><title>disease classification and manifestations of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/disease-classification-and-manifestations-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disease-classification-and-manifestations-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[chronic myelogenous leukemia (CML)]]
disease classification and manifestations of chronic myelogenous leukemia (CML) #üöß ÊñΩÂ∑•‰∏≠ disease classification and manifestations of chronic myelogenous leukemia (CML)¬† (WHO;¬†NCCN¬†v 2.</description></item><item><title>Diseases involving the Vasculature</title><link>https://www.physician.tw/Diseases-involving-the-Vasculature/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diseases-involving-the-Vasculature/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diseases involving the Vasculature #üöß ÊñΩÂ∑•‰∏≠ Diseases involving the Vasculature Pulmonary Embolism (PE) ‚Ä¢¬†Etiology: Virchow‚Äôs triad: 1) Endothelial injury, 2) Venous stasis, 3) Hypercoagulability.</description></item><item><title>Diseases of the Pleura</title><link>https://www.physician.tw/Diseases-of-the-Pleura/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diseases-of-the-Pleura/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diseases of the Pleura #üöß ÊñΩÂ∑•‰∏≠ Diseases of the Pleura ‚Ä¢¬†Pleural Effusion:</description></item><item><title>Diseases of the Vasculature</title><link>https://www.physician.tw/Diseases-of-the-Vasculature/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diseases-of-the-Vasculature/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diseases of the Vasculature #üöß ÊñΩÂ∑•‰∏≠ Diseases of the Vasculature Hypertensive emergency ‚Ä¢¬†Definitions: Elevated SBP with end-organ damage</description></item><item><title>Disorders of the Mucous Membranes</title><link>https://www.physician.tw/Disorders-of-the-Mucous-Membranes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-the-Mucous-Membranes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Disorders of the Mucous Membranes #üöß ÊñΩÂ∑•‰∏≠ Disorders of the Mucous Membranes ‚Ä¢¬†Aphthous ulcers (‚Äúcanker sores‚Äù): Painful, shallow oral ulcers with a gray base and a red surrounding halo; if recurrent or severe may suggest underlying disease such as Beh√ßet‚Äôs syndrome, Crohn‚Äôs disease, or HIV.</description></item><item><title>Dissociative Disorders</title><link>https://www.physician.tw/Dissociative-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dissociative-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Dissociative Disorders #üöß ÊñΩÂ∑•‰∏≠ Dissociative Disorders ‚Ä¢¬†Dissociative amnesia: Episodes of inability to remember salient details about one‚Äôs self.</description></item><item><title>Diverticular Disease</title><link>https://www.physician.tw/Diverticular-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diverticular-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Diverticular Disease #üöß ÊñΩÂ∑•‰∏≠ Diverticular Disease Diverticulosis ‚Ä¢¬†Pathophysiology: Multiple outpouchings of colonic mucosa/submucosa through areas of focal weakness in the setting of increased intraluminal pressure, particularly in the sigmoid colon.</description></item><item><title>DrugToxin-Induced Liver Injury</title><link>https://www.physician.tw/DrugToxin-Induced-Liver-Injury/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DrugToxin-Induced-Liver-Injury/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
DrugToxin-Induced Liver Injury #üöß ÊñΩÂ∑•‰∏≠ Drug/Toxin-Induced Liver Injury Acetaminophen ‚Ä¢¬†Epidemiology: Most common cause of intrinsic drug-induced liver injury.</description></item><item><title>DVTPE</title><link>https://www.physician.tw/DVTPE/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DVTPE/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
DVTPE #üöß ÊñΩÂ∑•‰∏≠ DVT/PE ‚Ä¢¬†Risk factors: ICU patients are considered high risk for VTE given immobility and severe inflammation</description></item><item><title>Dynamics Flow, Resistance, and VQ Matching</title><link>https://www.physician.tw/Dynamics-Flow-Resistance-and-VQ-Matching/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dynamics-Flow-Resistance-and-VQ-Matching/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Dynamics Flow, Resistance, and VQ Matching #üöß ÊñΩÂ∑•‰∏≠ Dynamics: Flow, Resistance, and V/Q Matching ‚Ä¢¬†Flow:</description></item><item><title>Eating Disorders</title><link>https://www.physician.tw/Eating-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eating-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Eating Disorders #üöß ÊñΩÂ∑•‰∏≠ Eating Disorders Anorexia nervosa ‚Ä¢¬†Definition: Intense fear of gaining weight leading to low body weight (&amp;lt;85% ideal, BMI &amp;lt;18.</description></item><item><title>Echocardiography</title><link>https://www.physician.tw/Echocardiography/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Echocardiography/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Echocardiography #üöß ÊñΩÂ∑•‰∏≠ Echocardiography Transthoracic echocardiography (TTE) ‚Ä¢¬†Definition: Most common type of echocardiogram.</description></item><item><title>Eczematous Dermatoses</title><link>https://www.physician.tw/Eczematous-Dermatoses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eczematous-Dermatoses/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Eczematous Dermatoses #üöß ÊñΩÂ∑•‰∏≠ Eczematous Dermatoses Dermatitis is red and scaly. The differential is primarily clinical ‚Äì breakdown the differential by distribution and appearance.</description></item><item><title>Electroencephalogram (EEG)</title><link>https://www.physician.tw/Electroencephalogram-EEG/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Electroencephalogram-EEG/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Electroencephalogram (EEG) #üöß ÊñΩÂ∑•‰∏≠ Electroencephalogram (EEG) ‚Ä¢¬†Definition: Test used to evaluate the electrical activity in the brain, particularly for seizure or ‚Äúinterictal‚Äù (between seizures) epileptiform discharges</description></item><item><title>Electromyography (EMG) and Nerve Conduction Studies</title><link>https://www.physician.tw/Electromyography-EMG-and-Nerve-Conduction-Studies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Electromyography-EMG-and-Nerve-Conduction-Studies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Electromyography (EMG) and Nerve Conduction Studies #üöß ÊñΩÂ∑•‰∏≠ Electromyography (EMG) and Nerve Conduction Studies ‚Ä¢¬†Definitions:</description></item><item><title>Endocarditis</title><link>https://www.physician.tw/Endocarditis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocarditis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Endocarditis #üöß ÊñΩÂ∑•‰∏≠ Endocarditis ‚Ä¢¬†[Guideline] Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American heart association.</description></item><item><title>Endocrine Axes</title><link>https://www.physician.tw/Endocrine-Axes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrine-Axes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Endocrine Axes #üöß ÊñΩÂ∑•‰∏≠ Endocrine Axes ‚Ä¢¬†Organization: There are five parallel endocrine axes in the hypothalamic-anterior pituitary regulatory system (Figure 5.</description></item><item><title>endocrine pancreas</title><link>https://www.physician.tw/endocrine-pancreas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrine-pancreas/</guid><description>[!info]
üå± ‰æÜËá™: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
endocrine pancreas #üöß ÊñΩÂ∑•‰∏≠ endocrine pancreas [[books/h_note/Diabetes Mellitus]]
[[books/h_note/Hypoglycemia]]</description></item><item><title>endocrinology anatomy and physiology</title><link>https://www.physician.tw/endocrinology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrinology-anatomy-and-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
endocrinology anatomy and physiology [[Endocrine Axes]]</description></item><item><title>Endocrinology of Huppert's Notes</title><link>https://www.physician.tw/Endocrinology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-of-Hupperts-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Endocrinology of Huppert&amp;rsquo;s Notes [[endocrinology anatomy and physiology]]
[[pituitary]]
[[thyroid]]
[[adrenal gland]]
[[reproductive endocrinology]]</description></item><item><title>engraftment syndrome</title><link>https://www.physician.tw/engraftment-syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/engraftment-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
engraftment syndrome #üöß ÊñΩÂ∑•‰∏≠ engraftment syndrome: fever, rash, noncardiogenic pulm.</description></item><item><title>ENL 2017 Genetic Risk Classification</title><link>https://www.physician.tw/ENL-2017-Genetic-Risk-Classification/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ENL-2017-Genetic-Risk-Classification/</guid><description>[!info]
üå± ‰æÜËá™: [[acute myelogenous leukemia (AML)]]
ENL 2017 Genetic Risk Classification #üöß ÊñΩÂ∑•‰∏≠ ENL 2017 Genetic Risk Classification ¬†(Blood¬†2017;129:424)</description></item><item><title>Epidemiology and risk factors</title><link>https://www.physician.tw/Epidemiology-and-risk-factors/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-risk-factors/</guid><description>[!info]
üå± ‰æÜËá™: [[hodgkin lymphoma (HL)]]
Epidemiology and risk factors #üöß ÊñΩÂ∑•‰∏≠ Epidemiology and risk factors ‚Ä¢ ~9,000 cases/y; bimodal distribution (15‚Äì35 &amp;amp; &amp;gt;50 y); ‚Üë ‚ôÇ; role of EBV in subsets of HL, esp.</description></item><item><title>epidemiology and risk factors of acute leukemia</title><link>https://www.physician.tw/epidemiology-and-risk-factors-of-acute-leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-and-risk-factors-of-acute-leukemia/</guid><description>[!info]
üå± ‰æÜËá™: [[acute leukemia]]
epidemiology and risk factors of acute leukemia #üöß ÊñΩÂ∑•‰∏≠ epidemiology and risk factors of acute leukemia ‚Ä¢ Acute myelogenous (AML): ~20k cases/y in U.</description></item><item><title>epidemiology and risk factors of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/epidemiology-and-risk-factors-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-and-risk-factors-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[chronic myelogenous leukemia (CML)]]
epidemiology and risk factors of chronic myelogenous leukemia (CML) #üöß ÊñΩÂ∑•‰∏≠ epidemiology and risk factors of chronic myelogenous leukemia (CML) ‚Ä¢ ~6600 new cases/y in U.</description></item><item><title>epidemiology and risk factors of non-Hodgkin lymphoma (NHL)</title><link>https://www.physician.tw/epidemiology-and-risk-factors-of-non-Hodgkin-lymphoma-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-and-risk-factors-of-non-Hodgkin-lymphoma-NHL/</guid><description>[!info]
üå± ‰æÜËá™: [[non-Hodgkin lymphoma (NHL)]]
epidemiology and risk factors of non-Hodgkin lymphoma (NHL) #üöß ÊñΩÂ∑•‰∏≠ epidemiology and risk factors of non-Hodgkin lymphoma (NHL) ‚Ä¢ 79 types of NHL, ~70,000 new cases/y; median age dx 65 y; ‚ôÇ predom; 85% B-cell origin</description></item><item><title>Epilepsy</title><link>https://www.physician.tw/Epilepsy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epilepsy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Epilepsy #üöß ÊñΩÂ∑•‰∏≠ Epilepsy ‚Ä¢¬†Veterans Affairs Status Epilepticus Cooperative Study Group: A comparison of four treatments for generalized convulsive status.</description></item><item><title>Esophagus</title><link>https://www.physician.tw/Esophagus/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Esophagus/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Esophagus #üöß ÊñΩÂ∑•‰∏≠ Esophagus Gastroesophageal reflux disease (GERD) ‚Ä¢¬†Pathophysiology: Decreased lower esophageal sphincter (LES) tone; may also have decreased esophageal motility, gastric outlet obstruction, and/or hiatal hernia</description></item><item><title>essential¬†thrombocythemia¬†(ET)</title><link>https://www.physician.tw/essential-thrombocythemia-ET/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/essential-thrombocythemia-ET/</guid><description>[!info]
üå± ‰æÜËá™: [[myeloproliferative neoplasms]]
essential¬†thrombocythemia¬†(ET) definition of essential thrombocythemia (ET)
‚Ä¢ Sustained ‚Üë in platelets (&amp;gt;450,000/¬µL) ¬± ‚Üë RBC and granulocytes</description></item><item><title>etiologies of erythrocytosis</title><link>https://www.physician.tw/etiologies-of-erythrocytosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-erythrocytosis/</guid><description>[!info]
üå± ‰æÜËá™: [[polycythemia vera (PV)]]
etiologies of erythrocytosis #üöß ÊñΩÂ∑•‰∏≠ etiologies of erythrocytosis¬† (absolute¬†‚Üë¬†RBC)</description></item><item><title>Etiologies of Liver Disease</title><link>https://www.physician.tw/Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Liver-Disease/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Etiologies of Liver Disease #üöß ÊñΩÂ∑•‰∏≠ Etiologies of Liver Disease</description></item><item><title>etiologies of myelofibrosis</title><link>https://www.physician.tw/etiologies-of-myelofibrosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-myelofibrosis/</guid><description>[!info]
üå± ‰æÜËá™: [[primary myelofibrosis (PMF)]]
etiologies of myelofibrosis #üöß ÊñΩÂ∑•‰∏≠ etiologies of myelofibrosis ‚Ä¢ 1¬∞ myelofibrosis (PMF): myeloproliferative neoplasm</description></item><item><title>etiologies of thrombocytosis</title><link>https://www.physician.tw/etiologies-of-thrombocytosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-thrombocytosis/</guid><description>[!info]
üå± ‰æÜËá™: [[essential thrombocythemia (ET)]]
etiologies of thrombocytosis #üöß ÊñΩÂ∑•‰∏≠ etiologies of thrombocytosis ‚Ä¢ 1¬∞ = ET or other MPN; myelodysplastic syndromes (5q-syndrome); RARS-T</description></item><item><title>Evaluation of a Peripheral Blood Smear</title><link>https://www.physician.tw/Evaluation-of-a-Peripheral-Blood-Smear/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-a-Peripheral-Blood-Smear/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Evaluation of a Peripheral Blood Smear #üöß ÊñΩÂ∑•‰∏≠ Evaluation of a Peripheral Blood Smear Evaluate a peripheral blood smear using a systematic and thorough approach:</description></item><item><title>Extra Heart Sounds</title><link>https://www.physician.tw/Extra-Heart-Sounds/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extra-Heart-Sounds/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Extra Heart Sounds #üöß ÊñΩÂ∑•‰∏≠ Extra Heart Sounds ‚Ä¢¬†S3 (Ventricular gallop): OVERLOAD; early diastolic sound, listen with the stethoscope‚Äôs bell</description></item><item><title>falls and fracture prevention</title><link>https://www.physician.tw/falls-and-fracture-prevention/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/falls-and-fracture-prevention/</guid><description> [!info]
üå± ‰æÜËá™: [[endocrinology]]
falls and fracture prevention #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Females</title><link>https://www.physician.tw/Females/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Females/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Females #üöß ÊñΩÂ∑•‰∏≠ Females Menstrual Cycle ‚Ä¢¬†Follicular phase (day 0‚Äì13): From the onset of menses to the LH surge.</description></item><item><title>Fever in a Returning Traveler</title><link>https://www.physician.tw/Fever-in-a-Returning-Traveler/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fever-in-a-Returning-Traveler/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Fever in a Returning Traveler #üöß ÊñΩÂ∑•‰∏≠ Fever in a Returning Traveler ‚Ä¢¬†Approach to Fever in the Returning Traveler.</description></item><item><title>Fluids, Electrolytes, and AcidBase Disorders</title><link>https://www.physician.tw/Fluids-Electrolytes-and-AcidBase-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fluids-Electrolytes-and-AcidBase-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Fluids, Electrolytes, and AcidBase Disorders #üöß ÊñΩÂ∑•‰∏≠ Fluids, Electrolytes, and Acid/Base Disorders For each electrolyte, we will discuss the normal regulation and then discuss what happens when levels of the electrolyte are too low or too high.</description></item><item><title>Functional Bowel Disorders</title><link>https://www.physician.tw/Functional-Bowel-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Functional-Bowel-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Functional Bowel Disorders #üöß ÊñΩÂ∑•‰∏≠ Functional Bowel Disorders ‚Ä¢¬†Cognitive-Behavioral Therapy Versus Education and Desipramine Versus Placebo for Moderate to Severe Functional Bowel Disorders.</description></item><item><title>Gallbladder and Biliary Tract</title><link>https://www.physician.tw/Gallbladder-and-Biliary-Tract/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gallbladder-and-Biliary-Tract/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Gallbladder and Biliary Tract #üöß ÊñΩÂ∑•‰∏≠ Gallbladder and Biliary Tract</description></item><item><title>Gallbladder Stone Diseases</title><link>https://www.physician.tw/Gallbladder-Stone-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gallbladder-Stone-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Gallbladder Stone Diseases #üöß ÊñΩÂ∑•‰∏≠ Gallbladder Stone Diseases Cholelithiasis ‚Ä¢¬†Etiology: Stone in the gallbladder</description></item><item><title>Gas exchange</title><link>https://www.physician.tw/Gas-exchange/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gas-exchange/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Gas exchange #üöß ÊñΩÂ∑•‰∏≠ Gas exchange ‚Ä¢¬†Oxygen:
-¬†Oxygen is transported in two forms: 1) Dissolved in blood; 2) Bound to Hgb (most important/majority)</description></item><item><title>gastroenterology anatomy and physiology</title><link>https://www.physician.tw/gastroenterology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-anatomy-and-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology anatomy and physiology [[Structure and Innervation of the GI Tract]]</description></item><item><title>gastroenterology approaches and chief complaints</title><link>https://www.physician.tw/gastroenterology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-approaches-and-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology approaches and chief complaints [[books/h_note/Abdominal Pain]]
[[NauseaVomiting]]
[[Acute Diarrhea (3 weeks)]]</description></item><item><title>gastroenterology diagnostics</title><link>https://www.physician.tw/gastroenterology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-diagnostics/</guid><description>[!info]
üå± ‰æÜËá™: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology diagnostics #üöß ÊñΩÂ∑•‰∏≠ gastroenterology diagnostics TABLE 4.2 ‚Ä¢ Diagnostic Tests in Gastroenterology</description></item><item><title>gastroenterology diseases and pathophysiology</title><link>https://www.physician.tw/gastroenterology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-diseases-and-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology diseases and pathophysiology #üöß ÊñΩÂ∑•‰∏≠ gastroenterology diseases and pathophysiology [[Esophagus]]</description></item><item><title>gastroenterology key clinical trials and publications</title><link>https://www.physician.tw/gastroenterology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-key-clinical-trials-and-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology key clinical trials and publications [[GI Bleed]]
[[Barrett‚Äôs Esophagus]]
[[books/h_note/Pancreatitis]]</description></item><item><title>gastroenterology key medications and interventions</title><link>https://www.physician.tw/gastroenterology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-key-medications-and-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology key medications and interventions #üöß ÊñΩÂ∑•‰∏≠ gastroenterology key medications and interventions [[Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology]]</description></item><item><title>Gastroenterology of Huppert's Notes</title><link>https://www.physician.tw/Gastroenterology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Gastroenterology of Huppert&amp;rsquo;s Notes #üöß ÊñΩÂ∑•‰∏≠ Gastroenterology of Huppert&amp;rsquo;s Notes</description></item><item><title>General Approach to the Diagnosis and Management of AKI</title><link>https://www.physician.tw/General-Approach-to-the-Diagnosis-and-Management-of-AKI/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-Approach-to-the-Diagnosis-and-Management-of-AKI/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
General Approach to the Diagnosis and Management of AKI #üöß ÊñΩÂ∑•‰∏≠ General Approach to the Diagnosis and Management of AKI ‚Ä¢¬†Step 1: Address any urgent management needs (e.</description></item><item><title>General Approaches to Treating Cancer</title><link>https://www.physician.tw/General-Approaches-to-Treating-Cancer/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-Approaches-to-Treating-Cancer/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
General Approaches to Treating Cancer #üöß ÊñΩÂ∑•‰∏≠ General Approaches to Treating Cancer Surgery, radiation, and medications</description></item><item><title>General Medicine of Huppert's Notes</title><link>https://www.physician.tw/General-Medicine-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-Medicine-of-Hupperts-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
General Medicine of Huppert&amp;rsquo;s Notes #üöß ÊñΩÂ∑•‰∏≠ General Medicine of Huppert&amp;rsquo;s Notes [[INTRODUCTION]]</description></item><item><title>Genitourinary (GU) Infections</title><link>https://www.physician.tw/Genitourinary-GU-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genitourinary-GU-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Genitourinary (GU) Infections #üöß ÊñΩÂ∑•‰∏≠ Genitourinary (GU) Infections Asymptomatic bacteriuria ‚Ä¢¬†Definition: Bacterial growth in a properly collected urine culture specimen from a patient without symptoms of inflammation of the GU system, such as urinary urgency, frequency, dysuria, or flank pain</description></item><item><title>GI Bleed</title><link>https://www.physician.tw/GI-Bleed/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-Bleed/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
GI Bleed #üöß ÊñΩÂ∑•‰∏≠ GI Bleed Ë©≥Ë¶ã Transfusion strategies for acute upper gastrointestinal bleeding.</description></item><item><title>GI bleeding</title><link>https://www.physician.tw/GI-bleeding/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-bleeding/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
GI bleeding #üöß ÊñΩÂ∑•‰∏≠ GI bleeding Deepa Rani Nandiwada, MD, MS
CHIEF COMPLAINT PATIENT</description></item><item><title>Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria</title><link>https://www.physician.tw/Glomerular-Pathologies-Commonly-Associated-with-Nephrotic-Range-Proteinuria/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-Pathologies-Commonly-Associated-with-Nephrotic-Range-Proteinuria/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria #üöß ÊñΩÂ∑•‰∏≠ Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria Minimal change glomerulopathy (MCG, ‚Äúminimal change disease‚Äù) ‚Ä¢¬†Epidemiology: Most common cause of nephrotic syndrome in children, less common in adults</description></item><item><title>Glomerular Pathology Associated with Nephritic Syndrome</title><link>https://www.physician.tw/Glomerular-Pathology-Associated-with-Nephritic-Syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-Pathology-Associated-with-Nephritic-Syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Glomerular Pathology Associated with Nephritic Syndrome #üöß ÊñΩÂ∑•‰∏≠ Glomerular Pathology Associated with Nephritic Syndrome Post-streptococcal glomerulonephritis ‚Ä¢¬†Epidemiology: More common in children</description></item><item><title>Goals of Intensive Care Unit (ICU) Care</title><link>https://www.physician.tw/Goals-of-Intensive-Care-Unit-ICU-Care/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Goals-of-Intensive-Care-Unit-ICU-Care/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Goals of Intensive Care Unit (ICU) Care #üöß ÊñΩÂ∑•‰∏≠ Goals of Intensive Care Unit (ICU) Care ‚Ä¢¬†Stabilize, diagnose, and treat patients with acute life-, limb-, or organ-threatening conditions</description></item><item><title>graft-versus-host disease</title><link>https://www.physician.tw/graft-versus-host-disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/graft-versus-host-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
graft-versus-host disease #üöß ÊñΩÂ∑•‰∏≠ ÊÄ•ÊÄß GVHD ÂèØË°®ÁèæÁÇ∫Êñë‰∏òÁñπ„ÄÅËÇùÂäüËÉΩÈöúÁ§ôÂíå/ÊàñËÖπÁÄâÔºåÂõ†ÁÇ∫ÊîªÊìäÁöÑ‰∏ªË¶ÅÁõÆÊ®ôÊòØÁöÆËÜö„ÄÅËÇùËáüÂíåËÉÉËÖ∏ÈÅì (GI)„ÄÇ
ÊÄ•ÊÄß GVHD ‰ªçÁÑ∂ÊòØÁôºÁóÖÁéáÂíåÊ≠ª‰∫°ÁéáÁöÑ‰∏ªË¶ÅÂéüÂõ†ÔºåÂ∞§ÂÖ∂ÊòØÂú®ÁÑ°ÈóúÁöÑÂêåÁ®ÆÁï∞È´îÁßªÊ§ç‰∏≠„ÄÇ</description></item><item><title>Gram-Negative Bacteremia</title><link>https://www.physician.tw/Gram-Negative-Bacteremia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gram-Negative-Bacteremia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Gram-Negative Bacteremia #üöß ÊñΩÂ∑•‰∏≠ Gram-Negative Bacteremia ‚Ä¢¬†Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia : A noninferiority randomized controlled trial.</description></item><item><title>GU Infections</title><link>https://www.physician.tw/GU-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GU-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
GU Infections #üöß ÊñΩÂ∑•‰∏≠ GU Infections ‚Ä¢¬†[Guideline] International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.</description></item><item><title>GYN Malignancies</title><link>https://www.physician.tw/GYN-Malignancies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GYN-Malignancies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
GYN Malignancies #üöß ÊñΩÂ∑•‰∏≠ GYN Malignancies Ovarian cancer
‚Ä¢¬†Epidemiology: Median age at diagnosis 63 yr, lifetime risk 1.</description></item><item><title>Gynecologic</title><link>https://www.physician.tw/Gynecologic/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gynecologic/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Gynecologic #üöß ÊñΩÂ∑•‰∏≠ Gynecologic</description></item><item><title>Hair and Nail Disorders</title><link>https://www.physician.tw/Hair-and-Nail-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hair-and-Nail-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hair and Nail Disorders #üöß ÊñΩÂ∑•‰∏≠ Hair and Nail Disorders ‚Ä¢¬†Hirsutism: Excess hair growth in androgen-dependent areas (upper lip, lateral cheeks, chin, chest, lower abdomen, groin, and buttocks); most commonly caused by polycystic ovary syndrome (~60% of cases) but can also be due to other forms of androgen excess (e.</description></item><item><title>Head &amp; Neck Malignancies</title><link>https://www.physician.tw/Head-Neck-Malignancies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Head-Neck-Malignancies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Head &amp;amp; Neck Malignancies #üöß ÊñΩÂ∑•‰∏≠ Head &amp;amp; Neck Malignancies Thyroid cancer
‚Ä¢¬†Diagnosis: Thyroid ultrasound and biopsy</description></item><item><title>Head and Neck</title><link>https://www.physician.tw/Head-and-Neck/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Head-and-Neck/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Head and Neck #üöß ÊñΩÂ∑•‰∏≠ Head and Neck</description></item><item><title>Health Care Maintenance and Disease Screening</title><link>https://www.physician.tw/Health-Care-Maintenance-and-Disease-Screening/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Health-Care-Maintenance-and-Disease-Screening/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Health Care Maintenance and Disease Screening #üöß ÊñΩÂ∑•‰∏≠ Health Care Maintenance and Disease Screening These health care maintenance and disease screening guidelines summarize recommendations from the U.</description></item><item><title>Hearing loss</title><link>https://www.physician.tw/Hearing-loss/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hearing-loss/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hearing loss #üöß ÊñΩÂ∑•‰∏≠ Hearing loss ‚Ä¢¬†Physical exam: Otoscopic exam, Weber test (performed by pressing the handle of the tuning fork to the center of the forehead), Rinne test (performed by comparing the sound heard when a tuning fork is placed on the mastoid bone behind the ear to when a tuning fork is held near the ear, in order to compare bone and air conduction)</description></item><item><title>Heart Failure (HF)</title><link>https://www.physician.tw/Heart-Failure-HF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-Failure-HF/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Heart Failure (HF) #üöß ÊñΩÂ∑•‰∏≠ Heart Failure (HF) ‚Ä¢¬†Etiology:
-¬†Left-sided HF: Ischemic vs.</description></item><item><title>Heart Failure with Preserved Ejection Fraction (HFpEF)</title><link>https://www.physician.tw/Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Heart Failure with Preserved Ejection Fraction (HFpEF) #üöß ÊñΩÂ∑•‰∏≠ Heart Failure with Preserved Ejection Fraction (HFpEF) ‚Ä¢¬†TOPCAT.</description></item><item><title>Heart Failure with Reduced Ejection Fraction (HFrEF)</title><link>https://www.physician.tw/Heart-Failure-with-Reduced-Ejection-Fraction-HFrEF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-Failure-with-Reduced-Ejection-Fraction-HFrEF/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Heart Failure with Reduced Ejection Fraction (HFrEF) #üöß ÊñΩÂ∑•‰∏≠ Heart Failure with Reduced Ejection Fraction (HFrEF) ‚Ä¢¬†PARADIGM-HF.</description></item><item><title>hematology of Huppert's Notes</title><link>https://www.physician.tw/hematology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematology-of-Hupperts-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
[[books/h_note/Hematopoiesis]]
[[The Coagulation Cascade]]
[[Evaluation of a Peripheral Blood Smear]]
First, some terminology and then we‚Äôll dive into each of these conditions separately below:</description></item><item><title>Hemoglobin Targets in Patients with CKD</title><link>https://www.physician.tw/Hemoglobin-Targets-in-Patients-with-CKD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemoglobin-Targets-in-Patients-with-CKD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hemoglobin Targets in Patients with CKD #üöß ÊñΩÂ∑•‰∏≠ Hemoglobin Targets in Patients with CKD ‚Ä¢¬†TREAT.</description></item><item><title>HIV-associated NHL</title><link>https://www.physician.tw/HIV-associated-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HIV-associated-NHL/</guid><description>[!info]
üå± ‰æÜËá™: [[non-Hodgkin lymphoma (NHL)]]
HIV-associated NHL #üöß ÊñΩÂ∑•‰∏≠ HIV-associated NHL¬† (Blood¬†2006;107:13)
‚Ä¢ HIV ‚äï imparts 60‚Äì100√ó relative risk</description></item><item><title>HIVAIDS</title><link>https://www.physician.tw/HIVAIDS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HIVAIDS/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
HIVAIDS #üöß ÊñΩÂ∑•‰∏≠ HIV/AIDS ‚Ä¢¬†[Guideline] Panel on Antiretroviral Guidelines for Adults and Adolescents.</description></item><item><title>hodgkin lymphoma (HL)</title><link>https://www.physician.tw/hodgkin-lymphoma-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hodgkin-lymphoma-HL/</guid><description>[!info]
üå± ‰æÜËá™: [[lymphoma and CLL]]
hodgkin lymphoma (HL) (Am J Hematol 2018;93:704; Lancet 2021;398:1518)
[[Epidemiology and risk factors]] [[pathology of hodgkin lymphoma (HL)]]</description></item><item><title>Hormone Therapy</title><link>https://www.physician.tw/Hormone-Therapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hormone-Therapy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hormone Therapy #üöß ÊñΩÂ∑•‰∏≠ Hormone Therapy ‚Ä¢¬†Definition: Medications that suppress endogenous hormones that drive growth of certain tumor types (e.</description></item><item><title>how to call a consult</title><link>https://www.physician.tw/how-to-call-a-consult/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-call-a-consult/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
how to call a consult #üöß ÊñΩÂ∑•‰∏≠ how to call a consult ‚Ä¢¬†Consult question: In general, consults should be structured around a specific question in regard to a patient‚Äôs care (e.</description></item><item><title>How to Do Daily Presentations and Notes</title><link>https://www.physician.tw/How-to-Do-Daily-Presentations-and-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-to-Do-Daily-Presentations-and-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
How to Do Daily Presentations and Notes #üöß ÊñΩÂ∑•‰∏≠ How to Do Daily Presentations and Notes ‚Ä¢¬†Format: Typically, daily presentations about each patient are presented in a ‚ÄúSOAP‚Äù note format.</description></item><item><title>how to pre-round</title><link>https://www.physician.tw/how-to-pre-round/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-pre-round/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
how to pre-round #üöß ÊñΩÂ∑•‰∏≠ how to pre-round ‚Ä¢¬†Purpose of pre-rounding: Pre-rounding refers to the activity of gathering data prior to rounds, typically including 24 hour and overnight events, nursing updates/concerns, the patient‚Äôs subjective report, vital signs, physical exam, labs, and other test results.</description></item><item><title>HOW TO WRITE A HISTORY AND PHYSICAL (H&amp;P)</title><link>https://www.physician.tw/HOW-TO-WRITE-A-HISTORY-AND-PHYSICAL-HP/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HOW-TO-WRITE-A-HISTORY-AND-PHYSICAL-HP/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
HOW TO WRITE A HISTORY AND PHYSICAL (H&amp;amp;P) #üöß ÊñΩÂ∑•‰∏≠ HOW TO WRITE A HISTORY AND PHYSICAL (H&amp;amp;P) Early in training, writing an H&amp;amp;P can sometimes seem overwhelming.</description></item><item><title>Hypercarbic Respiratory Failure</title><link>https://www.physician.tw/Hypercarbic-Respiratory-Failure/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypercarbic-Respiratory-Failure/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hypercarbic Respiratory Failure #üöß ÊñΩÂ∑•‰∏≠ Hypercarbic Respiratory Failure ‚Ä¢¬†Definition: Respiratory failure due to alveolar hypoventilation ‚Üí ineffective carbon dioxide elimination</description></item><item><title>Hyperkinetic Movement Disorders</title><link>https://www.physician.tw/Hyperkinetic-Movement-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hyperkinetic-Movement-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hyperkinetic Movement Disorders #üöß ÊñΩÂ∑•‰∏≠ Hyperkinetic Movement Disorders Tremor ‚Ä¢¬†Essential tremor: Postural and action tremor that usually starts in the hands/arms and spreads to the head, voice, and legs; often improves with alcohol intake.</description></item><item><title>Hyperlipidemia</title><link>https://www.physician.tw/Hyperlipidemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hyperlipidemia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hyperlipidemia #üöß ÊñΩÂ∑•‰∏≠ Hyperlipidemia ‚Ä¢¬†Risk factors:
-¬†Lifestyle: Diet (high saturated fats), inactivity, advanced age, family history, male gender (M&amp;gt;F)</description></item><item><title>Hypertension Management</title><link>https://www.physician.tw/Hypertension-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypertension-Management/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hypertension Management #üöß ÊñΩÂ∑•‰∏≠ Hypertension Management ‚Ä¢¬†SPRINT. N Eng J Med 2015;373(22):2103‚Äì2116</description></item><item><title>Hypokinetic Movement Disorders</title><link>https://www.physician.tw/Hypokinetic-Movement-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypokinetic-Movement-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hypokinetic Movement Disorders #üöß ÊñΩÂ∑•‰∏≠ Hypokinetic Movement Disorders Parkinsonism ‚Ä¢¬†Symptoms: Syndrome of bradykinesia (#1), rigidity, tremor, postural instability</description></item><item><title>hyponatremia. I have a patient with hypernatremia</title><link>https://www.physician.tw/hyponatremia.-I-have-a-patient-with-hypernatremia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyponatremia.-I-have-a-patient-with-hypernatremia/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
hyponatremia. I have a patient with hypernatremia #üöß ÊñΩÂ∑•‰∏≠ hyponatremia. I have a patient with hypernatremia Scott D.</description></item><item><title>Hypoxemic Respiratory Failure</title><link>https://www.physician.tw/Hypoxemic-Respiratory-Failure/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypoxemic-Respiratory-Failure/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Hypoxemic Respiratory Failure #üöß ÊñΩÂ∑•‰∏≠ Hypoxemic Respiratory Failure ‚Ä¢¬†Definition: PaO2 &amp;lt;60 mmHg, P/F &amp;lt;300, or PaO2 decrease from baseline of 10 mmHg</description></item><item><title>I have a healthy patient without HIV risk factors who asks about HIV screening. How do I diagnose or exclude HIV infection</title><link>https://www.physician.tw/I-have-a-healthy-patient-without-HIV-risk-factors-who-asks-about-HIV-screening.-How-do-I-diagnose-or-exclude-HIV-infection/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-healthy-patient-without-HIV-risk-factors-who-asks-about-HIV-screening.-How-do-I-diagnose-or-exclude-HIV-infection/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
I have a healthy patient without HIV risk factors who asks about HIV screening. How do I diagnose or exclude HIV infection #üöß ÊñΩÂ∑•‰∏≠ I have a healthy patient without HIV risk factors who asks about HIV screening.</description></item><item><title>I have a healthy patient. How do I determine which screening tests to order</title><link>https://www.physician.tw/I-have-a-healthy-patient.-How-do-I-determine-which-screening-tests-to-order/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-healthy-patient.-How-do-I-determine-which-screening-tests-to-order/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
I have a healthy patient. How do I determine which screening tests to order #üöß ÊñΩÂ∑•‰∏≠ I have a healthy patient.</description></item><item><title>I have a patient who is concerned that she has diabetes. How do I confirm the diagnosis and treat patients with diabetes</title><link>https://www.physician.tw/I-have-a-patient-who-is-concerned-that-she-has-diabetes.-How-do-I-confirm-the-diagnosis-and-treat-patients-with-diabetes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-patient-who-is-concerned-that-she-has-diabetes.-How-do-I-confirm-the-diagnosis-and-treat-patients-with-diabetes/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
I have a patient who is concerned that she has diabetes. How do I confirm the diagnosis and treat patients with diabetes #üöß ÊñΩÂ∑•‰∏≠ I have a patient who is concerned that she has diabetes.</description></item><item><title>I have a patient with a problem. How do I figure out the possible causes</title><link>https://www.physician.tw/I-have-a-patient-with-a-problem.-How-do-I-figure-out-the-possible-causes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-patient-with-a-problem.-How-do-I-figure-out-the-possible-causes/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
I have a patient with a problem. How do I figure out the possible causes #üöß ÊñΩÂ∑•‰∏≠ I have a patient with a problem.</description></item><item><title>I have an HIV-positive patient who complains of headache. How do I determine the cause</title><link>https://www.physician.tw/I-have-an-HIV-positive-patient-who-complains-of-headache.-How-do-I-determine-the-cause/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-an-HIV-positive-patient-who-complains-of-headache.-How-do-I-determine-the-cause/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
I have an HIV-positive patient who complains of headache. How do I determine the cause #üöß ÊñΩÂ∑•‰∏≠ I have an HIV-positive patient who complains of headache.</description></item><item><title>I have an HIV-positive patient with a cough and fever. How do I determine the cause</title><link>https://www.physician.tw/I-have-an-HIV-positive-patient-with-a-cough-and-fever.-How-do-I-determine-the-cause/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-an-HIV-positive-patient-with-a-cough-and-fever.-How-do-I-determine-the-cause/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
I have an HIV-positive patient with a cough and fever. How do I determine the cause #üöß ÊñΩÂ∑•‰∏≠ I have an HIV-positive patient with a cough and fever.</description></item><item><title>I have patients with AIDS-related complaints.</title><link>https://www.physician.tw/I-have-patients-with-AIDS-related-complaints./</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-patients-with-AIDS-related-complaints./</guid><description> [!info]
üå± ‰æÜËá™: [[sxtodx]]
I have patients with AIDS-related complaints. #üöß ÊñΩÂ∑•‰∏≠ I have patients with AIDS-related complaints.</description></item><item><title>IBD</title><link>https://www.physician.tw/IBD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IBD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
IBD #üöß ÊñΩÂ∑•‰∏≠ IBD ‚Ä¢¬†SONIC. N Engl J Med 2010;362:1383‚Äì1395.
-¬†Double-blind randomized controlled trial assessing the safety and efficacy of infliximab and azathioprine alone or in combination for patients with Crohn‚Äôs disease.</description></item><item><title>idiopathic pneumonia syndrome (IPS)</title><link>https://www.physician.tw/idiopathic-pneumonia-syndrome-IPS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/idiopathic-pneumonia-syndrome-IPS/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
idiopathic pneumonia syndrome (IPS) #üöß ÊñΩÂ∑•‰∏≠ idiopathic pneumonia syndrome (IPS) 5‚Äì25% of Pts, &amp;gt;50% mortality (Blood 2003;102:2777) Alveolar injury 2/2 direct toxicity ‚Üí fever, hypoxia, diffuse infiltrates; occult infxn frequent</description></item><item><title>Imaging</title><link>https://www.physician.tw/Imaging/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Imaging #üöß ÊñΩÂ∑•‰∏≠ Imaging Non-contrast head computed tomography (NCHCT) ‚Ä¢¬†Description: CT scanning is particularly useful for evaluation of bony defects, metallic objects, calcifications, hemorrhage, and hydrocephalus</description></item><item><title>Immunotherapy</title><link>https://www.physician.tw/Immunotherapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immunotherapy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Immunotherapy #üöß ÊñΩÂ∑•‰∏≠ Immunotherapy ‚Ä¢¬†Mechanism: Checkpoint inhibitors enable the patient‚Äôs own immune system to better target and destroy malignant cells by blocking the signals that turn the immune system off.</description></item><item><title>Impulse Control Disorders</title><link>https://www.physician.tw/Impulse-Control-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Impulse-Control-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Impulse Control Disorders #üöß ÊñΩÂ∑•‰∏≠ Impulse Control Disorders ‚Ä¢¬†Intermittent explosive disorder: Recurrent aggressive outbursts, out of proportion with stressor, then remorse (unlike antisocial personality).</description></item><item><title>indications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/indications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/indications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
indications of hematopoietic stem cell transplantation (BBMT 2015;21:1863; BMT 2015;50:1037) ‚Ä¢ Malignant disease: Auto HSCT allows high-dose myeloablative chemo and then rescue what would be otherwise lethal cytopenias with autologous stem cells.</description></item><item><title>induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/induction-chemotherapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/induction-chemotherapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[treatment of acute lymphoblastic leukemia (ALL)]]
induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL) #üöß ÊñΩÂ∑•‰∏≠ induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL) Ph ‚äï t(9;22) (seen in ~25% of B-ALL): tyrosine kinase inhibitor + chemo/steroids</description></item><item><title>Infections</title><link>https://www.physician.tw/Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Infections #üöß ÊñΩÂ∑•‰∏≠ Infections Central line-associated bloodstream infections (CLABSI)
‚Ä¢¬†Pathogens:
-¬†Typically skin flora with coagulase-negative staph, S.</description></item><item><title>infectious complications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/infectious-complications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-complications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
üå± ‰æÜËá™: [[complications of hematopoietic stem cell transplantation]]
infectious complications of hematopoietic stem cell transplantation #üöß ÊñΩÂ∑•‰∏≠ infectious complications of hematopoietic stem cell transplantation due to regimen-induced pancytopenia and immunosuppression auto HSCT recipients: no immunosuppression ‚à¥ at ‚Üë risk only pre-/postengraftment both primary infections and reactivation events occur (eg, CMV, HSV, VZV)</description></item><item><title>infectious diseases and pathophysiology</title><link>https://www.physician.tw/infectious-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-and-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
infectious diseases and pathophysiology #üöß ÊñΩÂ∑•‰∏≠ infectious diseases and pathophysiology Because diagnostic and therapeutic decisions in infectious diseases are heavily informed by a patient‚Äôs clinical syndrome, they are included with each specific disease.</description></item><item><title>infectious diseases key clinical trials &amp; publications</title><link>https://www.physician.tw/infectious-diseases-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-key-clinical-trials-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
infectious diseases key clinical trials &amp;amp; publications #üöß ÊñΩÂ∑•‰∏≠ infectious diseases key clinical trials &amp;amp; publications [[books/h_note/Fever of Unknown Origin]]</description></item><item><title>infectious diseases key medications &amp; interventions</title><link>https://www.physician.tw/infectious-diseases-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-key-medications-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
infectious diseases key medications &amp;amp; interventions #üöß ÊñΩÂ∑•‰∏≠ infectious diseases key medications &amp;amp; interventions [[books/h_note/Antibiotics]]</description></item><item><title>Infectious Diseases of Huppert's Notes</title><link>https://www.physician.tw/Infectious-Diseases-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-of-Hupperts-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Infectious Diseases of Huppert&amp;rsquo;s Notes #üöß ÊñΩÂ∑•‰∏≠ Infectious Diseases of Huppert&amp;rsquo;s Notes [[microbiology]]</description></item><item><title>Infectious Etiologies of Liver Disease</title><link>https://www.physician.tw/Infectious-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Etiologies-of-Liver-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Infectious Etiologies of Liver Disease #üöß ÊñΩÂ∑•‰∏≠ Infectious Etiologies of Liver Disease Hepatitis A virus (HAV), Hepatitis E virus (HAE) ‚Ä¢¬†HAV: Fecal‚Äìoral transmission.</description></item><item><title>Inflammatory and Autoimmune Conditions</title><link>https://www.physician.tw/Inflammatory-and-Autoimmune-Conditions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inflammatory-and-Autoimmune-Conditions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Inflammatory and Autoimmune Conditions #üöß ÊñΩÂ∑•‰∏≠ Inflammatory and Autoimmune Conditions Pyoderma gangrenosum (PG) ‚Ä¢¬†Pathophysiology: Neutrophilic dermatosis; often associated with underlying systemic disease (IBD, RA, malignancy)</description></item><item><title>Inflammatory Bowel Disease (IBD)</title><link>https://www.physician.tw/Inflammatory-Bowel-Disease-IBD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inflammatory-Bowel-Disease-IBD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Inflammatory Bowel Disease (IBD) #üöß ÊñΩÂ∑•‰∏≠ Inflammatory Bowel Disease (IBD) ‚Ä¢¬†History:
-¬†Even if you suspect IBD, always rule out infection first!</description></item><item><title>Influenza</title><link>https://www.physician.tw/Influenza/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Influenza/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Influenza #üöß ÊñΩÂ∑•‰∏≠ Influenza ‚Ä¢¬†Diagnosis of influenza in intensive care units: Lower respiratory tract samples are better than nose-throat swabs.</description></item><item><title>Inhaler Glossary</title><link>https://www.physician.tw/Inhaler-Glossary/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inhaler-Glossary/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Inhaler Glossary #üöß ÊñΩÂ∑•‰∏≠ Inhaler Glossary FIGURE 2.15: Respiratory treatments by inhaler class.</description></item><item><title>Inpatient Dermatology</title><link>https://www.physician.tw/Inpatient-Dermatology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inpatient-Dermatology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Inpatient Dermatology #üöß ÊñΩÂ∑•‰∏≠ Inpatient Dermatology ‚Ä¢¬†Prevalence of cutaneous findings in hospitalized medical patients.</description></item><item><title>Insterstitial Lung Disease</title><link>https://www.physician.tw/Insterstitial-Lung-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Insterstitial-Lung-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Insterstitial Lung Disease #üöß ÊñΩÂ∑•‰∏≠ Insterstitial Lung Disease ‚Ä¢¬†A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.</description></item><item><title>Intra-Abdominal Infections</title><link>https://www.physician.tw/Intra-Abdominal-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intra-Abdominal-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Intra-Abdominal Infections #üöß ÊñΩÂ∑•‰∏≠ Intra-Abdominal Infections Peritonitis/intra-abdominal abscess ‚Ä¢¬†Pathogenesis: Disruption of or inflammation in the GI tract may allow normal bowel flora to enter the abdominal cavity and cause frank peritonitis and/or the development of intra-abdominal abscesses</description></item><item><title>Intracranial Hemorrhage</title><link>https://www.physician.tw/Intracranial-Hemorrhage/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intracranial-Hemorrhage/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Intracranial Hemorrhage #üöß ÊñΩÂ∑•‰∏≠ Intracranial Hemorrhage Epidural hematoma ‚Ä¢¬†Etiology: Rupture middle meningeal artery due to head trauma.</description></item><item><title>INTRODUCTION</title><link>https://www.physician.tw/INTRODUCTION/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/INTRODUCTION/</guid><description>[!info]
üå± ‰æÜËá™: [[General Medicine of Huppert&amp;rsquo;s Notes]]
INTRODUCTION #üöß ÊñΩÂ∑•‰∏≠ INTRODUCTION This chapter will focus on general outpatient medicine, acknowledging that a whole textbook could be dedicated to this subject alone.</description></item><item><title>Invasive Candidiasis</title><link>https://www.physician.tw/Invasive-Candidiasis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Invasive-Candidiasis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Invasive Candidiasis #üöß ÊñΩÂ∑•‰∏≠ Invasive Candidiasis ‚Ä¢¬†[Guideline] Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.</description></item><item><title>Irregular Atrial Rhythms</title><link>https://www.physician.tw/Irregular-Atrial-Rhythms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Irregular-Atrial-Rhythms/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Irregular Atrial Rhythms #üöß ÊñΩÂ∑•‰∏≠ Irregular Atrial Rhythms Premature atrial complexes (PACs) ‚Ä¢¬†Description: Most common cause of irregular pulse and palpitations; benign, increased frequency with age, illness, tobacco/alcohol/caffeine</description></item><item><title>Ischemic Heart Disease</title><link>https://www.physician.tw/Ischemic-Heart-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ischemic-Heart-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Ischemic Heart Disease #üöß ÊñΩÂ∑•‰∏≠ Ischemic Heart Disease Stable coronary artery disease (CAD) ‚Ä¢¬†Types: Asymptomatic CAD or stable angina (angina that occurs reliably with exertion and emotional stress, relived with rest or nitroglycerin; due to fixed atherosclerosis)</description></item><item><title>jaundice or abnormal liver enzymes</title><link>https://www.physician.tw/jaundice-or-abnormal-liver-enzymes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jaundice-or-abnormal-liver-enzymes/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
jaundice or abnormal liver enzymes #üöß ÊñΩÂ∑•‰∏≠ jaundice or abnormal liver enzymes Jason Alexander, MD</description></item><item><title>joint pain</title><link>https://www.physician.tw/joint-pain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/joint-pain/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
joint pain #üöß ÊñΩÂ∑•‰∏≠ joint pain Adam S. Cifu, MD
CHIEF COMPLAINT PATIENT
Mrs. K is a 75-year-old woman who complains of a painful left knee.</description></item><item><title>key clinical trials and publications</title><link>https://www.physician.tw/Endocrinology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-key-clinical-trials-and-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
key clinical trials and publications #üöß ÊñΩÂ∑•‰∏≠ key clinical trials and publications [[Thyroid Disease key clinical trials]]</description></item><item><title>Key Terms and Definitions</title><link>https://www.physician.tw/Key-Terms-and-Definitions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Key-Terms-and-Definitions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Key Terms and Definitions #üöß ÊñΩÂ∑•‰∏≠ Key Terms and Definitions ‚Ä¢¬†Dyspnea: Subjective experience of breathing discomfort, must be self-reported</description></item><item><title>Large Vessel Vasculitis</title><link>https://www.physician.tw/Large-Vessel-Vasculitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Large-Vessel-Vasculitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Large Vessel Vasculitis #üöß ÊñΩÂ∑•‰∏≠ Large Vessel Vasculitis Temporal arteritis/giant cell arteritis (GCA) ‚Ä¢¬†Pathogenesis: Not fully elucidated; association with HLA-DRB*04 suggests cell-mediated autoimmunity resulting in granulomatous inflammation of vessel walls.</description></item><item><title>Left Heart CatheterizationCoronary Angiogram</title><link>https://www.physician.tw/Left-Heart-CatheterizationCoronary-Angiogram/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Left-Heart-CatheterizationCoronary-Angiogram/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Left Heart CatheterizationCoronary Angiogram #üöß ÊñΩÂ∑•‰∏≠ Left Heart Catheterization/Coronary Angiogram ‚Ä¢¬†Procedure: A thin catheter is placed in an artery (usually radial, sometimes femoral), advanced to the ascending aorta, and then contrast is injected to visualize the coronary arteries from their origin off of the aorta (diagnostic).</description></item><item><title>leukemia</title><link>https://www.physician.tw/leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leukemia/</guid><description>[!info]
üå± ‰æÜËá™: [[hematology]]
[[acute leukemia]]
[[acute myelogenous leukemia (AML)]]
[[acute lymphoblastic leukemia (ALL)]]
[[chronic myelogenous leukemia (CML)]]</description></item><item><title>Leukemias</title><link>https://www.physician.tw/Leukemias/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Leukemias/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Leukemias #üöß ÊñΩÂ∑•‰∏≠ Leukemias ‚Ä¢¬†Malignant hematology overview: Within malignant hematology, there are three broad categories of disease: 1) Leukemias, 2) Lymphomas, and 3) Multiple Myeloma</description></item><item><title>Liver</title><link>https://www.physician.tw/Liver/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Liver/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Liver #üöß ÊñΩÂ∑•‰∏≠ Liver</description></item><item><title>Lumbar Puncture</title><link>https://www.physician.tw/Lumbar-Puncture/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lumbar-Puncture/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Lumbar Puncture #üöß ÊñΩÂ∑•‰∏≠ Lumbar Puncture ‚Ä¢¬†Common indications: Concern for CNS infection, autoimmune or inflammatory condition, or malignancy; also can be used to diagnose subarachnoid hemorrhage, intracranial pressure abnormalities, or to reduce CSF pressure therapeutically</description></item><item><title>Lymphoma</title><link>https://www.physician.tw/Lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Lymphoma #üöß ÊñΩÂ∑•‰∏≠ Lymphoma ‚Ä¢¬†Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: An open-label, multicentre, randomised, phase 3 non-inferiority trial.</description></item><item><title>lymphoma and CLL</title><link>https://www.physician.tw/lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lymphoma-and-CLL/</guid><description> [!info]
üå± ‰æÜËá™: [[hematology]]
[[overview of lymphoma and CLL]]
[[hodgkin lymphoma (HL)]]
[[non-Hodgkin lymphoma (NHL)]]
[[small¬†lymphocytic¬†lymphoma]]¬†</description></item><item><title>Lymphomas</title><link>https://www.physician.tw/Lymphomas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lymphomas/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Lymphomas #üöß ÊñΩÂ∑•‰∏≠ Lymphomas ‚Ä¢¬†Organizational framework for lymphomas: See Table 7.3. Lymphoma may be Hodgkin‚Äôs or Non-Hodgkin‚Äôs.</description></item><item><title>Magnesium</title><link>https://www.physician.tw/Magnesium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Magnesium/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Magnesium #üöß ÊñΩÂ∑•‰∏≠ Magnesium Magnesium homeostasis (Mg2+ 1.8‚Äì2.5 mg/dL) ‚Ä¢¬†Distribution:
-¬†99% intracellular, two-third of that in bones</description></item><item><title>Major Depressive Disorder</title><link>https://www.physician.tw/Major-Depressive-Disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-Depressive-Disorder/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Major Depressive Disorder #üöß ÊñΩÂ∑•‰∏≠ Major Depressive Disorder ‚Ä¢¬†STAR*D Study. Cleve Clin J Med 2008;75(1):57‚Äì66.</description></item><item><title>Males</title><link>https://www.physician.tw/Males/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Males/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Males #üöß ÊñΩÂ∑•‰∏≠ Males Physiology: GnRH pulse elicits pulses of LH/FSH. LH acts on Leydig cells ‚Üí Testosterone.</description></item><item><title>Malnutrition</title><link>https://www.physician.tw/Malnutrition/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Malnutrition/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Malnutrition #üöß ÊñΩÂ∑•‰∏≠ Malnutrition ‚Ä¢¬†Risk factors: Critical illness often associated with increased catabolism and muscle breakdown</description></item><item><title>Management of Complications Associated with Advanced CKDESRD</title><link>https://www.physician.tw/Management-of-Complications-Associated-with-Advanced-CKDESRD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-Complications-Associated-with-Advanced-CKDESRD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Management of Complications Associated with Advanced CKDESRD #üöß ÊñΩÂ∑•‰∏≠ Management of Complications Associated with Advanced CKD/ESRD Blood pressure/volume ‚Ä¢¬†Pathophysiology of hypertension in CKD: Complex and multifactorial, attributed to reduced nephron mass, increased Na+ retention, extracellular volume expansion, activation of hormones (RAAS) and the sympathetic nervous system, and endothelial dysfunction</description></item><item><title>Mechanisms of Psychiatric Disease</title><link>https://www.physician.tw/Mechanisms-of-Psychiatric-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-of-Psychiatric-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Mechanisms of Psychiatric Disease #üöß ÊñΩÂ∑•‰∏≠ Mechanisms of Psychiatric Disease ‚Ä¢¬†Mechanisms of psychiatric disease remain partially understood</description></item><item><title>Medications</title><link>https://www.physician.tw/Medications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medications/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Medications #üöß ÊñΩÂ∑•‰∏≠ Medications TABLE 4.15 ‚Ä¢ Key Medications in Gastroenterology</description></item><item><title>Medium Vessel Vasculitis</title><link>https://www.physician.tw/Medium-Vessel-Vasculitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medium-Vessel-Vasculitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Medium Vessel Vasculitis #üöß ÊñΩÂ∑•‰∏≠ Medium Vessel Vasculitis Polyarteritis nodosa (PAN) ‚Ä¢¬†Epidemiology: Incidence 3‚Äì4.</description></item><item><title>Melanoma</title><link>https://www.physician.tw/Melanoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Melanoma/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Melanoma #üöß ÊñΩÂ∑•‰∏≠ Melanoma ‚Ä¢¬†Epidemiology: 5th most common cancer in the United States.</description></item><item><title>Menopause</title><link>https://www.physician.tw/Menopause/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Menopause/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Menopause #üöß ÊñΩÂ∑•‰∏≠ Menopause ‚Ä¢¬†Diagnosis:
-¬†Clinical diagnosis made after 12 consecutive months of amenorrhea.</description></item><item><title>Mental Status Exam</title><link>https://www.physician.tw/Mental-Status-Exam/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mental-Status-Exam/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Mental Status Exam #üöß ÊñΩÂ∑•‰∏≠ Mental Status Exam ‚Ä¢¬†Appearance: Apparent age, weight, clothing, personal hygiene, odor, skin markings, etc.</description></item><item><title>Metabolic Acidosis</title><link>https://www.physician.tw/Metabolic-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Acidosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Metabolic Acidosis #üöß ÊñΩÂ∑•‰∏≠ Metabolic Acidosis ‚ÜìpH, ‚Üì HCO3‚Äì, (Immediate respiratory compensation = Hyperventilation ‚ÜìPaCO2)</description></item><item><title>Metabolic Alkalosis</title><link>https://www.physician.tw/Metabolic-Alkalosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Alkalosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Metabolic Alkalosis #üöß ÊñΩÂ∑•‰∏≠ [[Metabolic Alkalosis A Brief Pathophysiologic Review]]
Metabolic Alkalosis ‚Üë pH, ‚Üë HCO 3‚Äì (Immediate respiratory compensation = Hypoventilation: ‚ÜëPaCO2)</description></item><item><title>Metabolic Emergencies</title><link>https://www.physician.tw/Metabolic-Emergencies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Emergencies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Metabolic Emergencies #üöß ÊñΩÂ∑•‰∏≠ Metabolic Emergencies Hypercalcemia of malignancy
‚Ä¢¬†Pathophysiology: Multiple possible mechanisms</description></item><item><title>Metabolic Etiologies of Liver Disease</title><link>https://www.physician.tw/Metabolic-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Etiologies-of-Liver-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Metabolic Etiologies of Liver Disease #üöß ÊñΩÂ∑•‰∏≠ Metabolic Etiologies of Liver Disease Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) ‚Ä¢¬†Risk factors: Associated with obesity, HLD, DM2</description></item><item><title>microbiology</title><link>https://www.physician.tw/microbiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/microbiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
microbiology #üöß ÊñΩÂ∑•‰∏≠ microbiology [[Overview of Clinically Important Pathogens]]
[[Bacterial Infections]]</description></item><item><title>Miscellaneous</title><link>https://www.physician.tw/Miscellaneous/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Miscellaneous/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Miscellaneous #üöß ÊñΩÂ∑•‰∏≠ Miscellaneous ‚Ä¢¬†Milaria (‚Äúheat rash‚Äù): Numerous non-follicular papules or pustules; caused by occlusion of the sweat ducts.</description></item><item><title>Mixed Acidosis</title><link>https://www.physician.tw/Mixed-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-Acidosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Mixed Acidosis #üöß ÊñΩÂ∑•‰∏≠ Mixed Acidosis ‚ÜìpH, ‚ÜëPaCO2, ‚ÜìHCO3‚Äì</description></item><item><title>Mixed Alkalosis</title><link>https://www.physician.tw/Mixed-Alkalosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-Alkalosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Mixed Alkalosis #üöß ÊñΩÂ∑•‰∏≠ Mixed Alkalosis ‚ÜëpH, ‚ÜìPaCO2**,** ‚ÜëHCO3‚Äì</description></item><item><title>Mixed PlateletCoagulation Disorders</title><link>https://www.physician.tw/Mixed-PlateletCoagulation-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-PlateletCoagulation-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Mixed PlateletCoagulation Disorders #üöß ÊñΩÂ∑•‰∏≠ Mixed Platelet/Coagulation Disorders Disseminated intravascular coagulation (DIC)
‚Ä¢¬†Pathophysiology: Tissue factor release (e.</description></item><item><title>monoclonal gammopathy of uncertain significance (MGUS)</title><link>https://www.physician.tw/monoclonal-gammopathy-of-uncertain-significance-MGUS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/monoclonal-gammopathy-of-uncertain-significance-MGUS/</guid><description>[!info]
üå± ‰æÜËá™: [[plasma cell dyscrasias]]
monoclonal gammopathy of uncertain significance (MGUS) #üöß ÊñΩÂ∑•‰∏≠ monoclonal gammopathy of uncertain significance (MGUS) (NEJM 2018;378:241) ‚Ä¢ ‚úì CBC, Ca, Cr, SPEP, serum free light chains, UPEP w/ immunofixation (to exclude MM) ‚Ä¢ Close observation: repeat SPEP in 6 mo, then yearly thereafter if stable ‚Ä¢ ~1%/y or ~25% lifetime risk ‚Üí MM, WM, amyloidosis, or malign.</description></item><item><title>Mood Disorders</title><link>https://www.physician.tw/Mood-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mood-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Mood Disorders #üöß ÊñΩÂ∑•‰∏≠ Mood Disorders Major depressive disorder (MDD) ‚Ä¢¬†Etiology: Multiple synergistic biopsychosocial risk factors at play.</description></item><item><title>Movement Disorders</title><link>https://www.physician.tw/Movement-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Movement-Disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Movement Disorders #üöß ÊñΩÂ∑•‰∏≠ Movement Disorders</description></item><item><title>Multiple Myeloma</title><link>https://www.physician.tw/Multiple-Myeloma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Multiple-Myeloma/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Multiple Myeloma #üöß ÊñΩÂ∑•‰∏≠ Multiple Myeloma ‚Ä¢¬†Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma.</description></item><item><title>multiple myeloma (MM)</title><link>https://www.physician.tw/multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/multiple-myeloma-MM/</guid><description>[!info]
üå± ‰æÜËá™: [[plasma cell dyscrasias]]
multiple myeloma (MM) [[definition and epidemiology of multiple myeloma (MM)]]
[[clinical manifestations of multiple myeloma (MM)]]</description></item><item><title>multiple myeloma staging systems</title><link>https://www.physician.tw/multiple-myeloma-staging-systems/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/multiple-myeloma-staging-systems/</guid><description>[!info]
üå± ‰æÜËá™: [[multiple myeloma (MM)]]
multiple myeloma staging systems #üöß ÊñΩÂ∑•‰∏≠ multiple myeloma staging systems (OS does not account for cytogenetics) Stage ISS Criteria* Durie-Salmon (DS) Criteria ISS Median OS I Œ≤2M &amp;lt;3.</description></item><item><title>Multiple Sclerosis</title><link>https://www.physician.tw/Multiple-Sclerosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Multiple-Sclerosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Multiple Sclerosis #üöß ÊñΩÂ∑•‰∏≠ Multiple Sclerosis ‚Ä¢¬†Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis [Cochrane Review].</description></item><item><title>Musculoskeletal (MSK)</title><link>https://www.physician.tw/Musculoskeletal-MSK/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Musculoskeletal-MSK/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Musculoskeletal (MSK) #üöß ÊñΩÂ∑•‰∏≠ Musculoskeletal (MSK)</description></item><item><title>mutations useful as clonal markers and dx tools of myeloproliferative neoplasms</title><link>https://www.physician.tw/mutations-useful-as-clonal-markers-and-dx-tools-of-myeloproliferative-neoplasms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mutations-useful-as-clonal-markers-and-dx-tools-of-myeloproliferative-neoplasms/</guid><description>[!info]
üå± ‰æÜËá™: [[overview of myeloproliferative neoplasms]]
mutations useful as clonal markers and dx tools of myeloproliferative neoplasms Gain of fxn mutations in¬†JAK2¬†V617F (Janus kinase) frequently present (PV ~95%, ET ~50%, PMF ~50%;¬†NEJM¬†2005;352:1779)</description></item><item><title>myelodysplastic syndromes (MDS) overview</title><link>https://www.physician.tw/myelodysplastic-syndromes-MDS-overview/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myelodysplastic-syndromes-MDS-overview/</guid><description>[!info]
üå± ‰æÜËá™: [[myelodysplastic syndromes]]
myelodysplastic syndromes (MDS) overview #üöß ÊñΩÂ∑•‰∏≠ myelodysplastic syndromes (MDS) overview (Lancet 2014;383:2239) ‚Ä¢ Acquired clonal stem cell disorder ‚Üí ineffective hematopoiesis ‚Üí cytopenias, dysmorphic blood cells and precursors, variable risk of leukemic transformation ‚Ä¢ Epidemiology: 20‚Äì30,000 cases/y; median age ~70 y; male predominance (1.</description></item><item><title>Myeloid neoplasm overview</title><link>https://www.physician.tw/Myeloid-neoplasm-overview/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myeloid-neoplasm-overview/</guid><description>[!info]
üå± ‰æÜËá™: [[myelodysplastic syndromes]]
Myeloid neoplasm overview (Blood 2016;1272391) #üöß ÊñΩÂ∑•‰∏≠ (Blood 2016;127:2391) ‚Ä¢ Categories based on clinical features, morphology, immunophenotyping, and genetics</description></item><item><title>Myelopathy and Radiculopathy</title><link>https://www.physician.tw/Myelopathy-and-Radiculopathy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myelopathy-and-Radiculopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Myelopathy and Radiculopathy #üöß ÊñΩÂ∑•‰∏≠ Myelopathy and Radiculopathy ‚Ä¢¬†Description: Neurologic deficit related to the spinal cord</description></item><item><title>Myocardial Diseases</title><link>https://www.physician.tw/Myocardial-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myocardial-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Myocardial Diseases #üöß ÊñΩÂ∑•‰∏≠ Myocardial Diseases Myocarditis ‚Ä¢¬†Etiology: Inflammation of the myocardium due to a viral infection (e.</description></item><item><title>Myocardial Viability Study</title><link>https://www.physician.tw/Myocardial-Viability-Study/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myocardial-Viability-Study/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Myocardial Viability Study #üöß ÊñΩÂ∑•‰∏≠ Myocardial Viability Study ‚Ä¢¬†Indications: Identifies ‚Äúhibernating‚Äù myocardium that could regain function after revascularization</description></item><item><title>Myopathies</title><link>https://www.physician.tw/Myopathies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myopathies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Myopathies #üöß ÊñΩÂ∑•‰∏≠ Myopathies ‚Ä¢¬†Definition: Myopathy refers to any disease that affects the muscle tissue, which can occur due to inherited or acquired causes</description></item><item><title>Narrow QRS Complex Tachycardia</title><link>https://www.physician.tw/Narrow-QRS-Complex-Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Narrow-QRS-Complex-Tachycardia/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Narrow QRS Complex Tachycardia #üöß ÊñΩÂ∑•‰∏≠ Narrow QRS Complex Tachycardia</description></item><item><title>NauseaVomiting</title><link>https://www.physician.tw/NauseaVomiting/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NauseaVomiting/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
NauseaVomiting #üöß ÊñΩÂ∑•‰∏≠ Nausea/Vomiting Differential diagnosis:
‚Ä¢¬†Neuropsychiatric:
-¬†Intracerebral: Increased intracranial pressure (ICP) due to malignancy, hemorrhage, abscess, hydrocephalus</description></item><item><title>neovim</title><link>https://www.physician.tw/neovim/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neovim/</guid><description>[!info]
üå± ‰æÜËá™: [[Ëú•Ëú¥ËàáVIM]]
neovim #üöß ÊñΩÂ∑•‰∏≠ [[lua]]</description></item><item><title>Nephritic Syndrome</title><link>https://www.physician.tw/Nephritic-Syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephritic-Syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Nephritic Syndrome #üöß ÊñΩÂ∑•‰∏≠ Nephritic Syndrome ‚Ä¢¬†Pathophysiology: Syndrome of symptoms and findings caused by inflammation of glomeruli</description></item><item><title>nephrology anatomy and physiology</title><link>https://www.physician.tw/nephrology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-anatomy-and-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology anatomy and physiology #üöß ÊñΩÂ∑•‰∏≠ nephrology anatomy and physiology [[Renal Anatomy]]</description></item><item><title>nephrology approaches and chief complaints</title><link>https://www.physician.tw/nephrology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-approaches-and-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology approaches and chief complaints #üöß ÊñΩÂ∑•‰∏≠ nephrology approaches and chief complaints [[books/h_note/Proteinuria]]</description></item><item><title>nephrology diseases and pathophysiology</title><link>https://www.physician.tw/nephrology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-diseases-and-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology diseases and pathophysiology #üöß ÊñΩÂ∑•‰∏≠ nephrology diseases and pathophysiology [[Renal Dysfunction]]</description></item><item><title>nephrology key clinical trials and publications</title><link>https://www.physician.tw/nephrology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-key-clinical-trials-and-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology key clinical trials and publications #üöß ÊñΩÂ∑•‰∏≠ nephrology key clinical trials and publications [[books/h_note/Acute Kidney Injury]]</description></item><item><title>nephrology key medications and interventions</title><link>https://www.physician.tw/nephrology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-key-medications-and-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology key medications and interventions #üöß ÊñΩÂ∑•‰∏≠ nephrology key medications and interventions TABLE 6.</description></item><item><title>Nephrology of Huppert's Notes</title><link>https://www.physician.tw/Nephrology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-of-Hupperts-Notes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Nephrology of Huppert&amp;rsquo;s Notes [[nephrology anatomy and physiology]]
[[DIAGNOSTICS]]</description></item><item><title>Neuro-oncology</title><link>https://www.physician.tw/Neuro-oncology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuro-oncology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neuro-oncology #üöß ÊñΩÂ∑•‰∏≠ Neuro-oncology Metastatic brain tumors ‚Ä¢¬†Radiographic findings: Multifocal lesions at the gray-white junction, ring enhancement with contrast</description></item><item><title>Neurocritical Care</title><link>https://www.physician.tw/Neurocritical-Care/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurocritical-Care/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neurocritical Care #üöß ÊñΩÂ∑•‰∏≠ Neurocritical Care ‚Ä¢¬†Mild Therapeutic Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest (HACA).</description></item><item><title>Neuroimmunology</title><link>https://www.physician.tw/Neuroimmunology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuroimmunology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neuroimmunology #üöß ÊñΩÂ∑•‰∏≠ Neuroimmunology Multiple sclerosis (MS) ‚Ä¢¬†Diagnostic criteria:
-¬†Relapsing-remitting MS: An attack, relapse, or exacerbation of symptoms typical of acute inflammatory demyelinating event with duration of at least 24 hours in the absence of fever or infection and clinical and/or radiographic evidence of dissemination in space and time</description></item><item><title>Neurologic Emergencies</title><link>https://www.physician.tw/Neurologic-Emergencies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurologic-Emergencies/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neurologic Emergencies #üöß ÊñΩÂ∑•‰∏≠ Neurologic Emergencies</description></item><item><title>neurology anatomy and physiology</title><link>https://www.physician.tw/neurology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-anatomy-and-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology anatomy and physiology #üöß ÊñΩÂ∑•‰∏≠ neurology anatomy and physiology In neurology, we talk about ‚Äúlocalizing‚Äù a lesion.</description></item><item><title>neurology approaches &amp; chief complaints</title><link>https://www.physician.tw/neurology-approaches-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-approaches-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology approaches &amp;amp; chief complaints #üöß ÊñΩÂ∑•‰∏≠ neurology approaches &amp;amp; chief complaints [[Altered Mental Status]]</description></item><item><title>neurology diagnostics</title><link>https://www.physician.tw/neurology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-diagnostics/</guid><description>[!info]
üå± ‰æÜËá™: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology diagnostics #üöß ÊñΩÂ∑•‰∏≠ neurology diagnostics [[The Neurologic Exam]]
[[Imaging]]
[[Lumbar Puncture]]</description></item><item><title>neurology diseases &amp; pathophysiology</title><link>https://www.physician.tw/neurology-diseases-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-diseases-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology diseases &amp;amp; pathophysiology #üöß ÊñΩÂ∑•‰∏≠ neurology diseases &amp;amp; pathophysiology [[Neurologic Emergencies]]</description></item><item><title>neurology key clinical trials &amp; publications</title><link>https://www.physician.tw/neurology-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-key-clinical-trials-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology key clinical trials &amp;amp; publications #üöß ÊñΩÂ∑•‰∏≠ neurology key clinical trials &amp;amp; publications [[books/h_note/Stroke]]</description></item><item><title>neurology key medications &amp; interventions</title><link>https://www.physician.tw/neurology-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-key-medications-interventions/</guid><description> [!info]
üå± ‰æÜËá™: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology key medications &amp;amp; interventions #üöß ÊñΩÂ∑•‰∏≠ neurology key medications &amp;amp; interventions</description></item><item><title>Neurology of Huppert's Notes</title><link>https://www.physician.tw/Neurology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neurology of Huppert&amp;rsquo;s Notes #üöß ÊñΩÂ∑•‰∏≠ Neurology of Huppert&amp;rsquo;s Notes</description></item><item><title>Neuromuscular</title><link>https://www.physician.tw/Neuromuscular/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neuromuscular #üöß ÊñΩÂ∑•‰∏≠ Neuromuscular ‚Ä¢¬†Intravenous immunoglobulin for Guillain-Barr√© syndrome. [Cochrane Review]. Cochrane Database of Systematic Reviews 2014;(9):CD002063.</description></item><item><title>Neuromuscular Disorders</title><link>https://www.physician.tw/Neuromuscular-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neuromuscular Disorders #üöß ÊñΩÂ∑•‰∏≠ Neuromuscular Disorders Motor Neuron Diseases Amyotrophic lateral sclerosis (ALS) ‚Ä¢¬†Pathophysiology: Degeneration of upper and lower motor neurons leading to a combination of hyperreflexia/spasticity and atrophy/fasciculations</description></item><item><title>Neuromuscular Junction Disorders</title><link>https://www.physician.tw/Neuromuscular-Junction-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular-Junction-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neuromuscular Junction Disorders #üöß ÊñΩÂ∑•‰∏≠ Neuromuscular Junction Disorders Exam is notable for LMN signs which are usually symmetric; may have proximal muscle weakness; check for bulbar signs/symptoms (‚ÄúD‚Äù symptoms ‚Äì Dysphagia, Diplopia, Dysarthria); may have extraocular movement restriction, ptosis and shortness of breath (especially orthopnea).</description></item><item><title>Neutropenic Fever</title><link>https://www.physician.tw/Neutropenic-Fever/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neutropenic-Fever/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Neutropenic Fever #üöß ÊñΩÂ∑•‰∏≠ Neutropenic Fever ‚Ä¢¬†[Guideline] Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America.</description></item><item><title>Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs)</title><link>https://www.physician.tw/Non-Biologic-Disease-Modifying-Antirheumatic-Drugs-DMARDs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Non-Biologic-Disease-Modifying-Antirheumatic-Drugs-DMARDs/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) #üöß ÊñΩÂ∑•‰∏≠ Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) ‚Ä¢¬†Definition: DMARDs comprise a group of otherwise unrelated medications that are used to treat rheumatoid arthritis and other rheumatic conditions.</description></item><item><title>non-Hodgkin¬†lymphoma¬†(NHL)</title><link>https://www.physician.tw/non-Hodgkin-lymphoma-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/non-Hodgkin-lymphoma-NHL/</guid><description>[!info]
üå± ‰æÜËá™: [[lymphoma and CLL]]
non-Hodgkin¬†lymphoma¬†(NHL) [[epidemiology and risk factors of non-Hodgkin lymphoma (NHL)]]
[[WHO Classification of Lymphoid Malignancies]]</description></item><item><title>Non-Hodgkin‚Äôs Lymphoma (NHL)</title><link>https://www.physician.tw/Non-Hodgkins-Lymphoma-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Non-Hodgkins-Lymphoma-NHL/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Non-Hodgkin‚Äôs Lymphoma (NHL) #üöß ÊñΩÂ∑•‰∏≠ Non-Hodgkin‚Äôs Lymphoma (NHL) ‚Ä¢¬†Risk factors: HIV, immunosuppression, EBV/HTLV-1 infection, H.</description></item><item><title>obesity</title><link>https://www.physician.tw/obesity/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/obesity/</guid><description> [!info]
üå± ‰æÜËá™: [[endocrinology]]
obesity #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Obstructive Lung Diseases</title><link>https://www.physician.tw/Obstructive-Lung-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obstructive-Lung-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Obstructive Lung Diseases #üöß ÊñΩÂ∑•‰∏≠ Obstructive Lung Diseases ‚Ä¢¬†Obstructive = ‚Üëcompliance, ‚Üìelastance ‚Üí problem emptying the lung.</description></item><item><title>Odds Ratio, Risk Ratio, and Related Statistics</title><link>https://www.physician.tw/Odds-Ratio-Risk-Ratio-and-Related-Statistics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Odds-Ratio-Risk-Ratio-and-Related-Statistics/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Odds Ratio, Risk Ratio, and Related Statistics #üöß ÊñΩÂ∑•‰∏≠ Odds Ratio, Risk Ratio, and Related Statistics FIGURE A2.</description></item><item><title>Ophthalmologic</title><link>https://www.physician.tw/Ophthalmologic/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ophthalmologic/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Ophthalmologic #üöß ÊñΩÂ∑•‰∏≠ Ophthalmologic</description></item><item><title>Osteoporosis</title><link>https://www.physician.tw/Osteoporosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Osteoporosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Osteoporosis #üöß ÊñΩÂ∑•‰∏≠ Osteoporosis ‚Ä¢¬†Bone biology:
-¬†Osteoblasts promote bone formation and osteoclasts promote bone absorption/breakdown.</description></item><item><title>Other Conditions that Affect the Small Bowel</title><link>https://www.physician.tw/Other-Conditions-that-Affect-the-Small-Bowel/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Conditions-that-Affect-the-Small-Bowel/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Conditions that Affect the Small Bowel #üöß ÊñΩÂ∑•‰∏≠ Other Conditions that Affect the Small Bowel Microscopic colitis ‚Ä¢¬†Epidemiology: Age of diagnosis typically 45‚Äì65 yr; more common in females than males</description></item><item><title>Other Diseases Affecting Renal Tubular Absorption</title><link>https://www.physician.tw/Other-Diseases-Affecting-Renal-Tubular-Absorption/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-Affecting-Renal-Tubular-Absorption/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Diseases Affecting Renal Tubular Absorption #üöß ÊñΩÂ∑•‰∏≠ Other Diseases Affecting Renal Tubular Absorption Renal papillary necrosis ‚Ä¢¬†Etiology: Poor medullary perfusion resulting in ischemia and necrosis.</description></item><item><title>Other Diseases Affecting the Colon</title><link>https://www.physician.tw/Other-Diseases-Affecting-the-Colon/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-Affecting-the-Colon/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Diseases Affecting the Colon #üöß ÊñΩÂ∑•‰∏≠ Other Diseases Affecting the Colon Angiodysplasia of the colon (AV malformations, vascular ectasia) ‚Ä¢¬†Clinical features: Tortuous dilated veins in the colon can rupture and cause a lower GI bleed.</description></item><item><title>Other Diseases Affecting the Kidney</title><link>https://www.physician.tw/Other-Diseases-Affecting-the-Kidney/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-Affecting-the-Kidney/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Diseases Affecting the Kidney #üöß ÊñΩÂ∑•‰∏≠ Other Diseases Affecting the Kidney</description></item><item><title>Other Diseases of the Biliary Tree</title><link>https://www.physician.tw/Other-Diseases-of-the-Biliary-Tree/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-of-the-Biliary-Tree/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Diseases of the Biliary Tree #üöß ÊñΩÂ∑•‰∏≠ Other Diseases of the Biliary Tree ‚Ä¢¬†Biliary cysts: Cysts in the biliary tree.</description></item><item><title>Other Malignant Hematologic Conditions</title><link>https://www.physician.tw/Other-Malignant-Hematologic-Conditions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Malignant-Hematologic-Conditions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Malignant Hematologic Conditions #üöß ÊñΩÂ∑•‰∏≠ Other Malignant Hematologic Conditions Hemophagocytic lymphohistiocytosis (HLH)</description></item><item><title>Other Neurologic Emergencies</title><link>https://www.physician.tw/Other-Neurologic-Emergencies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Neurologic-Emergencies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Neurologic Emergencies #üöß ÊñΩÂ∑•‰∏≠ Other Neurologic Emergencies Elevated intracranial pressure (ICP) ‚Ä¢¬†Definition: Elevation of the pressure in the cranium.</description></item><item><title>Other Organ Systems</title><link>https://www.physician.tw/Other-Organ-Systems/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Organ-Systems/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Organ Systems #üöß ÊñΩÂ∑•‰∏≠ Other Organ Systems</description></item><item><title>Other Pathologies Affecting the Liver</title><link>https://www.physician.tw/Other-Pathologies-Affecting-the-Liver/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Pathologies-Affecting-the-Liver/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Pathologies Affecting the Liver #üöß ÊñΩÂ∑•‰∏≠ Other Pathologies Affecting the Liver Hypoperfusion ‚Ä¢¬†Shock liver: Hypotension causes hypoperfusion of the liver; labs are notable for an elevated AST/ALT with relatively normal bilirubin/AlkP.</description></item><item><title>Other Rheumatologic Conditions</title><link>https://www.physician.tw/Other-Rheumatologic-Conditions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Rheumatologic-Conditions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Rheumatologic Conditions #üöß ÊñΩÂ∑•‰∏≠ Other Rheumatologic Conditions Polymyalgia rheumatica (PMR) ‚Ä¢¬†Clinical features:</description></item><item><title>Other Statistical Concepts and Formulas</title><link>https://www.physician.tw/Other-Statistical-Concepts-and-Formulas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Statistical-Concepts-and-Formulas/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Statistical Concepts and Formulas #üöß ÊñΩÂ∑•‰∏≠ Other Statistical Concepts and Formulas ‚Ä¢¬†Standard deviation (SD): For normal distribution, 68% of results within one SD, 95% of results within two SDs, 99% of results within three SDs</description></item><item><title>Other Systemic Disorders Associated with Nephrotic-Range Proteinuria</title><link>https://www.physician.tw/Other-Systemic-Disorders-Associated-with-Nephrotic-Range-Proteinuria/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Systemic-Disorders-Associated-with-Nephrotic-Range-Proteinuria/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Other Systemic Disorders Associated with Nephrotic-Range Proteinuria #üöß ÊñΩÂ∑•‰∏≠ Other Systemic Disorders Associated with Nephrotic-Range Proteinuria ‚Ä¢¬†Diabetes:</description></item><item><title>Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology</title><link>https://www.physician.tw/Overlap-of-Diagnostic-and-Therapeutic-Interventions-in-Gastroenterology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overlap-of-Diagnostic-and-Therapeutic-Interventions-in-Gastroenterology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology #üöß ÊñΩÂ∑•‰∏≠ Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology Several diagnostic tests commonly used by gastroenterologists also have therapeutic potential; for information about EGD, colonoscopy, ERCP, and other modalities, refer to the Diagnostics section of this chapter.</description></item><item><title>Overview</title><link>https://www.physician.tw/Overview-of-lung-anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-of-lung-anatomy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Overview #üöß ÊñΩÂ∑•‰∏≠ Overview ‚Ä¢¬†Mech
anics:
-¬†Statics refer to forces acting</description></item><item><title>Overview of Clinically Important Pathogens</title><link>https://www.physician.tw/Overview-of-Clinically-Important-Pathogens/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-of-Clinically-Important-Pathogens/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Overview of Clinically Important Pathogens #üöß ÊñΩÂ∑•‰∏≠ Overview of Clinically Important Pathogens TABLE 8.</description></item><item><title>overview of lymphoma and CLL</title><link>https://www.physician.tw/overview-of-lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overview-of-lymphoma-and-CLL/</guid><description>[!info]
üå± ‰æÜËá™: [[lymphoma and CLL]]
overview of lymphoma and CLL ‚Ä¢ Malignant disorder of lymphoid cells that reside predominantly in lymphoid tissues ‚Ä¢ Generally characterized as Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL)</description></item><item><title>overview of myeloproliferative neoplasms</title><link>https://www.physician.tw/overview-of-myeloproliferative-neoplasms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overview-of-myeloproliferative-neoplasms/</guid><description>[!info]
üå± ‰æÜËá™: [[myeloproliferative neoplasms]]
(NEJM¬†2017;376:2168)
‚Ä¢ Results from clonal expansion of multipotent hematopoietic stem cell
[[Categories of MPN]]</description></item><item><title>Pancreas</title><link>https://www.physician.tw/Pancreas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pancreas/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Pancreas #üöß ÊñΩÂ∑•‰∏≠ Pancreas Acute pancreatitis ‚Ä¢¬†Etiology: Premature activation of pancreatic digestive enzymes causes autodigestion of pancreatic tissue</description></item><item><title>Panic Disorder</title><link>https://www.physician.tw/Panic-Disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Panic-Disorder/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Panic Disorder #üöß ÊñΩÂ∑•‰∏≠ Panic Disorder ‚Ä¢¬†CBT, imipramine, or their combination for panic disorder.</description></item><item><title>Papulosquamous Dermatoses</title><link>https://www.physician.tw/Papulosquamous-Dermatoses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Papulosquamous-Dermatoses/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Papulosquamous Dermatoses #üöß ÊñΩÂ∑•‰∏≠ Papulosquamous Dermatoses Psoriasis ‚Ä¢¬†Pathophysiology: Immune dysregulation (Th1, Th17, excess IFN-gamma) and keratinocyte hyperproliferation</description></item><item><title>Paracentesis</title><link>https://www.physician.tw/Paracentesis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paracentesis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Paracentesis #üöß ÊñΩÂ∑•‰∏≠ Paracentesis ‚Ä¢¬†Indications: 1) All patients with new-onset ascites of uncertain cause, 2) All patients with preexisting ascites in whom SBP is suspected, 3) All patients with cirrhosis and ascites who are being admitted to the hospital</description></item><item><title>Parasitic Infections</title><link>https://www.physician.tw/Parasitic-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Parasitic-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Parasitic Infections #üöß ÊñΩÂ∑•‰∏≠ Parasitic Infections Protozoa infections Protozoa are single celled parasites under the parent category of parasites.</description></item><item><title>pathology of hodgkin lymphoma (HL)</title><link>https://www.physician.tw/pathology-of-hodgkin-lymphoma-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathology-of-hodgkin-lymphoma-HL/</guid><description>[!info]
üå± ‰æÜËá™: [[hodgkin lymphoma (HL)]]
pathology of hodgkin lymphoma (HL) #üöß ÊñΩÂ∑•‰∏≠ pathology of hodgkin lymphoma (HL) ‚Ä¢ Affected nodes show RS cells (&amp;lt;1%) in background of non-neoplastic inflammatory cells ‚Ä¢ Classic RS cells: bilobed nucleus &amp;amp; prominent nucleoli with surrounding clear space (‚Äúowl‚Äôs eyes‚Äù).</description></item><item><title>Peripheral Eosinophilia and Hypereosinophilia Syndromes</title><link>https://www.physician.tw/Peripheral-Eosinophilia-and-Hypereosinophilia-Syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peripheral-Eosinophilia-and-Hypereosinophilia-Syndromes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Peripheral Eosinophilia and Hypereosinophilia Syndromes #üöß ÊñΩÂ∑•‰∏≠ Peripheral Eosinophilia and Hypereosinophilia Syndromes ‚Ä¢¬†Definition</description></item><item><title>Peripheral Nervous System</title><link>https://www.physician.tw/Peripheral-Nervous-System/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peripheral-Nervous-System/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Peripheral Nervous System #üöß ÊñΩÂ∑•‰∏≠ Peripheral Nervous System Includes nerves and ganglia outside the brain and spinal cord.</description></item><item><title>Personality Disorders</title><link>https://www.physician.tw/Personality-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Personality-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Personality Disorders #üöß ÊñΩÂ∑•‰∏≠ Personality Disorders Definitions:
‚Ä¢¬†Personality: Patterns of relating to and perceiving the world and oneself that persist across multiple contexts</description></item><item><title>Phases of the Cardiac Cycle</title><link>https://www.physician.tw/Phases-of-the-Cardiac-Cycle/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phases-of-the-Cardiac-Cycle/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Phases of the Cardiac Cycle #üöß ÊñΩÂ∑•‰∏≠ Phases of the Cardiac Cycle ‚Ä¢¬†Diastole:</description></item><item><title>Phosphate</title><link>https://www.physician.tw/Phosphate/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phosphate/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Phosphate #üöß ÊñΩÂ∑•‰∏≠ Phosphate Phosphate regulation (PO4‚Äì 3.0‚Äì4.5 mg/dL) ‚Ä¢¬†Distribution: Most phosphorus is in the bones (85%), remainder is in the soft tissues (15%)</description></item><item><title>Physical Exam</title><link>https://www.physician.tw/Physical-Exam/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-Exam/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Physical Exam #üöß ÊñΩÂ∑•‰∏≠ Physical Exam ‚Ä¢¬†Purpose: The cornerstone of dermatologic diagnosis is the physical exam</description></item><item><title>Physical Exam, Labs, and Other Data</title><link>https://www.physician.tw/Physical-Exam-Labs-and-Other-Data/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-Exam-Labs-and-Other-Data/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Physical Exam, Labs, and Other Data #üöß ÊñΩÂ∑•‰∏≠ Physical Exam, Labs, and Other Data TABLE A1.</description></item><item><title>Plasma Cell Disorders</title><link>https://www.physician.tw/Plasma-Cell-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Plasma-Cell-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Plasma Cell Disorders #üöß ÊñΩÂ∑•‰∏≠ Plasma Cell Disorders A framework for plasma cell disorders:</description></item><item><title>plasma cell dyscrasias üöß ÊñΩÂ∑•‰∏≠</title><link>https://www.physician.tw/plasma-cell-dyscrasias/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/plasma-cell-dyscrasias/</guid><description>[!info]
üå± ‰æÜËá™: [[plasma cell dyscrasiasxxx]]
[[spectrum of nonmalignant to malignant clonal plasma cell disorders]]
[[monoclonal gammopathy of uncertain significance (MGUS)]]</description></item><item><title>polycystic ovary syndrome</title><link>https://www.physician.tw/polycystic-ovary-syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polycystic-ovary-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[endocrinology]]
polycystic ovary syndrome #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Polycythemia</title><link>https://www.physician.tw/Polycythemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polycythemia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Polycythemia #üöß ÊñΩÂ∑•‰∏≠ Polycythemia ‚Ä¢¬†Definition: High hemoglobin (Hbg &amp;gt;16.5 g/dL in men, Hbg &amp;gt;16 g/dL in women)</description></item><item><title>polycythemia¬†vera¬†(PV)</title><link>https://www.physician.tw/polycythemia-vera-PV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polycythemia-vera-PV/</guid><description>[!info]
üå± ‰æÜËá™: [[myeloproliferative neoplasms]]
polycythemia¬†vera¬†(PV) #üöß ÊñΩÂ∑•‰∏≠ polycythemia¬†vera¬†(PV) definition of myeloproliferative neoplasms
‚Ä¢ ‚Üë in RBC mass ¬± ‚Üë granulocytes and platelets in the absence of physiologic stimulus</description></item><item><title>Post-Intensive Care Syndrome &amp; Other Long-Term Physical and Cognitive Disability</title><link>https://www.physician.tw/Post-Intensive-Care-Syndrome-Other-Long-Term-Physical-and-Cognitive-Disability/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-Intensive-Care-Syndrome-Other-Long-Term-Physical-and-Cognitive-Disability/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Post-Intensive Care Syndrome &amp;amp; Other Long-Term Physical and Cognitive Disability #üöß ÊñΩÂ∑•‰∏≠ Post-Intensive Care Syndrome &amp;amp; Other Long-Term Physical and Cognitive Disability ‚Ä¢¬†Definition: Generally defined as new or worsening cognitive, psychiatric, and/or physical function</description></item><item><title>post-remission therapy of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/post-remission-therapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/post-remission-therapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[treatment of acute lymphoblastic leukemia (ALL)]]
post-remission therapy of treatment of acute lymphoblastic leukemia (ALL) #üöß ÊñΩÂ∑•‰∏≠ post-remission therapy of treatment of acute lymphoblastic leukemia (ALL) ¬†(choice depends on risk of recurrence)</description></item><item><title>Posterior Pituitary</title><link>https://www.physician.tw/Posterior-Pituitary/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Posterior-Pituitary/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Posterior Pituitary #üöß ÊñΩÂ∑•‰∏≠ Posterior Pituitary ‚ÜìAntidiuretic hormone (ADH): Diabetes insipidus (DI) ‚Ä¢¬†Etiology: ADH channels do not function to reabsorb water, either due to inadequate ADH (central) or lack of response to ADH at the kidneys (nephrogenic)</description></item><item><title>Potassium</title><link>https://www.physician.tw/Potassium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Potassium/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Potassium #üöß ÊñΩÂ∑•‰∏≠ Potassium Potassium regulation (K**+** 3.5‚Äì5.0 mEq/L) ‚Ä¢¬†Distribution:
-¬†98% intracellular, maintained by Na+/K+ ATPase</description></item><item><title>Practical Skills for Learners</title><link>https://www.physician.tw/Practical-Skills-for-Learners/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Practical-Skills-for-Learners/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
‰∏Ä‰∫õÂøÉÂæó [[medical textexapnd]]
Practical Skills for Learners [[how to write a history and physical]] (h&amp;amp;p)</description></item><item><title>Precision vs. Accuracy</title><link>https://www.physician.tw/Precision-vs.-Accuracy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precision-vs.-Accuracy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Precision vs. Accuracy #üöß ÊñΩÂ∑•‰∏≠ Precision vs. Accuracy ‚Ä¢¬†Precision/reliability: Does a test generate similar results on repeat measurements?</description></item><item><title>Preface</title><link>https://www.physician.tw/Preface/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preface/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
Preface #üöß ÊñΩÂ∑•‰∏≠ Preface Our goal in creating Symptom to Diagnosis was to develop an interesting, practical, and informative approach to teaching the diagnostic process in internal medicine.</description></item><item><title>Pregnancy-Related Liver Diseases</title><link>https://www.physician.tw/Pregnancy-Related-Liver-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pregnancy-Related-Liver-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Pregnancy-Related Liver Diseases #üöß ÊñΩÂ∑•‰∏≠ Pregnancy-Related Liver Diseases Hyperemesis gravidarum: First trimester, severe vomiting, elevated ALT.</description></item><item><title>preparing a patient for discharge</title><link>https://www.physician.tw/preparing-a-patient-for-discharge/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preparing-a-patient-for-discharge/</guid><description>[!info]
üå± ‰æÜËá™: [[Practical Skills for Learners]]
preparing a patient for discharge #üöß ÊñΩÂ∑•‰∏≠ preparing a patient for discharge [[Discharge Checklist]]</description></item><item><title>Prevalence vs. Incidence</title><link>https://www.physician.tw/Prevalence-vs.-Incidence/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevalence-vs.-Incidence/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Prevalence vs. Incidence #üöß ÊñΩÂ∑•‰∏≠ Prevalence vs. Incidence ‚Ä¢¬†Prevalence: Total cases in a population at a given time/total population (‚ÜìPrevalance can be due to more prevention or more treatment; ‚ÜëPrevalance if those living with the disease have a longer lifespan)</description></item><item><title>Preventative Health</title><link>https://www.physician.tw/Preventative-Health/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preventative-Health/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Preventative Health #üöß ÊñΩÂ∑•‰∏≠ Preventative Health ‚Ä¢¬†ASPREE. N Engl J Med 2018;379(16):1‚Äì10.</description></item><item><title>Primary Fever Syndromes</title><link>https://www.physician.tw/Primary-Fever-Syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Fever-Syndromes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Primary Fever Syndromes #üöß ÊñΩÂ∑•‰∏≠ Primary Fever Syndromes Fever ‚Ä¢¬†Definition: A regulated elevation in core body temperature, usually defined as ‚â•38.</description></item><item><title>Primary Headache Disorders</title><link>https://www.physician.tw/Primary-Headache-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Headache-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Primary Headache Disorders #üöß ÊñΩÂ∑•‰∏≠ Primary Headache Disorders Migraine headache ‚Ä¢¬†Symptoms:
-¬†POUND: Pulsatile quality, One day duration, Unilateral, Nausea/vomiting, Debilitating</description></item><item><title>primary¬†myelofibrosis¬†(PMF)</title><link>https://www.physician.tw/primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/primary-myelofibrosis-PMF/</guid><description>[!info]
üå± ‰æÜËá™: [[myeloproliferative neoplasms]]
primary¬†myelofibrosis¬†(PMF) [[definition of primary myelofibrosis (PMF)]]
[[etiologies of myelofibrosis]]
[[clinical manifestations of primary myelofibrosis (PMF)]]</description></item><item><title>Principles of Antibiotic Selection and Infection Management</title><link>https://www.physician.tw/Principles-of-Antibiotic-Selection-and-Infection-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-of-Antibiotic-Selection-and-Infection-Management/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Principles of Antibiotic Selection and Infection Management #üöß ÊñΩÂ∑•‰∏≠ Principles of Antibiotic Selection and Infection Management ‚Ä¢¬†Start antibiotics early: Early antibiotics in sepsis decrease mortality</description></item><item><title>ProceduralSurgical Interventions</title><link>https://www.physician.tw/ProceduralSurgical-Interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ProceduralSurgical-Interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
ProceduralSurgical Interventions #üöß ÊñΩÂ∑•‰∏≠ Procedural/Surgical Interventions Many procedures are done by cardiologists or cardiac surgeons.</description></item><item><title>prognosis of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/prognosis-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
üå± ‰æÜËá™: [[acute myelogenous leukemia (AML)]]
prognosis of acute myelogenous leukemia (AML) #üöß ÊñΩÂ∑•‰∏≠ prognosis of acute myelogenous leukemia (AML) ‚Ä¢ CR achieved in 70‚Äì80% of Pts &amp;lt;60 y and in 40‚Äì50% of Pts &amp;gt;60 y</description></item><item><title>prognosis of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/prognosis-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[chronic myelogenous leukemia (CML)]]
prognosis of chronic myelogenous leukemia (CML) #üöß ÊñΩÂ∑•‰∏≠ prognosis of chronic myelogenous leukemia (CML) ¬†(NEJM¬†2017;376:917)</description></item><item><title>prognosis of essential thrombocythemia (ET)</title><link>https://www.physician.tw/prognosis-of-essential-thrombocythemia-ET/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-essential-thrombocythemia-ET/</guid><description>[!info]
üå± ‰æÜËá™: [[essential thrombocythemia (ET)]]
prognosis of essential thrombocythemia (ET) #üöß ÊñΩÂ∑•‰∏≠ prognosis of essential thrombocythemia (ET) ‚Ä¢ Low-risk Pts have overall survival ‚âà control population</description></item><item><title>Prognosis of myelodysplastic syndromes</title><link>https://www.physician.tw/prognosis-of-myelodysplastic-syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-myelodysplastic-syndromes/</guid><description>[!info]
üå± ‰æÜËá™: [[myelodysplastic syndromes]]
Prognosis of myelodysplastic syndromes #üöß ÊñΩÂ∑•‰∏≠ Prognosis of myelodysplastic syndromes : mutations inTP53, ASXL1, EZH2, RUNX1, ETV6 (NEJM 2011; 364:2496) ‚Üì survival</description></item><item><title>prognosis of polycythemia vera (PV)</title><link>https://www.physician.tw/prognosis-of-polycythemia-vera-PV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-polycythemia-vera-PV/</guid><description>[!info]
üå± ‰æÜËá™: [[polycythemia vera (PV)]]
prognosis of polycythemia vera (PV) #üöß ÊñΩÂ∑•‰∏≠ prognosis of polycythemia vera (PV) ‚Ä¢ Median survival w/ Rx ~13.</description></item><item><title>prophylaxis supportive medications during HSCT</title><link>https://www.physician.tw/prophylaxis-supportive-medications-during-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prophylaxis-supportive-medications-during-HSCT/</guid><description> [!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
prophylaxis supportive medications during HSCT #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>psychiatric</title><link>https://www.physician.tw/psychiatric/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric/</guid><description>[!info]
üå± ‰æÜËá™: [[medical]]
psychiatric anatomy &amp;amp; physiology [[Mechanisms of Psychiatric Disease]]
psychiatric diagnostics [[Mental Status Exam]]
psychiatric approaches &amp;amp; chief complaints [[Depressed MoodSuicidal Ideation]]</description></item><item><title>psychiatric anatomy &amp; physiology</title><link>https://www.physician.tw/psychiatric-anatomy-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-anatomy-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric anatomy &amp;amp; physiology #üöß ÊñΩÂ∑•‰∏≠ psychiatric anatomy &amp;amp; physiology [[Mechanisms of Psychiatric Disease]]</description></item><item><title>psychiatric approaches &amp; chief complaints</title><link>https://www.physician.tw/psychiatric-approaches-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-approaches-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric approaches &amp;amp; chief complaints #üöß ÊñΩÂ∑•‰∏≠ psychiatric approaches &amp;amp; chief complaints [[Depressed MoodSuicidal Ideation]]</description></item><item><title>psychiatric diagnostics</title><link>https://www.physician.tw/psychiatric-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-diagnostics/</guid><description>[!info]
üå± ‰æÜËá™: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric diagnostics #üöß ÊñΩÂ∑•‰∏≠ psychiatric diagnostics [[Mental Status Exam]]</description></item><item><title>psychiatric diseases &amp; pathophysiology</title><link>https://www.physician.tw/psychiatric-diseases-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-diseases-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric diseases &amp;amp; pathophysiology #üöß ÊñΩÂ∑•‰∏≠ psychiatric diseases &amp;amp; pathophysiology [[Psychotic Disorders]]</description></item><item><title>psychiatric key clinical trials &amp; publications</title><link>https://www.physician.tw/psychiatric-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-key-clinical-trials-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric key clinical trials &amp;amp; publications #üöß ÊñΩÂ∑•‰∏≠ psychiatric key clinical trials &amp;amp; publications [[Major Depressive Disorder]]</description></item><item><title>psychiatric key medications &amp; interventions</title><link>https://www.physician.tw/psychiatric-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-key-medications-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric key medications &amp;amp; interventions #üöß ÊñΩÂ∑•‰∏≠ psychiatric key medications &amp;amp; interventions TABLE 13.</description></item><item><title>Psychiatry of Huppert's Notes</title><link>https://www.physician.tw/Psychiatry-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Psychiatry-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Psychiatry of Huppert&amp;rsquo;s Notes</description></item><item><title>Psychosis (e.g., Delusions andor Hallucinations)</title><link>https://www.physician.tw/Psychosis-e.g.-Delusions-andor-Hallucinations/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Psychosis-e.g.-Delusions-andor-Hallucinations/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Psychosis (e.g., Delusions andor Hallucinations) #üöß ÊñΩÂ∑•‰∏≠ Psychosis (e.g., Delusions and/or Hallucinations) ‚Ä¢¬†Definitions:</description></item><item><title>Psychotic Disorders</title><link>https://www.physician.tw/Psychotic-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Psychotic-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Psychotic Disorders #üöß ÊñΩÂ∑•‰∏≠ Psychotic Disorders Schizophrenia ‚Ä¢¬†Etiology: Likely multiple diseases with similar signs/symptoms (Neuropsychopharmacol 2009;34(9): 2081).</description></item><item><title>Pulmonary Function Testing (PFTs)</title><link>https://www.physician.tw/Pulmonary-Function-Testing-PFTs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Function-Testing-PFTs/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Pulmonary Function Testing (PFTs) #üöß ÊñΩÂ∑•‰∏≠ Pulmonary Function Testing (PFTs) ‚Ä¢¬†Approach to interpreting PFTs:</description></item><item><title>Pulmonary Hypertension (PH)</title><link>https://www.physician.tw/Pulmonary-Hypertension-PH/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Hypertension-PH/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Pulmonary Hypertension (PH) #üöß ÊñΩÂ∑•‰∏≠ Pulmonary Hypertension (PH) ‚Ä¢¬†Note: See Cardiology Chapter 1 for additional details</description></item><item><title>Pulmonary Infections</title><link>https://www.physician.tw/Pulmonary-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Pulmonary Infections #üöß ÊñΩÂ∑•‰∏≠ Pulmonary Infections Community acquired pneumonia (CAP) ‚Ä¢¬†Definition: An acute pulmonary infection that develops outside of the hospital or within the first 48 hours of admission</description></item><item><title>pulmonology anatomy and physiology</title><link>https://www.physician.tw/pulmonology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-anatomy-and-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology anatomy and physiology #üöß ÊñΩÂ∑•‰∏≠ pulmonology anatomy and physiology [[Anatomy of the Lungs]]</description></item><item><title>pulmonology approaches and chief complaints</title><link>https://www.physician.tw/pulmonology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-approaches-and-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology approaches and chief complaints #üöß ÊñΩÂ∑•‰∏≠ [[Key Terms and Definitions]]</description></item><item><title>pulmonology diagnostics</title><link>https://www.physician.tw/pulmonology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-diagnostics/</guid><description>[!info]
üå± ‰æÜËá™: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology diagnostics #üöß ÊñΩÂ∑•‰∏≠ pulmonology diagnostics [[Chest x-ray (CXR)]]
[[Chest CT]]</description></item><item><title>pulmonology diseases and pathophysiology</title><link>https://www.physician.tw/pulmonology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-diseases-and-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology diseases and pathophysiology #üöß ÊñΩÂ∑•‰∏≠ pulmonology diseases and pathophysiology [[Alveolar Hemorrhage]]</description></item><item><title>pulmonology key clinical trials and publications</title><link>https://www.physician.tw/pulmonology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-key-clinical-trials-and-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology key clinical trials and publications #üöß ÊñΩÂ∑•‰∏≠ pulmonology key clinical trials and publications [[books/h_note/Asthma]]</description></item><item><title>pulmonology key medications and interventions</title><link>https://www.physician.tw/pulmonology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-key-medications-and-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology key medications and interventions #üöß ÊñΩÂ∑•‰∏≠ pulmonology key medications and interventions [[Respiratory Support]]</description></item><item><title>Pulmonology of Huppert's Notes</title><link>https://www.physician.tw/Pulmonology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Pulmonology of Huppert&amp;rsquo;s Notes #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Qualitative Platelet Disorders</title><link>https://www.physician.tw/Qualitative-Platelet-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Qualitative-Platelet-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Qualitative Platelet Disorders #üöß ÊñΩÂ∑•‰∏≠ Qualitative Platelet Disorders ‚Ä¢¬†Definition: Normal platelet count but abnormal platelet function (i.</description></item><item><title>Quantitative Platelet Disorders</title><link>https://www.physician.tw/Quantitative-Platelet-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Quantitative-Platelet-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Quantitative Platelet Disorders #üöß ÊñΩÂ∑•‰∏≠ Quantitative Platelet Disorders Thrombocytopenia
‚Ä¢¬†Definition*:* Low number of platelets (&amp;lt;150K/Œºl)</description></item><item><title>Rash</title><link>https://www.physician.tw/Rash/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rash/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Rash #üöß ÊñΩÂ∑•‰∏≠ Rash ‚Ä¢¬†Approach to the patient with a rash:
-¬†General approach: Typically, start with a physical exam before taking an extensive history</description></item><item><title>RBC Disorders</title><link>https://www.physician.tw/RBC-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RBC-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
RBC Disorders #üöß ÊñΩÂ∑•‰∏≠ RBC Disorders Anemia
‚Ä¢¬†Definition: Low hemoglobin (Hg &amp;lt;13 g/dL in men, Hg &amp;lt;12 g/dL in women)</description></item><item><title>Regular Atrial Rhythms</title><link>https://www.physician.tw/Regular-Atrial-Rhythms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Regular-Atrial-Rhythms/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Regular Atrial Rhythms #üöß ÊñΩÂ∑•‰∏≠ Regular Atrial Rhythms Sinus tachycardia (ST) ‚Ä¢¬†Etiologies: Infection, hypovolemia/hemorrhage, hypoxia, anemia, anxiety, PE, alcohol withdrawal, hyperthyroidism.</description></item><item><title>relapse refractory of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/relapse-refractory-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/relapse-refractory-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[treatment of acute lymphoblastic leukemia (ALL)]]
relapse refractory of treatment of acute lymphoblastic leukemia (ALL) #üöß ÊñΩÂ∑•‰∏≠ relapse refractory of treatment of acute lymphoblastic leukemia (ALL) salvage therapy (below), then allogeneic HSCT if able</description></item><item><title>Renal Anatomy</title><link>https://www.physician.tw/Renal-Anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Anatomy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Anatomy #üöß ÊñΩÂ∑•‰∏≠ Renal Anatomy FIGURE 6.1: Anatomy of the urinary tract and kidney.</description></item><item><title>Renal Artery Stenosis</title><link>https://www.physician.tw/Renal-Artery-Stenosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Artery-Stenosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Artery Stenosis #üöß ÊñΩÂ∑•‰∏≠ Renal Artery Stenosis ‚Ä¢¬†CORAL. N Eng J Med 2014;370(1):13‚Äì22.</description></item><item><title>Renal Cystic Diseases</title><link>https://www.physician.tw/Renal-Cystic-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Cystic-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Cystic Diseases #üöß ÊñΩÂ∑•‰∏≠ Renal Cystic Diseases Renal cysts ‚Ä¢¬†Classification: Categorized as simple or complex based on imaging appearance</description></item><item><title>Renal Dysfunction</title><link>https://www.physician.tw/Renal-Dysfunction/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Dysfunction/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Dysfunction #üöß ÊñΩÂ∑•‰∏≠ Renal Dysfunction</description></item><item><title>Renal Formulas</title><link>https://www.physician.tw/Renal-Formulas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Formulas/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Formulas #üöß ÊñΩÂ∑•‰∏≠ Renal Formulas ‚Ä¢¬†Important renal concepts and formulas: See Table 6.</description></item><item><title>Renal Physiology</title><link>https://www.physician.tw/Renal-Physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Physiology #üöß ÊñΩÂ∑•‰∏≠ Renal Physiology FIGURE 6.2: Diagram of the nephron. The nephron is the functional unit of the kidney that uses four mechanisms to process the filtrate: filtration, reabsorption, secretion, and excretion.</description></item><item><title>Renal Tubular Acidosis (RTA)</title><link>https://www.physician.tw/Renal-Tubular-Acidosis-RTA/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Tubular-Acidosis-RTA/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Tubular Acidosis (RTA) #üöß ÊñΩÂ∑•‰∏≠ Renal Tubular Acidosis (RTA) RTA Type I (Distal) ‚Ä¢¬†Pathophysiology: Defect in collecting tubule‚Äôs ability to excrete H+ due to congenital causes, multiple myeloma, autoimmunity, amphotericin B toxicity</description></item><item><title>Renal Vascular Diseases</title><link>https://www.physician.tw/Renal-Vascular-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Vascular-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Renal Vascular Diseases #üöß ÊñΩÂ∑•‰∏≠ Renal Vascular Diseases Renal artery stenosis ‚Ä¢¬†Etiology: Majority of cases are due to atherosclerosis, most others are due to fibromuscular dysplasia (often in young women, 50% bilateral, can be hereditary).</description></item><item><title>reproductive endocrinology</title><link>https://www.physician.tw/reproductive-endocrinology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/reproductive-endocrinology/</guid><description>[!info]
üå± ‰æÜËá™: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
reproductive endocrinology #üöß ÊñΩÂ∑•‰∏≠ reproductive endocrinology FIGURE 5.5: Hypothalamic‚Äìpituitary‚Äìgonadal axis. Shown is the hypothalamic‚Äìpituitary‚Äìgonadal axis, which regulates the production of the sex hormones estradiol and testosterone.</description></item><item><title>Respiratory Acidosis</title><link>https://www.physician.tw/Respiratory-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Acidosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Respiratory Acidosis #üöß ÊñΩÂ∑•‰∏≠ Respiratory Acidosis ‚ÜìpH, ‚ÜëPaCO2**, (Delayed compensation:‚ÜëHCO3‚Äì)**
‚Ä¢¬†Clinical features: Somnolence, confusion, myoclonus, headache, papilledema</description></item><item><title>Respiratory Alkalosis</title><link>https://www.physician.tw/Respiratory-Alkalosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Alkalosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Respiratory Alkalosis #üöß ÊñΩÂ∑•‰∏≠ Respiratory Alkalosis ‚ÜëpH, ‚ÜìPaCO2**, (Delayed compensation:** ‚ÜìHCO3‚Äì)
‚Ä¢¬†Clinical features: Decreased cerebral blood flow: dizziness, anxiety; tetany (indistinguishable from hypocalcemia), arrhythmias if severe</description></item><item><title>Respiratory Distress</title><link>https://www.physician.tw/Respiratory-Distress/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Distress/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Respiratory Distress #üöß ÊñΩÂ∑•‰∏≠ Respiratory Distress ‚Ä¢¬†Ask for help: Call your team and consider rapid response</description></item><item><title>Respiratory Support</title><link>https://www.physician.tw/Respiratory-Support/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Support/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Respiratory Support #üöß ÊñΩÂ∑•‰∏≠ Respiratory Support TABLE 3.6 ‚Ä¢ Supplemental oxygen delivery devices</description></item><item><title>Restrictive Lung Diseases</title><link>https://www.physician.tw/Restrictive-Lung-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Restrictive-Lung-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Restrictive Lung Diseases #üöß ÊñΩÂ∑•‰∏≠ Restrictive Lung Diseases ‚Ä¢¬†Restrictive = ‚ÜìCompliance, ‚ÜëElastance‚Üí Problem getting air in.</description></item><item><title>Rheumatologic Differential Diagnosis for Common Clinical Syndromes</title><link>https://www.physician.tw/Rheumatologic-Differential-Diagnosis-for-Common-Clinical-Syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatologic-Differential-Diagnosis-for-Common-Clinical-Syndromes/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Rheumatologic Differential Diagnosis for Common Clinical Syndromes #üöß ÊñΩÂ∑•‰∏≠ Rheumatologic Differential Diagnosis for Common Clinical Syndromes TABLE 9.</description></item><item><title>rheumatology anatomy &amp; physiology</title><link>https://www.physician.tw/rheumatology-anatomy-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-anatomy-physiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology anatomy &amp;amp; physiology #üöß ÊñΩÂ∑•‰∏≠ rheumatology anatomy &amp;amp; physiology [[Axial and Appendicular Skeleton]]</description></item><item><title>rheumatology approaches &amp; chief complaints</title><link>https://www.physician.tw/rheumatology-approaches-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-approaches-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology approaches &amp;amp; chief complaints #üöß ÊñΩÂ∑•‰∏≠ rheumatology approaches &amp;amp; chief complaints [[Diagnostic Approach to Joint Pain]]</description></item><item><title>rheumatology diagnostics</title><link>https://www.physician.tw/rheumatology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-diagnostics/</guid><description>[!info]
üå± ‰æÜËá™: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology diagnostics #üöß ÊñΩÂ∑•‰∏≠ rheumatology diagnostics [[Diagnostic Reasoning in Rheumatology]]
[[Approach to Reading a Hand X-Ray]]</description></item><item><title>rheumatology diseases &amp; pathophysiology</title><link>https://www.physician.tw/rheumatology-diseases-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-diseases-pathophysiology/</guid><description>[!info]
üå± ‰æÜËá™: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology diseases &amp;amp; pathophysiology #üöß ÊñΩÂ∑•‰∏≠ rheumatology diseases &amp;amp; pathophysiology [[ANA-Associated Connective Tissue Disorders]]</description></item><item><title>rheumatology key clinical trials &amp; publications</title><link>https://www.physician.tw/rheumatology-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-key-clinical-trials-publications/</guid><description>[!info]
üå± ‰æÜËá™: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology key clinical trials &amp;amp; publications #üöß ÊñΩÂ∑•‰∏≠ rheumatology key clinical trials &amp;amp; publications [[books/h_note/Rheumatoid Arthritis]]</description></item><item><title>rheumatology key medications &amp; interventions</title><link>https://www.physician.tw/rheumatology-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-key-medications-interventions/</guid><description>[!info]
üå± ‰æÜËá™: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology key medications &amp;amp; interventions #üöß ÊñΩÂ∑•‰∏≠ rheumatology key medications &amp;amp; interventions [[Anti-Inflammatory Agents]]</description></item><item><title>Rheumatology of Huppert's Notes</title><link>https://www.physician.tw/Rheumatology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-of-Hupperts-Notes/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]</description></item><item><title>Rhinitis</title><link>https://www.physician.tw/Rhinitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rhinitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Rhinitis #üöß ÊñΩÂ∑•‰∏≠ Rhinitis ‚Ä¢¬†Physical exam: Inspect the nasal cavities and oropharynx</description></item><item><title>Right Heart Catheterization</title><link>https://www.physician.tw/Right-Heart-Catheterization/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Right-Heart-Catheterization/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Right Heart Catheterization #üöß ÊñΩÂ∑•‰∏≠ Right Heart Catheterization ‚Ä¢¬†Procedure: Insertation of a catheter into the right heart and pulmonary arteries usually via the IJ or brachial vein in order to measure the RA, RV, PA, and wedge pressures as well as cardiac output.</description></item><item><title>S. aureus Bacteremia</title><link>https://www.physician.tw/S.-aureus-Bacteremia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/S.-aureus-Bacteremia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
S. aureus Bacteremia #üöß ÊñΩÂ∑•‰∏≠ S. aureus Bacteremia ‚Ä¢¬†Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.</description></item><item><title>Sarcoma</title><link>https://www.physician.tw/Sarcoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sarcoma/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sarcoma #üöß ÊñΩÂ∑•‰∏≠ Sarcoma Soft tissue sarcoma
‚Ä¢¬†Epidemiology: Rare, heterogeneous tumor of mesenchymal origin.</description></item><item><title>Secondary Headache Disorders</title><link>https://www.physician.tw/Secondary-Headache-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-Headache-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Secondary Headache Disorders #üöß ÊñΩÂ∑•‰∏≠ Secondary Headache Disorders Medication overuse headache (‚Äúrebound headache‚Äù) ‚Ä¢¬†Drugs that cause rebound headaches: Abortive medications taken ‚â•2 times per week, such as acetaminophen-butalbital-caffeine, APAP, NSAIDs, caffeine, ergotamine, opioids, triptans</description></item><item><title>Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value</title><link>https://www.physician.tw/Sensitivity-Specificity-Positive-Predictive-Value-and-Negative-Predictive-Value/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sensitivity-Specificity-Positive-Predictive-Value-and-Negative-Predictive-Value/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value #üöß ÊñΩÂ∑•‰∏≠ Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value FIGURE A2.</description></item><item><title>Severe Cutaneous Drug Reactions</title><link>https://www.physician.tw/Severe-Cutaneous-Drug-Reactions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Severe-Cutaneous-Drug-Reactions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Severe Cutaneous Drug Reactions #üöß ÊñΩÂ∑•‰∏≠ Severe Cutaneous Drug Reactions Can be life threatening due to profound insensible losses and resultant fluid and electrolyte shifts.</description></item><item><title>Sexually Transmitted Diseases</title><link>https://www.physician.tw/Sexually-Transmitted-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sexually-Transmitted-Diseases/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sexually Transmitted Diseases #üöß ÊñΩÂ∑•‰∏≠ Sexually Transmitted Diseases ‚Ä¢¬†[Guideline] Sexually transmitted diseases treatment guidelines, 2015.</description></item><item><title>Sexually Transmitted Infections (STIs)</title><link>https://www.physician.tw/Sexually-Transmitted-Infections-STIs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sexually-Transmitted-Infections-STIs/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sexually Transmitted Infections (STIs) #üöß ÊñΩÂ∑•‰∏≠ Sexually Transmitted Infections (STIs) Chlamydia &amp;amp; gonorrhea ‚Ä¢¬†Pathogens: Chlamydia trachomatis &amp;amp; Neisseria gonorrhoeae.</description></item><item><title>SGLT2 Inhibitors in Diabetic Kidney Disease</title><link>https://www.physician.tw/SGLT2-Inhibitors-in-Diabetic-Kidney-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SGLT2-Inhibitors-in-Diabetic-Kidney-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
SGLT2 Inhibitors in Diabetic Kidney Disease #üöß ÊñΩÂ∑•‰∏≠ SGLT2 Inhibitors in Diabetic Kidney Disease ‚Ä¢¬†CREDENCE.</description></item><item><title>Shock Management</title><link>https://www.physician.tw/Shock-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Shock-Management/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Shock Management #üöß ÊñΩÂ∑•‰∏≠ Shock Management ‚Ä¢¬†SMART Trial. New Engl J Med 2018;378(9):829‚Äì839.</description></item><item><title>Sick Euthyroid Syndrome</title><link>https://www.physician.tw/Sick-Euthyroid-Syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sick-Euthyroid-Syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sick Euthyroid Syndrome #üöß ÊñΩÂ∑•‰∏≠ Sick Euthyroid Syndrome ‚Ä¢¬†Pathophysiology: Illness causes caloric deprivation and an increased inflammatory state, which may lead to abnormal thyroid function tests</description></item><item><title>Sinusitis</title><link>https://www.physician.tw/Sinusitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sinusitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sinusitis #üöß ÊñΩÂ∑•‰∏≠ Sinusitis ‚Ä¢¬†Physical exam: Palpate the sinuses (frontal, ethmoid, maxillary); inspect the oropharynx and nasal cavities; perform a cranial nerve exam</description></item><item><title>SIRS, Sepsis, Severe Sepsis, and Septic Shock</title><link>https://www.physician.tw/SIRS-Sepsis-Severe-Sepsis-and-Septic-Shock/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SIRS-Sepsis-Severe-Sepsis-and-Septic-Shock/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
SIRS, Sepsis, Severe Sepsis, and Septic Shock #üöß ÊñΩÂ∑•‰∏≠ SIRS, Sepsis, Severe Sepsis, and Septic Shock ‚Ä¢¬†Introduction:</description></item><item><title>Skin and Soft Tissue Infections (SSTIs)</title><link>https://www.physician.tw/Skin-and-Soft-Tissue-Infections-SSTIs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Skin-and-Soft-Tissue-Infections-SSTIs/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Skin and Soft Tissue Infections (SSTIs) #üöß ÊñΩÂ∑•‰∏≠ Skin and Soft Tissue Infections (SSTIs) Non-purulent and purulent cellulitis ‚Ä¢¬†Pathophysiology: Cellulitis is an infection of the deeper layers of the dermis.</description></item><item><title>Small Bowel</title><link>https://www.physician.tw/Small-Bowel/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Small-Bowel/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Small Bowel #üöß ÊñΩÂ∑•‰∏≠ Small Bowel</description></item><item><title>small lymphocytic lymphoma</title><link>https://www.physician.tw/small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/small-lymphocytic-lymphoma/</guid><description> [!info]
üå± ‰æÜËá™: [[leukemia]]
small lymphocytic lymphoma #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Small Vessel Vasculitis ANCA-Associated Vasculitides (AAV)</title><link>https://www.physician.tw/Small-Vessel-Vasculitis-ANCA-Associated-Vasculitides-AAV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Small-Vessel-Vasculitis-ANCA-Associated-Vasculitides-AAV/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Small Vessel Vasculitis ANCA-Associated Vasculitides (AAV) #üöß ÊñΩÂ∑•‰∏≠ Small Vessel Vasculitis: ANCA-Associated Vasculitides (AAV) Granulomatosis with polyangiitis (GPA, formerly Wegener‚Äôs granulomatosis)</description></item><item><title>Small Vessel Vasculitis Immune-Complex Mediated</title><link>https://www.physician.tw/Small-Vessel-Vasculitis-Immune-Complex-Mediated/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Small-Vessel-Vasculitis-Immune-Complex-Mediated/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Small Vessel Vasculitis Immune-Complex Mediated #üöß ÊñΩÂ∑•‰∏≠ Small Vessel Vasculitis: Immune-Complex Mediated Palpable purpura on exam, leukocytoclastic vasculitis on skin biopsy</description></item><item><title>small¬†lymphocytic¬†lymphoma</title><link>https://www.physician.tw/small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/small-lymphocytic-lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[non-Hodgkin lymphoma (NHL)]]
small¬†lymphocytic¬†lymphoma #üöß ÊñΩÂ∑•‰∏≠ (SLL)¬†OR¬†CHRONICLYMPHOCYTIC¬†LEUKEMIA¬†(CLL)
[[definition of small lymphocytic lymphoma]]</description></item><item><title>smears</title><link>https://www.physician.tw/smears/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/smears/</guid><description> [!info]
üå± ‰æÜËá™: [[hematology]]
smears #üöß ÊñΩÂ∑•‰∏≠ [[Evaluation of a Peripheral Blood Smear]] Evaluation of the peripheral blood smear - UpToDate</description></item><item><title>Sodium</title><link>https://www.physician.tw/Sodium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sodium/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Sodium #üöß ÊñΩÂ∑•‰∏≠ Sodium Sodium homeostasis (Na**+** 135 to 145 mmol/L) ‚Ä¢¬†Extracellular Na+ concentration reflects water homeostasis: Hyponatremia and hypernatremia are caused by too much/too little water.</description></item><item><title>Somatic Symptom and Related Disorders</title><link>https://www.physician.tw/Somatic-Symptom-and-Related-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Somatic-Symptom-and-Related-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Somatic Symptom and Related Disorders #üöß ÊñΩÂ∑•‰∏≠ Somatic Symptom and Related Disorders ‚Ä¢¬†Somatic symptom disorder: Somatic symptoms with excessive thoughts, anxieties, or behaviors causing significant disruption to social, occupational, and/or other areas of functioning lasting &amp;gt;6 months.</description></item><item><title>spectrum of nonmalignant to malignant clonal plasma cell disorders</title><link>https://www.physician.tw/spectrum-of-nonmalignant-to-malignant-clonal-plasma-cell-disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spectrum-of-nonmalignant-to-malignant-clonal-plasma-cell-disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[plasma cell dyscrasias]]
spectrum of nonmalignant to malignant clonal plasma cell disorders #üöß ÊñΩÂ∑•‰∏≠ spectrum of nonmalignant to malignant clonal plasma cell disorders see figure</description></item><item><title>Spondyloarthritis (SpA)</title><link>https://www.physician.tw/Spondyloarthritis-SpA/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spondyloarthritis-SpA/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Spondyloarthritis (SpA) #üöß ÊñΩÂ∑•‰∏≠ Spondyloarthritis (SpA) Group of disorders with shared features of inflammatory arthritis with varying degrees of axial skeleton involvement, enthesitis (inflammation of tendon-bone insertion points), overt or subclinical intestinal inflammation, association with uveitis, and association with the HLA-B27 MHC allele.</description></item><item><title>Statics Volumes Capacities, Compliance, and Surface Tension</title><link>https://www.physician.tw/Statics-Volumes-Capacities-Compliance-and-Surface-Tension/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Statics-Volumes-Capacities-Compliance-and-Surface-Tension/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Statics VolumesCapacities, Compliance, and Surface Tension #üöß ÊñΩÂ∑•‰∏≠ Statics: Volumes/Capacities, Compliance, and Surface Tension ‚Ä¢¬†Volumes and Capacities:</description></item><item><title>Statins in ESRD</title><link>https://www.physician.tw/Statins-in-ESRD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Statins-in-ESRD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Statins in ESRD #üöß ÊñΩÂ∑•‰∏≠ Statins in ESRD ‚Ä¢¬†4D. N Eng J Med 2005;353:238‚Äì248.</description></item><item><title>statistical concepts and test characteristics</title><link>https://www.physician.tw/statistical-concepts-and-test-characteristics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/statistical-concepts-and-test-characteristics/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
statistical concepts and test characteristics #üöß ÊñΩÂ∑•‰∏≠ statistical concepts and test characteristics [[Odds Ratio, Risk Ratio, and Related Statistics]]</description></item><item><title>Stem Cell Transplant Basics</title><link>https://www.physician.tw/Stem-Cell-Transplant-Basics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stem-Cell-Transplant-Basics/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Stem Cell Transplant Basics #üöß ÊñΩÂ∑•‰∏≠ Stem Cell Transplant Basics ‚Ä¢¬†Types of hematopoietic stem cells (HSCs):</description></item><item><title>Stomach</title><link>https://www.physician.tw/Stomach/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stomach/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Stomach #üöß ÊñΩÂ∑•‰∏≠ Stomach Peptic ulcer disease (PUD) ‚Ä¢¬†Pathophysiology: Ulcers that develop in the stomach or duodenum.</description></item><item><title>Stones and Obstructions</title><link>https://www.physician.tw/Stones-and-Obstructions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stones-and-Obstructions/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Stones and Obstructions #üöß ÊñΩÂ∑•‰∏≠ Stones and Obstructions Nephrolithiasis (kidney stones) ‚Ä¢¬†Types:</description></item><item><title>Structure and Function of the Skin</title><link>https://www.physician.tw/Structure-and-Function-of-the-Skin/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Structure-and-Function-of-the-Skin/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Structure and Function of the Skin #üöß ÊñΩÂ∑•‰∏≠ Structure and Function of the Skin ‚Ä¢¬†Function of skin: The skin is a large, complex organ with a variety of important functions: Mechanical barrier, temperature regulation, fluid balance, immune response</description></item><item><title>Structure and Innervation of the GI Tract</title><link>https://www.physician.tw/Structure-and-Innervation-of-the-GI-Tract/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Structure-and-Innervation-of-the-GI-Tract/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Structure and Innervation of the GI Tract #üöß ÊñΩÂ∑•‰∏≠ Structure and Innervation of the GI Tract ‚Ä¢¬†Components: The GI tract includes epithelial cells (specialized for absorption/secretion), muscularis mucosa (changes surface area for absorption/secretion), circular muscle (decreases the diameter of the lumen), and longitudinal muscle (shortens a segment of the GI tract)</description></item><item><title>Substance Use Disorders</title><link>https://www.physician.tw/Substance-Use-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Substance-Use-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Substance Use Disorders #üöß ÊñΩÂ∑•‰∏≠ Substance Use Disorders ‚Ä¢¬†Overview: Named by type of substance involved in problematic use (i.</description></item><item><title>Substance Use Disorders and Treatments</title><link>https://www.physician.tw/Substance-Use-Disorders-and-Treatments/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Substance-Use-Disorders-and-Treatments/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Substance Use Disorders and Treatments #üöß ÊñΩÂ∑•‰∏≠ Substance Use Disorders and Treatments ‚Ä¢¬†Methadone maintenance vs.</description></item><item><title>symptoms &amp; chief complaints</title><link>https://www.physician.tw/symptoms-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/symptoms-chief-complaints/</guid><description>[!info]
üå± ‰æÜËá™: [[General Medicine of Huppert&amp;rsquo;s Notes]]
symptoms &amp;amp; chief complaints #üöß ÊñΩÂ∑•‰∏≠ symptoms &amp;amp; chief complaints [[Head and Neck]]</description></item><item><title>Synovial Joint Anatomy</title><link>https://www.physician.tw/Synovial-Joint-Anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Synovial-Joint-Anatomy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Synovial Joint Anatomy #üöß ÊñΩÂ∑•‰∏≠ Synovial Joint Anatomy ‚Ä¢¬†Joint capsule (‚Äúarticular capsule‚Äù): Envelope surrounding a synovial joint that connects to the periosteum (Figure 9.</description></item><item><title>Systemic Fungal Infections</title><link>https://www.physician.tw/Systemic-Fungal-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-Fungal-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Systemic Fungal Infections #üöß ÊñΩÂ∑•‰∏≠ Systemic Fungal Infections ‚Ä¢¬†Pathogens:
-¬†See Tables 8.</description></item><item><title>Systemic Lupus Erythematosus (SLE)</title><link>https://www.physician.tw/Systemic-Lupus-Erythematosus-SLE/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-Lupus-Erythematosus-SLE/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Systemic Lupus Erythematosus (SLE) #üöß ÊñΩÂ∑•‰∏≠ Systemic Lupus Erythematosus (SLE) ‚Ä¢¬†A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.</description></item><item><title>Systemic Scleroderma</title><link>https://www.physician.tw/Systemic-Scleroderma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-Scleroderma/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Systemic Scleroderma #üöß ÊñΩÂ∑•‰∏≠ Systemic Scleroderma ‚Ä¢¬†Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II Study).</description></item><item><title>Tachycardia</title><link>https://www.physician.tw/Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tachycardia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Tachycardia #üöß ÊñΩÂ∑•‰∏≠ Tachycardia Tachycardia is defined as having a heart rate &amp;gt;100 bpm.</description></item><item><title>Targeted Therapies</title><link>https://www.physician.tw/Targeted-Therapies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Targeted-Therapies/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Targeted Therapies #üöß ÊñΩÂ∑•‰∏≠ Targeted Therapies ‚Ä¢¬†Nomenclature:
-¬†Small molecule inhibitors end in ‚Äú-inib‚Äù</description></item><item><title>The Assessment and Plan (A&amp;P)</title><link>https://www.physician.tw/The-Assessment-and-Plan-AP/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Assessment-and-Plan-AP/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
The Assessment and Plan (A&amp;amp;P) #üöß ÊñΩÂ∑•‰∏≠ The Assessment and Plan (A&amp;amp;P) The assessment and plan (A&amp;amp;P) is the most important part of the H&amp;amp;P (and the oral presentation).</description></item><item><title>The Coagulation Cascade</title><link>https://www.physician.tw/The-Coagulation-Cascade/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Coagulation-Cascade/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
The Coagulation Cascade #üöß ÊñΩÂ∑•‰∏≠ The Coagulation Cascade FIGURE 7.2: The coagulation cascade. The intrinsic pathway and extrinsic pathways converge in the common pathway.</description></item><item><title>The Neuroendocrine System of the Gut</title><link>https://www.physician.tw/The-Neuroendocrine-System-of-the-Gut/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Neuroendocrine-System-of-the-Gut/</guid><description> [!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
The Neuroendocrine System of the Gut #üöß ÊñΩÂ∑•‰∏≠ The Neuroendocrine System of the Gut [[Classification of GI regulatory substances]] [[GI regulatory substances]] [[Gastric secretions]]</description></item><item><title>The Neurologic Exam</title><link>https://www.physician.tw/The-Neurologic-Exam/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Neurologic-Exam/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
The Neurologic Exam #üöß ÊñΩÂ∑•‰∏≠ The Neurologic Exam Mental status ‚Ä¢¬†Orientation: Person, place, time, situation</description></item><item><title>Thrombocytosis</title><link>https://www.physician.tw/Thrombocytosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombocytosis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Thrombocytosis #üöß ÊñΩÂ∑•‰∏≠ Thrombocytosis ‚Ä¢¬†Definition: High number of platelets (platelets &amp;gt;450K/Œºl)
‚Ä¢¬†Etiologies:</description></item><item><title>Thrombotic Disorders</title><link>https://www.physician.tw/Thrombotic-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombotic-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Thrombotic Disorders #üöß ÊñΩÂ∑•‰∏≠ Thrombotic Disorders Inherited hypercoagulable states
‚Ä¢¬†Factor V Leiden: Autosomal dominant disorder, but heterozygotes have an increased risk of thrombosis (avoid OCPs).</description></item><item><title>Thyroid Disease</title><link>https://www.physician.tw/Thyroid-Disease-key-clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-Disease-key-clinical-trials/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Thyroid Disease #üöß ÊñΩÂ∑•‰∏≠ Thyroid Disease ‚Ä¢¬†Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association task force on thyroid hormone replacement.</description></item><item><title>Thyroid Nodule</title><link>https://www.physician.tw/Thyroid-Nodule/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-Nodule/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Thyroid Nodule #üöß ÊñΩÂ∑•‰∏≠ Thyroid Nodule ‚Ä¢¬†Etiologies:
-¬†Benign follicular epithelial cell adenomas (common, present in 5‚Äì10% of adults)</description></item><item><title>Tick-Borne Illnesses</title><link>https://www.physician.tw/Tick-Borne-Illnesses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tick-Borne-Illnesses/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Tick-Borne Illnesses #üöß ÊñΩÂ∑•‰∏≠ Tick-Borne Illnesses Lyme disease ‚Ä¢¬†Etiology: Borrelia burgdorferi spirochete is spread by the Ixodidae scapularis tick in the Northeastern United States, Northern Midwest.</description></item><item><title>timing of complications following allogeneic HSCT</title><link>https://www.physician.tw/timing-of-complications-following-allogeneic-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/timing-of-complications-following-allogeneic-HSCT/</guid><description> [!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
timing of complications following allogeneic HSCT #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Timing of Dialysis Initiation in CKD</title><link>https://www.physician.tw/Timing-of-Dialysis-Initiation-in-CKD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Timing-of-Dialysis-Initiation-in-CKD/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Timing of Dialysis Initiation in CKD #üöß ÊñΩÂ∑•‰∏≠ Timing of Dialysis Initiation in CKD ‚Ä¢¬†IDEAL.</description></item><item><title>Tracts of the CNS</title><link>https://www.physician.tw/Tracts-of-the-CNS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tracts-of-the-CNS/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Tracts of the CNS #üöß ÊñΩÂ∑•‰∏≠ Tracts of the CNS The CNS includes the brain and spinal cord.</description></item><item><title>Transfusion Medicine</title><link>https://www.physician.tw/Transfusion-Medicine/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-Medicine/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Transfusion Medicine #üöß ÊñΩÂ∑•‰∏≠ Transfusion Medicine Standard testing
‚Ä¢¬†ABO typing: Determine A/B antigens present on RBCs (blood type A, B, AB, or O)</description></item><item><title>Transient Ischemic Attack and Acute Ischemic Stroke</title><link>https://www.physician.tw/Transient-Ischemic-Attack-and-Acute-Ischemic-Stroke/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transient-Ischemic-Attack-and-Acute-Ischemic-Stroke/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Transient Ischemic Attack and Acute Ischemic Stroke #üöß ÊñΩÂ∑•‰∏≠ Transient Ischemic Attack and Acute Ischemic Stroke Transient ischemic attack (TIA) ‚Ä¢¬†Definition: Transient neurologic deficit that lasts &amp;lt;24 hr with a normal brain MRI</description></item><item><title>transient loss of consciousness</title><link>https://www.physician.tw/transient-loss-of-consciousness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transient-loss-of-consciousness/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
transient loss of consciousness #üöß ÊñΩÂ∑•‰∏≠ transient loss of consciousness Scott D. C. Stern, MD</description></item><item><title>transplantation procedure (for Allo HSCT)</title><link>https://www.physician.tw/transplantation-procedure-for-Allo-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transplantation-procedure-for-Allo-HSCT/</guid><description>[!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
transplantation procedure (for Allo HSCT) #üöß ÊñΩÂ∑•‰∏≠ transplantation procedure (for Allo HSCT) ‚Ä¢ Pre-Tx conditioning regimen goal: immunosuppression to allow donor cell engraftment &amp;amp; anti-tumor efficacy to ‚Üì relapse risk.</description></item><item><title>treatment and prognosis of multiple myeloma (MM)</title><link>https://www.physician.tw/treatment-and-prognosis-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-and-prognosis-of-multiple-myeloma-MM/</guid><description>[!info]
üå± ‰æÜËá™: [[multiple myeloma (MM)]]
treatment and prognosis of multiple myeloma (MM) #üöß ÊñΩÂ∑•‰∏≠ treatment and prognosis of multiple myeloma (MM) (NEJM 2016;375:754 &amp;amp; 1319; 2018;378:518 &amp;amp; 379:1811) ‚Ä¢ Decisions dictated by risk stratification and transplant eligibility; generally incurable.</description></item><item><title>Treatment for¬†JAK2¬†+ PV</title><link>https://www.physician.tw/Treatment-for-JAK2-+-PV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-for-JAK2-+-PV/</guid><description>[!info]
üå± ‰æÜËá™: [[polycythemia vera (PV)]]
Treatment for¬†JAK2¬†+ PV #üöß ÊñΩÂ∑•‰∏≠ Treatment for¬†JAK2¬†+ PV ‚Ä¢¬†Phlebotomy¬†to goal Hct &amp;lt;45%¬†(NEJM¬†2013;368:22), consider &amp;lt;42% in women</description></item><item><title>treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
üå± ‰æÜËá™: [[acute lymphoblastic leukemia (ALL)]]
treatment of acute lymphoblastic leukemia (ALL) [[induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL)]]</description></item><item><title>treatment of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/treatment-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
üå± ‰æÜËá™: [[chronic myelogenous leukemia (CML)]]
treatment of chronic myelogenous leukemia (CML) #üöß ÊñΩÂ∑•‰∏≠ treatment of chronic myelogenous leukemia (CML)¬† (Lancet¬†2015;385:1447;¬†Hematol Oncol Clin North Am2017;31:577)</description></item><item><title>treatment of hodgkin lymphoma (HL)</title><link>https://www.physician.tw/treatment-of-hodgkin-lymphoma-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-hodgkin-lymphoma-HL/</guid><description>[!info]
üå± ‰æÜËá™: [[hodgkin lymphoma (HL)]]
treatment of hodgkin lymphoma (HL) #üöß ÊñΩÂ∑•‰∏≠ treatment of hodgkin lymphoma (HL) (NCCN Guidelines v5.</description></item><item><title>treatment of myelodysplastic syndromes</title><link>https://www.physician.tw/treatment-of-myelodysplastic-syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-myelodysplastic-syndromes/</guid><description>[!info]
üå± ‰æÜËá™: [[myelodysplastic syndromes]]
treatment of myelodysplastic syndromes #üöß ÊñΩÂ∑•‰∏≠ treatment of myelodysplastic syndromes (Am J Hematol 2012;87:692): intensity based on IPSS-R (qv), age, performance status (PS) Poor PS, any risk ‚Üí supportive care (transfusions, G-CSF, Epo, TPO-mimetic, abx prn) Very low/low risk (IPSS-R) ‚Üí ESA if Epo &amp;lt;500; lenalidomide (esp.</description></item><item><title>treatment of non-Hodgkin lymphoma</title><link>https://www.physician.tw/treatment-of-non-Hodgkin-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-non-Hodgkin-lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[non-Hodgkin lymphoma (NHL)]]
treatment of non-Hodgkin lymphoma #üöß ÊñΩÂ∑•‰∏≠ treatment of non-Hodgkin lymphoma ¬†(Lancet¬†2017;390:298)</description></item><item><title>treatment of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/treatment-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-primary-myelofibrosis-PMF/</guid><description>[!info]
üå± ‰æÜËá™: [[primary myelofibrosis (PMF)]]
treatment of primary myelofibrosis (PMF) #üöß ÊñΩÂ∑•‰∏≠ treatment of primary myelofibrosis (PMF)¬† (Am J Hematol¬†2021;96:145)</description></item><item><title>treatment of small¬†lymphocytic¬†lymphoma</title><link>https://www.physician.tw/treatment-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-small-lymphocytic-lymphoma/</guid><description>[!info]
üå± ‰æÜËá™: [[small lymphocytic lymphoma]]
treatment of small¬†lymphocytic¬†lymphoma #üöß ÊñΩÂ∑•‰∏≠ treatment of small¬†lymphocytic¬†lymphoma ¬†(NEJM¬†2020;383:460)</description></item><item><title>treatment of waldenstrom‚Äôs macroglobulinemia (WM)</title><link>https://www.physician.tw/treatment-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
üå± ‰æÜËá™: [[waldenstrom‚Äôs macroglobulinemia (WM)]]
treatment of waldenstrom‚Äôs macroglobulinemia (WM) #üöß ÊñΩÂ∑•‰∏≠ treatment of waldenstrom‚Äôs macroglobulinemia (WM) ‚Ä¢ Hyperviscosity: plasmapheresis; limit transfusions if possible (worsen hyperviscosity) ‚Ä¢ Sx (eg, prog.</description></item><item><title>Types of Allo HSCT</title><link>https://www.physician.tw/Types-of-Allo-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-Allo-HSCT/</guid><description>[!info]
üå± ‰æÜËá™: [[hematopoietic stem cell transplantation]]
Types of Allo HSCT based on donor/recipient matching of major HLA antigens on Chr.</description></item><item><title>Types of Clinical Studies &amp; Trials</title><link>https://www.physician.tw/Types-of-Clinical-Studies-Trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-Clinical-Studies-Trials/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Types of Clinical Studies &amp;amp; Trials #üöß ÊñΩÂ∑•‰∏≠ Types of Clinical Studies &amp;amp; Trials ‚Ä¢¬†Case control study: Compares a group of patients with a disease (‚Äúcases‚Äù) to a group of patients who do not have the disease (‚Äúcontrols‚Äù).</description></item><item><title>unintentional weight loss</title><link>https://www.physician.tw/unintentional-weight-loss/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/unintentional-weight-loss/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
unintentional weight loss #üöß ÊñΩÂ∑•‰∏≠ unintentional weight loss Andrew Olson, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>upfront treatment of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/upfront-treatment-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/upfront-treatment-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
üå± ‰æÜËá™: [[acute myelogenous leukemia (AML)]]
upfront treatment of acute myelogenous leukemia (AML) #üöß ÊñΩÂ∑•‰∏≠ upfront treatment of acute myelogenous leukemia (AML) ‚Ä¢¬†Induction chemo¬†‚Äú7+3‚Äù: 7d cont.</description></item><item><title>Urinary Incontinence</title><link>https://www.physician.tw/Urinary-Incontinence/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Urinary-Incontinence/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Urinary Incontinence #üöß ÊñΩÂ∑•‰∏≠ Urinary Incontinence ‚Ä¢Physical exam: Abdominal exam, rectal exam, pelvic exam in females, consider post-void residual</description></item><item><title>Vascular Etiologies of Liver Disease</title><link>https://www.physician.tw/Vascular-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Etiologies-of-Liver-Disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Vascular Etiologies of Liver Disease #üöß ÊñΩÂ∑•‰∏≠ Vascular Etiologies of Liver Disease Portal vein thrombosis ‚Ä¢¬†Etiology: Blood clot in the hepatic portal vein, which can lead to increased pressure in the portal venous system and reduced blood supply to the liver</description></item><item><title>Vasculature of the GI Tract</title><link>https://www.physician.tw/Vasculature-of-the-GI-Tract/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vasculature-of-the-GI-Tract/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Vasculature of the GI Tract #üöß ÊñΩÂ∑•‰∏≠ Vasculature of the GI Tract FIGURE 4.</description></item><item><title>Vasculitis and Vasculopathy</title><link>https://www.physician.tw/Vasculitis-and-Vasculopathy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vasculitis-and-Vasculopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Vasculitis and Vasculopathy #üöß ÊñΩÂ∑•‰∏≠ Vasculitis and Vasculopathy ‚Ä¢¬†Leukocytoclastic vasculitis (LCV): Histopathologic term that describes nuclear debris from an inflammatory infiltrate; often used interchangeably with small vessel or cutaneous vasculitis</description></item><item><title>Vertigo</title><link>https://www.physician.tw/Vertigo/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vertigo/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Vertigo #üöß ÊñΩÂ∑•‰∏≠ Vertigo ‚Ä¢¬†Physical exam: Perform a cranial nerve exam and a HINTS exam (Head-Impulse, Nystagmus, Test of Skew); perform an otoscopic exam and assess for hearing loss; evaluate the patient‚Äôs gait; perform the Dix-Hallpike maneuver</description></item><item><title>vim TODO</title><link>https://www.physician.tw/vim-TODO/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim-TODO/</guid><description>[!info]
üå± ‰æÜËá™: [[Ëú•Ëú¥ËàáVIM]]
vim TODO #üöß ÊñΩÂ∑•‰∏≠ [[pandoc in vim]]
1
2
1. Enns RA, Hookey L, Armstrong D, et al.</description></item><item><title>Viral Infections</title><link>https://www.physician.tw/Viral-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Viral-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Viral Infections #üöß ÊñΩÂ∑•‰∏≠ Viral Infections DNA viruses TABLE 8.5 ‚Ä¢ Key Clinically Relevant DNA Viruses</description></item><item><title>Vision loss</title><link>https://www.physician.tw/Vision-loss/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vision-loss/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Vision loss #üöß ÊñΩÂ∑•‰∏≠ Vision loss ‚Ä¢¬†Physical exam: Perform a fundoscopic exam, pupillary exam, test visual acuity, extraocular motions, and peripheral vision.</description></item><item><title>Vulvovaginitis</title><link>https://www.physician.tw/Vulvovaginitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vulvovaginitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Vulvovaginitis #üöß ÊñΩÂ∑•‰∏≠ Vulvovaginitis ‚Ä¢¬†Physical exam: Pelvic exam
‚Ä¢¬†Differential diagnosis:
-¬†Bacterial vaginitis (BV)</description></item><item><title>waldenstrom‚Äôs macroglobulinemia (WM)</title><link>https://www.physician.tw/waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
üå± ‰æÜËá™: [[plasma cell dyscrasias]]
waldenstrom‚Äôs macroglobulinemia (WM) [[definition of waldenstrom‚Äôs macroglobulinemia (WM)]]
[[clinical manifestations of waldenstrom‚Äôs macroglobulinemia (WM)]]</description></item><item><title>WBC Disorders</title><link>https://www.physician.tw/WBC-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WBC-Disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
WBC Disorders #üöß ÊñΩÂ∑•‰∏≠ WBC Disorders Leukopenia
‚Ä¢¬†Definition: Low WBC (&amp;lt;4K/Œºl). If absolute neutrophil count (ANC) &amp;lt;1000/Œºl, that is called neutropenia and carries an increased risk of infection.</description></item><item><title>Weakness</title><link>https://www.physician.tw/Weakness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Weakness/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Weakness #üöß ÊñΩÂ∑•‰∏≠ Weakness ‚Ä¢¬†Step 1: Delineate neurologic versus non-neurologic causes of weakness and take a detailed history</description></item><item><title>wheezing or stridor</title><link>https://www.physician.tw/wheezing-or-stridor/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wheezing-or-stridor/</guid><description>[!info]
üå± ‰æÜËá™: [[sxtodx]]
wheezing or stridor #üöß ÊñΩÂ∑•‰∏≠ wheezing or stridor Nadia L. Bennett, MD, MSEd
CHIEF COMPLAINT PATIENT</description></item><item><title>WHO 2016 Classification of Myeloid Neoplasms &amp; Acute Leukemia</title><link>https://www.physician.tw/WHO-2016-Classification-of-Myeloid-Neoplasms-and-Acute-Leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-2016-Classification-of-Myeloid-Neoplasms-and-Acute-Leukemia/</guid><description>[!info]
üå± ‰æÜËá™: [[myelodysplastic syndromes]]
WHO 2016 Classification of Myeloid Neoplasms &amp;amp; Acute Leukemia #üöß ÊñΩÂ∑•‰∏≠ WHO 2016 Classification of Myeloid Neoplasms &amp;amp; Acute Leukemia Acute myeloid leukemia Clonal myeloid stem cell (SC) disorder w/ ‚â•20% blasts Myelodysplastic syndromes Dysplastic clonal myeloid SC disorder ‚Üí cytopenias; &amp;lt;20% blasts, risk of leukemic transformation Myeloproliferative neoplasms Nondysplastic multipotent myeloid SC clonal expansion MDS/MPN neoplasms Features of MDS &amp;amp; MPN (eg, CMML, atypical CML) Myeloid/lymphoid malig.</description></item><item><title>WHO 2016 Classification Systems for MDS</title><link>https://www.physician.tw/WHO-2016-Classification-Systems-for-MDS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-2016-Classification-Systems-for-MDS/</guid><description>[!info]
üå± ‰æÜËá™: [[myelodysplastic syndromes]]
WHO 2016 Classification Systems for MDS #üöß ÊñΩÂ∑•‰∏≠ WHO 2016 Classification Systems for MDS (Blood 2016;127:2391) Classification WHO 2008 Features MDS w/ single lineage dysplasia (MDS-SLD) RCUD (RA/RN/RT) 1 dysplastic lineage, 1‚Äì2 cytopenias, &amp;lt;15% RS*, &amp;lt;5% BM/ &amp;lt;1% PB blasts, no Auer rods MDS w/ multilineage dysplasia (MDS-MLD) RCMD 2‚Äì3 dysplastic lineages, 1‚Äì3 cytopenias, &amp;lt;15% RS*, &amp;lt;5% BM/ &amp;lt;1% PB blasts, no Auer rods MDS w/ ring sideroblast (MDS-RS) RARS ‚â•15% RS or ‚â•5% RS if SF3B1 mut.</description></item><item><title>WHO Classification of Lymphoid Malignancies</title><link>https://www.physician.tw/WHO-Classification-of-Lymphoid-Malignancies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-Classification-of-Lymphoid-Malignancies/</guid><description>[!info]
üå± ‰æÜËá™: [[non-Hodgkin lymphoma (NHL)]]
WHO Classification of Lymphoid Malignancies #üöß ÊñΩÂ∑•‰∏≠ WHO Classification of Lymphoid Malignancies (Blood¬†2016;127:2375)</description></item><item><title>WHO Histologic Classification of Classical HL</title><link>https://www.physician.tw/WHO-Histologic-Classification-of-Classical-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-Histologic-Classification-of-Classical-HL/</guid><description>[!info]
üå± ‰æÜËá™: [[hodgkin lymphoma (HL)]]
WHO Histologic Classification of Classical HL #üöß ÊñΩÂ∑•‰∏≠ WHO Histologic Classification of Classical HL Nodular sclerosis 60‚Äì80% Collagen bands; frequent mediastinal LAN; young adults; female predominance; usually stage I or II at dx Mixed cellularity 15‚Äì30% Pleomorphic; older age; male predominance; ‚â•50% stage III or IV at presentation; intermediate prognosis Lymphocyte rich 5% Abundant normal-appearing lymphocytes; mediastinal LAN uncommon; male predominance; good prognosis Lymphocyte depleted &amp;lt;1% Diffuse fibrosis and large numbers of RS cells; older, male patients; disseminated at dx; seen in HIV; worst prognosis ‚Ä¢ Nonclassical HL (5%): nodular lymphocyte predominant (NLP); involves peripheral LN 80% present in stages I‚ÄìII, Rx w/ RT vs.</description></item><item><title>Wide QRS Complex Tachycardia</title><link>https://www.physician.tw/Wide-QRS-Complex-Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wide-QRS-Complex-Tachycardia/</guid><description>[!info]
üå± ‰æÜËá™: [[Huppert&amp;rsquo;s Notes]]
Wide QRS Complex Tachycardia #üöß ÊñΩÂ∑•‰∏≠ Wide QRS Complex Tachycardia Ventricular tachycardia (VT) ‚Ä¢¬†Etiology: VT can be due to active ischemia, chronic ischemic heart disease (e.</description></item><item><title>Âú®macÈóúÈñâmicrfosoft update</title><link>https://www.physician.tw/diary/%E5%9C%A8mac%E9%97%9C%E9%96%89micrfosoft-update/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diary/%E5%9C%A8mac%E9%97%9C%E9%96%89micrfosoft-update/</guid><description>[!info]
üå± ‰æÜËá™: [[command line know how]]
Âú®macÈóúÈñâmicrfosoft update #üöß ÊñΩÂ∑•‰∏≠ launchctl disable gui/$(id -u)/com.microsoft.update.agent</description></item><item><title>Âú®macÈóúÈñâmicrfosoft update</title><link>https://www.physician.tw/%E5%9C%A8mac%E9%97%9C%E9%96%89micrfosoft-update/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%9C%A8mac%E9%97%9C%E9%96%89micrfosoft-update/</guid><description>[!info]
üå± ‰æÜËá™: [[command line know how]]
Âú®macÈóúÈñâmicrfosoft update #üöß ÊñΩÂ∑•‰∏≠ launchctl disable gui/$(id -u)/com.microsoft.update.agent</description></item><item><title>pericardiectomy</title><link>https://www.physician.tw/pericardiectomy/</link><pubDate>Sat, 21 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericardiectomy/</guid><description> [!info]
üå± ‰æÜËá™: [[pericardial disease]]
pericardiectomy #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>hugo</title><link>https://www.physician.tw/hugo/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hugo/</guid><description> [!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
hugo #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>R programing</title><link>https://www.physician.tw/R-programing/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/R-programing/</guid><description> [!info]
üå± ‰æÜËá™: [[Á®ãÂºèË™ûË®Ä]]
R programing #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>shell scripts</title><link>https://www.physician.tw/shell-scripts/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/shell-scripts/</guid><description>[!info]
üå± ‰æÜËá™: [[Á®ãÂºèË™ûË®Ä]]
shell scripts #üöß ÊñΩÂ∑•‰∏≠ [[shell scripts projects]] [[uploads a file as public gist to Github]]</description></item><item><title>Á®ãÂºèË™ûË®Ä</title><link>https://www.physician.tw/diary/%E7%A8%8B%E5%BC%8F%E8%AA%9E%E8%A8%80/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diary/%E7%A8%8B%E5%BC%8F%E8%AA%9E%E8%A8%80/</guid><description>[!info]
üå± ‰æÜËá™: [[index]]
Á®ãÂºèË™ûË®Ä [[regex]] [[R programing]] [[shell scripts]] [[dcheckifalive]]</description></item><item><title>Á®ãÂºèË™ûË®Ä</title><link>https://www.physician.tw/programming-language/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/programming-language/</guid><description> [!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
Á®ãÂºèË™ûË®Ä [[regex]] [[python]] [[R programing]] [[shell scripts]] [[Go]] [[markdown-lab]]</description></item><item><title>abdominopelvic emergencies</title><link>https://www.physician.tw/abdominopelvic-emergencies/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abdominopelvic-emergencies/</guid><description> [!info]
üå± ‰æÜËá™: [[nephrology]]
abdominopelvic emergencies #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>APS Type II</title><link>https://www.physician.tw/APS-Type-II/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/APS-Type-II/</guid><description>[!info]
üå± ‰æÜËá™: [[Hashimoto‚Äôs thyroiditis]]
APS Type II #üöß ÊñΩÂ∑•‰∏≠ Polyglandular Autoimmune Syndrome Type II - StatPearls - NCBI Bookshelf</description></item><item><title>chronic kidney disease</title><link>https://www.physician.tw/chronic-kidney-disease/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-kidney-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[nephrology]]
chronic kidney disease #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Cochrane 2009:CD001288</title><link>https://www.physician.tw/Cochrane-2009CD001288/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cochrane-2009CD001288/</guid><description>[!info]
üå± ‰æÜËá™: [[Corticosteroids of COPDAE]]
Cochrane 2009:CD001288 #üöß ÊñΩÂ∑•‰∏≠ Treatment of an exacerbation of COPD with oral or parenteral corticosteroids significantly reduces treatment failure and the need for additional medical treatment and shortens hospital stay.</description></item><item><title>evaluation of back and spinal cord disease</title><link>https://www.physician.tw/evaluation-of-back-and-spinal-cord-disease/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/evaluation-of-back-and-spinal-cord-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[back pain]]
evaluation of back and spinal cord disease Figure:</description></item><item><title>general physical exam of back pain</title><link>https://www.physician.tw/general-physical-exam-of-back-pain/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/general-physical-exam-of-back-pain/</guid><description> [!info]
üå± ‰æÜËá™: [[back pain]]
general physical exam of back pain #üöß ÊñΩÂ∑•‰∏≠ local tenderness ROM signs of infection or malignancy paraspinal tenderness or spasm in musculoskeletal strain</description></item><item><title>Haldane effect</title><link>https://www.physician.tw/Haldane-effect/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Haldane-effect/</guid><description>[!info]
üå± ‰æÜËá™: [[Oxygenation of COPDAE]]
Haldane effect #üöß ÊñΩÂ∑•‰∏≠ Haldane effect - Â∞èÂ∞èÊï¥ÁêÜÁ∂≤Á´ô Smallcollation
O2+hemoglobin = CO2 release</description></item><item><title>Hashimoto‚Äôs thyroiditis</title><link>https://www.physician.tw/Hashimotos-thyroiditis/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hashimotos-thyroiditis/</guid><description> [!info]
üå± ‰æÜËá™: [[hypothyroidism]]
Hashimoto‚Äôs thyroiditis Autoimmune destruction with diffuse lymphocytic infiltration Associated with other autoimmune disease and may be part of [[APS Type II]] ‚äï antithyroid peroxidase (anti-TPO) and antithyroglobulin (anti-Tg) Abs in &amp;gt;90%</description></item><item><title>hematopoiesis</title><link>https://www.physician.tw/hematopoiesis/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematopoiesis/</guid><description> [!info]
üå± ‰æÜËá™: [[Transcellular shifts]]
hematopoiesis #üöß ÊñΩÂ∑•‰∏≠ Figure:</description></item><item><title>Prednisone</title><link>https://www.physician.tw/Prednisone/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prednisone/</guid><description>[!info]
üå± ‰æÜËá™: [[Corticosteroids of COPDAE]]
Prednisone #üöß ÊñΩÂ∑•‰∏≠ The main difference between prednisone and prednisolone is that prednisone must be converted by liver enzymes to prednisolone before it can work.</description></item><item><title>Quartz</title><link>https://www.physician.tw/Quartz/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Quartz/</guid><description>[!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
Quartz #üöß ÊñΩÂ∑•‰∏≠ ü™¥ Quartz
[[open graph]]</description></item><item><title>signs of radiculopathy</title><link>https://www.physician.tw/signs-of-radiculopathy/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/signs-of-radiculopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[back pain]]
signs of radiculopathy #üöß ÊñΩÂ∑•‰∏≠ [[spurling sign]]
[[straight leg raise]]</description></item><item><title>treatment of CRAB</title><link>https://www.physician.tw/treatment-of-CRAB/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-CRAB/</guid><description>[!info]
üå± ‰æÜËá™: [[CRAB]]
treatment of CRAB #üöß ÊñΩÂ∑•‰∏≠ Ampicillin-sulbactam 9gIV q8h over 4 hours OR 27 gIV q24h as a continuous infusion</description></item><item><title>‰ªÄÈ∫ºÊòØÊï∏‰ΩçËä±Âúí</title><link>https://www.physician.tw/%E4%BB%80%E9%BA%BC%E6%98%AF%E6%95%B8%E4%BD%8D%E8%8A%B1%E5%9C%92/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E4%BB%80%E9%BA%BC%E6%98%AF%E6%95%B8%E4%BD%8D%E8%8A%B1%E5%9C%92/</guid><description>[!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
‰ªÄÈ∫ºÊòØÊï∏‰ΩçËä±Âúí ÊàëÂÄëÁîüÊ¥ªÂú®‰∏ÄÂÄãË≥áË®äÊôÇ‰ª£„ÄÇÊàëÂÄëÁî¢ÁîüÁöÑÊï∏ÊìöÈáèÈÅ†ÈÅ†Ë∂ÖÈÅéÊàëÂÄëÊ∂àËÄóÁöÑÊï∏ÊìöÈáèÔºå‰ª•Ëá≥ÊñºÂÆÉÈÅ†ÈÅ†Ë∂ÖÂá∫‰∫ÜÊàëÂÄëÊúâÊÑèÁæ©Âú∞Âà©Áî®ÂÆÉÁöÑËÉΩÂäõ„ÄÇ
ÈÄô‰∏çÊòØÂõ†ÁÇ∫Êàë‰∏çÂñúÊ≠°Áß©Â∫èÔºåËÄåÊòØÂõ†ÁÇ∫ÊàëË™çÁÇ∫‰∏ÄÈªûÊ∑∑‰∫ÇÂíåÁÜµÂ∞çÊñ∞ÊÉ≥Ê≥ïÊúâÂ•ΩËôï„ÄÇÂÆÉÂÄëÊúâÂä©ÊñºÈÄ£Êé•ÂÖ©ÂÄã‰Ω†ÈÄöÂ∏∏‰∏çÊúÉÁõ∏‰∫íÈóúËÅØÁöÑÁç®Á´ãÊÉ≥Ê≥ïÔºå‰∏¶Êõ¥È†ªÁπÅÂú∞ÊÉ≥ÂÉè‚ÄúÂÅáË®≠‚Äù„ÄÇ
‰ªÄÈ∫ºÊòØÊï∏‰ΩçÂúíËóùÔºü Áü•Ë≠òËä±Âúí‰∏çÊòØÊ™îÊ°àÊ´ÉÔºå‰πü‰∏çÊòØÂÆåÂÖ®ÁöÑÁ¥¢Âºï„ÄÇ‰∫ãÂØ¶‰∏äÔºåÊï∏Â≠óËä±ÂúíËàáÂÖ∂Ë™™ÊòØ‰∏ÄÂ°äÊï¥ÊΩîÁöÑËæ≤Âú∞Ôºå‰∏çÂ¶ÇË™™ÊòØ‰∏ÄÂúòÁ≥æÁ∫èÁöÑÁîüÈï∑ËçíÈáé„ÄÇÂÆÉÊòØ‰∏ÄÂÄãÁõ∏‰∫íËÅØÁπ´ÁöÑÊÉ≥Ê≥ïÂíåÊÄùÊÉ≥ÁöÑÁ∂≤Ë∑ØÔºåÁî±ÂÆÉÂÄëÂ¶Ç‰ΩïÁõ∏‰∫íÈóúËÅØËÄåËÅöÈõÜÂú®‰∏ÄËµ∑„ÄÇ
ÈÄô‰∏çÊòØÂõ†ÁÇ∫Êàë‰∏çÂñúÊ≠°Áß©Â∫èÔºåËÄåÊòØÂõ†ÁÇ∫ÊàëË™çÁÇ∫‰∏ÄÈªûÊ∑∑‰∫ÇÂíåÁÜµÂ∞çÊñ∞ÊÉ≥Ê≥ïÊúâÂ•ΩËôï„ÄÇÂÆÉÂÄëÊúâÂä©ÊñºÈÄ£Êé•ÂÖ©ÂÄã‰Ω†ÈÄöÂ∏∏‰∏çÊúÉÁõ∏‰∫íÈóúËÅØÁöÑÁç®Á´ãÊÉ≥Ê≥ïÔºå‰∏¶Êõ¥È†ªÁπÅÂú∞ÊÉ≥ÂÉè‚ÄúÂÅáË®≠‚Äù„ÄÇ
ÊàëÂ∞çÊï∏‰ΩçËä±ÂúíÁöÑÁõÆÊ®ô‰∏çÂÉÖÂÉÖÊòØ‰ΩúÁÇ∫‰∏ÄÂÄãÁµÑÁπîÁ≥ªÁµ±ÂíåË≥áË®äÂ≠òÂÑ≤ÔºåË™çÁÇ∫ÂÆÉÂ∞çÊ≠§ÊïàÊûúÂæàÂ•Ω„ÄÇÊàëÂ∏åÊúõÊàëÁöÑÊï∏‰ΩçËä±ÂúíÊàêÁÇ∫ÂâµÊÑèÈÄ£Êé•ÁöÑÊñ∞ÊñπÂºèÁöÑÈÅäÊ®ÇÂ†¥„ÄÇÂõ†Ê≠§ÔºåÁèæÊúâÁöÑÊ≠£ÂºèÁµÑÁπîÁ≥ªÁµ±ÔºàÂ¶ÇZettelkastenÔºâÊàñConceptÁöÑÂàÜÂ±§Ë≥áÊñôÂ§æÁµêÊßãÂ∞çÊàë‰æÜË™™ÊïàÊûú‰∏ç‰Ω≥„ÄÇÊúâÂ§™Â§öÁöÑÂâçÊúüÊë©Êì¶ÔºåÁï∂ÊàëËÄÉÊÖÆÂ¶Ç‰ΩïÂ∞áÊàëÁöÑÊÉ≥Ê≥ïÁµÑÁπîÊàêÈ°ûÂà•ÊôÇÔºåÊàëÂ∑≤Á∂ìÂ§±Âéª‰∫ÜÂÆÉ„ÄÇ
Ë®±Â§ö‰∫∫Ë©¶ÂúñÈÄöÈÅéË®òÁ≠ÜË®ò‰æÜÁµÑÁπîËá™Â∑±ÁöÑÁîüÊ¥ª„ÄÇÊúâ‰∏ÄÁ®ÆÁ∂ìÂÖ∏ÁöÑ‚ÄúËá™‰∏äËÄå‰∏ã‚ÄùËàá‚ÄúËá™‰∏ãËÄå‰∏ä‚ÄùÁöÑË®≠Ë®àÂºµÂäõÊäïÂ∞ÑÂà∞‰∫∫ÂÄëÂ¶Ç‰ΩïÂÅöÁ≠ÜË®ò‰∏ä„ÄÇÊúâ‰∫õ‰∫∫Áõ∏‰ø°‰ªñÂÄëÈ†êÊ∏¨Êú™‰æÜÁöÑËÉΩÂäõÔºå‰ªñÂÄëÊÉ≥Ë¶ÅËá™‰∏äËÄå‰∏ãÔºå‰ªñÂÄëÊÉ≥Âú®Ëä±ÂúíË£°Èã™Âπ≥ÈÅìË∑Ø„ÄÇÂÖ∂‰ªñ‰∫∫ÔºàÈÄöÂ∏∏ÊòØÈÇ£‰∫õÂòóË©¶ÈÅé‰ΩÜÂ§±ÊïóÁöÑ‰∫∫Ôºâ‰∏çÁõ∏‰ø°Ëá™Â∑±È†êÊ∏¨Êú™‰æÜÁöÑËÉΩÂäõÔºå‰ªñÂÄëÊÉ≥ËÆìÂ•∂ÁâõËÉΩÂ§†ÂÆâÂÖ®Âú∞Êº´ÈÅäÔºåÁÑ∂ÂæåÈã™Âπ≥ÈÅìË∑Ø„ÄÇÊÖæÊúõË∑ØÂæëÂú®ÂÆÉÂÄëÂΩ¢Êàê‰πãÂæå„ÄÇ
ÈÄôÂ∞±ÊòØÊ™îÊ°àÊ´ÉÁöÑÂïèÈ°åÔºöÂÆÉÂÅ¥ÈáçÊñºË®™ÂïèÊïàÁéáÂíå‰∫íÊìç‰ΩúÊÄßËÄå‰∏çÊòØÁîüÊàêÊÄßÂíåÂâµÈÄ†Âäõ„ÄÇÊÄùÁ∂≠‰∏çÊòØÁ∑öÊÄßÁöÑÔºå‰πü‰∏çÊòØÁ∑öÊÄßÁöÑÂ±§Ê¨°.‰∫ãÂØ¶‰∏äÔºåÊ≤íÊúâÂ§öÂ∞ë‰∫ãÊÉÖÊòØÁ∑öÊÄßÁöÑÊàñÂàÜÂ±§ÁöÑ„ÄÇÈÇ£È∫ºÔºåÁÇ∫‰ªÄÈ∫ºÂ§ßÂ§öÊï∏Â∑•ÂÖ∑ÂíåÊÄùÁ∂≠Á≠ñÁï•ÈÉΩÁÇ∫ÊàëÁöÑÊÄùÁ∂≠ÈÅéÁ®ãÂÅáË®≠‰∏ÄÂÄãÂæàÂ•ΩÁöÑÊôÇÈñìÈ†ÜÂ∫èÊàñÂ±§Ê¨°ÁµêÊßãÔºüÂ∞çÊàë‰æÜË™™ÔºåÁêÜÊÉ≥ÁöÑÊÄùËÄÉÂ∑•ÂÖ∑ÊòØÊìÅÊä±ÊàëÈ†≠ËÖ¶ÁöÑÊ∑∑‰∫ÇÔºå‰∏¶ÊúâÊ©üÂú∞Ë™¨ÊòéÊ¥ûÂØüÂäõÂæûÊ∑∑‰∫Ç‰∏≠Âá∫ÁèæÔºåËÄå‰∏çÊòØÂº∑Ëø´‰∫∫ÁÇ∫ÁöÑÁß©Â∫è„ÄÇ
ÊàëÂ¶Ç‰ΩïÂúíËóù Êï∏Â≠óËä±ÂúíÁöÑÈáçÈªû‰∏çÊòØÊàêÁÇ∫ÊòéÁ¢∫ÁöÑÁúüÁêÜ‰æÜÊ∫êÔºåËÄåÊòØÈö®ËëóÊÇ®Ëá™Â∑±ÁöÑÁü•Ë≠òÁöÑÂ¢ûÈï∑ÂíåËÆäÂåñËÄå‰∏çÊñ∑ÁôºÂ±ïÁöÑ‰æÜÊ∫ê„ÄÇ
ÊàëÁöÑÈÉ®ËêΩÊ†ºËÆìÊàëÂÆ≥ÊÄïÁôºÊñá„ÄÇÊàëÂÆ≥ÊÄïÊää‰∫ãÊÉÖÂÖ¨‰πãÊñºÁúæÔºåÂõ†ÁÇ∫ÊàëÊìîÂøÉ‰∫∫ÂÄëÂú®ÁèæÂú®ÂíåÂ∞á‰æÜÈÉΩËÉΩ‰ª•‰∏çÂêåÁöÑÊñπÂºèÁúãÂæÖÂÆÉ„ÄÇÂ¶ÇÊûúÊàëÁôº‰Ωà‰∫Ü‰∫∫ÂÄëË™çÁÇ∫ÊÑöË†¢ÁöÑÊù±Ë•øÊÄéÈ∫ºËæ¶ÔºüÊàñËÄÖÊõ¥Á≥üÁ≥ïÁöÑÊòØÔºåÂ∞á‰æÜÊúâ‰∫∫ÊúÉÁúãÂà∞ÊàëÁõÆÂâçÁöÑÂ∑•‰ΩúÔºå‰∏¶Âõ†ÁÇ∫ÊàëÁöÑÊÉ≥Ê≥ïÊòØÂ§öÈ∫ºÂπºÁ®öËÄåÁûß‰∏çËµ∑Êàë„ÄÇÊàëÂÆ≥ÊÄïÊï∏‰ΩçÊåÅ‰πÖÊÄß.
‰ΩÜËÄÅÂØ¶Ë™™ÔºåÊàëÂØ´ÂæóË∂äÂ§öÔºåÂè™ÊòØÊääÊù±Ë•øÊîæÂú®ÈÇ£Ë£°ÔºåÈÄôÁ®ÆÊÄùË∑ØÂ∞±Ë∂äÊ≤íÊúâÊÑèÁæ©„ÄÇ
Á∏ΩÁöÑ‰æÜË™™ÔºåÊàë‰ªçÁÑ∂ÁÇ∫Ëá™Â∑±ÂØ´‰Ωú„ÄÇÂØ´‰ΩúÔºåÂ∞çÊàë‰æÜË™™ÔºåÊòØ‰∏ÄÁ®ÆÂΩ¢ÂºèÁü•Ë≠òËí∏È§æÔºåÂÆÉÊúâÂä©ÊñºÊæÑÊ∏ÖÊàëÁöÑÊÉ≥Ê≥ï‰∏¶ÊøÉÁ∏ÆÊàëÁöÑÁü•Ë≠òÔºå‰ª•‰æøÊàëÂèØ‰ª•ËºïÈ¨ÜÂú∞Âêë‰ªñ‰∫∫Ë°®ÈÅî„ÄÇÂ¶ÇÊûúÂÅöÂæóÂ•ΩÔºåÊàëÊúâ‰∏ÄÂÄãÂèØÂàÜ‰∫´ÁöÑË°®ÈÅîÊàëÁöÑÊÉ≥Ê≥ïÔºåÊàëÂèØ‰ª•ÊääÂÆÉÁôºÈÄÅÂà∞‰∏ñÁïå‰∏äÔºå‰∫∫ÂÄëÂèØ‰ª•ÂõûÊáâ„ÄÇÂç≥‰ΩøÊòØÊàëÊúÄÂçäÁîü‰∏çÁÜüÁöÑÊÉ≥Ê≥ïÔºåÈÄô‰πüÊúâÂä©ÊñºÊàëÂâµÂª∫‰∏ÄÂÄãÂèçÈ•ãÈÄ±Êúü‰æÜÂä†Âº∑ÂíåÂÖÖÂàÜÂÖÖÂØ¶ÈÄôÂÄãÊÉ≥Ê≥ï„ÄÇ</description></item><item><title>abdominal swelling</title><link>https://www.physician.tw/abdominal-swelling/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abdominal-swelling/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Gastrointestinal Function]]
abdominal swelling [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>acute kidney injury</title><link>https://www.physician.tw/acute-kidney-injury/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-kidney-injury/</guid><description> [!info]
üå± ‰æÜËá™: [[symptom to diagnosis]]
acute kidney injury #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>acute respiratory tract infection</title><link>https://www.physician.tw/acute-respiratory-tract-infection/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-respiratory-tract-infection/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
acute respiratory tract infection #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>acute septic arthritis</title><link>https://www.physician.tw/acute-septic-arthritis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-septic-arthritis/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
acute septic arthritis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>aids hiv infection</title><link>https://www.physician.tw/aids-hiv-infection/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aids-hiv-infection/</guid><description> [!info]
üå± ‰æÜËá™: [[symptom to diagnosis]]
aids hiv infection [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>allergic rhinitis conjunctivitis sinusitis</title><link>https://www.physician.tw/allergic-rhinitis-conjunctivitis-sinusitis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/allergic-rhinitis-conjunctivitis-sinusitis/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
allergic rhinitis conjunctivitis sinusitis #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>allergy and immunology</title><link>https://www.physician.tw/allergy-and-immunology/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/allergy-and-immunology/</guid><description>[!info]
üå± ‰æÜËá™: [[resident360]]
allergy and immunology #üöß ÊñΩÂ∑•‰∏≠ The following topics are addressed in this rotation guide: [[allergic rhinitis conjunctivitis sinusitis]]</description></item><item><title>ambulatory care</title><link>https://www.physician.tw/ambulatory-care/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ambulatory-care/</guid><description>[!info]
üå± ‰æÜËá™: [[resident360]]
ambulatory care #üöß ÊñΩÂ∑•‰∏≠ The following topics are addressed in this rotation guide: [[acute respiratory tract infection]]</description></item><item><title>aphasia, memory loss, and other cognitive disorders</title><link>https://www.physician.tw/aphasia-memory-loss-and-other-cognitive-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aphasia-memory-loss-and-other-cognitive-disorders/</guid><description>[!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
aphasia, memory loss, and other cognitive disorders [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>approach to the patient with a heart murmur</title><link>https://www.physician.tw/approach-to-the-patient-with-a-heart-murmur/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-the-patient-with-a-heart-murmur/</guid><description>[!info]
üå± ‰æÜËá™: [[Alterations in Circulatory and Respiratory Functions]]
approach to the patient with a heart murmur [!</description></item><item><title>asphyxiation</title><link>https://www.physician.tw/asphyxiation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/asphyxiation/</guid><description> [!info]
üå± ‰æÜËá™: [[Treatment-hemoptysis]]
asphyxiation #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>atopic dermatitis</title><link>https://www.physician.tw/atopic-dermatitis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atopic-dermatitis/</guid><description> [!info]
üå± ‰æÜËá™: [[allergy and immunology]]
atopic dermatitis #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>autoimmune myocarditis</title><link>https://www.physician.tw/autoimmune-myocarditis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-myocarditis/</guid><description>[!info]
üå± ‰æÜËá™: [[MYOCARDITIS]]
autoimmune myocarditis Idiopathic [[giant cell myocarditis]] (GCM): avg age 42, fulminant, AVB/VT (Circ HF 2013;6:15) Eosinophilic (variable peripheral eos): hypersensitivity (mild HF but at risk for SCD) or acute necrotizing eosinophilic myocarditis (ANEM; STE, effusion, severe HF) Collagen vasc.</description></item><item><title>azotemia</title><link>https://www.physician.tw/azotemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/azotemia/</guid><description>[!info]
üå± ‰æÜËá™: [[Alterations in Renal and Urinary Tract Function]]
azotemia [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>bladder pain syndrome</title><link>https://www.physician.tw/bladder-pain-syndrome/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bladder-pain-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Alterations in Renal and Urinary Tract Function]]
bladder pain syndrome [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>bleeding disorders</title><link>https://www.physician.tw/bleeding-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bleeding-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[symptom to diagnosis]]
bleeding disorders #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>cancer screening</title><link>https://www.physician.tw/cancer-screening/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-screening/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
cancer screening #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Chagas</title><link>https://www.physician.tw/Chagas/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chagas/</guid><description> [!info]
üå± ‰æÜËá™: [[infectious myocarditis]]
Chagas [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>chronic pain and opioids</title><link>https://www.physician.tw/chronic-pain-and-opioids/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-pain-and-opioids/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
chronic pain and opioids #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>coma</title><link>https://www.physician.tw/coma/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coma/</guid><description> [!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
coma [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>contraindications to enteral nutrition</title><link>https://www.physician.tw/contraindications-to-enteral-nutrition/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/contraindications-to-enteral-nutrition/</guid><description>[!info]
üå± ‰æÜËá™: [[Nutrition in the ICU]]
contraindications to enteral nutrition #üöß ÊñΩÂ∑•‰∏≠ severe hemodynamic instability</description></item><item><title>critical care</title><link>https://www.physician.tw/critical-care/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care/</guid><description>[!info]
üå± ‰æÜËá™: [[resident360]]
critical care #üöß ÊñΩÂ∑•‰∏≠ Part 8:¬†[[Critical Care Medicine]] [[intensive care unit onboarding]] Resident 360 [[sepsis and shock]] [[respiratory failure]] [[mechanical ventilation]] [[acute respiratory distress syndrome]] [[Resuscitation Fluids and Transfusion]] [[acid-base disturbances]] [[sedation]] and [[delirium]] [[Nutrition in the ICU]] [[Hyperglycemic Emergencies]] (Endocrinology) [[disseminated intravascular coagulation]] (Hematology) [[neurologic outcomes after cardiac arrest]] (Neurology) [[cardiac arrest]] [[syncope]] [[overdose and toxidromes]] (Emergency Medicine) MOUNT SINAI EXPERT GUIDES Critical Care part 1: [[basic techniques and procedures]]</description></item><item><title>crystal-induced arthritis</title><link>https://www.physician.tw/crystal-induced-arthritis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crystal-induced-arthritis/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
crystal-induced arthritis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>definition of restrictive and infiltrative cardiomyopathy</title><link>https://www.physician.tw/definition-of-restrictive-and-infiltrative-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-restrictive-and-infiltrative-cardiomyopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[restrictive and infiltrative cardiomyopathy]]
definition of restrictive and infiltrative cardiomyopathy Restrictive CMP: ‚Üì ventricular filling with ‚Üì compliance in nonhypertrophied, nondilated ventricles; nl/‚Üì diastolic volumes, nl or near-nl EF; must r/o pericardial disease</description></item><item><title>delirium</title><link>https://www.physician.tw/delirium/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/delirium/</guid><description> [!info]
üå± ‰æÜËá™: [[critical care]]
delirium #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>dementia</title><link>https://www.physician.tw/dementia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dementia/</guid><description> [!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
dementia [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>diagnostic studies and workup of dilated cardiomyopathy</title><link>https://www.physician.tw/diagnostic-studies-and-workup-of-dilated-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies-and-workup-of-dilated-cardiomyopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[dilated cardiomyopathy]]
diagnostic studies and workup of dilated cardiomyopathy (JACC 2016;67:2996)
ECG of dilated cardiomyopathy may see PRWP, Q waves, or BBB; low-voltage; AF (20%); may be normal</description></item><item><title>diarrhea and constipation</title><link>https://www.physician.tw/diarrhea-and-constipation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diarrhea-and-constipation/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Gastrointestinal Function]]
diarrhea and constipation [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>disorders of hearing</title><link>https://www.physician.tw/disorders-of-hearing/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-hearing/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
disorders of hearing [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>disorders of smell and taste</title><link>https://www.physician.tw/disorders-of-smell-and-taste/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-smell-and-taste/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
disorders of smell and taste [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>disorders of the eye</title><link>https://www.physician.tw/disorders-of-the-eye/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-eye/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
disorders of the eye [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>dizziness</title><link>https://www.physician.tw/dizziness/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dizziness/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
dizziness #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>dizziness and vertigo</title><link>https://www.physician.tw/dizziness-and-vertigo/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dizziness-and-vertigo/</guid><description> [!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
dizziness and vertigo [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>drug allergy</title><link>https://www.physician.tw/drug-allergy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/drug-allergy/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
drug allergy #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>dysuria</title><link>https://www.physician.tw/dysuria/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysuria/</guid><description> [!info]
üå± ‰æÜËá™: [[symptom to diagnosis]]
dysuria #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>earache</title><link>https://www.physician.tw/earache/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/earache/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
earache [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>edema</title><link>https://www.physician.tw/edema/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/edema/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Circulatory and Respiratory Functions]]
edema [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>eosinophilia and mast-cell disorders</title><link>https://www.physician.tw/eosinophilia-and-mast-cell-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/eosinophilia-and-mast-cell-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[allergy and immunology]]
eosinophilia and mast-cell disorders #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>etiologies of dilated cardiomyopathy</title><link>https://www.physician.tw/etiologies-of-dilated-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-dilated-cardiomyopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[dilated cardiomyopathy]]
etiologies of dilated cardiomyopathy (JACC 2021;77:2551; can also be prior myocarditis, vide infra)</description></item><item><title>fever</title><link>https://www.physician.tw/fever/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Body Temperature]]
fever [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>fibromyalgia</title><link>https://www.physician.tw/fibromyalgia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fibromyalgia/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
fibromyalgia [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>fluid and electrolyte disturbances</title><link>https://www.physician.tw/fluid-and-electrolyte-disturbances/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fluid-and-electrolyte-disturbances/</guid><description>[!info]
üå± ‰æÜËá™: [[Alterations in Renal and Urinary Tract Function]]
fluid and electrolyte disturbances [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>food allergy</title><link>https://www.physician.tw/food-allergy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/food-allergy/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
food allergy #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>gait disorders, imbalance, and falls</title><link>https://www.physician.tw/gait-disorders-imbalance-and-falls/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gait-disorders-imbalance-and-falls/</guid><description>[!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
gait disorders, imbalance, and falls [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>giant cell myocarditis</title><link>https://www.physician.tw/giant-cell-myocarditis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/giant-cell-myocarditis/</guid><description> [!info]
üå± ‰æÜËá™: [[MYOCARDITIS]]
giant cell myocarditis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>glycemic management in the ICU setting</title><link>https://www.physician.tw/glycemic-management-in-the-ICU-setting/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glycemic-management-in-the-ICU-setting/</guid><description>[!info]
üå± ‰æÜËá™: [[Nutrition in the ICU]]
glycemic management in the ICU setting #üöß ÊñΩÂ∑•‰∏≠ [[Management of hyperglycemia in inPts]]</description></item><item><title>hypercholesterolemia</title><link>https://www.physician.tw/hypercholesterolemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypercholesterolemia/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
hypercholesterolemia #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>hypomagnesemia</title><link>https://www.physician.tw/hypomagnesemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypomagnesemia/</guid><description> [!info]
üå± ‰æÜËá™: [[refeeding syndrome]]
hypomagnesemia #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>hypophosphatemia</title><link>https://www.physician.tw/hypophosphatemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypophosphatemia/</guid><description> [!info]
üå± ‰æÜËá™: [[refeeding syndrome]]
hypophosphatemia #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>immune-mediated thrombocytopenia</title><link>https://www.physician.tw/immune-mediated-thrombocytopenia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-mediated-thrombocytopenia/</guid><description>[!info]
üå± ‰æÜËá™: [[Etiologies-of thrombocytopenia]]
immune-mediated thrombocytopenia #üöß ÊñΩÂ∑•‰∏≠ [[Primary immune thrombocytopenic purpura (ITP) ]]
2¬∞: infxn (HIV, HCV, HSV), collagen vascular dis.</description></item><item><title>immunodeficiency</title><link>https://www.physician.tw/immunodeficiency/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immunodeficiency/</guid><description> [!info]
üå± ‰æÜËá™: [[allergy and immunology]]
immunodeficiency #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>infectious myocarditis</title><link>https://www.physician.tw/infectious-myocarditis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-myocarditis/</guid><description>[!info]
üå± ‰æÜËá™: [[MYOCARDITIS]]
infectious myocarditis (Lancet 2012;379:738; JACC 2012;59:779)
Viruses (parvoB19, Coxsackie, adeno, HIV, SARS-CoV-2/vaccine, etc.) Bacterial, fungal, rickettsial, TB, Lyme (mild myocarditis, often with AVB) [[Chagas]]: apical aneurysm ¬± thrombus, RBBB, megaesophagus/colon (Lancet 2018;391:82)</description></item><item><title>interstitial cystitis</title><link>https://www.physician.tw/interstitial-cystitis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/interstitial-cystitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Alterations in Renal and Urinary Tract Function]]
interstitial cystitis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>jaundice</title><link>https://www.physician.tw/jaundice/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jaundice/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Gastrointestinal Function]]
jaundice [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>jaundice and abnormal liver enzymes</title><link>https://www.physician.tw/jaundice-and-abnormal-liver-enzymes/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jaundice-and-abnormal-liver-enzymes/</guid><description> [!info]
üå± ‰æÜËá™: [[symptom to diagnosis]]
jaundice and abnormal liver enzymes #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>Kimmelstiel-Wilson</title><link>https://www.physician.tw/Kimmelstiel-Wilson/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kimmelstiel-Wilson/</guid><description> [!info]
üå± ‰æÜËá™: [[Systemic diseases with secondary glomerular involvement]]
Kimmelstiel-Wilson [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>leukotrienes</title><link>https://www.physician.tw/leukotrienes/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leukotrienes/</guid><description> [!info]
üå± ‰æÜËá™: [[Clinical manifestations]]
leukotrienes #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>medical</title><link>https://www.physician.tw/medical/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medical/</guid><description>Ê≠°Ëøé‰æÜÂà∞ü¶éÁöÑMedical Wiki [[cardiology]] ü´Ä [[pulmonology]] ü´Å [[gastroenterology]] üí© [[nephrology]] üöΩ [[hematology]] ü©∏ [[oncology]] üêõ [[infectious disease]] ü¶† [[endocrinology]] üêº [[rheumatology]] ü§° ÂÖßÁßëÁöÑÂÖ∂‰ªñÁü•Ë≠ò ü§î [[critical care]] üò≠ [[clinical reasoning]] üí° [[practical skills for learners]] [[neurology]] üß† [[ambulatory]] üö∂ [[ACLS]] üòµ [[emergency medicine]] [[POCUS]] [[pain and palliative care]] [[other subspecialties]] EBM [[clinical trials]] [[statistical concepts and test characteristics]] references paper note: [[journals/index.</description></item><item><title>myelofibrosis</title><link>https://www.physician.tw/myelofibrosis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myelofibrosis/</guid><description> [!info]
üå± ‰æÜËá™: [[Etiologies-of thrombocytopenia]]
myelofibrosis #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>nausea, vomiting, and indigestion</title><link>https://www.physician.tw/nausea-vomiting-and-indigestion/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nausea-vomiting-and-indigestion/</guid><description>[!info]
üå± ‰æÜËá™: [[Alterations in Gastrointestinal Function]]
nausea, vomiting, and indigestion [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>neurologic causes of weakness and paralysis</title><link>https://www.physician.tw/neurologic-causes-of-weakness-and-paralysis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-causes-of-weakness-and-paralysis/</guid><description>[!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
neurologic causes of weakness and paralysis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>NICE-SUGAR trial</title><link>https://www.physician.tw/NICE-SUGAR-trial/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NICE-SUGAR-trial/</guid><description>[!info]
üå± ‰æÜËá™: [[glycemic management in the ICU setting]]
NICE-SUGAR trial March 26, 2009 N Engl J Med 2009; 360:1283-1297 DOI: 10.</description></item><item><title>numbness, tingling, and sensory loss</title><link>https://www.physician.tw/numbness-tingling-and-sensory-loss/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/numbness-tingling-and-sensory-loss/</guid><description>[!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
numbness, tingling, and sensory loss [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Nutrition in the ICU</title><link>https://www.physician.tw/Nutrition-in-the-ICU/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nutrition-in-the-ICU/</guid><description>[!info]
üå± ‰æÜËá™: [[critical care]]
Nutrition in the ICU #üöß ÊñΩÂ∑•‰∏≠ Patients in the intensive care unit (ICU) are at increased risk of malnutrition, and few can feed themselves.</description></item><item><title>obstructive sleep apnea</title><link>https://www.physician.tw/obstructive-sleep-apnea/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/obstructive-sleep-apnea/</guid><description> [!info]
üå± ‰æÜËá™: [[etiologies of dilated cardiomyopathy]]
obstructive sleep apnea [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>oral manifestations of disease</title><link>https://www.physician.tw/oral-manifestations-of-disease/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oral-manifestations-of-disease/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
oral manifestations of disease [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>other supraventricular rhythms</title><link>https://www.physician.tw/other-supraventricular-rhythms/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-supraventricular-rhythms/</guid><description> [!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
other supraventricular rhythms [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>palpitations</title><link>https://www.physician.tw/palpitations/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/palpitations/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Circulatory and Respiratory Functions]]
palpitations [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>PLASMIC score to discriminate TTP from other TMAs</title><link>https://www.physician.tw/PLASMIC-score-to-discriminate-TTP-from-other-TMAs/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PLASMIC-score-to-discriminate-TTP-from-other-TMAs/</guid><description>[!info]
üå± ‰æÜËá™: [[thrombotic thrombocytopenic purpura]]
PLASMIC score to discriminate TTP from other TMAs #üöß ÊñΩÂ∑•‰∏≠ Predicts ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura (TTP) with high discrimination.</description></item><item><title>rate of nutrition in the ICU</title><link>https://www.physician.tw/rate-of-nutrition-in-the-ICU/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rate-of-nutrition-in-the-ICU/</guid><description>[!info]
üå± ‰æÜËá™: [[Nutrition in the ICU]]
rate of nutrition in the ICU The recommendation in critically ill patients is to initiate feeding at 20%‚àí30% of metabolic need during the first week in the ICU.</description></item><item><title>refeeding syndrome</title><link>https://www.physician.tw/refeeding-syndrome/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/refeeding-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Nutrition in the ICU]]
refeeding syndrome #üöß ÊñΩÂ∑•‰∏≠ When starting artificial nutrition, it is important to monitor for refeeding syndrome</description></item><item><title>resident360</title><link>https://www.physician.tw/resident360/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/resident360/</guid><description>[!info]
üå± ‰æÜËá™: [[medical]]
resident360 [[allergy and immunology]] [[ambulatory care]] [[emergency medicine]] [[gastroenterology]] [[geriatrics]] [[hematology]] [[infectious disease]] [[mental health]] [[nephrology]] [[neurology]] [[oncology]] [[palliative care]] [[pulmonology]] [[rheumatology]] [[women‚Äôs health]] [[all list of resident360]]</description></item><item><title>restrictive and infiltrative cardiomyopathy</title><link>https://www.physician.tw/restrictive-and-infiltrative-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/restrictive-and-infiltrative-cardiomyopathy/</guid><description>[!info]
üå± ‰æÜËá™: [[cardiomyopathies]]
restrictive and infiltrative cardiomyopathy [[definition of restrictive and infiltrative cardiomyopathy]] (JACC 2018;71:1130 &amp;amp; 1149) Etiologies (JACC 2018;71:1130 &amp;amp; 1149) [[amyloidosis]]: age at presentation ~60 y; ‚ôÇ:‚ôÄ = 3:2 AL (eg, MM, etc.</description></item><item><title>sedation</title><link>https://www.physician.tw/sedation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sedation/</guid><description> [!info]
üå± ‰æÜËá™: [[critical care]]
sedation #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>sinus symptoms</title><link>https://www.physician.tw/sinus-symptoms/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sinus-symptoms/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
sinus symptoms [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>sleep disorders</title><link>https://www.physician.tw/sleep-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sleep-disorders/</guid><description> [!info]
üå± ‰æÜËá™: [[Nervous System Dysfunction]]
sleep disorders [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>smoking cessation</title><link>https://www.physician.tw/smoking-cessation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/smoking-cessation/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
smoking cessation #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>sore throat</title><link>https://www.physician.tw/sore-throat/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sore-throat/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
sore throat [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>stress ulcers of nutrition in the ICU</title><link>https://www.physician.tw/stress-ulcers-of-nutrition-in-the-ICU/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stress-ulcers-of-nutrition-in-the-ICU/</guid><description>[!info]
üå± ‰æÜËá™: [[Nutrition in the ICU]]
stress ulcers of nutrition in the ICU #üöß ÊñΩÂ∑•‰∏≠ Patients in the ICU are at increased risk for stress ulcers.</description></item><item><title>Takotsubo</title><link>https://www.physician.tw/Takotsubo/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Takotsubo/</guid><description> [!info]
üå± ‰æÜËá™: [[etiologies of dilated cardiomyopathy]]
Takotsubo [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
BacklinkÔºö [[Ddx causes of myocardial ischemia infarction other than atherosclerotic plaque rupture ]] [[EKG pocket brain]] [[etiologies of dilated cardiomyopathy]] [[Etiologies of Prolonged-QT-interval]] [[PocketBrain]] [[ST-elevation]] [[T-wave-inversion]] [[Troponin]]</description></item><item><title>timing of nutrition</title><link>https://www.physician.tw/timing-of-nutrition/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/timing-of-nutrition/</guid><description>[!info]
üå± ‰æÜËá™: [[Nutrition in the ICU]]
timing of nutrition #üöß ÊñΩÂ∑•‰∏≠ Timing of nutritional support is an important factor in ICU patients.</description></item><item><title>upper respiratory symptoms</title><link>https://www.physician.tw/upper-respiratory-symptoms/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/upper-respiratory-symptoms/</guid><description>[!info]
üå± ‰æÜËá™: [[Disorders of Eyes, Ears, Nose, and Throat]]
upper respiratory symptoms [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>urticaria and angioedema</title><link>https://www.physician.tw/urticaria-and-angioedema/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urticaria-and-angioedema/</guid><description> [!info]
üå± ‰æÜËá™: [[allergy and immunology]]
urticaria and angioedema #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>vaccination</title><link>https://www.physician.tw/vaccination/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vaccination/</guid><description> [!info]
üå± ‰æÜËá™: [[ambulatory care]]
vaccination #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>vitamin deficiencies</title><link>https://www.physician.tw/vitamin-deficiencies/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vitamin-deficiencies/</guid><description> [!info]
üå± ‰æÜËá™: [[refeeding syndrome]]
vitamin deficiencies #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>weight loss</title><link>https://www.physician.tw/weight-loss/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/weight-loss/</guid><description> [!info]
üå± ‰æÜËá™: [[Alterations in Gastrointestinal Function]]
weight loss [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Why is this NOT Wandering Pacer</title><link>https://www.physician.tw/Why-is-this-NOT-Wandering-Pacer/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Why-is-this-NOT-Wandering-Pacer/</guid><description>[!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
Why is this NOT Wandering Pacer [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>women‚Äôs health</title><link>https://www.physician.tw/womens-health/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/womens-health/</guid><description> [!info]
üå± ‰æÜËá™: [[resident360]]
women‚Äôs health #üöß ÊñΩÂ∑•‰∏≠</description></item><item><title>ATS Reading List</title><link>https://www.physician.tw/ATS-Reading-List/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ATS-Reading-List/</guid><description>[!info]
üå± ‰æÜËá™: [[pulmonary reading list]]
ATS Reading List [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
ARDS Asthma Bronchiectasis (Non-Cystic Fibrosis) Cardiology Critical Care Chest Imaging COPD Cough COVID-19 Cystic Fibrosis Drug-Induced Lung Disease ECMO Endocrine Critical Care Gastroenterology Critical Care Hematology Critical Care ICU Administration Immunocompromised Host Infection Control Interstitial Lung Disease Lung Cancer/Solitary Pulmonary Nodule Lung Transplantation Mycobacterial Diseases Nephrology Critical Care Neurology Critical Care Nutrition in Critical Illness Obstetrics and Critical Care Occupational and Environmental Medicine Palliative/End of Life Care in the ICU Pleural Disease Pneumonia Procedures Pulmonary Embolism Pulmonary Function Testing Pulmonary Hypertension Pulmonary Rehabilitation Sedation / Analgesia¬†/ Delirium Sepsis / Septic Shock Sleep Medicine Smoking Cessation Ultrasound in the ICU Ventilation and Weaning 2018 Update:Caraganis AJ, Kempainen RR, University of Minnesota2019 Update:Caraganis AJ, Kempainen RR, University of Minnesota2020 Update:Wong JL, Kempainen RR, University of Minnesota2021 Update:Lambert CS, Kempainen RR, University of Minnesota2022 Update:Schwegman A, Kempainen RR, University of Minnesota [[inbox]]</description></item><item><title>autoinflammatory syndromes</title><link>https://www.physician.tw/autoinflammatory-syndromes/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoinflammatory-syndromes/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
autoinflammatory syndromes [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults</title><link>https://www.physician.tw/Balanced-Multielectrolyte-Solution-versus-Saline-in-Critically-Ill-Adults/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Balanced-Multielectrolyte-Solution-versus-Saline-in-Critically-Ill-Adults/</guid><description>[!info]
üå± ‰æÜËá™: [[Fluids-sepsis and shock]]
Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults March 3, 2022 N Engl J Med 2022; 386:815-826 DOI: 10.</description></item><item><title>Bartonella</title><link>https://www.physician.tw/Bartonella/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bartonella/</guid><description>[!info]
üå± ‰æÜËá™: [[diagnosis of culture-negative endocarditis]]
Bartonella B. henselae, B. quintana
cats (B. henselae), homelessness (B. quintana), body lice (B.</description></item><item><title>basal cell skin cancer</title><link>https://www.physician.tw/basal-cell-skin-cancer/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basal-cell-skin-cancer/</guid><description> [!info]
üå± ‰æÜËá™: [[NCCN guideline]]
basal cell skin cancer [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Bazett formula</title><link>https://www.physician.tw/Bazett-formula/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bazett-formula/</guid><description>[!info]
üå± ‰æÜËá™: [[Prolonged-QT-interval]]
Bazett formula Which QT Correction Formulae to Use for QT Monitoring? | Journal of the American Heart Association Fridericia and Framingham correction formulae showed the best rate correction and significantly improved prediction of 30‚Äêday and 1‚Äêyear mortality.</description></item><item><title>bedside percutaneous dilational tracheostomy</title><link>https://www.physician.tw/bedside-percutaneous-dilational-tracheostomy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bedside-percutaneous-dilational-tracheostomy/</guid><description>[!info]
üå± ‰æÜËá™: [[basic techniques and procedures]]
bedside percutaneous dilational tracheostomy [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Berlin definition</title><link>https://www.physician.tw/Berlin-definition/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Berlin-definition/</guid><description>[!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
Berlin definition (JAMA 2012;307:2526)
Acute onset within 1 week of clinical insult or worsening respiratory status Bilateral infiltrates without alternative explanation (eg, effusion, atelectasis, nodules) Edema not fully explained by fluid overload or congestive heart failure Hypoxemia: PaO2/FiO2 determined with 5 cm H2O of PEEP PaO2/FiO2 200‚Äì300 = mild ARDS (may be on NPPV), 100‚Äì200 = mod, &amp;lt;100 = severe</description></item><item><title>bladder cancer</title><link>https://www.physician.tw/bladder-cancer/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bladder-cancer/</guid><description> [!info]
üå± ‰æÜËá™: [[NCCN guideline]]
bladder cancer [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Blood Products and Indications</title><link>https://www.physician.tw/Blood-Products-and-Indications/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blood-Products-and-Indications/</guid><description> [!info]
üå± ‰æÜËá™: [[transfusion therapy]]
Blood Products and Indications (Lancet 2013;381:1845)
[[Packed red blood cells]] (PRBCs) [[Platelets-transfusion]] (plts) (Annals Int Med 2015;162:205) [[Fresh frozen plasma]] (FFP) [[Cryoprecipitate]] [[Irradiated blood products]] [[CMV-negative]] [[Leuko-reduced blood products]] [[IV immune globulin]] (IVIg) [[Therapeutic apheresis]] [[Massive transfusion]]</description></item><item><title>blood products and transfusions</title><link>https://www.physician.tw/blood-products-and-transfusions/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blood-products-and-transfusions/</guid><description>[!info]
üå± ‰æÜËá™: [[hematology and oncology in critical care]]
blood products and transfusions [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>bronchodilator</title><link>https://www.physician.tw/bronchodilator/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bronchodilator/</guid><description> [!info]
üå± ‰æÜËá™: [[Diagnostic studies]]
bronchodilator [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>bronchoscopy</title><link>https://www.physician.tw/bronchoscopy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bronchoscopy/</guid><description> [!info]
üå± ‰æÜËá™: [[basic techniques and procedures]]
bronchoscopy [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Brucella</title><link>https://www.physician.tw/Brucella/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Brucella/</guid><description> [!info]
üå± ‰æÜËá™: [[diagnosis of culture-negative endocarditis]]
Brucella Consumption of unpasteurized dairy products, exposure to tissue or fluids from infected animals (cattle, goats, sheep, or dogs)</description></item><item><title>calcium pyrophosphate dihydrate - cppd - deposition disease</title><link>https://www.physician.tw/calcium-pyrophosphate-dihydrate-cppd-deposition-disease/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/calcium-pyrophosphate-dihydrate-cppd-deposition-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[crystal deposition arthritides]]
calcium pyrophosphate dihydrate - cppd - deposition disease</description></item><item><title>cancer epidemiology</title><link>https://www.physician.tw/cancer-epidemiology/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-epidemiology/</guid><description>[!info]
üå± ‰æÜËá™: [[general oncology]]
cancer epidemiology [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
remark-cli - npm</description></item><item><title>cancer of unknown primary</title><link>https://www.physician.tw/cancer-of-unknown-primary/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-of-unknown-primary/</guid><description> [!info]
üå± ‰æÜËá™: [[oncology]]
cancer of unknown primary [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>cancer prevention and screening</title><link>https://www.physician.tw/cancer-prevention-and-screening/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-prevention-and-screening/</guid><description> [!info]
üå± ‰æÜËá™: [[general oncology]]
cancer prevention and screening [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>cardiac arrest</title><link>https://www.physician.tw/cardiac-arrest/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiac-arrest/</guid><description> [!info]
üå± ‰æÜËá™: [[ICU]]
cardiac arrest [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>cardiology reading list</title><link>https://www.physician.tw/cardiology-reading-list/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiology-reading-list/</guid><description> [!info]
üå± ‰æÜËá™: [[cardiology]]
cardiology reading list #ü¶¥ [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>command line interface</title><link>https://www.physician.tw/command-line-interface/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/command-line-interface/</guid><description> [!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
command line interface [[vim]] [[command line know how]] [[shell scripts]]</description></item><item><title>comparison of gout and pseudogout</title><link>https://www.physician.tw/comparison-of-gout-and-pseudogout/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/comparison-of-gout-and-pseudogout/</guid><description>[!info]
üå± ‰æÜËá™: [[crystal deposition arthritides]]
comparison of [[gout]] and [[pseudogout]] [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>complications of endocarditis</title><link>https://www.physician.tw/complications-of-endocarditis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-endocarditis/</guid><description> [!info]
üå± ‰æÜËá™: [[Treatment-bacterial endocarditis]]
complications of endocarditis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
CHF, conduction block, osteomyelitis, new embolic phenomenon) which can occur even on abx</description></item><item><title>connective tissue diseases</title><link>https://www.physician.tw/connective-tissue-diseases/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/connective-tissue-diseases/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
connective tissue diseases [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>CRAB</title><link>https://www.physician.tw/CRAB/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CRAB/</guid><description>[!info]
üå± ‰æÜËá™: [[IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections]]
CRAB [[treatment of CRAB]] üíä</description></item><item><title>CVP</title><link>https://www.physician.tw/CVP/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CVP/</guid><description> [!info]
üå± ‰æÜËá™: [[The 6 Ps-acute respiratory distress syndrome]]
CVP [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>cystitis</title><link>https://www.physician.tw/cystitis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cystitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Clinical manifestations-urinary tract infections]]
cystitis dysuria, urgency, frequency, hematuria suprapubic pain; fever absent. R/o vaginitis if symptoms of cystitis &amp;amp; urethritis.</description></item><item><title>depression</title><link>https://www.physician.tw/depression/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/depression/</guid><description> [!info]
üå± ‰æÜËá™: [[fatigue]]
depression [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>diagnosis of culture-negative endocarditis</title><link>https://www.physician.tw/diagnosis-of-culture-negative-endocarditis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnosis-of-culture-negative-endocarditis/</guid><description> [!info]
üå± ‰æÜËá™: [[bacterial endocarditis]]
diagnosis of culture-negative endocarditis [[Bartonella]] [[Brucella]]</description></item><item><title>Diagnostic Approach in a Patient with Possible Primary Ovarian Insufficiency</title><link>https://www.physician.tw/Diagnostic-Approach-in-a-Patient-with-Possible-Primary-Ovarian-Insufficiency/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Approach-in-a-Patient-with-Possible-Primary-Ovarian-Insufficiency/</guid><description> [!info]
üå± ‰æÜËá™: [[primary ovarian insufficiency]]
Diagnostic Approach in a Patient with Possible Primary Ovarian Insufficiency Figure:</description></item><item><title>dm</title><link>https://www.physician.tw/dm/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dm/</guid><description> [!info]
üå± ‰æÜËá™: [[diabetes mellitus]]
dm</description></item><item><title>dyssynchrony</title><link>https://www.physician.tw/dyssynchrony/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dyssynchrony/</guid><description> [!info]
üå± ‰æÜËá™: [[The 6 Ps-acute respiratory distress syndrome]]
dyssynchrony [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>estradiol</title><link>https://www.physician.tw/estradiol/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/estradiol/</guid><description> [!info]
üå± ‰æÜËá™: [[primary ovarian insufficiency]]
estradiol [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Etiologies acute respiratory distress syndrome</title><link>https://www.physician.tw/Etiologies-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-acute-respiratory-distress-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
Etiologies acute respiratory distress syndrome Direct Injury Pneumonia (~40%) Aspiration (~15%) Near drowning Inhalation injury Lung contusion Indirect Injury Sepsis (~25%) Shock [[disseminated intravascular coagulation]] [[pancreatitis]] Trauma/multiple fractures [[transfusion-related acute lung injury]]</description></item><item><title>external beam radiation therapy</title><link>https://www.physician.tw/external-beam-radiation-therapy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/external-beam-radiation-therapy/</guid><description> [!info]
üå± ‰æÜËá™: [[radiation oncology]]
external beam radiation therapy [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>fatigue</title><link>https://www.physician.tw/fatigue/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fatigue/</guid><description>[!info]
üå± ‰æÜËá™: [[symptom to diagnosis]]
fatigue [[flowchart of approach to fatigue]]
A. Psychiatric [[depression]] Anxiety [[somatization disorder]] Substance abuse B.</description></item><item><title>flowchart of approach to fatigue</title><link>https://www.physician.tw/flowchart-of-approach-to-fatigue/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/flowchart-of-approach-to-fatigue/</guid><description>[!info]
üå± ‰æÜËá™: [[fatigue]]
flowchart of approach to fatigue Figure: history tier 1 recent life stressor? new medications or substance use?</description></item><item><title>follicle-stimulating hormone</title><link>https://www.physician.tw/follicle-stimulating-hormone/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/follicle-stimulating-hormone/</guid><description> [!info]
üå± ‰æÜËá™: [[primary ovarian insufficiency]]
follicle-stimulating hormone [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Glycemic Control in intensive care unit</title><link>https://www.physician.tw/Glycemic-Control-in-intensive-care-unit/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glycemic-Control-in-intensive-care-unit/</guid><description>[!info]
üå± ‰æÜËá™: [[basic techniques and procedures]]
Glycemic Control in intensive care unit [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>gout</title><link>https://www.physician.tw/gout/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gout/</guid><description> [!info]
üå± ‰æÜËá™: [[crystal deposition arthritides]]
gout [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>hematology and oncology in critical care</title><link>https://www.physician.tw/hematology-and-oncology-in-critical-care/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematology-and-oncology-in-critical-care/</guid><description>[!info]
üå± ‰æÜËá™: [[ICU]]
hematology and oncology in critical care 54 blood products and transfusions [[transfusion therapy]] 55 anticoagulation‚Äêrelated bleeding 56 coagulopathy and thrombocytopenia 57 venous thromboembolism and pulmonary embolism 58 oncologic emergencies</description></item><item><title>hemodynamic monitoring</title><link>https://www.physician.tw/hemodynamic-monitoring/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemodynamic-monitoring/</guid><description> [!info]
üå± ‰æÜËá™: [[cardiovascular critical care]]
hemodynamic monitoring</description></item><item><title>hormone-replacement therapy</title><link>https://www.physician.tw/hormone-replacement-therapy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hormone-replacement-therapy/</guid><description> [!info]
üå± ‰æÜËá™: [[primary ovarian insufficiency]]
hormone-replacement therapy [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>how not to overlook Aflutter</title><link>https://www.physician.tw/how-not-to-overlook-Aflutter/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-not-to-overlook-Aflutter/</guid><description>[!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
how not to overlook Aflutter [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>how to define sinus rhythm</title><link>https://www.physician.tw/how-to-define-sinus-rhythm/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-define-sinus-rhythm/</guid><description>[!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
how to define sinus rhythm [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections</title><link>https://www.physician.tw/IDSA-Guidance-on-the-Treatment-of-Antimicrobial-Resistant-Gram-Negative-Infections/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IDSA-Guidance-on-the-Treatment-of-Antimicrobial-Resistant-Gram-Negative-Infections/</guid><description>[!info]
üå± ‰æÜËá™: [[pathogen]]
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections [[CRAB]]
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.</description></item><item><title>IgG4-related disease</title><link>https://www.physician.tw/IgG4-related-disease/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IgG4-related-disease/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
IgG4-related disease [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>immune phenomena</title><link>https://www.physician.tw/immune-phenomena/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-phenomena/</guid><description>[!info]
üå± ‰æÜËá™: [[Modified Duke Criteria]]
immune phenomena glomerulonephritis [[Osler nodes]] Roth spots rheumatoid factor Explain by ChatGPT The immune system is a network of cells, tissues, and organs that work together to protect the body from infection.</description></item><item><title>indications-mechanical ventilation</title><link>https://www.physician.tw/indications-mechanical-ventilation/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/indications-mechanical-ventilation/</guid><description> [!info]
üå± ‰æÜËá™: [[mechanical ventilation]]
indications-mechanical ventilation [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>infectious arthritis and bursitis</title><link>https://www.physician.tw/infectious-arthritis-and-bursitis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-arthritis-and-bursitis/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
infectious arthritis and bursitis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>infectious diseases in critical care</title><link>https://www.physician.tw/infectious-diseases-in-critical-care/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-in-critical-care/</guid><description>[!info]
üå± ‰æÜËá™: [[ICU]]
infectious diseases in critical care 42 The Febrile Patient, 44 Infections Acquired in the Intensive Care Unit 45 Antimicrobial Therapy 48 Acquired Immune Deficiency Syndrome 55 Anticoagulation‚ÄêRelated Bleeding</description></item><item><title>infective endocarditis</title><link>https://www.physician.tw/infective-endocarditis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infective-endocarditis/</guid><description> [!info]
üå± ‰æÜËá™: [[bacteremia and endocarditis]]
infective endocarditis [[bacterial endocarditis]] [[native valve endocarditis]]</description></item><item><title>long QT syndrome</title><link>https://www.physician.tw/long-QT-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/long-QT-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Etiologies of Prolonged-QT-interval]]
long QT syndrome Those at risk for LQTS include: Children who are deaf at birth Children and young adults who have unexplained sudden death or syncope in family members Blood relatives of family members with LQTS Those with LQTS taking medications that can further prolong the QT intervals.</description></item><item><title>Mechanisms of VILI Ventilator Strategies</title><link>https://www.physician.tw/Mechanisms-of-VILI-Ventilator-Strategies/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-of-VILI-Ventilator-Strategies/</guid><description>[!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
Mechanisms of VILI Ventilator Strategies Barotrauma/volutrauma: alveolar dist ‚Üí mech damage VT ‚â§6 mL/kg, Pplat ‚â§30 cm H2O, tolerate ‚Üë PaCO2 (but keep pH &amp;gt;7.</description></item><item><title>medications of fatigue</title><link>https://www.physician.tw/medications-of-fatigue/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medications-of-fatigue/</guid><description> [!info]
üå± ‰æÜËá™: [[fatigue]]
medications of fatigue</description></item><item><title>Minor clinical criteria</title><link>https://www.physician.tw/Minor-clinical-criteria/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Minor-clinical-criteria/</guid><description>[!info]
üå± ‰æÜËá™: [[Modified Duke Criteria]]
Minor clinical criteria Presence of predisposing cardiac condition or intravenous drug use Temperature ‚â•38.</description></item><item><title>neurologic outcomes after cardiac arrest</title><link>https://www.physician.tw/neurologic-outcomes-after-cardiac-arrest/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-outcomes-after-cardiac-arrest/</guid><description> [!info]
üå± ‰æÜËá™: [[ICU]]
neurologic outcomes after cardiac arrest [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>obs gyn issues</title><link>https://www.physician.tw/obs-gyn-issues/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/obs-gyn-issues/</guid><description>[!info]
üå± ‰æÜËá™: [[medical]]
obs gyn issues [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
[[primary ovarian insufficiency]]</description></item><item><title>OGTT</title><link>https://www.physician.tw/OGTT/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/OGTT/</guid><description>[!info]
üå± ‰æÜËá™: [[Definition-diabetes mellitus]]
OGTT Âè£ÊúçËë°ËêÑÁ≥ñËÄêÈáèË©¶È©ó(Oral Glucose Tolerance TestÔºåOGTT)Â∞çÁ≥ñÂ∞øÁóÖË®∫Êñ∑ÂÖ∑ÊúâÂæàÂ§ßÁöÑÂÉπÂÄº„ÄÇ D.MÊÇ£ËÄÖÔºåËÄêÁ≥ñÂäüËÉΩ‰Ωé‰∏ãÔºåÂè£ÊúçËë°ËêÑÁ≥ñÂ≥∞ÂÄºË∂ÖÈÅé200mg/dLÔºå‰∏îÈ´òÂ≥∞Âª∂ÈÅ≤</description></item><item><title>ophthalmic</title><link>https://www.physician.tw/ophthalmic/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ophthalmic/</guid><description> [!info]
üå± ‰æÜËá™: [[medical]]
ophthalmic [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Osler nodes</title><link>https://www.physician.tw/Osler-nodes/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Osler-nodes/</guid><description>[!info]
üå± ‰æÜËá™: [[immune phenomena]]
Osler nodes Osler&amp;rsquo;s nodes result from the deposition of immune complexes. The resulting inflammatory response leads to swelling, redness, and pain that characterize these lesions.</description></item><item><title>overdose and toxidromes</title><link>https://www.physician.tw/overdose-and-toxidromes/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overdose-and-toxidromes/</guid><description> [!info]
üå± ‰æÜËá™: [[ICU]]
overdose and toxidromes [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Pathology acute respiratory distress syndrome</title><link>https://www.physician.tw/Pathology-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathology-acute-respiratory-distress-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
Pathology acute respiratory distress syndrome diffuse alveolar damage (DAD) seen in 40% of autopsies (AJRCCM 2013;187:761) If no clear inciting event and ILD considered as alt dx, consider bx (Chest 2015;148:1073)</description></item><item><title>Pathophysiology of acute respiratory distress syndrome</title><link>https://www.physician.tw/Pathophysiology-of-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-acute-respiratory-distress-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
Pathophysiology of acute respiratory distress syndrome (Lancet 2016;388:2416)
‚Üë intrapulmonary shunt ‚Üí hypoxemia (‚à¥ Rx w/ PEEP to prevent derecruitment) ‚Üë increased dead space fraction (see Appendix), predicts ‚Üë mort (NEJM 2002;346:1281) ‚Üì compliance: VT/(Pplat ‚Äì PEEP) &amp;lt;50 mL/cm H2O</description></item><item><title>PEEP titration methods</title><link>https://www.physician.tw/PEEP-titration-methods/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PEEP-titration-methods/</guid><description>[!info]
üå± ‰æÜËá™: [[The 6 Ps-acute respiratory distress syndrome]]
PEEP titration methods [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>PEEP titration methods of acute respiratory distress syndrome</title><link>https://www.physician.tw/PEEP-titration-methods-of-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PEEP-titration-methods-of-acute-respiratory-distress-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
PEEP titration methods of acute respiratory distress syndrome [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>polysomnogram</title><link>https://www.physician.tw/polysomnogram/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polysomnogram/</guid><description> [!info]
üå± ‰æÜËá™: [[flowchart of approach to fatigue]]
polysomnogram [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>primary ovarian insufficiency</title><link>https://www.physician.tw/primary-ovarian-insufficiency/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/primary-ovarian-insufficiency/</guid><description>[!info]
üå± ‰æÜËá™: [[obs gyn issues]]
primary ovarian insufficiency [[Diagnostic Approach in a Patient with Possible Primary Ovarian Insufficiency]].</description></item><item><title>pseudogout</title><link>https://www.physician.tw/pseudogout/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pseudogout/</guid><description> [!info]
üå± ‰æÜËá™: [[crystal deposition arthritides]]
pseudogout [!info]
[[calcium pyrophosphate dihydrate - cppd - deposition disease]]</description></item><item><title>pulmonary reading list</title><link>https://www.physician.tw/pulmonary-reading-list/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-reading-list/</guid><description>[!info]
üå± ‰æÜËá™: [[pulmonology]]
pulmonary reading list [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
[[ATS Reading List]]</description></item><item><title>Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin</title><link>https://www.physician.tw/Reduction-in-the-Incidence-of-Type-2-Diabetes-with-Lifestyle-Intervention-or-Metformin/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Reduction-in-the-Incidence-of-Type-2-Diabetes-with-Lifestyle-Intervention-or-Metformin/</guid><description>[!info]
üå± ‰æÜËá™: [[Definition-diabetes mellitus]]
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin [!</description></item><item><title>regex</title><link>https://www.physician.tw/regex/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/regex/</guid><description>[!info]
üå± ‰æÜËá™: [[command line interface]]
regex Regex for lazy developers - DEV Community üë©üíªüë®üíª</description></item><item><title>remark</title><link>https://www.physician.tw/remark/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/remark/</guid><description>[!info]
üå± ‰æÜËá™: [[macÁöÑ‰∏Ä‰∫õÂ•ΩÁî®ËªüÈ´î]]
remark [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
remark-cli - npm</description></item><item><title>renal disorders in critical care</title><link>https://www.physician.tw/renal-disorders-in-critical-care/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-disorders-in-critical-care/</guid><description>[!info]
üå± ‰æÜËá™: [[ICU]]
renal disorders in critical care 49 Fluid Resuscitation 50 Acute Kidney Injury 51 Dialysis 52 Electrolyte Disorders 53 Acid‚ÄìBase Disorders</description></item><item><title>S saprophyticus</title><link>https://www.physician.tw/S-saprophyticus/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/S-saprophyticus/</guid><description>[!info]
üå± ‰æÜËá™: [[Microbiology-urinary tract infections]]
S saprophyticus ÊÆ∫Â©ÜÈ£õË∏¢Âí≥Ê≠ª
Staphylo - bunch of grapes Staphylococcus - grape-like coccus Saprophyticus - ËÖêÁîüÁöÑ ÂÖºÊÄßÂé≠Ê∞ßËèåÔºàfacultative anaerobeÔºâ</description></item><item><title>seronegative spondyloarthritis</title><link>https://www.physician.tw/seronegative-spondyloarthritis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/seronegative-spondyloarthritis/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
seronegative spondyloarthritis [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>somatization disorder</title><link>https://www.physician.tw/somatization-disorder/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/somatization-disorder/</guid><description> [!info]
üå± ‰æÜËá™: [[fatigue]]
somatization disorder [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>systemic lupus erythematosus</title><link>https://www.physician.tw/systemic-lupus-erythematosus/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/systemic-lupus-erythematosus/</guid><description> [!info]
üå± ‰æÜËá™: [[rheumatology]]
systemic lupus erythematosus [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>The 6 Ps-acute respiratory distress syndrome</title><link>https://www.physician.tw/The-6-Ps-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-6-Ps-acute-respiratory-distress-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
The 6 Ps-acute respiratory distress syndrome [[PEEP titration methods]] (see below) Proning: if PaO2/FiO2 &amp;lt;150, prone positioning ‚â•16 h ‚Üì mort ~50% (NEJM 2013;368:2159) Paralysis: no benefit routinely (NEJM 2019;380:1997); consider if [[ventilator dyssynchrony]] Peeing (fluid balance): target [[CVP]] 4‚Äì6 cm H2O (if nonoliguric &amp;amp; normotensive) ‚Üí ‚Üë vent/ICU-free days, but no Œî mortality (NEJM 2006;354:2564); PA catheter unproven (NEJM 2006;354:2213); consider BNP &amp;gt;200 to trigger diuresis (UOP goal 4.</description></item><item><title>The Composition of Saline, Lactated Ringer‚Äôs Solution, and Plasma-Lyte 148</title><link>https://www.physician.tw/The-Composition-of-Saline-Lactated-Ringers-Solution-and-Plasma-Lyte-148/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Composition-of-Saline-Lactated-Ringers-Solution-and-Plasma-Lyte-148/</guid><description>[!info]
üå± ‰æÜËá™: [[Fluids-sepsis and shock]]
The Composition of Saline, Lactated Ringer‚Äôs Solution, and Plasma-Lyte 148 Saline Na: 154 Cl: 154 Lactated Ringer‚Äôs Solution Na: 130 K: 4 Ca: 1.</description></item><item><title>tip</title><link>https://www.physician.tw/tip/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tip/</guid><description>tip remark-renumber-references - npm Remark Definition &amp;amp; Meaning - Merriam-Webster</description></item><item><title>Treatment acute respiratory distress syndrome</title><link>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</guid><description> [!info]
üå± ‰æÜËá™: [[acute respiratory distress syndrome]]
Treatment acute respiratory distress syndrome (Lancet 2021;398:622)
Goal is to maintain gas exchange, sustain life, &amp;amp; avoid [[ventilator-induced lung injury]] (VILI) In Pts on O2 for COVID-19 PNA, dexamethasone ‚Üì 28-day mortality (NEJM 2021;384:693)</description></item><item><title>tricks</title><link>https://www.physician.tw/tricks/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tricks/</guid><description>[!info]
üå± ‰æÜËá™: [[Raycast]]
tricks [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß
remark-cli - npm</description></item><item><title>vagal maneuvers to confirm AFlutter</title><link>https://www.physician.tw/vagal-maneuvers-to-confirm-AFlutter/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vagal-maneuvers-to-confirm-AFlutter/</guid><description>[!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
vagal maneuvers to confirm AFlutter [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>vascular phenomena</title><link>https://www.physician.tw/vascular-phenomena/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vascular-phenomena/</guid><description> [!info]
üå± ‰æÜËá™: [[Modified Duke Criteria]]
vascular phenomena septic arterial or pulmonary emboli mycotic aneurysms Janeway lesions septic pulmonary emboli intracranial hemorrhage conjunctival hemorrhages</description></item><item><title>ventilator dyssynchrony</title><link>https://www.physician.tw/ventilator-dyssynchrony/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ventilator-dyssynchrony/</guid><description>[!info]
üå± ‰æÜËá™: [[The 6 Ps-acute respiratory distress syndrome]]
ventilator dyssynchrony [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>ventilator-induced lung injury</title><link>https://www.physician.tw/ventilator-induced-lung-injury/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ventilator-induced-lung-injury/</guid><description>[!info]
üå± ‰æÜËá™: [[Treatment acute respiratory distress syndrome]]
ventilator-induced lung injury [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>very fast Afib ‚Äî Think WPW</title><link>https://www.physician.tw/very-fast-Afib-Think-WPW/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/very-fast-Afib-Think-WPW/</guid><description>[!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
very fast Afib ‚Äî Think WPW [!info]
üë∑ Â∑•‰∫ã‰∏≠ üå± Êï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>vim</title><link>https://www.physician.tw/vim/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim/</guid><description>[!info]
üå± ‰æÜËá™: [[command line interface]]
vim Getting Started With Vim - A Practical Guide - DEV Community üë©üíªüë®üíª</description></item><item><title>Coxiella burnetii</title><link>https://www.physician.tw/Coxiella-burnetii/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coxiella-burnetii/</guid><description> [!info]
üå± ‰æÜËá™: [[Major clinical criteria]]
Coxiella burnetii QÁÜ±ÊòØË≤ùÊ∞èËÄÉÂÖãÊñØËèåÔºàCoxiella burnetiiÔºâ ÊâÄÂºïËµ∑‰πã‰∫∫ÁïúÂÖ±ÈÄöÂÇ≥ÊüìÁóÖÔºàzoonosisÔºâÔºå ÂèØÂàÜÁÇ∫ÊÄ•ÊÄßQÁÜ±ÂèäÊÖ¢ÊÄßQÁÜ±„ÄÇ ÂãïÁâ©ÊÑüÊüìQÁÜ±ÈÄöÂ∏∏Ê≤íÊúâÁóáÁãÄÔºå ‰ΩÜÂèØËÉΩÊúÉÈÄ†ÊàêÊá∑Â≠ïÁöÑÂãïÁâ©ÊµÅÁî¢„ÄÅ Ê≠ªÁî¢Êàñ‰∏çÂ≠ïÔºõ ÈÄô‰∫õÂãïÁâ©ÁöÑËÉéÁõ§ÁµÑÁπî„ÄÅÁæäÊ∞¥„ÄÅÊ≠ªËÉéÂèäÂ≠êÂÆÆÊéíÂá∫Áâ©Á≠âÂê´ÊúâÂ§ßÈáèÁöÑÁóÖÂéüÈ´îÔºåËã•Êú™Â¶•ÂñÑËôïÁêÜ‰∏îÈö®ÊÑèÊé©ÂüãÔºå Âç≥ÂèØËÉΩÊ±°ÊüìÁí∞Â¢ÉËÄåÊàêÁÇ∫‰∫∫È°ûÊÑüÊüìQÁÜ±ÁöÑÈáçË¶ÅÊÑüÊüìÊ∫ê„ÄÇ Áç∏ÈÜ´„ÄÅÊØõÁöÆÊ•≠ËÄÖ„ÄÅËæ≤Â†¥Âì°Â∑•„ÄÅÂ±†ÂÆ∞Â†¥Âì°Â∑•„ÄÅÁïúÁâßÊ•≠ËÄÖÂèäÁõ∏ÈóúÁ†îÁ©∂‰∫∫Âì°Á≠âÔºåÂ∞§ÂÖ∂ÊòØÁ∂ìÂ∏∏Êé•Ëß∏Áâ≤ÁïúÔºàÂ±±Áæä„ÄÅÁ∂øÁæä„ÄÅÁâõÈöªÁ≠âÔºâÁöÑÂ∑•‰ΩúËÄÖÔºå ÁÇ∫QÁÜ±ÁöÑÈ´òÂç±Èö™Áæ§„ÄÇ</description></item><item><title>Crystalloid</title><link>https://www.physician.tw/Crystalloid/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Crystalloid/</guid><description>[!info]
üå± ‰æÜËá™: [[Fluids-sepsis and shock]]
Crystalloid ÂÖ∂ÂØ¶ÊòØLactate RingerÂíå‰∫∫È´îÂÖßÈõ¢Â≠êÁµÑÊàêÊØîËºÉÁõ∏ËøëÁöÑÔºåÂõ†Ê≠§Âö¥Ê†º‰æÜË™™0.9% Saline‰∏çËÉΩÁ®±ÁÇ∫„Äå Normal Saline „Äç„ÄÇ</description></item><item><title>Cutibacterium</title><link>https://www.physician.tw/Cutibacterium/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutibacterium/</guid><description> [!info]
üå± ‰æÜËá™: [[Risk factors for bloodstream infections]]
Cutibacterium [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>definitions of bacteremia</title><link>https://www.physician.tw/definitions-of-bacteremia/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definitions-of-bacteremia/</guid><description>[!info]
üå± ‰æÜËá™: [[bacteremia]]
definitions of bacteremia 1¬∞ bacteremia: bloodstream infection due to direct inoculation of the blood Central line associated bloodstream infection (CLABSI): bacteremia in which the same organism is growing from peripheral and catheter cultures (CID 2009;49:1) 2¬∞ bacteremia: infection of another site (eg, UTI, PNA, colitis, etc.</description></item><item><title>disseminated intravascular coagulation</title><link>https://www.physician.tw/disseminated-intravascular-coagulation/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disseminated-intravascular-coagulation/</guid><description> [!info]
üå± ‰æÜËá™: [[Microangiopathic hemolytic anemia]]
disseminated intravascular coagulation [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>HELLP</title><link>https://www.physician.tw/HELLP/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HELLP/</guid><description> [!info]
üå± ‰æÜËá™: [[Microangiopathic hemolytic anemia]]
HELLP [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Major clinical criteria</title><link>https://www.physician.tw/Major-clinical-criteria/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-clinical-criteria/</guid><description>[!info]
üå± ‰æÜËá™: [[Modified Duke Criteria]]
Major clinical criteria Positive blood culture Typical microorganisms Staphylococcus aureus,</description></item><item><title>native valve endocarditis</title><link>https://www.physician.tw/native-valve-endocarditis/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/native-valve-endocarditis/</guid><description>[!info]
üå± ‰æÜËá™: [[bacterial endocarditis]]
native valve endocarditis The [[modified Duke criteria]], which are based on findings on physical examination, echocardiography, microbiologic studies, and computed tomographic and magnetic resonance imaging of target organs, are sensitive and specific for the clinical diagnosis of infective endocarditis.</description></item><item><title>propofol infusion syndrome</title><link>https://www.physician.tw/propofol-infusion-syndrome/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/propofol-infusion-syndrome/</guid><description>[!info]
üå± ‰æÜËá™: [[Sedation-and-Analgesia]]
propofol infusion syndrome PRISÂ∏∏Ë¶ãÁöÑËá®Â∫äÁâπÂæµÂèØËÉΩÂåÖÂê´‰∫Ü ‰ª£Ë¨ùÊÄßÈÖ∏‰∏≠ÊØí„ÄÅÊ©´Á¥ãËÇåÊ∫∂Ëß£„ÄÅÂøÉÂæã‰∏çÊï¥„ÄÅÂøÉËÇåÂèäËÖéÁöÑË°∞Á´≠„ÄÅËÇùËÖ´Â§ß„ÄÅÈ´òË°ÄÈâÄÂèäËÑÇË°Ä„ÄÇÊ©´Á¥ãËÇåÊ∫∂Ëß£ÁöÑÁóáÁãÄÂåÖÊã¨‰∫ÜËÇåËÇâÁÑ°Âäõ„ÄÅËÇåÁêÉËõãÁôΩÂ∞øÂèäËÖéË°∞Á´≠„ÄÇ
PRISÁöÑÂÆöÁæ©ÁÇ∫ (1)Á™ÅÁÑ∂ÊúâÈ°ØËëóÁöÑÂøÉÊêèÈÅéÁ∑©‰∏îÂ∞çÊ≤ªÁôÇÂèçÊáâ‰∏ç‰Ω≥Ôºå‰∏¶Êº∏Êº∏ÈÄ≤Â±ïÁÇ∫ÂøÉË∑≥ÂÅúÊ≠¢„ÄÇ(2)ËÑÇË°ÄÁóá„ÄÇ(3)Áî±ÊñºËÑÇËÇ™Êµ∏ÊΩ§ÊâÄÈÄ†ÊàêÁöÑËÇùËÖ´Â§ß„ÄÇ(4)Âö¥ÈáçÁöÑ‰ª£Ë¨ùÊÄßÈÖ∏‰∏≠ÊØí„ÄÇ(5)ËàáËÇåËÇâÁõ∏ÈóúÁöÑÊ©´Á¥ãËÇåÊ∫∂Ëß£ÊàñËÇåÁêÉËõãÁôΩÂ∞ø„ÄÇËÄåPRISÁöÑË®∫Êñ∑ÂâáÊòØÂú®ÂøÉÊêèÈÅéÁ∑©ÁöÑÂ≠òÂú®‰∏ãËá≥Â∞ëÊúâ‰ª•‰∏ãÂÖ∂‰∏≠‰∏ÄÈ†ÖÁóáÁãÄÔºöËÑÇË°ÄÁóá„ÄÅËÇùËÖ´Â§ß„ÄÅ‰ª£Ë¨ùÊÄßÈÖ∏‰∏≠ÊØí„ÄÅÊàñÊ©´Á¥ãËÇåÊ∫∂Ëß£Áóá</description></item><item><title>prostatitis</title><link>https://www.physician.tw/prostatitis/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prostatitis/</guid><description>[!info]
üå± ‰æÜËá™: [[Infection as Etiologies of Classic FUO]]
prostatitis Chronic: similar to cystitis + symptoms of obstruction (hesitancy, weak stream)</description></item><item><title>schistocytes</title><link>https://www.physician.tw/schistocytes/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/schistocytes/</guid><description> [!info]
üå± ‰æÜËá™: [[Microangiopathic hemolytic anemia]]
schistocytes [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Streptococcus gallolyticus</title><link>https://www.physician.tw/Streptococcus-gallolyticus/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Streptococcus-gallolyticus/</guid><description>[!info]
üå± ‰æÜËá™: [[Major clinical criteria]]
Streptococcus gallolyticus [!info]
Streptococcus gallolyticus (Sg), previously known as Streptococcus bovis</description></item><item><title>thrombotic thrombocytopenic purpura</title><link>https://www.physician.tw/thrombotic-thrombocytopenic-purpura/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thrombotic-thrombocytopenic-purpura/</guid><description>[!info]
üå± ‰æÜËá™: [[Microangiopathic hemolytic anemia]]
thrombotic thrombocytopenic purpura Pathophys: ‚Üì‚Üì ADAMTS13 protease activity (hereditary [Upshaw Schulman Syn.] or autoAb) ‚Üí vWF multimers persist on endothelial surface ‚Üí plt adhesion/aggregation ‚Üí thrombosis</description></item><item><title>vertebral osteomyelitis</title><link>https://www.physician.tw/vertebral-osteomyelitis/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vertebral-osteomyelitis/</guid><description> [!info]
üå± ‰æÜËá™: [[Risk factors for bloodstream infections]]
vertebral [[osteomyelitis]] [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>EKG pocket brain</title><link>https://www.physician.tw/EKG-pocket-brain/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/EKG-pocket-brain/</guid><description>[!info]
üå± ‰æÜËá™: [[electrocardiography]]
EKG pocket brain [!info]
original: [[PocketBrain]]
00.6 ‚Äì ECG Crib Sheet
00.7 ‚Äì The 6 Essential Lists</description></item><item><title>Systematic Approach to 12-Lead ECG Interpretation</title><link>https://www.physician.tw/Systematic-Approach-to-12-Lead-ECG-Interpretation/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systematic-Approach-to-12-Lead-ECG-Interpretation/</guid><description> [!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
Systematic Approach to 12-Lead ECG Interpretation [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>The 2 Steps to Systematic Interpretation</title><link>https://www.physician.tw/The-2-Steps-to-Systematic-Interpretation/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-2-Steps-to-Systematic-Interpretation/</guid><description> [!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
The 2 Steps to Systematic Interpretation [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>WHY 2 Separate Steps for Interpretation</title><link>https://www.physician.tw/WHY-2-Separate-Steps-for-Interpretation/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHY-2-Separate-Steps-for-Interpretation/</guid><description> [!info]
üå± ‰æÜËá™: [[EKG pocket brain]]
WHY 2 Separate Steps for Interpretation [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>Raycast</title><link>https://www.physician.tw/Raycast/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Raycast/</guid><description>[!info]
üå± ‰æÜËá™: [[macÁöÑ‰∏Ä‰∫õÂ•ΩÁî®ËªüÈ´î]]
Raycast [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
[[tip]] [[tricks]]</description></item><item><title>Ventilator-associated pneumonia</title><link>https://www.physician.tw/Ventilator-associated-pneumonia/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ventilator-associated-pneumonia/</guid><description>&lt;blockquote>
&lt;p>[!info]&lt;/p>
&lt;p>üå± ‰æÜËá™: [[Definitions-and-clinical-manifestations]]&lt;/p>
&lt;/blockquote>
&lt;h1 id="ventilator-associated-pneumonia">Ventilator-associated pneumonia&lt;/h1>
&lt;blockquote>
&lt;p>[!info]&lt;/p>
&lt;p>&lt;strong>üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß&lt;/strong>&lt;/p>
&lt;/blockquote></description></item><item><title>Áî®Zotero‰æÜÁÆ°ÁêÜPaper</title><link>https://www.physician.tw/diary/%E7%94%A8Zotero%E4%BE%86%E7%AE%A1%E7%90%86Paper/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diary/%E7%94%A8Zotero%E4%BE%86%E7%AE%A1%E7%90%86Paper/</guid><description>[!info]
üå± ‰æÜËá™: [[index]]
Áî®Zotero‰æÜÁÆ°ÁêÜPaper [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
[[wow]]
[[zotero plugin]]</description></item><item><title>Áî®Zotero‰æÜÁÆ°ÁêÜPaper</title><link>https://www.physician.tw/%E7%94%A8Zotero%E4%BE%86%E7%AE%A1%E7%90%86Paper/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E7%94%A8Zotero%E4%BE%86%E7%AE%A1%E7%90%86Paper/</guid><description>[!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
Áî®Zotero‰æÜÁÆ°ÁêÜPaper [!info]
üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
[[wow]]
[[zotero plugin]]</description></item><item><title>Aldosterone</title><link>https://www.physician.tw/Aldosterone/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aldosterone/</guid><description>[!info] üå± ‰æÜËá™: [[overview-sodium and water homeostasis]]
Aldosterone ÁïôÈàâÊéíÈâÄ
[[aldosterone synthetic pathway]]
primary hormone that regulates total body sodium (and ‚à¥ volume)</description></item><item><title>aldosterone synthetic pathway</title><link>https://www.physician.tw/aldosterone-synthetic-pathway/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aldosterone-synthetic-pathway/</guid><description>[!info] üå± ‰æÜËá™: [[Aldosterone]]
aldosterone synthetic pathway Figure: adrenocorticotropic hormone (ACTH) , angiotensin II (Ang II) , and K + regulate steroidogenic acute regulatory protein (StAR) , which stimulates cholesterol uptake by mitochondria and thus substrate availability for synthesis of all of the steroid hormones.</description></item><item><title>Antidiuretic hormone</title><link>https://www.physician.tw/Antidiuretic-hormone/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antidiuretic-hormone/</guid><description>[!info] üå± ‰æÜËá™: [[overview-sodium and water homeostasis]]
Antidiuretic hormone primary hormone that regulates sodium concentration stimuli: hyperosmolality (290‚Äì295 mOsm), ‚Üì‚Üì effective arterial volume, angiotensin II action: insertion of [[aquaporin-2 channels]] in [[principal cells]] ‚Üí passive water reabsorption urine osmolality is an indirect functional assay of the ADH-renal axis Uosm range 50 mOsm/L (no ADH) to 1200 mOsm/L (maximal ADH) The normal range for urine specific gravity is 1.</description></item><item><title>Calcium homeostasis in normal humans</title><link>https://www.physician.tw/Calcium-homeostasis-in-normal-humans/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium-homeostasis-in-normal-humans/</guid><description> [!info] üå± ‰æÜËá™: [[calcium disorders]]
[[Calcium]] homeostasis in normal humans Figure: [[Calcium Homeostasis]]</description></item><item><title>Low Back Pain</title><link>https://www.physician.tw/Low-Back-Pain/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Low-Back-Pain/</guid><description>[!info]
üå± ‰æÜËá™: [[ambulatory]]
Low Back Pain üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß</description></item><item><title>macÁöÑ‰∏Ä‰∫õÂ•ΩÁî®ËªüÈ´î</title><link>https://www.physician.tw/mac%E7%9A%84%E4%B8%80%E4%BA%9B%E5%A5%BD%E7%94%A8%E8%BB%9F%E9%AB%94/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mac%E7%9A%84%E4%B8%80%E4%BA%9B%E5%A5%BD%E7%94%A8%E8%BB%9F%E9%AB%94/</guid><description>[!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
macÁöÑ‰∏Ä‰∫õÂ•ΩÁî®ËªüÈ´î üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
[[Raycast]] [[remark]]</description></item><item><title>Obsidian</title><link>https://www.physician.tw/Obsidian/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obsidian/</guid><description>[!info] üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
Obsidian üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
Explain by ChatGPT Obsidian : (is a powerful knowledge base that works on top of a local folder of plain text Markdown files); Getting Started : (is simple and straightforward.</description></item><item><title>principal cells</title><link>https://www.physician.tw/principal-cells/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/principal-cells/</guid><description> [!info] üå± ‰æÜËá™: [[Antidiuretic hormone]]
principal cells BacklinkÔºö [[Aldosterone]] [[Antidiuretic hormone]]</description></item><item><title>VimwikiË®≠ÂÆö</title><link>https://www.physician.tw/Vimwiki%E8%A8%AD%E5%AE%9A/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vimwiki%E8%A8%AD%E5%AE%9A/</guid><description> [!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
Vimwiki VimwikiÊòØ‰∏ÄÂÄãÈùûÂ∏∏Âº∑Â§ßÁöÑÁ≠ÜË®òÁÆ°ÁêÜËªüÈ´îÔºåÊòØÂü∫ÊñºVimÁ∑®ËºØÂô®ÈñãÁôºÁöÑ‰∏ÄÂÄãÂ§ñÊéõ„ÄÇÂÆÉÂèØ‰ª•ËÆì‰Ω†Áî®Á∞°ÂñÆÁöÑÊñáÂ≠óÊ†ºÂºèÂâµÂª∫„ÄÅÁµÑÁπîÂíåÁÆ°ÁêÜ‰Ω†ÁöÑÁ≠ÜË®ò„ÄÇ
VimwikiÊîØÊè¥Â§öÁ®ÆÊ™îÊ°àÊ†ºÂºèÔºåÂåÖÊã¨Markdown, Mediawiki, Org-mode, LaTeXÁ≠â„ÄÇÂÆÉÈÇÑÊîØÊè¥Ë∂ÖÈèàÊé•ÔºåÂèØ‰ª•Âú®‰∏çÂêåÁöÑÁ≠ÜË®ò‰πãÈñìÂª∫Á´ãËÅØÁπ´Ôºå‰ΩøÂæóÁ≠ÜË®ò‰πãÈñìÁöÑË≥áË®äÂÖ±‰∫´Êõ¥Âä†Êñπ‰æø„ÄÇ
Á∏Ω‰πãÔºåVimwikiÊòØ‰∏ÄÂÄãÂäüËÉΩÂº∑Â§ßÔºåÊòìÁî®ÁöÑÁ≠ÜË®òÁÆ°ÁêÜÂ∑•ÂÖ∑ÔºåÂèØ‰ª•Âπ´Âä©‰Ω†Êõ¥Â•ΩÁöÑÁÆ°ÁêÜÂíåÁµÑÁπî‰Ω†ÁöÑÁ≠ÜË®òÔºå‰∏¶‰∏îÂèØ‰ª•ÊèêÈ´ò‰Ω†ÁöÑÂ∑•‰ΩúÊïàÁéá„ÄÇ
markdown ÁöÑÊìç‰Ωú [[Á®ãÂºèË™ûË®Ä]]
Figure:</description></item><item><title>Âç°ÁâáÁõíÁ≠ÜË®òÊ≥ï</title><link>https://www.physician.tw/%E5%8D%A1%E7%89%87%E7%9B%92%E7%AD%86%E8%A8%98%E6%B3%95/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%8D%A1%E7%89%87%E7%9B%92%E7%AD%86%E8%A8%98%E6%B3%95/</guid><description>[!info] üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
Âç°ÁâáÁõíÁ≠ÜË®òÊ≥ï üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
a card #üìö content
[[test123]]</description></item><item><title>Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí</title><link>https://www.physician.tw/diary/%E5%A6%82%E4%BD%95%E6%89%93%E9%80%A0%E4%B8%80%E5%BA%A7%E7%9F%A5%E8%AD%98%E8%8A%B1%E5%9C%92/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diary/%E5%A6%82%E4%BD%95%E6%89%93%E9%80%A0%E4%B8%80%E5%BA%A7%E7%9F%A5%E8%AD%98%E8%8A%B1%E5%9C%92/</guid><description> [!info]
üå± ‰æÜËá™: [[index]]
Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí [[‰ªÄÈ∫ºÊòØÊï∏‰ΩçËä±Âúí]] [[Âç°ÁâáÁõíÁ≠ÜË®òÊ≥ï]] [[Obsidian]] [[Ëú•Ëú¥ËàáVIM]] [[VimwikiË®≠ÂÆö]] [[hugo]] [[Quartz]]</description></item><item><title>Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí</title><link>https://www.physician.tw/%E5%A6%82%E4%BD%95%E6%89%93%E9%80%A0%E4%B8%80%E5%BA%A7%E7%9F%A5%E8%AD%98%E8%8A%B1%E5%9C%92/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%A6%82%E4%BD%95%E6%89%93%E9%80%A0%E4%B8%80%E5%BA%A7%E7%9F%A5%E8%AD%98%E8%8A%B1%E5%9C%92/</guid><description> [!info]
üå± ‰æÜËá™: Ëä±ÂúíÂ§ßÈñÄÂè£
Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí [[‰ªÄÈ∫ºÊòØÊï∏‰ΩçËä±Âúí]] [[Âç°ÁâáÁõíÁ≠ÜË®òÊ≥ï]] [[Obsidian]] [[Ëú•Ëú¥ËàáVIM]] [[markdown garden]] [[VimwikiË®≠ÂÆö]] [[hugo]] [[Quartz]] üëâ[[Áî®Zotero‰æÜÁÆ°ÁêÜPaper]]üëà [[testforwft]]</description></item><item><title>Ëú•Ëú¥ËàáVIM</title><link>https://www.physician.tw/%E8%9C%A5%E8%9C%B4%E8%88%87VIM/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E8%9C%A5%E8%9C%B4%E8%88%87VIM/</guid><description>[!info]
üå± ‰æÜËá™: [[Â¶Ç‰ΩïÊâìÈÄ†‰∏ÄÂ∫ßÁü•Ë≠òËä±Âúí]]
Ëú•Ëú¥ËàáVIM üë∑ Â∑•‰∫ã‰∏≠ÔºåÊï¨Ë´ãÊúüÂæÖ üöß
[[neovim]] [[vim TODO]]</description></item><item><title>24-hour urinary free cortisol</title><link>https://www.physician.tw/24-hour-urinary-free-cortisol/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/24-hour-urinary-free-cortisol/</guid><description>[!info] üå± ‰æÜËá™: [[3 options for screening for hypercortisolism]]
24-hour urinary free cortisol Normal range is 4 to 40 mcg/24 hours or 11 to 110 nmol/day.</description></item><item><title>3 options for screening for hypercortisolism</title><link>https://www.physician.tw/3-options-for-screening-for-hypercortisolism/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/3-options-for-screening-for-hypercortisolism/</guid><description> [!info] üå± ‰æÜËá™: [[Approach to suspected Cushing‚Äôs syndrome]]
3 options for screening for hypercortisolism [[24-hour urinary free cortisol]] (UFC) [[dexamethasone suppression test]]; [[11 pm Salivary Cortisol]]</description></item><item><title>48-hr LD-dexamethasone suppression test</title><link>https://www.physician.tw/48-hr-LD-dexamethasone-suppression-test/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/48-hr-LD-dexamethasone-suppression-test/</guid><description>[!info] üå± ‰æÜËá™: [[Approach to suspected Cushing‚Äôs syndrome]]
48-hr LD-dexamethasone suppression test 48-h LD DST + CRH = 0.</description></item><item><title>adrenal incidentaloma</title><link>https://www.physician.tw/adrenal-incidentaloma/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-incidentaloma/</guid><description>[!info] üå± ‰æÜËá™: [[Primary Hyperaldosteronism]]
adrenal incidentaloma All patients with an adrenal mass that is discovered during diagnostic testing for another condition (an ‚Äúincidentaloma‚Äù) should undergo biochemical testing to detect pheochromocytoma and excess cortisol secretion, and those who also have high blood pressure should undergo biochemical testing to detect primary hyperaldosteronism.</description></item><item><title>Approach to suspected Cushing‚Äôs syndrome</title><link>https://www.physician.tw/Approach-to-suspected-Cushings-syndrome/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-suspected-Cushings-syndrome/</guid><description> [!info] üå± ‰æÜËá™: [[Diagnosis-Cushing‚Äôs Syndrome]]
Approach to suspected Cushing‚Äôs syndrome</description></item><item><title>BIPSS</title><link>https://www.physician.tw/BIPSS/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BIPSS/</guid><description>[!info] üå± ‰æÜËá™: [[Diagnosis-Cushing‚Äôs Syndrome]]
BIPSS bilat. Inferior petrosal È°≥È™®Â≤©ÈÉ® sinus vein sampling; ‚úì petrosal:peripheral ACTH ratio (‚äï ‚â•2 basal, ‚â•3 after CRH)</description></item><item><title>catheter-directed pharmacomech</title><link>https://www.physician.tw/catheter-directed-pharmacomech/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/catheter-directed-pharmacomech/</guid><description>[!info] üå± ‰æÜËá™: [[Mechanical intervention-venous thromboembolism]]
catheter-directed pharmacomech low-dose lytic infused (eg, tPA 1 mg/h for 12‚Äì24 hr per catheter) + U/S or mech fragmentation of clot.</description></item><item><title>CRH stimulations test</title><link>https://www.physician.tw/CRH-stimulations-test/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CRH-stimulations-test/</guid><description> [!info] üå± ‰æÜËá™: [[Approach to suspected Cushing‚Äôs syndrome]]
CRH stimulations test CRH stim test = 1 ¬µg/kg IV; ‚úì cortisol and ACTH (‚äï if &amp;gt; 35% ‚Üë in ACTH or &amp;gt;20% ‚Üë in cortisol above baseline)</description></item><item><title>Cushing‚Äôs disease</title><link>https://www.physician.tw/Cushings-disease/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cushings-disease/</guid><description>[!info] üå± ‰æÜËá™: [[Approach to suspected Cushing‚Äôs syndrome]]
Cushing‚Äôs disease Cushing‚Äôs syndrome 2¬∞ to pituitary ACTH hypersecretion
[[Cushing‚Äôs Syndrome]]</description></item><item><title>dexamethasone suppression test</title><link>https://www.physician.tw/dexamethasone-suppression-test/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dexamethasone-suppression-test/</guid><description>[!info] üå± ‰æÜËá™: [[Diagnosis-Cushing‚Äôs Syndrome]]
dexamethasone suppression test give 1 mg at 11 p.m.; ‚úì 8 a.m. serum cortisol (suppression if &amp;lt;1.</description></item><item><title>Diagnosis Cushing‚Äôs Syndrome</title><link>https://www.physician.tw/Diagnosis-Cushings-Syndrome/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-Cushings-Syndrome/</guid><description>[!info] üå± ‰æÜËá™: [[Cushing‚Äôs Syndrome]]
Diagnosis Cushing‚Äôs Syndrome Typically performed in outPt setting Very difficult as inPt b/c hypercortisolism from acute illness and hosp.</description></item><item><title>Fondaparinux</title><link>https://www.physician.tw/Fondaparinux/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fondaparinux/</guid><description>[!info] üå± ‰æÜËá™: [[Initial anticoagulation options for-venous thromboembolism]]
Fondaparinux FondaparinuxÁöÑÂª∫Ë≠∞ÂäëÈáèÁÇ∫ÊØèÊó•‰∏ÄÊ¨°2.5ÊØ´ÂÖã„ÄÇÁ¨¨‰∏ÄÂäëFondaparinuxÊáâ‰ª•ÈùúËÑàÊ≥®. Â∞ÑÁöÑÊñπÂºèÁµ¶Ëó•ÔºåÂæåÁ∫åÁöÑÂäëÈáèÂâáÊáâ‰ª•ÁöÆ‰∏ãÊ≥®Â∞ÑÁöÑÊñπÂºèÁµ¶Ëó•</description></item><item><title>Nonaldosterone mineralocorticoid excess</title><link>https://www.physician.tw/Nonaldosterone-mineralocorticoid-excess/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonaldosterone-mineralocorticoid-excess/</guid><description>[!info] üå± ‰æÜËá™: [[Etiologies-hyperaldosteronism]]
Nonaldosterone mineralocorticoid excess 11Œ≤-HSD defic. (‚Üí lack of inactivation of cortisol, which binds to mineralocorticoid recept.</description></item><item><title>pheochromocytoma</title><link>https://www.physician.tw/pheochromocytoma/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pheochromocytoma/</guid><description> [!info] üå± ‰æÜËá™: [[Etiologies of hypercortisolism]]
pheochromocytoma</description></item><item><title>postthrombotic syndrome</title><link>https://www.physician.tw/postthrombotic-syndrome/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/postthrombotic-syndrome/</guid><description>[!info] üå± ‰æÜËá™: [[Complications &amp;amp; prognosis-venous thromboembolism]]
postthrombotic syndrome PTS symptoms include leg pain sensations of leg heaviness, pulling, or fatigue limb swelling Symptoms can be present in various combinations, may be persistent or intermittent, and are usually aggravated by standing or walking and tend to improve with rest and leg elevation.</description></item><item><title>Rationale of BIPSS</title><link>https://www.physician.tw/Rationale-of-BIPSS/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rationale-of-BIPSS/</guid><description>[!info] üå± ‰æÜËá™: [[BIPSS]]
Rationale of BIPSS In the setting of hypercortisolemia, the procedure is performed to differentiate a pituitary from an ectopic source of ACTH.</description></item><item><title>somatostatin scan</title><link>https://www.physician.tw/somatostatin-scan/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/somatostatin-scan/</guid><description>[!info] üå± ‰æÜËá™: [[Approach to suspected Cushing‚Äôs syndrome]]
somatostatin scan An octreotide scan is a type of SPECT scintigraphy used to find carcinoid, pancreatic neuroendocrine tumors, and to localize sarcoidosis.</description></item><item><title>surgical embolectomy</title><link>https://www.physician.tw/surgical-embolectomy/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgical-embolectomy/</guid><description>[!info] üå± ‰æÜËá™: [[Mechanical intervention-venous thromboembolism]]
surgical embolectomy if large, proximal PE + hemodynamic compromise + contraindic. to lysis; consider in experienced ctr if large prox.</description></item><item><title>54321-PUMA-ÂòîÊÄï</title><link>https://www.physician.tw/54321-PUMA-%E5%98%94%E6%80%95/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/54321-PUMA-%E5%98%94%E6%80%95/</guid><description>[!info] üå± ‰æÜËá™: [[Diagnosis of migraine]]
54321-PUMA-ÂòîÊÄï ‰∏ÄËà¨Â∞çÂÅèÈ†≠ÁóõÊúâ„Äå54321„ÄçÈÄôÂÄãË®∫Êñ∑Ê®ôÊ∫ñ 5ÊòØÊÇ£ËÄÖÂú®Â∞±Ë®∫‰πãÂâçÊúâ5Ê¨°‰ª•‰∏äÁöÑÈ†≠ÁóõÊÉÖÂΩ¢Ôºõ 4Ëàá3ÂàÜÂà•ÊòØÈ†≠ÁóõÊôÇÈñìÈÅî4Â∞èÊôÇÊàñÂà∞3Â§©‰πãÈñìÔºõ 2 in 4 ÊòØÂú®
unilateral location È†≠ÈÉ®ÂñÆÂÅ¥Áôº‰Ωú pulsating quality ÂçöÂãïÊÄßÁóáÁãÄËàáÈÅãÂãï moderate or severe pain intensity ‰∏≠„ÄÅÈáçÂ∫¶È†≠ÁóõÔºàÁñºÁóõÊåáÊï∏7Ëá≥10ÂàÜÔºâ aggravation by or causing avoidance of routine physical activity Ê¥ªÂãïÊôÇÁóáÁãÄÊúÉÂä†Âäá 1 in 2 ÂâáÊòØÊúâÂôÅÂøÉ„ÄÅÂòîÂêêÊàñÁïèÂÖâ„ÄÅÊÄïÂêµÈÄô2È†ÖÊìá1Ôºå Â¶ÇÊúâÈÄô5Á®ÆÊÉÖÂΩ¢ÔºåÂç≥ÂèØË™çÂÆöÊòØÂÅèÈ†≠ÁóõÁóÖÁóá„ÄÇ</description></item><item><title>central role of tissue factor in tumor progression and thrombosis</title><link>https://www.physician.tw/central-role-of-tissue-factor-in-tumor-progression-and-thrombosis/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/central-role-of-tissue-factor-in-tumor-progression-and-thrombosis/</guid><description> [!info] üå± ‰æÜËá™: [[Venous Thromboembolism and Cancer]]
central role of tissue factor in tumor progression and thrombosis</description></item><item><title>Cockcroft-Gault formula</title><link>https://www.physician.tw/Cockcroft-Gault-formula/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cockcroft-Gault-formula/</guid><description> [!info] üå± ‰æÜËá™: [[Hestia Criteria for Outpatient Pulmonary Embolism Treatment]]
Cockcroft-Gault formula</description></item><item><title>critical actions of Pulmonary Embolism Severity Index PESI</title><link>https://www.physician.tw/critical-actions-of-Pulmonary-Embolism-Severity-Index-PESI/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-actions-of-Pulmonary-Embolism-Severity-Index-PESI/</guid><description>[!info] üå± ‰æÜËá™: [[Pulmonary Embolism Severity Index PESI]]
critical actions of Pulmonary Embolism Severity Index PESI The PESI is only meant for risk stratification of pulmonary embolism after the diagnosis has been made.</description></item><item><title>d-dimer</title><link>https://www.physician.tw/d-dimer/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/d-dimer/</guid><description>[!info] üå± ‰æÜËá™: [[Diagnostic studies‚ÄîDVT]]
d-dimer by-product of the blood clotting and break-down process that can be measured via analysis of a blood sample.</description></item><item><title>deep vein thrombosis</title><link>https://www.physician.tw/deep-vein-thrombosis/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/deep-vein-thrombosis/</guid><description> [!info] üå± ‰æÜËá™: [[venous thromboembolism]]
deep vein thrombosis [[Clinical manifestations‚ÄîDVT]] [[Simplified Wells Pretest Probability Scoring of DVT]] [[Diagnostic studies‚ÄîDVT]]</description></item><item><title>Diagnostic studies‚ÄîDVT</title><link>https://www.physician.tw/Diagnostic-studiesDVT/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studiesDVT/</guid><description>[!info] üå± ‰æÜËá™: [[deep vein thrombosis]]
Diagnostic studies‚ÄîDVT [[d-dimer]]: (DVT excluded at D-dimer levels &amp;lt;0.5 ¬µg/mL = 500 ¬µg/L).</description></item><item><title>fluoroquinolones</title><link>https://www.physician.tw/fluoroquinolones/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fluoroquinolones/</guid><description>[!info] üå± ‰æÜËá™: [[preferred antibiotics for uncomplicated cystitis caused by ESBL-E]]
fluoroquinolones have been associated with an increased risk for prolonged QTc intervals, tendinitis and tendon rupture, aortic dissections, seizures, peripheral neuropathy, and Clostridioides difficile infections, compared to other antibiotics</description></item><item><title>Hestia Criteria for Outpatient Pulmonary Embolism Treatment</title><link>https://www.physician.tw/Hestia-Criteria-for-Outpatient-Pulmonary-Embolism-Treatment/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hestia-Criteria-for-Outpatient-Pulmonary-Embolism-Treatment/</guid><description>[!info] üå± ‰æÜËá™: [[Risk factors-venous thromboembolism]]
Hestia Criteria for Outpatient Pulmonary Embolism Treatment Hemodynamically unstable sBP &amp;lt;100 mmHg and HR &amp;gt;100, needing ICU care, or by clinician judgment</description></item><item><title>Homan‚Äôs sign</title><link>https://www.physician.tw/Homans-sign/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Homans-sign/</guid><description>[!info] üå± ‰æÜËá™: [[Clinical manifestations‚ÄîDVT]]
Homan‚Äôs sign Homan‚Äôs sign test also called dorsiflexon sign test is a physical examination procedure that is used to test for Deep Vein Thrombosis (DVT).</description></item><item><title>IDSA Guidance</title><link>https://www.physician.tw/IDSA-Guidance/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IDSA-Guidance/</guid><description>[!info] üå± ‰æÜËá™: [[Treatment of UTIs]]
IDSA Guidance [[treatment of antimicrobial-resistant gram-negative infections]]</description></item><item><title>Interpretation of Pulmonary Embolism Severity Index PESI</title><link>https://www.physician.tw/Interpretation-of-Pulmonary-Embolism-Severity-Index-PESI/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Interpretation-of-Pulmonary-Embolism-Severity-Index-PESI/</guid><description>[!info] üå± ‰æÜËá™: [[Pulmonary Embolism Severity Index PESI]]
Interpretation of Pulmonary Embolism Severity Index PESI 0-65 I 0.0-1.6%</description></item><item><title>preferred antibiotics for uncomplicated cystitis caused by ESBL-E</title><link>https://www.physician.tw/preferred-antibiotics-for-uncomplicated-cystitis-caused-by-ESBL-E/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preferred-antibiotics-for-uncomplicated-cystitis-caused-by-ESBL-E/</guid><description>[!info] üå± ‰æÜËá™: [[treatment of antimicrobial-resistant gram-negative infections]]
preferred antibiotics for uncomplicated cystitis caused by ESBL-E Nitrofurantoin and trimethoprim-sulfamethoxazole have been shown to be safe and effective options for uncomplicated cystitis, including uncomplicated ESBL-E cystitis.</description></item><item><title>PRES</title><link>https://www.physician.tw/PRES/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PRES/</guid><description>[!info] üå± ‰æÜËá™: [[warning signs of headache]]
PRES Posterior reversible encephalopathy syndrome (PRES)
characterized by headache, visual disturbances seizures altered mental states.</description></item><item><title>pulmonary embolism</title><link>https://www.physician.tw/pulmonary-embolism/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-embolism/</guid><description> [!info] üå± ‰æÜËá™: [[venous thromboembolism]]
pulmonary embolism [[Clinical manifestations‚ÄîPE]] [[Modified Wells Pretest Probability Scoring for PE ]] [[Diagnostic studies of PE]] [[Approach to suspected PE]] [[Workup for idiopathic VTE]] [[Risk stratification for Pts with PE]]</description></item><item><title>Pulmonary Embolism Severity Index PESI</title><link>https://www.physician.tw/Pulmonary-Embolism-Severity-Index-PESI/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Embolism-Severity-Index-PESI/</guid><description>[!info] üå± ‰æÜËá™: [[Risk factors-venous thromboembolism]]
Pulmonary Embolism Severity Index PESI Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria.</description></item><item><title>Red Flags-SNOOP for headache</title><link>https://www.physician.tw/Red-Flags-SNOOP-for-headache/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Red-Flags-SNOOP-for-headache/</guid><description>[!info] üå± ‰æÜËá™: [[warning signs of headache]]
Red Flags-SNOOP for headache Systemic Sx (fever, weight loss) Secondary risk factors (HIV, cancer) Neurologic Sx (confusion, impaired alertness or consciousness) Onset (sudden, abrupt, or split-second) Older (&amp;gt;50 yr) Pattern change Progressive Precipitated by Valsalva Postural aggravation Papilledema Dodick DW.</description></item><item><title>risk classification of pulmonary embolism</title><link>https://www.physician.tw/risk-classification-of-pulmonary-embolism/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/risk-classification-of-pulmonary-embolism/</guid><description>[!info] üå± ‰æÜËá™: [[Risk stratification for Pts with PE]]
risk classification of pulmonary embolism High risk (‚Äúmassive‚Äù): * hemodyn unstable w/ arrest, * obstructive shock * persistent HoTN Intermediate risk (‚Äúsubmassive‚Äù): * sPESI ‚â•1 * ‚ÄúIntermediate-high‚Äù if both RV dysfunction &amp;amp; elevated Tn * ‚ÄúIntermediate-low‚Äù if either or neither RV dysfunction or elevated Tn Low risk: * clinically stable, * sPESI = 0, * normal RV function, * normal Tn [[simplified PE severity index]]</description></item><item><title>simplified PE severity index</title><link>https://www.physician.tw/simplified-PE-severity-index/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/simplified-PE-severity-index/</guid><description>[!info] üå± ‰æÜËá™: [[Risk stratification for Pts with PE]]
simplified PE severity index age &amp;gt;80 y</description></item><item><title>tamoxifen</title><link>https://www.physician.tw/tamoxifen/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tamoxifen/</guid><description>[!info] üå± ‰æÜËá™: [[Virchow‚Äôs triad]]
tamoxifen Âª∫Ë≠∞ÂèÉËÄÉÂäëÈáè ÊØèÊó•20ÔΩû40mg„ÄÇ
Â∏∏Ë¶ãÂâØ‰ΩúÁî® ÊúàÁ∂ìÈÄ±Êúü‰∏çË¶èÂâá„ÄÅÊΩÆÁ¥Ö„ÄÅÈô∞ÈÅìÂàÜÊ≥åÁâ©„ÄÇ
Â∞ëË¶ã‰ΩÜÂö¥Èáç‰πãÂâØ‰ΩúÁî® Ê∑±Â±§ÈùúËÑàÊ†ìÂ°û„ÄÅ Âè≤ËíÇËä¨Âº∑ÁîüÁóáÂÄôÁæ§„ÄÅ ÁôΩÂÖßÈöú„ÄÅ Â≠êÂÆÆÂÖßËÜúÁôå„ÄÅ ÈñìË≥™ÊÄßËÇ∫ÁÇé„ÄÅ ËÇ∫Ê†ìÂ°û„ÄÇ
Ëá¥ÂêêÁ≠âÁ¥ö ‰Ωé„ÄÇ</description></item><item><title>treatment of antimicrobial-resistant gram-negative infections</title><link>https://www.physician.tw/treatment-of-antimicrobial-resistant-gram-negative-infections/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-antimicrobial-resistant-gram-negative-infections/</guid><description>[!info] üå± ‰æÜËá™: [[IDSA Guidance]]
treatment of antimicrobial-resistant gram-negative infections [[preferred antibiotics for uncomplicated cystitis caused by ESBL-E]]</description></item><item><title>Venous Thromboembolism and Cancer</title><link>https://www.physician.tw/Venous-Thromboembolism-and-Cancer/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Venous-Thromboembolism-and-Cancer/</guid><description>[!info] üå± ‰æÜËá™: [[Risk factors-venous thromboembolism]]
Venous Thromboembolism and Cancer Venous Thromboembolism and Cancer | Circulation
Pathophysiological changes that favor thrombosis in patients with cancer include platelet activation direct factor X activation, decreased hepatic anticoagulant synthesis reduced hepatic clearance of coagulation factors and autoimmune phenomena such as the development of antiphospholipid antibodies Most patients with active cancer have evidence of chronic systemic coagulation activation, such as elevated plasma d-dimer levels</description></item><item><title>Virchow‚Äôs triad</title><link>https://www.physician.tw/Virchows-triad/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Virchows-triad/</guid><description>[!info] üå± ‰æÜËá™: [[Risk factors-venous thromboembolism]]
Virchow‚Äôs triad s.i.t: statis, injury, thrombophilia
Stasis: bed rest, inactivity CHF CVA w/in 3 mo air travel &amp;gt;6 h.</description></item><item><title>warning signs of headache</title><link>https://www.physician.tw/warning-signs-of-headache/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/warning-signs-of-headache/</guid><description>[!info] üå± ‰æÜËá™: [[Clinical evaluation of Secondary causes of headaches]]
warning signs of headache (should prompt neuroimaging)
Explosive onset (vasc) ‚Äúworst HA of life‚Äù (SAH, RCVS) meningismus (SAH, infxn) Positional: lying &amp;gt;standing (‚Üë ICP) N/V (‚Üë ICP; migraines) coughing/bearing down (‚Üë ICP) Visual sx: diplopia, blurring, ‚Üì acuity (GCA, glaucoma, ‚Üë ICP) eye pain glaucoma, trigeminal autonomic cephalalgia optic neuritis Abnl exam (struct.</description></item><item><title>epithelial sodium channel - ENaC</title><link>https://www.physician.tw/epithelial-sodium-channel-ENaC/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epithelial-sodium-channel-ENaC/</guid><description>[!info] üå± ‰æÜËá™: [[Liddle‚Äôs syndrome]]
epithelial sodium channel - ENaC open in response to signals that sodium levels in the blood are too low, which allows sodium to flow into cells.</description></item><item><title>licorice</title><link>https://www.physician.tw/licorice/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/licorice/</guid><description>[!info] üå± ‰æÜËá™: [[Etiologies-of-Metabolic-Alkalosis]]
licorice (glycyrrhizic acid inhibits 11Œ≤-HSD)
ÁöÆË≥™ÈÜáÔºå‰∏ÄÁ®ÆÁ≥ñÁöÆË≥™ÊøÄÁ¥†ÔºåËàáÁ≥ñÁöÆË≥™ÊøÄÁ¥†ÂèóÈ´îÁµêÂêà„ÄÇ ÁÑ∂ËÄåÔºåÁî±ÊñºÂÖ∂ËàáÈÜõÂõ∫ÈÖÆÁöÑÂàÜÂ≠êÁõ∏‰ººÊÄßÔºå ÂÆÉ‰πüÂú®ËºÉÈ´òÊøÉÂ∫¶‰∏ãËàáÈπΩÁöÆË≥™ÊøÄÁ¥†ÂèóÈ´îÁµêÂêà„ÄÇ ÈÜõÂõ∫ÈÖÆÂíåÁöÆË≥™ÈÜáÂ∞çÈπΩÁöÆË≥™ÊøÄÁ¥†ÂèóÈ´îÊúâÁõ∏‰ººÁöÑË¶™ÂíåÂäõÔºõ ÁÑ∂ËÄåÔºåÂæ™Áí∞‰∏≠ÁöÑÁöÆË≥™ÈÜáÈÅ†ÈÅ†Â§öÊñºÈÜõÂõ∫ÈÖÆ„ÄÇ
ÁÇ∫‰∫ÜÈò≤Ê≠¢ÁöÆË≥™ÈÜáÂ∞çÈπΩÁöÆË≥™ÊøÄÁ¥†ÂèóÈ´îÁöÑÈÅéÂ∫¶Âà∫ÊøÄ 11Œ≤-HSDÂ∞áÂÖ∑ÊúâÁîüÁâ©Ê¥ªÊÄßÁöÑÁöÆË≥™ÈÜáËΩâÂåñÁÇ∫‰∏çÂÜçËàáÈπΩÁöÆË≥™ÊøÄÁ¥†ÂèóÈ´îÁµêÂêàÁöÑÈùûÊ¥ªÊÄßÁöÆË≥™ÈÜá 11Œ≤-HSDËàáËÖé‰∏äËÖ∫ÁöÆË≥™ÊøÄÁ¥†ÂèóÈ´îÂÖ±ÂÆö‰Ωç„ÄÇ ÁîòËçâÂê´ÊúâÁîòËçâÈÖ∏ÂíåÁîòËçâÊ¨°ÈÖ∏ÔºåËÉΩÊäëÂà∂11Œ≤-HSDÔºåÂ∞éËá¥ÈπΩÁöÆË≥™ÊøÄÁ¥†ÈÅéÂ§öÁóáÂÄôÁæ§„ÄÇ ÁöÆË≥™ÈÜáÊ∞¥Âπ≥Èö®‰πãÂçáÈ´ò</description></item><item><title>Liddle‚Äôs syndrome</title><link>https://www.physician.tw/Liddles-syndrome/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Liddles-syndrome/</guid><description>[!info] üå± ‰æÜËá™: [[Etiologies-hyperaldosteronism]]
Liddle‚Äôs syndrome Liddle syndrome is an inherited form of high blood pressure (hypertension).
caused by mutations in the SCNN1B or SCNN1G gene.</description></item><item><title>opportunistic infections</title><link>https://www.physician.tw/opportunistic-infections/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/opportunistic-infections/</guid><description>[!info] üå± ‰æÜËá™: [[infectious disease]]
opportunistic infections test</description></item><item><title>acid-base abnormalities</title><link>https://www.physician.tw/acid-base-abnormalities/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acid-base-abnormalities/</guid><description>acid-base abnormalities BacklinkÔºö [[an acid-base abnormality]] [[Contents]] [[Â∏∏Ë¶ã‰∏ªË®¥ÁöÑapporach]]</description></item><item><title>adult-onset Still‚Äôs disease</title><link>https://www.physician.tw/adult-onset-Stills-disease-/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adult-onset-Stills-disease-/</guid><description>from: [[rheumatology]]
adult-onset Still‚Äôs disease</description></item><item><title>approach to rheumatic disease</title><link>https://www.physician.tw/approach-to-rheumatic-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-rheumatic-disease/</guid><description>from: [[rheumatology]]
approach to rheumatic disease [[Major categories of inflammatory rheumatic disease]]
[[Approach to patient with joint pain]]</description></item><item><title>brother</title><link>https://www.physician.tw/brother/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/brother/</guid><description>from: [[orphan]]
brother [[cousin]]</description></item><item><title>BufNewFile</title><link>https://www.physician.tw/BufNewFile/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BufNewFile/</guid><description>BufNewFile</description></item><item><title>Clinical features-peripheral artery disease</title><link>https://www.physician.tw/Clinical-features-peripheral-artery-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-features-peripheral-artery-disease/</guid><description> [!info] üå± ‰æÜËá™: [[peripheral artery disease]]
Clinical features-peripheral artery disease</description></item><item><title>Conservative therapy of nerve root compression</title><link>https://www.physician.tw/Conservative-therapy-of-nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Conservative-therapy-of-nerve-root-compression/</guid><description>from: [[Evaluation and treatment of nerve root compression]]
Conservative therapy of nerve root compression avoid bending/lifting; soft collar (cervical radiculopathy); NSAIDs; muscle relaxants; lidocaine patch/ointment; Rx neuropathic pain (see ‚ÄúPeripheral Neuropathies‚Äù); physical/occup therapy.</description></item><item><title>crystal deposition arthritides</title><link>https://www.physician.tw/crystal-deposition-arthritides/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crystal-deposition-arthritides/</guid><description>from: [[rheumatology]]
crystal deposition arthritides [[comparison of gout and pseudogout]]
[[gout]]
[[calcium pyrophosphate dihydrate - cppd - deposition disease]] [[pseudogout]]</description></item><item><title>Diagnosis-peripheral artery disease</title><link>https://www.physician.tw/Diagnosis-peripheral-artery-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-peripheral-artery-disease/</guid><description> [!info] üå± ‰æÜËá™: [[peripheral artery disease]]
Diagnosis-peripheral artery disease</description></item><item><title>differential diagnosis of back pain</title><link>https://www.physician.tw/differential-diagnosis-of-back-pain/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/differential-diagnosis-of-back-pain/</guid><description>from: [[back pain]]
differential diagnosis of back pain [[Musculoskeletal ddx of back pain]]
Spinal cord (myelopathy) nerve root (radiculopathy):</description></item><item><title>Duty note of hypokalemia</title><link>https://www.physician.tw/Duty-note-of-hypokalemia/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Duty-note-of-hypokalemia/</guid><description>from: [[/Users/htlin/Documents/Medical/hypokalemia]]
Duty note of hypokalemia</description></item><item><title>Etiologies of spinal cord compression</title><link>https://www.physician.tw/Etiologies-of-spinal-cord-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-spinal-cord-compression/</guid><description>from: [[spinal cord compression]]
Etiologies of spinal cord compression tumor (vertebral mets intradural meningioma/[[neurofibroma]]) epidural abscess/ hematoma, vascular malformation (dural AV fistula) degen.</description></item><item><title>Evaluation and treatment of nerve root compression</title><link>https://www.physician.tw/Evaluation-and-treatment-of-nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-and-treatment-of-nerve-root-compression/</guid><description>from: [[nerve root compression]]
Evaluation and treatment of nerve root compression (NEJM 2016;374:1763)
MRI if sx not improved after 6 wk of conservative tx; if nondiagnostic, consider EMG/NCS</description></item><item><title>Evaluation and treatment of spinal cord compression</title><link>https://www.physician.tw/Evaluation-and-treatment-of-spinal-cord-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-and-treatment-of-spinal-cord-compression/</guid><description>from: [[spinal cord compression]]
Evaluation and treatment of spinal cord compression Empiric spine immobilization (collar, board) for all trauma patients</description></item><item><title>History taking of back and spinal cord disease</title><link>https://www.physician.tw/History-taking-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/History-taking-of-back-and-spinal-cord-disease/</guid><description>from: [[back and spinal cord disease]]
History taking of back and spinal cord disease location, timing (acute/subacute/chronic) worse w/ Valsalva radiation trauma wt loss cancer fever immunocompromised IVDU neurologic symptom saddle anesthesia Lhermitte phenomenon bowel/bladder/sexual sx (retention, incontinence)</description></item><item><title>inpatient diabetes management</title><link>https://www.physician.tw/inpatient-diabetes-management/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inpatient-diabetes-management/</guid><description> [!info] üå± ‰æÜËá™: [[endocrinology]]
inpatient diabetes management</description></item><item><title>Laboratory of back and spinal cord disease</title><link>https://www.physician.tw/Laboratory-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-of-back-and-spinal-cord-disease/</guid><description>from: [[back and spinal cord disease]]
Laboratory of back and spinal cord disease (depending on suspicion): CBC w/ diff, ESR/CRP, Ca, PO4, CSF, BCx</description></item><item><title>mother</title><link>https://www.physician.tw/mother/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mother/</guid><description>mother [[father]]</description></item><item><title>Musculoskeletal ddx of back pain</title><link>https://www.physician.tw/Musculoskeletal-ddx-of-back-pain/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Musculoskeletal-ddx-of-back-pain/</guid><description>from: [[differential diagnosis of back pain]]
Musculoskeletal ddx of back pain involving spine (vertebra, facet joints), paraspinal muscles &amp;amp; ligaments sacroiliac joint, or hip joint Spondylolisthesis vertebral fx OA inflam.</description></item><item><title>nerve root compression</title><link>https://www.physician.tw/nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nerve-root-compression/</guid><description>nerve root compression (NEJM 2015;372:1240 &amp;amp; Continuum 2021;27:163)
Radicular pain aggravated by activity (esp. bending, straining, coughing), relieved by lying</description></item><item><title>Neuro exam of back and spinal cord disease</title><link>https://www.physician.tw/Neuro-exam-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuro-exam-of-back-and-spinal-cord-disease/</guid><description>from: [[back and spinal cord disease]]
Neuro exam of back and spinal cord disease full motor (incl. sphincter tone); gait; sensory (temp/pain, position, vibration; ‚Üë perineal; ?</description></item><item><title>neurofibroma</title><link>https://www.physician.tw/neurofibroma/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurofibroma/</guid><description>from: [[Etiologies of spinal cord compression]]
neurofibroma</description></item><item><title>neurogenic claudication</title><link>https://www.physician.tw/neurogenic-claudication/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurogenic-claudication/</guid><description>from: [[nerve root compression]]
neurogenic claudication Lumbar spinal stenosis (with nerve root compression)
Radicular back/buttock pain
Radiating down legs
Worse with Walking &amp;amp; standing; Hyperextension/lying prone</description></item><item><title>Pathophysiology of nerve root compression</title><link>https://www.physician.tw/Pathophysiology-of-nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-nerve-root-compression/</guid><description>from: [[nerve root compression]]
Pathophysiology of nerve root compression &amp;lt;65 y: 90% from disc herniation. ‚â•65 y also w/ more degenerative contributors: ligamentous hypertrophy, osteophyte formation, facet arthropathy, neural foraminal narrowing</description></item><item><title>Patrick FABER test</title><link>https://www.physician.tw/Patrick-FABER-test/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Patrick-FABER-test/</guid><description>from: [[back and spinal cord disease]]
Patrick FABER test (SI joint synd): severe pain on hip ext rotation; 70% Se, 100% Sp</description></item><item><title>Red flags of back and spinal cord disease</title><link>https://www.physician.tw/Red-flags-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Red-flags-of-back-and-spinal-cord-disease/</guid><description>from: [[back pain]]
Red flags of back and spinal cord disease acute change (pain, weakness), upper motor neuron signs (hyperreflexia, upgoing toes) cauda equina conus medullaris syndromes (saddle anesthesia bowel/bladder or sexual dysfunction reduced rectal tone loss of sacral reflexes) dyspnea when flat (C3‚ÄìC5) pain at rest or at night</description></item><item><title>referred pain from visceral disease of back pain</title><link>https://www.physician.tw/referred-pain-from-visceral-disease-of-back-pain/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/referred-pain-from-visceral-disease-of-back-pain/</guid><description>from: [[differential diagnosis of back pain]]
referred pain from visceral disease of back pain GI: PUD cholelithiasis pancreatitis pancreatic cancer GU: pyelonephritis nephrolithiasis uterine or ovarian cancer salpingitis Vascular: aortic dissection leaking aortic aneurysm</description></item><item><title>rheumatoid arthritis</title><link>https://www.physician.tw/rheumatoid-arthritis/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatoid-arthritis/</guid><description>from: [[rheumatology]]
rheumatoid arthritis</description></item><item><title>sciatica</title><link>https://www.physician.tw/sciatica/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sciatica/</guid><description>from: [[nerve root compression]]
sciatica = radicular pain radiating from buttocks down lateral aspect of leg, often to knee or lateral calf ¬± numbness and paresthesias radiating to lateral foot.</description></item><item><title>screening and health maintenance</title><link>https://www.physician.tw/screening-and-health-maintenance/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/screening-and-health-maintenance/</guid><description>from: [[symptom to diagnosis]]
screening and health maintenance</description></item><item><title>spinal cord compression</title><link>https://www.physician.tw/spinal-cord-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spinal-cord-compression/</guid><description>from: [[neurology]]
spinal cord compression (Continuum 2021;27:163)
[[Etiologies of spinal cord compression]]
Acute: flaccid paraparesis and absent reflexes (‚Äúspinal shock‚Äù)</description></item><item><title>spondyloarthritis</title><link>https://www.physician.tw/spondyloarthritis/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spondyloarthritis/</guid><description>from: [[rheumatology]]
spondyloarthritis</description></item><item><title>spurling sign</title><link>https://www.physician.tw/spurling-sign/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spurling-sign/</guid><description>from: [[back and spinal cord disease]]
spurling sign (cervical radiculopathy):
radicular pain with: downward force to extended &amp;amp; ipsilaterally rotated head 30% Se, 93% Sp</description></item><item><title>straight leg raise</title><link>https://www.physician.tw/straight-leg-raise/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/straight-leg-raise/</guid><description>from: [[back and spinal cord disease]]
straight leg raise (sciatica or lumbosacral radiculopathy): radicular pain at 30‚Äì70¬∞
ipsilateral: 92% Se, 28% Sp</description></item><item><title>Vascular Claudication</title><link>https://www.physician.tw/Vascular-Claudication/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Claudication/</guid><description>from: [[nerve root compression]]
Vascular Claudication Peripheral artery disease
(with limb ischemia)
Cramping leg pain
Mostly in calves; radiating up legs</description></item><item><title>vim append</title><link>https://www.physician.tw/vim-append/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim-append/</guid><description>from: [[Vimwiki]]
vim append</description></item><item><title>Êá∂‰∫∫ÂøÖÂÇôÔºÅ‰∏ÄË°åÊåá‰ª§Â∞áÊñáÂ≠óËΩâpptÊ™î</title><link>https://www.physician.tw/blog/pandoc-md-to-pptx/</link><pubDate>Tue, 13 Sep 2022 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/pandoc-md-to-pptx/</guid><description>‰∏ÄÂÄãÊåá‰ª§Ëá™ÂãïÁîüÊàêÊäïÂΩ±Áâá(.PPTXÊ™î) ÊúÄËøëÂõ†ÁÇ∫Â∏∏Â∏∏Ë¶ÅÊ∫ñÂÇôÊäïÂΩ±Áâá‰∏äË™≤ÔºåÈÄôÁ®ÆÊäïÂΩ±Áâá‰∏ªÂ∞±ÊòØÂæûÊïôÁßëÊõ∏ÂºÑÂÖßÂÆπÂá∫‰æÜÔºåÊ®ôÈ°åÂä†Ê¢ùÂàóÂºèÁÇ∫‰∏ªÔºå‰∏¶‰∏çÈúÄË¶ÅË®±Â§öÂ§™Ë§áÈõúÁöÑÊéíÁâàÔºå‰ΩÜÂú®ÂºÑÊéíÁâàÂ∞±ÂæàËä±ÊôÇÈñì(ÊÄíÊÄí)„ÄÇÈõñÁÑ∂ÊúâÂæàÂ§ömarkdownËá™ÂãïËÆäÊàêÊäïÂΩ±ÁâáÊí≠ÊîæÁöÑÂäüËÉΩÔºå‰ΩÜÂ∞±‰∏çËÉΩÂ•óÁî®Ëá™Â∑±Â∏∏Áî®ÁöÑÊ®£ÂºèÈ¢®Ê†ºÔºå‰πü‰∏çÂÆπÊòì‰∫§ÊèõÊ™îÊ°à„ÄÇÁôºÁèæ What? Slides? From Markdown? | by Peter Conrad | Medium‰ªãÁ¥π‰∫ÜÁî®pandocËΩâÊ™îÁöÑÊñπÂºèÔºåÂõ†Ê≠§ÂéªÁúã‰∫ÜÂÆòÊñπÊñáÊ™îÊï¥ÁêÜÂ¶Ç‰∏ã„ÄÇ
TL;DR È¶ñÂÖàË¶Å‰∏ãËºâpandoc Pandoc - Installing pandoc ÊàëÂÄëË¶ÅÊ∫ñÂÇôÂ•ΩmarkdownÊ™îÊ°à(.md)ÔºåË∑üÁØÑÊú¨Ê™îÊ°à(.pptx)ÔºåÊîæÂú®Âêå‰∏ÄÂÄãË≥áÊñôÔºåcdÂà∞Ë≥áÊñôÂ§æ‰∏ãÂæåËº∏ÂÖ•‰ª•‰∏ãÊåá‰ª§Ôºö 1 pandoc ‰æÜÊ∫êÊ™î.</description></item><item><title>ÈÜ´Â≠∏Á∞°Â†±ÂøÖÂÇôJAMAÈ¢®Ê†ºÊ®°Áâà</title><link>https://www.physician.tw/blog/JAMA-Template/</link><pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/JAMA-Template/</guid><description> TL;DR ‰∏ãËºâÈÄ£Áµê Ê™îÊ°à‚ÜíÂª∫Á´ãÂâØÊú¨‚ÜíÊï¥‰ªΩÁ∞°Â†± Have a nice day</description></item><item><title>Â¶Ç‰Ωï‰ΩøÁî®Obsidian_to_Anki</title><link>https://www.physician.tw/blog/Obsidian-to-Anki/</link><pubDate>Mon, 29 Aug 2022 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/Obsidian-to-Anki/</guid><description>ËÉåÊôØ Âæà‰πÖ‰ª•ÂâçÂú®‰∏Ä‰∫õÈáçË¶ÅËÄÉË©¶Â∞±ÊúÉÊñ∑Êñ∑Á∫åÁ∫åÂú∞‰ΩøÁî®Anki‰ΩúÁÇ∫Âø´ÈÄüË§áÁøíÁöÑÂ∑•ÂÖ∑ÔºåÈóúÊñºAnkiÁöÑÂ•ΩÔºåÁ∂≤‰∏äÂ∑≤ÊúâÂ§™Â§öÊïôÂ≠∏„ÄÇËøëÂπæÂπ¥Âç°ÁâáÁõíÂ≠∏ÁøíÊ≥ïÈñãÂßãÊàêÁÇ∫È°ØÂ≠∏ÔºåObsidianÂèàÊòØÂÖ∂‰∏≠ÊúÄÂª£ÁÇ∫‰∫∫‰ΩøÁî®ÁöÑËªüÈ´îÔºåËÄåÁèæÂú®ÁöÑÂïèÈ°åÊòØÔºöÂ¶Ç‰ΩïÂà©Áî®Â§ñÊéõÁöÑÊê≠ÈÖçÔºåËÆìÊàëÂÄëÈö®ÊôÇÈö®Âú∞ÂèØ‰ª•Ë§áÁøíÊàëÂÄëÂú®Obsidian‰∏≠ÁöÑÈáçÈªûÔºå‰ª•‰∏ãÊé•Á¥πÊèí‰ª∂ÔºöObsidian_to_Anki
ÊñπÊ≥ï ÂâçÊèêÔºö Êú¨Ë∫´Â∞çÊñºObsidianË∑üAnkiÁöÑ‰ΩøÁî®Â∑≤Á∂ìË†ª‰∫ÜËß£ÁöÑÔºåÈÄôÁØáÊñáÁµ¶ÊÉ≥Ë¶ÅÁµêÂêàÂÖ©ËÄÖÁöÑ‰∫∫„ÄÇ AnkiConnect AnkiConnect key: 2055492159 Config 1 2 3 4 5 6 7 8 9 10 11 { &amp;#34;apiKey&amp;#34;: null, &amp;#34;apiLogPath&amp;#34;: null, &amp;#34;webBindAddress&amp;#34;: &amp;#34;127.</description></item><item><title>Áî®Raycast, Pandoc, ZoteroÂØ¶ÁèæCite While You Write</title><link>https://www.physician.tw/blog/raycast-pandoc-zotero-make/</link><pubDate>Sun, 28 Aug 2022 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/raycast-pandoc-zotero-make/</guid><description>Á∞°‰ªã Cite While You Write, Á∞°Á®±CWYWÔºåÈ°ßÂêçÊÄùÊÑèÂ∞±ÊòØËÆìÊàëÂÄëÂú®ÂØ´‰ΩúÊôÇÂèØ‰ª•Âç≥ÊôÇÂºïÁî®Ôºå‰∏¶‰∏îÁîüÊàêÂºïÁî®Ê¢ùÁõÆbibliographyÔºåÂ¶ÇÊûú‰Ω†ÊòØwordÊàñopen officeÁöÑ‰ΩøÁî®ËÄÖÔºåÂèØ‰ª•ÂæàÁ∞°ÂñÆÂú∞Ë£ùÂ•ΩzoteroÁöÑÂ§ñÊéõÂç≥ÂèØ‰ª•ÈñãÂßã‰ΩøÁî®„ÄÇÂ¶ÇÊûúÊòØRË™ûË®ÄÁöÑ‰ΩøÁî®ËÄÖÔºåRstuido‰πüÊèê‰æõÂÆåÊï¥ÁöÑÂØ´‰ΩúÁí∞Â¢É„ÄÇ‰ΩÜÂ¶ÇÊûúÊòØÊó•Â∏∏ÁøíÊÖ£‰ª•markdown‰æÜÂØ´‰ΩúÔºåÊÉ≥ÂØ¶ÁèæCWYWÂ∞±‰∏çÊòØ‰∏Ä‰ª∂Á∞°ÂñÆÁöÑ‰∫ã„ÄÇ
ÂæûÂÖ©ÂÄãÂ±§Èù¢ÊÄùËÄÉÔºö(1)‰∏ÄÂÄãÂèØ‰ª•Áõ¥Êé•Âè´Âá∫Â¶ÇÂêåzotero pickerË¶ñÁ™óÁöÑÊõø‰ª£ËªüÈ´îÔºåÊèíÂÖ•citation keyÔºåÈÄôË£°‰ΩøÁî®Raycast (2)Âà©Áî®pandocÔºåÊääbibÊ™îÂåØÂÖ•„ÄÇ
Êõ¥Â§öÂÖßÂÆπË´ãË¶ãÔºö htlin222/md-bib-make
ÂâçÁΩÆ‰ΩúÊ•≠ Á≥ªÁµ±ÔºöMac OS
ÈúÄË¶ÅÂÆâË£ùÁöÑÈ†ÖÁõÆÔºö
Zotero Your personal research assistant 1 2 # ÂèØ‰ª•Áõ¥Êé•ÂæûÂÆòÁ∂≤‰∏ãËºâÂÆâË£ùÊ™îÔºåÊàñÁî®Ôºö brew install --cask zotero ZoteroÈúÄË¶ÅÂÆâË£ùÁöÑplugin: Better BibTeX for Zotero :: Better BibTeX for Zotero</description></item><item><title>Âú®Mac‰∏≠ÈÅã‰ΩúPythonÁöÑÊ≠£Á¢∫ÊñπÊ≥ï</title><link>https://www.physician.tw/blog/pyenv-jupyter-in-macos/</link><pubDate>Mon, 22 Aug 2022 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/pyenv-jupyter-in-macos/</guid><description>ÂâçË®Ä Â¶ÇÊûú‰πãÂâçÊ≤íÊúâË∑üpythonÊâìÈÅé‰∫§ÈÅìÔºåÊÉ≥Âú®mac‰∏äÂÆâË£ùpythonÊôÇÔºåÈ¶ñÂÖàÂ∞±ÊúÉÈù¢Â∞çÂà∞ÔºöÊàëÊòØË™∞ÔºüÊàëÂú®Âì™Ë£°ÁöÑÂïèÈ°åÔºåÂõ†ÁÇ∫macÊú¨Ë∫´Ëá™Â∏∂‰∏ÄÂÄãpython3ÔºåÂ¶ÇÊûúÂú®ÁµÇÁ´ØÊ©üË£°Âü∑Ë°åÁöÑË©±Ôºå‰πüÊòØÂèØ‰ª•print(&amp;quot;hellow world&amp;quot;)ÔºåÊé•ËëóÔºåÊàëÂÄëÂèØËÉΩÂ∞±ÊúÉÊÉ≥ÈñãÂøÉÂú∞Âà©Áî®Á≥ªÁµ±ÁöÑpip‰æÜÂÆâË£ùÈúÄË¶ÅÁöÑÂ•ó‰ª∂ÔºåÁÑ∂ÂæåÈÄôÊ®£ÂÅöÊòØÂæàÂç±Èö™ÁöÑÔºåÂõ†Ê≠§pipÊôÇ‰∏çÊôÇÊúÉÊèêÈÜí‰Ω†Ë¶Å‰∏çË¶ÅÊõ¥Êñ∞pipÔºå‰ΩÜmacÁ≥ªÁµ±‰∏≠ÂÖ∂ÂØ¶ÊúâÂæàÂ§öÂ•ó‰ª∂ÔºåÂèØËÉΩÈúÄË¶ÅÊØîËºÉ‰ΩéÁâàÊú¨ÁöÑpythonÊâçËÉΩÂü∑Ë°åÔºåÊõ¥Êñ∞ÂèØËÉΩÈÄ†Êàê‰∏çÂèØÈÄÜÁöÑÂ¥©ÊΩ∞ÔºåÂõ†Ê≠§ÔºåÂè¶Â§ñ‰∏ãËºâ‰∏ÄÂÄãpython‰æÜÂÆâË£ùÊòØÂæàÈáçË¶ÅÁöÑ„ÄÇ
Êé•‰∏ã‰æÜÂ∞±ÊúÉÈù¢Â∞çÂè¶‰∏ÄÂÄãÂïèÈ°åÔºöË¶ÅËºâÂì™ÂÄãÁâàÊú¨ÔºüÊúÄÁõ¥Ë¶∫ÂæóÂÅöÊ≥ïÂ∞±ÊòØÂà∞ Python.org‰∏ãËºâÊúÄÊñ∞ÁöÑÁâàÊú¨ÔºåÊâìÈñãÂæå‰∏ã‰∏ÄÊ≠•‰∏ã‰∏ÄÊ≠•ÂÆâË£ùÂÆåÊàê„ÄÇÂè¶Â§ñ‰πüÂèØ‰ª•brew install python3‰æÜÂÆâË£ù„ÄÇÂêåÊôÇ‰πüÊúÉÊúâ‰∫∫Âª∫Ë≠∞Áî®anaconda‰æÜÂÆâË£ù‰∏Ä‰∫õÂøÖË¶ÅÁöÑÂ•ó‰ª∂„ÄÇÂà∞ÊúÄÂæåÔºåÊàëÂÄëÁöÑÈõªËÖ¶Ë£°Â∞±ÊúÉÂÖÖÊñ•ËëóÂêÑÁ®ÆÁâàÊú¨ÁöÑpythonÔºåÂ§ßÊ¶ÇÂÉè‰∏ãÈù¢ÈÄôÂºµÂúñ‰∏ÄÊ®£Ôºö ÈÄôÊôÇÂ∞±ÂÆπÊòìÊúÉÂá∫ÁèæÂïèÈ°åÔºåÂ∏∏Â∏∏ÊàëÂÄëÂª∫Á´ã‰∫ÜÊüêÂÄã.pyÊ™îÔºåÂú®Êüê‰∫õÊÉÖÊ≥Å‰∏ãÂèØ‰ª•Ê≠£Â∏∏importÊüê‰∫õpackageÔºå‰ΩÜÁï∂ÊàëÂÄëÁî®ÂÖ∂‰ªñËªüÈ´îÊâìÈñãÊôÇÔºåÂ¶Çjupyter lab„ÄÅpycharmÊôÇÔºåÂèàÊúÉÁôºÁèæÊüê‰∫õpipÊ≤íÂÆâË£ùÂà∞ÁöÑÂ•ó‰ª∂„ÄÇÈÄôÊ®£ÊàëÂÄëÁöÑÈñãÁôº/Â≠∏ÁøíÁí∞Â¢ÉËÆäÂæóÂæà‰∏çÂõ∫ÂÆöÔºåÊàñÊòØÊúÉÈáçË¶ÜÂú®‰∏çÂêåÂú∞ÊñπÂÆâË£ù‰∫ÜÁõ∏ÂêåÁöÑÂ•ó‰ª∂„ÄÇ
Ë¶ÅËß£Ê±∫ÈÄôÂÄãÂïèÈ°åÔºåÈ¶ñÂÖàË¶ÅÂ≠∏ÊúÉÂÖ©ÁµÑÂ∏∏Áî®ÂæóÊåá‰ª§Ôºö
Âú®ÁµÇÁ´ØÊ©ü‰∏≠Âü∑Ë°åÔºö 1 which python3 ÊàñÂú®python‰∏≠Ë∑ëÈÄôÁµÑÁ®ãÂºèÁ¢ºÔºö 1 2 import sys print(&amp;#34;User Current Version:-&amp;#34;, sys.</description></item><item><title>Áî®Homebrew‰æÜÂÆâË£ùÈúÄË¶ÅÁöÑAppË∑üÂ•ó‰ª∂</title><link>https://www.physician.tw/blog/homebrew-basic/</link><pubDate>Sun, 21 Aug 2022 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/homebrew-basic/</guid><description>ÂÆâË£ùxcode-select Â¶ÇÊûú‰Ω†ÊòØÁ¨¨‰∏ÄÊ¨°ÊâìÈñãÂèØÊÄïÁöÑÁµÇÁ´ØÊ©üÔºåÂèØËÉΩÊúÉË¢´ÊèêÁ§∫ÂÆâË£ùxcodeÂøÖË¶ÅÁöÑÂ•ó‰ª∂ÔºåË£ùÂ∞±Â∞ç‰∫Ü 1 xcode-select --install ÂÆâË£ùhomebrew ÂèÉËÄÉÂÆòÁ∂≤Ôºö ÁÇ∫ macOSÔºàÊàñ LinuxÔºâÊ∑ª‰∏äÂ•ó‰ª∂ÁÆ°ÁêÜÂ∑•ÂÖ∑ ‚Äî Homebrew
1 /bin/bash -c &amp;#34;$(curl -fsSL https://raw.</description></item><item><title>ÈÜ´Â≠∏Á∞°Â†±ÂøÉÊ≥ï</title><link>https://www.physician.tw/blog/how-to-present-cbd/</link><pubDate>Sun, 03 Jul 2022 17:53:28 +0000</pubDate><guid>https://www.physician.tw/blog/how-to-present-cbd/</guid><description>ÂâçË®Ä ÊàëË¶∫ÂæóÈÜ´Â≠∏Á∞°Â†±ÊúÄÈáçË¶ÅÁöÑÁ≤æÁ•ûÔºåÊòØËä±ÊúÄÂ∞ëÁöÑÊôÇÈñìÔºåËÆìËÅΩÁúæË¶∫Âæó‰Ω†ÊúâÂæàÁî®ÂøÉÁöÑÂú®Êï¥ÁêÜÔºåËá®Â∫äÂ∑•‰ΩúÁπÅÈáçÔºåÈÇÑË¶ÅÂÄºÁè≠ÔºåËä±ÂæàÂ§öÊôÇÈñì‰ΩúÂ†±ÂëäÁ≠âÊñºËÆäÁõ∏Ë¶Å‰∫∫Âä†Áè≠„ÄÇÂÖ∂ÂØ¶Â§ßÂÆ∂Ê≤íÊúâÂæàÂú®‰πéÊéíÁâà„ÄÅÁæéÁ∑®„ÄÅÈÖçËâ≤„ÄÅÂúñË°®‰ªÄÈ∫ºÁöÑÔºåÂ≠ó‰∏çË¶ÅÂ§™Â∞èÂ∞±Â•ΩÔºåÁôΩÂ∫ïÈªëÂ≠óÔºåË©≤Âº∑Ë™øÁöÑÂº∑Ë™ø„ÄÇÂèçËÄåÈáçË¶ÅÊòØÊï¥È´îÂ†±ÂëäÁöÑÈÇèËºØÔºåÂè£Ê¢ù„ÄÇËá®Â∫äÂ†±ÂëäÊúÄÂ∏∏Ë¶ãÔºåÁï∂Â∏∏ÊòØcase-based discussion„ÄÅEBM„ÄÅMMÔºå‰∏ªË¶ÅÂ∞±ÊòØÂæû‰∏ÄÂÄãÊâã‰∏äÁÖßÈ°ßÁöÑÁóÖ‰∫∫ÂéªÂª∂‰º∏‰∏Ä‰∫õË≠∞È°å‰æÜÊé¢Ë®éÔºåÊâÄ‰ª•ÊÉ≥Ë¶ÅÂàÜ‰∫´‰∏Ä‰∏ãËá™Â∑±‰ΩúÂ†±ÂëäÁöÑÊµÅÁ®ãÔºå‰πüÊ≠°ËøéÂ§ßÂÆ∂ÊèêÂá∫ÊÑèË¶ãË∑üÊÉ≥Ê≥ï„ÄÇ
Âü∫Êú¨Êû∂Êßã È¶ñÂÖàÔºåÊúÄÂ•ΩË¶ÅÊúâ‰∏ÄÂÄãÊ®°ÊùøÔºåÊØèÊ¨°ÈÉΩÁî®ÂêåÊ®£ÁöÑÊ®°ÊùøÂ∞±Â•ΩÔºåÊº∏Êº∏ÂÑ™ÂåñÂÆÉÔºåÂêåÊ®£Ê®ôÈ°å/ÂÖßÂÆπÁöÑÁâàÂºèÔºåÂ∞±ÂèØ‰ª•ÂÜçÁ¥∞ÂàÜÔºöÁ¥îÊñáÂ≠ó„ÄÅÂ≠óÈÖçÂúñ„ÄÅ‰∏âÊ¨Ñ‚Ä¶Á≠âÁ≠âÔºåÁõÆÊ®ôÂ∞±ÊòØÈªûÈñãË≤º‰∏äÂÖßÂÆπÂ∞±ÂèØÁî®Ôºå‰∏çË¶ÅÂÜçËä±ÊôÇÈñìË™øÂ≠óÈ´îÂ§ßÂ∞è„ÄÇÂ¶ÇÊûúÊâãÈÇäÊ≤íÊúâÊ®°ÊùøÂèØ‰ª•GoogleÊàëÁöÑÂêçÂ≠óÂæåÈù¢Âä†NEJMÔºåÂ∞±ÂèØ‰ª•ÊâæÂà∞ÊàëÂÅöÁöÑÊ®°Êùø„ÄÇÂú®Ê∫ñÂÇôÁóÖ‰∫∫ÁöÑÁóÖÂè≤ÊôÇÔºå‰∏çË¶ÅËä±ÊôÇÈñìÁï∂Êê¨ÈÅãÂ∑•ÔºåÁõ¥Êé•ÈªûÈñãÁ≥ªÁµ±ÈÇäË¨õÈÇäÈªûÂ∞±Â•ΩÔºåÂÅöÂæóÂæàÁæéÂÖ∂ÂØ¶Â§ßÂÆ∂‰πü‰∏çÊúÉÁ¥∞ÁúãÔºåÊúâÁöÑÊôÇÂÄôËá™Â∑±ÈÉΩÊá∂ÂæóÂî∏ÔºåËßÄÁúæÊúÄÂæåÈÉΩÊòØËÅΩ‰Ω†ÊÄéÈ∫ºË¨õÔºåÈÄôÈÉ®ÂàÜÊáâË©≤Ë¶ÅËä±ÊúÄÂ∞ëÁöÑÊôÇÈñìÔºåÊàëËá™Â∑±Â§ßÊ¶ÇÈÉΩÁî®ÂÖ©‰∏âÈ†ÅÊäïÂΩ±ÁâáÂ∞±Ëß£Ê±∫ÔºåÁî®Âü∫Êú¨ÁöÑÊ¢ùÂàóÂºèÂ∞±Â•Ω„ÄÇÁï∂ÁÑ∂Â¶ÇÊûúÈÄôÂÄãÊòØ‰∏ÄÂÄãÈô¢Á¥ö„ÄÅGrand RoundÁöÑÂ†±ÂëäÈÇÑÊòØË¶ÅÂÅöÁöÑË™çÁúü‰∏ÄÈªû„ÄÇ
ÈñãÂ†¥Âà∞ÁóÖÂè≤Á¥∞ÁØÄ Âú®ÁóÖÂè≤Á¥∞ÁØÄÊñπÈù¢ÔºåÂ¶ÇÊûúË∑üÈÄôÊ¨°‰ΩèÈô¢ÁÑ°Èóú„ÄÅË∑üÈÄôÊ¨°ÁöÑ‰∏ªÈ°åÁÑ°ÈóúÔºåÊàëÈÉΩÊúÉÁõ¥Êé•Áï•ÈÅé‰∏çË¨õÔºåÂ§™Â§öÈõúË®äÂè™ÊòØÂú®Êµ™Ë≤ªÂΩºÊ≠§ÁöÑÊôÇÈñìÔºåÊ™¢È©óÂ†±ÂëäÈô§ÈùûÁ≥ªÁµ±ÁúüÁöÑÂëàÁèæÂæóÂæàÈÜúÔºåÊàñËÄÖÊòØÈúÄË¶ÅÊµ™Ë≤ªÂæàÂ§öÈªûÊìäÔºåÊâçÈúÄË¶ÅÁúüÊ≠£ÊääÂÆÉË≤ºÂà∞ÊäïÂΩ±Áâá‰∏ä„ÄÇÂΩ±ÂÉèÂ∞±Áõ¥Êé•ÈªûÈñãÁ≥ªÁµ±Â∞±Â•ΩÔºåÊúÄÂ•Ω‰∏çË¶ÅËä±Ë∂ÖÈÅéÂçäÂ∞èÊôÇËôïÁêÜÈÄô‰∫õ‰∫ãÊÉÖ„ÄÇ
Ë®éË´ñ Êé•‰∏ã‰æÜÂ∞±ÊòØË®éË´ñÁöÑÈÉ®ÂàÜÔºåÊàëË¶∫ÂæóÈÄôÈÉ®ÂàÜÂ§ßÊ¶ÇË¶ÅÂç†Êï¥ÂÄãÂ†±ÂëäÁöÑ¬æÔºåÁï∂‰Ω†ÈÅ∏ÊìáË¶ÅÁî®ÈÄôÂÄãÁóÖ‰∫∫Â†±ÂëäÊôÇÔºåÊáâË©≤Â∞±Êúâ‰∏Ä‰∫õÊÉ≥Ë¶ÅÂÅöÁöÑ‰∏ªÈ°åÔºåÂ¶ÇÊûúÂè™Êúâ‰∏ÄÂÄã‰∏ªÈ°åÊúÉÂæàÁÑ°ËÅäÔºåÊâÄ‰ª•ÊàëÈÄöÂ∏∏ÊúÉÊâæÂÖ©‰∏âÂÄãÔºåÁ¨¨‰∏ÄÂèØËÉΩÊòØÈÄôÂÄãÁñæÁóÖÁöÑÂü∫Êú¨‰ªãÁ¥πÔºåÁõ¥Êé•ÊääÂ∞èÈ∫ª/ Uptodate Ë≤ºÈÅé‰æÜÂ∞±Â•ΩÔºåÂÜçÈÖç‰∏äÂπæÂºµNEJMÁöÑÁæéÂúñÔºåÂõ†ÁÇ∫Â§ßÂÆ∂ÂÖ∂ÂØ¶ÂèØ‰ª•Ëá™Â∑±ÂéªÁúãÊõ∏ÔºåÂÖ∂‰ªñTopicsÁõ°ÈáèÊâæ‰∏Ä‰∫õË®∫Êñ∑„ÄÅÊ≤ªÁôÇÁöÑÊúÄÊñ∞ÈÄ≤Â±ï„ÄÅÊàñÊòØÈÄôÂÄãÁóÖ‰∫∫ÁöÑ‰∏Ä‰∫õ‰∏çÂ∞ãÂ∏∏ÁöÑÁôºÁèæÔºåÊääÈÄô‰∫õÈóúÈçµË©ûÊãøÂéªÈ§µpubmedÔºåÈÅéÊøæ‰∏Ä‰∏ãÔºöÊôÇÈñìÈÅ∏‰∏âÂπ¥ÂÖß„ÄÅÁõ°Èáè‰∏çË¶ÅÊâæ‰∏Ä‰∫õQ3‰ª•‰∏äÁöÑÈáéÈõûÊúüÂàä„ÄÇ
Â¶Ç‰ΩïÊâæÂà∞ÂêàÈÅ©ÁöÑÊñáÁ´† ÊâæÂÖ©‰∏âÁØáÔºåË∑ü‰Ω†‰∏ªÈ°åÊúÄÁ¨¶ÂêàÁöÑÈªûÈñã‰æÜÁúãÔºåÂÖ∂ÂØ¶Â∞±‰∏çÁî®Âú®pubmed‰∏äÈù¢ÁûéÈÄõ‰∫ÜÔºåÂÅöÂ†±ÂëäÊúÄÊµ™Ë≤ªÊôÇÈñìÁöÑÈÉ®ÂàÜÂ∏∏Â∏∏Â∞±ÊòØÂú®‰∫ÇÊêúÂ∞ãÊù±Ë•ø„ÄÇÊääÊâæÂà∞ÁöÑpaper‰ΩúÁÇ∫Ê†∏ÂøÉÔºåÊàëÂÄëÂ∞±Âè´‰ªñÊ†∏ÂøÉpaperÂ•Ω‰∫ÜÔºö‰∏ÄÈ†ÅÊîæAbstractÔºå‰∏ÄÈ†ÅÊîæÂúñË°®ÔºåÊé•ËëóÁõ¥Êé•Ë∑≥Âà∞DiscussionÔºå‰∏ÄÈÇäËÆÄ‰∏ÄÈÇäÊääÂÆÉÊØèÂè•Ë©±ÂæåÈù¢ÁöÑreferenceÈªûÈñã‰æÜÔºåÊåâÁÖß‰ªñË°åÊñáÁöÑÈ†ÜÂ∫èÔºåÈÅ∏ÂÄã10ÁØáÂÅöÊàêÊäïÂΩ±ÁâáÔºåÁúãËµ∑‰æÜÂ∞±ÊúÉÂæàÊúâÊ∑±Â∫¶Ë∑üÂª£Â∫¶ÔºåË¨õËµ∑‰æÜÂèàÂæàÊúâÈÇèËºØÔºàÁï¢Á´üÂ∑≤Á∂ìÊúâËæõËã¶ÁöÑÊ†∏ÂøÉpaper‰ΩúËÄÖÂπ´ÊàëÂÄëÊï¥ÁêÜÈÅé‰∏ÄÊ¨°‰∫ÜÔºâÈÄô‰∫õpaperÊØè‰∏ÄÁØáÔºå‰∏ÄÊ®£ÊòØË≤ºÊëòË¶ÅË∑üÁæéÁæéÁöÑÂúñÁâáÔºåË¨õÊ≥ïÂ∞±ÊòØÔºö„ÄåÊúâ‰∫∫Âú®‰ªÄÈ∫ºÊôÇÂÄôÂÅö‰∫Ü‰∏ÄÂÄã‰ªÄÈ∫ºÈ°ûÂûãÁöÑÁ†îÁ©∂ÔºåÂ§ßÊ¶ÇÊî∂‰∫ÜÂ§öÂ∞ë‰∫∫ÔºåÊØîËºÉ‰ªÄÈ∫ºË∑ü‰ªÄÈ∫ºÁöÑÂ∑ÆÂà•ÔºåÂæûÈÄôÂÄãÂúñË°®ÂèØ‰ª•ÁúãÂæóÂá∫‰æÜÁµêË´ñÊòØÊüêÊüêÊüêÔºåÂ•óÁî®Âú®ÊàëÂÄëÁóÖ‰∫∫‰∏äÔºåÂèØ‰ª•Áü•ÈÅìÊÄéÊ®£ÊÄéÊ®£„ÄÇ„ÄçÁï∂ÁÑ∂‰Ω†‰πüÂèØ‰ª•Ë∑üÈ¢®Â≠∏‰∏Ä‰∏ãJAMAÊúÄËøëÂæàÂ∏∏Âá∫ÁèæÁöÑ‰∏ÄÈ†ÅÂºèÊëòË¶ÅÔºåÂ∞±Áúã‰Ω†ÁöÑÂ†±ÂëäÊôÇÈñìÊ±∫ÂÆöË¶ÅÊîæÂπæÁØáÔºå‰ª•ÊàëËá™Â∑±ÁöÑË™ûÈÄüÔºåÂçäÂ∞èÊôÇÁöÑÂ†±ÂëäÂåÖÂê´Á∞°ÂñÆÁöÑÁóÖ‰∫∫‰ªãÁ¥πÔºåÂ§ßÊ¶ÇÂÜçÂè¶Â§ñÊâæ10ÁØáÂ∞±ÂèØ‰ª•„ÄÇÈÄô‰∫õpaper‰πüÂèØ‰ª•ÊääÂéüÊñáÁöÑ‰∏Ä‰∫õÈáçË¶ÅÊÆµËêΩË≤ºÂπæÈ†ÅÔºåÁÑ∂ÂæåÂè≥ÈçµÁï•ÈÅéÔºåËê¨‰∏ÄË¢´ÂïèÂ∞±ÈÄÄÂá∫Á∞°Â†±Ê®°Âºè‰æÜÁúã‰∏Ä‰∏ãÔºå‰∏çË¶ÅÊîæÂú®Ë®ªËß£Ë£°ÔºåÂõ†ÁÇ∫Â≠óÂæàÂ∞èËá™Â∑±Â†±ÂëäÊôÇÊúÉÂ§™Á∑äÂºµÊâæ‰∏çÂà∞ÈáçÈªû„ÄÇ
Êî∂Â∞æ Ë¨õÂÆå‰∫ÜË®éË´ñÔºåÊúÄÂæåÂ∞±ÊòØBack To Our PatientÔºå‰∏ÄÊ®£Ê¢ùÂàóÂºèÔºåÂÜçÈáçÊñ∞Âπ´Â§ßÂÆ∂Ë§áÁøí‰∏ÄÊ¨°ÁóÖ‰∫∫ÁöÑÁóÖÂè≤ÔºåÊääDiscussionË£°ÁöÑÊù±Ë•øÊëòË¶Å‰∏Ä‰∏ã„ÄÇ‰∏ã‰∏ÄÈ†ÅÊòØTake Home MessagesÔºå‰∏ªË¶ÅÊòØ‰∏Ä‰∫õÁü•Ë≠òÈªûÔºåËÆìÂ§ßÂÆ∂ÂèØ‰ª•Áî®Âú®Ëá®Â∫ä‰∏äÔºå‰æãÂ¶Ç‰∏Ä‰∫õË®∫Êñ∑ÊñπÊ≥ï„ÄÅÁñæÁóÖË°®Áèæ„ÄÅÊµÅË°åÁóÖÂ≠∏„ÄÅÊ≤ªÁôÇÊåáÂºïÔºåÈÄôÊ®£Â∞±ÂèØ‰ª•Êî∂Â∑•‰∫Ü„ÄÇ</description></item><item><title>Êàëü¶é ÁöÑICU patient list</title><link>https://www.physician.tw/blog/iculist/</link><pubDate>Wed, 27 Apr 2022 03:16:54 +0000</pubDate><guid>https://www.physician.tw/blog/iculist/</guid><description>Ë∑åË∑åÊíûÊíûÈÅéÂÆå‰∏ÄÂÄãÊúàÂåóÊ¶Æ ICU courseÔºåÈõñÁÑ∂ÈÇÑÊòØË¶∫ÂæóËá™Â∑±ÂæàÂª¢Ôºå‰ΩÜÈÇÑÊòØË¶∫ÂæóÊúâÁ®çÁ®çÊéåÊè°‰∫Ücritical careÁöÑÁ≤æÁ•û„ÄÇÁ≤óÁÆó‰∏Ä‰∏ãÊØèÂÄãÁóÖ‰∫∫ÊØèÁè≠ÈÉΩÊúâÂ§ßÁ¥Ñ100‰ª∂ÈúÄË¶ÅÁü•ÈÅìÁöÑ‰∫ãÔºåÂæûÂëºÂê∏Âô®Ë®≠ÂÆöÂà∞Êé•‰∏ã‰æÜÁöÑÂãïÂêëÔºå10ÂÄãÁóÖ‰∫∫‰πòËµ∑‰æÜÂ∞±Êúâ1000‰ª∂‰∫ãÔºåËÄåÈ†êË®≠ÁöÑ‰∫§Áè≠ÂñÆÊòØÂéöÂéö‰∏ÄÁñäÁ¥ôÔºåË¶ÅÊü•Êâæ‰πü‰∏çÂ§†Âø´ÔºåÊü•ÊàøVSÈö®Âè£‰∏ÄÂè•ÔºöÊâÄ‰ª•ÁóÖ‰∫∫ÁöÑventilator settingÂ¶Ç‰ΩïÔºüÁõ¥Êé•ËÖ¶Ë¢ãÊâìÁµê„ÄÇÂõ†Ê≠§Ë¶ÅÂ¶Ç‰ΩïÊääÈÄô1000‰ª∂‰∫ãÊúâÊïàÁéáÁöÑÊï¥ÁêÜËµ∑‰æÜÁúüÁöÑÂæàÈúÄË¶Å‰∏ÄÂºµÊúâÂ§ßÂ±ÄËßÄÁöÑlist„ÄÇÈÄô‰ªΩlistÊòØÂæû‰∏äÁè≠ÁöÑÁ¨¨‰∏ÄÂ§©ÈñãÂßã‰∏ÄË∑ØËø≠‰ª£Âà∞ÊúàÂ∫ïÔºå‰ΩøÁî®Ëµ∑‰æÜÈÇÑÁÆóÈ†ÜÊâã„ÄÇ
ÊØèÂ§©Êé•Áè≠ÊôÇÂÖàÁî®ÈªëÁ≠ÜÂØ´ÂÆåÔºåÊúâ‰ªª‰ΩïÊõ¥Ê≠£„ÄÅÊñ∞‰∫ãÈ†ÖÁî®Á¥ÖÁ≠ÜÂØ´ÔºåÂØ´noteÊôÇÂ∞±ÊääÁ¥ÖÁ≠ÜÁöÑÈÉ®ÂàÜÊõ¥Ê≠£‰∏äÂéª
Ê™îÊ°àÈÄ£Áµê Ëá™Ë°åË§áË£ΩÂà∞Ëá™Â∑±ÁöÑgoole driveË£°
‚òëÔ∏èÊ≠£Èù¢ 5Ô∏è‚É£Â§ß‰∫ãÈ†Ö(ÂåóÊ¶ÆÁöÑÁøíÊÖ£)Ôºö ü´Å VENTILATION FiO2, VRate, PEEP, PC/VC (or other mode) ABG Weaning (RSBI, Cuff leak) Áó∞ ÂëºÂê∏Áõ∏ÈóúÁî®Ëó• e.</description></item><item><title>CVCÊîæÁΩÆÁ≠ÜË®ò</title><link>https://www.physician.tw/blog/CVC-insertion-note/</link><pubDate>Sat, 25 Sep 2021 07:08:44 +0000</pubDate><guid>https://www.physician.tw/blog/CVC-insertion-note/</guid><description>Â¶Ç‰ΩïÊâìCVC ? CVC insertion note tags: tutorials Prepare ‰∏ÄÈÇäÊÉ≥ËëóÊìç‰ΩúÈ†ÜÂ∫èÔºå‰∏ÄÈÇäÊääÊù±Ë•øÊéíÂ•ΩÔºö ‰∏âÂ∞çÈáùÁ≠í„ÄÅ‰∏âÈ†ÖÂâçËèú(Guide wire„ÄÅCut„ÄÅDilator)„ÄÅÂ∞éÁÆ°„ÄÅ ‰∏âÂÄãÂõ∫ÂÆö(clamp„ÄÅSuture„ÄÅTegaderm)
5ccÁ©∫Èáùfor local(Êé•25ËôüÈáùÈ†≠) 10ccÁ©∫Èáùfor blind try(Êé•23ËôüÈáùÈ†≠)Ôºå‰πüÂèØ‰ª•ÂÖ©ÈöªÔºå‰∏ÄÈöª‰æÜrinse Á¥óÂ∏É(‰∏çË¶ÅÊêûÂæóÂÉèNEJMÁ§∫ÂΩ±ÁâáÁöÑÂëΩÊ°àÁèæÂ†¥)ÔºåÂ§öÁöÑË°ÄÈÉΩÊâìÂú®Á¥óÂ∏É‰∏ä Suture Kit Tegaderm (‰∏üÂÄãÂÖ©ÁâáÔºåÊúâ‰∏ÄÁâáÂèØ‰ª•Êãø‰æÜÁï∂ÊàêÊääË∂ÖÈü≥Ê≥¢ËÆäÁÑ°ËèåÁöÑÂ∞èÊ≥ïÂØ∂) CVC kit Ë£°Èù¢ÊúâÁöÑÊù±Ë•øÔºö 18ËôüÁ≤óÈáùÊé•5ccÁöÑËóçËâ≤ syringe (ÊúâÂ±ÅÁúº)</description></item><item><title>markdownËá™ÂãïÁî¢ÁîüÊäïÂΩ±ÁâáÔºå‰ª•hackmdÁÇ∫‰æã</title><link>https://www.physician.tw/blog/medical-chart/</link><pubDate>Wed, 25 Nov 2020 06:41:58 +0000</pubDate><guid>https://www.physician.tw/blog/medical-chart/</guid><description>ÊúÄËøëËÄÅËÉ°ÂïüÂãï‰∫ÜÂ§ßÂìàËÆÄÊõ∏Ë®àÁï´ÔºåË¶ÅËä±ÂÖ©Âπ¥ÁöÑÊôÇÈñìÊääÊï¥Êú¨3000Â§öÈ†ÅÁöÑÂ§ßÁ£öÂ°äÂî∏ÂÆå„ÄÇÁóõÈªûÂú®ÊñºÊØèÊ¨°ÂÅöÁ∞°Â†±ÂæàÁÖ©ÔºåË¶ÅÊääÊïôÁßëÊõ∏ÁöÑÂÖßÂÆπËÆäÊàêÊäïÂΩ±ÁâáÔºåÊúÉÊúâÂæàÂ§öÊ©üÊ¢∞ÂºèÁöÑÂâ™Ë≤ºË∑üÊéíÁâà„ÄÇÂÅöÂà∞ËÆì‰∫∫Ë¶∫ÂæóÂé≠‰∏ñ„ÄÇÂõ†Ê≠§ÊÉ≥Á†îÁ©∂Â¶Ç‰ΩïÂú®ÊúâÈôêÊôÇÈñìÂÖßÁî®ÊúÄÂø´ÁöÑÈÄüÂ∫¶ÂÅöÁ∞°Â†±(Ê≠§ÊñπÊ≥ï‰πüÈÅ©Áî®Â†±paper)„ÄÇ Âú®ÈÄôÊ®£ÁöÑËÉåÊôØ‰∏ãÔºåÂè™Ë¶ÅËÉΩÊääÈáçÈªûÊ¢ùÂàóÂºèÂú∞ÂëàÁèæÂá∫‰æÜÂ∞±ÂèØ‰ª•„ÄÇÁ¨¨‰∫åÈ†Ü‰ΩçÂ∞±ÊòØË¶ÅÂø´„ÄÇÈÄöÂ∏∏ÁæéÁ∑®‰∏çÈáçË¶ÅÔºåÂ≠ó‰∏çË¶ÅÂ§™Â∞èÂ∞±Â•Ω„ÄÇ‰ª•‰∏ãÊòØÊë∏Á¥¢Âá∫ÁöÑËß£Ê±∫ÊñπÊ≥ï„ÄÇ‰∏ªË¶Å‰ΩøÁî®hackmdÁöÑÁ∞°Â†±ÂäüËÉΩ„ÄÇ
ÂÖàÊääË¶ÅÁöÑÂÖßÂÆπ‰∏ÄÊ¨°ÂÖ®ÈÉ®Ë≤ºÂà∞hackmdË£° ÊÆµËêΩËÆäÊàêÊ¢ùÂàóÂºèÔºåËá™ÂãïÂàÜË°åÂä†listÔºöÂ§ßËá¥ÊääÊØèÂè•Ë©±Áï∂ÊàêÊòØ‰∏ÄÂÄãÈáçÈªûÔºå‰ª•ÂÖ®ÊñáÊêúÂ∞ãShift-Ctrl-R (Win) / Shift-Cmd-Option-F (Mac) „Äå. „Äç(Âè•ËôüÂä†‰∏ÄÂÄãÁ©∫Ê†ºÔºåÂ¶ÇÊûúÂñÆÊêúÂè•ËôüÊúÉÊêúÂà∞‰∏Ä‰∫õÂ∞èÊï∏Èªû)ÔºåÂèñ‰ª£ÁÇ∫„Äå. \n * „Äç(Âè•Ëôü+‰∏ÄÂÄãÁ©∫Ê†º+‰∏ÄÂÄãÂèçÊñúÁ∑ö+n+‰∏ÄÂÄãÁ©∫Ê†º+‰∏ÄÂÄãÁ±≥Â≠óËôü+‰∏ÄÂÄãÁ©∫Ê†º)Ôºõ„Äå\n„ÄçÊòØmarkdownÁöÑÊèõË°åÔºõ„Äå* „ÄçÊòØÈ†ÖÁõÆÁ¨¶Ëôü Âéü‰æÜÊòØ sentence1. sentence2. sentence3. Êìç‰ΩúÂæåÂ∞±ËÆäÔºö sentence1.</description></item><item><title>SeminarÂøÖÂÇôÔºÅNEJM È¢®Google Á∞°Â†±ÁØÑÊú¨Ôºå2020Âπ¥Êñ∞Áâà</title><link>https://www.physician.tw/blog/nejm-slides/</link><pubDate>Wed, 25 Nov 2020 05:24:19 +0000</pubDate><guid>https://www.physician.tw/blog/nejm-slides/</guid><description>SeminarÂøÖÂÇôÔºÅNEJM È¢®Google Á∞°Â†±ÁØÑÊú¨Ôºå2020Âπ¥16:9Êñ∞Áâà Ë§áË£ΩÊñπÊ≥ïÔºö ÂÖàÈªûÊàëÈÄ≤Âà∞Google slide Background Á∂≤Ë∑Ø‰∏äÊµÅÁ´ÑËëóÂêÑÂºèÂêÑÊ®£ÁöÑÁ∞°Â†±Á¥†ÊùêÔºåÊúâÂêÑÁ®ÆÁ∞°Â†±Â§ßÂ∏´ÂÄëÂú®ÈñãÁè≠ÊéàË™≤ÔºåÂΩ∑ÂΩøÊúÉÂ≠∏ÊúÉ‰∫ÜÁ∞°Â†±Ë®≠Ë®àÔºåÂ∞±ÂèØ‰ª•Â†±Âá∫Ê£íÊ£íÁöÑÁ∞°Â†±„ÄÇÁÑ∂ÂæåËä±‰∫Ü‰∏ÄÂ†ÜÁîüÂëΩÂú®Á†îÁ©∂ÈÖçËâ≤„ÄÅÊéíÁâà„ÄÅÂ≠óÈ´îÔºåÂçª‰∏çÁü•ÈÅìËßÄÁúæ(Â¶ÇÊàë)ÂÖ∂ÂØ¶‰∏çÊòØÂæàcareÈÄô‰∫õÔºåËßÄÁúæÂè™care‰Ω†Ë¨õÁöÑÊù±Ë•øÔºåÊñ∞‰∏çÊñ∞ÔºüÂ∞ç‰∏çÂ∞çÔºüÊàëË¶∫ÂæóË®≠Ë®àÁ∞°Â†±ÂèØ‰ª•ÊòØÂ∞àÊ•≠Ôºå‰ΩÜ‰∏çÊòØÊØèÂÄã‰∫∫ÈÉΩË¶ÅÊúÉÁöÑÂ∞àÊ•≠ÔºåÈÄôÂÄãÊú¨ÊÑèÊòØÊãø‰æÜËºîÂä©Ê∫ùÈÄöÁöÑÂ∑•ÂÖ∑ÔºåÂ∞±ÊáâË©≤Â§öÂø´Â•ΩÁúÅËôïÁêÜÂÆå„ÄÇ
Âú®ÈÜ´Èô¢Ë£°ÁúãÈÅéÂêÑÁ®ÆÂêÑÊ®£ÁöÑÁ∞°Â†±ÔºåÊúâ‰∫õ‰∫∫Â•óÁî®PowerPointÂÖßÂª∫ÁöÑ‰∏Ä‰∫õËä±Ëä±Á∂†Á∂†ÁöÑÁØÑÊú¨ÔºåÂ≠óÈ´î‰∫Ç‰∏ÉÂÖ´Á≥üÔºåÂèàÂ∞èÂà∞Áúã‰∏çË¶ãÔºõ‰πüÊúâÊòØÁôΩÂ∫ïÈªëÂ≠óÂ§ßÔºåÁ∞°ÂñÆÂçªÂ≠óÂ≠óÁ≤æËèØÔºåËÅΩÂÆåÂæåËÄÉË©¶ÈÉΩËÄÉ100ÁôæÂàÜ‰∫Ü„ÄÇÂÅöÁ∞°Â†±ÁúüÁöÑ‰∏çÁî®Â§™ÁæéÂ∑•ÔºåÂ•ΩÁ∞°Â†±Âè™Ë¶ÅËÉΩÊúâ‰ª•‰∏ãÂπæÈªûÂ∞±Â•ΩÔºö
Ë©≤Â∞çÈΩäÁöÑÂ∞çÈΩä Â≠óÂ§ß‰∏ÄÈªû‚Ää-‚Ää24pt‰ª•‰∏ä Â¶ÇÊûúÊúâÊ¢ùÂàóÔºåÂä†ÂÄãÂãïÁï´ÂêßÔºå‰∏ÄÈªûÊé•Ëëó‰∏ÄÈªûÂá∫Áèæ ÂÖ®ÂçäÂΩ¢‰∏çË¶Å‰∫ÇÁî® ‰∏çË¶ÅÊúâÈåØÂ≠óe.g.ÊääSeminarÊãºÊàêSeminer, Sminiararaiaiari ÂúñÂ§ß‰∏ÄÈªûÔºåÊúÄÂ•ΩÊîæÂà∞Êªø ÈáçÈªûË®òÂæóÂº∑Ë™ø(Áúã‰Ω†Ë¶ÅÊòØÊ°ÜËµ∑‰æÜ„ÄÅÂºÑÁ≤ó„ÄÅÈÇÑÊòØÊîæÂ§ß) Ë¶ÅÊîæÈ†ÅÁ¢º„ÄÅÂá∫Ëôï ‰∏çË¶ÅÊîæËá™Â∑±‰∏çÊáÇÁöÑÊù±Ë•øÂú®slide‰∏äÔºå‰∏ÄÂÆöË¢´Èõª Êåâ‰∏ãÈù¢ÁöÑÊôÇÈñì‰æÜÂàÜÈÖçÈÄ≤Â∫¶</description></item><item><title/><link>https://www.physician.tw/Blood-Tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blood-Tests/</guid><description>Blood Tests erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels usually elevated1 other blood test findings reported with giant cell arteritis include anemia (hemoglobin &amp;lt; 12 g/dL) in about one-half of patients thrombocytosis in about one-half of patients leukocytosis in about one-quarter of patients Reference - [16148728Medicine (Baltimore) 2005 Sep;84(5):277][160] vascular endothelial growth factor (VEGF) may be elevated and play a role in pathogenesis, but clinical significance has not been established5 individual blood tests appear to have low-to-moderate performance for diagnosis of giant cell arteritis</description></item><item><title/><link>https://www.physician.tw/change/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/change/</guid><description/></item><item><title/><link>https://www.physician.tw/chest/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chest/</guid><description/></item><item><title/><link>https://www.physician.tw/coronary/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronary/</guid><description/></item><item><title/><link>https://www.physician.tw/duty/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/duty/</guid><description>title1 titles title2</description></item><item><title/><link>https://www.physician.tw/orphan/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/orphan/</guid><description>[[mother]] [[sister]] [[brother]]</description></item><item><title/><link>https://www.physician.tw/pH-of-Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pH-of-Urine-Dipstick/</guid><description/></item><item><title/><link>https://www.physician.tw/Rate-Control-atrial-fibrillation-1/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rate-Control-atrial-fibrillation-1/</guid><description>Saturday 23Âπ¥2Êúà25Êó• 23:58:21
Write about Rate Control-atrial fibrillation here!</description></item><item><title/><link>https://www.physician.tw/stable/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stable/</guid><description/></item><item><title/><link>https://www.physician.tw/Testing-Overview/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Testing-Overview/</guid><description>Testing Overview urgently refer patients with suspected giant cell arteritis to specialist3 diagnosis can be confirmed by either [temporal artery biopsy][123] [imaging][124] for temporal or other cranial arteries, [ultrasound][125] or [magnetic resonance imaging][126] (MRI) for aorta/extracranial arteries, [computed tomography][127] (CT), [positron emission tomography computed tomography][128] (PET-CT), MRI or ultrasound do not delay glucocorticoid therapy in patients with typical symptoms, increased inflammatory markers, and acute visual disturbance; diagnosis can still be confirmed after initiation of glucocorticoid therapy3 [blood tests][130] may show elevation in erythrocyte sedimentation rate or C-reactive protein</description></item><item><title/><link>https://www.physician.tw/%E6%9C%AA%E5%91%BD%E5%90%8D/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E6%9C%AA%E5%91%BD%E5%90%8D/</guid><description/></item><item><title>1</title><link>https://www.physician.tw/PART-1-The-Profession-of-Medicine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PART-1-The-Profession-of-Medicine/</guid><description>The Profession of Medicine PA RT 1 The Practice of Medicine The Editors
1 ENDURING VALUES OF THE MEDICAL PROFESSION No greater opportunity, responsibility, or obligation can fall to the lot of a human being than to become a physician.</description></item><item><title>2018 ACC AHA Cholesterol Guidelines</title><link>https://www.physician.tw/2018-ACC-AHA-Cholesterol-Guidelines/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/2018-ACC-AHA-Cholesterol-Guidelines/</guid><description>2018 ACC AHA Cholesterol Guidelines ASCVD Risk Estimator +
[[primary prevention of clinical ASCVD in patients at increased risk but who have not had a vascular event]] [[secondary prevention of clinical ascvd in patients with preexisting occlusive vascular disease]] Figure: Population Recommendation Figure 2.</description></item><item><title>5-y survival of lung cancer</title><link>https://www.physician.tw/5-y-survival-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/5-y-survival-of-lung-cancer/</guid><description>5-y survival of lung cancer ~70‚Äì90% for stage I, 50‚Äì60% stage II, 15‚Äì35% stage III, 0‚Äì10% stage IV (J Thorac Oncol 2016;11:39); survival improving with newer therapies (NEJM 2020;383:640).</description></item><item><title>5H5T</title><link>https://www.physician.tw/5H5T/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/5H5T/</guid><description>5H5T Figure: 5H Hypovolemia: volume Hypoxia: oxygenate H+ ions (acidosis): NaHCO3 Hypo/hyper K: KCI/Ca et al. Hypothermia: warm
5T [[POCUS]] Tension PTX: needle decomp.</description></item><item><title>ABG-vs-VBG</title><link>https://www.physician.tw/ABG-vs-VBG/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ABG-vs-VBG/</guid><description>ABG-vs-VBG concordant for pH (~0.04), HCO3 (~2 mEq) but not PCO2 (~8¬±17 mmHg) VBG can be used to screen for hypercarbia w/ PCO2 cutoff ‚â•45 mmHg (100% Se), but may not accurately assess degree of hypercarbia (Am J Emerg Med 2012;30:896)</description></item><item><title>Ablation-atrial fibrillation</title><link>https://www.physician.tw/Ablation-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ablation-atrial-fibrillation/</guid><description>Ablation-atrial fibrillation (Heart Rhythm 2017;14:e445; JACC 2020;75:1689)
ÂèÉËÄÉ‚û°Ô∏è 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation</description></item><item><title>abnormal liver tests</title><link>https://www.physician.tw/abnormal-liver-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abnormal-liver-tests/</guid><description>abnormal liver tests [[Tests of hepatocellular injury or cholestasis]] [[Tests of hepatic function]] [[Patterns of LFTs]] [[Acute mild-to-moderate elevation in ALT AST ]] [[Chronic mild-to-moderate elevation in ALT AST ]] [[Acute severe elevation in ALT AST]] [[Approach to abnormal liver tests with cholestatic pattern]] [[Approach to abnormal liver tests with infiltrative pattern]] [[Medication causes of abnormal LFTs]]</description></item><item><title>about line</title><link>https://www.physician.tw/about-line/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/about-line/</guid><description>about line</description></item><item><title>ACC AHA Classification for Office-Based BP</title><link>https://www.physician.tw/ACC-AHA-Classification-for-Office-Based-BP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACC-AHA-Classification-for-Office-Based-BP/</guid><description>ACC AHA Classification for Office-Based BP (HTN 2018;71:e13) Category Systolic (mmHg) Diastolic (mmHg) Normal &amp;lt;120 &amp;lt;80 Elevated 120‚Äì129 &amp;lt;80 Stage 1 hypertension 130‚Äì139 80‚Äì89 Stage 2 hypertension ‚â•140 ‚â•90</description></item><item><title>accessory pathways wolff-parkinson-white</title><link>https://www.physician.tw/accessory-pathways-wolff-parkinson-white/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/accessory-pathways-wolff-parkinson-white/</guid><description>accessory pathways (wolff-parkinson-white) [[Definitions-accessory pathways (wolff-parkinson-white)]] [[Classic tachycardias of WPW accessory pathways]] [[Treatment-accessory pathways (wolff-parkinson-white)]]</description></item><item><title>Acetaminophen hepatotoxicity</title><link>https://www.physician.tw/Acetaminophen-hepatotoxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acetaminophen-hepatotoxicity/</guid><description>Acetaminophen hepatotoxicity (Clin J Transl Hepatol 2016;4:131; BMJ 2016;353:i2579)
[[Pathophysiology-Acetaminophen hepatotoxicity]]
CYP2E1 induced by fasting, alcohol, certain anticonvulsants and anti-TB drugs, resulting in injury with even low doses (2‚Äì6 g) of acetaminophen</description></item><item><title>Acetaminophen-toxicology</title><link>https://www.physician.tw/Acetaminophen-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acetaminophen-toxicology/</guid><description>Acetaminophen-toxicology Vomiting, ‚Üë AG &amp;amp; nl OG metabolic acidosis, hepatitis &amp;amp; hepatic failure, renal failure
N-acetylcysteine (NAC) infusion
Hemodialysis if massive O/D</description></item><item><title>acid-base disturbances</title><link>https://www.physician.tw/acid-base-disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acid-base-disturbances/</guid><description>acid-base disturbances hupperts: [[Acid‚ÄìBase Disorders]]
[[physiology of acid-base disturbances]]
[[Definitions-acid-base disturbances]] [[Consequences-of-Severe-Acid-Base-Disturbances]] [[Workup-acid-base disturbances]] [[metabolic-acidosis]] [[metabolic-alkalosis]] [[respiratory-acidosis]] [[respiratory-alkalosis]]</description></item><item><title>Acinetobacter sp</title><link>https://www.physician.tw/Acinetobacter-sp/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acinetobacter-sp/</guid><description>Acinetobacter sp aerobic non-fermentative coccobacilary gram negative bacilli
cause soft tissue, wounds and bone, urinary tract infections, meningitis ;eye infection resistance is a problem 50% multidrug resistant extended spectrum beta-lactamase Tigecycine is not recommended sub-theraputic serum concentrations in bacteremia increased risk of all cause mortality [[IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections]]</description></item><item><title>ACLS</title><link>https://www.physician.tw/ACLS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACLS/</guid><description>ACLS [[CPR‰∫∫ÂäõÈÖçÁΩÆ]] [[ICU]]
[[electrocardiography]] [[arrhythmias]] [[Pulseless Arrest]] [[ACLS Tachycardia Algorithm]] [[ACLS Bradycardia Algorithm]]</description></item><item><title>ACLS Bradycardia Algorithm</title><link>https://www.physician.tw/ACLS-Bradycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACLS-Bradycardia-Algorithm/</guid><description>ACLS Bradycardia Algorithm Â∞èËóç‰∏ä‰∏çÂà∞4ÂÄãÂè´ÊÖ¢(&amp;lt;60pbm)ÔºåÂÖ´ÂÄãÂè´Âø´(100bpm+) bradycardia w/ Pulse (HR &amp;lt;50 &amp;amp; inadequate for clinical condition) Airway, IV Access, O2, monitor BP &amp;amp; rhythm, 12-lead ECG if Type ll 2¬∞ AVB or 3¬∞ AVB proceed to pacing ASAP ‰∫åÂ∫¶2‰ª•‰∏ä‰∏çÁî®Adenosine atropine 1 mg IV q3-5min, max 3 mg Êâì‰∏âÊ¨° ÂøÉÂæãÂà§ËÆÄ Ë¶èÂâá:‰∏ÄÊàñ‰∏â</description></item><item><title>ACLS Tachycardia Algorithm</title><link>https://www.physician.tw/ACLS-Tachycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACLS-Tachycardia-Algorithm/</guid><description>ACLS Tachycardia Algorithm [[electrocardiography]]
unstable = hypotension, change of MS, s/s shock, chest pain, heart failure</description></item><item><title>Acromegaly</title><link>https://www.physician.tw/Acromegaly/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acromegaly/</guid><description>Acromegaly (‚Üë GH; 10% of adenomas; Nat Rev Dis Primer 2019;5:1)
Physiology: stimulates secretion of insulin-like growth factor 1 (IGF-1) Clinical manifestations: ‚Üë soft tissue, arthralgias, jaw enlargement, headache, carpal tunnel syndrome, macroglossia, hoarseness, sleep apnea, amenorrhea, impotence, diabetes mellitus, acanthosis/skin tags, ‚Üë sweating, HTN/CMP, colonic polyps Diagnostic studies: low utility in checking random GH levels because of pulsatile secretion ‚Üë IGF-1 (somatomedin C); ¬± ‚Üë PRL; OGTT ‚Üí GH not suppressed to &amp;lt;1 (&amp;lt;0.</description></item><item><title>Acute Anti Ischemic and Analgesic Treatment</title><link>https://www.physician.tw/Acute-Anti-Ischemic-and-Analgesic-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Anti-Ischemic-and-Analgesic-Treatment/</guid><description>Acute Anti Ischemic and Analgesic Treatment Nitrates (SL or IV) 0.3‚Äì0.4 mg SL q5min √ó 3, then consider IV if still sx Use for relief of sx, Rx for HTN or HF.</description></item><item><title>acute aortic syndromes</title><link>https://www.physician.tw/acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-aortic-syndromes/</guid><description>acute aortic syndromes [[Definitions-acute aortic syndromes]] [[Classification-acute aortic syndromes]] [[Risk factors-acute aortic syndromes]] [[Clinical Manifestations and Physical Exam-acute aortic syndromes]] [[Initial evaluation diagnostic studies-acute aortic syndromes]] [[Treatment-acute aortic syndromes]] [[Complications-acute aortic syndromes]]</description></item><item><title>acute bacterial meningitis</title><link>https://www.physician.tw/acute-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-bacterial-meningitis/</guid><description>acute bacterial meningitis Definition Inflammation of tissue around the brain/spinal cord Usually arising from nasopharynx (hematogenous spread), bacteremia, or direct inoculation (surgery, contiguous infection, trauma, foreign body [eg, CSF shunt]) [[Microbiology in Bacterial Meningitis]] Clinical manifestations (Lancet 2016;339:16) Headache (84%), fever (74%), stiff neck (74%), photosensitivity, GCS &amp;lt;14 (71%), nausea (62%), seizure (23%); 95% have 2 of 4: HA, fever, stiff neck, ŒîMS Presentation may be atypical (eg, lethargy w/o fever) in elderly and immunosupp.</description></item><item><title>Acute bacterial skin and skin structure infections</title><link>https://www.physician.tw/Acute-bacterial-skin-and-skin-structure-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-bacterial-skin-and-skin-structure-infections/</guid><description>Acute bacterial skin and skin structure infections Primary Regimens Elevate the involved leg Inpatient parenteral therapy: Penicillin G 1 to 2 million units IV q6h If history of pencillin skin rash and nothing to suggest IgE-mediated allergic reaction: Cefazolin 1 gm IV q8h or Ceftriaxone 2 gm IV once daily If history/evidence of past IgE-mediated allergic reaction (anaphylaxis), then may be forced to use: Vancomycin 15-20 mg/kg IV q8-12h to achieve preferred target AUC24 400-600 Œºg/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 Œºg/mL Linezolid 600 mg IV/po bid Treat IV until afebrile; then outpatient Penicillin V-K 500 mg po qid ac and hs for a total of 10 days of therapy.</description></item><item><title>acute coronary syndromes</title><link>https://www.physician.tw/acute-coronary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-coronary-syndromes/</guid><description>acute coronary syndromes [[NSTE-ACS]] (Circ 2014;130:e344; EHJ 2021;42:1289) [[STEMI]] (Circ 2013;127:529; EHJ 2018;39:119) [[CHECKLIST AND LONG TERM POST ACS MANAGEMENT]]</description></item><item><title>Acute hemolytic</title><link>https://www.physician.tw/Acute-hemolytic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-hemolytic/</guid><description>Acute hemolytic : fever, HoTN, flank pain, AKI w/in 24 h. Due to ABO incompatibility ‚Üí preformed Abs vs. donor RBCs.</description></item><item><title>Acute Infectious Etiologies</title><link>https://www.physician.tw/Acute-Infectious-Etiologies-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Infectious-Etiologies-/</guid><description>Acute Infectious Etiologies [[NONINFLAMMATORY-Acute Infectious Etiologies]] [[INFLAMMATORY-Acute Infectious Etiologies]]</description></item><item><title>Acute interstitial nephritis</title><link>https://www.physician.tw/Acute-interstitial-nephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-interstitial-nephritis/</guid><description>Acute interstitial nephritis etiology Allergic: Œ≤-lactams, sulfa drugs, NSAIDs, PPIs Infection: pyelo, viral, legionella, TB, leptospirosis Infiltrative: sarcoid, lymphoma, leukemia Autoimmune: Sj√∂gren‚Äôs, TINU, IgG4, SLE, ICIs treatment (CJASN 2017;12:2046 &amp;amp; JASN 2020;31:435)</description></item><item><title>acute kidney injury AKI</title><link>https://www.physician.tw/acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-kidney-injury-AKI/</guid><description>acute kidney injury (AKI) [[Definition-acute kidney injury (AKI)]] [[Workup-acute kidney injury (AKI)]] [[Etiologies and Diagnosis of Acute Kidney Injury ]] [[General treatment-acute kidney injury (AKI)]] [[Managing complications-acute kidney injury (AKI)]]</description></item><item><title>Acute Kidney Injury in Patients with Liver Disease | American Society of Nephrology</title><link>https://www.physician.tw/Acute-Kidney-Injury-in-Patients-with-Liver-Disease-American-Society-of-Nephrology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Kidney-Injury-in-Patients-with-Liver-Disease-American-Society-of-Nephrology/</guid><description/></item><item><title>acute liver failure</title><link>https://www.physician.tw/acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-liver-failure/</guid><description>acute liver failure [[Definition-acute liver failure]] [[Etiology-acute liver failure]] [[Clinical manifestations-acute liver failure]] [[Workup-acute liver failure]] [[Management-acute liver failure]] [[Prognosis-acute liver failure]]</description></item><item><title>acute mesenteric ischemia</title><link>https://www.physician.tw/acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-mesenteric-ischemia/</guid><description>acute mesenteric ischemia [[Definition and causes-acute mesenteric ischemia]]
[[Clinical manifestations-acute mesenteric ischemia]]
[[Diagnostic studies-acute mesenteric ischemia]]</description></item><item><title>Acute mild-to-moderate elevation in ALT AST</title><link>https://www.physician.tw/Acute-mild-to-moderate-elevation-in-ALT-AST-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-mild-to-moderate-elevation-in-ALT-AST-/</guid><description>Acute mild-to-moderate elevation in ALT AST (&amp;lt;15√ó ULN)
Assess risk of EtOH/drug/toxin: H&amp;amp;P; in EtOH AST:ALT ratio &amp;gt;2:1</description></item><item><title>acute pancreatitis</title><link>https://www.physician.tw/acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-pancreatitis/</guid><description>acute pancreatitis [[Pathogenesis-acute pancreatitis]] [[Etiologies-acute pancreatitis]] [[Clinical manifestations-acute pancreatitis]] [[Diagnostic studies-acute pancreatitis]] [[Severity-acute pancreatitis]] [[Prognosis-acute pancreatitis]] [[Treatment-acute pancreatitis]] [[Complications-acute pancreatitis]]</description></item><item><title>acute respiratory distress syndrome</title><link>https://www.physician.tw/acute-respiratory-distress-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-respiratory-distress-syndrome/</guid><description>acute respiratory distress syndrome [[Berlin definition]] [[Pathophysiology of acute respiratory distress syndrome]] [[Pathology acute respiratory distress syndrome]] [[Etiologies acute respiratory distress syndrome]] [[Treatment acute respiratory distress syndrome]] [[Mechanisms of VILI Ventilator Strategies]] [[The 6 Ps-acute respiratory distress syndrome]] [[PEEP titration methods]] [[Prognosis of acute respiratory distress syndrome]]</description></item><item><title>Acute severe elevation in ALT AST</title><link>https://www.physician.tw/Acute-severe-elevation-in-ALT-AST/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-severe-elevation-in-ALT-AST/</guid><description>Acute severe elevation in ALT AST (&amp;gt;1000)
Massive elevations (&amp;gt;5000) usually due to ischemic injury or drug-induced hepatitis</description></item><item><title>Acute Treatment of Hypercalcemia</title><link>https://www.physician.tw/Acute-Treatment-of-Hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Treatment-of-Hypercalcemia/</guid><description>Acute Treatment of Hypercalcemia Normal saline (4‚Äì6 L/d) h during Rx Natriuresis ‚Üí ‚Üë renal Ca excretion ÊéíÈàâ ‚Üí ‚Üë ËÖéÈà£ÊéíÊ≥Ñ</description></item><item><title>Acute treatment of Migraine</title><link>https://www.physician.tw/Acute-treatment-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-treatment-of-Migraine/</guid><description>Acute treatment of Migraine First-line medication NSAIDs (acetylsalicylic acid, ibuprofen or diclofenac potassium) Second-line medication Triptans When triptans provide insufficient pain relief, combine with fast-acting NSAIDs Third-line medication Ditans Gepants Adjunct medications for nausea and/or vomiting Prokinetic antiemetics (domperidone or metoclopramide)</description></item><item><title>Acute treatment-nephrolithiasis</title><link>https://www.physician.tw/Acute-treatment-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-treatment-nephrolithiasis/</guid><description>Acute treatment-nephrolithiasis (JAMA 2020;323:1961)
Analgesia (narcotics ¬± NSAIDs; combination superior, Ann Emerg Med 2006;48:173), ensure adequate fluid repletion, antibiotics if UTI</description></item><item><title>Acute tubular necrosis ATN</title><link>https://www.physician.tw/Acute-tubular-necrosis-ATN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-tubular-necrosis-ATN/</guid><description>Acute tubular necrosis (ATN) Allergic: Œ≤-lactams, sulfa drugs, NSAIDs, PPIs
Infection: pyelo, viral, legionella, TB, leptospirosis</description></item><item><title>Additional Diabetes Treatment Options</title><link>https://www.physician.tw/Additional-Diabetes-Treatment-Options/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-Diabetes-Treatment-Options/</guid><description>Additional Diabetes Treatment Options DPP-4 inhibitors (~0.5‚Äì1%) Block degrad. GLP-1 &amp;amp; GIP ‚Üí ‚Üë insulin. ‚Üë risk of HF w/ saxagliptin (NEJM 2013;369:1317), not w/ others.</description></item><item><title>Additional pleural fluid studies</title><link>https://www.physician.tw/Additional-pleural-fluid-studies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-pleural-fluid-studies/</guid><description>Additional pleural fluid studies (NEJM 2002;346:1971)
NT-proBNP ‚â•1500 pg/mL has 91% Se &amp;amp; 93% Sp for CHF (Am J Med 2004;116:417)</description></item><item><title>Adeno or Other in Stage IV NSCLC Treatment</title><link>https://www.physician.tw/Adeno-or-Other-in-Stage-IV-NSCLC-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adeno-or-Other-in-Stage-IV-NSCLC-Treatment/</guid><description>Adeno or Other in Stage IV NSCLC Treatment Genetics % Treatment [[EGFR]] ~15 1st line: osimertinib if L858R, ex19del (NEJM 2018;378:113) [[EGFR ex20 insertion]] 2‚Äì3 Subsequent Rx w/ amivantamab (JCO 2021;39:3391) or mobocertinib (JAMA Onc 2021;7:e214761) after platinum chemo ALK ~4 1st line: alectinib pref.</description></item><item><title>Adrenal crisis in adrenal insufficiency</title><link>https://www.physician.tw/Adrenal-crisis-in-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-crisis-in-adrenal-insufficiency/</guid><description>Adrenal crisis in adrenal insufficiency (NEJM 2019;381;852)
Precipitants: preexisting adrenal insufficiency + serious infection or GI illness, bilateral adrenal hemorrhage or infarction, pituitary infarction Presentation: shock + anorexia, N/V, abd pain, weakness, fatigue, confusion, coma, fever Lab findings: hyponatremia, hyperkalemia (1¬∞) Rx: hydrocortisone 100 mg IV followed by 50 mg IV q6 + IVF; do not delay for dx tests</description></item><item><title>adrenal disorders</title><link>https://www.physician.tw/adrenal-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-disorders/</guid><description>adrenal disorders [[Cushing‚Äôs Syndrome]] (Hypercortisolism) [[hyperaldosteronism]] [[adrenal insufficiency]] FIGURE 5.4: Hypothalamic‚Äìpituitary‚Äìadrenal axis and adrenal hormone production. A) Shown is the hypothalamic‚Äìpituitary‚Äìadrenal axis, which regulates the production of adrenal hormones.</description></item><item><title>adrenal incidentalomas</title><link>https://www.physician.tw/adrenal-incidentalomas/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-incidentalomas/</guid><description>adrenal incidentalomas Epidemiology
4% of Pts undergoing abdominal CT scan have incidentally discovered adrenal mass; prevalence ‚Üë with age Differential diagnosis Nonfunctioning mass: adenoma, cysts, abscesses, granuloma, hemorrhage, lipoma, myelolipoma, primary or metastatic malignancy Functioning mass: pheochromocytoma, adenoma (cortisol, aldosterone, sex hormones), other endocrine tumor, carcinoma Hormonal workup (EJE 2016;175:G1; NEJM 2021;384:1542) Rule out subclinical Cushing‚Äôs syndrome in all Pts using 1 mg overnight DST (Sp 91%).</description></item><item><title>adrenal insufficiency</title><link>https://www.physician.tw/adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-insufficiency/</guid><description>adrenal insufficiency [[Etiologies-adrenal insufficiency]] [[Clinical manifestations-adrenal insufficiency]] [[Diagnostic studies-adrenal insufficiency]] [[Treatment-adrenal insufficiency]] [[Adrenal insufficiency and critical illness]] [[Adrenal crisis in adrenal insufficiency]] [[pheochromocytoma and paraganglioma]] [[adrenal incidentalomas]]</description></item><item><title>Adrenal insufficiency and critical illness</title><link>https://www.physician.tw/Adrenal-insufficiency-and-critical-illness/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-insufficiency-and-critical-illness/</guid><description>Adrenal insufficiency and critical illness (NEJM 2003;348:727; JAMA 2009;301:2362)
Low cortisol binding proteins; ‚à¥ dx of adrenal insufficiency problematic (NEJM 2013;368:1477) Adrenal insufficiency rare in most cases of shock unless adrenal infarction or bleed, Waterhouse-Friderichson, CNS or pituitary bleed Reasonable to collect cortisol level in HoTN Pt w/ suspicion for adrenal insufficiency Can consider above dx criteria, but decision for Rx should also be based on clinical assessment due to risk of false ‚äñ and ‚äï results in context of altered physiology If concerned, initiate corticosteroids early: use hydrocortisone 100 mg IV followed by 50 mg IV q6h Controversial data for empiric steroids in all critically ill Pts [[sepsis and shock]]</description></item><item><title>aflatoxin</title><link>https://www.physician.tw/aflatoxin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aflatoxin/</guid><description>ÈªÉÈ∫¥ÊØíÁ¥†ÔºàAflatoxinÔºâÊòØÁî±Ë®±Â§öÈ∫¥ËèåÂ±¨ÔºàAspergillusÔºâÈª¥ËèåÊâÄÁî¢ÁîüÁöÑÈª¥ËèåÊØíÁ¥†ÔºàmycotoxinÔºâÁµ±Á®±ÔºåÂÖ∂‰∏≠ÊúÄÊúâÂêçÁöÑÊòØÈªÉÈ∫¥ËèåÔºà[[Aspergillus flavus]]Ôºâ</description></item><item><title>AIP acute IP Hamman-Rich syndrome</title><link>https://www.physician.tw/AIP-acute-IP-Hamman-Rich-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AIP-acute-IP-Hamman-Rich-syndrome/</guid><description>AIP acute IP (Hamman-Rich syndrome) Diffuse ground-glass opacities, consolidations w/ lobular sparing. Path/imaging similar to DAD (diffuse, bilateral, central&amp;gt;periph ground glass or consolidative opacities).</description></item><item><title>Airway-Management</title><link>https://www.physician.tw/Airway-Management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Airway-Management/</guid><description>Airway-Management ‚ú®Functional anatomy of the upper airwayÈáçÈªû: Âú®ËàåÊ†π‰∏ãÊñπÔºåÊúÉÂé≠Â∞áÂè£ÂíΩËàáÂñâÂíΩÊàñ‰∏ãÂö•ÂàÜÈñã„ÄÇ ÊúÉÂé≠ÈÄöÈÅéÂú®ÂêûÂö•ÈÅéÁ®ã‰∏≠Ë¶ÜËìãÂñâÈÉ®ÔºàËÅ≤ÈñÄÔºâÁöÑÈñãÂè£‰æÜÈò≤Ê≠¢Ë™§Âê∏„ÄÇ ÂñâÊòØÁî±‰πùÂÄãËªüÈ™®‰ª•ÂèäÈüåÂ∏∂ÂíåËÇåËÇâÁµÑÊàêÁöÑËªüÈ™®È™®Êû∂„ÄÇ Áî≤ÁãÄËªüÈ™®ÁöÑÈÉ®ÂàÜÂäüËÉΩÊòØ‰øùË≠∑ËÅ≤Â∏∂„ÄÇ [[predictors of difficult mask ventilation]] [[equipment of airway-management]] [[positioning-airway-management]] [[preoxygenation]] [[bag and mask ventilation]] [[premedication of airway-management]] [[laryngoscopy and confirmation of placement]]</description></item><item><title>Albuterol of COPDAE</title><link>https://www.physician.tw/Albuterol-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Albuterol-of-COPDAE/</guid><description>Albuterol of COPDAE MDI 4‚Äì8 puffs q1‚Äì2h or Nebulizer 2.5‚Äì5 mg q1‚Äì2h Benefit if component of reversible bronchoconstriction</description></item><item><title>alcohol withdrawal</title><link>https://www.physician.tw/alcohol-withdrawal/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/alcohol-withdrawal/</guid><description/></item><item><title>Alcohol-associated hepatitis</title><link>https://www.physician.tw/Alcohol-associated-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alcohol-associated-hepatitis/</guid><description>Alcohol-associated hepatitis Sx: progressive jaundice, tender hepatomegaly, fever, ascites, GIB, encephalopathy Symptoms: gradual yellowing of the skin, painful enlargement of the liver, fever, accumulation of fluid in the abdomen, gastrointestinal bleeding, brain dysfunction.</description></item><item><title>Aldosterone-antagonists</title><link>https://www.physician.tw/Aldosterone-antagonists/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aldosterone-antagonists/</guid><description>Aldosterone-antagonists Add after RASi and bB if adeq. renal fxn and w/o hyperkalemia
25‚Äì30% ‚Üì mort. in NYHA II‚ÄìIV &amp;amp; EF ‚â§35% (NEJM 2011;364:11)</description></item><item><title>Allergic Transfusion reactions</title><link>https://www.physician.tw/Allergic-Transfusion-reactions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Allergic-Transfusion-reactions/</guid><description>Allergic Transfusion reactions urticaria; rarely, anaphylaxis due to rxn to txfused proteins, especially in IgA-deficient Pts w/ anti-IgA Abs (use washed products).</description></item><item><title>allergy immunology</title><link>https://www.physician.tw/allergy-immunology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/allergy-immunology/</guid><description>allergy immunology Allergic Rhinitis/Conjunctivitis/Sinusitis Anaphylaxis Drug Allergy Food Allergy Urticaria and Angioedema Eosinophilia and Mast-Cell Disorders Immunodeficiency</description></item><item><title>Alterations in Body Temperature</title><link>https://www.physician.tw/Alterations-in-Body-Temperature/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-Body-Temperature/</guid><description>Alterations in Body Temperature Chapter 18: [[fever]] Chapter 19: [[fever and rash]] Chapter 20: [[fever of unknown origin]]</description></item><item><title>Alterations in Circulatory and Respiratory Functions</title><link>https://www.physician.tw/Alterations-in-Circulatory-and-Respiratory-Functions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-Circulatory-and-Respiratory-Functions/</guid><description>Alterations in Circulatory and Respiratory Functions Chapter 37: [[dyspnea]] Chapter 38: [[cough]] Chapter 39: [[hemoptysis]] Chapter 40: [[Hypoxia and Cyanosis]] Chapter 41: [[edema]] Chapter 42: [[approach to the patient with a heart murmur]] Chapter 43: [[palpitations]]</description></item><item><title>Alterations in Renal and Urinary Tract Function</title><link>https://www.physician.tw/Alterations-in-Renal-and-Urinary-Tract-Function/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-Renal-and-Urinary-Tract-Function/</guid><description>Alterations in Renal and Urinary Tract Function Chapter 51: [[interstitial cystitis]] and [[bladder pain syndrome]] Chapter 52: [[azotemia]] and Urinary Abnormalities Chapter 53: [[fluid and electrolyte disturbances]] Chapter 54: [[hypercalcemia]] and [[hypocalcemia]] Chapter 55: Acidosis and Alkalosis</description></item><item><title>Amiodarone</title><link>https://www.physician.tw/Amiodarone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Amiodarone/</guid><description>Amiodarone 300 mg over 1 h then 10-50 mg/h X 24h
150 mg/3 mL
loading infusionÔºö150 mg in 100 mL over 10 minÔºõ</description></item><item><title>amiodarone and thyroid disease</title><link>https://www.physician.tw/amiodarone-and-thyroid-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/amiodarone-and-thyroid-disease/</guid><description>amiodarone and thyroid disease Overview (JCEM 2021;106:226) 6 mg iodine per 200-mg tablet; risk of thyroid dysfunction lower with lower doses ‚úì TSH prior to therapy, at 4-mo intervals on amio, and for 1 y after if amio d/c‚Äôd Hypothyroidism (occurs in ~10%; more common in iodine-replete areas) Pathophysiology (1) Wolff-Chaikoff effect: iodine load ‚Üì I‚Äì uptake, organification and release of T4 &amp;amp; T3 (2) inhibits T4 ‚Üí T3 conversion (3) ?</description></item><item><title>amyloidosis</title><link>https://www.physician.tw/amyloidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/amyloidosis/</guid><description>amyloidosis [[Systemic diseases with secondary glomerular involvement]]</description></item><item><title>anaphylaxis</title><link>https://www.physician.tw/anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/anaphylaxis/</guid><description>anaphylaxis [[Definition and pathophysiology-anaphylaxis]] [[Diagnosis-anaphylaxis]] [[Treatment-anaphylaxis]] [[Disposition-anaphylaxis]] [[Angioedema]] The term aspiration pneumonia should be reserved specifically for pneumonitis resulting from aspiration of oropharyngeal or gastric contents ( table 1 ) .</description></item><item><title>Anaplastic thyroid cancer</title><link>https://www.physician.tw/Anaplastic-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anaplastic-thyroid-cancer/</guid><description>Anaplastic thyroid cancer ‚ôÄ:‚ôÇ 1.5‚Äì2:1; poorly differentiated, extremely aggressive, mortality 90% at 5 y P/w rapidly growing fixed &amp;amp; hard neck mass, regional or distant spread in 90% at dx Rx options include surgery, radiation, trach, chemo, investigational clinical trials</description></item><item><title>ANCA positive Vasculitis</title><link>https://www.physician.tw/ANCA-positive-Vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ANCA-positive-Vasculitis/</guid><description>ANCA positive Vasculitis Differential diagnosis of ANCA (Nat Rev Dis Primers 2020;6:71) #‚≠ê
anti-PR3: GPA, EGPA, microscopic polyangiitis (rarely), levamisole (contam.</description></item><item><title>anemia</title><link>https://www.physician.tw/anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/anemia/</guid><description>anemia ‚Üì in RBC mass: Hct &amp;lt;41% or Hb &amp;lt;13.5 g/dL (men); Hct &amp;lt;36% or Hb &amp;lt;12 g/dL (women)</description></item><item><title>Anemia in chronic kidney disease</title><link>https://www.physician.tw/Anemia-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anemia-in-chronic-kidney-disease/</guid><description>Anemia in chronic kidney disease goal Hb 10‚Äì11.5 g/dL, worse outcomes if target higher (NEJM 2009;361:2019)
epoetin (start 80‚Äì120 U/kg SC, divided 3√ó/wk) or darbepoetin (0.</description></item><item><title>Anemia of chronic inflammation</title><link>https://www.physician.tw/Anemia-of-chronic-inflammation-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anemia-of-chronic-inflammation-/</guid><description>Anemia of chronic inflammation (ACI; NEJM 2012;366:4)
‚Üì RBC production due to impaired iron utilization and functional iron deficiency from ‚Üë hepcidin; cytokines (IL-6, TNF-Œ±) cause ‚Üì Epo responsiveness/production</description></item><item><title>Anemias of other chronic disorders</title><link>https://www.physician.tw/Anemias-of-other-chronic-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anemias-of-other-chronic-disorders/</guid><description>Anemias of other chronic disorders Anemia of CKD: ‚Üì Epo; treat w/ Epo &amp;amp; iron (see ‚ÄúChronic Kidney Disease‚Äù)</description></item><item><title>Angioedema</title><link>https://www.physician.tw/Angioedema/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Angioedema/</guid><description>Angioedema (J Allergy Clin Immunol 2013;131:1491)
Localized swelling of skin/mucosa; involves face, lips, tongue, uvula, larynx, and bowels</description></item><item><title>anion gap</title><link>https://www.physician.tw/anion-gap/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/anion-gap/</guid><description>anion gap (AG) = Na+ ‚Äì (Cl‚Äì + HCO3‚Äì) = unmeasured anions ‚Äì unmeasured cations If ‚Üë glc, use measured not corrected Na Expected AG is [albumin] √ó 2.</description></item><item><title>Annotations</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM/</guid><description>Annotations Mdnotes File Name: [[Nonspecific Low Back Pain]] Annotations (8/12/2022, 12:37:26 AM)
‚ÄúNonspecific Low Back Pain * Nonspecific low back pain is diagnosed on the basis of the exclusion of specific causes, usually by means of history taking and physical examination.</description></item><item><title>Anorectal disorders</title><link>https://www.physician.tw/Anorectal-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anorectal-disorders/</guid><description>Anorectal disorders Internal, external hemorrhoids; anal fissures, rectal ulcers, rectal varices (Rx by ‚Üì portal venous pressure in cirrhosis), XRT</description></item><item><title>Anti Depressant KFSYSCC</title><link>https://www.physician.tw/Anti-Depressant-KFSYSCC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-Depressant-KFSYSCC/</guid><description>1.2.3
Category Medication Selective Serotonin Reuptake Inhibitors Escitalopram, Sertraline Serotonin Norepinephrine Reuptake Inhibitors Duloxetine, Venlafaxine Tricyclic Amitriptyline, Amitriptyline 5-HT Triazolopyridine Trazodone Other 5-HT Receptor Modulators Vortioxetine Tetracyclic Mirtazapine, Aminoketone Bupropion [ How does this thing work?</description></item><item><title>Anti-GBM Disease</title><link>https://www.physician.tw/Anti-GBM-Disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-GBM-Disease/</guid><description>Anti-GBM Disease (linear staining) &amp;lt;15% of total (CJASN 2017;12:1162)
Goodpasture‚Äôs Glomerulonephritis: Êúâ Pulm Hemorrhage: Êúâ Anti-GBM disease: Êúâ Anti-GBM Glomerulonephritis: Êúâ Pulm Hemorrhage: - Anti-GBM disease: Êúâ</description></item><item><title>Anti-IL5</title><link>https://www.physician.tw/Anti-IL5/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-IL5/</guid><description>Anti-IL5 (eg, mepolizumab, benralizumab): mixed data on ‚Üì exacerb in Pts with eos (NEJM 2017;377:1613 ÊàëÂÄëÁôºÁèæË°ÄÊ∂≤‰∏≠Âê´ÊúâÂ§ßÈáèÂóúÈÖ∏ÊÄßÁôΩË°ÄÁêÉÁöÑÈáçÂ∫¶Ê∞£ÂñòÊÇ£ËÄÖÔºåÂèØ‰ª•ÂæûÊúçÁî® mepolizumab„ÄÅ reslizumab Êàñ benralizumab ‰æÜÊ∏õÂ∞ëÊ∞£ÂñòÁôº‰Ωú„ÄÇÂú®ÁîüÊ¥ªÂìÅË≥™ÂíåÂëºÂê∏Ê∏¨Ë©¶ÊñπÈù¢ÂùáÊúâÂ∞èÂπÖÁöÑÊîπÂñÑÔºå‰ΩÜÊîπÂñÑÂπÖÂ∫¶ÂèØËÉΩÂ§™Â∞è‰ª•Ëá≥ÊñºÁÑ°Ê≥ïË¢´ÊÇ£ËÄÖÂØüË¶∫„ÄÇÊàëÂÄëÂêåÊÑèÂúãÈöõÊåáÂºïÁ®±ÈÄô‰∫õËó•Áâ©ÂèØ‰ª•Êñ∞Â¢ûÂà∞ÈáçÂ∫¶Ê∞£ÂñòÊÇ£ËÄÖÁöÑÊ®ôÊ∫ñÊ≤ªÁôÇ‰∏≠‰πãË™™Ê≥ï„ÄÇÈúÄË¶ÅÈÄ≤‰∏ÄÊ≠•ÁöÑÁ†îÁ©∂‰æÜÈó°Êòé‰∏Ä‰∫õÊñπÈù¢Ôºå‰æãÂ¶ÇÂ¶Ç‰ΩïË©ïÂÉπÊ≤ªÁôÇÂèçÊáâ‰ª•ÂèäÁµ¶‰∫àÊ≤ªÁôÇÂ§öÈï∑ÊôÇÈñì„ÄÇ&amp;amp; 2019;381:1023)</description></item><item><title>Antiarrhythmic Drugs AAD for AF</title><link>https://www.physician.tw/Antiarrhythmic-Drugs-AAD-for-AF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiarrhythmic-Drugs-AAD-for-AF/</guid><description>Antiarrhythmic Drugs (AAD) for AF III [[Amiodarone]] [[Dronedarone]] [[Ibutilide]] [[Dofetilide]] [[Sonlol]] IC [[Flecainide]] [[Propafenone]] IA [[Procainamidel]] Underlying disease &amp;amp; maintenance AAD of choice: None or minimal (incl HTN wlo LVH): class IC (‚Äúpill in pocket&amp;quot;).</description></item><item><title>antibiotics</title><link>https://www.physician.tw/antibiotics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/antibiotics/</guid><description>antibiotics</description></item><item><title>Antibiotics of COPDAE</title><link>https://www.physician.tw/Antibiotics-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antibiotics-of-COPDAE/</guid><description>Antibiotics of COPDAE Amox, TMP-SMX, doxy, azithro, antipneumococcal FQ all reasonable (no single abx proven superior). Consider local flora and avoid repeat courses of same abx.</description></item><item><title>Antibiotics-sepsis and shock</title><link>https://www.physician.tw/Antibiotics-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antibiotics-sepsis-and-shock/</guid><description>Antibiotics-sepsis and shock Start empiric IV abx as soon as possible after recognition of severe sepsis or septic shock; every hr delay in abx admin a/w 7.</description></item><item><title>Anticoagulant in chronic kidney disease</title><link>https://www.physician.tw/Anticoagulant-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulant-in-chronic-kidney-disease/</guid><description>Anticoagulant in chronic kidney disease : ESRD at ‚Üë bleed risk; if using DOAC, consider apixiban &amp;gt;rivaroxaban &amp;gt;dabigatran due to protein binding/renal clearance (JASN 2017;28:2241)</description></item><item><title>Anticoagulant Therapy</title><link>https://www.physician.tw/Anticoagulant-Therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulant-Therapy/</guid><description>Anticoagulant Therapy For NSTEMI UFH: 60 U/kg IVB (max 4000 U) then 12 U/kg/h (max 1000 U/h initially) √ó 48 h or until end of PCI 24% ‚Üì D/MI (JAMA 1996;276:811)</description></item><item><title>Anticoagulation antiplatelet therapy-prosthetic-heart-valves</title><link>https://www.physician.tw/Anticoagulation-antiplatelet-therapy-prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulation-antiplatelet-therapy-prosthetic-heart-valves/</guid><description>Anticoagulation antiplatelet therapy-prosthetic-heart-valves (Circ 2021;143:e72)
Mechanical: warfarin (not DOAC), INR 3 or 2.5 if low-risk mech AVR (none of following: prior thromboembolism, AF, EF &amp;lt;30‚Äì35%, hypercoagulable).</description></item><item><title>Anticoagulation-Treatment of Chronic HF with Reduced EF</title><link>https://www.physician.tw/Anticoagulation-Treatment-of-Chronic-HF-with-Reduced-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulation-Treatment-of-Chronic-HF-with-Reduced-EF/</guid><description>Anticoagulation-Treatment of Chronic HF with Reduced EF [[antiplatelet Therapy of STEMI]] If AF, VTE, LV thrombus, ¬± if large akinetic LV segments.</description></item><item><title>antimetabolites</title><link>https://www.physician.tw/antimetabolites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/antimetabolites/</guid><description>antimetabolites [[Methotrexate]]</description></item><item><title>Antiphospholipid antibodies</title><link>https://www.physician.tw/Antiphospholipid-antibodies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiphospholipid-antibodies/</guid><description>Antiphospholipid antibodies [[Antiphospholipid syndrome (APS)]]
‚úì if: SLE, age &amp;lt;40 y &amp;amp; arterial thromb, recurrent venous thromb, spontaneous abortion</description></item><item><title>Antiphospholipid syndrome APS</title><link>https://www.physician.tw/Antiphospholipid-syndrome-APS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiphospholipid-syndrome-APS/</guid><description>Antiphospholipid syndrome (APS) [[Definition-Antiphospholipid syndrome]] (APS) Features: DVT/PE/CVA, recurrent fetal loss, ‚Üì plts, hemolytic anemia, livedo reticularis
‚ÄúCatastrophic APS‚Äù: ‚â•3 organ systems in &amp;lt;1 wk w/ ‚äï APLA &amp;amp; tissue microthrombi; 44% mortality (Arth Rheum 2006;54:2568); Rx w/ plasmapheresis, rituximab</description></item><item><title>Antiplatelet Therapy</title><link>https://www.physician.tw/Antiplatelet-Therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiplatelet-Therapy/</guid><description>Antiplatelet Therapy [[Aspirin]] P2Y12 (ADP receptor) inhibitor (choose one of the following in addition to ASA). Timing (on presentation or at angiography) remains controversial.</description></item><item><title>Antiplatelet Therapy of STEMI</title><link>https://www.physician.tw/Antiplatelet-Therapy-of-STEMI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiplatelet-Therapy-of-STEMI/</guid><description>Antiplatelet Therapy of STEMI Aspirin 162‚Äì325 mg √ó 1 (crushed/chewed) then 81 mg qd 23% ‚Üì in death (Lancet 1988;ii:349) Should not be stopped if CABG required</description></item><item><title>Antiretrovirals ARVs</title><link>https://www.physician.tw/Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiretrovirals-ARVs/</guid><description>Antiretrovirals (ARVs) [[nucleoside reverse transcriptase inhibitor NRTI-Antiretrovirals (ARVs)]] [[non- nucleoside reverse transcriptase inhibitor-NNRTI-Antiretrovirals (ARVs)]] [[protease inhibitors - PI-Antiretrovirals (ARVs)]] [[entry inhibitors-EI-Antiretrovirals (ARVs)]] [[integrase strand transfer inhibitor-INSTI-Antiretrovirals (ARVs)]]</description></item><item><title>Antituberculous Medications</title><link>https://www.physician.tw/Antituberculous-Medications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antituberculous-Medications/</guid><description>Antituberculous Medications [[Antituberculous Treatment Regimens]]
*Risk of hepatitis ‚Üë w/ pre-existing liver disease. Consult ID, consider holding/replacing PZA or INH.</description></item><item><title>Antituberculous Treatment Regimens</title><link>https://www.physician.tw/Antituberculous-Treatment-Regimens/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antituberculous-Treatment-Regimens/</guid><description>Antituberculous Treatment Regimens [[Antituberculous Medications]]
Pulmonary TB ‚â•4% INH-resist. in community (incl. most of U.S.) INH + RIF + PZA + EMB until suscept.</description></item><item><title>aortic aneurysms</title><link>https://www.physician.tw/aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortic-aneurysms/</guid><description>aortic aneurysms [[Definitions-aortic aneurysms]] [[Epidemiology-aortic aneurysms]] [[Pathophysiology risk factors -aortic aneurysms]] [[Screening-aortic aneurysms]] [[Diagnostic studies-aortic aneurysms]] [[Treatment-aortic aneurysms]]
Surgery-aortic aneurysms (EHJ 2014;25:2873)</description></item><item><title>aortic-regurgitation</title><link>https://www.physician.tw/aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortic-regurgitation/</guid><description>aortic-regurgitation [[Etiology-aortic-regurgitation]] (Circ 2006;114:422) [[Clinical-manifestations-aortic-regurgitation]] [[Physical-exam-aortic-regurgitation]] [[Classic-Eponymous-Signs-in-Chronic-AR]] (South Med J 1981;74:459) [[Diagnostic-studies-aortic-regurgitation]] [[Treatment-aortic-regurgitation]] (Lancet 2016;387:1312; Circ 2021;143:e72)</description></item><item><title>aortic-stenosis</title><link>https://www.physician.tw/aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortic-stenosis/</guid><description>aortic-stenosis [[Etiology-aortic-stenosis]] [[Clinical-manifestations-aortic-stenosis]] [[Physical-exam-aortic-stenosis]] [[Diagnostic-studies-aortic-stenosis]] [[valve-replacement]] (Circ 2021;143:e72) [[TAVI]] (transcatheter AoV implantation) (JAMA 2021;325:2480; Circ 2021;143:e72)</description></item><item><title>Aplastic anemia</title><link>https://www.physician.tw/Aplastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aplastic-anemia/</guid><description>Aplastic anemia (stem cell failure) (NEJM 2015;373:35)
Epidemiology: 2‚Äì5 cases/106/y; biphasic (major peak in adolescents, 2nd peak in elderly)</description></item><item><title>Appearance of cerebrospinal fluid</title><link>https://www.physician.tw/Appearance-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Appearance-of-cerebrospinal-fluid/</guid><description>Appearance of cerebrospinal fluid Clear and colorlessÔºöÊ≠£Â∏∏CSF TurbidÔºöÂèØËÉΩ‰ª£Ë°® WBC &amp;gt; 200 Êàñ RBC &amp;gt; 400 BloodyÔºöRBC &amp;gt; 6000 XanthochromiaÔºöCSF ‰∏≠ÁöÑ RBC ÂàÜËß£ ‚Üí ÂΩ¢Êàê oxyhemoglobin ‰Ωø CSF ËÆäÁ≤âÁ¥ÖËâ≤ ‚Üí Ë¢´ËΩâÊàê bilirubin ‰Ωø CSF ËÆäÊàêÈªÉËâ≤„ÄÇÔºàÈô§‰∫Ü SAH ‰πãÂ§ñÔºåÂú® CSF total protein &amp;gt; 150mg/dL Êàñ serum bilirubin &amp;gt; 10‚Äì15 mg/dL ÊôÇ‰πüÂèØËÉΩÁôºÁîüÔºâ</description></item><item><title>approach to abnormal hemostasis</title><link>https://www.physician.tw/approach-to-abnormal-hemostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-abnormal-hemostasis/</guid><description>approach to abnormal hemostasis (NEJM 2014;370:847)</description></item><item><title>Approach to abnormal liver tests with cholestatic pattern</title><link>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-cholestatic-pattern/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-cholestatic-pattern/</guid><description>Approach to abnormal liver tests with cholestatic pattern</description></item><item><title>Approach to abnormal liver tests with infiltrative pattern</title><link>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-infiltrative-pattern/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-infiltrative-pattern/</guid><description>Approach to abnormal liver tests with infiltrative pattern</description></item><item><title>Approach to acute AF</title><link>https://www.physician.tw/Approach-to-acute-AF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-acute-AF/</guid><description>Approach to acute AF (Adapted from Circ 2014;130:e199)
New or Recent onset atrial fibrillation Unstable: Urgent Cardioversion stable: [[Rate Control-atrial fibrillation]] Figure: [[Oral anticoagulation-atrial fibrillation]]</description></item><item><title>Approach to anemia and common causes</title><link>https://www.physician.tw/Approach-to-anemia-and-common-causes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-anemia-and-common-causes/</guid><description>Approach to anemia and common causes</description></item><item><title>Approach to Diuresis</title><link>https://www.physician.tw/Approach-to-Diuresis-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Diuresis-/</guid><description>Approach to Diuresis Loop diuretic PO: ‚úì response at 1‚Äì3 h, redose at 2√ó prior dose if needed</description></item><item><title>Approach to glomerulonephritis based on immunofluorescence pattern</title><link>https://www.physician.tw/Approach-to-glomerulonephritis-based-on-immunofluorescence-pattern/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-glomerulonephritis-based-on-immunofluorescence-pattern/</guid><description>Approach to glomerulonephritis based on immunofluorescence pattern ÁúãÂúñË™™ÊïÖ‰∫ã</description></item><item><title>Approach to hypernatremia</title><link>https://www.physician.tw/Approach-to-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-hypernatremia/</guid><description>Approach to hypernatremia</description></item><item><title>Approach to hypokalemia</title><link>https://www.physician.tw/Approach-to-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-hypokalemia/</guid><description>Approach to hypokalemia</description></item><item><title>Approach to metabolic acidosis</title><link>https://www.physician.tw/Approach-to-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-metabolic-acidosis/</guid><description>Approach to metabolic acidosis</description></item><item><title>Approach to microcytic anemias</title><link>https://www.physician.tw/Approach-to-microcytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-microcytic-anemias/</guid><description>Approach to microcytic anemias</description></item><item><title>Approach to newly diagnosed HIV positive Pt</title><link>https://www.physician.tw/Approach-to-newly-diagnosed-HIV-positive-Pt/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-newly-diagnosed-HIV-positive-Pt/</guid><description>Approach to newly diagnosed HIV positive Pt (CID 2020;73:e3572)
Counsel re: excellent prognosis w/adherence to treatment, treatment options, &amp;amp; disclosure Lab evaluation: CD4 count, HIV VL &amp;amp; genotype, CBC w/ diff.</description></item><item><title>Approach to oxygenation, hypoxemia, and hypoxemic respiratory failure</title><link>https://www.physician.tw/Approach-to-oxygenation-hypoxemia-and-hypoxemic-respiratory-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-oxygenation-hypoxemia-and-hypoxemic-respiratory-failure/</guid><description>Approach to oxygenation, hypoxemia, and hypoxemic respiratory failure Common misconceptions and mistakes Hypoxemia is a significant cause of dyspnea A cutaneous O 2 sat ‚â• 92% predicts adequate oxygenation and is the appropriate target for O 2 orders 100% O 2 suppresses respiratory drive in CO 2 retainers O 2 supplementation for patients with COPD is given to improve exercise tolerance Confusing failure of oxygen delivery to tissues, hypoxia (the job of the circulatory system) with hypoxemia, and failure to maintain an adequate Pa o 2 (the job of the respiratory system) Â∏∏Ë¶ãÁöÑË™§Ëß£ÂíåÈåØË™§ ‰ΩéÊ∞ßË°ÄÁóáÊòØÂ∞éËá¥ÂëºÂê∏Âõ∞Èõ£ÁöÑÈáçË¶ÅÂéüÂõ† ÁöÆËÜö O 2 sat ‚â• 92% È†êÁ§∫Ê∞ßÂêàÂÖÖË∂≥ÔºåÊòØ O 2 Á¥öÁöÑÂêàÈÅ©ÁõÆÊ®ô 100% O 2 ÊäëÂà∂ CO 2 ‰øùÊåÅÂô®‰∏≠ÁöÑÂëºÂê∏È©ÖÂãï ÁÇ∫ COPD ÊÇ£ËÄÖË£úÂÖÖ O 2 ‰ª•ÊèêÈ´òÈÅãÂãïËÄêÈáè Â∞áÁÑ°Ê≥ïÂêëÁµÑÁπîËº∏ÈÄÅÊ∞ßÊ∞£„ÄÅÁº∫Ê∞ßÔºàÂæ™Áí∞Á≥ªÁµ±ÁöÑÂ∑•‰ΩúÔºâËàá‰ΩéÊ∞ßË°ÄÁóá‰ª•ÂèäÁÑ°Ê≥ïÁ∂≠ÊåÅË∂≥Â§†ÁöÑ Pa o 2ÔºàÂëºÂê∏Á≥ªÁµ±ÁöÑÂ∑•‰ΩúÔºâÁõ∏Ê∑∑Ê∑Ü [[oxygenation]]</description></item><item><title>Approach to polyuria</title><link>https://www.physician.tw/Approach-to-polyuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-polyuria/</guid><description>Approach to polyuria</description></item><item><title>Approach to previously established HIV positive Pt</title><link>https://www.physician.tw/Approach-to-previously-established-HIV-positive-Pt/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-previously-established-HIV-positive-Pt/</guid><description>Approach to previously established HIV positive Pt H&amp;amp;P (mucocutaneous, neurocognitive, OIs, malignancies, STDs); meds and adherence Review ARVs (past and current); if hospitalized typically continue ARVs, if any must be held, stop all to ‚Üì risk of resistance Regimen failure: cannot achieve undetectable VL after months on ARVs, viral rebound (VL &amp;gt;200 copies/mL √ó2 after prior suppression), ‚Üì CD4 count or clinical worsening</description></item><item><title>Approach to suspected DVT</title><link>https://www.physician.tw/Approach-to-suspected-DVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-suspected-DVT/</guid><description>Approach to suspected DVT</description></item><item><title>Approach to suspected PE</title><link>https://www.physician.tw/Approach-to-suspected-PE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-suspected-PE/</guid><description>Approach to suspected PE [[simplified pulmonary embolism severity index]] ÂèÉËÄÉ‚û°Ô∏è Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism</description></item><item><title>Approach to syncope-syncope</title><link>https://www.physician.tw/Approach-to-syncope-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-syncope-syncope/</guid><description>Approach to syncope-syncope (Adapted from JACC 2017;70:e39)</description></item><item><title>Approach to thrombocytopenia</title><link>https://www.physician.tw/Approach-to-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-thrombocytopenia/</guid><description>Approach to thrombocytopenia BacklinkÔºö [[platelet disorders]]</description></item><item><title>Approach to treatment-of-hyponatremia</title><link>https://www.physician.tw/Approach-to-treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-treatment-of-hyponatremia/</guid><description>Approach to treatment-of-hyponatremia depends on volume status, acuity of hyponatremia, and if symptomatic
Acute sx: initial rapid correction of [Na]serum (2 mEq/L/h for the first 2‚Äì3 h) until sx resolve</description></item><item><title>Approach to TSH levels</title><link>https://www.physician.tw/Approach-to-TSH-levels/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-TSH-levels/</guid><description>Approach to TSH levels</description></item><item><title>Approach-electrocardiography</title><link>https://www.physician.tw/Approach-electrocardiography/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-electrocardiography/</guid><description>Approach-electrocardiography ‰∏ÄÂÄãÈÄüÂ∫¶„ÄÅÂÖ©ÂÄãÁØÄÂ•è„ÄÅ‰∏âÂÄãÈñìÈöî„ÄÅÂõõÂÄãËÖîÂÆ§„ÄÅ‰∫îÂÄãÊ¢óÂ°û
Rate tachy or brady rhythm ? P waves regularity P &amp;amp; QRS relationship ==&amp;gt; Afib or atrioventricular block Intervals PR, QRS, QT Axis LAD or RAD chamber abnormal LAA, RAA, LVH, RVH QRST changes ?</description></item><item><title>arrhythmias</title><link>https://www.physician.tw/arrhythmias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/arrhythmias/</guid><description>arrhythmias [[bradycardias av block and av dissociation]] [[supraventricular tachycardias (SVTS)]] [[accessory pathways (wolff-parkinson-white)]] [[wide-complex tachycardias (WCTS)]]</description></item><item><title>Arrhythmias post MI</title><link>https://www.physician.tw/Arrhythmias-post-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Arrhythmias-post-MI/</guid><description>Arrhythmias post MI Arrhythmias post-MI (treat all per ACLS protocols if unstable or symptomatic)
AF (10‚Äì16% incidence): Œ≤B or amio, ¬± digoxin (particularly if HF), heparin</description></item><item><title>ascites</title><link>https://www.physician.tw/ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ascites/</guid><description>ascites Due to portal HTN (defined as hepatic venous pressure gradient [HVPG] &amp;gt;5 mmHg)
Develops in 60% w/in 10 y; often first decompensating event</description></item><item><title>Ascites fluid total protein AFTP</title><link>https://www.physician.tw/Ascites-fluid-total-protein-AFTP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ascites-fluid-total-protein-AFTP/</guid><description>Ascites fluid total protein (AFTP) useful when SAAG ‚â•1.1 to distinguish cirrhosis (AFTP &amp;lt;2.5 g/dL) from cardiac ascites (AFTP ‚â•2.5 g/dL).</description></item><item><title>aseptic meningitis</title><link>https://www.physician.tw/aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aseptic-meningitis/</guid><description>aseptic meningitis Definition Clinical/lab evidence of meningeal inflammation with negative bacterial cx (CSF &amp;amp; blood)
[[Etiologies-aseptic meningitis]]</description></item><item><title>Aspergillosis</title><link>https://www.physician.tw/Aspergillosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aspergillosis/</guid><description>Aspergillosis (Lancet 2021;397:499)
ABPA: airway hypersensitivity secondary to aspergillus colonization Chronic pulmonary aspergillosis: includes aspergilloma (fungus ball), pulm. nodules, chronic cavitary and chronic fibrotic pulmonary aspergillosis that can present with subacute cough, dyspnea, hemoptysis; aspergilloma/nodules can be asymptomatic Invasive aspergillosis: seen in immunosupp.</description></item><item><title>Aspergillus flavus</title><link>https://www.physician.tw/Aspergillus-flavus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aspergillus-flavus/</guid><description>Monday 22Âπ¥7Êúà18Êó• 02:59:03
Write about Aspergillus flavus here!</description></item><item><title>Aspirin</title><link>https://www.physician.tw/Aspirin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aspirin/</guid><description>Aspirin 162‚Äì325 mg √ó 1, then 81 mg qd (non‚Äìenteric-coated, chewable) 50‚Äì70% ‚Üì D/MI (NEJM 1988;319:1105) Low dose (~81 mg) pref long term (NEJM 2010;363:930) If allergy, use clopi and/or desensitize to ASA</description></item><item><title>asthma</title><link>https://www.physician.tw/asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/asthma/</guid><description>asthma [[Definition and epidemiology]] [[Clinical manifestations]] [[Physical examination]] [[Diagnostic studies]] [[differential diagnosis]] [[differential diagnosis]] [[Asthma plus syndromes]] CHRONIC MANAGEMENT [[Reliever medications-asthma]] [[Controller medications]] [[Immunotherapies-asthma]] [[Principles of treatment-asthma]] [[Asthma Stepwise Therapy]] EXACERBATION [[Evaluation-asthma-EXACERBATION]] [[Severity of Asthma Exacerbation]] [[Initial treatment details of asthma]] [[Disposition of patients after initial treatment of asthma exacerbation]] [[ICU-level care-asthma-EXACERBATION]]</description></item><item><title>Asthma plus syndromes</title><link>https://www.physician.tw/Asthma-plus-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Asthma-plus-syndromes/</guid><description>Asthma plus syndromes Atopy = asthma + allergic rhinitis + atopic dermatitis
Aspirin-exacerbated respiratory disease (Samter‚Äôs syndrome) = asthma + ASA sensitivity + nasal polyps (J Allergy Clin Immunol 2015;135:676)</description></item><item><title>Asthma Stepwise Therapy</title><link>https://www.physician.tw/Asthma-Stepwise-Therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Asthma-Stepwise-Therapy/</guid><description>Asthma Stepwise Therapy</description></item><item><title>asymptomatic glomerular hematuria</title><link>https://www.physician.tw/asymptomatic-glomerular-hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/asymptomatic-glomerular-hematuria/</guid><description>asymptomatic glomerular hematuria Definition and etiologies Hematuria ¬± proteinuria of glomerular origin w/o renal insufficiency or systemic disease (nonglomerular more common; see ‚ÄúHematuria‚Äù) Ddx: any cause of GN (esp.</description></item><item><title>At client</title><link>https://www.physician.tw/setup/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/setup/</guid><description>[ÊïôÂ≠∏][NAS] Synology NAS SSH ÂÖçÂØÜÁ¢ºÁôªÂÖ• | Gary&amp;rsquo;s &amp;hellip;Lasamia (garynil.tw)
At client ssh-keygen at home Copy id rsa.pub file to NAS home dir via</description></item><item><title>atezolizumab</title><link>https://www.physician.tw/atezolizumab/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atezolizumab/</guid><description>‰ΩúÁî®Ê©üËΩâ AtezolizumabÊòØÂ±¨Êñº[[PD-L1]]ÁöÑÂÖçÁñ´Ê™¢Êü•ÈªûÊäëÂà∂Âäë„ÄÇTÊ∑ãÂ∑¥Á¥∞ËÉû (TÁ¥∞ËÉû)ËàáÁôåÁ¥∞ËÉû‰∏äÊúâË®±Â§öÂÖçÁñ´Ê™¢Êü•ÈªûÔºåÊúâ‰∫õÊòØ‰øÉÈÄ≤ÂÆÉÂÄëÊ¥ªÂåñÂ∞±ÂÉèË∏©Ê≤πÈñÄÔºåÊúâ‰∫õÂèçËÄåÊòØÊäëÂà∂ÂÆÉÂÄëÂ∞±ÂÉèË∏©ÁÖûËªä„ÄÇ
ÂÖ∂‰∏≠PD-L1ÊòØÂ±¨ÊñºÊäëÂà∂ÊÄßÂÖçÁñ´Ê™¢Êü•ÈªûÔºåËÄåPD-L1ÂÖçÁñ´Ê™¢Êü•ÈªûÊäëÂà∂ÂäëÂâáÊòØÊäëÂà∂PD-L1Ôºå‰πüÂ∞±ÊòØÊãøÊéâÁÖûËªäÔºåÈáçÊñ∞ÂñöÈÜíTÁ¥∞ËÉûÁôºÊèÆÂÖ∂ÊäóÁôå‰ΩúÁî®„ÄÇ
ÈÅ©ÊáâÁóá ËÇùÁ¥∞ËÉûÁôå„ÄÅÈùûÂ∞èÁ¥∞ËÉûËÇ∫Áôå„ÄÅÂ∞èÁ¥∞ËÉûËÇ∫Áôå„ÄÅÊ≥åÂ∞øÈÅì‰∏äÁöÆÁôå„ÄÅ‰∏âÈô∞ÊÄß‰π≥Áôå„ÄÅÈªëËâ≤Á¥†Á¥∞ËÉûÁò§„ÄÇ
Áî®Ê≥ïÁî®Èáè ÊØè‰∫åËá≥‰∏âÈÄ±‰∏ÄÊ¨°ÔºåÊØèÊ¨°Áµ¶‰∫à840-1200mg„ÄÇ
ÂâØ‰ΩúÁî®
Â∏∏Ë¶ã È´òË°ÄÂ£ì(17-30%)„ÄÅËÑ´È´Æ(32-56%)„ÄÅ‰æøÁßò(12-36%)„ÄÅÈ£üÊÖæÈôç‰Ωé(15-30%)„ÄÅËÖπÁÄâ(11-33%)„ÄÅÂôÅÂøÉ(12-50%)„ÄÅÈóúÁØÄÁóõ(12-26%)„ÄÅËôõÂº±(12-51%)„ÄÅÁ•ûÁ∂ìÁóÖËÆä(33-56%)„ÄÅÂí≥ÂóΩ(27%)„ÄÅÂëºÂê∏Âõ∞Èõ£(32%)„ÄÅÁñ≤ÂÄ¶(47-61%)
Âö¥Èáç ÂøÉËÇåÁÇé(1%)„ÄÅËÖé‰∏äËÖ∫ÂäüËÉΩ‰∏çÂÖ®(0.4-0.8%)„ÄÅÁ≥ñÂ∞øÁóÖ(0.1ÔºÖ)„ÄÅËÖ¶‰∏ãÂûÇÈ´îÁôºÁÇé(0.4%)„ÄÅÁî≤ÁãÄËÖ∫ÂäüËÉΩ‰∫¢ÈÄ≤(1.6ÔºÖ-19ÔºÖ)„ÄÅÁî≤ÁãÄËÖ∫ÂäüËÉΩ‰Ωé‰∏ã(4.6-22ÔºÖ)„ÄÅËÖπÈÉ®ÁñºÁóõ(10-17%)„ÄÅÂ§ßËÖ∏ÁÇé(2%)„ÄÅËÇùÁÇé(14-53%)„ÄÅÊÄ•ÊÄßËÖéÊêçÂÇ∑(2.2ÔºÖ)„ÄÅË°ÄÂ∞ø(14ÔºÖ)„ÄÅÊ≥åÂ∞øÈÅìÊÑüÊüì(22ÔºÖ)„ÄÅËÇ∫ÈÉ®ÁôºÁÇé(5.5ÔºÖ)„ÄÅÁôºÁáí(14-49ÔºÖ)„ÄÅËº∏Ê≥®ÂèçÊáâ(1.6-11ÔºÖ)</description></item><item><title>atrial fibrillation</title><link>https://www.physician.tw/atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atrial-fibrillation/</guid><description>atrial fibrillation [[Classification-atrial fibrillation]] [[Epidemiology and etiologies-atrial fibrillation]] Evaluation-atrial fibrillation H&amp;amp;P, ECG, CXR, TTE (LA size, thrombus, valves, LV fxn, pericardium), K, Mg, Cr, TFTs In acute AF &amp;lt;48¬∫, ~70% spont.</description></item><item><title>Atrial flutter</title><link>https://www.physician.tw/Atrial-flutter/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Atrial-flutter/</guid><description>Atrial flutter peice of note</description></item><item><title>Atrial-Abnormality</title><link>https://www.physician.tw/Atrial-Abnormality/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Atrial-Abnormality/</guid><description>Atrial-Abnormality ECG P-wave criteria
Left Atrial Abnormality (LAA) Right Atrial Abnormality (RAA)</description></item><item><title>ATTRACTION-3</title><link>https://www.physician.tw/ATTRACTION-3/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ATTRACTION-3/</guid><description>ATTRACTION-3 Summary Background Chemotherapy for patients with advanced oesophageal squamous cell carcinoma offers poor long-term survival prospects. We report the final analysis from our study of the immune checkpoint PD-1 inhibitor nivolumab versus chemotherapy in patients with previously treated advanced oesophageal squamous cell carcinoma.</description></item><item><title>Atypical ANCA patterns</title><link>https://www.physician.tw/Atypical-ANCA-patterns/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Atypical-ANCA-patterns/</guid><description>Atypical ANCA patterns drug-induced vasculitis, nonvasculitic rheumatic diseases, ulcerative colitis, primary sclerosing cholangitis, endocarditis, cystic fibrosis</description></item><item><title>aura</title><link>https://www.physician.tw/aura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aura/</guid><description>aura Aura is defined as transient focal neurological symptoms that usually precede, but sometimes accompany, the headache phase of a migraine attack.</description></item><item><title>Autoimmune hemolytic anemia</title><link>https://www.physician.tw/Autoimmune-hemolytic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-hemolytic-anemia/</guid><description>Autoimmune hemolytic anemia Acquired, antibody-mediated RBC destruction
Warm AIHA: IgG Abs opsonize RBCs at body temp ‚Üí removal by spleen</description></item><item><title>autoimmune hepatitis AIH</title><link>https://www.physician.tw/autoimmune-hepatitis-AIH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-hepatitis-AIH/</guid><description>autoimmune hepatitis (AIH) [[Classification-autoimmune hepatitis (AIH)]] [[Diagnosis and treatment-autoimmune hepatitis (AIH) ]]</description></item><item><title>autoimmune pancreatitis</title><link>https://www.physician.tw/autoimmune-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-pancreatitis/</guid><description>autoimmune pancreatitis Pathogenesis (Am J Gastro 2018;113:1301)
Type 1: lymphoplasmacytic sclerosing panc. w/ dense fibrosis; ‚Üë IgG4; high relapse</description></item><item><title>Autoimmune Polyglandular Syndromes</title><link>https://www.physician.tw/Autoimmune-Polyglandular-Syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-Polyglandular-Syndromes/</guid><description>Autoimmune Polyglandular Syndromes (NEJM 2018;378:1132) Type Features
I (APECED) Child onset, mucocutaneous candidiasis, hypoparathyroidism, adrenal insufficiency, AIRE mutation
II Adult onset, adrenal insufficiency, autoimmune thyroid disease, diabetes mellitus type 1; polygenic</description></item><item><title>AV Block</title><link>https://www.physician.tw/AV-Block/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AV-Block/</guid><description>AV Block (Circ 2019;140:e382) Type Features
1¬∞ Prolonged PR (&amp;gt;200 ms), all atrial impulses conducted (1:1).
2¬∞ Mobitz I (Wenckebach) Progressive ‚Üë PR until impulse not conducted (‚Üí ‚Äùgrouped beating‚Äù).</description></item><item><title>AV dissociation</title><link>https://www.physician.tw/AV-dissociation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AV-dissociation/</guid><description>AV dissociation Default: slowing of SA node allows subsidiary pacemaker (eg, AV junction) to take over Usurpation: acceleration of subsidiary pacemaker (eg, AV junctional tach, VT) 3¬∞ AV block: atrial pacemaker unable to capture ventricles, subsidiary pacemaker emerges; distinguish from isorhythmic dissociation (A ‚âà V rate, some P waves nonconducting)</description></item><item><title>Axis-deviation</title><link>https://www.physician.tw/Axis-deviation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Axis-deviation/</guid><description>Axis-deviation Left axis deviation (LAD) Definition: axis beyond ‚Äì30¬∞ (S &amp;gt;R in lead II)
Etiologies: LVH, LBBB, inferior MI, WPW</description></item><item><title>back pain</title><link>https://www.physician.tw/back-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/back-pain/</guid><description>Back pain [[differential diagnosis of back pain]] Lancet 2017;389:736 &amp;amp; Continuum 2021;27:12
initial [[evaluation of back and spinal cord disease]] [[differential diagnosis of back pain]] [[History taking of back and spinal cord disease]] [[general physical exam of back pain]]: [[signs of radiculopathy]] (sharp/lancinating pain radiating into limb): Neurogenic claudication in lumbar stenosis (see table on next page) [[Neuro exam of back and spinal cord disease]] [[Red flags of back and spinal cord disease]]: [[Laboratory of back and spinal cord disease]] Neuroimaging: low yield if nonradiating pain, high false ‚äï rate (incidental spondylosis); depending on suspicion: X-rays, CT or CT myelography, MRI, bone scan EMG/NCS: may be useful to distinguish root/plexopathies from peripheral neuropathies</description></item><item><title>Background of vasculitis</title><link>https://www.physician.tw/Background-of-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Background-of-vasculitis/</guid><description>Background of vasculitis [Vasculitis Pathophysiology Overview - YouTube]( https://www.youtube.com/watch?v=D9h6-LPySPI&amp;ab channel=ArmandoHasudungan) [Vasculitis | Clinical Presentation - YouTube]( https://www.youtube.com/watch?v=VfdeBT7e-dc&amp;ab channel=Medscape) Classified by size of predominant vessel affected (Arthritis Rheum 2013;65:1); overlap of vessel size affected is common Áúã‰∏Ä‰∏ãÈÄôÂºµÂúñÔºö ÊúâÂæàÂ§öÈÉ®ÂàÜÊúÉÈáçÁñäÔºöÊ≥®ÊÑèÊòØÊâÄÊúâÁ®ÆÁöÑÈÉΩÊúÉÂΩ±ÈüøÂà∞Â§ß‰∏≠Â∞èÔºåÊâÄ‰ª•‰∏çËÉΩÊéíÈô§ Clinical manifestations based on size of vessels involved; specific symptom constitutional sx (low-grade fever, fatigue, weight loss, myalgias, anorexia) common to all from inflammatory response Vasculitis is typically divided into 2 main categories: primary (idiopathic) secondary, caused by an underlying condition, such as an autoimmune process, infection, a neoplastic process, or certain medications Vasculitis can occur in any vessel type in any organ system of the body.</description></item><item><title>bacteremia</title><link>https://www.physician.tw/bacteremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacteremia/</guid><description>bacteremia [[definitions of bacteremia]] Diagnosis ‚â•2 sets BCx prior to abx (set = aerobic + aneaerobic cx) at separate puncture sites If proven bacteremia, daily surveillance cxs until 48 hrs of ‚äñ cxs.</description></item><item><title>bacteremia and endocarditis</title><link>https://www.physician.tw/bacteremia-and-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacteremia-and-endocarditis/</guid><description>bacteremia and endocarditis [[bacteremia]] [[bacterial endocarditis]] [[infective endocarditis]] BacklinkÔºö [[infectious disease]]</description></item><item><title>bacterial endocarditis</title><link>https://www.physician.tw/bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacterial-endocarditis/</guid><description>bacterial endocarditis Definition Infection of endothelium of heart (including but not limited to the valves) including both prosthetic valve endocarditis (PVE) and [[native valve endocarditis]] (NVE) [[Risk Factors-bacterial endocarditis]] Fungal: ‚Üë risk w/ DM, indwelling lines, immunosupp.</description></item><item><title>Bacterial peritonitis</title><link>https://www.physician.tw/Bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bacterial-peritonitis/</guid><description>Bacterial peritonitis (Gut 2012;61:297; Hepatology 2021;74:1014)
‚äï Ascites Culture Ascites PMN‚â•250/¬µL [[Spontaneous bacterial peritonitis (SBP)]] [[secondary bacterial peritonitis]] Ascites PMN&amp;lt;250/¬µL [[Nonneutrocytic bacterascites (NNBA)]] ‚äñ Ascites Culture Ascites PMN‚â•250/¬µL [[Culture-negative neutrocytic ascites (CNNA)]] [[Peritoneal dialysis-associated-Bacterial peritonitis]]</description></item><item><title>bag and mask ventilation</title><link>https://www.physician.tw/bag-and-mask-ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bag-and-mask-ventilation/</guid><description>bag and mask ventilation ‚ú®ÈáçÈªû: Âà∞ÁõÆÂâçÁÇ∫Ê≠¢Ôºå‰ΩøÁî®Ë¢ãÂ≠êÂíåÁΩ©ÁÇ∫ÊÇ£ËÄÖÈÄöÊ∞£ÁöÑËÉΩÂäõÊòØ‰ªª‰ΩïÊ∞£ÈÅìÊèê‰æõËÄÖÊéåÊè°ÁöÑÊúÄÈáçË¶ÅÁöÑÊäÄËÉΩ„ÄÇ Â¶ÇÊûúÂèØ‰ª•ÈÄ≤Ë°åÈù¢ÁΩ©ÈÄöÊ∞£ÔºåÂâáÁÑ°Ê≥ïÈÄ≤Ë°åÊ∞£ÁÆ°ÊèíÁÆ°‰∏¶‰∏çËá¥ÂëΩÔºåÈÄô‰ΩøÂÖ∂ÊàêÁÇ∫ ASA Âõ∞Èõ£Ê∞£ÈÅìÁÆóÊ≥ïÁöÑÈáçË¶ÅÁµÑÊàêÈÉ®ÂàÜ„ÄÇ Èù¢ÁΩ©ÈÄöÊ∞£ÁöÑÁõ∏Â∞çÁ¶ÅÂøåÁóáÊòØÈ£ΩËÖπ/ÂèçÊµÅÈ¢®Èö™„ÄÅÂö¥ÈáçÁöÑÈù¢ÈÉ®ÂâµÂÇ∑Âíå‰∏çÁ©©ÂÆöÁöÑÈ†∏Ê§éÈ™®Êäò„ÄÇ ÈÄ≤Ë°åÈù¢ÁΩ©ÈÄöÊ∞£ÊôÇÔºåÊèê‰æõËÄÖÂ∑¶ÊâãÊãøËëóÈù¢ÁΩ©ÔºåÂ∞áÈù¢ÁΩ©ÊîæÂú®ÊÇ£ËÄÖÁöÑÈºªÂ≠êÂíåÂò¥Â∑¥‰∏äÔºåÁ¨¨‰∏â„ÄÅÁ¨¨ÂõõÂíåÁ¨¨‰∫îÊ†πÊâãÊåáÊè°‰Ωè‰∏ãÈ†úÈ™®ÔºåÂ∞áÈù¢ÈÉ®Êä¨ÂÖ•Èù¢ÁΩ©Ôºå ÂêåÊôÇÊãáÊåáÂíåÈ£üÊåáÂú®Èù†ËøëÈõªË∑ØÈÄ£Êé•ÁöÑÈù¢ÁΩ©ÁöÑÈ†òÂè£Âë®ÂúçÂΩ¢Êàê‰∏ÄÂÄã‚ÄúC‚ÄùÂΩ¢„ÄÇ Áï∂Ë¢ãÂ≠êË¢´Êì†Â£ìÊôÇÔºåÊáâË©≤Ê≥®ÊÑèÂà∞ËÉ∏ÁΩ©‰∏äÂçáÂíåÂÜ∑ÂáùÔºå‰∏¶‰∏îÊáâË©≤ËÅΩÂà∞Ê≤íÊúâÁ©∫Ê∞£ÈÄ∏Âá∫ÔºåÈÄôË°®ÊòéÁî±ÊñºÂØÜÂ∞Å‰∏çË∂≥ËÄåÂ∞éËá¥Ê¥©Êºè„ÄÇ ÊáâÊ≥®ÊÑè‰∏çË¶ÅÂ£ìËø´‰∏ãÈ†ú‰∏ãÁµÑÁπîÔºåÂõ†ÁÇ∫ÈÄôÊúÉ‰ΩøÊ∞£ÈÅìÂ°åÈô∑‰∏¶‰ΩøÈÄöÊ∞£Êõ¥Âä†Âõ∞Èõ£„ÄÇ Â¶ÇÊûúÈù¢ÁΩ©ÈÄöÊ∞£Âõ∞Èõ£ÔºåÂèØ‰ª•Êé°Áî®ÈõôÊâãÊäÄË°ìÔºåÂÖ∂‰∏≠‰∏ÄÂêçÊèê‰æõËÄÖÈõôÊâãÊè°‰ΩèÈù¢ÁΩ©ÔºåÊãáÊåáÊîæÂú®Èù¢ÁΩ©È†ÇÈÉ®ÔºåÂÖ∂È§òÊâãÊåáÊîæÂú®‰∏ãÈ†úÈ™®‰∏äÔºåÂ∞áÈù¢ÈÉ®Êä¨ÂÖ•Èù¢ÁΩ©ÔºåÂêåÊôÇÂä©ÊâãÊì†Â£ìË¢ãÂ≠ê. Âè£ËÖîÂíåÈºªËÖîÊ∞£ÈÅì‰πüÂæàÊúâÁî®ÔºåÂõ†ÁÇ∫ÂÆÉÂÄëÂ∞áËàåÈ†≠ÂíåÊúÉÂé≠ÊãâÈõ¢ÂíΩÂæåÂ£ÅÔºåÂæûËÄåÂÖÅË®±Êõ¥Â§öÁöÑÊ∞£ÊµÅ„ÄÇ</description></item><item><title>Barrett‚Äôs esophagitis</title><link>https://www.physician.tw/Barretts-esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Barretts-esophagitis/</guid><description>Barrett‚Äôs esophagitis (BE): metaplastic columnar mucosa above GE jxn replaces squam epithel. Screen if chronic (&amp;gt;5 y) and/or frequent GERD (‚â•1/wk) in ‚ôÇ w/ ‚â•2 risk factor for Barrett‚Äôs/esophageal adeno: &amp;gt;50 y, white, hiatal hernia, central adiposity, smoking, FHx of Barrett‚Äôs/esophageal adeno.</description></item><item><title>basic techniques and procedures</title><link>https://www.physician.tw/basic-techniques-and-procedures/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basic-techniques-and-procedures/</guid><description>basic techniques and procedures [[Airway-Management]] [[Sedation-and-Analgesia]] [[Vascular-Access]] [[POCUS]] [[bedside percutaneous dilational tracheostomy]] [[Nutritional Support and Total Parenteral Nutrition]] [[Glycemic Control in intensive care unit]] [[Hyperglycemic Emergencies]] [[Prevention of Complications in intensive care unit]] [[pain and palliative care]] [[bronchoscopy]]</description></item><item><title>basophilia</title><link>https://www.physician.tw/basophilia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basophilia/</guid><description>basophilia Neoplasm MPN, CML, AML, Hodgkin lymph.
Infection TB, smallpox, parasites
Alteration in BM or reticuloendothelial compartment Hemolytic anemia, splenectomy</description></item><item><title>begins</title><link>https://www.physician.tw/begins/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/begins/</guid><description>begins [[zettle]]
BacklinkÔºö [[Clinical manifestations-cholelithiasis]] [[Clinical-manifestations-aortic-regurgitation]] [[Clinical-manifestations-mitral-regurgitation]]</description></item><item><title>Beh√ßet‚Äôs syndrome</title><link>https://www.physician.tw/Beh%C3%A7ets-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Beh%C3%A7ets-syndrome/</guid><description>Beh√ßet‚Äôs syndrome (Nat Rev Dis Primers 2021;7:67)
Systemic vasculitis affecting all vessel sizes, venous and arterial, a/w painful oral and/or genital ulcers Epi: usually young adults (25‚Äì35 y); ‚ôÇ = ‚ôÄ, ‚Üë severity in ‚ôÇ; a/w HLA-B51; ‚Üë prev on old Silk Road (Turkey, Middle East, Asia) w/ 5 vs.</description></item><item><title>Bell‚Äôs palsy</title><link>https://www.physician.tw/Bells-palsy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bells-palsy/</guid><description>Bell‚Äôs palsy Definition &amp;amp; clinical manifestations
Acute idiopathic unilat. facial nerve palsy (CN VII), often presumed HSV reactivation P/w unilateral facial muscle weakness, hyperacusis, ‚Üì taste, lacrimation, &amp;amp; salivation Risk factors: pregnancy (preeclampsia), obesity, HTN, diabetes, preceding URI Diagnosis (Otol Head Neck Surg 2013;149:656)</description></item><item><title>Benzodiazepines-toxicology</title><link>https://www.physician.tw/Benzodiazepines-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Benzodiazepines-toxicology/</guid><description>Benzodiazepines-toxicology ‚Üì mentation, ataxia, ‚Üì RR
Flumazenil not rec (can precipitate withdrawal/seizures)</description></item><item><title>Beta blockers-toxicology</title><link>https://www.physician.tw/Beta-blockers-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Beta-blockers-toxicology/</guid><description>Beta blockers-toxicology Bradycardia, AV block, hypotension, HF, hypoglycemia
Glucagon, vasopressors, pacing</description></item><item><title>bevacizumab</title><link>https://www.physician.tw/bevacizumab/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bevacizumab/</guid><description>bevacizumab Avastin¬ÆÔºõÁôåÊÄùÂÅú¬ÆÊ≥®Â∞ÑÂäë„ÄÇ
ËΩâÁßªÊÄßÂ§ßËÖ∏Áõ¥ËÖ∏Áôå(mCRC) Avastin¬Æ(bevacizumab) ËàáÂê´Êúâ5-fluorouracilÁÇ∫Âü∫Á§éÁöÑÂåñÂ≠∏ÁôÇÊ≥ïÂêà‰Ωµ‰ΩøÁî®ÔºåÂèØ‰ª•‰ΩúÁÇ∫ËΩâÁßªÊÄßÂ§ßËÖ∏ÊàñÁõ¥ËÖ∏ÁôåÁóÖ‰∫∫ÁöÑÁ¨¨‰∏ÄÁ∑öÊ≤ªÁôÇ„ÄÇ
Avastin¬ÆËàáÂê´Êúâ5-fluorouracil/leucovorin/oxaliplatinÁöÑÂåñÂ≠∏ÁôÇÊ≥ïÂêà‰Ωµ‰ΩøÁî®ÔºåÂèØ‰ª•‰ΩúÁÇ∫ÂÖàÂâçÊé•ÂèóÈÅé‰ª•fluoropyrimidineÁÇ∫Âü∫Á§éÁöÑÂåñÂ≠∏ÁôÇÊ≥ïÁÑ°Êïà‰∏îÊú™ÊõæÊé•ÂèóÈÅéAvastin¬ÆÊ≤ªÁôÇÁöÑËΩâÁßªÊÄßÂ§ßËÖ∏ÊàñÁõ¥ËÖ∏ÁôåÁóÖ‰∫∫ÁöÑÊ≤ªÁôÇ„ÄÇ
Avastin (bevacizumab)ËàáÂê´Êúâfluoropyrimidine-irinotecan-Êàñfluoropyrimidine-oxaliplatin-ÁÇ∫Âü∫Á§éÁöÑÂåñÂ≠∏ÁôÇÊ≥ïÂêà‰Ωµ‰ΩøÁî®ÔºåÂèØ‰ª•ÂÅöÁÇ∫Á¨¨‰∏ÄÁ∑öÂ∑≤Êé•ÂèóÈÅé‰ª•Avastin ‰ΩµÁî®ÂåñÁôÇÂæåÊÉ°Âåñ‰πãËΩâÁßªÊÄßÂ§ßËÖ∏ÊàñÁõ¥ËÖ∏ÁôåÁóÖ‰∫∫ÁöÑÁ¨¨‰∫åÁ∑öÊ≤ªÁôÇ„ÄÇ
Ë™™Êòé: Avastin (bevacizumab) ‰∏çÈÅ©Áî®ÊñºÈ´òÈ¢®Èö™ÁöÑ‰∫åÊúü‰ª•Âèä‰∏âÊúüÂ§ßËÖ∏ÁôåËºîÂä©ÊÄßÁôÇÊ≥ï (high risk stage II and III adjuvant colon cancer; aCC)</description></item><item><title>biliary tract disease</title><link>https://www.physician.tw/biliary-tract-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/biliary-tract-disease/</guid><description>biliary tract disease [[cholelithiasis]] [[cholecystitis]] [[choledocholithiasis]] [[cholangitis]] BacklinkÔºö [[Disorders of the Gastrointestinal System]] [[Etiologies-cirrhosis]] [[gastroenterology]]</description></item><item><title>Biologics</title><link>https://www.physician.tw/Biologics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Biologics/</guid><description>Biologics (eg, TNF inhibitors, anti-B- cell Rx; ‚úì for TB before starting) Bacteria: sepsis, septic arthritis, TB, NTM, Listeria, Legionella Fungi: Pneumocystis, Histo, Coccidio, Aspergillus, endemic fungi Viruses: JC virus (PML), EBV, HSV, VZV, HBV Parasites: Strongyloides reactivation</description></item><item><title>Bioprosthetic</title><link>https://www.physician.tw/Bioprosthetic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bioprosthetic/</guid><description>Bioprosthetic Bovine pericardial or porcine heterograft (eg, Carpentier-Edwards), homograft Less durable, but min. thrombogenic; consider if &amp;gt;~65 y, lifespan &amp;lt;20 y, or √ò anticoag If 50‚Äì69 y, 2√ó reop but ¬Ω bleeding or stroke vs.</description></item><item><title>Blastomycosis</title><link>https://www.physician.tw/Blastomycosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blastomycosis/</guid><description>Blastomycosis (CID 2008;46:1801)
Epidemiology endemic to the eastern ¬Ω of U.S. Clinical manifestations Acute: PNA w/o hilar LAN that can progress to ARDS Chronic: cough + ‚ÄúB‚Äù sx, fibronodular infiltrates, masses ¬± cavitary lesions (Ddx TB, histo) Disseminated (seen in immunosupp.</description></item><item><title>Bleeding Treatment for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/Bleeding-Treatment-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bleeding-Treatment-for-idiopathic-thrombocytopenic-purpura/</guid><description>Bleeding Treatment for idiopathic thrombocytopenic purpura Aminocaproic acid Inhibits plasmin activation
Methylprednisolone 1 g/d IV √ó 3 d See above</description></item><item><title>Blood Products and Indications</title><link>https://www.physician.tw/Blood-Products-and-Indications-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blood-Products-and-Indications-/</guid><description/></item><item><title>BP control in chronic kidney disease</title><link>https://www.physician.tw/BP-control-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BP-control-in-chronic-kidney-disease/</guid><description>BP control in chronic kidney disease goal ideally &amp;lt;120/80, a/w ‚Üì mortality. ACEI or ARB, not both. For outPts, ‚úì Cr &amp;amp; K in 1‚Äì2 wk, d/c if Cr ‚Üë 30% or K &amp;gt;5.</description></item><item><title>bradycardias av block and av dissociation</title><link>https://www.physician.tw/bradycardias-av-block-and-av-dissociation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bradycardias-av-block-and-av-dissociation/</guid><description>bradycardias av block and av dissociation [[Sinus bradycardia]] [[Tachycardia-bradycardia (‚Äútachy-brady‚Äù) syndrome]] [[AV Block]] [[AV dissociation]] [[Temporary pacing wires]]</description></item><item><title>Broad categories-interstitial lung disease</title><link>https://www.physician.tw/Broad-categories-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Broad-categories-interstitial-lung-disease/</guid><description>Broad categories-interstitial lung disease (1) Sarcoid; (2) Exposures (eg, drugs, XRT, organic &amp;amp; inorganic dusts, vaping);
(3) Collagen vasc dis (eg, scleroderma, ANCA, myositis, RA); (4) Idiopathic PNAs (qv)</description></item><item><title>bronchiectasis</title><link>https://www.physician.tw/bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bronchiectasis/</guid><description>bronchiectasis [[Definition and epidemiology-bronchiectasis]] [[Initial workup-bronchiectasis]] [[Treatment-bronchiectasis]] [[Non-tuberculous mycobacterium-bronchiectasis]]</description></item><item><title>Bronchodilators</title><link>https://www.physician.tw/Bronchodilators/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bronchodilators/</guid><description>Bronchodilators (1st-line): long-acting muscarinic antag (LAMA), Œ≤2-agonists (LABA) LAMA (eg, tiotropium): ‚Üì exacerb, slows ‚Üì FEV1, ‚Üì admit, ‚Üì resp failure; better than [[ipratropium]] or LABA (NEJM 2008;359:1543; 2011;364:1093; 2017;377:923)</description></item><item><title>Budd-Chiari syndrome</title><link>https://www.physician.tw/Budd-Chiari-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Budd-Chiari-syndrome/</guid><description>Budd-Chiari syndrome (World J Hepatol 2016;8:691)
Ë©≥Ë¶ã Redefining Budd-Chiari syndrome: A systematic review.
[[introduction of Budd-Chiari syndrome]]</description></item><item><title>Bundle-Branch-Blocks</title><link>https://www.physician.tw/Bundle-Branch-Blocks/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bundle-Branch-Blocks/</guid><description>Bundle-Branch-Blocks (Circ 2009;119:e235)
ÂèÉËÄÉ‚û°Ô∏è AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific¬†‚Ä¶</description></item><item><title>buy mac</title><link>https://www.physician.tw/buy-mac/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/buy-mac/</guid><description>M1 256GB 16GB with AirPods 2 NT$33,200
M2 512GB 8G with AirPods 2 NT$43,900
M2 512GB 16GB with AirPod 2 NT$49,300</description></item><item><title>C5-9 deficiency</title><link>https://www.physician.tw/C5-9-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/C5-9-deficiency/</guid><description>C5-9 deficiency Terminal complement pathway deficiency is a genetic condition affecting the complement membrane attack complex (MAC)
Suspect terminal complement pathway deficiency with patients who have more than one episode of Neisseria infection.</description></item><item><title>Calciphylaxis</title><link>https://www.physician.tw/Calciphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calciphylaxis/</guid><description>Calciphylaxis calcific uremic arteriopathy, NEJM 2018;378:1704)
Ë©≥Ë¶ã Calciphylaxis.
Pathophys: calcification of media in dermal small- to med-sized blood vessels &amp;amp; SC fat ‚Üí ischemia and skin necrosis w/ painful lesions (NEJM 2007;356:1049)</description></item><item><title>Calcitriol</title><link>https://www.physician.tw/Calcitriol/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcitriol/</guid><description>Calcitriol [Calcitriol (1, 25-OH Vitamin D3) | KFSYSCC Formulary]( https://www.unboundmedicine.com/ucentral/view/KFSYSCC%20Formulary/2236448/all/Calcitriol 1 25 OH Vitamin D3 ?q=D3)
Hypocalcemia: Dialysis patients: Adults: initially, 0.</description></item><item><title>Calcium channel blockers-toxicology</title><link>https://www.physician.tw/Calcium-channel-blockers-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium-channel-blockers-toxicology/</guid><description>Calcium channel blockers-toxicology Bradycardia, AV block, hypotension, HF, hyperglycemia
IVF, vasopressors, Ca infusion, hyperinsulinemic euglycemia,
? intralipid emulsion, pacing</description></item><item><title>calcium disorders</title><link>https://www.physician.tw/calcium-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/calcium-disorders/</guid><description>calcium disorders [[Calcium homeostasis in normal humans]] [[Laboratory Findings in Calcium Disorders]] [[Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor]].</description></item><item><title>Cameron‚Äôs lesions</title><link>https://www.physician.tw/Camerons-lesions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Camerons-lesions/</guid><description>Cameron‚Äôs lesions Linear erosions in hiatal hernia due to mech trauma of diaphragm</description></item><item><title>Cancer screening of inflammatory bowel disease</title><link>https://www.physician.tw/Cancer-screening-of-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cancer-screening-of-inflammatory-bowel-disease/</guid><description>Cancer screening of inflammatory bowel disease (NEJM 2015;372:1441)
Colon cancer: risk in UC ~2% at 10 y, ~8% at 20 y, ~18% at 30 y.</description></item><item><title>cancer survivorship</title><link>https://www.physician.tw/cancer-survivorship/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-survivorship/</guid><description>cancer survivorship</description></item><item><title>Candida species</title><link>https://www.physician.tw/Candida-species/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Candida-species/</guid><description>Candida species Microbiology: normal GI flora; C. albicans &amp;amp; nonalbicans spp. Epidemiology: neutropenia, immunosupp., broad-spectrum abx, intravascular catheters (esp. if TPN), IVDU, abd surgery, DM, renal failure, age &amp;gt;65 [[Clinical manifestations-Candida species]] [[Treatment-Candida species]] (CID 2016;62:409) ***(())</description></item><item><title>Cangrelor</title><link>https://www.physician.tw/Cangrelor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cangrelor/</guid><description>Cangrelor Only IV P2Y12 inhibitor Rapid onset/offset; t¬Ω 3‚Äì5 min 22% ‚Üì CV events (mostly peri-PCI MI and stent thrombosis) vs.</description></item><item><title>CAPT-resistant GNB</title><link>https://www.physician.tw/CAPT-resistant-GNB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CAPT-resistant-GNB/</guid><description>CAPT-resistant GNB Gram-negative bacteria (GNB) co-resistant to carbapanems, aminoglycosides, polymyxins and tigecycline (CAPT-resistant) Treatment options for K. pneumoniae, P.</description></item><item><title>CAR-T-Toxicity</title><link>https://www.physician.tw/CAR-T-Toxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CAR-T-Toxicity/</guid><description>CAR-T-Toxicity Toxicities Cytokine release syndrome (CRS): fever, HoTN, shock secondary to overwhelming cytokine release from proliferating T cells Immune effector cell-associated neurotoxicitiy synd.</description></item><item><title>Carbon monoxide-toxicology</title><link>https://www.physician.tw/Carbon-monoxide-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Carbon-monoxide-toxicology/</guid><description>Carbon monoxide-toxicology HA, dizziness, nausea, ŒîMS
carboxyHb level, CO-oximetry
100% normobaric oxygen, hyperbaric O2 in severe cases</description></item><item><title>Cardiac conditions-Endocarditis Prophylaxis</title><link>https://www.physician.tw/Cardiac-conditions-Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-conditions-Endocarditis-Prophylaxis/</guid><description>Cardiac conditions-Endocarditis Prophylaxis Prosthetic valve; previous endocarditis; congenital heart disease (CHD) including unrepaired or incompletely repaired cyanotic CHD (palliative shunts or conduits), 1st 6 mo after completely repaired CHD using prosthetic material; cardiac transplant recipients w/ valvulopathy.</description></item><item><title>Cardiac output PA catheter and tailored therapy</title><link>https://www.physician.tw/Cardiac-output-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-output-PA-catheter-and-tailored-therapy/</guid><description>Cardiac output PA catheter and tailored therapy Thermodilution: saline injected in RA or intermittent heating of prox thermal filament in some PA lines (‚Äúcontinuous CO‚Äù).</description></item><item><title>Cardiac resynch therapy (CRT) Biventricular BiV pacing</title><link>https://www.physician.tw/Cardiac-resynch-therapy-CRT-Biventricular-BiV-pacing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-resynch-therapy-CRT-Biventricular-BiV-pacing/</guid><description>Cardiac resynch therapy (CRT) Biventricular (BiV) pacing (JACC 2013;61:e6)
3-lead pacemaker (RA, RV, coronary sinus to LV); R &amp;gt;S in V1 suggests approp LV capture Synch LV fxn (‚Üë CO/EF, ‚Üì adv remodeling); ‚Üì HF sx &amp;amp; hosp, ‚Üë survival (NEJM 2010;363:2385) Indications: LVEF ‚â§35% + NYHA II‚ÄìIV despite med Rx + SR + LBBB ‚â•150 ms (also reasonable if LBBB ‚â•120 ms, any non-LBBB ‚â•150 ms, or &amp;gt;40% V-pacing); mort.</description></item><item><title>cardiac rhythm management devices</title><link>https://www.physician.tw/cardiac-rhythm-management-devices/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiac-rhythm-management-devices/</guid><description>cardiac rhythm management devices [[Pacemaker Code]] [[Common Pacing Modes]] [[Indications for Permanent Pacing]] [[Pacemaker Complications]] [[Cardiac resynch therapy (CRT) Biventricular (BiV) pacing]] [[Implantable cardiac defibrillator (ICD)]] [[Device infection]]</description></item><item><title>cardiac risk assessment for noncardiac surgery</title><link>https://www.physician.tw/cardiac-risk-assessment-for-noncardiac-surgery/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiac-risk-assessment-for-noncardiac-surgery/</guid><description>cardiac risk assessment for noncardiac surgery [[Preoperative evaluation]] [[Approach to preop CV eval for non-CV surgery]] [[Noninvasive Testing Result-cardiac risk assessment for noncardiac surgery]]</description></item><item><title>Cardiac-resynch-therapy</title><link>https://www.physician.tw/Cardiac-resynch-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-resynch-therapy/</guid><description>Cardiac-resynch-therapy Consider if EF ‚â§35%, LBBB (QRS ‚â•130 ms) and symptomatic HF
36% ‚Üì mort. &amp;amp; ‚Üë EF in NYHA III‚ÄìIV (CARE-HF, NEJM 2005;352:1539)</description></item><item><title>Cardiogenic shock</title><link>https://www.physician.tw/Cardiogenic-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiogenic-shock/</guid><description>Cardiogenic shock Myocardial infarction
Myocarditis
Arrhythmia
Valvular
Severe aortic valve insufficiency
Severe mitral valve insufficiency</description></item><item><title>cardiology</title><link>https://www.physician.tw/cardiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiology/</guid><description>cardiology ÂøÉË∑≥‰∏çÈΩäÔºåË°ÄÁÆ°ÁãπÁ™ÑÔºå ÁóÖÁóáÂ§öÁ´ØÔºåÈúÄÈ´òÊòé„ÄÇ Á∂ìÁµ°Áõ∏ÈÄöÔºåÈ´îÂÖßÈÅãË°åÔºå ÁóÖËãóÊªãÈï∑ÔºåËã¶Èõ£Â§ö„ÄÇ
[[electrocardiography]] [[chest pain]] [[noninvasive evaluation of CAD]] [[coronary angiography PCI]] [[stable ischemic heart disease]] [[acute coronary syndromes]] [[PA catheter and tailored therapy]] [[heart failure]] [[cardiomyopathies]] [[valvular heart disease]] [[pericardial disease]] [[hypertension]] [[aortic aneurysms]] [[acute aortic syndromes]] [[arrhythmias]] [[atrial fibrillation]] [[syncope]] [[cardiac rhythm management devices]] [[cardiac risk assessment for noncardiac surgery]] [[peripheral artery disease]] Additional topics Coronary Artery Disease (CAD) and Acute Coronary Syndrome (ACS) Congestive Heart Failure (CHF) Arrhythmias Valvular Disease Pericardial Disease and Myocarditis Other topics related to cardiology are covered in the following rotation guides: Hypertension, Hypercholesterolemia (Ambulatory Care)</description></item><item><title>cardiomyopathies</title><link>https://www.physician.tw/cardiomyopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiomyopathies/</guid><description>cardiomyopathies Diseases with mechanical and/or electrical dysfunction of the myocardium
[[dilated cardiomyopathy]] (DCM) [[myocarditis]] [[hypertrophic cardiomyopathy]] (HCM) [[restrictive and infiltrative cardiomyopathy]]</description></item><item><title>Cardiorenal syndrome</title><link>https://www.physician.tw/Cardiorenal-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiorenal-syndrome/</guid><description>Cardiorenal syndrome (CJASN 2017;12:1624)
Multifactorial pathophys including: ‚Üì CO, ‚Üë renal venous congestion, ‚Üë RAAS Bidirectionality: acute CHF ‚Üí AKI, and oliguric AKI can worsen CHF (JACC 2008;52:1527) Rx IV loop diuretics (bypass gut edema; dosing below) no diff.</description></item><item><title>cardiovascular critical care</title><link>https://www.physician.tw/cardiovascular-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiovascular-critical-care/</guid><description>cardiovascular critical care [[hemodynamic monitoring]] [[vasoactive drugs]] [[mechanical circulatory support]] [[cardiac arrhythmias]] [[Shock-Syndromes]] [[Cardiac-Arrest]]</description></item><item><title>Cardiovascular-complications of HIV AIDS</title><link>https://www.physician.tw/Cardiovascular-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiovascular-complications-of-HIV-AIDS/</guid><description>Cardiovascular-complications of HIV AIDS Higher rates of CAD, stroke, VTE, dilated CMP; pulm. HTN; pericarditis/effusion</description></item><item><title>Cardioversion</title><link>https://www.physician.tw/Cardioversion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardioversion/</guid><description>Cardioversion [[consider cardioversion if]] If AF &amp;gt;48 h 2‚Äì5% risk stroke w/ cardioversion (pharmacologic or electric) ‚à¥ either TEE to r/o thrombus or ensure therapeutic anticoagulation ‚â•3 wk prior If needs to cardiovert urgently, often anticoagulate acutely (eg, IV UFH) For AF &amp;lt;36 hrs, no Œî in % in SR at 4 wks w/ early cardioversion vs.</description></item><item><title>cardioversion of ACLS Tachycardia Algorithm</title><link>https://www.physician.tw/cardioversion-of-ACLS-Tachycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardioversion-of-ACLS-Tachycardia-Algorithm/</guid><description>cardioversion of ACLS Tachycardia Algorithm Ancillary equipment O2 sat monitor suction, IV line intubation equipment Premedicate call anesthesia service midazolam 1-5 mg fentanyl 100-300 mcg Synch cardioversion 100J ÈõôÂêë Ë∂äÂä†Ë∂äÂ§ß Â∞èÈ∫ª 50-200 J biphasic 100-200 J monophasic</description></item><item><title>Cat bite</title><link>https://www.physician.tw/Cat-bite/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cat-bite/</guid><description>Cat bite *Cat scratch disease caused by Bartonella acquired via cat scratch or bite. Results in lymphadenitis.
Pasturella spp Rapid onset erythema, swelling, lymphangitis, fever Amox/clav</description></item><item><title>Categories-diabetes mellitus</title><link>https://www.physician.tw/Categories-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Categories-diabetes-mellitus/</guid><description>Categories-diabetes mellitus [[type 1 diabetes mellitus]]
Type 2 (Lancet 2017;389:2239): insulin resistance + relative insulin ‚Üì; prevalence 6%; onset generally later in life; no HLA assoc.</description></item><item><title>Causes of Hemolytic Anemia by Mechanism</title><link>https://www.physician.tw/Causes-of-Hemolytic-Anemia-by-Mechanism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Causes-of-Hemolytic-Anemia-by-Mechanism/</guid><description>Causes of Hemolytic Anemia by Mechanism (Lancet 2000;355:1169 &amp;amp; 1260)
Intrinsic Enzyme deficiency G6PD deficiency Hemoglobinopathies Sickle cell anemia, thalassemia Membrane abnormalities Hereditary spherocytosis PNH, spur cell anemia in liver Extrinsic-Acquired Immune-mediated Autoimmune; drug-induced, tx rxn Traumatic MAHA; prostheses (valves, TIPS) Direct infections, toxins Malaria, babesiosis; snake &amp;amp; spider venoms; Wilson‚Äôs; hypotonic infusions Entrapment Hypersplenism</description></item><item><title>Causes of low Mg</title><link>https://www.physician.tw/Causes-of-low-Mg/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Causes-of-low-Mg/</guid><description>Causes of low Mg hypomagnesemia
GI loss (diarrhea, bypass, pancreatitis, malnutrition, PPI)
renal loss (diuretics, nephrotoxic drugs, EtOH, ‚Üë Ca, 1¬∞ wasting syndromes, volume expansion)</description></item><item><title>Causes of Shock Classified by Mechanism and Hemodynamics</title><link>https://www.physician.tw/Causes-of-Shock-Classified-by-Mechanism-and-Hemodynamics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Causes-of-Shock-Classified-by-Mechanism-and-Hemodynamics/</guid><description>Causes of Shock Classified by Mechanism and Hemodynamics ÂàÜÈ°û [[Distributive shock]] [[Hypovolemic shock]] [[Obstructive shock]] [[Cardiogenic shock]]
Shown is an algorithm for the initial assessment of a patient in shock (Panel A), relative frequencies of the main types of shock (Panel B), and schematic representations of the four main types of shock (Panel C).</description></item><item><title>Celiac disease</title><link>https://www.physician.tw/Celiac-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Celiac-disease/</guid><description>Celiac disease (JAMA 2017;318:647; Lancet 2018;391:70; Gastro 2019;156:4)
Immune rxn in genetically predisposed Pts (~1% pop) to gliadin, a component of gluten (wheat protein) ‚Üí small bowel inflammatory infiltrate ‚Üí impaired absorption</description></item><item><title>Cell count of ascites</title><link>https://www.physician.tw/Cell-count-of-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cell-count-of-ascites/</guid><description>Cell count of ascites normal limit of PMNs in ascitic fluid up to 250 PMNs/mm3. Bloody tap (typically from traumatic para) can skew cell count; subtract 1 PMN for every 250 RBCs to correct PMN count.</description></item><item><title>Cell count of cerebrospinal fluid</title><link>https://www.physician.tw/Cell-count-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cell-count-of-cerebrospinal-fluid/</guid><description>Cell count of cerebrospinal fluid RBC Ê≠£Â∏∏ CSF RBC &amp;lt; 5 Ëã•‰∏äÂçáÂèØËÉΩÂéüÂõ†Êúâ traumatic tapping„ÄÅSAH Á≠â</description></item><item><title>Cellulitis Treatment</title><link>https://www.physician.tw/Cellulitis-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cellulitis-Treatment/</guid><description>Cellulitis Treatment (NEJM 2014;370:2238; CID 2014;59:e10; JAMA 2016;316:325 &amp;amp; 2017;317:2088) | Purulent | Usual Micro | Severity | Treatment |</description></item><item><title>Central adrenal insufficiency</title><link>https://www.physician.tw/Central-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-adrenal-insufficiency/</guid><description>Central adrenal insufficiency Sx similar to 1¬∞ adrenal insufficiency (see ‚ÄúAdrenal Disorders‚Äù) except: no salt cravings or hyperkalemia (b/c aldo preserved) no hyperpigmentation (b/c ACTH/MSH is not ‚Üë)</description></item><item><title>Central diabetes insipidus</title><link>https://www.physician.tw/Central-diabetes-insipidus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-diabetes-insipidus/</guid><description>Central diabetes insipidus Arginine vasopressin deficiency (central diabetes insipidus): Treatment
polyuria, nocturia, and polydipsia
‚Üì ADH
Typically from mass lesion extrinsic to sella; pituitary tumor does not typically present w/ DI</description></item><item><title>Central hypogonadism</title><link>https://www.physician.tw/Central-hypogonadism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-hypogonadism/</guid><description>Central hypogonadism Clinical manifestations: ‚Üì libido, impotence, oligomenorrhea or amenorrhea, infertility, ‚Üì muscle mass, osteoporosis Physical exam: ‚Üì testicular size; loss of axillary, pubic and body hair Dx with: ‚Üì a.</description></item><item><title>Central hypothyroidism</title><link>https://www.physician.tw/Central-hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-hypothyroidism/</guid><description>Central hypothyroidism ‚Üì TSH
Sx of central hypothyroidism similar to 1¬∞ (see ‚ÄúThyroid Disorders‚Äù) except absence of goiter Dx with free T4 in addition to TSH, as TSH may be low or inappropriately normal</description></item><item><title>Central vein stenosis</title><link>https://www.physician.tw/Central-vein-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-vein-stenosis/</guid><description>Central vein stenosis assoc. with longer HD duration, tunneled catheters. HeRO grafts bypass subclavian stenosis with flow into central vein (J Vasc Access 2016;17:138).</description></item><item><title>Cerebral edema-Management-acute liver failure</title><link>https://www.physician.tw/Cerebral-edema-Management-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cerebral-edema-Management-acute-liver-failure/</guid><description>Cerebral edema-Management-acute liver failure consider ICP monitoring if grade 3/4 enceph; if ‚Üë ICP ‚Üí mannitol 0.5‚Äì1.0 mg/kg; if arterial NH3 &amp;gt;150, grade 3/4 enceph, AKI or on vasopressors ‚Üí prophylactic 3% saline with goal Na 145‚Äì155 mEq/L; barbiturates &amp;amp; hypothermia if refractory ‚Üë ICP</description></item><item><title>cerebrospinal fluid lab results</title><link>https://www.physician.tw/cerebrospinal-fluid-lab-results/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cerebrospinal-fluid-lab-results/</guid><description>cerebrospinal fluid lab results Ê≠£Â∏∏ÔºöÊ∏Ö„ÄÅ‰ΩéÂ£ì&amp;lt;18„ÄÅÂ∞ëÁêÉ&amp;lt;5„ÄÅÂê´Á≥ñ50+„ÄÅ‰ΩéËõãÁôΩ&amp;lt;40
[[Appearance of cerebrospinal fluid]] [[open pressure]] Ê≠£Â∏∏ 9‚Äì18 cmH2O [[Cell count of cerebrospinal fluid]] Ê≠£Â∏∏ CSF RBC &amp;lt; 5 [[WBC of cerebrospinal fluid]] Ê≠£Â∏∏ CSF WBC &amp;lt; 5 [[Protein of cerebrospinal fluid]] Ê≠£Â∏∏ 15‚Äì40 mg/dL [[Glucose of cerebrospinal fluid]] Ê≠£Â∏∏Á¥Ñ 50‚Äì75 mg/dLÔºåÁ¥ÑÊòØ serum ÁöÑ 0.</description></item><item><title>CHA2DS2-VASc</title><link>https://www.physician.tw/CHA2DS2-VASc/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CHA2DS2-VASc/</guid><description>CHA2DS2-VASc CHF (1 point); HTN (1); Age ‚â•75 y (2) DM (1), Stroke/TIA (2); Vascular disease (eg, MI, PAD, Ao plaque) (1); Age 65‚Äì74 (1) ‚ôÄ Sex category (1) Annual risk of stroke (Lancet 2012;379:648): at low end, ~1% per point: 0 ‚Üí ~0%, 1 ‚Üí 1.</description></item><item><title>change in mental status</title><link>https://www.physician.tw/change-in-mental-status/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/change-in-mental-status/</guid><description>change in mental status [[Consciousness Arousal]] [[Etiologies of Decreased Responsiveness]] [[Initial evaluation of change in mental status]] see [[Stepwise Evaluation of a Patient with Delirium]] [[The Confusion Assessment Method]]</description></item><item><title>Characteristics of Pleural Fluid</title><link>https://www.physician.tw/Characteristics-of-Pleural-Fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Characteristics-of-Pleural-Fluid/</guid><description>Characteristics of Pleural Fluid</description></item><item><title>CHECKLIST AND LONG TERM POST ACS MANAGEMENT</title><link>https://www.physician.tw/CHECKLIST-AND-LONG-TERM-POST-ACS-MANAGEMENT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CHECKLIST-AND-LONG-TERM-POST-ACS-MANAGEMENT/</guid><description>CHECKLIST AND LONG TERM POST ACS MANAGEMENT Risk stratification Stress test if anatomy undefined; consider stress if signif residual CAD post-PCI of culprit Assess LVEF prior to d/c; EF ‚Üë ~6% in STEMI over 6 mo (JACC 2007;50:149) Antiplatelet therapy Aspirin: 81 mg daily (no clear benefit to higher doses) P2Y12 inhibitor: ticagrelor or prasugrel preferred over clopi.</description></item><item><title>Chemical Causes of Cellular Hypoxia</title><link>https://www.physician.tw/Chemical-Causes-of-Cellular-Hypoxia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chemical-Causes-of-Cellular-Hypoxia/</guid><description>Chemical Causes of Cellular Hypoxia CO binds to Hb more avidly than does O2. Pulse oximeter (Ox) misreads COHb as HbO2 ‚Üí falsely nl sat.</description></item><item><title>Chest Discomfort</title><link>https://www.physician.tw/Chest-Discomfort/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-Discomfort/</guid><description>Chest Discomfort [[chest pain]]</description></item><item><title>chest pain</title><link>https://www.physician.tw/chest-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chest-pain/</guid><description>[[Typical Characteristics and Diagnostic Studies of Chest Pain]]
Initial diagnostic studies [[Focused history of chest pain]]
Targeted exam: VS (incl.</description></item><item><title>chest radiograph</title><link>https://www.physician.tw/chest-radiograph/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chest-radiograph/</guid><description>chest radiograph Tips: Are There Many Lung Lesion Can I ?
Consolidation: Ê∞¥„ÄÅË°Ä„ÄÅËÜø SILHOUETTE SIGN heart, aorta, or diaphragm bronchopneumonia: Multifocal consolidation DIFFUSE CONSOLIDATION: crazy paving pulmonary edema ARDS pulmonary hemorrhage Pneumocystis Cryptogenic organizing pneumonia predominant peribronchial and peripheral distribution FOCAL AND MULTIFOCAL CONSOLIDATION EXTENSIVE CONFLUENT AND DIFFUSE CONSOLIDATION ACUTE CAUSES OF PARENCHYMAL CONSOLIDATION CHRONIC CAUSES OF PARENCHYMAL CONSOLIDATION Atelectasis Obstructive atelectasis Distal to obstruction of a bronchus</description></item><item><title>cholangitis</title><link>https://www.physician.tw/cholangitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholangitis/</guid><description>cholangitis Definition &amp;amp; etiologies (World J Gasrointest Pathophysiol 2018:9:1)
Bile duct obstruction causes stasis ‚Üí infection proximal to the obstruction Etiologies: BD stone (~85%); malignant (biliary, pancreatic) or benign stricture; infection w/ fluke (Clonorchis sinensis, Opisthorchis viverrini); recurrent pyrogenic cholangitis Clinical manifestations [[Charcot‚Äôs triad]]: RUQ pain, jaundice, fever/chills; present in ~70% of Pts [[Reynolds‚Äô pentad]]: Charcot‚Äôs triad + shock and Œî MS; present in ~15% of Pts Diagnostic studies RUQ U/S: often demonstrates dilation of bile ducts Labs: ‚Üë WBC (with left shift), bilirubin, AœÜ, amylase; may see ‚äï BCx ERCP; percutaneous transhepatic cholangiogram if ERCP unsuccessful [[Treatment-cholangitis]]</description></item><item><title>choledocholithiasis</title><link>https://www.physician.tw/choledocholithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/choledocholithiasis/</guid><description>choledocholithiasis Definition Gallstone lodged in common bile duct (CBD) Epidemiology Occurs in 15% of Pts w/ gallbladder stones; can form de novo in CBD due to biliary stasis Clinical manifestations RUQ/epigastric pain 2¬∞ obstrxn of bile flow ‚Üí ‚Üë CBD pressure, jaundice, pruritus, nausea Rarely asymptomatic [[Diagnostic studies-choledocholithiasis]] Treatment ERCP &amp;amp; papillotomy w/ stone extraction (¬± lithotripsy) CCY w/in 6 wk unless contraindication (&amp;gt;15% Pts develop indication for CCY if unRx‚Äôd) Complications [[cholangitis]], [[cholecystitis]], [[pancreatitis]], stricture</description></item><item><title>cholelithiasis</title><link>https://www.physician.tw/cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholelithiasis/</guid><description>cholelithiasis [[Epidemiology pathogenesis-cholelithiasis]] [[Types of gallstones-cholelithiasis]] [[Clinical manifestations-cholelithiasis]] [[Diagnostic studies-cholelithiasis]] [[Treatment-cholelithiasis]] [[Complications-cholelithiasis]]</description></item><item><title>chronic kidney disease CKD</title><link>https://www.physician.tw/chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-kidney-disease-CKD/</guid><description>chronic kidney disease (CKD) [[Definition and etiologies-chronic kidney disease (CKD)]] [[Stages of CKD]] [[Signs and Symptoms of Uremia -chronic kidney disease (CKD)]] [[Complications-treatment-chronic kidney disease (CKD)]]</description></item><item><title>Chronic migraine</title><link>https://www.physician.tw/Chronic-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-migraine/</guid><description>Chronic migraine Chronic migraine is defined as ‚â•15 headache days per month for &amp;gt;3 months and fulfilment of ICHD-3 criteria for migraine on ‚â•8 days per month.</description></item><item><title>Chronic mild-to-moderate elevation in ALT AST</title><link>https://www.physician.tw/Chronic-mild-to-moderate-elevation-in-ALT-AST-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-mild-to-moderate-elevation-in-ALT-AST-/</guid><description>Chronic mild-to-moderate elevation in ALT AST (&amp;lt;15√ó ULN)
Viral hepatitis: ‚úì HBsAg, anti-HBs, anti-HBc, anti-HCV, IgM anti-HAV
NAFLD: consider BMI, ‚úì lipid panel, HbA1c, liver U/S or elastography</description></item><item><title>chronic obstructive pulmonary disease</title><link>https://www.physician.tw/chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-obstructive-pulmonary-disease/</guid><description>CHRONIC OBSTRUCTIVE PULMONARY DISEASE [[Definition and epidemiology-chronic obstructive pulmonary disease]] [[Emphysema vs. Chronic Bronchitis]] [[Pathogenesis-chronic obstructive pulmonary disease]] [[Clinical manifestations-chronic obstructive pulmonary disease]] [[Diagnostic studies-chronic obstructive pulmonary disease]] [[Chronic treatment-chronic obstructive pulmonary disease]] [[Staging and prognosis-chronic obstructive pulmonary disease]] EXACERBATION [[COPD Exacerbation Treatment]]</description></item><item><title>Chronic or refractory for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/Chronic-or-refractory-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-or-refractory-for-idiopathic-thrombocytopenic-purpura/</guid><description>Chronic or refractory for idiopathic thrombocytopenic purpura Romiplostim or eltrombopag Allows splenectomy to be deferred
Fostamatinib: 75‚Äì150 mg BID Spleen tyrosine kinase (SYK) inhibitor</description></item><item><title>chronic pancreatitis</title><link>https://www.physician.tw/chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-pancreatitis/</guid><description>chronic pancreatitis [[Pathogenesis etiology-chronic pancreatitis]] [[Clinical manifestations-chronic pancreatitis]] [[Diagnostic studies-chronic pancreatitis ]] [[Treatment-chronic pancreatitis]]</description></item><item><title>Chronic treatment-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Chronic-treatment-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-treatment-chronic-obstructive-pulmonary-disease/</guid><description>Chronic treatment-chronic obstructive pulmonary disease COPD Staging and Recommended Therapies by GOLD Criteria
‰∏ÄÂπ¥ÂÖ©Ê¨°‰ª•‰∏ãÁÆóA,B A Short-acting inh dilator prn B LAMA ‰∏ÄÂπ¥ÂÖ©Ê¨°‰ª•‰∏äÁÆóC,D C LAMA D LAMA + LABA ¬± ICS ËÄÉÊÖÆÂú®ÊîØÊ∞£ÁÆ°Êì¥ÂºµÂäë‰∏≠Ê∑ªÂä†PDE-4ÊäëÂà∂ Treatment [[Bronchodilators]] [[Corticosteroids for chronic obstructive pulmonary disease]] Triple Therapy (LAMA+LABA+ICS) ‚Üì exac, ‚Üì hosp, ‚Üë PNA (NEJM 2020;383:35) [[Roflumilast]] [[Anti-IL5]] daily azithro ‚Üì exacerbations, but not routine (JAMA 2014;311:2225) [[Oxygen for chronic obstructive pulmonary disease]] Night NPPV if recent exacerb &amp;amp; PaCO2 &amp;gt;&amp;ldquo;53&amp;rdquo; ‚Üì risk of readmit or death (JAMA 2017;317:2177) [[Prevention of chronic obstructive pulmonary disease]] Rehabilitation: ‚Üì dyspnea and fatigue, ‚Üë exercise tolerance, ‚Üë QoL (NEJM 2009;360:1329) Surgery &amp;amp; bronchoscopic interventions Lung volume reduction surgery: ‚Üë exercise capacity, ‚Üì mortality if FEV1 &amp;gt;20%, upper lobe, low exercise capacity (NEJM 2003;348:2059) Bronchoscopic lung reduction with endobronchial valves or coils: ‚Üë lung fxn but significant complications (PTX, PNA) (NEJM 2015;373:2325; Lancet 2015;386:1066; JAMA 2016;315:175) Lung transplant: ‚Üë QoL and ‚Üì sx (Lancet 1998;351:24), ?</description></item><item><title>Chronic treatment-nephrolithiasis</title><link>https://www.physician.tw/Chronic-treatment-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-treatment-nephrolithiasis/</guid><description>Chronic treatment-nephrolithiasis (CJASN 2016;11:1305 &amp;amp; 2017;12:1699)
Increase fluid intake (&amp;gt;2 L/d) for goal UOP 2 L/d (J Nephrol 2016;29:211)</description></item><item><title>Chvostek sign</title><link>https://www.physician.tw/Chvostek-sign/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chvostek-sign/</guid><description>Chvostek sign Ëàá‰ΩéÈà£Ë°ÄÁóáÁõ∏ÈóúÁöÑËá®Â∫äÁôºÁèæ
ÊåáÁöÑÊòØÈù¢ÈÉ®ËÇåËÇâÁöÑÊäΩÊêê Áï∂ËºïËºïÊï≤Êìä‰∏ÄÂÄã‰∫∫ÁöÑ ËáâÈ†∞ÔºåÂú®ËÄ≥Ââç„ÄÇ
ÂºïËµ∑Èù¢ÈÉ®Á•ûÁ∂ìÁöÑÈùûÂÖ∏ÂûãÂèçÊáâÔºå (CN VII) ÊîØÈÖçÈù¢ÈÉ®ÁöÑË®±Â§öËÇåËÇâ„ÄÇ
ÈÄöÈÅéËºïËºïÊãçÊâìÂÄã‰∫∫ÁöÑËáâÈ†∞ ËÄ≥Ââç 2 ÂéòÁ±≥ÔºàÁ¥Ñ 0.75 Ëã±ÂØ∏ÔºâÔºå Âú®Á¨¨ 7 È°±ËÖ¶ (CN VII) ÁöÑÈù¢Á•ûÁ∂ìË∑ØÁ∑ö‰∏ä„ÄÇ</description></item><item><title>cirrhosis</title><link>https://www.physician.tw/cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cirrhosis/</guid><description>cirrhosis [[Definition-cirrhosis]] [[Etiologies-cirrhosis]] [[Clinical manifestations-cirrhosis]] [[Physical exam-cirrhosis]] [[Laboratory studies-cirrhosis]] [[Workup-cirrhosis]] [[Prognosis-cirrhosis]] [[ascites]] [[Spontaneous bacterial peritonitis]] [[Gastroesophageal varices and UGIB-cirrhosis]] [[Hepatic encephalopathy (HE)]] [[Hepatorenal syndrome (HRS)]] [[hepatocellular carcinoma]] [[Hepatopulmonary syndrome (HPS)]] [[Other Complication-cirrhosis]] [[Liver transplantation]] Other Etiologies [[Hemochromatosis &amp;amp; iron overload syndromes]] [[Wilson disease]] [[Œ±1-antitrypsin deficiency (Œ±1-AT)]] [[Primary biliary cholangitis (PBC)]] [[Primary sclerosing cholangitis (PSC)]]</description></item><item><title>classes of hemorrhagic shock</title><link>https://www.physician.tw/classes-of-hemorrhagic-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classes-of-hemorrhagic-shock/</guid><description>classes of hemorrhagic shock 15 30 40</description></item><item><title>Classic tachycardias of WPW accessory pathways</title><link>https://www.physician.tw/Classic-tachycardias-of-WPW-accessory-pathways/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classic-tachycardias-of-WPW-accessory-pathways/</guid><description>Classic tachycardias of WPW accessory pathways Orthodromic AVRT: narrow-complex SVT (typically), conducting ‚Üì AVN &amp;amp; ‚Üë accessory pathway; requires retrograde conduction and ‚à¥ can occur w/ concealed bypass tracts Antidromic AVRT (rare): wide-complex SVT, conducting ‚Üì accessory pathway &amp;amp; ‚Üë AVN; requires antegrade conduction and ‚à¥ should see pre-excitation pattern during SR AF w/ rapid conduction down accessory pathway; ‚à¥ wide-complex irregular SVT; requires antegrade conduction; ‚à¥ should see pre-excitation in SR.</description></item><item><title>Classic-Eponymous-Signs-in-Chronic-AR</title><link>https://www.physician.tw/Classic-Eponymous-Signs-in-Chronic-AR/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classic-Eponymous-Signs-in-Chronic-AR/</guid><description>Classic-Eponymous-Signs-in-Chronic-AR Sign Description Corrigan‚Äôs pulse ‚Äúwater hammer‚Äù pulse (ie, rapid rise/fall or distention/collapse) Hill‚Äôs sign (popliteal SBP ‚Äì brachial SBP) &amp;gt;60 mmHg Duroziez‚Äôs sign to-and-fro murmur heard over femoral artery w/ light compression Pistol shot sounds pistol shot sound heard over femoral artery Traube‚Äôs sound double sound heard over femoral artery when compressed distally de Musset‚Äôs sign head-bobbing with each heartbeat (low Se) M√ºller‚Äôs sign systolic pulsations of the uvula Quincke‚Äôs pulses subungual capillary pulsations (low Sp)</description></item><item><title>Classification criteria of Beh√ßet‚Äôs syndrome</title><link>https://www.physician.tw/Classification-criteria-of-Beh%C3%A7ets-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-criteria-of-Beh%C3%A7ets-syndrome/</guid><description>Classification criteria of Beh√ßet‚Äôs syndrome (#1 + ‚â•2 others is 91% Se &amp;amp; 96% Sp; Lancet 1990;335:1078)
Recurrent oral aphthous ulceration (‚â•3√ó in 1 y, usually 1st manifestation) Recurrent genital ulceration (labia in females, scrotum in males) Eye lesions: uveitis, scleritis, retinal vasculitis, optic neuritis; may threaten vision Skin lesions: pustules, papules, folliculitis, erythema nodosum (scarring) ‚äï pathergy test (prick forearm w/ sterile needle ‚Üí pustule) (not sensitive in Caucasians)</description></item><item><title>Classification of Pain</title><link>https://www.physician.tw/Classification-of-Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-of-Pain/</guid><description>Classification of Pain ‚ú®ÈáçÈªû: Êé®Êñ∑ÁöÑÁóÖÁêÜÁîüÁêÜÂ≠∏ÔºàÂÇ∑ÂÆ≥ÊÄßËàáÈùûÂÇ∑ÂÆ≥ÊÄßÔºâ ÊôÇÈñìÈÄ≤Á®ãÔºàÊÄ•ÊÄßËàá‰∫ûÊÄ•ÊÄßËàáÊÖ¢ÊÄßÔºâ ‰ΩçÁΩÆÔºàÂ±ÄÈÉ®ÁñºÁóõÂçÄÂüüËàáÂª£Áæ©Ôºâ ÁóÖÂõ†Ôºà‰æãÂ¶ÇÔºåÁôåÁóá„ÄÅÈóúÁØÄÁÇé„ÄÅÁ•ûÁ∂ìÊêçÂÇ∑ÊàñÈÄô‰∫õÁöÑÁµÑÂêàÔºâ neurophysiologic classification of pain Á•ûÁ∂ìÁîüÁêÜÂ≠∏ÂàÜÈ°ûÂü∫ÊñºÊé®Êñ∑ÁöÑÁñºÁóõÊ©üÂà∂„ÄÇ Âü∫Êú¨‰∏äÊúâÂÖ©Á®ÆÈ°ûÂûãÔºöÔºà1ÔºâÂÇ∑ÂÆ≥ÊÄßÔºåÈÄôÊòØÁî±ÊñºÁñºÁóõÊïèÊÑüÁµêÊßãÁöÑÊêçÂÇ∑ÔºåÂíåÔºà2ÔºâÈùûÂÇ∑ÂÆ≥ÊÄßÔºåÂÆÉÊòØÁ•ûÁ∂ìÊÄßÂíåÂøÉÁêÜÊÄßÁöÑ„ÄÇ ÂÇ∑ÂÆ≥ÊÄßÁñºÁóõÂèØÁ¥∞ÂàÜÁÇ∫ËªÄÈ´îÊÄßÁñºÁóõÂíåÂÖßËáüÊÄßÁñºÁóõÔºàÂèñÊ±∫ÊñºÊøÄÊ¥ª‰∫ÜÂì™ÁµÑÂÇ∑ÂÆ≥ÊÑüÂèóÂô®Ôºâ„ÄÇ Á•ûÁ∂ìÊÄßÁñºÁóõÂèØÁ¥∞ÂàÜÁÇ∫Â§ñÂë®ÊÄßÁñºÁóõÂíå‰∏≠Ê®ûÊÄßÁñºÁóõÔºàÂèñÊ±∫ÊñºË¢´Ë™çÁÇ∫Ë≤†Ë≤¨Á∂≠ÊåÅÁñºÁóõÁöÑÁ•ûÁ∂ìÁ≥ªÁµ±‰∏≠ÁöÑÊêçÂÇ∑ÈÉ®‰ΩçÔºâ„ÄÇ ÂÑòÁÆ°ÈÄôÂÄãË°ìË™ûÂ∑≤Á∂ì‰ΩøÁî®‰∫ÜÂæàÂ§öÂπ¥Ôºå‰ΩÜÂøÉÂõ†ÊÄßÁñºÁóõÊòØ‰∏ÄÂÄãÈùûÂ∏∏Ê®°Á≥äÁöÑË°ìË™ûÔºåÊáâË©≤Âè™Áî®ÊñºÈÇ£‰∫õÊúÄÁµÇÊéíÈô§‰∫ÜÊâÄÊúâÈùûÂøÉÂõ†ÊÄßÂéüÂõ†ÁöÑÊÉÖÊ≥Å‚Äî‚Äî‰πüÂ∞±ÊòØË™™Ôºå‰∏ÄÂÄã‰∫∫ÂæàÂ∞ëÁ∂ìÊ≠∑ÂøÉÂõ†ÊÄßÁñºÁóõÁç®Ëá™ÁöÑ„ÄÇ ÊàëÂÄëÁ∂ìÂ∏∏ÁúãÂà∞Ë¢´‰Ωé‰º∞ÁöÑÊÖ¢ÊÄßÁñºÁóõÊÇ£ËÄÖË¢´Ë®∫Êñ∑ÁÇ∫ÂøÉÂõ†ÊÄßÁñºÁóõÔºåËÄå‰∫ãÂØ¶‰∏äÔºå‰ªñÂÄëÁöÑÁñºÁóõÊúâ‰∏ÄÂÄãÊòéÁ¢∫ÁöÑÁóÖÂõ†Ôºå‰ΩÜÁî±ÊñºË®∫Êñ∑Ë©ï‰º∞‰∏çÁêÜÊÉ≥ËÄåË¢´ÂøΩË¶ñ„ÄÇ</description></item><item><title>Classification-acute aortic syndromes</title><link>https://www.physician.tw/Classification-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-acute-aortic-syndromes/</guid><description>Classification-acute aortic syndromes (proximal more common than distal; JACC 2019;74:1494 &amp;amp; 2020;76:1703)
Proximal: involves ascending Ao, regardless of origin (= Stanford A, DeBakey I &amp;amp; II) Distal: involves descending Ao only, distal to L subclavian art.</description></item><item><title>Classification-atrial fibrillation</title><link>https://www.physician.tw/Classification-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-atrial-fibrillation/</guid><description>Classification-atrial fibrillation (Circ 2014;130:e199)
ÂèÉËÄÉ‚û°Ô∏è Reassessment of risk for stroke during follow-up of patients with atrial fibrillation
Paroxysmal Terminates spontaneously or with intervention within 7 days of onset.</description></item><item><title>Classification-autoimmune hepatitis AIH</title><link>https://www.physician.tw/Classification-autoimmune-hepatitis-AIH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-autoimmune-hepatitis-AIH/</guid><description>Classification-autoimmune hepatitis (AIH) (J Hep 2015;62:S100, World J Gastro 2015;21:60)
Type 1: anti-smooth muscle Ab (ASMA), ANA; anti-soluble liver antigen (anti-SLA), a/w more severe disease and relapsing disease (found in 10‚Äì30% Pts), IgG often ‚Üë</description></item><item><title>clinical case of epidural abscess</title><link>https://www.physician.tw/clinical-case-of-epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-case-of-epidural-abscess/</guid><description>clinical case of epidural abscess A 50-year-old woman with end-stage kidney disease from hypertensive nephrosclerosis presents for her regularly scheduled hemodialysis session.</description></item><item><title>clinical characteristics of bleeding disorders</title><link>https://www.physician.tw/clinical-characteristics-of-bleeding-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-characteristics-of-bleeding-disorders/</guid><description>clinical characteristics of bleeding disorders Platelet/Vascular Defect Skin, mucous membranes Petechiae, ecchymoses Bleeding After minor cuts: yes Bleeding After surgery: immediate, mild Coagulation Defect Deep in soft tissues (muscles, joints) Hemarthroses, hematomas Bleeding After minor cuts: unusual Bleedgin After surgery: delayed, severe Explain by ChatGPT The first paragraph is discussing platelet/vascular defects.</description></item><item><title>Clinical evaluation of Secondary causes of headaches</title><link>https://www.physician.tw/Clinical-evaluation-of-Secondary-causes-of-headaches/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-evaluation-of-Secondary-causes-of-headaches/</guid><description>Clinical evaluation of Secondary causes of headaches (Neurology 2019;92:134 &amp;amp; JAMA 2021;325:1874)
Hx: onset (sudden vs. gradual), quality, evolution (progressive), severity, location, duration, triggers, alleviating factors, positional, hormonal (menstruation), preceding trauma, assoc.</description></item><item><title>Clinical features-cystic fibrosis</title><link>https://www.physician.tw/Clinical-features-cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-features-cystic-fibrosis/</guid><description>Clinical features-cystic fibrosis Recurrent PNA, sinus infections
Distal intestinal obstruction syndrome (DIOS), pancreatic insufficiency (steatorrhea, malabsorption, failure to thrive, weight loss), CF-related diabetes, infertility</description></item><item><title>Clinical manifestation-bacterial endocarditis</title><link>https://www.physician.tw/Clinical-manifestation-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestation-bacterial-endocarditis/</guid><description>Clinical manifestation-bacterial endocarditis (Lancet 2016;387:882)
Persistent bacteremia ‚Üí fever (80‚Äì90%), rigors, night sweats, anorexia, myalgias Valvular or perivalvular infection ‚Üí HF, conduction abnormalities (eg, AVB) Septic emboli: stroke, embolic MI, renal/splenic/pulmonary infarcts, septic arthritis, osteo Immune complex phenomena: arthritis, glomerulonephritis Subacute endocarditis can present with subacute progressive ‚ÄúB‚Äù sx (fatigue, wt loss)</description></item><item><title>Clinical manifestations</title><link>https://www.physician.tw/Clinical-manifestations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations/</guid><description>Clinical manifestations Classic triad = wheezing, cough, dyspnea; others include chest tightness, sputum; symptoms typically chronic with episodic exacerbation</description></item><item><title>Clinical manifestations dx studies-hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/Clinical-manifestations-dx-studies-hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-dx-studies-hyperosmolar-hyperglycemic-state/</guid><description>Clinical manifestations dx studies-hyperosmolar hyperglycemic state (Diabetes Care 2014;37:3124)
Volume depletion and Œî MS ‚Üë serum glc (usually &amp;gt;600 mg/dL) and ‚Üë meas.</description></item><item><title>Clinical Manifestations and Physical Exam-acute aortic syndromes</title><link>https://www.physician.tw/Clinical-Manifestations-and-Physical-Exam-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Manifestations-and-Physical-Exam-acute-aortic-syndromes/</guid><description>Clinical Manifestations and Physical Exam-acute aortic syndromes (JAMA 2000;283:897) Feature
Proximal Distal ‚ÄúAortic‚Äù pain (abrupt, severe, tearing or ripping quality, maximal at onset [vs.</description></item><item><title>Clinical manifestations complications-herpes zoster</title><link>https://www.physician.tw/Clinical-manifestations-complications-herpes-zoster/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-complications-herpes-zoster/</guid><description>Clinical manifestations complications-herpes zoster Uncomplicated: pain in a dermatomal distribution ‚Üí dermatomal eruption of erythematous papules ‚Üí vesicles ‚Üí crusted plaques in varying stages of evolution Disseminated: vesicles across multiple dermatomes, visceral organ involvement (pneumonia, hepatitis, CNS) seen in immunosupp.</description></item><item><title>Clinical manifestations gastroesophageal reflux disease</title><link>https://www.physician.tw/Clinical-manifestations-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-gastroesophageal-reflux-disease/</guid><description>Clinical manifestations gastroesophageal reflux disease Esophageal: heartburn, atypical chest pain, regurgitation, sour taste, dysphagia Extraesophageal: dry cough, asthma (often poorly controlled), laryngitis, dental erosions Patients with GERD often present with heartburn, regurgitation, mild dysphagia, and noncardiac chest pain.</description></item><item><title>Clinical manifestations of acute coronary syndromes</title><link>https://www.physician.tw/Clinical-manifestations-of-acute-coronary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-acute-coronary-syndromes/</guid><description>Clinical manifestations of acute coronary syndromes Cardiac chest pain (‚Äúangina‚Äù): retrosternal pressure/pain/tightness ¬± radiation to neck, jaw, arms. Precipitated by exertion (physical or emotional), ‚Üì w/ rest or NTG.</description></item><item><title>Clinical manifestations of breast cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-breast-cancer/</guid><description>Clinical manifestations of breast cancer Breast mass (hard, irregular, fixed, nontender), nipple discharge (higher risk if unilateral, limited to 1 duct, bloody, associated with mass) Special types: Paget disease ‚Üí unilateral nipple eczema + nipple discharge; inflammatory breast cancer ‚Üí skin erythema and edema (peau d‚Äôorange) Metastases: lymph nodes, bone, liver, lung, brain Áõ∏ÈóúÈÄ£ÁµêÔºö [[breast cancer]]</description></item><item><title>Clinical manifestations of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Clinical-manifestations-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Cryoglobulinemic-vasculitis/</guid><description>Clinical manifestations of Cryoglobulinemic vasculitis Type I hyperviscosity (cold worsens sx) ‚Üí HA, visual Œî, livedo, digital ischemia
Type II/III vasculitis (not affected by cold) ‚Üí fever, derm (54‚Äì80%; purpura, livedo reticularis, ulcers), arthralgia (44‚Äì70%; symmetric migratory, small/med joints), glomerulonephritis (50%; MPGN), neurologic (17‚Äì60%; peripheral neuropathy (polyneuropathy &amp;gt;mononeuritis multiplex), ‚Üì Hgb, ‚Üì plt, ‚Üë B-cell lymphoma risk, GI (5%; pain, HSM, ‚Üë LFTs).</description></item><item><title>Clinical manifestations of Eosinophilic gran with polyangiitis</title><link>https://www.physician.tw/Clinical-manifestations-of-Eosinophilic-gran-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Eosinophilic-gran-with-polyangiitis/</guid><description>Clinical manifestations of Eosinophilic gran with polyangiitis (Rheumatol 2020;59:iii84)
Initial sx: asthma sinusitis allergic rhinitis (new asthma in adult raises suspicion) Eosinophilic infiltrative disease: transient pulm infiltrates, gastroenteritis esophagitis Systemic small-vessel vasculitis: neuropathy (mononeuritis multiplex), renal (glomerulonephritis), skin (palpable purpura, petechial, nodules) Cardiac: coronary arteritis, myocarditis, CHF valvular insufficiency (Medicine 2009;88:236)</description></item><item><title>Clinical manifestations of Giant cell arteritis</title><link>https://www.physician.tw/Clinical-manifestations-of-Giant-cell-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Giant-cell-arteritis/</guid><description>Clinical manifestations of Giant cell arteritis (NEJM 2014;371:50): constitutional sx: fevers, fatigue, wt loss
Temporal artery (TA) ‚Üí headache, tender TAs and scalp, absent TA pulse</description></item><item><title>Clinical manifestations of Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Clinical-manifestations-of-Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Granulomatosis-with-polyangiitis/</guid><description>Clinical manifestations of Granulomatosis with polyangiitis Upper respiratory tract: perforation of nasal septum, chronic sinusitis, otitis media, mastoiditis. Lower respiratory tract: hemoptysis, cough, dyspnea.</description></item><item><title>Clinical manifestations of IgA vasculitis</title><link>https://www.physician.tw/Clinical-manifestations-of-IgA-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-IgA-vasculitis/</guid><description>Clinical manifestations of IgA vasculitis ÈóúÁØÄ„ÄÅËÇöÂ≠ê„ÄÅËÖé„ÄÅÁöÆ
Palpable purpura on extensor surfaces (lower extremity first) &amp;amp; buttocks Polyarthralgias (nondeforming) esp. involving hips, knees, &amp;amp; ankles Colicky abdominal pain ¬± GIB or intussusception Nephritis ranging from microscopic hematuria &amp;amp; proteinuria to ESRD</description></item><item><title>Clinical manifestations of lung cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-lung-cancer/</guid><description>Clinical manifestations of lung cancer ~10% asymptomatic at dx, detected incidentally (only 16% w/ localized dis. at presentation) Endobronchial growth of 1¬∞ tumor: cough, hemoptysis, dyspnea, pain, wheezing, post-obstructive pneumonia; more common with squamous or small cell (central location) Regional spread: can cause dysphagia (esophageal compression), stridor (tracheal obstruction), hoarseness (recurrent laryngeal nerve palsy).</description></item><item><title>clinical manifestations of peptic ulcer disease</title><link>https://www.physician.tw/clinical-manifestations-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-peptic-ulcer-disease/</guid><description>clinical manifestations of peptic ulcer disease Epigastric gnawing abdominal pain: relieved with food (DU) or worsened by food (GU) Complic.</description></item><item><title>Clinical manifestations of Polyarteritis nodosa</title><link>https://www.physician.tw/Clinical-manifestations-of-Polyarteritis-nodosa/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Polyarteritis-nodosa/</guid><description>Clinical manifestations of Polyarteritis nodosa (Arth Rheum 2010;62:616):
const. sx (80%): wt loss, fever, fatigue Neuro (79%): mononeuritis multiplex, peripheral neuropathies, stroke Musculoskeletal (64%): extremity pain, myalgias, arthralgias, arthritis Renal (51%): HTN, hematuria, proteinuria, renal failure; glomerulonephritis unusual GI (38%): abd pain, GIB/infarction, cholecystitis; GU (25%): ovarian or testicular pain Skin (50%): livedo reticularis, purpura, nodules, ulcers, Raynaud‚Äôs Ophthalmic (9%): retinal vasculitis, retinal exudates, conjunctivitis, uveitis Cardiac (22%): coronary arteritis, cardiomyopathy, pericarditis Pulmonary: rare; if lung involvement, suspect other vasculitis</description></item><item><title>Clinical Manifestations of Sarcoidosis</title><link>https://www.physician.tw/Clinical-Manifestations-of-Sarcoidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Manifestations-of-Sarcoidosis/</guid><description>Clinical Manifestations of Sarcoidosis Pulmonary
Hilar LAN; fibrosis; pulm hypertension. Stages: I = bilat hilar
LAN; II = LAN + ILD; III = ILD only; IV = diffuse fibrosis.</description></item><item><title>Clinical manifestations peptic ulcer disease</title><link>https://www.physician.tw/Clinical-manifestations-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-peptic-ulcer-disease-/</guid><description>Clinical manifestations peptic ulcer disease Epigastric gnawing abdominal pain: relieved with food (DU) or worsened by food (GU)</description></item><item><title>Clinical manifestations-acute liver failure</title><link>https://www.physician.tw/Clinical-manifestations-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-acute-liver-failure/</guid><description>Clinical manifestations-acute liver failure Initial presentation: N/V, malaise, RUQ pain, jaundice, encephalopathy, multiorgan failure
Neurologic: encephalopathy: grade 1 = attn deficit, disordered sleep; grade 2 = asterixis, confusion; grade 3 = somnolence, rigidity; grade 4 = coma; ‚Üë ICP w/ bradycardia &amp;amp; HTN</description></item><item><title>Clinical manifestations-acute mesenteric ischemia</title><link>https://www.physician.tw/Clinical-manifestations-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-acute-mesenteric-ischemia/</guid><description>Clinical manifestations-acute mesenteric ischemia Arterial occlusion: sudden intense abd pain out of proportion to tenderness on exam
Venous occlusion: often more insidious in onset, intermittent pain with peaks and valleys</description></item><item><title>Clinical manifestations-acute pancreatitis</title><link>https://www.physician.tw/Clinical-manifestations-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-acute-pancreatitis/</guid><description>Clinical manifestations-acute pancreatitis Epigastric abdominal or LUQ pain (90%), only ¬Ω w/ bandlike pain radiating to back
10% pain-free (due to analgesic/steroid use, immunosuppressed, ŒîMS, ICU); ‚à¥ ‚úì lipase in unexplained shock, periumbilical or flank (Cullen or Grey Turner signs) bruising</description></item><item><title>Clinical manifestations-adrenal insufficiency</title><link>https://www.physician.tw/Clinical-manifestations-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-adrenal-insufficiency/</guid><description>Clinical manifestations-adrenal insufficiency (Lancet 2021;397:613)
Primary or secondary: weakness and fatigability (95%), weight loss (70%), orthostatic hypotension (60%), nausea (50%), vomiting (50%), hyponatremia (75%) Primary only (extra s/s due to lack of aldosterone and ‚Üë ACTH): marked orthostatic hypotension (because volume depleted), salt craving, hyperpigmentation (seen in creases, mucous membranes, pressure areas, nipples), hyperkalemia Secondary only: ¬± other manifestations of [[hypopituitary syndromes]]</description></item><item><title>clinical manifestations-anemia</title><link>https://www.physician.tw/clinical-manifestations-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-anemia/</guid><description>clinical manifestations-anemia Symptoms: ‚Üì O2 delivery ‚Üí fatigue, exertional dyspnea, angina (if CAD)
Signs: pallor (mucous membranes, palmar creases), tachycardia, orthostatic hypotension</description></item><item><title>Clinical manifestations-Candida species</title><link>https://www.physician.tw/Clinical-manifestations-Candida-species/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Candida-species/</guid><description>Clinical manifestations-Candida species Mucocutaneous cutaneous (eg, red, macerated lesions in intertriginous zones); oral thrush (exudative, erythematous or atrophic; if unexplained, r/o HIV); esophageal (odynophagia; ¬± oral thrush); vulvovaginal, balanitis</description></item><item><title>Clinical manifestations-cholecystitis</title><link>https://www.physician.tw/Clinical-manifestations-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-cholecystitis/</guid><description>Clinical manifestations-cholecystitis History: RUQ/epigastric pain ¬± radiation to R shoulder/back, nausea, vomiting, fever
Physical exam: RUQ tenderness, Murphy‚Äôs sign = ‚Üë RUQ pain and inspiratory arrest with deep breath during palpation of R subcostal region, ¬± palpable gallbladder</description></item><item><title>Clinical manifestations-cholelithiasis</title><link>https://www.physician.tw/Clinical-manifestations-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-cholelithiasis/</guid><description>Clinical manifestations-cholelithiasis Asx in ~80%. Biliary pain develops in 1‚Äì4%/y. Once sx, rate of complications ~1‚Äì3%/y.
Biliary pain = episodic RUQ or epigastric pain; begins abruptly, continuous, resolves slowly and lasts 30 min‚Äì3 h; ¬± radiation to scapula; precip by fatty foods; nausea</description></item><item><title>Clinical manifestations-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Clinical-manifestations-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-chronic-obstructive-pulmonary-disease/</guid><description>Clinical manifestations-chronic obstructive pulmonary disease Chronic cough, sputum production, dyspnea; later stages ‚Üí freq exacerb, AM headache, wt loss</description></item><item><title>Clinical manifestations-chronic pancreatitis</title><link>https://www.physician.tw/Clinical-manifestations-chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-chronic-pancreatitis/</guid><description>Clinical manifestations-chronic pancreatitis Epigastric pain, N/V; over time can be painless; signs of exocrine insuff (steatorrhea, wt loss) or endocrine insuff (DM: polydipsia, polyuria); 13√ó ‚Üë risk of pancreatic cancer</description></item><item><title>Clinical manifestations-cirrhosis</title><link>https://www.physician.tw/Clinical-manifestations-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-cirrhosis/</guid><description>Clinical manifestations-cirrhosis Nonspecific sx (anorexia, fatigue) or jaundice, encephalopathy, ascites, variceal bleeding</description></item><item><title>Clinical manifestations-clostridioides difficile infection</title><link>https://www.physician.tw/Clinical-manifestations-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-clostridioides-difficile-infection/</guid><description>Clinical manifestations-clostridioides difficile infection Asx colonization: &amp;lt;3% healthy adults; ~20% in hospitalized patients on antibiotics Acute watery diarrhea (&amp;gt;3 stool/d), occ bloody ¬± mucus, lower abd pain, fever, ‚Üë‚Üë‚Üë WBC Pseudomembranous colitis: above sx + pseudomembranes + bowel wall thickening Fulminant colitis (2‚Äì3%): toxic megacolon (colonic atony/absence of BMs, colon dilatation ‚â•6 cm on KUB, systemic toxicity) and/or bowel perforation [[Clostridioides difficile - sanford guide]] [[Zar score]] Explain by ChatGPT Clostridioides difficile infection is a infection caused by a bacteria.</description></item><item><title>Clinical manifestations-crohn‚Äôs disease</title><link>https://www.physician.tw/Clinical-manifestations-crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-crohns-disease/</guid><description>Clinical manifestations-crohn‚Äôs disease Abdominal pain,
loose/frequent stools (up to 50% ‚äï FOBT),
malaise,
wt loss</description></item><item><title>Clinical manifestations-Cushing‚Äôs Syndrome</title><link>https://www.physician.tw/Clinical-manifestations-Cushings-Syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Cushings-Syndrome/</guid><description>Clinical manifestations-Cushing‚Äôs Syndrome Nonspecific: glucose intolerance or DM, HTN, obesity, oligo- or amenorrhea, osteoporosis More specific: central obesity w/ extremity wasting, dorsocervical fat pads, spont.</description></item><item><title>Clinical manifestations-diabetic ketoacidosis</title><link>https://www.physician.tw/Clinical-manifestations-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-diabetic-ketoacidosis/</guid><description>Clinical manifestations-diabetic ketoacidosis (Diabetes Care 2009;32:1335 &amp;amp; 2016;39:S99)
ÂèÉËÄÉ‚û°Ô∏è Guidelines for management of diabetic ketoacidosis: time to revise?
Polyuria, polydipsia, &amp;amp; dehydration ‚Üí ‚Üë HR, HoTN, dry mucous membranes, ‚Üì skin turgor N/V, abdominal pain (either due to intra-abdominal process or DKA), ileus [[Kussmaul‚Äôs respirations]] (deep) to compensate for metabolic acidosis with odor of acetone Œî MS ‚Üí somnolence, stupor, coma; mortality ~1% even at tertiary care centers ÂêÉÂ§öÂñùÂ§öÂ∞øÂ§ö„ÄÅÂôÅÂêêËÖπÁóõÊòèÂñò</description></item><item><title>Clinical manifestations-hyperaldosteronism</title><link>https://www.physician.tw/Clinical-manifestations-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hyperaldosteronism/</guid><description>Clinical manifestations-hyperaldosteronism Mild-to-moderate HTN: 16-22% of all HTN, 11% of refractory cases (Annals 2020;173:10) Headache, muscle weakness, polyuria, polydipsia; no peripheral edema because of ‚Äúescape‚Äù from Na retention; malignant HTN is rare Classically hypokalemia (but often normal), metabolic alkalosis, mild hypernatremia</description></item><item><title>Clinical manifestations-hypercalcemia</title><link>https://www.physician.tw/Clinical-manifestations-hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hypercalcemia/</guid><description>Clinical manifestations-hypercalcemia (‚Äúbones, stones, abdominal groans, and psychic moans‚Äù)
[[Primary hyperparathyroidism]]
Hypercalcemic crisis (usually when Ca &amp;gt;13‚Äì15): polyuria, dehydration, ŒîMS</description></item><item><title>Clinical manifestations-hyperkalemia</title><link>https://www.physician.tw/Clinical-manifestations-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hyperkalemia/</guid><description>Clinical manifestations-hyperkalemia Weakness, nausea, paresthesias, palpitations; Renal: ‚Üì NH4+ secretion ‚Üí acidosis
ECG: ST depression, peaked T waves, ‚Üì QT, ‚Üë PR interval, ‚Üë QRS width, loss of P wave, sine wave pattern, PEA/VF (ECG: low sens.</description></item><item><title>Clinical manifestations-hypocalcemia</title><link>https://www.physician.tw/Clinical-manifestations-hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hypocalcemia/</guid><description>Clinical manifestations-hypocalcemia Neuromuscular irritability: perioral paresthesias, cramps, ‚äï Trousseau‚Äôs (inflation of BP cuff ‚â•3 min ‚Üí carpal spasm), ‚äï Chvostek‚Äôs (tapping facial nerve ‚Üí contraction of facial muscles), laryngospasm; irritability, depression, psychosis, seizures, ‚Üë QT</description></item><item><title>Clinical manifestations-hypokalemia</title><link>https://www.physician.tw/Clinical-manifestations-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hypokalemia/</guid><description>Clinical manifestations-hypokalemia Nausea, vomiting, ileus, weakness, muscle cramps, rhabdomyolysis, ‚Üì insulin secretion
Renal: ammoniagenesis, phosphaturia, hypocitraturia, NaCl &amp;amp; HCO3 retention, polyuria</description></item><item><title>Clinical manifestations-mitral-stenosis</title><link>https://www.physician.tw/Clinical-manifestations-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-mitral-stenosis/</guid><description>Clinical manifestations-mitral-stenosis Dyspnea and pulmonary edema (if due to RHD, sx usually begin in 30s) precipitants: exercise, fever, anemia, volume overload (incl.</description></item><item><title>Clinical manifestations-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Clinical-manifestations-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-necrotizing-soft-tissue-infections/</guid><description>Clinical manifestations-necrotizing soft-tissue infections Erythema, edema, warmth + systemic illness ¬± crepitus, bullae, necrosis Rapid progression of clinical signs Pain out of proportion to apparent cellulitis; skin hyperesthetic and later anesthetic</description></item><item><title>Clinical manifestations-nephrolithiasis</title><link>https://www.physician.tw/Clinical-manifestations-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-nephrolithiasis/</guid><description>Clinical manifestations-nephrolithiasis Hematuria (absence does not exclude diagnosis), flank pain, N/V, dysuria, frequency
Ureteral obstruction (stones &amp;gt;5 mm unlikely to pass spont.</description></item><item><title>Clinical manifestations-osteomyelitis</title><link>https://www.physician.tw/Clinical-manifestations-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-osteomyelitis/</guid><description>Clinical manifestations-osteomyelitis Surrounding soft-tissue compromise ¬± fistula to superficial skin
¬± Fever, malaise, and night sweats (more common in hematogenous than contiguous)</description></item><item><title>Clinical manifestations-pericardial tamponade</title><link>https://www.physician.tw/Clinical-manifestations-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-pericardial-tamponade/</guid><description>Clinical manifestations-pericardial tamponade Cardiogenic shock (hypotension, fatigue) without pulmonary edema Dyspnea (seen in ~85%) may be due to ‚Üë respiratory drive to augment venous return ÁóáÁãÄÔºöËÉ∏Áóõ„ÄÅÊöàÂé•ÂâçÂÖÜÊàñÊöàÂé•„ÄÅÂëºÂê∏Âõ∞Èõ£ÊàñÂëºÂê∏ÊÄ•‰øÉ„ÄÅÁ´ØÂùêÂëºÂê∏ È´îÊ†ºÊ™¢Êü•Ôºö‰ΩéË°ÄÂ£ì„ÄÅÂøÉÂãïÈÅéÈÄü„ÄÅJVP ÂçáÈ´ò„ÄÅÁÑ°ËÇ∫ÁàÜË£ÇÈü≥„ÄÅÂøÉÈü≥Ê∏õÂº±„ÄÅÂøÉÂåÖÊë©Êì¶Èü≥ÔºàÁΩïË¶ãÔºâ„ÄÅÂ§ñÂë®Ê∞¥ËÖ´ ÁüõÁõæËÑàÔºàÂê∏Ê∞£ÊôÇÊî∂Á∏ÆÂ£ìÈôç‰Ωé&amp;gt;10 mmHgÔºâ ECGÔºö‰∏çÊïèÊÑüÊàñÁâπÁï∞ÔºöÂøÉÂãïÈÅéÈÄü„ÄÅ‰ΩéÈõªÂ£ìÔºàËÇ¢È´îÂ∞éËÅØÊúÄÂ§ß QRS ÊåØÂπÖ &amp;lt;0.</description></item><item><title>Clinical manifestations-pericarditis and pericardial effusion</title><link>https://www.physician.tw/Clinical-manifestations-pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-pericarditis-and-pericardial-effusion/</guid><description>Clinical manifestations-pericarditis and pericardial effusion NEJM 2014;371:2410; JACC 2020;75:76)
Pericarditis: retrosternal CP, pleuritic, positional (often ‚Üì by sitting forward), ‚Üí trapezius; may be absent in TB, neoplastic, XRT, or uremic; ¬± fever; ¬± s/s of systemic etiologies</description></item><item><title>Clinical manifestations-pheochromocytoma and paraganglioma</title><link>https://www.physician.tw/Clinical-manifestations-pheochromocytoma-and-paraganglioma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-pheochromocytoma-and-paraganglioma/</guid><description>Clinical manifestations-pheochromocytoma and paraganglioma (NEJM 2019;381:552)
Neuroendocrine neoplasm leads to inappropriate and paroxysmal release of adrenergic agents including epinephrine, norepinephrine, and rarely dopamine Classic triad: episodic headaches, palpitations and profuse sweating; only 50% have paroxysmal hypertension and most Pts do not have three classic sx Paroxysms can be triggered by meds (eg, Œ≤-blockers), abdominal manipulation Up to 40% of pheos/paragangliomas thought to have underlying genetic etiology; genetic testing frequently recommended Associated with MEN2A/2B, von Hippel Lindau, NF1, familial paraganglioma (mutations in succinate dehydrogenase gene B, C and D), MAX or TMEM127 mutations</description></item><item><title>Clinical manifestations-Portal vein thrombosis PVT</title><link>https://www.physician.tw/Clinical-manifestations-Portal-vein-thrombosis-PVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Portal-vein-thrombosis-PVT/</guid><description>Clinical manifestations-Portal vein thrombosis (PVT) acute: abd pain, fever, variceal bleed or asx w/ incidental finding on U/S or CT. If mesenteric vein involved may p/w intestinal infarct.</description></item><item><title>Clinical manifestations-Screening for latent TB</title><link>https://www.physician.tw/Clinical-manifestations-Screening-for-latent-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Screening-for-latent-TB/</guid><description>Clinical manifestations-Screening for latent TB (Lancet 2016;387:1211)
Constitutional symptoms are common in all manifestations, but may be absent Primary TB pneumonia: middle or lower lobe consolidation, ¬± effusion, ¬± cavitation TB pleurisy: pulmonary effusion ¬± pericardial and peritoneal effusions secondary to granuloma breakdown and local inflammation; can occur in primary or reactivation Reactivation TB pulmonary disease: upper lobe infiltrate ¬± volume loss ¬± cavitation Milliary TB: diffuse millet seed-sized lesions, more common in immunosupp.</description></item><item><title>Clinical manifestations-ulcerative colitis</title><link>https://www.physician.tw/Clinical-manifestations-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-ulcerative-colitis/</guid><description>Clinical manifestations-ulcerative colitis Grossly bloody diarrhea, lower abdominal cramps, tenesmus, small, frequent BM
Extracolonic (&amp;gt;25%): erythema nodosum, pyoderma gangrenosum, aphthous ulcers, uveitis, episcleritis, thromboembolic events (esp.</description></item><item><title>Clinical manifestations-urinary tract infections</title><link>https://www.physician.tw/Clinical-manifestations-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-urinary-tract-infections/</guid><description>Clinical manifestations-urinary tract infections [[cystitis]] Urethritis: dysuria, urethral discharge (see ‚ÄúSTI‚Äù) [[prostatitis]] pyelonephritis: fever, chills, flank or back pain, nausea, vomiting, diarrhea Renal abscess: pyelonephritis sx + persistent fever on appropriate antibiotics</description></item><item><title>Clinical manifestations‚ÄîDVT</title><link>https://www.physician.tw/Clinical-manifestationsDVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestationsDVT/</guid><description>Clinical manifestations‚ÄîDVT Calf pain
swelling (&amp;gt;3 cm c/w unaffected side)
venous distention
erythema, warmth, tenderness, palpable cord,</description></item><item><title>Clinical manifestations‚ÄîPE</title><link>https://www.physician.tw/Clinical-manifestationsPE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestationsPE/</guid><description>Clinical manifestations‚ÄîPE Dyspnea (~50%),
pleuritic chest pain (~40%),
cough (~23%),
hemoptysis (~8%)</description></item><item><title>clinical reasoning</title><link>https://www.physician.tw/clinical-reasoning/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-reasoning/</guid><description>clinical reasoning [[The Profession of Medicine]] [[positive and negative predictive values of tests]] [[symptom to diagnosis]] [[Physical Exam Secret]] [[National Academy of Medicine Recommendations for Improving Diagnosis in Health Care]] [[selected cognitive biases contributing to diagnostic errors]] [[Conceptualizing Diagnosis and Diagnosis Improvement]] cardinal manifestations ¬†[[Cardinal Manifestations and Presentation of Diseases]]</description></item><item><title>Clinical-manifestations-aortic-regurgitation</title><link>https://www.physician.tw/Clinical-manifestations-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-aortic-regurgitation/</guid><description>Clinical-manifestations-aortic-regurgitation Acute: sudden ‚Üì forward SV and ‚Üë LVEDP (noncompliant ventricle) ‚Üí pulmonary edema ¬± hypotension and cardiogenic shock Chronic: clinically silent while LV dilates (to ‚Üë compliance to keep LVEDP low) more than it hypertrophies ‚Üí chronic volume overload ‚Üí LV decompensation ‚Üí CHF Natural hx: variable progression (unlike AS, can be fast or slow); once decompensation begins, prognosis poor w/o AVR (mortality ~10%/y)</description></item><item><title>Clinical-manifestations-aortic-stenosis</title><link>https://www.physician.tw/Clinical-manifestations-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-aortic-stenosis/</guid><description>Clinical-manifestations-aortic-stenosis (usually indicates AVA &amp;lt;1 cm2 or concomitant CAD
Angina: ‚Üë O2 demand (hypertrophy) + ‚Üì O2 supply (‚Üì cor perfusion pressure) ¬± CAD Syncope (exertional): peripheral vasodil.</description></item><item><title>Clinical-manifestations-mitral-regurgitation</title><link>https://www.physician.tw/Clinical-manifestations-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-mitral-regurgitation/</guid><description>Clinical-manifestations-mitral-regurgitation Acute: sudden ‚Üì forward SV and ‚Üë LVEDP (noncompliant ventricle) ‚Üí pulmonary edema ¬± hypotension and cardiogenic shock Chronic: clinically silent while LV dilates (to ‚Üë compliance to keep LVEDP low) more than it hypertrophies ‚Üí chronic volume overload ‚Üí LV decompensation ‚Üí CHF Natural hx: variable progression (unlike AS, can be fast or slow); once decompensation begins, prognosis poor w/o AVR (mortality ~10%/y)</description></item><item><title>Clopidogrel</title><link>https://www.physician.tw/Clopidogrel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clopidogrel/</guid><description>Clopidogrel 300‚Äì600 mg √ó 1 ‚Üí 75 mg qd ~6 h to steady state Wait 5 d prior to surgery ASA+clopi ‚Üí 20% ‚Üì CVD/MI/stroke vs.</description></item><item><title>clostridioides difficile infection</title><link>https://www.physician.tw/clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clostridioides-difficile-infection/</guid><description>clostridioides difficile infection [[Pathogenesis epidemiology-clostridioides difficile infection]] [[Clinical manifestations-clostridioides difficile infection]] [[Diagnosis-clostridioides difficile infection]] [[Initial treatment-clostridioides difficile infection ]] [[Recurrent infection-clostridioides difficile infection]] Figure: BacklinkÔºö [[bacterial inflammatory acute diarrhea]] [[diarrhea]] [[fluoroquinolones]]</description></item><item><title>Cluster headache</title><link>https://www.physician.tw/Cluster-headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cluster-headache/</guid><description>Cluster headache and other trigeminal autonomic cephalalgias (TACs) (Continuum 2018;24:1137) Characterized by unilateral headache a/w ipsilateral autonomic sx (rhinorrhea, red/tearing eye, miosis, ptosis, lid edema, sweating), subtypes differentiated by timing.</description></item><item><title>CMV-negative</title><link>https://www.physician.tw/CMV-negative/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CMV-negative/</guid><description>CMV-negative From CMV-negative donors. For CMV-seronegative pregnant women, transplant candidates/recipients, SCID, AIDS Pts.</description></item><item><title>coagulation cascade and sites of action for anticoagulants</title><link>https://www.physician.tw/coagulation-cascade-and-sites-of-action-for-anticoagulants/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coagulation-cascade-and-sites-of-action-for-anticoagulants/</guid><description>coagulation cascade and sites of action for anticoagulants See ‚ÄúCoagulopathies‚Äù for reversal agents for anticoagulants. APC, activated protein C; AT, antithrombin; PrC, protein C; PrS, protein S; TF, tissue factor; TFPI, tissue factor pathway inhib.</description></item><item><title>Coagulation factor inhibitors</title><link>https://www.physician.tw/Coagulation-factor-inhibitors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coagulation-factor-inhibitors/</guid><description>Coagulation factor inhibitors (anti-factor antibodies; anti-factor VIII most common)
Etiologies: hemophilia; postpartum; lymphoproliferative &amp;amp; autoimmune disorders; cancers
Diagnosis: ‚Üë PTT (does not normalize w/ mixing study); Bethesda assay quantitates titer</description></item><item><title>coagulopathies</title><link>https://www.physician.tw/coagulopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coagulopathies/</guid><description>coagulopathies [[Screening Test Abnormalities in Inherited and Acquired Coagulopathies]] [[Further coagulation tests]] [[Hemophilias]] [[Coagulation factor inhibitors]] [[Disseminated intravascular coagulation (DIC)]] [[Vitamin K deficiency]] [[Properties and Antidotes for Anticoagulants Fibrinolytics]] [[The Coagulation Cascade]]</description></item><item><title>Coccidioidomycosis</title><link>https://www.physician.tw/Coccidioidomycosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coccidioidomycosis/</guid><description>Coccidioidomycosis Epidemiology: endemic to SW U.S., Central and South America Clinical manifestations Acute: subclinical PNA, arthralgias, rash (erythema nodosum) Chronic lung disease (seen in immunosupp): dyspnea, chest pain, hemoptysis, ‚ÄúB‚Äù sx Disseminated (immunosupp, pregnant): meningitis, osteo, monoarthritis, cutaneous Treatment: no Rx for mild PNA in immunosupp.</description></item><item><title>Collagen vascular diseases</title><link>https://www.physician.tw/Collagen-vascular-diseases/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Collagen-vascular-diseases/</guid><description>Collagen vascular diseases (Chest 2013;143:814)
Rheumatologic disease Scleroderma: ILD in ~50%; PHT seen in ~10% of Pts with limited disease</description></item><item><title>colonoscopy for LGIB</title><link>https://www.physician.tw/colonoscopy-for-LGIB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/colonoscopy-for-LGIB/</guid><description>colonoscopy for LGIB colonoscopy (identifies cause in &amp;gt;70%); early colo (w/in 24 h) unlikely to improve outcome vs. late (24-96 h) (Gastro 2020;158:168).</description></item><item><title>colorectal cancer</title><link>https://www.physician.tw/colorectal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/colorectal-cancer/</guid><description>colorectal cancer colon cancer Ëä±ÂúíÂ§ßÈñÄÂè£
[[Role of Circulating Tumor DNA in Guiding Adjuvant Therapy in Colon Cancer]]
colon cancer</description></item><item><title>Common biases in clinical reasoning</title><link>https://www.physician.tw/Common-biases-in-clinical-reasoning/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-biases-in-clinical-reasoning/</guid><description>Common biases in clinical reasoning Availability ‰∏ã‰∫ÜËá™Â∑±ÁÜüÁöÑÁöÑË®∫Êñ∑ Considering easily remembered diagnoses more likely irrespective of prevalence
Base rate neglect Êâæ‰∫ÜÊñëÈ¶¨ Pursuing &amp;ldquo;zebras‚Äù</description></item><item><title>Common Diagnostic Tests in Thyroid Disorders</title><link>https://www.physician.tw/Common-Diagnostic-Tests-in-Thyroid-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Diagnostic-Tests-in-Thyroid-Disorders/</guid><description>Common Diagnostic Tests in Thyroid Disorders Thyroid-stimulating hormone (TSH) Most sensitive test to detect 1¬∞ hypo- and hyperthyroidism. Used as primary screening test for thyroid disease.</description></item><item><title>Common Etiologies of SVT</title><link>https://www.physician.tw/Common-Etiologies-of-SVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Etiologies-of-SVT/</guid><description>Common Etiologies of SVT Atrial Sinus tachycardia (ST) Caused by pain, fever, hypovolemia, hypoxia, PE, anemia, anxiety, withdrawal, Œ≤-agonists, etc.</description></item><item><title>Common Pacing Modes</title><link>https://www.physician.tw/Common-Pacing-Modes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Pacing-Modes/</guid><description>Common Pacing Modes VVI Ventricular pacing on demand w/ single lead in RV. Sensed ventricular beat inhibits V pacing. Used in chronic AF with symptomatic bradycardia.</description></item><item><title>Commonly drug-induced Acute interstitial nephritis</title><link>https://www.physician.tw/Commonly-drug-induced-Acute-interstitial-nephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Commonly-drug-induced-Acute-interstitial-nephritis/</guid><description>Commonly drug-induced Acute interstitial nephritis Œ≤-lactams, sulfa drugs, NSAIDs, PPIs, quinolones, allopurinol</description></item><item><title>Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Comparison-of-bronchodilator-responsiveness-in-asthma-and-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Comparison-of-bronchodilator-responsiveness-in-asthma-and-chronic-obstructive-pulmonary-disease/</guid><description>Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease Â∞áÊîØÊ∞£ÁÆ°Êì¥ÂºµÂäëÂèçÊáâË¶ñÁÇ∫ÈôΩÊÄßÁöÑÂÖ∂‰ªñÊ®ôÊ∫ñÊòØÊîØÊ∞£ÁÆ°Êì¥ÂºµÂäëÂæå FEV1 ÁôæÂàÜÊØîÂ¢ûÂä†Â§ßÊñºÂü∫Á∑öÁöÑ 15%ÔºåÊîØÊ∞£ÁÆ°Êì¥ÂºµÂäëÂæå FEV1 Â¢ûÂä†Â§ßÊñºÈ†êÊ∏¨ÂÄºÁöÑ 10% (10) Êàñ FEV1 ÁµïÂ∞çÂ¢ûÂä† 400 ml (6)„ÄÇ</description></item><item><title>Compensation-for-Acid-Base-Disorders</title><link>https://www.physician.tw/Compensation-for-Acid-Base-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Compensation-for-Acid-Base-Disorders/</guid><description>Compensation-for-Acid-Base-Disorders (NEJM 2014;371:1434) Respiratory: hyper/hypoventilation alters PaCO2 to counteract 1¬∞ metabolic process Renal: excretion/retention of H+/HCO3‚Äì to counteract 1¬∞ respiratory process Respiratory compensation occurs in mins-hrs; renal compensation takes days</description></item><item><title>Complicated vs uncomplicated parapneumonic</title><link>https://www.physician.tw/Complicated-vs-uncomplicated-parapneumonic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complicated-vs-uncomplicated-parapneumonic/</guid><description>Complicated vs uncomplicated parapneumonic complicated ‚äï Gram stain or culture or pH &amp;lt;7.2 or glucose &amp;lt;60
complicated parapneumonic effusions usually require tube thoracostomy for resolution</description></item><item><title>Complications Gastro 2020;158:760</title><link>https://www.physician.tw/Complications-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-gastroesophageal-reflux-disease/</guid><description>Complications (Gastro 2020;158:760) Reflux esophagitis (erosions/ulcers above GE jxn), strictures (caused by chronic inflamm) [[Barrett‚Äôs esophagitis]].</description></item><item><title>Complications &amp; prognosis-venous thromboembolism</title><link>https://www.physician.tw/Complications-prognosis-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-prognosis-venous-thromboembolism/</guid><description>Complications &amp;amp; prognosis-venous thromboembolism [[postthrombotic syndrome]] (23‚Äì60%) pain, edema, venous ulcers
Recurrent VTE:
1%/y (after 1st VTE) to 5%/y (after recurrent VTE) Chronic thromboembolic PHT after acute PE ~2‚Äì3%, consider thromboendarterectomy</description></item><item><title>Complications gastroesophageal reflux disease</title><link>https://www.physician.tw/Complications-gastroesophageal-reflux-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-gastroesophageal-reflux-disease-/</guid><description>Complications gastroesophageal reflux disease (Gastro 2020;158:760)
Reflux esophagitis (erosions/ulcers above GE jxn), strictures (caused by chronic inflamm)
Barrett‚Äôs esoph.</description></item><item><title>complications of bacterial meningitis</title><link>https://www.physician.tw/complications-of-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-bacterial-meningitis/</guid><description>complications of bacterial meningitis The neurologic complications of bacterial meningitis include: Impaired mental status
Increased intracranial pressure and cerebral edema</description></item><item><title>complications of HIV AIDS</title><link>https://www.physician.tw/complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-HIV-AIDS/</guid><description>complications of HIV AIDS Any S. pneumo, TB, VZV, HPV complications, Kaposi‚Äôs sarcoma, lymphoma, ‚Üë CVD risk, ‚Üì bone density.</description></item><item><title>Complications of HTN</title><link>https://www.physician.tw/Complications-of-HTN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-of-HTN/</guid><description>Complications of HTN ËÖ¶ÂøÉÁÆ°ÁúºËÖé
Neurologic: TIA/CVA, ruptured aneurysms, vascular dementia
Retinopathy stage I = arteriolar(Â∞èÂãïËÑà) narrowing stage II = copper-wiring, AV nicking stage III = hemorrhages and exudates stage IV = papilledema Cardiac: CAD, LVH, HF, AF</description></item><item><title>Complications PA catheter and tailored therapy</title><link>https://www.physician.tw/Complications-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-PA-catheter-and-tailored-therapy/</guid><description>Complications PA catheter and tailored therapy Central venous access: pneumo/hemothorax (~1%), arterial puncture (if inadvertent cannulation w/ dilation ‚Üí surgical/endovasc eval), air embolism, thoracic duct injury</description></item><item><title>Complications-acute aortic syndromes</title><link>https://www.physician.tw/Complications-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-acute-aortic-syndromes/</guid><description>Complications-acute aortic syndromes (occur in ~20%; Circ 2010;121:e266; Lancet 2015;385:800)
Freq assess (sx, BP, UOP), pulses, labs (Cr, Hb, lactic acid), imaging (~7 d or sooner if ‚àÜs) Uncontrolled BP or persistent pain may indicate complication/extension Progression: propagation of dissection, ‚Üë aneurysm size, ‚Üë false lumen size Rupture: pericardial sac ‚Üí tamponade (avoid pericardiocentesis unless PEA); blood in pleural space, mediast.</description></item><item><title>Complications-acute pancreatitis</title><link>https://www.physician.tw/Complications-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-acute-pancreatitis/</guid><description>Complications-acute pancreatitis Systemic: ARDS, abdominal compartment syndrome, AKI, GIB (pseudoaneurysm), DIC
Metabolic: hypocalcemia, hyperglycemia, hypertriglyceridemia
Fluid collections:</description></item><item><title>Complications-aortic aneurysms</title><link>https://www.physician.tw/Complications-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-aortic-aneurysms/</guid><description>Complications-aortic aneurysms (Circ 2010;121:e266; Nat Rev Cardiol 2011;8:92)
Pain: gnawing chest, back, or abdominal pain; new or worse pain may signal rupture Rupture: risk ‚Üë w/ diameter, ‚ôÄ, current smoking, HTN TAA: ~2.</description></item><item><title>Complications-cholecystitis</title><link>https://www.physician.tw/Complications-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-cholecystitis/</guid><description>Complications- [[cholecystitis]] Gangrenous cholecystitis: necrosis w/ risk of empyema and perforation
Emphysematous cholecystitis: infection by gas-forming organisms (air in GB wall)</description></item><item><title>Complications-cholelithiasis</title><link>https://www.physician.tw/Complications-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-cholelithiasis/</guid><description>Complications-cholelithiasis Cholecystitis: 20% of Pts with symptomatic biliary pain progress to cholecystitis w/in 2 y
Choledocholithiasis ‚Üí cholangitis or gallstone pancreatitis</description></item><item><title>Complications-crohn‚Äôs disease</title><link>https://www.physician.tw/Complications-crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-crohns-disease/</guid><description>Complications-crohn‚Äôs disease Perianal disease: fissures, fistulas, skin tags, perirectal abscesses (in 24% of Pts; perianal disease precedes intestinal symptoms)</description></item><item><title>Complications-diabetes mellitus</title><link>https://www.physician.tw/Complications-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-diabetes-mellitus/</guid><description>Complications-diabetes mellitus (NEJM 2004;350:48; 2016;374:1455; CJASN 2017;12:1366)
[[retinopathy of diabetes mellitus]] [[nephropathy of diabetes mellitus]] [[neuropathy of diabetes mellitus]]</description></item><item><title>Complications-prosthetic-heart-valves</title><link>https://www.physician.tw/Complications-prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-prosthetic-heart-valves/</guid><description>Complications-prosthetic-heart-valves Structural failure (r/o endocarditis); mechanical valves: rare except for Bjork-Shiley; bioprosth: up to 30% rate w/in 10‚Äì15 y, mitral &amp;gt;aortic; consider TAVR (JACC 2017; 69:2253) Paravalvular leak (r/o endocarditis); small central jet of regurg is normal in mech.</description></item><item><title>Complications-treatment-chronic kidney disease CKD</title><link>https://www.physician.tw/Complications-treatment-chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-treatment-chronic-kidney-disease-CKD/</guid><description>Complications-treatment-chronic kidney disease (CKD) (JAMA 2019;322:1294; KI 2021;99:S1)
General: renal referral when GFR &amp;lt;30 or proteinuria, access planning (avoid subclavian lines, preserve an arm by avoiding phlebotomy, BP measurements, IVs)</description></item><item><title>Complications-ulcerative colitis</title><link>https://www.physician.tw/Complications-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-ulcerative-colitis/</guid><description>Complications-ulcerative colitis Toxic megacolon (5%): colon dilatation (‚â•6 cm on KUB), colonic atony, systemic toxicity, &amp;amp; ‚Üë risk of perf.</description></item><item><title>computed tomogram in central nervous system infection</title><link>https://www.physician.tw/computed-tomogram-in-central-nervous-system-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/computed-tomogram-in-central-nervous-system-infection/</guid><description>computed tomogram in central nervous system infection ‰ªÄÈ∫ºÊÉÖÊ≥Å‰∏ãË¶ÅÂÖàÂÅöCTÂÜçÂÅöLumbar PunctureÔºö #üìö The most appropriate sequence in managing a patient with suspected bacterial meningitis and a new-onset, 10-second seizure is to obtain blood cultures, then initiate dexamethasone and empiric antimicrobial therapy, and then obtain a CT scan of the head (before performing a lumbar puncture)</description></item><item><title>config</title><link>https://www.physician.tw/config/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/config/</guid><description>echo -e &amp;ldquo;site name:MyDocs\ntheme:\n\tname:material&amp;rdquo; &amp;raquo; /volume1/docker/mkdocs/mkdocs.yml
docker run &amp;ndash;rm -i -v /volume1/docker/mkdocs:/docs squidfunk/mkdocs-material new . docker run -d &amp;ndash;name=mkdocs -p 9898:8000 -v /volume1/docker/mkdocs:/docs &amp;ndash;restart always squidfunk/mkdocs-material</description></item><item><title>Confusion and Delirium</title><link>https://www.physician.tw/Confusion-and-Delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Confusion-and-Delirium/</guid><description>Confusion and Delirium [[terms used to describe patients with delirium]]
altered attention &amp;amp; awareness,
develops over hrs to days,</description></item><item><title>Connective tissue disease as Etiologies of Classic FUO</title><link>https://www.physician.tw/Connective-tissue-disease-as-Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Connective-tissue-disease-as-Etiologies-of-Classic-FUO/</guid><description>Connective tissue disease as Etiologies of Classic FUO [[Giant cell arteritis]] [[Polymyalgia rheumatica]] headache, scalp pain, jaw claudication, visual disturbances, myalgias, arthralgias, ‚Üë ESR</description></item><item><title>Consciousness Arousal</title><link>https://www.physician.tw/Consciousness-Arousal/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Consciousness-Arousal/</guid><description>Consciousness Arousal Arousal: spectrum from awake/alert ‚Üí drowsy ‚Üí stupor ‚Üí coma Terms vague &amp;amp; subjective, so most useful to describe response to increasing stimulation (eg, voice ‚Üí noxious).</description></item><item><title>Consequences-of-Severe-Acid-Base-Disturbances</title><link>https://www.physician.tw/Consequences-of-Severe-Acid-Base-Disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Consequences-of-Severe-Acid-Base-Disturbances/</guid><description>Consequences-of-Severe-Acid-Base-Disturbances (NEJM 1998;338:26 &amp;amp; 107)
Cardiovascular Acidemia (pH &amp;lt;7.20) ‚Üì contractility, arteriolar vasodilation ‚Üì MAP &amp;amp; CO; ‚Üì response to catecholamines ‚Üë risk of arrhythmias Alkalemia (pH &amp;gt;7.</description></item><item><title>Consider Advanced Airway</title><link>https://www.physician.tw/Consider-Advanced-Airway/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Consider-Advanced-Airway/</guid><description>Consider Advanced Airway Endotracheal intubation or supraglottic advanced aiway Clinical assessment: bilat. chest expansion &amp;amp; breath sounds Device to ‚úî tube placement Continuous waveform capnography (~100% Se ÔºÜ Sp) Colorimetric exhaled CO, detection (~clinical assess.</description></item><item><title>consider the potential harms</title><link>https://www.physician.tw/consider-the-potential-harms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consider-the-potential-harms/</guid><description>consider the potential harms Consider the potential harms of both a missed diagnosis and the treatment. A. It is very harmful to miss certain diagnoses, such as MI or pulmonary embolism, while it is not so harmful to miss others, such as mild carpal tunnel syndrome.</description></item><item><title>Constipation</title><link>https://www.physician.tw/Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Constipation/</guid><description>Constipation (Annals 2015;162:ITC1, Nat Rev Dis Primers 2017;3:17095; JAMA 2019;322:2239)
[[Definition of Constipation]] [[Etiologies of Constipation]] Dx: H&amp;amp;P w/ DRE.</description></item><item><title>constrictive pericarditis</title><link>https://www.physician.tw/constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/constrictive-pericarditis/</guid><description>constrictive pericarditis [[Etiology-constrictive pericarditis]] [[Pathophysiology-constrictive pericarditis]]
Clinical manifestations (NEJM 2011;364:1350)
Right-sided &amp;gt;left-sided heart failure (systemic congestion &amp;gt;pulmonary congestion) [[Physical exam-constrictive pericarditis]] [[Diagnostic studies-constrictive pericarditis]] [[Constrictive Pericarditis vs.</description></item><item><title>Contact</title><link>https://www.physician.tw/Contact/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contact/</guid><description>Site officiel: http://www.notational.net/fr/
D√©velopment: http://github.com/scrod/nv/tree/
Contact: Zachary Schneirov scrod@notational.net
Traduction: David Bosman david.bosman@gmail.com</description></item><item><title>Context sensitive half time</title><link>https://www.physician.tw/Context-sensitive-half-time/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Context-sensitive-half-time/</guid><description>Context sensitive half time Context sensitive half time | Deranged Physiology</description></item><item><title>Continuous veno-venous hemofiltration CVVH</title><link>https://www.physician.tw/Continuous-veno-venous-hemofiltration-CVVH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Continuous-veno-venous-hemofiltration-CVVH/</guid><description>Continuous veno-venous hemofiltration (CVVH) Hemofiltration rather than dialysis. Blood under pressure passes down one side highly permeable membrane filtering H2O and solutes via TMP gradient (convective clearance); filtrate discarded.</description></item><item><title>Contraindications to Fibrinolysis</title><link>https://www.physician.tw/Contraindications-to-Fibrinolysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contraindications-to-Fibrinolysis/</guid><description>Contraindications to Fibrinolysis Absolute Contraindications *Any prior ICH *Intracranial neoplasm, aneurysm, AVM *Ischemic stroke or closed head trauma w/in 3 mo; head/spinal surg.</description></item><item><title>Contrast-induced acute kidney injury</title><link>https://www.physician.tw/Contrast-induced-acute-kidney-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contrast-induced-acute-kidney-injury/</guid><description>Contrast-induced acute kidney injury Definition increase in the creatinine of 0.5mg/dL or a 25% increase from basline w/i 3 days after the contrast media and abscense of alternative cause (CIAKI) (NEJM 2019;380:2146) natural history 24-48h increase after exposure and peak at 3-5 days resolves in 7 to 10 days if prolonged duration: look for other cause, e.</description></item><item><title>Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor</title><link>https://www.physician.tw/Control-of-Mineral-Homeostasis-by-Parathyroid-Hormone-and-the-Calcium-Sensing-Receptor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Control-of-Mineral-Homeostasis-by-Parathyroid-Hormone-and-the-Calcium-Sensing-Receptor/</guid><description>Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor ÈáçË¶ÅÂêçË©ûÔºö Èà£ÊïèÊÑüÂèóÈ´îÔºöcalcium-sensing receptor (CaSR), ÈáçÈªû Ë°ÄÈà£Èôç‰ΩéÊúÉÂºïÁôº: ‰∏ªË¶ÅÈÄöÈÅéÁî≤ÁãÄÊóÅËÖ∫ÊøÄÁ¥† (PTH) ÂíåÈõ¢Â≠êÈà£ (Ca2+) Â∞ç PTH ÂèóÈ´îÂíåÈà£ÊïèÊÑüÂèóÈ´î (CaSR) ÁöÑ‰ΩúÁî®‰ªãÂ∞éÔºåÈÄôÂÖ©ËÄÖÈÉΩÊòØ 7-Ë∑®ËÜúGËõãÁôΩÂÅ∂ËÅØÂèóÈ´î( 7-transmembrane, G-protein‚Äìcoupled receptors.</description></item><item><title>Controller medications</title><link>https://www.physician.tw/Controller-medications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Controller-medications/</guid><description>Controller medications (JAMA 2020;324:2301)
ICS Rx of choice. Superior to LAMA if sputum w/ ‚â•2% eos (NEJM 2019;380:2009). PO steroids may be needed for severely uncontrolled asthma; avoid if possible b/c of systemic side effects.</description></item><item><title>COP cryptogenic organizing PNA</title><link>https://www.physician.tw/COP-cryptogenic-organizing-PNA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COP-cryptogenic-organizing-PNA/</guid><description>COP cryptogenic organizing PNA Patchy, migratory consolidations; subpleural &amp;amp; peribronchial. Excessive proliferation of granulation tissue in small airways and alveolar ducts.</description></item><item><title>COPD Exacerbation Treatment</title><link>https://www.physician.tw/COPD-Exacerbation-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COPD-Exacerbation-Treatment/</guid><description>COPD Exacerbation Treatment [[Ipratropium of COPDAE]] [[Albuterol of COPDAE]] [[Corticosteroids of COPDAE]] [[Antibiotics of COPDAE]] [[Oxygenation of COPDAE]] [[Noninvasive positive-pressure ventilation of COPDAE]] [[Endotracheal intubation of COPDAE]] [[Other measures of COPDAE]] [[Post-exacerb care of COPDAE]]</description></item><item><title>Coronary angiography</title><link>https://www.physician.tw/Coronary-angiography/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-angiography/</guid><description>Coronary angiography Immediate/urgent coronary angiography (w/in 2 h) if refractory/recurrent angina or hemodynamic or electrical instability
Routine angiography (aka ‚Äúinvasive strategy‚Äù) = coronary angiography for all</description></item><item><title>coronary angiography PCI</title><link>https://www.physician.tw/coronary-angiography-PCI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronary-angiography-PCI/</guid><description>coronary angiography PCI Ë°Ä‰πãÂæ™Áí∞ÔºåÂëΩ‰πãÊâÄÂú®Ôºå ‰øùÂÖ∂ÂÅ•Â∫∑ÔºåÊ∞∏Á∫åÁîüÊ©ü„ÄÇ
Precath checklist Peripheral arterial exam (radial, femoral, DP, PT pulses; bruits); palmar arch eval (eg, w/ pulse oximetry &amp;amp; plethysmography) not routinely done.</description></item><item><title>Coronary artery bypass grafting CABG -related MI</title><link>https://www.physician.tw/Coronary-artery-bypass-grafting-CABG-related-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-artery-bypass-grafting-CABG-related-MI/</guid><description>Coronary artery bypass grafting (CABG)-related MI is arbitrarily defined as elevation of cTn values &amp;gt;10 times the 99th percentile URL in patients with normal baseline cTn values.</description></item><item><title>Coronary-angiography-for-SIHD</title><link>https://www.physician.tw/Coronary-angiography-for-SIHD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-angiography-for-SIHD/</guid><description>Coronary-angiography-for-SIHD High-risk noninvasive testing results suggestive of left main or multivessel CAD Angina that is refractory to optimal medical therapy Uncertain dx after noninvasive testing, occupational need (eg, pilot) Unexplained heart failure or ‚Üì EF</description></item><item><title>coronavirus covid-19</title><link>https://www.physician.tw/coronavirus-covid-19/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronavirus-covid-19/</guid><description>coronavirus (covid-19) Microbiology &amp;amp; epidemiology
Person-to-person transmission via respiratory particles; asx &amp;amp; pre-sx transmission can occur Incubation period: up to 14 days, median time of 4‚Äì5 days from exposure to sx onset Presentation Ranges from asx to severe illness.</description></item><item><title>Correction of overanticoagulation</title><link>https://www.physician.tw/Correction-of-overanticoagulation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Correction-of-overanticoagulation/</guid><description>Correction of overanticoagulation (Circ 2021;143:e72)
Risk from major bleeding must be weighed against risk of valve thrombosis Not bleeding: if INR 5‚Äì10, withhold warfarin Bleeding: PCC (or FFP); reversal agent for DOACs; ¬± low-dose (1 mg) vit K IV if on VKA</description></item><item><title>Corticosteroids for chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Corticosteroids-for-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Corticosteroids-for-chronic-obstructive-pulmonary-disease/</guid><description>Corticosteroids for chronic obstructive pulmonary disease (inhaled, ICS): ~11% ‚Üì in exacerbations &amp;amp; slows ‚Üì FEV1; no Œî in mortality (Lancet 2016;387:1817).</description></item><item><title>Corticosteroids of COPDAE</title><link>https://www.physician.tw/Corticosteroids-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Corticosteroids-of-COPDAE/</guid><description>Corticosteroids of COPDAE [[Prednisone]] 40 mg/d √ó 5d (JAMA 2013;309:2223); some Pts will benefit from higher dose/longer course if severe Methylprednisolone 125 mg IV q6h √ó 72 h for more severe exacerbations</description></item><item><title>COVID-19 associated AKI</title><link>https://www.physician.tw/COVID-19-associated-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COVID-19-associated-AKI/</guid><description>COVID-19 associated AKI</description></item><item><title>CPR‰∫∫ÂäõÈÖçÁΩÆ</title><link>https://www.physician.tw/CPR%E4%BA%BA%E5%8A%9B%E9%85%8D%E7%BD%AE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CPR%E4%BA%BA%E5%8A%9B%E9%85%8D%E7%BD%AE/</guid><description>CPR‰∫∫ÂäõÈÖçÁΩÆ Figure: ‰∏â‰∫∫ÁµÑÔºö
Êèõ‰∏ã‰æÜÁöÑ‰∫∫Ë¶ÅË≤†Ë≤¨check pulse Áµ¶Ëó•ÁöÑ‰∫∫Ë¶ÅË≤†Ë≤¨Èõª(Â¶ÇÊûúÂèØ‰ª•ÁöÑË©±) EndoÂâçË¶ÅÂÆåÊàêÂ£ìËÉ∏ÈõªÊìäÁµ¶Ëó•ÂÖ©ÂàÜÈêò</description></item><item><title>CPS-22C3</title><link>https://www.physician.tw/CPS-22C3/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CPS-22C3/</guid><description>CPS-22C3 PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs</description></item><item><title>CRC screening</title><link>https://www.physician.tw/CRC-screening/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CRC-screening/</guid><description>CRC screening (JAMA 2021;325:1978)
Colonoscopy gold standard. Other options: FOBT/FIT yearly, flex sig q5y or flex sig q10y + FIT every year, fecal DNA testing (eg, Cologuard) q3y or CT colonography q5y Start screening in average risk Pts at age 45 (typically q10y unless abnl found) If ‚äï FHx, start age 40, or 10 y before age of dx in youngest family member, repeat q5y</description></item><item><title>Criteria-Hepatorenal syndrome HRS</title><link>https://www.physician.tw/Criteria-Hepatorenal-syndrome-HRS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Criteria-Hepatorenal-syndrome-HRS/</guid><description>Criteria-Hepatorenal syndrome (HRS) (1) cirrhosis w/ ascites; (2) acute kidney injury (serum Cr ‚Üë ‚â•0.3 mg/dL w/in 48 h or ‚â•50% ‚Üë in serum Cr from baseline; Gut 2015;64:531) (3) √ò improvement in Cr after d/c diuretic &amp;amp; volume expansion (1 g/kg/d of albumin √ó 2 d); (4) √ò shock (prerenal azotemia/ATN); (5) √ò nephrotoxic meds; (6) √ò intrinsic kidney disease</description></item><item><title>crohn‚Äôs disease</title><link>https://www.physician.tw/crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crohns-disease/</guid><description>crohn‚Äôs disease (Lancet 2017;389:1741)
[[Clinical manifestations-crohn‚Äôs disease]] [[Diagnosis-crohn‚Äôs disease]] [[Complications-crohn‚Äôs disease]] Prognosis Variable at 1 y: ~50% in remission, ~20% flare, ~20% low activity, ~10% chronic active At 20 y, majority will have required some surgery; overall life expectancy is slightly ‚Üì</description></item><item><title>Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryoglobulinemic-vasculitis/</guid><description>Cryoglobulinemic vasculitis (Lancet 2012;379:348; Nat Rev Dis Primers 2018;4:11)
Cryoglobulins: proteins that precipitate from serum or plasma on exposure to cold and redissolve on rewarming, characterized by their composition; a/w chronic immune stimulation and/or lymphoproliferation Distinguish from cryofibrinogenemia = proteins (eg, fibrin, fibrinogen) that precipitate only from plasma; found in autoimmune dis, malignancies, infxns; unclear clinical significance [[Types of Cryoglobulinemia]] (J Autoimmun 2019;105:102313) Epidemiology: ~1/100,000, but prevalence varies with HCV rates; ‚ôÄ &amp;gt;‚ôÇ Etiologies (idiopathic in ~10%) Hematologic diseases: multiple myeloma, MGUS, Waldenstr√∂m‚Äôs, chronic lymphocytic leukemia in type I; B-cell lymphomas or solid-organ malignancies in type II Infxns (types II &amp;amp; III): viral (HCV [&amp;gt;80% RNA ‚äï], HBV, HIV, HAV, EBV, CMV), bacterial (endocarditis, strep, etc.</description></item><item><title>Cryoprecipitate</title><link>https://www.physician.tw/Cryoprecipitate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryoprecipitate/</guid><description>Cryoprecipitate Enriched for fibrinogen, vWF, VIII, and XIII. 1st line for fibrinogen &amp;lt;100 mg/dL. For bleeding in vWD factor XIII deficiency, use if other products not available.</description></item><item><title>Cryptococcus</title><link>https://www.physician.tw/Cryptococcus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryptococcus/</guid><description>Cryptococcus Epidemiology: immunosupp. most susceptible (espec. AIDS, transplant recipients, and cirrhosis); can occur in healthy hosts (esp C. gattii) Clinical manifestations CNS (meningoencephalitis): subacute HA, fever, meningismus, CN abnl, ¬± stupor Other sites: pulm.</description></item><item><title>Cryptococcus neoformans</title><link>https://www.physician.tw/Cryptococcus-neoformans/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryptococcus-neoformans/</guid><description>Cryptococcus neoformans A common infectious cause of subacute and chronic meningoencephalitis associated with raised intracranial pressure in immunocompromised patients is Cryptococcus neoformans.</description></item><item><title>CSF leak</title><link>https://www.physician.tw/CSF-leak/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CSF-leak/</guid><description>CSF leak headache clear fluid leaking from the nose or ear. Some CSF leaks may heal with conservative treatments such as bed rest.</description></item><item><title>culture negative-bacterial endocarditis</title><link>https://www.physician.tw/culture-negative-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/culture-negative-bacterial-endocarditis/</guid><description>culture negative-bacterial endocarditis abiotrophic strep [[HACEK]] (Haemophilus para-influenzae &amp;amp; aphrophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella), T. whipplei [[Bartonella]], [[Coxiella burnetii]] Chlamydia Legionella [[Brucella]] (JAMA 2007;297:1354; Annals 2007;147:829; J Clin Microbiol 2012;50:216)</description></item><item><title>Culture-negative neutrocytic ascites CNNA</title><link>https://www.physician.tw/Culture-negative-neutrocytic-ascites-CNNA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Culture-negative-neutrocytic-ascites-CNNA/</guid><description>Culture-negative neutrocytic ascites (CNNA) cell counts suggest infxn but cx ‚äñ. No recent abx, w/o other explanation for counts. Often do have [[Spontaneous bacterial peritonitis]] and should be treated with empiric regimen.</description></item><item><title>Cushing‚Äôs Syndrome</title><link>https://www.physician.tw/Cushings-Syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cushings-Syndrome/</guid><description>Cushing‚Äôs Syndrome Cushing‚Äôs syndrome = cortisol excess Cushing‚Äôs disease = Cushing‚Äôs syndrome 2¬∞ to pituitary ACTH hypersecretion [[Etiologies of hypercortisolism]] [[Clinical manifestations-Cushing‚Äôs Syndrome]] [[Diagnosis Cushing‚Äôs Syndrome]] [[Treatment of Cushing‚Äôs syndrome]]</description></item><item><title>Cutaneous arteritis</title><link>https://www.physician.tw/Cutaneous-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutaneous-arteritis/</guid><description>Cutaneous arteritis Sometimes called &amp;ldquo;benign cutaneous [[Polyarteritis nodosa]]&amp;rdquo; cPAN can nevertheless result in significant morbidity due to painful skin nodules, digital infarcts, ulcerations, and other complications</description></item><item><title>cutaneous leukocytoclastic angiitis</title><link>https://www.physician.tw/cutaneous-leukocytoclastic-angiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cutaneous-leukocytoclastic-angiitis/</guid><description>cutaneous leukocytoclastic angiitis Occurs 7‚Äì10 days after certain medications (penicillins, cephalosporins, sulfonamides, phenytoin, allopurinol) or infections (eg, HCV, HIV). Palpable purpura, no visceral involvement.</description></item><item><title>Cutaneous-complications of HIV AIDS</title><link>https://www.physician.tw/Cutaneous-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutaneous-complications-of-HIV-AIDS/</guid><description>Cutaneous-complications of HIV AIDS Eosinophilic folliculitis; warts (HPV); HSV &amp;amp; VZV; MRSA SSTI; scabies; candidiasis; eczema; prurigo nodularis; psoriasis; drug eruption; subungual onychomycosis Molluscum contagiosum (poxvirus): 2‚Äì5 mm pearly papules w/ central umbilication Kaposi‚Äôs sarcoma (KSHV or HHV8): red-purple nonblanching nodular lesions Bacillary angiomatosis (disseminated Bartonella): friable violaceous vascular papules</description></item><item><title>CXR of Diagnostic studies-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/CXR-of-Diagnostic-studies-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CXR-of-Diagnostic-studies-chronic-obstructive-pulmonary-disease/</guid><description>CXR of Diagnostic studies-chronic obstructive pulmonary disease (see Radiology inserts):
hyperinflation, flat diaphragms, ¬± interstitial markings &amp;amp; bullae</description></item><item><title>Cyanide-toxicology</title><link>https://www.physician.tw/Cyanide-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cyanide-toxicology/</guid><description>Cyanide-toxicology Coma, seizure, metabolic acidosis, hypotension
IV Na nitrite and Na thiosulfate
IV hydroxocobalamin
Call local Poison Control for assistance with management.</description></item><item><title>Cyclic vomiting syndrome</title><link>https://www.physician.tw/Cyclic-vomiting-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cyclic-vomiting-syndrome/</guid><description>Cyclic vomiting syndrome acute recurrent vomiting; a/w marijuana use, personal or FHx of migraine. Acute Rx: antiemetics, IVF, sumatriptan (1st line, followed by aprepitant x 3 d), BDZs; prevention: TCAs/AEDs; avoid marijuana.</description></item><item><title>cynosis</title><link>https://www.physician.tw/cynosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cynosis/</guid><description>cynosis central cyanosis can be detected reliably when the SaO2 has fallen to 85%; in others, particularly in dark-skinned persons, it may not be detected until it has declined to 75%</description></item><item><title>cystic fibrosis</title><link>https://www.physician.tw/cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cystic-fibrosis/</guid><description>cystic fibrosis [[Definition and pathophysiology-cystic fibrosis]] [[Clinical features-cystic fibrosis]] [[Treatment-cystic fibrosis]]</description></item><item><title>Cytomegalovirus</title><link>https://www.physician.tw/Cytomegalovirus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cytomegalovirus/</guid><description>Cytomegalovirus Retinitis, esophagitis, colitis, hepatitis, neuropathies, encephalitis. CMV VL may be ‚äñ. Consider tissue biopsy. Rx: ganciclovir, valganciclovir, foscarnet, or cidofovir.</description></item><item><title>Dako 28-8</title><link>https://www.physician.tw/Dako-28-8/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dako-28-8/</guid><description>Dako 28-8 S</description></item><item><title>ddMVAC</title><link>https://www.physician.tw/ddMVAC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ddMVAC/</guid><description>Dose-dense MVAC chemotherapy for urothelial carcinoma Keyword: ddMVAC [Dose-dense MVAC chemotherapy for urothelial carcinoma - UpToDate]( https://www.uptodate.com/contents/image?imageKey=ONC%2F111814&amp;topicKey=ONC%2F3000&amp;source=see link)
durg: methotrexate vinblastine doxorubicin cisplatin Pretreatment considerations: Âêê: È´ò vesicant/irritant properties Infection prophylaxis: È´ò G-CSF: 240mcg/m2 SC daily on d4-d10 Monitor Parameters: CBC/Electrolytes/Neurologic/3rd space fluid collection/LVEF</description></item><item><title>Ddx causes of myocardial ischemia infarction other than atherosclerotic plaque rupture</title><link>https://www.physician.tw/Ddx-causes-of-myocardial-ischemia-infarction-other-than-atherosclerotic-plaque-rupture-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ddx-causes-of-myocardial-ischemia-infarction-other-than-atherosclerotic-plaque-rupture-/</guid><description>Ddx causes of myocardial ischemia infarction other than atherosclerotic plaque rupture Ischemia w/o plaque rupture (‚Äútype 2‚Äù MI): ‚Üë demand (eg, ‚Üë HR), ‚Üì supply (eg, HoTN).</description></item><item><title>Ddx-of-dominant-R-wave-in-V1-or-V2</title><link>https://www.physician.tw/Ddx-of-dominant-R-wave-in-V1-or-V2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ddx-of-dominant-R-wave-in-V1-or-V2/</guid><description>Ddx-of-dominant-R-wave-in-V1-or-V2 Ventricular abnl: RVH (RAD, RAA, deep S waves in I, V5, V6); HCM; Duchenne‚Äôs
Posterior MI: anterior R wave = posterior Q wave; often with IMI</description></item><item><title>deafferentation pain</title><link>https://www.physician.tw/deafferentation-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/deafferentation-pain/</guid><description>deafferentation pain ÂÇ≥ÂÖ•Á•ûÁ∂ìÁóõÊòØÁ•ûÁ∂ìÊÄßÁñºÁóõÁöÑ‰∏ÄÂÄãÂàÜÊîØÔºåÂÆÉÂèØËÉΩ‰ΩøÂπæ‰πé‰ªª‰ΩïÈ°ûÂûãÁöÑËªÄÈ´îÊÑüË¶∫Á≥ªÁµ±ÊêçÂÇ∑Âú®ÂÖ∂ÈÅéÁ®ã‰∏≠ÁöÑ‰ªª‰ΩïÊôÇÂÄôÈÉΩË§áÈõúÂåñ„ÄÇ ‰æãÂ≠êÂåÖÊã¨Áî±Â§ñÂë®ÔºàÂπªËÇ¢ÔºâÊàñ‰∏≠Ê®ûÔºà‰∏òËÖ¶ÁñºÁóõÔºâÁóÖËÆäÂºïËµ∑ÁöÑÊòéÁ¢∫ÁöÑÁ∂úÂêàÂæµ„ÄÇ Âú®ÊâÄÊúâÈÄô‰∫õÊÉÖÊ≥Å‰∏ãÔºåÁñºÁóõÈÄöÂ∏∏ÁôºÁîüÂú®Ëá®Â∫äÊÑüË¶∫Âñ™Â§±ÁöÑÂçÄÂüü„ÄÇ Â∞çÊñºÂπªËÇ¢ÁóõÔºåÁñºÁóõÂØ¶Èöõ‰∏äÊòØÂú®‰∏çÂÜçÂ≠òÂú®ÁöÑÂçÄÂüüÊÑüË¶∫Âà∞ÁöÑ„ÄÇ ‰∏òËÖ¶ÁñºÁóõÊÇ£ËÄÖÔºå‰πüÁ®±ÁÇ∫ Dejerine-Roussy Á∂úÂêàÂæµÔºåÂ†±ÂëäËá®Â∫äÊÑüË¶∫Âñ™Â§±ÂçÄÂüüÁöÑÂÖ®ÈÉ®ÊàñÈÉ®ÂàÜÁñºÁóõ„ÄÇ</description></item><item><title>Decreased GFR-hyperkalemia</title><link>https://www.physician.tw/Decreased-GFR-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Decreased-GFR-hyperkalemia/</guid><description>Decreased GFR-hyperkalemia Any cause of oliguric or anuric AKI or any cause of end-stage renal disease</description></item><item><title>Definition and causes-acute mesenteric ischemia</title><link>https://www.physician.tw/Definition-and-causes-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-causes-acute-mesenteric-ischemia/</guid><description>Definition and causes-acute mesenteric ischemia Reduced or absent blood flow to small intestine, typically caused by arterial (ie, SMA or its branches) occlusion or transient hypoperfusion or less often by venous occlusion</description></item><item><title>Definition and clinical manifestations of Migraine</title><link>https://www.physician.tw/Definition-and-clinical-manifestations-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-clinical-manifestations-of-Migraine/</guid><description>Definition and clinical manifestations of Migraine (Lancet 2018;391:1315 &amp;amp; Continuum 2021;27:586) [[POUNDing Mnemonic]]
Epidemiology: affects 15% of women and 6% of men; onset usually by 30 y</description></item><item><title>Definition and epidemiology</title><link>https://www.physician.tw/Definition-and-epidemiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-epidemiology/</guid><description>Definition and epidemiology (Lancet 2018;391:783)
Chronic inflam disorder w/ airway hyperresponsiveness + variable airflow obstruction
Affects 5‚Äì10% population; ~85% of cases by age 40 y</description></item><item><title>Definition and epidemiology-bronchiectasis</title><link>https://www.physician.tw/Definition-and-epidemiology-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-epidemiology-bronchiectasis/</guid><description>Definition and epidemiology-bronchiectasis (NEJM 2002;346:1383)
Obstructive airways disease of bronchi and bronchioles, chronic transmural inflammation w/ airway dilatation and thickening, collapsibility, mucus plugging w/ impaired clearance</description></item><item><title>Definition and epidemiology-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Definition-and-epidemiology-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-epidemiology-chronic-obstructive-pulmonary-disease/</guid><description>Definition and epidemiology-chronic obstructive pulmonary disease Progressive airflow limitation caused by airway and parenchymal inflammation</description></item><item><title>definition and etiologies of peptic ulcer disease</title><link>https://www.physician.tw/definition-and-etiologies-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-and-etiologies-of-peptic-ulcer-disease/</guid><description>definition and etiologies of peptic ulcer disease (BMJ 2019;367:5495)
Ulcers (break in mucosal lining &amp;gt;5 mm) &amp;amp; erosions (&amp;lt;5 mm) in stomach and duodenum Principal risk factors: H.</description></item><item><title>Definition and etiologies-chronic kidney disease CKD</title><link>https://www.physician.tw/Definition-and-etiologies-chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-etiologies-chronic-kidney-disease-CKD/</guid><description>Definition and etiologies-chronic kidney disease (CKD) (Lancet 2021;10302:786)
GFR &amp;lt;60 for ‚â•3 mo and/or kidney damage (albuminuria, structural abnormality)</description></item><item><title>Definition and pathophysiology-anaphylaxis</title><link>https://www.physician.tw/Definition-and-pathophysiology-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-pathophysiology-anaphylaxis/</guid><description>Definition and pathophysiology-anaphylaxis (Ann Emerg Med 2006;47:373)
Severe, rapid onset (mins to hrs), potentially life-threatening systemic allergic response</description></item><item><title>Definition and pathophysiology-cystic fibrosis</title><link>https://www.physician.tw/Definition-and-pathophysiology-cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-pathophysiology-cystic-fibrosis/</guid><description>Definition and pathophysiology-cystic fibrosis (NEJM 2015;372:351)
Autosomal recessive genetic disorder due to mutations in chloride channel (CFTR gene)</description></item><item><title>Definition and pathophysiology-hemoptysis</title><link>https://www.physician.tw/Definition-and-pathophysiology-hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-pathophysiology-hemoptysis/</guid><description>Definition and pathophysiology-hemoptysis Expectoration of blood or blood-streaked sputum Massive hemoptysis: &amp;gt;100 mL/h or &amp;gt;500 mL in 24 h; massive hemoptysis usually from tortuous or invaded bronchial arteries [[Etiologies-hemoptysis]]</description></item><item><title>Definition Clinical Manifestations-HIV AIDS</title><link>https://www.physician.tw/Definition-Clinical-Manifestations-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-Clinical-Manifestations-HIV-AIDS/</guid><description>Definition Clinical Manifestations-HIV AIDS Acute HIV: rash, lymphadenopathy, fever, oral ulcers, pharyngitis, myalgias, diarrhea Presents ~2‚Äì6 wk after exposure; not all HIV infections result in symptoms of acute HIV AIDS: HIV + CD4 &amp;lt;200/mm3 or AIDS-defining opportunistic infection (OI) or malignancy</description></item><item><title>Definition etiologies peptic ulcer disease</title><link>https://www.physician.tw/Definition-etiologies-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-etiologies-peptic-ulcer-disease-/</guid><description>Definition etiologies peptic ulcer disease Ulcers (break in mucosal lining &amp;gt;5 mm) &amp;amp; erosions (&amp;lt;5 mm) in stomach and duodenum</description></item><item><title>Definition of Constipation</title><link>https://www.physician.tw/Definition-of-Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-of-Constipation/</guid><description>Definition of Constipation Defined as dissatisfaction w/ defecation or (per Rome IV): ‚â•2 of following during last 3‚Äì6 mos ‚â•25% of the time: straining, lumpy/hard stools, incomplete evacuation, sensation of anorectal obstruction, manual maneuvers to facilitate defecation, stool frequency &amp;lt;3/wk</description></item><item><title>Definition of fever and neutropenia</title><link>https://www.physician.tw/Definition-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-of-fever-and-neutropenia/</guid><description>Definition of fever and neutropenia Fever: single oral temp ‚â•38.3¬∞C (101¬∞F) or ‚â•38¬∞C (100.4¬∞F) for ‚â•1 h Neutropenia: ANC &amp;lt;500 cells/¬µL or &amp;lt;1000 cells/¬µL with predicted nadir &amp;lt;500 cells/¬µL</description></item><item><title>Definition, precipitants, pathophysiology-hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/Definition-precipitants-pathophysiology-hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-precipitants-pathophysiology-hyperosmolar-hyperglycemic-state/</guid><description>Definition, precipitants, pathophysiology-hyperosmolar hyperglycemic state (Med Clin North Am 2017;101:587)
Extreme hyperglycemia (w/o ketoacidosis) + hyperosm. + Œî MS in T2D (typically elderly) Precip same as for DKA, but also include dehydration and renal failure Hyperglycemia ‚Üí osmotic diuresis ‚Üí vol depletion ‚Üí prerenal azotemia ‚Üí ‚Üë glc, etc.</description></item><item><title>Definition-acute kidney injury AKI</title><link>https://www.physician.tw/Definition-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-acute-kidney-injury-AKI/</guid><description>Definition-acute kidney injury (AKI) (KDIGO 2012;2:1)
Stages in ICU correspond to ‚Üë hospital mortality and LOS (Crit Care Med 2009;37:2552) Diagnostic criteria Increase in serum creatinine of ‚â•0.</description></item><item><title>Definition-acute liver failure</title><link>https://www.physician.tw/Definition-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-acute-liver-failure/</guid><description>Definition-acute liver failure Acute liver injury + coagulopathy + encephalopathy w/o preexisting liver dis. (&amp;lt;26 wks)
Fulminant if encephalopathy &amp;lt;8 wks from jaundice onset, subfulminant if 8‚Äì26 wks</description></item><item><title>Definition-Antiphospholipid syndrome</title><link>https://www.physician.tw/Definition-Antiphospholipid-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-Antiphospholipid-syndrome/</guid><description>Definition-Antiphospholipid syndrome dx requires ‚â•1 clinical &amp;amp; ‚â•1 laboratory criteria
Clinical: thrombosis (any) or complication of pregnancy (‚â•3 spont. abortions before 10 wk or ‚â•1 fetal loss after 10 wk or premature birth before 34 wk)</description></item><item><title>Definition-cirrhosis</title><link>https://www.physician.tw/Definition-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-cirrhosis/</guid><description>Definition-cirrhosis (Dig Dis 2016;34:374; NEJM 2016;375:767; J Hep 2016;64:717)
Definition fibrosis &amp;amp; regenerative nodules causing distortion of hepatic architecture</description></item><item><title>Definition-diabetes mellitus</title><link>https://www.physician.tw/Definition-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-diabetes-mellitus/</guid><description>Definition-diabetes mellitus (Diabetes Care 2022;45:S256)
HbA1c ‚â•6.5 fasting glc ‚â•126 mg/dL glc 2 h after [[OGTT]] ‚â•200 mg/dL √ó 2 (for any test) or single random glc ‚â•200 mg/dL w/ classic sx of hyperglycemia; all tests equally reasonable (nb, may be ‚äï on one test but not another); OGTT preferred during preg Blood glc higher than normal, but not frank DM (‚Äúprediabetics,‚Äù ~40% U.</description></item><item><title>Definition-glomerulonephritis</title><link>https://www.physician.tw/Definition-glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-glomerulonephritis/</guid><description>Definition-glomerulonephritis Lancet 2016;387:2036; JASN 2016;27:1278)
ÂèÉËÄÉ‚û°Ô∏è Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN ÂèÉËÄÉ‚û°Ô∏è Primary glomerulonephritides</description></item><item><title>Definition-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Definition-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-necrotizing-soft-tissue-infections/</guid><description>Definition-necrotizing soft-tissue infections Fulminant tissue destruction, systemic toxicity &amp;amp; high mortality. Surgical emergency. May include cellulitis, fasciitis, myositis, myonecrosis (gas gangrene).</description></item><item><title>Definition-nephrotic syndrome</title><link>https://www.physician.tw/Definition-nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-nephrotic-syndrome/</guid><description>Definition-nephrotic syndrome ( JASN 2014;25:2393)
Podocyte injury (effacement) ‚Üí loss of proteins (albumin, ATIII, Ig)
Clinically: proteinuria &amp;gt;3.</description></item><item><title>Definition-syncope</title><link>https://www.physician.tw/Definition-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-syncope/</guid><description>Definition-syncope Symptom of sudden transient loss of consciousness due to global cerebral hypoperfusion If CPR or cardioversion required, then SCD and not syncope (different prognosis) Presyncope = prodrome of light-headedness without LOC</description></item><item><title>Definitions heart failure</title><link>https://www.physician.tw/Definitions-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-heart-failure/</guid><description>Definitions heart failure ÂêÑÁ®ÆÂÆöÁæ©
Failure of heart to pump blood forward at rate sufficient to meet metabolic demands of peripheral tissues, or ability to do so only at abnormally high cardiac filling pressures Low output (‚Üì cardiac output) vs.</description></item><item><title>Definitions-accessory pathways wolff-parkinson-white</title><link>https://www.physician.tw/Definitions-accessory-pathways-wolff-parkinson-white/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-accessory-pathways-wolff-parkinson-white/</guid><description>Definitions-accessory pathways (wolff-parkinson-white) Accessory pathway (bypass tract) of conducting myocardium connecting atria &amp;amp; ventricles, allowing impulses to bypass normal AVN delay Pre-excitation (WPW) pattern: ‚Üì PR interval, ‚Üë QRS width w/ Œ¥ wave (slurred onset, can be subtle).</description></item><item><title>Definitions-acid-base disturbances</title><link>https://www.physician.tw/Definitions-acid-base-disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-acid-base-disturbances/</guid><description>Definitions-acid-base disturbances Acidemia ‚Üí pH &amp;lt;7.36, alkalemia ‚Üí pH &amp;gt;7.44; pH = 6.10 + log([HCO3]/[0.03xPCO2]) Acidosis ‚Üí process that ‚Üë [H+] or ‚Üì pH by ‚Üì HCO3 or ‚Üë PaCO2 Alkalosis ‚Üí process that ‚Üì [H+] or ‚Üë pH by ‚Üë HCO3 or ‚Üì PaCO2 Primary disorders: metabolic acidosis or alkalosis, respiratory acidosis or alkalosis [[Compensation-for-Acid-Base-Disorders]] The physiological approach uses the carbonic acid‚Äìbicarbonate buffer system.</description></item><item><title>Definitions-acute aortic syndromes</title><link>https://www.physician.tw/Definitions-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-acute-aortic-syndromes/</guid><description>Definitions-acute aortic syndromes (Circ 2010;121:e266; Eur Heart J 2012;33:26)
Aortic dissection: intimal tear ‚Üí blood extravasates into Ao media (creates false lumen) Intramural hematoma (IMH): vasa vasorum rupture ‚Üí medial hemorrhage that does not communicate with aortic lumen; 6% of aortic syndromes; clinically managed as AoD Penetrating ulcer: atherosclerotic plaque penetrates elastic lamina ‚Üí medial hemorrhage</description></item><item><title>Definitions-and-clinical-manifestations</title><link>https://www.physician.tw/Definitions-and-clinical-manifestations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-and-clinical-manifestations/</guid><description>Definitions-and-clinical-manifestations Pneumonia: s/s (fever, cough, purulent sputum, dyspnea) + new infiltrate on chest imaging Community-acquired pneumonia (CAP): pneumonia acquired outside of hospital setting [[Hospital-acquired pneumonia]] (HAP): pneumonia acquired ‚â•48 hrs after hospitalization [[Ventilator-associated pneumonia]] (VAP): pneumonia acquired ‚â•48 hrs after intubation Lung empyema: accumulation of pus in pleural space Lung abscess: parenchymal necrosis with confined cavitation [[Aspiration pneumonitis]]: acute lung injury after inhalation of gastric contents without infection, though bacterial infection can occur within 24‚Äì72 hrs of injury</description></item><item><title>Definitions-aortic aneurysms</title><link>https://www.physician.tw/Definitions-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-aortic-aneurysms/</guid><description>Definitions-aortic aneurysms True (‚â•50% dilation of all 3 layers; &amp;lt;50% = ectasia) vs. false (rupture w/in adventitia) Location: root (annuloaortic ectasia), thoracic aortic aneurysm (TAA), thoracoabdominal aortic aneurysm (TAAA), abdominal aortic aneurysm (AAA) Type: fusiform (circumferential dilation) vs.</description></item><item><title>Definitions-sepsis and shock</title><link>https://www.physician.tw/Definitions-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-sepsis-and-shock/</guid><description>Definitions-sepsis and shock Sepsis [!tldr] TLDR
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.</description></item><item><title>Definitions-skin and soft tissue infections</title><link>https://www.physician.tw/Definitions-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-skin-and-soft-tissue-infections/</guid><description>Definitions-skin and soft tissue infections Cellulitis: infection of dermis and subcutaneous tissue characterized by erythema, warmth, tenderness, and swelling; often occurs as a result of skin breaches (JAMA 2016;315:3) ËúÇÁ™©ÁπîÁÇéÔºö‰ª•Á¥ÖÊñë„ÄÅÁôºÁÜ±„ÄÅÂ£ìÁóõÂíåËÖ´ËÑπÁÇ∫ÁâπÂæµÁöÑÁúüÁöÆÂíåÁöÆ‰∏ãÁµÑÁπîÊÑüÊüìÔºõÁ∂ìÂ∏∏Âõ†ÁöÆËÜöÁ†¥Ë£ÇËÄåÁôºÁîü (JAMA 2016;315:3) Skin abscess: subcutaneous collection of pus Staph toxic shock syndrome: rapid onset fever, rash, hypotension, and multiorgan injury.</description></item><item><title>Definitions-tuberculosis</title><link>https://www.physician.tw/Definitions-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-tuberculosis/</guid><description>Definitions-tuberculosis Primary: new Mycobacterium tuberculosis (TB) in a na√Øve host; symptomatic or asymptomatic; 90% of infected normal hosts will never develop clinically evident disease Latent: well-controlled infection without clinical or radiographic evidence of active disease; can persist for years to decades Reactivated: activation of latent; more likely in the setting of immunosuppression.</description></item><item><title>Definitions-urinary tract infections</title><link>https://www.physician.tw/Definitions-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-urinary-tract-infections/</guid><description>Definitions-urinary tract infections Asymptomatic bacteriuria: presence of bacteria in urine without signs or sx of infection
Uncomplicated: confined to bladder. No upper tract or systemic infection signs.</description></item><item><title>Definitions-venous thromboembolism</title><link>https://www.physician.tw/Definitions-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-venous-thromboembolism/</guid><description>Definitions-venous thromboembolism Superficial thrombophlebitis: * pain, tenderness, erythema along superficial vein [[deep vein thrombosis]] Proximal = thrombosis of iliac, femoral, or popliteal veins (nb, ‚Äúsuperficial‚Äù femoral vein part of deep venous system).</description></item><item><title>Delayed hemolytic</title><link>https://www.physician.tw/Delayed-hemolytic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Delayed-hemolytic/</guid><description>Delayed hemolytic : generally less severe than acute hemolytic; 5‚Äì7 d after transfusion, but can be severe ‚Üí hyperhemolysis. Due to undetected allo-Abs vs.</description></item><item><title>delta-delta</title><link>https://www.physician.tw/delta-delta/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/delta-delta/</guid><description>delta-delta (Œî/Œî = ŒîAG/ŒîHCO3) to assess if there is an additional metabolic acid-base disturbance; ŒîAG = (calculated AG ‚Äì expected AG), ŒîHCO3 = (24 ‚Äì HCO3) Œî/Œî = 1‚Äì2 ‚Üí pure AG metabolic acidosis Œî/Œî &amp;lt;1 ‚Üí AG metabolic acidosis and simultaneous non-AG acidosis Œî/Œî &amp;gt;2 ‚Üí AG metabolic acidosis and simultaneous metabolic alkalosis For pure lactic acidosis Œî/Œî 1.</description></item><item><title>dermatology</title><link>https://www.physician.tw/dermatology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dermatology/</guid><description>Ëä±ÂúíÂ§ßÈñÄÂè£
Keratinocyte Carcinomas (Squamous- and Basal-Cell Carcinomas) Melanoma Acne and Rosacea Psoriasis Atopic Dermatitis &amp;amp; Contact Dermatitis Stasis Dermatitis Cutaneous Herpes Infections Molluscum Contagiosum Warts ddate ddd Other relevant topics in Dermatology are covered in the following rotation guides:</description></item><item><title>Device infection</title><link>https://www.physician.tw/Device-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Device-infection/</guid><description>Device infection (Heart Rhythm 2017;14:e503, NEJM 2019;380:1895)
Presents as pocket infection (warmth, erythema, tenderness) and/or sepsis w/ bacteremia ~2% over 5 y; if S.</description></item><item><title>diabetes mellitus</title><link>https://www.physician.tw/diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetes-mellitus/</guid><description>diabetes mellitus [[Definition-diabetes mellitus]] (Diabetes Care 2022;45:S256) [[Categories-diabetes mellitus]]
alias: [[dm]]
Clinical manifestations Polyuria, polydipsia, polyphagia with unexplained weight loss; may be asymptomatic Topic [[Diabetes Treatment Approach for ASCVD, HF, or CKD]] [[Additional Diabetes Treatment Options]] [[Insulin Preparations]] (Diabetes Care 2019;42:S90) [[Complications-diabetes mellitus]] [[Outpatient screening and treatment goals-diabetes mellitus]] [[Management of hyperglycemia in inPts]] [[diabetic ketoacidosis]] (DKA) [[hyperosmolar hyperglycemic state]] [[hypoglycemia]] [[SGLT2i]] [[inpatient diabetes management]]</description></item><item><title>Diabetes Treatment Approach for ASCVD, HF, or CKD</title><link>https://www.physician.tw/Diabetes-Treatment-Approach-for-ASCVD-HF-or-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetes-Treatment-Approach-for-ASCVD-HF-or-CKD/</guid><description>Diabetes Treatment Approach for ASCVD, HF, or CKD Med (‚Üì HbA1C) Comments
GLP-1 receptor agonists (~1‚Äì2%) ‚Üë glc-depend. insulin secretion. Delay gastric emptying.</description></item><item><title>Diabetic Foot Infection</title><link>https://www.physician.tw/Diabetic-Foot-Infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetic-Foot-Infection/</guid><description>Diabetic Foot Infection ‰æÜËá™: [[infectious disease]]</description></item><item><title>diabetic foot infections</title><link>https://www.physician.tw/diabetic-foot-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetic-foot-infections/</guid><description>diabetic foot infections [[Microbiology and severity-diabetic foot infections]] Initial evaluation-diabetic foot infections Cleanse, debride, probe, and obtain deep anaerobic + aerobic cultures Assess for PVD: sensation, pulses, ABIs Diagnosis Deep tissue wound cx at time of debridement (ideally prior to antibiotics).</description></item><item><title>diabetic ketoacidosis</title><link>https://www.physician.tw/diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetic-ketoacidosis/</guid><description>diabetic ketoacidosis [[Precipitants-diabetic ketoacidosis]] (the I‚Äôs) [[Pathophysiology-diabetic ketoacidosis]] [[Clinical manifestations-diabetic ketoacidosis]] [[Diagnostic studies-diabetic ketoacidosis]] [[Treatment of DKA]]</description></item><item><title>Diagnosis and treatment-autoimmune hepatitis AIH</title><link>https://www.physician.tw/Diagnosis-and-treatment-autoimmune-hepatitis-AIH-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-and-treatment-autoimmune-hepatitis-AIH-/</guid><description>Diagnosis and treatment-autoimmune hepatitis (AIH) (J Hepatol 2015;63:1543, Clin Liver Dis 2015;19:57)
70% female; bimodal presentation in the second and fifth decades of life</description></item><item><title>Diagnosis gastroesophageal reflux</title><link>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease/</guid><description>Diagnosis gastroesophageal reflux (Annals 2015;163:ITC1; Nat Rev Gastro Hepatol 2016;13:501)
Clinical diagnosis based on sx and response to empiric trial of PPI (‚ÄúPPI test‚Äù) EGD if: √ò response to PPI or alarm features: dysphagia, vomiting, ‚Üì wt, anemia, age &amp;gt;60 If dx uncertain &amp;amp; EGD nl ‚Üí esoph manometry w/ 24-h pH monitoring ¬± impedance to dx: ‚ÄúNonerosive reflux disease‚Äù: no erosion, ulceration or Barrett‚Äôs; ¬Ω abnl pH.</description></item><item><title>Diagnosis gastroesophageal reflux disease</title><link>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease-/</guid><description>Diagnosis gastroesophageal reflux disease (Annals 2015;163:ITC1; Nat Rev Gastro Hepatol 2016;13:501)
Clinical diagnosis based on sx and response to empiric trial of PPI (‚ÄúPPI test‚Äù)</description></item><item><title>diagnosis of Giant cell arteritis</title><link>https://www.physician.tw/diagnosis-of-Giant-cell-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnosis-of-Giant-cell-arteritis/</guid><description>diagnosis of Giant cell arteritis ‚Üë ESR (Se 84%, Sp 30%), ‚Üë CRP (Se 86%, Sp 30%), anemia.</description></item><item><title>Diagnosis of heparin-induced thrombocytopenia</title><link>https://www.physician.tw/Diagnosis-of-heparin-induced-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-heparin-induced-thrombocytopenia/</guid><description>Diagnosis of heparin-induced thrombocytopenia [[Evaluation of Suspected HIT]] (‚Äú4T‚Äôs‚Äù) Clinical: plt &amp;lt;100k or ‚Üì 50% from baseline; or venous (DVT/PE) or arterial (limb ischemia, CVA, MI) thrombosis (4:1 ratio); skin necrosis; ?</description></item><item><title>Diagnosis of migraine</title><link>https://www.physician.tw/Diagnosis-of-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-migraine/</guid><description>Diagnosis of migraine Record medical history Apply diagnostic criteria Consider differential diagnoses Examine patient to exclude other causes Use neuroimaging only when a secondary headache disorder is suspected [[54321-PUMA-ÂòîÊÄï]]</description></item><item><title>Diagnosis of SVT Type</title><link>https://www.physician.tw/Diagnosis-of-SVT-Type/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-SVT-Type/</guid><description>Diagnosis of SVT Type (NEJM 2012;367:1438)
Onset Abrupt on/off argues against sinus tachycardia
Rate Not dx b/c most can range from 140‚Äì250 bpm, but: ST usually &amp;lt;150; AFL often conducts 2:1 ‚Üí vent.</description></item><item><title>Diagnosis of Thrombotic microangiopathies</title><link>https://www.physician.tw/Diagnosis-of-Thrombotic-microangiopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-Thrombotic-microangiopathies/</guid><description>Diagnosis of Thrombotic microangiopathies unexplained thrombocytopenia (typically &amp;lt;20k) + MAHA ‚Üí sufficient for dx ‚äï schistocytes (&amp;gt;2‚Äì3/hpf), ‚äñ Coombs, normal PT/PTT &amp;amp; fibrinogen ‚Üë‚Üë LDH (tissue ischemia + hemolysis), ‚Üë indirect bili.</description></item><item><title>Diagnosis-anaphylaxis</title><link>https://www.physician.tw/Diagnosis-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-anaphylaxis/</guid><description>Diagnosis-anaphylaxis any of the three following criteria
Acute illness with skin ¬± mucosal involvement (rash, flushing, hives), AND at least one of: Respiratory compromise (wheeze, stridor, dyspnea, hypoxemia)</description></item><item><title>Diagnosis-aseptic meningitis</title><link>https://www.physician.tw/Diagnosis-aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-aseptic-meningitis/</guid><description>Diagnosis-aseptic meningitis Obtain LP for CSF analysis: lymphocytic pleocytosis common in viral etiologies (see Typical CSF Findings in Meningitis table above) Consider CSF cytology and MRI brain/spine to evaluate for malignancy Consider serum autoimmune and serum viral testing in appropriate settings if CSF is unrevealing and there is no improvement with empiric treatment</description></item><item><title>Diagnosis-bacterial endocarditis</title><link>https://www.physician.tw/Diagnosis-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-bacterial-endocarditis/</guid><description>Diagnosis-bacterial endocarditis [[Modified Duke Criteria]]
(CID 2010;51:131; EHJ 2015;36:3075; Circ 2015;132:1435)
ÂèÉËÄÉ‚û°Ô∏è Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the¬†‚Ä¶</description></item><item><title>Diagnosis-clostridioides difficile infection</title><link>https://www.physician.tw/Diagnosis-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-clostridioides-difficile-infection/</guid><description>Diagnosis-clostridioides difficile infection (Ann Intern Med 2018;169:49)
Only test if symptomatic (diarrhea, s/s of colitis); test liquid stool (unless concern for ileus)</description></item><item><title>Diagnosis-crohn‚Äôs disease</title><link>https://www.physician.tw/Diagnosis-crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-crohns-disease/</guid><description>Diagnosis-crohn‚Äôs disease Ileocolonoscopy + bx along w/ small bowel assessment (eg, MR-enterography)
Small bowel/ileitis (~25%), ileocolonic (~50%), colonic (~25%); isolated upper tract rare</description></item><item><title>Diagnosis-Glucose-6-phosphate dehydrogenase</title><link>https://www.physician.tw/Diagnosis-Glucose-6-phosphate-dehydrogenase/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-Glucose-6-phosphate-dehydrogenase/</guid><description>Diagnosis-Glucose-6-phosphate dehydrogenase smear may show RBC Heinz bodies (oxidized Hb) that result in bite cells once removed by spleen; ‚Üì G6PD levels (may be normal after acute hemolysis because older RBCs have already lysed and young RBCs may still have near-normal levels)</description></item><item><title>Diagnosis-hyperaldosteronism</title><link>https://www.physician.tw/Diagnosis-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-hyperaldosteronism/</guid><description>Diagnosis-hyperaldosteronism (JCEM 2016;101:1889; Endo Metab Clin 2019;48:681; J Clin Endo Met 2021;106:2423)
5‚Äì10% of Pts w/ HTN; ‚à¥ screen if HTN + hypoK, adrenal mass, refractory/early onset HTN Screening: ‚Üì‚Üì renin, aldo &amp;gt;15‚Äì20 ng/dL, plasma aldo:renin ratio (&amp;gt;20 if 1¬∞); obtain 8 a.</description></item><item><title>Diagnosis-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Diagnosis-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-necrotizing-soft-tissue-infections/</guid><description>Diagnosis-necrotizing soft-tissue infections Clinical dx is sufficient to initiate urgent surgical exploration Aspiration of necrotic center; BCx; Gram stain; lactate, AST, &amp;amp; CK for deep tissue necrosis Imaging: noncontrast CT, but do not delay Rx/surgery (Arch Surg 2010;145:452) Microbiologic dx from Gram stain and culture of surgical specimens LRINEC score: ‰∏ªË¶ÅÊòØLabÁöÑÂèÉËÄÉ If high suspicion for necrotizing fasciitis through clinical history and physical exam, do not calculate a LRINEC score and go straight to operative debridement.</description></item><item><title>Diagnosis-osteomyelitis</title><link>https://www.physician.tw/Diagnosis-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-osteomyelitis/</guid><description>Diagnosis-osteomyelitis (JAMA 2008;299:806)
ÂèÉËÄÉ‚û°Ô∏è Does this patient with diabetes have osteomyelitis of the lower extremity?
Crucial to obtain cx data of causative organism to avoid long-term empiric abx Bone biopsy or tissue cx obtained surgically or via percutaneous biopsy (send aerobic, anaerobic, mycobacterial, and fungal cultures + pathology) unless ‚äï blood cx.</description></item><item><title>Diagnosis-sexually transmitted infections</title><link>https://www.physician.tw/Diagnosis-sexually-transmitted-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-sexually-transmitted-infections/</guid><description>Diagnosis-sexually transmitted infections (MMWR 2021;70:1; JAMA 2022;327:161)
Syphilis: 1st step is treponemal test: IgG to T. pallidum. ‚äï for life.</description></item><item><title>Diagnosis-skin and soft tissue infections</title><link>https://www.physician.tw/Diagnosis-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-skin-and-soft-tissue-infections/</guid><description>Diagnosis-skin and soft tissue infections [[Differential Diagnosis of Cellulitis]] Clinical diagnosis based on physical examination Cultures from intact skin are not helpful and should not be performed (CID 2014;59:e10) BCx are typically low yield (~5‚Äì10%) Ultrasound can be used to identify deep abscesses and facilitate drainage.</description></item><item><title>Diagnosis-ulcerative colitis</title><link>https://www.physician.tw/Diagnosis-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-ulcerative-colitis/</guid><description>Diagnosis-ulcerative colitis Colonoscopy: involves rectum (95%) &amp;amp; extends prox., circumfer., &amp;amp; contig. w/in colon
Location: proctitis (30‚Äì60%), L-sided (15‚Äì45%) and extensive (pancolitis; 15‚Äì35%)</description></item><item><title>Diagnostic and staging evaluation of lung cancer</title><link>https://www.physician.tw/Diagnostic-and-staging-evaluation-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-and-staging-evaluation-of-lung-cancer/</guid><description>Diagnostic and staging evaluation of lung cancer [[Staging of lung cancer]]
[[5-y survival of lung cancer]]
Imaging: CT w/ contrast of chest &amp;amp; abd/pelvis to assess for mets (adrenal, liver, bones).</description></item><item><title>Diagnostic approach-fever syndromes</title><link>https://www.physician.tw/Diagnostic-approach-fever-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-approach-fever-syndromes/</guid><description>Diagnostic approach-fever syndromes Thorough history including ROS, PMH/PSH, immunizations, including from childhood Fever curve (holding antipyretics); look at trend/pattern. Less likely to mount fever if: ESRD/ESLD, extremes of age, protein calorie malnutrition, immunosupp.</description></item><item><title>Diagnostic clues that favor VT</title><link>https://www.physician.tw/Diagnostic-clues-that-favor-VT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-clues-that-favor-VT/</guid><description>Diagnostic clues that favor VT (assume until proven o/w)
Prior MI, CHF, or LV dysfunction best predictors that WCT is VT (Am J Med 1998;84:53) Hemodynamics and rate do not reliably distinguish VT from SVT MMVT is regular, but initially it may be slightly irregular, mimicking AF w/ aberrancy; grossly irregularly irregular rhythm suggests AF w/ aberrancy or pre-excitation ECG features that favor VT (Circ 2016;133:e506) AV dissociation (independent P waves, capture or fusion beats) proves VT Very wide QRS (&amp;gt;140 ms in RBBB-type or &amp;gt;160 in LBBB-type); extreme axis deviation QRS morphology atypical for BBB (longest precordial RS &amp;gt;100 ms and R wider than S) RBBB-type: absence of tall R‚Ä≤ (or presence of monophasic R) in V1, r/S ratio &amp;lt;1 in V6 LBBB-type: onset to nadir &amp;gt;60 ms in V1, q wave in V6 Initial R wave in aVR; concordance (QRS in all precordial leads w/ same pattern/direction)</description></item><item><title>Diagnostic evaluation of breast cancer</title><link>https://www.physician.tw/Diagnostic-evaluation-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-breast-cancer/</guid><description>Diagnostic evaluation of breast cancer Palpable breast mass: age &amp;lt;30 y ‚Üí observe for resolution over 1‚Äì2 menstrual cycles; age &amp;lt;30 y, unchanging mass ‚Üí U/S ‚Üí aspiration if mass not simple cyst; age &amp;gt;30 y or solid mass on U/S or bloody aspirate or recurrence after aspiration ‚Üí mammo (detect other lesions) and either fine-needle asp.</description></item><item><title>Diagnostic evaluation of fever and neutropenia</title><link>https://www.physician.tw/Diagnostic-evaluation-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-fever-and-neutropenia/</guid><description>Diagnostic evaluation of fever and neutropenia Exam: skin, oropharynx, lung, perirectal area, surgical &amp;amp; catheter sites; avoid rectal exam Studies: U/A, blood (periph &amp;amp; through each indwelling catheter port), urine, &amp;amp; sputum cx; for localizing s/s ‚Üí ‚úì stool (C.</description></item><item><title>Diagnostic evaluation of hypercoagulable states</title><link>https://www.physician.tw/Diagnostic-evaluation-of-hypercoagulable-states/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-hypercoagulable-states/</guid><description>Diagnostic evaluation of hypercoagulable states (not routinely required for initial VTE; NEJM 2017;377:1177)
APC resistance screen; prothrombin PCR test; functional assays for proteins C and S, ATIII; homocysteine level; factor VIII levels; anticardiolipin and lupus anticoagulant Ab.</description></item><item><title>Diagnostic evaluation of thrombocytopenia</title><link>https://www.physician.tw/Diagnostic-evaluation-of-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-thrombocytopenia/</guid><description>Diagnostic evaluation of thrombocytopenia H&amp;amp;P: meds, infxns, underlying conditions, splenomegaly, lymph nodes, bleeding hx
CBC with differential: isolated thrombocytopenia vs.</description></item><item><title>Diagnostic evaluation-anemia</title><link>https://www.physician.tw/Diagnostic-evaluation-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-anemia/</guid><description>Diagnostic evaluation-anemia History: bleeding, systemic illness, drugs, exposures, alcohol, diet (including pica), FHx
CBC w/ diff.; RBC params incl.</description></item><item><title>Diagnostic evaluation-hemolytic anemias</title><link>https://www.physician.tw/Diagnostic-evaluation-hemolytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-hemolytic-anemias/</guid><description>Diagnostic evaluation-hemolytic anemias ‚Üë retic count (RI &amp;gt;2%), ‚Üë LDH, ‚Üì hapto (83% Se, 96% Sp), ‚Üë indirect bili, ‚úì vit C &amp;amp; Cu</description></item><item><title>Diagnostic evaluation-hypopituitary syndromes</title><link>https://www.physician.tw/Diagnostic-evaluation-hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-hypopituitary-syndromes/</guid><description>Diagnostic evaluation-hypopituitary syndromes Hormonal studies Chronic: ‚Üì target gland hormone + ‚Üì or (inappropriately) normal trophic pituitary hormone Acute: will develop defic.</description></item><item><title>diagnostic process</title><link>https://www.physician.tw/diagnostic-process/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-process/</guid><description>diagnostic process [[Common biases in clinical reasoning]]. [[model for clinical reasoning]] [[determine the pretest probability]] [[consider the potential harms]] [[the threshold model]]: likelihood ratio nomogram [[sensitivity and specificity]]</description></item><item><title>Diagnostic studies</title><link>https://www.physician.tw/diagnostic-studies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies/</guid><description>Diagnostic studies (JAMA 2017;318:279)
Spirometry: ‚Üì FEV1, ‚Üì FEV1/FVC, coved flow-volume loop; lung volumes: ¬± ‚Üë RV &amp;amp; TLC ‚äï [[bronchodilator]] response (‚Üë FEV1 ‚â•12% &amp;amp; ‚â•200 mL) strongly suggestive of asthma</description></item><item><title>Diagnostic studies acute coronary syndromes</title><link>https://www.physician.tw/Diagnostic-studies-acute-coronary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-acute-coronary-syndromes/</guid><description>Diagnostic studies acute coronary syndromes ECG: ST ‚Üì/‚Üë, TWI, new LBBB, hyperacute Tw; Qw/PRWP may suggest prior MI &amp;amp; ‚à¥ CAD ‚úì ECG w/in 10 min of presentation, with any ‚àÜ in sx &amp;amp; at 6‚Äì12 h; compare w/ baseline</description></item><item><title>Diagnostic studies of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Diagnostic-studies-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-hypertrophic-cardiomyopathy/</guid><description>Diagnostic studies of hypertrophic cardiomyopathy (EHJ 2014;35:2733)
ECG: LVH, anterolateral TWI and inferior pseudo-Qw, ¬± apical giant TWI (apical variant)</description></item><item><title>Diagnostic studies of PE</title><link>https://www.physician.tw/Diagnostic-studies-of-PE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-PE/</guid><description>Diagnostic studies of PE (EHJ 2014;35:3033)
CXR (limited Se &amp;amp; Sp): 12% nl, atelectasis, effusion, ‚Üë hemidiaphragm, Hampton hump (wedge-shaped density abutting pleura); Westermark sign (avascularity distal to PE)</description></item><item><title>diagnostic studies of peptic ulcer disease</title><link>https://www.physician.tw/diagnostic-studies-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies-of-peptic-ulcer-disease/</guid><description>diagnostic studies of peptic ulcer disease Testing for H. pylori: stool Ag, urea breath testing (UBT) or EGD + rapid urease test (RUT) False ‚äñ Ag, UBT, RUT if on abx, bismuth, PPI; ‚à¥ stop prior to testing if possible Serology: ‚Üì utility, useful only to exclude infection in lower prevalence areas EGD (definitive dx): if fail empiric Rx or alarm features (see ‚ÄúGERD‚Äù); bx GU to r/o malig &amp;amp; H.</description></item><item><title>Diagnostic studies of solitary pulmonary nodule</title><link>https://www.physician.tw/Diagnostic-studies-of-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-solitary-pulmonary-nodule/</guid><description>Diagnostic studies of solitary pulmonary nodule PET: detects metab. activity of tumors, 97% Se &amp;amp; 78% Sp for malig (esp if &amp;gt;8 mm).</description></item><item><title>Diagnostic studies of thoracentesis</title><link>https://www.physician.tw/Diagnostic-studies-of-thoracentesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-thoracentesis/</guid><description>Diagnostic studies of thoracentesis ‚úì total protein, LDH, glucose, cell count with differential, Gram stain &amp;amp; culture, pH; (arterial blood gas)</description></item><item><title>Diagnostic studies peptic ulcer disease</title><link>https://www.physician.tw/Diagnostic-studies-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-peptic-ulcer-disease-/</guid><description>Diagnostic studies peptic ulcer disease Testing for H. pylori: stool Ag, urea breath testing (UBT) or EGD + rapid urease test (RUT) False ‚äñ Ag, UBT, RUT if on abx, bismuth, PPI; ‚à¥ stop prior to testing if possible Serology: ‚Üì utility, useful only to exclude infection in lower prevalence areas</description></item><item><title>Diagnostic studies-acute mesenteric ischemia</title><link>https://www.physician.tw/Diagnostic-studies-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-acute-mesenteric-ischemia/</guid><description>Diagnostic studies-acute mesenteric ischemia Dx relies on high level of suspicion; rapid dx essential to avoid infarction (occurs w/in hrs)</description></item><item><title>Diagnostic studies-acute pancreatitis</title><link>https://www.physician.tw/Diagnostic-studies-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-acute-pancreatitis/</guid><description>Diagnostic studies-acute pancreatitis (Am J Gastro 2013;108:1400)
Dx requires 2 of 3: characteristic abd pain; lipase or amylase &amp;gt;3√ó ULN; ‚äï imaging</description></item><item><title>Diagnostic studies-adrenal insufficiency</title><link>https://www.physician.tw/Diagnostic-studies-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-adrenal-insufficiency/</guid><description>Diagnostic studies-adrenal insufficiency (JCEM 2016;101:364)
ÂèÉËÄÉ‚û°Ô∏è Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline ‚¨ÜÔ∏è UptodateüìÖ: [[Diagnosis of adrenal insufficiency in adults]]</description></item><item><title>Diagnostic studies-aortic aneurysms</title><link>https://www.physician.tw/Diagnostic-studies-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-aortic-aneurysms/</guid><description>Diagnostic studies-aortic aneurysms (JACC 2020;76:201)
Contrast CT: quick, noninvasive, high Se &amp;amp; Sp for all aortic aneurysms TTE/TEE: TTE most useful for root and proximal Ao; TEE can visualize other sites of TAA MRI: favored over CT for AoRoot imaging; useful in AAA but time consuming; noncontrast ‚Äúblack blood‚Äù MR to assess aortic wall Abdominal U/S: screening/surveillance test of choice for infrarenal AAA</description></item><item><title>Diagnostic studies-cholecystitis</title><link>https://www.physician.tw/Diagnostic-studies-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-cholecystitis/</guid><description>Diagnostic studies- cholecystitis RUQ U/S: high Se &amp;amp; Sp for stones, but need specific signs of cholecystitis: [!</description></item><item><title>Diagnostic studies-choledocholithiasis</title><link>https://www.physician.tw/Diagnostic-studies-choledocholithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-choledocholithiasis/</guid><description>Diagnostic studies [[choledocholithiasis]] chole docho lithiasis
ËÜΩ Á∏Ω Áü≥ ÁÇé
(J Hepatol 2016;65:146; Gastrointest Endosc 2019;89:1075)
Ë©≥Ë¶ã EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones</description></item><item><title>Diagnostic studies-cholelithiasis</title><link>https://www.physician.tw/Diagnostic-studies-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-cholelithiasis/</guid><description>Diagnostic studies-cholelithiasis Labs normal in most
RUQ U/S: Se &amp;amp; Sp &amp;gt;95% for stones &amp;gt;5 mm; should be performed after ‚â•8 h fast for distended, bile-filled gallbladder.</description></item><item><title>Diagnostic studies-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Diagnostic-studies-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-chronic-obstructive-pulmonary-disease/</guid><description>Diagnostic studies-chronic obstructive pulmonary disease [[CXR of Diagnostic studies-chronic obstructive pulmonary disease]]
PFTs: obstruction: ‚Üì‚Üì FEV1, ‚Üì FVC, FEV1/FVC &amp;lt;0.</description></item><item><title>Diagnostic studies-chronic pancreatitis</title><link>https://www.physician.tw/Diagnostic-studies-chronic-pancreatitis-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-chronic-pancreatitis-/</guid><description>Diagnostic studies-chronic pancreatitis (Pancreas 2014;43:1143; Am J Gastro 2020;115:322)
Labs: amylase/lipase ‚Üë early, may be nl later. ‚äï fecal fat, ‚Üì stool elastase &amp;amp; A1AT.</description></item><item><title>Diagnostic studies-constrictive pericarditis</title><link>https://www.physician.tw/Diagnostic-studies-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-constrictive-pericarditis/</guid><description>Diagnostic studies-constrictive pericarditis ECG: nonspecific, AF common (up to 33%) in advanced cases CXR: calcification (MTb most common), espec in lateral view (although not specific) Echocardiogram: ¬± thickened pericardium, ‚Äúseptal bounce‚Äù = abrupt displacement of septum during rapid filling in early diastole Cardiac catheterization: atria w/ Ms or Ws (prominent x and y descents) ventricles: dip-and-plateau or square-root sign (rapid ‚Üì pressure at onset of diastole, rapid ‚Üë to early plateau) discordance between LV &amp;amp; RV pressure peaks during respiratory cycle (Circ 1996;93:2007) CT or MRI: thickened pericardium (&amp;gt;4 mm; Se ~80%) w/ tethering (Circ 2011;123:e418)</description></item><item><title>Diagnostic studies-diabetic ketoacidosis</title><link>https://www.physician.tw/Diagnostic-studies-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-diabetic-ketoacidosis/</guid><description>Diagnostic studies-diabetic ketoacidosis ‚Üë Anion gap metabolic acidosis (pH &amp;lt;7.3 &amp;amp; HCO3 &amp;lt;18): can later develop nonanion gap acidosis due to urinary loss of ketones (HCO3 equiv.</description></item><item><title>Diagnostic studies-encephalitis</title><link>https://www.physician.tw/Diagnostic-studies-encephalitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-encephalitis/</guid><description>Diagnostic studies-encephalitis (CID 2013;57:1114)
CSF analysis: lymphocytic pleocytosis; PCR for HSV (95% Se &amp;amp; Sp), VZV; consider other PCR based on risk factors (CMV/EBV, HIV, JC, adeno/enterovirus, WNV) Consider testing for autoimmune etiologies and serologic viral testing in appropriate settings if CSF is unrevealing and there is no improvement with empiric HSV/VZV Rx MRI (CT if unavailable); HSV temporal lobe; W.</description></item><item><title>Diagnostic studies-hypercalcemia</title><link>https://www.physician.tw/Diagnostic-studies-hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-hypercalcemia/</guid><description>Diagnostic studies-hypercalcemia [[hyperparathyroidism]] Hyperparathyroidism (HPT) and malignancy account for 90% of cases of ‚Üë Ca; HPT more likely if asx or chronic; malignancy (usually overt) more likely if acute or sx Áî≤ÁãÄÊóÅËÖ∫ÂäüËÉΩ‰∫¢ÈÄ≤ÔºàHPTÔºâÂíåÊÉ°ÊÄßËÖ´Áò§‰Ωî‚ÜëCaÁóÖ‰æãÁöÑ90%Ôºõ Â¶ÇÊûú asx ÊàñÊÖ¢ÊÄßÔºåHPT Êõ¥ÊúâÂèØËÉΩÔºõÂ¶ÇÊûúÊÄ•ÊÄßÊàñ sxÔºåÂâáÊõ¥ÊúâÂèØËÉΩÁôºÁîüÊÉ°ÊÄßËÖ´Áò§ÔºàÈÄöÂ∏∏ÊòØÊòéÈ°ØÁöÑÔºâ [[Parathyroid MIBI Scan]] Ca, alb, ICa, PTH (may be inapprop.</description></item><item><title>Diagnostic studies-interstitial lung disease</title><link>https://www.physician.tw/Diagnostic-studies-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-interstitial-lung-disease/</guid><description>Diagnostic studies-interstitial lung disease see Appendix &amp;amp; Radiology inserts)
CXR and high-resolution chest CT Upper lobe predom: hypersensitivty, coal, silica, smoking-related, sarcoidosis, Langerhan‚Äôs</description></item><item><title>Diagnostic studies-mitral-stenosis</title><link>https://www.physician.tw/Diagnostic-studies-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-mitral-stenosis/</guid><description>Diagnostic studies-mitral-stenosis ECG: LAE (‚ÄúP mitrale‚Äù), ¬± AF, ¬± RVH CXR: dilated LA (flat L heart border, R double density, displaced L mainstem bronchus) Echo: estimate pressure gradient (‚àá), RVSP, valve area, valve echo score (0‚Äì16, based on leaflet mobility &amp;amp; thick, subvalvular thick.</description></item><item><title>Diagnostic studies-pericardial tamponade</title><link>https://www.physician.tw/Diagnostic-studies-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pericardial-tamponade/</guid><description>Diagnostic studies-pericardial tamponade ECG: ‚Üë HR, ‚Üì voltage (seen in 42%), electrical alternans (20%), ¬± signs of pericarditis</description></item><item><title>Diagnostic studies-pericarditis and pericardial effusion</title><link>https://www.physician.tw/Diagnostic-studies-pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pericarditis-and-pericardial-effusion/</guid><description>Diagnostic studies-pericarditis and pericardial effusion Need ‚â•2 of the following: chest pain (as noted above), friction rub, ECG findings, effusion [[typical electrocardiogram in a patient with acute pericarditis]] CXR: if lg effusion (&amp;gt;250 mL) ‚Üí ‚Üë cardiac silhouette w/ ‚Äúwater-bottle‚Äù heart &amp;amp; epicardial halo Echocardiogram: presence, size, &amp;amp; location of effusion; presence of tamponade physiology; pericarditis itself w/o spec.</description></item><item><title>Diagnostic studies-pheochromocytoma and paraganglioma</title><link>https://www.physician.tw/Diagnostic-studies-pheochromocytoma-and-paraganglioma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pheochromocytoma-and-paraganglioma/</guid><description>Diagnostic studies-pheochromocytoma and paraganglioma (JCEM 2014;99:1915)
24¬∞ urinary fractionated metanephrines: 98% Se, 98% Sp. Screening test of choice if low-risk (b/c false ‚äï with severe illness, renal failure, OSA, labetalol due to assay interference, acetaminophen, TCAs, medications containing sympathomimetics).</description></item><item><title>Diagnostic studies-pleural effusion</title><link>https://www.physician.tw/Diagnostic-studies-pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pleural-effusion/</guid><description>Diagnostic studies-pleural effusion [[Thoracentesis]] [[Transudate vs exudate]] [[Complicated vs uncomplicated parapneumonic]] (Chest 1995;108:299) [[Additional pleural fluid studies]]</description></item><item><title>Diagnostic studies-pneumonia</title><link>https://www.physician.tw/Diagnostic-studies-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pneumonia/</guid><description>Diagnostic studies-pneumonia (AJRCC 2019;200:e45)
Sputum Gram stain/Cx: reliable if high quality (ie, sputum not saliva; &amp;lt;10 squam cells/lpf). If bacterial PNA should be purulent (&amp;gt;25 PMN/lpf).</description></item><item><title>Diagnostic studies-urinary tract infections</title><link>https://www.physician.tw/Diagnostic-studies-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-urinary-tract-infections/</guid><description>Diagnostic studies-urinary tract infections (NEJM 2016;374:562)
Urinalysis: pyuria + bacteriuria ¬± hematuria ¬± nitrites
Urine Cx (clean-catch midstream or straight-cath) Obtain cx only if symptoms (although in ill Pts, can include ‚àÜMS, autonomic instability) ‚äï if: ‚â•105 CFU/mL, though &amp;lt;105 but ‚â•102/mL may still indicate UTI in some scenarios Pyuria &amp;amp; ‚äñ UCx=sterile pyuria.</description></item><item><title>Diagnostic workup-hemoptysis</title><link>https://www.physician.tw/Diagnostic-workup-hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-workup-hemoptysis/</guid><description>Diagnostic workup-hemoptysis Localize bleeding site
(r/o GI or ENT source by H&amp;amp;P ¬± endo);
determine whether</description></item><item><title>Diagnostic-studies-aortic-regurgitation</title><link>https://www.physician.tw/Diagnostic-studies-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-aortic-regurgitation/</guid><description>Diagnostic-studies-aortic-regurgitation ECG: can see LVH, LAD, abnl repol; CXR: cardiomegaly ¬± ascending Ao dilatation Echo: severity of AR (severe = regurg jet width ‚â•65% LVOT, regurg fraction ‚â•50%, effective regurg orifice ‚â•0.</description></item><item><title>Diagnostic-studies-aortic-stenosis</title><link>https://www.physician.tw/Diagnostic-studies-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-aortic-stenosis/</guid><description>Diagnostic-studies-aortic-stenosis ECG: may see LVH, LAE, LBBB, AF (in late disease) CXR: cardiomegaly, AoV calcification, poststenotic dilation of ascending Ao, pulmonary congestion Echo: valve morph.</description></item><item><title>Diagnostic-studies-mitral-regurgitation</title><link>https://www.physician.tw/Diagnostic-studies-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-mitral-regurgitation/</guid><description>Diagnostic-studies-mitral-regurgitation Diagnostic studies
ECG: can see LVH, LAD, abnl repol; CXR: cardiomegaly ¬± ascending Ao dilatation Echo: severity of AR (severe = regurg jet width ‚â•65% LVOT, regurg fraction ‚â•50%, effective regurg orifice ‚â•0.</description></item><item><title>Diagnostic-studies-workup-pulmonary hypertension</title><link>https://www.physician.tw/Diagnostic-studies-workup-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-workup-pulmonary-hypertension/</guid><description>Diagnostic-studies-workup-pulmonary hypertension High-res chest CT: dilat. &amp;amp; pruning of pulm arteries, ‚Üë RA &amp;amp; RV; r/o parenchymal lung dis. ECG: RAD, RBBB, RAE (‚ÄúP pulmonale‚Äù), RVH (Se 55%, Sp 70%) PFTs: disproportionate ‚Üì DLCO, mild restrictive pattern; r/o obstructive &amp;amp; restrictive lung dis.</description></item><item><title>Diagnostics for active TB</title><link>https://www.physician.tw/Diagnostics-for-active-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostics-for-active-TB/</guid><description>Diagnostics for active TB (CID 2017;64:11)
Pulmonary TB: common CXR findings discussed above; induced sputum AFB smear &amp;amp; culture (3 samples at least 8 h apart) ¬± NAAT/ PCR (GeneXpert); consider bronchoscopy + BAL ¬± transbronchial biopsy.</description></item><item><title>differential diagnosis</title><link>https://www.physician.tw/differential-diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/differential-diagnosis/</guid><description>differential diagnosis (‚Äúall that wheezes is not asthma‚Ä¶‚Äù)
Hyperventilation &amp;amp; panic attacks
Upper airway obstruction or inh foreign body; laryngeal/vocal cord dysfxn (eg, 2¬∞ to GERD)</description></item><item><title>Differential Diagnosis of Cellulitis</title><link>https://www.physician.tw/Differential-Diagnosis-of-Cellulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Differential-Diagnosis-of-Cellulitis/</guid><description>Differential Diagnosis of Cellulitis Stasis dermatitis Bilateral leg involvement; circumferential erythema and swelling; usually no fevers ÈõôËÖøÔºõÂë®ÂúçÁ¥ÖÊñëÂíåËÖ´ËÑπ;ÈÄöÂ∏∏‰∏çÁôºÁáí Contact dermatitis Unusual patterns of distribution; pruritus; no fevers Inflammatory arthritis Erythema overlies a joint; pain with range of motion</description></item><item><title>Differential Diagnosis of Delirium</title><link>https://www.physician.tw/Differential-Diagnosis-of-Delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Differential-Diagnosis-of-Delirium/</guid><description>Differential Diagnosis of Delirium Toxins Prescription medications: especially those with anticholinergic properties, narcotics, and benzodiazepines Drugs of abuse: alcohol intoxication and alcohol withdrawal, opiates, ecstasy, LSD, GHB, PCP, ketamine, cocaine, ‚Äúbath salts,‚Äù marijuana and its synthetic forms Poisons: inhalants, carbon monoxide, ethylene glycol, pesticides Metabolic Conditions Electrolyte disturbances: hypoglycemia, hyperglycemia, hyponatremia, hypernatremia, hypercalcemia, hypocalcemia, hypomagnesemia Hypothermia and hyperthermia Pulmonary failure: hypoxemia and hypercarbia Liver failure/hepatic encephalopathy Renal failure/uremia Cardiac failure Vitamin deficiencies: B12, thiamine, folate, niacin Dehydration and malnutrition Anemia Infections Systemic infections: urinary tract infections, pneumonia, skin and soft tissue infections, sepsis CNS infections: meningitis, encephalitis, brain abscess Endocrine Conditions Hyperthyroidism, hypothyroidism Hyperparathyroidism Adrenal insufficiency Cerebrovascular Disorders Global hypoperfusion states Hypertensive encephalopathy Focal ischemic strokes and hemorrhages (rare): especially nondominant parietal and thalamic lesions Autoimmune Disorders CNS vasculitis Cerebral lupus Neurologic paraneoplastic and autoimmune encephalitis Seizure-Related Disorders Nonconvulsive status epilepticus Intermittent seizures with prolonged postictal states Neoplastic Disorders Diffuse metastases to the brain Gliomatosis cerebri Carcinomatous meningitis CNS lymphoma Hospitalization Terminal end-of-life delirium</description></item><item><title>Differential Diagnosis of Dyspnea</title><link>https://www.physician.tw/Differential-Diagnosis-of-Dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Differential-Diagnosis-of-Dyspnea/</guid><description>Differential Diagnosis of Dyspnea Lung Airways Alveoli (can fill with water, pus, or blood) Interstitium Pleural Heart Endocardium Conduction system Myocardium: HF Coronary arteries Pericardium Chest wall neuromuscular disease Blood Metabolic disorders</description></item><item><title>Digoxin</title><link>https://www.physician.tw/Digoxin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Digoxin/</guid><description>Digoxin 0.5 then 0.25 mg q6h up to 1.5 mg/24 h 0.125-0.375 mg qd (adjust for CrCl) Consider in HF or low BP Poor exertional HR ctrl</description></item><item><title>Digoxin-toxicology</title><link>https://www.physician.tw/Digoxin-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Digoxin-toxicology/</guid><description>Digoxin-toxicology N/V, bradycardia, AV block, delirium, xanthopsia
‚úì serum dig level (but may be inaccurate if &amp;lt;6 h since last dose), renal function</description></item><item><title>dilated cardiomyopathy</title><link>https://www.physician.tw/dilated-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dilated-cardiomyopathy/</guid><description>dilated cardiomyopathy Definition and epidemiology (JACC 2016;67:2996; Lancet 2017;390:400) LV or biventricular dilatation and global ‚Üì contractility ¬± ‚Üì wall thickness in the absence of ischemia/infarct, valvular disease or HTN.</description></item><item><title>DILATED-CARDIOMYOPATHY</title><link>https://www.physician.tw/DILATED-CARDIOMYOPATHY/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DILATED-CARDIOMYOPATHY/</guid><description>DILATED-CARDIOMYOPATHY</description></item><item><title>diltiazem</title><link>https://www.physician.tw/diltiazem/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diltiazem/</guid><description>diltiazem Wt/4
15-20 mg IV over 2 min, 20-25 mg 15 later prn, 5-15 mg/h 1 ibutilide 1 mg over 10 min, repeat * 1 if needed</description></item><item><title>DIP desquamative IP</title><link>https://www.physician.tw/DIP-desquamative-IP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DIP-desquamative-IP/</guid><description>DIP desquamative IP Diffuse ground-glass opacities, reticular lines; lower zones. Peripheral macrophage in alveoli.
30‚Äì50 yo smokers
Sx wks‚Äìmos
Death rare</description></item><item><title>Direct Oral Anticoagulants DOACs for NVAF</title><link>https://www.physician.tw/Direct-Oral-Anticoagulants-DOACs-for-NVAF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Direct-Oral-Anticoagulants-DOACs-for-NVAF/</guid><description>Direct Oral Anticoagulants (DOACs) for NVAF Apixaban (FXa inhib) 5 mg bid (2.5 mg bid if ‚â• 2 of: ‚â•80 y, ‚â§60 kg, Cr ‚â•1.</description></item><item><title>Disease state specific regimens-diuresis</title><link>https://www.physician.tw/Disease-state-specific-regimens-diuresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disease-state-specific-regimens-diuresis/</guid><description>Disease state specific regimens-diuresis Renal insufficiency: loop diuretic (‚Üë dose to achieve effective delivery to ThAL) ¬± thiazide</description></item><item><title>disease-specific management of kidney disease</title><link>https://www.physician.tw/disease-specific-management-of-kidney-disease-2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disease-specific-management-of-kidney-disease-2/</guid><description>disease-specific management of kidney disease [[Acute interstitial nephritis]] [[Cardiorenal syndrome]] [[Contrast-induced acute kidney injury]] [[Hepatorenal syndrome (HRS)]] [[Pulmonary-Renal Syndromes]] [[Obstructive diseases-disease-specific management of kidney disease ]] [[Polycystic kidney disease]] [[Rhabdomyolysis]] [[Scleroderma renal crisis]] [[COVID-19 associated AKI]] [[Thrombotic microangiopathies]]</description></item><item><title>disease-specific management of kidney disease</title><link>https://www.physician.tw/disease-specific-management-of-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disease-specific-management-of-kidney-disease/</guid><description>disease-specific management of kidney disease</description></item><item><title>disorder of test</title><link>https://www.physician.tw/disorder-of-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorder-of-test/</guid><description>disorder of test ‰æÜËá™: [[disorders of hemostasis]]</description></item><item><title>Disorders of EGJ Outflow</title><link>https://www.physician.tw/Disorders-of-EGJ-Outflow/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-EGJ-Outflow/</guid><description>Disorders of EGJ Outflow Isolated EGJ outflow obstruction or achalasia. Achalasia: simult. ‚Üì amp contractions &amp;amp; ‚Üì LES relaxation; barium swallow w/ dilated esophagus &amp;amp; distal ‚Äúbird‚Äôs beak‚Äù narrowing; mostly idiopathic, although can be a/w Chagas; Rx: pneumatic dilation as effective as Heller myotomy (local expertise dependent) (Gut 2016;65:732); peroral endoscopic myotomy; CCB/nitrates/PDEi; botox if √ò surg cand.</description></item><item><title>Disorders of Eyes, Ears, Nose, and Throat</title><link>https://www.physician.tw/Disorders-of-Eyes-Ears-Nose-and-Throat/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-Eyes-Ears-Nose-and-Throat/</guid><description>Disorders of Eyes, Ears, Nose, and Throat Chapter 32: [[disorders of the eye]] Chapter 33: [[disorders of smell and taste]] Chapter 34: [[disorders of hearing]] Chapter 35: [[upper respiratory symptoms]], Including [[earache]], [[sinus symptoms]], and [[sore throat]] Chapter 36: [[oral manifestations of disease]]</description></item><item><title>disorders of hemostasis</title><link>https://www.physician.tw/disorders-of-hemostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-hemostasis/</guid><description>disorders of hemostasis [[clinical characteristics of bleeding disorders]]
[[approach to abnormal hemostasis]]
[[coagulation cascade and sites of action for anticoagulants]]</description></item><item><title>disorders of leukocytes</title><link>https://www.physician.tw/disorders-of-leukocytes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-leukocytes/</guid><description>disorders of leukocytes [[neutrophilia]] [[neutropenia]] [[monocytosis]] [[eosinophilia]] [[basophilia]] [[lymphocytosis]] [[lymphadenopathy]]</description></item><item><title>Disorders of Peristalsis</title><link>https://www.physician.tw/Disorders-of-Peristalsis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-Peristalsis/</guid><description>Disorders of Peristalsis Absent contractility (failed peristalsis); distal esophageal spasm (uncord. peristalsis w/ simult. contractions); hypercontractile esoph (high amp contract.</description></item><item><title>disorders of the colon</title><link>https://www.physician.tw/disorders-of-the-colon/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-colon/</guid><description>disorders of the colon [[diverticulosis]] [[diverticulitis]] [[polyps]]</description></item><item><title>Disposition of patients after initial treatment of asthma exacerbation</title><link>https://www.physician.tw/Disposition-of-patients-after-initial-treatment-of-asthma-exacerbation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disposition-of-patients-after-initial-treatment-of-asthma-exacerbation/</guid><description>Disposition of patients after initial treatment of asthma exacerbation</description></item><item><title>Disposition-anaphylaxis</title><link>https://www.physician.tw/Disposition-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disposition-anaphylaxis/</guid><description>Disposition-anaphylaxis Mild rxn limited to urticaria or mild bronchospasm can be observed for ‚â•6 h; admit all others</description></item><item><title>Disseminated intravascular coagulation DIC</title><link>https://www.physician.tw/Disseminated-intravascular-coagulation-DIC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disseminated-intravascular-coagulation-DIC/</guid><description>Disseminated intravascular coagulation (DIC) (NEJM 2014;370:847)
Etiologies: trauma, shock, infection, malignancy (esp. APL), obstetric complications
[[pathogenesis of disseminated intravascular coagulation (DIC)]]:</description></item><item><title>Disseminated Mycobacterium avium complex DMAC</title><link>https://www.physician.tw/Disseminated-Mycobacterium-avium-complex-DMAC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disseminated-Mycobacterium-avium-complex-DMAC/</guid><description>Disseminated Mycobacterium avium complex (DMAC) Fever, night sweats, wt loss, abd pain, diarrhea, pancytopenia. Can cause localized lymphadenitis. Rx: clarithro/azithro + ethambutol ¬± rifampin/rifabutin.</description></item><item><title>Distinguihing Characteristics of Vascuiti Subtypes</title><link>https://www.physician.tw/Distinguihing-Characteristics-of-Vascuiti-Subtypes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Distinguihing-Characteristics-of-Vascuiti-Subtypes/</guid><description>Distinguihing Characteristics of Vascuiti Subtypes</description></item><item><title>Distributive shock</title><link>https://www.physician.tw/Distributive-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Distributive-shock/</guid><description>Distributive shock Septic shock
Pancreatitis
Severe burns
Anaphylactic shock
Neurogenic shock
Endocrine shock
Adrenal crisis</description></item><item><title>diuresis</title><link>https://www.physician.tw/diuresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diuresis/</guid><description>diuresis [[General considerations-diuresis]] [[Loop diuretics]] [[Thiazide diuretics ]] [[K-sparing diuretics]] [[Approach to Diuresis ]](if inadequate diuresis, go to next step) [[Disease state specific regimens-diuresis]]</description></item><item><title>Diverticular bleed</title><link>https://www.physician.tw/Diverticular-bleed/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diverticular-bleed/</guid><description>Diverticular bleed Pathophysiology: Intimal thickening and medial thinning of vasa recta as they course over dome of diverticulum ‚Üí weakening of vascular wall ‚Üí arterial rupture.</description></item><item><title>diverticulitis</title><link>https://www.physician.tw/diverticulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diverticulitis/</guid><description>diverticulitis [[Pathophysiology of diverticulitis]] Diagnostic studies Abdominal CT (I+O+): diverticula, bowel wall thickening, pericolic fat ¬± abscess, fistula Colonoscopy contraindic.</description></item><item><title>diverticulosis</title><link>https://www.physician.tw/diverticulosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diverticulosis/</guid><description>diverticulosis Definition &amp;amp; pathophysiology (Aliment Pharm Ther 2015;42:664)
Acquired herniations of colonic mucosa &amp;amp; submucosa in areas where vasa recta penetrate Abnormal motility and ‚Üë intraluminal pressure cause protrusion of colonic wall Epidemiology Risk factors: ‚Üì fiber, chronic constipation, obesity, smoking, physical inactivity, EtOH, NSAIDs, ‚Üë age (10% if &amp;lt;40 y; 50‚Äì66% if &amp;gt;80 y); ‚Üë red meat consumption Left side (90%, mostly sigmoid) &amp;gt;R side of colon (except in Asia where 75‚Äì85% R-sided) Clinical manifestations Usually asx; 5‚Äì15% develop diverticular hemorrhage (see ‚ÄúGIB‚Äù) and 10‚Äì25% diverticulitis Limited data for ‚Üë fiber diet or avoiding nuts/seeds (Thera Adv Gastro 2016;9:213)</description></item><item><title>Dofetilide</title><link>https://www.physician.tw/Dofetilide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dofetilide/</guid><description>Dofetilide 500 mcg PO bid 500 mcg bid increase QT, increase risk of TdP; renal adj %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Dog bite</title><link>https://www.physician.tw/Dog-bite/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dog-bite/</guid><description>Dog bite Pasturella &amp;amp; Capnocytophaga spp Can cause severe sepsis w/ DIC &amp;amp; gangrene in asplenic/cirrhotics and other immunosupp. Amox/clav If Capno.</description></item><item><title>dotfile</title><link>https://www.physician.tw/dotfile/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dotfile/</guid><description>Dotfiles (MacOS custom configuration specifications) ‚Äì Index
@epperla2021doublerefractory</description></item><item><title>Dronedarone</title><link>https://www.physician.tw/Dronedarone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dronedarone/</guid><description>Dronedarone n/a 400 mg bid decrease side effects &amp;amp; effic. vs. [[Amiodarone]]
Dronedarone, which lacks iodine moieties of amiodarone, slows the resting rate in AF by an average of 12 bpm and also improves exercise heart rate control303; however, it should not be used for rate control in permanent AF, as it was found to increase rates of HF, stroke, cardiovascular death, and unplanned hospitalization.</description></item><item><title>Drug fever</title><link>https://www.physician.tw/Drug-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-fever/</guid><description>Drug fever Anticonvulsants Minocycline [[Other antimicrobial agents of Drug fever]] Allopurinol Heparin Immune checkpoint inhibitors</description></item><item><title>Drug Therapy of Pulseless Arrest</title><link>https://www.physician.tw/Drug-Therapy-of-Pulseless-Arrest/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-Therapy-of-Pulseless-Arrest/</guid><description>Drug Therapy of Pulseless Arrest Establish IV/O access (do not interrupt CPR) Epinephrine 1 mg IV q3-5min (or 2 mg via ETT) Amiodarone 300 mg IVB; 2&amp;quot; dose 150 mg Â¶ÇÊûúÊòØVFÂÜçËÄÉÊÖÆÔºå‰∏ÄËà¨ÁöÑPEAÂ∞±‰∏çÈúÄË¶Å Lidocaine 1-1.</description></item><item><title>Drug Treatment-lipid disorders</title><link>https://www.physician.tw/drug-treatment-lipid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/drug-treatment-lipid-disorders/</guid><description>Drug Treatment-lipid disorders Drug ‚Üì LDL ‚Üì TG Side Effects/Comments
[[statins]] 30‚Äì60% 10‚Äì25% Ezetimibe ~24% ‚Äî Well tolerated
Bempedoic acid ~16% ‚Äî Hyperuricemia/gout; ‚Üì eGFR.</description></item><item><title>Drug-induced hemolytic anemia</title><link>https://www.physician.tw/Drug-induced-hemolytic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-induced-hemolytic-anemia/</guid><description>Drug-induced hemolytic anemia Acquired, Ab-drug mediated destruction vs. direct drug effect. Abx: ceph., sulfa drugs, rifampin, ribavirin. CV: methyldopa, procainamide, quinidine, thiazides.</description></item><item><title>Drug-induced TMA</title><link>https://www.physician.tw/Drug-induced-TMA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-induced-TMA/</guid><description>Drug-induced TMA (clinically similar to TTP; Blood 2017;129:2857) [[thrombotic thrombocytopenic purpura]] Immune-mediated (Ab reacts w/ plts &amp;amp; endothelial cells): eg, quinine, gemcitabine?</description></item><item><title>Drugs and toxins that cause acute liver failure</title><link>https://www.physician.tw/Drugs-and-toxins-that-cause-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drugs-and-toxins-that-cause-acute-liver-failure/</guid><description>Drugs and toxins that cause acute liver failure (nearly 80% of cases in U.S.; Gastro 2015;148:1353, Clin Liver Dis 2017;21:151)</description></item><item><title>drugs routinely used for intrathecal application</title><link>https://www.physician.tw/drugs-routinely-used-for-intrathecal-application/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/drugs-routinely-used-for-intrathecal-application/</guid><description>drugs routinely used for intrathecal application [[Methotrexate]] MTX, AraC a.k.a Cytarabin (including the depot form of liposome-encapsulated AraC) and thiotepa.</description></item><item><title>Duration of full-intensity anticoagulation-venous thromboembolism</title><link>https://www.physician.tw/Duration-of-full-intensity-anticoagulation-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Duration-of-full-intensity-anticoagulation-venous-thromboembolism/</guid><description>Duration of full-intensity anticoagulation-venous thromboembolism Superficial venous thrombosis: 4 wk
1st prox DVT or PE 2¬∞ reversible/time-limited risk factor or distal DVT:</description></item><item><title>Duration of therapy of fever and neutropenia</title><link>https://www.physician.tw/Duration-of-therapy-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Duration-of-therapy-of-fever-and-neutropenia/</guid><description>Duration of therapy of fever and neutropenia Known source: complete standard course (eg, 14 d for bacteremia) Unknown source: continue antibiotics until afebrile and ANC &amp;gt;500 cells/¬µL Less clear when to d/c abx when Pt is afebrile but prolonged neutropenia</description></item><item><title>Dx of Hemochromatosis</title><link>https://www.physician.tw/Dx-of-Hemochromatosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-of-Hemochromatosis/</guid><description>Dx of Hemochromatosis iron sat &amp;gt;45% (iron/TIBC √ó 100%); ‚Üë ferritin (acute phase reactant, so poor Sp; often nl in young Pts).</description></item><item><title>Dx studies of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Dx-studies-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-studies-of-Cryoglobulinemic-vasculitis/</guid><description>Dx studies of Cryoglobulinemic vasculitis ‚úì Cryoglobulins (keep blood warmed to 37¬∞C en route to lab to avoid false ‚äñ, loss of RF and ‚Üì‚Üì C3, C4).</description></item><item><title>Dx studies of Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Dx-studies-of-Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-studies-of-Granulomatosis-with-polyangiitis/</guid><description>Dx studies of Granulomatosis with polyangiitis 90% ‚äï ANCA (80% PR3, 20% MPO), less Se in limited upper-airway disease
CXR or CT ‚Üí nodules, infiltrates, cavities; sinus CT ‚Üí sinusitis ¬± bone erosions ‚Üë BUN &amp;amp; Cr, proteinuria, hematuria; sediment w/ RBC casts, dysmorphic RBCs Biopsy ‚Üí necrotizing granulomatous inflammation of arterioles, capillaries, veins.</description></item><item><title>Dx-Portal vein thrombosis PVT</title><link>https://www.physician.tw/Dx-Portal-vein-thrombosis-PVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-Portal-vein-thrombosis-PVT/</guid><description>Dx-Portal vein thrombosis (PVT) LFTs usually nl; begin w/ U/S w/ Doppler, confirm w/ MRA or CT (I+), angio; consider hypercoag w/u.</description></item><item><title>Dx-Wilson disease</title><link>https://www.physician.tw/Dx-Wilson-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-Wilson-disease/</guid><description>Dx-Wilson disease ‚Üë 24-h urine Cu, ‚Üì serum ceruloplasmin (Se 90%), liver bx w/ hepatic Cu content, genetic testing for ATP7B gene helpful if unclear dx.</description></item><item><title>Dyslipidemias</title><link>https://www.physician.tw/Dyslipidemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dyslipidemias/</guid><description>Dyslipidemias 1¬∞ (inherited causes): familial hyperchol. (1:250): defective LDL receptor; ‚Üë‚Üë chol; ‚Üë CAD; familial hyperTG: ‚Üë TG &amp;amp; pancreatitis; familial combined hyperlipid.</description></item><item><title>dysmotility and nutrition</title><link>https://www.physician.tw/dysmotility-and-nutrition/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysmotility-and-nutrition/</guid><description>dysmotility and nutrition [[Functional GI disease]] [[Gastroparesis]] [[Paralytic ileus of the colon &amp;amp; small bowel]] [[ileus vs small bowel obstruction]] [[Constipation]] [[Nutritional Support and Total Parenteral Nutrition]]</description></item><item><title>dysnatremias</title><link>https://www.physician.tw/dysnatremias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysnatremias/</guid><description>dysnatremias [[overview-sodium and water homeostasis]]</description></item><item><title>Dysphagia</title><link>https://www.physician.tw/Dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dysphagia/</guid><description>Dysphagia Oropharyngeal: inability to propel food from mouth through UES into esophagus Esophageal: difficulty swallowing &amp;amp; passing food from esophagus into stomach [[Structural dysphagia]] [[Neuromuscular dysphagia]]</description></item><item><title>dyspnea</title><link>https://www.physician.tw/dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dyspnea/</guid><description>dyspnea [[Evaluation-dyspnea]] [[alterations in circulatory and respiratory functions]] (Harrison&amp;rsquo;s) [[symptom to diagnosis of dyspnea]] Airway obstruction (‚Üë resistance to airflow) Asthma, COPD, bronchiectasis, cystic fibrosis, tumor, foreign body, vocal cord dysfunction, anaphylaxis</description></item><item><title>Early Goal-Directed Therapy EGDT</title><link>https://www.physician.tw/Early-Goal-Directed-Therapy-EGDT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Early-Goal-Directed-Therapy-EGDT/</guid><description>Early Goal-Directed Therapy (EGDT) Historically: IVF &amp;amp; pressors for MAP ‚â•65 mmHg, CVP 8‚Äì12 mmHg, UOP ‚â•0.5 mL/kg/h; inotropes &amp;amp; PRBCs for ScvO2 ‚â•70% in 6 h (NEJM 2001;345:1368)</description></item><item><title>Early intravenous administration of glucocorticoids in central nervous system infection</title><link>https://www.physician.tw/Early-intravenous-administration-of-glucocorticoids-in-central-nervous-system-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Early-intravenous-administration-of-glucocorticoids-in-central-nervous-system-infection/</guid><description>Early intravenous administration of glucocorticoids in central nervous system infection Developed regions Â∞çÊâÄÊúâÁñë‰ººÁ¥∞ËèåÊÄßËÖ¶ËÜúÁÇé‰∏îÂæÆÁîüÁâ©Êú™Áü•ÁöÑÊàêÂπ¥‰∫∫‰ΩøÁî®Dexamethasone Âè™ÊúâÁï∂ CSF Èù©Ëò≠ÊüìËâ≤Âíå/Êàñ CSF ÊàñË°ÄÂüπÈ§äÈ°ØÁ§∫ËÇ∫ÁÇéÈèàÁêÉËèåÊôÇÔºåÊâçÊáâÁπºÁ∫å‰ΩøÁî® Dexamethasone ÁÇ∫ 0.</description></item><item><title>Eaton-Lambert</title><link>https://www.physician.tw/Eaton-Lambert/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eaton-Lambert/</guid><description>Eaton-Lambert Lambert-Eaton myasthenic syndrome
anti-P/Q-type voltage-gated Ca2+ channel Abs Á•ûÁ∂ìÈÉ® - Ëóç‰ºØ - ‰ºäÈ†ìËÇåÁÑ°ÂäõÁóá (Lambert-Eaton myasthenic syndrome, LEMS)</description></item><item><title>ECG-in-young-athletes</title><link>https://www.physician.tw/ECG-in-young-athletes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ECG-in-young-athletes/</guid><description>ECG-in-young-athletes (JACC 2017;69:805)
Normal patterns may include LVH, RVH, early repolarization Evaluate if: arrhythmia, HR &amp;lt;30, ‚Üë QT, Œµ/Œ¥ waves, LBBB, Brugada pattern, QRS &amp;gt;140 ms, PR &amp;gt;400 ms, Mobitz II, 3Àö AVB, ST depression, TWI Explain by ChatGPT Exercise-induced RVH is normal Exercise-induced ST-T changes are normal ECGs in young athletes may show normal patterns including LVH, RVH, and early repolarization.</description></item><item><title>Echocardiogram for Constrictive vs Restrictive Pericarditis</title><link>https://www.physician.tw/Echocardiogram-for-Constrictive-vs-Restrictive-Pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Echocardiogram-for-Constrictive-vs-Restrictive-Pericarditis/</guid><description>Echocardiogram for Constrictive vs Restrictive Pericarditis Constrictive Respirophasic variation (25‚Äì40%): inspir. ‚Üí ‚Üë flow across TV and ‚Üì flow across MV e‚Ä≤ (tissue velocity) nl/‚Üë (&amp;gt;12 cm/sec) Expir.</description></item><item><title>Education and patient centricity</title><link>https://www.physician.tw/Education-and-patient-centricity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Education-and-patient-centricity/</guid><description>Education and patient centricity Provide appropriate reassurance Agree on realistic objectives Identify predisposing and/or trigger factors Follow strategy to individualize therapy according to symptoms and needs</description></item><item><title>Effect of 1 L infusion in 70-kg male</title><link>https://www.physician.tw/Effect-of-1-L-infusion-in-70-kg-male/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Effect-of-1-L-infusion-in-70-kg-male/</guid><description>Effect of 1 L infusion in 70-kg male w/ [Na]serum 110 mEq/L &amp;amp; Uosm 616 mOsm/kg
0.9% NaCl 154 mEq/L No UOP +1.</description></item><item><title>Effect of IV fluids-treatment-of-hyponatremia</title><link>https://www.physician.tw/Effect-of-IV-fluids-treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Effect-of-IV-fluids-treatment-of-hyponatremia/</guid><description>Effect of IV fluids-treatment-of-hyponatremia complex as depends not only on [Na]infusate but also UOP and Uosm
If minimal UOP and none of infused Na excreted ÂàÜÂ≠ê: (current [Na] serum √óTBW) + [Na]infusate ÂàÜÊØçÔºöTBW + 1 If euvolemic (eg, in SIADH) &amp;amp; all infused Na excreted ÂàÜÂ≠ê: (current [Na] serum x TBW) + [Na]infusate - [Na]infusate ÂàÜÊØç: TBW+1 - (Infusate osm/U osm) In SIADH ‚Äúfixed‚Äù high Uosm.</description></item><item><title>Efficacy concerns PA catheter and tailored therapy</title><link>https://www.physician.tw/Efficacy-concerns-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Efficacy-concerns-PA-catheter-and-tailored-therapy/</guid><description>Efficacy concerns PA catheter and tailored therapy Efficacy concerns (NEJM 2006;354:2213; JAMA 2005;294:1664)
No benefit to routine PAC use in high-risk surgery (JACC 2014;62:e77), sepsis, ARDS</description></item><item><title>EGFR ex20 insertion</title><link>https://www.physician.tw/EGFR-ex20-insertion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/EGFR-ex20-insertion/</guid><description>EGFR ex20 insertion EGFR Á¨¨20ËôüÂ§ñÈ°ØÂ≠ê(exon 20ÔºâÊèíÂÖ•Á™ÅËÆäÊòØÈùûÂ∞èÁ¥∞ËÉûËÇ∫Áôå(NSCLC) ‰∏≠ÁöÑÁâπ‰∫ûÁæ§ Á¥Ñ‰ΩîÊâÄÊúâ EGFR Á™ÅËÆä 9%ÔºåÈÄôÈ°ûÂûãÊÇ£ËÄÖÂ∞çÊñºÁèæÊúâÁöÑ‰∏â‰ª£ EGFR ÂèóÈ´îÈÖ™ËÉ∫ÈÖ∏ÊøÄÈÖ∂ÊäëË£ΩÂäëÔºàTKIÔºâÊ≤ªÁôÇ‰∏¶‰∏çÊïèÊÑü ËàáÂ∏∏Ë¶ãÁöÑ EGFR exon 19 Áº∫Â§±Êàñ L858R Á™ÅËÆäÁöÑÊÇ£ËÄÖÁõ∏ÊØîÔºåÈ†êÂæåÊõ¥Â∑Æ Â≠òÊ¥ªÊúü‰∏≠‰ΩçÊï∏‰∏çÂà∞ 17 ÂÄãÊúàÔºå5 Âπ¥ÁîüÂ≠òÁéáÂÉÖÁÇ∫ 6% Âõ†Ê≠§ÔºåÁõÆÂâçËá®Â∫ä‰∏äÁöÑÊ®ôÊ∫ñÊ≤ªÁôÇÊñπÊ°àÊòØÊòØÂ∏∏Ë¶èÂåñÁôÇÔºåÂ∞öÁÑ° FDA Ê†∏ÂáÜÁöÑÊ®ôÈù∂ÁôÇÊ≥ï„ÄÇ Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer</description></item><item><title>electrocardiography</title><link>https://www.physician.tw/electrocardiography/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/electrocardiography/</guid><description>approach to EKG [[Approach-electrocardiography]] (a systematic approach is vital) [[Axis-deviation]] [[Bundle-Branch-Blocks]] [[Prolonged-QT-interval]] [[Atrial-Abnormality]] [[Left-ventricular-hypertrophy]] (LVH) [[Right-ventricular-hypertrophy]] (RVH) [[Ddx-of-dominant-R-wave-in-V1-or-V2]] [[Poor-R-wave-progression]] (PRWP) [[Pathologic-Q-waves]] [[ST-elevation]] (STE) [[ST-depression]] (STD) [[T-wave-inversion]] (TWI; generally ‚â•1 mm; deep if ‚â•5 mm) [[Low-voltage]] [[Electrolyte-abnormalities]] [[ECG-in-young-athletes]] [[Ë≤ºÁâá]] [!</description></item><item><title>Electrolyte-abnormalities</title><link>https://www.physician.tw/Electrolyte-abnormalities/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Electrolyte-abnormalities/</guid><description>Electrolyte-abnormalities ‚Üë K: tented Tw, ‚Üì QT, ‚Üë PR, AVB, wide QRS, STE; ‚Üì K: flattened Tw, U waves, ‚Üë QT</description></item><item><title>emergency medicine</title><link>https://www.physician.tw/emergency-medicine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/emergency-medicine/</guid><description>emergency medicine [[thereis]] a note t[[est zettel]]</description></item><item><title>empiric replacement fluids can be used for fluid losses</title><link>https://www.physician.tw/empiric-replacement-fluids-can-be-used-for-fluid-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/empiric-replacement-fluids-can-be-used-for-fluid-losses/</guid><description>empiric replacement fluids can be used for fluid losses Sample Osmolarity calculations - GlobalRPH
Sweat: 5% dextrose (D5) {1/4} normal saline solution with 5 KCl/L Gastric, colon: D 5 {1/2} normal saline solution with 30 KCl/L Bile, pancreas, small bowel: lactated Ringer‚Äôs solution Third space (interstitial loss): lactated Ringer‚Äôs solution ÈóúÊñº [[TaitaNo5]]</description></item><item><title>Empiric Treatment of Bacterial Meningitis</title><link>https://www.physician.tw/Empiric-Treatment-of-Bacterial-Meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Empiric-Treatment-of-Bacterial-Meningitis/</guid><description>Empiric Treatment of Bacterial Meningitis (Lancet 2012;380:1693)
Adults &amp;lt;50 y: Ceftriaxone + vancomycin (trough 15‚Äì20), consider acyclovir IV Adults &amp;gt;50 y: Ceftriaxone + vancomycin + ampicillin, consider acyclovir IV Immunosuppressed: [Cefepime or meropenem] + vanc ¬± amp (not nec.</description></item><item><title>Empiric treatment-aseptic meningitis</title><link>https://www.physician.tw/Empiric-treatment-aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Empiric-treatment-aseptic-meningitis/</guid><description>Empiric treatment-aseptic meningitis Suspected bacterial meningitis: see empiric treatment of bacterial meningitis above Suspected viral meningitis: if concern for HSV meningoencephalitis ‚Üí IV acyclovir Unclear etiology: consider initiation of empiric bacterial meningitis treatment while observing and awaiting CSF studies</description></item><item><title>encephalitis</title><link>https://www.physician.tw/encephalitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/encephalitis/</guid><description>encephalitis Definition Inflammation of brain parenchyma characterized by impaired cerebral function (AMS, neurologic deficits) often due to primary viral infection or post-viral inflammation [[Etiologies-encephalitis]] Clinical manifestations Fever + ŒîMS (subtle to severe), seizure, focal neuro deficit, HA in meningoencephalitis [[Diagnostic studies-encephalitis]] Treatment HSV/VZV: IV acyclovir 10 mg/kg IV q8h; consider empiric treatment given frequency</description></item><item><title>Endocarditis Prophylaxis</title><link>https://www.physician.tw/Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocarditis-Prophylaxis/</guid><description>Endocarditis Prophylaxis [[Cardiac conditions-Endocarditis Prophylaxis]] [[Procedures-Endocarditis Prophylaxis]] [[Regimens-Endocarditis Prophylaxis]]</description></item><item><title>Endocrine metabolic</title><link>https://www.physician.tw/Endocrine-metabolic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrine-metabolic/</guid><description>Endocrine metabolic Hypogonadism; adrenal insufficiency (CMV, MAC, TB, HIV, or med-related); sarcopenia; osteopenia/porosis/fragility fractures (at all CD4 counts) Lipodystrophy: central obesity, peripheral lipoatrophy, dyslipidemia, hyperglycemia</description></item><item><title>endocrine-Secondary Causes of Hypertension</title><link>https://www.physician.tw/endocrine-Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrine-Secondary-Causes-of-Hypertension/</guid><description>endocrine-Secondary Causes of Hypertension Hyperaldo or Cushing‚Äôs (1‚Äì5%) Hypokalemia Metabolic alkalosis See ‚ÄúAdrenal Disorders‚Äù [[adrenal disorders]]
Pheochromocytoma (&amp;lt;1%) Paroxysmal HTN, H/A, palp.</description></item><item><title>endocrinology</title><link>https://www.physician.tw/endocrinology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrinology/</guid><description>endocrinology Part 12:¬†[[Endocrinology and Metabolism]]
[[pituitary disorders]]
[[thyroid disorders]]
[[adrenal disorders]]</description></item><item><title>Endotracheal intubation of COPDAE</title><link>https://www.physician.tw/Endotracheal-intubation-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endotracheal-intubation-of-COPDAE/</guid><description>Endotracheal intubation of COPDAE Consider if PaO2 &amp;lt;55‚Äì60, ‚Üë‚Äôing PaCO2, ‚Üì‚Äôing pH, ‚Üë RR, respiratory fatigue, Œî MS or hemodynamic instability</description></item><item><title>Endovascular repair EVAR-aortic aneurysms</title><link>https://www.physician.tw/Endovascular-repair-EVAR-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endovascular-repair-EVAR-aortic-aneurysms/</guid><description>Endovascular repair EVAR-aortic aneurysms (Circ 2015;131:1291; NEJM 2019;380:2126)
Requires favorable aortic anatomy TEVAR (thoracic EVAR) for descending TAA ‚â•5.5 cm may ‚Üì periop morbidity and possibly mortality (Circ 2010;121:2780; JACC 2010;55:986; J Thorac CV Surg 2010;140:1001 &amp;amp; 2012;144:604) AAA: guidelines support open repair or EVAR for infrarenal AAA in good surg candidates ‚Üì short-term mort.</description></item><item><title>Entecavir or tenofovir</title><link>https://www.physician.tw/Entecavir-or-tenofovir/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Entecavir-or-tenofovir/</guid><description>Entecavir or tenofovir nucleo(s/t)ide analogs, well tolerated, low resistance; at 5 y, HBeAg seroconversion is 30‚Äì40% &amp;amp; loss of HBsAg is 5‚Äì10% (Lancet Gastro Hep 2016;1:185).</description></item><item><title>entry inhibitors-EI-Antiretrovirals ARVs</title><link>https://www.physician.tw/entry-inhibitors-EI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/entry-inhibitors-EI-Antiretrovirals-ARVs/</guid><description>entry inhibitors-EI-Antiretrovirals (ARVs) maraviroc (MVC; Selzentry) Dizziness, hepatotoxicity; ‚úì CCR5 tropism assay</description></item><item><title>eosinophilia</title><link>https://www.physician.tw/eosinophilia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/eosinophilia/</guid><description>eosinophilia (&amp;gt;500/¬µL)
Infection Usually parasitic (helminths)
Allergic Drugs; asthma, hay fever, eczema; ABPA
Collagen vasc dis. RA, EGPA (Churg-Strauss), eosinophilic fasciitis, PAN</description></item><item><title>Eosinophilic esophagitis</title><link>https://www.physician.tw/Eosinophilic-esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eosinophilic-esophagitis/</guid><description>Eosinophilic esophagitis (JAMA 2021;326:1310):
often young/middle-aged ‚ôÇ. Dx: &amp;gt;15 eos/hpf on bx, esoph dysfxn (ie, dysphagia, food impaction). Rx: 1st line is PPI (¬Ω respond); alternative (or if fail PPI) is 3Ds: 1st elimination Diet (√ò milk, soy, eggs, wheat, nuts, fish); if no Œî, Drugs (swallow inh steroids); if ongoing sx &amp;amp; stricturing, Dilation (Gastro 2020;158:1776).</description></item><item><title>Eosinophilic gran with polyangiitis</title><link>https://www.physician.tw/Eosinophilic-gran-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eosinophilic-gran-with-polyangiitis/</guid><description>Eosinophilic gran with polyangiitis Eosinophilic granulomatosis with polyangiitis
EGPA,
formerly Churg-Strauss
Similar to GPA w/ more frequent cardiac involvement,</description></item><item><title>Epidemiology pathogenesis-cholelithiasis</title><link>https://www.physician.tw/Epidemiology-pathogenesis-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-pathogenesis-cholelithiasis/</guid><description>Epidemiology pathogenesis-cholelithiasis (J Hepatol 2016;65:146; Gastro 2016;151:351)
Affects ~10% of Western populations, 15‚Äì25% of people develop sx over 10‚Äì15 y</description></item><item><title>Epidemiology and etiologies-atrial fibrillation</title><link>https://www.physician.tw/Epidemiology-and-etiologies-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-etiologies-atrial-fibrillation/</guid><description>Epidemiology and etiologies-atrial fibrillation (Circ A&amp;amp;E 2018;11:e006350)
1‚Äì2% of pop. has AF (10% of those age ‚â•80); M &amp;gt;F; lifetime risk ~25%; mean age 75 y Acute (up to 50% w/o identifiable cause) Cardiac: HF, new CMP, myo/pericarditis, ischemia/MI, HTN crisis, valve dis.</description></item><item><title>Epidemiology and risk factors-lung cancer</title><link>https://www.physician.tw/Epidemiology-and-risk-factors-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-risk-factors-lung-cancer/</guid><description>Epidemiology and risk factors-lung cancer Most common cause of cancer-related death for both men and women in the U.S. Two main types: non-small cell (NSCLC, ~85% of cases); small cell (SCLC, ~15%) ÂÖ©Á®Æ‰∏ªË¶ÅÈ°ûÂûãÔºöÈùûÂ∞èÁ¥∞ËÉûÔºàNSCLCÔºåÁ¥Ñ85ÔºÖÁöÑÁóÖ‰æãÔºâÔºõÂ∞èÂñÆÂÖÉÔºàSCLCÔºå„Äú15ÔºÖÔºâ NSCLC comprised of adeno (40%), squamous cell (SCC, 20%), &amp;amp; large cell (5%) carcinomas, as well as other / not classified (20%) NSCLCÁî±AdenoÔºà40ÔºÖÔºâÔºåÈ±óÁãÄÁ¥∞ËÉûÔºàSCCÔºå20ÔºÖÔºâÂíåÂ§ßÁ¥∞ËÉûÔºà5ÔºÖÔºâÁôåÁµÑÊàêÔºå‰ª•ÂèäÂÖ∂‰ªñ /Êú™ÂàÜÈ°ûÔºà20ÔºÖÔºâ Cigarette smoking: 85% of lung cancers occur in smokers; risk ‚àù total pack-yrs, ‚Üì risk after quitting/reducing but not to baseline (Int J Cancer 2012;131:1210).</description></item><item><title>Epidemiology of breast cancer</title><link>https://www.physician.tw/Epidemiology-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-of-breast-cancer/</guid><description>Epidemiology of breast cancer Epidemiology In U.S., most common cancer in women; 2nd leading cause of cancer death in women</description></item><item><title>Epidemiology-aortic aneurysms</title><link>https://www.physician.tw/Epidemiology-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-aortic-aneurysms/</guid><description>Epidemiology-aortic aneurysms (Circ 2010;121:e266, 2011;124:2020; Nat Rev Cardiol 2011;8:92)
TAA: ~10/100,000 Pt-yrs; ‚ôÇ:‚ôÄ 2:1; ~60% root/ascending; 40% descending AAA: ~4‚Äì8% prev in those &amp;gt;60 y; 5√ó more common in ‚ôÇ; mostly infrarenal</description></item><item><title>Epidemiology-HIV AIDS</title><link>https://www.physician.tw/Epidemiology-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-HIV-AIDS/</guid><description>Epidemiology-HIV AIDS ~1.2 million Americans living w/ HIV (13% unaware); ~37 million worldwide High risk groups: MSM, transgender women, IVDU, sex worker, partners of high-risk Pts Transmission: sexual (risk 0.</description></item><item><title>Epidemiology-tuberculosis</title><link>https://www.physician.tw/Epidemiology-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-tuberculosis/</guid><description>Epidemiology-tuberculosis (NEJM 2016;375:1081)
Transmission via aerosols; untreated active dx requires airborne isolation in healthcare facilities and community isolation measures; must involve local public health authorities Acquisition: residents/travel in TB-endemic area, IVDU, resident/worker in correctional facility or homeless shelter, close contact w/ active TB Reactivation: risk is 5% in first 2 yr, 5‚Äì10% overall; ‚Üë if HIV ‚äï, immunosupp.</description></item><item><title>epidural abscess</title><link>https://www.physician.tw/epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidural-abscess/</guid><description>epidural abscess [[clinical case of epidural abscess]] [[Etiology-epidural abscess]] Clinical manifestations-epidural abscess ËÉåÁóõÔºàÁ¥ÑÂõõÂàÜ‰πã‰∏âÁöÑÊÇ£ËÄÖÔºâ
ÁôºÁáíÔºàÂπæ‰πé‰∏ÄÂçäÁöÑÊÇ£ËÄÖÔºâ
Á•ûÁ∂ìÂäüËÉΩÁº∫ÊêçÔºàÁ¥Ñ‰∏âÂàÜ‰πã‰∏ÄÁöÑÊÇ£ËÄÖÔºâ</description></item><item><title>equipment of airway-management</title><link>https://www.physician.tw/equipment-of-airway-management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/equipment-of-airway-management/</guid><description>equipment of airway-management ‚ú®ÈáçÈªû: ÈÅ©Áï∂ÁöÑÊ∫ñÂÇôÂ∞çÊñºÊâÄÊúâÊ∞£ÈÅìÁÆ°ÁêÜÊÉÖÊ≥ÅÈÉΩÊòØÂøÖ‰∏çÂèØÂ∞ëÁöÑ„ÄÇ Âü∫Êú¨Ë®≠ÂÇôÂåÖÊã¨Ê∞ßÊ∞£Ê∫êÔºàÁâÜÂ£ÅÊàñÁΩêÔºâ„ÄÅÊäΩÂê∏Ë£ùÁΩÆ„ÄÅÊ∞£ÂõäÈù¢ÁΩ©ÈÄöÊ∞£Ëø¥Ë∑Ø„ÄÅÁõ¥Êé•Âíå/ÊàñË¶ñÈ†ªÂñâÈè°„ÄÅÂ§öÁ®ÆÂ∞∫ÂØ∏ÁöÑÊ∞£ÁÆ°ÊèíÁÆ°„ÄÅËÅ≤ÈñÄ‰∏äÊ∞£ÈÅìË£ùÁΩÆ„ÄÅË°ÄÂ£ì/ÂøÉÈõªÂúñ/ËÑàÊêèË°ÄÊ∞ßÂÑÄÂíå CO 2 Ê™¢Ê∏¨Ë£ùÁΩÆ„ÄÇ ËÅ≤ÈñÄ‰∏äÊ∞£ÈÅìË£ùÁΩÆÂåÖÊã¨ÊèíÂÖ•ÊÇ£ËÄÖÂè£ËÖî‰∏¶‰ΩçÊñºËÅ≤ÈñÄ‰∏äÊñπÁöÑÂñâÁΩ©Ê∞£ÈÅì (LMA)„ÄÇ Áî±ÊñºÈÄô‰∫õË£ùÁΩÆ‰∏çËÉΩÈò≤Ê≠¢ËÉÉÂÖßÂÆπÁâ©Âê∏ÂÖ•ÔºåÂõ†Ê≠§Âú® ICU ‰∏≠ÔºåÂÆÉÂÄëÈÄöÂ∏∏ÂÉÖÈôêÊñºÈù¢ÁΩ©ÈÄöÊ∞£ÂíåÊ∞£ÁÆ°ÊèíÁÆ°Âõ∞Èõ£ÊÉÖÊ≥Å‰∏ãÁöÑÊïëÊè¥Ë£ùÁΩÆ„ÄÇ ÈõñÁÑ∂ÊúâÂ§öÁ®ÆÈ°ûÂûãÁöÑÁõ¥Êé•ÂñâÈè°ÂèØ‰æõÈÅ∏ÊìáÔºå‰ΩÜÊúÄÂ∏∏Ë¶ãÁöÑÂÖ©Á®ÆÊòØ Macintosh ÂàÄÁâá (MAC) ÂÖ©ËÄÖÈÉΩÊúâÂ§öÁ®ÆÂ∞∫ÂØ∏Ôºå‰ΩÜÈÄöÂ∏∏ MAC 3 ËøëÂπ¥‰æÜÔºåË¶ñÈ†ªÂñâÈè°ÊòØÈñìÊé•ÂñâÈè°Ê™¢Êü•ÁöÑ‰∏ÄÁ®ÆÂΩ¢ÂºèÔºåÂ∑≤Âú®Â§ßÂ§öÊï∏Ê©üÊßã‰∏≠ÂæàÂÆπÊòìÁç≤Âæó„ÄÇ Ë¶ñÈ†ªÂñâÈè°Âú®ÂàÄÁâáÁöÑÂΩ¢ÁãÄ„ÄÅÊèíÂÖ•Âè£ËÖîÊôÇÁöÑÊ≠£Á¢∫‰ΩçÁΩÆ„ÄÅË¶ñÈ†ªÊ∫êÁöÑ‰ΩçÁΩÆ‰ª•ÂèäÂèØÈáçË§á‰ΩøÁî®/‰∏ÄÊ¨°ÊÄßÈÉ®‰ª∂ÊñπÈù¢ÂêÑ‰∏çÁõ∏Âêå„ÄÇ Glidescope¬Æ ÊúâËá™Â∑±ÁöÑÔºàÈùû‰∏ÄÊ¨°ÊÄßÔºâÁÆ°ÂøÉÈáùÔºå‰º¥Èö®ËëóÁç®ÁâπÁöÑÂàÄÁâáÂΩ¢ÁãÄ„ÄÇ Ë¶ñÈ†ªÂñâÈè°ÁöÑ‰∏ÄÂÄãÊΩõÂú®ÂïèÈ°åÊòØÔºåÈõñÁÑ∂ÂÆÉÂèØ‰ª•Êèê‰æõËÅ≤ÈñÄÈñãÂè£ÁöÑÊ∏ÖÊô∞Ë¶ñÂúñÔºå‰ΩÜ‰ªçÂèØËÉΩÈõ£‰ª•Â∞áÊ∞£ÁÆ°ÊèíÁÆ°ÊìçÁ∏±Âà∞Ê≠£Á¢∫‰ΩçÁΩÆ„ÄÇ ‚ú®ÈáçÈªû: Ê∞£ÁÆ°Â∞éÁÆ° (ETT) ‰πüÊúâÂêÑÁ®ÆÊùêÊñôÂíåÂ∞∫ÂØ∏ÂèØ‰æõÈÅ∏Êìá„ÄÇ ICU ‰∏≠ÊúÄÂ∏∏Áî®ÁöÑÊòØÁî±ËÅöÊ∞Ø‰πôÁÉØË£ΩÊàêÁöÑ ETTÔºåÂ∏∂ÊúâÊñúÈù¢Â∞ñÁ´Ø‰ª•Êõ¥Â•ΩÂú∞ËßÄÂØüÊèíÂÖ•ÔºåÂÅ¥Â≠îÔºàÂ¢®Ëè≤ÁúºÔºâ‰ª•Èò≤Ê≠¢Âú®Á≤òÊ∂≤Ê†ìÁöÑÊÉÖÊ≥Å‰∏ãÂÆåÂÖ®ÈñâÂ°ûÔºå‰ª•ÂèäÂÖÖÊ∞£Ë¢ñÂ∏∂„ÄÇ ETT ÁöÑÂ∞∫ÂØ∏Ê†πÊìö‰ª•ÊØ´Á±≥ÁÇ∫ÂñÆ‰ΩçÁöÑ ÂÖßÂæë Á¢∫ÂÆöÔºåÈÄöÂ∏∏ÈÅ©ÂêàÊàê‰∫∫ÁöÑÂ∞∫ÂØ∏„ÄÇ 7.</description></item><item><title>ER PR</title><link>https://www.physician.tw/ER-PR/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ER-PR/</guid><description>ER PR Endo (NEJM 2019;380: 1226) Tamoxifen: adjuvant Rx for low-risk pre-meno; ‚Üì recurrence &amp;amp; ‚Üì mortality; 10 y superior to 5 y (Lancet 2011;378:771 &amp;amp; 2013;381:805) Aromatase inhib (AI; anastrozole, letrozole, exemestane): adjuvant Rx for post-meno; ‚Üë OS vs.</description></item><item><title>Erosive gastropathy</title><link>https://www.physician.tw/Erosive-gastropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Erosive-gastropathy/</guid><description>Erosive gastropathy (4‚Äì30%)
Precipitants: ASA/NSAID, EtOH, cocaine, gut ischemia, XRT Stress-related mucosal injury in ICU Pts. Risk factors include severe coagulopathy,</description></item><item><title>Erythema multiforme</title><link>https://www.physician.tw/Erythema-multiforme/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Erythema-multiforme/</guid><description>Erythema multiforme symmetric ‚Äútarget‚Äù lesions often of palms, soles, &amp;amp; mucous memb Infxn etiol: HSV, Mycoplasma, syphilis, VZV, EBV, CMV, adenovirus, etc.</description></item><item><title>Erythema nodosum</title><link>https://www.physician.tw/Erythema-nodosum/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Erythema-nodosum/</guid><description>Erythema nodosum tender erythematous or violaceous nodules usually symmetric on LE Infxn etiol: Strep, TB, EBV, Bartonella, HBV, psittacosis, fungal, L.</description></item><item><title>esophageal and gastric disorders</title><link>https://www.physician.tw/esophageal-and-gastric-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/esophageal-and-gastric-disorders/</guid><description>esophageal and gastric disorders dysphagia [[structural dysphagia]] [[neuromuscular dysphagia]] [[gastroesophageal reflux disease]] [[peptic ulcer disease]] [[definition and etiologies of peptic ulcer disease]] [[clinical manifestations of peptic ulcer disease]] [[diagnostic studies of peptic ulcer disease]] [[treatment of peptic ulcer disease]] [[GI prophylaxis if taking ASA and nonsteroidal anti-inflam drug]]</description></item><item><title>esophageal and gastric disorders</title><link>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease.md/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease.md/</guid><description>esophageal and gastric disorders [[Dysphagia]] [[Etiologies of and approach to dysphagia]] [[Structural dysphagia]] [[Neuromuscular dysphagia]]
GASTROESOPHAGEAL REFLUX DISEASE (GERD) [[Pathophysiology-gastroesophageal reflux disease]] [[Clinical manifestations gastroesophageal reflux disease]] [[Diagnosis gastroesophageal reflux disease]] [[Treatment gastroesophageal reflux disease]] [[Complications gastroesophageal reflux disease ]]</description></item><item><title>esophageal cancer</title><link>https://www.physician.tw/esophageal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/esophageal-cancer/</guid><description>esophageal cancer OVERALL BOTTOM LINE The incidence of esophageal cancer has increased in certain populations (e.g. adenocarcinoma in patients with undertreated reflux esophagitis) without much improvement in survival over the past three decades.</description></item><item><title>Esophageal or gastric varices</title><link>https://www.physician.tw/esophageal-or-gastric-varices/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/esophageal-or-gastric-varices/</guid><description>Esophageal or gastric varices (4‚Äì20%)
(Clin Gastro Hepatol 2015;13:2109; J Gastro Hepatol 2016;31:1519; Hep 2017;65:310)
See ‚Äú[[cirrhosis]]‚Äù
2¬∞ to portal HTN.</description></item><item><title>Esophagitis</title><link>https://www.physician.tw/Esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Esophagitis/</guid><description>Esophagitis (15%)
Rx offending cause + high-dose PPI; repeat EGD to r/o [[Barrett‚Äôs esophagitis]]</description></item><item><title>est zettel</title><link>https://www.physician.tw/est-zettel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/est-zettel/</guid><description>est zettel ‰æÜËá™: [[emergency medicine]]</description></item><item><title>Ethylene glycol-toxicology</title><link>https://www.physician.tw/Ethylene-glycol-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ethylene-glycol-toxicology/</guid><description>Ethylene glycol-toxicology CNS depression, ‚Üë AG &amp;amp; OG metabolic acidosis
Ethanol or fomepizole, NaHCO3
Consider hemodialysis</description></item><item><title>Etiologies and Diagnosis of Acute Kidney Injury</title><link>https://www.physician.tw/Etiologies-and-Diagnosis-of-Acute-Kidney-Injury-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-and-Diagnosis-of-Acute-Kidney-Injury-/</guid><description>Etiologies and Diagnosis of Acute Kidney Injury [[Prerenal acute kidney injury etiology]] [[Intrinsic acute kidney injury etiology]] [[Post-renal acute kidney injury etiology]] [[Urine Dipstick]]</description></item><item><title>Etiologies of Acute Pericarditis</title><link>https://www.physician.tw/Etiologies-of-Acute-Pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Acute-Pericarditis/</guid><description>Etiologies of Acute Pericarditis ‚ú® Â≠∏ÁøíÈáçÈªû ü¶é ÊÄ•ÊÄßÂøÉÂåÖÁÇéÔºàÁóÖÊØíÊÄß„ÄÅÁ¥∞ËèåÊÄß„ÄÅÁµêÊ†∏ÊÄßÊàñÁâπÁôºÊÄßËµ∑Ê∫êÔºâ„ÄÇ Ëá™Ë∫´ÂÖçÁñ´ÊÄßÁñæÁóÖ„ÄÇ ÂøÉËÇåÊ¢óÂ°ûÊàñÂøÉËáüÊâãË°ìÂæå„ÄÇ Â∞ñÈä≥ÊàñÈàçÊÄßËÉ∏ÈÉ®ÂâµÂÇ∑ÔºåÂåÖÊã¨ÂøÉËáüË®∫Êñ∑Êàñ‰ªãÂÖ•ÊâãË°ì„ÄÇ ÊÉ°ÊÄßËÖ´Áò§ÔºåÁâπÂà•ÊòØÈùûÂøÉËáüÂéüÁôºÊÄßËÖ´Áò§ÁöÑËΩâÁßªÊì¥Êï£„ÄÇ Á∏±ÈöîËºªÂ∞Ñ„ÄÇ ËÖéÂäüËÉΩË°∞Á´≠‰º¥Â∞øÊØíÁóá„ÄÇ Á≤òÊ∂≤ÊÄßÊ∞¥ËÖ´„ÄÇ ‰∏ªÂãïËÑàÂ§æÂ±§Âª∂‰º∏Âà∞ÂøÉÂåÖ„ÄÇ Ëó•Áâ© Idiopathic (~90%) Most presumed to be undiagnosed viral etiologies Â§ßÂ§öÊï∏Ë¢´Ë™çÁÇ∫ÊòØÊú™Á¢∫Ë®∫ÁöÑÁóÖÊØíÁóÖÂõ†</description></item><item><title>Etiologies of and approach to dysphagia</title><link>https://www.physician.tw/Etiologies-of-and-approach-to-dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-and-approach-to-dysphagia/</guid><description>Etiologies of and approach to dysphagia</description></item><item><title>Etiologies of Classic FUO</title><link>https://www.physician.tw/Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Classic-FUO/</guid><description>Etiologies of Classic FUO [[Infection as Etiologies of Classic FUO]] ~30%
[[Connective tissue disease as Etiologies of Classic FUO]] ~30%</description></item><item><title>Etiologies of Constipation</title><link>https://www.physician.tw/Etiologies-of-Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Constipation/</guid><description>Etiologies of Constipation Primary etiologies: slow transit vs. pelvic floor dyssynergia Secondary etiologies (4 Ms; JAMA 2016:315:185) Mech obstruction: malignancy, compression, rectocele, strictures</description></item><item><title>Etiologies of Decreased Responsiveness</title><link>https://www.physician.tw/Etiologies-of-Decreased-Responsiveness/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Decreased-Responsiveness/</guid><description>Etiologies of Decreased Responsiveness see: [[Differential Diagnosis of Delirium]]
1¬∞ Neurologic (usually with focal signs) Vasc: ischemic stroke/TIA, ICH, VST, PRES, vasculitis, pituitary apoplexy Seizure: postictal, status, nonconvulsive Infxn: meningitis, encephalitis, abscess Trauma: TBI, concussion, diffuse axonal injury ‚Üë intracranial pressure: mass, edema, hydrocephalus, herniation Autoimmune/paraneoplastic enceph.</description></item><item><title>Etiologies of Hematuria</title><link>https://www.physician.tw/Etiologies-of-Hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Hematuria/</guid><description>Etiologies of Hematuria Extrarenal (far more common) Nephrolithiasis Neoplasm: transitional cell, prostate Infxn: cystitis, urethritis, prostatitis Foley trauma BPH [[Schistosoma haematobium]] Intrarenal Nephrolithiasis or crystalluria Neoplasm Trauma/exercise Vascular: renal infarcts, renal v.</description></item><item><title>Etiologies of High elevated PaCO2</title><link>https://www.physician.tw/Etiologies-of-High-elevated-PaCO2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-High-elevated-PaCO2/</guid><description>Etiologies of High elevated PaCO2 Hypercapnia - P.CO2 = k x VCO2 / (respiratory rate * tidal volume * (1-Vd/tidal volume))</description></item><item><title>Etiologies of Hypercalcemia</title><link>https://www.physician.tw/Etiologies-of-Hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Hypercalcemia/</guid><description>Etiologies of Hypercalcemia [[hyperparathyroidism]] (HPT) (NEJM 2018;379:1050; Lancet 2018;391:168) Ë©≥Ë¶ã Primary Hyperparathyroidism.
1¬∞: adenoma (85%), hyperplasia (15‚Äì20%; spont.</description></item><item><title>Etiologies of hypercortisolism</title><link>https://www.physician.tw/Etiologies-of-hypercortisolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-hypercortisolism/</guid><description>Etiologies of hypercortisolism Most commonly iatrogenic caused by exogenous glucocorticoids (though underreported) [[Cushing‚Äôs disease]] (60‚Äì70% of non-iatrogenic CS): ACTH-secreting pituitary adenoma (usually microadenoma) or hyperplasia Adrenal tumor (10‚Äì15%): adenoma or (rarely) carcinoma Ectopic ACTH (10‚Äì15%): SCLC, carcinoid, islet cell tumors, medullary thyroid carcinoma, [[pheochromocytoma]]</description></item><item><title>Etiologies of Hypocalcemia</title><link>https://www.physician.tw/Etiologies-of-Hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Hypocalcemia/</guid><description>Etiologies of Hypocalcemia [[Laboratory Findings in Calcium Disorders]]
[[Hypoparathyroidism]] [[Pseudo-hypoparathyroidism]] Vit D defic. or resist (NEJM 2011;364:248; JCEM 2012;97:1153)
‚≠ê Â≠∏ÁøíÈáçÈªû ‚≠ê Â§ßÂ§öÊï∏Ë°ÄÊ∏Ö 25-Áæ•Âü∫Á∂≠ÁîüÁ¥† D (25[OH]D) ÁÇ∫ 12 Ëá≥ 20 ng/mLÔºà30 Ëá≥ 50 nmol/LÔºâÁöÑÂÅ•Â∫∑Êàê‰∫∫‰∏çÈúÄË¶Å‰ªª‰ΩïÈ°çÂ§ñË©ï‰º∞„ÄÇ Ë°ÄÊ∏Ö 25(OH)D Ê∞¥Âπ≥ &amp;lt;12 ng/mL ÁöÑÊÇ£ËÄÖÊúâÁôºÁîüÈ™®ËªüÂåñÁóáÁöÑÈ¢®Èö™„ÄÇ Âú®Ê≠§È°ûÊÇ£ËÄÖ‰∏≠ÔºåÊàëÂÄëÊ∏¨ÈáèË°ÄÊ∏ÖÈà£„ÄÅÁ£∑„ÄÅÈπºÊÄßÁ£∑ÈÖ∏ÈÖ∂„ÄÅÁî≤ÁãÄÊóÅËÖ∫ÊøÄÁ¥† (PTH)„ÄÅÈõªËß£Ë≥™„ÄÅË°ÄÂ∞øÁ¥†Ê∞Æ (BUN)„ÄÅËÇåÈÖêÂíåÁµÑÁπîËΩâË∞∑Ê∞®ÈÖ∞ËÉ∫ÈÖ∂ÊäóÈ´îÔºà‰ª•Ë©ï‰º∞‰π≥Á≥úÁÄâÔºâ„ÄÇ Âú®Êüê‰∫õÊÉÖÊ≥Å‰∏ãÈúÄË¶Å X ÂÖâÁâáÔºå‰æãÂ¶ÇÂ≠òÂú®È™®Áóõ„ÄÇ [[Synthesis and Metabolism of Vitamin D]].</description></item><item><title>Etiologies of Non-AG Metabolic Acidosis</title><link>https://www.physician.tw/Etiologies-of-Non-AG-Metabolic-Acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Non-AG-Metabolic-Acidosis/</guid><description>Etiologies of Non-AG Metabolic Acidosis GI losses of HCO3 Diarrhea, intestinal or pancreatic fistulas or drainage
RTAs [[Renal tubular acidoses]] Early renal failure Impaired generation of ammonia Ingestions Acetazolamide, sevelamer, cholestyramine, toluene Dilutional Due to rapid infusion of bicarbonate-free IV fluids Posthypocapnia Respiratory alkalosis ‚Üí renal wasting of HCO3; rapid correction of resp.</description></item><item><title>Etiologies of Prolonged-QT-interval</title><link>https://www.physician.tw/Etiologies-of-Prolonged-QT-interval/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Prolonged-QT-interval/</guid><description>Etiologies of Prolonged-QT-interval Antiarrhythmics class Ia (procainamide, disopyramide), class III (amio, sotalol, dofet)
Psych drugs antipsychotics (phenothiazines, haloperidol, atypicals), Li, ?</description></item><item><title>Etiologies of Proteinuria</title><link>https://www.physician.tw/Etiologies-of-Proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Proteinuria/</guid><description>Etiologies of Proteinuria [[Glomerular proteinuria]] [[Tubulointerstitial proteinuria]] [[Overflow proteinuria]] [[Isolated proteinuria]]</description></item><item><title>Etiologies-acute pancreatitis</title><link>https://www.physician.tw/Etiologies-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-acute-pancreatitis/</guid><description>Etiologies-acute pancreatitis (JAMA 2021;325:382)
Ë©≥Ë¶ã Acute Pancreatitis: A Review.
Gallstones (40%): ‚ôÄ &amp;gt;‚ôÇ; usually due to small stones (&amp;lt;5 mm) or microlithiasis/sludge</description></item><item><title>Etiologies-adrenal insufficiency</title><link>https://www.physician.tw/Etiologies-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-adrenal-insufficiency/</guid><description>Etiologies-adrenal insufficiency Primary = adrenocortical disease = Addison‚Äôs disease autoimmune: isolated or in assoc w/ APS (see table on page 7-2) infection: TB, CMV, histoplasmosis, paracoccidioidomycosis vascular: hemorrhage (usually in setting of sepsis), adrenal vein thrombosis, HIT, trauma metastatic disease: (90% of adrenals must be destroyed to cause insufficiency) deposition diseases: hemochromatosis, amyloidosis, sarcoidosis drugs: azole antifungals, etomidate (even after single dose), rifampin, anticonvulsants Secondary = pituitary failure of ACTH secretion (but adrenal aldosterone intact b/c RAA axis) any cause of primary or secondary hypopituitarism (see ‚ÄúPituitary Disorders‚Äù) glucocorticoid therapy (can occur after ‚â§2 wk of ‚Äúsuppressive doses‚Äù; dose effect variable; even &amp;lt;10 mg of prednisone daily chronically can be suppressive) megestrol (a progestin with some glucocorticoid activity)</description></item><item><title>Etiologies-Aplastic anemia</title><link>https://www.physician.tw/Etiologies-Aplastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-Aplastic-anemia/</guid><description>Etiologies-Aplastic anemia idiopathic (¬Ω ‚Äì ‚Öî of cases)
Stem cell destruction: radiation, chemotherapy, chemicals (eg, benzene)</description></item><item><title>Etiologies-ascites</title><link>https://www.physician.tw/Etiologies-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-ascites/</guid><description>Etiologies-ascites Portal HTN Related (SAAG ‚â•1.1) Presinusoidal obstruction portal or splenic vein thrombosis, schisto- somiasis, sarcoidosis
Sinusoidal obstruction: cirrhosis, acute hepatitis (including EtOH), malignancy (HCC or mets)</description></item><item><title>Etiologies-aseptic meningitis</title><link>https://www.physician.tw/Etiologies-aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-aseptic-meningitis/</guid><description>Etiologies-aseptic meningitis (Neurology 2006;66:75)
Viral: enteroviruses are most common cause (summer/fall; rash, GI, URI sx), HIV, HSV, VZV, mumps (parotitis), lymphocytic choriomeningitis virus (rodent exposure), encephalitis viruses, adenovirus, polio, CMV, EBV, WNV Focal bacterial infection: brain/epidural/subdural abscess, CNS septic thrombophlebitis Partially treated bacterial meningitis Other infectious: TB, fungal (cryptococcus, coccidiodes), Lyme, syphilis, leptospirosis Neoplasm: intracranial tumors (or cysts), lymphomatous or carcinomatous meningitis Drug-induced meningitis: NSAIDs, IVIG, antibiotics (TMP-SMX, PCN), anti-epileptics Systemic autoimmune illness: SLE, sarcoidosis, Beh√ßet‚Äôs, Sj√∂gren‚Äôs syndrome, RA Mollaret‚Äôs: recurrent lymphocytic meningitis, spontaneously resolving (often HSV-2)</description></item><item><title>Etiologies-cirrhosis</title><link>https://www.physician.tw/Etiologies-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-cirrhosis/</guid><description>Etiologies- [[cirrhosis]] Alcohol, toxins (eg, arsenic)
Nonalcoholic fatty liver disease (NAFLD) is the cause of most ‚Äúcryptogenic cirrhosis‚Äù</description></item><item><title>Etiologies-encephalitis</title><link>https://www.physician.tw/Etiologies-encephalitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-encephalitis/</guid><description>Etiologies-encephalitis (specific etiology found in &amp;lt;20% of cases; Neurology 2006;66:75; CID 2008;47:303)
HSV-1 all ages/seasons. If sxs recur after Rx, consider viral relapse vs.</description></item><item><title>Etiologies-hyperaldosteronism</title><link>https://www.physician.tw/Etiologies-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hyperaldosteronism/</guid><description>Etiologies-hyperaldosteronism [[Primary Hyperaldosteronism]] [[Secondary Hyperaldosteronism]] [[Nonaldosterone mineralocorticoid excess]] mimics hyperaldosteronism</description></item><item><title>Etiologies-hypertension</title><link>https://www.physician.tw/Etiologies-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hypertension/</guid><description>Etiologies-hypertension Essential (95%): onset 25‚Äì55 y; ‚äï FHx. Unclear mechanism but ? additive microvasc renal injury over time w/ contribution of hyperactive sympathetics (NEJM 2002;346:913).</description></item><item><title>Etiologies-hyperthyroidism</title><link>https://www.physician.tw/Etiologies-hyperthyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hyperthyroidism/</guid><description>Etiologies-hyperthyroidism Graves‚Äô disease (60‚Äì80% of thyrotoxicosis) Thyroiditis: thyrotoxic phase of subacute (granulomatous) or painless (lymphocytic) Toxic adenomas (single or multinodular goiter) Extremely rare: TSH-secreting pituitary tumor or pituitary resistant to thyroid hormone (‚Üë TSH, ‚Üë free T4) Misc: amiodarone, iodine-induced, thyrotoxicosis factitia, struma ovarii (3% of ovarian dermoid tumors and teratomas), tumors (eg, choriocarcinoma) secreting hCG (weak bioactivity against TSH-R), large deposits of metastatic follicular thyroid cancer</description></item><item><title>Etiologies-hypoglycemia</title><link>https://www.physician.tw/Etiologies-hypoglycemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hypoglycemia/</guid><description>Etiologies-hypoglycemia Pts w/ diabetes: excess insulin, oral hypoglycemics, missed meals, renal failure (‚Üì insulin &amp;amp; SU clearance); Œ≤-blockers can mask adrenergic symptoms of hypoglycemia Pt without diabetes: low fasting glucose w/o sx can be normal ‚Üë insulin: exogenous insulin, sulfonylureas, insulinoma, anti-insulin antibodies ‚Üì glucose production: hypopituitarism, adrenal insufficiency, glucagon deficiency, hepatic failure, renal failure, CHF, alcoholism, sepsis, severe malnutrition Postprandial, esp.</description></item><item><title>Etiologies-hypopituitary syndromes</title><link>https://www.physician.tw/Etiologies-hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hypopituitary-syndromes/</guid><description>Etiologies-hypopituitary syndromes Primary: surgery radiation (develops after avg 4‚Äì5 y), tumors (primary or metastatic), infection infiltration (sarcoid, hemochromatosis) autoimmune ischemia (including [[Sheehan‚Äôs syndrome]] caused by pituitary infarction intrapartum), carotid aneurysms [[cavernous sinus thrombosis]] trauma medications (eg, [[ipilimumab]]) apoplexy empty sella genetic Secondary: (hypothalamic dysfunction or stalk interruption): tumors (including craniopharyngioma) infection infiltration radiation surgery trauma</description></item><item><title>Etiologies-of thrombocytopenia</title><link>https://www.physician.tw/Etiologies-of-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-thrombocytopenia/</guid><description>Etiologies-of thrombocytopenia ‚Üì production Hypocellular bone marrow: [[aplastic anemia]] (qv), rarely MDS, drugs (eg, thiazides, antibiotics, chemotherapy), alcohol, cirrhosis, viral infection</description></item><item><title>Etiologies-of-AG-Metabolic-Acidosis</title><link>https://www.physician.tw/Etiologies-of-AG-Metabolic-Acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-AG-Metabolic-Acidosis/</guid><description>Etiologies-of-AG-Metabolic-Acidosis ‚ÄúGOLD MARK‚Äù = Glycols, Oxoproline, Lactic, D-Lactic, Methanol, ASA, Renal, Ketoacidosis
ÈÖÆÈÖ∏„ÄÅ‰π≥ÈÖ∏„ÄÅÊ∞¥Ê•äÈÖ∏ Áî≤ÈÜá„ÄÅ‰∏ô(ÁÉØ)ÈÜá„ÄÅ‰πô‰∫åÈÜá ËÖé‰∏çÂ•Ω
[[diabetic ketoacidosis]] [[diabetes mellitus]], alcoholism, starvation (NEJM 2015;372:546)</description></item><item><title>Etiologies-of-Metabolic-Alkalosis</title><link>https://www.physician.tw/Etiologies-of-Metabolic-Alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Metabolic-Alkalosis/</guid><description>Etiologies-of-Metabolic-Alkalosis Saline responsive UCl &amp;lt;25
GI loss of H+: emesis, NGT suction, villous adenoma, chloridorrhea Renal loss: loop/thiazide, ‚Üì Cl intake, milk-alkali, Pendred syndrome Posthypercapnia(bilevel positive airway pressure for chronic obstructive pulmonary disease AE), sweat losses in cystic fibrosis Saline resistant UCl &amp;gt;40</description></item><item><title>Etiologies-pancytopenia</title><link>https://www.physician.tw/Etiologies-pancytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-pancytopenia/</guid><description>Etiologies-pancytopenia Hypocellular bone marrow (nl cellularity ~100 ‚Äì age): aplastic anemia, hypoplastic MDS
Cellular bone marrow: MDS, aleukemic leukemia, PNH, severe megaloblastic anemia</description></item><item><title>Etiologies-pulmonary hypertension</title><link>https://www.physician.tw/Etiologies-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-pulmonary-hypertension/</guid><description>Etiologies-pulmonary hypertension Primary pulmonary arterial HTN (PAH) (group 1) Precapillary PHT PCWP ‚â§15 mmHg ‚Üë transpulm grad ‚Üë PVR
Idiopathic (IPAH): yearly incidence 1‚Äì2 per million; mean age of onset 36 y (‚ôÇ older than ‚ôÄ); ‚ôÇ: ‚ôÄ = ~2:1, usually mild ‚Üë in PAP Familial (FPAH) Associated conditions (APAH) Connective tissue dis.</description></item><item><title>Etiologies-solitary pulmonary nodule</title><link>https://www.physician.tw/Etiologies-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-solitary-pulmonary-nodule/</guid><description>Etiologies-solitary pulmonary nodule Benign (70%) Granuloma (80%): TB, histo, coccidio Hamartoma (10%) Bronchogenic cyst, AVM, pulm infarct Echinococcosis, ascariasis, aspergilloma GPA, rheumatoid nodule, sarcoidosis Lipoma, fibroma, amyloidoma</description></item><item><title>Etiologies-syncope</title><link>https://www.physician.tw/Etiologies-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-syncope/</guid><description>Etiologies-syncope Vasovagal (a.k.a. neurocardiogenic, ~25%): ‚Üë sympathetic tone ‚Üí vigorous contraction of LV ‚Üí LV mechanoreceptors trigger ‚Üë vagal tone (hyperactive Bezold-Jarisch reflex) ‚Üí ‚Üì HR (cardioinhib.</description></item><item><title>Etiologies-wide-complex tachycardias WCTS</title><link>https://www.physician.tw/Etiologies-wide-complex-tachycardias-WCTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-wide-complex-tachycardias-WCTS/</guid><description>Etiologies-wide-complex tachycardias (WCTS) (Lancet 2012;380:1520)
Ventricular tachycardia (VT): accounts for 80% of WCT in unselected population SVT conducted with aberrancy: either fixed BBB, rate-dependent BBB (usually RBBB), conduction via an accessory pathway or atrially triggered ventricular pacing</description></item><item><title>Etiology-acute liver failure</title><link>https://www.physician.tw/Etiology-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-acute-liver-failure/</guid><description>Etiology-acute liver failure (J Hepatol 2015;62:S112)
[[Drugs and toxins that cause acute liver failure]]
Viral: HAV, HBV, HCV (rare), HDV + HBV, HEV (esp.</description></item><item><title>Etiology-aortic-regurgitation</title><link>https://www.physician.tw/Etiology-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-aortic-regurgitation/</guid><description>Etiology-aortic-regurgitation Valve disease (43%): rheumatic (usually mixed AS/AR + MV disease); bicuspid AoV (natural hx: ‚Öì‚Üí normal, ‚Öì‚Üí AS, ‚Öô‚Üí AR, ‚Öô‚Üí endocarditis ‚Üí AR); infective endocarditis; valvulitis (RA, SLE, certain anorectics &amp;amp; serotonergics, XRT) Root disease (57%): HTN, aortic aneurysm/dissection, annuloaortic ectasia (ie, Marfan), aortic inflammation (GCA, Takayasu‚Äôs, ankylosing spond.</description></item><item><title>Etiology-aortic-stenosis</title><link>https://www.physician.tw/Etiology-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-aortic-stenosis/</guid><description>Etiology-aortic-stenosis Calcific: predominant cause in Pts &amp;gt;70 y; risk factors: HTN, ‚Üë LDL-C, ‚Üë Lp(a), ESRD Congenital (ie, bicuspid AoV w/ premature calcification): cause in 50% of Pts &amp;lt;70 y Rheumatic heart disease (AS usually accompanied by AR and MV disease) AS mimickers: subvalvular (HCMP, subaortic membrane) or supravalvular stenosis</description></item><item><title>Etiology-constrictive pericarditis</title><link>https://www.physician.tw/Etiology-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-constrictive-pericarditis/</guid><description>Etiology-constrictive pericarditis (Circ 2011;124:1270)
Any cause of pericarditis (~1‚Äì2% incidence overall after acute pericarditis) Highest risk w/ TB, bacterial, neoplastic, XRT, connective tissue, postcardiac surgery Viral/idiopathic, b/c most common cause of pericarditis, also account for signif proportion</description></item><item><title>Etiology-epidural abscess</title><link>https://www.physician.tw/Etiology-epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-epidural-abscess/</guid><description>Etiology-epidural abscess Hematogenous spread (‚Öî): skin infection, soft tissue (dental abscess), or endocarditis Direct extension (‚Öì): vertebral osteo, sacral ulcer, spinal anesthesia or surgery, LP Risk factors: IVDU diabetes, renal failure, alcoholism, immunosuppression S.</description></item><item><title>Etiology-mitral-regurgitation</title><link>https://www.physician.tw/Etiology-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-mitral-regurgitation/</guid><description>Etiology-mitral-regurgitation Valve disease (43%): rheumatic (usually mixed AS/AR + MV disease); bicuspid AoV (natural hx: ‚Öì‚Üí normal, ‚Öì‚Üí AS, ‚Öô‚Üí AR, ‚Öô‚Üí endocarditis ‚Üí AR); infective endocarditis; valvulitis (RA, SLE, certain anorectics &amp;amp; serotonergics, XRT) Root disease (57%): HTN, aortic aneurysm/dissection, annuloaortic ectasia (ie, Marfan), aortic inflammation (GCA, Takayasu‚Äôs, ankylosing spond.</description></item><item><title>Etiology-mitral-stenosis</title><link>https://www.physician.tw/Etiology-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-mitral-stenosis/</guid><description>Etiology-mitral-stenosis Rheumatic heart disease (RHD): fusion of commissures ‚Üí ‚Äúfish-mouth‚Äù valve from autoimmune rxn to Œ≤ strep infxn; seen largely in developing world (Circ 2020;142:e337) Mitral annular calcification: encroachment upon leaflets ‚Üí fxnal MS; espec in ESRD Postsurgical repair or post-TEER w/ reduced mitral valve area (MVA) Congenital, infectious endocarditis w/ large lesion, myxoma near MV, thrombus Valvulitis (eg, SLE, amyloid, carcinoid) or infiltration (eg, mucopolysaccharidoses)</description></item><item><title>Etiology-osteomyelitis</title><link>https://www.physician.tw/Etiology-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-osteomyelitis/</guid><description>Etiology-osteomyelitis (Lancet 2004;364:369)
Hematogenous: S. aureus; mycobacterial infection of vertebral body = Pott‚Äôs disease Contiguous focus (may be acute or chronic) Open fracture, orthopedic surgery, etc.</description></item><item><title>Etiology-pericardial tamponade</title><link>https://www.physician.tw/Etiology-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-pericardial-tamponade/</guid><description>Etiology-pericardial tamponade Any cause of pericarditis but espec malignancy, infectious, uremia, ascending AoD, myocardial rupture, periprocedural complication, trauma, post-cardiotomy Rapidly accumulating effusions most likely to cause tamponade b/c no time for pericardium to stretch (eg, to ‚Üë compliance) and accommodate ‚Üë intrapericardial fluid volume</description></item><item><title>Euvolemic-hypotonic-hyponatremia</title><link>https://www.physician.tw/Euvolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Euvolemic-hypotonic-hyponatremia/</guid><description>Euvolemic-hypotonic-hyponatremia (ie, ‚Üë TBW relative to total body Na)
[[SIADH]]
Endocrinopathies: ‚Üë ADH activity seen in glucocorticoid deficiency (co-secretion of ADH &amp;amp; CRH) and severe hypothyroidism/myxedema coma (‚Üì CO/SVR ‚Üí ADH release &amp;amp; ‚Üì GFR)</description></item><item><title>Evaluation acute diarrhea</title><link>https://www.physician.tw/Evaluation-acute-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-acute-diarrhea/</guid><description>Evaluation acute diarrhea (NEJM 2014;370:1532; Digestion 2017;95:293; PLOS One 2017;12:11) Acute infectious diarrhea in immunocompetent adults.
Ddx: hyperthyroid, adrenal insufficiency, meds (abx, antacids, immune checkpt inhibitors), appendicitis, diverticulitis, radiation, 1st presentation of bowel disorder (eg, IBD, celiac)</description></item><item><title>Evaluation for the potential causes of heart failure</title><link>https://www.physician.tw/Evaluation-for-the-potential-causes-of-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-for-the-potential-causes-of-heart-failure/</guid><description>Evaluation for the potential causes of heart failure ECG: evidence for CAD, LVH, LAE, heart block or low voltage (?</description></item><item><title>Evaluation for the presence of heart failure</title><link>https://www.physician.tw/Evaluation-for-the-presence-of-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-for-the-presence-of-heart-failure/</guid><description>Evaluation for the presence of heart failure CXR (see Radiology insert): pulm edema, pleural effusions ¬± cardiomegaly, cephalization, Kerley B-lines; lung U/S better than CXR (PPV &amp;amp; NPV 92% vs.</description></item><item><title>Evaluation in patients without diabetes- but have hypoglycemia</title><link>https://www.physician.tw/Evaluation-in-patients-without-diabetes-but-have-hypoglycemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-in-patients-without-diabetes-but-have-hypoglycemia/</guid><description>Evaluation in patients without diabetes- but have hypoglycemia (JCEM 2009;94:709)
If clinically ill: take measures to avoid recurrent hypoglycemia; ‚úì BUN, Cr, LFTs, TFTs, prealbumin; IGF-I/IGF-II ratio when appropriate If otherwise healthy: 72-h fast w/ monitored blood glc; stop for neuroglycopenic sx At time of hypoglycemia: insulin, C peptide (‚Üë w/ insulinoma and sulfonylureas, ‚Üì w/ exogenous insulin), Œ≤-OH-butyrate, sulfonylurea levels At end of fast, give 1 mg glucagon IV and measure response of plasma glc before feeding</description></item><item><title>Evaluation of Suspected HIT</title><link>https://www.physician.tw/Evaluation-of-Suspected-HIT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-Suspected-HIT/</guid><description>Evaluation of Suspected HIT [[Diagnosis of heparin-induced thrombocytopenia]]
(4T‚Äôs)
Thrombocytopenia ‚Üì &amp;gt;50% and nadir ‚â•20k</description></item><item><title>Evaluation of vasculitis</title><link>https://www.physician.tw/Evaluation-of-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-vasculitis/</guid><description>Evaluation of vasculitis complete blood count (CBC) (with differential) inflammatory markers (erythrocyte sedimentation rate [ESR] and C-reactive protein [CRP]) blood urea nitrogen (BUN)/creatinine levels chest x-ray liver function panel urinalysis antineutrophil cytoplasmic antibody (ANCA) electrolytes [[Principles of Imaging in Vasculitides]]</description></item><item><title>Evaluation-ascites</title><link>https://www.physician.tw/Evaluation-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-ascites/</guid><description>Evaluation-ascites (World J Hepatol 2013;5:251; JAMA 2016;316:340)
Figure: Physical exam: flank dullness (&amp;gt;1500 mL needed), shifting dullness (Se ~83%)</description></item><item><title>Evaluation-asthma-EXACERBATION</title><link>https://www.physician.tw/Evaluation-asthma-EXACERBATION/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-asthma-EXACERBATION/</guid><description>Evaluation-asthma-EXACERBATION History: baseline PEF, steroid requirement, ED visits, hospital admissions, prior intubation Current exacerbation: duration, severity, potential precipitants, meds used</description></item><item><title>Evaluation-dyspnea</title><link>https://www.physician.tw/Evaluation-dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-dyspnea/</guid><description>Evaluation-dyspnea [[books/sxtodx/dyspnea]]
History: quality of sensation, tempo, positional dependence, exac./allev. factors, exertion
Èô§‰∫ÜÂäáÁÉàÈÅãÂãïÂ§ñÔºå‰∏çÊúÉÂõ†ÂëºÂê∏Âõ∞Èõ£ËÄåÁÖ©ÊÉ±„ÄÇ Âú®Âπ≥Âù¶ÁöÑÂú∞Èù¢‰∏äË°åËµ∞ÊàñÂú®Â∞èÂ±±Âù°‰∏äË°åËµ∞ÊôÇÂëºÂê∏Áü≠‰øÉ„ÄÇ Áî±ÊñºÂëºÂê∏Âõ∞Èõ£ÔºåÂú®Âπ≥Âú∞‰∏äËµ∞ÂæóÊØîÂêåÈΩ°‰∫∫ÊÖ¢ÔºåÊàñÂú®Âπ≥Âú∞‰∏ä‰ª•Ëá™Â∑±ÁöÑÊ≠•Ë™øË°åËµ∞ÊôÇ‰∏çÂæó‰∏çÂÅú‰∏ã‰æÜ‰ºëÊÅØ„ÄÇ Ê≠•Ë°å 100 m ÊàñÂπ≥Âú∞Ê≠•Ë°åÂπæÂàÜÈêòÂæåÂÅúÊ≠¢‰ºëÊÅØ„ÄÇ Ê∞£ÂñòÂêÅÂêÅÈõ¢ÈñãÂÆ∂ÔºåÊàñÊó•Â∏∏ÁîüÊ¥ªÊ¥ªÂãïÊ∞£ÂñòÂêÅÁ±≤ Ôºà‰æãÂ¶ÇÔºåÁ©øË°£/ËÑ´Ë°£Ôºâ Cardiopulmonary exam, SaO2, CXR, ECG, ABG, U/S Predictors of CHF: h/o CHF, PND, S3, CXR w/ venous congestion, AF (JAMA 2005;294:1944) Dyspnea w/ nl CXR: CAD, asthma, PE, PHT, early ILD, anemia, acidosis, NM disease Based on results of initial evaluation: PFT, chest CT, TTE, cardiopulmonary testing BNP &amp;amp; NT-proBNP ‚Üë in CHF (also ‚Üë in AF, RV strain from PE, COPD flare, PHT, ARDS) &amp;lt;100 pg/mL to r/o CHF (90% Se), 400 to r/i (NEJM 2002;347:161) NT-proBNP</description></item><item><title>Evolution of Necrotizing Fasciitis or Myonecrosis</title><link>https://www.physician.tw/Evolution-of-Necrotizing-Fasciitis-or-Myonecrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evolution-of-Necrotizing-Fasciitis-or-Myonecrosis/</guid><description>Evolution of Necrotizing Fasciitis or Myonecrosis</description></item><item><title>Excruciatingly Useful Shortcuts</title><link>https://www.physician.tw/Excruciatingly-Useful-Shortcuts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Excruciatingly-Useful-Shortcuts/</guid><description>In the order of most to least useful:
‚åò L Place insertion point in search/title area Escape Clear current search Return Begin editing note, creating it if necessary Tab Move insertion point between text areas ‚åò K Select previous note in list ‚åò J Select next note in list ‚åò D De-select current note, restoring the search text ‚åò ‚áß V Paste clipboard as a new note ‚åò R Rename the selected note ‚åò ‚å´ Delete the selected note(s) ‚åò ‚áß T Tag the selected note ‚åò G Find next occurrence of search text ‚åò ‚áß G Find previous occurrence of search text ‚åò ‚Ü© Open any URL under the insertion point ‚åò ‚Üê Move to title-editing when at start of the note-body ‚åò ‚Üí Move to the note-body when at the end of a title ‚åò ‚áß D Bookmark the selected note ‚åò P Print the selected note(s) ‚åò E Export the selected note(s) to other formats</description></item><item><title>excursion</title><link>https://www.physician.tw/excursion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/excursion/</guid><description>excursion Wandering from the usual course. The extent of movement of a part such as the extremities or eyes. In diabetes, an increase in blood glucose levels above normal or typical values, esp.</description></item><item><title>Exercise-tolerance-test</title><link>https://www.physician.tw/Exercise-tolerance-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Exercise-tolerance-test/</guid><description>Exercise-tolerance-test Generally preferred if Pt can meaningfully exercise; ECG ‚àÜs w/ Se ~65%, Sp ~80%
Typically via treadmill w/ Bruce protocol (modified Bruce or submax if decond.</description></item><item><title>Exposure-interstitial lung disease</title><link>https://www.physician.tw/Exposure-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Exposure-interstitial-lung-disease/</guid><description>Exposure-interstitial lung disease Drugs/Iatrogenic Amiodarone: interstitial pneumonitis ‚Üî org. PNA ‚Üî ARDS; Rx: d/c amio; steroids
Other drugs: nitrofurantoin, sulfonamides, inh, hydralazine</description></item><item><title>Extended DOAC strategies-venous thromboembolism</title><link>https://www.physician.tw/Extended-DOAC-strategies-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extended-DOAC-strategies-venous-thromboembolism/</guid><description>Extended DOAC strategies-venous thromboembolism After ‚â•6 mo of anticoag, following regimens compared w/ no extended Rx (or ASA): Full-dose DOAC: * 80‚Äì90% ‚Üì recurrent VTE, 2‚Äì5√ó bleeding, * but no signif excess in major bleeding * (NEJM 2010;363:2499; 2013;368:699 &amp;amp; 709) ¬Ω dose apixa or riva: * ‚â•75% ‚Üì recur.</description></item><item><title>Extrapulmonary TB</title><link>https://www.physician.tw/Extrapulmonary-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extrapulmonary-TB/</guid><description>Extrapulmonary TB Pleural/pericardial effusions or ascites: fluid sampling for AFB cx/smear, NAAT/ PCR, cell counts. Adenosine deaminase (ADA) can be ‚Üë, best validated in ascites.</description></item><item><title>Extrarenal H2O loss Uosm >700‚Äì800</title><link>https://www.physician.tw/Extrarenal-H2O-loss-Uosm-700800/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extrarenal-H2O-loss-Uosm-700800/</guid><description>Extrarenal H2O loss (Uosm &amp;gt;700‚Äì800) GI H2O loss: vomiting, NGT drainage, osmotic diarrhea, fistula, lactulose, malabsorption
Insensible loss: fever, exercise, ventilation, burns</description></item><item><title>Exudates</title><link>https://www.physician.tw/Exudates/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Exudates/</guid><description>Exudates Lung parenchymal infection (25%) Bacterial (parapneumonic): can evolve along spectrum of exudative (but sterile) ‚Üí fibropurulent (infected fluid) ‚Üí organization (fibrosis &amp;amp; formation of rigid pleural peel).</description></item><item><title>Factitious disorder</title><link>https://www.physician.tw/Factitious-disorder/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Factitious-disorder/</guid><description>Factitious disorder ÊâÄ‰ª•Ë£ùÁóÖÁóáÂÄôÁæ§Ë®∫Êñ∑ÁöÑ‰∏âÂÄãÊ¢ù‰ª∂Ôºö
1.ÊïÖÊÑèË°®ÁèæÂá∫‰∏Ä‰∫õË∫´È´îÊàñÂøÉÁêÜÁöÑÁóáÁãÄ
2.ÂæàÂñÆÁ¥îÁöÑÂè™ÊòØË¶Å‰º¥ÊºîÁóÖ‰∫∫ÁöÑËßíËâ≤
3.‰∏çËÉΩÊúâÂÖ∂‰ªñÁöÑÈôÑÂ∏∂ÂÉπÂÄºÊàñÊî∂Áç≤
ÈÇÑÊúâ‰∏ÄÁ®ÆË£ùÁóÖÊòØÂÆ£Á®±‰ªñÊâÄÁÖßÈ°ßÁöÑ‰∫∫ÁîüÁóÖÔºåËÄåÈÄôÂÄãÁóÖ‰∫∫ÂøÖÈ†àË¶Å‰ª∞Ë≥¥ÈÄôÂÄãÂÆ£Á®±ËÄÖÁöÑÁÖßÈ°ßÔºàÂ¶ÇÔºöÊØçË¶™ËàáÂ∞èÂ≠©ÁöÑÈóú‰øÇÔºâÔºõÂºïËµ∑Ë£ùÁóÖÁöÑÂéüÂõ†ÁõÆÂâçÁöÑËß£ÈáãÊòØË™™ÔºåÂú®ÁîüÈï∑ÈÅéÁ®ã‰∏≠‰∏ÄÁõ¥ÂèóÂà∞ÂøΩÁï•ÊàñÊîæÊ£ÑÔºåÊâÄ‰ª•Â∏åÊúõËÆäÊàê‰∏ÄÂÄãÁóÖ‰∫∫ÔºåÂæûÊñ∞Áç≤ÂæóÈáçË¶ñ„ÄÅÂÉπÂÄºÂèäÂèñÂæóÁõ∏‰∫í‰æùË≥¥ÁöÑÊÑüË¶∫„ÄÇÂè¶‰∏ÄÁ®ÆÊòØËóâÁî±Ë£ùÁóÖÈ®ôÈÅéÈÜ´ÁîüÔºåÂèØ‰ª•ÂæóÂà∞‰∏ÄÁ®ÆÂø´ÊÑüÔºõÂ¶ÇÊûúÊòØÂÆ£Á®±Ë¢´ÁÖßÈ°ßÁöÑ‰∫∫ÁîüÁóÖÔºåÈÇ£ÈÄôË¢´ÁÖßÈ°ßËÄÖÊòØË¢´Âà©Áî®ÊàêÁÇ∫Â∑•ÂÖ∑‰æÜÁç≤Âèñ‰∏äÂàóÊâÄË™™ÁöÑ‰∏Ä‰∫õÁµêÊûú„ÄÇÊúâÊôÇÂ™ΩÂ™ΩÂæûÂ©öÂßª‰∏≠ÁÑ°Ê≥ïÂæóÂà∞ÊÉ≥Ë¶ÅÂæóÂà∞ÁöÑÊªøË∂≥ÔºåËóâËëóÂ∞èÊúãÂèãÁöÑÁîüÁóÖÊúâÊ©üÊúÉÁÖßÈ°ß‰ªñÔºå‰æÜÊªøË∂≥Ëá™Â∑±ÁöÑ‰∏çÊªøË∂≥„ÄÇ
Ë£ùÁóÖÁöÑ‰∫∫ÁóáÁãÄÁâπË≥™ÊúâÔºöÁ∂ìÂ∏∏‰∏çÂÅúÁöÑÂéªÁúãÈÜ´Áîü„ÄÅÂ∞ç‰∏Ä‰∫õÈÜ´Â≠∏ÁóÖÂêçÂèäÊ≤ªÁôÇÊñπÂºèÈÉΩÁû≠Ëã•ÊåáÊéåÔºåÁîöËá≥ÂèØ‰ª•‰ΩøÁî®‰∏Ä‰∫õÈÜ´Â≠∏ÂêçË©û„ÄÅÁóáÁãÄË°®ÁèæÂèàÈùûÂ∏∏Êà≤ÂäáÂåñÔºåÂ¶ÇÊûúÈÜ´ÁîüË¶ÅÂè´‰ªñÂÅöÊüê‰∫õÊ™¢Êü•ÔºåÂç≥‰ΩøÊúâ‰∏Ä‰∫õÂç±Èö™ÊÄßÔºåÈÉΩÊúÉÊØ´‰∏çËÄÉÊÖÆÁ≠îÊáâÔºåÁîöËá≥Ê®ÇÊñºÊé•ÂèóÔºåÊúâÊôÇÈÄ£ÈñãÂàÄ‰πü‰∏ÄÊ®£„ÄÇÂ¶ÇÊûúÂèØ‰ª•ÂÅ∑ÂÅ∑ËßÄÂØüÔºåÂ∞±ÊúÉÁôºÁèæ‰∏çÁÆ°ÊòØËá™Â∑±ÁöÑÁóáÁãÄÊàñÊòØÁÖßÈ°ß‰ªñ‰∫∫ÁöÑË£ùÁóÖÔºåÈÉΩÊúÉÂøÖÈ†àÂú®Êúâ‰∫∫ÁöÑÊôÇÂÄôÊâçÊúÉÁôºÁîüÔºåÂõ†ÁÇ∫ÁÇ∫‰∫ÜË£ùÁóÖÔºåÊúâÊôÇÊúÉÈôÑÂ∏∂ÂÖ∂‰ªñÁöÑ‰∫ãÈúÄË¶ÅÈö±ÁûûÔºå‰ΩÜÂæÄÂæÄÈÉΩÊòØÁî±ÈÄô‰∫õÈñãÂßãË¢´‰∫∫Ê≥®ÊÑèÁöÑÔºà‰æãÂ¶ÇÔºöË¨äÁ®±Ëá™Â∑±ÊòØÊüêÂÖ¨Âè∏ÁöÑ‰∏ªÁÆ°ÔºåÁÇ∫‰∫ÜÁîüÁóÖËÄå‰∏ü‰∫ÜÂ∑•‰ΩúÔºå‰ΩÜÂæûÊ≤íÁúãÈÅé‰ªñÁöÑÂêå‰∫ã‰æÜÁúã‰ªñ„ÄÇ)
„ÄêÊ≤ªÁôÇ„Äë
1.‰∏ªË¶ÅÊòØ‰ª•ÂøÉÁêÜÊ≤ªÁôÇÁÇ∫‰∏ªÔºå‰πüÁû≠Ëß£ÁóÖ‰∫∫ÁöÑËÉåÊôØ‰ª•ÂèäÁîüÊ¥ª‰∏äÁöÑÈúÄË¶ÅÔºåËàáÁóÖ‰∫∫Á´ãËâØÂ•ΩÁöÑÈóú‰øÇ 2.Êüê‰∫õÊäóÊÜÇÈ¨±ÁöÑËó•Áâ©‰πüÂèØ‰ª•Âπ´‰∏ä‰∏Ä‰∫õÂøô
3.Â∞çÊñº‰ªñË£ùÁóÖÁöÑ‰∫ãÂØ¶Ë¶ÅÁî®ÂíåÁ∑©ÁöÑÊÖãÂ∫¶ÂéªÊÖ¢ÊÖ¢Á†¥Ëß£ÔºåÊâç‰∏çÊúÉÊúâÂèçÊïàÊûú
4.ÈÄöÂ∏∏ÁóÖ‰∫∫ÈÉΩÈÇÑÂ†ÖÊåÅËá™Â∑±‰∏çÊòØË£ùÁóÖÔºåÈõñÁÑ∂ÈÄ±ÈÅ≠ÁöÑ‰∫∫ÈÉΩ‰∏çÂ§™Áõ∏‰ø°Âç≥‰Ωø‰∫ãÂØ¶Â∑≤Á∂ìÂæàÊòéÈ°Ø</description></item><item><title>factitious fever</title><link>https://www.physician.tw/factitious-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/factitious-fever/</guid><description>factitious fever ‚ú®ÈáçÈªû: ‰∏ÄÁ®ÆËá™ÊàëË™òÁôºÁöÑ‰∫∫Â∑•ÁôºÁÜ±Ôºà‰æÜËá™Êãâ‰∏ÅË™ûfactitiusÔºåÁî±ËóùË°ìË£ΩÈÄ†Ôºâ„ÄÇ ÈÄôÂèØËÉΩ‰ª•Â§öÁ®ÆÊñπÂºèÁôºÁîüÔºåÊúÄÂ∏∏Ë¶ãÁöÑÊòØÂú®Ê∫´Â∫¶Ê™¢Êü•‰πãÂâçÊîùÂÖ•ÔºàÂíåÂò¥Â∑¥Âê´‰ΩèÔºâÁÜ±Ê∂≤È´î„ÄÇ ‰∫∫ÁÇ∫ÁöÑÁôºÁáíÈÄöÂ∏∏Ôºà‰ΩÜ‰∏çÁ∏ΩÊòØÔºâÂèØ‰ª•ÈÄöÈÅéÊ∏¨ÈáèÁõ¥ËÖ∏Ê∫´Â∫¶ÔºàÁîöËá≥ÂèØ‰ª•‰ΩúÁÇ∫Êá≤ÁΩ∞ÊÄßÂ®ÅÊáæÔºâÊàñÊéíÂ∞øÊôÇÁöÑÂ∞øÊ∫´‰æÜÊäµÊ∂à„ÄÇ Â¶ÇÊûúÈÄôÊ®£ÂÅöÔºåË´ãË®ò‰ΩèÂ∞øÊ∫´Áï•‰ΩéÊñºÂè£ËÖîÊ∫´Â∫¶„ÄÇ</description></item><item><title>Familial Mediterranean fever</title><link>https://www.physician.tw/Familial-Mediterranean-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Familial-Mediterranean-fever/</guid><description>Familial Mediterranean fever (peritonitis, episodic fever, pleuritis; ‚Üë WBC &amp;amp; ESR during attacks);</description></item><item><title>Family history of migraine</title><link>https://www.physician.tw/Family-history-of-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Family-history-of-migraine/</guid><description>Family history of migraine Migraine has a strong genetic component and its prevalence is higher among people with directly affected first-degree relatives than among the general population18,19.</description></item><item><title>Fanconi‚Äôs syndrome</title><link>https://www.physician.tw/Fanconis-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fanconis-syndrome/</guid><description>Fanconi‚Äôs syndrome Proximal convoluted tubule Â§öÂ∞ø„ÄÅÂ§öÈ£≤ÂèäËÑ´Ê∞¥„ÄÇ</description></item><item><title>Febrile nonhemolytic</title><link>https://www.physician.tw/Febrile-nonhemolytic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Febrile-nonhemolytic/</guid><description>Febrile nonhemolytic : fever, rigors 0‚Äì6 h post transfusion. Due to Abs vs. donor WBCs and cytokines in blood product. Rx: acetaminophen ¬± meperidine; r/o infection, hemolysis.</description></item><item><title>fever and neutropenia</title><link>https://www.physician.tw/fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-and-neutropenia/</guid><description>fever and neutropenia [[fever in oncology - duty note]]
[[Definition of fever and neutropenia]] [[Pathophysiology and microbiology of fever and neutropenia]] [[Prevention of fever and neutropenia]] (only if intermediate or high-risk) [[Role of hematopoietic growth factors]] [[Diagnostic evaluation of fever and neutropenia]] [[Risk stratification of fever and neutropenia]] (factors that predict lower risk) [[Initial antibiotic therapy of fever and neutropenia]] [[Modification to initial antibiotic regimen based on site-specific evaluation of fever and neutropenia]] [[Duration of therapy of fever and neutropenia]] ÁÜ±ÁóÖÔºö[[Neutropenia-Febrile-High-Risk]]</description></item><item><title>fever and rash</title><link>https://www.physician.tw/fever-and-rash/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-and-rash/</guid><description>fever and rash Approach to diagnostic workup
Meningococcemia, endocarditis, RMSF, sepsis, &amp;amp; toxic shock need urgent dx &amp;amp; Rx Workup: CBC w/diff, BMP, LFTs, LDH, CK, U/A, HIV Ag/Ab ¬± PCR, BCx off abx) To narrow Ddx: characterize time course of rash, progression, &amp;amp; morphology [[Erythema multiforme]] [[Erythema nodosum]] [[Variable and Possible Etiology-fever and rash]] Treatment</description></item><item><title>fever in a returned traveler</title><link>https://www.physician.tw/fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-in-a-returned-traveler/</guid><description>fever in a returned traveler See CDC.gov/travel for up to date information on regional risks and recommendations [[Region or Exposure Common Etiologies -fever in a returned traveler]]</description></item><item><title>fever in oncology - duty note</title><link>https://www.physician.tw/fever-in-oncology-duty-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-in-oncology-duty-note/</guid><description>fever in oncology - duty note ECOG 0‚Äì1, age &amp;lt;60 y, solid tumor, no sx, no major comorbidities, no h/o fungal infection, [[MASCC Risk Index]] ‚â•21 (Support Care Cancer 2013;21:1487)</description></item><item><title>fever of unknown origin</title><link>https://www.physician.tw/fever-of-unknown-origin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-of-unknown-origin/</guid><description>fever of unknown origin Definition &amp;amp; etiologies (NEJM 2022;386:463) Fever (as per above def) on &amp;gt;1 occasion during ‚â•3 wk &amp;amp; no dx despite 1 wk of evaluation More likely to be unusual manifestation of common disease than an uncommon disease In Pts with HIV: &amp;gt;75% causes are infectious, but rarely due to HIV itself Frequent reassessment needed to identify focal signs and progression of disease [[Etiologies of Classic FUO]] [[Workup-fever of unknown origin]] (Archives 2009;169:2018; AJM 2015;128:1138) [[Treatment-fever of unknown origin]]</description></item><item><title>fever syndromes</title><link>https://www.physician.tw/fever-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-syndromes/</guid><description>fever syndromes Temperature ‚â•100.4¬∞F or ‚â•38¬∞C [[What are the most commonly encountered fever patterns]] [[physical findings may help identify the cause of a fever]]</description></item><item><title>Fever workup in patient with HIV AIDS</title><link>https://www.physician.tw/Fever-workup-in-patient-with-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fever-workup-in-patient-with-HIV-AIDS/</guid><description>Fever workup in patient with HIV AIDS Etiologies (Infect Dis Clin North Am 2007;21:1013) infxn (82‚Äì90%): MAC, TB, CMV, early PCP, Histo, Crypto, Coccidio, Toxo, endocarditis noninfectious: lymphoma, drug reaction.</description></item><item><title>Fibrinolysis vs Hospital Transfer for Primary PCI</title><link>https://www.physician.tw/Fibrinolysis-vs-Hospital-Transfer-for-Primary-PCI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fibrinolysis-vs-Hospital-Transfer-for-Primary-PCI/</guid><description>1.Time required for transport to skilled PCI lab: door-to-balloon &amp;lt;120 min &amp;amp; [door-to-balloon]‚Äì[door-to-needle] &amp;lt;1 h favors transfer for PCI
2.Risk from STEMI: high-risk Pts (eg, shock) fare better with mechanical reperfusion</description></item><item><title>Fibromuscular dysplasia</title><link>https://www.physician.tw/Fibromuscular-dysplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fibromuscular-dysplasia/</guid><description>Fibromuscular dysplasia Á∫ñÁ∂≠ËÇåÁôºËÇ≤‰∏çËâØÔºàFMDÔºâÊòØËÖéÂãïËÑàÁãπÁ™ÑÁöÑÈáçË¶ÅÂéüÂõ†ÔºåÂ∞§ÂÖ∂ÊòØÂú®Âπ¥ËºïÂ•≥ÊÄß‰∏≠„ÄÇ ÊìöÂ†±Â∞éÔºåFMDÂíåAlpha 1-ÊäóÊäóËõãÁôΩÈÖ∂ÔºàAlpha 1-ATÔºâÁº∫‰πèÁóá‰πãÈñìÂ≠òÂú®ÁΩïË¶ãÁöÑÈóúËÅØ„ÄÇ</description></item><item><title>First-line or upfront therapy for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/First-line-or-upfront-therapy-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/First-line-or-upfront-therapy-for-idiopathic-thrombocytopenic-purpura/</guid><description>First-line or upfront therapy for idiopathic thrombocytopenic purpura Steroids: prednisone 0.5‚Äì2 mg/kg/d PO tapered ~4 wk, or dexamethasone 40 mg PO √ó 4 d</description></item><item><title>Flecainide</title><link>https://www.physician.tw/Flecainide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Flecainide/</guid><description>Flecainide 300 mg PO x1 100-150 mg bid PreRx w/ AVN blocker. avoid if: structural/ischemic heart dis.
%
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Fluid Resuscitation</title><link>https://www.physician.tw/Fluid-Resuscitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fluid-Resuscitation/</guid><description>Fluid Resuscitation [[sensible and insensible fluid losses]] [[classes of hemorrhagic shock]] [[empiric replacement fluids can be used for fluid losses]]</description></item><item><title>Fluids-sepsis and shock</title><link>https://www.physician.tw/Fluids-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fluids-sepsis-and-shock/</guid><description>Fluids-sepsis and shock [[The Composition of Saline, Lactated Ringer‚Äôs Solution, and Plasma-Lyte 148]]
Aggressive IV fluid resuscitation (30 mL/kg) admin in boluses w/in 3 h of presentation [[Crystalloid]] as good as colloid for resuscitation (JAMA 2013;310:1809; NEJM 2014;370:1412) No consistently seen benefit of balanced crystalloid (LR, Plasma-Lyte) vs.</description></item><item><title>Focal segmental glomerulosclerosis</title><link>https://www.physician.tw/Focal-segmental-glomerulosclerosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Focal-segmental-glomerulosclerosis/</guid><description>Focal segmental glomerulosclerosis (40%; CJASN 2017;12:502).
Primary: permeability factor.
Secondary adaptive (hyperfiltration, sickle cell, obesity, anabolic steroids, OSA, ‚Üë protein, vesico-ureteral reflux); meds/toxins (IFN, bisphosphonates, NSAIDs, heroin), viral (COVID-19, HIV) or genetic (ApoL1 mutation in AA; JASN 2015;26:1443).</description></item><item><title>Focused history of chest pain</title><link>https://www.physician.tw/Focused-history-of-chest-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Focused-history-of-chest-pain/</guid><description>Focused history of chest pain quality, severity, location, radiation; provoking/palliating factors; intensity at onset; duration, freq, &amp;amp; pattern; setting; assoc sx; cardiac hx &amp;amp; risk factors</description></item><item><title>Folate deficiency</title><link>https://www.physician.tw/Folate-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Folate-deficiency/</guid><description>Folate deficiency Folate present in leafy green vegetables and fruit; total body stores sufficient for 2‚Äì3 mo
Etiologies: malnutrition (alcoholics, anorectics, elderly), ‚Üì absorption (sprue), impaired metabolism (methotrexate, pyrimethamine, trimethoprim; NEJM 2015;373:1649), ‚Üë requirement (chronic hemolytic anemia, pregnancy, malignancy, dialysis)</description></item><item><title>Follicular thyroid cancer</title><link>https://www.physician.tw/Follicular-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Follicular-thyroid-cancer/</guid><description>Follicular thyroid cancer Peak incidence 40 to 60 y, ‚ôÄ:‚ôÇ 3:1; RFs: childhood radiation; FHx; familial syndrome Mortality 10‚Äì20% at 20 y; mets frequently distal due to hematogenous spread Hurthle cell carcinoma: pathologic dx; variant a/w poorer prognosis and ‚Üë recurrence rate</description></item><item><title>Follow-up, treatment response and failure of Migraine</title><link>https://www.physician.tw/Follow-up-treatment-response-and-failure-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Follow-up-treatment-response-and-failure-of-Migraine/</guid><description>Follow-up, treatment response and failure of Migraine Use headache calendars Assess effectiveness and adverse events When outcomes are suboptimal, review diagnosis, treatment strategy, dosing and adherence When treatment fails, re-evaluate before changing Referral to specialist care should be reserved for patients whose condition is diagnostically challenging, difficult to treat or complicated by comorbidities</description></item><item><title>Follow-up-aortic aneurysms</title><link>https://www.physician.tw/Follow-up-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Follow-up-aortic-aneurysms/</guid><description>Follow-up-aortic aneurysms (Circ 2010;121:e266; Nat Rev Cardiol 2011;8:92; JAMA 2013;309:806)
Expansion rate ~0.1 cm/y for TAA, ~0.3‚Äì0.4 cm/y for AAA TAA: 6 mo after dx to ensure stable, and if stable, then annually (Circ 2005;111:816) AAA: &amp;lt;4 cm q2‚Äì3y; 4‚Äì5.</description></item><item><title>Fourth Universal Definition of Myocardial Infarction 2018</title><link>https://www.physician.tw/Fourth-Universal-Definition-of-Myocardial-Infarction-2018/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fourth-Universal-Definition-of-Myocardial-Infarction-2018/</guid><description>Fourth Universal Definition of Myocardial Infarction (2018) myocardial cell death due to prolonged ischemia Increases in cTnI values have not been reported to occur following injury to noncardiac tissues.</description></item><item><title>Fresh frozen plasma</title><link>https://www.physician.tw/Fresh-frozen-plasma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fresh-frozen-plasma/</guid><description>Fresh frozen plasma Contains all coagulation factors. For bleeding due to defic. of multiple coag factors (eg, DIC, TTP/HUS, liver disease, dilution).</description></item><item><title>Fresh H2O soft tissue infections</title><link>https://www.physician.tw/Fresh-H2O-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fresh-H2O-soft-tissue-infections/</guid><description>Fresh H2O soft tissue infections Aeromonas Myonecrosis/rhabdo can occur. FQ, TMP-SMX, or CTX</description></item><item><title>fromNonspecific Low Back Pain-metadata</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM-1/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM-1/</guid><description>fromNonspecific Low Back Pain-metadata</description></item><item><title>Functional GI disease</title><link>https://www.physician.tw/Functional-GI-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Functional-GI-disease/</guid><description>Functional GI disease (~30 types per Rome IV criteria; ) (&amp;gt; Ë©≥Ë¶ã‚û°Ô∏èÔºö Gastro 2016;150:1257)
Recurrent GI sx caused by disorders of gut-brain interaction rather than structural cause</description></item><item><title>Fungal diagnostics</title><link>https://www.physician.tw/Fungal-diagnostics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fungal-diagnostics/</guid><description>Fungal diagnostics Antigen detection 1,3-Œ≤-D glucan (Se 75%, Sp 85%): ÂèØ‰ª•Âú®Âì™‰∫õfungusÁúãÂæóÂà∞Ôºü Candida, Aspergillus, Histo, Coccidio, PCP, for invasive infxn in immunocomp host.</description></item><item><title>fungal infections</title><link>https://www.physician.tw/fungal-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fungal-infections/</guid><description>fungal infections [[Fungal diagnostics]] [[Candida species]] [[Aspergillosis]] (Lancet 2021;397:499) [[Zygomycetes]] (eg, Mucor, Rhizopus) ENDEMIC FUNGI [[Cryptococcus]] (CID 2010;50:291) [[Histoplasmosis]] [[Coccidioidomycosis]] (CID 2016;63:112) [[Blastomycosis]]</description></item><item><title>Further coagulation tests</title><link>https://www.physician.tw/Further-coagulation-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Further-coagulation-tests/</guid><description>Further coagulation tests (JAMA 2016;316:2146)
Mixing study: useful if ‚Üë PT or PTT; mix Pt‚Äôs plasma 1:1 w/ normal plasma and retest PT/PTT normalizes ‚Üí factor deficiency; PT/PTT remains elevated ‚Üí factor inhibitor</description></item><item><title>Gardening</title><link>https://www.physician.tw/Gardening/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gardening/</guid><description>Gardening Sporothrix Ulcerating nodules, lymphatic spread Itraconazole</description></item><item><title>gastroenterology</title><link>https://www.physician.tw/gastroenterology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology/</guid><description>ËÉÉÁóõËÖπÁóõÔºåÊ∂àÂåñ‰∏çËâØÔºå ÁóÖÁóáÂ§öÁ´ØÔºåÈúÄÈ´òÊòé„ÄÇ È£üÁâ©‰∏çÊ∂àÔºåËÉÉÈÖ∏ÂÄíÊµÅÔºå ËÖ∏ËÉÉÂÖßÁóÖÔºåËã¶Èõ£Â§ö„ÄÇ
gastroenterology Part 10:¬†[[Disorders of the Gastrointestinal System]]
[[esophageal and gastric disorders]]</description></item><item><title>Gastroesophageal varices and UGIB-cirrhosis</title><link>https://www.physician.tw/Gastroesophageal-varices-and-UGIB-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroesophageal-varices-and-UGIB-cirrhosis/</guid><description>Gastroesophageal varices and UGIB-cirrhosis See: [[gastrointestinal bleeding]]
Presence of varices correlates w/ severity of liver dis (40% of Child A Pts ‚Üí 85% Child C)</description></item><item><title>Gastroparesis</title><link>https://www.physician.tw/Gastroparesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroparesis/</guid><description>Gastroparesis Gastroparesis.
Delayed gastric emptying w/o mechanical obstruction, typically p/w nausea (&amp;gt;90%), vomiting (&amp;gt;80%), early satiety (60%), postprandial fullness/pain</description></item><item><title>general approach to treatment of breast cancer</title><link>https://www.physician.tw/general-approach-to-treatment-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/general-approach-to-treatment-of-breast-cancer/</guid><description>general approach to treatment of breast cancer (JAMA 2019;321:288 &amp;amp; 1716)
DCIS Mastectomy or lumpectomy ¬± RT ¬± chemoprevention (Lancet 2016;387:849 &amp;amp; 866)</description></item><item><title>General considerations-diuresis</title><link>https://www.physician.tw/General-considerations-diuresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-considerations-diuresis/</guid><description>General considerations-diuresis ‚Üë Na &amp;amp; H2O excretion for treatment of HTN or edema in CHF, renal failure, and cirrhosis</description></item><item><title>General evaluation or chronic diarrhea</title><link>https://www.physician.tw/General-evaluation-or-chronic-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-evaluation-or-chronic-diarrhea/</guid><description>General evaluation or chronic diarrhea (JAMA 2016;315:2712; Gastro 2019;157:3)
Ë©≥Ë¶ã Persistent Diarrhea: A Clinical Review.
Clinically can be classified as watery, fatty, inflammatory</description></item><item><title>General treatment-acute kidney injury AKI</title><link>https://www.physician.tw/General-treatment-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-treatment-acute-kidney-injury-AKI/</guid><description>General treatment-acute kidney injury (AKI) (CJASN 2008;3:962)
Prerenal: isotonic IVF ‚âà alb (NEJM 2004;350:22). No clear benefit of balanced crystalloids (eg, LR) over normal saline (NEJM 2018;378:829 &amp;amp; 2022;386:815).</description></item><item><title>General-renal replacement and dialysis</title><link>https://www.physician.tw/General-renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-renal-replacement-and-dialysis/</guid><description>General-renal replacement and dialysis Acute indications: see ‚ÄúAKI‚Äù; choices CVVH vs. HD
Chronic indications: timing of RRT initiation should factor in Pt QoL, uremic sx, risk of development of urgent/acute indications; modalities PD vs.</description></item><item><title>Genetics of Diagnostic and staging evaluation of lung cancer</title><link>https://www.physician.tw/Genetics-of-Diagnostic-and-staging-evaluation-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genetics-of-Diagnostic-and-staging-evaluation-of-lung-cancer/</guid><description>Genetics of Diagnostic and staging evaluation of lung cancer (usually just in adv/metastatic disease):
EGFR (include in stage IIA-IIIB), ALK, ROS1, MET, KRAS, RET, BRAF, NTRK fusion for all non-squamous disease (incidence lower in SCC but still consider testing); PD-L1 expression</description></item><item><title>Genital Discharge</title><link>https://www.physician.tw/Genital-Discharge/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genital-Discharge/</guid><description>Genital Discharge Gonorrhea (N. gonorrhoeae) &amp;amp; Chlamydia (C. trachomatis) ‚ôÄ: Mucopurulent cervicitis, dysuria, PID; can be asx ‚ôÇ: Urethritis, infxn of epididymis/prostate All: pharyngitis</description></item><item><title>Genital Lesions</title><link>https://www.physician.tw/Genital-Lesions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genital-Lesions/</guid><description>Genital Lesions Painless Syphilis (T. pallidum) 1¬∞: chancre = firm, indurated, clean base 2¬∞: fever, LAN, rash palms/soles, uveitis, condylomata lata 3¬∞: aortitis/aneurysm, gumma, CN palsies (7/8), tabes dorsalis, aseptic meningitis Latent = asx; early latent &amp;lt;1yr; late &amp;gt;1yr/unknown</description></item><item><title>geriatrics</title><link>https://www.physician.tw/geriatrics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/geriatrics/</guid><description>geriatrics The topics covered are organized as follows:
falls frailty dementia delirium medication management geriatric assessment
other important topics related to geriatrics are covered in the following rotation guides: palliative care delivering bad news (patient communication) ICU delirium (Critical Care) depression, Anxiety (Mental Health) symptom management in oncology</description></item><item><title>GI potassium losses</title><link>https://www.physician.tw/GI-potassium-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-potassium-losses/</guid><description>GI potassium losses GI losses plus metabolic acidosis: diarrhea, laxative abuse, [[villous adenoma]]
Vomiting &amp;amp; NGT drainage usually manifest as renal losses due to 2¬∞ hyperaldo &amp;amp; met.</description></item><item><title>GI prophylaxis if taking ASA and nonsteroidal anti-inflam drug</title><link>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-and-nonsteroidal-anti-inflam-drug/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-and-nonsteroidal-anti-inflam-drug/</guid><description>GI prophylaxis if taking ASA and nonsteroidal anti-inflam drug (Am J Gastro 2009;104:728)
PPI if h/o PUD/UGIB and either (a) on P2Y12 inhib or anticoag, or (b) ‚â•2 of the following: &amp;gt;60 y, steroids or dyspepsia.</description></item><item><title>GI prophylaxis if taking ASA NSAID peptic ulcer disease</title><link>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease-/</guid><description>GI prophylaxis if taking ASA NSAID peptic ulcer disease (Am J Gastro 2009;104:728)
PPI if h/o PUD/UGIB and either (a) on P2Y12 inhib or anticoag, or (b) ‚â•2 of the following: &amp;gt;60 y, steroids or dyspepsia.</description></item><item><title>Giant cell arteritis</title><link>https://www.physician.tw/Giant-cell-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Giant-cell-arteritis/</guid><description>Giant cell arteritis Females &amp;gt; 50 years old. ÈòøÂ´≤
Unilateral headache, possible temporal artery tenderness, jaw claudication.</description></item><item><title>Glasgow-Blatchford</title><link>https://www.physician.tw/Glasgow-Blatchford/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glasgow-Blatchford/</guid><description>Glasgow-Blatchford Glasgow-Blatchford scores range from 0 to 23, with higher scores indicating higher risk. Positive predictive values were calculated in a study by Laursen et al.</description></item><item><title>glomerular disease</title><link>https://www.physician.tw/glomerular-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glomerular-disease/</guid><description>glomerular disease [[glomerulonephritis]] (GN) [[asymptomatic glomerular hematuria]] [[nephrotic syndrome]]</description></item><item><title>Glomerular Diseases</title><link>https://www.physician.tw/Glomerular-Diseases/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-Diseases/</guid><description>Glomerular Diseases BacklinkÔºö [[nephrology]] [[nephrotic syndrome]] [[Primary glomerular diseases (grouped by pathology)]]</description></item><item><title>Glomerular proteinuria</title><link>https://www.physician.tw/Glomerular-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-proteinuria/</guid><description>Glomerular proteinuria (can be &amp;gt;3.5 g/d) Disruption of filtration barrier ‚Üí lose albumin
Etiologies
Glomerulonephritis Nephrotic syndrome</description></item><item><title>glomerulonephritis</title><link>https://www.physician.tw/glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glomerulonephritis/</guid><description>glomerulonephritis [[Definition-glomerulonephritis]] [[ANCA positive Vasculitis]] [[Anti-GBM Disease]] [[Immune Complex (IC) Disease (granular staining) ]] [[Oncology-related glomerulopathy]] [[Workup-glomerulonephritis]] [[Approach to glomerulonephritis based on immunofluorescence pattern]] [[Treatment-glomerulonephritis]]</description></item><item><title>Glucose of cerebrospinal fluid</title><link>https://www.physician.tw/Glucose-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glucose-of-cerebrospinal-fluid/</guid><description>Glucose of cerebrospinal fluid Ê≠£Â∏∏Á¥Ñ 50‚Äì75 mg/dLÔºåÁ¥ÑÊòØ serum ÁöÑ 0.5‚Äì0.8 ‰∏äÂçáÔºöÈÄöÂ∏∏ÊòØÂõ†ÁÇ∫È´òË°ÄÁ≥ñ ‰∏ãÈôçÔºöÈÄöÂ∏∏ÊòØ bacteria„ÄÅTB„ÄÅfungus„ÄÅÊüê‰∫õËÖ´Áò§ ‚Üì‚Üì (&amp;lt;20)ÔºöÈÄöÂ∏∏ÊòØ bacteria ‚ÜìÔºöTB„ÄÅfungus„ÄÅÊüê‰∫õËÖ´Áò§ Viral meningitis„ÄÅencephalitis ÁöÑ glucose Â∏∏Â∏∏ÊòØÊ≠£Â∏∏ÁöÑ</description></item><item><title>glucose water osmolarity</title><link>https://www.physician.tw/glucose-water-osmolarity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glucose-water-osmolarity/</guid><description>glucose water osmolarity g/180 * 1000
ÈÄüÁÆóÔºö% * 50 = osm/L
e.g. D5W = 5*50 = 250 osm/L</description></item><item><title>Glucose-6-phosphate dehydrogenase</title><link>https://www.physician.tw/Glucose-6-phosphate-dehydrogenase/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glucose-6-phosphate-dehydrogenase/</guid><description>Glucose-6-phosphate dehydrogenase (G6PD) deficiency (Lancet 2008;371:64)
X-linked defect of metabolism (G6PD mutations) w/ ‚Üë susceptibility to oxidative damage</description></item><item><title>Grading-of-Mitral-Stenosis</title><link>https://www.physician.tw/Grading-of-Mitral-Stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Grading-of-Mitral-Stenosis/</guid><description>Grading-of-Mitral-Stenosis Grading of Mitral Stenosis Stage Mean V (mmHg) Pressure ¬Ω Time MVA (cm-) PA sys (mmHg) Normal 0 n/a 4-6 Ôºú25 Mild-mod &amp;lt;5 100-149 1.</description></item><item><title>Granulocytopenia or neutropenia</title><link>https://www.physician.tw/Granulocytopenia-or-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Granulocytopenia-or-neutropenia/</guid><description>Granulocytopenia or neutropenia (includes DM, ESRD ‚Üí functional impairment) Bacteria: Gram positive: coag ‚äñ staph, S. aureus, viridans strep, S. pneumo, other strep; Corynebacterium spp.</description></item><item><title>Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Granulomatosis-with-polyangiitis/</guid><description>Granulomatosis with polyangiitis GPA, formerly Wegener‚Äôs granulomatosis
Predominant type; can see either type (NEJM 2012;367:214);
Necrotizing granulomatous systemic vasculitis frequently affecting upper respiratory tract (nose, sinuses) in addition to kidneys, lower resp tract (lungs), and other organs</description></item><item><title>Graves‚Äô disease</title><link>https://www.physician.tw/Graves-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Graves-disease/</guid><description>Graves‚Äô disease ‚ôÄ:‚ôÇ ratio is 5‚Äì10:1, most Pts between 40 and 60 y at dx ‚äï thyroid antibodies: TSI or TBII (‚äï in 80%), anti-TPO, antithyroglobulin; ANA Clinical manifestations in addition to those of hyperthyroidism (see above): Goiter: diffuse, nontender, w/ thyroid bruit Ophthalmopathy (NEJM 2010;362:726): seen in 50%; up to 90% if formally tested.</description></item><item><title>Growth hormone deficiency</title><link>https://www.physician.tw/Growth-hormone-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Growth-hormone-deficiency/</guid><description>Growth hormone deficiency ‚Üì GH
‚Üë chronic risk for osteoporosis, fatigue, decreased lean body mass Dx with failure to ‚Üë GH w/ appropriate stimulus (eg, insulin tolerance test, glucagon stimulation, and macimorelin stimulation) GH replacement in adults controversial (Annals 2003;35:419; NEJM 2019;380:2551)</description></item><item><title>HACEK</title><link>https://www.physician.tw/HACEK/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HACEK/</guid><description>HACEK fastidious gram-negative bacilli ÊåëÂâîÁöÑ‰∏ÄÁæ§ÂóúË°ÄÂáùËÅöÂøÉÁöÑÊÑõÂïÉÁéã
Haemophilus species ÂóúË°Ä Aggregat-ibacter ÂáùËÅöÊ°ø Cardio-bacterium ÂøÉÊ°øËèå Eiken-ella ÊÑõÂïÉ King-ella Áéã 10% of [[culture negative-bacterial endocarditis]]</description></item><item><title>head injury</title><link>https://www.physician.tw/head-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/head-injury/</guid><description>head injury È´òÈ¢®Èö™Ê®ôÊ∫ñÔºàÊ†πÊìöÈúÄË¶ÅÁ•ûÁ∂ìÂ§ñÁßëÂπ≤È†êÁöÑÁµÇÈªûÂæóÂá∫ÔºâÔºö ‰ª•‰∏ã‰ªª‰Ωï‰∏ÄÈ†ÖÁÇ∫ÈôΩÊÄßÔºåË°å CT ÊéÉÊèèÔºö
ÊÑèË≠ò„ÄÅÊ∑§Èùí(Áúº****)„ÄÅÈ™®Êäò„ÄÅËÄÅ„ÄÅÂêê
2Â∞èÊôÇÂÖßGCS &amp;lt;15
Áñë‰ººÈñãÊîæÊÄßÊàñÂáπÈô∑ÊÄßÈ°±È™®È™®Êäò
È°±Â∫ïÈ™®ÊäòÁöÑ‰ªª‰ΩïË∑°Ë±°ÔºàÈºìÂÆ§Ë°Ä„ÄÅÊµ£ÁÜäÁúº„ÄÅÊà∞È¨•Âæµ‚Äî‚Äî‰π≥Á™ÅÁòÄÊñë„ÄÅËÖ¶ËÑäÊ∂≤ [CSF] ËÄ≥ÊºèÊàñÈºªÊºè„ÄÅÈ°±Á•ûÁ∂ìÁï∞Â∏∏Ôºâ(hemotympanum, raccoon eyes, Battle sign‚Äîmastoid ecchymosis, cerebrospinal fluid [CSF] otorrhea or rhinorrhea, cranial nerve abnormality)</description></item><item><title>headache</title><link>https://www.physician.tw/headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/headache/</guid><description>headache [[Primary headache syndromes]] [[Secondary causes of headaches]] [[Migraine]] [[Clinical evaluation of Secondary causes of headaches]] [[headaches from symptom to diagnosis]] BacklinkÔºö [[Acromegaly]] [[acute bacterial meningitis]] [[ambulatory]] [[Clinical manifestations of Giant cell arteritis]] [[Clinical manifestations-chronic obstructive pulmonary disease]] [[Clinical manifestations-hyperaldosteronism]] [[Clinical manifestations-pheochromocytoma and paraganglioma]] [[CSF leak]] [[Etiologies of Classic FUO]] [[Fever workup in patient with HIV AIDS]] [[hypoglycemia]] [[hypopituitary syndromes]] [[hypothyroidism]] [[neurology]] [[Pain]] [[Pituitary apoplexy]] [[Pituitary tumors]] [[Select clinical manifestations-fever in a returned traveler]] Approaching patients with headache and refractory headache</description></item><item><title>headaches from symptom to diagnosis</title><link>https://www.physician.tw/headaches-from-symptom-to-diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/headaches-from-symptom-to-diagnosis/</guid><description>headaches from symptom to diagnosis is the headache new or old ? [[old headache]] [[new headache]]</description></item><item><title>heart failure</title><link>https://www.physician.tw/heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/heart-failure/</guid><description>heart failure [[Definitions heart failure]] (Braunwald‚Äôs Heart Disease, 12th ed., 2022) [[History heart failure]] [[New York Heart Association class]] [[Physical exam heart failure]] [[Evaluation for the presence of heart failure]] [[Evaluation for the potential causes of heart failure]] [[precipitants of acute heart failure]] [[Treatment of acute advanced heart failure]] [[Recommended Chronic Therapy by HF Stage]] [[Treatment of Chronic HF with Reduced EF]] [[Heart failure with preserved EF]]</description></item><item><title>Heart failure with preserved EF</title><link>https://www.physician.tw/Heart-failure-with-preserved-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-failure-with-preserved-EF/</guid><description>Heart failure with preserved EF (JACC 2022;epub)
Epidemiology: ~¬Ω of Pts w/ HF have normal (EF ‚â•50%); risk factors for HFpEF incl ‚Üë age, ‚ôÄ, DM, AF.</description></item><item><title>hectic fever</title><link>https://www.physician.tw/hectic-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hectic-fever/</guid><description>hectic fever ‚ú®ÈáçÈªû: ‰æÜËá™Â∏åËáòË™û hektikosÔºàÁøíÊÖ£ÊÄßÔºâÔºåÈÄôÊòØ‰∏ÄÁ®ÆÈñìÊ≠áÊÄßÁôºÁáíÔºåÂÖ∂ÁâπÈªûÊòØÊ≥¢ÂãïÂπÖÂ∫¶ÂæàÂ§ßÔºåÈÄöÂ∏∏È´òÊñº 2.5¬∞F (1.4¬∞C)„ÄÇ ÂÆÉÊúâ‰∏ÄÂÄãÂÖ∏ÂûãÁöÑÊØèÊó•‰∏ãÂçàÈ´òÂ≥∞ÔºåÈÄöÂ∏∏‰º¥ÊúâÈù¢ÈÉ®ÊΩÆÁ¥ÖÔºåÂÇ≥Áµ±‰∏äËàáÊ¥ªÂãïÊÄßËÇ∫ÁµêÊ†∏ÊúâÈóú„ÄÇ</description></item><item><title>Hematologic Alterations</title><link>https://www.physician.tw/Hematologic-Alterations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematologic-Alterations/</guid><description>Hematologic Alterations Chapter 62:¬†[[Interpreting Peripheral Blood Smears]] Chapter 63:¬†[[Anemia and Polycythemia]] Chapter 64:¬†[[Disorders of Granulocytes and Monocytes]] Chapter 65:¬†[[Bleeding and Thrombosis]] Chapter 66:¬†[[Enlargement of Lymph Nodes and Spleen]]</description></item><item><title>Hematologic oncologic-complications of HIV AIDS</title><link>https://www.physician.tw/Hematologic-oncologic-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematologic-oncologic-complications-of-HIV-AIDS/</guid><description>Hematologic oncologic-complications of HIV AIDS (NEJM 2018;378:1029)
Cytopenia: ACD, BM infiltration by tumor/infxn (eg, MAC/TB), drug toxicity, hemolysis, ITP Non-Hodgkin lymphoma: ‚Üë frequency with any CD4 count, but incidence ‚Üë with ‚Üì CD4 Hodgkin lymphoma (any CD4; impact of ART unclear) CNS lymphoma: CD4 count &amp;lt;50, EBV-associated Kaposi‚Äôs sarcoma (HHV-8): at any CD4 count, incidence ‚Üë b/c CD4 ‚Üì, usu.</description></item><item><title>hematology</title><link>https://www.physician.tw/hematology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematology/</guid><description>hematology ÂáùË°ÄÁï∞Â∏∏ÔºåË°ÄÁôåÁñ´ÊÉÖÔºå Ê∑ãÂ∑¥ÁôåÁóõÔºåË≤ßË°ÄÁóÖËÆä„ÄÇ Ë°ÄÊ∂≤‰∏çÊøüÔºåÈ´îÂÖßÁº∫‰πèÔºå ÁóÖÁóáÂ§öÁ´ØÔºåÈúÄÈ´òÊòé„ÄÇ
qv [[oncology]]
Section 2:¬†[[Hematopoietic Disorders]] Section 3:¬†[[Disorders of Hemostasis]] [[anemia]]</description></item><item><title>hematopoietic stem cell transplantation</title><link>https://www.physician.tw/hematopoietic-stem-cell-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematopoietic-stem-cell-transplantation/</guid><description>hematopoietic stem cell transplantation [[graft-versus-host disease]]
Transplantation of donor pluripotent cells that can reconstitute all recipient blood lineages
[[categories of stem cell transplantation]]</description></item><item><title>hematuria</title><link>https://www.physician.tw/hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematuria/</guid><description>hematuria [[Etiologies of Hematuria]] [[Workup-of-hematuria]]
BacklinkÔºö [[asymptomatic glomerular hematuria]] [[Clinical manifestations of Granulomatosis with polyangiitis]] [[Clinical manifestations of IgA vasculitis]] [[Clinical manifestations of Polyarteritis nodosa]] [[Clinical manifestations-nephrolithiasis]] [[Clinical manifestations-urinary tract infections]] [[Definition-glomerulonephritis]] [[Diagnostic studies-urinary tract infections]] [[Dx studies of Granulomatosis with polyangiitis]] [[Etiologies of Hematuria]] [[glomerular disease]] [[hypertensive crises]] [[IgA nephropathy]] [[Neoplasm Etiologies of Classic FUO]] [[urinalysis]] [[Urine Dipstick]] [[Workup-acute kidney injury (AKI)]] [[Workup-of-hematuria]]</description></item><item><title>Hemochromatosis &amp; iron overload syndromes</title><link>https://www.physician.tw/Hemochromatosis-iron-overload-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemochromatosis-iron-overload-syndromes/</guid><description>Hemochromatosis &amp;amp; iron overload syndromes (Am J Gastro 2019;114:1202)
Recessive disorder of iron sensing or transport leading to tissue iron deposition</description></item><item><title>Hemodialysis HD</title><link>https://www.physician.tw/Hemodialysis-HD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemodialysis-HD/</guid><description>Hemodialysis (HD) Solute removal across semipermeable membrane, countercurrent blood &amp;amp; dialysate flow
Volume removal: Na/H2O ultrafiltered via transmembrane pressure (TMP) gradient Solutes: Cr, urea, K diffuse from blood ‚Üí dialysate, HCO3 from dialysate ‚Üí blood Solute removal inversely proportional to size ‚à¥ effective removal of K, urea, Cr, not PO4 6√ó vs.</description></item><item><title>Hemodynamic-Monitoring</title><link>https://www.physician.tw/Hemodynamic-Monitoring/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemodynamic-Monitoring/</guid><description>Hemodynamic-Monitoring</description></item><item><title>hemolytic anemias</title><link>https://www.physician.tw/hemolytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemolytic-anemias/</guid><description>hemolytic anemias [[Causes of Hemolytic Anemia by Mechanism]] [[Diagnostic evaluation-hemolytic anemias]] [[Glucose-6-phosphate dehydrogenase]] [[Sickle cell anemia ]] [[Hereditary spherocytosis (HS) ]] [[Paroxysmal nocturnal hemoglobinuria]] [[Autoimmune hemolytic anemia]] [[Drug-induced hemolytic anemia]] [[Microangiopathic hemolytic anemia]] [[Hypersplenism]]</description></item><item><title>Hemolytic-uremic syndrome</title><link>https://www.physician.tw/Hemolytic-uremic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemolytic-uremic-syndrome/</guid><description>Hemolytic-uremic syndrome Pathophys: (1) Shiga toxin damages renal endothelial cells ‚Üí intrarenal thrombi; or (2) complement dysregulation (hereditary or acquired), so-called ‚Äúatypical HUS‚Äù</description></item><item><title>Hemophilias</title><link>https://www.physician.tw/Hemophilias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemophilias/</guid><description>Hemophilias (Lancet 2016;388:187)
X-linked recessive factor VIII (hemophilia A) or factor IX (hemophilia B) deficiency
Classification: mild (5‚Äì25% normal factor activity), moderate (1‚Äì5%), or severe (&amp;lt;1%)</description></item><item><title>hemoptysis</title><link>https://www.physician.tw/hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemoptysis/</guid><description>hemoptysis [[Definition and pathophysiology-hemoptysis]] [[Diagnostic workup-hemoptysis]] [[Treatment-hemoptysis]]</description></item><item><title>Hemothroax</title><link>https://www.physician.tw/Hemothroax/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemothroax/</guid><description>Hemothroax Hemothorax is an accumulation of blood within the pleural space. Hematocrit of the pleural fluid is greater than 50% of the hematocrit of the patient‚Äôs peripheral blood in hemothorax.</description></item><item><title>Heparin-Induced Thrombocytopenias</title><link>https://www.physician.tw/Heparin-Induced-Thrombocytopenias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heparin-Induced-Thrombocytopenias/</guid><description>Heparin-Induced Thrombocytopenias (Chest 2012;141:e495S; NEJM 2015;373:252)
Type I Heparin-Induced Thrombocytopenias(not clin. signif) Direct effect of heparin (non-immune) Incidence 10‚Äì20% After 1‚Äì4 d of heparin therapy Platelet nadir: &amp;gt;100,000/¬µL Sequelae: None Can continue heparin and observe Type II Heparin-Induced Thrombocytopenias (clinically significant HIT) Immune (Ab)-mediated IgG against plt factor 4‚Äîheparin complex 1‚Äì3% with UFH, 0‚Äì0.</description></item><item><title>Hepatic encephalopathy HE</title><link>https://www.physician.tw/Hepatic-encephalopathy-HE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatic-encephalopathy-HE/</guid><description>Hepatic encephalopathy (HE) (NEJM 2016;375:1660; Hepatology 2014; 60:715)
Pathogenesis: failure of liver to detoxify NH3 + other substances (eg, ADMA; J Hepatol 2013;58:38) that cause cerebral edema, ‚Üì O2 consumption, ‚Üë ROS ‚Üí brain dysfxn</description></item><item><title>Hepatic hydrothorax</title><link>https://www.physician.tw/Hepatic-hydrothorax/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatic-hydrothorax/</guid><description>Hepatic hydrothorax 2¬∞ diaphragmatic defect; often unilateral, R &amp;gt;L, ¬± ascites
Treatment: avoid chest tube (‚Üë complications); Rx same as ascites (TIPS if refractory).</description></item><item><title>hepatic vascular disease</title><link>https://www.physician.tw/hepatic-vascular-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatic-vascular-disease/</guid><description>hepatic vascular disease [[Normal hepatic vasculature]] [[Portal vein thrombosis (PVT) ]] [[Splenic vein thrombosis]] [[Budd-Chiari syndrome]] [[Sinusoidal obstruction syndrome (SOS)]]</description></item><item><title>hepatitis</title><link>https://www.physician.tw/hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis/</guid><description>hepatitis VIRAL [[Hepatitis A]] [[Hepatitis B]] [[Hepatitis C]] [[Hepatitis D]] [[Hepatitis E]] Other viruses (human pegivirus, CMV, EBV, HSV, VZV) [[autoimmune hepatitis (AIH)]] [[Alcohol-associated hepatitis]] [[Acetaminophen hepatotoxicity]] [[Ischemic hepatitis]] [[Nonalcoholic fatty liver disease (NAFLD)]]</description></item><item><title>Hepatitis A</title><link>https://www.physician.tw/Hepatitis-A/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-A/</guid><description>Hepatitis A (ssRNA; 30‚Äì45% of acute viral hepatitis in U.S; MMWR 2018;67:1208)
Transmission &amp;amp; RFs: fecal‚Äìoral route; contam. food, water, shellfish; daycare ctr; intl travel Incubation: 2‚Äì6 wk; no chronic carrier state; once antibody forms ‚Üí lifelong immunity Sx: ‚Üì appetite, malaise, fever, N/V, RUQ pain, jaundice; rarely ALF (‚Üë w/ chronic HCV) Diagnosis: acute hepatitis = ‚äï IgM anti-HAV; past exposure = ‚äï IgG anti-HAV (‚äñIgM) Rx for acute HAV: supportive care; refer to liver txplnt center if acute liver failure Vaccinate if: MSM, IVDU, chronic liver disease, international travel; Havrix (2 doses)</description></item><item><title>Hepatitis B</title><link>https://www.physician.tw/Hepatitis-B/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-B/</guid><description>Hepatitis B [[Symptoms of HBV Clinical Presentation]] [[Laboratory Abnormalities of HBV Clinical Presentation]] [[Serologic and virologic tests]] [[Extrahepatic Manifestations of HBV Clinical Presentation]] [[Staging of HBV Clinical Presentation]] [[Prevention of HBV Clinical Presentation]] [[HBV Natural History]] Transmission: blood (IVDU, transfusion), sexual, perinatal (vertical) Incubation: 6 wk‚Äì6 mo (mean 12‚Äì14 wk) Acute infxn: 70% subclinical, 30% jaundice, &amp;lt;1% acute liver failure (up to 60% mortality) Chronic infxn: HBsAg ‚äï &amp;gt;6 mo in &amp;lt;5% of adult-acquired (‚Üë if immunosupp), &amp;gt;90% of perinatal; ~40% chronic HBV ‚Üí cirrhosis (‚Üë risk w/ HCV, HDV, or HIV coinfxn, EtOH) HCC: ‚Üë risk if cirrhosis, ‚äï FHx HCC, African &amp;gt;20 y old, Asian ‚ôÇ &amp;gt;40 y old or ‚ôÄ &amp;gt;50 y old, or &amp;gt;40 y old w/ ‚Üë ALT ¬± HBV DNA &amp;gt;2000.</description></item><item><title>hepatitis B virus Rx duration</title><link>https://www.physician.tw/hepatitis-B-virus-Rx-duration/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-B-virus-Rx-duration/</guid><description>hepatitis B virus Rx duration (1) HBeAg ‚äï immune active w/o cirrhosis: if seroconversion (HBeAg ‚äñ, anti- HBe ‚äï), can stop after 1 y if ALT nl &amp;amp; HBV DNA suppressed or until HBsAg clears; (2) HBeAg ‚äñ immune reactivation: indefinite; (3) cirrhosis: indefinite</description></item><item><title>Hepatitis C</title><link>https://www.physician.tw/Hepatitis-C/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-C/</guid><description>Hepatitis C (ssRNA; ~10% of acute viral hepatitis in U.S.; Lancet 2015;385:1124)
[[Recommended First-Line Oral Direct-Acting Antiviral (DAA) Regimens]]</description></item><item><title>hepatitis C virus acute infxn</title><link>https://www.physician.tw/hepatitis-C-virus-acute-infxn/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-acute-infxn/</guid><description>hepatitis C virus acute infxn 80% subclinical; 10‚Äì20% sx hepatitis w/ jaundice; acute liver failure rare; prob of spont clearance a/w IL28B &amp;amp; HLA class II genotypes (Annals 2013;158:235)</description></item><item><title>hepatitis C virus extrahepatic syndromes</title><link>https://www.physician.tw/hepatitis-C-virus-extrahepatic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-extrahepatic-syndromes/</guid><description>hepatitis C virus extrahepatic syndromes mixed cryoglobulinemia, porphyria cutanea tarda, lichen planus, leukocytoclastic vasculitis, thyroiditis, MPGN, IPF, NHL and monoclonal gammopathies</description></item><item><title>hepatitis C virus Monitoring on Rx</title><link>https://www.physician.tw/hepatitis-C-virus-Monitoring-on-Rx/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-Monitoring-on-Rx/</guid><description>hepatitis C virus Monitoring on Rx CBC, INR, LFTs, GFR, HCV VL prior to starting Rx. PIs contraindicated if decomp. liver dx (ascites, encephalopathy) or CPS ‚â•7.</description></item><item><title>hepatitis C virus recommended First-Line Oral Direct-Acting Antiviral DAA Regimens</title><link>https://www.physician.tw/hepatitis-C-virus-recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</guid><description>hepatitis C virus recommended First-Line Oral Direct-Acting Antiviral (DAA) Regimens Sofosbuvir &amp;amp; velpatasvir Genotypes 1‚Äì6, 12 weeks Rx
Glecaprevir &amp;amp; pibrentasvir Gentotypes 1‚Äì6; 8 weeks Rx</description></item><item><title>hepatitis C virus Serologic, virologic, &amp; genetic tests</title><link>https://www.physician.tw/hepatitis-C-virus-Serologic-virologic-genetic-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-Serologic-virologic-genetic-tests/</guid><description>hepatitis C virus Serologic, virologic, &amp;amp; genetic tests (screen all adults [‚úì anti-HCV] JAMA 2020;323:970) anti-HCV (ELISA): ‚äï in 6 wk, does not = recovery or immunity; can be ‚äñ after recovery</description></item><item><title>hepatitis C virus Treatment indications</title><link>https://www.physician.tw/hepatitis-C-virus-Treatment-indications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-Treatment-indications/</guid><description>hepatitis C virus Treatment indications ( www.hcvguidelines.org) (Lancet 2019;393:1453; Hepatology 2020;71:686)
Acute: if no spont. clearance at 12‚Äì16 wk, can Rx w/ same regimens for chronic HCV Chronic: ‚Üì HCC &amp;amp; mortality.</description></item><item><title>Hepatitis D</title><link>https://www.physician.tw/Hepatitis-D/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-D/</guid><description>Hepatitis D (RNA; Gastro 2019:156;461)
Transmission: blood or sexual; endemic in Africa &amp;amp; E. Europe. Generally requires host to already have HBV infxn in order to cause co-infection or superinfection; in rare cases (immunosupp s/p liver transplant) can replicate autonomously.</description></item><item><title>Hepatitis E</title><link>https://www.physician.tw/Hepatitis-E/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-E/</guid><description>Hepatitis E (ssRNA; World J Gastro 2016;22:7030; Gastro Clin N Am 2017;46:393)
Most common cause of acute viral hepatitis in endemic areas</description></item><item><title>hepatocellular carcinoma</title><link>https://www.physician.tw/hepatocellular-carcinoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatocellular-carcinoma/</guid><description>hepatocellular carcinoma [[Risk factors of hepatocellular carcinoma]] [[Screening of hepatocellular carcinoma]] [[Clinical manifestations of hepatocellular carcinoma]] [[Diagnosis of hepatocellular carcinoma]] [[Treatment of hepatocellular carcinoma]]</description></item><item><title>Hepatopulmonary syndrome HPS</title><link>https://www.physician.tw/Hepatopulmonary-syndrome-HPS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatopulmonary-syndrome-HPS/</guid><description>Hepatopulmonary syndrome (HPS) (Dig Dis Sci 2015;60:1914, Hepatology 2021;74:1014) Abnl gas exchange (A-a gradient ‚â•15 or PaO2 &amp;lt;80) caused by intrapulmonary vascular dilatations leading to intrapulmonary shunting (improves with O2) S/S: platypnea-orthodeoxia (dyspnea &amp;amp; hypoxia w/ sitting up), clubbing, spider angiomas Dx w/ contrast echo showing ‚Äúlate‚Äù A-V shunting (contrast in LA 3‚Äì6 cycles after RA) Rx: O2; potential embolization if large vessel on CT, TIPS, liver tx only definitive Rx</description></item><item><title>Hepatorenal syndrome HRS</title><link>https://www.physician.tw/Hepatorenal-syndrome-HRS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatorenal-syndrome-HRS/</guid><description>Hepatorenal syndrome (HRS) Reference Hepatology 2021;74:1014 Gastro 2016;150:1525 AJKD 2013;62:1198 Pathophysiology: splanchnic vasodilation and renal vasoconstriction w/ ‚Üì renal blood flow</description></item><item><title>HER2</title><link>https://www.physician.tw/HER2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HER2/</guid><description>HER2 (Lancet 2017;389: 2415)
HER2- targeted
Trastuzumab (anti-HER2): 1st-line Rx combined w/ chemo Trastuzumab emtansine (mAb linked to chemo): ‚Üì risk of recurrence/death if residual disease post neoadj.</description></item><item><title>Hereditary spherocytosis HS</title><link>https://www.physician.tw/Hereditary-spherocytosis-HS-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hereditary-spherocytosis-HS-/</guid><description>Hereditary spherocytosis (HS) (Lancet 2008;372:1411)
Defect in cytoskeleton of RBC membrane (ankyrin, Œ±- and Œ≤-spectrin, band 3, &amp;amp; pallidin)</description></item><item><title>herpes simplex virus infection</title><link>https://www.physician.tw/herpes-simplex-virus-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/herpes-simplex-virus-infection/</guid><description>herpes simplex virus infection ÈÄöÂ∏∏ÂºïËµ∑ÊÄ•ÊÄßËÖ¶ÁÇéÔºå‰º¥ÊúâÂø´ÈÄüÁôºÁÜ±„ÄÅÈ†≠Áóõ„ÄÅÁô≤ÁôáÁôº‰Ωú„ÄÅ Â±ÄÁÅ∂ÊÄßÁ•ûÁ∂ìÁ≥ªÁµ±È´îÂæµÂíåÊÑèË≠òÊîπËÆä„ÄÇ Á•ûÁ∂ìÂΩ±ÂÉèÂ≠∏ÈÄöÂ∏∏È°ØÁ§∫È°≥ËëâËÆäÂåñ„ÄÇ ËÖ¶ËÑäÊ∂≤ÂàÜÊûêÈ°ØÁ§∫‰ª•Ê∑ãÂ∑¥Á¥∞ËÉûÁÇ∫‰∏ªÔºåÂ∏∏‰º¥ÊúâÁ¥ÖÁ¥∞ËÉûÔºåËë°ËêÑÁ≥ñÊ∞¥Âπ≥Ê≠£Â∏∏ ‰º¥ÊúâÊÄßÊ†ºÊîπËÆäÂíåMRIÈ°≥ËëâÂ¢ûÂº∑ÁöÑËÖ¶ÁÇéÔºöÂñÆÁ¥îÁö∞ÁñπÁóÖÊØíËÖ¶ÁÇéÁöÑÁâπÂæµ„ÄÇ ÈõôÂÅ¥È°≥Ëëâ‰∫ÆËµ∑‰æÜÈ´òÂ∫¶ÊèêÁ§∫ HSV ËÖ¶ÁÇé„ÄÇ</description></item><item><title>herpes zoster</title><link>https://www.physician.tw/herpes-zoster/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/herpes-zoster/</guid><description>herpes zoster Definition &amp;amp; etiology Painful vesicular rash in a peripheral nerve distribution due to reactivation of VZV Spread by contact with active lesion (prior to crusting) in uncomplicated zoster or via airborne transmission in disseminated zoster [[Clinical manifestations complications-herpes zoster]] Diagnosis Clinical diagnosis if uncomplicated.</description></item><item><title>High-risk features-syncope</title><link>https://www.physician.tw/High-risk-features-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/High-risk-features-syncope/</guid><description>High-risk features-syncope (admit w/ tele; JACC 2017;70:620; EHJ 2018;39:1883)
Age &amp;gt;60 y, h/o CAD, HF/CMP, valvular or congenital heart dis.</description></item><item><title>Histoplasmosis</title><link>https://www.physician.tw/Histoplasmosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Histoplasmosis/</guid><description>Histoplasmosis (CID 2007;45:807)
Epidemiology: endemic to central &amp;amp; SE U.S., but sporadic cases throughout U.S. Clinical manifestations Acute: PNA ¬± hilar LAN, often subacute, but high inoculum can cause acute severe PNA Chronic lung disease: cough + B sx ¬± cavitary lesions (Ddx TB, blasto) Disseminated (seen in immunosupp.</description></item><item><title>History and physical exam-interstitial lung disease</title><link>https://www.physician.tw/History-and-physical-exam-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/History-and-physical-exam-interstitial-lung-disease/</guid><description>History and physical exam-interstitial lung disease Occupational, exposures (eg, birds), tobacco, meds, XRT, FHx, precipitating event
Tempo (acute ‚Üí infxn, CHF, hypersens pneumonitis, eos PNA, AIP, COP, drug-induced)</description></item><item><title>History heart failure</title><link>https://www.physician.tw/History-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/History-heart-failure/</guid><description>History heart failure Low output: fatigue, weakness, exercise intolerance, ‚àÜ MS, anorexia Congestive: left-sided ‚Üí dyspnea, orthopnea, paroxysmal nocturnal dyspnea right-sided ‚Üí peripheral edema, RUQ discomfort, bloating, satiety</description></item><item><title>HIV AIDS</title><link>https://www.physician.tw/HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HIV-AIDS/</guid><description>HIV AIDS [[Definition Clinical Manifestations-HIV AIDS]] [[Epidemiology-HIV AIDS]] [[Prophylaxis-HIV AIDS]] [[Screening and Diagnosis-HIV AIDS]] [[Approach to newly diagnosed HIV positive Pt]] [[Antiretrovirals (ARVs)]] [[Approach to previously established HIV positive Pt]] [[OI Prophylaxis-HIV AIDS]] [[complications of HIV AIDS]]</description></item><item><title>Home</title><link>https://www.physician.tw/Home/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Home/</guid><description/></item><item><title>Horner‚Äôs syndrome</title><link>https://www.physician.tw/Horners-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Horners-syndrome/</guid><description>Horner‚Äôs syndrome ÊòØ‰∏ÄÁ®ÆÂΩ±ÈüøË∫´È´î‰∏ÄÂÅ¥ÁöÑÈù¢ÈÉ®ÂíåÁúºÁùõÁöÑÁñæÁóÖ„ÄÇ ÈÄôÊòØÁî±ÊñºÂæûÂ§ßËÖ¶Âà∞È†≠ÈÉ®ÂíåÈ†∏ÈÉ®ÁöÑÁ•ûÁ∂ìÈÄöË∑ØÁöÑÁ†¥Â£ûÂºïËµ∑ÁöÑ„ÄÇ
ÈÄöÂ∏∏ÔºåÈúçÁ¥çÁ∂úÂêàÂæµÁöÑÈ´îÂæµÂíåÁóáÁãÄÂåÖÊã¨
TL;DR Áû≥Â≠îÂ§ßÂ∞èÁöÑÈôç‰ΩéÔºå ÁúºÁûº‰∏ãÂûÇ ËáâÈÉ®ÂèóÂΩ±ÈüøÂÅ¥ÁöÑÂá∫Ê±óÊ∏õÂ∞ë„ÄÇ Common Sings A persistently small pupil (miosis) A notable difference in pupil size between the two eyes (anisocoria) Little or delayed opening (dilation) of the affected pupil in dim light Drooping of the upper eyelid (ptosis) Slight elevation of the lower lid, sometimes called upside-down ptosis Sunken appearance of the affected eye Little or no sweating (anhidrosis) on the affected side of the face anhidrosis:no sweating</description></item><item><title>How does this thing work?</title><link>https://www.physician.tw/How-does-this-thing-work/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-does-this-thing-work/</guid><description>Always begin typing in the
When you select one of the found notes (e.g., using the up/down keys) NV displays its body in the lower text area (what you&amp;rsquo;re reading now).</description></item><item><title>how the human body breathes</title><link>https://www.physician.tw/how-the-human-body-breathes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-the-human-body-breathes/</guid><description>how the human body breathes ‚ú®ÈáçÈªû: Ë¶Å‰∫ÜËß£Ê©üÊ¢∞ÈÄöÊ∞£ÔºåÊÇ®È¶ñÂÖàÂøÖÈ†àÂ∞ç‰∫∫È´îÁöÑÂëºÂê∏ÊñπÂºèÊúâ‰∏ÄÂÄãÂü∫Êú¨ÁöÑ‰∫ÜËß£„ÄÇ Ê∞ßÊ∞£ÊòØ‰∫∫È´îÁöÑÈ£üÁâ©„ÄÇ ÊØèÂÄãÁ¥∞ËÉûÈÉΩÈúÄË¶ÅÂÆÉ‰æÜÁî¢ÁîüËÉΩÈáè‰∏¶Âü∑Ë°åÂÖ∂ÂêÑÁ®ÆÂäüËÉΩ„ÄÇ Âè¶‰∏ÄÊñπÈù¢Ôºå‰∫åÊ∞ßÂåñÁ¢≥ (CO2) ÊòØÊØèÂÄãÁ¥∞ËÉû‰ΩúÁÇ∫ÂÖ∂ÂäüËÉΩÁöÑÂâØÁî¢ÂìÅÁî¢ÁîüÁöÑ‰∫∫È´îÂûÉÂúæ„ÄÇ ÁúæÊâÄÂë®Áü•ÔºåËÇ∫ÊòØÂæûÁ©∫Ê∞£‰∏≠Âê∏Êî∂Ê∞ßÊ∞£‰∏¶Â∞áÂÖ∂Â∏∂ÂÖ•È´îÂÖßÁöÑÂô®ÂÆòÔºåÂêåÊôÇ‰πüÊéíÂá∫ÔºàÂëºÂá∫Ôºâ‰∫åÊ∞ßÂåñÁ¢≥„ÄÇ ‰ΩÜÊòØËß∏ÁôºÈÄôÁ®ÆÊÉÖÊ≥ÅÁôºÁîüÁöÑÊ©üÂà∂ÊòØ‰ªÄÈ∫ºÔºåÈÄôÁ®Æ‰∫§ÊèõÁ©∂Á´üÊòØÂ¶Ç‰ΩïÁôºÁîüÁöÑÔºü Âú®Êú¨Á´†ÁµêÊùüÊôÇÔºåÊÇ®Â∞áËÉΩÂ§†Ôºö Ëß£ÈáãÂê∏Ê∞£ÂíåÂëºÊ∞£ÁöÑË∫´È´îÊ©üÂà∂„ÄÇ Ë≠òÂà•ÂèÉËàáÂëºÂê∏ÁöÑË∫´È´îÈóúÈçµÈÉ®‰Ωç„ÄÇ ÂÆöÁæ© FRC ÂíåÂÖßÂú® PEEP ‰ª•ÂèäÂ∞çËÇ∫Ê≥°ÁöÑÈáçË¶ÅÊÄß„ÄÇ ‰∫ÜËß£ÂëºÂê∏ÈÅéÁ®ã‰∏≠ËÇ∫ÈÉ®ÁôºÁîüÁöÑÂü∫Êú¨Â£ìÂäõËÆäÂåñ„ÄÇ ‚ú®ÈáçÈªû: Êï∏‰ª•ÁôæËê¨Ë®àÁöÑ‚ÄúÂ∞èÊ∞£ÁêÉ‚Äù‰ªçÁÑ∂ËÉΩÂ§†Âê∏ÂÖ•ËàáÁõ∏ÂêåÂ§ßÂ∞èÁöÑÂñÆÂÄãÊ∞£ÁêÉÁõ∏ÂêåÁöÑÁ∏ΩÁ©∫Ê∞£ÈáèÔºå‰ΩÜÊòØÈÄöÈÅéÂ∞áÁ©∫Ê∞£ÈáèÂàÜÊàêËÇ∫Ê≥°ËÄå‰∏çÊòØ‰∏ÄÂÄãÂ§ßÊ∞£ÁêÉÔºåËÇ∫ÁöÑÁ∏ΩË°®Èù¢Á©çÂ¢ûÂä†ÊàêÂÄçÂ¢ûÈï∑„ÄÇ ÁÇ∫‰ªÄÈ∫ºÈÄôÂæàÈáçË¶ÅÔºüÂóØÔºåÊØèÂÄãÂñÆÁç®ÁöÑËÇ∫Ê≥°ÈÉΩË¢´Á®±ÁÇ∫‚ÄúÊØõÁ¥∞Ë°ÄÁÆ°‚ÄùÁöÑË°ÄÁÆ°ÂåÖÂúç„ÄÇËÇ∫Ê≥°ÂíåÊØõÁ¥∞Ë°ÄÁÆ°Áõ∏ÈÅáÁöÑÂú∞ÊñπÊòØÂØ¶ÈöõÁôºÁîüÊ∞£È´î‰∫§ÊèõÁöÑÂú∞Êñπ„ÄÇ ÂèØ‰ª•ÁôºÁîüÈÄôÁ®Æ‰∫§ÊèõÁöÑË°®Èù¢Á©çÁöÑÂ§ßÂπÖÂ¢ûÂä†ÂÖÅË®±Ê∞£È´î‰∫§ÊèõÊõ¥Ê¥ªË∫çÁöÑÂçÄÂüüÔºå‰∏¶‰∏îÈÄôÁ®Æ‰∫§ÊèõÂèØ‰ª•‰ª•Êõ¥ÊúâÊïàÂíåÊõ¥Âø´ÁöÑÈÄüÂ∫¶ÁôºÁîü„ÄÇ Ê∞ßÊ∞£ÂæûËÇ∫Ê≥°Êì¥Êï£Âà∞Ë°ÄÊ∂≤‰∏≠Ôºå‰∫åÊ∞ßÂåñÁ¢≥ÂæûË°ÄÊ∂≤‰∏≠Êì¥Êï£Âà∞ËÇ∫Ê≥°ÔºåÁÑ∂ÂæåÂæûËÇ∫‰∏≠ÂëºÂá∫„ÄÇ</description></item><item><title>Humoral immune dysfunction</title><link>https://www.physician.tw/Humoral-immune-dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Humoral-immune-dysfunction/</guid><description>Humoral immune dysfunction (eg, CVID, myeloma) and asplenia Encapsulated bacteria: S. pneumo, H. flu, N. meningitidis (vaccinate against these 3, ideally prior to splenectomy) Other bacteria: E.</description></item><item><title>hyaline casts</title><link>https://www.physician.tw/hyaline-casts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyaline-casts/</guid><description>hyaline casts Casts are clusters of urinary sediment elements (red blood cells, white blood cells, fat bodies, etc.) wrapped in a protein matrix.</description></item><item><title>Hydralazine---nitrates</title><link>https://www.physician.tw/Hydralazine---nitrates/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hydralazine---nitrates/</guid><description>Hydralazine&amp;mdash;nitrates Consider if cannot tolerate ACEI/ARB or in black Pts w/ class III/IV
25% ‚Üì mort. (NEJM 1986;314:1547); infer. to ACEI (NEJM 1991;325:303)</description></item><item><title>hyperactive delirium</title><link>https://www.physician.tw/hyperactive-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperactive-delirium/</guid><description>hyperactive delirium The cognitive syndrome associated with severe alcohol withdrawal (i.e., ‚Äúdelirium tremens‚Äù) remains the classic example of the hyperactive subtype, prominent hallucinations, agitation, and hyperarousal, accompanied by life-threatening autonomic instability.</description></item><item><title>hyperaldosteronism</title><link>https://www.physician.tw/hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperaldosteronism/</guid><description>hyperaldosteronism [[Etiologies-hyperaldosteronism]] [[Clinical manifestations-hyperaldosteronism]] [[Diagnosis-hyperaldosteronism]] [[Treatment-hyperaldosteronism]] [[Aldosterone and Treatment-Resistant Hypertension]] [[adrenal disorders]] [[adrenal incidentalomas]] [[Clinical manifestations-hyperaldosteronism]] [[Diagnosis-hyperaldosteronism]] [[Disease state specific regimens-diuresis]] [[Etiologies-hyperaldosteronism]] [[Etiologies-of-Metabolic-Alkalosis]] [[Liddle‚Äôs syndrome]] [[metabolic-alkalosis]] [[Pathophysiology-metabolic-alkalosis]] [[Primary Hyperaldosteronism]] [[Renal potassium losses]] [[Secondary Hyperaldosteronism]] [[Treatment-hyperaldosteronism]]</description></item><item><title>hypercalcemia</title><link>https://www.physician.tw/hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypercalcemia/</guid><description>hypercalcemia [[Etiologies of Hypercalcemia]] [[Clinical manifestations-hypercalcemia]] (‚Äúbones, stones, abdominal groans, and psychic moans‚Äù) [[Diagnostic studies-hypercalcemia]] [[Acute Treatment of Hypercalcemia]] (BMJ 2015;350:h2723) [[Treatment of asymptomatic 1¬∞ HPT]] (JCEM 2014;99:3561; JAMA 2020;323:1186) BacklinkÔºö [[Acute Treatment of Hypercalcemia]] [[Adrenal Insufficiency (AI)]] [[Alterations in Renal and Urinary Tract Function]] [[Calciphylaxis]] [[calcium disorders]] [[Calcium]] [[clinical manifestations of multiple myeloma (MM)]] [[Clinical Manifestations of Sarcoidosis]] [[Clinical manifestations-hypercalcemia]] [[Contents]] [[Contributing Authors]] [[Diagnostic studies-hypercalcemia]] [[Differential Diagnosis of Delirium]] [[EKG pocket brain]] [[endocrine-Secondary Causes of Hypertension]] [[Etiologies of Hypercalcemia]] [[hyperthyroidism]] [[hyponatremia.</description></item><item><title>hypercoagulable states</title><link>https://www.physician.tw/hypercoagulable-states/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypercoagulable-states/</guid><description>hypercoagulable states Suspect in Pts with venous or arterial thrombosis at young age or unusual locations, recurrent thromboses or pregnancy loss, or ‚äï FHx</description></item><item><title>hyperkalemia</title><link>https://www.physician.tw/hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperkalemia/</guid><description>hyperkalemia [[Transcellular shifts-hyperkalemia]] [[Decreased GFR-hyperkalemia]] [[Normal GFR but with ‚Üì renal K excretion-hyperkalemia]] [[Clinical manifestations-hyperkalemia]] [[Workup-hyperkalemia]] [[Treatment of Hyperkalemia-hyperkalemia]]</description></item><item><title>hypernatremia</title><link>https://www.physician.tw/hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypernatremia/</guid><description>hypernatremia [[Pathophysiology-hypernatremia]] [[Workup-hypernatremia]] [[Approach to hypernatremia]] [[Extrarenal H2O loss (Uosm &amp;gt;700‚Äì800)]] [[Renal H2O loss (Uosm &amp;lt;700‚Äì800)]] [[Other (Uosm &amp;gt;700‚Äì800)]] [[Treatment-hypernatremia]]</description></item><item><title>hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperosmolar-hyperglycemic-state/</guid><description>hyperosmolar hyperglycemic state [[Definition, precipitants, pathophysiology-hyperosmolar hyperglycemic state]] [[Clinical manifestations dx studies-hyperosmolar hyperglycemic state]] [[Treatment-hyperosmolar hyperglycemic state]]</description></item><item><title>hyperparathyroidism</title><link>https://www.physician.tw/hyperparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperparathyroidism/</guid><description>hyperparathyroidism Áî≤ÁãÄÊóÅËÖ∫ÂäüËÉΩ‰∫¢ÈÄ≤ÁóáÊòØÁî≤ÁãÄÊóÅËÖ∫ÔºàÂú®È†∏ÈÉ®ÔºåÈù†ËøëÁî≤ÁãÄËÖ∫ÔºâÁî¢ÁîüÈÅéÂ§öÁöÑÁî≤ÁãÄÊóÅËÖ∫ÊøÄÁ¥†„ÄÇ Êúâ 4 ÂÄãÂ∞èËÖ∫È´îÁî¢ÁîüÈÄôÁ®ÆÊøÄÁ¥†ÔºåÂèØÂπ´Âä©ÊÇ®ÁöÑË∫´È´îÊéßÂà∂ÊâÄÈúÄÁöÑÈà£Ê∞¥Âπ≥„ÄÇ</description></item><item><title>hyperpituitary syndromes</title><link>https://www.physician.tw/hyperpituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperpituitary-syndromes/</guid><description>hyperpituitary syndromes [[Pituitary tumors]] (NEJM 2020;382:937) [[Hyperprolactinemia]] [[Acromegaly]] [[Cushing‚Äôs Syndrome]] (‚Üë ACTH): 5% of adenomas; see ‚ÄúAdrenal Disorders‚Äù (Hypercortisolism) Central hyperthyroidism (‚Üë TSH, ‚Üë Œ±-subunit): extremely rare; see [[hyperthyroidism]] ‚Üë FSH &amp;amp; LH: often non-fxn, may present as hypopituitarism b/c compression effects [[Multiple Endocrine Neoplasia]] (MEN) Syndromes [[Autoimmune Polyglandular Syndromes]] (APS)</description></item><item><title>Hyperprolactinemia</title><link>https://www.physician.tw/Hyperprolactinemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hyperprolactinemia/</guid><description>Hyperprolactinemia * Etiology Prolactinoma (50% of pituitary adenomas) Stalk compression due to nonprolactinoma ‚Üí ‚Üì inhibitory dopamine ‚Üí ‚Üë PRL (mild)</description></item><item><title>Hypersplenism</title><link>https://www.physician.tw/Hypersplenism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypersplenism/</guid><description>Hypersplenism Stasis/trapping in spleen ‚Üí Mœï attack/remodel RBCs ‚Üí spherocytosis ‚Üí hemolysis
Causes of Splenomegaly RES hyperplasia Hemolytic anemia, sickle cell disease, thalassemia major Immune hyperplasia Infxn [HIV, EBV, CMV, TB, malaria, kala azar (‚Äúblack water fever‚Äù from visceral leishmaniasis), Mycobacterium avium complex], autoimmune disorders (SLE, RA w/ Felty‚Äôs syndrome), sarcoidosis, serum sickness Congestion Cirrhosis, CHF, portal/splenic vein thrombosis, schistosomiasis Infiltration (nonmalignant) Lysosomal storage disorders (Gaucher‚Äôs, Niemann-Pick), glycogen storage diseases histiocytosis X, splenic cysts Neoplasm causes of massive splenomegaly.</description></item><item><title>hypertension</title><link>https://www.physician.tw/hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertension/</guid><description>Ëä±ÂúíÂ§ßÈñÄÂè£
[[ACC AHA Classification for Office-Based BP]]
[[Epidemiology of hypertension]] [[Etiologies-hypertension]] [[Standard workup-hypertension]] [[Complications of HTN]] [[Treatment-hypertension]] [[Resistant HTN]] [[hypertensive crises]]</description></item><item><title>hypertensive crises</title><link>https://www.physician.tw/hypertensive-crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertensive-crises/</guid><description>hypertensive crises Hypertensive emergency: ‚Üë BP (usually SBP &amp;gt;180 or DBP &amp;gt;120) ‚Üí target-organ damage Neurologic damage: encephalopathy, hemorrhagic or ischemic stroke, papilledema Cardiac damage: ACS, HF/pulmonary edema, aortic dissection Renal damage: proteinuria, hematuria, acute renal failure; scleroderma renal crisis Microangiopathic hemolytic anemia; preeclampsia-eclampsia Hypertensive urgency: SBP &amp;gt;180 or DBP &amp;gt;120 (?</description></item><item><title>hyperthyroidism</title><link>https://www.physician.tw/hyperthyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperthyroidism/</guid><description>hyperthyroidism [[Etiologies-hyperthyroidism]] Clinical manifestations Restlessness, sweating, tremor, moist warm skin, fine hair, tachycardia, AF, weight loss, ‚Üë frequency of stools, menstrual irregularities, hyperreflexia, osteoporosis, stare and lid lag (due to sympathetic overactivity) Apathetic thyrotoxicosis: seen in elderly who can present with lethargy as only sx Laboratory testing ‚Üë free T4 and total T3; ‚Üì TSH (except in TSH-secreting tumors) RAIU scan is very useful study to differentiate causes (see table on page 7-3); cannot do if recent IV contrast or amio load b/c iodine blocks uptake, so ‚úì autoantibodies instead Rarely need to ‚úì for autoantibodies except in pregnancy (to assess risk of fetal Graves‚Äô) May see hypercalciuria ¬± hypercalcemia, ‚Üë Aœï, anemia [[Graves‚Äô disease]] [[Thyroiditis]] [[Treatment-hyperthyroidism]] (Thyroid 2016;26:1343; JCEM 2020;105:3704) Subclinical hyperthyroidism (NEJM 2018;378:2411) Mild ‚Üì TSH and normal free T4 with only subtle or no sx ~15% ‚Üí overt hyperthyroidism in 2 y; ‚Üë risk of AF, CHD, fracture (JAMA 2015;313:2055) Rx controversial: consider if TSH &amp;lt;0.</description></item><item><title>hypertrophic cardiomyopathy</title><link>https://www.physician.tw/hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertrophic-cardiomyopathy/</guid><description>hypertrophic cardiomyopathy Definition, epidemiology, pathology (Circ Res 2017;121:749) LV (usually ‚â•15 mm) and/or RV hypertrophy disproportionate to hemodynamic load</description></item><item><title>hypertrophic pulm osteoarthropathy</title><link>https://www.physician.tw/hypertrophic-pulm-osteoarthropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertrophic-pulm-osteoarthropathy/</guid><description>hypertrophic pulm osteoarthropathy HPOAÊòØ‰∏ÄÁµÑÂèØËÉΩÂΩ±ÈüøÂô®ÂÆòÔºåËÇ∫ÔºåÈ™®È™ºÂíåÈóúÁØÄÁöÑÁóáÁãÄ„ÄÇÈÄôÊòØ‰∏ÄÁ®ÆÁΩïË¶ãÁöÑÁ∂úÂêàÁóáÔºåÂõ†Ê≠§Ê≤íÊúâÂ§™Â§ö‰ø°ÊÅØ„ÄÇÂÆÉ‰πüË¢´Á®±ÁÇ∫Bamberger-Marie
ÊÇ£ÊúâËÇ∫ÈÉ®ÁãÄÊ≥ÅÁöÑ‰∫∫ÂèØ‰ª•Áç≤ÂæóHPOA„ÄÇÂú®ÁôåÁóá‰∏≠ÔºåÂú®ÈùûÂ∞èÁ¥∞ËÉûËÇ∫ÁôåÊÇ£ËÄÖ‰∏≠ÊúÄÂ∏∏Ë¶ã„ÄÇÂÆÉÈÇÑÂΩ±ÈüøËÉ∏ËÜúÈñìÁöÆÁò§ÊÇ£ËÄÖ„ÄÇ
HPOAÁöÑÁóáÁãÄ HPOAÈÄöÂ∏∏ÊúÉÂºïËµ∑ÊâãËÖïÂíåËÖ≥Ë∏ùÁöÑÈ™®È™ºÂíåÈóúÁØÄÁöÑÁÇéÁóá„ÄÇÊúâÊôÇÔºåÈÄôÊúÉÈ°ØÁ§∫Âú®È™®ÊéÉÊèèÊàñXÂ∞ÑÁ∑ö‰∏ä„ÄÇËÖ≥Ë∏ùÂíåÊâãËÖïÊúÉËÖ´ËÑπÂíåÁôºÁÇéÔºåÂæûËÄåÂºïËµ∑ÂæàÂ§öÁóõËã¶ÂíåÈÅãÂãïÁöÑÂõ∞Èõ£„ÄÇ
HPOAÊúÄÂ∏∏Ë¶ãÁöÑÁóáÁãÄ‰πã‰∏ÄÊòØ‰∏ÄÁ®ÆÁ®±ÁÇ∫Clubbing finger„ÄÇÈÄôÊÑèÂë≥ËëóÊâãÊåáÂíåËÖ≥Ë∂æÂú®Êú´Á´ØÂØ¨Èóä „ÄÇÊåáÁî≤Êõ≤Á∑öÔºåËÆäÁ®†‰∏¶È°ØÂæóÂã∫ÁãÄ„ÄÇ
ÊâãÊåáÁöÑÊ£çÊ£íÊòØËÇ∫ÂíåÂøÉÈ´íÁóÖÁöÑÂ∏∏Ë¶ãÁóáÁãÄ„ÄÇÊ≤íÊúâ‰∫∫Á¢∫ÂàáÁü•ÈÅìÁÇ∫‰ªÄÈ∫ºÊúÉclubbing ‰ΩÜÈÄôÂèØËÉΩÊòØÂõ†ÁÇ∫Ë°ÄÊ∂≤‰∏≠Ê≤íÊúâË∂≥Â§†ÁöÑÊ∞ßÊ∞£„ÄÇ
REF: Hypertrophic osteoarthropathy (HPOA) | Lung cancer | Cancer Research UK</description></item><item><title>Hypervolemic hypotonic hyponatremia</title><link>https://www.physician.tw/Hypervolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypervolemic-hypotonic-hyponatremia/</guid><description>Hypervolemic hypotonic hyponatremia (ie, ‚Üë total body Na, ‚Üë ‚Üë TBW)
‚Üì EAV ‚Üí ‚Üë RAAS ‚Üí ‚Üë aldosterone &amp;amp; ‚Üë adrenergic tone ‚Üí ‚Üë‚Üë ADH (Am J Med 2013;126:S1)</description></item><item><title>hypoactive delirium</title><link>https://www.physician.tw/hypoactive-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypoactive-delirium/</guid><description>hypoactive delirium In striking contrast is the hypoactive subtype, exemplified by benzodiazepine intoxication, in which patients are withdrawn and quiet, with prominent apathy and psychomotor slowing.</description></item><item><title>hypocalcemia</title><link>https://www.physician.tw/hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypocalcemia/</guid><description>hypocalcemia [[serum calcium]]
[[Etiologies of Hypocalcemia]] [[Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor]]. [[Clinical manifestations-hypocalcemia]] Diagnostic studies Ca, alb, ICa, PTH, 25-(OH)D, 1,25-(OH) 2D (if renal failure or rickets), Cr, Mg, PO4, Aœï, UCa e.</description></item><item><title>hypoglycemia</title><link>https://www.physician.tw/hypoglycemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypoglycemia/</guid><description>hypoglycemia Clinical manifestations (glucose &amp;lt;~55 mg/dL)
CNS: headache, visual Œîs, Œî MS, weakness, seizure, LOC (neuroglycopenic sx) Autonomic: diaphoresis, palpitations, tremor (adrenergic sx) [[Etiologies-hypoglycemia]] [[Evaluation in patients without diabetes- but have hypoglycemia]] Treatment Glucose tablets, paste, &amp;amp; fruit juice are first-line Rx for Pts who can take POs 25‚Äì50 g of D 50 IV; if no access, glucagon 0.</description></item><item><title>hypokalemia</title><link>https://www.physician.tw/hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypokalemia/</guid><description>hypokalemia [[Transcellular shifts]] (UK:Cr &amp;lt;13 mEq/g) [[GI potassium losses]] (UK:Cr &amp;lt;13 mEq/g) [[Renal potassium losses]] (UK:Cr &amp;gt;13 mEq/g) [[Clinical manifestations-hypokalemia]] [[Workup-hypokalemia]] (JAMA 2021;12:1216) [[Approach to hypokalemia]] [[Treatment-hypokalemia]] [[Duty note of hypokalemia]]</description></item><item><title>hyponatremia</title><link>https://www.physician.tw/hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyponatremia/</guid><description>hyponatremia [[Pathophysiology-hyponatremia]] [[workup-hyponatremia]] [[Hypovolemic-hypotonic-hyponatremia]] [[Euvolemic-hypotonic-hyponatremia]] [[Hypervolemic hypotonic hyponatremia]] [[Treatment-of-hyponatremia]] [[JAMA review of hyponatremia]]</description></item><item><title>Hypoparathyroidism</title><link>https://www.physician.tw/Hypoparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypoparathyroidism/</guid><description>Hypoparathyroidism (NEJM 2019;380:1738; JCEM 2020;105:1722)
[[Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor]]. Iatrogenic (s/p thyroidectomy, rarely after parathyroidectomy); sporadic; familial (APS1, activating Ca-sensing receptor mutations; see page 7-2); Wilson‚Äôs, hemochromatosis; hypoMg (‚Üì secretion and effect); activating Ca-sensing receptor autoAb</description></item><item><title>Hypophosphatemia - Approach to the Patient</title><link>https://www.physician.tw/Hypophosphatemia-Approach-to-the-Patient/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypophosphatemia-Approach-to-the-Patient/</guid><description>Hypophosphatemia - Approach to the Patient Hypophosphatemia is commonly defined as a serum phosphate concentration that is &amp;lt; 2.5 mg/dL (0.</description></item><item><title>hypopituitary syndromes</title><link>https://www.physician.tw/hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypopituitary-syndromes/</guid><description>hypopituitary syndromes (Lancet 2016;388:2403; JCEM 2016;11:3888)
[[Etiologies-hypopituitary syndromes]] Clinical manifestations * Hormonal deficiencies: * ACTH, TSH, FSH and LH, GH, prolactin, and ADH * Panhypopituitarism: * deficiencies in multiple hormonal axes * Mass effect: * headache, visual field Œîs, cranial nerve palsies [[Central adrenal insufficiency]]: ‚Üì ACTH [[Central hypothyroidism]] Hypoprolactinemia: ‚Üì prolactin Inability to lactate [[Growth hormone deficiency]] [[Central hypogonadism]]: ‚Üì FSH &amp;amp; LH [[Central diabetes insipidus]] [[Pituitary apoplexy]] [[Diagnostic evaluation-hypopituitary syndromes]] [[Treatment-hypopituitary syndromes]]</description></item><item><title>hypotension</title><link>https://www.physician.tw/hypotension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypotension/</guid><description>hypotension Ë©ï‰º∞‰∏ÄÂÄã‰ΩéË°ÄÂ£ìÁöÑÁóÖ‰∫∫
Distributive SepticÔºöÁ¥∞Ëèå„ÄÅËèáËèá„ÄÅÁóÖÊØí„ÄÅÂØÑÁîüËü≤ Non-septic: ÁôºÁÇé„ÄÅÁ•ûÁ∂ì„ÄÅÈÅéÊïè„ÄÅÂÖßÂàÜÊ≥å Inflammatory , Neurogenic , Anaphylactic Other: Andrenal, Arteriovenous shunts Cardiogenic ÁâÜCardiomyopathic MI, dilated cardiomyopathy, Myocarditis, Drug-induced (eg, beta blockers) ÈõªË∑ØArrhythmogenic Tachyarrhythmia ‚Äì Atrial, ventricular Brady - atrioventricular block, Mobiz type 2 Ê∞¥Ë∑ØMechanical valvular, [[myxoma]] Hypovolemic Hemorrhagic trauma, GI, ÊâãË°ì, Â•≥ÊÄßÁîüÊÆñ Non-hemorrhagic ‰∏äÂêê‰∏ãÁÄâ„ÄÅ‰∏≠Êöë„ÄÅrenal loss(salt wasting)„ÄÅ3rd space loss Obstructive Pulmonary vascular pulmonary embolism, pulmonary hypertension Mechanical Mixed/unknown</description></item><item><title>hypothyroidism</title><link>https://www.physician.tw/hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypothyroidism/</guid><description>hypothyroidism Etiologies Primary (&amp;gt;90% of cases of hypothyroidism; ‚Üì free T4, ‚Üë TSH) Goitrous: [[Hashimoto‚Äôs thyroiditis]] (after hyperthyroid phase of thyroiditis), iodine deficiency, lithium, amiodarone Nongoitrous: surgical destruction, s/p radioactive iodine or XRT, amiodarone Secondary (central): ‚Üì free T4; TSH low, inappropriately nl, or slightly high (although functionally inactive due to abnormal glycosylation); due to hypothalamic or pituitary failure Hashimoto‚Äôs thyroiditis Clinical manifestations (Annals 2020;173:ITC1) Early: weakness, fatigue, arthralgias, myalgias, headache, depression, cold intolerance, weight gain, constipation, menorrhagia, dry skin, coarse brittle hair, brittle nails, carpal tunnel syndrome, delayed DTRs (‚Äúhung up‚Äù reflexes), diastolic HTN, hyperlipidemia Late: slow speech; hoarseness; loss of outer third of eyebrows; myxedema (nonpitting skin thickening due to ‚Üë glycosaminoglycans); periorbital puffiness; bradycardia; pleural, pericardial, &amp;amp; peritoneal effusions; atherosclerosis Myxedema crisis: vide infra Diagnostic studies (Lancet 2017;390:1550) ‚Üì free T4; ‚Üë TSH in 1¬∫ hypothyroidism; ‚äï antithyroid Ab (TPO) in Hashimoto‚Äôs thyroiditis May see hyponatremia, hypoglycemia, anemia, ‚Üë LDL, ‚Üì HDL and ‚Üë CK Screening recommended for pregnant women [[Treatment of overt hypothyroidism]] (Endocrine 2019;66:18) [[Subclinical hypothyroidism]] (NEJM 2017;376:2556; JAMA 2019;322:153) [[Myxedema coma]] (ie, profound hypothyroidism; Thyroid 2014;24:1670) BacklinkÔºö [[amiodarone and thyroid disease]] [[Central hypothyroidism]] [[Common Diagnostic Tests in Thyroid Disorders]] [[Differential Diagnosis of Delirium]] [[Dyslipidemias]] [[Etiologies of Acute Pericarditis]] [[Etiologies of Classic FUO]] [[Etiologies of Prolonged-QT-interval]] [[Euvolemic-hypotonic-hyponatremia]] [[Heart failure with preserved EF]] [[Hyperprolactinemia]] [[hypopituitary syndromes]] [[Myxedema coma]] [[nonthyroidal illness (sick euthyroid syndrome) ]] [[# The Profession of Medicine PA RT 1 ]] [[Physical Exam Secret]] [[respiratory-acidosis]] [[Subclinical hypothyroidism]] [[Thyroiditis]] [[thyroid disorders]] [[Treatment of overt hypothyroidism]] [[Treatment-hypopituitary syndromes]] [[Washington Manual Thyroid Disorders]] [[workup-hyponatremia]]</description></item><item><title>Hypovolemic shock</title><link>https://www.physician.tw/Hypovolemic-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypovolemic-shock/</guid><description>Hypovolemic shock Hemorrhagic Trauma
GI bleeding
Ruptured ectopic pregnancy
GI losses Burns Polyuria
Diabetic ketoacidosis
Diabetes insipidus</description></item><item><title>Hypovolemic-hypotonic-hyponatremia</title><link>https://www.physician.tw/Hypovolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypovolemic-hypotonic-hyponatremia/</guid><description>Hypovolemic-hypotonic-hyponatremia (ie, ‚Üì‚Üì total body Na, ‚Üì TBW)
[[Renal losses of Hypovolemic-hypotonic-hyponatremia]] Extrarenal losses (UNa &amp;lt;10 mEq/L, UCl &amp;lt;10 mEq/L if alkalemia, FENa &amp;lt;1%): hemorrhage, GI loss (diarrhea or vomiting), third-spacing (pancreatitis), ‚Üì PO intake, insensible losses</description></item><item><title>Hypoxia and Cyanosis</title><link>https://www.physician.tw/Hypoxia-and-Cyanosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypoxia-and-Cyanosis/</guid><description>Hypoxia and Cyanosis Respiratory Anemic Carbon Monoxide Circulatory Specific Organ hypoxia Increeased o2 requirments [[cynosis]]
BacklinkÔºö [[Alterations in Circulatory and Respiratory Functions]]</description></item><item><title>Ibutilide</title><link>https://www.physician.tw/Ibutilide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ibutilide/</guid><description>Ibutilide 1 mg IV over 10‚Äô may repeat x 1 n/a Contraindic. if J K or 1 QT (3-8% risk of TdP) give wl IV Mg %</description></item><item><title>ICD</title><link>https://www.physician.tw/ICD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ICD/</guid><description>ICD For 1¬∞ prevention if EF ‚â§30‚Äì35% or 2¬∞ prevention; not if NYHA IV
‚Üì mort. in ischemic CMP but perhaps only SCD in modern era in niCMP (NEJM 2005;352:225 &amp;amp; 2016;375:1221)</description></item><item><title>ICU-level care-asthma-EXACERBATION</title><link>https://www.physician.tw/ICU-level-care-asthma-EXACERBATION/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ICU-level-care-asthma-EXACERBATION/</guid><description>ICU-level care-asthma-EXACERBATION Invasive ventilation: Large ET tube, Pplat &amp;lt;30 cm H2O (predicts barotrauma better than PIP), max exp time</description></item><item><title>Idiopathic interstitial pneumonias IIPs</title><link>https://www.physician.tw/Idiopathic-interstitial-pneumonias-IIPs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Idiopathic-interstitial-pneumonias-IIPs/</guid><description>from [[interstitial lung disease]]
Idiopathic interstitial pneumonias (IIPs) (AJRCCM 2013;188:733)
ÂèÉËÄÉ‚û°Ô∏è An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial¬†‚Ä¶</description></item><item><title>IgA nephropathy</title><link>https://www.physician.tw/IgA-nephropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IgA-nephropathy/</guid><description>IgA nephropathy (CJASN 2017;12:677; AJKD 2021;78:429)
Most common cause of GN; ‚ôÇ pred; peak incidence 20‚Äì30s; can also be post-infectious Wide range of clinical presentations: asx hematuria (30‚Äì40%), gross hematuria ~1‚Äì3 d after URI (10‚Äì15%), chronic GN (10%), nephrotic syndrome (5%), RPGN (&amp;lt;5%) Though clinical presentation can be highly suggestive, definitive dx only w/ bx Prognosis: ‚ÜëCr, HTN, proteinuria a/w poor prog.</description></item><item><title>IgA vasculitis</title><link>https://www.physician.tw/IgA-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IgA-vasculitis/</guid><description>IgA vasculitis (formerly Henoch-Sch√∂nlein purpura [HSP]) (Rheumatol 2019;58:1607)
IgA-mediated [[small-vessel vasculitis]] w/ predilectionÂÅèÂ•Ω for skin, GI tract, and kidneys Epidemiology: * incidence 140/million/y; * ÂÜ¨Â§©ÁöÑÂ•≥Â≠© * ‚ôÇ &amp;gt;‚ôÄ, * children &amp;gt;adults, * winter &amp;gt;summer * May develop ~10 d after onset of upper resp infx or after drug exposure [[Clinical manifestations of IgA vasculitis]] Dx studies: skin bx w/ immunofluorescence ‚Üí leukocytoclastic vasculitis w/ IgA and C3 deposition in vessel wall; renal bx ‚Üí mesangial IgA deposition Treatment: * often self-limiting over 4 wk; * steroids ¬± DMARDs for renal or severe disease [Henoch-Schonlein purpura | Circulatory System and Disease | NCLEX-RN | Khan Academy - YouTube]( https://www.</description></item><item><title>Imaging studies of acute pancreatitis</title><link>https://www.physician.tw/Imaging-studies-of-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-studies-of-acute-pancreatitis/</guid><description>Imaging studies of acute pancreatitis (Am J Gastro 2013;108:1400)
Abd U/S: bowel gas often obscures pancreas visualization; however should be ordered to r/o biliary etiology (ie, gallstones, BD dilatation)</description></item><item><title>Imaging-Diagnosis-osteomyelitis</title><link>https://www.physician.tw/Imaging-Diagnosis-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-Diagnosis-osteomyelitis/</guid><description>Imaging-Diagnosis-osteomyelitis Plain radiographs: normal early in disease; lytic lesions seen after 2‚Äì6 wk MRI: preferred imaging study (overall Se 90%, Sp 82%; Archives 2007;167:125) CT: can demonstrate periosteal reaction and cortical and medullary destruction CT &amp;amp; MRI very Se but ‚Üì Sp; false ‚äï if contig focus w/ periosteal reaction, Charcot Œîs Radionuclide imaging: very Se but non-Sp (false ‚äï if soft-tissue inflammation) Explain by ChatGPT Plain x-rays: normal in the beginning stages of the disease; after 2-6 weeks, lytic lesions can be seen.</description></item><item><title>Imaging-for-stress-test</title><link>https://www.physician.tw/Imaging-for-stress-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-for-stress-test/</guid><description>Imaging-for-stress-test Use if uninterpretable ECG (V-paced, LBBB, resting ST ‚Üì &amp;gt;1 mm, digoxin, LVH, WPW), after indeterminate ECG test, or if pharmacologic test</description></item><item><title>IMI complications</title><link>https://www.physician.tw/IMI-complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IMI-complications/</guid><description>IMI complications Heart block: ~20%, occurs in part because RCA typically supplies AV node 40% on present., 20% w/in 24 h, rest by 72 h; high-grade AVB can develop abruptly</description></item><item><title>immune complex IC ‚Äìassociated small-vessel vasculitis</title><link>https://www.physician.tw/immune-complex-ICassociated-small-vessel-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-complex-ICassociated-small-vessel-vasculitis/</guid><description>immune complex (IC)‚Äìassociated small-vessel vasculitis see [[Immune Complex (IC) Disease (granular staining) ]]
[[IgA vasculitis]] [[Cryoglobulinemic vasculitis]] [[connective tissue disease‚Äìassociated vasculitis]] [[cutaneous leukocytoclastic angiitis]]</description></item><item><title>Immune Complex (IC) Disease granular staining</title><link>https://www.physician.tw/Immune-Complex-IC-Disease-granular-staining-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immune-Complex-IC-Disease-granular-staining-/</guid><description>Immune Complex (IC) Disease (granular staining) Renal-Limited Diseases Infection-Related GN (Staph &amp;amp; Strep; ‚Üì C3, ¬± ASLO) Membranoproliferative GN (MPGN) (‚Üì C3) Fibrillary and immunotactoid GN (normal C3/C4) [[IgA nephropathy]] (normal C3, ¬±‚Üë IgA) (NEJM 2013;368:2402; CJASN 2017;12:677) Systemic Diseases SLE (CJASN 2017;12:825) (‚äï ANA, ‚äï anti-dsDNA, ‚äï anti-Sm, ‚Üì C3, ‚Üì C4) Cryoglobulinemia (‚äï cryocrit, ‚äï RF, ‚äï HCV, SPEP, ‚Üì C3, ‚Üì C4) Endocarditis (fever, ‚äï BCx, valvular disease, ‚Üì C3) Henoch-Sch√∂nlein purpura ([[IgA nephropathy]] + syst.</description></item><item><title>Immunosuppression-Kidney transplantation</title><link>https://www.physician.tw/Immunosuppression-Kidney-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immunosuppression-Kidney-transplantation/</guid><description>Immunosuppression-Kidney transplantation : calcineurin inhib (tacrolimus&amp;gt;CsA) or CTLA4 inhib (belatacept) (NEJM 2016;374:333), antimetabolite (MMF&amp;gt;AZA), prednisone, mTOR inhib (sirolimus) if others contraindicated</description></item><item><title>Immunotherapies-asthma</title><link>https://www.physician.tw/Immunotherapies-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immunotherapies-asthma/</guid><description>Immunotherapies-asthma (NEJM 2017;377:965)
Allergen ImmunoRx (‚Äúallergy shots‚Äù) may help if sig. allerg. component (JAMA 2016;315:1715)
Anti-IgE (omalizumab) for uncontrolled mod-to-severe allergic asthma (w/ IgE &amp;gt;30) on ICS ¬± LABA (JAMA 2017; 318:279); ‚Üì exacerbations in severe asthma (Cochrane 2014;CD003559)</description></item><item><title>immunotherapy and cellular therapy</title><link>https://www.physician.tw/immunotherapy-and-cellular-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immunotherapy-and-cellular-therapy/</guid><description>immunotherapy and cellular therapy [[template]]
[Toxicities associated with checkpoint inhibitor immunotherapy - UpToDate]( https://www.uptodate.com/contents/toxicities-associated-with-checkpoint-inhibitor-immunotherapy?search=irae&amp;source=search result&amp;amp;selectedTitle=1~53&amp;amp;usage type=default&amp;amp;display rank=1) Science: Cancer immunotherapy using checkpoint blockade - PubMed [[irAE]]</description></item><item><title>Impaired cell-mediated immunity</title><link>https://www.physician.tw/Impaired-cell-mediated-immunity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Impaired-cell-mediated-immunity/</guid><description>Impaired cell-mediated immunity (CMI) (eg, HIV/AIDS, chronic steroids, posttransplant, DM, ESRD, autoimmune dis.) Bacteria: Salmonella spp., Campylobacter, Listeria, Yersinia, Legionella (Lancet 2016;387:376), Rhodococcus, Nocardia, TB, non-TB mycobacteria Fungi: Candida, Crypto, Histo, Coccidio, Aspergillus, Pneumocystis, Zygomycetes spp.</description></item><item><title>Implantable cardiac defibrillator ICD</title><link>https://www.physician.tw/Implantable-cardiac-defibrillator-ICD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Implantable-cardiac-defibrillator-ICD/</guid><description>Implantable cardiac defibrillator (ICD) (Circ 2019;140:e382)
RV lead: defib &amp;amp; pacing (¬± antitachycardia pacing [ATP] = burst pacing &amp;gt; VT rate to stop VT); ¬± RA lead for dual-chamber PPM.</description></item><item><title>incidence of vasculitides</title><link>https://www.physician.tw/incidence-of-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/incidence-of-vasculitides/</guid><description>incidence of vasculitides reported to be 40-60 cases per 1 million persons, with giant cell arteritis (GCA) being the most common type of primary systemic vasculitis among adults, particularly those aged &amp;gt; 50 years.</description></item><item><title>Indications for Permanent Pacing</title><link>https://www.physician.tw/Indications-for-Permanent-Pacing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-for-Permanent-Pacing/</guid><description>Indications for Permanent Pacing (JACC 2013;61:e6 &amp;amp; 2017;70:e39, Circ 2019;140:e382)
AV block 2¬∞ type II, high-grade or 3¬∞ AVB; symptomatic 1¬∞, 2¬∞ type I AVB or asx with Lamin A/C or neuromuscular disease; bifasc or alter.</description></item><item><title>Indications for surgery-bacterial endocarditis</title><link>https://www.physician.tw/Indications-for-surgery-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-for-surgery-bacterial-endocarditis/</guid><description>Indications for surgery-bacterial endocarditis (consult early; JTCS 2017;153:1241; Circ 2021;143:e72)
Emergent if refractory cardiogenic shock Urgent (during initial hospitalization): Sx HF Penetrating infection: periannular abscess, heart block, fistula, worsening conduction Persistent infection: ‚äï BCx after &amp;gt;5 d of appropriate abx, ‚Üë or ?</description></item><item><title>Indications for urgent dialysis</title><link>https://www.physician.tw/Indications-for-urgent-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-for-urgent-dialysis/</guid><description>Indications for urgent dialysis Acid-base disturbance: refractory acidemia
Electrolyte disorder: hyperK; hyperCa, hyperPO4, tumor lysis syndrome</description></item><item><title>indications of thoracentesis</title><link>https://www.physician.tw/indications-of-thoracentesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/indications-of-thoracentesis/</guid><description>indications of thoracentesis all effusions &amp;gt;1 cm in decubitus view if suspect due to CHF, can diurese and see if effusions resolve (75% do so in 48 h); asymmetry, fever, chest pain or failure to resolve ‚Üí thoracentesis [[parapneumonic effusions]] should be tapped ASAP (cannot exclude infxn clinically)</description></item><item><title>Indications PA catheter and tailored therapy</title><link>https://www.physician.tw/Indications-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-PA-catheter-and-tailored-therapy/</guid><description>Indications PA catheter and tailored therapy * Diagnosis and evaluation Ddx of shock (cardiogenic vs. distributive; espec if trial of IVF failed or is high risk) and of pulmonary edema (cardiogenic vs.</description></item><item><title>Infection as Etiologies of Classic FUO</title><link>https://www.physician.tw/Infection-as-Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infection-as-Etiologies-of-Classic-FUO/</guid><description>Infection as Etiologies of Classic FUO Tuberculosis: disseminated or extrapulm. disease can have normal CXR, PPD/IGRA, sputum AFB; bx (lung, liver, bone marrow) for granulomas has 80‚Äì90% yield in milliary disease</description></item><item><title>infections of the nervous system</title><link>https://www.physician.tw/infections-of-the-nervous-system/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infections-of-the-nervous-system/</guid><description>infections of the nervous system [[cerebrospinal fluid lab results]]
[[acute bacterial meningitis]] [[aseptic meningitis]] [[encephalitis]] [[Bell‚Äôs palsy]] [[herpes zoster]] (SHINGLES) [[Cryptococcus neoformans]] [[herpes simplex virus infection]] ÂñÆÁ¥îÁö∞ÁñπÁóÖÊØí [[computed tomogram in central nervous system infection]]</description></item><item><title>infectious disease</title><link>https://www.physician.tw/infectious-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-disease/</guid><description>infectious disease [[pneumonia]] [[fungal infections]] [[infxns in immunosuppressed hosts]] [[urinary tract infections]] [[sexually transmitted infections]] [[skin and soft tissue infections]] [[infections of the nervous system]] [[bacteremia and endocarditis]] [[infective endocarditis]] [[tuberculosis]] [[HIV AIDS]] [[tick-borne diseases]] [[fever syndromes]] [[antibiotics]] [[pathogen]] Resident 360 topics [[Diabetic Foot Infection]] [[opportunistic infections]] Tuberculosis Clostridium difficile Infection Epidural Abscess and [[vertebral osteomyelitis]], Meningitis/Encephalitis (Neurology) others [[An Approach to Diagnosing and Treating Infectious Diseases]] [[infectious diseases and pathophysiology]] [[infectious diseases key medications &amp;amp; interventions]] [[infectious diseases key clinical trials &amp;amp; publications]] [!</description></item><item><title>inflammatory bowel disease</title><link>https://www.physician.tw/inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inflammatory-bowel-disease/</guid><description>inflammatory bowel disease Definition (NEJM 2020;383:2652) Ulcerative colitis (UC): inflammation of the colonic mucosa; contiguous, starting at rectum Crohn‚Äôs disease (CD): transmural inflammation anywhere along GI tract, skip lesions Epidemiology &amp;amp; pathophysiology (Lancet 2016;387:156 &amp;amp; 2017;390:2769) Age of onset 15‚Äì30 y; bimodal w/ 2nd peak at 50‚Äì70 y; 1:1 M:F in N America</description></item><item><title>INFLAMMATORY-Acute Infectious Etiologies</title><link>https://www.physician.tw/INFLAMMATORY-Acute-Infectious-Etiologies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/INFLAMMATORY-Acute-Infectious-Etiologies/</guid><description>INFLAMMATORY-Acute Infectious Etiologies Predom. colonic invasion. Small-vol diarrhea. LLQ cramps, tenesmus, fever, typically ‚äï fecal WBC or FOB.
[bacterial inflammatory acute diarrhea] Parasitic E.</description></item><item><title>infxns in immunosuppressed hosts</title><link>https://www.physician.tw/infxns-in-immunosuppressed-hosts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infxns-in-immunosuppressed-hosts/</guid><description>infxns in immunosuppressed hosts Overview
Many Pts have ‚â•1 risk (eg, DM, ESRD, transplant, extremes of age) Accurate dx of opportunistic infections and targeted Rx key in this population The following is not an exhaustive list, but a delineation of common or classic etiologies (NEJM 2007;357:2601; Am J Med 2007;120:764; CID 2011;53:798) [[Humoral immune dysfunction]] [[Granulocytopenia or neutropenia]] [[Impaired cell-mediated immunity]] [[Organ dysfunction]] [[Biologics]]</description></item><item><title>Ingestions-caused-metabolic-acidosis</title><link>https://www.physician.tw/Ingestions-caused-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ingestions-caused-metabolic-acidosis/</guid><description>Ingestions-caused-metabolic-acidosis (NEJM 2018;378:270) Call poison control for guidance (02-28757525-821 ÂåóÊ¶ÆÊØíÁâ©Áßë)
ÂèÉËÄÉ‚û°Ô∏è Toxic alcohols
Acetaminophen Hepatitis Salicylates Fever, tachycardia, tinnitus; met.</description></item><item><title>Inherited Disorders of Connective Tissue</title><link>https://www.physician.tw/Inherited-Disorders-of-Connective-Tissue/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inherited-Disorders-of-Connective-Tissue/</guid><description>Ehlers-Danlos syndrome (EDS) Epidermolysis bullosa (EB) Marfan syndrome Osteogenesis imperfecta</description></item><item><title>Inherited Hypercoagulable States</title><link>https://www.physician.tw/Inherited-Hypercoagulable-States/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inherited-Hypercoagulable-States/</guid><description>Inherited Hypercoagulable States Factor V Leiden 3‚Äì7% 2.65 Activated protein C (APC) resistance Prothrombin mutation 2% 1.45 G20210A ‚Üí ‚Üë prothrombin level Hyperhomocysteinemia 5‚Äì10% Inherited or acquired (vitamin defic.</description></item><item><title>Initial antibiotic therapy of fever and neutropenia</title><link>https://www.physician.tw/Initial-antibiotic-therapy-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-antibiotic-therapy-of-fever-and-neutropenia/</guid><description>Initial antibiotic therapy of fever and neutropenia Empiric regimens should include antipseudomonal activity; consider VRE coverage if ‚äï Low risk: PO abx or home IV abx may be considered in select Pts (JCO 2013;31:1149) PO options: cipro+amoxicillin-clavulanate; levofloxacin; moxifloxacin (avoid if FQ Ppx) High risk: hospital admission &amp;amp; IV abx; monotherapy preferred options: cefepime, imipenem, meropenem, piperacillin/tazobactam, ceftazidime Antifungal Rx added for neutropenic fever ‚â•4 d despite abx: micafungin, liposomal amphotericin B, caspofungin, anidulafungin, voriconazole, &amp;amp; posaconazole are options</description></item><item><title>Initial anticoagulation options for-venous thromboembolism</title><link>https://www.physician.tw/Initial-anticoagulation-options-for-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-anticoagulation-options-for-venous-thromboembolism/</guid><description>Initial anticoagulation options for-venous thromboembolism (EHJ 2020;41:543; Chest 2021;160:e545)
Initiate immediately if high or intermed suspicion but dx test results will take ‚â•4 h</description></item><item><title>Initial evaluation diagnostic studies-acute aortic syndromes</title><link>https://www.physician.tw/Initial-evaluation-diagnostic-studies-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-diagnostic-studies-acute-aortic-syndromes/</guid><description>Initial evaluation diagnostic studies-acute aortic syndromes (Circ 2010;121:e266; EHJ 2018;39:739)
H&amp;amp;P, incl. bilat BP &amp;amp; radial pulses for symmetry; ECG w/ STE if propagates to cor CXR: abnl in 60‚Äì90% [‚Üë mediast.</description></item><item><title>Initial evaluation of change in mental status</title><link>https://www.physician.tw/Initial-evaluation-of-change-in-mental-status/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-of-change-in-mental-status/</guid><description>Initial evaluation of change in mental status see [[Stepwise Evaluation of a Patient with Delirium]]
History (witness &amp;amp; background crucial): tempo, premorbid sx (eg, focal neuro deficits, HA, infxn, pain, falls), medical conditions (eg, dementia, epilepsy, onc, cardiac, psych, infection/immune status), accompanied by head trauma, current meds (eg, sedatives, opioids, anticoag, anticonvulsants, immunosuppressants), drug/alcohol use General exam: VS, breathing pattern (eg, Cheyne-Stokes), tongue bite (seizure), nuchal rigidity (meningitis, SAH; do not test if c/f trauma/cervical spine fx), ecchymoses, rash, signs of head trauma (eg, Battle sign, raccoon eyes, hemotympanum, CSF rhinorrhea), asterixis, liver disease stigmata, embolic phenomena/endocarditis, s/s drug use Neuro exam</description></item><item><title>Initial evaluation-management-inflammatory bowel disease</title><link>https://www.physician.tw/Initial-evaluation-management-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-management-inflammatory-bowel-disease/</guid><description>Initial evaluation-management-inflammatory bowel disease H&amp;amp;P (‚úì for intestinal &amp;amp; extraintestinal manifestations) and dx studies as above
Lab: consider CBC/diff, LFTs, iron studies, B12, folate, vit D, ESR, CRP, fecal calprotectin</description></item><item><title>Initial evaluation-solitary pulmonary nodule</title><link>https://www.physician.tw/Initial-evaluation-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-solitary-pulmonary-nodule/</guid><description>Initial evaluation-solitary pulmonary nodule History: h/o cancer, smoking, age (&amp;lt;30 y = 2% malignant, +15% each decade &amp;gt;30)</description></item><item><title>initial test of hypophosphatemia</title><link>https://www.physician.tw/initial-test-of-hypophosphatemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/initial-test-of-hypophosphatemia/</guid><description>initial test of hypophosphatemia serum calcium, vitamin D, and parathyroid hormone levels; arterial blood gas; urine phosphorus and creatinine levels; fractional excretion of phosphorus; fractional excretion of phosphorus &amp;lt; 5% suggests a nonrenal mechanism (intracellular uptake or gastrointestinal); x-ray, if osteomalacia is suspected.</description></item><item><title>Initial treatment details of asthma</title><link>https://www.physician.tw/Initial-treatment-details-of-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-treatment-details-of-asthma/</guid><description>Initial treatment details of asthma Oxygen to keep SaO2 ‚â•93‚Äì95%
Inhaled SABA (eg, albuterol) by MDI (4‚Äì8 puffs) or nebulizer (2.</description></item><item><title>Initial treatment-clostridioides difficile infection</title><link>https://www.physician.tw/Initial-treatment-clostridioides-difficile-infection-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-treatment-clostridioides-difficile-infection-/</guid><description>Initial treatment-clostridioides difficile infection (CID 2021;73:5; Am J Gastro 2021;116:1124)
If possible, d/c abx ASAP; stop antimotility agents &amp;amp; [[cholestyramine]] if using (binds vanco) Fidaxomicin is now preferred over vancomycin regardless of severity; may be limited by $ Mild-mod: fidaxomicin 200 mg BID (‚Üì recurrence rate) or vanco 125 mg PO q6h √ó 10 d Severe (any of the following: &amp;gt;12 BM/d, Temp &amp;gt;103¬∞F, WBC &amp;gt;15, HoTN, ICU care required, ileus): as above; could consider PO+PR vanco Fulminant disease: vanco 500 mg PO qid + MNZ 500 mg IV q8h; consider FMT If worsening (ileus, ‚Üë WBC, ‚Üë lactate, shock, toxic megacolon, peritonitis): abd CT &amp;amp; urgent surgical consult - subtotal colectomy, diverting loop ileostomy or colonic lavage If need to cont abx, cont C.</description></item><item><title>Initial workup-bronchiectasis</title><link>https://www.physician.tw/Initial-workup-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-workup-bronchiectasis/</guid><description>Initial workup-bronchiectasis H&amp;amp;P: cough, dyspnea, copious sputum production, ¬±hemoptysis, inspiratory ‚Äúsqueaks‚Äù
CXR: scattered or focal; rings of bronchial cuffing; ‚Äútram track‚Äù of dilated, thick airways</description></item><item><title>inpatient oncology</title><link>https://www.physician.tw/inpatient-oncology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inpatient-oncology/</guid><description>inpatient oncology [[assessment of hospitalized cancer patients]]
Cancer type Anatomical location of primary tumor (e.g., bladder) Histologic type or subtype (e.</description></item><item><title>Insulin Preparations</title><link>https://www.physician.tw/Insulin-Preparations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Insulin-Preparations/</guid><description>Insulin Preparations Type (example) Onset Peak Duration Comments Rapid (lispro, aspart) Immed 1-2h &amp;lt;4h Give immediately before meal Short (regular) ~30 min 2-3 h 5-8 h Give ~30 min before meal Intermed.</description></item><item><title>integrase strand transfer inhibitor-INSTI-Antiretrovirals ARVs</title><link>https://www.physician.tw/integrase-strand-transfer-inhibitor-INSTI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/integrase-strand-transfer-inhibitor-INSTI-Antiretrovirals-ARVs/</guid><description>integrase strand transfer inhibitor-INSTI-Antiretrovirals (ARVs) bictegravir (BIC; Biktarvy) dolutegravir (DTG; Tivicay) elvitegravir (EVG; Vitekta) raltegravir (RAL; Isentress) cabotegravir (CAB; Vocabria) Class: diarrhea; weight gain; ‚Üë CPK DTG/BIC ‚Üë metformin levels; monitor glc DTG a/w 0.</description></item><item><title>interpretation of serum calcium</title><link>https://www.physician.tw/interpretation-of-serum-calcium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/interpretation-of-serum-calcium/</guid><description>interpretation of serum calcium Èõ¢Â≠êÈà£‰ªçÁÑ∂ÊòØË©ï‰º∞Èà£ÁãÄÊÖãÁöÑÈáëÊ®ôÊ∫ñÔºåÁâπÂà•ÊòØÂ¶ÇÊûúÁî±Êñº‰ΩéÁôΩËõãÁôΩË°ÄÁóá„ÄÅÈùûÂÖ∏ÂûãÊàñÁÑ°ÁóáÁãÄÊàñË°ÄÊ∏ÖÈà£ÊøÉÂ∫¶ÊúÄ‰ΩéÈôêÂ∫¶Èôç‰ΩéËÄåÂ∞ç‰ΩéÈà£Ë°ÄÁóáÁöÑË®∫Êñ∑Â≠òÂú®ÁñëÂïè„ÄÇÂ¶ÇÊûúÊ≤íÊúâÂ∑≤Áü•ÁöÑÂèØÈù†Ê∏¨ÈáèÈõ¢Â≠êÈà£ÁöÑÂØ¶È©óÂÆ§ÔºåÂâáÊáâ‰ΩøÁî®Èà£Ê†°Ê≠£ÂÖ¨ÂºèÂ∞çË°ÄÊ∏ÖÁôΩËõãÁôΩ‰∏≠ÁöÑ‰ªª‰ΩïÁï∞Â∏∏ÈÄ≤Ë°åÁ∏ΩÈà£Ê†°Ê≠£„ÄÇ
Â∞çÊñºËºïÂ∫¶‰ΩéÈà£Ë°ÄÁóáÊàñÊÖ¢ÊÄß‰ΩéÈà£Ë°ÄÁóáÔºàÁî±ÊñºÁî≤ÁãÄÊóÅËÖ∫ÂäüËÉΩÊ∏õÈÄÄÁóáÔºâÁöÑÊÇ£ËÄÖÔºåÁÑ°Ê≥ïÊúçÁî®ÊàñÂê∏Êî∂Âè£ÊúçË£úÂÖÖÂäëÔºàÂ¶ÇÂú®ÈúÄË¶ÅÈï∑ÊôÇÈñì‰ºëÈ§äÁöÑË§áÈõúÂ§ñÁßëÊâãË°ìÂæåÂèØËÉΩÁôºÁîüÔºâÔºåÂèØËÉΩÈúÄË¶ÅÈùúËÑàË£úÈà£‰ª•È†êÈò≤ÊÄ•ÊÄß‰ΩéÈà£Ë°ÄÁóá„ÄÇ
ÊúÄÂàùÔºåIV Èà£Ôºà1 Êàñ 2 g Ëë°ËêÑÁ≥ñÈÖ∏Èà£ÔºåÁõ∏Áï∂Êñº 90 Êàñ 180 mg ÂÖÉÁ¥†Èà£ÔºåÂú® 50 mL D5W Êàñ NS ‰∏≠ÔºâÂèØ‰ª•Âú® 10 Âà∞ 20 ÂàÜÈêòÂÖßËº∏Ê≥®„ÄÇÂ¶ÇÊûúÈúÄË¶ÅËß£Ê±∫ÁóáÁãÄÔºåÂèØÂú® 10 Ëá≥ 60 ÂàÜÈêòÂæåÈáçË§á„ÄÇÁ≠âÊïàÂäëÈáèÔºåSI ÂñÆ‰ΩçÔºö2.</description></item><item><title>interstitial lung disease</title><link>https://www.physician.tw/interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/interstitial-lung-disease/</guid><description>interstitial lung disease workup of ILD [[Broad categories-interstitial lung disease]] [[Rule out mimickers of ILD]] [[History and physical exam-interstitial lung disease]] [[Diagnostic studies-interstitial lung disease]] specific etiologies of ILD [[Sarcoidosis]] [[Exposure-interstitial lung disease]] [[Collagen vascular diseases]] [[Idiopathic interstitial pneumonias (IIPs)]] [[Pulmonary infiltrates with eosinophilia (PIE)]] Miscellaneous Pulm alveolar proteinosis (PAP): accumulation of surfactant-like phospholipids; white &amp;amp; gummy sputum; BAL milky fluid (NEJM 2003;349:2527); Rx w/ lung lavage &amp;amp; GMCSF ÂèÉËÄÉ‚û°Ô∏è Update on Pulmonary Alveolar Proteinosis</description></item><item><title>Intracardiac pressures PA catheter and tailored therapy</title><link>https://www.physician.tw/Intracardiac-pressures-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intracardiac-pressures-PA-catheter-and-tailored-therapy/</guid><description>Intracardiac pressures PA catheter and tailored therapy Transmural pressure (‚âà preload) = measured intracardiac pressure ‚Äì intrathoracic pressure</description></item><item><title>intrathecal chemotherapy</title><link>https://www.physician.tw/intrathecal-chemotherapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/intrathecal-chemotherapy/</guid><description>intrathecal chemotherapy The distinction between the two different leptomeningeal tumor spreading patterns described above has an impact on the indication for an intrathecal chemotherapy:</description></item><item><title>Intrinsic acute kidney injury etiology</title><link>https://www.physician.tw/Intrinsic-acute-kidney-injury-etiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intrinsic-acute-kidney-injury-etiology/</guid><description>Intrinsic acute kidney injury etiology [[Acute tubular necrosis (ATN)]] Pigmented granular [[muddy brown casts]] ¬± RBCs &amp;amp; protein from tubular damage FENa &amp;gt;2%, BUN/Cr &amp;lt;20 (except pigment, CIN) FEUN &amp;gt;50% [[Acute interstitial nephritis]] WBCs, WBC casts, ¬± RBCs w/ neg UCx ‚äï urine eos in abx ‚äï lymphs in NSAIDs [[Small-med vessel acute kidney injury]] ¬± RBCs ‚äï urine eos in chol emboli [[glomerulonephritis]] [[dysmorphic red blood cell]], RBC casts Explain by ChatGPT WBC casts ¬± proteinuria ¬± hematuria ATN is characterized by pigmented granular muddy brown casts, ¬± RBCs &amp;amp; protein from tubular damage, and FENa * FEUN Acute interstitial nephritis is characterized by WBCs, WBC casts, ¬± RBCs w/ neg UCx, ‚äï urine eos in abx, ‚äï lymphs in NSAIDs Small-med vessel acute kidney injury is characterized by ¬± RBCs, ‚äï urine eos in chol emboli Glomerulonephritis is characterized by Dysmorphic RBCs, RBC casts, WBC casts, ¬± proteinuria, ¬± hematuria Á™©ÁöÑËã±Êñá‰∏çÂ§™Â•Ω ATN ÁöÑÁâπÂæµÊòØÊúâËâ≤Á¥†ÁöÑÈ°ÜÁ≤íÁãÄÊ∏æÊøÅÊ£ïËâ≤ÁÆ°Âûã„ÄÅ¬± Á¥ÖÁ¥∞ËÉûÂíå‰æÜËá™ÁÆ°ÁãÄÊêçÂÇ∑ÁöÑËõãÁôΩË≥™Ôºå‰ª•Âèä FENa * FEUN ÊÄ•ÊÄßÈñìË≥™ÊÄßËÖéÁÇéÁöÑÁâπÂæµÊòØ WBC„ÄÅWBC ÁÆ°Âûã„ÄÅ¬± RBC w/ neg UCx„ÄÅ‚äï abx ‰∏≠ÁöÑÂ∞øÊ∂≤ eos„ÄÅ‚äï ÈùûÁîæÈ´îÊäóÁÇéËó•‰∏≠ÁöÑÊ∑ãÂ∑¥ Â∞èË°ÄÁÆ°ÊÄ•ÊÄßËÖéÊêçÂÇ∑ÁöÑÁâπÂæµÊòØ ¬± Á¥ÖÁ¥∞ËÉûÔºå‚äï ËÜΩÊ†ìÂ°û‰∏≠ÁöÑÂ∞øÊ∂≤ eos ËÖéÂ∞èÁêÉËÖéÁÇéÁöÑÁâπÂæµÊòØÁ¥ÖÁ¥∞ËÉûËÆäÂΩ¢„ÄÅÁ¥ÖÁ¥∞ËÉûÁÆ°Âûã„ÄÅÁôΩÁ¥∞ËÉûÁÆ°Âûã„ÄÅ¬±ËõãÁôΩÂ∞ø„ÄÅ¬±Ë°ÄÂ∞ø</description></item><item><title>IPF idiopathic pulm fibrosis</title><link>https://www.physician.tw/IPF-idiopathic-pulm-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IPF-idiopathic-pulm-fibrosis/</guid><description>IPF idiopathic pulm fibrosis UIP imaging pattern: reticular opacities, honeycombing, traction bronchiectasis; peripheral, subpleural, &amp;amp; basal
Sx &amp;gt;12 mo
5-y mort ~80%</description></item><item><title>ipratropium</title><link>https://www.physician.tw/ipratropium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ipratropium/</guid><description>ipratropium AtroventÔºåÂ±¨Êñº‰∏ÄÁ®ÆÊîØÊ∞£ÁÆ°Êì¥ÂºµËó•„ÄÇ
Êú¨ÂìÅÈÄöÂ∏∏Áî®ÊñºÊ≤ªÁôÇÊÖ¢ÊÄßÈòªÂ°ûÊÄßËÇ∫ÁóÖ‰ª•ÂèäÂìÆÂñòÔºåÈÄöÂ∏∏‰ª•Âê∏ÂÖ•ÂäëÊàñÈúßÂåñÂäëÁöÑÂΩ¢ÂºèÈä∑ÂîÆ„ÄÇ ÈÄöÂ∏∏Ëó•ÊïàÊúÉÊñº15-30ÂàÜÈêòÂæåÈñãÂßã‰ΩúÁî®Ôºå ‰ΩúÁî®ÊôÇÈñìÁ∂≠ÊåÅ3Ëá≥5Â∞èÊôÇ„ÄÇ Âè£‰πæ„ÄÅÂí≥ÂóΩÔºå‰ª•ÂèäÊîØÊ∞£ÁÆ°ÁÇé„ÄÇ ÊΩõÂú®ÂâØ‰ΩúÁî®ÂåÖÂê´Â∞øÁÄ¶Áïô„ÄÅÂëºÂê∏ÈÅìÁóôÊî£Ôºå</description></item><item><title>Ipratropium of COPDAE</title><link>https://www.physician.tw/Ipratropium-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ipratropium-of-COPDAE/</guid><description>Ipratropium of COPDAE MDI 4‚Äì8 puffs q1‚Äì2h or Nebulizer 0.5 mg q1‚Äì2h First-line therapy (NEJM 2011;364:1093)</description></item><item><title>irAE</title><link>https://www.physician.tw/irAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/irAE/</guid><description>irAE [[my report about irAE]] [[oncology]] [[immunotherapy and cellular therapy]]
reference Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series - PubMed PD-1/PD-L and autoimmunity: A growing relationship - ScienceDirect Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab - PubMed Oral mucositis‚Äîcase series of a rare adverse effect associated with immunotherapy | SpringerLink</description></item><item><title>Iron deficiency</title><link>https://www.physician.tw/Iron-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Iron-deficiency/</guid><description>Iron deficiency (Lancet 2021;397:233)
‚Üì marrow iron &amp;amp; depleted body iron stores ‚Üí ‚Üì heme synthesis ‚Üí microcytosis ‚Üí anemia</description></item><item><title>Iron-supplementation</title><link>https://www.physician.tw/Iron-supplementation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Iron-supplementation/</guid><description>Iron-supplementation ? IV (not PO) if NYHA II/III, EF ‚â§40%, Fe-defic (ferritin &amp;lt;100 or 100‚Äì 300 &amp;amp; TSAT &amp;lt;20%). ~20% ‚Üì HF hosp.</description></item><item><title>Irradiated blood products</title><link>https://www.physician.tw/Irradiated-blood-products/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Irradiated-blood-products/</guid><description>Irradiated blood products Prevents donor T-cell engraftment and risk of transfusion-assoc. GVHD (HSCT, heme malignancy, congenital immunodeficiency).</description></item><item><title>irregular of narrow complex</title><link>https://www.physician.tw/irregular-of-narrow-complex/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/irregular-of-narrow-complex/</guid><description>irregular of narrow complex AF, AFL, or MAT
Control rate w/ diltiazem or metoprolol or amiodarone</description></item><item><title>Irritable bowel syndrome</title><link>https://www.physician.tw/Irritable-bowel-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Irritable-bowel-syndrome/</guid><description>Irritable bowel syndrome (JAMA 2015;313:949; Gastro 2015;149:1399 &amp;amp; 2018;154:1140)
ÂèÉËÄÉ‚û°Ô∏è Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial ÂèÉËÄÉ‚û°Ô∏è Irritable bowel syndrome: a clinical review</description></item><item><title>ischemic colitis</title><link>https://www.physician.tw/ischemic-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ischemic-colitis/</guid><description>ischemic colitis Definition &amp;amp; pathophysiology Nonocclusive disease 2¬∞ to Œîs in systemic circulation or anatomic/fxnal Œîs in local mesenteric vasculature; often underlying etiology unknown, frequently seen in elderly ‚ÄúWatershed‚Äù areas (splenic flexure &amp;amp; rectosigmoid) most susceptible; 25% involve R side; confers worse prognosis (Clin Gastroenterol Hepatol 2015;13:1969) Clinical manifestations, diagnosis, &amp;amp; treatment Usually p/w cramping LLQ pain w/ overtly bloody stool; fever and peritoneal signs should raise clinical suspicion for infarction Disease spectrum: reversible colopathy (35%), transient colitis (15%), chronic ulcerating colitis (20%), resulting stricture (10%), gangrene (15%), fulminant colitis (&amp;lt;5%) Dx: flex sig/colonoscopy or CT abd/pelvis to make diagnosis; r/o IBD, infectious colitis Treatment: bowel rest, IV fluids, broad-spectrum abx, serial abd exams; surgery for infarction, fulminant colitis, hemorrhage, failure of med Rx, recurrent sepsis, stricture Resolution w/in 48 h w/ conservative measures occurs in &amp;gt;50% of cases</description></item><item><title>Ischemic hepatitis</title><link>https://www.physician.tw/Ischemic-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ischemic-hepatitis/</guid><description>Ischemic hepatitis ‚ÄúShock liver‚Äù w/ AST &amp;amp; ALT &amp;gt;1000 + ‚Üë‚Üë LDH (ALT:LDH ratio often &amp;lt;1:5); delayed ‚Üë‚Üë Tbili</description></item><item><title>Isolated proteinuria</title><link>https://www.physician.tw/Isolated-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Isolated-proteinuria/</guid><description>Isolated proteinuria By def‚Äôn: asx, normal renal fxn, sed, &amp;amp; imaging, no h/o renal disease Etiologies Functional (fever, exercise, CHF) Orthostatic (only when upright) Idiopathic (transient or persistent)</description></item><item><title>Isopropanol-toxicology</title><link>https://www.physician.tw/Isopropanol-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Isopropanol-toxicology/</guid><description>Isopropanol-toxicology CNS depression, gastritis
Supportive care</description></item><item><title>IV Drugs for Hypertensive Crises</title><link>https://www.physician.tw/IV-Drugs-for-Hypertensive-Crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IV-Drugs-for-Hypertensive-Crises/</guid><description>IV Drugs for Hypertensive Crises (Circ 2018;138:e426; Stroke 2018;49:46) Labetalol 20‚Äì80 mg IVB q10min or 0.4‚Äì2 mg/min AoD, ACS, Stroke, Eclampsia Esmolol 0.</description></item><item><title>IV immune globulin</title><link>https://www.physician.tw/IV-immune-globulin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IV-immune-globulin/</guid><description>IV immune globulin Polyvalent IgG from &amp;gt;1000 donors. For postexposure prophylaxis (eg, HAV), certain autoimmune disorders (eg, ITP, Guillain-Barr√©, MG, CIDP), congenital or acquired hypogammaglobulinemia (CVID, CLL).</description></item><item><title>Ivabradine</title><link>https://www.physician.tw/Ivabradine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ivabradine/</guid><description>Ivabradine Reasonable if EF ‚â§35%, NYHA II or III, HR ‚â•70, NSR on max bB.
18% ‚Üì CV mort or HF hosp (Lancet 2010;376:875)</description></item><item><title>JAMA 2021;325:962</title><link>https://www.physician.tw/JAMA-2021325962/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/JAMA-2021325962/</guid><description>JAMA 2021;325:962 ÈáçË¶ÅÊÄß ËÇ∫ÁôåÊòØÁæéÂúãÁ¨¨‰∫åÂ∏∏Ë¶ãÁöÑÁôåÁóáÔºå‰πüÊòØÁæéÂúãÁôåÁóáÊ≠ª‰∫°ÁöÑ‰∏ªË¶ÅÂéüÂõ†„ÄÇ 2020Âπ¥Ôºå‰º∞Ë®àÊúâ228820‰∫∫Ë¢´Ë®∫Êñ∑Âá∫ÊÇ£ÊúâËÇ∫ÁôåÔºå135720‰∫∫Ê≠ªÊñºË©≤ÁñæÁóÖ„ÄÇËÇ∫ÁôåÊúÄÈáçË¶ÅÁöÑÂç±Èö™Âõ†Á¥†ÊòØÂê∏ÁÖô„ÄÇÂπ¥ÈΩ°Â¢ûÈï∑‰πüÊòØËÇ∫ÁôåÁöÑÂç±Èö™Âõ†Á¥†„ÄÇËÇ∫ÁôåÁöÑÈ†êÂæåÈÄöÂ∏∏‰∏ç‰Ω≥ÔºåÁ∏Ω5Âπ¥ÁîüÂ≠òÁéáÁÇ∫20.5ÔºÖ„ÄÇ ‰ΩÜÊòØÔºåÊó©ÊúüËÇ∫ÁôåÁöÑÈ†êÂæåËºÉÂ•ΩÔºå‰∏¶‰∏îÊõ¥ÈÅ©ÂêàÊ≤ªÁôÇ„ÄÇ
ÁõÆÁöÑ ÊòØÊõ¥Êñ∞ÂÖ∂2013Âπ¥Âª∫Ë≠∞ÔºåÁæéÂúãÈ†êÈò≤ÊúçÂãôÂ∑•‰ΩúÁµÑÔºàUSPSTFÔºâÂßîË®óÂ∞ç‰ΩøÁî®‰ΩéÂäëÈáèË®àÁÆóÊ©üÊñ∑Â±§ÊéÉÊèèÔºàLDCTÔºâÔºàLDCTÔºâÈÄ≤Ë°åÁØ©Êü•ÁöÑÊ∫ñÁ¢∫ÊÄß‰ª•ÂèäËÇ∫ÁôåÁØ©Êü•ÁöÑÁõäËôïÂíåÂç±ÂÆ≥Ôºå‰∏¶ÂßîË®ó‰∏ÄÈ†ÖÂçî‰ΩúÂª∫Ê®°Á†îÁ©∂ÔºåÊó®Âú®Êèê‰æõÊúâÈóúÈñãÂßãÂíåÁµêÊùüÁØ©Êü•ÔºåÊúÄ‰Ω≥ÁØ©ÈÅ∏ÈñìÈöî‰ª•ÂèäËàáÂ§öÂÖÉÈ¢®Èö™È†êÊ∏¨Ê®°ÂûãÁöÑ‰øÆÊîπÁâàÊú¨Áõ∏ÊØîÔºå‰∏çÂêåÁØ©ÈÅ∏Á≠ñÁï•ÁöÑÁõ∏Â∞çÁõäËôïÂíåÂç±ÂÆ≥ÁöÑ‰ø°ÊÅØ„ÄÇ
‰∫∫Âè£ Ê≠§Âª∫Ë≠∞ËÅ≤ÊòéÈÅ©Áî®Êñº50Ëá≥80Ê≠≤ÁöÑÊàêÂπ¥‰∫∫Ôºå‰ªñÂÄëÊúâ20Âπ¥ÁöÑÂê∏ÁÖôÂè≤ÔºåÁõÆÂâçÂê∏ÁÖôÊàñÂú®ÈÅéÂéª15Âπ¥ÂÖßÊàíËè∏„ÄÇ
Ë≠âÊìö Ë©ï‰º∞USPSTF‰ª•ÈÅ©Â∫¶ÁöÑÁ¢∫ÂÆöÊÄßÂæóÂá∫ÁµêË´ñÔºö‰ΩøÁî®LDCTÈÄ≤Ë°åËÇ∫ÁôåÁöÑÂπ¥Â∫¶ÁØ©Êü•Âú®ËÇ∫ÁôåÈ´òÈ¢®Èö™ÁöÑ‰∫∫‰∏≠ÂÖ∑ÊúâÈÅ©Â∫¶ÁöÑÊ∑®ÁõäËôïÔºåÂõ†ÁÇ∫Âπ¥ÈΩ°ÔºåÁ¥ØÁ©çÁ¥ØÁ©çÊö¥Èú≤ÊñºËè∏ËçâÁÖôÈúß‰ª•ÂèäËá™ÂæûÊàíËè∏‰ª•‰æÜÁöÑÂπ¥‰ªΩ„ÄÇ
Âª∫Ë≠∞ USPSTFÂª∫Ë≠∞Âú®50Ëá≥80Ê≠≤ÁöÑÊàêÂπ¥‰∫∫‰∏≠Â∞çLDCTÈÄ≤Ë°å Âπ¥Â∫¶ÁØ©Êü•Ôºå‰ªñÂÄëÊìÅÊúâ20Âπ¥ÁöÑÂê∏ÁÖôÂè≤ÔºåÁõÆÂâçÂê∏ÁÖôÊàñÂú®ÈÅéÂéª15Âπ¥ÂÖßÊàíËè∏„ÄÇ ‰∏ÄÊó¶‰∏ÄÂÄã‰∫∫Âú®15Âπ¥Ê≤íÊúâÂê∏ÁÖôÊàñË£ΩÂÆöÂÅ•Â∫∑ÂïèÈ°åÔºåË©≤ÁØ©Êü•ÊáâÂÅúÊ≠¢ÁØ©Êü•ÔºåË©≤ÂïèÈ°åÂØ¶Ë≥™‰∏äÈôêÂà∂‰∫ÜÈ†êÊúüÂ£ΩÂëΩÊàñÈÄ≤Ë°åÊ≤ªÊÑàÊÄßËÇ∫ÊâãË°ìÁöÑËÉΩÂäõÊàñÊÑèÈ°ò„ÄÇ ÔºàbÂª∫Ë≠∞ÔºâË©≤Âª∫Ë≠∞Âèñ‰ª£‰∫Ü2013Âπ¥USPSTFËÅ≤ÊòéÔºåË©≤ËÅ≤ÊòéÂª∫Ë≠∞Âú®55Ëá≥80Ê≠≤ÁöÑÊàêÂπ¥‰∫∫‰∏≠Â∞çLDCTÈÄ≤Ë°åÂπ¥Â∫¶ÁØ©Êü•Ôºå‰ªñÂÄëÊìÅÊúâ30Âπ¥ÁöÑÂê∏ÁÖôÂè≤ÔºåÁõÆÂâçÂú®ÈÅéÂéª15Âπ¥ÂÖßÂê∏ÁÖôÊàñÈÄÄÂá∫„ÄÇ
‰æÜËá™: [[lung cancer]]</description></item><item><title>JAMA review of hyponatremia</title><link>https://www.physician.tw/JAMA-review-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/JAMA-review-of-hyponatremia/</guid><description>Diagnosis and Management of Hyponatremia JAMA.¬†2022;328(3):280-291. Á∂ìÈÅéÈÄôÈ∫ºÂ§öÂπ¥ÂæåÔºåÁÜ±È®∞È®∞ÁöÑHyponatremia review.
&amp;ldquo;Hyponatremia, which is defined as a serum sodium level of less than 135 mEq/L, affects approximately 5% of adults.</description></item><item><title>jupyter</title><link>https://www.physician.tw/jupyter/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jupyter/</guid><description>docker run -i &amp;ndash;rm &amp;ndash;user root -p 8888:8888 -e NB UID=1026 -e NB GID=100 -e NB USER=lizard -e CHOWN HOME=yes -e CHOWN HOME OPTS=&amp;quot;-R&amp;quot; -w &amp;ldquo;/home/${NB USER}&amp;rdquo; -v /volume1/docker/jupyter:/home/${NB USER}/ jupyter/minimal-notebook:latest</description></item><item><title>K-sparing diuretics</title><link>https://www.physician.tw/K-sparing-diuretics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/K-sparing-diuretics/</guid><description>K-sparing diuretics (NEJM 2017;377:1964)
Drugs: spironolactone (Aldactone), amiloride, triamterene, eplerenone
Mech: ‚Üì Na reabsorption (~1%) in collecting duct (amiloride/triamterene inhibit principal cell Na channel [ENaC]; spironolactone/eplerenone inhibit mineralocorticoid receptor).</description></item><item><title>Kawasaki disease</title><link>https://www.physician.tw/Kawasaki-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kawasaki-disease/</guid><description>Kawasaki disease Usually Asian children &amp;lt; 4 years old.
CRASH Conjunctivitis, Bilateral nonexudative bulbar Rash (polymorphous desquamating), Adenopathy (cervical) Strawberry tongue (oral mucositis), Hand-foot changes (edema, erythema), Burn: fever.</description></item><item><title>ketamine</title><link>https://www.physician.tw/ketamine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ketamine/</guid><description>ketamine contraindicated in patients with underlying conditions in which increased blood pressure would pose a risk of complications such as aortic dissection, uncontrolled hypertension, myocardial infarction, or aneurysms.</description></item><item><title>KEYNOTE-181</title><link>https://www.physician.tw/KEYNOTE-181/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/KEYNOTE-181/</guid><description>KEYNOTE-181 Purpose: Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy.
Patients and methods: In this open-label, phase III study, we randomly assigned (1:1) 628 patients with advanced/metastatic squamous cell carcinoma or adenocarcinoma of the esophagus, that progressed after one prior therapy, to pembrolizumab 200 mg every 3 weeks for up to 2 years or chemotherapy (investigator&amp;rsquo;s choice of paclitaxel, docetaxel, or irinotecan).</description></item><item><title>kidney disease</title><link>https://www.physician.tw/kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/kidney-disease/</guid><description>kidney disease [[acute kidney injury (AKI)]] [[disease-specific management of kidney disease]] [[chronic kidney disease (CKD)]] [[diuresis]] [[renal replacement and dialysis]]</description></item><item><title>Kidney transplantation</title><link>https://www.physician.tw/Kidney-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kidney-transplantation/</guid><description>Kidney transplantation (Med Clin N Am 2016;100:435)
Refer when GFR &amp;lt;20. Contraindic: active malig, infxn, ischemia, noncompl, subst use 5-yr survival: living donor 91%; deceased donor 70‚Äì84% (AJKD 2016;23:281).</description></item><item><title>King‚Äôs College Criteria for Liver Transplantation consideration</title><link>https://www.physician.tw/Kings-College-Criteria-for-Liver-Transplantation-consideration/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kings-College-Criteria-for-Liver-Transplantation-consideration/</guid><description>King‚Äôs College Criteria for Liver Transplantation consideration Acetaminophen ALF: arterial pH &amp;lt;7.30 or Grade III/IV enceph + INR &amp;gt;6.5 + Cr &amp;gt;3.</description></item><item><title>Laboratory Findings in Calcium Disorders</title><link>https://www.physician.tw/Laboratory-Findings-in-Calcium-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-Findings-in-Calcium-Disorders/</guid><description>Laboratory Findings in Calcium Disorders [[interpretation of serum calcium]] [[Serum parathyroid hormone (PTH) concentrations in hypercalcemia and hypocalcemia]] Ca: bones parathyroid hormone: thief of bones 25-(OH)D: intestine to blood Ca PTH Disease PO4 25-(OH)D 1,25-(OH),D up upup Hyperparathyroidism (1¬∞ and 3¬∞) down down to normal normal to up up up or normal Familial hypocalciuric hypercalcemia down var.</description></item><item><title>Laboratory studies-cirrhosis</title><link>https://www.physician.tw/Laboratory-studies-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-studies-cirrhosis/</guid><description>Laboratory studies-cirrhosis LFTs: ‚Üë bili, ‚Üë PT/INR (poor correlation w/ bleeding; factor VIII nl b/c not synthesized by liver), ‚Üì alb, ¬± ‚Üë aminotransferases (AST &amp;gt;ALT if late) and ‚Üë Aœï (variable)</description></item><item><title>Lactic acidosis</title><link>https://www.physician.tw/Lactic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lactic-acidosis/</guid><description>Lactic acidosis Type A: hypoxic (eg, shock, mesenteric ischemia, CO poisoning, cyanide) Type B: nonhypoxic. ‚Üì clearance (eg, hepatic dysfxn) or ‚Üë generation [eg, malig, EtOH, thiamine def.</description></item><item><title>laryngoscopy and confirmation of placement</title><link>https://www.physician.tw/laryngoscopy-and-confirmation-of-placement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/laryngoscopy-and-confirmation-of-placement/</guid><description>laryngoscopy and confirmation of placement ‚ú®ÈáçÈªû: Âú®Á¢∫‰øùÈÅ©Áï∂ÁöÑÊ∫ñÂÇô„ÄÅË®≠ÂÇôË®≠ÁΩÆ„ÄÅÂäüËÉΩÁõ£Ê∏¨Âô®„ÄÅÂÆö‰ΩçÂíåÈ†êÊ∞ßÂêàÂæåÔºåÈÄöÂ∏∏ÊúÉÁÇ∫ÊÇ£ËÄÖÊñΩÁî®ÂºïËµ∑ÂëºÂê∏Êö´ÂÅúÁöÑËó•Áâ©ÂíåÈ∫ªÁó∫ÂäëÔºåÈÄôÂÖ©Á®ÆËó•Áâ©ÈÉΩÊòØÊ†πÊìöÊÇ£ËÄÖÁöÑÊÉÖÊ≥ÅÂíåËá®Â∫äÊÉÖÊ≥ÅÈÅ∏ÊìáÁöÑ„ÄÇ ÈÇÑÊáâÊ≥®ÊÑèÔºåÂú®Êüê‰∫õÊÉÖÊ≥Å‰∏ãÔºå‰æãÂ¶ÇÂøÉËáüÈ©üÂÅúÔºåÂèØËÉΩ‰∏çÈúÄË¶ÅË™òÂ∞éÂäë„ÄÇ Áï∂ÊÇ£ËÄÖË¢´Ë™çÁÇ∫Â∑≤ÈÅ©Áï∂È∫ªÈÜâÊôÇÔºåÂñâÈè°Áî±Êèê‰æõËÄÖÁöÑÂ∑¶ÊâãÊãøËëóÔºåËÄåÂè≥ÊâãÁî®‰ªñÊàñÂ•πÁöÑÊãáÊåáÂíåÈ£üÊåá‰ª•Ââ™ÁãÄÂãï‰ΩúÊâìÈñãÊÇ£ËÄÖÁöÑÂò¥„ÄÇ ÁÑ∂ÂæåÂ∞áÂñâÈè°ÊèíÂÖ•Âè£‰∏≠ÔºåÊ≥®ÊÑè‰∏çË¶ÅÊêçÂ£ûÊÇ£ËÄÖÁöÑÂò¥ÂîáÊàñÁâôÈΩí„ÄÇ Âú®ÂΩéÊõ≤ÁöÑ MAC ÂàÄÁâáÁöÑÊÉÖÊ≥Å‰∏ãÔºåËàåÈ†≠ÂêëÂ∑¶ÊéÉÈÅéÔºåÂàÄÁâáÁöÑÂ∞ñÁ´ØÊîæÁΩÆÂú®ÊúÉÂé≠ÂâçÈù¢ÁöÑÊúÉÂé≠Ë∞∑‰∏≠ÔºåËÄåÁõ¥ÁöÑÁ±≥ÂãíÂàÄÁâáÊèíÂÖ•ÊúÉÂé≠‰∏ãÊñπÁöÑ‰∏≠Á∑ö‰ΩçÁΩÆ„ÄÇ ÂñâÈè°ÊâãÊüÑÂêë‰∏äÂêëÂâçÊèêËµ∑ÔºåÈú≤Âá∫ËÅ≤Â∏∂„ÄÇ ÂàáÂãøÂ∞áÊâãÊüÑÂêëÂæåÂÇæÊñúÔºåÂõ†ÁÇ∫ÈÄôÊúÉÂ∞éËá¥ÁâôÈΩíÊêçÂÇ∑„ÄÇ ÁÑ∂ÂæåÂú®Áõ¥Êé•ÂèØË¶ñÂåñ‰∏ãÈÄöÈÅéËÅ≤Â∏∂ÊèíÂÖ• ETT„ÄÇ ÊèíÂÖ• ETT ÂæåÔºåÁÆ°ÂøÉÈáùÔºàÂ¶ÇÊûú‰ΩøÁî®ÔºâÂíåÂñâÈè°‰∏ÄÊ®£Ë¢´ÁßªÈô§„ÄÇ ÁÑ∂Âæå‰ΩøÁî® 10 mL Ê≥®Â∞ÑÂô®Â∞áÂºïÂ∞éÊ∞£ÁêÉÂÖÖÊ∞£Ëá≥‰∏çË∂ÖÈÅé 30 mmHg ÁöÑÂ£ìÂäõ„ÄÇ ÁÇ∫‰∫ÜÁ¢∫Ë™çÊ∞£ÁÆ°ÊîæÁΩÆÔºåETT ÈÄ£Êé•Âà∞Ê∞£ÂõäÈÄöÊ∞£Ëø¥Ë∑Ø‰∏¶ÈÄ≤Ë°åÈÄöÊ∞£ÔºåËßÄÂØüÈõôÂÅ¥ËÉ∏ÈÉ®‰∏äÂçá„ÄÅETT ‰∏≠ÁöÑÂÜ∑ÂáùÊ∞£ÔºåÊúÄÈáçË¶ÅÁöÑÊòØÔºåÈÄöÈÅé‰∫åÊ∞ßÂåñÁ¢≥ÂúñËßÄÂØüÈÄ£Á∫åÁöÑÂëºÊ∞£Êú´ CO 2 - Ë¢´Ë™çÁÇ∫ÊòØÈªÉÈáëÊ®ôÊ∫ñ„ÄÇ Â¶ÇÊûúÊú™Ê™¢Ê∏¨Âà∞ÊåÅÁ∫åÁöÑÂëºÊ∞£Êú´ CO 2 ÔºåÊáâÊá∑ÁñëÈ£üÁÆ°ÊèíÁÆ°‰∏¶ÈáçÊñ∞ÂòóË©¶ÂñâÈè°Ê™¢Êü•„ÄÇ ETT ÁöÑÈÅ†Á´ØÊáâ‰ΩçÊñºËÅ≤Â∏∂‰πãÂ§ñ‰ΩÜÂú®carinaÈöÜÁ™Å‰πã‰∏äÔºåÈÅøÂÖç‰∏ªÂππÊèíÁÆ°„ÄÇ Âú®Êàê‰∫∫‰∏≠ÔºåÈÄôÈÄöÂ∏∏ËàáÊÇ£ËÄÖÂîáÈÉ®ÁöÑ 21-23 ÂéòÁ±≥Áõ∏Èóú„ÄÇ ÊîæÁΩÆÂæåÊáâÁ´ãÂç≥ CXR ‰ª•Á¢∫Ë™çÊ≠£Á¢∫‰ΩçÁΩÆ„ÄÇ</description></item><item><title>Late renal dysfxn</title><link>https://www.physician.tw/Late-renal-dysfxn/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Late-renal-dysfxn/</guid><description>Late renal dysfxn usual AKI causes + calcineurin tox, rejection (NEJM 2010;363:1451), BK virus, recurrence of 1¬∞ disease; usual w/u + immunosupp levels, donor-specific antigen (DSA), BK virus load, U/S, then bx if no other cause (CJASN 2008;3:S56; CJASN 2011;6:1774)</description></item><item><title>Left-ventricular-hypertrophy</title><link>https://www.physician.tw/Left-ventricular-hypertrophy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Left-ventricular-hypertrophy/</guid><description>Left-ventricular-hypertrophy (Circ 2009;119:e251)
ÂèÉËÄÉ‚û°Ô∏è AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac¬†‚Ä¶</description></item><item><title>Lennox Gastaut Syndrome</title><link>https://www.physician.tw/Lennox-Gastaut-Syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lennox-Gastaut-Syndrome/</guid><description>Lennox Gastaut Syndrome ÈÄôÂÄãÁóáÂÄôÁæ§ÊòØ‰∏ÄÂÄãÂ§öÂÖÉÊÄßÁô≤ÁôáÁôº‰ΩúÈ°ûÂûãÁöÑÈ†ëÂõ∫ÊÄßÁô≤ÁôáÊÇ£ËÄÖÊúÉÂá∫ÁèæÂ§öÁ®Æ‰∏çÂêåÈ°ûÂûãÁöÑÁôº‰ΩúË°®ÁèæÔºõ‰æãÂ¶ÇÔºöÂú®Áù°Áú†ÁöÑÈùûÂø´ÈÄüÂãïÁúºÊúüÊôÇÂá∫ÁèæÂÉµÁõ¥Áôº‰Ωú„ÄÅÈùûÂÖ∏ÂûãÂ§±Á•ûÊÄßÁôº‰Ωú„ÄÅÂ§±ÂºµÂäõÂûãÁôº‰ΩúÊàñÊòØËºÉÂ∞ëË¶ãÁöÑËÇåÊäΩË∫çÁôº‰Ωú„ÄÅÂª£Ê≥õÊÄßÂ§ßÁôº‰ΩúÂèäÂ±ÄÈÉ®ÊÄßÊäΩÊêê„ÄÇÂú®ÁôºÁóÖ‰πãÂæåÔºåÂÆÉÊúÉÈÄ†ÊàêÊô∫ËÉΩÈöúÁ§ôÂíåÈÄÄÂåñ„ÄÇÂú®ËÖ¶ÈõªÂúñ‰∏≠ÁúãË¶ãÂΩåÊº´ÊÄßÊÖ¢Ê£òË§áÂêàÊ≥¢Ôºàdiffuse slow spike-and-waveÔºâÂíåÈô£ÁôºÊÄßÂø´ÈÄüÊ¥ªÂãïÊúüÁöÑËÆäÂåñ„ÄÇ
Â•ΩÁôºÂπ¥ÈΩ°Áî±1Ê≠≤Ëá≥7Ê≠≤ÔºàÈ´òÂ≥∞Âπ¥ÈΩ°ÁÇ∫3Ê≠≤Ëá≥5Ê≠≤Ôºâ„ÄÇÊÇ£ËÄÖÁöÑÁî∑Â•≥ÊØîÁ¥ÑÁÇ∫5:1Â∑¶Âè≥„ÄÇÊó¢ÂæÄÁóÖÂè≤„ÄÅÂá∫ÁîüÂè≤ÂíåÊñ∞ÁîüÂÖíÂè≤ÂèØËÉΩÊòØÊ≠£Â∏∏ÁöÑÔºåÊàñÂèØËÉΩÊúÉÊúâËÖ¶ÈÉ®ÁµêÊßãÁï∞Â∏∏ÁöÑÁóÖÂè≤„ÄÇÁ•ûÁ∂ìÂ≠∏Ê™¢Êü•ÂíåÈ†≠ÂúçÂèØËÉΩÊòØÊ≠£Â∏∏ÔºåÊàñËÄÖÊúÉÂá∫ÁèæËàáÂÖ∂ËÖ¶ÈÉ®ÁµêÊßãÁï∞Â∏∏Áõ∏ÈóúÁöÑÁ•ûÁ∂ìÁôºÁï∞Â∏∏„ÄÇÁîüÈï∑ÁôºÂ±ï„ÄÅÊô∫ËÉΩÂíåË™çÁü•Â∏∏ÊúâÁôºÂ±ïÈöúÁ§ôÔºå‰ΩÜÂÅ∂ÁÑ∂ÈÇÑÊòØÊúÉÁúãÂà∞Ê≠£Â∏∏ÁôºÂ±ïÁöÑÂ∞èÂ≠©„ÄÇ‰ΩÜÁï∂Áôº‰ΩúÂæåÔºåÂ∞èÂ≠©Â≠êÁöÑÂÖ∂ÂæåÁîüÈï∑ÁôºÂ±ïÂ∞±ÊúÉÂÅúÊªØÊàñÁîöËá≥ÈÄÄÊ≠•„ÄÇ
Â§ßÁ¥ÑÊúâ10-30%ÁöÑÊÇ£ËÄÖÂú®Êó©ÊúüÊõæÊúâÈÅéÂÖ∂‰ªñÁ®ÆÈ°ûÁöÑÁô≤ÁôáÁóáÂÄôÁæ§Ôºå‰æãÂ¶ÇWest syndromesÂíåOhtahara syndromesÁ≠âÁóÖÂè≤Ôºõ‰∏çÈÅéÂ∞±ÁôºÁóÖÂπ¥ÈΩ°‰æÜË™™ÔºåÊúâÈÅéÂéªÁô≤ÁôáÁóÖÂè≤ÂíåÊ≤íÊúâÁöÑÊóèÁæ§ÔºåÂÖ∂ÁôºÁóÖÂπ¥Á¥Ä‰∏¶Ê≤íÊúâÂ§™Â§ßÂ∑ÆÁï∞„ÄÇÂÅ∂ÁÑ∂Êúâ‰∫õÂÄãÊ°àÈÅéÂéªÊúÉÊúâÁÜ±ÁóôÊî£„ÄÅÂ±ÄÈÉ®Áôº‰ΩúÊàñÂÖ®Ë∫´ÊÄßÁôº‰ΩúÁ≠âÁóÖÂè≤„ÄÇÁõÆÂâçË™çÁÇ∫ÁöÑÊàêÂõ†ÂåÖÂê´‰∫ÜËÖ¶ÈÉ®ÁµêÊßãÁï∞Â∏∏ÔºàÈÄôÊòØÂ§ßÈÉ®ÂàÜ‰∏ªË¶ÅÁöÑÂéüÂõ†ÔºåÁ¥Ñ‰Ωî‰∫Ü70%ÁöÑÂÄãÊ°àÔºâ„ÄÅÈÅ∫ÂÇ≥ÊÄßÁóÖÂõ†Ôºå‰ΩÜ‰ªçÊúâ‰∫õÁóÖ‰∫∫ÊòØÊâæ‰∏çÂà∞Ëá¥ÁóÖÂéüÂõ†ÁöÑ„ÄÇÈõñÁÑ∂ÁõÆÂâçÁöÑÁóÖÁîüÁêÜÈÇÑ‰∏çÊ∏ÖÊ•öÔºå‰πüÊ≤íÊúâÂãïÁâ©Ê®°ÂºèË¢´Âª∫Á´ãÔºå‰∏çÈÅéÊúâ‰∏Ä‰∫õÂÅáË™™Ë™çÁÇ∫Ë∑üÂÖçÁñ´Ë™òÁôºÁöÑÊ©üËΩâ‰∫õÈóúËÅØ„ÄÇ
Èï∑Êúü‰æÜË™™ÔºåÂÖ∂È†êÂæå‰∏¶‰∏çÊ®ÇËßÄÔºå‰∏çÈÅéÈÇÑÊòØÊúâÂæàÂ§ßËÆäÁï∞ÊÄßÁöÑ„ÄÇÊúâÂæàÂ∞ëÊï∏ÁöÑÊÇ£ËÄÖÈÇÑÊòØÂèØ‰ª•ÊìÅÊúâÊ≠£Â∏∏Â∑•‰ΩúÔºå‰ΩÜÁ¥ÑÊúâ‰∫îÂà∞ÂÖ´ÊàêÁöÑÊÇ£ËÄÖÂÖ∑ÊúâÊô∫ËÉΩÈöúÁ§ôÔºå‰∏îÈúÄË¶ÅË®±Â§öÈ°çÂ§ñÁöÑÂçîÂä©„ÄÇÂÉµÁõ¥Áôº‰ΩúÈÄöÂ∏∏ÊòØÊ≠§ÁóáÂÄôÁæ§ÁöÑÂ§öÂÖÉÁôº‰ΩúÈ°ûÂûã‰∏≠ÊúÄ‰∏çÊòìÊéßÂà∂ÁöÑ‰∏ÄÁ®ÆÔºå‰πüÂõ†Ê≠§Á¥ÑÊúâ3-7%ÁöÑÊÇ£ËÄÖÊúÉÂõ†ÁÇ∫ÈÄôÈ°ûÁôº‰ΩúÊâÄÈÄ†ÊàêÁöÑÊÑèÂ§ñË∫´ÊïÖ„ÄÇ</description></item><item><title>lenvatinib</title><link>https://www.physician.tw/lenvatinib/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lenvatinib/</guid><description> Ëó•Áâ©‰ªãÁ¥πÔºöLenvatinib (Lenvima¬Æ,Ê®ÇË°õÁë™)-Ë≤°ÂúòÊ≥ï‰∫∫Âè∞ÁÅ£ÁôåÁóáËá®Â∫äÁ†îÁ©∂ÁôºÂ±ïÂü∫ÈáëÊúÉ
[[hepatocellular carcinoma]]] LenvatinibÂú®2017Âπ¥ÁôºË°®ÁöÑÁ¨¨‰∫åÊúüËá®Â∫äË©¶È©óÊï∏ÊìöÈ°ØÁ§∫ÔºåÁÑ°Ê≥ïÈñãÂàÄÊàñÂ±ÄÈÉ®Ê≤ªÁôÇÁöÑËÇùÁôåÊÇ£ËÄÖ(46‰∫∫)Ôºå‰ΩøÁî®lenvatinibÔºåÊúâ37% (17‰∫∫)ÁöÑËÖ´Áò§ÂèØ‰ª•Á∏ÆÂ∞èÔºåÊúâ41%(19‰∫∫)ËÖ´Áò§ÂèØ‰ª•Á∂≠ÊåÅ‰∏çËÆä„ÄÇ Êé•ËëóÔºålenvatinibÂèàÈÄ≤Ë°å‰∫Ü‰∏ÄÂÄãËàáËÇùÁôåÂè¶‰∏ÄÊ®ôÈù∂Ëó•Áâ©sorafenibÁôÇÊïàÊØîËºÉÁöÑÁ¨¨‰∏âÊúüËá®Â∫äË©¶È©óÔºåÊ†πÊìö2017ÁæéÂúãÁôåÁóáÈÜ´Â≠∏ÊúÉÂπ¥ÊúÉ (ASCO)Êñº2017-06-04ÁôºË°®ÁöÑÊúÄÊñ∞Êï∏ÊìöÔºåÁ∏ΩÂÖ±Á¥Ñ950‰∫∫ÂèÉÂä†Ê≠§Ëá®Â∫äË©¶È©óÔºå‰∏ÄÁµÑ‰ΩøÁî®lenvatinibÈÄôÂÄãËó•Áâ©ÔºåÂè¶‰∏ÄÁµÑ‰ΩøÁî®sorafenibÈÄôÂÄãËó•Áâ©ÔºåÁµêÊûúÁôºÁèæÔºå‰ΩøÁî®lenvatinibÁöÑÂ≠òÊ¥ªÊúü(13.6ÂÄãÊúà)‰∏¶‰∏çËº∏Áµ¶sorafenib(12.3ÂÄãÊúà)Ôºå‰∏îÊúâËºÉÂ§ö(24%)ÁöÑÁóÖ‰∫∫ËÖ´Áò§È°ØËëóÁ∏ÆÂ∞èÔºåÂ∞çÁÖßÁµÑÂâáÂè™Êúâ9.2%„ÄÇÊÉ°ÂåñÊôÇÈñìÁÇ∫7.4ÂÄãÊúàÔºåÂ∞çÁÖßÁµÑÁÇ∫3.7ÂÄãÊúàÔºåÊØîÂ∞çÁÖßÁµÑÂª∂Èï∑3.7ÂÄãÊúà„ÄÇÈõñÁÑ∂lenvatnibÂÖ∂È´òË°ÄÂ£ìÁöÑÂâØ‰ΩúÁî®ÁôºÁîüÁéáËºÉÂ∞çÁÖßÁµÑÈ´òÔºå‰ΩÜÊúÄ‰ª§ÊÇ£ËÄÖÂõ∞ÊìæÁöÑÁöÆËÜöÂâØ‰ΩúÁî®ÂâáËºÉÂ∞ëÔºålenvatinibÁÇ∫27%ÔºåÂ∞çÁÖßÁµÑÂâáÊúâ52%„ÄÇ ÈõñÁÑ∂lenvatinibÁõÆÂâçÂ∞öÊú™ÂèñÂæóÂú®ËÇùÁôåÁöÑËá®Â∫äÈÅ©ÊáâÁóáÔºåÊ≠§Ëó•Âú®ËÇùÁôåÁöÑÊïàÊûúÂ∑≤ÊúâÁ¨¨‰∏âÊúüËá®Â∫äË©¶È©óË≥áÊñôÂèØÂèÉËÄÉ„ÄÇ</description></item><item><title>leptomeningeal disease</title><link>https://www.physician.tw/leptomeningeal-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leptomeningeal-disease/</guid><description>leptomeningeal disease [[urgent symptomatic interventions of leptomeningeal disease]]</description></item><item><title>Leuko-reduced blood products</title><link>https://www.physician.tw/Leuko-reduced-blood-products/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Leuko-reduced-blood-products/</guid><description>Leuko-reduced blood products WBCs cause HLA alloimmunization &amp;amp; fever (cytokines) and carry CMV. For chronically transfused Pts, potential Tx recip., h/o febrile nonhemolytic transfusion rxn, cases in which CMV-neg products desired but unavailable.</description></item><item><title>levamisole</title><link>https://www.physician.tw/levamisole/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/levamisole/</guid><description>levamisole ÈÅ©ÊáâÁóá Ê≤ªÁôÇËõîËü≤„ÄÅÈâ§Ëü≤„ÄÅÁ≥ûÂúìËü≤
LevamisoleÊòØtetramisoleÁöÑÂ∑¶ÊóãÁï∞ÊßãÁâ©ÔºåÁÇ∫‰∏ÄÂª£ÊïàÁöÑÊäóÂØÑÁîüËü≤Ëó•Áâ©Ôºå ÂèØ‰ΩøËü≤È´îÁöÑÁ•ûÁ∂ìËàáÂ•ÆÔºå‰∏¶Â∞éËá¥ËÇåËÇâÂº∑Áõ¥„ÄÅÁô±ÁòìÔºåÈÇÑÊúâÈòªÊñ∑ÂêàÊàêËÉΩÈáèÊâÄ ÈúÄÁöÑÈÖµÁ¥†Ôºå‰ΩøËü≤È´îÁÑ°Ê≥ïÁç≤ÂæóËÉΩÈáèËÄåÊ≠ª‰∫°„ÄÇ</description></item><item><title>Lidocaine</title><link>https://www.physician.tw/Lidocaine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lidocaine/</guid><description>Lidocaine 1.0~1.5mg/kg 2% 50kg 75mg ËÉñ‰∏ÄÈªûÁöÑ100mg</description></item><item><title>Likelihood of ACS Circ 2007 116 e148 Circ 1994 90 1 613 22</title><link>https://www.physician.tw/Likelihood-of-ACS-Circ-2007-116-e148-Circ-1994-90-1-613-22-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Likelihood-of-ACS-Circ-2007-116-e148-Circ-1994-90-1-613-22-/</guid><description>Likelihood of ACS Circ 2007 116 e148 Circ 1994 90 1 613 22 | Feature | High (any of below) | Intermediate (no high features, any of below) | Low (no high/inter.</description></item><item><title>lipid disorders</title><link>https://www.physician.tw/lipid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lipid-disorders/</guid><description>lipid disorders [[Measurements-lipid disorders]] [[dyslipidemias]] [[Drug Treatment-lipid disorders]] [[Treatment of LDL-C]] (Lancet 2014;384:607) [[Treatment of other lipid fractions]] (Lancet 2014;384:618 &amp;amp; 626) [[2018 ACC AHA Cholesterol Guidelines]] (Circ 2019;139:e1082) [[statins actions, side effects, and administration]]</description></item><item><title>Lithium-toxicology</title><link>https://www.physician.tw/Lithium-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lithium-toxicology/</guid><description>Lithium-toxicology N/V/D, tremor, hyperreflexia, clonus, drowsiness, seizure, ‚Üë QT, AV block, bradycardia
IVF (NS), maintain UOP
Consider hemodialysis</description></item><item><title>Localization of MI</title><link>https://www.physician.tw/Localization-of-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Localization-of-MI/</guid><description>Localization of MI Anatomic Area ECG Leads w/ STE Coronary Artery Septal V1‚ÄìV2 ¬± aVR Proximal LAD Anterior V3‚ÄìV4 LAD Apical V5‚ÄìV6 Distal LAD, LCx, or RCA Lateral I, aVL LCx Inferior II, III, aVF ¬± aVR RCA (~85%), LCx (~15%) RV V1‚ÄìV2 &amp;amp; V4R (most Se) Proximal RCA Posterior ST depression V1‚ÄìV3 (= STE V7‚ÄìV9 posterior leads, ‚úì if clinical suspicion) RCA or LCx</description></item><item><title>Long-term anticoagulation options-venous thromboembolism</title><link>https://www.physician.tw/Long-term-anticoagulation-options-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Long-term-anticoagulation-options-venous-thromboembolism/</guid><description>Long-term anticoagulation options-venous thromboembolism For nonpregnant Pt without severe renal dysfunction or active cancer ‚Üí DOAC
For severe renal insufficiency or APLAS ‚Üí warfarin.</description></item><item><title>Long-term follow-up of Migraine</title><link>https://www.physician.tw/Long-term-follow-up-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Long-term-follow-up-of-Migraine/</guid><description>Long-term follow-up of Migraine Manage migraine long-term in primary care Repatriate patients from specialist care in a timely manner and with a comprehensive treatment plan Maintain stability of effective treatment in primary care and react to change</description></item><item><title>Long-term management-wide-complex tachycardias WCTS</title><link>https://www.physician.tw/Long-term-management-wide-complex-tachycardias-WCTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Long-term-management-wide-complex-tachycardias-WCTS/</guid><description>Long-term management-wide-complex tachycardias (WCTS) (EHJ 2015;36:2793; Circ 2018;138:e272; NEJM 2019;380:1555)
Workup: echo to ‚úì LV fxn, cath or stress test to r/o ischemia, ?</description></item><item><title>Loop diuretics</title><link>https://www.physician.tw/Loop-diuretics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Loop-diuretics/</guid><description>Loop diuretics (NEJM 2017;377:1964)
Drugs: furosemide (Lasix), torsemide, bumetanide (Bumex), ethacrynic acid [[Mechanisms-Loop diuretics]] Dosing: bioavailability PO furosemide ~50%, PO torsemide &amp;amp; bumetanide ~90% 40 mg IV = 80 mg PO Lasix = 20 mg PO/IV torsemide = 1 mg IV/PO bumetanide Dose furosemide bid-qid; qd dosing can yield initial diuresis, but then anti-natriuresis.</description></item><item><title>Low-voltage</title><link>https://www.physician.tw/Low-voltage/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Low-voltage/</guid><description>Low-voltage QRS amplitude (R + S) &amp;lt;5 mm in all limb leads &amp;amp; &amp;lt;10 mm in all precordial leads</description></item><item><title>lumbar puncture after brain imaging</title><link>https://www.physician.tw/lumbar-puncture-after-brain-imaging/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lumbar-puncture-after-brain-imaging/</guid><description>lumbar puncture after brain imaging A computed tomography (CT) scan of the head is frequently ordered by clinicians prior to performing a lumbar puncture (LP) to rule out an intracranial abnormality with elevated intracranial pressure</description></item><item><title>lung cancer</title><link>https://www.physician.tw/lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lung-cancer/</guid><description>lung cancer</description></item><item><title>lung transplant</title><link>https://www.physician.tw/lung-transplant/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lung-transplant/</guid><description>lung transplant Overview Indications: end stage, progressive decline despite max medical Rx, &amp;lt;2-y life expectancy; COPD, ILD (IPF), pulmonary HTN, cystic fibrosis, alpha 1-antitrypsin Contraindic: age &amp;gt;70, uncontrolled/unRx‚Äôd infxn, malig in prior 5 yrs, severe non-pulm dis.</description></item><item><title>LV failure</title><link>https://www.physician.tw/LV-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/LV-failure/</guid><description>LV failure Diurese to achieve PCWP ~14 ‚Üí ‚Üì pulmonary edema, ‚Üì myocardial O2 demand ‚Üì Afterload ‚Üí ‚Üë stroke volume &amp;amp; CO, ‚Üì myocardial O2 demand.</description></item><item><title>lymphadenopathy</title><link>https://www.physician.tw/lymphadenopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lymphadenopathy/</guid><description>lymphadenopathy Viral HIV, EBV, CMV, HSV, VZV, hepatitis, measles, rubella
Bacterial Generalized (brucellosis, leptospirosis, TB, atypical mycobacteria, syphilis)
Localized (streptococci, staphylococci, cat-scratch disease, tularemia)</description></item><item><title>Lymphocytic pleocytosis</title><link>https://www.physician.tw/Lymphocytic-pleocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lymphocytic-pleocytosis/</guid><description>Lymphocytic pleocytosis Lymphocytic [[pleocytosis]] is an abnormal increase in the amount of lymphocytes in the cerebrospinal fluid (CSF)</description></item><item><title>lymphocytosis</title><link>https://www.physician.tw/lymphocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lymphocytosis/</guid><description>lymphocytosis (&amp;gt;4000‚Äì5000/¬µL)
Infection Usually viral; ‚Äúatypical lymphocytes‚Äù with mononucleosis syndromes Other: pertussis, toxoplasmosis
Hypersensitivity Drug-induced, serum sickness
Autoimmune Rheumatoid arthritis (large granular lymphocytes), malignant thymoma</description></item><item><title>macos config</title><link>https://www.physician.tw/macos-config/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/macos-config/</guid><description>macos config MACOS CATALINA 10.15 Á¨¨‰∏âÊñπËΩØ‰ª∂Êñá‰ª∂ÊèêÁ§∫Â∑≤ÊçüÂùèËß£ÂÜ≥ÂäûÊ≥ï macOS 10.15 ÂêéÔºåËãπÊûúÂä†Âº∫‰∫ÜÂØπÁ¨¨‰∏âÊñπÊ∏†ÈÅì‰∏ãËΩΩËΩØ‰ª∂ÁöÑËØÅ‰π¶Ê†°È™åÔºåÂØπ‰∫éÊó†ËØÅ‰π¶ÁöÑÂ∫îÁî®Ôºå‰∏çÂÖÅËÆ∏ÊâìÂºÄ„ÄÇÂèØ‰ª•ËØïËØï‰ΩøÁî®‰∏ãÈù¢ÂëΩ‰ª§Ôºö
1 sudo xattr -r -d com.apple.quarantine xxx.app</description></item><item><title>macrocytic anemias</title><link>https://www.physician.tw/macrocytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/macrocytic-anemias/</guid><description>macrocytic anemias includes megaloblastic and nonmegaloblastic causes
[[Megaloblastic anemia]] [[Folate deficiency]] [[Vitamin B12 deficiency]] [[Nonmegaloblastic macrocytic anemias]]</description></item><item><title>Major-risk-factor-modification-stable ischemic heart disease</title><link>https://www.physician.tw/Major-risk-factor-modification-stable-ischemic-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-risk-factor-modification-stable-ischemic-heart-disease/</guid><description>Major-risk-factor-modification-stable ischemic heart disease Lipids: statin (typically high-intensity) ¬± ezetimibe &amp;amp; PCSK9i (see ‚ÄúDyslipidemia‚Äù) BP &amp;lt;130/80 (see ‚ÄúHypertension‚Äù); in SIHD may opt for ACEI and Œ≤B (if angina) Diabetes management (qv): HbA1c ‚â§7% and consider GLP1RA or SGLT2i Smoking cessation; influenza vaccine Diet (‚Üë vegetables, fruits, whole grains; ‚Üì saturated fat, trans fatty acids, sweets, red meat, Na); target BMI 18.</description></item><item><title>Malabsorption</title><link>https://www.physician.tw/Malabsorption/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Malabsorption/</guid><description>Malabsorption (fatty; ‚Üë fecal fat, ‚Üë osmotic gap, ‚Üì diarrhea w/ fasting)
Defective mucosal absorption of nutrients b/c Œîs in: mucosal surface (surgical resection) or gen.</description></item><item><title>Malignancy workup-adrenal incidentalomas</title><link>https://www.physician.tw/Malignancy-workup-adrenal-incidentalomas/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Malignancy-workup-adrenal-incidentalomas/</guid><description>Malignancy workup-adrenal incidentalomas CT and MRI characteristics may suggest adenoma vs. carcinoma Benign features: unenhanced CT &amp;lt;10 Hounsfield units or CT contrast-medium washout &amp;gt;50% at 10 min; size &amp;lt;4 cm; smooth margins, homogenous and hypodense appearance; can follow such incidentalomas w/ periodic scans Suspicious features: size ‚â•4 cm or ‚Üë size on repeat scan; &amp;gt;10 Hounsfield units on CT, irregular margins, heterogeneous, dense or vascular appearance; h/o malignancy or young age.</description></item><item><title>Mallory-Weiss tear</title><link>https://www.physician.tw/Mallory-Weiss-tear/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mallory-Weiss-tear/</guid><description>Mallory-Weiss tear GE jxn lacerations due to vomiting ‚Üí ‚Üë intraabd pressure &amp;amp; shearing Often self-resolve; Rx‚Üí antiemetics, PPI, endoscopic therapy</description></item><item><title>management of Barrett‚Äôs esophagitis</title><link>https://www.physician.tw/management-of-Barretts-esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-of-Barretts-esophagitis/</guid><description>management of Barrett‚Äôs esophagitis PPI.
W/o dysplasia: surveillance EGD q3‚Äì5y.
Low-grade dysplasia: EGD q12mo; possible endoscopic eradication.
High-grade dysplasia: endoscopic eradication; consider chemoprophylaxis w/ high-dose PPI &amp;amp; ASA (Lancet 2018;392:400).</description></item><item><title>Management of hyperglycemia in inPts</title><link>https://www.physician.tw/Management-of-hyperglycemia-in-inPts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-hyperglycemia-in-inPts/</guid><description>Management of hyperglycemia in inPts (for ICU: see ‚ÄúSepsis‚Äù) (Clin Ther 2013;35:724)
[[Hyperglycemic Emergencies]] (Endocrinology)
Identify reversibl causes/precipitants (dextrose IVF, glucocorticoids, postop, ‚Üë carb diet)</description></item><item><title>Management of ICU patient-pulmonary hypertension</title><link>https://www.physician.tw/Management-of-ICU-patient-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-ICU-patient-pulmonary-hypertension/</guid><description>Management of ICU patient-pulmonary hypertension Avoid tachyarrhythmias &amp;amp; overly aggressive volume resuscitation
Caution w/ vasodilators if any L-sided dysfunction</description></item><item><title>Management-acute liver failure</title><link>https://www.physician.tw/Management-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-acute-liver-failure/</guid><description>Management-acute liver failure (J Clin Exp Hepatol 2015;5:S104; Gastro 2017;152:644)
ICU care at liver transplant center for hemodynamic &amp;amp; ventilatory support; CVVH for AKI</description></item><item><title>management-inflammatory bowel disease</title><link>https://www.physician.tw/management-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-inflammatory-bowel-disease/</guid><description>management-inflammatory bowel disease (Lancet 2017;398:1756; Mayo 2017;92:1088)
[[Initial evaluation-management-inflammatory bowel disease]] Goals of treatment (Ther Adv Gastro 2015;8:143)
Induce remission of acute flare ‚Üí maintain remission; mucosal healing 1¬∞ goal Step-up Rx (least ‚Üí most toxic) vs.</description></item><item><title>Management-solitary pulmonary nodule</title><link>https://www.physician.tw/Management-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-solitary-pulmonary-nodule/</guid><description>Management-solitary pulmonary nodule Low risk (&amp;lt;5%): serial CT (freq depending on risk); shared decision w/ Pt re: bx</description></item><item><title>Managing complications of Migraine</title><link>https://www.physician.tw/Managing-complications-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Managing-complications-of-Migraine/</guid><description>Managing complications of Migraine Identify comorbid conditions Select drugs and adiust their use according to comorbidities present Alleviate comborbidities if possible to improve outcome</description></item><item><title>Managing complications-acute kidney injury AKI</title><link>https://www.physician.tw/Managing-complications-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Managing-complications-acute-kidney-injury-AKI/</guid><description>Managing complications-acute kidney injury (AKI) May take 1‚Äì3 wk to recover from ATN; anticipate volume overload, ‚Üë K, ‚Üë PO4, acidosis</description></item><item><title>Managing migraine in special populations</title><link>https://www.physician.tw/Managing-migraine-in-special-populations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Managing-migraine-in-special-populations/</guid><description>Managing migraine in special populations Older people Secondary headache, comorbidities and adverse events are all more likely Poor evidence base for all drugs in this age group Children and adolescents Be aware that presentation can differ from migraine in adults Parents and schools have important roles in the management of young children Bed rest alone can be sufficient Use ibuprofen for acute treatment and propranolol, amitriptyline or topiramate for prevention Women who are pregnant or breastfeeding Use paracetamol for acute treatment Avoid preventive treatment if possible Women with menstrual migraine Perimenstrual preventive therapy with long-acting NSAID or triptan</description></item><item><title>Markdownify</title><link>https://www.physician.tw/Markdownify/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Markdownify/</guid><description>To import a URL as Markdown, turn on the option under &amp;ldquo;Editing&amp;rdquo; in nvALT&amp;rsquo;s Preferences. Now, when you drag a URL to the notes list, it will convert it to Markdown as much as possible.</description></item><item><title>MASCC Risk Index</title><link>https://www.physician.tw/MASCC-Risk-Index/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/MASCC-Risk-Index/</guid><description>MASCC Risk Index Use in neutropenic patients (see ANC calculator) with fever at least 100.4¬∞F (38¬∫C). Do not use in patients with acute leukemia undergoing induction chemotherapy or allogeneic hematopoietic stem cell transplant conditioning, per IDSA guidelines.</description></item><item><title>Massive transfusion</title><link>https://www.physician.tw/Massive-transfusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Massive-transfusion/</guid><description>Massive transfusion Large-vol. PRBC ‚Üí ‚Üì Ca, ‚Üë K, ‚Üì plt, ‚Üë coags; initial ratio of 1 PRBC: 1 plt:1 FFP accepted but controversial, follow labs (JAMA Surg 2017;152:574).</description></item><item><title>Measure plasma osmolality</title><link>https://www.physician.tw/Measure-plasma-osmolality/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Measure-plasma-osmolality/</guid><description>Measure plasma osmolality Hypotonic (Posm &amp;lt;280) most common scenario; true excess of free H2O relative to Na
Isotonic (Posm 280‚Äì295): rare lab artifact from</description></item><item><title>Measure Uosm</title><link>https://www.physician.tw/Measure-Uosm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Measure-Uosm/</guid><description>Measure Uosm although useful for dx in limited circumstances, b/c almost always &amp;gt;300 Uosm &amp;lt;100 in ‚Üë H2O intake (1o polydipsia) or ‚Üì solute intake (beer potomania, ‚Äútea &amp;amp; toast‚Äù)</description></item><item><title>Measurements-lipid disorders</title><link>https://www.physician.tw/Measurements-lipid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Measurements-lipid-disorders/</guid><description>Measurements-lipid disorders ËÖ∞Âúç: È´îÈáç*1/2 from ileic creast
Lipoproteins = lipid core (cholesteryl esters &amp;amp; triglycerides) + phospholipid surface + proteins.</description></item><item><title>Mechanical complications</title><link>https://www.physician.tw/Mechanical-complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanical-complications/</guid><description>Mechanical complications Mechanical complications (incid. &amp;lt;1% for each; typically occur a few days post-MI)
Free wall rupture: ‚Üë risk w/ lysis, large MI, ‚Üë age, ‚ôÄ, HTN; p/w PEA or hypoTN, pericardial sx, tamponade; Rx: volume resusc.</description></item><item><title>Mechanical intervention-venous thromboembolism</title><link>https://www.physician.tw/Mechanical-intervention-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanical-intervention-venous-thromboembolism/</guid><description>Mechanical intervention-venous thromboembolism (JACC 2020;76:2117)
[[catheter-directed pharmacomech]]
Catheter-based clot extraction (eg, AngioVac or FlowTriever): ‚Üì PA pressure</description></item><item><title>mechanical ventilation</title><link>https://www.physician.tw/mechanical-ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mechanical-ventilation/</guid><description>mechanical ventilation [[indications-mechanical ventilation]]
supportive strategies prior to intub. or after extub. [[oxygen delivery systems]] [[Noninvasive Positive Pressure Ventilation (NPPV)]] ventilator management [[Ventilator Modes and Principles]] [[Volume or Pressure Targeted]] [[Variables on the Ventilator]] [[Tailoring the ventilator settings]] [[Acute ventilatory deterioration (usually elevated PIP)]] [[Liberating from the ventilator]] [[Complications-mechanical ventilation]]</description></item><item><title>Mechanical-prosthetic-heart-valves</title><link>https://www.physician.tw/Mechanical-prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanical-prosthetic-heart-valves/</guid><description>Mechanical-prosthetic-heart-valves Bileaflet (eg, St. Jude Medical); tilting disk; caged-ball Very durable (20‚Äì30 y), but thrombogenic and ‚à¥ require anticoagulation consider if age &amp;lt;50 y or if anticoagulation already indicated (JACC 2010;55:2413)</description></item><item><title>Mechanisms and Etiologies of Platelet Function Abnormalities</title><link>https://www.physician.tw/Mechanisms-and-Etiologies-of-Platelet-Function-Abnormalities/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-and-Etiologies-of-Platelet-Function-Abnormalities/</guid><description>Mechanisms and Etiologies of Platelet Function Abnormalities</description></item><item><title>mechanisms of hypophosphatemia</title><link>https://www.physician.tw/mechanisms-of-hypophosphatemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mechanisms-of-hypophosphatemia/</guid><description>mechanisms of hypophosphatemia Intracellular uptake of phosphate from the extracellular fluid #anki acute respiratory alkalosis: increased intracellular pH stimulates phosphofructokinase activity and glycolysis which leads to intracellular uptake of phosphate; hyperventilation (caused for example by sepsis, anxiety, diabetic ketoacidosis, or other underlying conditions) can precipitate intracellular shift of phosphate into cells; refeeding of malnourished patients; administration of insulin or glucose (which stimulates insulin secretion); hungry bone syndrome.</description></item><item><title>Mechanisms-Loop diuretics</title><link>https://www.physician.tw/Mechanisms-Loop-diuretics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-Loop-diuretics/</guid><description>Mechanisms-Loop diuretics inhib NaK2Cl cotransporter in thick ascending limb (ThAL, site of 25% Na reabsorp) ‚Üí ‚Üì medullary osmotic gradient &amp;amp; ‚Üì free H2O reabsorption via ADH</description></item><item><title>Meckel‚Äôs diverticulum</title><link>https://www.physician.tw/Meckels-diverticulum/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Meckels-diverticulum/</guid><description>Meckel‚Äôs diverticulum Congenital intestinal pouch due to incomplete obliteration of vitelline duct. 2% of pop, w/in 2‚Ä≤ of IC valve, 2‚Ä≥ long, ‚ôÇ:‚ôÄ 2:1, can present as obscure GIB in adults.</description></item><item><title>Medical Therapy for IBD</title><link>https://www.physician.tw/Medical-Therapy-for-IBD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medical-Therapy-for-IBD/</guid><description>Medical Therapy for IBD (NEJM 2021;385:1302)
[[Medical Therapy of Ulcerative Colitis]] [[Medical Therapy of Crohn‚Äôs Disease]]</description></item><item><title>Medical Therapy of Crohn‚Äôs Disease</title><link>https://www.physician.tw/Medical-Therapy-of-Crohns-Disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medical-Therapy-of-Crohns-Disease/</guid><description>Medical Therapy of Crohn‚Äôs Disease Mild Oral 5-ASA: for colonic Crohn‚Äôs disease
Symptom control: loperamide/cholestyramine for diarrhea management.</description></item><item><title>Medical Therapy of Ulcerative Colitis</title><link>https://www.physician.tw/Medical-Therapy-of-Ulcerative-Colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medical-Therapy-of-Ulcerative-Colitis/</guid><description>Medical Therapy of Ulcerative Colitis Mild Rectal mesalamine or glucocorticoids as suppository or enema Mild- moderate Oral 5-ASA: many formulations (sulfasalazine, mesalamine, olsalazine, balsalazide) depending on disease location.</description></item><item><title>Medication causes of abnormal LFTs</title><link>https://www.physician.tw/Medication-causes-of-abnormal-LFTs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medication-causes-of-abnormal-LFTs/</guid><description>Medication causes of abnormal LFTs</description></item><item><title>Medullary thyroid cancer</title><link>https://www.physician.tw/Medullary-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medullary-thyroid-cancer/</guid><description>Medullary thyroid cancer Neuroendocrine tumor of C cells, peak incidence 40 to 60 y, a/w MEN2A and MEN2B Most commonly solitary nodule; calcitonin production (presents with diarrhea, flushing) and level used to trend dz progression, dx w/ FNA (Se 50‚Äì80%); mortality 25‚Äì50% at 5 y Surgery first-line treatment</description></item><item><title>Megaloblastic anemia</title><link>https://www.physician.tw/Megaloblastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Megaloblastic-anemia/</guid><description>Megaloblastic anemia Impaired DNA synthesis ‚Üí cytoplasm matures faster than nucleus ‚Üí ineffective erythropoiesis and macrocytosis; due to folate or B12 deficiency; also in MDS</description></item><item><title>Membranoproliferative GN</title><link>https://www.physician.tw/Membranoproliferative-GN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Membranoproliferative-GN/</guid><description>Membranoproliferative GN (5%, mixed nephrotic/nephritic features; CJASN 2014;9:600)
Immune complex mediated: infection (esp. HCV ¬± cryos, IE, HBV, ‚Äúshunt‚Äù nephritis, other chronic infxns), SLE, cryos, Sj√∂gren‚Äôs, lymphomas, dysproteinemia, idiopathic</description></item><item><title>Membranous nephropathy</title><link>https://www.physician.tw/Membranous-nephropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Membranous-nephropathy/</guid><description>Membranous nephropathy (30%; CJASN 2017;12:938, JASN 2021;32:268):
Primary: Ab to PLA2R [70%], THSD7A [5%], other (EXT1-2, NELL1, Sema3B)
Secondary: infxn (HBV, HCV, HIV, syphilis) autoimmune (eg, SLE) carcinomas drugs (NSAIDs, penicillamine).</description></item><item><title>mental health</title><link>https://www.physician.tw/mental-health/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mental-health/</guid><description>mental health</description></item><item><title>Mesangial proliferative GN</title><link>https://www.physician.tw/Mesangial-proliferative-GN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mesangial-proliferative-GN/</guid><description>Mesangial proliferative GN (? atypical forms of MCD/FSGS, 5%) IgM, C1q nephropathy</description></item><item><title>metabolic-acidosis</title><link>https://www.physician.tw/metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metabolic-acidosis/</guid><description>metabolic-acidosis Initial workup (NEJM 2014;371:1434) CPS [[Metabolic Acidosis: Overview]]
‚úì [[anion gap]]
[[Etiologies-of-AG-Metabolic-Acidosis]]
[[Workup-for-AG-metabolic-acidosis]] (AJKD 2021;78:A16)</description></item><item><title>metabolic-alkalosis</title><link>https://www.physician.tw/metabolic-alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metabolic-alkalosis/</guid><description>metabolic-alkalosis [[Metabolic Alkalosis A Brief Pathophysiologic Review]] [[Pathophysiology-metabolic-alkalosis]] [[Etiologies-of-Metabolic-Alkalosis]] Workup metabolic alkalosis Check volume status and UCl UCl &amp;lt;25 mEq/L ‚Üí saline responsive UCl &amp;gt;40 mEq/L ‚Üí saline resistant (unless currently receiving diuretics) (UNa unreliable determinant of volume status in alkalemia ‚Üí ‚Üë HCO3- excretion ‚Üí ‚Üë Na excretion; negatively charged HCO3- w/ Na+ maintaining electrical neutrality) If UCl &amp;gt;40 and volume replete, ‚úì UK; UK &amp;lt;20 laxative abuse; UK &amp;gt;30, ‚úì blood pressure Treatment of severe metabolic alkalosis (pH &amp;gt;7.</description></item><item><title>metastatic esophageal cancer</title><link>https://www.physician.tw/metastatic-esophageal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metastatic-esophageal-cancer/</guid><description>metastatic esophageal cancer trial after fluropyrimidine and platinum-based chemotherapy
[[KEYNOTE-181]] [[ATTRACTION-3]] [[CPS-22C3]] [[Dako 28-8]] [[Diagnostic and staging evaluation]]</description></item><item><title>Methanol-toxicology</title><link>https://www.physician.tw/Methanol-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Methanol-toxicology/</guid><description>Methanol-toxicology CNS depression, blindness
‚Üë AG &amp;amp; OG met. acidosis
Ethanol or fomepizole, NaHCO3
Consider hemodialysis</description></item><item><title>Methotrexate</title><link>https://www.physician.tw/Methotrexate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Methotrexate/</guid><description>Methotrexate MTX is a folic acid antagonist. DNA synthesis is inhibited by inhibition of dihydrofolate reductase, which provides reduced folates for purine synthesis.</description></item><item><title>methylprednisolone</title><link>https://www.physician.tw/methylprednisolone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/methylprednisolone/</guid><description>methylprednisolone [[acute respiratory distress syndrome]] IV (succinate): Loading dose of 1 mg/kg over 30 minutes, 1 to 14: 1 mg/kg/day in divided doses or as a continuous infusion.</description></item><item><title>MI in absence of obstructive CAD</title><link>https://www.physician.tw/MI-in-absence-of-obstructive-CAD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/MI-in-absence-of-obstructive-CAD/</guid><description>MI in absence of obstructive CAD Definition: MI but w/o coronary stenosis ‚â•50% in any major epicardial vessel More common in younger Pts, women, Black/Pacific race or Hispanic Advanced coronary imaging (eg, OCT) &amp;amp; cardiac MRI to exclude missed coronary obstruction, other causes of myocyte injury (eg, myocarditis), other causes of ‚Üë Tn (eg, PE) ~75% ischemic (ie, plaque disruption identified) and 25% alternative dx (eg, myocarditis)</description></item><item><title>Microangiopathic hemolytic anemia</title><link>https://www.physician.tw/Microangiopathic-hemolytic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microangiopathic-hemolytic-anemia/</guid><description>Microangiopathic hemolytic anemia (MAHA; NEJM 2014;371:654)
Intra-arteriolar fibrin damages RBCs ‚Üí acquired intravascular hemolysis
Etiologies: [[hemolytic-uremic syndrome]] (HUS), [[thrombotic thrombocytopenic purpura]] (TTP), [[disseminated intravascular coagulation]] (DIC), malignancy, malignant HTN, eclampsia/[[HELLP]], mech.</description></item><item><title>Microbiology and severity-diabetic foot infections</title><link>https://www.physician.tw/Microbiology-and-severity-diabetic-foot-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-and-severity-diabetic-foot-infections/</guid><description>Microbiology and severity-diabetic foot infections (CID 2004;39:885)
Mild (superficial ulcer, no involvement of deeper structures, surrounding erythema &amp;lt;2 cm, and no systemic illness): usually S.</description></item><item><title>Microbiology in Bacterial Meningitis</title><link>https://www.physician.tw/Microbiology-in-Bacterial-Meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-in-Bacterial-Meningitis/</guid><description>Microbiology in Bacterial Meningitis ÂÖ≠ÈöªÔºöS.N.H.L.E.S
(NEJM 2011;364:2016)
S. pneumoniae (30‚Äì60%) Look for preceding infection (bacteremia, pneumonia, endocarditis) Drug-resistant S. pneumoniae: ~40% PCN-resistant (even intermediate resistance problematic) ~&amp;lt;10% 3rd-gen.</description></item><item><title>Microbiology-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Microbiology-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-necrotizing-soft-tissue-infections/</guid><description>Microbiology-necrotizing soft-tissue infections Necrotizing soft tissue infections = NSTI
Type I: polymicrobial (mixed aerobes &amp;amp; anaerobes), typically in older Pts w/ above RFs.</description></item><item><title>Microbiology-of-Pneumonia</title><link>https://www.physician.tw/Microbiology-of-Pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-of-Pneumonia/</guid><description>Microbiology-of-Pneumonia Clinical Setting: CAP Etiologies No pathogen identified in 50‚Äì60%, virus alone in ~25%, bacteria alone in ~10%, virus-bacteria coinfection in &amp;lt;5% Viruses: influenza, RSV, hMPV, parainfluenza, rhinovirus, coronavirus S.</description></item><item><title>Microbiology-skin and soft tissue infections</title><link>https://www.physician.tw/Microbiology-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-skin-and-soft-tissue-infections/</guid><description>Microbiology-skin and soft tissue infections ÁöÆËÜöÂíåËªüÁµÑÁπîÊÑüÊüì (SSTI) ÂæàÂ∏∏Ë¶ãÔºåÁØÑÂúçÂæûËºïÂ∫¶ËúÇÁ™©ÁµÑÁπîÁÇéÂà∞Âç±ÂèäÁîüÂëΩÁöÑÂ£ûÊ≠ªÊÄßËªüÁµÑÁπîÊÑüÊüì (NSTI)„ÄÇÈóúÈçµÁöÑÁÆ°ÁêÜËÄÉÊÖÆÂõ†Á¥†ÂåÖÊã¨ÂÅöÂá∫Ê∫ñÁ¢∫ÁöÑË®∫Êñ∑„ÄÅË©ï‰º∞ÊÑüÊüìÁöÑÂåñËÜøÊÄßÂíåÂö¥ÈáçÁ®ãÂ∫¶Ôºå‰ª•ÂèäÈÅ∏ÊìáÊäóÁîüÁ¥†‰ª•ÈáùÂ∞çÊúÄÂèØËÉΩÁöÑÂæÆÁîüÁâ©„ÄÇÂú®Êú¨ÁØÄ‰∏≠ÔºåÊàëÂÄëÂ∞á‰ªãÁ¥π‰ª•‰∏ãÁñæÁóÖÁöÑË®∫Êñ∑ÂíåÊ≤ªÁôÇ
(CID 2014;59:e10)
Purulent: MRSA (NEJM 2006;355:666) causes up to 75% of purulent skin/soft tissue infections, followed by MSSA and strep Non-purulent: Strep, MSSA, aerobic GNRs.</description></item><item><title>Microbiology-urinary tract infections</title><link>https://www.physician.tw/Microbiology-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-urinary-tract-infections/</guid><description>Microbiology-urinary tract infections Uncomplicated: E. coli (80%), [[S saprophyticus]] (CID 2004;39:75). Proteus Klebsiella
In healthy, nonpregnant women: lactobacilli, enterococci, Group B strep, and coag-neg staph (except S.</description></item><item><title>microcytic anemias</title><link>https://www.physician.tw/microcytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/microcytic-anemias/</guid><description>microcytic anemias [[Approach to microcytic anemias]] [[Iron deficiency]] [[Thalassemias]] [[Sideroblastic anemia]]</description></item><item><title>Microscopic polyangiitis</title><link>https://www.physician.tw/Microscopic-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microscopic-polyangiitis/</guid><description>Microscopic polyangiitis Necrotizing vasculitis commonly involving lung, kidneys, and skin with pauci-immune glomerulonephritis and palpable purpura. Presentation similar to granulomatosis with polyangiitis Similar to GPA, but w/o ENT/upper airway involvement &amp;amp; nongranulomatous Epidemiology: incidence 4/million/y.</description></item><item><title>Migraine</title><link>https://www.physician.tw/Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Migraine/</guid><description>Migraine Â∞èÈ∫ªÂÖßÂÆπ [[Definition and clinical manifestations of Migraine]] [[Treatment of Migraine]] (Lancet 2021;397:1505 &amp;amp; Continuum 2021;27:613) Step 1: [[When to suspect migraine]] Step 2: [[Diagnosis of migraine]] Step 3: [[Education and patient centricity]] Step 4: [[Acute treatment of Migraine]] Step 5: [[Preventive treatment of Migraine]] Step 6: [[Managing migraine in special populations]] Step 7: [[Follow-up, treatment response and failure of Migraine]] Step 8: [[Managing complications of Migraine]] Step 9: [[Recognizing and managing comorbidities of Migraine]] Step 10: [[Long-term follow-up of Migraine]]</description></item><item><title>Migraine with aura</title><link>https://www.physician.tw/Migraine-with-aura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Migraine-with-aura/</guid><description>Migraine with aura [[aura]]
Approximately one third of individuals with migraine experience aura, either with every attack or with some attacks.</description></item><item><title>Migraine without aura</title><link>https://www.physician.tw/Migraine-without-aura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Migraine-without-aura/</guid><description>Migraine without aura Migraine without aura is characterized by recurrent headache attacks that last 4‚Äì72 h. Typical features of an attack include a unilateral location, pulsating quality, moderate or severe pain intensity, and aggravation by routine physical activity,</description></item><item><title>Milk-alkali syndrome</title><link>https://www.physician.tw/Milk-alkali-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Milk-alkali-syndrome/</guid><description>Milk-alkali syndrome ‰π≥ÈπºÁ∂úÂêàÂæµÁî±È´òÈà£Ë°ÄÁóá„ÄÅ‰ª£Ë¨ùÊÄßÈπº‰∏≠ÊØíÂíåËàáÊîùÂÖ•Â§ßÈáèÈà£ÂíåÂèØÂê∏Êî∂ÈπºÁõ∏ÈóúÁöÑÊÄ•ÊÄßËÖéÊêçÂÇ∑‰∏âËÅØÂæµÁµÑÊàê„ÄÇ Ë©≤Á∂úÂêàÂæµÊúÄÂàùËàá‰ΩøÁî®ÁâõÂ•∂ÂíåÁ¢≥ÈÖ∏Ê∞´ÈàâÊ≤ªÁôÇÊ∂àÂåñÊÄßÊΩ∞ÁòçÁñæÁóÖÊúâÈóú[1]„ÄÇ ÁâõÂ•∂-ÈπºÁ∂úÂêàÂæµÊõæÁ∂ìÊòØÈ´òÈà£Ë°ÄÁóáÁöÑÂÖ∏ÂûãÁóÖÂõ†Ôºå‰ΩÜÈö®ËëóÊ∂àÂåñÊÄßÊΩ∞ÁòçÁóÖÊñ∞ÁôÇÊ≥ïÁöÑÂá∫ÁèæÂπæ‰πéÊ∂àÂ§±‰∫ÜÔºå‰∏¶‰∏îË¢´Ë™çÁÇ∫ÊòØÂ∞éËá¥È´òÈà£Ë°ÄÁóáÁóÖ‰æã‰∏çÂà∞ 1% ÁöÑÂéüÂõ† ‰∏âÂÄãÂõ†Á¥†ÊòØÈÄ†ÊàêÈÄôÁ®ÆÁôºÁóÖÁéáÂ¢ûÂä†ÁöÑÂéüÂõ†Ôºö - ÈáçË¶ñÈà£ÁôÇÊ≥ïÂ∞çÈ™®Ë≥™ÁñèÈ¨ÜÁóáÁöÑÈò≤Ê≤ª„ÄÇ - ÁèæÊàêÁöÑÈùûËôïÊñπÁ¢≥ÈÖ∏Èà£Ë£ΩÂäë„ÄÇ - ‰ΩøÁî®Á¢≥ÈÖ∏Èà£‰ª•Ê∏õÂ∞ëÊÖ¢ÊÄßËÖéÁóÖÊÇ£ËÄÖÁπºÁôºÊÄßÁî≤ÁãÄÊóÅËÖ∫ÂäüËÉΩ‰∫¢ÈÄ≤ÔºàÂèÉË¶ã‚ÄúÊàê‰∫∫ÊÖ¢ÊÄßËÖéÁóÖÈ´òÁ£∑Ë°ÄÁóáÁöÑÁÆ°ÁêÜ‚ÄùÔºâ</description></item><item><title>Minimal change disease</title><link>https://www.physician.tw/Minimal-change-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Minimal-change-disease/</guid><description>Minimal change disease (20%, more common in children; CJASN 2017;12:332) allergies, NSAIDs, ampicillin, Hodgkin‚Äôs disease, SLE, DM, MG, celiac disease</description></item><item><title>mitral-regurgitation</title><link>https://www.physician.tw/mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mitral-regurgitation/</guid><description>mitral-regurgitation [[Etiology-mitral-regurgitation]] (NEJM 2010;363:156 &amp;amp; 2020;383:1458) [[Clinical-manifestations-mitral-regurgitation]] [[Physical-exam-mitral-regurgitation]] [[Diagnostic-studies-mitral-regurgitation]] (Circ 2021;143:e72) [[Treatment-mitral-regurgitation]] (Circ 2021;143:e72)</description></item><item><title>mitral-stenosis</title><link>https://www.physician.tw/mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mitral-stenosis/</guid><description>mitral-stenosis [[Etiology-mitral-stenosis]] (Lancet 2012;379:953) [[Clinical manifestations-mitral-stenosis]] (Lancet 2009;374:1271) [[Physical exam-mitral-stenosis]] [[Diagnostic studies-mitral-stenosis]] [[Treatment-mitral-stenosis]] (Lancet 2016;387:1324; Circ 2021;143:e72)</description></item><item><title>mitral-valve-prolapse</title><link>https://www.physician.tw/mitral-valve-prolapse/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mitral-valve-prolapse/</guid><description>mitral-valve-prolapse Definition and Etiology
Billowing of MV leaflet ‚â•2 mm above mitral annulus in parasternal long axis echo view Primary: sporadic or familial myxomatous proliferation of spongiosa of MV apparatus Secondary: trauma, endocarditis, congenital, CTD (eg, Marfan‚Äôs, OI, Ehlers-Danlos) Clinical manifestations (usually asymptomatic) MR, endocarditis, emboli, arrhythmias (rarely SCD from VT from papillary muscle) High-pitched, midsystolic click (earlier w/ ‚Üì preload) ¬± mid-to-late systolic murmur No Rx per se [endocarditis Ppx not rec.</description></item><item><title>Mixed-disorders</title><link>https://www.physician.tw/Mixed-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-disorders/</guid><description>Mixed-disorders If compensation less or greater than predicted, may be two disorders: PaCO2 too low ‚Üí concomitant 1¬∞ resp. alk.</description></item><item><title>Modalities-renal replacement and dialysis</title><link>https://www.physician.tw/Modalities-renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Modalities-renal-replacement-and-dialysis/</guid><description>Modalities-renal replacement and dialysis [[Hemodialysis (HD)]] Physiology: Diffusion Access: AV fistula/graft or CVC Prescription: Duration, volume goal; K, Na, Ca, HCO3 in bath, anticoag Complic.</description></item><item><title>model for clinical reasoning</title><link>https://www.physician.tw/model-for-clinical-reasoning/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/model-for-clinical-reasoning/</guid><description>model for clinical reasoning Step 1: Identify the Problem Step 2: Frame the Differential Diagnosis Step 3: Organize the Differential Diagnosis Step 4: Limit the Differential Diagnosis Step 5: Explore Possible Diagnoses Using History and Physical Exam Findings Step 6: [[Rank the Differential Diagnosis]] Step 7: Test Your Hypotheses Step 8: Re-rank the Differential Based on New Data Step 9: Test the New Hypotheses</description></item><item><title>Modification to initial antibiotic regimen based on site-specific evaluation of fever and neutropenia</title><link>https://www.physician.tw/Modification-to-initial-antibiotic-regimen-based-on-site-specific-evaluation-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Modification-to-initial-antibiotic-regimen-based-on-site-specific-evaluation-of-fever-and-neutropenia/</guid><description>Modification to initial antibiotic regimen based on site-specific evaluation of fever and neutropenia Vancomycin only if HoTN, PNA, clinically apparent catheter-related or soft-tissue infxn, gram ‚äï BCx, mucositis + on quinolone Ppx; d/c when BCx ‚äñ √ó 48 h for GPCs Mouth/esoph (ulcer, thrush): anaerobic (if necrotizing), anti-HSV and/or antifungal Rx Sinus/nasal: add vanc if periorbital cellulitis, ampho if concern for Aspergillus/Mucor Abd pain/diarrhea: PO vanc if concern for C.</description></item><item><title>Modified Duke Criteria</title><link>https://www.physician.tw/Modified-Duke-Criteria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Modified-Duke-Criteria/</guid><description>Modified Duke Criteria Â§ßÁöÑ2.5ÂàÜ„ÄÅÂ∞èÁöÑ‰∏ÄÂàÜ„ÄÅÁ∏ΩÂàÜË¶Å‰∫îÂàÜ
Definitive: ‰∫îÂàÜ 2 major or 1 major + 3 minor or 0 major + 5 minor;</description></item><item><title>Molecular description of lymphoma</title><link>https://www.physician.tw/Molecular-description-of-lymphoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Molecular-description-of-lymphoma/</guid><description>Molecular description of lymphoma Marginal zone B cell lymphoma, MALT type IGH clonally rearranged t(11;18)
DLBCL IGH clonally rearranged t(8;14) c-myc-IGH t(14;18) IGH-BCL2</description></item><item><title>monocytosis</title><link>https://www.physician.tw/monocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/monocytosis/</guid><description>monocytosis (&amp;gt;500/¬µL)
Infection Usually TB, SBE, Listeria, Brucella, Rickettsia, fungi, parasites, syphilis
Inflammation IBD, sarcoidosis, collagen vascular diseases
Stress MI, splenectomy, exercise (Cytokine 2013;61:364)</description></item><item><title>Monomorphic ventricular tachycardia MMVT</title><link>https://www.physician.tw/Monomorphic-ventricular-tachycardia-MMVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Monomorphic-ventricular-tachycardia-MMVT/</guid><description>Monomorphic ventricular tachycardia (MMVT) All beats look similar; predominantly upward in V1 = RBBB-type vs. downward = LBBB-type In obviously structurally abnormal heart: prior MI (scar); CMP In apparently nl heart that is actually diseased: subtle HCM, infiltrative CMP, myocarditis, arrhythmogenic CMP (ACM): incomplete RBBB, Œµ wave (terminal notch in QRS) &amp;amp; TWI in V1‚ÄìV3 on resting ECG LBBB-type VT, dx w/ MRI (Lancet 2009;373:1289) In structurally normal heart w/ normal resting ECG &amp;amp; cardiac MRI: RVOT VT: LBBB-type VT or PVCs w/ inferior axis; typically ablate LVOT VT: RBBB-type VT or PVCs w/ superior axis; responds to verapamil</description></item><item><title>Mount-Sinai-Expert-Guides</title><link>https://www.physician.tw/Mount-Sinai-Expert-Guides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mount-Sinai-Expert-Guides/</guid><description>Mount-Sinai-Expert-Guides PART 1: BASIC TECHNIQUES AND PROCEDURES, 1 1 [[Airway-Management]], 3 2 Sedation and Analgesia, 10 3 Vascular Access, 17 4 Bedside Ultrasound, 26 5 Bronchoscopy, 37 6 Bedside Percutaneous Dilational Tracheostomy, 42 7 Nutritional Support and Total Parenteral Nutrition, 49 8 Glycemic Control, 55 9 Prevention of Complications, 62 10 Palliative Care, 68</description></item><item><title>muddy brown casts</title><link>https://www.physician.tw/muddy-brown-casts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/muddy-brown-casts/</guid><description>muddy brown casts Urine Sediment of the Month: Granular &amp;amp; &amp;ldquo;Muddy Brown&amp;rdquo; Casts - Renal Fellow Network
Â∞øÊ∂≤Ê≤âÁ©çÁâ©È°ØÁ§∫Â§öÁ®ÆÊ≥•ÊøòÁöÑÊ£ïËâ≤È°ÜÁ≤íÈëÑ‰ª∂„ÄÇ ÈÄô‰∫õÁôºÁèæÂº∑ÁÉàÊöóÁ§∫ËëóÊÄ•ÊÄßËÖéÊêçÂÇ∑ÊÇ£ËÄÖÔºàÊÄ•ÊÄßËÖéË°∞Á´≠ÔºâÁöÑÊÄ•ÊÄßÁÆ°ÁãÄÂ£ûÊ≠ª„ÄÇ</description></item><item><title>Multiple Endocrine Neoplasia</title><link>https://www.physician.tw/Multiple-Endocrine-Neoplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Multiple-Endocrine-Neoplasia/</guid><description>Multiple Endocrine Neoplasia Type Main Features
1 (MENIN inactiv.) Parathyroid hyperplasia/adenomas ‚Üí hypercalcemia (~100% penetrance) Pancreatic islet cell neoplasia (gastrin, VIP, insulin, glucagon) Pituitary adenomas (fxn or non-fxn)</description></item><item><title>Mx of ACLS Tachycardia Algorithm</title><link>https://www.physician.tw/Mx-of-ACLS-Tachycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mx-of-ACLS-Tachycardia-Algorithm/</guid><description>Mx of ACLS Tachycardia Algorithm adenosine 6 mg rapid IVP then 20-cc NS bolus, 12 mg IVP q2min 2 if needed</description></item><item><title>my report about irAE</title><link>https://www.physician.tw/my-report-about-irAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/my-report-about-irAE/</guid><description>https://docs.google.com/presentation/d/1JZhMp-Iv gJbsajKC7M-fHTpygJ3Or npNY85xAuhTg/edit?usp=sharing</description></item><item><title>myelodysplastic syndromes</title><link>https://www.physician.tw/myelodysplastic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myelodysplastic-syndromes/</guid><description>myelodysplastic syndromes see: [[pancytopenia]]
[[Myeloid neoplasm overview]]
[[WHO 2016 Classification of Myeloid Neoplasms and Acute Leukemia]]</description></item><item><title>Myelophthisic anemia</title><link>https://www.physician.tw/Myelophthisic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myelophthisic-anemia/</guid><description>Myelophthisic anemia (see also ‚ÄúPrimary Myelofibrosis‚Äù)
Infiltration of bone marrow by cancer (commonly metastatic solid tumors), leukemia, infection, fibrosis (primary myelofibrosis), granulomas, lysosomal storage disorders</description></item><item><title>myeloproliferative neoplasms</title><link>https://www.physician.tw/myeloproliferative-neoplasms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myeloproliferative-neoplasms/</guid><description>Ëä±ÂúíÂ§ßÈñÄÂè£
[[overview of myeloproliferative neoplasms]]
[[polycythemia vera (PV)]]
[[essential thrombocythemia (ET)]]
[[primary myelofibrosis (PMF)]]</description></item><item><title>myocarditis</title><link>https://www.physician.tw/MYOCARDITIS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/MYOCARDITIS/</guid><description>myocarditis Etiologies [[infectious myocarditis]]
[[autoimmune myocarditis]]
Clinical manifestations Highly variable, ranging from incidental dx based on labs/imaging to fulminant HF w/ shock Can present as ACS-like syndrome (chest pain, ECG Œîs, ‚Üë Tn), acute HF, arrhythmias Diagnostic studies and workup Echo: systolic dysfxn (typically global but can be regional); ¬± ‚Üë LV wall thickness due to edema; LV size may be small in fulminant and dilated in chronic; ¬± pericardial effusion Cardiac MRI: can show hyperemia, edema, and scar (JACC 2009;53:1475) Endomyocardial biopsy: useful in GCM &amp;amp; eosinophilic; ‚à¥ consider if rapidly progressive HF, high-grade AVB or sustained VT, suspected allergic rxn or eosinophilia Treatment Standard HF Rx if LV dysfxn (but do not start if e/o shock); temporary MCS as needed Immunosuppression: for GCM (high-dose steroids + CsA or tacrolimus ¬± AZA), collagen vascular disease, peripartum (?</description></item><item><title>myofascial pain syndrome</title><link>https://www.physician.tw/myofascial-pain-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myofascial-pain-syndrome/</guid><description>myofascial pain syndrome ‚ú®ÈáçÈªû: myofascial pain syndromeËÇåÁ≠ãËÜúÁñºÁóõÁ∂úÂêàÂæµË¢´ÂÆöÁæ©ÁÇ∫‰∏ÄÁ®ÆÂçÄÂüüÊÄßÁñºÁóõÁ∂úÂêàÂæµÔºåÂÖ∂ÁâπÂæµÊòØÂú®ÁπÉÁ∑äÁöÑËÇåËÇâÂ∏∂‰∏≠Â≠òÂú®Ëß∏ÁôºÈªûÂíåÂ±ÄÈÉ®Ê∑±ÈÉ®ËÇåËÇâÂ£ìÁóõÂçÄÂüü„ÄÇ Ëß∏ÁôºÈªû‰∏äÁöÑÂ£ìÂäõÊúÉÈáçÁèæÁñºÁóõ„ÄÇ Áõ∏ÊØî‰πã‰∏ãÔºåÁ∫ñÁ∂≠ËÇåÁóõÊòØ‰∏ÄÁ®ÆÂÖ®Ë∫´ÊÄßÁñºÁóõÁñæÁóÖÔºåËàáË∫´È´îÊâÄÊúâÂõõÂÄãÂÉèÈôêÁöÑÂ£ìÁóõÈªûÁõ∏ÈóúÔºå ÊåÅÁ∫åËá≥Â∞ë 3 ÂÄãÊúàÔºåÈÄöÂ∏∏‰º¥ÊúâÁù°Áú†ÈöúÁ§ô„ÄÅËÖ∏ÊòìÊøÄÁ∂úÂêàÂæµÂíåÊäëÈ¨±Áóá„ÄÇ Âú®ËÇåÁ≠ãËÜúÁñºÁóõÁ∂úÂêàÂæµ‰∏≠ÔºåÈÄô‰∫õÁõ∏ÈóúÁâπÂæµÊòéÈ°Ø‰∏çÈÇ£È∫ºÈ†ªÁπÅ„ÄÇ</description></item><item><title>Myxedema coma</title><link>https://www.physician.tw/Myxedema-coma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myxedema-coma/</guid><description>Myxedema coma Presentation: hypothermia, hypotension, hypoventilation, Œî MS (coma rare), hyponatremia, hypoglycemia; often precipitated by infxn or major cardiopulmonary or neurologic illness Treatment: supportive care most important.</description></item><item><title>myxoma</title><link>https://www.physician.tw/myxoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myxoma/</guid><description>myxoma ÈªèÊ∂≤Áò§„ÄçÔºàmyxomaÔºâÔºåËÑÇËÇ™Áò§Ë£°ÊòØËÑÇËÇ™Ôºå ËÄåÈªèÊ∂≤Áò§ÂâáÊòØ‰ª•ÈªèÊ∂≤Á¥†ÊàñÁ®±ÈªèËõãÁôΩÔºàmucinÔºâÁÇ∫‰∏ªË¶ÅÊàê‰ªΩÔºå ÊúÄÂ∏∏Ë¶ãÁöÑÊòØÈï∑Âú®ÂøÉËáüË£°Ôºå‰ΩÜ‰πüÊúÉÈï∑Âú®È™®È™º„ÄÅÊ≥åÂ∞øÁîüÊÆñÈÅìÔºåÂú®ÁöÆ‰∏ãÊàñÊòØÁöÆËÜö‰∏≠ÊØîËºÉÂ∞ëË¶ã„ÄÇ</description></item><item><title>Names for vasculitides</title><link>https://www.physician.tw/Names-for-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Names-for-vasculitides/</guid><description>Names for vasculitides [[other names for vasculitides]]
Immune complex SVV Anti-glomerular basement membrane (anti-GBM) disease Cryoglobulinemic vasculitis (CV) IgA vasculitis (Henoch-Sch√∂nlein) (IgAV) Hypocomplementemic urticarial vasculitis (HUV) (anti-C1g vasculitis)</description></item><item><title>narrow complex</title><link>https://www.physician.tw/narrow-complex/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/narrow-complex/</guid><description>narrow complex regular [[vagal maneuvers]] adenosine 6 12 12 ‚ò†Ô∏è ÂèØËÉΩÊúÉÊÉ°ÂåñÊàêVt converts: Likely AVNRT Or AVRT Rx recurrence w/ adenosine or long-acting AV nodal agent such as diltiazem or metoprolol does not convert: Possibly AFL, ATAC, NPUT Control rate w/ [[diltiazem]] or metoprolol or [[amiodarone]] 150 bolus drip 30min [[irregular of narrow complex]]</description></item><item><title>NCCN guideline</title><link>https://www.physician.tw/NCCN-guideline/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NCCN-guideline/</guid><description>NCCN guideline [[acute lymphoblastic leukemia]] acute myeloid leukemia ampullary adenocarcinoma [[anal carcinoma]] [[basal cell skin cancer]] B-cell lymphomas [[bladder cancer]] bone cancer breast cancer central nervous system cancers cervical cancer chronic lymphocytic leukemia small lymphocytic lymphoma chronic myeloid leukemia colon cancer dermatofibrosarcoma protuberans esophageal and esophagogastric junction cancers gastric cancer gastrointestinal stromal tumors (GIST) gestational trophoblastic neoplasia hairy cell leukemia head and neck cancers hepatobiliary cancers histiocytic neoplasms hodgkin lymphoma kaposi sarcoma kidney cancer malignant peritoneal mesothelioma malignant pleural mesothelioma melanoma cutaneous melanoma uveal merkel cell carcinoma multiple myeloma myelodysplastic syndromes myeloidlymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes myeloproliferative neoplasms neuroendocrine and adrenal tumors non-small cell lung cancer occult primary ovarian cancerfallopian tube cancerprimary peritoneal cancer pancreatic adenocarcinoma pediatric acute lymphoblastic leukemia pediatric aggressive mature B-cell lymphomas pediatric central nervous system cancers pediatric hodgkin lymphoma penile cancer primary cutaneous lymphomas prostate cancer rectal cancer small bowel adenocarcinoma small cell lung cancer soft tissue sarcoma squamous cell skin cancer systemic light chain amyloidosis systemic mastocytosis T-cell lymphomas testicular cancer thymomas and thymic carcinomas thyroid carcinoma uterine neoplasms vulvar cancer Waldenstr√∂m macroglobulinemia lymphoplasmacytic lymphoma Wilms tumor (Nephroblastoma)</description></item><item><title>necrotizing soft-tissue infections</title><link>https://www.physician.tw/necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/necrotizing-soft-tissue-infections/</guid><description>necrotizing soft-tissue infections (NEJM 2017;377:2253)
[[Definition-necrotizing soft-tissue infections]] [[Evolution of Necrotizing Fasciitis or Myonecrosis]] [[Microbiology-necrotizing soft-tissue infections]] [[Clinical manifestations-necrotizing soft-tissue infections]] [[Diagnosis-necrotizing soft-tissue infections]]</description></item><item><title>Neoplasm Etiologies of Classic FUO</title><link>https://www.physician.tw/Neoplasm-Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neoplasm-Etiologies-of-Classic-FUO/</guid><description>Neoplasm Etiologies of Classic FUO Lymphoma: LAN, HSM, ‚Üì Hct or plt, ‚Üë LDH; leukemia; myelodysplasia
Renal cell carcinoma: microscopic hematuria, ‚Üë Hct</description></item><item><title>nephrolithiasis</title><link>https://www.physician.tw/nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrolithiasis/</guid><description>nephrolithiasis [[Types of stones and risk factors]] [[Clinical manifestations-nephrolithiasis]] [[Workup-nephrolithiasis]] [[Acute treatment-nephrolithiasis]] [[Chronic treatment-nephrolithiasis]]</description></item><item><title>nephrology</title><link>https://www.physician.tw/nephrology-copy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-copy/</guid><description>nephrology [[acid-base disturbances]] [[sodium and water homeostasis]] [[potassium homeostasis]] [[kidney disease]] [[glomerular disease]] [[urinalysis]] [[nephrolithiasis]] Acute Kidney Injury (AKI) Chronic Kidney Disease (CKD) and End-Stage Kidney Disease (ESKD) Glomerular Diseases Disorders of Sodium Homeostasis Kidney Transplant Immunosuppression Kidney Stones Additional topics are covered in the following rotation guides:</description></item><item><title>nephrology</title><link>https://www.physician.tw/nephrology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology/</guid><description>Â∞øÊØíÁóáÔºåËÖéË°∞Á´≠Ôºå ÁóÖÁóáÂ§öÁ´ØÔºåÈúÄÈ´òÊòé„ÄÇ Ê∞¥Ê∂≤‰∏çÂπ≥ÔºåÈ´îÂÖßÊØíÁ¥†Ôºå ËÖéËáüÂÖßÁóÖÔºåËã¶Èõ£Â§ö„ÄÇ
nephrology Part 9:¬†[[Disorders of the Kidney and Urinary Tract]]
[[acid-base disturbances]] [[sodium and water homeostasis]] [[potassium homeostasis]] [[kidney disease]] [[glomerular disease]] [[urinalysis]] [[nephrolithiasis]] [[resident360]] Acute Kidney Injury (AKI) [[chronic kidney disease]] (CKD) and [[end-stage kidney disease]] (ESKD) [[Glomerular Diseases]] Disorders of Sodium Homeostasis [[Kidney]] Transplant Immunosuppression Kidney Stones Additional topics are covered in the following rotation guides: [[replenishers and regulators of water and electrolytes]] Acid/Base Disorders (Critical Care) Hypertension (Ambulatory Care) Urinary Tract Infection, Opportunistic Infections in Transplant (Infectious Diseases)</description></item><item><title>nephrotic syndrome</title><link>https://www.physician.tw/nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrotic-syndrome/</guid><description>nephrotic syndrome [[proteinuria]] [[Definition-nephrotic syndrome]] [[Primary glomerular diseases (grouped by pathology)]] [[Systemic diseases with secondary glomerular involvement]] [[Workup-nephrotic syndrome]] [[Treatment-nephrotic syndrome]] [[glomerular disease]]</description></item><item><title>Nervous System Dysfunction</title><link>https://www.physician.tw/Nervous-System-Dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nervous-System-Dysfunction/</guid><description>Nervous System Dysfunction Chapter 21: [[syncope]] Chapter 22: [[dizziness and vertigo]] Chapter 23: [[fatigue]] Chapter 24: [[neurologic causes of weakness and paralysis]] Chapter 25: [[numbness, tingling, and sensory loss]] Chapter 26: [[gait disorders, imbalance, and falls]] Chapter 27: [[Confusion and Delirium]] Chapter 28: [[coma]] Chapter 29: [[dementia]] Chapter 30: [[aphasia, memory loss, and other cognitive disorders]] Chapter 31: [[sleep disorders]]</description></item><item><title>neurologic critical care</title><link>https://www.physician.tw/neurologic-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-critical-care/</guid><description>neurologic critical care 26 Delirium 30 Intracranial Pressure and Neuromonitoring 31 Coma and Brain Death 32 Toxicology and Drug Reactions</description></item><item><title>Neurologic Psychologic-complications of HIV AIDS</title><link>https://www.physician.tw/Neurologic-Psychologic-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurologic-Psychologic-complications-of-HIV-AIDS/</guid><description>Neurologic Psychologic-complications of HIV AIDS Meningitis: Crypto (dx w/ CSF; serum CrAg 90% Se), bacterial (inc. Listeria), viral (HSV, CMV, 1¬∞ HIV), TB, histo, Coccidio, lymphoma; neurosyphilis (cranial nerve palsies) Space-occupying lesions: may present as HA, focal deficits or Œî MS.</description></item><item><title>neurology</title><link>https://www.physician.tw/neurology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology/</guid><description>neurology [[change in mental status]] [[seizures]] [[alcohol withdrawal]] [[dizziness]] [[stroke]] [[weakness and neuromuscular dysfunction]] [[headache]] [[back pain]] [[spinal cord compression]] [[nerve root compression]] [[head injury]] part 4: [[neurologic critical care]] [[neurology anatomy and physiology]]</description></item><item><title>Neuromuscular dysphagia</title><link>https://www.physician.tw/Neuromuscular-dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular-dysphagia/</guid><description>Neuromuscular dysphagia (solids &amp;amp; liquids; Neurogastero Motil 2021;33:e14058)
Caused by aberrant motility or innervation of oropharynx/esophagus Oropharyngeal: consider CNS disorders (eg, stroke, ALS, myopathies, CNS tumors) Esophageal: motility disorder w/ dysphagia, chest pain, GERD; dx: conventional or high-res manometry w/ esophageal pressure topography.</description></item><item><title>neutropenia</title><link>https://www.physician.tw/neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neutropenia/</guid><description>neutropenia (&amp;lt;1000/¬µL)
Congenital Myelokathexis, Shwachman-Diamond-Oski, Ch√©diak-Higashi, retic dysgen., WHIM syndrome, cyclic neutropenia, monoMAC syndrome (‚Üì monos, NKs)
Infection Viral (CMV, EBV, HIV); bacterial (Brucella, Rickettsia, TB); malaria</description></item><item><title>neutrophilia</title><link>https://www.physician.tw/neutrophilia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neutrophilia/</guid><description>neutrophilia UpToDate table: [[classification of neutrophilia]] [[approach to the patient with neutrophilia]] (&amp;gt;7500‚Äì10,000/¬µL)
Infection Usually bacterial; ¬± [[toxic granulations]], [[D√∂hle bodies]]</description></item><item><title>new note</title><link>https://www.physician.tw/new-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/new-note/</guid><description>AM/AMP Ampicillin Aminopenicillin 10 AMC/&amp;lsquo;A/C&amp;rsquo;/AUG/XL/AML* Amoxicillin + clavulanic acid Aminopenicillin 25/10 AMX/AMOX/AC/AML* Amoxicillin</description></item><item><title>new report</title><link>https://www.physician.tw/new-report/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/new-report/</guid><description>https://docs.google.com/presentation/d/1JZhMp-Iv gJbsajKC7M-fHTpygJ3Or npNY85xAuhTg/edit?usp=sharing</description></item><item><title>New York Heart Association class</title><link>https://www.physician.tw/New-York-Heart-Association-class/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/New-York-Heart-Association-class/</guid><description>New York Heart Association class Class I: no sx w/ ordinary activity class II: sx w/ ordinary activity class III: sx w/ minimal activity class IV: sx at rest title herer1</description></item><item><title>nitrofurantoin</title><link>https://www.physician.tw/nitrofurantoin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nitrofurantoin/</guid><description>nitrofurantoin Tradename Macrodantin, Furadantin, Macrobid
Usage and Dosing Nitrofurantoin is used to treat uncomplicated lower urinary tract infections (UTI), e.</description></item><item><title>nnnnnnnnew note</title><link>https://www.physician.tw/nnnnnnnnew-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nnnnnnnnew-note/</guid><description>A new note</description></item><item><title>non- nucleoside reverse transcriptase inhibitor-NNRTI-Antiretrovirals ARVs</title><link>https://www.physician.tw/non-nucleoside-reverse-transcriptase-inhibitor-NNRTI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/non-nucleoside-reverse-transcriptase-inhibitor-NNRTI-Antiretrovirals-ARVs/</guid><description>non- nucleoside reverse transcriptase inhibitor-NNRTI-Antiretrovirals (ARVs) efavirenz (EFV; Sustiva) etravirine (ETR; Intelence) nevirapine (NVP; Viramune) rilpivirine (RPV; Edurant) Class: rash, hepatitis, mixed CYP450 inducer/inhib EFV: CNS effects (incl depression) NVP: rash and hypersensitivity [risk factors are female, CD4 &amp;gt;250, pregnancy (‚à¥ avoid)]</description></item><item><title>Non-tuberculous mycobacterium-bronchiectasis</title><link>https://www.physician.tw/Non-tuberculous-mycobacterium-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Non-tuberculous-mycobacterium-bronchiectasis/</guid><description>Non-tuberculous mycobacterium-bronchiectasis (NTM; eg, MAC, Mycobacterium kansaii)
Chronic cough, ‚Üì wt; Lady Windermere syndrome: R middle lobe and lingula bronchiectasis in elderly ‚ôÄ who suppress expectoration</description></item><item><title>Nonalcoholic fatty liver disease NAFLD</title><link>https://www.physician.tw/Nonalcoholic-fatty-liver-disease-NAFLD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonalcoholic-fatty-liver-disease-NAFLD/</guid><description>Nonalcoholic fatty liver disease (NAFLD) (JAMA 2020;323:1175; Lancet 2021;397:2212)
Definition: fatty infiltration of liver + absence of EtOH or other cause of steatosis (HCV, etc.</description></item><item><title>NONINFLAMMATORY-Acute Infectious Etiologies</title><link>https://www.physician.tw/NONINFLAMMATORY-Acute-Infectious-Etiologies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NONINFLAMMATORY-Acute-Infectious-Etiologies/</guid><description>NONINFLAMMATORY-Acute Infectious Etiologies Predom. disruption small intestine absorp. &amp;amp; secretion. Voluminous diarrhea, N/V. ‚äñ Fecal WBC &amp;amp; FOB. [[preformed toxin]] [[Viral diarrhea]] [[Bacterial diarrhea]] [[Parasitic diarrhea]]</description></item><item><title>Noninvasive positive-pressure ventilation of COPDAE</title><link>https://www.physician.tw/Noninvasive-positive-pressure-ventilation-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Noninvasive-positive-pressure-ventilation-of-COPDAE/</guid><description>Noninvasive positive-pressure ventilation of COPDAE Initiate early if moderate/severe dyspnea, ‚Üì pH / ‚Üë PaCO2, RR &amp;gt;25
Results in 58% ‚Üì intubation, ‚Üì LOS by 3.</description></item><item><title>Nonmegaloblastic macrocytic anemias</title><link>https://www.physician.tw/Nonmegaloblastic-macrocytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonmegaloblastic-macrocytic-anemias/</guid><description>Nonmegaloblastic macrocytic anemias Liver disease: often macrocytic, may see target cells, or spur cell anemia w/ hemolysis
Alcoholism: BM suppression &amp;amp; macrocytosis independent of folate/B12 defic.</description></item><item><title>Nonneutrocytic bacterascites NNBA</title><link>https://www.physician.tw/Nonneutrocytic-bacterascites-NNBA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonneutrocytic-bacterascites-NNBA/</guid><description>Nonneutrocytic bacterascites (NNBA) ‚äï cx w/o ‚Üë PMNs. Natural course may resolve w/o Rx. Start abx if symptomatic; if asymptomatic repeat para in 48 hrs.</description></item><item><title>Nonpharmacologic stroke prevent</title><link>https://www.physician.tw/Nonpharmacologic-stroke-prevent-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonpharmacologic-stroke-prevent-/</guid><description>Nonpharmacologic stroke prevent</description></item><item><title>Nonspecific Low Back Pain</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-metadata/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-metadata/</guid><description>Nonspecific Low Back Pain Metadata Item Type: [[Article]] Authors: [[Alessandro Chiarotto]], [[Bart W. Koes]] Date: [[2022-05-05]] Date Added: [[2022-08-07]] URL: https://doi.</description></item><item><title>Nonspecific Low Back Pain</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain/</guid><description>Nonspecific Low Back Pain ![[Nonspecific Low Back Pain-metadata#Metadata]]
Other files:
Mdnotes File Name: [[Nonspecific Low Back Pain]] Metadata File Name: [[Nonspecific Low Back Pain-metadata]] Zotero links [Local library](zotero://select/items/1 YKXMT6WM) Cloud library Notes</description></item><item><title>Nonspecific Low Back Pain - New Note</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-New-Note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-New-Note/</guid><description>Related to: [[Nonspecific Low Back Pain-zotero]]
Notes [[Annotations]]</description></item><item><title>nonthyroidal illness sick euthyroid syndrome</title><link>https://www.physician.tw/nonthyroidal-illness-sick-euthyroid-syndrome-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nonthyroidal-illness-sick-euthyroid-syndrome-/</guid><description>nonthyroidal illness (sick euthyroid syndrome) (J Endocrinol 2010;205:1)
TFT abnormalities in Pts w/ severe nonthyroidal illness (‚à¥ in acute illness, ‚úì TFTs only if ‚Üë concern for thyroid disease); may have acquired transient central hypothyroidism If thyroid dysfxn suspected in critically ill Pt, TSH alone not reliable; must measure total T4, free T4, &amp;amp; T3 Mild illness: ‚Üì T4 ‚Üí T3 conversion, ‚Üë rT3 ‚Üí ‚Üì T3; in severe illness: ‚Üì TBG &amp;amp; albumin, ‚Üë‚Üë rT3 ‚Üí ‚Üì‚Üì T3, ‚Üë degradation of T4, central ‚Üì TSH ‚Üí ‚Üì‚Üì T3, ‚Üì‚Üì T4, ‚Üì free T4, ‚Üì TSH Recovery phase: ‚Üë TSH followed by recovery of T4 and then T3 Replacement thyroxine not helpful or recommended for critically ill Pts w/ ‚Üì T3 and T4 unless other s/s of hypothyroidism</description></item><item><title>Normal GFR but with ‚Üì renal K excretion-hyperkalemia</title><link>https://www.physician.tw/Normal-GFR-but-with-renal-K-excretion-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Normal-GFR-but-with-renal-K-excretion-hyperkalemia/</guid><description>Normal GFR but with ‚Üì renal K excretion-hyperkalemia Normal aldosterone function ‚Üì EAV (K excretion limited by ‚Üì distal Na delivery &amp;amp; urine flow): CHF, cirrhosis</description></item><item><title>Normal hepatic vasculature</title><link>https://www.physician.tw/Normal-hepatic-vasculature/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Normal-hepatic-vasculature/</guid><description>Normal hepatic vasculature (Modified from The Nature of Disease Pathology for the Health Professions, 2007. Hepatology 2009;49:1729.)</description></item><item><title>normocytic anemias</title><link>https://www.physician.tw/normocytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/normocytic-anemias/</guid><description>normocytic anemias [[Anemia of chronic inflammation ]] [[Anemias of other chronic disorders]] [[Pure red cell aplasia]]</description></item><item><title>Norovirus</title><link>https://www.physician.tw/norovirus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/norovirus/</guid><description>[!info]
üå± ‰æÜËá™: [[Acute Diarrhea (3 weeks)]]
Norovirus Transmitted via fecal-oral route, by airborne droplets of vomit, or by contaminated food or water with an incubation period of &amp;lt;48 hours.</description></item><item><title>NSCLC Treatment</title><link>https://www.physician.tw/NSCLC-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NSCLC-Treatment/</guid><description>NSCLC Treatment Localized disease: surgery if possible; RT (eg, stereotactic ablative radiotherapy [SABR]) vs. chemo/RT if not (see Figure 5-7)</description></item><item><title>NSIP nonspecific IP</title><link>https://www.physician.tw/NSIP-nonspecific-IP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NSIP-nonspecific-IP/</guid><description>NSIP nonspecific IP Homogenous ground-glass opacities or consolid., reticular irreg lines; subpleural sparing; symmetric, peripheral, basal. Cellular &amp;amp; fibrotic subtypes.</description></item><item><title>NSTE-ACS</title><link>https://www.physician.tw/NSTE-ACS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NSTE-ACS/</guid><description>NSTE-ACS Key issues are antithrombotic regimen and decision regarding angiography
[[Antiplatelet Therapy]] [[Anticoagulant Therapy]] (choose one) [[Coronary angiography]] (Circ 2014;130:e344) [[TIMI Risk Score]] (TRS) for UA/NSTEMI (JAMA 2000;284:835)</description></item><item><title>nucleoside reverse transcriptase inhibitor NRTI-Antiretrovirals ARVs</title><link>https://www.physician.tw/nucleoside-reverse-transcriptase-inhibitor-NRTI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nucleoside-reverse-transcriptase-inhibitor-NRTI-Antiretrovirals-ARVs/</guid><description>nucleoside reverse transcriptase inhibitor NRTI-Antiretrovirals (ARVs) Class: GI intol, lipoatrophy, lactic acidosis
abacavir (ABC; Ziagen) ABC: hypersensitivity (3%), ‚úì HLA-B*5701</description></item><item><title>Nutritional Support and Total Parenteral Nutrition</title><link>https://www.physician.tw/Nutritional-Support-and-Total-Parenteral-Nutrition/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nutritional-Support-and-Total-Parenteral-Nutrition/</guid><description>Nutritional Support and Total Parenteral Nutrition Enteral &amp;amp; parenteral with similar clinical outcomes (Lancet 2018;391:133) Enteral (EN): starting w/in 48 h of ICU admit may ‚Üì infection &amp;amp; mortality.</description></item><item><title>NV would have selected</title><link>https://www.physician.tw/NV-would-have-selected/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NV-would-have-selected/</guid><description>Wow</description></item><item><title>Obscure GIB</title><link>https://www.physician.tw/Obscure-GIB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obscure-GIB/</guid><description>Obscure GIB (Am J Gastro 2015;110:1265; Gastro 2017;152:497)
[!tldr] Definition
continued bleeding (melena, hematochezia) despite ‚äñ EGD &amp;amp; colo; 5% of GIB</description></item><item><title>Obstructive diseases-disease-specific management of kidney disease</title><link>https://www.physician.tw/Obstructive-diseases-disease-specific-management-of-kidney-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obstructive-diseases-disease-specific-management-of-kidney-disease-/</guid><description>Obstructive diseases-disease-specific management of kidney disease Dx: renal U/S if undifferentiated or CT abd/pelvic (I‚Äì) if suspect nephrolithiasis
Rx: Foley if urethra vs.</description></item><item><title>Obstructive shock</title><link>https://www.physician.tw/Obstructive-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obstructive-shock/</guid><description>Obstructive shock Tension pneumothorax
Cardiac tamponade
Constrictive pericarditis
Pulmonary embolism
Aortic dissection</description></item><item><title>OI Prophylaxis-HIV AIDS</title><link>https://www.physician.tw/OI-Prophylaxis-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/OI-Prophylaxis-HIV-AIDS/</guid><description>OI Prophylaxis-HIV AIDS ( https://aidsinfo.nih.gov/guidelines &amp;amp; JAMA 2018;320:379, HIV.gov:2020) OI Indication 1¬∞ Prophylaxis
Tuberculosis ‚äï PPD (‚â•5 mm), IGRA, or high-risk exposure See treatment for latent TB</description></item><item><title>old headache</title><link>https://www.physician.tw/old-headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/old-headache/</guid><description>old headache Are there indication for brain imaging? YES: Obtain appropriate imaging
Does the headache fufill the highly specific [[POUNDing Mnemonic]] for migraines</description></item><item><title>Ommaya</title><link>https://www.physician.tw/Ommaya/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ommaya/</guid><description>Ommaya Ôºà1ÔºâÊìç‰ΩúÊõ¥Âä†ÂÆâÂÖ®„ÄÅ‰æøÊç∑ÔºåÊÇ£ËÄÖÁñºÁóõÂ∞ë„ÄÇ Ôºà2ÔºâÂèØ‰æùÊìöÈ°±ÂÖßÂ£ìË°åËÖ¶ËÑäÊ∂≤ÂºïÊµÅÔºåÂèäÊôÇÊîπÂñÑÈ°±È´òÂ£ìÁóáÁãÄÔºõ‰æøÊñºÈáçË§áÈÄÅÊ™¢ËÖ¶ËÑäÊ∂≤ÔºåÁû≠Ëß£Ëó•Áâ©ÊøÉÂ∫¶ÂèäËÖ´Áò§ÊåáÊ®ôÁöÑÂãïÊÖãËÆäÂåñÔºåÊúâÂä©ÊñºË™øÊï¥Áî®Ëó•„ÄÅÁôÇÊïàË©ïÂÉπÂèäË©ï‰º∞È†êÂæå„ÄÇ Ôºà3ÔºâËó•Áâ©Èö®ËÖ¶ËÑäÊ∂≤ÁöÑÂæ™Áí∞ÔºåÂèØÂùáÂãªÂàÜ‰ΩàÊñº‰∏≠Ê®ûÁ•ûÁ∂ìÁ≥ªÁµ±Ôºàcentral nervous system, CNSÔºâÁöÑÂêÑÂÄãÈÉ®‰ΩçÔºåËó•Áâ©ÊøÉÂ∫¶ÂèØÈÅîÂà∞ÂêåÁ≠âÂäëÈáèÁ∂ìËÖ∞Ê§éÁ©øÂà∫Áµ¶Ëó•ÁöÑ10ÂÄç[6]ÔºåÂõ†ËÄåÊúâÊõ¥Â•ΩÁöÑÁîüÂ≠òÁç≤Áõä[14]„ÄÇ
Âü∫ÊñºÊ≠§ÔºåÂÑ™ÂÖàÊé®Ëñ¶ÈÅ∏ÊìáÁ∂ìOmmayaÂõäËÖ¶ÂÆ§ÂÖßÁµ¶Ëó•‰æÜÈÄ≤Ë°åÈûòÂÖßÂåñÁôÇ [7, 15-17] Á∂ìOmmayaÂõäÈûòÂÖßÂåñÁôÇÂ∑≤ÊàêÂäüÁî®ÊñºÊ≤ªÁôÇÂ§öÁ®ÆÊÉ°ÊÄßËÖ´Áò§Áõ∏ÈóúÁöÑLMÔºàË°® 1Ôºâ„ÄÇ
OmmayaÂõäÁΩÆÂÖ•Ë°ìÂæå‰ΩµÁôºÁóáÁôºÁîüÁéáËºÉ‰Ωé[18]ÔºåÂ∏∏Ë¶ãÁöÑ‰ΩµÁôºÁóáÂåÖÊã¨ÔºöÈ°±ÂÖßÂá∫Ë°Ä„ÄÅÂ∞éÁÆ°Êòì‰ΩçÂíåÂ†µÂ°û„ÄÅÁπºÁôºÊÑüÊüì‰ª•ÂèäÂåñÁôÇËó•Áâ©ÊØíÂâØÂèçÊáâÁ≠â„ÄÇË©≤ÊÇ£ËÄÖOmmayaÂõäÁΩÆÂÖ•Ë°ìÂæåÔºåÁü≠ÊúüÂÖßÂá∫ÁèæÂôÅÂøÉ„ÄÅÂòîÂêê‰ª•ÂèäÁù°Áú†ÈöúÁ§ôÔºåËÄÉÊÖÆÂíåËó•Áâ©Âà∫ÊøÄ„ÄÅËÖ¶ËÑäÊ∂≤Ê≥¢ÂãïÁõ∏Èóú„ÄÇ</description></item><item><title>oncologic emergencies</title><link>https://www.physician.tw/oncologic-emergencies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oncologic-emergencies/</guid><description>oncologic emergencies [[fever and neutropenia]] (FN) (NCCN Guidelines v.1.2021) [[spinal cord compression]] [[tumor lysis syndrome]]</description></item><item><title>oncology</title><link>https://www.physician.tw/oncology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oncology/</guid><description>oncology ËÖ´Áò§ËîìÂª∂ÔºåÁôåÁóáÁñ´ÊÉÖÔºå ÁóÖÁóáÂ§öÁ´ØÔºåÈúÄÈ´òÊòé„ÄÇ È´îÂÖßÁï∞Áâ©ÔºåÁóÖËãóÊªãÈï∑Ôºå ËÖ´Áò§ÂÖßÁóÖÔºåËã¶Èõ£Â§ö„ÄÇ
[[hematology]] Section 1:¬†[[Neoplastic Disorders]]
[[NCCN guideline]] [[inpatient oncology]]
Pocket medicine [[thoracic malignancies]] [[prostate cancer]] [[gastrointestinal malignancies]] [[chemo side effects]] [[inpatient oncology]] [[cancer complications]] [[pain and palliative care]] [[immunotherapy and cellular therapy]] [[oncologic emergencies]] Pocket Oncology [[general oncology]] [[clinical research methods]] [[radiation oncology]] [[principles of surgery and interventional oncology]] [[cancer biology]] [[molecular diagnostics]] [[cancer immunology]] [[cancer genetics]] [[cancer pharmacology]] [[cancer complications]] [[palliative and supportive care]] [[cancer survivorship and fertility preservation]] [[infectious disease]] solid [[cancer of unknown primary]] (cup) [[genitourinary malignancies]] [[thoracic malignancies]] [[other solid tumors]] [[breast cancer]] [[neurological oncology]] [[pediatric cancers]] [[resident360]] Neutropenic Fever Superior Vena Cava (SVC) Syndrome Symptom Management Metastatic Spinal Cord Compression &amp;amp; Brain Metastases Venous Thromboembolism (VTE) in Malignancy Malignant Bowel Obstruction (MBO) Treatment Toxicities</description></item><item><title>Oncology-related glomerulopathy</title><link>https://www.physician.tw/Oncology-related-glomerulopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-related-glomerulopathy/</guid><description>Oncology-related glomerulopathy (CJASN 2016;11:1681)
Associations between malig (solid tumors &amp;amp; heme) and/or their Rx (HSCT &amp;amp; chemo- therapeutics) and GN, nephrotic syndrome, and thrombotic microangiopathies (TMA)</description></item><item><title>open pressure</title><link>https://www.physician.tw/open-pressure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/open-pressure/</guid><description>open pressure Ê≠£Â∏∏ 9‚Äì18 cmH2O Open pressure ‰∏äÂçáÂèØËÉΩÂéüÂõ†ÂåÖÊã¨Ôºöinfection„ÄÅbleeding„ÄÅtumor „ÄÅÊüê‰∫õ encephalitis Á≠â„ÄÇ</description></item><item><title>OpenAIDemo</title><link>https://www.physician.tw/OpenAIDemo/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/OpenAIDemo/</guid><description>What are the treatment of lung cancer
Lung cancer is the leading cause of cancer death in both men and women in the United States.</description></item><item><title>Ophthalmologic-complications of HIV AIDS</title><link>https://www.physician.tw/Ophthalmologic-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ophthalmologic-complications-of-HIV-AIDS/</guid><description>Ophthalmologic-complications of HIV AIDS CMV retinitis (CD4 usu &amp;lt;50); Rx: ganciclovir or valganciclovir, foscarnet, or cidofovir HZV, VZV, syphilis (any CD4 count, treat as neurosyphilis) or Toxo (CD4 usually &amp;lt;100)</description></item><item><title>Opioids-toxicology</title><link>https://www.physician.tw/Opioids-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Opioids-toxicology/</guid><description>Opioids-toxicology ‚Üì mentation, ‚Üì RR, miosis
IV naloxone</description></item><item><title>Optimal-medical-therapy-stable ischemic heart disease</title><link>https://www.physician.tw/Optimal-medical-therapy-stable-ischemic-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Optimal-medical-therapy-stable-ischemic-heart-disease/</guid><description>Optimal-medical-therapy-stable ischemic heart disease ASA 75‚Äì162 mg/d; can substitute clopi if ASA-intolerant. ~12 mos after PCI, clopi monoRx ‚Üì risk of ischemic and bleeding events by ~30% c/w ASA monoRx (Lancet 2021;397:2487).</description></item><item><title>Oral anticoagulation-atrial fibrillation</title><link>https://www.physician.tw/Oral-anticoagulation-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oral-anticoagulation-atrial-fibrillation/</guid><description>Oral anticoagulation-atrial fibrillation (Circ 2014;130:e199 &amp;amp; 2019;140:125; EHJ 2021;42:373)
All valvular AF because stroke risk very high Nonvalvular AF (NVAF): stroke risk ~4.</description></item><item><title>Oral-complications of HIV AIDS</title><link>https://www.physician.tw/Oral-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oral-complications-of-HIV-AIDS/</guid><description>Oral-complications of HIV AIDS Aphthous ulcers; KS; thrush/oral candidiasis (curd-like patches, often painless)
Oral hairy leukoplakia: painless proliferation of papillae w/ adherent white coating usually on lateral tongue, caused by EBV but not precancerous</description></item><item><title>Organ dysfunction</title><link>https://www.physician.tw/Organ-dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Organ-dysfunction/</guid><description>Organ dysfunction Liver (esp. cirrhosis): Vibrio spp., encapsulated bacteria ESRD: impaired granulocyte fxn and CMI as above Iron overload (or deferoxamine Rx): Yersinia, Zygomycetes</description></item><item><title>Organopho- sphate-toxicology</title><link>https://www.physician.tw/Organopho-sphate-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Organopho-sphate-toxicology/</guid><description>Organopho- sphate-toxicology Salivation, lacrimation, diaphoresis, miosis, emesis, bronchospasm, ŒîMS
Endotracheal intubation for respiratory failure, atropine, pralidoxime, benzodiazepines</description></item><item><title>orthopaedic</title><link>https://www.physician.tw/orthopaedic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/orthopaedic/</guid><description>orthopaedic [[Joint Hypermobility Syndrome]]</description></item><item><title>Orthostatic proteinuria</title><link>https://www.physician.tw/Orthostatic-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Orthostatic-proteinuria/</guid><description>Orthostatic proteinuria typically in adolescents; ~90% of young ‚ôÇ with isolated proteinuria have orthostatic proteinuria; typically resolves spontaneously</description></item><item><title>osteomyelitis</title><link>https://www.physician.tw/osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/osteomyelitis/</guid><description>osteomyelitis [!note]
Infection of bone due to hematogenous seeding or direct spread from contiguous focus
[[Etiology-osteomyelitis]] [[Clinical manifestations-osteomyelitis]] [[Diagnosis-osteomyelitis]] [[Treatment-osteomyelitis]] BacklinkÔºö [[Complications-diabetes mellitus]] [[diabetic foot infections]] [[Diagnosis-osteomyelitis]] [[differential diagnosis of back pain]] [[Etiology-osteomyelitis]] [[Imaging-Diagnosis-osteomyelitis]] [[Infection as Etiologies of Classic FUO]] [[infectious disease]] [[Risk factors for bloodstream infections]] [[Sickle cell anemia ]] [[skin and soft tissue infections]] [[Treatment-bacterial endocarditis]] [[Treatment-osteomyelitis]] [[vertebral osteomyelitis]]</description></item><item><title>Other Uosm >700‚Äì800</title><link>https://www.physician.tw/Other-Uosm-700800/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Uosm-700800/</guid><description>Other (Uosm &amp;gt;700‚Äì800) Na overload: hypertonic saline (eg, resuscitation w/ NaHCO3), mineralocorticoid excess
Seizures, ‚Üë exercise: ‚Üë intracellular osmoles ‚Üí H2O shifts ‚Üí transient ‚Üë [Na]serum</description></item><item><title>Other antimicrobial agents of Drug fever</title><link>https://www.physician.tw/Other-antimicrobial-agents-of-Drug-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-antimicrobial-agents-of-Drug-fever/</guid><description>Other antimicrobial agents of Drug fever antimicrobial agents are also the most common cause of drug fever, accounting for approximately one-third of episodes</description></item><item><title>Other Complication-cirrhosis</title><link>https://www.physician.tw/Other-Complication-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Complication-cirrhosis/</guid><description>Other Complication-cirrhosis [[Portopulmonary hypertension (POPH)]] Cirrhotic cardiomyopathy: ‚Üì inotropic &amp;amp; chronotropic response, ‚Üì systolic &amp;amp; diastolic fxn, ‚Üë QT, hyperkinetic circulation, high output; ‚Üë troponin &amp;amp; BNP Infxns: unless immune, vaccinate for HAV, HBV, PCV13, PPSV23, COVID-19; flu yearly.</description></item><item><title>Other diagnostic studies-syncope</title><link>https://www.physician.tw/Other-diagnostic-studies-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-diagnostic-studies-syncope/</guid><description>Other diagnostic studies-syncope (consider based on results of H&amp;amp;P and ECG)
Ambulatory ECG monitoring: if suspect arrhythmogenic syncope Holter monitoring (continuous ECG 24‚Äì72 h): useful if frequent events Event recorder (activated by Pt to record rhythm): limited role if LOC w/o prodrome External loop recorder (continuously saves rhythm, ‚à¥ can be activated after an event): useful for episodes (including w/o prodrome) likely to occur w/in 2‚Äì6 wks; can be coupled w/ mobile cardiac telemetry than can be auto-triggered for specific rhythms External patch recorder (1-lead recording; saves for 1‚Äì4 wks): Pt-activated or auto-triggered; more comfortable for Pts Implantable loop recorders (SC; can record 2‚Äì3 y; can be triggered): useful if episodes &amp;lt;1/mo; dx in 55% of cases; recommended for recurrent syncope w/o prodrome Echo: consider to r/o structural heart disease (eg, CMP [incl HCMP &amp;amp; ARVC], valvular disease [incl AS, MS, MVP], myxoma, amyloid, PHT, ¬± anomalous coronaries) ETT/CCTA/Cath: esp.</description></item><item><title>Other measures of COPDAE</title><link>https://www.physician.tw/Other-measures-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-measures-of-COPDAE/</guid><description>Other measures of COPDAE Mucolytics overall not supported by data (Chest 2001;119:1190) Monitor for cardiac arrhythmias</description></item><item><title>other names for vasculitides</title><link>https://www.physician.tw/other-names-for-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-names-for-vasculitides/</guid><description>other names for vasculitides Variable vessel vasculitis (VVV) Behcet&amp;rsquo;s disease (BD) Cogan&amp;rsquo;s syndrome (CS)
Single-organ vasculitis (SOV) Cutaneous leukocytoclastic angiitis Cutaneous arteritis Primary central nervous system vasculitis Isolated aortitis Others</description></item><item><title>Other Post MI Complications</title><link>https://www.physician.tw/Other-Post-MI-Complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Post-MI-Complications/</guid><description>Other Post MI Complications Complication Clinical Features Treatment LV thrombus ~30% incid. (espec lg antero-apical MI) AC√ó3-6 mo (?</description></item><item><title>other solid tumors</title><link>https://www.physician.tw/other-solid-tumors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-solid-tumors/</guid><description> Ëä±ÂúíÂ§ßÈñÄÂè£
[[hepatocellular carcinoma]] (HCC) [[urothelial carcinoma]] [[ddMVAC]]] [[esophageal cancer]] [[renal-cell-carcinoma]] [[skin cancers and sarcomas]] [[head and neck malignancies]] [[endocrine malignancies]] [[gynecologic malignancies]]</description></item><item><title>other-Secondary Causes of Hypertension</title><link>https://www.physician.tw/other-Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-Secondary-Causes-of-Hypertension/</guid><description>other-Secondary Causes of Hypertension Obstructive sleep apnea (qv); alcohol Medications: OCP, steroids, [[licorice]]; NSAIDs (espec COX-2); Epo; CsA; TKI Aortic coarctation: ‚Üì LE pulses, systolic murmur, radial-femoral delay; abnl TTE, CXR Polycythemia vera: ‚Üë Hct</description></item><item><title>Outpatient screening and treatment goals-diabetes mellitus</title><link>https://www.physician.tw/Outpatient-screening-and-treatment-goals-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Outpatient-screening-and-treatment-goals-diabetes-mellitus/</guid><description>Outpatient screening and treatment goals-diabetes mellitus (Diabetes Care 2022;45;S83 &amp;amp; S144)
‚úì HbA1C q3‚Äì6mo, goal &amp;lt;7% for most Pts. Goal &amp;lt;6.</description></item><item><title>Overflow proteinuria</title><link>https://www.physician.tw/Overflow-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overflow-proteinuria/</guid><description>Overflow proteinuria ‚Üë production of freely filtered proteins Etiologies Multiple myeloma Myoglobinuria</description></item><item><title>Overview-immunotherapy and cellular therapy</title><link>https://www.physician.tw/Overview-immunotherapy-and-cellular-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-immunotherapy-and-cellular-therapy/</guid><description>Overview-immunotherapy and cellular therapy immunotherapy and cellular therapy
Immune checkpoints: co-inhibitory signaling molecules that limit immune responses Cytotoxic T-lymphocyte-assoc. protein 4 (CTLA-4): ‚Üì T cell activation via negative signals and ligand competition w/ CD28 (activating co-stim.</description></item><item><title>Overview-potassium homeostasis</title><link>https://www.physician.tw/Overview-potassium-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-potassium-homeostasis/</guid><description>Overview-potassium homeostasis Renal: K excretion regulated at distal nephron (CCD) by principal &amp;amp; Œ±-intercalated cells Distal Na delivery &amp;amp; urine flow: Na absorption ‚Üí lumen electronegative ‚Üí K secretion Metabolic alkalemia and aldosterone: increase Na absorption and K secretion nb, diurnal urinary K excretion (day &amp;gt;night), ‚à¥ 24-h sample preferred over spot Transcellular shifts: most common cause of acute ‚àÜ in serum K (98% intracellular)</description></item><item><title>overview-sodium and water homeostasis</title><link>https://www.physician.tw/overview-sodium-and-water-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overview-sodium-and-water-homeostasis/</guid><description>overview-sodium and water homeostasis General (NEJM 2015;372:55 &amp;amp; 373:1350)
Disorders of serum sodium are generally due to Œîs in total body water, not sodium Hyper- or hypo-osmolality ‚Üí rapid water shifts ‚Üí Œîs in brain cell volume ‚Üí Œî MS, seizures Key hormones [[Antidiuretic hormone]] (ADH) [[Aldosterone]]</description></item><item><title>Oxygen for chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Oxygen-for-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oxygen-for-chronic-obstructive-pulmonary-disease/</guid><description>Oxygen for chronic obstructive pulmonary disease if PaO2 ‚â§55 mmHg or SaO2 ‚â§89% (during rest, exercise, or sleep) to prevent cor pulmonale; only Rx proven to ‚Üì mortality (Annals 1980;93:391; Lancet 1981;i:681); no benefit in Pts with moderate hypoxemia (SaO2 89‚Äì93%) (NEJM 2016;375:1617) or nocturnal O2 alone (NEJM 2020;383:1129); unknown benefit of isolated exertional O2 (AJRCCM 2020;202:121).</description></item><item><title>oxygenation</title><link>https://www.physician.tw/oxygenation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oxygenation/</guid><description>oxygenation Ê≠£Â∏∏Ê∞ßÂêàÔºàÊµ∑Âπ≥Èù¢ÔºâÈ†êÊ∏¨Ôºö Ê∞ßÂàÜÂ£ì (Pa o 2 ) ÁÇ∫ 75‚Äì100 mm HgÔºå21% FiO2ÔºàÂÆ§ÂÖßÁ©∫Ê∞£ÔºâÔºåPaO2 ÁÇ∫ ~ 660 mm HgÔºå100% FiO2 ÂæûËºïÂ∫¶ÔºàÁï∞Â∏∏ A-a Ê¢ØÂ∫¶ÔºâÂà∞ÈáçÂ∫¶ÔºàÂàÜÊµÅÔºâÔºåÊ∞ßÂêàÂèóÊêçÔºö Pao2 &amp;lt; 200 mm Hg on Fio2 of 100% = ‚ÄúÂàÜÊµÅÁîüÁêÜÂ≠∏‚Äù Â¶ÇÊûúÊ≤íÊúâ‚ÄúÂàÜÊµÅÁîüÁêÜÂ≠∏‚ÄùÔºåFio2 &amp;gt; 40%Ôºà~ &amp;gt; 6 L/min ÈÄöÈÅéÈºªÊèíÁÆ° (NC)ÔºâÊáâË©≤Áµ¶Âá∫ Pao2 &amp;gt; 60 mm HgÔºåÂÑòÁÆ°ÁóÖÁêÜÊúÉÂ∞éËá¥ A-a Ê¢ØÂ∫¶Áï∞Â∏∏Â¢ûÂä† 6LÁöÑncÂ§ßÊ¶ÇÂ∞±Ë¶ÅÊèõ‰æÜPaO2 60+ Ë°®ÁèæÂá∫ÂàÜÊµÅÁîüÁêÜÂ≠∏ÁöÑÊÇ£ËÄÖÁôºÁîü‰ΩéÊ∞ßÊÄßÂëºÂê∏Ë°∞Á´≠ÁöÑÈ¢®Èö™ÂæàÈ´òÔºåÈúÄË¶ÅÂ∞ãÊâæÊ†πÊú¨ÂéüÂõ†Ôºå‰ª•ÂèäÂØÜÂàáËßÄÂØüÂíåÁ©çÊ•µÊîØÊåÅÔºà‰æãÂ¶ÇËÉ∏ÈÉ®ÊàêÂÉèÔºå100% Fi0 2 Ôºâ Hypoxemic respiratory failure is practically defined as a Pa o 2 &amp;lt; 60 mm Hg ÈáçË¶ÅÂÆöÁæ©(Êï∏Â≠óË¶ÅË®ò‰∏Ä‰∏ã60) An acute drop in Pa o 2 &amp;lt; 60 mm Hg (but &amp;gt; 54 mm Hg), ie, ‚Äúmild hypoxemia,‚Äù may cause a range of symptoms: Increased left ventricular end-diastolic pressure (LVEDP) (a.</description></item><item><title>Oxygenation of COPDAE</title><link>https://www.physician.tw/Oxygenation-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oxygenation-of-COPDAE/</guid><description>Oxygenation of COPDAE ‚Üë FiO2 to achieve PaO2 ‚â•55‚Äì60 or SaO2 88‚Äì92%
Watch for CO2 retention (due to ‚Üë V/Q mismatch, loss of hypoxemic resp drive, [[Haldane effect]]), but must maintain acceptable SaO2!</description></item><item><title>PA catheter and tailored therapy</title><link>https://www.physician.tw/PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PA-catheter-and-tailored-therapy/</guid><description>Ëä±ÂúíÂ§ßÈñÄÂè£
Rationale [[Rationale PA catheter and tailored therapy]]
Indication [[Indications PA catheter and tailored therapy]] (NEJM 2013;369:e35; Circ 2017;136:e268)</description></item><item><title>Pacemaker Code</title><link>https://www.physician.tw/Pacemaker-Code/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pacemaker-Code/</guid><description>Pacemaker Code</description></item><item><title>Pacemaker Complications</title><link>https://www.physician.tw/Pacemaker-Complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pacemaker-Complications/</guid><description>Pacemaker Complications Perforation Effusion/tamp/pain Typically acute, consider if HoTN
Failure to pace Bradycardia ‚Üì Battery, lead fx/dislodgment, ‚Üë pacing threshold due to tissue rxn/injury; oversense ‚Üí inapprop.</description></item><item><title>Packed red blood cells</title><link>https://www.physician.tw/Packed-red-blood-cells/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Packed-red-blood-cells/</guid><description>Packed red blood cells For acute blood loss or to ‚Üë O2-carrying capacity if end organ ischemia. 1 U PRBC ‚Üí ‚Üë Hb by ~1 g/dL.</description></item><item><title>Pain</title><link>https://www.physician.tw/Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pain/</guid><description>Pain [[Pain: Pathophysiology and Management]] [[Chest Discomfort]] [[Abdominal Pain]] [[headache]] [[Back and Neck Pain]] Chapter 13:¬†[[Pain: Pathophysiology and Management]] Chapter 14:¬†[[Chest Discomfort]] Chapter 15:¬†[[Abdominal Pain]] Chapter 16:¬†[[Headache]] Chapter 17:¬†[[Back and Neck Pain]]</description></item><item><title>pain and palliative care</title><link>https://www.physician.tw/pain-and-palliative-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pain-and-palliative-care/</guid><description>pain and palliative care ‚ú®ÈáçÈªû: ÁñºÁóõÂèØÊ†πÊìöÊé®Êñ∑ÁöÑÁóÖÁêÜÁîüÁêÜÂ≠∏„ÄÅÊôÇÈñìÈÄ≤Á®ã„ÄÅÈÉ®‰ΩçÊàñÁóÖÂõ†ÈÄ≤Ë°åÂàÜÈ°û„ÄÇ Ê≠£Á¢∫ÁöÑÁñºÁóõÂàÜÈ°ûÂèØËÉΩÊúâÂä©ÊñºÊ≠£Á¢∫Ê≤ªÁôÇÁñºÁóõÂïèÈ°å„ÄÇ ÊÖ¢ÊÄßÈùûÁôåÁóáÁõ∏ÈóúÁñºÁóõËàáÊÄ•ÊÄßÁñºÁóõÈ°ØËëó‰∏çÂêåÔºåÂõ†ÁÇ∫ÊÖ¢ÊÄßÈùûÁôåÁóáÁõ∏ÈóúÁñºÁóõÊ≤íÊúâÊúâÁî®ÁöÑÁîüÁâ©Â≠∏ÁõÆÁöÑ„ÄÇ Topics: [[Classification of Pain]] [[paresthesia and dysesthesia]] [[deafferentation pain]] [[myofascial pain syndrome]]</description></item><item><title>Pancoast‚Äôs syndrome</title><link>https://www.physician.tw/Pancoasts-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pancoasts-syndrome/</guid><description>Pancoast‚Äôs syndrome apical tumor ‚Üí brachial plexus involvement (C8, T1, T2) ‚Üí [[Horner‚Äôs syndrome]], shoulder pain, rib destruction, atrophy of hand muscles</description></item><item><title>pancreatic tumors</title><link>https://www.physician.tw/pancreatic-tumors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatic-tumors/</guid><description>pancreatic tumors</description></item><item><title>pancreatitis</title><link>https://www.physician.tw/pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatitis/</guid><description>pancreatitis [[acute pancreatitis]] [[chronic pancreatitis]] [[autoimmune pancreatitis]] hellow</description></item><item><title>pancytopenia</title><link>https://www.physician.tw/pancytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancytopenia/</guid><description>pancytopenia [[Etiologies-pancytopenia]] [!note] Clinical manifestations
Anemia ‚Üí fatigue; neutropenia ‚Üí recurrent infections; thrombocytopenia ‚Üí mucosal bleeding &amp;amp; easy bruisability</description></item><item><title>Papillary thyroid cancer</title><link>https://www.physician.tw/Papillary-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Papillary-thyroid-cancer/</guid><description>Papillary thyroid cancer Most common form (85% of differentiated thyroid cancers); peak incidence 30 to 50 y Risk factors: childhood radiation exposure, FHx in 1¬∞ relative, familial syndrome Low-risk, mort.</description></item><item><title>Paralytic ileus of the colon &amp; small bowel</title><link>https://www.physician.tw/Paralytic-ileus-of-the-colon-small-bowel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paralytic-ileus-of-the-colon-small-bowel/</guid><description>Paralytic ileus of the colon &amp;amp; small bowel The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines</description></item><item><title>Paraneoplastic syndromes</title><link>https://www.physician.tw/Paraneoplastic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paraneoplastic-syndromes/</guid><description>Paraneoplastic syndromes ÂÖßÂàÜÊ≥å„ÄÅËÇåËÇâ„ÄÅÁ•ûÁ∂ì„ÄÅË°ÄÊ∂≤
Endo SIADH (SCLC); ACTH (SCLC) ‚Üí Cushing‚Äôs; PTH-rP (SCC) ‚Üí hyperCa
Skeletal digital clubbing (NSCLC), [[hypertrophic pulm osteoarthropathy]] (adenocarcinoma) = symmetric polyarthritis and proliferative periostitis of long bones Neuro (SCLC) [[Eaton-Lambert]] peripheral neuropathy (anti-Hu, anti-PCA-2, anti-CRMP5), cerebellar degeneration (anti-Hu, anti-Yo, anti-Ri, anti-Tr), encephalomyelitis (anti-Hu, anti-Ma1/2, anti-CRMP5) Hematologic hypercoagulable state (adenocarcinoma) DIC</description></item><item><title>parapneumonic effusions</title><link>https://www.physician.tw/parapneumonic-effusions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/parapneumonic-effusions/</guid><description>parapneumonic effusions parapneumonicÁ©çÊ∂≤ÊòØÂú®ËàáËÇ∫ÁÇéÁõ∏ÈÑ∞ÁöÑËÉ∏ËÜúÁ©∫Èñì‰∏≠ÂΩ¢ÊàêÁöÑËÉ∏ËÖîÁ©çÊ∂≤„ÄÇ Áï∂ÂæÆÁîüÁâ©ÊÑüÊüìËÉ∏ËÜúÁ©∫ÈñìÊôÇÔºåÂèØËÉΩÊúÉÂ∞éËá¥Ë§áÈõúÁöÑparapneumonicÁ©çÊ∂≤ÊàñËÜøËÉ∏„ÄÇ Âú®Ê≤íÊúâÁõ∏ÈÑ∞ÁöÑËÇ∫ÁÇéÁöÑÊÉÖÊ≥Å‰∏ãÔºåËÜøËÉ∏‰πüÂèØ‰ª•ÁôºÂ±ï„ÄÇ</description></item><item><title>Parathyroid MIBI Scan</title><link>https://www.physician.tw/Parathyroid-MIBI-Scan/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Parathyroid-MIBI-Scan/</guid><description>Parathyroid MIBI Scan https://www.insideradiology.com.au/parathyroid-mibi-scan-hp/
Áî≤ÁãÄÊóÅËÖ∫ MIBI ÊéÉÊèèÁî®ÊñºÊ†∏ÈÜ´Â≠∏
Áî≤ÁãÄÊóÅËÖ∫ÊéÉÊèè‰ΩøÁî®ÊîæÂ∞ÑÊÄßÂêå‰ΩçÁ¥†Èéù 99m sestamibiÔºàÊàñ MIBIÔºâÔºåÂ∞áÂÖ∂Ë®ªÂÖ•È´îÂÖß‰∏¶Ë¢´ÈÅéÂ∫¶Ê¥ªË∫çÁöÑÁî≤ÁãÄÊóÅËÖ∫Á∑öÁ≤íÈ´îÂê∏Êî∂„ÄÇ Â∞ç‰ºΩÈ¶¨Áõ∏Ê©üÊãçÊîùÁöÑÂúñÂÉèÈÄ≤Ë°åÊéÉÊèèÔºåÁôºÁèæ‰∏ÄÂÄãÈÅéÂ∫¶Ê¥ªË∫çÁöÑËÖ∫È´î„ÄÇ Âú®Êüê‰∫õÊÉÖÊ≥Å‰∏ãÔºåÂú® MIBI ‰πãÂâçÁµ¶‰∫àÂè¶‰∏ÄÁ®ÆÊîæÂ∞ÑÊÄßÁâ©Ë≥™ÔºàÈ´òÈîùÈÖ∏ÈàâÔºâÔºå‰ª•‰æøÂÉÖË≠òÂà•Áî≤ÁãÄËÖ∫„ÄÇ ÈÄôÂÖÅË®±Ë©ï‰º∞Áî≤ÁãÄÊóÅËÖ∫Áõ∏Â∞çÊñºÁî≤ÁãÄËÖ∫ÁöÑ‰ΩçÁΩÆ„ÄÇ ÈÄ≤Ë°åÁî≤ÁãÄÊóÅËÖ∫ MIBI ÊéÉÊèèÁöÑÂÖàÊ±∫Ê¢ù‰ª∂ÊòØ‰ªÄÈ∫ºÔºü</description></item><item><title>paresthesia and dysesthesia</title><link>https://www.physician.tw/paresthesia-and-dysesthesia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/paresthesia-and-dysesthesia/</guid><description>paresthesia and dysesthesia ‚ú®ÈáçÈªû: paresthesia ÊÑüË¶∫È∫ªÊú®Ë¢´Á∞°ÂñÆÂú∞ÊèèËø∞ÁÇ∫‰∏ÄÁ®ÆÁÑ°ÁóõÁöÑÊÑüË¶∫ÊîπËÆäÔºà‰æãÂ¶ÇÔºåÈ∫ªÊú®Ôºâ„ÄÇ dysesthesia ÊÑüË¶∫ÈÅ≤ÈàçÊòØ‰∏ÄÁ®ÆÁñºÁóõÁöÑÊÑüË¶∫ÊîπËÆäÔºà‰æãÂ¶ÇÔºåÁñºÁóõÁöÑÈ∫ªÊú®Ôºâ„ÄÇ</description></item><item><title>Paroxysmal nocturnal hemoglobinuria</title><link>https://www.physician.tw/Paroxysmal-nocturnal-hemoglobinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paroxysmal-nocturnal-hemoglobinuria/</guid><description>Paroxysmal nocturnal hemoglobinuria (PNH) (Blood 2009;113:6522)
Acquired clonal stem cell disorder = inactivating somatic mutation of PIG-A gene ‚Üí deficiency of GPI-anchor for CD55 &amp;amp; CD59 (inhib of complement) ‚Üí complement-mediated RBC lysis, plt aggregation, &amp;amp; hypercoagulability</description></item><item><title>pathogen</title><link>https://www.physician.tw/pathogen/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathogen/</guid><description>pathogen [[Acinetobacter sp]] [[CAPT-resistant GNB]] [[HACEK]] [[Pneumocystis pneumonia, PJP, Adult]] [[clostridioides difficile infection]]</description></item><item><title>Pathogenesis epidemiology-clostridioides difficile infection</title><link>https://www.physician.tw/Pathogenesis-epidemiology-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-epidemiology-clostridioides-difficile-infection/</guid><description>Pathogenesis epidemiology-clostridioides difficile infection Ingestion of C. diff spores ‚Üí colonization when colonic flora Œî‚Äôd by abx or chemo ‚Üí release of toxin A/B ‚Üí colonic mucosal necrosis &amp;amp; inflammation ‚Üí pseudomembranes</description></item><item><title>Pathogenesis etiology-chronic pancreatitis</title><link>https://www.physician.tw/Pathogenesis-etiology-chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-etiology-chronic-pancreatitis/</guid><description>Pathogenesis etiology-chronic pancreatitis (Gastro 2013;144:1292; JAMA 2019;322:2422)
Often recurrent acute attacks ‚Üí inflam infiltrate ‚Üí fibrosis ‚Üí loss of exocrine &amp;amp; endocrine tissue.</description></item><item><title>pathogenesis of disseminated intravascular coagulation DIC</title><link>https://www.physician.tw/pathogenesis-of-disseminated-intravascular-coagulation-DIC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathogenesis-of-disseminated-intravascular-coagulation-DIC/</guid><description>pathogenesis of disseminated intravascular coagulation (DIC) massive activation of coagulation that overwhelms control mechanisms
Thrombosis in microvasculature ‚Üí ischemia + microangiopathic hemolytic anemia</description></item><item><title>pathogenesis of vasculitides</title><link>https://www.physician.tw/pathogenesis-of-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathogenesis-of-vasculitides/</guid><description>pathogenesis of vasculitides is not well understood, but potential pathophysiologic processes leading to vascular damage include immune complex deposition, antineutrophil cytoplasmic antibodies (ANCAs) (humoral mechanism), and T-lymphocyte response with granuloma formation (cell-mediated mechanism).</description></item><item><title>Pathogenesis-acute pancreatitis</title><link>https://www.physician.tw/Pathogenesis-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-acute-pancreatitis/</guid><description>Pathogenesis-acute pancreatitis Pancreatic duct and acinar injury via direct or indirect toxicity ‚Üí impaired secretion and premature activation of digestive enzymes ‚Üí autodigestion and acute inflammation</description></item><item><title>Pathogenesis-cholecystitis</title><link>https://www.physician.tw/Pathogenesis-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-cholecystitis/</guid><description>Pathogenesis - [[cholecystitis]] Acute cholecystitis: stone impaction in cystic duct ‚Üí inflammation behind obstruction ‚Üí GB swelling ¬± secondary infection (50%) of biliary fluid</description></item><item><title>Pathogenesis-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Pathogenesis-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-chronic-obstructive-pulmonary-disease/</guid><description>Pathogenesis-chronic obstructive pulmonary disease Lancet 2017;389:1931
Cigarette smoke (centrilobular emphysema, affects 15‚Äì20% of smokers) Recurrent airway infections [[Œ±1-antitrypsin deficiency]] Low FEV1 in early adulthood associated with COPD (NEJM 2015;373:111)</description></item><item><title>Pathologic-Q-waves</title><link>https://www.physician.tw/Pathologic-Q-waves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathologic-Q-waves/</guid><description>Pathologic-Q-waves Q wave, Q
Definition: ‚â•30 msec (‚â•20 msec V2‚ÄìV3) or &amp;gt;25% height of R wave in that QRS complex</description></item><item><title>Pathology pathogenesis esophageal cancer</title><link>https://www.physician.tw/Pathology-pathogenesis-esophageal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathology-pathogenesis-esophageal-cancer/</guid><description>Pathology pathogenesis esophageal cancer Squamous cell carcinoma Squamous cell carcinomas (SCCs) are usually located in the proximal or mid third of the esophagus.</description></item><item><title>Pathophysiology risk factors -aortic aneurysms</title><link>https://www.physician.tw/Pathophysiology-risk-factors-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-risk-factors-aortic-aneurysms/</guid><description>Pathophysiology risk factors -aortic aneurysms (JACC 2020:76:201 &amp;amp; 2021;78:201)
Medial degen and/or ‚Üë wall stress; wall stress ‚àù [(‚àÜP √ó r) / (wall thickness)] (Laplace‚Äôs law) TAA: medial degeneration (muscle apoptosis, elastin fiber weakening); a/w CTD, aortitis AAA: long-standing HTN + athero/inflammation ‚Üí medial weakening Clinical risk factors: HTN, athero, smoking, age, ‚ôÇ, presence of other aortic dilation CTD (Marfan, Ehlers-Danlos type IV, Loeys-Dietz); congenital (bicuspid AoV, Turner‚Äôs) aortitis (Takayasu‚Äôs GCA, spondyloarthritis, IgG4); infection (eg, syphilis); FQ; trauma</description></item><item><title>Pathophysiology and microbiology of fever and neutropenia</title><link>https://www.physician.tw/Pathophysiology-and-microbiology-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-and-microbiology-of-fever-and-neutropenia/</guid><description>Pathophysiology and microbiology of fever and neutropenia Predisposing factors: catheters, skin breakdown, GI mucositis, obstruction (lymphatics, biliary tract, GI, urinary tract), immune defect associated with malignancy Often thought due to seeding of bloodstream by GI flora, eg, GNRs (esp.</description></item><item><title>pathophysiology gastroesophageal reflux disease</title><link>https://www.physician.tw/pathophysiology-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathophysiology-gastroesophageal-reflux-disease/</guid><description>pathophysiology gastroesophageal reflux disease (JAMA 2020;324:2536)
‚Üë acid exposure in esophagus, caused by ‚Üë transient LES relaxations. Worsened by ‚Üë intraabd pressure (eg, obesity, pregnancy), ‚Üì esophagogastric motility, hiatal hernia.</description></item><item><title>Pathophysiology of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Pathophysiology-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-Cryoglobulinemic-vasculitis/</guid><description>Pathophysiology of Cryoglobulinemic vasculitis Type I: cryo precipitation in microcirculation ‚Üí hyperviscosity &amp;amp; vascular occlusion Types II/III: defective/insufficient immune complex (IC) clearance ‚Üí IC-mediated inflammation of blood vessels w/ complement activation ‚Üí vasculitis</description></item><item><title>Pathophysiology of diverticulitis</title><link>https://www.physician.tw/Pathophysiology-of-diverticulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-diverticulitis/</guid><description>Pathophysiology of diverticulitis (NEJM 2007;357:2057; Gastro 2015;149:1944)
Retention of undigested food and bacteria in diverticulum ‚Üí fecalith formation ‚Üí obstruction ‚Üí compromise of diverticulum‚Äôs blood supply, infection, microperforation Uncomplicated (75%): microperforation ‚Üí localized infection, LLQ pain, fever, ‚Üë WBC Complicated (25%): macroperf ‚Üí abscess, peritonitis, fistula (65% w/ bladder), obstrxn Clinical manifestations LLQ abdominal pain, fever, nausea, vomiting, constipation or diarrhea PEx ranges from LLQ tenderness ¬± palpable mass to peritoneal signs &amp;amp; septic shock Ddx includes IBD, infectious colitis, PID, tubal pregnancy, cystitis, colorectal cancer</description></item><item><title>Pathophysiology of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Pathophysiology-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-hypertrophic-cardiomyopathy/</guid><description>Pathophysiology of hypertrophic cardiomyopathy LV outflow tract obstruction (LVOTO) in ‚â•70%: narrowed tract 2¬∞ hypertrophied septum + systolic anterior motion (SAM) of ant.</description></item><item><title>Pathophysiology-Acetaminophen hepatotoxicity</title><link>https://www.physician.tw/Pathophysiology-Acetaminophen-hepatotoxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-Acetaminophen-hepatotoxicity/</guid><description>Pathophysiology-Acetaminophen hepatotoxicity 90% of acetaminophen (N-acetyl-p-aminophenol, APAP) metab into nontoxic metab, but ~5% metab by CYP2E1 into NAPQI, a hepatotoxic metab detoxified by glutathione conjugation; APAP overdose (&amp;gt;10 g) depletes glutathione stores ‚Üí injury</description></item><item><title>Pathophysiology-ascites</title><link>https://www.physician.tw/Pathophysiology-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-ascites/</guid><description>Pathophysiology-ascites ( Hepatology 2021;74:1014) [[Pathogenesis of ascites and related complications of cirrhosis]]
Portal HTN ‚Üí ‚Üë NO &amp;amp; prostaglandins ‚Üí splanchnic vasodilatation‚Üí ‚Üì effective arterial volume ‚Üí ‚Üë RAAS &amp;amp; ADH ‚Üí renal Na &amp;amp; H2O retention ‚Üí volume overload and ascites Portal hypertension leads to increased nitric oxide and prostaglandins, resulting in splanchnic vasodilation and decreased effective arterial volume.</description></item><item><title>Pathophysiology-constrictive pericarditis</title><link>https://www.physician.tw/Pathophysiology-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-constrictive-pericarditis/</guid><description>Pathophysiology-constrictive pericarditis Adhesion of visceral and parietal pericardial layers ‚Üí rigid pericardium that limits diastolic filling of ventricles ‚Üí ‚Üë systemic venous pressures Venous return is limited only after early rapid filling phase; ‚à¥ rapid ‚Üì in RA pressure with atrial relaxation and opening of tricuspid valve and prominent x and y descents Kussmaul sign: JVP does not decrease with inspiration (‚Üë venous return with inspiration, but negative intrathoracic pressure not transmitted to heart because of rigid pericardium)</description></item><item><title>Pathophysiology-diabetic ketoacidosis</title><link>https://www.physician.tw/Pathophysiology-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-diabetic-ketoacidosis/</guid><description>Pathophysiology-diabetic ketoacidosis (NEJM 2015;372:546)
Occurs in T1D (and in ketosis-prone T2D); ‚Üë glucagon and ‚Üì insulin Hyperglycemia due to: ‚Üë gluconeogenesis, ‚Üë glycogenolysis, ‚Üì glucose uptake into cells Ketosis due to: insulin deficiency ‚Üí mobilization and oxidation of fatty acids, ‚Üë substrate for ketogenesis, ‚Üë ketogenic state of the liver, ‚Üì ketone clearance Explain by ChatGPT Acidosis due to: accumulation of [[ketone bodies]] Diabetic ketoacidosis (DKA) is a condition that can occur in people with type 1 diabetes (T1D) or ketosis-prone type 2 diabetes (T2D).</description></item><item><title>Pathophysiology-gastroesophageal reflux disease</title><link>https://www.physician.tw/Pathophysiology-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-gastroesophageal-reflux-disease/</guid><description>Pathophysiology-gastroesophageal reflux disease Gastroesophageal reflux disease (GERD) is the second most common gastrointestinal diagnosis in the ambulatory setting and affects 18%‚Äì28% of people living in the North America.</description></item><item><title>Pathophysiology-Heparin-Induced Thrombocytopenias</title><link>https://www.physician.tw/Pathophysiology-Heparin-Induced-Thrombocytopenias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-Heparin-Induced-Thrombocytopenias/</guid><description>Pathophysiology-Heparin-Induced Thrombocytopenias Ab binds heparin-PF4 ‚Üí immune complex binds to plt ‚Üí plt activation, further PF4 release ‚Üí plt aggregates removed from circulation ‚Üí thrombocytopenia; procoagulants released by plts and tissue factor released by endothelial cells damaged by HIT Abs ‚Üí prothrombotic state</description></item><item><title>Pathophysiology-hypernatremia</title><link>https://www.physician.tw/Pathophysiology-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-hypernatremia/</guid><description>Pathophysiology-hypernatremia (Crit Care 2013;17:206; NEJM 2015;372:55)
Deficit of water relative to sodium; by definition, all hypernatremic Pts are hypertonic</description></item><item><title>Pathophysiology-hyponatremia</title><link>https://www.physician.tw/Pathophysiology-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-hyponatremia/</guid><description>Pathophysiology-hyponatremia (JASN 2008;19:1076; NEJM 2015;372:1349)
Pathophysiology (JASN 2008;19:1076; NEJM 2015;372:1349)
Excess H2O relative to Na, usually due to ‚Üë ADH ‚Üë ADH may be appropriate (eg, hypovolemia or hypervolemia with ‚Üì EAV) ‚Üë ADH may be inappropriate (SIADH) Rarely, ‚Üì ADH (appropriately suppressed), but kidneys unable to maintain nl [Na]serum at steady state, solute intake = solute excretion; urine output = solute excretion/Uosm nl dietary solute load ~750 mOsm/d, min Uosm = 50 mOsm/L, ‚à¥ UOP can be up to ~15 L ‚Üë H2O intake (1¬∞ polydipsia): ingestion of massive quantities (usually &amp;gt;15 L/d) of free H2O overwhelms diluting ability of kidney ‚Üí H2O retention ‚Üì solute intake (‚Äútea &amp;amp; toast‚Äù &amp;amp; beer potomania): ‚Üì‚Üì daily solute load ‚Üí insufficient solute to excrete H2O intake (eg, if only 250 mOsm/d, minimum Uosm = 50 mOsm/L ‚Üí excrete in ~5 L; if H2O ingestion exceeds this amount ‚Üí H2O retention)</description></item><item><title>Pathophysiology-metabolic-alkalosis</title><link>https://www.physician.tw/Pathophysiology-metabolic-alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-metabolic-alkalosis/</guid><description>Pathophysiology-metabolic-alkalosis (CJASN 2020;15:1848)
Saline-responsive etiologies require
initiating event and maintenance phase Initiating event: net HCO3‚àí reabsorption (due to loss of volume, Cl-, and/or K+) or loss of H+ Loss of H+ (¬± Cl-) from GI tract, kidneys, or transcellular shift in hypokalemia Contraction alkalosis: loss of HCO3&amp;ndash;poor fluid ‚Üí extracellular fluid ‚Äúcontracts‚Äù around fixed amount of HCO3- ‚Üí ‚Üë HCO3- concentration ÊµÅÂ§±ÊéâÈÖ∏Ê∂≤ Exogenous alkali: iatrogenic HCO3- (with renal impairment), [[milk-alkali syndrome]] Posthypercapnia: resp.</description></item><item><title>Pathophysiology-pericardial tamponade</title><link>https://www.physician.tw/Pathophysiology-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-pericardial-tamponade/</guid><description>Pathophysiology-pericardial tamponade ‚Üë intrapericardial pressure, compression of heart chambers, ‚Üì venous return ‚Üí ‚Üì CO Diastolic pressures ‚Üë &amp;amp; equalize in all cardiac chambers ‚Üí minimal flow of blood from RA to RV when TV opens ‚Üí blunted y descent ‚Üë ventricular interdependence ‚Üí pulsus paradoxus (pathologic exaggeration of nl physio) Inspiration ‚Üí ‚Üì intrapericardial &amp;amp; RA pressures ‚Üí ‚Üë venous return ‚Üí ‚Üë RV size ‚Üí septal shift to left.</description></item><item><title>Pathophysiology-pleural effusion</title><link>https://www.physician.tw/Pathophysiology-pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-pleural-effusion/</guid><description>Pathophysiology-pleural effusion Systemic factors (eg, ‚Üë PCWP, ‚Üì oncotic pressure) ‚Üí transudative effusion pcwp ËÇ∫ÊØõÁ¥∞Ë°ÄÁÆ°Â•ëÂ£ì Local factors (ie, Œî pleural surface permeability) ‚Üí exudative effusion</description></item><item><title>Patient isolation-tuberculosis</title><link>https://www.physician.tw/Patient-isolation-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Patient-isolation-tuberculosis/</guid><description>Patient isolation-tuberculosis Decision based on likelihood of active disease. Consider when cough, dyspnea, hemoptysis, ‚â•1 risk factor (HIV ‚äï, foreign born, substance use disorder, homeless, recent incarceration, prior TB or exposure).</description></item><item><title>Patterns of LFTs</title><link>https://www.physician.tw/Patterns-of-LFTs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Patterns-of-LFTs/</guid><description>Patterns of LFTs LFTsÁï∞Â∏∏ÁöÑÂõõÂ§ßÈ°ûDDx hepatocellular ‰∏äÂçáÁöÑALT, aspartate aminotransferaseÔºåÂÖ∂‰ªñÁöÑ‰∏ç‰∏ÄÂÆö Cholestatic Infiltrative Nonhepatic hepatocellular ÊÉ≥ÂõõÂÄãDDx Viral hepatitis, non-alcoholic fatty liver disease ‰∏ÄËà¨‰æÜË™™ÊúÉÊòØALT&amp;gt;AST Alchololic hepatitis AST&amp;gt;2*ALT Ischemic injury ÂõõÈ†ÖÈÉΩÈ´òÔºåÂõ†Ê≠§shock liverÁöÑË®∫Êñ∑ÈÇÑÊòØÊääÂõõÈ†ÖÈÉΩÊäΩ‰∏ÄÊäΩ Wilson Disease AœÜ : Tbili &amp;lt; 4 (if fulminat) Cholestatic Infiltrative ÂèçËÄåÊòØAœÜ, BilirubinÈ´ò Nonhepatic Skeletal muscle injury Bone Disease Hemolysis</description></item><item><title>PD peritonitis</title><link>https://www.physician.tw/PD-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PD-peritonitis/</guid><description>PD peritonitis abd pain &amp;amp; cloudy drainage (WBC &amp;gt;100 &amp;amp; &amp;gt;50% PMNs). 60‚Äì70% GPC, 15‚Äì20% GNR. Rx: abx IV or in PD, catheter removal for certain org (yeast, Pseudomonas).</description></item><item><title>PD-1 PD-L1 pathway</title><link>https://www.physician.tw/PD-1-PD-L1-pathway/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PD-1-PD-L1-pathway/</guid><description>PD-1 PD-L1 pathway Programmed Cell Death Protein 1 (PD-1) original: PD-1/PD-L1 pathway: current researches in cancer
PD-1/PD-L1 pathway controls the induction and maintenance of immune tolerance within the tumor microenvironment.</description></item><item><title>PD-L1</title><link>https://www.physician.tw/PD-L1/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PD-L1/</guid><description>ÂÖçÁñ´Ê≤ªÁôÇ|‰∏ÄÊñáËÆÄÊáÇPD-L1Ê™¢Ê∏¨‰πãÊäóÈ´îÈÅ∏Êìá [[PD-1 PD-L1 pathway]]: current researches in cancer [[atezolizumab]]
TPSÔºöËÖ´Áò§Á¥∞ËÉûÈôΩÊÄßÊØî‰æãÂàÜÊï∏ÔºàTumor Proportion Score)ÔºåË®àÁÆóÂÖ¨ÂºèÂ¶Ç‰∏ãÔºö
PD-L1Âà§ËÆÄÊ®ôÊ∫ñÔºàTPSÔºâÔºö
PD-L1Âº∑Ë°®ÈÅîÔºàTPS‚â•50%ÔºâÔºõPD-L1Ë°®ÈÅîÔºà1%‚â§TPS‚â§49%ÔºâÔºõPD-L1Êú™Ë°®ÈÅîÔºàTPSÔºú1%Ôºâ
CPSÔºöÈôΩÊÄßËÅØÂêàÂàÜÊï∏ÔºàCombined Positive ScoreÔºâ„ÄÇÈô§‰∫ÜËÖ´Áò§Á¥∞ËÉûË°®ÈÅîPD-L1‰πãÂ§ñÔºåÊ∑ãÂ∑¥Á¥∞ËÉû„ÄÅÂ∑®Âô¨Á¥∞ËÉûÁ≠âÂÖçÁñ´Á¥∞ ËÉû‰πüÊúÉÊúâPD-L1Ë°®ÈÅî„ÄÇË®àÁÆóÂÖ¨ÂºèÂ¶Ç‰∏ãÔºö
PD-L1Âà§ËÆÄÊ®ôÊ∫ñÔºàCPSÔºâÔºö</description></item><item><title>Pel-Ebstein fever</title><link>https://www.physician.tw/Pel-Ebstein-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pel-Ebstein-fever/</guid><description>Pel-Ebstein fever ‚ú®ÈáçÈªû: ÈÄôÊòØ 16% ÁöÑÈúçÂ•áÈáëÁóÖÁóÖ‰æãÁöÑÁôºÁáí„ÄÇ ÂÆÉÁöÑÁâπÈªûÊòØÁôº‰ΩúÊåÅÁ∫åÊï∏Â∞èÊôÇÊàñÊï∏Â§©ÔºåÁÑ∂ÂæåÊòØÊï∏Â§©ÁîöËá≥Êï∏ÈÄ±ÁöÑÁÑ°ÁôºÁÜ±Êúü„ÄÇ Âõ†Ê≠§ÔºåÈÄôÊòØÂÖ∏ÂûãÁöÑÂõûÊ≠∏ÁÜ±„ÄÇ ÂÆÉÊñº 19 ‰∏ñÁ¥ÄÁî±Ëç∑Ëò≠‰∫∫ Pieter Pel ÂíåÂæ∑Âúã‰∫∫ Wilhelm Ebstein È¶ñÊ¨°ÊèèËø∞„ÄÇ ÂæåËÄÖÂèØËÉΩÂõ†ÁÇ∫‰ªñÁöÑË™≤Â§ñËààË∂£ËÄåË¢´Êõ¥Â•ΩÂú∞Ë®ò‰ΩèÔºåÂæûËóùË°ìÂíåÊñáÂ≠∏Âà∞Ê≠∑Âè≤„ÄÇ</description></item><item><title>Pembrolizumab plus Chemotherapy in Metastatic Non‚ÄìSmall-Cell Lung Cancer</title><link>https://www.physician.tw/Pembrolizumab-plus-Chemotherapy-in-Metastatic-NonSmall-Cell-Lung-Cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pembrolizumab-plus-Chemotherapy-in-Metastatic-NonSmall-Cell-Lung-Cancer/</guid><description>Pembrolizumab plus Chemotherapy in Metastatic Non‚ÄìSmall-Cell Lung Cancer After a median follow-up of 10.5 months, the estimated rate of overall survival at 12 months was 69.</description></item><item><title>Penetrating injury</title><link>https://www.physician.tw/Penetrating-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Penetrating-injury/</guid><description>Penetrating injury Pseudomonas Can be a/w deep tissue abscess Directed based on suscept.</description></item><item><title>peptic ulcer disease</title><link>https://www.physician.tw/peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/peptic-ulcer-disease/</guid><description>[[definition and etiologies of peptic ulcer disease]]
peptic ulcer disease (20‚Äì60%; duodenal&amp;gt;gastric)
(Am J Gastro 2021;116:899)
See ‚Äú[[PUD]]‚Äù
Treatment: PPI: 40 mg PO or IV BID Endoscopic therapy: epi inj + bipolar cautery or hemoclip.</description></item><item><title>pericardial disease</title><link>https://www.physician.tw/pericardial-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericardial-disease/</guid><description>pericardial disease Anatomy
2-layered (parietal &amp;amp; visceral) tissue sac surrounding heart &amp;amp; proximal great vessels Disease states
Inflammation (w/ or w/o fluid accumulation) ‚Üí pericarditis</description></item><item><title>pericardial tamponade</title><link>https://www.physician.tw/pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericardial-tamponade/</guid><description>pericardial tamponade [[Etiology-pericardial tamponade]] [[Pathophysiology-pericardial tamponade]] [[Clinical manifestations-pericardial tamponade]] [[Physical exam-pericardial tamponade]] [[Diagnostic studies-pericardial tamponade]] [[Treatment-pericardial tamponade]]</description></item><item><title>pericarditis and pericardial effusion</title><link>https://www.physician.tw/pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericarditis-and-pericardial-effusion/</guid><description>pericarditis and pericardial effusion [[Etiologies of Acute Pericarditis]] [[Clinical manifestations-pericarditis and pericardial effusion]] [[Physical exam-pericarditis and pericardial effusion]] [[Diagnostic studies-pericarditis and pericardial effusion]] [[Workup for effusion]] [[Treatment of pericarditis]]</description></item><item><title>peripheral artery disease</title><link>https://www.physician.tw/peripheral-artery-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/peripheral-artery-disease/</guid><description>peripheral artery disease [[Clinical features-peripheral artery disease]] [[Diagnosis-peripheral artery disease]] [[Treatment-peripheral artery disease]] [[Acute limb ischemia (ALI)-peripheral artery disease]]</description></item><item><title>Periprocedural ‚ÄúBridging‚Äù of Anticoagulation in Pts with Mechanical Valve s</title><link>https://www.physician.tw/Periprocedural-Bridging-of-Anticoagulation-in-Pts-with-Mechanical-Valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Periprocedural-Bridging-of-Anticoagulation-in-Pts-with-Mechanical-Valves/</guid><description>Periprocedural ‚ÄúBridging‚Äù of Anticoagulation in Pts with Mechanical Valve(s) AVR w/o risk factors d/c warfarin 2‚Äì4 d before surg; restart 12‚Äì24 h after surg</description></item><item><title>Peritoneal dialysis PD</title><link>https://www.physician.tw/Peritoneal-dialysis-PD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peritoneal-dialysis-PD/</guid><description>Peritoneal dialysis (PD) (JAMA 2017;317:1864)
Peritoneal Dialysis | NEJM
Fluid removed via convection using oncotic pressure (eg, dextrose).</description></item><item><title>Peritoneal dialysis-associated-Bacterial peritonitis</title><link>https://www.physician.tw/Peritoneal-dialysis-associated-Bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peritoneal-dialysis-associated-Bacterial-peritonitis/</guid><description>Peritoneal dialysis-associated-Bacterial peritonitis cloudy fluid, abd pain, fever, nausea. Dx can be made with &amp;gt;50 PMNs. Culture most often GPC (50%) or GNR (15%).</description></item><item><title>Pharmacologic options-Treatment-hypertension</title><link>https://www.physician.tw/Pharmacologic-options-Treatment-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pharmacologic-options-Treatment-hypertension/</guid><description>Pharmacologic options-Treatment-hypertension Pre-HTN: ARB prevents onset of HTN, no ‚Üì in clinical events (NEJM 2006;354:1685) HTN: choice of therapy controversial, concomitant disease and stage may help guide Rx; ?</description></item><item><title>Pharmacologic-stress-test</title><link>https://www.physician.tw/Pharmacologic-stress-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pharmacologic-stress-test/</guid><description>Pharmacologic-stress-test Use if unable to exercise, low exercise tolerance, or recent MI. Se &amp;amp; Sp ‚âà exercise.
Preferred if LBBB, WPW or V-paced, because higher prob of false ‚äï imaging with exercise</description></item><item><title>Phases of Chronic HBV Infection</title><link>https://www.physician.tw/Phases-of-Chronic-HBV-Infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phases-of-Chronic-HBV-Infection/</guid><description>Phases of Chronic HBV Infection</description></item><item><title>pheochromocytoma and paraganglioma</title><link>https://www.physician.tw/pheochromocytoma-and-paraganglioma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pheochromocytoma-and-paraganglioma/</guid><description>pheochromocytoma and paraganglioma [[Clinical manifestations-pheochromocytoma and paraganglioma]] [[Diagnostic studies-pheochromocytoma and paraganglioma]] Treatment
Œ±-blockade first (usually phenoxybenzamine) ¬± Œ≤-blockade (often propranolol) ‚Üí surgery Preoperative volume expansion is critical due to possible hypotension after tumor excision</description></item><item><title>phosphate disorders</title><link>https://www.physician.tw/phosphate-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/phosphate-disorders/</guid><description>phosphate disorders [[Hypophosphatemia - Approach to the Patient]]</description></item><item><title>phosphate replacement therapies</title><link>https://www.physician.tw/phosphate-replacement-therapies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/phosphate-replacement-therapies/</guid><description>phosphate replacement therapies In adults with symptomatic mild hypophosphatemia (2-2.5 mg/dL [0.65-0.81 mmol/L]) treat with increased dietary phosphate or oral phosphate supplements 1,000-2,000 mg/day.</description></item><item><title>Physical exam heart failure</title><link>https://www.physician.tw/Physical-exam-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-heart-failure/</guid><description>Physical exam heart failure (‚Äú2-minute‚Äù hemodynamic profile; JAMA 1996;275:630 &amp;amp; 2002;287:628)
Physical exam (‚Äú2-minute‚Äù hemodynamic profile; JAMA 1996;275:630 &amp;amp; 2002;287:628)</description></item><item><title>Physical exam of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Physical-exam-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-of-hypertrophic-cardiomyopathy/</guid><description>Physical exam of hypertrophic cardiomyopathy Sustained PMI, S2 paradoxically split if severe outflow obstruction, ‚äï S4 (occ. palpable)</description></item><item><title>Physical Exam Secret</title><link>https://www.physician.tw/Physical-Exam-Secret/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-Exam-Secret/</guid><description>Physical Exam Secret Postural dizziness (severe enough to stop the test) or an increase in heart rate of at least 30 beats/minute has sensitivity of 97% and specificity of 96% for blood loss &amp;gt;630 mL.</description></item><item><title>Physical exam-acute bacterial meningitis</title><link>https://www.physician.tw/Physical-exam-acute-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-acute-bacterial-meningitis/</guid><description>Physical exam-acute bacterial meningitis Brudzinski and Kernig signs of meningeal irritation appear unreliable for diagnosis or ruling out of meningitis.</description></item><item><title>Physical exam-bacterial endocarditis</title><link>https://www.physician.tw/Physical-exam-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-bacterial-endocarditis/</guid><description>Physical exam-bacterial endocarditis Cardiac murmur (85%), s/s of new HF (pulmonary edema, JVP elevation, edema) Skin/ocular changes (uncommon but highly specific) Janeway lesions (painless hemorrhagic macules on palms/ soles due to septic emboli) Osler‚Äôs nodes (painful nodules on pads of digits due to immune complex deposition) Splinter hemorrhages in fingernails or toenails Roth spots (retinal hemorrhages) MSK: point tenderness along spine, red/hot joints Neurologic deficits c/f embolic stroke; vertebral tenderness c/f osteo or epidural abscess Devices: evaluate CVCs, PM/ICD pocket, and sites of other hardware/ prosthetics</description></item><item><title>Physical exam-cirrhosis</title><link>https://www.physician.tw/Physical-exam-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-cirrhosis/</guid><description>Physical exam-cirrhosis Liver: initially enlarged, palpable (L lobe predom), firm; eventually shrunken, nodular
Signs of liver failure: jaundice (bili &amp;gt;2.</description></item><item><title>Physical exam-constrictive pericarditis</title><link>https://www.physician.tw/Physical-exam-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-constrictive-pericarditis/</guid><description>Physical exam-constrictive pericarditis ‚Üë JVP with prominent y descent, ‚äï Kussmaul sign [Ddx: tricuspid stenosis, acute cor pulmonale, RV dysfxn (CMP, RV MI), SVC syndrome] Hepatosplenomegaly, ascites, peripheral edema.</description></item><item><title>Physical exam-mitral-stenosis</title><link>https://www.physician.tw/Physical-exam-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-mitral-stenosis/</guid><description>Physical exam-mitral-stenosis Low-pitched mid-diastolic rumble at apex w/ presystolic accentuation (if not in AF); best heard in L lat decubitus position during expiration, ‚Üë w/ exercise; severity proportional to duration (not intensity) of murmur; loud S 1 Opening snap (high-pitched early diastolic sound at apex) from fused leaflet tips; MVA proportional to S2‚ÄìOS interval (tighter valve ‚Üí ‚Üë LA pressure ‚Üí shorter interval) Loud S1 (unless MV calcified and immobile)</description></item><item><title>Physical exam-pericardial tamponade</title><link>https://www.physician.tw/Physical-exam-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-pericardial-tamponade/</guid><description>Physical exam-pericardial tamponade Beck‚Äôs triad (present in minority of cases): distant heart sounds (28%), ‚Üë JVP (76%) w/ blunted y descent, hypotension (26%); ¬± pericardial friction rub (30%) Reflex tachycardia (77%), cool extremities Pulsus paradoxus (Se 82%, Sp 70%) = ‚Üì SBP ‚â•10 mmHg during inspiration ‚äï LR 3.</description></item><item><title>Physical exam-pericarditis and pericardial effusion</title><link>https://www.physician.tw/Physical-exam-pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-pericarditis-and-pericardial-effusion/</guid><description>Physical exam-pericarditis and pericardial effusion Pericarditis: multiphasic friction rub best heard at LLSB w/ diaphragm of stethoscope. Notoriously variable and evanescent leathery sound w/ up to 3 components: atrial contraction, ventricular contraction, ventricular relaxation (NEJM 2012;367:e20).</description></item><item><title>Physical Examination</title><link>https://www.physician.tw/Physical-examination/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-examination/</guid><description>Physical Examination Wheezing and prolonged expiratory phase
Presence of nasal polyps, rhinitis, rash ‚Üí allergic component</description></item><item><title>physical findings may help identify the cause of a fever</title><link>https://www.physician.tw/physical-findings-may-help-identify-the-cause-of-a-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/physical-findings-may-help-identify-the-cause-of-a-fever/</guid><description>physical findings may help identify the cause of a fever ‚ú®ÈáçÈªû: ÁÑ°Ê±óÁóáÊîØÊåÅ‰∏≠ÊöëÊàñ‰πæÊìæÂá∫Ê±óÁöÑËó•Áâ©„ÄÇ
ËÇåËÇâÂº∑Áõ¥ÊèêÁ§∫Á•ûÁ∂ìÈòªÊªØÂäëÊÉ°ÊÄßÁ∂úÂêàÂæµÊàñÊÉ°ÊÄßÈ´òÁÜ±„ÄÇ
ÈªÉÁñ∏ÂèØË¶ãÊñºÁ¥∞ËèåÊÑüÊüìÔºåËàáËÇùËÜΩÁ≥ªÁµ±Áõ¥Êé•ÂèóÁ¥ØÁÑ°ÈóúÔºàÂ¶ÇËÜΩÁÆ°ÁÇéÊàñËÇùÁÇéÔºåË¶ãÂïèÈ°å 14Ôºâ„ÄÇ</description></item><item><title>Physical-exam-aortic-regurgitation</title><link>https://www.physician.tw/Physical-exam-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-aortic-regurgitation/</guid><description>Physical-exam-aortic-regurgitation Early diastolic decrescendo murmur at LSB (RSB if dilated Ao root); ‚Üë w/ sitting forward, expir, handgrip; severity of AR ‚àù duration of murmur (except in acute and severe late); Austin Flint murmur: mid-to-late diastolic rumble at apex (AR jet interfering w/ mitral inflow) Wide pulse pressure due to ‚Üë stroke volume, hyper-dynamic pulse; pulse pressure narrows in late AR with ‚Üì LV fxn; bisferiens (twice-beating) arterial pulse PMI diffuse and laterally displaced; soft S1 (early closure of MV); ¬± S3 (‚â† ‚Üì EF but rather just volume overload in AR)</description></item><item><title>Physical-exam-aortic-stenosis</title><link>https://www.physician.tw/Physical-exam-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-aortic-stenosis/</guid><description>Physical-exam-aortic-stenosis Midsystolic crescendo-decrescendo murmur at RUSB, harsh, high-pitched, radiates to carotids, apex (holosystolic = Gallavardin effect), ‚Üë w/ passive leg raise, ‚Üì w/ standing &amp;amp; Valsalva.</description></item><item><title>Physical-exam-mitral-regurgitation</title><link>https://www.physician.tw/Physical-exam-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-mitral-regurgitation/</guid><description>Physical-exam-mitral-regurgitation Early diastolic decrescendo murmur at LSB (RSB if dilated Ao root); ‚Üë w/ sitting forward, expir, handgrip; severity of AR ‚àù duration of murmur (except in acute and severe late); Austin Flint murmur: mid-to-late diastolic rumble at apex (AR jet interfering w/ mitral inflow) Wide pulse pressure due to ‚Üë stroke volume, hyper-dynamic pulse; pulse pressure narrows in late AR with ‚Üì LV fxn; bisferiens (twice-beating) arterial pulse PMI diffuse and laterally displaced; soft S1 (early closure of MV); ¬± S3 (‚â† ‚Üì EF but rather just volume overload in AR) Classic Eponymous Signs in Chronic AR Corrigan‚Äôs pulse ‚Äúwater hammer‚Äù pulse (ie, rapid rise/fall or distention/collapse) Hill‚Äôs sign (popliteal SBP ‚Äì brachial SBP) &amp;gt;60 mmHg Duroziez‚Äôs sign to-and-fro murmur heard over femoral artery w/ light compression Pistol shot sounds pistol shot sound heard over femoral artery Traube‚Äôs sound double sound heard over femoral artery when compressed distally de Musset‚Äôs sign head-bobbing with each heartbeat (low Se) M√ºller‚Äôs sign systolic pulsations of the uvula Quincke‚Äôs pulses subungual capillary pulsations (low Sp)</description></item><item><title>physiology of pulmary</title><link>https://www.physician.tw/physiology-of-pulmary/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/physiology-of-pulmary/</guid><description>physiology of pulmary ÊΩÆÊ∞£2.5L~3L ÊúÄÂ§ß(Total lung capacity)ÂÖ©ÂÄç=5L~6L ÊúÄÂ∞è(Residual Vol)‰∏ÄÂçä=1.25~1.5L Vital capacity = ÊúÄÂ§ß-ÊúÄÂ∞è reserve ÊΩÆÊ∞£ - ÊúÄÂ∞è ÊúÄÂ§ß - ÊΩÆÊ∞£</description></item><item><title>PIK3CA</title><link>https://www.physician.tw/PIK3CA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PIK3CA/</guid><description>PIK3CA PI3K inhib Alpelisib + fulvestrant ‚Üë PFS in met HR‚äï (NEJM 2019;380:1929)</description></item><item><title>Pituitary apoplexy</title><link>https://www.physician.tw/Pituitary-apoplexy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pituitary-apoplexy/</guid><description>Pituitary apoplexy Rapid expansion of pituitary tumor (typically adenoma) due to hemorrhage or infarction Sx include excruciating headache, diplopia, hypopituitarism Rx: immediate high-dose glucocorticoids; prompt surgical decompression if severe neurologic impairment or Œî MS; conservative management if mild</description></item><item><title>pituitary disorders</title><link>https://www.physician.tw/pituitary-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pituitary-disorders/</guid><description>pituitary disorders [[hypopituitary syndromes]] [[hyperpituitary syndromes]] FIGURE 5.2: Hormones secreted by the pituitary gland and their functions. The pituitary is a small gland that is positioned in the base of the brain.</description></item><item><title>Pituitary tumors</title><link>https://www.physician.tw/Pituitary-tumors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pituitary-tumors/</guid><description>Pituitary tumors Pathophysiology: adenoma ‚Üí excess of trophic hormone (if tumor fxnal, but 30‚Äì40% not) and potentially deficiencies in other trophic hormones due to compression; cosecretion of PRL and growth hormone in 10% of prolactinomas Clinical manifestations: specific syndromes due to oversecretion of hormones (see below) ¬± non-specific mass effect: headache, visual Œîs, diplopia, cranial neuropathies Workup: MRI brain pituitary protocol, hormone levels, ¬± visual field testing if &amp;lt;10 mm, no mass effect, no hormone overproduction, can f/up in 12 mos</description></item><item><title>Placement PA catheter and tailored therapy</title><link>https://www.physician.tw/Placement-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Placement-PA-catheter-and-tailored-therapy/</guid><description>Placement PA catheter and tailored therapy Insertion site: R IJ or L subclavian veins preferred for ‚Äúanatomic‚Äù flotation into PA</description></item><item><title>platelet disorders</title><link>https://www.physician.tw/platelet-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/platelet-disorders/</guid><description>platelet disorders thrombocytopenia [[Thrombocytopenia and Risk of Bleeding]] [[Etiologies-of thrombocytopenia]] [[Diagnostic evaluation of thrombocytopenia]] [[Approach to thrombocytopenia]] [[Primary immune thrombocytopenic purpura (ITP) ]] [[Secondary immune thrombocytopenic purpura (2¬∞ ITP)]] [[Heparin-Induced Thrombocytopenias]] [[Thrombotic microangiopathies]] [[Disseminated intravascular coagulation (DIC)]] disorders of platelet function [[Mechanisms and Etiologies of Platelet Function Abnormalities]] Platelet aggregation tests: measure aggregation in response to agonists (eg, ADP) [[von Willebrand‚Äôs disease (vWD)]] [[Uremic bleeding]] BacklinkÔºö [[Diagnostic evaluation of thrombocytopenia]] [[hematology]] [[Microangiopathic hemolytic anemia]]</description></item><item><title>Platelets-transfusion</title><link>https://www.physician.tw/Platelets-transfusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Platelets-transfusion/</guid><description>Platelets-transfusion For plts &amp;lt;10k (NEJM 2010;362:600) due to chemo/abx. If &amp;lt;20k or if &amp;lt;50k w/ active bleeding. Variable pre-procedure.100k for neurosurgery.</description></item><item><title>pleocytosis</title><link>https://www.physician.tw/pleocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pleocytosis/</guid><description>pleocytosis Âú®Ë°Ä‰∏≠Âè´leukocytosis Âú®CSF ‰∏≠Âè´ÂÅöpleocytosis ÂÖ©ËÄÖÈÉΩÂú®ÊòØÂú®Á¥∞ËÉûÂ¢ûÂ§öÁöÑÊÑèÊÄù
In medicine, pleocytosis (or pleiocytosis) is an increased cell count (from Greek pleion, &amp;ldquo;more&amp;rdquo;) particularly an increase in white blood cell count, in a bodily fluid, such as cerebrospinal fluid.</description></item><item><title>pleural effusion</title><link>https://www.physician.tw/pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pleural-effusion/</guid><description>pleural effusion [[Pathophysiology-pleural effusion]] [[Transudates]] [[Exudates]] [[Diagnostic studies-pleural effusion]] [[Characteristics of Pleural Fluid]] [[Treatment-pleural effusion]] [[Hemothroax]]</description></item><item><title>Pneumocystis jiroveci PCP pneumonia</title><link>https://www.physician.tw/Pneumocystis-jiroveci-PCP-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pneumocystis-jiroveci-PCP-pneumonia/</guid><description>Pneumocystis jiroveci (PCP) pneumonia fever, night sweats, dyspnea on exertion, dry (‚Äúdoorstop‚Äù) cough CXR w/ interstitial pattern, ‚Üì PaO2, ‚Üë A-a ‚àá, ‚Üë LDH, ‚äï PCP sputum stain, ‚äï Œ≤-glucan Rx if PaO2 &amp;gt;70: TMP-SMX 15‚Äì20 mg of TMP/kg divided tid, avg dose = DS 2 tabs PO tid Rx if PaO2 &amp;lt;70 or A-a gradient &amp;gt;35: prednisone before abx (40 mg PO bid; ‚Üì after 5 d) HIV ‚äï smokers much more likely to die from lung cancer than OI (JAMA 2017;177:1613)</description></item><item><title>pneumonia</title><link>https://www.physician.tw/pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pneumonia/</guid><description>pneumonia [[Definitions-and-clinical-manifestations]] [[Microbiology-of-Pneumonia]] [[Diagnostic studies-pneumonia]] (AJRCC 2019;200:e45) [[Triage-pneumonia]] [[Treatment-pneumonia]] (NEJM 2019;380:651; AJRCC 2019;200:e45) [[Prevention-pneumonia]] [[viral respiratory infections]] [[coronavirus (covid-19)]] / sars-cov-2 infection</description></item><item><title>Polyarteritis nodosa</title><link>https://www.physician.tw/Polyarteritis-nodosa/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polyarteritis-nodosa/</guid><description>Polyarteritis nodosa Usually middle-aged males. Hepatitis B seropositivity in 30% of patients. Fever, weight loss, malaise, headache. GI: abdominal pain, melena.</description></item><item><title>Polycystic kidney disease</title><link>https://www.physician.tw/Polycystic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polycystic-kidney-disease/</guid><description>Polycystic kidney disease (NEJM 2008;359:1477; 2017;377:1988)
Mostly AD PKD1/PKD2 mutations ‚Üí renal cysts. PKD1 (85%) younger-onset ESRD.
Rx: hydration, low-salt diet; tolvaptan reduces GFR decline.</description></item><item><title>Polymorphic ventricular tachycardia PMVT</title><link>https://www.physician.tw/Polymorphic-ventricular-tachycardia-PMVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polymorphic-ventricular-tachycardia-PMVT/</guid><description>Polymorphic ventricular tachycardia (PMVT) QRS morphology changes from beat to beat Etiologies: ischemia; CMP; catecholaminergic torsades de pointes (TdP = ‚Äútwisting of the points,‚Äù PMVT + ‚Üë QT): ‚Üë QT acquired (meds, lytes, stroke, see ‚ÄúECG‚Äù) w/ risk ‚Üë w/ ‚Üì HR, freq PVCs (pause dependent) or congenital (K/Na channelopathies) w/ resting Tw abnl &amp;amp; TdP triggered by sympathetic stimulation (eg, exercise, emotion, sudden loud noises) (Lancet 2008;372:750) Brugada syndrome (Na channelopathy; JACC 2018;72:1046): ‚ôÇ &amp;gt; ‚ôÄ; pseudo-RBBB w/ STE in V1‚ÄìV3 (provoked w/ class IA or IC) on resting ECG</description></item><item><title>Polymyalgia rheumatica</title><link>https://www.physician.tw/Polymyalgia-rheumatica/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polymyalgia-rheumatica/</guid><description>Polymyalgia rheumatica (JAMA 2016;315:2442; Lancet 2017;390:1700)
Prev 7/1000 of age ‚â•50. In 50% of GCA Pts; 15% of PMR Pts develop GCA.</description></item><item><title>Polyp or Tumor</title><link>https://www.physician.tw/Polyp-or-Tumor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polyp-or-Tumor/</guid><description>Polyp or Tumor Typically slow ooze, p/w fatigue, weight loss, iron deficiency, anemia</description></item><item><title>polyps</title><link>https://www.physician.tw/polyps/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polyps/</guid><description>polyps Pathophysiology &amp;amp; epidemiology (NEJM 2016;374:1065) Accumulation of mutations in colonic epithelial cell DNA affecting oncogenes &amp;amp; tumor suppressor genes ‚Üí tumor initiation (formation of adenoma; APC loss of fxn) ‚Üí tumor progression (adenoma ‚Üí carcinoma; K-ras gain of fxn, DCC, p53 loss of fxn) Risk factors: ‚Üë age, FHx (sporadic in 1¬∞ relatives, Lynch, FAP), IBD, ‚Üë dietary fat, central adiposity, ‚Üë EtOH, ‚Üì fiber, ‚Üë red meat, smoking, DM Protective factors: ‚Üë physical activity, ASA/NSAIDs, Ca2+ intake, HRT, ‚Üì BMI; possibly ‚Üë fiber, vitamin D, fish oil, statins, selenium Neoplastic polyps: adenomas (tubular, villous, tubulovillous dysplasia), sessile serrated adenomas/polyps (concern for interval CRC), carcinomas Non-neoplastic polyps: hyperplastic, juvenile, Peutz-Jeghers (can undergo malignant transformation), inflammatory [[CRC screening]]</description></item><item><title>polyuria</title><link>https://www.physician.tw/polyuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polyuria/</guid><description>polyuria Definition and pathophysiology Polyuria defined as &amp;gt;3 L UOP per day Due to an osmotic or a water diuresis; almost always due to osmotic diuresis in inpatients Workup Perform a timed urine collection (6 h sufficient) and measure Uosm 24-h osmole excretion rate = 24-h UOP (actual or estimate) √ó Uosm 1000 mOsm/d ‚Üí osmotic diuresis; &amp;lt;800 mOsm/d ‚Üí water diuresis</description></item><item><title>Poor-R-wave-progression</title><link>https://www.physician.tw/Poor-R-wave-progression/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Poor-R-wave-progression/</guid><description>Poor-R-wave-progression (Am Heart J 2004;148:80)
ÂèÉËÄÉ‚û°Ô∏è Electrocardiographic poor R-wave progression: analysis of multiple criteria reveals little usefulness
Definition: loss of anterior forces w/o frank Q waves (V1‚ÄìV3); R wave in V3 ‚â§3 mm</description></item><item><title>Portal HTN gastropathy</title><link>https://www.physician.tw/Portal-HTN-gastropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Portal-HTN-gastropathy/</guid><description>Portal HTN gastropathy ‚Üë portal venous pressure ‚Üí ectatic vessels, hyperemia in gastric antrum. Rx: reduce portal HTN (octreotide), Œ≤B, TIPS.</description></item><item><title>Portal vein thrombosis PVT</title><link>https://www.physician.tw/Portal-vein-thrombosis-PVT-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Portal-vein-thrombosis-PVT-/</guid><description>Portal vein thrombosis (PVT) (Clin Liver Dis 2017;10:152; Gastro 2019;156:1582)
Definition: thrombosis of portal vein often w/ extension into mesenteric vein/splenic vein Etiologies: commonly due to cirrhosis or hypercoaguable state (cancer, infection, OCP, collagen vascular diseases, Beh√ßet‚Äôs, IBD, surgery, trauma, OCPs, preg) [[Clinical manifestations-Portal vein thrombosis (PVT)]] [[Dx-Portal vein thrombosis (PVT)]] [[Treatment-Portal vein thrombosis (PVT)]]</description></item><item><title>Portopulmonary hypertension POPH</title><link>https://www.physician.tw/Portopulmonary-hypertension-POPH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Portopulmonary-hypertension-POPH/</guid><description>Portopulmonary hypertension (POPH) (Expert Rev Gastro Hepatol 2015;9:983)
Pulm HTN in Pt w/ portal HTN w/o other cause. ESLD‚Üí ‚Üë endothelin‚Üí pulm vasoconst.</description></item><item><title>positioning-airway-management</title><link>https://www.physician.tw/positioning-airway-management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/positioning-airway-management/</guid><description>positioning-airway-management ‚ú®ÈáçÈªû: Êèê‰æõËÄÖÁ´ôÂú®Â∫äÈ†≠ÔºåÊÇ£ËÄÖÁöÑÈ†≠ÈÉ®ÊáâÁõ°ÂèØËÉΩÈù†ËøëÂ∫äÈ†≠„ÄÇ Ê≠£Á¢∫ÁöÑÂÆö‰ΩçÂèØ‰ª•ÂâµÂª∫ÂæûÊÇ£ËÄÖÂè£ËÖîÂà∞ÂñâÈÉ®ÁöÑÁõ¥Êé•Ë¶ñÁ∑ö„ÄÇ ÈÄôÊòØÈÄöÈÅé‰ΩøÁî®ÊûïÈ†≠/ÊØØÂ≠ê‰ΩøÈ†∏Ê§éÂΩéÊõ≤Â§ßÁ¥Ñ 30¬∞ ‰ª•Âèä‰º∏Â±ïÂØ∞ÊûïÈóúÁØÄÔºàÁ∂ìÂÖ∏ÁöÑ‚ÄúÂóÖÊé¢ÂßøÂã¢‚ÄùÔºâ‰æÜÂØ¶ÁèæÁöÑ„ÄÇ ÂÆö‰ΩçËÇ•ËÉñÊÇ£ËÄÖÂèØËÉΩÁâπÂà•ÂÖ∑ÊúâÊåëÊà∞ÊÄß„ÄÇ ÈÄôÂèØ‰ª•ÈÄöÈÅéÂΩ¢Êàê‰∏ÄÂÄãÂù°ÈÅì‰æÜÂØ¶ÁèæÔºåÊä¨È´ò‰∏äËÉåÈÉ®ÂíåËÇ©ÈÉ®‰ª•ÈÅ©ÊáâË∂≥Â§†ÁöÑÈ†∏Ê§éÂ±àÊõ≤„ÄÇ Confirming horizontal alignment of the external auditory meatus with the sternal notch can be a useful guide.</description></item><item><title>positive and negative predictive values of tests</title><link>https://www.physician.tw/positive-and-negative-predictive-values-of-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/positive-and-negative-predictive-values-of-tests/</guid><description>positive and negative predictive values of tests ‚ú®ÈáçÈªû: ÊïèÊÑüÊÄßÔºöÊÇ£ÊúâÊ≠£Âú®Êé•ÂèóÊ™¢Ê∏¨ÁöÑÁñæÁóÖ‰∏¶‰∏îÊ™¢Ê∏¨ÁµêÊûúÂëàÈôΩÊÄßÁöÑÊÇ£ËÄÖÁöÑÁôæÂàÜÊØî ÁâπÁï∞ÊÄßÔºöÊú™ÊÇ£ÁóÖ‰∏îÊ™¢Ê∏¨ÁµêÊûúÁÇ∫Èô∞ÊÄßÁöÑÊÇ£ËÄÖÁôæÂàÜÊØî ÈôΩÊÄßÈ†êÊ∏¨ÂÄºÔºöÊ™¢Ê∏¨ÁµêÊûúÂëàÈôΩÊÄß‰∏¶ÊÇ£ÊúâÊ≠£Âú®Ê™¢Ê∏¨ÁöÑÁñæÁóÖÁöÑÊÇ£ËÄÖÁôæÂàÜÊØî Èô∞ÊÄßÈ†êÊ∏¨ÂÄºÔºöÊ™¢Ê∏¨ÁµêÊûúÁÇ∫Èô∞ÊÄß‰ΩÜÊú™ÊÇ£ÁóÖÁöÑÊÇ£ËÄÖÁôæÂàÜÊØî</description></item><item><title>Post-exacerb care of COPDAE</title><link>https://www.physician.tw/Post-exacerb-care-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-exacerb-care-of-COPDAE/</guid><description>Post-exacerb care of COPDAE Follow up within 1 mo; smoking cessation if current smoker; vaccinations (influenza, pneumococcal), referral to pulm rehab (AJRCCM 2007;176:532)</description></item><item><title>Post-renal acute kidney injury etiology</title><link>https://www.physician.tw/Post-renal-acute-kidney-injury-etiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-renal-acute-kidney-injury-etiology/</guid><description>Post-renal acute kidney injury etiology Bladder neck: BPH, prostate cancer, neurogenic bladder, anticholinergic meds Ureteral (bilateral or unilateral in single kidney): malig, LAN, retroperitoneal fibrosis, nephrolithiasis UA, Sediment, Indices Bland ¬± non-dysmorphic RBCs, WBC, crystals</description></item><item><title>Post-sphincter-otomy bleeding</title><link>https://www.physician.tw/Post-sphincter-otomy-bleeding/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-sphincter-otomy-bleeding/</guid><description>Post-sphincter-otomy bleeding Occurs in ~2% of ERCP w/ sphincterotomy; ‚Üë risk w/ more complic. procedure. Bleeding into duodenum. Rx w/ endo hemostasis.</description></item><item><title>potassium homeostasis</title><link>https://www.physician.tw/potassium-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/potassium-homeostasis/</guid><description>potassium homeostasis [[Overview-potassium homeostasis]] [[hypokalemia]] [[hyperkalemia]]</description></item><item><title>POUNDing Mnemonic</title><link>https://www.physician.tw/POUNDing-Mnemonic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/POUNDing-Mnemonic/</guid><description>POUNDing Mnemonic Pulsatile hOurs (duration of 4-72 hours) Unilateral Nauseating Disabling</description></item><item><title>Prasugrel</title><link>https://www.physician.tw/Prasugrel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prasugrel/</guid><description>Prasugrel 60 mg √ó 1 at PCI ‚Üí 10 mg qd (consider 5 mg/d if &amp;lt;60 kg) Wait 7 d prior to surgery Contraindicated if h/o TIA/CVA; caution if &amp;gt;75 y More rapid and potent plt inhib c/w clopi 19% ‚Üì CVD/MI/stroke in ACS w/ planned PCI vs.</description></item><item><title>Precipitants of acute heart failure</title><link>https://www.physician.tw/Precipitants-of-acute-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-of-acute-heart-failure/</guid><description>Precipitants of acute heart failure Dietary indiscretion or medical nonadherence (~40% of cases) Myocardial ischemia or infarction (~10‚Äì15% of cases); myocarditis Renal failure (acute, progression of CKD, or insufficient dialysis) ‚Üí ‚Üë preload Hypertensive crisis (incl.</description></item><item><title>Precipitants of Migraine</title><link>https://www.physician.tw/Precipitants-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-of-Migraine/</guid><description>Precipitants of Migraine stress foods (cheese, chocolate, MSG) fatigue EtOH menses exercise</description></item><item><title>Precipitants-diabetic ketoacidosis</title><link>https://www.physician.tw/Precipitants-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-diabetic-ketoacidosis/</guid><description>Precipitants-diabetic ketoacidosis 1+2+2+2 = 7 Á¥†ÁÇéÁº∫ÊØí
(the I‚Äôs)
Insulin defic. (ie, failure to take enough insulin); ÁÇé Infection (pneumonia, UTI) or Inflammation (pancreatitis, cholecystitis) Áº∫Ë°Ä Ischemia or Infarction (myocardial, cerebral, gut); Â§ñÁâ© Iatrogenesis (glucocorticoids; SGLT2 inhibitors‚Äîcan be w/o marked hyperglycemia; Diabetes Care 2016;39:532) ÂèÉËÄÉ‚û°Ô∏è Diabetic ketoacidosis with canagliflozin, a sodium‚Äìglucose cotransporter 2 inhibitor, in patients with type 1 diabetes</description></item><item><title>Precipitants-hypertensive crises</title><link>https://www.physician.tw/Precipitants-hypertensive-crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-hypertensive-crises/</guid><description>Precipitants-hypertensive crises Progression of essential HTN ¬± medical noncompliance (espec clonidine) or ‚àÜ in diet Progression of renovascular disease; acute glomerulonephritis; scleroderma; preeclampsia Endocrine: pheochromocytoma, Cushing‚Äôs Sympathomimetics: cocaine, amphetamines, MAO inhibitors + foods rich in tyramine</description></item><item><title>predictors of difficult mask ventilation</title><link>https://www.physician.tw/predictors-of-difficult-mask-ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/predictors-of-difficult-mask-ventilation/</guid><description>predictors of difficult mask ventilation ÁÑ°ÁâôÈ†úÂπ¥ÈΩ° 55 Ê≠≤Êàñ‰ª•‰∏ä Áî∑ÊÄßÊÇ£ËÄÖ Èù¢ÈÉ®ÊØõÈ´Æ ËÇ•ËÉñ ÈòªÂ°ûÊÄßÁù°Áú†ÂëºÂê∏Êö´ÂÅú</description></item><item><title>premedication of airway-management</title><link>https://www.physician.tw/premedication-of-airway-management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/premedication-of-airway-management/</guid><description>premedication of airway-management A: Atopine 1mg C: Cardiac monitor L: [[Lidocaine]] 1.0~1.5mg/kg 2% 50kg 75mg ËÉñ‰∏ÄÈªûÁöÑ100mg S: Sedation: * dormicum 0.</description></item><item><title>Preoperative evaluation</title><link>https://www.physician.tw/Preoperative-evaluation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preoperative-evaluation/</guid><description>Preoperative evaluation (Circ 2014;130:e278, NEJM 2015;373:2258, JAMA 2020;324:279)
(Modified with permission Circulation. 2014;130:2215-2245 ¬© 2014 American Heart Association, Inc.)</description></item><item><title>preoxygenation</title><link>https://www.physician.tw/preoxygenation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preoxygenation/</guid><description>preoxygenation Èô§ÊúÄÁ∑äÊÄ•ÁöÑÊÉÖÊ≥ÅÂ§ñÔºåÊáâÂú®ÊâÄÊúâÊÉÖÊ≥Å‰∏ãÊèê‰æõÂÖÖÂàÜÁöÑÈ†êÊ∞ßÂêà„ÄÇ
ÁõÆÁöÑÊòØÁî®Ê∞ßÊ∞£‰ª£ÊõøËÇ∫ÈÉ®ÁöÑÊ∞ÆÊ∞£„ÄÇ
Áï∂ÊÇ£ËÄÖÂá∫ÁèæÂëºÂê∏Êö´ÂÅúÊôÇÔºåÈÄôÊúÉÂ¢ûÂä†ÂéªÈ£ΩÂíåÂâçÁöÑÊôÇÈñìÈï∑Â∫¶Ôºà‚ÄúÂëºÂê∏Êö´ÂÅúÊôÇÈñì‚ÄùÔºâÔºåÂæûËÄåÂú®ÈÄöÊ∞£ÂíåÊèíÁÆ°ËÆäÂæóÂõ∞Èõ£ÁöÑÊÉÖÊ≥Å‰∏ãÊèê‰æõÂÆâÂÖ®ÈÇäÈöõ„ÄÇ
ÂèØ‰ª•‰ΩøÁî®Èù¢ÁΩ©„ÄÅÈÄ£Á∫åÊàñÈõôÊ∞¥Âπ≥Ê∞£ÈÅìÊ≠£Â£ìÊàñÈ´òÊµÅÈáèÈºªÂ∞éÁÆ° (HFNC) ÈÄ≤Ë°åÈ†êÊ∞ßÂêàÔºå‰ª•Ëá≥Â∞ë 10 L/min ÁöÑÊµÅÈáèÊèê‰æõ 100% Ê∞ßÊ∞£„ÄÇ</description></item><item><title>Prerenal acute kidney injury etiology</title><link>https://www.physician.tw/Prerenal-acute-kidney-injury-etiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prerenal-acute-kidney-injury-etiology/</guid><description>Prerenal acute kidney injury etiology ‚Üì Effective arterial volume (NEJM 2007;357:797) Hypovolemia, ‚Üì CO (CHF), ‚Üì oncotic pressure (cirrhosis, nephrotic), vasodilation (sepsis) Œî local renal perfusion: NSAIDs, ACEI/ARB, contrast, calcineurin inhib, HRS, hyperCa Large vessel: RAS (bilateral + ACEI), VTE, dissection, abd compart.</description></item><item><title>Presentation of Thyroid storm</title><link>https://www.physician.tw/Presentation-of-Thyroid-storm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Presentation-of-Thyroid-storm/</guid><description>Presentation of Thyroid storm delirium, fever, tachycardia, systolic HTN w/ wide pulse pressure and ‚Üì MAP, GI symptoms; 20‚Äì30% mortality</description></item><item><title>Pressors inotropes-sepsis and shock</title><link>https://www.physician.tw/Pressors-inotropes-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pressors-inotropes-sepsis-and-shock/</guid><description>Pressors inotropes-sepsis and shock MAP target 65 mmHg as good as 80‚Äì85 and ‚Üì AF (NEJM 2014;370:1583; JAMA 2020;323:938)</description></item><item><title>Prevention of chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Prevention-of-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-of-chronic-obstructive-pulmonary-disease/</guid><description>Prevention of chronic obstructive pulmonary disease Flu/Pneumovax; smoking cessation ‚Üí 50% ‚Üì in lung function decline (AJRCCM 2002;166:675) and ‚Üì long-term mortality (Annals 2005;142:223)</description></item><item><title>Prevention-Contrast-induced acute kidney injury</title><link>https://www.physician.tw/Prevention-Contrast-induced-acute-kidney-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-Contrast-induced-acute-kidney-injury/</guid><description>Prevention-Contrast-induced acute kidney injury consider if eGFR &amp;lt;60 (espec. w/ proteinuria) DM MI HoTN (CJASN 2013;8:1618) Prevention Isotonic IV fluids: may be helpful if high risk (Lancet 2017;389:1312) Outpatients: 3 mL/kg/h √ó 1 h prior, 1‚Äì1.</description></item><item><title>Prevention-pneumonia</title><link>https://www.physician.tw/Prevention-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-pneumonia/</guid><description>Prevention-pneumonia All persons &amp;gt;65 or age 19‚Äì64 w/ CHF, lung disease, cirrhosis, DM, EtOH, smoker, immunosupp. (eg, ESRD, organ transplant, HIV, leukemia, lymphoma, asplenia) PCV20 vaccine or PCV15 + PPSV23 1 yr later</description></item><item><title>Preventive treatment of Migraine</title><link>https://www.physician.tw/Preventive-treatment-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preventive-treatment-of-Migraine/</guid><description>Preventive treatment of Migraine Recommended for patients adversely affected on ‚â•2 days per month despite optimized acute therapy First-line medication Beta blockers (propranolol, metoprolol, atenolol, bisoprolol) [[Topiramate]] Candesartan Second-line medication Flunarizine Amitriptyline Sodium valproate Third-line medication CGRP monoclonal antibodies</description></item><item><title>Primary biliary cholangitis PBC</title><link>https://www.physician.tw/Primary-biliary-cholangitis-PBC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-biliary-cholangitis-PBC/</guid><description>Primary biliary cholangitis (PBC) (Hep 2019;69:394; Nat Rev 2020;17:93; Lancet 2020;396:1915)
Autoimmune destruction of intrahepatic bile ducts
Epi: ‚ôÄ 40‚Äì60 y; a/w Sj√∂gren‚Äôs (50%), Raynaud‚Äôs, scleroderma, celiac &amp;amp; thyroid disease; may be triggered by infxns or toxins; a/w X monosomy, variants in IL12Œ± &amp;amp; IL12R genes</description></item><item><title>Primary central nervous system vasculitis</title><link>https://www.physician.tw/Primary-central-nervous-system-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-central-nervous-system-vasculitis/</guid><description>Primary central nervous system vasculitis ÂéüÁôºÊÄß‰∏≠Ê®ûÁ•ûÁ∂ìÁ≥ªÁµ±Ë°ÄÁÆ°ÁÇéÊòØ‰∏ÄÁ®ÆÁΩïË¶ãÁöÑ‰∏îÁü•Ë≠òÊ∑µÂçöÁöÑË°ÄÁÆ°ÁÇéÔºåÂÉÖÈôêÊñºÂ§ßËÖ¶ÂíåËÑäÈ´ì„ÄÇ Ë™çË≠òÂà∞ÈÄôÁ®ÆÁñæÁóÖÊòØ‰∏ÄÁ®ÆÁç®ÁâπÁöÑÁóÖÊÖãÂØ¶È´îÔºåÂÖ∂Ê≠∑Âè≤ÂèØ‰ª•ËøΩÊ∫ØÂà∞1950Âπ¥‰ª£‰∏≠ÊúüÔºå Áï∂ÊôÇCraviotoÂíåFeigin1ÊèèËø∞‰∫ÜËàáÁ•ûÁ∂ìÁ≥ªÁµ±Áõ∏ÈóúÁöÑÂπæ‰æãÈùûÊÑüÊüìÊÄßËÇâËäΩËÖ´ÊÄßË°ÄÁÆ°ÁÇé„ÄÇ
CNSÔºå3„ÄÅ4ÊàñÊõ¥ÂÖ∑È´îÂú∞ÔºåCNSÁöÑÈùûÊÑüÊüìÊàñÁâπÁôºÊÄßÈ°ÜÁ≤íÁãÄË°ÄÁÆ°ÁÇéÂíå‰∏≠Ê®ûÁ•ûÁ∂ìÁ≥ªÁµ±ÁöÑÈâÖÁ¥∞ËÉûÂãïËÑàÁÇéÔºå7ÂÄãCNSÁöÑ7ÂÄãÂ≠§Á´ãË°ÄÁÆ°ÁÇéÔºå8ÂÄãCNSÁöÑÂéüÁôºÊÄßË°ÄÁÆ°ÁÇéÔºå9ÂíåCNSÁöÑÂéüÁôºÊÄßË°ÄÁÆ°ÁÇéÔºå9ÂíåCNSÁÇé„ÄÇCNS.</description></item><item><title>Primary glomerular diseases grouped by pathology</title><link>https://www.physician.tw/Primary-glomerular-diseases-grouped-by-pathology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-glomerular-diseases-grouped-by-pathology/</guid><description>Primary glomerular diseases (grouped by pathology) [[Focal segmental glomerulosclerosis]] [[Membranous nephropathy]] [[Minimal change disease]] [[Membranoproliferative GN]] [[Fibrillary-immunotactoid glomerulopathy]] (1%) Fibrillary Glomerulonephritis and Immunotactoid Glomerulopat&amp;hellip; : Journal of the American Society of Nephrology [[Mesangial proliferative GN]]</description></item><item><title>Primary headache syndromes</title><link>https://www.physician.tw/Primary-headache-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-headache-syndromes/</guid><description>Primary headache syndromes [[Tension-type headache]] [[Cluster headache]] [[Migraine]]</description></item><item><title>Primary Hyperaldosteronism</title><link>https://www.physician.tw/Primary-Hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Hyperaldosteronism/</guid><description>Primary Hyperaldosteronism (adrenal disorders, renin-independent increase in aldosterone; JCEM 2015;100:1)
[[adrenal hyperplasia]] (60‚Äì70%), adenoma ([[Conn‚Äôs syndrome]], 30‚Äì40%), [[adrenocortical cancer]], [[glucocorticoid-remediable aldosteronism]] (GRA; ACTH-dep.</description></item><item><title>Primary hyperparathyroidism</title><link>https://www.physician.tw/Primary-hyperparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-hyperparathyroidism/</guid><description>Primary hyperparathyroidism The serum level of parathyroid hormone, calcium, phosphorus, and 25-hydroxyvitamin D should be measured. Patients with secondary hyperparathyroidism usually have low-normal calcium and elevated parathyroid hormone.</description></item><item><title>Primary immune thrombocytopenic purpura ITP</title><link>https://www.physician.tw/Primary-immune-thrombocytopenic-purpura-ITP-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-immune-thrombocytopenic-purpura-ITP-/</guid><description>Primary immune thrombocytopenic purpura (ITP) (Blood 2010;115:168)
Isolated thrombocytopenia due to immune plt destruction (auto-Ab to plts) &amp;amp; ‚Üì production (auto-Ab to megakaryocytes) without precipitant</description></item><item><title>Primary sclerosing cholangitis PSC</title><link>https://www.physician.tw/Primary-sclerosing-cholangitis-PSC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-sclerosing-cholangitis-PSC/</guid><description>Primary sclerosing cholangitis (PSC) (NEJM 2016;375:1161; Clin Liver Dis 2020;15:125)
Diffuse inflammation of intrahepatic and extrahepatic bile ducts leading to fibrosis &amp;amp; stricturing of biliary system.</description></item><item><title>Principles of Imaging in Vasculitides</title><link>https://www.physician.tw/Principles-of-Imaging-in-Vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-of-Imaging-in-Vasculitides/</guid><description>Principles of Imaging in Vasculitides for large- and certain medium-vessel vasculitides, various imaging techniques can be useful magnetic resonance angiography (MRA) or computed tomography angiography (CTA) allow for the assessment of extensive vascular territories vessels not readily accessible for tissue biopsy ultrasound, particularly color-coded duplex sonography, is often used as first-line imaging in patients with suspected giant cell arteritis (GCA) small-vessel vasculitides difficult to directly visualize with imaging indirect signs can be detected; this may play a role in evaluating disease activity and extent of involvement Reference - Curr Rheumatol Rep 2020 Jun 19;22(8):34</description></item><item><title>Principles of treatment-asthma</title><link>https://www.physician.tw/Principles-of-treatment-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-of-treatment-asthma/</guid><description>Principles of treatment-asthma Education and avoidance of environmental triggers (Lancet 2015;386:1075); yearly flu shot
Use quick-relief rescue medication as needed for all Pts</description></item><item><title>Principles-solitary pulmonary nodule</title><link>https://www.physician.tw/Principles-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-solitary-pulmonary-nodule/</guid><description>Principles-solitary pulmonary nodule Definition: single, well-defined, &amp;lt;3 cm, surrounded by nl lung, no LAN or pleural effusion
Often ‚Äúincidentalomas,‚Äù esp with ‚Üë CT use, but may still be early, curable malignancy</description></item><item><title>Prinzmetal's variant angina</title><link>https://www.physician.tw/Prinzmetal-s-variant-angina/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prinzmetal-s-variant-angina/</guid><description>Prinzmetal&amp;rsquo;s variant angina Coronary spasm ‚Üí transient STE usually w/o MI (but MI, AVB, VT can occur) Pts usually young, smokers ¬± other vasospastic disorders (eg, migraines, Raynaud‚Äôs) Angiography: nonobstructive CAD (spasm can be provoked during cath but rarely done) [[Treatment of Prinzmetals variant angina]] Cocaine-induced vasospasm: CCB, nitrates, ASA; ?</description></item><item><title>Procainamide</title><link>https://www.physician.tw/Procainamide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Procainamide/</guid><description>Procainamide 10-15 mg/kg IV n/a decrease BP: 1 QT:¬± AVN blocker %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Procedures-Endocarditis Prophylaxis</title><link>https://www.physician.tw/Procedures-Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Procedures-Endocarditis-Prophylaxis/</guid><description>Procedures-Endocarditis Prophylaxis Dental: manipulation of gingival tissue or periapical region of teeth or perf oral mucosa (eg, extraction, periodontal, implant, root canal, cleaning)</description></item><item><title>Prognosis-acute liver failure</title><link>https://www.physician.tw/Prognosis-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-acute-liver-failure/</guid><description>Prognosis-acute liver failure (Ann Intern Med 2016;164:724; World J Gastro 2016;22:1523)
Non-acetaminophen ALF mortality ~70%, acetaminophen-induced ALF mortality ~25‚Äì30%</description></item><item><title>Prognosis-acute pancreatitis</title><link>https://www.physician.tw/Prognosis-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-acute-pancreatitis/</guid><description>Prognosis-acute pancreatitis Acute pancreatitis; an analysis of 76 cases with especial reference to clinical signs of the severity of the disease - PubMed</description></item><item><title>Prognosis-Alcohol-associated hepatitis</title><link>https://www.physician.tw/Prognosis-Alcohol-associated-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-Alcohol-associated-hepatitis/</guid><description>Prognosis-Alcohol-associated hepatitis scoring systems include Maddrey‚Äôs discriminant fxn (MDF), Lille model, MELD
MDF (4.6 √ó [PT ‚Äì control] + Tb) ‚â•32 w/ 30‚Äì50% 1-mo mortality if unRx‚Äôd (Gastro 1996;110:1847)</description></item><item><title>Prognosis-cirrhosis</title><link>https://www.physician.tw/Prognosis-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-cirrhosis/</guid><description>Prognosis-cirrhosis ( www.mdcalc.com/child-pugh-score-cirrhosis-mortality)
Modified Child-Turcotte-Pugh (CPS) score based on ascites, enceph., &amp;amp; labs (bili, alb &amp;amp; INR; see Appendix).</description></item><item><title>Prognosis-pulmonary hypertension</title><link>https://www.physician.tw/Prognosis-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-pulmonary-hypertension/</guid><description>Prognosis-pulmonary hypertension Median survival after dx ~2.8 y; PAH (all etiologies): 2-y 66%, 5-y 48% (Chest 2004;126:78‚ÄìS)
Poor prognostic factors: clinical evidence of RV failure, rapidly progressive sx, WHO (modified NYHA) class IV, 6MWT &amp;lt;300 m, peak VO2 &amp;lt;10.</description></item><item><title>Prognosis-syncope</title><link>https://www.physician.tw/Prognosis-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-syncope/</guid><description>Prognosis-syncope (Ann Emerg Med 1997;29:459; NEJM 2002;347:878)
22% overall recurrence rate if idiopathic, else 3% recurrence Cardiac syncope has poor prognosis (20‚Äì40% 1-y SCD rate); vasovagal good prognosis Unexplained syncope w/ 1.</description></item><item><title>Prognosis-ulcerative colitis</title><link>https://www.physician.tw/Prognosis-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-ulcerative-colitis/</guid><description>Prognosis-ulcerative colitis 50% in remission at any given time. Intermittent exacerbations in 90%; continual active disease in ~18%. Prox progression in 25% at 10 y.</description></item><item><title>Prolonged-QT-interval</title><link>https://www.physician.tw/Prolonged-QT-interval/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prolonged-QT-interval/</guid><description>Prolonged-QT-interval (NEJM 2008;358:169; www.torsades.org)
ÂèÉËÄÉ‚û°Ô∏è Long-QT syndrome
Prolonged QT interval (NEJM 2008;358:169; www.torsades.org) Measure QT using threshold method (start of QRS to end of Tw at isoelectric line) or tangent (QRS to where tangent of Tw downslope intersects baseline) when long tail.</description></item><item><title>Propafenone</title><link>https://www.physician.tw/Propafenone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Propafenone/</guid><description>Propafenone 600 mg PO x 150-300mg tid n/a [[Flecainide]] %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Properties and Antidotes for Anticoagulants Fibrinolytics</title><link>https://www.physician.tw/Properties-and-Antidotes-for-Anticoagulants-Fibrinolytics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Properties-and-Antidotes-for-Anticoagulants-Fibrinolytics/</guid><description>Properties and Antidotes for Anticoagulants Fibrinolytics [[Direct Oral Anticoagulants (DOACs) for NVAF]]
UFH 60‚Äì90‚Ä≤, RES ‚Üë PTT Protamine IV 1 mg/100 U UFH (max 50 mg).</description></item><item><title>Prophylaxis-HIV AIDS</title><link>https://www.physician.tw/Prophylaxis-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prophylaxis-HIV-AIDS/</guid><description>Prophylaxis-HIV AIDS (NEJM 2015;373:2237; Lancet 2016;387:53; J Infect Dis 2018;218:16; CDC 2021)
Pre-exposure (PrEP): TDF/FTC daily, ‚Üì transmission &amp;gt;90% if adherent.</description></item><item><title>prostate cancer</title><link>https://www.physician.tw/prostate-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prostate-cancer/</guid><description>prostate cancer Epidemiology and risk factors (NEJM 2003;349:366) Most common cancer in U.S. men; 2nd most common cause of cancer death in men Lifetime risk of prostate cancer dx ~16%; lifetime risk of dying of prostate cancer ~3% ‚Üë risk with ‚Üë age (rare if &amp;lt;45 y), in African Americans, ‚äï FHx, BRCA mutations Clinical manifestations Most prostate cancers (78%) are asymptomatic and localized at diagnosis Metastatic dis.</description></item><item><title>prosthetic-heart-valves</title><link>https://www.physician.tw/prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prosthetic-heart-valves/</guid><description>prosthetic-heart-valves [[Mechanical-prosthetic-heart-valves]] [[Bioprosthetic]]
Physical exam Crisp sounds ¬± soft murmur during forward flow (normal to have small ‚àá) [[Anticoagulation antiplatelet therapy-prosthetic-heart-valves]] [[Correction of overanticoagulation]] (Circ 2021;143:e72) Endocarditis prophylaxis: for all prosthetic valves [[bacterial endocarditis]] [[Complications-prosthetic-heart-valves]]</description></item><item><title>protease inhibitors - PI-Antiretrovirals ARVs</title><link>https://www.physician.tw/protease-inhibitors-PI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protease-inhibitors-PI-Antiretrovirals-ARVs/</guid><description>protease inhibitors - PI-Antiretrovirals (ARVs) atazanavir (ATV; Reyataz) darunavir (DRV; Prezista) lopinavir (LPV; Kaletra) PIs given w/boosters ritonavir or cobicistat for ‚Üë PK Class: GI intol; hepatotoxicity; inhibit CYP450 (many DDIs, eg statins, steroids, DOACs); ‚Üë glc; hyperlipid (less w/ ATV); MI (NEJM 2007;356:1723) ATV: crystalluria ‚Üí nephrolithiasis DRV: rash (10%); possible sulfa cross-reactivity</description></item><item><title>Protein of cerebrospinal fluid</title><link>https://www.physician.tw/Protein-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Protein-of-cerebrospinal-fluid/</guid><description>Protein of cerebrospinal fluid ÊòØÂ§ßÂàÜÂ≠êÔºåÊúÉË¢´BBBÊìã‰ΩèÔºåÊ≠£Â∏∏Á¥Ñ 15‚Äì40 mg/dL ‰∏äÂçáÂéüÂõ†ÂåÖÊã¨ÊÑüÊüì„ÄÅËÖ´Áò§„ÄÅËÖ¶ÁÇéÁ≠â ‚Üë‚Üë (ÂèØËÉΩ&amp;gt;200)Ôºöbacteria ‚ÜëÔºöviral„ÄÅfungus„ÄÅTB„ÄÅparasite„ÄÅmalignancy„ÄÅviral/autoimmune encephalitis Á≠â Âè¶Â§ñ SAH„ÄÅtraumatic tapping ‰πüÂèØËÉΩ‰Ωø protein Á®çÂæÆ‰∏äÂçá</description></item><item><title>Protein of Urine Dipstick</title><link>https://www.physician.tw/Protein-of-Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Protein-of-Urine-Dipstick/</guid><description>Protein of Urine Dipstick Detects albuminuria (&amp;gt;300 mg/d); False ‚äñ: dilute urine
1+ ‚âà30 mg/dL, 2+ ‚âà100 mg/dL, 3+ ‚âà300 mg/dL, 4+ &amp;gt;2 g/dL;</description></item><item><title>proteinuria</title><link>https://www.physician.tw/proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/proteinuria/</guid><description>proteinuria [[Etiologies of Proteinuria]]
[[Urine dipstick]] 1+ ‚âà30 mg/dL, 2+ ‚âà100 mg/dL, 3+ ‚âà300 mg/dL, 4+ &amp;gt;2 g/dL; interpretation depends on SG; eg, 3+ in very concentrated urine might not indicate heavy proteinuria</description></item><item><title>Pseudo-hypoparathyroidism</title><link>https://www.physician.tw/Pseudo-hypoparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pseudo-hypoparathyroidism/</guid><description>Pseudo-hypoparathyroidism (Endo Metab Clin North Am 2018;47:865)
1a, 1b, &amp;amp; 1c: PTH end-organ resistance (‚à¥ ‚Üë serum PTH) 1a &amp;amp; 1c: + skeletal abnormalities, short stature &amp;amp; developmental delay 1b: w/o extra features Pseudopseudohypoparathyroidism = 1a mutation inherited from father, no hormonal abnormalities</description></item><item><title>Pseudoinfarct</title><link>https://www.physician.tw/Pseudoinfarct/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pseudoinfarct/</guid><description>Pseudoinfarct In left ventricular hypertrophy, there is often a QS deflection or poor R wave progression in the right precordial leads that suggests anterior myocardial infarction.</description></item><item><title>pulmonary critical care</title><link>https://www.physician.tw/pulmonary-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-critical-care/</guid><description>pulmonary critical care 20 Respiratory Monitoring 21 Mechanical Ventilatory Support 22 Non‚ÄêInvasive Positive Pressure Ventilation 23 Acute Respiratory Distress Syndrome 24 Bronchospasm and Chronic Obstructive Pulmonary Disease 25 [[Weaning from Mechanical Ventilation]]</description></item><item><title>pulmonary function tests</title><link>https://www.physician.tw/pulmonary-function-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-function-tests/</guid><description>pulmonary function tests [[physiology of pulmary]]
Spirometry: evaluate for obstructive disease ËÇ∫Ê¥ªÈáèÊ∏¨ÂÆöÔºöË©ï‰º∞ÈòªÂ°ûÊÄßÁñæÁóÖ Flow-volume loops: diagnose and/or localize obstructionÔºöË®∫Êñ∑Âíå/ÊàñÂÆö‰ΩçÈòªÂ°û</description></item><item><title>pulmonary hypertension</title><link>https://www.physician.tw/pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-hypertension/</guid><description>pulmonary hypertension PHT defined as PA mean pressure ‚â•20 mmHg at rest (ERJ 2019;53:1801913) PA mean = CO √ó PVR + PA wedge pressure.</description></item><item><title>Pulmonary infiltrates with eosinophilia PIE</title><link>https://www.physician.tw/Pulmonary-infiltrates-with-eosinophilia-PIE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-infiltrates-with-eosinophilia-PIE/</guid><description>Pulmonary infiltrates with eosinophilia (PIE) eos on BAL or peripheral blood
Allergic bronchopulmonary aspergillosis (ABPA)
EGPA</description></item><item><title>Pulmonary-complications of HIV AIDS</title><link>https://www.physician.tw/Pulmonary-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-complications-of-HIV-AIDS/</guid><description>Pulmonary-complications of HIV AIDS Radiographic Pattern Common Causes
Normal Early PCP
Diffuse interstitial infiltrates PCP, TB, viral, or disseminated fungal</description></item><item><title>Pulmonary-Renal Syndromes</title><link>https://www.physician.tw/Pulmonary-Renal-Syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Renal-Syndromes/</guid><description>Pulmonary-Renal Syndromes differential diagnosis: hemorrhagic pulmonary edema associated with renal failure from superimposed CHF or pulmonary emboli.
Most Pulmonary-Renal Syndromes are associated with: antineutrophilic cytoplasmic Ab (anca) Ë¨õÂá∫‰æÜÂèØ‰ª•Â∏•‰∏ÄÊ≥¢ÁöÑË®∫Êñ∑: Micorsopic polyangiitis Granulomatosis with polyangiitis Churg-Strauss systemic lupus erythematosus Goodpastur&amp;rsquo;s syndrome Behcet&amp;rsquo;s disease Rheumatoid vasculitis</description></item><item><title>pulmonology</title><link>https://www.physician.tw/pulmonology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology/</guid><description>ËÇ∫ËáüÁñæÁóÖÔºåÊ∞£ÁÆ°ÁóÖËÆäÔºå ÁóÖÁóáÂ§öÁ´ØÔºåÈúÄÈ´òÊòé„ÄÇ ÂëºÂê∏‰∏çÈ†ÜÔºåÊ∞£ÂñòÂõ∞ÊìæÔºå ËÉ∏ËÖîÂÖßÁóÖÔºåËã¶Èõ£Â§ö„ÄÇ
Part 7:¬†[[Disorders of the Respiratory System]] pulmonary [[dyspnea]]
[[pulmonary function tests]]</description></item><item><title>Pulseless Arrest</title><link>https://www.physician.tw/Pulseless-Arrest/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulseless-Arrest/</guid><description>Pulseless Arrest È†∏60 ËÇ°70 Êâã80 Ë∂≥90
CPR Compressions
Push hard (2-2.4 inches) &amp;amp; fast (100-120/min) Minimize interruptions; rotate compressor q2min Airway: open airway (eg, head tilt-chin lift) Breathing: 10 breaths/min; 2 breaths q 30 compressions Bag-mask acceptable; supplemental O2</description></item><item><title>pulsus paradoxus</title><link>https://www.physician.tw/pulsus-paradoxus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulsus-paradoxus/</guid><description>pulsus paradoxus Ê≠£Â∏∏ÊÉÖÊ≥Å‰∏ãÔºåÂê∏Ê∞£ÊôÇË°ÄÂ£ìÊúÉÁ®çÂæÆÈôç‰ΩéÔºå ËÄåÂëºÊ∞£ÊôÇË°ÄÂ£ìÊúÉÁ®çÂæÆ‰∏äÂçáÔºå‰∏ãÈôçÁöÑÊ≠£Â∏∏ÁØÑÂúçÊòØ&amp;lt;10 mmHg Â¶ÇÊûú‰∏ãÈôçÁöÑÂπÖÂ∫¶&amp;gt;10mmHgÂâáÁ®±ÁÇ∫pulsus paradoxus ÁêÜÂ≠∏Ê™¢Êü•‰∏äÁöÑÁôºÁèæÔºöËÅΩË®∫Âô®ÂèØËÅΩÂà∞ÂøÉË∑≥‰ΩÜÂú®radial arteryÊë∏‰∏çÂà∞pulse„ÄÇ</description></item><item><title>Pure red cell aplasia</title><link>https://www.physician.tw/Pure-red-cell-aplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pure-red-cell-aplasia/</guid><description>Pure red cell aplasia Destructive antibodies or lymphocytes ‚Üí ineffective erythropoiesis
Associated with thymoma, CLL, parvovirus infection, autoimmunity, drugs</description></item><item><title>purpura</title><link>https://www.physician.tw/purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/purpura/</guid><description>purpura (nonblanching purple/red lesions due to extravasation of RBCs into dermis)
Nonpalpable (macular; ‚â§3 mm in diameter = petechiae; &amp;gt;3 mm = ecchymoses) platelet disorder: thrombocytopenia, defect in platelet fxn</description></item><item><title>pyenv</title><link>https://www.physician.tw/pyenv/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pyenv/</guid><description>/Users/htlin/.pyenv/versions/neovim2/bin/python
/Users/htlin/.pyenv/versions/neovim3/bin/python</description></item><item><title>radiology</title><link>https://www.physician.tw/radiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/radiology/</guid><description>radiology [[chest radiograph]]</description></item><item><title>Rank the Differential Diagnosis</title><link>https://www.physician.tw/Rank-the-Differential-Diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rank-the-Differential-Diagnosis/</guid><description>Rank the Differential Diagnosis</description></item><item><title>Rapid correction of Treatment-of-hyponatremia</title><link>https://www.physician.tw/Rapid-correction-of-Treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rapid-correction-of-Treatment-of-hyponatremia/</guid><description>Rapid correction of Treatment-of-hyponatremia can lead to CPM/ODS (esp if chronic or Na &amp;lt;120 mEq/L). Should be emergently reversed w/ dDAVP ¬± D5W; partial neuro recovery possible (CJASN 2014;9:229).</description></item><item><title>rapid progressive glomerulonephritis RPGN</title><link>https://www.physician.tw/rapid-progressive-glomerulonephritis-RPGN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rapid-progressive-glomerulonephritis-RPGN/</guid><description>rapid progressive glomerulonephritis (RPGN) ÂàáÁâá‰∏ãÂÖ∏ÂûãÊúÉÂá∫ÁèæÂª£Ê≥õÁöÑÊñ∞ÊúàÂΩ¢Êàê(crescent formation)„ÄÇ
Êñ∞ÊúàÂΩ¢Êàê(Crescent formation)
ÁÇ∫ÊáâÂ∞çËÖéÁµ≤ÁêÉÂæÆË°ÄÁÆ°Â£ÅÂö¥ÈáçÂÇ∑ÂÆ≥ÁöÑÈùûÁâπÁï∞ÊÄßÂèçÊáâÔºåÂú®Â§öÁ®ÆÂö¥ÈáçÁöÑËÖéÁµ≤ÁêÉÁôºÁÇéÁñæÁóÖÈÉΩÂèØËÉΩÂá∫Áèæ ËÖéÁµ≤ÁêÉÂæÆË°ÄÁÆ°Â£ÅÂèóÊêçÂæåÔºåË°ÄÊºø‰∏≠ÁöÑÁâ©Ë≥™ÊúÉÈÄ≤ÂÖ•Bowman‚Äôs spaceÔºåÈÄ≤ËÄåÂ∞éËá¥fibrinÂΩ¢Êàê„ÄÇÊ≠§Â§ñÔºåÁôºÁÇéÁ¥∞ËÉûÂíåÁ¥∞ËÉûÊøÄÁ¥†ÁöÑÈÄ≤ÂÖ•Ôºå‰πüÊäëÂà∂‰∫ÜfibrinÂàÜËß£ÁöÑÈÅéÁ®ã RPGNÁöÑÁ®ÆÈ°û (1) Anti-GBMÊäóÈ´î
Â¶ÇGoodpasture‚Äôs diseaseÔºåÂÖ∏ÂûãÊúâËÖéËáüÂíåËÇ∫ÈÉ®ÁöÑ‰æµÁäØ (2) ÂÖçÁñ´Ë§áÂêàÈ´î‰ªãÂ∞é
Âú®ËÖéÁµ≤ÁêÉ‰∏≠ËÉΩÁúãÂà∞ÂÖçÁñ´Ë§áÂêàÈ´îÁöÑÊ≤âÁ©çÔºå‰∏çÂêåÁñæÁóÖÁöÑÊ≤âÁ©çÂàÜÂ≠êÊúâÂ∑ÆÁï∞ÔºåÂ¶ÇIgA nephropathy„ÄÅPSGN„ÄÅlupus nephritis„ÄÅÂÜ∑ÂáùÁêÉËõãÁôΩË°ÄÁóáÁ≠â (3) Pauci-immune</description></item><item><title>RASi ACEI ARB</title><link>https://www.physician.tw/RASi-ACEI-ARB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RASi-ACEI-ARB/</guid><description>RASi ACEI ARB Choose one of ARNI (ARB + neprilysin inhib), ACEI or ARB
36-hr washout when transitioning ACEI to ARNI</description></item><item><title>Rate Control-atrial fibrillation</title><link>https://www.physician.tw/Rate-Control-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rate-Control-atrial-fibrillation/</guid><description>Rate Control-atrial fibrillation (if sxÔºå goal HR ‚â§80; if asx &amp;amp; EF &amp;gt;40%. goal HR ‚â§110Ôºõ Circ 2014:130e199)
Agent Acute (IV) Maint.</description></item><item><title>Rate of correction of hypernatremia</title><link>https://www.physician.tw/Rate-of-correction-of-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rate-of-correction-of-hypernatremia/</guid><description>Rate of correction of hypernatremia depends on acuity of onset and risk:
chronic (&amp;gt;48 hr): ~12 mEq/d appears safe w/o risk of cerebral edema (CJASN 2019;14:656)</description></item><item><title>Rationale PA catheter and tailored therapy</title><link>https://www.physician.tw/Rationale-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rationale-PA-catheter-and-tailored-therapy/</guid><description>Rationale PA catheter and tailored therapy Cardiac output (CO) = SV √ó HR; optimize SV (and thereby CO) by manipulating preload/ LVEDV (w/ IVF, diuretics), contractility (w/ inotropes), &amp;amp; afterload (w/ vasodilators)</description></item><item><title>Raynaud phenomenon</title><link>https://www.physician.tw/Raynaud-phenomenon/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Raynaud-phenomenon/</guid><description>Raynaud phenomenon a problem that causes decreased blood flow to the fingers. In some cases, it also causes less blood flow to the ears, toes, nipples, knees, or nose.</description></item><item><title>RB-ILD resp bronchiolitis-assoc ILD</title><link>https://www.physician.tw/RB-ILD-resp-bronchiolitis-assoc-ILD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RB-ILD-resp-bronchiolitis-assoc-ILD/</guid><description>RB-ILD resp bronchiolitis-assoc ILD Bronchial thickening, centrilobular nodules, patchy ground-glass opacities; upper lobe predom. MœÜ in alveoli.</description></item><item><title>Recognizing and managing comorbidities of Migraine</title><link>https://www.physician.tw/Recognizing-and-managing-comorbidities-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recognizing-and-managing-comorbidities-of-Migraine/</guid><description>Recognizing and managing comorbidities of Migraine Identify comorbid conditions Select drugs and adjust their use according to comorbidities present Alleviate comborbidities if possible to improve outcome</description></item><item><title>Recommended Chronic Therapy by HF Stage</title><link>https://www.physician.tw/Recommended-Chronic-Therapy-by-HF-Stage/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recommended-Chronic-Therapy-by-HF-Stage/</guid><description>Recommended Chronic Therapy by HF Stage (JACC 2021;77:772)
Utility of BNP-guided Rx (inPt and outPt) remains debated (Eur Heart J 2014;35:16) Implantable PA pressure sensor in sx Pts: ~19‚Äì37% ‚Üì risk of hosp (Lancet 2016;387:453 &amp;amp; 2021;398:991) Stage (not NYHA Class) Therapy A At risk for HF (eg, HTN); but asx &amp;amp; w/o struct.</description></item><item><title>Recommended First-Line Oral Direct-Acting Antiviral DAA Regimens</title><link>https://www.physician.tw/Recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</guid><description>Recommended First-Line Oral Direct-Acting Antiviral (DAA) Regimens Sofosbuvir &amp;amp; velpatasvir Genotypes 1‚Äì6, 12 weeks Rx Glecaprevir &amp;amp; pibrentasvir Gentotypes 1‚Äì6; 8 weeks Rx Simplified treatment: adults w/ HCV w/o cirrhosis or w/ compensated cirrhosis &amp;amp; no prior HCV treatment; cannot have HIV, HBsAg ‚äï, pregnancy, HCC, ESRD, or liver transplant; if decompensated or previously treated, refer to GI for assistance.</description></item><item><title>Recurrent infection-clostridioides difficile infection</title><link>https://www.physician.tw/Recurrent-infection-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recurrent-infection-clostridioides-difficile-infection/</guid><description>Recurrent infection-clostridioides difficile infection (15‚Äì30% risk after d/c of abx, most w/in 2 wk of stopping abx)
1st recurrence: fidaxomicin 200 mg PO bid √ó 10 d or vanco 125 mg PO q6h √ó 10‚Äì14 d.</description></item><item><title>Refractory ascites</title><link>https://www.physician.tw/Refractory-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Refractory-ascites/</guid><description>Refractory ascites seen in 5‚Äì10% of Pts; 2-y survival 25%
Defined as [[diuretic-resistant]] if on 2-g Na diet w/ minimal weight loss on max diuretics, or diuretic-induced complications (AKI, Na &amp;lt;125, ‚Üë K, encephalopathy) Conflicting evid.</description></item><item><title>Regimens-Endocarditis Prophylaxis</title><link>https://www.physician.tw/Regimens-Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Regimens-Endocarditis-Prophylaxis/</guid><description>Regimens-Endocarditis Prophylaxis Oral: amoxicillin 2 g 30‚Äì60 min before Unable to take PO: amp 2 g IM/IV or cefazolin or CTX 1 g IM/IV PCN-allergic: cephalexin or azithro or claritho or doxy</description></item><item><title>Region or Exposure Common Etiologies -fever in a returned traveler</title><link>https://www.physician.tw/Region-or-Exposure-Common-Etiologies-fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Region-or-Exposure-Common-Etiologies-fever-in-a-returned-traveler/</guid><description>Region or Exposure Common Etiologies -fever in a returned traveler Sub-Saharan Africa Malaria &amp;raquo; dengue and other arboviruses, rickettsial disease, enteric fever</description></item><item><title>Rejection-Kidney transplantation</title><link>https://www.physician.tw/Rejection-Kidney-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rejection-Kidney-transplantation/</guid><description>Rejection-Kidney transplantation : Ab (ABMR) or T-cell mediated (TCMR), a/w poor graft survival; BANFF criteria (Am J Transplant 2018;18:293). Rx options: ‚Üë immunosupp.</description></item><item><title>Reliever medications-asthma</title><link>https://www.physician.tw/Reliever-medications-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Reliever-medications-asthma/</guid><description>Reliever medications-asthma (used prn to quickly relieve sx)
Low-dose inhaled corticosteroids (ICS) + long-acting inh Œ≤2-agonists (LABA): budesonide-formoterol (NEJM 2019;380:2020)</description></item><item><title>Renal H2O loss Uosm &lt;700‚Äì800</title><link>https://www.physician.tw/Renal-H2O-loss-Uosm-700800/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-H2O-loss-Uosm-700800/</guid><description>Renal H2O loss (Uosm &amp;lt;700‚Äì800) Diuresis: osmotic (glucose, mannitol, urea), loop diuretics
Diabetes insipidus (Nature Reviews Nephrology 2015;11:576)</description></item><item><title>Renal losses of Hypovolemic-hypotonic-hyponatremia</title><link>https://www.physician.tw/Renal-losses-of-Hypovolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-losses-of-Hypovolemic-hypotonic-hyponatremia/</guid><description>Renal losses of Hypovolemic-hypotonic-hyponatremia (UNa &amp;gt;20 mEq/L, FENa &amp;gt;1%): diuretics (esp. thiazides, because loop diuretics ‚Üì tonicity of medullary interstitium, Œî for H2O absorption, &amp;amp; ‚à¥ urine concentrating ability), salt-wasting nephropathy, cerebral salt wasting, mineralocorticoid deficiency</description></item><item><title>Renal potassium losses</title><link>https://www.physician.tw/Renal-potassium-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-potassium-losses/</guid><description>Renal potassium losses Hypotensive or normotensive acidosis: DKA, RTA [distal RTAs (type I) &amp;gt;proximal RTAs (type II)]
alkalosis: diuretics (thiazide &amp;gt;loop), vomiting/NGT drainage (via 2¬∞ hyperaldosteronism)</description></item><item><title>renal replacement and dialysis</title><link>https://www.physician.tw/renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-replacement-and-dialysis/</guid><description>renal replacement and dialysis [[General-renal replacement and dialysis]] [[Modalities-renal replacement and dialysis]] [[Hemodialysis (HD)]] [[Vascular Access-renal replacement and dialysis]] [[Continuous veno-venous hemofiltration (CVVH)]] [[Peritoneal dialysis (PD)]] [[Kidney transplantation]]</description></item><item><title>Renal tubular acidoses</title><link>https://www.physician.tw/Renal-tubular-acidoses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-tubular-acidoses/</guid><description>Renal tubular acidoses (RTAs) (Adv Ther 2021;38:949)
(Adv Ther 2021;38:949)
Proximal (Type II): ‚Üì proximal reabsorption of HCO3 1¬∞ (Fanconi‚Äôs syndrome) = ‚Üì proximal reabsorption of HCO3, PO4, glc, amino acids Acquired: paraprotein (MM, amyloidosis), metals (Pb, Cd, Hg, Cu), ‚Üì vit D, PNH, renal Tx Meds: acetazolamide, aminoglycosides, ifosfamide, cisplatin, topiramate, tenofovir Distal (Type I): defective distal H+ secretion 1¬∞, autoimmune (Sj√∂gren‚Äôs, RA, SLE), hypercalciuria, meds (ampho, Li, ifosfamide); normally a/w ‚Üì K; if with ‚Üë K ‚Üí sickle cell, obstruction, renal transplant Hypoaldo (Type IV): hypoaldo ‚Üí ‚Üë K ‚Üí ‚Üì NH3 synthesis ‚Üí ‚Üì urine acid-carrying capacity ‚Üì renin: diabetic nephropathy, NSAIDs, chronic interstitial nephritis, calcineurin inh, HIV ‚Üì aldo production: 1¬∞ AI, ACEI/ARBs, heparin, severe illness, inherited (‚Üì 21-hydroxylase) ‚Üì response to aldosterone Meds: K-sparing diuretics, TMP-SMX, pentamidine, calcineurin inhibitors Tubulointerstitial disease: sickle cell, SLE, amyloid, DM</description></item><item><title>renal-cell-carcinoma</title><link>https://www.physician.tw/renal-cell-carcinoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-cell-carcinoma/</guid><description>renal-cell-carcinoma [[systematic-Treatment]]</description></item><item><title>Renal-complications of HIV AIDS</title><link>https://www.physician.tw/Renal-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-complications-of-HIV-AIDS/</guid><description>Renal-complications of HIV AIDS HIV-assoc. nephropathy (collapsing FSGS); nephrotoxic drugs (eg, TDF ‚Üí prox tub dysfxn)</description></item><item><title>Renal-limited vasculitis</title><link>https://www.physician.tw/Renal-limited-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-limited-vasculitis/</guid><description>Renal-limited vasculitis Small vessel pauci-immune vasculitis causing RPGN w/o other organ involvement Dx studies: 80% ‚äï ANCA (MPO &amp;gt;PR3); biopsy with pauci-immune GN ¬± granulomas Treatment identical to that for GPA/MPA</description></item><item><title>renal-Secondary Causes of Hypertension</title><link>https://www.physician.tw/renal-Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-Secondary-Causes-of-Hypertension/</guid><description>renal-Secondary Causes of Hypertension Renal parenchymal (2‚Äì3%) h/o DM, polycystic kidney disease, glomerulonephritis CrCl, albuminuria See ‚ÄúKidney Disease‚Äù
Renovascular (1‚Äì2%) Athero (90%) FMD (10%, young women) PAN, scleroderma ARF induced by ACEI/ARB Recurrent flash pulm edema Renal bruit; hypokalemia (NEJM 2009;361:1972) MRA (&amp;gt;90% Se &amp;amp; Sp, less for FMD), CTA, duplex U/S, angio, plasma renin (low Sp)</description></item><item><title>Replace free H2O deficit</title><link>https://www.physician.tw/Replace-free-H2O-deficit/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Replace-free-H2O-deficit/</guid><description>Replace free H2O deficit (also replace concurrent volume deficit if appropriate):
eg, 1 L D5W given to 70-kg man w/ [Na] = 160 mEq/L will ‚Üì [Na]serum by 3.</description></item><item><title>Replacement fluid of continuous veno-venous hemofiltration</title><link>https://www.physician.tw/Replacement-fluid-of-continuous-veno-venous-hemofiltration/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Replacement-fluid-of-continuous-veno-venous-hemofiltration/</guid><description>Replacement fluid of continuous veno-venous hemofiltration Choice of replacement fluid buffer:
HCO3 (+ heparin to prevent clotting, although can be run heparin-free)</description></item><item><title>Residual syndrome</title><link>https://www.physician.tw/Residual-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Residual-syndrome/</guid><description>Residual syndrome Inadequate removal of uremic toxins through conventional dialysis may result in a phenomenon known as residual syndrome. Patients with this syndrome may experience subtle signs of malnutrition, mild lethargy, infection, and serositis</description></item><item><title>Resistant HTN</title><link>https://www.physician.tw/Resistant-HTN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Resistant-HTN/</guid><description>Resistant HTN ‰∏âÁ∑öÂà©Â∞ø‰ªçÈ´ò (BP &amp;gt;goal on ‚â•3 drugs incl diuretic; HTN 2018;72:e53)
ÂèÉËÄÉ‚û°Ô∏è Pharmacological Treatment of Hypertension: From the Golden Trio to the Octet</description></item><item><title>respiratory failure</title><link>https://www.physician.tw/respiratory-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/respiratory-failure/</guid><description>respiratory failure A-a gradient = PAO2 ‚Äì PaO2: normal (on room air) = ‚Äú4 + age/4‚Äù or ‚Äú2.5 + (0.</description></item><item><title>respiratory-acidosis</title><link>https://www.physician.tw/respiratory-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/respiratory-acidosis/</guid><description>respiratory-acidosis (NEJM 1989;321:1223; Crit Care 2010;14:220)
[[Etiologies of High elevated PaCO2]]
Etiologies (also see ‚ÄúHypercapnia‚Äù; PaCO2 = VCO2/VE(1-VD/VT); VE = RR x VT)</description></item><item><title>respiratory-alkalosis</title><link>https://www.physician.tw/respiratory-alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/respiratory-alkalosis/</guid><description>respiratory-alkalosis Etiologies (NEJM 2002;347:43; Crit Care 2010;14:220)
Hypoxia ‚Üí hyperventilation: pneumonia, CHF, PE, restrictive lung disease, anemia Primary hyperventilation CNS stimulation, pain, anxiety, trauma, stroke, CNS infection, pontine tumors drugs: salicylates toxicity (early), Œ≤-agonists, progesterone, methylxanthines, nicotine pregnancy, sepsis, hepatic failure, hyperthyroidism, fever Pseudorespiratory alkalosis: ‚Üì perfusion w/ preserved ventilation (eg, CPR, severe HoTN) ‚Üí ‚Üì delivery of CO2 to lungs for excretion; low PaCO2 but ‚Üë tissue CO2 Explain by ChatGPT Hypoxia : (Hypoxia ‚Üí hyperventilation: pneumonia, CHF, PE, restrictive lung disease, anemia); Primary hyperventilation : (CNS stimulation, pain, anxiety, trauma, stroke, CNS infection, pontine tumors drugs: salicylates toxicity (early), Œ≤-agonists, progesterone, methylxanthines, nicotine pregnancy, sepsis, hepatic failure, hyperthyroidism, fever); Pseudorespiratory alkalosis : (‚Üì perfusion w/ preserved ventilation (eg, CPR, severe HoTN) ‚Üí ‚Üì delivery of CO2 to lungs for excretion; low PaCO2 but ‚Üë tissue CO2).</description></item><item><title>RESTRICTIVE---INFILTRATIVE</title><link>https://www.physician.tw/RESTRICTIVE---INFILTRATIVE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RESTRICTIVE---INFILTRATIVE/</guid><description>RESTRICTIVE&amp;mdash;INFILTRATIVE</description></item><item><title>Revascularization</title><link>https://www.physician.tw/Revascularization/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Revascularization/</guid><description>Revascularization OMT should be initial focus if stable &amp;amp; w/o evidence of critical anatomy &amp;amp; w/ normal EF Goal of revasc should be to ‚Üì risk of CV morbidity &amp;amp; mortality or to relieve refractory sx Older studies: survival benefit w/ revascularization (CABG) vs.</description></item><item><title>Rhabdomyolysis</title><link>https://www.physician.tw/Rhabdomyolysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rhabdomyolysis/</guid><description>Rhabdomyolysis (NEJM 2009;361:62)
Pathophys: myoglobin-induced oxidant injury, vasoconstriction, myoglobin precipitation &amp;amp; pre-renal (extravasation). Can lead to ‚Üì Ca, ‚Üë K, and ‚Üë PO4.</description></item><item><title>rheumatology</title><link>https://www.physician.tw/rheumatology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology/</guid><description>rheumatology Part 11:¬†[[Immune-Mediated, Inflammatory, and Rheumatologic Disorders]]
[[allergy immunology]] [[approach to rheumatic disease]] [[rheumatoid arthritis]] [[adult-onset Still‚Äôs disease ]]&amp;amp; relapsing polychondritis [[crystal deposition arthritides]] [[seronegative spondyloarthritis]] [[infectious arthritis and bursitis]] [[connective tissue diseases]] [[systemic lupus erythematosus]] [[IgG4-related disease]] [[vasculitis]] [[autoinflammatory syndromes]] [[amyloidosis]] [[osteoarthritis]] (OA) [[Undifferentiated Inflammatory Arthritis]]</description></item><item><title>Rhythm control</title><link>https://www.physician.tw/Rhythm-control/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rhythm-control/</guid><description>Rhythm control (Lancet 2016;388:829)
ÂèÉËÄÉ‚û°Ô∏è Rhythm control in atrial fibrillation
Consider if sx w/ rate control (eg, HF), difficult to control rate, or tachycardia-mediated CMP If minimally sx or asx, previously no clear benefit vs.</description></item><item><title>Right-ventricular-hypertrophy</title><link>https://www.physician.tw/Right-ventricular-hypertrophy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Right-ventricular-hypertrophy/</guid><description>Right-ventricular-hypertrophy (Circ 2009;119:e251; JACC 2014;63:672)
ÂèÉËÄÉ‚û°Ô∏è AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac¬†‚Ä¶</description></item><item><title>risk factor of delirium</title><link>https://www.physician.tw/risk-factor-of-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/risk-factor-of-delirium/</guid><description>risk factor of delirium older aged &amp;gt;65 baseline cognitive dysfunction preexisting hearing and visual impairment, as well as indices for poor overall health, including baseline immobility, malnutrition, and underlying medical or neurologic illness.</description></item><item><title>Risk Factors and Screening</title><link>https://www.physician.tw/Risk-Factors-and-Screening/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Factors-and-Screening/</guid><description>Risk Factors and Screening High risk: &amp;gt;10 lifetime sexual partners, prior STI, MSM, sex workers Screening recommendations: differ based on sexual practices and risk.</description></item><item><title>Risk factors for bloodstream infections</title><link>https://www.physician.tw/Risk-factors-for-bloodstream-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-for-bloodstream-infections/</guid><description>Risk factors for bloodstream infections (JAMA 2012;308:502; CID;2020;71)
Syndromes with high likelihood of bacteremia: Sepsis Endovascular infxns: endocarditis, infection of pacemaker, vascular graft or IV catheter [[vertebral osteomyelitis]], epidural abscess, septic arthritis Risk factors: indwelling lines, IVDU, immunosupp.</description></item><item><title>Risk factors-acute aortic syndromes</title><link>https://www.physician.tw/Risk-factors-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-acute-aortic-syndromes/</guid><description>Risk factors-acute aortic syndromes (Lancet 2015;385:800)
Classic (in older Pts): HTN (h/o HTN in &amp;gt;70% of dissections); age (60s‚Äì70s), sex (~65% ‚ôÇ); smoking; ‚Üë lipids.</description></item><item><title>Risk Factors-bacterial endocarditis</title><link>https://www.physician.tw/Risk-Factors-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Factors-bacterial-endocarditis/</guid><description>Risk Factors-bacterial endocarditis Abnormal valve (JAMA 1997;277:1794; JACC 2018;72:2443) High risk: prior endocarditis, prosthetic valve or ring, some congenital heart disease (unrepaired cyanotic; shunt/conduit; prosthesis in past 6 mos), transplant heart, valvulopathy, VAD Medium risk previous rheumatic fever non-rheumatic valve disease (including MVP w/ MR or thickened leaflet), HCM bicuspid AoV Risk of bacteremia: IVDU indwelling venous catheters, hemodialysis, prosthetic material in heart (eg, pacemaker, ICD, graft), poor dentition</description></item><item><title>Risk factors-venous thromboembolism</title><link>https://www.physician.tw/Risk-factors-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-venous-thromboembolism/</guid><description>Risk factors-venous thromboembolism [[Virchow‚Äôs triad]] for thrombogenesis.
Malignancy (12% of ‚Äúidiopathic‚Äù DVT/PE; Circ 2013;128:2614)
[[Venous Thromboembolism and Cancer]] History of thrombosis</description></item><item><title>Risk stratification for Pts with PE</title><link>https://www.physician.tw/Risk-stratification-for-Pts-with-PE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-stratification-for-Pts-with-PE/</guid><description>Risk stratification for Pts with PE clinical: [[simplified PE severity index]]
[[Hestia Criteria for Outpatient Pulmonary Embolism Treatment]] [[Pulmonary Embolism Severity Index PESI]] imaging:</description></item><item><title>Risk stratification of fever and neutropenia</title><link>https://www.physician.tw/Risk-stratification-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-stratification-of-fever-and-neutropenia/</guid><description>Risk stratification of fever and neutropenia History: outPt, ECOG 0‚Äì1, age &amp;lt;60 y, solid tumor, no sx, no major comorbidities, no h/o fungal infection, MASCC Risk Index ‚â•21 (Support Care Cancer 2013;21:1487) Exam: temp &amp;lt;39 ¬∞C, no tachypnea, no HoTN, no Œî MS, no dehydration Labs: ANC &amp;gt;100 cells/¬µL, anticipated duration of neutropenia ‚â§100 cells/¬µL &amp;lt;7 d</description></item><item><title>Risk-Stratification-andreatment-of-Localized-Prostate</title><link>https://www.physician.tw/Risk-Stratification-andreatment-of-Localized-Prostate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Stratification-andreatment-of-Localized-Prostate/</guid><description>Risk-Stratification-andreatment-of-Localized-Prostate IMAGE: Risk Stratification and Treatment of Localized Prostate Cancer</description></item><item><title>Roflumilast</title><link>https://www.physician.tw/Roflumilast/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Roflumilast/</guid><description>Roflumilast (PDE-4 inhib) + bronchodil: ‚Üë FEV1, ‚Üì exacerb in Pts with severe COPD, chronic bronchitis, and a hx of exacerbations (Lancet 2015;385:857)</description></item><item><title>Role of Circulating Tumor DNA in Guiding Adjuvant Therapy in Colon Cancer</title><link>https://www.physician.tw/Role-of-Circulating-Tumor-DNA-in-Guiding-Adjuvant-Therapy-in-Colon-Cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Role-of-Circulating-Tumor-DNA-in-Guiding-Adjuvant-Therapy-in-Colon-Cancer/</guid><description>Role of Circulating Tumor DNA in Guiding Adjuvant Therapy in Colon Cancer Adjuvant chemotherapy after resection of stage III colon cancer appears to improve outcomes, but many patients are treated to benefit a few.</description></item><item><title>Role of hematopoietic growth factors</title><link>https://www.physician.tw/Role-of-hematopoietic-growth-factors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Role-of-hematopoietic-growth-factors/</guid><description>Role of hematopoietic growth factors Granulocyte (G-CSF) and granulocyte-macrophage (GM-CSF) colony-stimulating factors can be used (but not in AML) as 1¬∞ Ppx when expected FN incidence &amp;gt;20% or as 2¬∞ Ppx after FN has occurred in a prior cycle (to maintain dose-intensity for curable tumors) CSFs ‚Üì rate of FN but have not been shown to affect mortality (Cochrane 2014 CD003039)</description></item><item><title>Rule out mimickers of ILD</title><link>https://www.physician.tw/Rule-out-mimickers-of-ILD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rule-out-mimickers-of-ILD/</guid><description>Rule out mimickers of ILD Congestive heart failure (‚úì BNP, trial of diuresis); infection: viral, atypical bacterial; malignancy: lymphangitic carcinomatosis, bronchoalveolar, leukemia, lymphoma</description></item><item><title>Rx-Primary biliary cholangitis PBC</title><link>https://www.physician.tw/Rx-Primary-biliary-cholangitis-PBC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rx-Primary-biliary-cholangitis-PBC/</guid><description>Rx-Primary biliary cholangitis (PBC) Obeticholic acid (FXR agonist): monoRx if cannot tolerate UDCA (but not in decompen cirrhosis) or if no Œî w/ UDCA after 1 y; found to ‚Üì AœÜ, ‚Üë pruritus (NEJM 2016;375:631) ursodeoxycholic acid (UDCA) (13‚Äì15 mg/kg bid), monitor for 3‚Äì6 mos ‚Üí ~25% complete response, ‚Üë survival &amp;amp; ‚Üì histologic change &amp;amp; ‚Üì complications (varices).</description></item><item><title>Salicylates-toxicology</title><link>https://www.physician.tw/Salicylates-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Salicylates-toxicology/</guid><description>Salicylates-toxicology Tinnitus, hyperventilation, abd. pain, vomiting, ŒîMS, mixed ‚Üë AG &amp;amp; nl OG metabolic acidosis + respiratory alkalosis
IVF resuscitation</description></item><item><title>Salt H2O or raw oysters fish</title><link>https://www.physician.tw/Salt-H2O-or-raw-oysters-fish/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Salt-H2O-or-raw-oysters-fish/</guid><description>Salt H2O or raw oysters fish V. vulnificus Hemorrhagic bullae &amp;amp; sepsis (esp. in cirrhotics) Doxy + Ceftaz/CTX Mycobacterium marinum Indolent, nodules on extremities/ superficial lymphadenitis Macrolide + rifampin/ ethambutol</description></item><item><title>Sarcoidosis</title><link>https://www.physician.tw/Sarcoidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sarcoidosis/</guid><description>Sarcoidosis (AJRCCM 2020;201:e26; JAMA 2022;327:856)
Prevalence: African Americans, northern Europeans, and females; onset in 3rd-5th decade
Pathophysiology: depression of cellular immune system peripherally, activation centrally</description></item><item><title>Schistosoma haematobium</title><link>https://www.physician.tw/Schistosoma-haematobium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Schistosoma-haematobium/</guid><description>Schistosoma haematobium ÂüÉÂèäË°ÄÂê∏Ëü≤Ôºå‰∏ÄÁ®ÆÊâÅÂΩ¢ÂãïÁâ©ÔºåÂØÑÁîüËü≤ÔºåÊòØÂØÑÁîüÊñº‰∫∫È°ûÂºïËµ∑Ë°ÄÂê∏Ëü≤ÁóÖÁöÑ‰∏ÄÁ®ÆË°ÄÂê∏Ëü≤</description></item><item><title>SCLC staging and treatment</title><link>https://www.physician.tw/SCLC-staging-and-treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SCLC-staging-and-treatment/</guid><description>SCLC staging and treatment SCLC usually disseminated at presentation; poor overall survival Can be very responsive to chemotherapy, but rapidly develop resistance Diagnosis: all have Rb &amp;amp; p53 mutations (Nature 2015;524:47); 90% w/ neuroendo markers Treatment: primarily chemo (platinum + etoposide); adding anti-[[PD-L1]] Ab [[atezolizumab]] ‚Üë survival (NEJM 2018;379:2220), as does concurrent thoracic RT in limited-stage disease Prophylactic cranial irradiation (PCI) controversial.</description></item><item><title>Scleroderma renal crisis</title><link>https://www.physician.tw/Scleroderma-renal-crisis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Scleroderma-renal-crisis/</guid><description>Scleroderma renal crisis (Nature Neph 2016;12:678)
5‚Äì20% diffuse cutaneous SSc w/ narrowing glomerular vessels. Sx: renal failure, severe HTN, encephalopathy.</description></item><item><title>Screening and Diagnosis-HIV AIDS</title><link>https://www.physician.tw/Screening-and-Diagnosis-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-and-Diagnosis-HIV-AIDS/</guid><description>Screening and Diagnosis-HIV AIDS (JAMA 2018;320:379)
Screen all 13‚Äì64 yo at least once, every preg, if new STI dx; screen high risk annually HIV Ab/p24Ag (ELISA assay): ‚äï 1‚Äì12 wk after acute infxn; &amp;gt;99% Se; 1¬∞ screening test If ‚äï, Ab differentiation assay confirms and differentiates HIV-1 vs.</description></item><item><title>Screening for latent TB</title><link>https://www.physician.tw/Screening-for-latent-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-for-latent-TB/</guid><description>Screening for latent TB Whom to screen: high likelihood of exposure and/or high risk of progression to active disease including HIV ‚äï and prior to immunosuppression (pre-transplant or anti-TNF) Relies on host immune system, so limited Se in immunosuppressed individuals Nb, testing for host exposure &amp;amp; immune response to TB, not whether TB active (vide infra) Screening tests IFN-Œ≥ release assays (IGRA): preferred test; Ag-stimulated IFN-Œ≥ release from Pt‚Äôs T-cells.</description></item><item><title>Screening of breast cancer</title><link>https://www.physician.tw/Screening-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-of-breast-cancer/</guid><description>Screening of breast cancer (JAMA 2015;314:1599; Annals 2019;170:547)
Mammography: ~20‚Äì30% ‚Üì in breast cancer mortality, smaller abs. benefit in women &amp;lt;50 y (JAMA 2018;319:1814); digital breast tomosynthesis (3-D) ‚Üë specificity (JAMA Oncol 2019;5:635); suspicious findings: clustered microcalcifications, spiculated, enlarging ACS: annual mammo starting at 45 (consider biennial after 54), cont.</description></item><item><title>Screening Test Abnormalities in Inherited and Acquired Coagulopathies</title><link>https://www.physician.tw/Screening-Test-Abnormalities-in-Inherited-and-Acquired-Coagulopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-Test-Abnormalities-in-Inherited-and-Acquired-Coagulopathies/</guid><description>Screening Test Abnormalities in Inherited and Acquired Coagulopathies</description></item><item><title>Screening-aortic aneurysms</title><link>https://www.physician.tw/Screening-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-aortic-aneurysms/</guid><description>Screening-aortic aneurysms (JAMA 2015;313:1156)
TAA: if bicuspid AoV or 1¬∞ relative w/: (a) TAA or bicuspid AoV, (b) CTD as above AAA: ‚úì for pulsatile abd mass; U/S ‚ôÇ &amp;gt;60 y w/ FHx of AAA &amp;amp; ‚ôÇ 65‚Äì75 y w/ prior tobacco</description></item><item><title>Second-line or maintainence therapy for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/Second-line-or-maintainence-therapy-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Second-line-or-maintainence-therapy-for-idiopathic-thrombocytopenic-purpura/</guid><description>Second-line or maintainence therapy for idiopathic thrombocytopenic purpura Romiplostim, el/avatrombopag TPO-R agonists ‚Üí ‚Üë plt prod
Rituximab (anti-CD20) ¬± dex anti‚ÄìB-cell Ab</description></item><item><title>secondary bacterial peritonitis</title><link>https://www.physician.tw/secondary-bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/secondary-bacterial-peritonitis/</guid><description>secondary bacterial peritonitis 2/2 intra-abd abscess, perf. Runyon‚Äôs criteria: AFTP &amp;gt;1 g/dL, glc &amp;lt;50 mg/dL, LDH &amp;gt;ULN for serum. Cx polymicrobial.</description></item><item><title>Secondary causes of headaches</title><link>https://www.physician.tw/Secondary-causes-of-headaches/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-causes-of-headaches/</guid><description>Secondary causes of headaches Traumatic: post-concussion, SAH, SDH, postcraniotomy ‚Üë ICP: mass (tumor, abscess, vascular malformations, ICH), hydrocephalus, idiopathic intracranial hypertension (pseudotumor cerebri), altitude-associated cerebral edema ‚Üì ICP: post-LP headache, CSF leak/dural tear, overshunting Vascular: stroke (esp.</description></item><item><title>Secondary Causes of Hypertension</title><link>https://www.physician.tw/Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-Causes-of-Hypertension/</guid><description>Secondary Causes of Hypertension [[renal-Secondary Causes of Hypertension]] [[endocrine-Secondary Causes of Hypertension]] [[other-Secondary Causes of Hypertension]]</description></item><item><title>Secondary causes of iron overload</title><link>https://www.physician.tw/Secondary-causes-of-iron-overload/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-causes-of-iron-overload/</guid><description>Secondary causes of iron overload iron-loading anemias (eg, thalassemia major, sideroblastic anemia, aplastic anemia), parenteral iron overload (RBC transfusions, long-term HD), chronic liver disease (due to EtOH, HBV, HCV, NASH, etc.</description></item><item><title>Secondary Hyperaldosteronism</title><link>https://www.physician.tw/Secondary-Hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-Hyperaldosteronism/</guid><description>Secondary Hyperaldosteronism (extra-adrenal disorders, ‚Üë aldosterone is renin-dependent) 2¬∞ hyperaldosteronism (eg, renovascular dis., [[renin-secreting tumor]])
Primary reninism: renin-secreting tumor (very rare) Secondary reninism: renovascular disease: RAS, malignant hypertension; edematous states w/ ‚Üì effective arterial volume: CHF, cirrhosis, nephrotic syndrome; hypovolemia, diuretics, T2D, Bartter‚Äôs (defective Na/K/2Cl transporter ‚âà receiving loop diuretic), Gitelman‚Äôs (defective renal Na/Cl transporter ‚âà receiving thiazide diuretic)</description></item><item><title>Secondary hyperPTH</title><link>https://www.physician.tw/Secondary-hyperPTH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-hyperPTH/</guid><description>Secondary hyperPTH ‚Üë PO4, ‚Üë FGF-23, ‚Üì calcitriol, &amp;amp; ‚Üì Ca ‚Üí ‚Üë PTH ‚Üí renal osteodystrophy
Abnormalities of calcium, phosphorus, parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and vitamin D metabolism</description></item><item><title>Secondary immune thrombocytopenic purpura 2¬∞ ITP</title><link>https://www.physician.tw/Secondary-immune-thrombocytopenic-purpura-2-ITP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-immune-thrombocytopenic-purpura-2-ITP/</guid><description>Secondary immune thrombocytopenic purpura (2¬∞ ITP) Diagnosis: viral serologies (HIV, HCV, HBV, EBV), H. pylori Ab, ANA, pregnancy test, APLA, TSH, parvovirus, &amp;amp; CMV PCR.</description></item><item><title>Sedation-and-Analgesia</title><link>https://www.physician.tw/Sedation-and-Analgesia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sedation-and-Analgesia/</guid><description>Sedation-and-Analgesia [[Context sensitive half time]] [[propofol infusion syndrome]]</description></item><item><title>seizures</title><link>https://www.physician.tw/seizures/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/seizures/</guid><description/></item><item><title>Select clinical manifestations-fever in a returned traveler</title><link>https://www.physician.tw/Select-clinical-manifestations-fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Select-clinical-manifestations-fever-in-a-returned-traveler/</guid><description>Select clinical manifestations-fever in a returned traveler Ebola: fever in traveler from area with active transmission of Ebola w/in 21 d Malaria: nonspecific sx including diarrhea, headache, myalgias, cough, Œî MS Dengue: nonspecific sx including headache, severe myalgias, rash/petechiae Chikungunya: nonspecific sx including joint pain, moderate myalgias Typhoid (Lancet 2015;385:1136): diarrhea/constipation, abd pain, ¬± rash, relative bradycardia Rickettsial disease: headache, myalgias, lymphadenopathy, ¬± rash/eschar Zika: rash, arthralgia, headache, conjunctivitis; often less severe than dengue, Chikungunya</description></item><item><title>selexipag</title><link>https://www.physician.tw/selexipag/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/selexipag/</guid><description>selexipag k</description></item><item><title>sensible and insensible fluid losses</title><link>https://www.physician.tw/sensible-and-insensible-fluid-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sensible-and-insensible-fluid-losses/</guid><description>sensible and insensible fluid losses Insensible losses (nonmeasurable) Lungs: 200 mL Skin: 600 mL Sweat: Variable Sensible losses (measurable) Fecal: 200 mL Urine: 800 to 1500 mL These losses account for 2000 to 2500 mL/day, giving a 24-hour fluid requirement of 30 to 35 mL/kg to maintain normal fluid balance.</description></item><item><title>sepsis and shock</title><link>https://www.physician.tw/sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sepsis-and-shock/</guid><description>sepsis and shock [[Definitions-sepsis and shock]] [[Shock]] MANAGEMENT [[Fluids-sepsis and shock]] [[Pressors inotropes-sepsis and shock]] [[Targets-sepsis and shock]] [[Antibiotics-sepsis and shock]] [[Steroids-sepsis and shock]] [[Early Goal-Directed Therapy (EGDT)]] BacklinkÔºö [[Adrenal insufficiency and critical illness]] [[Antibiotics-sepsis and shock]] [[Definitions-sepsis and shock]] [[Fluids-sepsis and shock]] [[ICU]] [[Pressors inotropes-sepsis and shock]] [[pulmonology]] [[Steroids-sepsis and shock]] [[Targets-sepsis and shock]]</description></item><item><title>Sequential management of bacterial meningitis</title><link>https://www.physician.tw/Sequential-management-of-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sequential-management-of-bacterial-meningitis/</guid><description>Sequential management of bacterial meningitis Blood cx, initiate empiric antibiotics, consider corticosteroids (vide infra) CT head if indicated (see below) LP ASAP (if not contraindicated); yield of CSF cx unlikely to be changed if obtained w/in ~4 h of initiation of abx Diagnostic studies (NEJM 2017;388:3036) Blood cultures √ó2 before abx WBC count: &amp;gt;10,000 in &amp;gt;90% of bacterial meningitis in healthy hosts Head CT to r/o mass effect before LP if ‚â•1 high-risk feature: immunosupp.</description></item><item><title>Serologic and virologic tests</title><link>https://www.physician.tw/Serologic-and-virologic-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serologic-and-virologic-tests/</guid><description>Serologic and virologic tests Precore mutant: HBeAg not made, but anti-HBe can develop due to x-reactivity w/ HBcAg; a/w ‚Üë HBV DNA</description></item><item><title>Serum parathyroid hormone PTH concentrations in hypercalcemia and hypocalcemia</title><link>https://www.physician.tw/Serum-parathyroid-hormone-PTH-concentrations-in-hypercalcemia-and-hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serum-parathyroid-hormone-PTH-concentrations-in-hypercalcemia-and-hypocalcemia/</guid><description>Serum parathyroid hormone (PTH) concentrations in hypercalcemia and hypocalcemia raise plasma calcium via bone resorption and renal calcium reabsorption</description></item><item><title>Serum-ascites albumin gradient SAAG</title><link>https://www.physician.tw/Serum-ascites-albumin-gradient-SAAG/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serum-ascites-albumin-gradient-SAAG/</guid><description>Serum-ascites albumin gradient (SAAG) serum alb (g/dL) ‚Äì ascites alb (g/dL)
SAAG ‚â•1.1 diagnoses portal HTN with ~97% accuracy Ann Intern Med 1992;117:215</description></item><item><title>Severity of Asthma Exacerbation</title><link>https://www.physician.tw/Severity-of-Asthma-Exacerbation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Severity-of-Asthma-Exacerbation/</guid><description>Severity of Asthma Exacerbation Mild-Moderate Talks in phrases RR &amp;gt;20, HR 100-120, Room air Sa02 90-95%
50% predicted or best 02, SABA 4-10 puffs q20min, prednisone</description></item><item><title>Severity-acute pancreatitis</title><link>https://www.physician.tw/Severity-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Severity-acute-pancreatitis/</guid><description>Severity-acute pancreatitis (Gut 2013;62:102; Gastro 2018;154:1096)
Severity defined by presence of organ failure (AKI, resp failure, GIB, shock) &amp;amp; local or systemic complic.</description></item><item><title>sexually transmitted infections</title><link>https://www.physician.tw/sexually-transmitted-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sexually-transmitted-infections/</guid><description>sexually transmitted infections [[Risk Factors and Screening]] (MMWR 2021;70:1) [[Genital Lesions]] (MMWR 2021; 70:1) [[Genital Discharge]] [[Diagnosis-sexually transmitted infections]] [[Treatment-sexually transmitted infections]]</description></item><item><title>SGLT2i</title><link>https://www.physician.tw/SGLT2i/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SGLT2i/</guid><description>SGLT2i ~25% ‚Üì death or HF hospitalization in NYHA II‚ÄìIV (DAPA-HF, NEJM 2019; 381:1995, EMPEROR-Reduced; NEJM 2020;383:1413).</description></item><item><title>SGLT2i in chronic kidney disease</title><link>https://www.physician.tw/SGLT2i-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SGLT2i-in-chronic-kidney-disease/</guid><description>SGLT2i in chronic kidney disease in proteinuric CKD (min eGFR 25-30) w/ or w/o DM, transient ‚Üì in eGFR (&amp;lt;5) but then 30-40% ‚Üì risk of CKD progression &amp;amp; ‚Üì mortality (NEJM 2019;380:2295 &amp;amp; 2020;383:1436)</description></item><item><title>Shock</title><link>https://www.physician.tw/Shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Shock/</guid><description>Shock Ë¢´ÂÆöÁæ©ÁÇ∫Áî±ÊñºÊ∞ßÊ∞£ÈÅûÈÄÅÊàñËêÉÂèñÂ§±Ë™øËÄåÂ∞éËá¥Êú´Á´ØÊêçÂÇ∑Â∞éËá¥ÁµÑÁπîÁº∫Ê∞ßÁöÑÁãÄÊÖã„ÄÇËá®Â∫äË°®ÁèæÂåÖÊã¨Ôºö Ê≥®ÊÑèÔºå‰∏çÊòØË°ÄÂ£ì‰ΩéÂ∞±ÊòØshock‰∏çÊòØË°ÄÂ£ì‰ΩéÂ∞±ÊòØshock
SHOCKÁöÑÂÖ¨ÂºèÔºö #anki SHOCK Â∞±ÊòØÊåáDO2‰∏çÂ§™Ë°åÁî¢Áîüend organ damamges
DO2 = (HR √ó SV) √ó CaO2 ÊâÄ‰ª•shockÁöÑÈÉ®ÂàÜÔºåÂåÖÂê´ÂÖ©ÂÄãÂ±§Èù¢ÔºöË°ÄÂ£ìË∑üË°ÄÊ∞ß CaO2 = (Hb √ó 1.</description></item><item><title>Short-Term Central Venous Catheter-Related Bloodstream Infxns</title><link>https://www.physician.tw/Short-Term-Central-Venous-Catheter-Related-Bloodstream-Infxns/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Short-Term-Central-Venous-Catheter-Related-Bloodstream-Infxns/</guid><description>Short-Term Central Venous Catheter-Related Bloodstream Infxns S. aureus Risk of endocarditis in bacteremia: ~25% (JACC 1997;30:1072). ID consult a/w ‚Üì mortality (ClD 2015;60:1451).</description></item><item><title>SIADH</title><link>https://www.physician.tw/SIADH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SIADH/</guid><description>SIADH (euvolemia or mild hypervolemia, typically inapprop Uosm &amp;gt;100, UNa &amp;gt;20 mEq/L ) Malignancy: lung (SCLC), brain, GI, GU, lymphoma, leukemia, thymoma, mesothelioma Pulmonary: pneumonia, TB, aspergillosis, asthma, COPD, PTX, mechanical ventilation Intracranial: trauma, stroke, SAH, seizure, infxn, hydrocephalus, Guillain-Barr√© Drugs: antipsychotics, antidepress.</description></item><item><title>Sickle cell anemia</title><link>https://www.physician.tw/Sickle-cell-anemia-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sickle-cell-anemia-/</guid><description>Sickle cell anemia (NEJM 2017;376:1561 &amp;amp; Lancet 2017;390:311)
Recessive Œ≤-globin mutation ‚Üí structurally abnl hemoglobin (HbS). ~8% African Americans heterozygotes (‚Äúsickle trait‚Äù; usually w/o sx); ~1/400 homozygotes (sickle cell disease).</description></item><item><title>Sideroblastic anemia</title><link>https://www.physician.tw/Sideroblastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sideroblastic-anemia/</guid><description>Sideroblastic anemia Defective heme biosynthesis within RBC precursors
Etiologies: hereditary/X-linked (ALAS2 mutations), idiopathic, MDS-RARS, reversible (alcohol, lead, isoniazid, chloramphenicol, copper deficiency, hypothermia)</description></item><item><title>Signs and Symptoms of Uremia -chronic kidney disease CKD</title><link>https://www.physician.tw/Signs-and-Symptoms-of-Uremia-chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Signs-and-Symptoms-of-Uremia-chronic-kidney-disease-CKD/</guid><description>Signs and Symptoms of Uremia -chronic kidney disease (CKD) (NEJM 2018;379:669)
General Nausea, anorexia, malaise, uremic fetor, metallic taste, hypothermia</description></item><item><title>Sinus bradycardia</title><link>https://www.physician.tw/Sinus-bradycardia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sinus-bradycardia/</guid><description>Sinus bradycardia (SB, &amp;lt;50‚Äì60 bpm) (NEJM 2000;342:703, Circ 2019;140:e382)
Etiologies: meds (incl Œ≤B, CCB, amio, Li, dig), ‚Üë vagal tone (incl.</description></item><item><title>Sinusoidal obstruction syndrome SOS</title><link>https://www.physician.tw/Sinusoidal-obstruction-syndrome-SOS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sinusoidal-obstruction-syndrome-SOS/</guid><description>Sinusoidal obstruction syndrome (SOS) (Bone Marrow Transplant 2020:55:485)
Occlusion of hepatic venules &amp;amp; sinusoids (formerly veno-occlusive disease) 2/2 toxic insult</description></item><item><title>skin and soft tissue infections</title><link>https://www.physician.tw/skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/skin-and-soft-tissue-infections/</guid><description>skin and soft tissue infections [[Definitions-skin and soft tissue infections]] Risk Factors Trauma, edema, preceding skin inflammation or infection, obesity, DM, other immunosupp.</description></item><item><title>sodium and water homeostasis</title><link>https://www.physician.tw/sodium-and-water-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sodium-and-water-homeostasis/</guid><description>sodium and water homeostasis [[overview-sodium and water homeostasis]] [[hyponatremia]] [[hypernatremia]] [[polyuria]]</description></item><item><title>solitary pulmonary nodule</title><link>https://www.physician.tw/solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/solitary-pulmonary-nodule/</guid><description>solitary pulmonary nodule [[Principles-solitary pulmonary nodule]] [[Etiologies-solitary pulmonary nodule]] [[Initial evaluation-solitary pulmonary nodule]] [[Diagnostic studies of solitary pulmonary nodule]] [[Management-solitary pulmonary nodule]]</description></item><item><title>sorafenib</title><link>https://www.physician.tw/sorafenib/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sorafenib/</guid><description>sorafenib inhib RAS and B-Raf
ËÖ´Áò§ÁîüÈï∑Èèà RAS-&amp;gt;B-RAF-MEK-MAPK-Nuclear Transcription-Tumor cell prolifertaion</description></item><item><title>Sotalol</title><link>https://www.physician.tw/Sotalol/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sotalol/</guid><description>Sotalol n/a 80-160 mg bid check for HR, 1 QT; renal adj %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Specialized Diagnostic Tests in Thyroid Disorders</title><link>https://www.physician.tw/Specialized-Diagnostic-Tests-in-Thyroid-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Specialized-Diagnostic-Tests-in-Thyroid-Disorders/</guid><description>Specialized Diagnostic Tests in Thyroid Disorders Total T4 Total serum concentrations (‚à¥ influenced by TBG). Checked if concern that TSH and free T4 are not accurate.</description></item><item><title>Specific gravity of Urine Dipstick</title><link>https://www.physician.tw/Specific-gravity-of-Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Specific-gravity-of-Urine-Dipstick/</guid><description>Specific gravity of Urine Dipstick Ê≠£Â∏∏ÂÄºÔºö300-1000 mOsm/kg H2O
Estimate Uosm: each 0.001 above 1 ‚âà 30 osm (SG 1.</description></item><item><title>Splenic vein thrombosis</title><link>https://www.physician.tw/Splenic-vein-thrombosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Splenic-vein-thrombosis/</guid><description>Splenic vein thrombosis Can occur 2/2 local inflam. (eg, panc.). Can p/w isol. gastric varices. Splenectomy curative.</description></item><item><title>Spontaneous bacterial peritonitis</title><link>https://www.physician.tw/Spontaneous-bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spontaneous-bacterial-peritonitis/</guid><description>Spontaneous bacterial peritonitis (SBP; see ‚ÄúAscites‚Äù; Hepatology 2021;74:1014)
High mortality rate; risk factors include ascitic TP &amp;lt;1 g/dL, hx of SBP, current GIB</description></item><item><title>Spontaneous bacterial peritonitis SBP</title><link>https://www.physician.tw/Spontaneous-bacterial-peritonitis-SBP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spontaneous-bacterial-peritonitis-SBP/</guid><description>[[Spontaneous bacterial peritonitis]] (SBP) gut bacterial translocation to ascites. In cirrhosis, ‚Üì ascites opsonins (esp. if ‚ÜìAFTP) ‚Üë risk of infxn.</description></item><item><title>Spot urine</title><link>https://www.physician.tw/Spot-urine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spot-urine/</guid><description>Spot urine protein (mg/dL)/creatinine (mg/dL) ‚âà g/d of proteinuria (NEJM 1983;309:1543) unlike urine dipstick, will accurately measure myeloma light chains</description></item><item><title>ST-depression</title><link>https://www.physician.tw/ST-depression/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ST-depression/</guid><description>ST-depression Myocardial ischemia (¬± Tw abnl)
Acute true posterior MI: posterior STE appearing as anterior STD (¬± ‚Üë R wave) in V1‚ÄìV3 ‚úì posterior ECG leads; manage as a STEMI with rapid reperfusion (see ‚ÄúACS‚Äù)</description></item><item><title>ST-elevation</title><link>https://www.physician.tw/ST-elevation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ST-elevation/</guid><description>ST-elevation (NEJM 2003;349:2128; Circ 2009;119:e241 &amp;amp; e262)
ÂèÉËÄÉ‚û°Ô∏è AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a¬†‚Ä¶</description></item><item><title>stable ischemic heart disease</title><link>https://www.physician.tw/stable-ischemic-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stable-ischemic-heart-disease/</guid><description>stable ischemic heart disease Definition SIHD refers to asx and stably sx Pts as well as low-risk new-onset chest pain felt to be due to IHD, and excludes Pts w/ rapidly progressive sx or rest sx (ie, ACS)</description></item><item><title>Stages of CKD</title><link>https://www.physician.tw/Stages-of-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stages-of-CKD/</guid><description>Stages of CKD (Kid Int 2013;3[Suppl]:5)
GFR Stage GFR mL/min/1.73 m2 : Goals
1 (nl or ‚Üë GFR) &amp;gt;90 Dx/Rx of underlying condition &amp;amp; comorbidities, slow progression; cardiovascular risk reduction</description></item><item><title>Staging and prognosis-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Staging-and-prognosis-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-and-prognosis-chronic-obstructive-pulmonary-disease/</guid><description>Staging and prognosis-chronic obstructive pulmonary disease Assess breathlessness, cough, sputum, exercise capacity &amp;amp; energy (tools such as CAT and mMRC may be used as part of assessment) Ratio of diam PA/aorta &amp;gt;1 associated with ~3√ó ‚Üë risk of exacerbations (NEJM 2012;367:913) FEV1 stages: I = ‚â•80%; II = 50‚Äì79% (~11% 3-y mort.</description></item><item><title>Staging of breast cancer</title><link>https://www.physician.tw/Staging-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-of-breast-cancer/</guid><description>Staging of breast cancer Anatomic: tumor size, chest wall invasion, axillary LN mets (strongest prognostic factor) Histopathologic: type (little prognostic relevance) &amp;amp; grade; lymphatic/vascular invasion In situ carcinoma: no invasion of surrounding stroma Ductal (DCIS): ‚Üë risk of invasive cancer in ipsilateral breast (~30%/10 y) Lobular (LCIS): benign entity; marker of ‚Üë risk of inv.</description></item><item><title>Staging of lung cancer</title><link>https://www.physician.tw/Staging-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-of-lung-cancer/</guid><description>Staging of lung cancer based on tumor size and extent of invasion (T), regional LN involvement [N: N0 (none), N1 (ipsilat.</description></item><item><title>Standard workup-hypertension</title><link>https://www.physician.tw/Standard-workup-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Standard-workup-hypertension/</guid><description>Standard workup-hypertension Goals: (1) identify CV risk factors; (2) consider 2¬∞ causes; (3) assess for target-organ damage History: CAD, HF, TIA/CVA, PAD, DM, renal insufficiency, sleep apnea, preeclampsia; ‚äï FHx for HTN; diet, Na intake, smoking, alcohol, prescription and OTC meds, OCP Physical exam: ‚úì BP in both arms; funduscopic exam, BMI, cardiac (LVH, murmurs), vascular (bruits, radial-femoral delay), abdominal (masses or bruits), neuro exam Testing: K, BUN, Cr, Ca, glc, Hct, U/A, lipids, TSH, urinary albumin:creatinine (if ‚Üë Cr, DM, peripheral edema), ?</description></item><item><title>STEMI</title><link>https://www.physician.tw/STEMI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/STEMI/</guid><description>STEMI Requisite STE (at J point) ‚â•2 contiguous leads w/ ‚â•1 mm (except for V2‚ÄìV3: ‚â•2 mm in ‚ôÇ and ‚â•1.</description></item><item><title>Stepwise Evaluation of a Patient with Delirium</title><link>https://www.physician.tw/Stepwise-Evaluation-of-a-Patient-with-Delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stepwise-Evaluation-of-a-Patient-with-Delirium/</guid><description>Stepwise Evaluation of a Patient with Delirium from Harrison&amp;rsquo;s Principles of Internal Medicine, 21e
Initial Evaluation History with special attention to medications (including over-the-counter and herbals) General physical examination and neurologic examination Complete blood count Electrolyte panel including calcium, magnesium, phosphorus Liver function tests, including albumin Renal function tests First-Tier Further Evaluation Guided by Initial Evaluation Systemic infection screen - Urinalysis and culture - Chest radiograph - Blood cultures Electrocardiogram Arterial blood gas Serum and/or urine toxicology screen (perform earlier in young persons) Brain imaging with MRI with diffusion and gadolinium (preferred) or CT Suspected CNS infection or other inflammatory disorder: [[lumbar puncture after brain imaging]] Suspected seizure-related etiology: electroencephalogram (EEG) (if high suspicion, should be performed immediately)</description></item><item><title>Steroids-sepsis and shock</title><link>https://www.physician.tw/Steroids-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Steroids-sepsis-and-shock/</guid><description>Steroids-sepsis and shock Steroids (Crit Care Med 2018;46:1411)
Hydrocortisone 50 mg IV q6 + fludrocortisone 50 ¬µg via NGT daily in septic shock ‚Üì duration of shock and may ‚Üì mortality (NEJM 2018; 378:797 &amp;amp; 809)</description></item><item><title>Stress testing</title><link>https://www.physician.tw/Stress-testing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stress-testing/</guid><description>Stress testing Indications: evaluate possible CAD sx or ‚àÜ in clinical status in Pt w/ known CAD, risk stratify after chest pain, evaluate exercise tolerance, localize ischemia (imaging required)</description></item><item><title>stroke</title><link>https://www.physician.tw/stroke/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stroke/</guid><description>stroke ÊÄ•ÊÄß‰∏≠È¢®ÂàÜÁÇ∫ÂÖ©Á®ÆÔºö Áº∫Ë°ÄÊÄßÔºàÁ¥Ñ 85% ÁöÑÁóÖ‰æãÔºâ Âá∫Ë°ÄÊÄßÔºàÁ¥Ñ 15% ÁöÑÁóÖ‰æãÔºâ</description></item><item><title>Structural dysphagia</title><link>https://www.physician.tw/Structural-dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Structural-dysphagia/</guid><description>Structural dysphagia (solids &amp;gt;liquids; JAMA 2015;313:18; Gastro 2018;155:1022)
Oropharyngeal [[Zenker‚Äôs divertic]]. (pharyngeal pouch): in elderly, a/w aspir., dx w/ video fluoro, Rx endo/surg Malignancy; proximal strictures/rings/webs; infection; radiation injury; goiter; osteophytes Esophageal Rings (intermittent dysphagia, concentric obstructing tissue, Schatzki ring): near GE jxn, a/w food impaction, linked to GERD; Rx w/ PPI, dilation Webs: thin, partially occlusive structure, proximal, a/w Fe defic.</description></item><item><title>Subclinical hypothyroidism</title><link>https://www.physician.tw/Subclinical-hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Subclinical-hypothyroidism/</guid><description>Subclinical hypothyroidism Mild ‚Üë TSH and normal free T4 with only subtle or no sx If TSH &amp;lt;7 or ‚äñ anti-TPO Ab, ~¬Ω resolve after 2 y (JCEM 2012;97:1962) if ‚Üë titers of antithyroid Abs, progression to overt hypothyroidism is ~4%/y No clear benefit to Rx (NEJM 2017;376:2534).</description></item><item><title>supraventricular tachycardias SVTS</title><link>https://www.physician.tw/supraventricular-tachycardias-SVTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/supraventricular-tachycardias-SVTS/</guid><description>supraventricular tachycardias (SVTS) Arise above the ventricles, ‚à¥ narrow QRS unless aberrant conduction or pre-excitation. [[Common Etiologies of SVT]] [[Diagnosis of SVT Type]] [[Treatment of SVT]]</description></item><item><title>surgery and radiation for local control of breast cancer</title><link>https://www.physician.tw/surgery-and-radiation-for-local-control-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgery-and-radiation-for-local-control-of-breast-cancer/</guid><description>surgery and radiation for local control of breast cancer Intervention Indication Breast conserving Stage I‚ÄìII, lumpectomy + sentinel lymph node biopsy* + RT Modified radical mastectomy Large tumor relative to breast, multicentric dis.</description></item><item><title>Surgery of inflammatory bowel disease</title><link>https://www.physician.tw/Surgery-of-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Surgery-of-inflammatory-bowel-disease/</guid><description>Surgery of inflammatory bowel disease UC: colectomy if sx refractory to or intolerable side effects from meds, CRC, perforation, toxic megacolon, uncontrolled hemorrhage.</description></item><item><title>surgical critical care</title><link>https://www.physician.tw/surgical-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgical-critical-care/</guid><description>surgical critical care 33 gastrointestinal bleeding 34 Acute Abdomen and Abdominal Sepsis 35 Abdominal Compartment Syndrome 36 Acute Mesenteric Ischemia 37 Surgical Trauma 38 Burns 39 Acute Hepatic Failure 40 Abdominal Organ Transplantation 41 Obstetric Emergencies</description></item><item><title>surgical issues</title><link>https://www.physician.tw/surgical-issues/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgical-issues/</guid><description>surgical issues [[orthopaedic]]</description></item><item><title>SVC syndrome</title><link>https://www.physician.tw/SVC-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SVC-syndrome/</guid><description>SVC syndrome (NEJM 2007;356:1862): central tumor ‚Üí SVC compression ‚Üí face/arm swelling (&amp;gt;80%), neck/chest vein distention (~60%), SOB/cough (~50%), HA (~10%); Rx = steroids, diuretics, RT ¬± chemo, SVC stent if severe sx, anticoag if clot</description></item><item><title>Sx of Hemochromatosis</title><link>https://www.physician.tw/Sx-of-Hemochromatosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sx-of-Hemochromatosis/</guid><description>Sx of Hemochromatosis fatigue &amp;amp; arthralgias, loss of libido in ‚ôÇ. In advanced disease (rare): bronze skin (melanin + iron), hypogonadism (esp.</description></item><item><title>symptom to diagnosis of dyspnea</title><link>https://www.physician.tw/symptom-to-diagnosis-of-dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/symptom-to-diagnosis-of-dyspnea/</guid><description>symptom to diagnosis of dyspnea Four most common Heart failure Pneumonia Obstructive lung disease (chronic obstructive pulmonary disease/asthma) Pulmonary embolism Immediate threat to life (ACT ASAP) (Â§ßÊ¶ÇÂ∞±ÊòØ5T) Arrhythmia Coronary syndrome, Acute Tamponade Airway obstruction Stenosis, Aortic Anaphylaxis Pneumothorax [[Differential Diagnosis of Dyspnea]]</description></item><item><title>Symptoms-ascites</title><link>https://www.physician.tw/Symptoms-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Symptoms-ascites/</guid><description>Symptoms-ascites ‚Üë abd girth, wt gain, new abd hernia, abd pain, dyspnea, nausea, early satiety</description></item><item><title>syncope</title><link>https://www.physician.tw/syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/syncope/</guid><description>syncope [[Definition-syncope]] [[Etiologies-syncope]] [[Workup-syncope]] [[Other diagnostic studies-syncope]] [[Approach to syncope-syncope]] [[High-risk features-syncope]] [[Treatment-syncope]] [[Prognosis-syncope]]</description></item><item><title>Synthesis and Metabolism of Vitamin D</title><link>https://www.physician.tw/Synthesis-and-Metabolism-of-Vitamin-D/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Synthesis-and-Metabolism-of-Vitamin-D/</guid><description>Synthesis and Metabolism of Vitamin D Á∂≠ÁîüÁ¥† D ÊúÄÂàùÊòØÂú®ÁöÆËÜö‰∏≠ÈÄöÈÅéÁ∂≠ÁîüÁ¥† D3 Âà∞Á∂≠ÁîüÁ¥† D3 ÁöÑÈùûÈÖ∂ËΩâÂåñÁî¢ÁîüÁöÑ„ÄÇ Á∂≠ÁîüÁ¥† D ÁöÑËÜ≥È£üÊîùÂÖ•ÈáèÈÄöÂ∏∏Áõ∏Â∞çÊúâÈôêÔºåÂõ†ÁÇ∫Èô§Êüê‰∫õÈ≠öÈ°ûÂ§ñÔºåÂæàÂ∞ëÊúâÈ£üÁâ©Âê´ÊúâÂ§ßÈáèÔºõË£úÂÖÖÂäëÊòØÂ∏∏Áî®ÁöÑ„ÄÇ Á∂≠ÁîüÁ¥† D Ë¶Å‰πàÂÑ≤Â≠òÂú®ËÑÇËÇ™ÁµÑÁπî‰∏≠ÔºåË¶Å‰πàÈÄöÈÅé 25-Áæ•ÂåñÈÖ∂Âú®ËÇùËáü‰∏≠ËΩâÂåñÁÇ∫ 25-Áæ•Âü∫Á∂≠ÁîüÁ¥† D3 (25[OH]D3)ÔºåÈÄôÁ®ÆÂΩ¢Âºè‰ª•ÊúÄÈ´òÊøÉÂ∫¶Âæ™Áí∞‰∏¶ÂèçÊò†ÈôΩÂÖâÂíåÈ£≤È£üÊö¥Èú≤„ÄÇ ÂÆÉÂú®ËÖéËáü‰∏≠ËΩâÂåñÁÇ∫Ê¥ªÊÄß‰ª£Ë¨ùÁâ© 25-‰∫åÁæ•Âü∫Á∂≠ÁîüÁ¥† D (25[OH]2D) ÊàñÈ™®Âåñ‰∏âÈÜáÔºåÂÑòÁÆ°ÂÖ∂‰ªñÁµÑÁπîÂÖ∑Êúâ 1Œ±-Áæ•ÂåñÈÖ∂ÈÖ∂Ê¥ªÊÄß„ÄÇ È™®Âåñ‰∏âÈÜáÁöÑÂêàÊàêÈÄöÈÅéÂ¢ûÂä†Áî≤ÁãÄÊóÅËÖ∫ÊøÄÁ¥† (PTH) ÁöÑÊ∞¥Âπ≥‰æÜÂ¢ûÂº∑ (+)ÔºåÁî≤ÁãÄÊóÅËÖ∫Á¥† (PTH) ÊúÉÈö®ËëóË°ÄÊ∏ÖÈà£Ê∞¥Âπ≥ÁöÑÈôç‰ΩéËÄåÂçáÈ´ò„ÄÇ Ë°ÄÊ∏ÖÁ£∑ÈÖ∏ÈπΩÊ∞¥Âπ≥Èôç‰Ωé‰πüÂèØ‰ª•Â¢ûÂä†Ôºà+ÔºâÈ™®Âåñ‰∏âÈÜáÁöÑÁî¢Áîü„ÄÇ ÂÆÉÁöÑÂêàÊàêË¢´ÊàêÁ∫ñÁ∂≠Á¥∞ËÉûÁîüÈï∑Âõ†Â≠ê 23 (FGF-23) ÁöÑÁî¢ÁîüÊäëÂà∂ (-)ÔºåË©≤Âõ†Â≠êÁî±È™®Âü∫Ë≥™‰∏≠ÁöÑÈ™®Á¥∞ËÉûÂàÜÊ≥å„ÄÇ È™®Âåñ‰∏âÈÜáÊäëÂà∂ 1Œ±-Áæ•ÂåñÈÖ∂ (CYP27B1) ÁöÑÊ¥ªÊÄß‰∏¶Âà∫ÊøÄ 24-Áæ•ÂåñÈÖ∂ (CYP24R1) ÁöÑÊ¥ªÊÄßÔºåË©≤ÈÖ∂ÂèØ‰øÉÈÄ≤ 25(OH)2D ÁöÑÁî¢ÁîüÔºåÈÄôÊòØ‰∏ÄÁ®ÆÈùûÁîüÁâ©Ê¥ªÊÄßÁöÑÁ∂≠ÁîüÁ¥† D Áî¢ÂìÅ„ÄÇ Âú® CYP2R CYP27B Âíå CYP24R ‰∏≠ÔºåCYP Ë°®Á§∫Á¥∞ËÉûËâ≤Á¥† P„ÄÇ KEY: ÈôΩÂÖâÂú®ÁöÆËÜöÁîüÊàêD3 ËÇùÂä†25„ÄÅËÖéÂä†1</description></item><item><title>systematic-Treatment</title><link>https://www.physician.tw/systematic-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/systematic-Treatment/</guid><description>systematic-Treatment The poor risk model used in the global ARCC trial to direct treatment with temsirolimus included at least 3 of the following 6 predictors of short survival:</description></item><item><title>Systemic diseases with secondary glomerular involvement</title><link>https://www.physician.tw/Systemic-diseases-with-secondary-glomerular-involvement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-diseases-with-secondary-glomerular-involvement/</guid><description>Systemic diseases with secondary glomerular involvement [[diabetes mellitus]] (CJASN 2017;12:2032): nodular glomerulosclerosis ([[Kimmelstiel-Wilson]] lesion); glomerular hyperfiltration ‚Üí microalbuminuria ‚Üí dipstick ‚äï ‚Üí nephrotic range (10‚Äì15 y).</description></item><item><title>systemic therapy of breast cancer</title><link>https://www.physician.tw/systemic-therapy-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/systemic-therapy-of-breast-cancer/</guid><description>systemic therapy of breast cancer [[ER PR]] [[PIK3CA]] [[HER2]] treatment Stage I‚ÄìIII (above) Chemo
Neoadjuvant: to conserve breast &amp;amp; evaluate Rx efficacy, equivalent OS as adjuvant (JCO 2008;26:778) Adjuvant: use anthracycline ¬± taxane.</description></item><item><title>Systemic thrombolysis</title><link>https://www.physician.tw/Systemic-thrombolysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-thrombolysis/</guid><description>Systemic thrombolysis (EHJ 2020;41:543; Chest 2021;160:e545)
Typically TPA 100 mg over 2h or wt-adjusted TNK bolus; risk of ICH ~2-5%, ‚Üë w/ age</description></item><item><title>T-wave-inversion</title><link>https://www.physician.tw/T-wave-inversion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/T-wave-inversion/</guid><description>T-wave-inversion (Circ 2009;119:e241)
ÂèÉËÄÉ‚û°Ô∏è AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a¬†‚Ä¶</description></item><item><title>Tachycardia-bradycardia ‚Äútachy-brady‚Äù syndrome</title><link>https://www.physician.tw/Tachycardia-bradycardia-tachy-brady-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tachycardia-bradycardia-tachy-brady-syndrome/</guid><description>Tachycardia-bradycardia (‚Äútachy-brady‚Äù) syndrome (‚Äútachy-brady‚Äù) syndrome
Features may include: periods of unprovoked SB, SA arrest, paroxysms of SB and atrial tachyarrhythmias, chronotropic incompetence w/ ETT Treatment: meds alone usually fail (adeq.</description></item><item><title>Tailored therapy in cardiogenic shock</title><link>https://www.physician.tw/Tailored-therapy-in-cardiogenic-shock-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tailored-therapy-in-cardiogenic-shock-/</guid><description>Tailored therapy in cardiogenic shock Goals: optimize both MAP and CO while ‚Üì risk of pulmonary edema MAP = CO √ó SVR; CO = HR √ó SV (which depends on preload, afterload, and contractility)</description></item><item><title>TaitaNo5</title><link>https://www.physician.tw/TaitaNo5/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/TaitaNo5/</guid><description>TaitaNo5 ÈàâÈõ¢Â≠ê 36mEq/L Ê∞ØÈõ¢Â≠ê 17 mEq/L ÈâÄÈõ¢Â≠ê 18 mEq/L ÈéÇÈõ¢Â≠ê 3 mEq/L phosphate 12 mM/L acetate 28 mEq/L 10% [[glucose water osmolarity]] Êª≤ÈÄèÂ£ìÁÇ∫ 669 mOsm/L -&amp;gt; ÈÉΩÊòØÁ≥ñÊ∞¥Ë≤¢ÁçªÁöÑ Acetate 28mEq/L ÈÅ©Áî®Êñº‰ΩéÁ£∑Ë°ÄÁóáÁóÖ‰∫∫‰πã phosphorus Ë£úÂÖÖ(ÈùûÁ≥ñÂ∞øÁóÖ‰∫∫Ôºâ ÊåÅÁ∫åÊÄß‰∏ã Áó¢„ÄÅËÇùÁÇé„ÄÅÈÖíÁ≤æ‰∏≠ÊØí ÁáüÈ§ä‰∏çËâØÊÇ£ËÄÖ‰πãÈ´òÁÜ±ËÉΩÂèäÈõªËß£Ë≥™Ë£úÂÖÖ Â§ñÁßë„ÄÅÂ©¶Áî¢ÁßëÊâãË°ì ÂâçÂæåÁáüÈ§äÂèäÈõªËß£Ë≥™‰πãË£úÂÖÖ(Â∞§ÂÖ∂ÊòØÈ™®ÊäòÁóÖ‰∫∫)„ÄÇ ‰∏≠ÂøÉÈùúËÑàÁáüÈ§äÊ≥®Â∞Ñ‰πãÂü∫Á§éÊ∂≤„ÄÇ</description></item><item><title>Takayasu‚Äôs arteritis</title><link>https://www.physician.tw/Takayasus-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Takayasus-arteritis/</guid><description>Takayasu‚Äôs arteritis TL;DR
Usually Asian females &amp;lt; 40 years old.
&amp;ldquo;Pulseless disease&amp;rdquo; (weak upper extremity pulses), fever, night sweats, arthritis, myalgias, skin nodules, ocular disturbances.</description></item><item><title>Targets-sepsis and shock</title><link>https://www.physician.tw/Targets-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Targets-sepsis-and-shock/</guid><description>Targets-sepsis and shock Lactate clearance (‚â•20%/2 h) as effective as ScvO2 to guide resusc. (JAMA 2010;303:739)
Targeting capillary refill time ‚â§3 sec (check q30min) as good if not better than lactate clearance (JAMA 2019;321:654)</description></item><item><title>TAVI</title><link>https://www.physician.tw/TAVI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/TAVI/</guid><description>TAVI TAVI (transcatheter AoV implantation) (JAMA 2021;325:2480; Circ 2021;143:e72)
Valves: balloon-expandable or self-expanding. Most commonly deployed retrograde via perc. transfemoral access (best outcomes) Peri- &amp;amp; postprocedural complic.</description></item><item><title>Temporary pacing wires</title><link>https://www.physician.tw/Temporary-pacing-wires/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Temporary-pacing-wires/</guid><description>Temporary pacing wires Consider w/ bradycardia with hemodyn instability or unstable escape rhythm when perm pacer not readily available. Risks: infxn, RV perf, VT, PTX, CHB if existing LBBB.</description></item><item><title>tension pneumocephalus</title><link>https://www.physician.tw/tension-pneumocephalus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tension-pneumocephalus/</guid><description>tension pneumocephalus Tension pneumocephalus is a neurosurgical emergency that occurs when subdural air causes a mass-effect over the underlying brain parenchyma, often from a ball-valve mechanism causing one-way entry of air into the subdural space 1.</description></item><item><title>Tension-type headache</title><link>https://www.physician.tw/Tension-type-headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tension-type-headache/</guid><description>Tension-type headache bilateral, pressure-like pain of mild‚Äìmod intensity, not throbbing or aggravated by physical activity. A/w photophobia or phonophobia, not N/V.</description></item><item><title>terms used to describe patients with delirium</title><link>https://www.physician.tw/terms-used-to-describe-patients-with-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/terms-used-to-describe-patients-with-delirium/</guid><description>terms used to describe patients with delirium encephalopathy acute brain failure acute confusional state postoperative intensive care unit (ICU) psychosis</description></item><item><title>test pandoc</title><link>https://www.physician.tw/demo/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/demo/</guid><description>test pandoc [@alavi2021american] Output [@2022evolution]</description></item><item><title>Test results noninvasive evaluation of CAD</title><link>https://www.physician.tw/noninvasive-evaluation-of-CAD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/noninvasive-evaluation-of-CAD/</guid><description>[[Test-results-noninvasive evaluation of CAD]] [[Stress testing]] (J Nucl Cardiol 2016;23:606; EHJ 2020;41:407) [[Exercise-tolerance-test]] (w/ ECG alone) [[Pharmacologic-stress-test]] (nb, requires imaging because ECG not interpretable) [[Imaging-for-stress-test]] High-risk test results (PPV ~50% for LM or 3VD, ‚à¥ consider coronary angio) ECG: ST ‚Üì ‚â•2 mm or ‚â•1 mm in stage 1 or in ‚â•5 leads or ‚â•5 min in recovery; ST ‚Üë; VT</description></item><item><title>Test-results-noninvasive evaluation of CAD</title><link>https://www.physician.tw/Test-results-noninvasive-evaluation-of-CAD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Test-results-noninvasive-evaluation-of-CAD/</guid><description>Test-results-noninvasive evaluation of CAD HR (must achieve ‚â•85% of max pred HR [220-age] for exer. test to be dx), BP response, peak double product (HR √ó BP; nl &amp;gt;20k), HR recovery (HRpeak ‚Äì HR1 min later; nl &amp;gt;12)</description></item><item><title>test202207</title><link>https://www.physician.tw/test202207/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/test202207/</guid><description>Test</description></item><item><title>Tests of hepatic function</title><link>https://www.physician.tw/Tests-of-hepatic-function/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tests-of-hepatic-function/</guid><description>Tests of hepatic function Albumin: marker for liver protein synthesis, can help differentiate acute vs. chronic liver failure, may be normal in acute hepatocellular injury (t1/2 ~15‚Äì18 d)</description></item><item><title>Tests of hepatocellular injury or cholestasis</title><link>https://www.physician.tw/Tests-of-hepatocellular-injury-or-cholestasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tests-of-hepatocellular-injury-or-cholestasis/</guid><description>Tests of hepatocellular injury or cholestasis (J Clin Transl Hepatol 2017;5:394)
Ë©≥Ë¶ã Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?</description></item><item><title>Thalassemias</title><link>https://www.physician.tw/Thalassemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thalassemias/</guid><description>Thalassemias (Lancet 2018;391:155)
‚Üì synthesis of Œ±- or Œ≤-globin chains of Hb ‚Üí ‚â† subunits ‚Üí destruction of RBCs and erythroid precursors; ‚à¥ anemia from hemolysis and ineffective erythropoiesis</description></item><item><title>The Confusion Assessment Method</title><link>https://www.physician.tw/The-Confusion-Assessment-Method/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Confusion-Assessment-Method/</guid><description>The Confusion Assessment Method (CAM) Diagnostic Algorithm
The diagnosis of delirium requires the presence of
features 1 and 2 and either feature 3 or 4.</description></item><item><title>The Effect of Advances in Lung-Cancer Treatment on Population Mortality</title><link>https://www.physician.tw/The-Effect-of-Advances-in-Lung-Cancer-Treatment-on-Population-Mortality/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Effect-of-Advances-in-Lung-Cancer-Treatment-on-Population-Mortality/</guid><description>The Effect of Advances in Lung-Cancer Treatment on Population Mortality NSCLCÁöÑÊ≠£Â∏∏ÊÄßÊØîË©≤‰∫ûÂûãÁöÑÁôºÁîüÁéáÊõ¥Âø´Ôºå‰∏¶‰∏îÈÄôÁ®ÆÈôç‰ΩéËàáÈö®ËëóÊôÇÈñìÁöÑÊµÅÈÄùÁöÑÁîüÂ≠òÁéáÈ°ØËëóÊèêÈ´òÔºåÈÄôËàáÈù∂ÂêëÊ≤ªÁôÇÁöÑÊâπÂáÜÊôÇÈñìÁõ∏Â∞çÊáâ„ÄÇ Âú®Áî∑ÊÄß‰∏≠ÔºåÂæû2013Âπ¥Âà∞2016Âπ¥ÔºåNSCLCÁöÑÁôºÁóÖÁéáÊ≠ª‰∫°ÁéáÊØèÂπ¥‰∏ãÈôç6.3ÔºÖÔºåËÄåÂæû2008Âπ¥Âà∞2016Âπ¥ÔºåÁôºÁóÖÁéáÊØèÂπ¥Èôç‰Ωé3.1ÔºÖ„ÄÇ Áõ∏ÊáâÁöÑËÇ∫ÁôåÁâπÁï∞ÊÄßÁîüÂ≠òÁéáÂæû2001Âπ¥Ë®∫Êñ∑ÁÇ∫NSCLCÁöÑÁî∑ÊÄßÁöÑ26ÔºÖÊèêÈ´òÂà∞2001Âπ¥ÁöÑ26ÔºÖ„ÄÇ Âú®2014Âπ¥Ë¢´Ë®∫Êñ∑Âá∫ÁöÑ‰∫∫‰∏≠ÔºåÊúâ35ÔºÖÁöÑ‰∫∫Âú®ÊâÄÊúâÁ®ÆÊóèÂíåÁ®ÆÊóè‰∏≠ÈÉΩÁôºÁèæ‰∫ÜÈÄôÁ®ÆÁîüÂ≠òÁöÑÊîπÂñÑ„ÄÇ Âú®NSCLCÂ•≥ÊÄß‰∏≠ÁôºÁèæ‰∫ÜÈ°û‰ººÁöÑÊ®°Âºè„ÄÇ Áõ∏ÊØî‰πã‰∏ãÔºåSCLCÁöÑÊ≠ª‰∫°ÁéáÂπæ‰πéÁî±ÊñºÁôºÁóÖÁéá‰∏ãÈôçËÄå‰∏ãÈôçÔºåÁîüÂ≠òÁéáÊ≤íÊúâÊèêÈ´ò„ÄÇ Ë©≤ÁµêÊûúËàáÊàëÂÄëÊ™¢Êü•ÁöÑÊôÇÈñìÁØÑÂúç‰∏≠SCLCÁöÑÊ≤ªÁôÇÈÄ≤Â±ïÊúâÈôêÁõ∏Èóú„ÄÇ</description></item><item><title>Therapeutic apheresis</title><link>https://www.physician.tw/Therapeutic-apheresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Therapeutic-apheresis/</guid><description>Therapeutic apheresis Removes plasma large molec wt subst. (eg, cryoglobulinemia, Goodpasture‚Äôs, Guillain-Barr√©, hyperviscosity syndrome), or cells (eg, leukemia w/ hyperleukocytosis, sx thrombocytosis) from plasma.</description></item><item><title>thereis</title><link>https://www.physician.tw/thereis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thereis/</guid><description>thereis ‰æÜËá™: [[emergency medicine]]</description></item><item><title>Thiazide diuretics</title><link>https://www.physician.tw/Thiazide-diuretics-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thiazide-diuretics-/</guid><description>Thiazide diuretics (JASN 2017;28:3414)
Drugs: hydrochlorothiazide (HCTZ), chlorothiazide (Diuril), metolazone (Zaroxolyn)
Mech: inhib Na-Cl cotransporter in the distal convoluted tubule (DCT); 5% Na reabsorp</description></item><item><title>this is a book</title><link>https://www.physician.tw/this-is-a-book/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/this-is-a-book/</guid><description/></item><item><title>Thoracentesis</title><link>https://www.physician.tw/Thoracentesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thoracentesis/</guid><description>Thoracentesis (ideally U/S guided) (NEJM 2006;355:e16) [[indications of thoracentesis]]
[[Diagnostic studies of thoracentesis]]
Complications: PTX (5‚Äì10%), hemothorax (~1%), re-expansion pulm edema (if &amp;gt;1.</description></item><item><title>three-component friction rub</title><link>https://www.physician.tw/three-component-friction-rub/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/three-component-friction-rub/</guid><description>three-component friction rub ‚ú® Â≠∏ÁøíÈáçÈªû ü¶é (1) ‰∏ÄÁ®ÆÁôºÁîüÂú®Êî∂Á∏ÆÊúüÁöÑ‰ªª‰ΩïÂú∞ÊñπÔºåÂÑòÁÆ°ÊúÄÂ∏∏Ë¶ãÊñºÊî∂Á∏Æ‰∏≠ÊúüÔºàÂõ†Ê≠§Â∞çÊáâÊñºÂøÉÂÆ§Êî∂Á∏ÆÔºâÔºõ (2) ÂÖ©ÂÄãÁôºÁîüÂú®ËàíÂºµÊó©ÊúüÂíåÊôöÊúüÔºàÂõ†Ê≠§ÂàÜÂà•Â∞çÊáâÊñºÊó©ÊúüÂøÉÂÆ§ÂÖÖÁõàÂíåÂøÉÊàøÊî∂Á∏ÆÔºâ„ÄÇ</description></item><item><title>thromboangiitis obliterans</title><link>https://www.physician.tw/thromboangiitis-obliterans/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thromboangiitis-obliterans/</guid><description>thromboangiitis obliterans Buerger disease Heavy tobacco smoking history, males &amp;lt; 40 years old. Intermittent claudication. May lead to gangrene, autoamputation of digits, superficial nodular phlebitis.</description></item><item><title>Thrombocytopenia and Risk of Bleeding</title><link>https://www.physician.tw/Thrombocytopenia-and-Risk-of-Bleeding/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombocytopenia-and-Risk-of-Bleeding/</guid><description>Thrombocytopenia and Risk of Bleeding 50,000‚Äì100,000 Risk with major trauma; can proceed with general surgery
&amp;lt;50,000 Risk with minor trauma or surgery</description></item><item><title>Thromboprophylaxis</title><link>https://www.physician.tw/Thromboprophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thromboprophylaxis/</guid><description>Thromboprophylaxis Blood Adv 2018;2:3198
Low-risk med; same-day surg &amp;amp; &amp;lt;40 y Early, aggressive ambulation ¬± mechanical
Moderate-risk (hosp., ‚â•1 risk factor) or high-risk medical (hosp.</description></item><item><title>Thrombotic microangiopathies</title><link>https://www.physician.tw/Thrombotic-microangiopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombotic-microangiopathies/</guid><description>Thrombotic microangiopathies (TMA; NEJM 2014;371:654; Lancet 2017;390:681)
Endothelial injury ‚Üí plt aggreg. &amp;amp; microvasc. thrombosis ‚Üí ‚Üì plt &amp;amp; RBC hemolysis (MAHA)</description></item><item><title>thyroid cancer</title><link>https://www.physician.tw/thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thyroid-cancer/</guid><description>thyroid cancer [[Thyroid nodules]] (JAMA 2018;319:914) [[Papillary thyroid cancer]] [[Follicular thyroid cancer]] [[Anaplastic thyroid cancer]] (Endo Metab Clin NA 2019;48:269) [[Medullary thyroid cancer]] (Endo Metab Clin NA 2019;48:285)</description></item><item><title>thyroid disorders</title><link>https://www.physician.tw/thyroid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thyroid-disorders/</guid><description>thyroid disorders [[Common Diagnostic Tests in Thyroid Disorders]] [[Specialized Diagnostic Tests in Thyroid Disorders]] [[hypothyroidism]] [[hyperthyroidism]] [[nonthyroidal illness (sick euthyroid syndrome) ]] [[amiodarone and thyroid disease]] [[thyroid cancer]] [[Washington Manual Thyroid Disorders]] FIGURE 5.</description></item><item><title>Thyroid nodules</title><link>https://www.physician.tw/Thyroid-nodules/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-nodules/</guid><description>Thyroid nodules Prevalence 5‚Äì10% (50‚Äì60% if screen with U/S), ‚ôÄ &amp;gt; ‚ôÇ, ~7‚Äì15% malignant Screening U/S recommended if FHx of MEN2 or medullary thyroid cancer, personal h/o neck XRT, palpable nodules or multinodular goiter Features a/w ‚Üë risk of malig: age &amp;lt;30 y, h/o neck XRT, family history of thyroid cancer U/S features a/w benign dx: cystic nodules, ‚Äúspongiform‚Äù sonographic pattern Worrisome findings: hypoechoic, solid, irregular borders, microCa2+, height&amp;gt;width, &amp;gt;20 mm Indications for FNA: &amp;gt;10-mm nodule w/ suspicious features</description></item><item><title>Thyroid storm</title><link>https://www.physician.tw/Thyroid-storm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-storm/</guid><description>Thyroid storm [[Presentation of Thyroid storm]]: Diagnosis: no universally accepted criteria. Biochemical hyperthyroidism + severe sx, consider additional dx that may explain/contribute to sx.</description></item><item><title>Thyroiditis</title><link>https://www.physician.tw/Thyroiditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroiditis/</guid><description>Thyroiditis Acute: bacterial infection (very rare in U.S. except postsurgical), typically Staph/Strep spp. Subacute: transient thyrotoxicosis ‚Üí transient hypothyroidism ‚Üí normal thyroid fxn</description></item><item><title>Ticagrelor</title><link>https://www.physician.tw/Ticagrelor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ticagrelor/</guid><description>Ticagrelor 180 mg √ó 1 ‚Üí 90 mg bid Reversible, but wait 3‚Äì5 d prior to surg. Antidote being developed (NEJM 2019;380:1825).</description></item><item><title>tick-borne diseases</title><link>https://www.physician.tw/tick-borne-diseases/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tick-borne-diseases/</guid><description>tick-borne diseases</description></item><item><title>timeV</title><link>https://www.physician.tw/timeV/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/timeV/</guid><description>#![[Title 2 test]] #![[title 2 test test]]</description></item><item><title>TIMI Risk Score</title><link>https://www.physician.tw/TIMI-Risk-Score/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/TIMI-Risk-Score/</guid><description>TIMI Risk Score TIMI Score
Calculation of Risk Score Historical Age ‚â•65 y ‚â•3 Risk factors for CAD Known CAD (stenosis ‚â•50%) ASA use in past 7 d Presentation Severe angina (‚â•2 episodes w/in 24 h) ST deviation ‚â•0.</description></item><item><title>Title 2 test</title><link>https://www.physician.tw/Title-2-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Title-2-test/</guid><description>Title 2 test some content</description></item><item><title>Topiramate</title><link>https://www.physician.tw/Topiramate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Topiramate/</guid><description>Topiramate ‰ΩúÁî® Áî®ÊñºÊàê‰∫∫ÂèäÂÖ©Ê≠≤‰ª•‰∏äÂÖíÁ´•Â±ÄÈÉ®Áô≤ÁôáÊàñ‰ΩµÊúâ [[Lennox Gastaut Syndrome]] ÁóáÂÄôÁæ§‰πãÁô≤ÁôáÂèäÂéüÁôºÊÄßÂÖ®Ë∫´ÊÄßÂº∑Áõ¥Èô£Êî£Áô≤ÁôáÁöÑËºîÂä©Ê≤ªÁôÇÔºåÁî®ÊñºPartial Onset SeizureÁóÖÊÇ£‰πãÂñÆ‰∏ÄËó•Áâ©Ê≤ªÁôÇ„ÄÅÈ†êÈò≤ÂÅèÈ†≠Áóõ„ÄÇ
Ê≥®ÊÑè‰∫ãÈ†Ö ‰∏çÂèØÊìÖËá™ÂÅúËó•ÔºåÁ™ÅÁÑ∂ÂÅúËó•ÂèØËÉΩÊúÉÂ∞éËá¥ÂèçÂΩàÊÄßÁô≤Áôá‰πãÁôº‰Ωú„ÄÇ ‰∏≠„ÄÅÈáçÂ∫¶ËÖéÂäüËÉΩ‰∏çÂÖ®ÁöÑÁóÖ‰∫∫ÈúÄË¶ÅÈôç‰ΩéÂäëÈáè„ÄÇËÇùÂäüËÉΩ‰∏çÂÖ®ÁöÑÁóÖ‰∫∫ÊáâÂ∞èÂøÉ‰ΩøÁî®„ÄÇ ÊòìÁΩπÊÇ£ËÖéÁµêÁü≥ÁöÑÁóÖ‰∫∫ÊúçÁî®Ê≠§Ëó•ÂèØËÉΩÊúÉÂ¢ûÂä†ËÖéÁµêÁü≥ÂΩ¢ÊàêÁöÑÂç±Èö™ÊÄßÔºåÂª∫Ë≠∞Áµ¶ËàáË∂≥ÈáèÁöÑÊ∞¥‰ªΩ‰ª•Èôç‰ΩéÊ≠§Âç±Èö™ÊÄß„ÄÇ</description></item><item><title>toxicology</title><link>https://www.physician.tw/toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/toxicology/</guid><description>toxicology [[Acetaminophen-toxicology]] [[Salicylates-toxicology]] [[Opioids-toxicology]] [[Benzodiazepines-toxicology]] [[Calcium channel blockers-toxicology]] [[Beta blockers-toxicology]] [[Digoxin-toxicology]] [[Tricyclic antidepressants-toxicology]] [[Lithium-toxicology]] [[Ethylene glycol-toxicology]] [[Methanol-toxicology]] [[Isopropanol-toxicology]] [[Carbon monoxide-toxicology]] [[Organopho- sphate-toxicology]] [[Cyanide-toxicology]]</description></item><item><title>Transcellular shifts</title><link>https://www.physician.tw/Transcellular-shifts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transcellular-shifts/</guid><description>Transcellular shifts Alkalemia, insulin, catecholamines [[Œ≤2-agonists]] hypothermia hypokalemic/thyrotoxic periodic paralysis, acute ‚Üë [[hematopoiesis]] (megaloblastic anemia Rx w/ B12, AML crisis), [[chloroquine]] overdose: Ba/Cs, antipsychotics (risperidone, quetiapine) theophylline</description></item><item><title>Transcellular shifts-hyperkalemia</title><link>https://www.physician.tw/Transcellular-shifts-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transcellular-shifts-hyperkalemia/</guid><description>Transcellular shifts-hyperkalemia (BMJ 2009;339:1019)
Acidemia, ‚Üì insulin (DM), cell lysis (tumor, rhabdo, ischemic bowel, hemolysis, transfusions, resorbing hematomas, hyperthermia, rewarming), hyperkalemic periodic paralysis, ‚Üë osmolality.</description></item><item><title>Transfusion Complications</title><link>https://www.physician.tw/Transfusion-Complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-Complications/</guid><description>Transfusion Complications Noninfectious Risk (per unit) Infectious Risk (per unit) Febrile 1:100 CMV Common Allergic 1:100 Hepatitis B 1:220,000 Delayed hemolytic 1:50‚Äì75,000 Hepatitis C 1:1,600,000 Acute hemolytic 1:200,000 HIV 1:1,800,000 Febr.</description></item><item><title>Transfusion reactions</title><link>https://www.physician.tw/Transfusion-reactions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-reactions/</guid><description>Transfusion reactions Reason why blood products (unless massive txfusion) run 1 at a time. For all rxns (except minor allergic): stop txfusion; send remaining blood product + fresh blood draw to blood bank.</description></item><item><title>transfusion therapy</title><link>https://www.physician.tw/transfusion-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transfusion-therapy/</guid><description>transfusion therapy [[Blood Products and Indications]] [[Transfusion Complications]] [[Transfusion reactions]]</description></item><item><title>Transfusion-associated circulatory overload</title><link>https://www.physician.tw/Transfusion-associated-circulatory-overload/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-associated-circulatory-overload/</guid><description>Transfusion-associated circulatory overload : ‚Üë volume ‚Üí pulm. edema, ‚Üë BP. Rx: slow transfusion rate, diuretics, O2, ¬± nitrates, ¬± positive pressure ventilation.</description></item><item><title>transfusion-related acute lung injury</title><link>https://www.physician.tw/transfusion-related-acute-lung-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transfusion-related-acute-lung-injury/</guid><description>transfusion-related acute lung injury : non-cardiogenic pulm. edema due to donor allo-Abs (from multiparous ‚ôÄ plasma) binding recipient WBCs, which then aggregate in pulmonary vasculature and release mediators causing ‚Üë capillary permeability.</description></item><item><title>Transjugular intrahepatic portosystemic shunt TIPS</title><link>https://www.physician.tw/Transjugular-intrahepatic-portosystemic-shunt-TIPS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transjugular-intrahepatic-portosystemic-shunt-TIPS/</guid><description>Transjugular intrahepatic portosystemic shunt (TIPS) (Gastro 2017;152:157) ‚Üì ascites in 75%; ‚Üë CrCl, ‚Üë enceph, survival benefit over LVP remains controversial Contraindic: grade II enceph, CHF or pulm HTN, active infxn or biliary obstruction Complications: bleeding, fistula; stent thrombosis (1-y patency w/ coated stents ~80%); infxn (‚Äúendotipsitis‚Äù); new or ‚Üë enceph in 20‚Äì30% (Am J Gastro 2016;111:523), hemolysis Consider for liver transplant if above fail</description></item><item><title>transthoracic echo vs transesophageal echo in-Diagnosis-bacterial endocarditis</title><link>https://www.physician.tw/transthoracic-echo-vs-transesophageal-echo-in-Diagnosis-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transthoracic-echo-vs-transesophageal-echo-in-Diagnosis-bacterial-endocarditis/</guid><description>transthoracic echo vs transesophageal echo in-Diagnosis-bacterial endocarditis NVE PVE Abscess Transthoracic (TTE) 39‚Äì58% 33% 18‚Äì63% Transesophageal (TEE) &amp;gt;90% 86% 76‚Äì100% (Mayo Clin Proc 2014;89:799; Circ 2015;132:1435; Eur Radiol 2015; 25:2125; J Am Soc Echo 2016;29:315)</description></item><item><title>Transudate vs exudate</title><link>https://www.physician.tw/Transudate-vs-exudate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transudate-vs-exudate/</guid><description>Transudate vs exudate (JAMA 2014;311:2422)
Light‚Äôs criteria Âü∫Êú¨‰∏äÈÉΩÊòØË∑üÂàÜÂ≠êÈÉΩÊòØpleuralÔºåÂàÜÊØçÈÉΩÊòØË°Ä ËõãÂ§ßÊñº‰∫îÊàê„ÄÅLDHÂ§ßÊñºÂÖ≠ÊàêÊàñ2/3
protein/serum protein ratio greater than 0.5 lactate dehydrogenase (LDH)/serum LDH ratio greater than 0.</description></item><item><title>Transudates</title><link>https://www.physician.tw/Transudates/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transudates/</guid><description>Transudates Congestive heart failure (40%): 80% bilateral, ¬± cardiomegaly on CXR occasionally exudative (especially after aggressive diuresis or if chronic) Constrictive pericarditis (knock on exam, calcification or thickening on imaging) Cirrhosis (‚Äúhepatic hydrothorax‚Äù): diaphragmatic pores allow passage of ascitic fluid often right-sided (¬≤‚àï¬≥) &amp;amp; massive (even witho marked ascites) Nephrotic syndrome: usually small, bilateral, asymptomatic (r/o PE b/c hypercoag) Other: PE (usually exudate), malignancy (lymphatic obstruction), myxedema, CAPD</description></item><item><title>Treatment acute diarrhea</title><link>https://www.physician.tw/Treatment-acute-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-diarrhea/</guid><description>Treatment acute diarrhea (Am J Gastro 2016;111:602; Clin Infect Dis 2017;65:e45)
ÂèÉËÄÉ‚û°Ô∏è 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea</description></item><item><title>Treatment and prognosis-Aplastic anemia</title><link>https://www.physician.tw/Treatment-and-prognosis-Aplastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-and-prognosis-Aplastic-anemia/</guid><description>Treatment and prognosis-Aplastic anemia Immunosuppression (CsA/tacrolimus, ATG): 70‚Äì80% respond, with 80‚Äì90% 5-y survival in responders (96% vs. 76% w/ horse vs.</description></item><item><title>Treatment for acute HBV</title><link>https://www.physician.tw/Treatment-for-acute-HBV/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-for-acute-HBV/</guid><description>Treatment for acute HBV [[When to treat chronic HBV with anti-virals]]
[[Entecavir or tenofovir]]
[[hepatitis B virus Rx duration]]</description></item><item><title>Treatment gastroesophageal reflux disease</title><link>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease-/</guid><description>Treatment [[gastroesophageal reflux disease]] (World J Gastrointest Endosc 2018;10:175; Am J Gastro 2022;117:27)
Lifestyle: avoid precipitants, lose weight, no eating 2 hrs before bed, exercise, √ò tobacco</description></item><item><title>treatment gastroesophageal reflux disease</title><link>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease/</guid><description>treatment gastroesophageal reflux disease (World J Gastrointest Endosc 2018;10:175; Am J Gastro 2022;117:27)
Lifestyle: avoid precipitants, lose weight, no eating 2 hrs before bed, exercise, √ò tobacco Medical: start low-dose PPI, uptitrate up to 40 mg bid; H2 blockers for intermittent sx Refractory (max dose ‚â•8 wks): confirm w/ pH testing on or off PPI, consider hernia repair If acidic or sx correlate w/ reflux episodes: surgical fundoplication (emerging Rx: LES sphincter augmentation w/ radiofrequency, implantable magnetic or electrical devices) If nl pH or no sx correlation = ‚Äúfxnal dyspepsia‚Äù (Gastro 2020;158:2286); Rx w/ TCA, SSRI</description></item><item><title>Treatment of active tuberculosis</title><link>https://www.physician.tw/Treatment-of-active-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-active-tuberculosis/</guid><description>Treatment of active tuberculosis (NEJM 2015;373:2149; Lancet 2016;387:1211)
Prior to treatment, consult ID, check LFTs, Cr, HIV &amp;amp; hepatitis A/B/C screen, DM screen, pregnancy screen, vision testing for acuity and color, EtOH use history Treatment requires several drugs to prevent resistance (see below) Suspect MDR TB if prior TB Rx (esp.</description></item><item><title>Treatment of acute advanced heart failure</title><link>https://www.physician.tw/Treatment-of-acute-advanced-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-acute-advanced-heart-failure/</guid><description>Treatment of acute advanced heart failure (Circ 2013;128:e240)
ÂèÉËÄÉ‚û°Ô∏è ‚ÄúI Need Help‚Äù‚ÄîA mnemonic to aid timely referral in advanced heart failure</description></item><item><title>treatment of acute decompensating heart failure</title><link>https://www.physician.tw/treatment-of-acute-decompensating-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-acute-decompensating-heart-failure/</guid><description>treatment of acute decompensating heart failure (NEJM 2017;377:1964)
Assess congestion &amp;amp; adequacy of perfusion
For congestion: ‚ÄúLMNOP‚Äù Lasix IV; 1‚Äì2.</description></item><item><title>Treatment of Alchololic-associated hepatitis</title><link>https://www.physician.tw/Treatment-of-Alchololic-associated-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Alchololic-associated-hepatitis/</guid><description>Treatment of Alchololic-associated hepatitis consider if MDF ‚â•32, MELD &amp;gt;18, or presence of encephalopathy
Glucocorticoids (eg, methylprednisolone 32 mg/d or prednisolone 40 mg/d √ó 4 wk ‚Üí 4‚Äì6 wk taper) may ‚Üì 1-mo but not 6-mo mortality, a/w ‚Üë infection (NEJM 2015;372:1619, CD001511)</description></item><item><title>Treatment of Antiphospholipid syndrome</title><link>https://www.physician.tw/Treatment-of-Antiphospholipid-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Antiphospholipid-syndrome/</guid><description>Treatment of Antiphospholipid syndrome UFH/LMWH ‚Üí warfarin (lifelong for most Pts)
Rivaroxaban inferior to warfarin in triple positive (‚äï ACL, LA, &amp;amp; Œ≤2-GP) (Blood 2018;132:1365)</description></item><item><title>Treatment of asymptomatic 1¬∞ HPT</title><link>https://www.physician.tw/Treatment-of-asymptomatic-1-HPT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-asymptomatic-1-HPT/</guid><description>Treatment of asymptomatic 1¬∞ HPT Surgery if: age &amp;lt;50 y; serum Ca &amp;gt;1 mg/dL &amp;gt;ULN; CrCl &amp;lt;60 mL/min, DEXA T score &amp;lt;‚Äì2.</description></item><item><title>Treatment of Beh√ßet‚Äôs syndrome</title><link>https://www.physician.tw/Treatment-of-Beh%C3%A7ets-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Beh%C3%A7ets-syndrome/</guid><description>Treatment of Beh√ßet‚Äôs syndrome Mucocutaneous: Mild: topical steroids, colchicine (esp. for erythema nodosum), dapsone, apremilast (PDE-4 inhib) for oral ulcers and ?</description></item><item><title>Treatment of Chronic HF with Reduced EF</title><link>https://www.physician.tw/Treatment-of-Chronic-HF-with-Reduced-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Chronic-HF-with-Reduced-EF/</guid><description>Treatment of Chronic HF with Reduced EF (Circ 2017;136:e137; JACC 2021;77:772)
Diuretics | Loop ¬± thiazides diuretics (sx relief; no mortality benefit) [[RASi ACEI ARB]] [[Œ≤-blocker]] [[Aldosterone-antagonists]] [[SGLT2i]] [[Hydralazine&amp;mdash;nitrates]] [[Ivabradine]] (If blocker w/o ‚äñ ino) [[Digoxin]] [[Vericiguat]] [[Cardiac-resynch-therapy]] (CRT, qv) [[ICD]] (see ‚ÄúCardiac Rhythm Mgmt Devices‚Äù) [[Iron-supplementation]] [[Anticoagulation-Treatment of Chronic HF with Reduced EF]] Heart rhythm If AF &amp;amp; NYHA II‚ÄìIV w/ EF &amp;lt;35%, catheter ablation ‚Üì D/HF hosp vs.</description></item><item><title>Treatment of Constipation</title><link>https://www.physician.tw/Treatment-of-Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Constipation/</guid><description>Treatment of Constipation 1st line ‚Üë fluid, fiber, exercise; emollient laxative (docusate) to soften stool.
2nd line: Bulk laxatives (psyllium, methylcellulose) to ‚Üë colonic residue, ‚Üë peristalsis.</description></item><item><title>Treatment of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Treatment-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Cryoglobulinemic-vasculitis/</guid><description>Treatment of Cryoglobulinemic vasculitis (Blood 2017;129:289; J Inflamm Res 2017;10:49): Rx underlying disorder. Heme malig ‚Üí chemoradiation; HCV ‚Üí antivirals; CTD ‚Üí DMARD/steroids ¬± RTX.</description></item><item><title>Treatment of Cushing‚Äôs syndrome</title><link>https://www.physician.tw/Treatment-of-Cushings-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Cushings-syndrome/</guid><description>Treatment of Cushing‚Äôs syndrome (JCEM 2015;100:2807. J Intern Med 2019;286:526)
Surgical: * resection of pituitary adenoma, adrenal tumor or ectopic ACTH-secreting tumor, or bilateral surgical adrenalectomy if unable to control source of ACTH Medical: [[ketoconazole]] [[metyrapone]] [[osilodrostat]] [[cabergoline]] [[pasireotide]] mitotane to ‚Üì cortisol, and/or mifepristone to block cortisol action at glucocorticoid receptor frequently used as bridge to surgery or when surgery contraindicated Radiation: can do pituitary XRT, but not effective immediately (takes 6 mo to 2 y) Glucocorticoid replacement therapy √ó 6‚Äì36 mo after TSS (lifelong glucocorticoid + mineralocorticoid replacement if medical or surgical adrenalectomy)</description></item><item><title>Treatment of DKA</title><link>https://www.physician.tw/Treatment-of-DKA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-DKA/</guid><description>Treatment of DKA (BMJ 2019;365:1114)
ÂèÉËÄÉ‚û°Ô∏è Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients</description></item><item><title>Treatment of Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Treatment-of-Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Granulomatosis-with-polyangiitis/</guid><description>Treatment of Granulomatosis with polyangiitis assess severity w/ BVAS/GPA score (Arth Rheum Dis 2009;68:1827) same as [[Microscopic polyangiitis.md]]
Mild disease (no end-organ dysfxn; BVAS 0‚Äì3): MTX + steroids (Arth Rheum 2012;64:3472)</description></item><item><title>Treatment of Heart failure with preserved EF</title><link>https://www.physician.tw/Treatment-of-Heart-failure-with-preserved-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Heart-failure-with-preserved-EF/</guid><description>Treatment of Heart failure with preserved EF diuresis, Rx HTN, tachycardia, and ischemia
SGLT2i ‚Üì CV death or HF hosp (NEJM 2021;385:1451; DELIVER)</description></item><item><title>Treatment of Hemochromatosis</title><link>https://www.physician.tw/Treatment-of-Hemochromatosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hemochromatosis/</guid><description>Treatment of Hemochromatosis phlebotomy (250 mL = 1 unit, ~250 mg of Fe) qwk until Fe sat &amp;lt;50% &amp;amp; ferritin 50‚Äì100 ¬µg/L, then q3‚Äì4mo; PPI ‚Üì intestinal Fe absorption &amp;amp; may ‚Üì need for phlebotomy; avoid vit C &amp;amp; uncooked seafood; deferoxamine if phleb.</description></item><item><title>Treatment of HIT</title><link>https://www.physician.tw/Treatment-of-HIT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-HIT/</guid><description>Treatment of HIT (NEJM 2015;373:252; Blood Adv 2018;2:3360)
Discontinue heparin (incl. flushes, LMWH Ppx, heparin lines). Avoid plts (anecdotal link w/ thrombosis); if given warfarin, give vit K to reverse, prevent warfarin skin necrosis.</description></item><item><title>Treatment of Hyperkalemia-hyperkalemia</title><link>https://www.physician.tw/Treatment-of-Hyperkalemia-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hyperkalemia-hyperkalemia/</guid><description>Treatment of Hyperkalemia-hyperkalemia [[Ca gluconate Ca chloride]] 1‚Äì2 amps IV onset &amp;lt;3 min with Transient effect (30‚Äì60 min) Stabilizes cell membrane CaCl contains more calcium and is typically reserved for codes (‚Üë risk of tissue necrosis) or via central line</description></item><item><title>Treatment of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Treatment-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-hypertrophic-cardiomyopathy/</guid><description>Treatment of hypertrophic cardiomyopathy (Circ 2020;142:e558; Lancet 2021;398:2102; JACC 2022;79:390)
Heart failure ‚äñ inotropes/chronotropes: Œ≤-blockers (JACC 2021;78:2505), CCB (verapamil), disopyramide</description></item><item><title>Treatment of Hypervolemic hyponatremia</title><link>https://www.physician.tw/Treatment-of-Hypervolemic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hypervolemic-hyponatremia/</guid><description>Treatment of Hypervolemic hyponatremia free water restrict (1st line), diurese w/ loop diuretics (avoid thiazides) &amp;amp; ‚Üë EAV (vasodilators to ‚Üë CO in CHF, colloid infusion in cirrhosis)</description></item><item><title>Treatment of Hypovolemic hyponatremia</title><link>https://www.physician.tw/Treatment-of-Hypovolemic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hypovolemic-hyponatremia/</guid><description>Treatment of Hypovolemic hyponatremia volume repletion with isotonic 0.9% saline at a slow rate. Once volume replete ‚Üí stimulus for ADH removed (w/ very short ADH t¬Ω) ‚Üí kidneys excrete free H2O ‚Üí serum Na will correct rapidly (D5W ¬± dDAVP if overcorrection)</description></item><item><title>Treatment of latent TB</title><link>https://www.physician.tw/Treatment-of-latent-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-latent-TB/</guid><description>Treatment of latent TB If screening test ‚äï and no risk factors, confirm prior to treatment; if ‚äï w/ risk factors, proceed to treatment (CID 2017;64:11).</description></item><item><title>Treatment of LDL-C</title><link>https://www.physician.tw/Treatment-of-LDL-C/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-LDL-C/</guid><description>Treatment of LDL-C Statins: every 1 mmol (39 mg/dL) ‚Üì LDL-C ‚Üí 22% ‚Üì major vascular events (CV death, MI, stroke, revasc) in individuals w/ &amp;amp; w/o CAD (Lancet 2010;376:1670) Ezetimibe: ‚Üì major vascular events incl MI &amp;amp; stroke when added to statin post-ACS, w/ magnitude of benefit consistent w/ LDL-statin relationship (IMPROVE-IT, NEJM 2015;372:2387) PCSK9 inhibitors: ~60% ‚Üì LDL-C on top of statin, as monoRx, and in FH (EHJ 2014;35:2249); ‚Üì CV outcomes (NEJM 2017;376:1713 &amp;amp; 2018;379:2097) In homozygous FH: apheresis; evinacumab (ANGPTL3 inhib) ‚Üì LDL-C by ~50% (NEJM 2020;383:711)</description></item><item><title>Treatment of Migraine</title><link>https://www.physician.tw/Treatment-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Migraine/</guid><description>Treatment of Migraine Abortive Rx: 5-HT1 agonists (triptans) effective if given early in migraine attack; Abortive: The goal of abortive treatment is to stop a migraine once it starts.</description></item><item><title>Treatment of other lipid fractions</title><link>https://www.physician.tw/Treatment-of-other-lipid-fractions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-other-lipid-fractions/</guid><description>Treatment of other lipid fractions HDL-C: low levels a/w ‚Üë risk of MI, but no clinical benefit shown by raising</description></item><item><title>Treatment of overt hypothyroidism</title><link>https://www.physician.tw/Treatment-of-overt-hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-overt-hypothyroidism/</guid><description>Treatment of overt hypothyroidism Levothyroxine (1.5‚Äì1.7 ¬µg/kg/d), re ‚úì TSH q5‚Äì6wk, titrate q8-12 wks if TSH not in range Lower starting dose (0.</description></item><item><title>treatment of peptic ulcer disease</title><link>https://www.physician.tw/treatment-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-peptic-ulcer-disease/</guid><description>treatment of peptic ulcer disease (Lancet 2016;388:2355; Gastro 2016;151:51; Gut 2017;66:6; AJG 2017;112:212)
If H. pylori ‚äï ‚Üí eradicate (‚Äútest and treat‚Äù); if ‚äñ ‚Üí gastric acid suppression w/ PPI 1st line: Quad.</description></item><item><title>Treatment of pericarditis</title><link>https://www.physician.tw/Treatment-of-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-pericarditis/</guid><description>Treatment of pericarditis High-dose NSAID (eg, ibuprofen 600‚Äì800 mg tid) or ASA (eg, 650‚Äì1000 mg tid) √ó 7‚Äì14 d then taper over wks; ASA preferred over NSAID in acute MI; consider PPI to ‚Üì risk of GIB Add colchicine 0.</description></item><item><title>Treatment of Primary ITP in Adults</title><link>https://www.physician.tw/Treatment-of-Primary-ITP-in-Adults/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Primary-ITP-in-Adults/</guid><description>Treatment of Primary ITP in Adults [[First-line or upfront therapy for idiopathic thrombocytopenic purpura]] [[Second-line or maintainence therapy for idiopathic thrombocytopenic purpura]] [[Chronic or refractory for idiopathic thrombocytopenic purpura]] [[Bleeding Treatment for idiopathic thrombocytopenic purpura]]</description></item><item><title>Treatment of Prinzmetals variant angina</title><link>https://www.physician.tw/Treatment-of-Prinzmetals-variant-angina/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Prinzmetals-variant-angina/</guid><description>Treatment of Prinzmetals variant angina high-dose CCB &amp;amp; standing nitrates (+SL prn), ? Œ±-blockers/statins; d/c smoking; avoid high-dose ASA (can inhibit prostacyclin and worsen spasm), nonselect Œ≤B, triptans</description></item><item><title>Treatment of SIADH</title><link>https://www.physician.tw/Treatment-of-SIADH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-SIADH/</guid><description>Treatment of SIADH (NEJM 2007;356:2064; AJKD 2020;76:203): fluid restrict + treat underlying cause
hypertonic saline (¬± loop diuretic; AJKD 2020;76:203) if sx or Na fails to ‚Üë w/ fluid restriction Intermittent bolus of 3% saline (~2 mL/kg q6h) vs.</description></item><item><title>Treatment of SVT</title><link>https://www.physician.tw/Treatment-of-SVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-SVT/</guid><description>Treatment of SVT Rhythm Acute Treatment Long-term Treatment
Unstable Acute: Cardioversion per ACLS n/a
ST Acute: Treat underlying stressor(s) Long-term: n/a</description></item><item><title>Treatment of Thyroid storm</title><link>https://www.physician.tw/Treatment-of-Thyroid-storm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Thyroid-storm/</guid><description>Treatment of Thyroid storm Œ≤-blocker, PTU or methimazole, iopanoic acid or iodide (for [[Wolff-Chaikoff effect]]) &amp;gt;1 h after PTU, ¬± steroids (‚Üì T4 ‚Üí T3)</description></item><item><title>Treatment of UTIs</title><link>https://www.physician.tw/Treatment-of-UTIs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-UTIs/</guid><description>Treatment of UTIs Scenario Empiric Treatment Guidelines (narrow based on UCx)
Asymptomatic bacteruria Do not treat. Exceptions: pregnant women, renal transplant, prophylaxis prior to invasive urologic procedures (CID 2019;68:1611).</description></item><item><title>Treatment peptic ulcer disease</title><link>https://www.physician.tw/Treatment-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-peptic-ulcer-disease-/</guid><description>Treatment peptic ulcer disease (Lancet 2016;388:2355; Gastro 2016;151:51; Gut 2017;66:6; AJG 2017;112:212)
If H. pylori ‚äï ‚Üí eradicate (‚Äútest and treat‚Äù); if ‚äñ ‚Üí gastric acid suppression w/ PPI 1st line: Quad.</description></item><item><title>Treatment prevention-herpes zoster</title><link>https://www.physician.tw/Treatment-prevention-herpes-zoster/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-prevention-herpes-zoster/</guid><description>Treatment prevention-herpes zoster Uncomplicated: acyclovir, valacyclovir, or famciclovir x 7 d; initiate w/in 72 h of onset for greatest benefit; consider after 72 h if new lesions present; minimal benefit after crusting Superimposed bacterial cellulitis is common; if suspected, treat with appropriate antibiotics Disseminated/immunosupp.</description></item><item><title>Treatment-accessory pathways wolff-parkinson-white</title><link>https://www.physician.tw/Treatment-accessory-pathways-wolff-parkinson-white/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-accessory-pathways-wolff-parkinson-white/</guid><description>Treatment-accessory pathways (wolff-parkinson-white) (Heart Rhythm 2012;9:1006, Circ 2014;130:e199 &amp;amp; 2016;133:e506)
AVRT (orthodromic): vagal, Œ≤B, CCB; care w/ adenosine (can precip AF); have defib ready AF/AFL w/ conduction down accessory pathway: need to Rx arrhythmia and ‚Üë pathway refractoriness.</description></item><item><title>Treatment-Acetaminophen hepatotoxicity</title><link>https://www.physician.tw/Treatment-Acetaminophen-hepatotoxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Acetaminophen-hepatotoxicity/</guid><description>Treatment-Acetaminophen hepatotoxicity NG lavage, activated charcoal if w/in 4 h. Consider early transfer to transplant ctr
N-acetylcysteine: administer up to 72 h after ingestion, if time of ingestion unknown or chronic ingestion &amp;gt;4g/d; low threshold to start NAC w/ low or undetectable APAP levels</description></item><item><title>Treatment-acute aortic syndromes</title><link>https://www.physician.tw/Treatment-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-aortic-syndromes/</guid><description>Treatment-acute aortic syndromes (Circ 2010;121:1544; EHJ 2018;39:739; JACC 2019;74:1494 &amp;amp; 2020;76:1703)
‚Üì dP/dt targeting HR &amp;lt;60 &amp;amp; central BP &amp;lt;120 (or lowest that preserves perfusion; r/o pseudohypotension, eg, arm BP ‚Üì due to subclavian dissection; use highest BP reading) First IV Œ≤B (eg, esmolol, labetalol) to blunt reflex ‚Üë HR &amp;amp; inotropy in response to vasodilators; verapamil/diltiazem if Œ≤B contraindic; then ‚Üì SBP w/ IV vasodilators (eg, nitroprusside) If HoTN: urgent surgical consult, IVF to achieve euvolemia, pressors to keep MAP 60-65 mmHg; r/o complication (eg, tamponade, contained rupture, severe AI) Proximal: surgery considered in all acute and in chronic if c/b progression, AI or aneurysm Distal: med Rx unless complication (see below) or favorable TEVAR anatomy w/ high-risk imaging features (JACC 2019;74:1494); pre-emptive TEVAR may ‚Üì late complic.</description></item><item><title>Treatment-acute mesenteric ischemia</title><link>https://www.physician.tw/Treatment-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-mesenteric-ischemia/</guid><description>Treatment-acute mesenteric ischemia IVF, NPO, optimize hemodynamics (minimize pressors), broad-spectrum abx, anticoagulation w/ heparin ¬± tPA (for occlusive disease), IV papaverine (vasodilator; for non-occlusive mesenteric ischemia)</description></item><item><title>Treatment-acute pancreatitis</title><link>https://www.physician.tw/Treatment-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-pancreatitis/</guid><description>Treatment-acute pancreatitis Fluid resusc.: aggressive in 1st 24 hrs, even if mild. 20 mL/kg IVB ‚Üí 3 mL/kg/hr. Goal ‚Üì BUN &amp;amp; Hct over 12‚Äì24 h.</description></item><item><title>Treatment-acute respiratory distress syndrome</title><link>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</guid><description>Treatment-acute respiratory distress syndrome [[methylprednisolone]]</description></item><item><title>Treatment-adrenal insufficiency</title><link>https://www.physician.tw/Treatment-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-adrenal-insufficiency/</guid><description>Treatment-adrenal insufficiency Acute insufficiency: volume resusc. w/ normal saline + hydrocortisone IV (see below) Chronic insufficiency: (1) prednisone ~4‚Äì5 mg PO qam or hydrocortisone 15‚Äì25 mg PO qd (2/3 a.</description></item><item><title>Treatment-anaphylaxis</title><link>https://www.physician.tw/Treatment-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-anaphylaxis/</guid><description>Treatment-anaphylaxis Epi: 0.5 mg IM (0.5 mL of 1 mg/mL solution) q5‚Äì15min as needed. For those who do not respond, IV infusion starting at 0.</description></item><item><title>Treatment-Anemia of chronic inflammation</title><link>https://www.physician.tw/Treatment-Anemia-of-chronic-inflammation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Anemia-of-chronic-inflammation/</guid><description>Treatment-Anemia of chronic inflammation treat underlying disease ¬± iron and/or erythropoiesis-stimulating agent (ESA; eg, Epo). Iron if ferritin &amp;lt;100 or Fe/TIBC &amp;lt;20%.</description></item><item><title>Treatment-aortic aneurysms</title><link>https://www.physician.tw/Treatment-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-aortic-aneurysms/</guid><description>Treatment-aortic aneurysms (Circ 2010;121:e266 &amp;amp; 2016;133:680; JACC 2020;76:201; NEJM 2021;385:1690)
Goal is to prevent rupture (50% mortality prior to hospital) by modifying risk factors Risk factor modification: smoking cessation; statins to achieve LDL-C &amp;lt;70 mg/dL BP control (goal SBP 100‚Äì120): Œ≤B (‚Üì dP/dt) ‚Üì aneurysm growth; ACEI a/w ‚Üì rupture risk (Lancet 2006;368:659); ARB may ‚Üì rate of aortic root growth in Marfan (NEJM 2008;358:2787) Mod CV exercise OK, no burst activity requiring Valsalva maneuvers (eg, heavy lifting) Indications for intervention (individualized based on FHx, body size, sex, anatomy) TAA: sxs; ascending Ao ‚â•5.</description></item><item><title>Treatment-aortic-regurgitation</title><link>https://www.physician.tw/Treatment-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-aortic-regurgitation/</guid><description>Treatment-aortic-regurgitation Acute decompensation (consider endocarditis as possible acute precipitant): surgery usually urgently needed for acute severe AR, which is poorly tolerated by LV IV afterload reduction (nitroprusside) and inotropic support (dobutamine) ¬± chronotropic support (‚Üë HR ‚Üí ‚Üì diastole ‚Üí ‚Üì time for regurgitation) pure vasoconstrictors and IABP contraindicated In chronic AR, management decisions based on LV size and fxn (and before sx occur); low diastolic BP and high resting HR associated with mortality (JACC 2020;75:29) Surgery (AVR, replacement or repair if possible): Severe and sx (if equivocal, consider stress test) Asx and either EF ‚â§55%, LV dilation [LVESD &amp;gt;50 mm or LVESDi (indexed to BSA) ‚â• 25 mm/m2 (JACC 2019;73:1741)], or undergoing cardiac surg Transcatheter AoV implantation (TAVI) being explored (JACC 2013;61:1577 &amp;amp; 2017;70:2752) Medical therapy: vasodilators (nifedipine, ACEI/ARB, hydralazine) if severe AR w/ sx or LV dysfxn &amp;amp; not operative candidate or to improve hemodynamics before AVR.</description></item><item><title>Treatment-ascites</title><link>https://www.physician.tw/Treatment-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-ascites/</guid><description>Treatment-ascites ‚Üì Na intake (1‚Äì2 g/d); restrict intake of free water if Na &amp;lt;125
Diuretics: goal diurese ~1 L/d.</description></item><item><title>Treatment-bacterial endocarditis</title><link>https://www.physician.tw/Treatment-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-bacterial-endocarditis/</guid><description>Treatment-bacterial endocarditis Empiric NVE or PVE &amp;gt;12 mos post-op: vanc + CTX PVE &amp;lt;12 mos post op: vanc + CTX ¬± gentamicin (if OK renal fxn)</description></item><item><title>Treatment-bronchiectasis</title><link>https://www.physician.tw/Treatment-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-bronchiectasis/</guid><description>Treatment-bronchiectasis Acute exacerbations: antibiotics directed against prior pathogens; if no prior Cx data ‚Üí FQ
Chronic mgmt: treat underlying condition, chest PT, inhaled hypertonic saline, bronchodil.</description></item><item><title>Treatment-Candida species</title><link>https://www.physician.tw/Treatment-Candida-species/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Candida-species/</guid><description>Treatment-Candida species Mucocutaneous Clotrimazole, nystatin, fluconazole, itraconazole Candiduria (if pyuria or sx of infxn) Fluconazole or intravesical ampho if severe infxn, immunosupp.</description></item><item><title>Treatment-cholangitis</title><link>https://www.physician.tw/Treatment-cholangitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cholangitis/</guid><description>Treatment-cholangitis Antibiotics (broad spectrum) to cover common bile pathogens (see above) ampicillin + gentamicin (or levofloxacin) ¬± MNZ (if severe); carbapenems; pip/tazo</description></item><item><title>Treatment-cholecystitis</title><link>https://www.physician.tw/Treatment-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cholecystitis/</guid><description>Treatment- [[cholecystitis]] (Ann Surg 2013;258:385; NEJM 2015;373:357)
Ë©≥Ë¶ã Interventional Approaches to Gallbladder Disease. [[guidelines for the diagnosis and determination of severity of acute cholecystitis]] Ë©≥Ë¶ã Acute cholecystitis: early versus delayed cholecystectomy, a multicenter</description></item><item><title>Treatment-cholelithiasis</title><link>https://www.physician.tw/Treatment-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cholelithiasis/</guid><description>Treatment-cholelithiasis (Am Fam Physician 2014;89:795; J Hepatol 2016;65:146)
Cholecystectomy (CCY), usually laparoscopic, if symptomatic (earlier is better)
CCY in asx Pts if: GB calcification (‚Üë risk of cancer), GB polyps &amp;gt;10 mm, stones &amp;gt;3 cm; Pts undergoing bariatric surgery, cardiac Tx candidates, hemolytic anemia (sickle cell)</description></item><item><title>Treatment-chronic pancreatitis</title><link>https://www.physician.tw/Treatment-chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-chronic-pancreatitis/</guid><description>Treatment-chronic pancreatitis (JAMA 2019;322:2422; Lancet 2020;396:499)
Pancreatic enzyme replacement (may ‚Üì pain by reducing CCK). Rx routine vitamin D &amp;amp; Ca.</description></item><item><title>Treatment-cystic fibrosis</title><link>https://www.physician.tw/Treatment-cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cystic-fibrosis/</guid><description>Treatment-cystic fibrosis Lancet 2021;397:2195)
Acute exacerbations: may be assoc w/ persistent drop in FEV1 (AJRCCM 2010;182:627); continue aggressive airway clearance, target abx based on sputum cx (incl double coverage for PsA); common pathogens include PsA, S.</description></item><item><title>Treatment-diabetic foot infections</title><link>https://www.physician.tw/Treatment-diabetic-foot-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-diabetic-foot-infections/</guid><description>Treatment-diabetic foot infections (CID 2012;54:e132)
Mild infxn: oral abx. Target GPCs (diclox, cephalexin, or amox/clav); use TMP-SMX or doxy for MRSA.</description></item><item><title>Treatment-diverticulitis</title><link>https://www.physician.tw/Treatment-diverticulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-diverticulitis/</guid><description>Treatment-diverticulitis (JAMA 2017;318:291; NEJM 2018;379:1635; Gastro 2021;160:906)
Mild: outPt Rx indicated if Pt has few comorbidities and can tolerate POs PO abx: (MNZ + FQ) or amox/clav for 7 d; liquid diet until clinical improvement No abx is noninferior to abx in uncomplicated diverti (Clin Gastroenterol Hepatol 2021;19:503)</description></item><item><title>Treatment-epidural abscess</title><link>https://www.physician.tw/Treatment-epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-epidural-abscess/</guid><description>Treatment-epidural abscess Antibiotics (typically MRSA and gram-negative coverage initially then narrowed based on culture data) ¬± surgery (decompressive laminectomy and debridement) for failure to improve on medical Rx.</description></item><item><title>Treatment-fever of unknown origin</title><link>https://www.physician.tw/Treatment-fever-of-unknown-origin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-fever-of-unknown-origin/</guid><description>Treatment-fever of unknown origin Empiric abx not indicated (unless Pt neutropenic or critically ill) Empiric glucocorticoids not indicated unless strong suspicion for specific rheumatologic dx Stop unnecessary meds (only 20% with a med cause have eos or rash) Up to 30% of cases remain undiagnosed, most spontaneously defervesce (wks to mos)</description></item><item><title>Treatment-glomerulonephritis</title><link>https://www.physician.tw/Treatment-glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-glomerulonephritis/</guid><description>Treatment-glomerulonephritis (AJKD 2020;75:124 &amp;amp; 2020;76:265)
If acute GN/RPGN suspected, give 500‚Äì1000 mg methylpred. IV qd √ó 3d ASAP while awaiting bx results.</description></item><item><title>Treatment-hemoptysis</title><link>https://www.physician.tw/Treatment-hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hemoptysis/</guid><description>Treatment-hemoptysis Death is from [[asphyxiation]]Á™íÊÅØ not exsanguination; maintain gas exchange, reverse coagulopathy and Rx underlying condition; cough suppressant may ‚Üë risk of asphyxiation Inhaled tranexamic acid promising (Chest 2018;154:1379) nebulized TA (500 mg tid) Massive hemoptysis: put bleeding side dependent; selectively intubate nl lung if needed Angiography: Dx &amp;amp; Rx (vascular occlusion balloons or selective embol of bronchial art) Rigid bronch: allows more options (electrocautery, laser) than flexible bronch Surgical resection</description></item><item><title>Treatment-Hepatorenal syndrome HRS</title><link>https://www.physician.tw/Treatment-Hepatorenal-syndrome-HRS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Hepatorenal-syndrome-HRS/</guid><description>Treatment-Hepatorenal syndrome (HRS) if critically ill ‚Üí vasopressor (eg, norepinephrine or vasopressin) + albumin (1 g/kg, max 100 g, bolus daily) to ‚Üë MAP 10 mmHg.</description></item><item><title>Treatment-hyperaldosteronism</title><link>https://www.physician.tw/Treatment-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hyperaldosteronism/</guid><description>Treatment-hyperaldosteronism (SCNA 2014;94:643)
Adenoma ‚Üí adrenalectomy vs. medical Rx w/ spironolactone or eplerenone Hyperplasia ‚Üí spironolactone or eplerenone; GRA ‚Üí glucocorticoids ¬± spironolactone Carcinoma ‚Üí adrenalectomy</description></item><item><title>Treatment-hypernatremia</title><link>https://www.physician.tw/Treatment-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypernatremia/</guid><description>Treatment-hypernatremia Restore access to H2O or supply daily requirement of H2O (‚â•1 L/d)
[[Replace free H2O deficit]]</description></item><item><title>Treatment-hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/Treatment-hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hyperosmolar-hyperglycemic-state/</guid><description>Treatment-hyperosmolar hyperglycemic state Rule-out possible precipitants; ~15% mortality due to precipitating factors Aggressive hydration: initially NS, then ¬Ω NS, average fluid loss up to 8‚Äì10 L Insulin (eg, 10 U IV followed by 0.</description></item><item><title>Treatment-hypertension</title><link>https://www.physician.tw/Treatment-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypertension/</guid><description>Treatment-hypertension Every ‚Üì 5 mmHg ‚Üí ~10% ‚Üì ischemic heart disease, stroke, and HF (Lancet 2021;397:1625) Lifestyle modifications as Treatment-hypertension (each may ‚Üì SBP ~5 mmHg) weight loss: goal BMI 18.</description></item><item><title>Treatment-hypertensive crises</title><link>https://www.physician.tw/Treatment-hypertensive-crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypertensive-crises/</guid><description>Treatment-hypertensive crises (Circ 2018;138:e426)
AoD, eclampsia/severe preeclampsia, pheo: target SBP &amp;lt;140 (&amp;lt;120 for AoD) in 1 hour Emerg w/o above: ‚Üì BP by ~25% in 1 h; to 160/100‚Äì110 over next 2‚Äì6 h, then nl over 1‚Äì2 d Acute ischemic stroke (w/in 72 hr from sx onset): &amp;lt;185/110 before lysis initiated, o/w target &amp;lt;220/120 (same SBP goal for ICH) Watch UOP, Cr, mental status: may indicate a lower BP is not tolerated [[IV Drugs for Hypertensive Crises]] HTN urgency: goal to return to normal BP over hrs to days.</description></item><item><title>Treatment-hyperthyroidism</title><link>https://www.physician.tw/Treatment-hyperthyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hyperthyroidism/</guid><description>Treatment-hyperthyroidism Œ≤-blockers: control tachycardia (propranolol also ‚Üì T4 ‚Üí T3 conversion) Graves‚Äô disease: either antithyroid drugs or radioactive iodine (NEJM 2016;375:1552) methimazole: 60% chance of recurrence after 1 y; side effects include pruritus, rash, arthralgia, fever, N/V and agranulocytosis in 0.</description></item><item><title>Treatment-hypocalcemia</title><link>https://www.physician.tw/Treatment-hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypocalcemia/</guid><description>Treatment-hypocalcemia also treat concomitant vitamin D deficiency; Endocrine 2020;69:485
‰πüË¶ÅÊ≤ªÁôÇÁ∂≠ÁîüÁ¥† D Áº∫‰πèÁóá
Severely symptomatic: Ca gluconate (1‚Äì2 g IV over 20 min) + oral Ca + calcitriol (but takes hrs to work) ¬± Mg (50‚Äì100 mEq/d); 10% CaCl2 in codes or via CVL</description></item><item><title>Treatment-hypokalemia</title><link>https://www.physician.tw/Treatment-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypokalemia/</guid><description>Treatment-hypokalemia (JAMA 2000;160:2429)
If true potassium deficit: potassium repletion (‚Üì 1 mEq/L ‚âà 200 mEq total body loss) Dosage: 40 mEq PO q4h, 10 mEq/h (IV), 20 mEq/h (central line), 40 mEq in 1 L IVF</description></item><item><title>Treatment-hypopituitary syndromes</title><link>https://www.physician.tw/Treatment-hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypopituitary-syndromes/</guid><description>Treatment-hypopituitary syndromes Replace deficient target gland hormones Most important deficiencies to recognize and treat in inpatients are adrenal insufficiency and hypothyroidism; if both present, treat with glucocorticoids first, then replace thyroid hormone so as not to precipitate adrenal crisis</description></item><item><title>Treatment-mitral-regurgitation</title><link>https://www.physician.tw/Treatment-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-mitral-regurgitation/</guid><description>Treatment-mitral-regurgitation Treatment (Lancet 2016;387:1312; Circ 2021;143:e72)
Acute decompensation (consider endocarditis as possible acute precipitant): surgery usually urgently needed for acute severe AR, which is poorly tolerated by LV IV afterload reduction (nitroprusside) and inotropic support (dobutamine) ¬± chronotropic support (‚Üë HR ‚Üí ‚Üì diastole ‚Üí ‚Üì time for regurgitation) pure vasoconstrictors and IABP contraindicated In chronic AR, management decisions based on LV size and fxn (and before sx occur); low diastolic BP and high resting HR associated with mortality (JACC 2020;75:29) Surgery (AVR, replacement or repair if possible): Severe and sx (if equivocal, consider stress test) Asx and either EF ‚â§55%, LV dilation [LVESD &amp;gt;50 mm or LVESDi (indexed to BSA) ‚â• 25 mm/m2 (JACC 2019;73:1741)], or undergoing cardiac surg Transcatheter AoV implantation (TAVI) being explored (JACC 2013;61:1577 &amp;amp; 2017;70:2752) Medical therapy: vasodilators (nifedipine, ACEI/ARB, hydralazine) if severe AR w/ sx or LV dysfxn &amp;amp; not operative candidate or to improve hemodynamics before AVR.</description></item><item><title>Treatment-mitral-stenosis</title><link>https://www.physician.tw/Treatment-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-mitral-stenosis/</guid><description>Treatment-mitral-stenosis Medical: Na restriction, cautious diuresis, Œ≤B, AF control, sx-limited physical stress Antibiotic Ppx recommended if h/o RHD w/ valvular disease for 10 y or until age 40 Anticoag w/ warfarin (not DOAC) if: AF; prior embolism; LA clot Mechanical intervention indicated if sx severe MS; reasonable if asx severe MS but PASP &amp;gt;50 mmHg and morphology favorable for PMBC; consider PMBC if non-severe MS but exertional sx and hemodyn signif w/ exercise, or if asx severe MS and new-onset AF Percutaneous mitral balloon commissurotomy (PMBC): preferred Rx if RHD; ‚âà MVR if valvuloplasty score &amp;lt;8, √ò if mod-severe MR or LA clot Surgical (MV repair if possible, o/w replacement) if PMBC contraindicated Calcific MS: surgical MVR if severe &amp;amp; highly sx; use of transcatheter aortic prosthesis experimental and w/ high rate of complications (Circ CVI 2020;13:e008425) Pregnancy: if NYHA class III/IV ‚Üí PMBC, o/w medical Rx w/ low-dose diuretic &amp;amp; Œ≤B</description></item><item><title>Treatment-nephrotic syndrome</title><link>https://www.physician.tw/Treatment-nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-nephrotic-syndrome/</guid><description>Treatment-nephrotic syndrome (NEJM 2013;368:10)
General: protein suppl.; diuretics for edema; treat hyperlipidemia, Na restriction (&amp;lt;2 g/d)
ACEI or ARB: ‚Üì proteinuria ‚Üí slow nonimmunologic progression of renal disease</description></item><item><title>Treatment-Nonalcoholic fatty liver disease NAFLD</title><link>https://www.physician.tw/Treatment-Nonalcoholic-fatty-liver-disease-NAFLD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Nonalcoholic-fatty-liver-disease-NAFLD/</guid><description>Treatment-Nonalcoholic fatty liver disease (NAFLD) wt loss (‚â•10%), exercise, DM control, liraglutide (Lancet 2016;387:679), statins (Metabolism 2017;71:17), vit E in Pts w/o DM (Hepatol 2018;67:328), bariatric surgery (World J Hepatol 2019;11:138).</description></item><item><title>Treatment-of-hyponatremia</title><link>https://www.physician.tw/Treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-hyponatremia/</guid><description>Treatment-of-hyponatremia NEJM 2015;372:55; JASN 2017;28:1340; CJASN 2018;13:641 &amp;amp; 984)
[[Approach to treatment-of-hyponatremia]]: Frequent lab draws and IVF rate adjustments are cornerstones of treatment [[Rapid correction of Treatment-of-hyponatremia]]: [[Effect of IV fluids-treatment-of-hyponatremia]] [[Effect of 1 L infusion in 70-kg male]] ÂàÜÈ°ûÔºö [[Treatment of Hypovolemic hyponatremia]] [[Treatment of SIADH]] [[Treatment of Hypervolemic hyponatremia]]</description></item><item><title>Treatment-osteomyelitis</title><link>https://www.physician.tw/Treatment-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-osteomyelitis/</guid><description>Treatment-osteomyelitis Antibiotics: based on cx data. If clinically stable, consider holding antibiotics until bone bx obtained. Duration depends on Rx strategy/goals of Rx management (eg, 6 wks for vertebral osteo; Lancet 2015;385:875).</description></item><item><title>Treatment-Paroxysmal nocturnal hemoglobinuria</title><link>https://www.physician.tw/Treatment-Paroxysmal-nocturnal-hemoglobinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Paroxysmal-nocturnal-hemoglobinuria/</guid><description>Treatment-Paroxysmal nocturnal hemoglobinuria supportive care (iron, folate, transfusions); consider anticoagulation.
Allogeneic HSCT for hypoplasia or severe thrombosis.
Pegcetacoplan (binds C3, prevents complement cascade activation) superior to eculizumab (Ab inactivates terminal complement C5s) in ‚Üì hemolysis &amp;amp; stabilizing Hb levels (NEJM 2021;384:1028).</description></item><item><title>Treatment-pericardial tamponade</title><link>https://www.physician.tw/Treatment-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pericardial-tamponade/</guid><description>Treatment-pericardial tamponade Volume (but be careful b/c overfilling can worsen tamponade) and ‚äï inotropes (avoid Œ≤B) Avoid vasoconstrictors b/c will ‚Üì stroke volume &amp;amp; potentially ‚Üì HR Avoid positive pressure ventilation b/c it can further impair cardiac filling (Circ 2006;113:1622) Pericardiocentesis (except if due to aortic/myocardial rupture, for which emergent surgery is treatment of choice; if too unstable, consider small pericardiocentesis to prevent PEA) Surgical drainage considered if fluid rapidly reaccumulates, loculated, or hemorrhagic</description></item><item><title>Treatment-pleural effusion</title><link>https://www.physician.tw/Treatment-pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pleural-effusion/</guid><description>Treatment-pleural effusion Symptomatic effusion: therapeutic thoracentesis, treat underlying disease process
Parapneumonic effusion (Chest 2000;118:1158)
uncomplicated ‚Üí antibiotics for pneumonia</description></item><item><title>Treatment-pneumonia</title><link>https://www.physician.tw/Treatment-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pneumonia/</guid><description>Treatment-pneumonia CAP (outPt) Amoxicillin, azithro, or doxy (avoid latter two if &amp;gt;25% resistance locally)
CAP (ward) [3rd-gen ceph + azithro] or levoflox; omadacycline ‚âà FQ (NEJM 2019;380:517)</description></item><item><title>Treatment-polyuria</title><link>https://www.physician.tw/Treatment-polyuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-polyuria/</guid><description>Treatment-polyuria 1¬∞ polydipsia: treat psychiatric illness, check meds, restrict access to free H2O Osmotic diuresis: address underlying cause, replace free H 2O deficit (see ‚ÄúHypernatremia‚Äù for formula to calculate) and ongoing losses Treatment of Diabetes insipidus [[treatment of Central DI]]: [[desmopressin]] (dDAVP, 1st line), low Na/protein diet + HCTZ, chlorpropamide Nephrogenic DI: treat underlying cause if possible; Na restriction + HCTZ (mild volume depletion ‚Üí ‚Üì delivery of filtrate for free H2O absorption), consider amiloride for Li- induced DI (Kid Int 2009;76:44), indomethacin (NEJM 1991;324:850) or trial desmopression Pregnancy-induced DI: due to vasopressinase from placenta, ‚à¥ Rx w/ dDAVP</description></item><item><title>Treatment-Portal vein thrombosis PVT</title><link>https://www.physician.tw/Treatment-Portal-vein-thrombosis-PVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Portal-vein-thrombosis-PVT/</guid><description>Treatment-Portal vein thrombosis (PVT) Treatment: Acute: If noncirrhotic, LMWH ‚Üí warfarin or DOAC √ó 6 mo, or indefinitely if irreversible cause.</description></item><item><title>Treatment-Primary sclerosing cholangitis PSC</title><link>https://www.physician.tw/Treatment-Primary-sclerosing-cholangitis-PSC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Primary-sclerosing-cholangitis-PSC/</guid><description>Treatment-Primary sclerosing cholangitis (PSC) supportive care, fat-soluble vitamins; no meds have improved survival
UDCA may ‚Üì Aœï &amp;amp; improve Sx, but unclear if beneficial</description></item><item><title>Treatment-pulmonary hypertension</title><link>https://www.physician.tw/Treatment-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pulmonary-hypertension/</guid><description>Treatment-pulmonary hypertension Principles: 1) prevent &amp;amp; reverse vasoactive substance imbalance and vascular remodeling 2) prevent RV failure: ‚Üì wall stress (‚Üì PVR, PAP, RV diam); ensure adeq systemic DBP Supportive Oxygen: maintain SaO2 &amp;gt;90‚Äì92% (reduces vasoconstriction) Diuretics: ‚Üì RV wall stress and relieve RHF sx; gentle b/c RV is preload dependent Anticoag: not routinely used; ‚Üì VTE risk of RHF; ?</description></item><item><title>Treatment-Pure red cell aplasia</title><link>https://www.physician.tw/Treatment-Pure-red-cell-aplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Pure-red-cell-aplasia/</guid><description>Treatment-Pure red cell aplasia thymectomy if thymus enlarged; IVIg if parvovirus and immunosuppressed (Clin Infect Dis 2013;56:968); immunosuppression/chemoRx if CLL or idiopathic; supportive care w/ PRBC transfusions; ?</description></item><item><title>Treatment-sexually transmitted infections</title><link>https://www.physician.tw/Treatment-sexually-transmitted-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-sexually-transmitted-infections/</guid><description>Treatment-sexually transmitted infections (MMWR 2021;70:1; JAMA 2022;327:161)
Syphilis 1¬∞/2¬∞/early latent: PCN G benzathine 2.4 mil U IM √ó 1 3¬∞/late latent: PCN G 2.</description></item><item><title>Treatment-skin and soft tissue infections</title><link>https://www.physician.tw/Treatment-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-skin-and-soft-tissue-infections/</guid><description>Treatment-skin and soft tissue infections (CID 2014;60:169)
Urgent surgical exploration with debridement of necrotic tissue and ID consultation Empiric antibiotics: [pip/tazo or ceftriaxone + metronidazole or carbapenem] + [vanco or linezolid].</description></item><item><title>Treatment-syncope</title><link>https://www.physician.tw/Treatment-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-syncope/</guid><description>Treatment-syncope (JACC 2017;70:620 &amp;amp; 2019;74:2410; EHJ 2018;39:1883)
Arrhythmia, cardiac mechanical or neurologic syncope: treat underlying disorder, ? ICD if Brugada pattern, sarcoid, ARVC, early repol + syncope Vasovagal: avoidance of triggers; physical counterpressure; consider ‚Üë Na &amp;amp; fluid intake, fludrocortisone or midodrine (JACC 2016;68:1; Ann Intern Med 2021;174:1349); SSRI; ?</description></item><item><title>Treatment-Vitamin B12 deficiency</title><link>https://www.physician.tw/Treatment-Vitamin-B12-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Vitamin-B12-deficiency/</guid><description>Treatment-Vitamin B12 deficiency 1 mg B12 IM qd √ó 7 d ‚Üí q wk √ó 4‚Äì8 wk ‚Üí q month for life</description></item><item><title>Treatment-Wilson disease</title><link>https://www.physician.tw/Treatment-Wilson-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Wilson-disease/</guid><description>Treatment-Wilson disease chelation w/ D-penicillamine (supplement B6 as D-pen inactivates); alternative is trientine (‚Üì toxicity w/ ‚âà efficacy, but $$), ammonium or bis-choline tetrathiomolybdate (investigational) may ‚Üì neurologic deterioration compared to trientine.</description></item><item><title>Triage-pneumonia</title><link>https://www.physician.tw/Triage-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Triage-pneumonia/</guid><description>Triage-pneumonia qSOFA predicts poor outcomes, prolonged ICU stay, and in-hospital mortality if &amp;gt;2 of 3: RR&amp;gt;22, AMS, SBP&amp;lt;100 (JAMA 2016; 315:801)</description></item><item><title>tricuspid-regurgitation</title><link>https://www.physician.tw/tricuspid-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tricuspid-regurgitation/</guid><description>tricuspid-regurgitation TRICUSPID REGURGITATION (Circ 2014;129:2440; Lancet 2016;388:2431)
Fxnl etiol (90%): RV dilation, PHT (may be 2¬∞ to L-sided dis.), large L ‚Üí R shunts 1¬∞ etiol: myxomatous, IE, pacemaker leads, RHD, CTD, XRT, Ebstein‚Äôs, carcinoid, tumors Holosystolic murmur, 3rd/4th ICS, ‚Üë w/ insp (Carvallo‚Äôs sign); S3; prominent cv wave in JVP Consider repair/replacement in severe TR (eg, ERO ‚â•0.</description></item><item><title>Tricyclic antidepressants-toxicology</title><link>https://www.physician.tw/Tricyclic-antidepressants-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tricyclic-antidepressants-toxicology/</guid><description>Tricyclic antidepressants-toxicology Hypotension, seizures, arrhythmia, ‚Üë QRS, ‚Üë QT
IVF resuscitation, IV sodium bicarbonate, vasopressors</description></item><item><title>Troponin</title><link>https://www.physician.tw/Troponin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Troponin/</guid><description>Troponin 99th %ile w/ rise and/or fall in approp. setting is dx of AMI (Circ 2018;138:e618)
[[Fourth Universal Definition of Myocardial Infarction (2018)]]</description></item><item><title>Tuberculin skin test</title><link>https://www.physician.tw/Tuberculin-skin-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tuberculin-skin-test/</guid><description>Tuberculin skin test (TST/ PPD): inject purified protein intradermally, examine for wheal 48‚Äì72 hrs later. Interpret based on max diameter of induration, not erythema.</description></item><item><title>tuberculosis</title><link>https://www.physician.tw/tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tuberculosis/</guid><description>tuberculosis [[Definitions-tuberculosis]] [[Epidemiology-tuberculosis]] [[Screening for latent TB]] [[Clinical manifestations-Screening for latent TB]] [[Diagnostics for active TB]] [[Extrapulmonary TB]] [[Treatment of latent TB]] [[Patient isolation-tuberculosis]] [[Treatment of active tuberculosis]] [[Antituberculous Medications]] [[Antituberculous Treatment Regimens]]</description></item><item><title>Tubulointerstitial proteinuria</title><link>https://www.physician.tw/Tubulointerstitial-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tubulointerstitial-proteinuria/</guid><description>Tubulointerstitial proteinuria (usually &amp;lt;1‚Äì2 g/d) ‚Üì reabsorption of freely filtered proteins ‚Üí lose globulins
Etiologies ATN; AIN [[Fanconi‚Äôs syndrome]]</description></item><item><title>tutorial</title><link>https://www.physician.tw/tutorial/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tutorial/</guid><description> CS 61AÔºöÁºñÁ®ãÂÖ•Èó®ÔºàÁî®ÁöÑ PythonÔºå‰πãÂâçÁî®ÁöÑÊòØ SchemeÔºâ CS 61BÔºöÁÆóÊ≥ï‰∏éÊï∞ÊçÆÁªìÊûÑÔºàÁî®ÁöÑ JavaÔºâ CS 61CÔºöËÆ°ÁÆóÊú∫‰ΩìÁ≥ªÁªìÊûÑÔºàÁî®ÁöÑ CÔºâ</description></item><item><title>type</title><link>https://www.physician.tw/type/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type/</guid><description>type</description></item><item><title>type 1 MI</title><link>https://www.physician.tw/type-1-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-1-MI/</guid><description>type 1 MI includes detection of a rise and/or fall of cTn with at least one value above the 99th percentile and with at least one of the following: Symptoms of acute myocardial ischemia; New ischemic electrocardiographic (ECG) changes; Development of pathological Q waves; Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with an ischemic etiology; Identification of a coronary thrombus by angiography including intracoronary imaging or by autopsy.</description></item><item><title>type 2 MI</title><link>https://www.physician.tw/type-2-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-2-MI/</guid><description>type 2 MI includes detection of a rise and/or fall of cTn with at least one value above the 99th percentile and evidence of an imbalance between myocardial oxygen supply and demand unrelated to coronary thrombosis, requiring at least one of the following: Symptoms of acute myocardial ischemia; New ischemic ECG changes; Development of pathological Q waves; Imaging evidence of new loss of viable myocardium, or new regional wall motion abnormality in a pattern consistent with an ischemic etiology.</description></item><item><title>type 3 myocardial infarction</title><link>https://www.physician.tw/type-3-myocardial-infarction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-3-myocardial-infarction/</guid><description>type 3 myocardial infarction Cardiac death in patients with symptoms suggestive myocardialischaemia and presumed new ischaemic EcG changes before cTn values become available or abnormal meets criteria for type 3 MI</description></item><item><title>type my note</title><link>https://www.physician.tw/type-my-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-my-note/</guid><description>content</description></item><item><title>Type of Idiopathic interstitial pneumonias IIPs</title><link>https://www.physician.tw/Type-of-Idiopathic-interstitial-pneumonias-IIPs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Type-of-Idiopathic-interstitial-pneumonias-IIPs/</guid><description>Type of Idiopathic interstitial pneumonias (IIPs) [[IPF idiopathic pulm fibrosis]] [[NSIP nonspecific IP]] [[COP cryptogenic organizing PNA]] [[AIP acute IP (Hamman-Rich syndrome)]] [[DIP desquamative IP]] [[RB-ILD resp bronchiolitis-assoc ILD]]</description></item><item><title>Types of Cryoglobulinemia</title><link>https://www.physician.tw/Types-of-Cryoglobulinemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-Cryoglobulinemia/</guid><description>Types of Cryoglobulinemia</description></item><item><title>Types of gallstones-cholelithiasis</title><link>https://www.physician.tw/Types-of-gallstones-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-gallstones-cholelithiasis/</guid><description>Types of gallstones-cholelithiasis (J Hepatol 2016;65:146)
Cholesterol (90%): 2 subtypes mixed: contain &amp;gt;50% cholesterol; typically smaller, multiple stones</description></item><item><title>Types of stones and risk factors</title><link>https://www.physician.tw/Types-of-stones-and-risk-factors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-stones-and-risk-factors/</guid><description>Types of stones and risk factors (Nat Rev Dis Prim 2016;2:16008)
Calcium (Ca oxalate &amp;gt;Ca phosphate): 70‚Äì90% of kidney stones (NEJM 2010;363:954)</description></item><item><title>Typical Characteristics and Diagnostic Studies of Chest Pain</title><link>https://www.physician.tw/Typical-Characteristics-and-Diagnostic-Studies-of-Chest-Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Typical-Characteristics-and-Diagnostic-Studies-of-Chest-Pain/</guid><description>Typical Characteristics and Diagnostic Studies of Chest Pain Cardiovascular Causes Pulmonary Causes GI Causes Musculoskeletal and Miscellaneous Causes [@hematology]</description></item><item><title>typical electrocardiogram in a patient with acute pericarditis</title><link>https://www.physician.tw/typical-electrocardiogram-in-a-patient-with-acute-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/typical-electrocardiogram-in-a-patient-with-acute-pericarditis/</guid><description>typical electrocardiogram in a patient with acute pericarditis Âú®ÊâÄÊèèÁπ™ÁöÑÂøÉÈõªÂúñ‰∏≠ÔºåÊúâ‰∏ÄÂÄã ST ÊÆµÁü¢ÈáèÊåáÂêëÂâçÊñπ„ÄÅ‰∏ãÊñπÂíåÂ∑¶ÂÅ¥ÔºåÈÄôÂ∞éËá¥Èô§ AVR Âíå V1 ‰πãÂ§ñÁöÑÊâÄÊúâÂ∞éËÅØ ST ÊÆµÊä¨È´ò„ÄÇ ÈÇÑÊúâ PR ÊÆµÂ£ì‰ΩéÔºåÈÄôÂú®Â∞éËÅØ II ‰∏≠ÊúÄÁÇ∫ÊòéÈ°Ø„ÄÇ</description></item><item><title>UIP usual interstitial PNA IP</title><link>https://www.physician.tw/UIP-usual-interstitial-PNA-IP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/UIP-usual-interstitial-PNA-IP/</guid><description>UIP usual interstitial PNA (IP) UIP imaging pattern: reticular opacities, honeycombing, traction bronchiectasis; peripheral, subpleural, &amp;amp; basal
Sx &amp;gt;12 mo</description></item><item><title>ulcerative colitis</title><link>https://www.physician.tw/ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ulcerative-colitis/</guid><description>ulcerative colitis (Lancet 2018;389:1756; Am J Gastro 2019:114:384)
[[Clinical manifestations-ulcerative colitis]] [[Diagnosis-ulcerative colitis]] [[Complications-ulcerative colitis]] [[Prognosis-ulcerative colitis]]</description></item><item><title>Uremia</title><link>https://www.physician.tw/Uremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Uremia/</guid><description>Uremia hemodialysis indication: pericarditis, encephalopathy, bleeding
[[Residual syndrome]]
Classical signs of uremia are: progressive weakness and easy fatigue, loss of appetite due to nausea and vomiting, muscle atrophy, tremors, abnormal mental function, frequent shallow respiration, and metabolic acidosis.</description></item><item><title>Uremic bleeding</title><link>https://www.physician.tw/Uremic-bleeding/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Uremic-bleeding/</guid><description>Uremic bleeding Uremia ‚Üí platelet dysfunction including ‚Üì aggregation, impaired adhesiveness
Treatment: dDAVP, cryoprecipitate, correct anemia (improves plt aggregation and adhesion by increasing plt interactions with endothelium), consider holding anti-plt agents</description></item><item><title>urgent symptomatic interventions of leptomeningeal disease</title><link>https://www.physician.tw/urgent-symptomatic-interventions-of-leptomeningeal-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urgent-symptomatic-interventions-of-leptomeningeal-disease/</guid><description>urgent symptomatic interventions of leptomeningeal disease Radiation to symptomatic sites
Hydrocephalus and increased intracranial pressure Glucocorticoids 8 to 16 mg Lumbar puncture</description></item><item><title>urinalysis</title><link>https://www.physician.tw/urinalysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urinalysis/</guid><description>urinalysis [[Urine Dipstick]] [[Urine Sediment]] (microscopic examination) [[Urinalysis interpretation]] Â§ßÂÆâËÅØÂêàÈÜ´‰∫ãÊ™¢È©óÊâÄ
[[proteinuria]] [[hematuria]] [[Etiologies of Hematuria]] [[Workup-of-hematuria]]
BacklinkÔºö [[Clinical manifestations-nephrolithiasis]] [[Diagnostic studies-urinary tract infections]] [[Diagnostic workup-hemoptysis]] [[Evaluation of vasculitis]] [[nephrology]] [[# The Profession of Medicine PA RT 1 ]] [[Stepwise Evaluation of a Patient with Delirium]] [[Workup-acute kidney injury (AKI)]]</description></item><item><title>urinary tract infections</title><link>https://www.physician.tw/urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urinary-tract-infections/</guid><description>urinary tract infections [[Definitions-urinary tract infections]] [[Microbiology-urinary tract infections]] [[Clinical manifestations-urinary tract infections]] [[Diagnostic studies-urinary tract infections]] [[Treatment of UTIs]]</description></item><item><title>Urine Dipstick</title><link>https://www.physician.tw/Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Urine-Dipstick/</guid><description>Urine Dipstick [[Specific gravity of Urine Dipstick]] [[pH of Urine Dipstick]] Range: 4.5‚Äì8.5; useful in evaluation of stones, RTAs, infection (urease UTI) [[Protein of Urine Dipstick]] Blood [[Workup-of-hematuria]] ‚äï from RBCs, free Hgb, or free myoglobin (eg, rhabdo) False ‚äï: semen, dilute urine (‚Üí osmotic cell lysis), ‚Üë pH, vaginal blood False ‚äñ: vit C WBC Suggests inflammation (UTI, interstitial nephritis, GN) Ketones Detects acetoacetate (ie, ketoacidosis) but not Œ≤-hydroxybutyrate Leuk est Lysed PMNs.</description></item><item><title>Urine Sediment</title><link>https://www.physician.tw/Urine-Sediment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Urine-Sediment/</guid><description>Urine Sediment (Am J Kidney Dis 2008;51:1052)
Method Centrifuge fresh sample (prox. port if Foley) √ó 3‚Äì5 min at 1500‚Äì3000 rpm pour off supernatant in one motion resuspend pellet by agitating base of tube pour suspension onto slide w/ coverslip view under ‚Äúhigh dry‚Äù power phase contrast for RBC morphology Urine Sediment Cells RBCs: assess amount &amp;amp; morphology (many dysmorphic ‚Üí glomerular) WBCs: PMNs (UTI) vs.</description></item><item><title>urothelial carcinoma</title><link>https://www.physician.tw/urothelial-carcinoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urothelial-carcinoma/</guid><description>topic: [[ddMVAC]]]</description></item><item><title>Use of 1,3-Œ≤-D-glucan in invasive fungal diseases in hematology patients</title><link>https://www.physician.tw/Use-of-13-%CE%B2-D-glucan-in-invasive-fungal-diseases-in-hematology-patients/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Use-of-13-%CE%B2-D-glucan-in-invasive-fungal-diseases-in-hematology-patients/</guid><description>Use of 1,3-Œ≤-D-glucan in invasive fungal diseases in hematology patients ‚ú®ÈáçÈªû: ÂÖ•‰æµÊÄßÁúüËèåÁñæÁóÖÔºàIFDÔºâ‰ªçÁÑ∂ÊòØË°ÄÊ∂≤Â≠∏ÊÇ£ËÄÖÁôºÁóÖÂíåÊ≠ª‰∫°ÁéáÁöÑ‰∏ªË¶ÅÂéüÂõ†„ÄÇ Âú®Ë®∫Êñ∑È©ÖÂãïÁöÑÊñπÊ≥ï‰∏≠Ôºå‰ΩøÁî®Ë°ÄÊ∏ÖÔºà1Ôºâ-Œ≤-D-GlucanÔºàBDGÔºâÊ∏¨Ë©¶‰ª£Ë°®‰∫ÜIFDÊó©ÊúüË®∫Êñ∑ÂíåÊ≤ªÁôÇÁöÑÊúâÊïàÂ∑•ÂÖ∑„ÄÇ Ê∂µËìãÁöÑÂçÄÂüüÔºöÁ≥ªÁµ±Âú∞Ê™¢Á¥¢‰∫ÜÊúâÈóúBDGÂú®Ë°ÄÊ∂≤Â≠∏ÊÇ£ËÄÖ‰∏≠‰ΩøÁî®ÁöÑÂèØÁî®ÊñáÁçª„ÄÇ ÁÑ∂ÂæåÔºåÈÄ≤Ë°å‰∫ÜÂØ©Êü•ÂíåË®éË´ñÔºå‰ª•Á¢∫ÂÆöËàáË©≤‰∏ªÈ°åÁöÑËá®Â∫äÊïò‰∫ã‰ªãÁ¥πÊúâÈóúÁöÑÈóúÈçµÂïèÈ°å„ÄÇ Â∞àÂÆ∂Ë©ïË´ñÔºö ‰ΩøÁî®BDGÂú®Êúâ‰æµÂÖ•ÊÄßÊõ≤ÈúâÁóÖÈ¢®Èö™ÁöÑË°ÄÊ∂≤Â≠∏ÊÇ£ËÄÖ‰∏≠‰ΩøÁî®ÊòØ‰ΩøÁî®Âçä‰π≥Á≥ñÈáè‰ΩøÁî®ÁöÑ„ÄÇ ‰ΩÜÊòØÔºåÁî±ÊñºBDG‰∏¶ÈùûÈáùÂ∞çIAÁâπÂÆöÔºåÂõ†Ê≠§ÂÆÉÊèê‰æõ‰∫ÜË®∫Êñ∑ÂÖ∂‰ªñIFDÁöÑÂÑ™Âã¢Ôºå ‰æãÂ¶ÇÂøµÁè†ËèåÁóÖÂíåËÇ∫ÁÇéÁ¥∞ËÉûÁóá„ÄÇ ËàáÂÖ∂‰ªñÈöäÂàóÁõ∏ÊØîÔºåBDGÁöÑÂ±ÄÈôêÊÄßÂåÖÊã¨Ë°ÄÊ∂≤Â≠∏ÊÇ£ËÄÖÁöÑÈ´òÊàêÊú¨ÂíåËºÉ‰ΩéÁöÑÊïèÊÑüÊÄß„ÄÇ Âú®ÁèæÂØ¶ÁîüÊ¥ª‰∏≠ÔºåÂÅáÈôΩÊÄßÁµêÊûúÁöÑÈ¢®Èö™ÂèØËÉΩ‰ΩéÊñºÁêÜË´ñ‰∏äÔºå Âõ†ÁÇ∫ÁÑ°Ëë°ËÅöÈÜ£Ë®≠ÂÇôÂèØÁî®ÔºåÁèæ‰ª£ÈÄèÊûêËÜúÂíåË°ÄÊ∂≤Áî¢ÂìÅÈÄöÂ∏∏‰∏çÊúÉÈáãÊîæBDG„ÄÇ Âõ†Ê≠§ÔºåÂú®Á∂ìÈ©óË±êÂØåÁöÑÊâãÂíåÈÅ∏ÂÆöÁöÑËá®Â∫äÊÉÖÊ≥Å‰∏ãÔºåBDGÊòØ‰∏ÄÁ®ÆÊúâÁî®ÁöÑË®∫Êñ∑Â∑•ÂÖ∑Ôºå Â∞§ÂÖ∂ÊòØÁî±ÊñºÂ§±Ë™§ÊôÇÈñìÁü≠ÔºåÁµêÊûúÂíåÂ§öÂäüËÉΩÊÄßÂú®Ë®∫Êñ∑‰∏çÂêåÁöÑIFDÊñπÈù¢„ÄÇ</description></item><item><title>vagal maneuvers</title><link>https://www.physician.tw/vagal-maneuvers/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vagal-maneuvers/</guid><description>vagal maneuvers 10s
È†∏ÂãïËÑàÁ´áÊåâÊë©: Â∞áÊÇ£ËÄÖÁΩÆÊñº‰ª∞Ëá•‰ΩçÔºåÈ†∏ÈÉ®‰º∏Â±ï‰∏¶ÊóãËΩâÂà∞Êèê‰æõËÄÖÊâìÁÆóÊåâÊë©ÁöÑÈ†∏ÂãïËÑàÁ´áÁöÑÂè¶‰∏ÄÂÅ¥„ÄÇÈ†∏ÂãïËÑàÁ´á‰ΩçÊñº‰∏ãÈ†úËßí‰∏ãÊñπ„ÄÅËÉ∏Èéñ‰π≥Á™ÅËÇåÂâçÊñπÂíåÁî≤ÁãÄËªüÈ™®‰∏äÂ±§ÁöÑÂãïËÑàË°ùÂãïËôï„ÄÇÊèê‰æõËÄÖ‰ΩøÁî®È£üÊåáÂíå‰∏≠ÊåáÁöÑÊåáÂ∞ñÂú®ÂæåÂÖßÂÅ¥ÊñπÂêëÊñΩÂä†Â£ìÂäõ 5 Âà∞ 10 Áßí„ÄÇÂ¶ÇÊûú‰∏çÊàêÂäüÔºåË©≤ÈÅéÁ®ãÂèØÂú® 1 ÂàÜÈêòÂæåÈáçË§á„ÄÇÂ¶ÇÊûú‰ªçÁÑ∂‰∏çÊàêÂäüÔºåËá®Â∫äÈÜ´ÁîüÂèØËÉΩÊúÉÂòóË©¶Âú®Âè¶‰∏ÄÂÅ¥ÈÄ≤Ë°åÊìç‰Ωú„ÄÇ CSM ÁöÑËºîÂä©ÂåÖÊã¨Â∞áÊÇ£ËÄÖÁΩÆÊñºÁâπÂÄ´Âæ∑ÂÄ´‰ºØËá•‰Ωç„ÄÅÊä¨ËÖø„ÄÅ‰º¥Èö® VM ÊàñÂêåÊôÇÂ∞çÊÇ£ËÄÖÁöÑ‰∏äËÖπÈÉ®ÊñΩÂä†Â£ìÂäõ„ÄÇÂ∞ç CSM ÁöÑÂèØËÉΩÂèçÊáâÂåÖÊã¨ÊÇ£ËÄÖÂøÉÁéáÊ∏õÊÖ¢„ÄÅÂøÉÂæãÂ§±Â∏∏ÁµÇÊ≠¢ÊàñÁÑ°ÂèçÊáâ„ÄÇ</description></item><item><title>valve-replacement</title><link>https://www.physician.tw/valve-replacement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/valve-replacement/</guid><description>valve-replacement (Circ 2021;143:e72)
Based on symptoms: once they develop ‚Üí AVR needed Indicated in: sx severe (stage D1; D2; D3 if AS felt to be cause of sx); asx severe + EF &amp;lt;50% (stage C2); or severe (stage C1) and undergoing other cardiac surgery Reasonable if: asx severe (C1) but either sx or ‚Üì BP w/ exercise (can carefully exercise asx AS to uncover sx; do not exercise sx AS), very severe, ‚Üë BNP, rapid progression Growing data to support AVR in asx severe AS (NEJM 2020;382:111; Circ 2021;143:e72) Type of valve: mechanical reasonable if Pt &amp;lt;50 yrs, bioprosthetic if &amp;gt;65 yrs or cannot tolerate long-term anticoagulation; individualize if 50‚Äì65 yrs Transcatheter AoV implantation (TAVI, see below) attractive alternative to surgery Medical (if not AVR candidate or to temporize): careful diuresis prn, control HTN, maintain SR; digoxin if ‚Üì EF &amp;amp; HF or if AF; avoid venodilators (nitrates) &amp;amp; ‚äñ inotropes (Œ≤B/CCB) if severe AS; avoid vigorous physical exertion once AS mod‚Äìsevere ?</description></item><item><title>valvular heart disease</title><link>https://www.physician.tw/valvular-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/valvular-heart-disease/</guid><description>valvular heart disease [[aortic-stenosis]] (AS) [[aortic-regurgitation]] (AR) [[mitral-regurgitation]] (MR) [[mitral-valve-prolapse]] (MVP) [[mitral-stenosis]] (MS) [[tricuspid-regurgitation]] (Circ 2014;129:2440; Lancet 2016;388:2431) [[prosthetic-heart-valves]]</description></item><item><title>Variable and Possible Etiology-fever and rash</title><link>https://www.physician.tw/Variable-and-Possible-Etiology-fever-and-rash/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Variable-and-Possible-Etiology-fever-and-rash/</guid><description>Variable and Possible Etiology-fever and rash Summer/fall &amp;gt; other seasons Enterovirus Winter Parvovirus, Meningococcemia Spring/summer Lyme, RMSF, Ehrlichiosis, Anaplasmosis Year-round Adenovirus, Mycoplasma Cat and dog exposure Bartonella, Pasteurella, Toxoplasma, Capnocytophaga Tick exposure Lyme, RMSF, Ehrlichiosis, Anaplasmosis Adult &amp;lt;30 y Mononucleosis (EBV or CMV) Inadequate immunization Measles, Rubella, VZV, influenza Sexually active HIV, syphilis, disseminated gonococcal infection, HSV</description></item><item><title>Vascular Access-renal replacement and dialysis</title><link>https://www.physician.tw/Vascular-Access-renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Access-renal-replacement-and-dialysis/</guid><description>Vascular Access-renal replacement and dialysis AV fistula Pros
Highest patency Lowest risk of bacteremia Lowest mortality (JASN 2013;24:465) Cons Long maturation time (2‚Äì6 mo) Primary nonfunction (20%) AVgraft Easier to create than AVF Maturation time (2‚Äì3 wk) Cons: Poor 1¬∞ patency, often requiring thrombectomy or angioplasty Catheter Immediate use Use as bridge to AVF/AVG Cons: Highest risk of bacteremia ‚Üì blood flow ‚Üí ‚Üì HD efficiency</description></item><item><title>Vascular Beds Affected by Inherited and Acquired Hypercoagulable States</title><link>https://www.physician.tw/Vascular-Beds-Affected-by-Inherited-and-Acquired-Hypercoagulable-States/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Beds-Affected-by-Inherited-and-Acquired-Hypercoagulable-States/</guid><description>Vascular Beds Affected by Inherited and Acquired Hypercoagulable States Inher. Venous Factor V Leiden Prothrombin mutation ‚Üì protein C, S or AT III Venous and Arterial Hyperhomocysteinemia (inherited or acquired) Dysfibrinogenemia Acquired Venous Stasis: immobilization, surgery, CHF Malignancy Hormonal: OCPs, HRT, tamoxifen, pregnancy Nephrotic syndrome## Venous Venous and Arterial Platelet defects: myeloproliferative disorders, HIT, PNH (although venous &amp;gt;arterial) Hyperviscosity: polycythemia vera, Waldenstr√∂m‚Äôs -macroglobulinemia, sickle cell, acute leukemia Vessel wall defects: vasculitis, trauma, foreign bodies Others: antiphospholipid syndrome, IBD</description></item><item><title>vasculitis</title><link>https://www.physician.tw/vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vasculitis/</guid><description>vasculitis [[Background of vasculitis]] [[Evaluation of vasculitis]] [[Distinguihing Characteristics of Vascuiti Subtypes]] LARGE-VESSEL VASCULITIS [[Takayasu‚Äôs arteritis]] [[Giant cell arteritis]] (GCA) MEDIUM-VESSEL VASCULITIS [[Kawasaki disease]] (KD) [[Polyarteritis nodosa]] (PAN) [[thromboangiitis obliterans]] Buerger disease SMALL VESSEL VASCULITIS [[ANCA positive Vasculitis]] (AAV) [[immune complex (IC)‚Äìassociated small-vessel vasculitis]] VARIABLE-VESSEL VASCULITIS [[Beh√ßet‚Äôs syndrome]] [[Cogan&amp;rsquo;s syndrome]] Single-organ vasculitis [[Cutaneous leukocytoclastic angiitis]] [[Cutaneous arteritis]] [[Primary central nervous system vasculitis]] Isolated aortitis Others Vasculitis associated with systemic disease Lupus vasculitis Rheumatoid vasculitis Sarcoid vasculitis Others Vasculitis associated with probable etiology Hepatitis C virus-associated cryoglobulinemic vasculitis Hepatitis B virus-associated vasculitis Syphilis-associated aortitis Drug-associated immune complex vasculitis Drug-associated ANCA-associated vasculitis Cancer-associated vasculitis Others</description></item><item><title>Vasoactive Agents as Treatment-pulmonary hypertension</title><link>https://www.physician.tw/Vasoactive-Agents-as-Treatment-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vasoactive-Agents-as-Treatment-pulmonary-hypertension/</guid><description>Vasoactive Agents as Treatment-pulmonary hypertension PDE-5 inhibitor sildenafil, tadalafil, [[vardenafil]] ‚Üë cGMP ‚Üí vasodilatation, ‚Üì smooth muscle proliferation, ‚Üì sx, ‚Üë 6MWT, no data on clinical outcomes.</description></item><item><title>venous thromboembolism</title><link>https://www.physician.tw/venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/venous-thromboembolism/</guid><description>venous thromboembolism [[Definitions-venous thromboembolism]] [[Risk factors-venous thromboembolism]] [[Thromboprophylaxis]] clinical manifestations [[deep vein thrombosis]] [[pulmonary embolism]] treatment [[Whom to treat-venous thromboembolism]] [[Initial anticoagulation options for-venous thromboembolism]] [[Systemic thrombolysis]] [[Mechanical intervention-venous thromboembolism]] [[Duration of full-intensity anticoagulation-venous thromboembolism]] [[Long-term anticoagulation options-venous thromboembolism]] [[Extended DOAC strategies-venous thromboembolism]] [[Complications &amp;amp; prognosis-venous thromboembolism]] Ref: Acute Pulmonary Embolism: A Review | Emergency Medicine | JAMA | JAMA Network</description></item><item><title>Ventilator Modes and Principles</title><link>https://www.physician.tw/Ventilator-Modes-and-Principles/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ventilator-Modes-and-Principles/</guid><description>Ventilator Modes and Principles REF: Volume Control Ventilation ‚Äì Basic Principles of Mechanical Ventilation
[[how the human body breathes]]
BacklinkÔºö [[mechanical ventilation]]</description></item><item><title>Vericiguat</title><link>https://www.physician.tw/Vericiguat/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vericiguat/</guid><description>Vericiguat 10% ‚Üì CV mort or HF hosp in NYHA II‚ÄìIV (NEJM 2020;382:1883)</description></item><item><title>viral respiratory infections</title><link>https://www.physician.tw/viral-respiratory-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/viral-respiratory-infections/</guid><description>viral respiratory infections Microbiology epidemiology-viral respiratory infections ( http://www.cdc.gov/flu/weekly)
Typical pathogens: Short, mild = rhinovirus, other non-SARS-CoV-2 coronavirus. Longer, more severe or complicated = influenza, parainfluenza, RSV, adenovirus, metapneumovirus, COVID-19 (vide infra).</description></item><item><title>Vitamin B12 deficiency</title><link>https://www.physician.tw/Vitamin-B12-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vitamin-B12-deficiency/</guid><description>Vitamin B12 deficiency (NEJM 2013;368:149)
B12 present only in foods of animal origin; total body stores sufficient for 2‚Äì3 y</description></item><item><title>vitamin D replacement</title><link>https://www.physician.tw/vitamin-D-replacement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vitamin-D-replacement/</guid><description>vitamin D replacement uptodate: - Á∂≠ÁîüÁ¥† D ÂèäÂÖ∂‰ª£Ë¨ùÁâ©Âõ†ÂÖ∂ËàáÈà£Á©©ÊÖãÂíåÈ™®‰ª£Ë¨ùÁöÑÁõ∏‰∫íÈóú‰øÇËÄåÂÖ∑ÊúâÈáçË¶ÅÁöÑËá®Â∫ä‰ΩúÁî®„ÄÇ - ÈõñÁÑ∂Áî±ÊñºÂö¥ÈáçÁöÑÁ∂≠ÁîüÁ¥† D Áº∫‰πèÁóáÔºàÂÖíÁ´•ÔºâÂíåÈ™®ËªüÂåñÁóáÔºàÂÖíÁ´•ÂíåÊàê‰∫∫ÔºâÁèæÂú®‰∏¶‰∏çÂ∏∏Ë¶ãÔºàÈô§‰∫ÜÂú®ÈôΩÂÖâÁÖßÂ∞ÑÁï∞Â∏∏‰Ωé„ÄÅÂº∑ÂåñÈ£üÂìÅ‰∏≠Áº∫‰πèÁ∂≠ÁîüÁ¥† D ÂíåÂê∏Êî∂‰∏çËâØÁ∂úÂêàÂæµÁöÑ‰∫∫Áæ§Ôºâ„ÄÅ‰∫ûËá®Â∫äÁ∂≠ÁîüÁ¥† D Áº∫‰πèÁóá„ÄÅÁî±‰ΩéË°ÄÊ∏Ö 25-Áæ•Âü∫Á∂≠ÁîüÁ¥† D (25[OH]D) Ê∏¨ÈáèÔºåÊòØÂæàÂ∏∏Ë¶ãÁöÑ„ÄÇ - Ë®±Â§ö‰∫ûËá®Â∫äÁ∂≠ÁîüÁ¥† D Áº∫‰πèÁóáÊÇ£ËÄÖÂ≠òÂú®Áõ∏Â∞ç‰ΩéÈà£Ë°ÄÁóáÂíåÈ´òË°ÄÊ∏ÖÁî≤ÁãÄÊóÅËÖ∫ÊøÄÁ¥† (PTH) ÊøÉÂ∫¶ÔºåÈÄôÂèØËÉΩÂ∞éËá¥È™®Ë≥™ÁñèÈ¨ÜÁóáÁöÑÁôºÂ±ïÔºå‰∏¶Â¢ûÂä†ËÄÅÂπ¥‰∫∫È™®ÊäòÂíåË∑åÂÄíÁöÑÈ¢®Èö™„ÄÇ - ÈÄôÁ®ÆÁπºÁôºÊÄßÁî≤ÁãÄÊóÅËÖ∫ÂäüËÉΩ‰∫¢ÈÄ≤ÂèØ‰ª•ÈÄöÈÅéÊúçÁî®Á∂≠ÁîüÁ¥† D Ë£úÂÖÖÂäë‰æÜÊ∏õËºï [58-60]„ÄÇ ‚≠ê Â≠∏ÁøíÈáçÈªû ‚≠ê Á∂≠ÁîüÁ¥† D ÂèäÂÖ∂‰ª£Ë¨ùÁâ©ÁöÑÂ§öÁ®ÆË£ΩÂäëÂèØÁî®ÊñºÊ≤ªÁôÇÁ∂≠ÁîüÁ¥† D Áº∫‰πèÁóá„ÄÇ Áõ°ÂèØËÉΩ‰ΩøÁî®Á∂≠ÁîüÁ¥† DÔºåËÄå‰∏çÊòØÂÖ∂‰ª£Ë¨ùÁâ©ÔºåÂõ†ÁÇ∫ÊàêÊú¨ËºÉ‰Ωé„ÄÇ ÂÖ©Á®ÆÂ∏∏Áî®ÂΩ¢ÂºèÁöÑÁ∂≠ÁîüÁ¥† D Ë£úÂÖÖÂäëÊòØËÜΩÈà£ÂåñÈÜáÔºàÁ∂≠ÁîüÁ¥† D3ÔºâÂíåÈ∫•ËßíÈà£ÂåñÈÜáÔºàÁ∂≠ÁîüÁ¥† D2Ôºâ„ÄÇ Âú®‰∏ÄÈ†Ö‰∏ÉÈ†ÖÈö®Ê©üË©¶È©óÁöÑËñàËêÉÂàÜÊûê‰∏≠ÔºåË©ï‰º∞Ë£úÂÖÖËÜΩÈà£ÂåñÈÜáËàáÈ∫•ËßíÈà£ÂåñÈÜáÂæåË°ÄÊ∏Ö 25(OH)D ÊøÉÂ∫¶ÔºåËÜΩÈà£ÂåñÈÜáÊØîÈ∫•ËßíÈà£ÂåñÈÜáÊõ¥ÊúâÊïàÂú∞Â¢ûÂä†Ë°ÄÊ∏Ö 25(OH)DÔºàË°ÄÊ∏Ö 25[OH]D ÁöÑÂπ≥ÂùáÂ∑ÆÁï∞ÁÇ∫ 6 ng/ÊØ´Âçá [15.</description></item><item><title>Vitamin K deficiency</title><link>https://www.physician.tw/Vitamin-K-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vitamin-K-deficiency/</guid><description>Vitamin K deficiency Etiologies: malnutrition, ‚Üì absorption (antibiotic suppression of vitamin K-producing intestinal flora or malabsorption), liver disease (‚Üì stores), warfarin</description></item><item><title>volume status</title><link>https://www.physician.tw/volume-status/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/volume-status/</guid><description>volume status (JVP, skin turgor, dry axilla, mucous membranes, edema, ascites), effusions, vital signs, orthostatics, BUN/Cr, FEUricAcid, UNa</description></item><item><title>von Willebrand‚Äôs disease vWD</title><link>https://www.physician.tw/von-Willebrands-disease-vWD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/von-Willebrands-disease-vWD/</guid><description>von Willebrand‚Äôs disease (vWD) (NEJM 2016;375:2067)
von Willebrand‚Äôs factor (vWF) function = platelet glue &amp;amp; plasma carrier of factor VIII</description></item><item><title>Washington Manual Thyroid Disorders</title><link>https://www.physician.tw/Washington-Manual-Thyroid-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Washington-Manual-Thyroid-Disorders/</guid><description>Washington Manual Thyroid Disorders Hyperthyroidism4,5 GENERAL PRINCIPLES
Graves‚Äô disease causes most cases of hyperthyroidism, especially in young patients. This autoimmune disorder may also cause proptosis (exophthalmos) and pretibial myxedema, neither of which is found in other causes of hyperthyroidism.</description></item><item><title>WBC of cerebrospinal fluid</title><link>https://www.physician.tw/WBC-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WBC-of-cerebrospinal-fluid/</guid><description>WBC of cerebrospinal fluid Ê≠£Â∏∏ CSF WBC &amp;lt; 5 Ëã• traumatic tappingÔºåÊØè 500‚Äì1500 ÂÄã RBC Ë¶ÅÊ∏õÂéª 1 WBC Ëã• neutrophil ÁÇ∫‰∏ª‰∏äÂçáÔºåÂèØËÉΩÂéüÂõ†ÂåÖÊã¨Ôºöbacteria Ëã• lymphocyte ÁÇ∫‰∏ª‰∏äÂçáÔºåÂèØËÉΩÂéüÂõ†ÂåÖÊã¨Ôºö virus„ÄÅfungus„ÄÅTB„ÄÅmalignancy„ÄÅviral/autoimmune encephalitis [[Lymphocytic pleocytosis]] Ëã• eosinophils ÁÇ∫‰∏ª‰∏äÂçá„ÄÅÂèØËÉΩÂéüÂõ†ÂåÖÊã¨Ôºöparasite„ÄÅÊüê‰∫õÁâπÊÆäÊÑüÊüìÊàñË°ÄÊ∂≤ÁñæÁóÖÁ≠â</description></item><item><title>weakness and neuromuscular dysfunction</title><link>https://www.physician.tw/weakness-and-neuromuscular-dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/weakness-and-neuromuscular-dysfunction/</guid><description/></item><item><title>Weaning from Mechanical Ventilation</title><link>https://www.physician.tw/Weaning-from-Mechanical-Ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Weaning-from-Mechanical-Ventilation/</guid><description>Weaning from Mechanical Ventilation ËÇ∫ÊêçÂÇ∑Á©©ÂÆöÊàñÊ∂àÈÄÄ ÂÖÖÂàÜÁöÑÊ∞£È´î‰∫§ÊèõÔºåÂëºÊ∞£Êú´Ê≠£Â£ì (PEEP) ÂíåÂê∏ÂÖ•Ê∞ßÂàÜÊï∏ (FiO 2 ) Ë¶ÅÊ±Ç‰ΩéÔºà‰æãÂ¶ÇÔºåPEEP &amp;lt; 5‚Äì8 cm H2OÔºåFiO 2 &amp;lt; 0.4‚Äì0.5Ôºâ Ë°ÄÊµÅÂãïÂäõÂ≠∏Á©©ÂÆöÊÄßÔºà‰æãÂ¶ÇÔºå‰∏çÈúÄË¶ÅÂçáÂ£ìÊàñÊñ∑Â•∂Ôºå‰∏¶‰∏îÊ≤íÊúâÂö¥ÈáçÁöÑÂøÉÂæãÂ§±Â∏∏Ôºâ ËÉΩÂ§†ÂïüÂãïÂê∏Ê∞£Âä™ÂäõÁöÑÊÇ£ËÄÖ ‚ú® Â≠∏ÁøíÈáçÈªû ü¶é ‰∏äËø∞Ê®ôÊ∫ñÊáâ‰ΩúÁÇ∫Êñ∑Â•∂ÁØ©Êü•ÊØèÂ§©ÈÄ≤Ë°åË©ï‰º∞„ÄÇÂ∞çÊñºÈÄöÈÅéÊØèÊó•Êñ∑Â•∂ÁØ©Êü•ÁöÑÊÇ£ËÄÖÔºåÈ¶ñÂÖàÈÄ≤Ë°åÂàùÊ≠•ÁöÑÁ∞°Áü≠Ë©¶È©óÊàñÊ∫ñÂÇôÊÉÖÊ≥ÅË©ï‰º∞ÔºåÂú®Ê≠§ÊúüÈñìÂ∞çÊÇ£ËÄÖÈÄ≤Ë°å 1 Ëá≥ 5 ÂàÜÈêòÁöÑÂØÜÂàáËßÄÂØüÔºåÂêåÊôÇÊé•ÂèóÊúÄÂ∞ëÊàñ‰∏çÊé•ÂèóÊîØÊåÅÔºàÊåÅÁ∫åÊ∞£ÈÅìÊ≠£Â£ìÈÄöÊ∞£ [CPAP] ‚â§ 5 cm H 2 O)ÔºåË©ï‰º∞‰ªñÂÄëÈÄ≤Ë°åÊ≠£ÂºèËá™‰∏ªÂëºÂê∏Ë©¶È©ó (SBT) ÁöÑËÉΩÂäõ„ÄÇ Â¶ÇÊûúÊÇ£ËÄÖÂú®Ê∫ñÂÇôÊÉÖÊ≥ÅË©ï‰º∞ÊúüÈñìË°®ÁèæËâØÂ•ΩÔºåÂâáÈÄ≤Ë°åÂ§ßÁ¥Ñ 30 ÂàÜÈêòÁöÑ SBT„ÄÇ Âú®Ê≠§ÊúüÈñìÔºåÂØÜÂàáÁõ£Ê∏¨ÊÇ£ËÄÖÂëºÂê∏ÂäüËÉΩ‰∏çÂÖ®„ÄÅË°ÄÊµÅÂãïÂäõÂ≠∏ÊÉ°Âåñ„ÄÅÊ∞£È´î‰∫§ÊèõÂïèÈ°åÊàñÊÇ£ËÄÖ‰∏çÈÅ©ÁöÑË∑°Ë±°„ÄÇ Â¶ÇÊûúÂá∫ÁèæÂïèÈ°åÔºåÂ∞áÁ´ãÂç≥ÈáçÊñ∞ÂïüÂãïÂÖ®Èù¢ÁöÑÂëºÂê∏Ê©üÊîØÊåÅ„ÄÇ ÊàêÂäüÂÆåÊàê SBT ÂèØÈ´òÂ∫¶È†êÊ∏¨ÊàêÂäüÂÅúÁî®ÂëºÂê∏Ê©ü„ÄÇ</description></item><item><title>What are the most commonly encountered fever patterns</title><link>https://www.physician.tw/What-are-the-most-commonly-encountered-fever-patterns/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/What-are-the-most-commonly-encountered-fever-patterns/</guid><description>What are the most commonly encountered fever patterns Sustained or continued (little variability from day to day): this used to be the pattern of lobar pneumonia , steady until abruptly resolving by either crisis or death.</description></item><item><title>When to suspect migraine</title><link>https://www.physician.tw/When-to-suspect-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/When-to-suspect-migraine/</guid><description>When to suspect migraine Recurrent headache of moderate to severe intensity Visual aura Family history of migraine Onset of symptoms at or around puberty In the third edition of the International Classification of Headache Disorders (ICHD-3), migraine is classified into three main types:</description></item><item><title>When to treat chronic HBV with anti-virals</title><link>https://www.physician.tw/When-to-treat-chronic-HBV-with-anti-virals/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/When-to-treat-chronic-HBV-with-anti-virals/</guid><description>When to treat chronic HBV with anti-virals (1) immune active phase; (2) HBeAg ‚äñ chronic hepatitis B; (3) cirrhosis w/ HBV DNA ‚â•2K; (4) decomp.</description></item><item><title>Whipple‚Äôs disease</title><link>https://www.physician.tw/Whipples-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Whipples-disease/</guid><description>Whipple‚Äôs disease infxn w/ T. whipplei (Lancet 2016;16:13)
Other s/s: fever, LAN, edema, arthritis, CNS Œîs, gray-brown skin pigmentation, AI &amp;amp; MS, oculomasticatory myorhythmia (eye oscillations + mastication muscle contract).</description></item><item><title>Whom to treat-venous thromboembolism</title><link>https://www.physician.tw/Whom-to-treat-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Whom-to-treat-venous-thromboembolism/</guid><description>Whom to treat-venous thromboembolism (JAMA 2020;324:1765; Chest 2021;160:e545)
Superficial venous thrombosis:
elevate extremity, warm compresses, compression stockings, NSAIDs for sx.</description></item><item><title>wide complex</title><link>https://www.physician.tw/wide-complex/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wide-complex/</guid><description>wide complex regular VT or unknown WCT try adenosine
if no response then: [[amiodarone]] or procainamide or sotalol or lidocaine (if VT) &amp;amp; prepare for synch cardioversion</description></item><item><title>wide-complex tachycardias WCTS</title><link>https://www.physician.tw/wide-complex-tachycardias-WCTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wide-complex-tachycardias-WCTS/</guid><description>wide-complex tachycardias (WCTS) [[Etiologies-wide-complex tachycardias (WCTS)]] [[Monomorphic ventricular tachycardia (MMVT)]] [[Polymorphic ventricular tachycardia (PMVT)]] [[Diagnostic clues that favor VT]] [[Long-term management-wide-complex tachycardias (WCTS)]]</description></item><item><title>Wilson disease</title><link>https://www.physician.tw/Wilson-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wilson-disease/</guid><description>Wilson disease (World J Hepatol 2015;7:2859)
Recessive disorder of copper transport (mutation in ATP7B) ‚Üí copper overload
Epidemiology: 1 in ~30,000 w/ age of presentation generally ranging from 3 to 55 y</description></item><item><title>Wolff-Chaikoff effect</title><link>https://www.physician.tw/Wolff-Chaikoff-effect/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wolff-Chaikoff-effect/</guid><description>Wolff-Chaikoff effect Excess iodide transiently inhibits thyroid iodide organification (step 2) In individuals with a normal thyroid, the gland escapes from this inhibitory effect In individuals with underlying autoimmune thyroid disease (Hashimoto&amp;rsquo;s thyroiditis or Graves&amp;rsquo; disease), the suppressive effect may persist</description></item><item><title>woman health</title><link>https://www.physician.tw/woman-health/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/woman-health/</guid><description>woman health Contraception Vaginitis/Sexually Transmitted Infections (STIs)/Pelvic Inflammatory Disease (PID) Polycystic Ovary Syndrome (PCOS) Menstrual and Bleeding Disorders Menopause Preconception Care and Pregnancy Infertility Miscarriage and Abortion</description></item><item><title>Won‚Äôt Breathe as Etiologies of High elevated PaCO2</title><link>https://www.physician.tw/Wont-Breathe-as-Etiologies-of-High-elevated-PaCO2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wont-Breathe-as-Etiologies-of-High-elevated-PaCO2/</guid><description>Won‚Äôt Breathe as Etiologies of High elevated PaCO2 decreae RR Respiratory Drive Voluntary hypervent. NI Pimax &amp;amp; A-a grad Metabolic alkalosis 1¬∞ neurologic: brain- stem stroke, tumor, 1¬∞ alveolar hypovent 2¬∞ neurologic: sedatives, CNS infxn, [[hypothyroidism]]</description></item><item><title>Workup for effusion</title><link>https://www.physician.tw/Workup-for-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-effusion/</guid><description>Workup for effusion r/o infxn: usually apparent from Hx &amp;amp; CXR; ? value of ‚úì acute and convalescent serologies</description></item><item><title>Workup for idiopathic VTE</title><link>https://www.physician.tw/Workup-for-idiopathic-VTE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-idiopathic-VTE/</guid><description>Workup for idiopathic VTE (NEJM 2015;373:697)
Thrombophilia workup ‚úì if ‚äï FH; may be helpful but consider timing as thrombus, heparin and warfarin Œî results Useful for relatives, if dx APLAS (given requires warfarin), or if not planning lifelong anticoagulation for Pt.</description></item><item><title>Workup for non-AG metabolic acidosis</title><link>https://www.physician.tw/Workup-for-non-AG-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-non-AG-metabolic-acidosis/</guid><description>Workup for non-AG metabolic acidosis Evaluate history for causes (see above)
‚úì urine anion gap (UAG) = (UNa + UK) ‚Äì UCl UAG = unmeasured anions ‚Äì unmeasured cations; NH4+ is primary unmeasured cation (represented by UCl).</description></item><item><title>Workup of acute hypoxemia</title><link>https://www.physician.tw/Workup-of-acute-hypoxemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-of-acute-hypoxemia/</guid><description>Workup of acute hypoxemia Cyanosis: when &amp;gt;5 g/dL of deoxygenated Hb in vessels of skin/mucous membranes.
Central: ‚Üì SaO2 (pulm disease, shunt); abnl Hb [metHb, sulfHb, COHb (not true cyanosis)]</description></item><item><title>Workup of chronic diarrhea</title><link>https://www.physician.tw/Workup-of-chronic-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-of-chronic-diarrhea/</guid><description>Workup of chronic diarrhea positive: FOB WBC calprotectin lactoferrin Inflammatory: stool culture, colonoscopy
positive: fecal fat Malabsorption: * Based on hx: ‚úî tissue transglut.</description></item><item><title>Workup-acid-base disturbances</title><link>https://www.physician.tw/Workup-acid-base-disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-acid-base-disturbances/</guid><description>Workup-acid-base disturbances Traditional or physiologic approach (Br√∏nsted-Lowry definition of acids &amp;amp; bases) Determine primary disorder: ‚úì pH, PaCO2, HCO3 Determine if degree of compensation is appropriate [[Compensation-for-Acid-Base-Disorders]] Alternative approaches Base excess/deficit (NEJM 2018;378:1419) ÂèÉËÄÉ‚û°Ô∏è Diagnostic use of base excess in acid‚Äìbase disorders [[Diagnostic Use of Base Excess in Acid‚ÄìBase Disorders]] Strong ion difference or ‚ÄúStewart Method‚Äù (NEJM 2014;371:1821)</description></item><item><title>Workup-acute kidney injury AKI</title><link>https://www.physician.tw/Workup-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-acute-kidney-injury-AKI/</guid><description>Workup-acute kidney injury (AKI) H&amp;amp;P: meds, contrast, or other nephrotoxins; ‚Üì PO intake, HoTN, infxn/sepsis; trauma, myalgias; BPH/retention. Search for insult 24‚Äì48 hr prior ‚Üë Cr.</description></item><item><title>Workup-acute liver failure</title><link>https://www.physician.tw/Workup-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-acute-liver-failure/</guid><description>Workup-acute liver failure (Clin Liver Dis 2017;21:769)
CBC, PT/PTT, LFTs, lytes, BUN/Cr, NH3, pH, arterial lactate, acetaminophen level, HIV, amylase/lipase, viral serologies (qv) in all Pts, with additional labs as below if suspected</description></item><item><title>Workup-cirrhosis</title><link>https://www.physician.tw/Workup-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-cirrhosis/</guid><description>Workup-cirrhosis (Am J Gastro 2017;112:18; Lancet 2021;398:1359)
Abd U/S w/ Doppler: liver size &amp;amp; echotexture, r/o HCC, ascites, ‚úì patency of vasculature</description></item><item><title>Workup-fever in a returned traveler</title><link>https://www.physician.tw/Workup-fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-fever-in-a-returned-traveler/</guid><description>Workup-fever in a returned traveler Routine testing: CBC w/ diff, BMP, LFTs, BCx, UA, rapid malaria test Fever in a traveler from a malaria zone is malaria until proven otherwise; consider a medical emergency ‚Üí hospitalization &amp;amp; empiric Rx.</description></item><item><title>Workup-fever of unknown origin</title><link>https://www.physician.tw/Workup-fever-of-unknown-origin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-fever-of-unknown-origin/</guid><description>Workup-fever of unknown origin Initial: CBC w/ diff, CMP, ESR, CRP, 3 sets BCx (off abx), U/A, UCx, CXR Additional workup based on sx: ANA, RF, cryoglobulin, LDH, CK/aldolase, SPEP, TFTs, PPD or IGRA, HIV Ag/Ab ¬± PCR, RPR, EBV serologies, CMV PCR, HBV/HCV serologies Consider imaging: chest &amp;amp; abd CT, tagged WBC scan, FDG-PET, TTE, LE duplex US Tissue dx: consider bx of LN (excisional preferred), liver (especially if ‚Üë Aœï), TA (for GCA), BM, kidney (RPGN)</description></item><item><title>Workup-for-AG-metabolic-acidosis</title><link>https://www.physician.tw/Workup-for-AG-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-AG-metabolic-acidosis/</guid><description>Workup-for-AG-metabolic-acidosis (AJKD 2021;78:A16)
‚úì for ketonuria (dipstick acetoacetate) or plasma Œ≤-hydroxybutyrate (Œ≤OHB) nb, urine acetoacetate often not present in early ketoacidosis due to shunting to Œ≤OHB; ‚à¥ acetoacetate may later turn ‚äï but does not signify worsening disease If ‚äñ ketones, ‚úì renal function, lactate, toxin screen, and [[Serum osmolal gap]] If obtunded or ‚Üë‚Üë AG, check osmolal gap (OG) = measured osmoles ‚Äì calculated osmoles Calculated osmoles = (2 √ó Na) + (glucose/18) + (BUN/2.</description></item><item><title>Workup-glomerulonephritis</title><link>https://www.physician.tw/Workup-glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-glomerulonephritis/</guid><description>Workup-glomerulonephritis (JAMA 2017;318:1276)
Acute GN/RPGN ¬± lung hemorrhage is an emergency ‚Üí requires early Dx and Rx
UA + sediment (dysmorphic RBCs) ‚úì ANCA, anti-GBM, C3/C4, SPEP, serum FLC</description></item><item><title>Workup-hyperkalemia</title><link>https://www.physician.tw/Workup-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-hyperkalemia/</guid><description>Workup-hyperkalemia (Crit Care Med 2008;36:3246)
Rule out pseudohyperkalemia (IVF w/ K, tourniquet, hemolysis, ‚Üë plt or WBC), rule out transcellular shift</description></item><item><title>Workup-hypernatremia</title><link>https://www.physician.tw/Workup-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-hypernatremia/</guid><description>Workup-hypernatremia ‚úì Uosm, UNa, volume status (vital signs, orthostatics, JVP, skin turgor, BUN, Cr)</description></item><item><title>Workup-hypokalemia</title><link>https://www.physician.tw/Workup-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-hypokalemia/</guid><description>Workup-hypokalemia (JAMA 2021;12:1216)
Identify transcellular shifts &amp;amp; treat. TTKG validity questioned (Curr Op Nephro 2011;20:547).
‚úì UK:Cr: &amp;gt;13 mEq/g ‚Üí renal loss; &amp;lt;13 mEq/g ‚Üí extrarenal loss (AJKD 2019;74:682)</description></item><item><title>workup-hyponatremia</title><link>https://www.physician.tw/workup-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/workup-hyponatremia/</guid><description>workup-hyponatremia (JASN 2012;23:1140 &amp;amp; 2017;28:1340; Crit Care 2013;17:206; NEJM 2015;372:55)
Workup History: acute vs. chronic (&amp;gt;48 h); sx severity; risk for neuro complications (alcoholism, malnourished, cirrhosis, older women on thiazides, hypoxia, hypoK) [[Measure plasma osmolality]] For hypotonic hyponatremia, ‚úì [[volume status]] [[Measure Uosm]] If euvolemic and ‚Üë Uosm, evaluate for glucocorticoid insufficiency and hypothyroidism If available, consider FEUricAcid as &amp;gt;12% suggests SIADH (J Clinc Endo 2008;93:2991) BacklinkÔºö [[sodium and water homeostasis]]</description></item><item><title>Workup-nephrolithiasis</title><link>https://www.physician.tw/Workup-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-nephrolithiasis/</guid><description>Workup-nephrolithiasis Non-contrast CT 97% Se, 96% Sp (ureteral dilation w/o stone suggests recent passage); U/S (Se 57%, Sp 98%) may serve as initial test in stable patient (NEJM 2014;371:1100)</description></item><item><title>Workup-nephrotic syndrome</title><link>https://www.physician.tw/Workup-nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-nephrotic-syndrome/</guid><description>Workup-nephrotic syndrome (BMJ 2008;336:1185)
U/A + sediment: usually benign; ¬± oval fat bodies (‚ÄúMaltese crosses‚Äù; NEJM 2007;357:806)
Measure proteinuria: 24-h urine or spot urine protein/Cr ratio (not accurate in AKI), renal bx</description></item><item><title>Workup-of-hematuria</title><link>https://www.physician.tw/Workup-of-hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-of-hematuria/</guid><description>Workup-of-hematuria (NEJM 2021;385:153)
Urine dipstick: ‚äï if ‚â•3 RBCs; ‚äï dipstick and ‚äñ sediment ‚Üí myo- or hemoglobinuria</description></item><item><title>Workup-syncope</title><link>https://www.physician.tw/Workup-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-syncope/</guid><description>Workup-syncope (etiology cannot be determined in ~40% of cases) (JAMA 2019;321:2448)
H&amp;amp;P incl. orthostatic VS have highest yield and most cost effective R/o life-threatening dx including: cardiac syncope, severe blood loss, PE, SAH History (from Pt and witnesses if available) activity and posture before the incident precipitating factors: exertion (AS, HCMP, PHT), positional ‚àÜ (orthostatic HoTN), stressors such as sight of blood, pain, emotional distress, fatigue, prolonged standing, warm environment, N/V, cough/deglutition/micturition/defecation (neurocardiogenic), head turning or shaving (carotid sinus hypersens.</description></item><item><title>wowoowow</title><link>https://www.physician.tw/wowoowow/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wowoowow/</guid><description>wowoowow Thromboembolism is a book of writing is therefore is a book of BacklinkÔºö [[ÈÄôË£°‰∏ªË¶ÅÂ∞±ÊòØ‰∏Ä‰∫õÂØ¶È©óÁöÑÂÖßÂÆπ]]</description></item><item><title>YPM0hbw1azf qwq2fpw</title><link>https://www.physician.tw/YPM0hbw1azf-qwq2fpw/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/YPM0hbw1azf-qwq2fpw/</guid><description/></item><item><title>zettle</title><link>https://www.physician.tw/zettle/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zettle/</guid><description>zettle</description></item><item><title>Zygomycetes</title><link>https://www.physician.tw/Zygomycetes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Zygomycetes/</guid><description>Zygomycetes Epidemiology: diabetes (espec. those w/ prior DKA), heme malignancy, neutropenia, transplant, chronic steroids, iron overload, trauma, h/o voriconazole Rx or Ppx Clinical: rhinocerebral = severe periorbital/facial pain, swelling, vision changes, sinusitis, opthalmoplegia, nasal ulcerations/ necrosis, HA.</description></item><item><title>Œ±1-antitrypsin deficiency</title><link>https://www.physician.tw/%CE%B11-antitrypsin-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B11-antitrypsin-deficiency/</guid><description>Œ±1-antitrypsin deficiency early-onset panacinar emphysema or signif basilar disease,
1‚Äì3% of COPD cases. Suspect if age &amp;lt;45,
lower lungs affected,</description></item><item><title>Œ±1-antitrypsin deficiency Œ±1-AT</title><link>https://www.physician.tw/%CE%B11-antitrypsin-deficiency-%CE%B11-AT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B11-antitrypsin-deficiency-%CE%B11-AT/</guid><description>Œ±1-antitrypsin deficiency (Œ±1-AT) (J Hepatol 2016;65:413; NEJM 2020;382:1443)
Abnl Œ±1-AT ‚Üí polymerization in liver (cirrhosis) &amp;amp; uninhibited protease activity in lung (emphysema).</description></item><item><title>Œ≤-blocker</title><link>https://www.physician.tw/%CE%B2-blocker/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B2-blocker/</guid><description>Œ≤-blocker (data for carvedilol, metoprolol, bisoprolol)
Add in concert w/ RASi
35% ‚Üì mort. &amp;amp; 40% ‚Üì rehosp. in NYHA II‚ÄìIV (JAMA 2002;287:883)</description></item><item><title>ÂÖ∂‰ªñÁßë</title><link>https://www.physician.tw/diary/%E5%85%B6%E4%BB%96%E7%A7%91/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diary/%E5%85%B6%E4%BB%96%E7%A7%91/</guid><description>ÂÖ∂‰ªñÁßë</description></item><item><title>ÂÖ∂‰ªñÁßë</title><link>https://www.physician.tw/%E5%85%B6%E4%BB%96%E7%A7%91/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%85%B6%E4%BB%96%E7%A7%91/</guid><description>ÂÖ∂‰ªñÁßë</description></item><item><title>ÂØ∂ÁõäÂÖíÂ§öÁ®ÆÁ∂≠‰ªñÂëΩ</title><link>https://www.physician.tw/%E5%AF%B6%E7%9B%8A%E5%85%92%E5%A4%9A%E7%A8%AE%E7%B6%AD%E4%BB%96%E5%91%BD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%AF%B6%E7%9B%8A%E5%85%92%E5%A4%9A%E7%A8%AE%E7%B6%AD%E4%BB%96%E5%91%BD/</guid><description>ÂØ∂ÁõäÂÖíÂ§öÁ®ÆÁ∂≠‰ªñÂëΩ ÂØ∂ÁõäÂÖíÂ∞èÂÖíÊª¥ÂäëÔºåÊØèÊó•1ccÁÇ∫ÂØ∂ÂØ∂ÁöÑÂÅ•Â∫∑Âä†ÂàÜÔºÅ ÂÖ®Êñ∞ÁöÑÁ∂úÂêàÈÖçÊñπÔºàÂê´Á∂≠‰ªñÂëΩD3 400IU)‰∏ÄÊ¨°Âà∞‰ΩçÊèê‰æõÂØ∂ÂØ∂ÈúÄË¶ÅÁöÑÂêÑÁ®ÆÁáüÈ§äÁ¥†„ÄÇ
È£üÁî®ÊñπÂºè(Áî®Ê≥ïÁî®Èáè) : 3 Ê≠≤‰ª•‰∏ãÊØèÊó•1ccÔºå4-12 Ê≠≤ÊØèÊó•1.5ccÔºå 13 Ê≠≤‰ª•‰∏äÊØèÊó•2ccÔºåËÄÅÂπ¥‰∫∫ÊØèÊó•2-3cc„ÄÇ Ë´ãÁî®Âê∏ÁÆ°ÊåâÂ£ìÂê∏ÂèñËá≥ÂàªÂ∫¶1ÁÇ∫1cc„ÄÇÂèØÁõ¥Êé•È§µÈ£üÊñºÂè£ÂÖßÊàñÊ∑ªÂä†ÊñºÈñãÊ∞¥„ÄÅÁâõÂ•∂„ÄÅÊûúÊ±Å‰∏≠È£≤Áî®„ÄÇ</description></item><item><title>Â∏∏Ë¶ã‰∏ªË®¥ÁöÑapporach</title><link>https://www.physician.tw/symptom-to-diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/symptom-to-diagnosis/</guid><description>Â∏∏Ë¶ã‰∏ªË®¥ÁöÑapporach ÈÄôÊòØ‰∏ÄÂÄãÂæàÂ•ΩÁöÑÊÄùËÄÉÁ∑¥ÂçÄ [[sxtodx]]
[[diagnostic process]] [[screening and health maintenance]] [[abdominal pain]] [[acid-base abnormalities]] [[AIDS HIV infection]] [[anemia]] [[back pain]] [[bleeding disorders]] [[chest pain]] [[cough, fever, and respiratory infections]] [[delirium and dementia]] [[Diabetes key clinical trials]] [[diarrhea, acute]] [[dizziness]] [[dyspnea]] [[dysuria]] [[edema]] [[fatigue]] [[gi bleeding]] [[headache]] [[hematuria]] [[hypercalcemia]] [[hypertension]] [[hyponatremia and hypernatremia]] [[hypotension]] [[jaundice and abnormal liver enzymes]] [[joint pain]] [[acute kidney injury]] [[rash]] [[sore throat]] [[syncope]] [[unintentional weight loss]] [[wheezing and stridor]]</description></item><item><title>Ë≤ºÁâá</title><link>https://www.physician.tw/%E8%B2%BC%E7%89%87/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E8%B2%BC%E7%89%87/</guid><description>Ë≤ºÁâá ÈñãÊ©üÂ∞±ËΩâÂà∞ÈõªÊìäÊ®°Âºè Á¥ÖÂøÉ(ÂÖ∂ÂØ¶ÊòØËÖ≥)</description></item></channel></rss>